<SEC-DOCUMENT>0001437749-13-003092.txt : 20130318
<SEC-HEADER>0001437749-13-003092.hdr.sgml : 20130318
<ACCEPTANCE-DATETIME>20130318100947
ACCESSION NUMBER:		0001437749-13-003092
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20121231
FILED AS OF DATE:		20130318
DATE AS OF CHANGE:		20130318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52091
		FILM NUMBER:		13696324

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>geovax_10k-123112.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<html>
<head>
    <title>geovax_10k-123112.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.3.1-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Washington, D.C. 20549</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 10-K</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline;" face="Wingdings 2, serif">R</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>SECURITIES EXCHANGE ACT OF 1934.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>For fiscal year ended December 31, 2012</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline;" face="Wingdings 2, serif">&#163;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Commission File No. 000-52091</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of Registrant as specified in its charter)</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: center; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: center;">
<td valign="top" width="45%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">incorporation or organization)</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1900 Lake Park Drive, Suite 380</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -14.4pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Smyrna, GA</font></div>
</td>
<td valign="top" width="38%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">87-0455038</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(IRS Employer</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification Number)</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">30080</font></div>
</td>
</tr><tr>
<td valign="top" width="45%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>
</td>
<td valign="top" width="38%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Zip Code)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(678) 384-7220</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Registrant&#8217;s telephone number, including area code:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Securities registered pursuant to Section 12(b) of the Act:</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">None</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Securities registered pursuant to Section 12(g) of the Act:</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock $.001 par value</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Title of class)</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;&#160;Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&#167; 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.&#160;&#160;See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Large accelerated filer <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accelerated filer <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-accelerated filer <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Smaller reporting company<font id="TAB1" style="MARGIN-LEFT: 12pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">&#163;</font>&#160;&#160;No <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold" face="Wingdings 2, serif">R</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The aggregate market value of Common Stock held by non-affiliates of the registrant on June 30, 2012, based on the closing price on that date was $10,176,944.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Number of shares of Common Stock outstanding as of March 15, 2013: 20,499,944.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">DOCUMENTS INCORPORATED BY REFERENCE</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Portions of the registrant&#8217;s definitive Proxy Statement with respect to its 2013 Annual Meeting of Stockholders are incorporated by reference in Part III</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%">&#160;</div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="100%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Table of Contents</font></font></div>
</td>
</tr><tr>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td colspan="3" valign="top" width="100%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">PART I</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 1</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Business</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 1A</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Risk Factors</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 1B</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unresolved Staff Comments</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 2</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Properties</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 3</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Legal Proceedings</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 4</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mine Safety Disclosures</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td colspan="3" valign="top" width="100%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">PART II</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 5</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuer Purchases of Equity Securities</font></div>
</div>
</td>
<td valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" colspan="2" valign="top" width="91%">&#160;</td>
<td valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 6</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Selected Financial Data</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 7</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 7A</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quantitative and Qualitative Disclosures about Market Risk</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 8</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statements and Supplementary Data</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 9</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 9A</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Controls and Procedures</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 9B</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other Information</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td colspan="3" valign="top" width="100%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">PART III</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 10</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Directors, Executive Officers and Corporate Governance</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 11</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Executive Compensation</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 12</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Security Ownership of Certain Beneficial Owners and Management and </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Related Stockholder Matters</font></font></div>
</div>
</td>
<td valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font></font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" colspan="2" valign="top" width="91%">&#160;</td>
<td valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 13</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certain Relationships and Related Party Transactions, and Director Independence</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 14</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Principal Accountant Fees and Services</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td colspan="3" valign="top" width="100%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">PART IV</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Item 15</font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibits and Financial Statement Schedules</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" colspan="2" valign="top" width="6%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Signatures</font></font></font></div>
</div>
</td>
<td valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34</font></font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" colspan="2" valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibit Index</font></font></td>
<td valign="top" width="9%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></font></div>
</td>
</tr></table>
</div>

<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br>
</font><br>
<div id="PGBRK" style="TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ii</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8220;SAFE HARBOR&#8221; STATEMENT</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">From time to time, we make oral and written statements that constitute &#8220;forward-looking statements&#8221; (rather than historical facts).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">All statements in this Annual Report that are not statements of historical fact are forward-looking statements, including any projections of financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or financial performance, any statements regarding action by the FDA or other regulatory authorities, and any statement of assumptions underlying any of the foregoing.&#160;&#160;In some cases, forward-looking statements can be identified by the use of terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;potential&#8221; or &#8220;could&#8221; or the negative thereof or other comparable terminology.&#160;&#160;Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations or any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or assumed in the forward-looking statements.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, including but not limited to the risk factors set forth under the heading &#8220;Risk Factors&#8221; in this Annual Report, and including risks or uncertainties regarding the clinical testing required by regulatory authorities for products under development; the need for future clinical testing of our products under development; the significant time and expense that will be incurred in developing any of the potential commercial applications for our products; the possibility that our products may not demonstrate adequate clinical performance or obtain market acceptance, our ability to obtain capital to fund our current and future operations; and risks relating to the enforceability of any patents covering our products and to the possible infringement of third party patents by those products.&#160;&#160;All forward-looking statements included in this Annual Report are made as of the date hereof, and we assume no obligation to update them.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PART I</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">BUSINESS</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Company Overview</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax, Labs, Inc. was formed in 2001 and is a biotechnology company developing vaccines that prevent and fight human immunodeficiency virus (HIV).&#160;&#160;HIV infections result in acquired immunodeficiency syndrome (AIDs).&#160;&#160;We are incorporated in Delaware, and our offices and laboratory facilities are located in<font style="DISPLAY: inline; FONT-WEIGHT: bold"> S</font>myrna, Georgia (metropolitan Atlanta).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccines are being evaluated to determine their potential to (a) prevent HIV infection and (b) to serve as a treatment for individuals who are already infected with HIV.&#160;&#160;These vaccines are currently being evaluated in human clinical trials.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our most advanced vaccines under development are designed to function against the clade B subtype of the HIV virus that is prevalent in the Americas and western Europe.&#160;&#160;An estimated 3.3 million people are infected with clade B HIV virus worldwide, with 130,000 new infections each year (between 55,000 and 58,000 in the United States).&#160;&#160;The cost of treating HIV-infected individuals in the U.S. is estimated at $500,000 for each infected individual over their lifetime.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subject to the availability of funding support from governmental or nongovernmental organizations, we also plan to develop vaccines designed for use to combat the subtypes of HIV that predominate in the developing countries.&#160;&#160;We have licensed from the U.S. National Institutes of Health (NIH) the modified vaccinia Ankara&#160;(MVA) construct for the clade C version of HIV prevalent in South Africa and India, and have begun early development work a vaccine for this subtype of the virus.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Work on our vaccines began during the 1990s at Emory University in Atlanta, Georgia, under the direction of Dr. Harriet L. Robinson, who is now our Chief Scientific Officer. Our vaccine technology was developed in collaboration with researchers at Emory University, the NIH, and the U.S. Centers for Disease Control and Prevention (CDC). The technology developed by the collaboration is exclusively licensed to us from Emory University. We also have nonexclusive licenses to certain patents owned by the NIH and exclusive license rights to certain manufacturing process patents of MFD, Inc.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Vaccine Pipeline</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes key information regarding our vaccine candidates:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Vaccine</font></div>
</td>
<td align="left" valign="top" width="27%">&#160;</td>
<td valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Clinical</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Candidate</font></font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Indication</font></font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Stage of Development</font></font></div>
</td>
<td align="left" valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Trial Sponsor</font></font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Clade B Vaccines (Americas, Western Europe)</font></font></div>
</td>
<td valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="31%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA/MVA</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prevention</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical &#8211; Phase 2a completed</font></div>
</td>
<td align="left" valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH/HVTN</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="31%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA-G/MVA</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prevention (2nd generation)</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical &#8211; Phase 1</font></div>
</td>
<td align="left" valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH/HVTN</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="31%">&#160;</td>
<td align="left" valign="top" width="27%">&#160;</td>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Planning &#8211; Phase 2 efficacy</font></font></div>
</td>
<td valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH/HVTN</font></font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="31%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA/MVA</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Therapeutic (treatment interruption)</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical &#8211; Phase 1/2</font></div>
</td>
<td align="left" valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">GeoVax</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="31%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA-G/MVA</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Therapeutic (drug combo)</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Planning &#8211; Phase 1</font></div>
</td>
<td align="left" valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH/IMPAACT</font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="31%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Clade C Vaccines (South Africa, India)</font></font></div>
</td>
<td valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="27%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="31%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA-G/MVA</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prevention</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research/Preclinical</font></div>
</td>
<td align="left" valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">n/a</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="31%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA-G/MVA</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Therapeutic</font></div>
</td>
<td align="left" valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research/Preclinical</font></div>
</td>
<td align="left" valign="top" width="15%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">n/a</font></div>
</td>
</tr></table>
</div>

<br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our clade B preventive vaccines are being tested in humans by the HIV Vaccine Trials Network (HVTN) and are funded by the NIH. The first generation of our preventive vaccine is one of only 5 vaccine candidates out of more than 90 tested by the HVTN to have successfully progressed to Phase 2 clinical testing.&#160;&#160;In Phase 1 human trials in uninfected people (150 total participants), our vaccines showed excellent safety and induced both anti-viral antibodies and anti-viral T cells.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A 300 participant Phase 2a clinical trial of our preventive vaccine (HVTN 205) further tested safety and immunogenicity of the two most promising regimens evaluated in Phase 1:&#160;&#160;(1) Priming with DNA at months 0 and 2 and boosting with MVA at months 4 and 6 (DDMM regimen) and (2) priming and boosting with MVA at months 0, 2 and 6 (MMM regimen).&#160;&#160;The HVTN 205 trial was completed in 2012 and was the subject of an oral presentation at the <font style="FONT-STYLE: italic; DISPLAY: inline">AIDS Vaccine 2012 Conference</font> in September 2012. The Phase 2a trial confirmed the Phase 1 results, setting the stage for Phase 2 efficacy trials. We expect formal publication of the full study results by the end of 2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The NIH and HVTN are also sponsoring and conducting a Phase 1 clinical trial of a new version of our preventive vaccine. GeoVax&#8217;s second-generation vaccines include the use of an adjuvant together with our DNA/MVA vaccine.&#160;&#160;Adjuvants are additives to vaccines that improve vaccine efficacy.&#160;&#160;One of these, granulocyte-macrophage colony-stimulating factor (GM-CSF), a normal human protein that stimulates the first stages of immune responses, has shown particular promise.&#160;&#160;When GM-CSF is co-expressed in our DNA priming vaccine, with a subsequent boost with our MVA vaccine, the vaccine achieved 70% prevention of infection with a &gt;90% reduction in the per exposure risk of transmission in a study employing 12 successive weekly exposures to simian immunodeficiency virus (<font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases 204:164 (2011))</font>. The 48-participant Phase 1 trial is fully enrolled and we expect it to be completed in late 2013.&#160;&#160;Pending successful outcome of this trial, we expect to carry forward this version of our preventive vaccine into Phase 2 efficacy testing.&#160;&#160;We have begun discussions about protocol development and funding for the Phase 2 trial with potential government sponsors.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our therapeutic vaccine is currently in a pilot Phase 1/2 clinical trial in HIV-positive individuals who are on standard-of-care drug therapy with well-controlled infections.&#160;&#160;Through a &#8220;treatment interruption&#8221; protocol, this 9-participant trial is investigating the concept of removing patients from drug therapy following inoculation with our vaccine to evaluate how well our vaccine may stimulate the patient&#8217;s own immune system to successfully control their infection.&#160;&#160;We have completed patient enrollment of this study and expect to begin generating data in late 2013, which might indicate the potential use of our vaccines to treat HIV infection, either as a standalone therapy or in conjunction with an oral drug regimen.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are also planning a Phase 1 clinical trial to investigate the use of our therapeutic vaccine in combination with standard-of-care drug therapy in young adults.&#160;&#160;We expect this trial to be conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trial Group (IMPAACT) with financial support from the NIH.&#160;&#160;The NIH has recently prioritized searching for a cure for those individuals who are HIV positive. Because of the mechanisms by which current oral drugs work, if the virus is in a latent phase these drugs are not effective, thus it is impossible to totally eradicate the virus. Current approaches to a cure include using an effective vaccine and oral medication together to more effectively eradicate the virus. This trial has been assigned a clinical study number (P-1082) and we expect that this study will commence in mid-2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Background &#8211; Viruses and Vaccines</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What are Viruses?</font>&#160;&#160;Viruses are microscopic organisms consisting of genetic material comprised of deoxyribonucleic acid (&#8220;DNA&#8221;) or ribonucleic acid (&#8220;RNA&#8221;), surrounded by a protein, lipid (fat), or glycoprotein coat. Viruses invade healthy, living host cells in order to replicate and spread. In many cases, the body&#8217;s immune system can recognize and effectively combat an infection caused by a virus. However, with certain viral infections, the body&#8217;s immune system is unable to fully destroy or inhibit the replication of the virus, which results in persistent and ongoing viral replication resulting in disease.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Infections caused by viruses can be chronic or acute. Chronic infections, such as those caused by HIV, do not typically self-resolve with time and can cause chronic disease. Acute infections associated with viruses, such as influenza, generally last for a relatively short period of time, and self-resolve in most immuno-competent individuals.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Viruses can also be characterized as either active or latent. An active virus can cause a persistent infection or disease over an extended period of time. A latent virus will remain in the body for very long periods of time after the initial infection and generally will only cause disease when the body&#8217;s immune system weakens, fails or is suppressed, allowing the virus to once again replicate. Vaccines have been widely used to prevent active viral infections from occurring.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Viruses that develop resistance to antiviral drugs are increasingly becoming a challenge in the treatment of viral infections, particularly those that are chronic in nature. The ability of viruses to mutate spontaneously during replication allows drug-resistant strains to emerge when patients are using drugs that are not potent enough to quickly and completely inhibit viral replication. Drug resistance occurs because viruses continually replicate making millions of copies of themselves, some of which contain mutations in their genetic material. Mutations that emerge in the presence of a suppressive antiviral drug will give rise to mutant strains that are wholly or partially resistant to that drug. These mutant viruses, while initially low in number, eventually become the predominant strain in an infected patient as those strains that remain susceptible to the drug are inhibited from replicating. Once this occurs, the treatment benefit of that particular antiviral drug often diminishes, resulting in treatment failure and the need for an alternate therapy with different or possibly new drugs, or classes of drugs. In general, viruses that cause chronic infections, such as HIV, are more likely to develop drug resistance due to the long-term and persistent exposure of the virus to the antiviral therapy.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What are Vaccines?</font>&#160;&#160;Vaccines represent an approach to broaden the ability to prevent serious infectious diseases caused by both viruses and bacteria.&#160;&#160;A vaccine is a substance introduced into the human body that teaches the immune system to detect and destroy a pathogen (a virus or bacterium that causes disease). All vaccines contain some harmless form or part of the pathogen they target. They exert their effects through the adaptive immune response, an arm of the immune system that learns to recognize and neutralize specific pathogens.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are several types of vaccines:</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Whole-killed/Whole-inactivated vaccines</font>: The active ingredient in these vaccines is an intact virus or bacterium that has been killed or otherwise stripped of its ability to infect humans. Examples include the cholera and injectable polio vaccines. This approach has not been applied to the development of vaccines against HIV due to the small but inevitable risk that the viruses harvested for such preparations may not all have been killed or adequately inactivated.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Live attenuated vaccines</font>:&#160; These vaccines use a form of the targeted pathogen that is highly unlikely to be harmful&#8212;one capable, say, of multiplying, but not causing disease. Examples include the measles vaccine and the oral vaccine against polio, which has been widely deployed in global eradication efforts. Such vaccines can be very effective because they closely mimic the behavior of the targeted pathogen, giving the immune system a truer picture of what it would be up against. Due to the risk that attenuated HIV might revert to its disease-causing form, this approach has not been applied to the development of human AIDS vaccines.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Subunit vaccines:</font> Vaccines of this variety are composed of purified pieces of the pathogen (known as antigens) that generate a vigorous, protective immune response. Common subunit vaccines include the seasonal flu and hepatitis B vaccines. This approach was employed to devise the first AIDS vaccine candidate tested in humans, which failed to induce protection from HIV infection.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">DNA vaccines</font>: These vaccine candidates are also designed to train the immune system to recognize a piece of the targeted bacterium or virus. The difference is that the active ingredients are not the purified antigens themselves but circles of DNA, called plasmids, that carry genes encoding those antigens. Human cells passively take up these plasmids and produce the antigens that, in turn, train the immune system to recognize the targeted pathogen.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Recombinant vector vaccines</font>: These vaccines, like DNA vaccines, introduce genes for targeted antigens into the body. But the genes are inserted into a virus that actively infects human cells. The viruses chosen as vectors are safe to use because they do not ordinarily cause disease in humans and/or have been stripped of their ability to proliferate.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview of HIV/AIDS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What is HIV? </font>HIV is a retrovirus that carries its genetic code in the form of ribonucleic acid, or RNA. Retroviruses use RNA and the reverse transcriptase enzyme to create DNA from the RNA template. The HIV-1 virus invades human cells and produces its viral DNA that is subsequently inserted into the chromosomes, which are the genetic material of a cell. HIV preferentially infects and replicates in T-cells, which are a type of white blood cell. Infection of T-cells alters them from immunity mediating cells to cells that produce and release HIV. This process results in the destruction of the immune defense system of infected individuals and ultimately, the development of AIDS.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are several AIDS-causing HIV virus subtypes, or clades, that are found in different regions of the world. These clades are identified as clade A, clade B and so on. The predominant clade found in Europe, North America, parts of South America, Japan and Australia is clade B whereas the predominant clades in Africa are clades A and C. In India the predominant clade is clade C. Each clade differs by at least 20% with respect to its genetic sequence from other clades. These differences may mean that vaccines or treatments developed against HIV of one clade may only be partially effective or ineffective against HIV of other clades. Thus there is often a geographical focus to designing and developing vaccines suited for the local clade.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">HIV, even within clades, has a high rate of mutation that supports a significant level of genetic variation. In drug treatment programs, virus mutation can result in the development of drug resistance, referred to as virus drug escape, thereby rendering drug therapy ineffective. Hence, we believe that multi-drug therapy is very important. If several drugs are active against virus replication, the virus must undergo multiple simultaneous mutations to escape, which is less likely. The same is true for immune responses. HIV can escape single targeted immune responses. However, our scientists believe if an immune response is directed against multiple targets, which are referred to as epitopes, virus escape is much less frequent. Vaccination against more than one of the proteins found in HIV increases the number of targets for the immune response as well as the chance that HIV will not escape the vaccine-stimulated immune response, thus resulting in protection against infection or the development of clinical AIDS once infection occurs.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">What is AIDS?</font> AIDS is the final, life-threatening stage of infection with the virus known as HIV. Infection with HIV severely damages the immune system, the body&#8217;s defense against disease. HIV infects and gradually destroys T-cells and macrophages, which are white blood cells that play key roles in protecting humans against infectious disease caused by viruses, bacteria, fungi and other micro-organisms.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Opportunistic infections by organisms, normally posing no problem for control by a healthy immune system, can ravage persons with immune systems damaged by HIV infections. Destruction of the immune system occurs over years. The average onset of the clinical disease recognized as AIDS occurs after three to ten years of HIV infection if the virus is not treated effectively with drugs, but the time to developing AIDS is highly variable.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AIDS in humans was first identified in the United States in 1981, but researchers believe that it was present in Central Africa as early as 1959. AIDS is most often transmitted sexually from one person to another but it is also transmitted by blood in shared needles and through pregnancy and childbirth. Heterosexual activity is the most frequent route of transmission worldwide.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The level of virus in blood, known as viral load, is the best indicator of the speed with which an individual will progress to AIDS and the frequency with which an individual will spread infection. An estimated 1% or fewer of those infected have low enough levels of the virus to preclude progression to AIDS and to not transmit the infection. These individuals are commonly called elite controllers or long-term non-progressors.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AIDS is considered by many in the scientific and medical community to be the most lethal infectious disease in the world. According to the 2011 World AIDS Day Report published by UNAIDS, the Joint United Nations Programme on HIV/AIDS, at the end of 2010, an estimated 34 million people were living with HIV worldwide, with approximately 2.7&#160;million newly infected in 2010 alone. Approximately 25&#160;million people infected with HIV have died since the 1981 start of the HIV pandemic. The United States currently suffers about 56,000 infections per year.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At present, the standard approach to treating HIV infection is to inhibit viral replication through the use of combinations of drugs. Available drugs include reverse transcriptase inhibitors, protease inhibitors, integration inhibitors and inhibitors of cell entry to block multiple essential steps in virus replication. However, HIV is prone to genetic changes that can produce strains that are resistant to currently approved drugs. When HIV acquires resistance to one drug within a class, it can often become resistant to the entire class, meaning that it may be impossible to re-establish control of a genetically altered strain by substituting different drugs in the same class. Furthermore, these treatments continue to have significant limitations which include toxicity, patient non-adherence to the treatment regimens and cost. As a result, over time, many patients develop intolerance to these medications or simply give up taking the medications due to the side effects.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">According to the International AIDS Vaccine Initiative (IAVI), the cost and complexity of new treatment advances for AIDS puts them out of reach for most people in the countries where treatment is most needed, and as noted above, in industrialized nations, where drugs are more readily available, side effects and increased rates of viral resistance have raised concerns about their long term use. AIDS vaccines, therefore, are seen by many as the most promising way to end the HIV/AIDS pandemic. It is expected that vaccines for HIV/AIDS, once developed, will be used universally and administered worldwide by organizations that provide health care services, including hospitals, medical clinics, the military, prisons and schools.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Vaccine Candidates</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccines, initially developed by our Chief Scientific Officer, Dr. Harriet L. Robinson at Emory University in collaboration with scientists at the NIH and the CDC, incorporate two vaccine delivery components: (1) a recombinant DNA (deoxyribonucleic acid) and (2) a recombinant poxvirus, known as MVA (modified vaccinia Ankara), both of which deliver genes that encode inactivated HIV derived proteins to the immune system. Both the DNA and MVA vaccines contain sufficient HIV genes to support the production of non-infectious virus-like particles which display the native trimeric membrane-bound form of the viral envelope glycoprotein that appears authentic to the immune system. When used together, the recombinant DNA component is used to prime the immune response, which is then boosted by administration of the recombinant MVA component. However, in certain settings the recombinant MVA alone may be sufficient for priming and boosting the immune responses.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our initial work focused on the development of a preventive vaccine for use in uninfected humans to prevent infection should they be exposed to the virus. Later, based on encouraging data in preclinical primate models, we undertook the development of a therapeutic vaccine for use in HIV infected humans to supplement approved drug regimens. For both preventive and therapeutic applications, our primary focus is on a vaccine for use against clade B, which is common in the United States and the industrially developed world. However, if efficacy is documented against clade B, we plan to develop vaccines designed for use to combat the subtypes of HIV that predominate in developing countries, including clades A, C and an AG recombinant.<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>We have licensed from the NIH the MVA construct for the clade C version of HIV prevalent in South Africa and India, and have begun early development work on a vaccine for this subtype of the virus.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Induction of T-cell and Antibody Immune Responses. </font>In both preclinical and clinical trials, our vaccines induce both anti-viral antibody and T-cell responses. The induction of both antibodies and T-cells is beneficial because these immune responses work through different mechanisms. Antibodies can prevent infection by blocking viruses from infecting cells.&#160;&#160;In preclinical vaccine studies using repeated rectal challenges with moderate doses of virus, the avidity, or tightness, of antibody binding to the surface envelope glycoprotein of HIV correlates with the prevention of infection (<font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases, </font>204:164 (2011)).&#160;&#160;In high dose challenges that infect all animals at the first exposure, the avidity of the antibody for envelope glycoprotein correlates with reduced levels of virus replication (<font style="FONT-STYLE: italic; DISPLAY: inline">Journal of Virology</font>, 83:4102 (2009)).&#160;&#160;These results likely reflect the tightly binding antibody both blocking infection as well as tagging the virus and infected cells for destruction.&#160;&#160;Our vaccines elicit CD8 T-cells, a type of T-cell that can recognize and kill cells that become infected by virus. CD8 T-cells are important for the control of the virus that has established an infection.&#160;&#160;In our therapeutic vaccinations, our vaccines elicit high frequencies of CD8 T-cells with the functional characteristics of CD8 T-cells associated with control of viral infections in individuals termed &#8220;elite controllers&#8221;.&#160;&#160;Elite controllers, who constitute less than 1% of all HIV-infected individuals, enjoy years of disease-free life without the use of drugs.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">DNA and MVA as Vaccine Vectors. </font>Both the DNA and MVA vaccines produce virus-like particles containing the three major proteins of HIV.&#160;&#160;The virus-like particles cannot cause disease because they were designed with mutated or deleted enzymatic functions that are essential for virus replication.&#160;&#160;The virus-like particles display trimeric membrane bound forms of the HIV envelope glycoprotein (Env).&#160;&#160;This is important because the natural form of the envelope glycoprotein elicits antibody capable of recognizing incoming virus and blocking infections.&#160;&#160;Expression of multiple proteins by the vaccine is important because each protein provides targets for cytotoxic T-cells.&#160;&#160;Elicitation of a multi-target T-cell response limits immune escape, just as multi-drug therapies limit drug escape.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><img src="geovax_10k-1231120.jpg" alt=""></div>
</td>
</tr></table>

<div>&#160;</div>

<div style="MARGIN-LEFT: 99pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%" style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Figure 1. Electron micrographs showing the virus-like-particles (VLPs) produced by GeoVax recombinant DNA and recombinant MVA vaccines.</font> For the DNA Prime, VLPs are seen budding from a DNA-expressing cell.&#160;&#160;For the MVA boost, fully formed particles as well as a budding particle are shown.&#160;&#160;The VLPs display trimeric membrane-bound forms of the viral envelope glycoprotein (Env).&#160;&#160;This is an important feature of the vaccine because display of the normal Env means that the antibody elicited by the vaccine can recognize the Env on incoming viruses. The VLPs are immature and are rendered non-infectious by deletion of essential genes and introduction of inactivating mutations in essential viral enzymes.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MVA was selected for use as the live viral component of our vaccines because of its well established safety record and because of the ability of this vector to carry sufficient HIV proteins to produce virus-like particles. MVA was originally developed as a safer smallpox vaccine for use in immune compromised humans.&#160;&#160;It was developed by attenuating the standard smallpox vaccine by making over 500 passages of the virus in chicken embryos or chick embryo fibroblasts which resulted in large genomic deletions. These deletions limited the ability of MVA to replicate in human cells, which can cause safety problems, but did not compromise the ability of MVA to grow on avian cells that are used for manufacturing the virus. The deletions also resulted in the loss of immune evasion genes which assist the spread of wild type smallpox infections, even in the presence of human immune responses. MVA was safely administered to over 120,000&#160;people in the 1970s as a smallpox vaccine.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The availability of DNA and MVA vaccine delivery vectors provides GeoVax with the means to use combination vaccines that induce different patterns of T-cell and antibody responses. Specifically, the use of DNA to prime immune responses and MVA to boost immune responses elicits high levels of T-cells and thus could be particularly well-suited for therapeutic uses. Alternatively, the use of MVA to both prime and boost the immune response elicits higher levels of antibodies and therefore could be well-suited for use in prevention.&#160;&#160;The DNA prime also facilitates expressing genetic adjuvants, which are co-expressed by the vaccine vector with HIV proteins, at the site of immunization.&#160;&#160;This has proven to be particularly effective in our work using GM-CSF as an adjuvant in which a single DNA expresses both virus-like particles and GM-CSF.&#160;&#160;By co-expressing GM-CSF and HIV proteins in the DNA vaccine, GM-CSF is present at the site of the HIV vaccination where it enhances the ability of the vaccine to elicit blocking antibodies for the HIV virus.&#160;&#160;Blocking antibodies can stop a virus before it infects cells.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preclinical Studies. </font>During the development of our preventive vaccines, preclinical efficacy trials were conducted by vaccinating non-human primates with simian immunodeficiency virus prototypes of our HIV vaccines and then testing them for resistance to simian immunodeficiency virus. The experimental data produced by these trials documented the ability of the simian prototypes of our vaccines to induce immune responses that can prevent infection as well as reduce the levels of viral replication in those animals that become infected.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax&#8217;s second-generation vaccines include the use of adjuvants together with our DNA/MVA vaccine.&#160;&#160;Adjuvants are additives to vaccines that improve vaccine efficacy.&#160;&#160;One of these, GM-CSF, a normal human protein that stimulates the first stages of immune responses, has shown particular promise.&#160;&#160;In normal humans, GM-CSF stimulates the expansion and differentiation of cells in the macrophage and dendritic cell lineages that promote immune responses. The use of GM-CSF in humans is anticipated to have good safety based on its licensure for stimulating production of white blood cells after autologous bone marrow transplantation, as a treatment for fungal infections, and as an adjuvant for the Provenge&#174; prostate cancer vaccine.&#160;&#160;In preclinical studies in non-human primates, co-expression of GM-CSF in a simian prototype of the DNA vaccine improved the ability of the vaccine to prevent infection. In a study employing 12 successive weekly exposures to simian immunodeficiency virus (SIV), vaccinating in the presence of co-expressed GM-CSF prevented infection in 70% of the animals for a 90% reduction in per exposure risk of transmission, whereas vaccinating in the absence of the co-expressed GM-CSF prevented infection in only 25% of animals and achieved a less effective 60% reduction in the per exposure risk of transmission (<font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases, 204:164 (2011</font>)).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Survivors from this first series of exposures were rested a year, boosted once with the MVA vaccine, and then exposed to a 2<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">nd</font> series of challenges (Figure 2). Greater than 90% reduction in risk of infection per exposure was achieved against the 2<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">nd</font> series of exposures. Survivors of this 2<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">nd</font> series of exposures were again rested for 6 months and then exposed to a 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> series of challenges. Again, 94% reduction in risk of infection per exposure was achieved.&#160;&#160;The 1<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font> two series of exposures were to SIVE660, a virus that has neutralization characteristics like viruses undergoing transmission in the current epidemic.&#160;&#160;The 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> series of challenges was with SIV251, a virus that is considered the most potent SIV used in nonhuman primate studies and is an outlier in its high resistance to neutralization.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><img src="geovax_10k-1231121.jpg" alt=""></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Figure 2.&#160;&#160;Schematic of serial exposures testing vaccine efficacy.</font>&#160;&#160;Heavy vertical arrows indicate vaccinations, clusters of thin arrows, serial exposures.&#160;&#160;Exposures to virus were rectal to mimic mucosal transmissions.&#160;&#160;&#160;Protection against the 3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> series of exposures is shown in Figure 3C below.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To our knowledge, the level of protection achieved by the simian prototype for the GeoVax GM-CSF-adjuvanted HIV vaccine is unprecedented and far better than has been achieved with simian prototypes of other vaccines currently in, or slated for efficacy trials (see Figure 3 below).&#160;&#160;Figure 3A shows prevention of serial infections by the vaccine currently in efficacy trials that was developed by the NIH Vaccine Research Center.&#160;&#160;This vaccine consists of priming with a DNA vaccine and boosting with a recombinant Adenovirus 5 vaccine (DNA/Ad5).&#160;&#160;When challenged with SIV251, vaccinated animals were infected more rapidly than the unvaccinated animals.&#160;&#160;Figure 3B shows a Johnson and Johnson (Crucell) vaccine developed at Harvard and tested in conjunction with the U.S. military.&#160;&#160;This vaccine initially provides some protection, however only 13% of the animals remained protected after 6 exposures to SIV251.&#160;&#160;Figure 3C shows data from serial exposures to the simian prototype for the GeoVax GM-CSF-co-expressing vaccine. This vaccine has provided a 72% per exposure reduction in risk of infection over 12 serial exposures.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><img src="img2.jpg" alt=""></div>

<div>&#160;</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 90pt">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="80%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td width="100%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Figure 3. Comparison of protection against serial exposures to SIV251 induced by vaccines undergoing or slated for efficacy trials.</font></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 43.2pt" align="justify">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A.&#160; &#160; <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vaccine consisting of priming with a recombinant canarypox vaccine and boosting with a bivalent mixture of the gp120 subunit of the Env protein from HIV clades B and C.&#160;&#160;This vaccine regimen progressed to </font></font></font></div>

<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Phase 3 human clinical testing in Thailand, yielding 31% protection.</font></font></font></div>

<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">B. &#160;&#160; <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vaccine consisting of priming with an adenovirus 26 vaccine (Ad26) and boosting with an MVA vaccine developed by Harvard and the U.S. Military, owned by Johnson and Johnson (Crucell) and slated for an </font></font></font></font></div>

<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">efficacy trial in South Africa.</font></font></font></font></div>

<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">C.&#160;&#160;&#160; &#160;GeoVax vaccine consisting of priming with a GM-CSF co-expressing DNA and boosting with MVA</font></font></font></div>
</div>
</div>
</div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preclinical Studies &#8211; Therapeutic Vaccine.</font> In 2007-2008, data were generated in three pilot studies on therapeutic vaccination in simian immunodeficiency virus-infected non-human primates. The vaccine used in these pilot studies was specific for simian immunodeficiency virus but with the design features of our HIV/AIDS vaccine. In these pilot studies, conducted at Yerkes National Primate Research Center of Emory University, non-human primates were infected, drug-treated, vaccinated and then drug-interrupted.&#160;&#160;Following treatment interruption, median levels of virus in blood, measured as viral RNA, were 10 to 1000-times lower (overall median of 100-times lower) than those measured prior to drug and vaccine treatment.&#160;&#160;The therapeutic reductions in virus levels were associated with the vaccination regimen eliciting T-cells (a form of white blood cell) with functional characteristics known to successfully control viral infections.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preventive Vaccine &#8212; Phase 1 Human Clinical Trials. </font>All of our preventive vaccination trials in humans have been conducted by the HIV Vaccine Trials Network (HVTN) a network that is funded and supported by the NIH. The HVTN is the largest worldwide clinical trials network focused on the development and testing of HIV/AIDS vaccines. The results of a two group, 30 participant, Phase 1 trial (designated HVTN 045) are published in <font style="FONT-STYLE: italic; DISPLAY: inline">AIDS RESEARCH AND HUMAN RETROVIRUSES </font>22:678 (2006) and of a four group 120 participant trial (HVTN 065) in <font style="FONT-STYLE: italic; DISPLAY: inline">The Journal of Infectious Diseases</font> 203:610 (2011).&#160;&#160;Our Phase 1 trials have tested both safety and dosing regimens.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our first Phase 1 clinical trial, HVTN 045, our DNA vaccine was tested without MVA boosting to document the safety of the DNA. Our second Phase 1 clinical trial, HVTN 065, was designed to test the combined use of DNA and MVA and consisted of a dose escalation as well as regimen studies. The low dose consisted of 0.3&#160;mg of DNA and 1x10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">7</font> tissue culture infectious doses (TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50</font>) of MVA. Once safety was demonstrated for the low dose in 10 participants, the full dose (3 mg of DNA and 1x10<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">8</font> TCID<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: sub">50 </font>of MVA) was administered to 30 participants. A single dose of DNA at time 0 followed by MVA at weeks 8 and 24, a DMM regimen, and three doses of MVA administered at weeks 0, 8 and 24, an MMM regimen, were also tested in 30 participants each. Participants were followed for 12 months to assess vaccine safety and to measure vaccine-induced immune responses.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Data from the HVTN 065 trial again documented the safety of the vaccine products but also showed that the DDMM and MMM regimens induced different patterns of immune responses. The full dose DDMM regimen induced higher response rates of CD4+ T-cells (77%) and CD8+ T-cells (42%) compared to the MMM regimen (43% CD4 and 17% CD8 response rates). In contrast, the highest response rates and highest titers of antibodies to the HIV Env protein were induced in the group that received only the MVA using the MMM regimen. Antibody response rates were documented to be higher for the MMM group using three different assays designed to measure total binding antibody levels for an immune dominant portion of the Env protein (27% for DDMM and 75% for MMM), binding of antibodies to the gp120 subunit of the envelope glycoprotein (81% for DDMM and 86% for MMM)&#160;and neutralizing antibodies (7% for DDMM and 30% for MMM). The 1/10th&#160;dose DDMM regimen induced overall similar T-cell responses but reduced antibody responses while the response rates were intermediate in the DMM group.&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The HVTN is also sponsoring and conducting Phase 1 clinical testing in humans of a new version of our preventive vaccine that has substantially enhanced prevention of infection in non-human primates.&#160;&#160;This vaccine co-expresses GM-CSF as an adjuvant and achieved a much higher level of prevention of infection than our unadjuvanted vaccine in non-human primate testing.&#160;&#160;Prevention of infection is seen for serial challenges with tested animals being protected against more than 34 challenges administered over two and one-half years in a &gt;3 year vaccine trial.&#160;&#160;&#160;The co-expressed GM-CSF enhances antibody responses with the enhanced prevention of infection correlating with enhanced tightness of binding of the antibody to the viral envelope glycoprotein that mediates HIV entry into cells. Commencement of a&#160;48 participant Phase 1 clinical testing of the GM-CSF co-expressing vaccine in a trial designated HVTN 094 began in 2012 and is fully enrolled.&#160;&#160;The study will assess safety and immunogenicity of the adjuvanted vaccine at low-dose and full-dose regimens and is expected to be completed in late 2013.&#160;&#160;Pending successful outcome of this trial, we expect to carry forward this version of our preventive vaccine into Phase 2 efficacy testing.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preventive Vaccine &#8212; Phase 2 Human Clinical Trials. </font>Based on the safety and the immunogenicity results in the HVTN 045 and HVTN 065 trials, the full dose DNA/MVA and MVA-only regimens were selected for testing by the HVTN in a Phase 2a trial (designated HVTN 205) which was completed in 2012 and the subject of an oral presentation at the <font style="FONT-STYLE: italic; DISPLAY: inline">AIDS Vaccine 2012 Conference</font> in September 2012.&#160;&#160;Both vaccine regimens appeared safe and well-tolerated. Similar to Phase 1 testing, the DNA/MVA regimen induced higher rates of T cell responses whereas the MVA-only regimen induced higher rates of antibody responses. Antibody responses to the HIV Envelope protein were seen in more than 90 percent of both groups. The Phase 2a trial confirmed Phase 1 results, setting the stage for Phase 2 efficacy trials. We expect formal publication of the full study results by the end of 2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Phase 2 Efficacy Trial Planning. </font>Pending successful outcome of Phase 1 testing of our second generation vaccine (GM-CSF adjuvanted), we expect to carry forward this version of our preventive vaccine into Phase 2 efficacy testing. We are currently in discussions with the HVTN regarding protocol development for Phase 2 efficacy testing.&#160;&#160;Depending on government funding support and other considerations, the Phase 2 trial may have as many as 4,200 participants equally divided between placebo and vaccine groups, or it may be a multi-stage trial with additional study groups.&#160;&#160;We anticipate knowing more about the trial design and the government funding consortium in late 2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Therapeutic Vaccine &#8212;Human Clinical Trials. </font>To help treat those people who are already infected with HIV, we are testing the feasibility of using our vaccine to supplement, or even eliminate, the need for antiretroviral therapeutic drugs in HIV-infected individuals. Antiretroviral therapeutic drugs, which are taken for life by individuals once infected with HIV, have side effects and are expensive, costing $12,000 - $15,000 per year (drug cost only, not including physician visits and related costs).&#160;&#160;And according to a 2010 study by the CDC, of those individuals in the United States who are diagnosed with HIV, only 35% ultimately achieve stable viral load suppression through drug treatment.&#160; Thus, even in the United States where the availability of drugs and treatment is good, there is still obvious compelling need for therapies that complement drugs.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Phase 1/2 Trial (Treatment Interruption).</font> Based on encouraging preclinical data, we are conducting a pilot Phase 1/2 clinical trial in HIV-infected individuals who began successful antiretroviral drug treatment within 18 months of a negative HIV-1 antibody test. The primary goals of this clinical trial are to document the safety and immunogenicity of the vaccine in patients with well-controlled infections.&#160;&#160;Vaccine efficacy will be directly assessed through a brief period of anti-retroviral drug cessation.&#160;&#160;We have completed patient enrollment of this 9 participant study and expect to begin generating data in late 2013, which might indicate the potential use of our vaccines to treat HIV infection, either as a standalone therapy or in conjunction with an oral drug regimen.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Phase 1 Trial Planning (Drug Combo).</font> We are also planning a Phase 1 clinical trial to investigate the use of our vaccine in combination with standard-of-care drug therapy in young adults.&#160;&#160;We expect this trial to be conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trial Group (IMPAACT) with financial support from the NIH. The NIH has recently prioritized searching for a cure for those individuals who are HIV positive. Because of the mechanisms by which current oral drugs&#160;&#160;work, if the virus is in a latent phase these drugs are not effective, thus it is impossible to totally eradicate the virus. Current approaches to a cure include using an effective vaccine and oral medication together to more effectively eradicate virus.&#160;&#160;&#160;This trial is planned to have two groups of 20 participants, one of which will remain on drugs while being vaccinated and the second of which will remain on drugs but receive placebo.&#160;&#160;The participants will be monitored for vaccine-associated reductions in viral reservoirs. This trial has been assigned a clinical study number (P-1082) and we expect it to begin in mid-2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Support from the United States Government</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">With the exception of the Phase 1/2 therapeutic trial (treatment interruption protocol), all of our human clinical trials to date have been conducted by the HVTN and funded by NIH.&#160;&#160;The NIH is also supporting the ongoing Phase 1 trial of our second generation vaccine (GM-CSF adjuvanted), and we anticipate their support for our planned Phase 1 trial with IMPAACT for the therapeutic use of our vaccine. Our responsibility for these clinical trials has been to provide sufficient supplies of vaccine materials and technical expertise when necessary.&#160;&#160;We are currently in discussions with the HVTN regarding protocol development and government support for Phase 2 efficacy testing of our preventive vaccine.&#160;&#160;We anticipate knowing more about the trial design and the government funding consortium in late 2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2007, the NIH awarded us an<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>Integrated Preclinical-Clinical AIDS Vaccine Development (IPCAVD) grant to support our HIV/AIDS vaccine program, which was subsequently amended such that the total award now totals approximately $20.4&#160;million. The original project period for the grant covered a five year period ending in August 2012, but was extended for an additional one year period.&#160;&#160;As of December 31, 2012, there was approximately $1.6 million of this grant remaining and available for use.&#160;&#160;IPCAVD grants are awarded on a competitive basis and are designed to support later stage vaccine research, development and human trials. We are utilizing this funding to further our HIV/AIDS vaccine development, optimization and production.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2012, the NIH awarded us an additional grant of $1.9 million to support development of versions of our HIV/AIDS vaccines to address the clade C subtype of the HIV virus prevalent in the developing world.&#160;&#160;The project period of this grant covers a one year period ending in August 2013.&#160;&#160;There is approximately $1.4 million from this grant remaining and available for use as of December 31, 2012.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Please refer to our Financial Statements at Item 15(a) of this report, and to Management's Discussion and Analysis of Financial Condition and Results of Operations at Item 7 of this report, for additional information regarding revenue.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Regulations</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Regulation by governmental authorities in the United States and other countries is a significant factor in our ongoing research and development activities and in the manufacture of our products under development. Complying with these regulations involves a considerable amount of time and expense.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the United States, drugs are subject to rigorous federal and state regulation. The Federal Food, Drug and Cosmetic Act, as amended, or the FDC Act, and the regulations promulgated thereunder, and other federal and state statutes and regulations govern, among other things, the testing, manufacture, safety, efficacy, labeling, storage, record keeping, approval, advertising and promotion of medications and medical devices. Product development and approval within this regulatory framework is difficult to predict, takes a number of years and involves great expense.&#160;&#160;The steps required before a pharmaceutical agent may be marketed in the United States include:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">pre-clinical laboratory tests, in vivo pre-clinical studies and formulation studies;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the submission to the FDA of an Investigational New Drug (IND) application for human clinical testing which must become effective before human clinical trials can commence;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">adequate and well-controlled human clinical trials to establish the safety and efficacy of the product;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the submission of a New Drug Application to the FDA;&#160;and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">FDA approval of the New Drug Application prior to any commercial sale or shipment of the product.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each of these steps is described further below. In addition to obtaining FDA approval for each product, each domestic manufacturing establishment must be registered with, and approved by, the FDA. Domestic manufacturing establishments are subject to biennial inspections by the FDA and must comply with the FDA&#8217;s Good Manufacturing Practices for products, drugs and devices.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Preclinical Testing. </font>Pre-clinical testing includes laboratory evaluation of chemistry and formulation, as well as cell culture and animal studies to assess the safety and potential efficacy of the product. Pre-clinical safety tests must be conducted by laboratories that comply with the FDA&#8217;s Good Laboratory Practices, or GLP. The results of pre-clinical testing are submitted to the FDA as part of the IND application and are reviewed by the FDA prior to the commencement of human clinical trials. Unless the FDA objects to an IND, the IND becomes effective 30&#160;days following its receipt by the FDA.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Clinical Trials. </font>Clinical trials involve the administration of the HIV vaccines to volunteers or to patients under the supervision of a qualified, medically trained principal investigator. Clinical trials are conducted in accordance with Good Clinical Practices under protocols that detail the objectives of the trial, the parameters to be used to monitor safety and the efficacy criteria to be evaluated. Each protocol must be submitted to the FDA as part of the IND. Further, each clinical trial must be conducted under the auspices of an independent institutional review board at the institution where the trial will be conducted. The institutional review board will consider, among other things, ethical factors, the safety of human subjects and the possible liability of the institution.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Clinical trials are typically conducted in three sequential phases, but the phases may overlap. In the Phase 1 clinical trial, the initial introduction of the product into healthy human subjects, the vaccine is tested for safety (including adverse side effects) and dosage tolerance. The Phase 2 clinical trial is the proof of principal stage and involves trials in a limited patient population to determine whether the product induces the desired effect (for our vaccines this means immune responses) and to better determine optimal dosage. The continued identification of possible safety risks is also a focus. When there is evidence that the product may be effective and has an acceptable safety profile in Phase 2 clinical trials, Phase 3 clinical trials are undertaken to evaluate clinical efficacy and to test for safety within an expanded patient population. Phase&#160;3 trials are completed using multiple clinical study sites which are geographically dispersed. The manufacturer or the FDA may suspend clinical trials at any time if either believes that the individuals participating in the trials are being exposed to unacceptable health risks.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">New Drug Application and FDA Approval Process. </font>The results and details of the pre-clinical studies and clinical trials are submitted to the FDA in the form of a New Drug Application. If the New Drug Application is approved, the manufacturer may market the product in the United States.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">International Approval. </font>Whether or not the FDA has approved the drug, approval of a product by regulatory authorities in foreign countries must be obtained prior to the commencement of commercial sales of the drug in such countries. The requirements governing the conduct of clinical trials and drug approvals vary widely from country to country, and the time required for approval may be longer or shorter than that required for FDA approval.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Other Regulations. </font>In addition to FDA regulations, our business activities may also be regulated by the Occupational Safety and Health Act, the Environmental Protection Act, the Toxic Substances Control Act, the Resource Conservation and Recovery Act and other present and potential future federal, state or local regulations. Violations of regulatory requirements at any stage may result in various adverse consequences, including regulatory delay in approving or refusal to approve a product, enforcement actions, including withdrawal of approval, labeling restrictions, seizure of products, fines, injunctions and/or civil or criminal penalties. Any product that we develop must receive all relevant regulatory approvals or clearances before it may be marketed.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Strategy</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our immediate goal is to bring both our preventive and therapeutic HIV/AIDS vaccines into efficacy testing, with the ultimate goal of becoming a leading biopharmaceutical company that develops differentiated products to prevent and treat serious infections, focusing on unmet medical needs. To achieve these strategic goals, we intend to employ the following strategies:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman, serif; FONT-SIZE: 1pt">&#160;</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Leverage the Support of Federal Government Agencies for Trials of our Preventive Vaccine</font>.&#160;&#160;The NIH and HVTN have been very supportive of our efforts to date in developing our preventive vaccines, and we intend to continue to solicit their assistance and financial support for the efficacy testing of our preventive vaccines.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Development of Our Therapeutic Vaccine Candidates</font>.&#160;&#160;We plan to focus our resources on developing our therapeutic vaccines to show initial proof of efficacy in humans.&#160;&#160;We will leverage governmental support where possible.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Seek the Support of Nongovernmental Organizations</font>.&#160;&#160;We also intend to solicit the support of Nongovernmental Organizations (NGOs) toward the development of our vaccine candidates for the versions of the HIV virus prevalent in the developing world.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Seek Strategic Collaborations to Accelerate the Development of Our Vaccine Candidates to Optimize Economic Returns while Managing Risk</font>.&#160;&#160;We intend to establish strategic licenses and collaborations, partnerships, alliances or enter into other transactions in the future with pharmaceutical or biopharmaceutical companies with greater clinical development, manufacturing and commercialization capabilities that we believe can accelerate the development and/or commercialization of our vaccine candidates.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">New Business Opportunities</font>.&#160;&#160;We will be open to new business development opportunities to potentially expand our technology and product pipeline or to otherwise provide additional revenue sources.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Manufacturing</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have the facilities or expertise to manufacture any of the clinical or commercial supplies of any of our products. To be successful, our products must be manufactured in commercial quantities in compliance with regulatory requirements and at an acceptable cost. To date, we have not commercialized any products, nor have we demonstrated that we can manufacture commercial quantities of our product candidates in accordance with regulatory requirements. If we cannot manufacture products in suitable quantities and in accordance with regulatory standards, either on our own or through contracts with third parties, it may delay clinical trials, regulatory approvals and marketing efforts for such products. Such delays could adversely affect our competitive position and our chances of achieving profitability. We cannot be sure that we can manufacture, either on our own or through contracts with third parties, such products at a cost or in quantities which are commercially viable.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We currently rely and intend to continue to rely on third-party contract manufacturers to produce vaccines needed for research and clinical trials. We have entered into arrangements with third party manufacturers for the supply of our DNA and MVA vaccines for use in our planned clinical trials. These suppliers operate under the FDA&#8217;s Good Manufacturing Practices and similar regulations of the European Medicines Agency. We anticipate that these suppliers will be able to provide sufficient vaccine supplies to complete our currently planned clinical trials. Various contractors are generally available in the United States and Europe for manufacture of vaccines for clinical trial evaluation, however, it may be difficult to replace existing contractors for certain manufacturing and testing activities and costs for contracted services may increase substantially if we switch to other contractors.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Development of Improved Manufacturing Techniques for MVA &#8211; </font>The MVA component of our vaccine is currently manufactured in cells that are cultured from embryonated chicken eggs.&#160;&#160;&#160;This is cumbersome and prone to contamination during the processing of the eggs required to make a large batch of vaccine.&#160;&#160;GeoVax has explored a number of approaches to growing MVA in continuous cell lines that can be grown in bioreactors. In this process we have identified a duck stem-cell-derived line (termed EB66), that is proprietary to Vivalis, Ltd, Nantes France. We are currently working with Vivalis on the use of EB66 cells for the growth of our MVA vaccines and are pleased with the results the collaboration is obtaining. We anticipate that by the time process development is complete we will be producing vaccine at significantly higher titers, allowing for quality improvements over the current process as well as meaningful cost reductions.&#160;&#160;The U.S. FDA has reviewed our early-stage plans for transitioning from MVA growth in egg-derived cells to a continuous cell line.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Competition</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There currently is no FDA licensed and commercialized HIV/AIDS vaccine or competitive vaccine available in the world market. However, the market for vaccines that protect against or treat HIV/AIDS is intensely competitive and is subject to rapid and significant technological change. We will have numerous competitors in the United States and abroad, including large companies with substantially greater resources than us. These competitors may develop technologies and products that are more effective or less costly than any of our future technology or products or that could render our technology or products obsolete or noncompetitive.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are several small and large biopharmaceutical companies pursuing HIV/AIDS vaccine research and development, including Novartis, Sanofi-Aventis and GlaxoSmithKline. Other HIV/AIDS vaccines are in varying stages of research, testing and clinical trials including those supported by the NIH Vaccine Research Center, the U.S. Military, IAVI, the European Vaccine Initiative, and the South African AIDS Vaccine Initiative. Following the reported failure of the vaccine developed by Merck&#160;&amp; Co., Inc. in September 2007, Merck&#160;&amp; Co., Inc.&#8217;s vaccine program and the NIH Vaccine Research Center vaccine program, both of which use Ad5 vectors, were placed on hold. Since then, the NIH Vaccine Research Center product has moved into an experimental Phase 2b clinical trial to learn more about immune responses and AIDS control. This clinical trial has been restricted to individuals who do not have high levels of antibodies to the Ad5 vector used in the vaccine (approximately 50% of U.S.&#160;citizens) and to men who are circumcised.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In October 2009, the results from a Phase 3 community-based clinical trial in Thailand using a recombinant canarypox (designated ALVAC and produced by Sanofi Pasteur) as a priming vaccine and a bivalent mixture of the gp120 subunit of Env from HIV clades&#160;B and C (produced by VaxGen, Inc. and currently licensed to Global Solutions for Infectious Diseases) as a protein booster vaccine were reported. In this clinical trial, protection against HIV infection at the rate of 31% was reported. The results of this clinical trial are encouraging because they represent the first success of an AIDS vaccine in humans and demonstrate that a vaccine can provide protection against HIV infections.&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To our knowledge, none of our competitors&#8217; products have been tested in large scale non-human primate trials that have included experimental infection through the rectal site and shown to induce levels of protection or duration of protection comparable to that achieved using experimental prototypes of GeoVax&#8217;s vaccines. Furthermore, many of our competitors&#8217; vaccine development programs require vaccine compositions which are more complicated than ours. For these reasons, we believe that it may be possible for our vaccine to compete successfully in the marketplace if licensed.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Overall, the biopharmaceutical industry is competitive and subject to rapid and substantial technological change. Developments by others may render our proposed vaccination technologies noncompetitive or obsolete, or we may be unable to keep pace with technological developments or other market factors. Technological competition in the industry from pharmaceutical and biotechnology companies, universities, governmental entities and others diversifying into the field is intense and is expected to increase. Many of the pharmaceutical companies that compete with us have significantly greater research and development capabilities than we have, as well as substantially more marketing, manufacturing, and financial resources. In addition, acquisitions of, or investments in, small pharmaceutical or biotechnology companies by such large corporations could increase their research, financial, marketing, manufacturing and other resources. Competitive technologies may ultimately prove to be safer, more effective or less costly than any vaccine that we develop.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">FDA and other regulatory approvals of our vaccines have not yet been obtained and we have not yet generated any revenues from product sales. Our future competitive position depends on our ability to obtain FDA and other regulatory approvals of our vaccines and to license or sell the vaccines to third parties on favorable terms.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Intellectual Property</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary rights are described by valid and enforceable patents or are effectively maintained as trade secrets. Accordingly, we are pursuing and will continue to pursue patent protection for our proprietary technologies developed through our collaborations with Emory University, the NIH, and the CDC, or developed by us alone. Patent applications have been filed with the U.S. Patent and Trademark Office and in specific international markets (countries). Patent applications include provisions to cover our DNA and MVA based HIV vaccines, their genetic inserts expressing multiple HIV protein components, composition, structure, claim of immunization against multiple subtypes of HIV, routes of administration, safety and other related factors. Patent claims filed for our vaccines include provisions for their therapeutic and prophylactic use against HIV and smallpox.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are the exclusive, worldwide licensee of a number of patents and patent applications, which we refer to as the Emory Technology, owned, licensed or otherwise controlled by Emory University for HIV or smallpox vaccines pursuant to a License Agreement originally entered into on August&#160;23, 2002 and restated on June&#160;23, 2004, which we refer to as the Emory License. Through the Emory License we are also a non-exclusive licensee of four issued United States patents owned by the NIH related to the ability of our MVA vector vaccine to operate as a vehicle to deliver HIV virus antigens, and also to induce an immune response in humans. The four issued United States patents owned by the NIH expire in 2023. All of our obligations with respect to the NIH-owned MVA patents are covered by the Emory License. In addition to the issued United States patents owned by the NIH, and a recently issued patent owned by Emory&#160;University, there are six issued and five pending United States patent applications, 29&#160;issued or pending patents in countries other than the United States. The Emory License expires on the expiration date of the last to expire of the patents licensed thereunder including those that are issued on patents currently pending. We will not know the final termination date of the Emory License until such patents are issued. The Company may terminate the Emory University License upon 90&#160;days&#8217; written notice. The Emory License also contains standard provisions allowing Emory University to terminate upon breach of contract by the Company or upon the Company&#8217;s bankruptcy.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Emory License, among other contractual obligations, requires payments based on the following:</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Milestone Payments.</font>&#160;&#160;An aggregate of $3,450,000 is potentially due to Emory University in the future upon the achievement of clinical development and regulatory approval milestones as defined in the Emory License. To date, we have paid a nominal milestone fee upon entering Phase 2 clinical trials for our preventive HIV/AIDS vaccine.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Maintenance Fees.</font>&#160;&#160;The Company has achieved the specified milestones and met its obligations with regard to the related payments, and no maintenance fees are (or will be) owed to Emory University.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Royalties.</font>&#160;&#160;Upon commercialization of products covered by the Emory License, we will owe royalties to Emory University of between 5% and 7.5%, depending on annual sales volume, of net sales made directly by GeoVax. The Emory License also requires minimum annual royalty payments of $3&#160;million in the third year following product launch, increasing annually to $12&#160;million in the sixth year.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Sublicense Royalties.</font>&#160;&#160;In the event that we sublicense a covered product to a third party, we will owe royalties to Emory University based on all payments, cash or noncash, that we receive from our sublicensees. Those royalties will be 19% of all sublicensing consideration we receive prior to the first commercial sale of a related product. Commencing with the first commercial sale, the royalty owed to Emory University will be 27.5% of all sublicensing consideration we receive.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Patent Reimbursements.</font>&#160;&#160;During the term of the Emory License we are obligated to reimburse Emory University for ongoing third party costs in connection with the filing, prosecution and maintenance of patent applications subject to the Emory License. The expense associated with these ongoing patent cost reimbursements to Emory University amounted to $89,885, $249,907, and $193,674 for the years ended December 31, 2012, 2011 and 2010, respectively.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We may only use the Emory Technology for therapeutic or prophylactic HIV or smallpox vaccines. Emory University also reserved the right to use the Emory Technology for research, educational and non-commercial clinical purposes. Due to the use of federal funds in the development of the Emory Technology, the U.S. Government has the irrevocable, royalty-free, paid-up right to practice and have practiced certain patents throughout the world, should it choose to exercise such rights.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are not a party to any litigation, opposition, interference, or other potentially adverse proceeding with regard to our patent positions. However, if we become involved in litigation, interference proceedings, oppositions or other intellectual property proceedings, for example as a result of an alleged infringement or a third-party alleging an earlier date of invention, we may have to spend significant amounts of money and time and, in the event of an adverse ruling, we could be subject to liability for damages, invalidation of our intellectual property and injunctive relief that could prevent us from using technologies or developing products, any of which could have a significant adverse effect on our business, financial conditions or results of operations. In addition, any claims relating to the infringement of third-party proprietary rights, or earlier date of invention, even if not meritorious, could result in costly litigation, lengthy governmental proceedings, divert management&#8217;s attention and resources and require us to enter royalty or license agreements which are not advantageous if available at all.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are also the exclusive licensee of five patents from MFD, Inc., which we refer to as the MFD Patents, pursuant to a license agreement dated December 26, 2004 with MFD, Inc., which we refer to as the MFD license agreement, related to certain manufacturing processes used in the production of our vaccines. Pursuant to the MFD license agreement, we obtained a fully paid, worldwide, irrevocable, exclusive license in and to the MFD Patents to use, market, offer for sale, sell, lease and import any AIDS and smallpox vaccine made with GeoVax Technology, as such term is defined in the MFD license agreement, and non-exclusive rights for other products. The term of the MFD license agreement ends on the expiration date of the last to expire of the MFD Patents, one of which expires in 2017. The license granted also extends to any and all current or future customers of GeoVax the right to commercially practice the GeoVax Technology, as such term is defined in the MFD license agreement, or any portion thereof. The license also extends to any and all current or future GeoVax Users, as such term is defined in the MFD license agreement, the right to use any GeoVax Technology, as such term is defined in the MFD license agreement.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to patent protection, we also attempt to protect our proprietary products, processes and other information by relying on trade secrets and non-disclosure agreements with our employees, consultants and certain other persons who have access to such products, processes and information. Under these agreements, all inventions conceived by employees are our exclusive property. Nevertheless, there can be no assurance that these agreements will afford significant protection against misappropriation or unauthorized disclosure of our trade secrets and confidential information.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We cannot be certain that any of the current pending patent applications we have licensed, or any new patent applications we may file or license, will ever be issued in the United States or any other country. Even if issued, there can be no assurance that those patents will be sufficiently broad to prevent others from using our products or processes. Furthermore, our patents, as well as those we have licensed or may license in the future, may be held invalid or unenforceable by a court, or third parties could obtain patents that we would need to either license or to design around, which we may be unable to do. Current and future competitors may have licensed or filed patent applications or received patents, and may acquire additional patents or proprietary rights relating to products or processes competitive to ours. In addition, any claims relating to the infringement of third-party proprietary rights, or earlier date of invention, even if not meritorious, could result in costly litigation, lengthy governmental proceedings, divert management&#8217;s attention and resources and require us to enter royalty or license agreements which are not advantageous to us, if available at all.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our expenditures for research and development activities were $3,043,522, $4,276,375, and $4,793,956 during the years ended December 31, 2012, 2011 and 2010, respectively. As our vaccines continue to go through the process to obtain regulatory approval, we expect our research and development costs to continue to increase significantly as even larger human clinical trials proceed in the United States and foreign countries. We have not yet formulated any plans for marketing and sales of any vaccine candidate we may successfully develop. Compliance with environmental protection laws and regulations has not had a material effect on our capital expenditures, earnings or competitive position to date.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Properties and Employees</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We lease approximately 8,400 square feet of office and laboratory space located at 1900 Lake Park Drive, Suite 380, Smyrna, Georgia under a 62 month lease agreement which began November 1, 2009.&#160;&#160;We believe this space is adequate for our current needs. As of March 15, 2013, we had nine full-time employees.&#160;&#160;None of our employees are covered by collective bargaining agreements and we believe that our employee relations are good.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Background and Structure</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our primary business is conducted by our subsidiary, GeoVax, Inc., which was incorporated under the laws of Georgia in June 2001.&#160;&#160;The predecessor of our parent company, GeoVax Labs, Inc. (the reporting entity) was originally incorporated in June 1988 under the laws of Illinois as Dauphin Technology, Inc. (&#8220;Dauphin&#8221;).&#160;&#160;In September 2006, Dauphin completed a merger (the &#8220;Merger&#8221;) with GeoVax, Inc.&#160;&#160;As a result of the Merger, GeoVax, Inc. became a wholly-owned subsidiary of Dauphin, and Dauphin changed its name to GeoVax Labs, Inc.&#160;&#160;Unless otherwise indicated, information for periods prior to the September 2006 merger is that of GeoVax, Inc.&#160;&#160;In June 2008, the Company was reincorporated under the laws of Delaware.&#160;&#160;We currently do not conduct any business other than GeoVax, Inc.&#8217;s business of developing new products for the treatment or prevention of human diseases.&#160;&#160;Our principal offices are located in Smyrna, Georgia (metropolitan Atlanta).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Available Information</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our website address is www.geovax.com.&#160;&#160;We make available on this website under &#8220;Investors &#8211; SEC Reports,&#8221; free of charge, our proxy statements, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports as soon as reasonably practicable after we electronically file or furnish such materials to the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;We also make available our Code of Ethics on this website under the heading &#8220;Investors&#8211;Corporate Governance&#8221;.&#160;&#160;Information contained on our website is not incorporated into this Form 10-K.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1A.&#160;&#160;&#160; <font style="DISPLAY: inline; TEXT-DECORATION: underline">RISK FACTORS</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We face a number of substantial risks.&#160;&#160;Our business, financial condition, results of operations and stock price could be materially adversely affected by any of these risks.&#160;&#160;The following factors should be considered in connection with the other information contained in this Annual Report on Form 10-K, including our financial statements and the related notes.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Our Financial Results and Need for Additional Financing</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have a history of operating losses, and we expect losses to continue for the foreseeable future.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have had no product revenue to date and there can be no assurance that we will ever generate any product revenue. We have experienced operating losses since we began operations in 2001. As of December 31, 2012, we had an accumulated deficit of approximately $24.8 million. We expect to incur additional operating losses and expect cumulative losses to increase as our research and development, pre-clinical, clinical, manufacturing and marketing efforts expand. Our ability to generate revenue and achieve profitability depends on our ability to successfully complete the development of our product candidates, conduct pre-clinical tests and clinical trials, obtain the necessary regulatory approvals, and manufacture and market the resulting products. Unless we are able to successfully meet these challenges, we will not be profitable and may not remain in business.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our business will require continued funding. If we do not receive adequate funding, we will not be able to continue our operations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To date, we have financed our operations principally through the private placement of equity securities and through NIH grants. We will require substantial additional financing at various intervals for our operations, including clinical trials, operating expenses, intellectual property protection and enforcement, for pursuit of regulatory approvals, and for establishing or contracting out manufacturing, marketing and sales functions. There is no assurance that such additional funding will be available on terms acceptable to us or at all. If we are not able to secure the significant funding that is required to maintain and continue our operations at current levels, or at levels that may be required in the future, we may be required to delay clinical studies or clinical trials, curtail operations, or obtain funds through collaborative arrangements that may require us to relinquish rights to some of our products or potential markets.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The costs of conducting all of our human clinical trials to date for our preventive HIV vaccine have been borne by the HVTN, funded by the NIH, and we expect NIH support for additional clinical trials. GeoVax incurs costs associated with manufacturing the clinical vaccine supplies and other study support. We cannot predict the level of support we will receive from the HVTN or the NIH for any additional clinical trials.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our operations are also partially supported by the NIH grants awarded to us to support our HIV/AIDS vaccine program. As of December 31, 2012, there is approximately $3.5 million of unused grant funds remaining and available for use through August 31, 2013. We intend to pursue additional grants from the federal government. However, as we progress to the later stages of our vaccine development activities, government financial support may be more difficult to obtain, or may not be available at all. Furthermore, there is some risk that actual funding for grants could be delayed, cut back, or eliminated due to government budget constraints.&#160;&#160;Therefore, it will be necessary for us to look to other sources of funding in order to finance our development activities.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our current working capital, combined with proceeds from grants awarded to us from the NIH will be sufficient to support our planned level of operations into the first quarter of 2014.&#160;&#160;In order to meet our operating cash flow requirements we plan additional offerings of our equity securities, debt, or convertible debt instruments.&#160;&#160;Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences could have a material adverse effect on our business, operating results, financial condition and prospects.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The current economic conditions may adversely impact our ability to raise capital.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The recent recession and adverse conditions in the national and global markets may negatively affect both our ability to raise capital and our operations in the future. The volatile equity markets and adverse credit markets may make it difficult for us to raise capital or procure credit in the future to fund the growth of our business, which could have a negative impact on our business and results of operations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Development and Commercialization of Product Candidates and Dependence on Third Parties</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our products are still being developed and are unproven. These products may not be successful.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To become profitable, we must generate revenue through sales of our products. However our products are in varying stages of development and testing. Our products have not been proven in human clinical trials and have not been approved by any government agency for sale. If we cannot successfully develop and prove our products and processes, or if we do not develop other sources of revenue, we will not become profitable and at some point we would discontinue operations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Whether we are successful will be dependent, in part, upon the leadership provided by our management. If we were to lose the services of any of these individuals, our business and operations may be adversely affected. Further, we may not carry key man life insurance on our executive officers or directors.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Whether our business will be successful will be dependent, in part, upon the leadership provided by our officers, particularly our President and Chief Executive Officer and our Chief Scientific Officer. The loss of the services of these individuals may have an adverse effect on our operations. Although we carry some key man life insurance on Dr.&#160;Harriet L. Robinson, the amount of such coverage may not be sufficient to offset any adverse economic effects on our operations and we do not carry key man insurance on any of our other executive officers or directors. Further, our employees, including our executive officers and directors, are not subject to any covenants not to compete against the Company, and our business could be adversely affected if any of our employees or directors engaged in an enterprise competitive with the Company.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Regulatory and legal uncertainties could result in significant costs or otherwise harm our business.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To manufacture and sell our products, we must comply with extensive domestic and international regulation. In order to sell our products in the United States, approval from the FDA is required. Satisfaction of regulatory requirements, including FDA requirements, typically takes many years, and if approval is obtained at all, it is dependent upon the type, complexity and novelty of the product, and requires the expenditure of substantial resources. We cannot predict whether our products will be approved by the FDA. Even if they are approved, we cannot predict the time frame for approval. Foreign regulatory requirements differ from jurisdiction to jurisdiction and may, in some cases, be more stringent or difficult to meet than FDA requirements. As with the FDA, we cannot predict if or when we may obtain these regulatory approvals. If we cannot demonstrate that our products can be used safely and successfully in a broad segment of the patient population on a long-term basis, our products would likely be denied approval by the FDA and the regulatory agencies of foreign governments.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We will face intense competition and rapid technological change that could result in products that are superior to the products we will be commercializing or developing.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The market for vaccines that protect against or treat HIV/AIDS is intensely competitive and is subject to rapid and significant technological change. We will have numerous competitors in the United States and abroad, including, among others, large companies with substantially greater resources than us. These competitors may develop technologies and products that are more effective or less costly than any of our future technology or products or that could render our technology or products obsolete or noncompetitive. If our technology or products are not competitive, we may not be able to remain in business.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our product candidates are based on new medical technology and, consequently, are inherently risky. Concerns about the safety and efficacy of our products could limit our future success.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are subject to the risks of failure inherent in the development of product candidates based on new medical technologies. These risks include the possibility that the products we create will not be effective, that our product candidates will be unsafe or otherwise fail to receive the necessary regulatory approvals, and that our product candidates will be hard to manufacture on a large scale or will be uneconomical to market.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Many pharmaceutical products cause multiple potential complications and side effects, not all of which can be predicted with accuracy and many of which may vary from patient to patient. Long term follow-up data may reveal additional complications associated with our products. The responses of potential physicians and others to information about complications could materially affect the market acceptance of our products, which in turn would materially harm our business.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may experience delays in our clinical trials that could adversely affect our financial results and our commercial prospects.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not know whether planned clinical trials will begin on time or whether we will complete any of our clinical trials on schedule, if at all. Product development costs will increase if we have delays in testing or approvals or if we need to perform more or larger clinical trials than planned. Significant delays may adversely affect our financial results and the commercial prospects for our products, and delay our ability to become profitable.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We rely heavily on the HVTN, independent clinical investigators, and other third party service providers for successful execution of our clinical trials, but do not control many aspects of their activities. We are responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with standards, commonly referred to as Good Clinical Practices, for conducting, recording, and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. Our reliance on third parties that we do not control does not relieve us of these responsibilities and requirements. Third parties may not complete activities on schedule, or may not conduct our clinical trials in accordance with regulatory requirements or our stated protocols. The failure of these third parties to carry out their obligations could delay or prevent the development, approval and commercialization of our product candidates.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Failure to obtain timely regulatory approvals required to exploit the commercial potential of our products could increase our future development costs or impair our future sales.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None of our vaccines are approved by the FDA for sale in the United States or by other regulatory authorities for sale in foreign countries. To exploit the commercial potential of our technologies, we are conducting and planning to conduct additional pre-clinical studies and clinical trials. This process is expensive and can require a significant amount of time. Failure can occur at any stage of testing, even if the results are favorable. Failure to adequately demonstrate safety and efficacy in clinical trials could delay or preclude regulatory approval and restrict our ability to commercialize our technology or products. Any such failure may severely harm our business. In addition, any approvals we obtain may not cover all of the clinical indications for which approval is sought, or may contain significant limitations in the form of narrow indications, warnings, precautions or contraindications with respect to conditions of use, or in the form of onerous risk management plans, restrictions on distribution, or post-approval study requirements.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State pharmaceutical marketing compliance and reporting requirements may expose us to regulatory and legal action by state governments or other government authorities.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In recent years, several states have enacted legislation requiring pharmaceutical companies to establish marketing compliance programs and file periodic reports on sales, marketing, pricing and other activities. Similar legislation is being considered in other states. Many of these requirements are new and uncertain, and available guidance is limited. Unless we are in full compliance with these laws, we could face enforcement action and fines and other penalties and could receive adverse publicity, all of which could harm our business.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may be subject to new federal and state legislation to submit information on our open and completed clinical trials to public registries and databases.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 1997, a public registry of open clinical trials involving drugs intended to treat serious or life-threatening diseases or conditions was established under the FDA Modernization Act, or the FDMA, to promote public awareness of and access to these clinical trials. Under the FDMA, pharmaceutical manufacturers and other trial sponsors are required to post the general purpose of these trials, as well as the eligibility criteria, location and contact information of the trials. Since the establishment of this registry, there has been significant public debate focused on broadening the types of trials included in this or other registries, as well as providing for public access to clinical trial results. A voluntary coalition of medical journal editors has adopted a resolution to publish results only from those trials that have been registered with a no-cost, publicly accessible database, such as www.clinicaltrials.gov. Federal legislation was introduced in the fall of 2004 to expand www.clinicaltrials.gov and to require the inclusion of trial results in this registry. The Pharmaceutical Research and Manufacturers of America also issued voluntary principles for its members to make results from certain clinical trials publicly available and established a website for this purpose. Other groups have adopted or are considering similar proposals for clinical trial registration and the posting of clinical trial results. Failure to comply with any clinical trial posting requirements could expose us to negative publicity, fines and other penalties, all of which could materially harm our business.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We will face uncertainty related to pricing and reimbursement and health care reform.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In both domestic and foreign markets, sales of our products will depend in part on the availability of reimbursement from third-party payers such as government health administration authorities, private health insurers, health maintenance organizations and other health care-related organizations. Reimbursement by such payers is presently undergoing reform and there is significant uncertainty at this time how this will affect sales of certain pharmaceutical products.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Medicare, Medicaid and other governmental healthcare programs govern drug coverage and reimbursement levels in the United States. Federal law requires all pharmaceutical manufacturers to rebate a percentage of their revenue arising from Medicaid-reimbursed drug sales to individual states. Generic drug manufacturers&#8217; agreements with federal and state governments provide that the manufacturer will remit to each state Medicaid agency, on a quarterly basis, 11% of the average manufacturer price for generic products marketed and sold under abbreviated new drug applications covered by the state&#8217;s Medicaid program. For proprietary products, which are marketed and sold under new drug applications, manufacturers are required to rebate the greater of (a)&#160;15.1% of the average manufacturer price or (b)&#160;the difference between the average manufacturer price and the lowest manufacturer price for products sold during a specified period.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Both the federal and state governments in the United States, and foreign governments, continue to propose and pass new legislation, rules and regulations designed to contain or reduce the cost of health care. Existing regulations that affect the price of pharmaceutical and other medical products may also change before any of our products are approved for marketing. Cost control initiatives could decrease the price that we receive for any product developed in the future. In addition, third-party payers are increasingly challenging the price and cost-effectiveness of medical products and services and litigation has been filed against a number of pharmaceutical companies in relation to these issues. Additionally, some uncertainty may exist as to the reimbursement status of newly approved injectable pharmaceutical products. Our products may not be considered cost-effective or adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an adequate return on our investment.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may not be successful in establishing collaborations for product candidates we may seek to commercialize, which could adversely affect our ability to discover, develop, and commercialize products.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect to seek collaborations for the development and commercialization of product candidates in the future. The timing and terms of any collaboration will depend on the evaluation by prospective collaborators of the clinical trial results and other aspects of our vaccine&#8217;s safety and efficacy profile. If we are unable to reach agreements with suitable collaborators for any product candidate, we will be forced to fund the entire development and commercialization of such product candidates, ourselves, and we may not have the resources to do so. If resource constraints require us to enter into a collaboration agreement early in the development of a product candidate, we may be forced to accept a more limited share of any revenues this product may eventually generate. We face significant competition in seeking appropriate collaborators. Moreover, these collaboration arrangements are complex and time-consuming to negotiate and document. We may not be successful in our efforts to establish collaborations or other alternative arrangements for any product candidate. Even if we are successful in establishing collaborations, we may not be able to ensure fulfillment by collaborators of their obligations or our expectations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We do not have manufacturing, sales or marketing experience.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not have experience in manufacturing, selling, or marketing vaccines. To obtain the expertise necessary to successfully manufacture, market, and sell our vaccines, we will require the development of our own commercial infrastructure and/or collaborative commercial arrangements and partnerships. Our ability to execute our current operating plan is dependent on numerous factors, including, the performance of third party collaborators with whom we may contract.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our vaccines under development may not gain market acceptance.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccines may not gain market acceptance among physicians, patients, healthcare payers and the medical community. Significant factors in determining whether we will be able to compete successfully include:</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the efficacy and safety of our vaccines;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the time and scope of regulatory approval;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">reimbursement coverage from insurance companies and others;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the price and cost-effectiveness of our products, and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the ability to maintain patent protection.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may be required to defend lawsuits or pay damages for product liability claims.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Product liability is a major risk in testing and marketing biotechnology and pharmaceutical products. We may face substantial product liability exposure in human clinical trials and for products that we sell after regulatory approval. We carry product liability insurance and we expect to continue such policies. However, product liability claims, regardless of their merits, could exceed policy limits, divert management&#8217;s attention, and adversely affect our reputation and the demand for our products.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Our Intellectual Property</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We could lose our license rights to our important intellectual property if we do not fulfill our contractual obligations to our licensors.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our rights to significant parts of the technology we use in our vaccines are licensed from third parties and are subject to termination if we do not fulfill our contractual obligations to our licensors. Termination of intellectual property rights under any of our license agreements could adversely impact our ability to produce or protect our vaccines. Our obligations under our license agreements include requirements that we make milestone payments to our licensors upon the achievement of clinical development and regulatory approval milestones, royalties as we sell commercial products, and reimbursement of patent filing and maintenance expenses. Should we become bankrupt or otherwise unable to fulfill our contractual obligations, our licensors could terminate our rights to critical technology that we rely upon.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other parties may claim that we infringe their intellectual property or proprietary rights, which could cause us to incur significant expenses or prevent us from selling products.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our success will depend in part on our ability to operate without infringing the patents and proprietary rights of third parties. The manufacture, use and sale of new products have been subject to substantial patent rights litigation in the pharmaceutical industry. These lawsuits generally relate to the validity and infringement of patents or proprietary rights of third parties. Infringement litigation is prevalent with respect to generic versions of products for which the patent covering the brand name product is expiring, particularly since many companies that market generic products focus their development efforts on products with expiring patents. Pharmaceutical companies, biotechnology companies, universities, research institutions or other third parties may have filed patent applications or may have been granted patents that cover aspects of our products or our licensors&#8217; products, product candidates or other technologies.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Future or existing patents issued to third parties may contain patent claims that conflict with our products. We expect to be subject to infringement claims from time to time in the ordinary course of business, and third parties could assert infringement claims against us in the future with respect to our current products or with respect to products that we may develop or license. Litigation or interference proceedings could force us to:</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">stop or delay selling, manufacturing or using products that incorporate, or are made using the challenged intellectual property;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">pay damages; or</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 27pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">enter into licensing or royalty agreements that may not be available on acceptable terms, if at all.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any litigation or interference proceedings, regardless of their outcome, would likely delay the regulatory approval process, be costly and require significant time and attention of our key management and technical personnel.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Any inability to protect intellectual property rights in the United States and foreign countries could limit our ability to manufacture or sell products.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We will rely on trade secrets, unpatented proprietary know-how, continuing technological innovation and, in some cases, patent protection to preserve our competitive position. Our patents and licensed patent rights may be challenged, invalidated, infringed or circumvented, and the rights granted in those patents may not provide proprietary protection or competitive advantages to us. We and our licensors may not be able to develop patentable products. Even if patent claims are allowed, the claims may not issue, or in the event of issuance, may not be sufficient to protect the technology owned by or licensed to us. If patents containing competitive or conflicting claims are issued to third parties, we may be prevented from commercializing the products covered by such patents, or may be required to obtain or develop alternate technology. In addition, other parties may duplicate, design around or independently develop similar or alternative technologies.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We may not be able to prevent third parties from infringing or using our intellectual property, and the parties from whom we may license intellectual property may not be able to prevent third parties from infringing or using the licensed intellectual property. We generally will attempt to control and limit access to, and the distribution of, our product documentation and other proprietary information. Despite efforts to protect this proprietary information, unauthorized parties may obtain and use information that we may regard as proprietary. Other parties may independently develop similar know-how or may even obtain access to these technologies.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The laws of some foreign countries do not protect proprietary information to the same extent as the laws of the United States, and many companies have encountered significant problems and costs in protecting their proprietary information in these foreign countries.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Neither the U.S.&#160;Patent and Trademark Office nor the courts have established a consistent policy regarding the breadth of claims allowed in pharmaceutical patents. The allowance of broader claims may increase the incidence and cost of patent interference proceedings and the risk of infringement litigation. On the other hand, the allowance of narrower claims may limit the value of our proprietary rights.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Risks Related to Our Common Stock</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The market price of our common stock is highly volatile.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The market price of our common stock has been, and is expected to continue to be, highly volatile. Certain factors, including announcements of new developments by us or other companies, regulatory matters, new or existing medicines or procedures, concerns about our financial position, operating results, litigation, government regulation, developments or disputes relating to agreements, patents or proprietary rights, may have a significant impact on the market price of our stock. In addition, potential dilutive effects of future sales of shares of common stock by us, and subsequent sales of common stock by the holders of warrants and options could have an adverse effect on the market price of our shares.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our common stock does not have a vigorous trading market and investors may not be able to sell their securities when desired.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have a limited active public market for our common shares.&#160;&#160;A more active public market, allowing investors to buy and sell large quantities of our common stock, may never develop. Consequently, investors may not be able to liquidate their investments in the event of an emergency or for any other reason.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have never paid dividends and have no plans to do so.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Holders of shares of our common stock are entitled to receive such dividends as may be declared by our Board of Directors. To date, we have paid no cash dividends on our shares of common stock and we do not expect to pay cash dividends on our common stock in the foreseeable future. We intend to retain future earnings, if any, to provide funds for operations of our business. Therefore, any potential return investors may have in our common stock will be in the form of appreciation, if any, in the market value of their shares of common stock.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are subject to reporting obligations under the United States securities laws. The Securities and Exchange Commission, or the SEC, as required by the Sarbanes-Oxley Act of 2002, adopted rules requiring every public company to include a management report on such company&#8217;s internal controls over financial reporting in its annual report. Effective internal controls are necessary for us to produce reliable financial reports and are important to help prevent fraud. As a result, our failure to achieve and maintain effective internal controls over financial reporting could result in the loss of investor confidence in the reliability of our financial statements, which in turn could negatively impact the trading price of our stock.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we fail to remain current in our reporting requirements, our securities could be removed from the OTC Market, which would limit the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">United States companies trading on the OTC Market must be reporting issuers under Section&#160;12 of the Exchange Act, and must be current in their reports under Section&#160;13. If we fail to remain current on our reporting requirements, we could be removed from the OTC Market. As a result, the market liquidity for our securities could be severely adversely affected by limiting the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We expect to need additional capital, and the sale of additional shares or other equity securities could result in additional dilution to our stockholders.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that our current cash and cash equivalents, combined with anticipated cash flow from our NIH grants, will be sufficient to meet our anticipated cash needs into the first quarter of 2014.&#160;&#160;In order to meet our operating cash flow requirements we plan additional offerings of our equity securities, debt, or convertible debt instruments. The sale of additional equity securities could result in additional dilution to our stockholders.&#160;&#160;Certain equity securities, such as convertible preferred stock, or warrants, may contain anti-dilution provisions which could result in the issuance of additional shares at lower prices if we sell other shares below specified prices.&#160;&#160;The incurrence of indebtedness would result in debt service obligations and could result in operating and financing covenants that would restrict our operations. We cannot assure investors that financing will be available in amounts or on terms acceptable to us, if at all.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our directors and executive officers beneficially own a significant amount of our common stock and will be able to exercise significant influence on matters requiring stockholder approval.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our directors and executive officers collectively beneficially own approximately 11.9% of our common stock as of March 15, 2013.&#160;&#160;Consequently, our directors and executive officers as a group are able to exert significant influence over the election of directors and the outcome of most corporate actions requiring stockholder approval and our business, which may have the effect of delaying or precluding a third party from acquiring control of us. Furthermore, Emory University beneficially owns 22.5% of our common stock as of March 15, 2013. If our directors and executive officers move to act in concert with Emory University, their ability to influence stockholder actions will be even more significant.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The exercise of warrants or options or conversion of our Series A Convertible Preferred Stock may depress our stock price and may result in significant dilution to our common stockholders<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">.</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are a significant number of outstanding warrants and options to purchase our stock and we have issued Series A Convertible Preferred Stock that is convertible into our Common Stock. If the market price of our Common Stock exceeds the exercise price of outstanding warrants and options or the conversion price of the Series A Convertible Preferred Stock, holders of those securities may be likely to exercise their warrants and options or convert their preferred shares and sell the Common Stock acquired upon exercise or conversion of such securities, as applicable, in the open market. Sales of a substantial number of shares of our Common Stock in the public market by holders of warrants, options, or preferred shares may depress the prevailing market price for our Common Stock and could impair our ability to raise capital through the future sale of our equity securities. Additionally, if the holders of outstanding options, warrants, or preferred shares exercise those options or warrants or convert those preferred shares, as applicable, our common stockholders will incur dilution in their relative percentage ownership.&#160;&#160;The prospect of this possible dilution may also impact the price of our Common Stock.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our outstanding warrants include warrants to purchase up to 7,033,332 shares of our Common Stock that were issued in March 2012.&#160;&#160;Of these, warrants to purchase up to 1,166,666 shares have an exercise price of $0.60 per share, and warrants to purchase up to 5,866,666 shares have an exercise price of $1.00 per share. These warrants contain anti-dilution provisions, which may, under certain circumstances, reduce the exercise price (but have no effect on the number of shares subject to the warrants) to match if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the exercise price of the warrants, or if we announce plans to do so.&#160;&#160;This potential reduction in exercise price could reduce the funds the Company receives upon exercise of the warrants, and increase the likelihood that a dilutive issuance will occur.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Common Stock is and likely will remain subject to the SEC&#8217;s &#8220;Penny Stock&#8221; rules, which may make its shares more difficult to sell.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Common Stock is currently and may remain classified as a &#8220;penny stock.&#8221; The SEC rules regarding penny stocks may have the effect of reducing trading activity in our shares, making it more difficult for investors to sell. Under these rules, broker-dealers who recommend such securities to persons other than institutional or accredited investors must:</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 14.4pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">make a special written suitability determination for the purchaser;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 14.4pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">receive the purchaser&#8217;s written agreement to a transaction prior to sale;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 14.4pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">provide the purchaser with risk disclosure documents which identify certain risks associated with investing in &#8220;penny stocks&#8221; and which describe the market for these &#8220;penny stocks&#8221; as well as a purchaser&#8217;s legal remedies;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 14.4pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">obtain a signed and dated acknowledgment from the purchaser demonstrating that the purchaser has received the required risk disclosure document before a transaction in a &#8220;penny stock&#8221; can be completed; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 14.4pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">give bid and offer quotations and broker and salesperson compensation information to the customer orally or in writing before or with the confirmation.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These rules make it more difficult for broker-dealers to effectuate customer transactions and trading activity in our securities and may result in a lower trading volume of our common stock and lower trading prices.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Certain provisions of our certificate of incorporation which authorize the issuance of additional shares of preferred stock may make it more difficult for a third party to effect a change in control.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our certificate of incorporation authorizes our Board of Directors to issue up to 10,000,000&#160;shares of preferred stock. During 2012, we issued 2,200 shares of Series A Convertible Preferred Stock, of which 788 shares remain outstanding as of March 15, 2013.&#160;&#160;We believe the terms of these preferred shares would not have a substantial impact on the ability of a third party to effect a change in control. The remaining shares of preferred stock may be issued in one or more series, the terms of which may be determined at the time of issuance by our Board of Directors without further action by the stockholders. These terms may include voting rights including the right to vote as a series on particular matters, preferences as to dividends and liquidation, conversion rights, redemption rights and sinking fund provisions. The issuance of any preferred stock could diminish the rights of holders of our common stock, and therefore could reduce the value of our common stock. In addition, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with, or sell assets to, a third party. The ability of our Board of Directors to issue preferred stock could make it more difficult, delay, discourage, prevent or make it more costly to acquire or effect a change-in-control, which in turn could prevent the stockholders from recognizing a gain in the event that a favorable offer is extended and could materially and negatively affect the market price of our common stock.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Certain provisions of the warrants we issued in March 2012 may make it more difficult for a third party to effect a change in control.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The warrants we issued in March 2012 contain provisions which permit the holders to require the payment&#160;&#160;to them of an amount of cash equal to the value (based on a Black-Scholes computation) of the remaining unexercised portion of the warrants on the date of the consummation of a fundamental transaction (as defined, but generally a change in control of the Company) that is (i) an all cash transaction, (ii) a &#8220;going private&#8221; transaction, or (ii) a transaction involving a person or entity not traded on a national securities exchange.&#160;&#160;The prospect of making such payments may discourage a potential third party acquirer.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">UNRESOLVED STAFF COMMENTS</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">PROPERTIES</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We lease approximately 8,400 square feet of office and laboratory space located at 1900 Lake Park Drive, Suite 380, Smyrna, Georgia under a 62 month lease agreement which began November 1, 2009.&#160;&#160;We believe this space is adequate for our current needs.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">LEGAL PROCEEDINGS</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are not currently a party to any material legal proceedings.&#160;&#160;We may from time to time become involved in various legal proceedings arising in the ordinary course of business.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">MINE SAFETY DISCLOSURES</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Not applicable.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PART II</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY,RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</font></div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Market Information</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our common stock is currently traded on the OTC Market under the symbol &#8220;GOVX&#8221;.&#160;&#160;The following table sets forth the high and low bid prices for our common stock for the periods indicated.&#160;&#160;The prices represent quotations between dealers and do not include retail mark-up, markdown, or commission, and do not necessarily represent actual transactions:</font></div>

<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">High</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Low</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">2013</font></font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">First Quarter (through March 15, 2013)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.85</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">2012</font></font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fourth Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.52</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Third Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.96</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.76</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Second Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.07</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.75</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">First Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.24</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.77</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">2011</font></font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fourth Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.94</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.82</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Third Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Second Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.40</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.76</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 3%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">First Quarter</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.53</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Holders</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 15, 2013, there were approximately 900 holders of record of our common stock.&#160;&#160;The number of record holders does not reflect the number of beneficial owners of our common stock for whom shares are held by brokerage firms and other institutions.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dividends</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have not paid any dividends since our inception and do not contemplate paying dividends in the foreseeable future.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Sales of Unregistered Securities</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no sales of unregistered securities during the period covered by this report that have not previously been reported on Form 10-Q or Form 8-K.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Issuer Purchases of Equity Securities</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We did not repurchase any of our equity securities during the fourth quarter of 2012.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities Authorized for Issuance Under Equity Compensation Plans</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item will be included in our definitive proxy statement for our 2013 meeting of shareholders to be filed with the SEC under the caption &#8220;Securities Authorized for Issuance under Equity Compensation Plans&#8221; and is incorporated herein by this reference.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">SELECTED FINANCIAL DATA</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following selected financial data are derived from our audited consolidated financial statements.&#160;&#160;The historical results presented below are not necessarily indicative of the results to be expected for any future period.&#160;&#160;The information set forth below should be read in conjunction with the information contained in Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, and our consolidated financial statements and the related notes, beginning on page F-1 of this Report.</font></div>

<div style="TEXT-ALIGN: left" align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="18" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years Ended December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2008</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Statement of Operations Data:</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total revenues (grant income)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,657,327</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,899,885</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,185,257</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,668,195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,910,170</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,135,140</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,474,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,728,187</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted net loss per common share</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="18" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As of December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2008</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance Sheet Data:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,477,970</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,645,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,357,834</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,315,597</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,056,241</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stockholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,150,935</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">703,607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,836,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,744,232</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,709,819</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 63pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND RESULTS OF OPERATIONS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following discussion and analysis of our financial condition and results of operations should be read together with the discussion under &#8220;Selected Financial Data&#8221; and our consolidated financial statements included in this Annual Report.&#160;&#160;This discussion contains forward-looking statements that involve risks and uncertainties because they are based on current expectations and relate to future events and our future financial performance.&#160;&#160;Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many important factors, including those set forth under &#8220;Risk Factors&#8221; and elsewhere in this Annual Report.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax is a biotechnology company developing vaccines that prevent and fight HIV/AIDS. We have exclusively licensed from Emory University vaccine technology which was developed in collaboration with the NIH and the CDC.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our current vaccines under development address the clade B subtype of the HIV virus that is most prevalent in the United States and the developed world.&#160;&#160;Our vaccines are being evaluated to determine their potential to (a) prevent HIV infection and (b) to serve as a therapy for individuals who are already infected with HIV.&#160;&#160;These vaccines are currently being evaluated in human clinical trials -- both in those infected with HIV and those who are not.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have neither received regulatory approval for any of our vaccine candidates, nor do we have any commercialization capabilities; therefore, it is possible that we may never successfully derive significant product revenues from any of our existing or future development programs or product candidates.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect for the foreseeable future our operations will result in a net loss on a quarterly and annual basis.&#160;&#160;As of December 31, 2012, we had an accumulated deficit of $24.8 million.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Critical Accounting Policies and Estimates</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates and adjusts the estimates as necessary. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our significant accounting policies are summarized in Note&#160;2 to our consolidated financial statements for the year ended December&#160;31, 2012. We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impairment of Long-Lived Assets</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future net cash flows expected to be generated by such assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the discounted expected future net cash flows from the assets.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue Recognition</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recognize revenue in accordance with the SEC&#8217;s Staff Accounting Bulletin&#160;No.&#160;101, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition in Financial Statements,</font> as amended by Staff Accounting Bulletin&#160;No.&#160;104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition</font> (&#8220;SAB 104&#8221;).&#160;&#160;SAB&#160;104 provides guidance in applying U.S.&#160;generally accepted accounting principles to revenue recognition issues, and specifically addresses revenue recognition for upfront, non-refundable fees received in connection with research collaboration agreements. Our revenue consists solely of grant funding received from the NIH. Revenue from this arrangement is approximately equal to the costs incurred and is recorded as income as the related costs are incurred.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based Compensation</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for stock-based transactions in which the Company receives services from employees, directors or others in exchange for equity instruments based on the fair value of the award at the grant date. Compensation cost for awards of common stock is estimated based on the price of the underlying common stock on the date of issuance. Compensation cost for stock options or warrants is estimated at the grant date based on each instrument&#8217;s fair-value as calculated by the Black-Scholes option pricing model. The Company recognizes stock-based compensation cost as expense ratably on a straight-line basis over the requisite service period for the award.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2012, we had cash and cash equivalents of $1,035,925 and total assets of $1,477,970, as compared to $1,167,980 and $1,645,142, respectively, at December&#160;31, 2011. Working capital totaled $1,017,439 at December 31, 2012, compared to $476,468 at December&#160;31, 2011.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Sources and Uses of Cash</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a development-stage company as defined by Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 915,&#160;&#160;&#8220;Development Stage Entities&#8221;&#160;&#160;and do not have any products approved for sale. Due to our significant research and development expenditures, we have not been profitable and have generated operating losses since our inception in 2001. Our primary sources of cash are from sales of our equity securities and from government grant funding.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash Flows from Operating Activities</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash used in operating activities was $2,441,247, $303,621, and $2,437,571 for the years ended December&#160;31, 2012, 2011 and 2010, respectively. Generally, the differences between periods are due to fluctuations in our net losses, offset by non-cash charges such as depreciation and stock-based compensation expense, and by net changes in our assets and liabilities.&#160;&#160;Our net losses generally fluctuate based on expenditures for our research activities, offset by government grant revenues.&#160;&#160;During 2011, net cash used in operating activities was lower (as compared to 2010 and 2012) due mostly to higher than usual offsets for net changes in assets and liabilities (primarily a $430,402 change in deferred offering costs and a $419,927 change in accounts payable and accrued expenses).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The NIH has funded the costs of conducting all of our completed and ongoing human clinical trials to date, except for our ongoing pilot Phase 1/2 therapeutic trial, with GeoVax incurring costs associated with manufacturing the clinical vaccine supplies and other study support.&#160;&#160;We expect the NIH will fund the costs of another Phase 1 therapeutic trial planned to begin in mid-2013. We are also having discussions with the HVTN and NIH with regard to the conduct of a Phase 2 efficacy trial of our preventive vaccine, and we expect the NIH will provide support for this trial as well.&#160;&#160;We cannot, however, predict the level of support we will receive from the HVTN or the NIH for any additional clinical trials.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to clinical trial support from the NIH, our operations are partially funded by NIH grants. We record the funding we receive pursuant to these grants as revenue at the time the related expenditures are incurred.&#160;&#160;In September 2007, the NIH awarded us an Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant to support our HIV/AIDS vaccine program.&#160;&#160;We are utilizing this funding to further our HIV/AIDS vaccine development, optimization and production.&#160;&#160;The original project period for the grant covered a five year period ending in August 2012, but was extended for an additional one year period.&#160;&#160;The aggregate award totaled $20.4 million, with approximately $1.6 million remaining and available for use as of December 31, 2012.&#160;&#160;In September 2012, the NIH awarded us an additional grant of $1.9 million to support development of versions of our HIV/AIDS vaccines to address the clade C subtype of the HIV virus prevalent in the developing world.&#160;&#160;The project period of this grant covers a one year period ending in August 2013.&#160;&#160;There is approximately $1.4 million from this grant remaining and available for use as of December 31, 2012.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are pursuing additional grants from the federal government. However, as we progress to the later stages of our vaccine development activities, government financial support may be more difficult to obtain, or may not be available at all. Therefore, it will be necessary for us to look to other sources of funding in order to finance our clinical trials and other vaccine development activities.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash Flows from Investing Activities</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our investing activities have consisted predominantly of capital expenditures. Capital expenditures for the years ended December&#160;31, 2012, 2011 and 2010, were $-0-, $11,896, and $4,706, respectively, and during 2010, we received $5,580 in proceeds from the sale of equipment.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash Flows from Financing Activities</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net cash provided by financing activities was $2,309,192, $404,410, and $-0- for the years ended December 31, 2012, 2011 and 2010, respectively.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2012, we sold 2,200 shares of Series A Convertible Preferred Stock to a group of institutional investors for an aggregate purchase price of $2.2 million, and five-year Class A warrants to purchase an aggregate of 2,933,333 shares of our common stock at $1.00 per share.&#160;&#160;The preferred stock is convertible at any time into shares of our common stock at $0.75 per share (originally 2,933,333 shares in the aggregate).&#160;&#160;We also granted to the investors one-year Class B warrants to purchase up to 2,933,333 of our common stock with an exercise price of $0.75 per share, and five-year Class C warrants to purchase up to 2,933,333 shares of our common stock at $1.00 per share.&#160;&#160;The Class B warrants were immediately exercisable upon issuance; the Class C warrants only become exercisable at the time, and to the extent, that the Class B warrants are exercised.&#160;&#160;During 2012 a total of 1,412 preferred shares were converted into 1,882,667 shares of common stock; as of December 21, 2012, there were 788 shares of preferred stock outstanding, convertible into 1,050,667 shares of common stock.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In January 2013, we reduced the exercise price of our then-outstanding Series B Common Stock Purchase Warrants. The exercise price for all the Series B Warrants was reduced from $0.75 to $0.60 per share.&#160;&#160;The exercise price for the Series A Warrants and Series C Warrants that were issued concurrently with the Series B Warrants did not change.&#160;&#160;In consideration for the reduction of the exercise price, the holders of the Series B Warrants immediately exercised 1,766,667 of the Series B Warrants for cash, resulting in total proceeds to the Company of $1,060,000.&#160;&#160;The expiration date of the remaining Series B Warrants with respect to 1,166,667 shares was extended from March 21, 2013 to May 21, 2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The cash generated by our financing activities during 2011 relates to the sale of our common stock to individual accredited investors in a private placement offering initiated during December 2011.&#160;&#160;During January 2012, we received an additional $310,160 from stock sales pursuant to this offering (including $36,800 received in payment of a stock subscription receivable from December 2011).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our capital requirements, particularly as they relate to product research and development, have been and will continue to be significant. We anticipate incurring additional losses for several years as we expand our drug development and clinical programs and proceed into higher cost human clinical trials. Conducting clinical trials for our vaccine candidates in development is a lengthy, time-consuming and expensive process. We will not generate revenues from the sale of our technology or products for at least several years, if at all. For the foreseeable future, we will be dependent on obtaining financing from third parties in order to maintain our operations, including our clinical program. Due to the existing uncertainty in the capital and credit markets, and adverse regional and national economic conditions that may persist or worsen, capital may not be available on terms acceptable to the Company or at all. If we fail to obtain additional funding when needed, we would be forced to scale back or terminate our operations, or to seek to merge with or to be acquired by another company.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect that our current working capital combined with the remaining available funds from the NIH grants will be sufficient to support our planned level of operations into the first quarter of 2014.&#160;&#160;We anticipate raising additional capital during 2013, although there can be no assurance that we will be able to do so. While we believe that we will be successful in obtaining the necessary financing to fund our operations through grants, exercise of options and warrants, and/or other sources, there can be no assurances that such additional funding will be available to us on reasonable terms or at all.&#160;&#160;Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences could have a material adverse effect on our business, operating results, financial condition and prospects.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have no off-balance sheet arrangements that are likely or reasonably likely to have a material effect on our financial condition or results of operations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Contractual Obligations</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Contractual obligations represent future cash commitments and liabilities under agreements with third parties, and exclude contingent liabilities for which we cannot reasonably predict future payment.&#160;&#160;Additionally, the expected timing of payment of the obligations presented below is estimated based on current information.&#160;&#160;Timing of payments and actual amounts paid may be different depending on the timing of receipt of goods or services or changes to agreed-upon terms or amounts for some obligations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table represents our contractual obligations as of December 31, 2012, aggregated by type (in thousands):</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt">
<table cellpadding="0" cellspacing="0" width="90%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="18" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Payments Due by Period</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contractual Obligations</font></div>
</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Less than</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1 Year</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-3</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4-5</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">More than</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5 years</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating Lease Obligations <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">254</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Firm Purchase Commitments <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(2)</font></font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">510</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">510</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Emory University</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#8211; License Agreement <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(3)</font></font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">764</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">635</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 9pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our operating lease obligations relate to the facility lease for our 8,430 square foot facility in Smyrna, Georgia, which houses our laboratory operations and our administrative offices.&#160;&#160;The lease, which was effective November 1, 2009, expires on December 31, 2014.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 9pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Firm purchase commitments relate to contracts for production and testing of our vaccine products, conduct of clinical trials, and other research-related activities.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 9pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the Emory License, we have committed to make potential future milestone and royalty payments which are contingent upon the occurrence of future events.&#160;&#160;Such events include development milestones, regulatory approvals and product sales.&#160;&#160;Because the achievement of these milestones is currently neither probable nor reasonably estimable, the contingent payments have not been included in the table above or recorded on our Consolidated Balance Sheets.&#160;&#160;The aggregate total of all potential milestone payments included in the Emory License (excluding royalties on net sales) is approximately $3.5 million.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December&#160;31, 2012, except as disclosed in the table above, we had no other material firm purchase obligations or commitments for capital expenditures and no committed lines of credit or other committed funding or long-term debt. We have employment agreements with our executive officers and a consulting agreement with a member of our Board of Directors, each of which may be terminated with no more than 90&#160;days advance written notice. The table also excludes budgeted expenses under our a research agreements with Emory University which are fully reimbursable to us pursuant to the IPCAVD grant from the NIH and cover a period of less than one year.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Operating Loss Carryforwards</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December&#160;31, 2012, we had consolidated net operating loss carryforwards for income tax purposes of $69.8 million, which will expire in 2013 through 2032 if not utilized. Approximately $51.9 million of our net operating loss carryforwards relate to the operations of our predecessor, Dauphin Technology, Inc. prior to the 2006 merger between Dauphin Technology, Inc. and GeoVax, Inc. We also have research and development tax credits of approximately $764,000 available to reduce income taxes, if any, which will expire in 2022 through 2031 if not utilized. The amount of net operating loss carryforwards and research tax credits available to reduce income taxes in any particular year may be limited in certain circumstances. Based on an assessment of all available evidence including, but not limited to, our limited operating history in our core business and lack of profitability, uncertainties of the commercial viability of our technology, the impact of government regulation and healthcare reform initiatives, and other risks normally associated with biotechnology companies, we have concluded that it is more likely than not that these net operating loss carryforwards and credits will not be realized and, as a result, a 100% deferred tax valuation allowance has been recorded against these assets.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of Operations</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net Loss</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded net losses of $2,135,140, $2,346,826, and $2,747,328 for the years ended December 31, 2012, 2011 and 2010, respectively. Our operating results typically fluctuate due to the timing of activities and related costs associated with our vaccine research and development activities and our general and administrative costs, as described in more detail below.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Grant Revenue</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded grant revenues of $2,657,327, $4,899,885, and $5,185,257 for the years ended December 31, 2012, 2011 and 2010, respectively.&#160;&#160;Grant revenues for all three years relate to grants from the NIH for our vaccine development activities, except that 2010 includes $244,479 related to our receipt of a Qualified Therapeutic Discover Program (QTDP) grant.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2007, the NIH awarded us an IPCAVD grant to support our HIV/AIDS vaccine development, optimization and production.&#160;&#160;The original project period for the grant covered a five year period ending in August 2012, but was extended for an additional one year period.&#160;&#160;The aggregate award totaled $20.4 million and there is approximately $1.6 million remaining and available for use as of December 31, 2012.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2012, the NIH awarded us an additional grant of $1.9 million to support development of versions of our HIV/AIDS vaccines for the clade C subtype of the HIV virus prevalent in the developing world.&#160;&#160;The project period of this grant covers a one year period ending in August 2013.&#160;&#160;There is approximately $1.4 million from this grant remaining and available for use as of December 31, 2012.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and Development</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our research and development expenses were $3,043,522, $4,276,375, and $4,793,956 for the years ended December&#160;31, 2012, 2011 and 2010, respectively. Research and development expense for these periods includes stock-based compensation expense of $78,140, $179,400, and $206,501 for 2012, 2011 and 2010, respectively (see discussion under &#8220;Stock-Based Compensation Expense&#8221; below).&#160;&#160;Our research and development costs do not include costs incurred by the HVTN in conducting clinical trials of our vaccines; those costs are funded directly by the NIH.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our research and development expenses can fluctuate considerably on a period-to-period basis, depending on our need for vaccine manufacturing by third parties, the timing of expenditures related to our grants from the NIH, and the timing of costs associated with clinical trials being funding directly by us.&#160;&#160;The recently completed Phase 2a clinical trial for our preventive vaccine was conducted and funded by the HVTN as is the ongoing Phase 1 clinical trial of our second generation preventive vaccine, but we are responsible for the manufacture of vaccine product to be used in the trials.&#160;&#160;We are not currently receiving any government support for the ongoing Phase 1 clinical trial of our therapeutic vaccine (treatment interruption protocol).&#160;&#160;We cannot predict the level of support we may receive from HVTN or other federal agencies (or divisions thereof) for our future clinical trials.&#160;&#160;We expect that our research and development costs will increase in the future as we progress into the later stage human clinical trials leading up to possible product approval by the FDA.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since our inception, all of our research and development efforts have been focused on development of our HIV/AIDS vaccines, which we have managed and evaluated to date as a single project.&#160;&#160;Upon receipt of the IPCAVD grant from the NIH in late 2007, we began incurring additional costs associated with the grant, and reallocated personnel and other internal resources toward activities supported by the grant.&#160;&#160;The table below summarizes our research and development expenses for each of the years in the three year period ended December&#160;31, 2012. The amounts shown related to NIH grants represent all direct costs associated with grant activities, including salaries and personnel-related expenses, supplies, consulting, contract services and travel. The remainder of our research and development expense is allocated to our general HIV/AIDS vaccine program.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt">
<table cellpadding="0" cellspacing="0" width="90%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">R&amp;D Project</font></font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIH Grant Activities</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,837,085</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,015,812</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,385,193</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">DNA/MVA Vaccines &#8211; HIV/AIDS</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,206,437</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,260,563</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,408,763</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total Research and Development Expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,043,522</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,276,375</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,793,956</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our vaccine candidates still require significant, time-consuming and costly research and development, testing and regulatory clearances. Completion of clinical development will take several years or more, but the length of time generally varies substantially according to the type, complexity, novelty and intended use of a product candidate. The NIH has funded the costs of conducting all of our completed and ongoing human clinical trials to date, except for our ongoing pilot Phase 1/2 therapeutic trial, with GeoVax incurring costs associated with manufacturing the clinical vaccine supplies and other study support.&#160;&#160;We expect the NIH will fund the costs of another Phase 1 therapeutic trial which we anticipate will start in mid-2013. We are also having discussions with the HVTN and NIH with regard to the conduct of a planned Phase 2 efficacy trial of our preventive vaccine, and we expect the NIH will provide support for this trial as well.&#160;&#160;We intend to seek government and/or third party support for future clinical human trials, but there can be no assurance that we will be successful. The duration and the cost of future clinical trials may vary significantly over the life of the project as a result of differences arising during development of the human clinical trial protocols, including, among others:</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the number of patients that ultimately participate in the clinical trial;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the duration of patient follow-up that seems appropriate in view of the results;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the number of clinical sites included in the clinical trials; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the length of time required to enroll suitable patient subjects.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Due to the uncertainty regarding the timing and regulatory approval of clinical trials and pre-clinical studies, our future expenditures are likely to be highly volatile in future periods depending on the outcomes of the trials and studies. From time to time, we will make determinations as to how much funding to direct to these programs in response to their scientific, clinical and regulatory success, anticipated market opportunity and the availability of capital to fund our programs.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In developing our product candidates, we are subject to a number of risks that are inherent in the development of products based on innovative technologies. For example, it is possible that our vaccines may be ineffective or toxic, or will otherwise fail to receive the necessary regulatory clearances, causing us to delay, extend or terminate our product development efforts. Any failure by us to obtain, or any delay in obtaining, regulatory approvals could cause our research and development expenditures to increase which, in turn, could have a material adverse effect on our results of operations and cash flows. Because of the uncertainties of clinical trials, estimating the completion dates or cost to complete our research and development programs is highly speculative and subjective. As a result of these factors, we are unable to accurately estimate the nature, timing and future costs necessary to complete the development of our product candidates. In addition, we are unable to reasonably estimate the period when material net cash inflows could commence from the sale, licensing or commercialization of such product candidates, if ever.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and Administrative Expense</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our general and administrative expenses were $1,752,765, $2,972,555, and $3,162,134 for the years ended December&#160;31, 2012, 2011 and 2010, respectively. General and administrative costs include officers&#8217; salaries, legal and accounting costs, patent costs, amortization expense associated with intangible assets, and other general corporate expenses. General and administrative expense includes stock-based compensation expense of $231,936, $593,597, and $544,031 for 2012, 2011 and 2010, respectively (see discussion under &#8220;Stock-Based Compensation Expense&#8221; below). The decline in general and administrative expense from 2011 to 2012 is primarily due to lower legal costs, patent costs and stock-based compensation expense related to investment advisory fees and investor warrant extensions.&#160;&#160;However, we expect that our general and administrative costs may increase in the future in support of expanded research and development activities and other general corporate activities.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based Compensation Expense</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recorded total stock-based compensation expense of $310,076, $772,997, and $750,532 during the years ended December&#160;31, 2012, 2011 and 2010, respectively, which was allocated to research and development expense or general and administrative expense according to the classification of cash compensation paid to the employee, consultant or director to whom the stock compensation was granted. In addition to amounts related to the issuance of stock options to employees, the figures include amounts related to common stock and stock purchase warrants issued to consultants and non-employee directors. The overall decline in stock-based compensation expense during 2012, as compared to 2011 and 2010, can be attributed to expense in the prior years associated with stock issuances for investment advisory fees, warrants granted to investor relations consultants, and extensions to investor warrants.&#160;&#160;For the three years ended December 31, 2012, stock-based compensation expense was allocated as follows:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt">
<table cellpadding="0" cellspacing="0" width="90%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">231,936</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">593,597</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">544,031</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78,140</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179,400</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206,501</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stock option expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">310,076</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">772,997</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">750,532</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other Income</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Interest income was $3,820, $2,219, and $23,505 for the years ended December&#160;31, 2012, 2011 and 2010, respectively. The variances between years are primarily attributable to the cash available for investment and to interest rate fluctuations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impact of Inflation</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three year period ended December&#160;31, 2012, we do not believe that inflation and changing prices had a material impact on our operations or on our financial results.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off-Balance Sheet Arrangements</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have not entered into off-balance sheet financing arrangements, other than operating leases.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 7A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our exposure to market risk is limited primarily to interest income sensitivity, which is affected by changes in the general level of United States interest rates, particularly because a significant portion of our investments are in institutional money market funds.&#160;&#160;The primary objective of our investment activities is to preserve principal while at the same time maximizing the income received without significantly increasing risk.&#160;&#160;Due to the nature of our short-term investments, we believe that we are not subject to any material market risk exposure.&#160;&#160;We do not have any derivative financial instruments or foreign currency instruments.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our consolidated financial statements and supplemental schedule and notes thereto as of December 31, 2012 and 2011, and for each of the three years ended December 31, 2012, 2011 and 2010, and from inception through December 31, 2012, together with the independent registered public accounting firms&#8217; reports thereon, are set forth on pages F-1 to F-18 of this Annual Report on Form 10-K.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND FINANCIAL DISCLOSURE</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no disagreements with our accountants on matters of accounting or financial disclosure, or other reportable events requiring disclosure under this Item 9.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 9A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Evaluation of Disclosure Controls and Procedures</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We maintain disclosure controls and procedures designed to ensure that financial information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized, and reported within the required time periods, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding disclosure.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">An evaluation was performed by our Chief Executive Officer and Chief Financial Officer of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2012.&#160;&#160;Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of December 31, 2012 to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Management&#8217;s Report on Internal Control Over Financial Reporting</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) of the Exchange Act.&#160;&#160;Management has assessed the effectiveness of our internal control over financial reporting as of December 31, 2012 based on criteria established in <font style="FONT-STYLE: italic">Internal Control Integrated Framework</font> issued by the Committee of Sponsoring Organizations of the Treadway Commission.&#160;&#160;As a result of this assessment, management concluded that, as of December 31, 2012, our internal control over financial reporting was effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in Internal Control Over Financial Reporting</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Limitations on Controls</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud.&#160;&#160;Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met.&#160;&#160;Further, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 9B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;OTHER INFORMATION</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">PART III</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Information required by this Item is included in our definitive proxy statement for our 2013 meeting of shareholders to be filed with the SEC under the captions &#8220;Directors and Executive Officers&#8221; and &#8220;Corporate Governance&#8221; and is incorporated herein by this reference.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Code of Ethics</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have adopted a Code of Ethics in compliance with the applicable rules of the SEC that applies to our principal executive officer, our principal financial officer and our principal accounting officer or controller, or persons performing similar functions.&#160;&#160;A copy of this policy is available on our website at <font style="FONT-STYLE: italic; DISPLAY: inline">www.geovax.com</font> under the heading&#160;&#160;&#8220;Investors &#8211; Corporate Governance&#8221; and is also available free of charge upon written request to the attention of our Corporate Secretary by regular mail, e-mail to mreynolds@geovax.com, or facsimile at (678) 384-7281. We intend to disclose any amendment to, or a waiver from, a provision of our code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions and that relates to any element of the code of ethics enumerated in applicable rules of the SEC.&#160;&#160;Such disclosures will be made on our website at <font style="FONT-STYLE: italic; DISPLAY: inline">www.geovax.com</font>.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2013 meeting of shareholders to be filed with the SEC under the captions &#8220;Corporate Governance&#8221; and &#8220;Compensation Discussion and Analysis&#8221; and is incorporated herein by this reference.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 12.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AND RELATED STOCKHOLDER MATTERS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2013 meeting of shareholders to be filed with the SEC under the captions &#8220;Security Ownership of Principal Stockholders, Directors and Executive Officers&#8221; and &#8220;Securities Authorized for Issuance under Equity Compensation Plans&#8221; and is incorporated herein by this reference.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 13.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS,</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB1" style="MARGIN-LEFT: 54pt"></font>AND DIRECTOR INDEPENDENCE</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2013 meeting of shareholders to be filed with the SEC under the captions &#8220;Corporate Governance&#8221; and &#8220;Certain Relationships and Related Party Transactions&#8221; and is incorporated herein by this reference.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information required by this Item is included in our definitive proxy statement for our 2013 meeting of shareholders to be filed with the SEC under the caption &#8220;Ratification of Appointment of the Independent Registered Public Accounting Firm&#8221; and is incorporated herein by this reference.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="2%">&#160;</td>
<td colspan="3" valign="top" width="98%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">PART IV</font></font></div>
</td>
</tr><tr>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" colspan="3" valign="top" width="97%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 15.&#160;&#160;&#160;&#160; <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</font></font></font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(a)&#160;&#160;</font></td>
<td align="left" colspan="2" valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Documents filed as part of this report:</font></font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="4%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td align="left" valign="top" width="91%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statements</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Page</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reports of Independent Registered Public Accounting Firms on Financial Reporting</font></div>
</td>
<td valign="top" width="3%">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-2</font></font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Balance Sheets as of December 31, 2012 and 2011</font></div>
</td>
<td valign="top" width="3%">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-4</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Operations for the years ended December 31, 2012, 2011 and 2010</font></font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2012</font></div>
</td>
<td valign="top" width="3%">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-5</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Stockholders&#8217; Equity (Deficiency) for the Period from</font></font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inception (June 27, 2001) to December 31, 2012</font></div>
</td>
<td valign="top" width="3%">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-6</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Cash Flows for the years ended December 31, 2012, 2011 and 2010</font></font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2012</font></div>
</td>
<td valign="top" width="3%">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-9</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notes to Consolidated Financial Statements</font></div>
</td>
<td valign="top" width="3%">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-10</font></font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statement Schedules</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td colspan="2" valign="top" width="94%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The following financial statement schedule is set forth on page F-18 of this Annual Report on Form 10-K:</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td colspan="2" valign="top" width="94%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Schedule II&#8212;Valuation and Qualifying Accounts for the years ended December 31, 2012, 2011 and 2010</font></font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td colspan="2" valign="top" width="94%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All other financial statement schedules have been omitted because they are not applicable or not required or because the information is included elsewhere in the Consolidated Financial Statements or the Notes thereto.</font></font></div>
</td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibits</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%">&#160;</td>
<td align="left" valign="top" width="4%">&#160;</td>
<td colspan="2" valign="top" width="94%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See Item 15(b) below. Each management contract or compensatory plan or arrangement required to be filed has been identified.</font></font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="91%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="top" width="2%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(b)</font></font></div>
</td>
<td align="left" valign="top" width="4%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibits</font></div>
</td>
<td align="left" valign="top" width="91%">&#160;</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div align="left">&#160;</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exhibit</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Number</font>&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.1</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Agreement and Plan of Merger dated January 20, 2006 by and among GeoVax, Inc., GeoVax Acquisition Corp. and Dauphin Technology, Inc. (1)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.2</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">First Amendment to Agreement and Plan of Merger (2)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.3</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Second Amendment to Agreement and Plan of Merger (3)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.1</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Incorporation (6)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.1.1</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Amendment to the Certificate of Incorporation of GeoVax Labs, Inc. filed April 13, 2010 (10)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.1.2</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Amendment to the Certificate of Incorporation of GeoVax Labs, Inc. filed April 27, 2010 (11)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.2</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Bylaws (6)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.1</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock filed March 20, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.2</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Stock Certificate for the Series A Convertible Preferred Stock (13)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.1 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Employment Agreement between GeoVax Labs, Inc. and Robert T. McNally effective as of April 1, 2008 (7)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.2 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Employment Agreement between GeoVax, Inc. and Mark W. Reynolds Amended and Restated effective as of January 1, 2010 (9)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.3 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Employment Agreement between GeoVax, Inc. and Harriet Robinson effective as of November 19, 2007 (9)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.4 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax Labs, Inc. 2006 Equity Incentive Plan (4)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.5</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">License Agreement (as amended and restated) between GeoVax, Inc. and Emory University, dated August 23, 2002 (3)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.6</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Technology Sale and Patent License Agreement between GeoVax, Inc. and MFD, Inc., dated December 26, 2004 (3)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.7</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office and Laboratory Lease between UCB, Inc. and GeoVax, Inc. (8)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.8 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Summary of the GeoVax Labs, Inc. Director Compensation Plan (9)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.9</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Warrant dated December 30, 2011 (12)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.10</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Securities Purchase Agreement dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.11</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Registration Rights Agreement dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.12</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Series A Warrant dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.13</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Series B Warrant dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.14</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Series C Warrant dated March 16, 2012 (13)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.15</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Warrant Reset Offer Agreements dated January 17, 2013 (14)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14.1</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Code of Ethics (5)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21.1</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subsidiaries of the Registrant (5)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.1 **</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.2 **</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.1 **</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 45pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.2 **</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 63pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101 **,***</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following financial information from GeoVax Labs, Inc. Annual Report on Form 10-K for the year ended December 31, 2012, formatted in Extensible Business Reporting Langue (XBRL):&#160;&#160;(i) Consolidated Balance Sheets as of December 31, 2012 and December 31, 2011, (ii) Consolidated Statements of Operations for the years ended December 31, 2012, 2011 and 2010 and for the period from inception (June 27, 2001) to December 31, 2012, (iii) Consolidated Statements of Stockholders' Equity (Deficiency) for the period from inception (June 27, 2001) to December 31, 2012, (iv) Consolidated Statements of Cash Flows for the years ended Dec ember 31, 2012, 2011 and 2010 and for the period from Inception (June 27, 2001) to December 31, 2012, and (v) Notes to Condensed Consolidated Financial Statements.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<hr style="COLOR: black" align="left" noshade size="1" width="10%">
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Indicates a management contract or compensatory plan or arrangement.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">**&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Filed herewith.</font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">***</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended and otherwise are not subject to liability under those sections.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed January 24, 2006.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed July 13, 2006.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed October 4, 2006.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s definitive Information Statement (Schedule 14C) filed August 18, 2006.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Annual Report on Form 10-K filed March 28, 2007.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed June 23, 2008.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(7)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed March 24, 2008.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(8)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Quarterly Report on Form 10-Q filed November 6, 2009.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(9)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Annual Report on Form 10-K filed March 8, 2010.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(10)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed April 14, 2010.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(11)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed April 28, 2010.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(12)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed January 5, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(13)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed March 22, 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(14)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Incorporated by reference from the registrant&#8217;s Current Report on Form 8-K filed January 17, 2013.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="24%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></font></font></div>
</td>
<td valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="22%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="2%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="22%" style="BORDER-BOTTOM: black 2px solid">/s/ Robert T. McNally&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </td>
<td valign="top" width="26%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="24%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. McNally</font></font></div>
</td>
<td valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="24%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></font></td>
<td valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="24%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Executive Officer)</font></font></div>
</td>
<td valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="24%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="24%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date:&#160;&#160;March 15, 2013</font></font></div>
</td>
<td valign="top" width="26%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><br>
&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been duly signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Signature / Name</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ Robert T. McNally</font></font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 15, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. McNally</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Executive Officer)</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ Mark W. Reynolds</font></font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 15, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark W. Reynolds</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Financial and Accounting Officer)</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ David A. Dodd</font></font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 15, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">David A. Dodd</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ Dean G. Kollintzas</font></font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 15, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dean G. Kollintzas</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ Robert T. McNally</font></font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 15, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Robert T. McNally</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ Harriet L. Robinson</font></font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 15, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Harriet L. Robinson</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ John N. Spencer, Jr.</font></font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="top" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 15, 2013</font></div>
</td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">John N. Spencer, Jr.</font></div>
</td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="18%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="17%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="45%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exhibit</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Number</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.1 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.2 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.1 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.2 *</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101 *,**</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following financial information from GeoVax Labs, Inc. Annual Report on Form 10-K for the year ended December 31, 2012, formatted in Extensible Business Reporting Langue (XBRL):&#160;&#160;(i) Consolidated Balance Sheets as of December 31, 2012 and December 31, 2011, (ii) Consolidated Statements of Operations for the years ended December 31, 2012, 2011 and 2010 and for the period from inception (June 27, 2001) to December 31, 2012, (iii) Consolidated Statements of Stockholders' Equity (Deficiency) for the period from inception (June 27, 2001) to December 31, 2012, (iv) Consolidated Statements of Cash Flows for the years ended Dec ember 31, 2012, 2011 and 2010 and for the period from Inception (June 27, 2001) to December 31, 2012, and (v) Notes to Condensed Consolidated Financial Statements.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<hr style="COLOR: black" align="left" noshade size="1" width="10%">
</div>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Filed herewith.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">**</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended and otherwise are not subject to liability under those sections.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="WIDTH: 100%" align="left">&#160;</div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE)</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INDEX TO 2012 CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reports of Independent Registered Public Accounting Firms on Financial Statements</font></div>
</td>
<td valign="top" width="5%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-2</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Balance Sheets as of December 31, 2012 and 2011</font></div>
</td>
<td valign="top" width="5%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-4</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Operations for the years ended December 31, 2012, 2011 and 2010 </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2012</font></font></div>
</div>
</td>
<td valign="top" width="5%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-5</font></td>
</tr><tr bgcolor="white">
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Stockholders&#8217; Equity (Deficiency) for the Period from </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inception (June 27, 2001) to December 31, 2012</font></font></div>
</div>
</td>
<td valign="top" width="5%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-6</font></td>
</tr><tr bgcolor="white">
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consolidated Statements of Cash Flows for the years ended December 31, 2012, 2011 and 2010 </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and for the Period from Inception (June 27, 2001) to December 31, 2012</font></font></div>
</div>
</td>
<td valign="top" width="5%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-8</font></td>
</tr><tr bgcolor="white">
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Notes to Consolidated Financial Statements</font></div>
</td>
<td valign="top" width="5%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-9</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial Statement Schedule:</font></div>
</td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Schedule II &#8211; Valuation and Qualifying Accounts for the years ended</font></div>
</td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="top" width="95%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012, 2011 and 2010</font></div>
</td>
<td valign="top" width="5%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-18</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="95%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ON FINANCIAL STATEMENTS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To the Board of Directors</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax Labs, Inc.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Atlanta, Georgia</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have audited the accompanying consolidated balance sheets of GeoVax Labs, Inc. and subsidiary (a development stage company) (the &#8220;Company&#8221;) as of December 31, 2012 and 2011, and the related consolidated statements of operations, stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2012, and for the period of time considered part of the development stage from June 27, 2001 to December 31, 2012, except we did not audit the Company&#8217;s financial statements for the period from June 27, 2001 to December 31, 2005 which were audited by other auditors. Our audits also included the financial statement schedule of the Company listed in Item 15(a).&#160;&#160;These financial statements and financial statement schedule are the responsibility of the Company&#8217;s management.&#160;&#160;Our responsibility is to express an opinion on these financial statements based on our audits.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).&#160;&#160;Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.&#160;&#160;The Company is not required to have, nor were we engaged to perform an audit of its internal control over financial reporting.&#160;&#160;Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion of the effectiveness of the Company&#8217;s internal control over financial reporting.&#160;&#160;Accordingly, we express no such opinion.&#160;&#160;An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.&#160;&#160;We believe that our audits provide a reasonable basis for our opinion.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of GeoVax Labs, Inc. and subsidiary as of December 31, 2012 and 2011, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2012, and for the period of time considered part of the development stage from June 27, 2001 to December 31, 2012, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/S/ PORTER KEADLE MOORE LLC</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Atlanta, Georgia</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">March 7, 2013</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ON FINANCIAL STATEMENTS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Board of Directors</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax, Inc.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Atlanta, Georgia</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have audited the statements of operations, stockholders&#8217; deficiency and cash flows of GeoVax, Inc. (a Georgia corporation in the development stage) for the period from inception (June 27, 2001) to December 31, 2005.&#160;&#160;These financial statements are the responsibility of the Company&#8217;s management.&#160;&#160;Our responsibility is to express an opinion on these financial statements based on our audit.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States).&#160;&#160;Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.&#160;&#160;An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.&#160;&#160;An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.&#160;&#160;We believe that our audit provides a reasonable basis for our opinion.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: justify; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our opinion, the financial statements of GeoVax, Inc. referred to above present fairly, in all material respects, the results of its operations, changes in stockholders&#8217; deficiency and cash flows for the period from inception (June 27, 2001) to December&#160;31, 2005, in conformity with accounting principles generally accepted in the United States of America.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/s/ TRIPP, CHAFIN &amp; COMPANY, LLC</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Marietta, Georgia</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">February 8, 2006</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED BALANCE SHEETS</font></font></font></div>
</div>
</div>

<br>
</div>

<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="6" valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" width="70%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ASSETS</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current assets:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,035,925</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,167,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant funds receivable</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">266,248</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">183,515</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,301</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,508</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total current assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,344,474</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,418,003</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net of accumulated depreciation and amortization</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,486</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Licenses, net of accumulated amortization of $228,856 and $208,933 </font>at December 31, 2012 and 2011 respectively</div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39,923</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deposits and other assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total other assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,933</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,477,970</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,645,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>163,788</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>138,339</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33,877</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125,869</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts payable to Emory University (a related party)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129,370</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">677,327</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total current liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">327,035</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">941,535</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Commitments (Note 4)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217; equity:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preferred stock, $.01 par value, 10,000,000 shares authorized; </font>Series A Convertible Preferred Stock, $1,000 stated value; </font>788 and -0- shares issued and outstanding at December 31, 2012 </font>and December 31, 2011, respectively</font></div>
</div>
</div>
</div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">312,196</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock, $.001 par value, 40,000,000 shares authorized; </font>18,733,277 and 16,442,611 shares issued and outstanding at December 31, 2012 and 2011, respectively</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,733</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,443</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional paid-in capital</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,587,148</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,319,166</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit accumulated during the development stage</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,767,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,632,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stockholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,150,935</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">703,607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total liabilities and stockholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,477,970</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12pt"></font>1,645,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.7pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.7pt"><br>
&#160;</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS. INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF OPERATIONS</font></font></font></div>
</div>

<br>
</div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years Ended December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From Inception</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(June 27, 2001) to</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.3pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant revenue</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,657,327</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,899,885</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,185,257</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,969,019</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,043,522</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>4,276,375</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,793,956</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.9pt"></font>28,674,198</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,752,765</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>2,972,555</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,162,134</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.9pt"></font>19,400,424</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,796,287</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.3pt"></font>7,248,930</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,956,090</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.9pt"></font>48,074,622</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss from operations</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,138,960</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,349,045</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,770,833</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 6pt"></font>(25,105,603</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other income (expense):</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest income</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 23.15pt"></font>3,820</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.65pt"></font>2,219</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.45pt"></font>23,505</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 32.3pt"></font>344,130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 53.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 48.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36.75pt"></font>(5,669</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 23.15pt"></font>3,820</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.65pt"></font>2,219</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.45pt"></font>23,505</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 31.55pt"></font>338,461</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,135,140</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,767,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss per common share</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.09</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="48%" style="TEXT-ALIGN: left; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average shares outstanding</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,315,669</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,735,541</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,651,308</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 15.65pt"></font>11,871,955</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td colspan="16" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIENCY)</font></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
</div>
</div>
</div>

<div align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="31%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="6" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Series A Convertible</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preferred Stock</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="6" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="11%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subscription</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">During the</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" width="31%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid-in Capital</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Receivable</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Deficiency)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Capital contribution at inception (June 27, 2001)</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the period ended December 31, 2001</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(170,592</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(170,592</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2001</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 34pt"></font>10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(170,592</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(170,582</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,789,954</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>2,790</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 8.45pt"></font>(2,320</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 27.35pt"></font>470</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for technology license</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>704,534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>705</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>148,151</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>148,856</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2002</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(618,137</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(618,137</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2002</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,494,488</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>3,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>145,841</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(788,729</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(639,393</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,229,278</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>1,229</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,458,380</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,459,609</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2003</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(947,804</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(947,804</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2003</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,723,766</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>4,724</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,604,221</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,736,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>872,412</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash and stock </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">subscription receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,482,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>1,483</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,988,436</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,750,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>239,919</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash payments received on stock subscription receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.5pt"></font>750,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>750,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for technology license</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.2pt"></font>49,420</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 35.55pt"></font>49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>99,951</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>100,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2004</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,351,828</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,351,828</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2004</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,255,791</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>6,256</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,692,608</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,000,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,088,361</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(389,497</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash payments received on stock subscription receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2005</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,611,086</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,611,086</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2005</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,255,791</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>6,256</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,692,608</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,699,447</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(500,583</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash payments received on stock subscription receivable</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.5pt"></font>500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversion of preferred stock to common stock</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,550,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>3,551</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,071,565</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,075,116</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock issued in connection with merger</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,359,891</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>4,360</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,708,489</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,712,849</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for cashless warrant exercise</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.2pt"></font>56,825</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 35.55pt"></font>57</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 25.1pt"></font>(57</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2006</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(584,166</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(584,166</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2006</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,223,358</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12.2pt"></font>14,224</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,472,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,283,613</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,203,216</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>406,729</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>407</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,162,543</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,162,950</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash upon stock option exercise</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 15.9pt"></font>2,471</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.2pt"></font>2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.35pt"></font>4,998</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.35pt"></font>5,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,518,496</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,518,496</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2007</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,241,796</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,241,796</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2007</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,632,558</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12.2pt"></font>14,633</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,158,642</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10,525,409</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,647,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>306,419</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>306</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,770,785</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,771,091</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for services</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.2pt"></font>10,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 35.55pt"></font>10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>73,990</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>74,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,945,049</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,945,049</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2008</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,728,187</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,728,187</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2008</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,948,977</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12.2pt"></font>14,949</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,948,466</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,253,596</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,709,819</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>216,261</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>216</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,519,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,520,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash upon warrant exercise</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>462,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,499,537</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for services</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 15.9pt"></font>4,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.2pt"></font>5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>31,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>31,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,267,165</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,267,165</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2009</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,284,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2009</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,632,564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12.2pt"></font>15,633</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,266,447</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17,537,848</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,744,232</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC. </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIENCY)</font></font></font></div>
</div>
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="31%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="6" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Series A Convertible</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Preferred Stock</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="6" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common Stock</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="11%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subscription</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deficit</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">During the</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Development</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" width="31%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amount</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Paid-in Capital</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Receivable</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stage</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td colspan="2" valign="bottom" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Deficiency)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2009</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,632,564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,633</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,266,447</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17,537,848</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,744,232</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock in lieu of cash payment</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.2pt"></font>12,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 35.55pt"></font>12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>89,988</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>90,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for services</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.2pt"></font>10,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 35.55pt"></font>10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>53,803</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10.65pt"></font>53,813</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>696,719</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>696,719</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fractional share cash payout upon reverse split</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17pt"></font>(218</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 8.45pt"></font>(1,210</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 8.45pt"></font>(1,210</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.15pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,654,846</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12.2pt"></font>15,655</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,105,747</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,285,176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,836,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>658,520</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>659</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>440,551</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>441,210</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock for services</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>129,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>149,871</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>622,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>622,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="31%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2011</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,442,611</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 12.2pt"></font>16,443</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,319,166</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,632,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>703,607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of common stock for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.55pt"></font>407,999</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>408</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>272,952</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>273,360</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sale of convertible preferred stock and warrants for cash</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>2,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.05pt"></font>871,614</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,127,418</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,999,032</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversion of preferred stock to common stock</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 10pt"></font>(1,412</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(559,418</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,882,667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.9pt"></font>1,882</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>557,536</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>310,076</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4pt"></font>310,076</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="31%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the year ended December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.95pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 42.9pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 41.4pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,135,140</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,135,140</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="31%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.9pt"></font>788</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">312,196</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,733,277</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,733</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25,587,148</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,767,142</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,150,935</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS. INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE) </font></font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></font></font></div>
</div>

<br>
</div>

<div style="TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years Ended December 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From Inception</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(June 27, 2001) to</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" width="52%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.3pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from operating activities:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="10%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,135,140</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,346,826</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,747,328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,767,142</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments to reconcile net loss to net cash </font>used in operating activities:</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation and amortization</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.2pt"></font>93,643</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>109,017</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>119,773</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.3pt"></font>659,280</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -18pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accretion of preferred stock redemption value</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.3pt"></font>346,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense, </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">including common stock issued for services</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>310,076</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 3.8pt"></font>772,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>750,532</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>6,669,815</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in assets and liabilities:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 8%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant funds receivable</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.35pt"></font>(82,733</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>290,760</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(153,954</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.4pt"></font>(266,248</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 8%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prepaid expenses and other current assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.35pt"></font>(12,593</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.95pt"></font>19,122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.75pt"></font>(4,215</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 24.1pt"></font>(42,301</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 8%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred offering costs</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(430,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 65.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 8%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deposits</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.65pt"></font>980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 3.1pt"></font>(11,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 24.1pt"></font>(11,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 8%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable and accrued expenses</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(614,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>419,927</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.95pt"></font>39,033</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.3pt"></font>415,825</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 8%">
<div style="TEXT-ALIGN: left; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total adjustments</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(306,107</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,043,205</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>309,757</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>7,772,034</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash used in operating activities</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,441,247</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(303,621</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,437,571</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 0.75pt"></font>(16,995,108</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from investing activities:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of property and equipment</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.35pt"></font>(11,896</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.75pt"></font>(4,706</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.4pt"></font>(538,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of property and equipment</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.65pt"></font>5,580</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 39.65pt"></font>5,580</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided (used) by investing activities</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 43.45pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 3.1pt"></font>(11,896</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.65pt"></font>874</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 17.4pt"></font>(532,910</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash flows from financing activities:</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of common stock</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.55pt"></font>310,160</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>404,410</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.65pt"></font>15,836,468</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of preferred stock</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,999,032</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>2,727,475</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 2%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided by financing activities</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,309,192</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5.3pt"></font>404,410</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 44.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.65pt"></font>18,563,943</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net increase (decrease) in cash and cash equivalents</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(132,055</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.95pt"></font>88,893</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,436,697</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.3pt"></font>1,035,925</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at beginning of period</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,167,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,079,087</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,515,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 65.2pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at end of period</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,035,925</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,167,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,079,087</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,035,925</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supplemental disclosure of cash flow information</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest paid</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,669</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -2.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Supplemental disclosure of non-cash investing and financing activities:&#160; </font></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -2.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In connection with the Merger discussed in Note 5, all of the then outstanding shares of the Company&#8217;s mandatory redeemable convertible preferred stock were converted into shares of common stock as of September 28, 2006.&#160; </font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -2.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: -2.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As discussed in Note 6, during 2012, an aggregate of 1,412 shares of the Company&#8217;s outstanding Series A Convertible Preferred Stock were converted into 1,882,667 shares of common stock.</font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See accompanying notes to consolidated financial statements.</font></div>

<br>
<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(A DEVELOPMENT-STAGE ENTERPRISE)</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Years Ended December 31, 2012, 2011 and 2010 and</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Period from Inception (June 27, 2001) to December 31, 2012</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nature of Business</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax Labs, Inc. (&#8220;GeoVax&#8221; or the &#8220;Company&#8221;), is a biotechnology company developing vaccines that prevent and fight Human Immunodeficiency Virus (&#8220;HIV&#8221;) infections.&#160;&#160;HIV infections result in Acquired Immunodeficiency Syndrome (&#8220;AIDS&#8221;).&#160;&#160;We have exclusively licensed from Emory University (&#8220;Emory&#8221;) vaccine technology which was developed in collaboration with the National Institutes of Health (&#8220;NIH&#8221;) and the Centers for Disease Control and Prevention (&#8220;CDC&#8221;).&#160;&#160;GeoVax is incorporated under the laws of the State of Delaware and our principal offices are located in Smyrna, Georgia (metropolitan Atlanta area).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our most advanced vaccines under development address the clade B subtype of the HIV virus that is most prevalent in the United States and the developed world.&#160;&#160;Our vaccines are being evaluated to determine their potential to (a) prevent HIV infection and (b) to serve as a therapy for individuals who are already infected with HIV.&#160;&#160;These vaccines are currently being evaluated in humans -- both in those infected with HIV and those who are not.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As discussed in Note 2, the Company is a development-stage enterprise and we are devoting substantially all of our present efforts to research and development.&#160;&#160;We have funded our activities to date from government grants and clinical trial assistance, and from sales of our equity securities. We will continue to require substantial funds to continue these activities.&#160;&#160;We anticipate that our existing cash resources, combined with the proceeds from the NIH grant discussed in Note 3 and the financing events discussed in Note 11, should be sufficient to fund our operations into the first quarter of 2014.&#160;&#160;In order to meet our operating cash flow requirements, we intend to conduct additional offerings of our equity securities or convertible debt instruments. We are also seeking additional funding for our research programs through government grant funding mechanisms.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Summary of Significant Accounting Policies</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basis of Presentation and Principles of Consolidation</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our primary business is conducted by our wholly-owned subsidiary, GeoVax, Inc. The accompanying consolidated financial statements include the accounts of GeoVax, Inc. from inception together with those of GeoVax Labs, Inc. from September 28, 2006 (see Note 5).&#160;&#160;All intercompany transactions have been eliminated in consolidation.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Development-Stage Enterprise</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are devoting all of our present efforts to research and development and GeoVax is a development stage enterprise as defined by Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 915, <font style="FONT-STYLE: italic; DISPLAY: inline">Development Stage Entities</font>.&#160;&#160;All losses accumulated since inception (June 27, 2001) have been considered as part of our development stage activities.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Use of Estimates</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;&#160;Actual results may differ from those estimates.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash and Cash Equivalents</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We consider all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.&#160;&#160;Our cash and cash equivalents consist primarily of bank deposits and money market accounts.&#160;&#160;The recorded values approximate fair market values due to the short maturities.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair Value of Financial Instruments and Concentration of Credit Risk</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial instruments that subject us to concentration of credit risk consist primarily of cash and cash equivalents, which are maintained by a high credit quality financial institution. The carrying values reported in the balance sheets for cash and cash equivalents approximate fair values.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and Equipment</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and equipment are stated at cost, less accumulated depreciation and amortization.&#160;&#160;The components of property and equipment as of December 31, 2012 and 2011 are as follows:</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory equipment</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other furniture, fixtures &amp; equipment</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total property and equipment</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated depreciation and amortization</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(429,804</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(356,084</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,486</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expenditures for maintenance and repairs are charged to operations as incurred, while additions and improvements are capitalized.&#160;&#160;Depreciation is computed using the straight-line method over the estimated useful lives of the assets which range from three to five years.&#160;&#160;Amortization of leasehold improvements is computed using the straight-line method over the remaining term of the related lease.&#160;&#160;Depreciation and amortization expense was $73,720, $84,131, and $94,887 during the years ended December 31, 2012, 2011 and 2010, respectively.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other Assets</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other assets consist principally of license agreements for the use of technology obtained through the issuance of the Company&#8217;s common stock.&#160;&#160;These license agreements are amortized on a straight line basis over ten years.&#160;&#160;Amortization expense related to these agreements was $19,923, $24,886, and $24,886 during years ended December 31, 2012, 2011, and 2010, respectively, and is expected to be $10,000, $10,000, $-0-, $-0-, and $-0- for each of the next five years, respectively.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impairment of Long-Lived Assets</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.&#160;&#160;Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future net cash flows expected to be generated by such assets.&#160;&#160;If we consider such assets to be impaired, the impairment to be<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>recognized is measured by the amount by which the carrying amount of the assets exceeds the expected future net cash flows from the assets.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accrued Liabilities</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As part of the process of preparing our financial statements, we estimate expenses that we believe we have incurred, but have not yet been billed by our third party vendors. This process involves identifying services and activities that have been performed by such vendors on our behalf and estimating the level to which they have been performed and the associated cost incurred for such service as of each balance sheet date in our financial statements. Examples of expenses for which we accrue include fees for professional services and fees owed to contract manufacturers in conjunction with the manufacture of vaccines for our clinical trials. We make these estimates based upon progress of activities related to contractual obligations and information received from vendors.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net Loss Per Share</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic and diluted loss per common share are computed based on the weighted average number of common shares outstanding. All common share equivalents (which consist of options and warrants) are excluded from the computation of diluted loss per share since the effect would be anti-dilutive. Common share equivalents which could potentially dilute basic earnings per share in the future, and which were excluded from the computation of diluted loss per share, totaled approximately 12.3 million, 2.8 million, and 2.0 million at December 31, 2012, 2011 and 2010, respectively.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue Recognition</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recognize revenue in accordance with the SEC&#8217;s Staff Accounting Bulletin No. 101, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition in Financial Statements, </font>as amended by Staff Accounting Bulletin No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue Recognition, </font>(&#8220;SAB 104&#8221;). SAB 104 provides guidance in applying GAAP to revenue recognition issues, and specifically addresses revenue recognition for upfront, nonrefundable fees received in connection with research collaboration agreements.&#160;&#160;During 2012, 2011 and 2010, our revenue consisted of grant funding received primarily from the NIH (see Note 3).&#160;&#160;Revenue from this arrangement is approximately equal to the costs incurred and is recorded as income as the related costs are incurred.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and Development Expense</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expense primarily consists of costs incurred in the discovery, development, testing and manufacturing of our product candidates. These expenses consist primarily of (i) fees paid to third-party service providers to perform, monitor and accumulate data related to our preclinical studies and clinical trials, (ii) costs related to sponsored research agreements, (iii) the costs to procure and manufacture materials used in clinical trials, (iv) laboratory supplies and facility-related expenses to conduct development, and (v) salaries, benefits, and share-based compensation for personnel.&#160;&#160;These costs are charged to expense as incurred.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patent Costs</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our expenditures relating to obtaining and protecting patents are charged to expense when incurred, and are included in general and administrative expense.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Period to Period Comparisons</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our operating results are expected to fluctuate for the foreseeable future. Therefore, period-to-period comparisons should not be relied upon as predictive of the results for future periods.&#160;&#160;Certain prior year amounts have been reclassified to conform to the current year financial statement presentation.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income Taxes</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for income taxes using the liability method. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;&#160;Deferred tax assets and liabilities are measured using enacted rates in effect for the year in which temporary differences are expected to be recovered or settled.&#160;&#160;Deferred tax assets are reduced by a valuation allowance unless, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will be realized.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based Compensation</font><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We account for stock-based transactions in which the Company receives services from employees, directors or others in exchange for equity instruments based on the fair value of the award at the grant date.&#160;&#160;Compensation cost for awards of common stock is estimated based on the price of the underlying common stock on the date of issuance.&#160;&#160;Compensation cost for stock options or warrants is estimated at the grant date based on each instrument&#8217;s fair value as calculated by the Black-Scholes option pricing model.&#160;&#160;We recognize stock-based compensation cost as expense ratably on a straight-line basis over the requisite service period for the award.&#160;&#160;See Note 6 for additional stock-based compensation information.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recent Accounting Pronouncements</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There have been no recent accounting pronouncements or changes in accounting pronouncements which we expect to have a material impact on our financial statements, nor do we believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on our financial statements.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Government Grants</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NIH Grants</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2007, the NIH awarded us an Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant to support our HIV/AIDS vaccine program.&#160;&#160;We are utilizing this funding to further our HIV/AIDS vaccine development, optimization and production.&#160;&#160;The original project period for the grant covered a five year period ending in August 2012, but was extended for an additional one year period.&#160;&#160;The aggregate award totaled $20.4 million, with approximately $1.6 million remaining and available for use as of December 31, 2012.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2012, the NIH awarded us an additional grant of $1.9 million to support development of versions of our HIV/AIDS vaccines to address the clade C subtype of the HIV virus prevalent in the developing world.&#160;&#160;The project period of this grant covers a one year period ending in August 2013.&#160;&#160;There is approximately $1.4 million from this grant remaining and available for use as of December 31, 2012.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We record revenue associated with these grants as the related costs and expenses are incurred and such revenue is reported as a separate line item in our statements of operations.&#160;&#160;During 2012, 2011, and 2010, we recorded $2,657,327, $4,899,885, and $4,940,778, respectively, of revenue associated with these grants.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">QTDP Grant</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In November 2010, we were awarded a one-time grant of $244,479 pursuant to the Qualifying Therapeutic Discovery Project (QTDP) program enacted as part of the Patient Protection and Affordable Care Act of 2010.&#160;&#160;The QTDP program was intended to provide incentive to smaller companies who are focusing on innovative therapeutic discoveries.&#160;&#160;We received the full amount of the grant during 2010, which is recorded as revenue for 2010 in the accompanying Consolidated Statement of Operations.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Commitments</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Lease Agreements</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We lease approximately 8,400 square feet of office and laboratory space located in Smyrna, Georgia (metropolitan Atlanta). Rent expense for the years ended December 31, 2012, 2011 and 2010 was $118,801, $119,255, and $118,988, respectively.&#160;&#160;Future minimum lease payments pursuant to the 62 month lease total $125,180 in 2013 and $128,920 in 2014.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other Commitments</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the normal course of business, we may enter into various firm purchase commitments related to production and testing of our vaccine material, conduct of clinical trials, and other research-related activities. As of December 31, 2012, we had approximately $510,000 of unrecorded outstanding purchase commitments to our vendors and subcontractors, all of which we expect will be due in 2013.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2006 Merger and Recapitalization</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company was originally incorporated in June 1988 under the laws of Illinois as Dauphin Technology, Inc. (&#8220;Dauphin&#8221;).&#160;&#160;Dauphin was unsuccessful and its operations were terminated in December 2003.&#160;&#160;In September 2006, Dauphin completed a merger (the &#8220;Merger&#8221;) with GeoVax, Inc. which was incorporated under the laws of Georgia in June 2001.&#160;&#160;As a result of the Merger, the shareholders of GeoVax, Inc. exchanged their shares of common stock for Dauphin common stock and GeoVax, Inc. became a wholly-owned subsidiary of Dauphin.&#160;&#160;Dauphin then changed its name to GeoVax Labs, Inc. and replaced its officers and directors with those of GeoVax, Inc.&#160;&#160;Subsequent to the Merger, the Company has not conducted any business other than GeoVax, Inc.&#8217;s business of developing human vaccines.&#160;&#160;The Merger was accounted for under the purchase method of accounting as a reverse acquisition in accordance with GAAP. Under this method of accounting, Dauphin was treated as the acquired company and, accordingly, all financial information prior to the date of Merger presented in the accompanying consolidated financial statements, or in the notes herein, as well as any references to prior operations, are those of GeoVax, Inc.&#160;&#160;In June 2008, the Company was reincorporated under the laws of Delaware.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stockholders&#8217; Equity</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Series A Convertible Preferred Stock</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Certificate of Incorporation authorizes us to issue up to 10,000,000 shares of preferred stock, $.01 par value.&#160;&#160;In March 2012, we established from the authorized preferred stock a series of preferred stock, consisting of 2,200 shares of Series A Convertible Preferred Stock, $1,000 stated value (&#8220;Series A Preferred Shares&#8221;) and entered into a Securities Purchase Agreement (&#8220;SPA&#8221;) whereby we issued to three institutional investors (&#8220;Purchasers&#8221;) the Series A Preferred Shares for gross proceeds of $2.2 million.&#160;&#160;Net proceeds to the Company from this transaction, after deduction of placement agent fees and other expenses, were approximately $2.0 million.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Series A Preferred Shares may be converted at any time at the option of the Purchasers into shares of our common stock at a conversion price of $0.75 per share (&#8220;Conversion Price&#8221;), for an initial aggregate total of 2,933,333 shares of our common stock (&#8220;Conversion Shares&#8221;).&#160;&#160;The Series A Preferred Shares have a liquidation preference equal to the initial purchase price, have no voting rights, and are not entitled to a dividend.&#160;&#160;Through December 31, 2012, a total of 1,412 Series A Preferred Shares have been converted into 1,882,667 shares of our common stock.&#160;&#160;As of December 31, 2012, there were 788 shares of Series A Preferred Shares outstanding, convertible into 1,050,667 shares of our common stock.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the terms of the SPA, we issued to each Purchaser Series A, B and C Warrants (collectively, the &#8220;Warrants&#8221;), each to purchase up to a number of shares of our common stock equal to 100% of the Conversion Shares underlying the Series A Preferred Shares (up to 2,933,333 shares in the aggregate for each of the three series of warrants, or 8,799,999 shares in total) (&#8220;Warrant Shares&#8221;).&#160;&#160;The Series A Warrants have an exercise price of $1.00 per share, are exercisable immediately, and expire on March 21, 2017.&#160;&#160;The Series B Warrants have an exercise price of $0.75 per share, are exercisable immediately, and expire on March 21, 2013. The Series C Warrants have an exercise price of $1.00 per share and expire on March 21, 2017, but only vest and become exercisable upon, and in proportion to, the exercise of the one-year Series B Warrants.&#160;&#160;The Warrants contain anti-dilution provisions, which may, under certain circumstances, reduce the exercise price (but have no effect on the number of shares subject to the Warrants) if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the exercise price of the Warrants, or if we announce plans to do so.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the sale of the Series A Preferred Shares, we entered into a Registration Rights Agreement (&#8220;RRA&#8221;) with the Purchasers, pursuant to which we filed a registration statement with the Securities and Exchange Commission (&#8220;SEC&#8221;) on April 3, 2012 covering resale of the Conversion Shares and the Warrant Shares.&#160;&#160;&#160;It was declared effective by the SEC on April 13, 2012</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Accounting Treatment and Allocation of Proceeds</font>.&#160;&#160;We first assessed the Series A Preferred Shares under ASC Topic 480, &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Distinguishing Liabilities from Equity</font>&#8221; (&#8220;ASC 480&#8221;) and determined such preferred stock not to be a liability under ASC 480.&#160;&#160;We next assessed the preferred stock under ASC Topic 815. &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Derivatives and Hedging</font>&#8221; (&#8220;ASC 815&#8221;).&#160;&#160;The preferred stock contains an embedded feature allowing an optional conversion by the holder into common stock which meets the definition of a derivative.&#160;&#160;However, we believe that the preferred stock is an &#8220;equity host&#8221; (as described by ASC 815) for purposes of assessing the embedded derivative for potential bifurcation and determined that the optional conversion feature is clearly and closely associated to the preferred stock host; we therefore determined that the embedded derivative does not require bifurcation and separate recognition under ASC 815.&#160;&#160;We then assessed the preferred stock under ASC Topic 470, &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Debt</font>&#8221; (&#8220;ASC 470&#8221;), and determined there to be a beneficial conversion feature (&#8220;BCF&#8221;) requiring recognition at its intrinsic value.&#160;&#160;Since the conversion option of the preferred stock was immediately exercisable, the amount allocated to the BCF was immediately accreted to preferred dividends, resulting in an increase in the carrying value of the preferred stock.&#160;&#160;We also assessed the warrants issued in connection with the financing under ASC 815 and determined that they did not initially meet the definition of a derivative, but will require evaluation on an on-going basis.&#160;&#160;As of December 31, 2012, we determined that the warrants still did not meet the definition of a derivative.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following is a summary of the allocation of the net proceeds from the preferred stock financing, and reconciliation to the carrying value at December 31, 2012:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt">
<div align="left">
<table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net proceeds after transaction costs</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,999,032</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less:&#160;&#160;&#160;&#160;&#160; &#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair value of warrants (recorded to Additional Paid-in Capital)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,127,418</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beneficial conversion feature (recorded to Additional Paid-in Capital)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(762,667</font></font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net proceeds allocated to preferred stock</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108,947</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accretion of beneficial conversion feature (deemed dividend)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">762,667</font></font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial carrying value of preferred stock</font></div>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">871,614</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversions to common stock</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(559,418</font></font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying value of preferred stock at December 31, 2012</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">312,196</font></font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Common Stock Transactions</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2010, we issued 12,000 shares of our common stock in settlement of an obligation accrued at December 31, 2009 in the amount of $90,000.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During December 2011, we sold an aggregate of 658,520 shares of our common stock to a group of individual accredited investors (including members of our board of directors and management --see Note 9) for an aggregate purchase price of $441,210, $36,800 of which was received in January 2012 and is therefore reflected as a receivable (Other Current Asset) in the accompanying Consolidated Balance Sheet as of December 31, 2011.&#160;&#160;We also issued to the investors warrants to purchase an aggregate of 987,783 shares of common stock at a price of $1.00 per share, which expire in December 2016.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During January 2012, we sold an aggregate of 407,999 shares of our common stock to a group of individual accredited investors (including members of our board of directors and management --see Note 9) for an aggregate purchase price of $273,360.&#160;&#160;We also issued to the investors warrants to purchase an aggregate of 612,001 shares of common stock at a price of $1.00 per share, which expire in January 2017.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, we issue shares of our common stock to consultants or others in exchange for services.&#160;&#160;During 2012, 2011 and 2010 we issued -0-, 129,245, and 10,500 shares, respectively, for such services; and we recorded general and administrative expense of $-0-, $150,000, and $53,813 during each respective period related to these issuances.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock Options</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2006, we adopted the GeoVax Labs, Inc. 2006 Equity Incentive Plan (the &#8220;Stock Option Plan&#8221;) for the granting of qualified incentive stock options (&#8220;ISO&#8217;s&#8221;), nonqualified stock options, restricted stock awards or restricted stock bonuses to employees, officers, directors, consultants and advisors of the Company.&#160;&#160;The exercise price for any option granted may not be less than fair value (110% of fair value for ISO&#8217;s granted to certain employees).&#160;&#160;Options granted under the Stock Option Plan have a maximum ten-year term and generally vest over three years.&#160;&#160;The Company has reserved 1,200,000 shares of its common stock for issuance under the Stock Option Plan.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A summary of activity under the Stock Option Plan as of December 31, 2012, and changes during the year then ended is presented below:</font></div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of Shares</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term (yrs)</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2011</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">928,242</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.43</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">238,500</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>0.70</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(97,601</font></td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>4.02</font></td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2012</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,069,141</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.50</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>6.2</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable at December 31, 2012</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">698,995</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.38</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>4.6</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional information concerning our stock options for the years ended December 31, 2012, 2011 and 2010 is as follows:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average fair value of options granted during the period</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.59</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.79</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.95</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic value of options exercised during the period</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total fair value of options vested during the period</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">319,920</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">540,339</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">499,557</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We use the Black-Scholes model for determining the grant date fair value of our stock option grants.&#160;&#160;This model utilizes certain information, such as the interest rate on a risk-free security with a term generally equivalent to the expected life of the option being valued and requires certain other assumptions, such as the expected amount of time an option will be outstanding until it is exercised or expired, to calculate the fair value of stock options granted.&#160;&#160;The significant assumptions we used in our fair value calculations were as follows:</font></div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average risk-free interest rates</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected dividend yield</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected life of option (yrs)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7 </font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7 </font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: right">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7 </font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected volatility</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-based compensation expense related to the Stock Option Plan was $310,076, $463,752, and $575,662 during the years ended December 31, 2012, 2011 and 2010, respectively.&#160;&#160;Stock option expense is allocated to research and development expense or to general and administrative expense based on the related employee classifications and corresponds to the allocation of employee salaries.&#160;&#160;For the three years ended December 31, 2012, stock option expense was allocated as follows:</font></div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">231,936</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">284,352</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">369,161</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78,140</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179,400</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206,501</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total stock option expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">310,076</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463,752</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575,662</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of December 31, 2012, there was $271,901 of unrecognized compensation expense related to stock-based compensation arrangements.&#160;&#160;The unrecognized compensation expense is expected to be recognized over a weighted average remaining period of 2.1 years.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock Purchase Warrants</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have issued stock purchase warrants in connection with financing transactions and also in exchange for services from consultants and others.&#160;&#160;The following table presents a summary of stock purchase warrant transactions during the year ended December 31, 2012:</font></div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted Average</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise Price</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2011</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,870,559</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.96</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued &#8211; Series A Warrants (1)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued &#8211; Series B Warrants (1)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.75</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued &#8211; Series C Warrants (1)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued &#8211; Other Warrants (2)</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">612,001</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited or expired</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(57,000</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding at December 31, 2012</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,225,559</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable at December 31, 2012</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,290,376</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.44</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)&#160;&#160;&#160;&#160;&#160;&#160;See discussion under &#8220;Series A Convertible Preferred Stock&#8221; above.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)&#160;&#160;&#160;&#160;&#160;&#160;See discussion under &#8220;Common Stock Transactions&#8221; above.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For stock purchase warrants issued to consultants or others in exchange for services, we record the related expense over the service period, or upon the date, that the service was rendered.&#160;&#160;Expense associated with such compensatory warrants was $-0-, $7,119, and $121,057 during the years ended December 31, 2012, 2011 and 2010, respectively All such expense was allocated to general and administrative expense.&#160;&#160;As of December 31, 2012, there was no unrecognized compensation expense related to compensatory warrants. .&#160;&#160;In addition to compensatory warrant expense, during 2011 we recorded $152,126 of general and administrative expense associated with the extension of certain investor warrants which were due to expire in 2011 to 2013.&#160;&#160;In January 2013, certain modifications were made to the terms of the Class B Warrants in exchange for the exercise of a portion of those warrants (see Note 11).</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Retirement Plan</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We participate in a multi-employer defined contribution retirement plan (the &#8220;401k Plan&#8221;) administered by a third party service provider; and the Company contributes to the 401k Plan on behalf of its employees based upon a matching formula.&#160;&#160;During the years ended December 31, 2012, 2011 and 2010 our contributions to the 401k Plan were $50,500, $56,928, and $52,632, respectively.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income Taxes</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At December 31, 2012, we have a consolidated federal net operating loss (&#8220;NOL&#8221;) carryforward of approximately $69.8 million, available to offset against future taxable income which expires in varying amounts in 2013 through 2032.&#160;&#160;Additionally, we have approximately $764,000 in research and development (&#8220;R&amp;D&#8221;) tax credits that expire in 2022 through 2031 unless utilized earlier.&#160;&#160;No income taxes have been paid to date.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As a result of the Merger discussed in Note 5, our NOL carryforward increased substantially due to the addition of historical NOL carryforwards for Dauphin Technology, Inc.&#160;&#160;However, Section 382 of the Internal Revenue Code contains provisions that may limit our utilization of NOL and R&amp;D tax credit carryforwards in any given year as a result of significant changes in ownership interests that have occurred in past periods or may occur in future periods.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.&#160;&#160;Significant components of our deferred tax assets and liabilities included the following at December 31, 2012 and 2011:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets:</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net operating loss carryforward</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,429,472</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,872,082</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development tax credit carryforward</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,965</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,690</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,097,194</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,991,769</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total deferred tax assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,290,631</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,627,541</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,125</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36,311</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total deferred tax liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,125</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36,311</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net deferred tax assets</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,274,506</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,230</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation allowance</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,274,506</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,591,230</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have established a full valuation allowance equal to the amount of our net deferred tax assets due to uncertainties with respect to our ability to generate sufficient taxable income to realize these assets in the future. A reconciliation of the income tax benefit on losses at the U.S. federal statutory rate to the reported income tax expense is as follows:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S. federal statutory rate applied to pretax loss</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(725,948</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(797,921</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(934,092</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Permanent differences</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 32.15pt"></font>2,674</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,216</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 19.6pt"></font>(77,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development credits</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 57.7pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,675</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 28.45pt"></font>59,959</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change in valuation allowance</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.8pt"></font>723,274</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">761,030</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 21.8pt"></font>951,333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reported income tax expense</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are obligated to reimburse Emory University (a significant stockholder of the Company) for ongoing costs in connection with the filing, prosecution and maintenance of patent applications subject to a license agreement for technology associated with the vaccines we are developing.&#160;&#160;The expense associated with these ongoing patent cost reimbursements to Emory amounted to $89,885, $249,907, and $193,674 for the years ended December 31, 2012, 2011, and 2010, respectively.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with our IPCAVD grant from the NIH (see Note 3), we have entered into two subcontracts with Emory for the purpose of conducting research and development activities related to the grant.&#160;&#160;During 2012, 2011, and 2010, we recorded $552,403, $1,172,758, and $1,391,203, respectively, of expense associated with these subcontracts.&#160;&#160;All amounts paid to Emory under these subcontracts are reimbursable to us pursuant to the NIH grant.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2008, we entered into a consulting agreement with Donald Hildebrand, a former member of our Board of Directors and our former President &amp; Chief Executive Officer, pursuant to which Mr. Hildebrand has provided business and technical advisory services to the Company.&#160;&#160;The term of the consulting agreement, as amended, began on April 1, 2008 and ended on December 31, 2012.&#160;&#160;During 2012, 2011, and 2010, we recorded $24,000, $24,000, and $57,600, respectively, of expense associated with the consulting agreement.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December 2011 and January 2012, members of our management and Board of Directors participated in the private placement offering of our common stock and warrants (see Note 6), whereby they purchased an aggregate of 380,954 shares of our common stock for a total purchase price of $255,239 and received five-year warrants to purchase an additional 571,432 shares of our common stock exercisable at $1.00 per share.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selected Quarterly Financial Data (unaudited)</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A summary of selected quarterly financial data for 2012 and 2011 is as follows:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012 Quarter Ended</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue from grants</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">854,063</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">705,698</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">638,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">459,566</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(730,513</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(497,763</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(296,779</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(610,085</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss per share</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011 Quarter Ended</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue from grants</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">893,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,753,033</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,297,006</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">956,844</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(606,282</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(211,344</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(375,852</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,153,348</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss per share</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent Events</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Warrant Modification and Exercise</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Effective January 17, 2013, we reduced the exercise price of our then-outstanding Series B Common Stock Purchase Warrants (see Note 6).&#160;&#160;The exercise price for all the Series B Warrants was reduced from $0.75 to $0.60 per share.&#160;&#160;The exercise price for the Series A Warrants and Series C Warrants that were issued concurrently with the Series B Warrants did not change.&#160;&#160;In consideration for the reduction of the exercise price, the holders of the Series B Warrants immediately exercised 1,766,667 of the Series B Warrants for cash, resulting in total proceeds to the Company of $1,060,000.&#160;&#160;The expiration date of Series B Warrants with respect to the remaining 1,166,667 shares was extended from March 21, 2013 to May 21, 2013.&#160;&#160;In January 2013, we recorded general and administrative expense of $218,551 associated with the warrant modifications.</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div id="PGBRK" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; WIDTH: 100%; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div style="WIDTH: 100%" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>

<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE II &#8211; VALUATION AND QUALIFYING ACCOUNTS</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the Years Ended December 31, 2012, 2011 and 2010</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left" align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Description</font></div>
</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beginning</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of Period</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged to</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Costs and</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expenses</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged to</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deductions</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">&#160;</td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">End</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of Period</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve Deducted in the Balance Sheet</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From the Asset to Which it Applies:</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowance for Deferred Tax Assets</font></div>
</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td colspan="2" valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9pt"></font>Year ended December 31, 2012</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,230</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">796,237</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,112,961</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,274,506</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9pt"></font>Year ended December 31, 2011</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.1pt"></font>888,561</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 46.75pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 0.2pt"></font>(873,584</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,230</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9pt"></font>Year ended December 31, 2010</font></div>
</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,091,338</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 1.1pt"></font>1,160,405</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 46.75pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 0.2pt"></font>(675,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deductions represent the effect of expiring NOL carryforwards from prior years.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: center">F - 18</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
    <title>ex31-1.htm</title>
    <!--Licensed to: rdg filings-->
    <!--Document Created using EDGARizerAgent 5.4.3.1-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 31.1</font></div>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO RULE 13a-14(a) or 15d-14(a)</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Robert T. McNally, certify that:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this annual report on Form 10-K of GeoVax Labs, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 15, 2013&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Robert T. McNally</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Robert T. McNally</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; President and Chief Executive Officer</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
    <title>ex31-2.htm</title>
    <!--Licensed to: rdg filings-->
    <!--Document Created using EDGARizerAgent 5.4.3.1-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 31.2</font></div>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO RULE 13a-14(a) or 15d-14(a)</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Mark W. Reynolds, certify that:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this annual report on Form 10-K of GeoVax Labs, Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 54pt">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: left; WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 15, 2013&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Mark W. Reynolds</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark W. Reynolds</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chief Financial Officer</font></div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: left">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
    <title>ex32-1.htm</title>
    <!--Licensed to: rdg filings-->
    <!--Document Created using EDGARizerAgent 5.4.3.1-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 32.1</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO 18 U.S.C. SECTION 1350</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO SECTION 906</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the annual report of GeoVax Labs, Inc. (the "Company") on Form 10-K for the year ended December&#160;31, 2012, I, Robert T. McNally, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that to the best of my knowledge:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The annual report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 15, 2013&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Robert T. McNally</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Robert T. McNally</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; President and Chief Executive Officer</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
    <title>ex32-2.htm</title>
    <!--Licensed to: rdg filings-->
    <!--Document Created using EDGARizerAgent 5.4.3.1-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: left"><br>
</div>

<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 32.2</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO 18 U.S.C. SECTION 1350</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AS ADOPTED PURSUANT TO SECTION 906</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OF THE SARBANES-OXLEY ACT OF 2002</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the annual report of GeoVax Labs, Inc. (the "Company") on Form 10-K for the year ended December&#160;31, 2012, I, Mark W. Reynolds, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that to the best of my knowledge:</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The annual report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">
<td style="TEXT-ALIGN: left; WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;March 15, 2013&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="TEXT-DECORATION: underline"><font style="DISPLAY: inline">/s/ Mark W. Reynolds</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mark W. Reynolds</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 288pt"></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Chief Financial Officer</font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>govx-20121231.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 14 22:47:45 UTC 2013 -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:govx="http://geovax.com/20121231" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:compsci="http://compsciresources.com" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="govx-20121231.xsd"/>
  <context id="c0_AsOf31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c1_AsOf31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c3_AsOf31Dec2011_SeriesAConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c4_From1Jan2012To31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c5_From1Jan2011To31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c6_From1Jan2010To31Dec2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c7_From27Jun2001To31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c8_From27Jun2001To31Dec2001_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="c9_From27Jun2001To31Dec2001">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="c10_From27Jun2001To31Dec2001_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2001-06-27</startDate>
      <endDate>2001-12-31</endDate>
    </period>
  </context>
  <context id="c11_AsOf31Dec2001_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="c12_AsOf31Dec2001_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="c13_AsOf31Dec2001">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2001-12-31</instant>
    </period>
  </context>
  <context id="c14_From1Jan2002To31Dec2002_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c15_From1Jan2002To31Dec2002_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c16_From1Jan2002To31Dec2002">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c17_From1Jan2002To31Dec2002_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2002-01-01</startDate>
      <endDate>2002-12-31</endDate>
    </period>
  </context>
  <context id="c18_AsOf31Dec2002_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c19_AsOf31Dec2002_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c20_AsOf31Dec2002_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c21_AsOf31Dec2002">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2002-12-31</instant>
    </period>
  </context>
  <context id="c22_From1Jan2003To31Dec2003_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c23_From1Jan2003To31Dec2003_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c24_From1Jan2003To31Dec2003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c25_From1Jan2003To31Dec2003_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2003-01-01</startDate>
      <endDate>2003-12-31</endDate>
    </period>
  </context>
  <context id="c26_AsOf31Dec2003_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c27_AsOf31Dec2003_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c28_AsOf31Dec2003_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c29_AsOf31Dec2003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2003-12-31</instant>
    </period>
  </context>
  <context id="c30_From1Jan2004To31Dec2004_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c31_From1Jan2004To31Dec2004_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c32_From1Jan2004To31Dec2004_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c33_From1Jan2004To31Dec2004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c34_From1Jan2004To31Dec2004_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="c35_AsOf31Dec2004_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c36_AsOf31Dec2004_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c37_AsOf31Dec2004_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c38_AsOf31Dec2004_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c39_AsOf31Dec2004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="c40_From1Jan2005To31Dec2005_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="c41_From1Jan2005To31Dec2005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="c42_From1Jan2005To31Dec2005_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="c43_AsOf31Dec2005_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c44_AsOf31Dec2005_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c45_AsOf31Dec2005_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c46_AsOf31Dec2005_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c47_AsOf31Dec2005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="c48_From1Jan2006To31Dec2006_StockSubscriptionReceivableMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">govx:StockSubscriptionReceivableMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c49_From1Jan2006To31Dec2006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c50_From1Jan2006To31Dec2006_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c51_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c52_From1Jan2006To31Dec2006_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c53_AsOf31Dec2006_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c54_AsOf31Dec2006_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c55_AsOf31Dec2006_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c56_AsOf31Dec2006">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="c57_From1Jan2007To31Dec2007_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c58_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c59_From1Jan2007To31Dec2007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c60_From1Jan2007To31Dec2007_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="c61_AsOf31Dec2007_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c62_AsOf31Dec2007_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c63_AsOf31Dec2007_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c64_AsOf31Dec2007">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="c65_From1Jan2008To31Dec2008_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c66_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c67_From1Jan2008To31Dec2008">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c68_From1Jan2008To31Dec2008_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="c69_AsOf31Dec2008_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c70_AsOf31Dec2008_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c71_AsOf31Dec2008_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c72_AsOf31Dec2008">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c73_From1Jan2009To31Dec2009_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c74_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c75_From1Jan2009To31Dec2009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c76_From1Jan2009To31Dec2009_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="c77_AsOf31Dec2009_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c78_AsOf31Dec2009_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c79_AsOf31Dec2009_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c80_AsOf31Dec2009">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c81_From1Jan2010To31Dec2010_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c82_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c83_From1Jan2010To31Dec2010_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c84_AsOf31Dec2010_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c85_AsOf31Dec2010_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c86_AsOf31Dec2010_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c87_AsOf31Dec2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c88_From1Jan2011To31Dec2011_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c89_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c90_From1Jan2011To31Dec2011_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c91_AsOf31Dec2011_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c92_AsOf31Dec2011_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c93_AsOf31Dec2011_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c94_From1Jan2012To31Dec2012_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c95_From1Jan2012To31Dec2012_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c96_From1Jan2012To31Dec2012_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c97_From1Jan2012To31Dec2012_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c98_AsOf31Dec2012_SeriesAPreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c99_AsOf31Dec2012_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c100_AsOf31Dec2012_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c101_AsOf31Dec2012_AccumulatedDeficitDuringDevelopmentStageMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c102_AsOf15Mar2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2013-03-15</instant>
    </period>
  </context>
  <context id="c103_AsOf30Jun2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2012-06-30</instant>
    </period>
  </context>
  <context id="c104_From1Jan2012To31Dec2012_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c105_From1Jan2012To31Dec2012_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c106_From1Jan2010To31Dec2010_LicensingAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c107_From1Jan2012To31Dec2012_LicensingAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c108_From1Jan2011To31Dec2011_LicensingAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c109_AsOf31Dec2012_LicensingAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c110_AsOf31Dec2012_LaboratoryEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">govx:LaboratoryEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c111_AsOf31Dec2011_LaboratoryEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">govx:LaboratoryEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c112_AsOf31Dec2012_LeaseholdImprovementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c113_AsOf31Dec2011_LeaseholdImprovementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c114_AsOf31Dec2012_OtherFurnitureFixturesAndEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">govx:OtherFurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c115_AsOf31Dec2011_OtherFurnitureFixturesAndEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">govx:OtherFurnitureFixturesAndEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c116_From1Oct2007To31Aug2012_FirstNIHGrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:FirstNIHGrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2007-10-01</startDate>
      <endDate>2012-08-31</endDate>
    </period>
  </context>
  <context id="c117_From1Sep2012To31Aug2013_FirstNIHGrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:FirstNIHGrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-09-01</startDate>
      <endDate>2013-08-31</endDate>
    </period>
  </context>
  <context id="c118_AsOf31Dec2012_FirstNIHGrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:FirstNIHGrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c119_From1Sep2012To31Aug2013_SecondNIHGrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:SecondNIHGrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-09-01</startDate>
      <endDate>2013-08-31</endDate>
    </period>
  </context>
  <context id="c120_AsOf31Dec2012_SecondNIHGrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:SecondNIHGrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c121_From1Jan2012To31Dec2012_NIHGrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:NIHGrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c122_From1Jan2011To31Dec2011_NIHGrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:NIHGrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c123_From1Jan2010To31Dec2010_NIHGrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:NIHGrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c124_From1Jan2010To31Dec2010_QTDPGrantMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">govx:QTDPGrantMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c125_From1Jan2012To31Dec2012_SeriesAConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c126_AsOf31Mar2012_SeriesAConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-03-31</instant>
    </period>
  </context>
  <context id="c127_From1Apr2012To31Dec2012_SeriesAConvertiblePreferredStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c128_AsOf31Dec2012_SeriesAWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesAWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c129_AsOf31Dec2012_SeriesBWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesBWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c130_AsOf31Dec2012_SeriesCWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesCWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c131_From1Feb2010To28Feb2010">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2010-02-01</startDate>
      <endDate>2010-02-28</endDate>
    </period>
  </context>
  <context id="c132_From1Dec2011To31Dec2011_IndividualAccreditedInvestorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="govx:SaleOfCommonStockAxis">govx:IndividualAccreditedInvestorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-12-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c133_From1Jan2012To31Jan2012_IndividualAccreditedInvestorsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="govx:SaleOfCommonStockAxis">govx:IndividualAccreditedInvestorsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-01-31</endDate>
    </period>
  </context>
  <context id="c134_From1Jan2012To31Dec2012_CommonStockIssuedForServicesMember_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:CommonStockIssuedForServicesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c135_From1Jan2011To31Dec2011_CommonStockIssuedForServicesMember_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:CommonStockIssuedForServicesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c136_From1Jan2010To31Dec2010_CommonStockIssuedForServicesMember_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:CommonStockIssuedForServicesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c137_From1Jan2006To31Dec2006_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c138_From1Jan2006To31Dec2006_StockOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="c139_From1Jan2012To31Dec2012_StockOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c140_From1Jan2011To31Dec2011_StockOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c141_From1Jan2010To31Dec2010_StockOptionsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c142_From1Jan2012To31Dec2012_CompensatoryWarrantsMember_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:CompensatoryWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c143_From1Jan2011To31Dec2011_CompensatoryWarrantsMember_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:CompensatoryWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c144_From1Jan2010To31Dec2010_CompensatoryWarrantsMember_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:CompensatoryWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c145_From1Apr2012To31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c146_AsOf31Mar2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <instant>2012-03-31</instant>
    </period>
  </context>
  <context id="c147_From1Jan2012To31Dec2012_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c148_From1Jan2011To31Dec2011_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c149_From1Jan2010To31Dec2010_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c150_From1Jan2012To31Dec2012_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c151_From1Jan2011To31Dec2011_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c152_From1Jan2010To31Dec2010_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesAWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesBWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesCWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c156_From1Jan2012To31Dec2012_OtherWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:OtherWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c157_From1Jan2012To31Dec2012_OngoingPatentCostReimbursementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:OngoingPatentCostReimbursementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c158_From1Jan2011To31Dec2011_OngoingPatentCostReimbursementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:OngoingPatentCostReimbursementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c159_From1Jan2010To31Dec2010_OngoingPatentCostReimbursementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:OngoingPatentCostReimbursementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c160_From1Jan2012To30Sep2012_ResearchAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:ResearchAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="c161_From1Jan2011To31Dec2011_ResearchAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:ResearchAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c162_From1Jan2010To31Dec2010_ResearchAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:ResearchAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c163_From1Jan2012To31Dec2012_ConsultingAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:ConsultingAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c164_From1Jan2011To31Dec2011_ConsultingAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:ConsultingAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c165_From1Jan2010To31Dec2010_ConsultingAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">govx:ConsultingAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="c166_From1Jan2012To31Jan2012_MembersOfBoardOfDirectorsAndManagementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="govx:SaleOfCommonStockAxis">govx:MembersOfBoardOfDirectorsAndManagementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-01-31</endDate>
    </period>
  </context>
  <context id="c167_AsOf31Jan2012_MembersOfBoardOfDirectorsAndManagementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="govx:SaleOfCommonStockAxis">govx:MembersOfBoardOfDirectorsAndManagementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-01-31</instant>
    </period>
  </context>
  <context id="c168_From1Jan2012To31Mar2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-03-31</endDate>
    </period>
  </context>
  <context id="c169_From1Apr2012To30Jun2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-06-30</endDate>
    </period>
  </context>
  <context id="c170_From1Jul2012To30Sep2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2012-07-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="c171_From1Oct2012To31Dec2012">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c172_From1Jan2011To31Mar2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-03-31</endDate>
    </period>
  </context>
  <context id="c173_From1Apr2011To30Jun2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2011-04-01</startDate>
      <endDate>2011-06-30</endDate>
    </period>
  </context>
  <context id="c174_From1Jul2011To30Sep2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2011-07-01</startDate>
      <endDate>2011-09-30</endDate>
    </period>
  </context>
  <context id="c175_From1Oct2011To31Dec2011">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c176_AsOf17Jan2013_SeriesBWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesBWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-01-17</instant>
    </period>
  </context>
  <context id="c177_From1Jan2013To31Jan2013_SeriesBWarrantsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">govx:SeriesBWarrantsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-01-31</endDate>
    </period>
  </context>
  <context id="c178_AsOf31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="c179_From1Jan2012To31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="c180_AsOf31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="c181_AsOf31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="c182_From1Jan2011To31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="c183_AsOf31Dec2009_ValuationAllowanceOfDeferredTaxAssetsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c184_From1Jan2010To31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <unit id="usd">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="usdPershares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="shares">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="sqft">
    <measure>utr:sqft</measure>
  </unit>
  <unit id="pure">
    <measure>xbrli:pure</measure>
  </unit>
  <unit id="usdPeritem">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>compsci:item</measure>
      </unitDenominator>
    </divide>
  </unit>
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:label="_NetCashProvidedByUsedInFinancingActivities-c4_From1Jan2012To31Dec2012_usd" xlink:href="#_NetCashProvidedByUsedInFinancingActivities-c4_From1Jan2012To31Dec2012_usd"/>
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="ftnt_0" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities: In connection with the Merger discussed in Note 5, all of the then outstanding shares of the Company&apos;s mandatory redeemable convertible preferred stock were converted into shares of common stock as of September 28, 2006.  As discussed in Note 6, during 2012, an aggregate of 1,412 shares of the Company&apos;s outstanding Series A Convertible Preferred Stock were converted into 1,882,667 shares of common stock.</link:footnote>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_NetCashProvidedByUsedInFinancingActivities-c4_From1Jan2012To31Dec2012_usd" xlink:to="ftnt_0" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_NetCashProvidedByUsedInFinancingActivities-c5_From1Jan2011To31Dec2011_usd" xlink:href="#_NetCashProvidedByUsedInFinancingActivities-c5_From1Jan2011To31Dec2011_usd"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_NetCashProvidedByUsedInFinancingActivities-c5_From1Jan2011To31Dec2011_usd" xlink:to="ftnt_0" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_NetCashProvidedByUsedInFinancingActivities-c6_From1Jan2010To31Dec2010_usd" xlink:href="#_NetCashProvidedByUsedInFinancingActivities-c6_From1Jan2010To31Dec2010_usd"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_NetCashProvidedByUsedInFinancingActivities-c6_From1Jan2010To31Dec2010_usd" xlink:to="ftnt_0" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_NetCashProvidedByUsedInFinancingActivities-c7_From27Jun2001To31Dec2012_usd" xlink:href="#_NetCashProvidedByUsedInFinancingActivities-c7_From27Jun2001To31Dec2012_usd"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_NetCashProvidedByUsedInFinancingActivities-c7_From27Jun2001To31Dec2012_usd" xlink:to="ftnt_0" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantOrRightIssuedDuringPeriod-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usd" xlink:href="#_ClassOfWarrantOrRightIssuedDuringPeriod-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usd"/>
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="ftnt_1" xml:lang="en-US">See discussion under &quot;Series A Convertible Preferred Stock&quot; above.</link:footnote>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantOrRightIssuedDuringPeriod-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usd" xlink:to="ftnt_1" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usdPershares" xlink:href="#_ClassOfWarrantIssuedWeightedAverageExercisePrice-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usdPershares"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usdPershares" xlink:to="ftnt_1" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantOrRightIssuedDuringPeriod-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usd" xlink:href="#_ClassOfWarrantOrRightIssuedDuringPeriod-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usd"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantOrRightIssuedDuringPeriod-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usd" xlink:to="ftnt_1" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usdPershares" xlink:href="#_ClassOfWarrantIssuedWeightedAverageExercisePrice-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usdPershares"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usdPershares" xlink:to="ftnt_1" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantOrRightIssuedDuringPeriod-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usd" xlink:href="#_ClassOfWarrantOrRightIssuedDuringPeriod-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usd"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantOrRightIssuedDuringPeriod-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usd" xlink:to="ftnt_1" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usdPershares" xlink:href="#_ClassOfWarrantIssuedWeightedAverageExercisePrice-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usdPershares"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usdPershares" xlink:to="ftnt_1" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantOrRightIssuedDuringPeriod-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usd" xlink:href="#_ClassOfWarrantOrRightIssuedDuringPeriod-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usd"/>
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="ftnt_2" xml:lang="en-US">See discussion under &quot;Common Stock Transactions&quot; above.</link:footnote>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantOrRightIssuedDuringPeriod-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usd" xlink:to="ftnt_2" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usdPershares" xlink:href="#_ClassOfWarrantIssuedWeightedAverageExercisePrice-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usdPershares"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usdPershares" xlink:to="ftnt_2" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ValuationAllowancesAndReservesDeductions-c179_From1Jan2012To31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember_usd" xlink:href="#_ValuationAllowancesAndReservesDeductions-c179_From1Jan2012To31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember_usd"/>
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="ftnt_3" xml:lang="en-US">Deductions represent the effect of expiring NOL carryforwards from prior years.</link:footnote>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ValuationAllowancesAndReservesDeductions-c179_From1Jan2012To31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember_usd" xlink:to="ftnt_3" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ValuationAllowancesAndReservesDeductions-c182_From1Jan2011To31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember_usd" xlink:href="#_ValuationAllowancesAndReservesDeductions-c182_From1Jan2011To31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember_usd"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ValuationAllowancesAndReservesDeductions-c182_From1Jan2011To31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember_usd" xlink:to="ftnt_3" order="1"/>
    <link:loc xlink:type="locator" xlink:label="_ValuationAllowancesAndReservesDeductions-c184_From1Jan2010To31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember_usd" xlink:href="#_ValuationAllowancesAndReservesDeductions-c184_From1Jan2010To31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember_usd"/>
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="_ValuationAllowancesAndReservesDeductions-c184_From1Jan2010To31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember_usd" xlink:to="ftnt_3" order="1"/>
  </link:footnoteLink>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">1035925</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">1167980</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:GrantsReceivable unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">266248</us-gaap:GrantsReceivable>
  <us-gaap:GrantsReceivable unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">183515</us-gaap:GrantsReceivable>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">42301</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">66508</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">1344474</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">1418003</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">102486</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">176206</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">20000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">39923</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:DepositsAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">11010</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:DepositsAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">11010</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">31010</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">50933</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">1477970</us-gaap:Assets>
  <us-gaap:Assets unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">1645142</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">163788</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">138339</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">33877</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">125869</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">129370</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">677327</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">327035</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">941535</us-gaap:LiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c0_AsOf31Dec2012" xs:nil="true"/>
  <us-gaap:CommitmentsAndContingencies unitRef="usd" contextRef="c1_AsOf31Dec2011" xs:nil="true"/>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">312196</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">18733</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">16443</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">25587148</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">23319166</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">24767142</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">22632002</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">1150935</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">703607</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">1477970</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">1645142</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">228856</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">208933</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf31Dec2012" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2011" decimals="2">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2011" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
  <govx:PreferredStockStatedValue unitRef="usdPershares" contextRef="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="0">1000</govx:PreferredStockStatedValue>
  <govx:PreferredStockStatedValue unitRef="usdPershares" contextRef="c3_AsOf31Dec2011_SeriesAConvertiblePreferredStockMember" decimals="0">0</govx:PreferredStockStatedValue>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="INF">788</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued unitRef="shares" contextRef="c3_AsOf31Dec2011_SeriesAConvertiblePreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="INF">788</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding unitRef="shares" contextRef="c3_AsOf31Dec2011_SeriesAConvertiblePreferredStockMember" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c0_AsOf31Dec2012" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="usdPershares" contextRef="c1_AsOf31Dec2011" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized unitRef="shares" contextRef="c1_AsOf31Dec2011" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">18733277</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued unitRef="shares" contextRef="c1_AsOf31Dec2011" decimals="INF">16442611</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">18733277</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2011" decimals="INF">16442611</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">2657327</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">4899885</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">5185257</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">22969019</us-gaap:RevenueFromGrants>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">3043522</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">4276375</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">4793956</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">28674198</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">1752765</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">2972555</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">3162134</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">19400424</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">4796287</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">7248930</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">7956090</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">48074622</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">-2138960</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-2349045</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">-2770833</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">-25105603</us-gaap:OperatingIncomeLoss>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">3820</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">2219</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">23505</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">344130</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InterestExpense unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">5669</us-gaap:InterestExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">3820</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">2219</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">23505</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">338461</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">-2135140</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-2346826</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">-2747328</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">-24767142</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c4_From1Jan2012To31Dec2012" decimals="2">-0.12</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c5_From1Jan2011To31Dec2011" decimals="2">-0.15</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c6_From1Jan2010To31Dec2010" decimals="2">-0.18</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted unitRef="usdPershares" contextRef="c7_From27Jun2001To31Dec2012" decimals="2">-2.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="INF">18315669</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c5_From1Jan2011To31Dec2011" decimals="INF">15735541</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c6_From1Jan2010To31Dec2010" decimals="INF">15651308</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted unitRef="shares" contextRef="c7_From27Jun2001To31Dec2012" decimals="INF">11871955</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception unitRef="usd" contextRef="c8_From27Jun2001To31Dec2001_AdditionalPaidInCapitalMember" decimals="0">10</govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception>
  <govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception unitRef="usd" contextRef="c9_From27Jun2001To31Dec2001" decimals="0">10</govx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c10_From27Jun2001To31Dec2001_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-170592</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c9_From27Jun2001To31Dec2001" decimals="0">-170592</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c11_AsOf31Dec2001_AdditionalPaidInCapitalMember" decimals="0">10</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c12_AsOf31Dec2001_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-170592</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c13_AsOf31Dec2001" decimals="0">-170582</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c14_From1Jan2002To31Dec2002_CommonStockMember" decimals="INF">2789954</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c14_From1Jan2002To31Dec2002_CommonStockMember" decimals="0">2790</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c15_From1Jan2002To31Dec2002_AdditionalPaidInCapitalMember" decimals="0">-2320</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c16_From1Jan2002To31Dec2002" decimals="0">470</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets unitRef="shares" contextRef="c14_From1Jan2002To31Dec2002_CommonStockMember" decimals="INF">704534</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c14_From1Jan2002To31Dec2002_CommonStockMember" decimals="0">705</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c15_From1Jan2002To31Dec2002_AdditionalPaidInCapitalMember" decimals="0">148151</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c16_From1Jan2002To31Dec2002" decimals="0">148856</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c17_From1Jan2002To31Dec2002_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-618137</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c16_From1Jan2002To31Dec2002" decimals="0">-618137</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c18_AsOf31Dec2002_CommonStockMember" decimals="INF">3494488</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c18_AsOf31Dec2002_CommonStockMember" decimals="0">3495</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c19_AsOf31Dec2002_AdditionalPaidInCapitalMember" decimals="0">145841</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c20_AsOf31Dec2002_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-788729</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c21_AsOf31Dec2002" decimals="0">-639393</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c22_From1Jan2003To31Dec2003_CommonStockMember" decimals="INF">1229278</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c22_From1Jan2003To31Dec2003_CommonStockMember" decimals="0">1229</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c23_From1Jan2003To31Dec2003_AdditionalPaidInCapitalMember" decimals="0">2458380</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c24_From1Jan2003To31Dec2003" decimals="0">2459609</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c25_From1Jan2003To31Dec2003_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-947804</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c24_From1Jan2003To31Dec2003" decimals="0">-947804</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c26_AsOf31Dec2003_CommonStockMember" decimals="INF">4723766</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c26_AsOf31Dec2003_CommonStockMember" decimals="0">4724</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c27_AsOf31Dec2003_AdditionalPaidInCapitalMember" decimals="0">2604221</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c28_AsOf31Dec2003_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-1736533</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c29_AsOf31Dec2003" decimals="0">872412</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c30_From1Jan2004To31Dec2004_CommonStockMember" decimals="INF">1482605</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c30_From1Jan2004To31Dec2004_CommonStockMember" decimals="0">1483</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c31_From1Jan2004To31Dec2004_AdditionalPaidInCapitalMember" decimals="0">2988436</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c32_From1Jan2004To31Dec2004_StockSubscriptionReceivableMember" decimals="0">-2750000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c33_From1Jan2004To31Dec2004" decimals="0">239919</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c32_From1Jan2004To31Dec2004_StockSubscriptionReceivableMember" decimals="0">750000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c33_From1Jan2004To31Dec2004" decimals="0">750000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets unitRef="shares" contextRef="c30_From1Jan2004To31Dec2004_CommonStockMember" decimals="INF">49420</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c30_From1Jan2004To31Dec2004_CommonStockMember" decimals="0">49</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c31_From1Jan2004To31Dec2004_AdditionalPaidInCapitalMember" decimals="0">99951</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets unitRef="usd" contextRef="c33_From1Jan2004To31Dec2004" decimals="0">100000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c34_From1Jan2004To31Dec2004_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-2351828</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c33_From1Jan2004To31Dec2004" decimals="0">-2351828</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c35_AsOf31Dec2004_CommonStockMember" decimals="INF">6255791</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c35_AsOf31Dec2004_CommonStockMember" decimals="0">6256</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c36_AsOf31Dec2004_AdditionalPaidInCapitalMember" decimals="0">5692608</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c37_AsOf31Dec2004_StockSubscriptionReceivableMember" decimals="0">-2000000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c38_AsOf31Dec2004_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-4088361</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c39_AsOf31Dec2004" decimals="0">-389497</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c40_From1Jan2005To31Dec2005_StockSubscriptionReceivableMember" decimals="0">1500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c41_From1Jan2005To31Dec2005" decimals="0">1500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c42_From1Jan2005To31Dec2005_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-1611086</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c41_From1Jan2005To31Dec2005" decimals="0">-1611086</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c43_AsOf31Dec2005_CommonStockMember" decimals="INF">6255791</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c43_AsOf31Dec2005_CommonStockMember" decimals="0">6256</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c44_AsOf31Dec2005_AdditionalPaidInCapitalMember" decimals="0">5692608</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c45_AsOf31Dec2005_StockSubscriptionReceivableMember" decimals="0">-500000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c46_AsOf31Dec2005_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-5699447</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c47_AsOf31Dec2005" decimals="0">-500583</us-gaap:StockholdersEquity>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c48_From1Jan2006To31Dec2006_StockSubscriptionReceivableMember" decimals="0">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c49_From1Jan2006To31Dec2006" decimals="0">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="shares" contextRef="c50_From1Jan2006To31Dec2006_CommonStockMember" decimals="INF">3550851</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c50_From1Jan2006To31Dec2006_CommonStockMember" decimals="0">3551</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c51_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember" decimals="0">1071565</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c49_From1Jan2006To31Dec2006" decimals="0">1075116</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions unitRef="shares" contextRef="c50_From1Jan2006To31Dec2006_CommonStockMember" decimals="INF">4359891</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c50_From1Jan2006To31Dec2006_CommonStockMember" decimals="0">4360</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c51_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember" decimals="0">1708489</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodValueAcquisitions unitRef="usd" contextRef="c49_From1Jan2006To31Dec2006" decimals="0">1712849</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c50_From1Jan2006To31Dec2006_CommonStockMember" decimals="INF">56825</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c50_From1Jan2006To31Dec2006_CommonStockMember" decimals="0">57</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c51_From1Jan2006To31Dec2006_AdditionalPaidInCapitalMember" decimals="0">-57</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c52_From1Jan2006To31Dec2006_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-584166</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c49_From1Jan2006To31Dec2006" decimals="0">-584166</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c53_AsOf31Dec2006_CommonStockMember" decimals="INF">14223358</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c53_AsOf31Dec2006_CommonStockMember" decimals="0">14224</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c54_AsOf31Dec2006_AdditionalPaidInCapitalMember" decimals="0">8472605</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c55_AsOf31Dec2006_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-6283613</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c56_AsOf31Dec2006" decimals="0">2203216</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c57_From1Jan2007To31Dec2007_CommonStockMember" decimals="INF">406729</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c57_From1Jan2007To31Dec2007_CommonStockMember" decimals="0">407</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c58_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember" decimals="0">3162543</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c59_From1Jan2007To31Dec2007" decimals="0">3162950</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c57_From1Jan2007To31Dec2007_CommonStockMember" decimals="INF">2471</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c57_From1Jan2007To31Dec2007_CommonStockMember" decimals="0">2</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c58_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember" decimals="0">4998</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c59_From1Jan2007To31Dec2007" decimals="0">5000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c58_From1Jan2007To31Dec2007_AdditionalPaidInCapitalMember" decimals="0">1518496</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c59_From1Jan2007To31Dec2007" decimals="0">1518496</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c60_From1Jan2007To31Dec2007_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-4241796</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c59_From1Jan2007To31Dec2007" decimals="0">-4241796</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c61_AsOf31Dec2007_CommonStockMember" decimals="INF">14632558</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c61_AsOf31Dec2007_CommonStockMember" decimals="0">14633</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c62_AsOf31Dec2007_AdditionalPaidInCapitalMember" decimals="0">13158642</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c63_AsOf31Dec2007_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-10525409</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c64_AsOf31Dec2007" decimals="0">2647866</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c65_From1Jan2008To31Dec2008_CommonStockMember" decimals="INF">306419</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008_CommonStockMember" decimals="0">306</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c66_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">1770785</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c67_From1Jan2008To31Dec2008" decimals="0">1771091</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c65_From1Jan2008To31Dec2008_CommonStockMember" decimals="INF">10000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c65_From1Jan2008To31Dec2008_CommonStockMember" decimals="0">10</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c66_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">73990</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c67_From1Jan2008To31Dec2008" decimals="0">74000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c66_From1Jan2008To31Dec2008_AdditionalPaidInCapitalMember" decimals="0">1945049</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c67_From1Jan2008To31Dec2008" decimals="0">1945049</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c68_From1Jan2008To31Dec2008_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-3728187</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c67_From1Jan2008To31Dec2008" decimals="0">-3728187</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c69_AsOf31Dec2008_CommonStockMember" decimals="INF">14948977</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c69_AsOf31Dec2008_CommonStockMember" decimals="0">14949</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c70_AsOf31Dec2008_AdditionalPaidInCapitalMember" decimals="0">16948466</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c71_AsOf31Dec2008_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-14253596</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c72_AsOf31Dec2008" decimals="0">2709819</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c73_From1Jan2009To31Dec2009_CommonStockMember" decimals="INF">216261</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c73_From1Jan2009To31Dec2009_CommonStockMember" decimals="0">216</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c74_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">1519784</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c75_From1Jan2009To31Dec2009" decimals="0">1520000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c73_From1Jan2009To31Dec2009_CommonStockMember" decimals="INF">462826</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c73_From1Jan2009To31Dec2009_CommonStockMember" decimals="0">463</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c74_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">1499537</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised unitRef="usd" contextRef="c75_From1Jan2009To31Dec2009" decimals="0">1500000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c73_From1Jan2009To31Dec2009_CommonStockMember" decimals="INF">4500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c73_From1Jan2009To31Dec2009_CommonStockMember" decimals="0">5</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c74_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">31495</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c75_From1Jan2009To31Dec2009" decimals="0">31500</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c74_From1Jan2009To31Dec2009_AdditionalPaidInCapitalMember" decimals="0">1267165</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c75_From1Jan2009To31Dec2009" decimals="0">1267165</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c76_From1Jan2009To31Dec2009_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-3284252</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c75_From1Jan2009To31Dec2009" decimals="0">-3284252</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c77_AsOf31Dec2009_CommonStockMember" decimals="INF">15632564</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c77_AsOf31Dec2009_CommonStockMember" decimals="0">15633</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c78_AsOf31Dec2009_AdditionalPaidInCapitalMember" decimals="0">21266447</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c79_AsOf31Dec2009_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-17537848</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c80_AsOf31Dec2009" decimals="0">3744232</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c81_From1Jan2010To31Dec2010_CommonStockMember" decimals="INF">12000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c81_From1Jan2010To31Dec2010_CommonStockMember" decimals="0">12</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c82_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">89988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">90000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c81_From1Jan2010To31Dec2010_CommonStockMember" decimals="INF">10500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c81_From1Jan2010To31Dec2010_CommonStockMember" decimals="0">10</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c82_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">53803</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">53813</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c82_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">696719</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">696719</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits unitRef="shares" contextRef="c81_From1Jan2010To31Dec2010_CommonStockMember" decimals="INF">-218</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit unitRef="usd" contextRef="c82_From1Jan2010To31Dec2010_AdditionalPaidInCapitalMember" decimals="0">-1210</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">-1210</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockSplit>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c83_From1Jan2010To31Dec2010_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-2747328</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c84_AsOf31Dec2010_CommonStockMember" decimals="INF">15654846</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c84_AsOf31Dec2010_CommonStockMember" decimals="0">15655</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c85_AsOf31Dec2010_AdditionalPaidInCapitalMember" decimals="0">22105747</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c86_AsOf31Dec2010_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-20285176</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c87_AsOf31Dec2010" decimals="0">1836226</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c88_From1Jan2011To31Dec2011_CommonStockMember" decimals="INF">658520</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c88_From1Jan2011To31Dec2011_CommonStockMember" decimals="0">659</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c89_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember" decimals="0">440551</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">441210</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c88_From1Jan2011To31Dec2011_CommonStockMember" decimals="INF">129245</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c88_From1Jan2011To31Dec2011_CommonStockMember" decimals="0">129</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c89_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember" decimals="0">149871</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">150000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c89_From1Jan2011To31Dec2011_AdditionalPaidInCapitalMember" decimals="0">622997</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">622997</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c90_From1Jan2011To31Dec2011_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-2346826</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c91_AsOf31Dec2011_CommonStockMember" decimals="INF">16442611</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c91_AsOf31Dec2011_CommonStockMember" decimals="0">16443</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c92_AsOf31Dec2011_AdditionalPaidInCapitalMember" decimals="0">23319166</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c93_AsOf31Dec2011_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-22632002</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c94_From1Jan2012To31Dec2012_CommonStockMember" decimals="INF">407999</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c94_From1Jan2012To31Dec2012_CommonStockMember" decimals="0">408</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c95_From1Jan2012To31Dec2012_AdditionalPaidInCapitalMember" decimals="0">272952</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">273360</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesOther unitRef="shares" contextRef="c96_From1Jan2012To31Dec2012_SeriesAPreferredStockMember" decimals="INF">2200</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c96_From1Jan2012To31Dec2012_SeriesAPreferredStockMember" decimals="0">871614</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c95_From1Jan2012To31Dec2012_AdditionalPaidInCapitalMember" decimals="0">1127418</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodValueOther unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">1999032</us-gaap:StockIssuedDuringPeriodValueOther>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="shares" contextRef="c96_From1Jan2012To31Dec2012_SeriesAPreferredStockMember" decimals="INF">-1412</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c96_From1Jan2012To31Dec2012_SeriesAPreferredStockMember" decimals="0">-559418</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="shares" contextRef="c94_From1Jan2012To31Dec2012_CommonStockMember" decimals="INF">1882667</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c94_From1Jan2012To31Dec2012_CommonStockMember" decimals="0">1882</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities unitRef="usd" contextRef="c95_From1Jan2012To31Dec2012_AdditionalPaidInCapitalMember" decimals="0">557536</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c95_From1Jan2012To31Dec2012_AdditionalPaidInCapitalMember" decimals="0">310076</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">310076</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c97_From1Jan2012To31Dec2012_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-2135140</us-gaap:NetIncomeLoss>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c98_AsOf31Dec2012_SeriesAPreferredStockMember" decimals="INF">788</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c98_AsOf31Dec2012_SeriesAPreferredStockMember" decimals="0">312196</us-gaap:StockholdersEquity>
  <us-gaap:SharesIssued unitRef="shares" contextRef="c99_AsOf31Dec2012_CommonStockMember" decimals="INF">18733277</us-gaap:SharesIssued>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c99_AsOf31Dec2012_CommonStockMember" decimals="0">18733</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c100_AsOf31Dec2012_AdditionalPaidInCapitalMember" decimals="0">25587148</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity unitRef="usd" contextRef="c101_AsOf31Dec2012_AccumulatedDeficitDuringDevelopmentStageMember" decimals="0">-24767142</us-gaap:StockholdersEquity>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">93643</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">109017</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">119773</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">659280</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:PreferredStockAccretionOfRedemptionDiscount unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">346673</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">310076</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">772997</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">750532</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">6669815</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">82733</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-290760</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">153954</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInReceivables unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">266248</us-gaap:IncreaseDecreaseInReceivables>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">12593</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-19122</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">4215</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">42301</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInDeferredCharges unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-430402</us-gaap:IncreaseDecreaseInDeferredCharges>
  <us-gaap:IncreaseDecreaseInDeferredCharges unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">430402</us-gaap:IncreaseDecreaseInDeferredCharges>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-980</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">11010</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">11010</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">-614500</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">419927</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">39033</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">415825</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">-306107</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">2043205</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">309757</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">7772034</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">-2441247</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-303621</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">-2437571</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">-16995108</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">11896</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">4706</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">538490</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">5580</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">5580</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-11896</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">874</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">-532910</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">310160</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">404410</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">15836468</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">1999032</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">2727475</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="_NetCashProvidedByUsedInFinancingActivities-c4_From1Jan2012To31Dec2012_usd" unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">2309192</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="_NetCashProvidedByUsedInFinancingActivities-c5_From1Jan2011To31Dec2011_usd" unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">404410</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="_NetCashProvidedByUsedInFinancingActivities-c6_From1Jan2010To31Dec2010_usd" unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" xs:nil="true"/>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="_NetCashProvidedByUsedInFinancingActivities-c7_From27Jun2001To31Dec2012_usd" unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">18563943</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">-132055</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">88893</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">-2436697</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">1035925</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c87_AsOf31Dec2010" decimals="0">1079087</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="usd" contextRef="c80_AsOf31Dec2009" decimals="0">3515784</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:InterestPaid unitRef="usd" contextRef="c7_From27Jun2001To31Dec2012" decimals="0">5669</us-gaap:InterestPaid>
  <dei:EntityRegistrantName contextRef="c4_From1Jan2012To31Dec2012">GeoVax Labs, Inc.</dei:EntityRegistrantName>
  <dei:DocumentType contextRef="c4_From1Jan2012To31Dec2012">10-K</dei:DocumentType>
  <dei:CurrentFiscalYearEndDate contextRef="c4_From1Jan2012To31Dec2012">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityCommonStockSharesOutstanding unitRef="shares" contextRef="c102_AsOf15Mar2013" decimals="INF">20499944</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat unitRef="usd" contextRef="c103_AsOf30Jun2012" decimals="0">10176944</dei:EntityPublicFloat>
  <dei:AmendmentFlag contextRef="c4_From1Jan2012To31Dec2012">false</dei:AmendmentFlag>
  <dei:EntityCentralIndexKey contextRef="c4_From1Jan2012To31Dec2012">0000832489</dei:EntityCentralIndexKey>
  <dei:EntityCurrentReportingStatus contextRef="c4_From1Jan2012To31Dec2012">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="c4_From1Jan2012To31Dec2012">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory contextRef="c4_From1Jan2012To31Dec2012">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityWellKnownSeasonedIssuer contextRef="c4_From1Jan2012To31Dec2012">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:DocumentFiscalYearFocus contextRef="c4_From1Jan2012To31Dec2012">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="c4_From1Jan2012To31Dec2012">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentPeriodEndDate contextRef="c4_From1Jan2012To31Dec2012">2012-12-31</dei:DocumentPeriodEndDate>
  <us-gaap:NatureOfOperations contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;1.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Nature&#xd;
      of Business&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;GeoVax&#xd;
      Labs, Inc. (&amp;#8220;GeoVax&amp;#8221; or the&#xd;
      &amp;#8220;Company&amp;#8221;), is a biotechnology company developing&#xd;
      vaccines that prevent and fight Human Immunodeficiency Virus&#xd;
      (&amp;#8220;HIV&amp;#8221;) infections.&amp;#160;&amp;#160;HIV infections&#xd;
      result in Acquired Immunodeficiency Syndrome&#xd;
      (&amp;#8220;AIDS&amp;#8221;).&amp;#160;&amp;#160;We have exclusively licensed&#xd;
      from Emory University (&amp;#8220;Emory&amp;#8221;) vaccine&#xd;
      technology which was developed in collaboration with the&#xd;
      National Institutes of Health (&amp;#8220;NIH&amp;#8221;) and the&#xd;
      Centers for Disease Control and Prevention&#xd;
      (&amp;#8220;CDC&amp;#8221;).&amp;#160;&amp;#160;GeoVax is incorporated under&#xd;
      the laws of the State of Delaware and our principal offices&#xd;
      are located in Smyrna, Georgia (metropolitan Atlanta&#xd;
      area).&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      most advanced vaccines under development address the clade B&#xd;
      subtype of the HIV virus that is most prevalent in the United&#xd;
      States and the developed world.&amp;#160;&amp;#160;Our vaccines are&#xd;
      being evaluated to determine their potential to (a) prevent&#xd;
      HIV infection and (b) to serve as a therapy for individuals&#xd;
      who are already infected with HIV.&amp;#160;&amp;#160;These vaccines&#xd;
      are currently being evaluated in humans -- both in those&#xd;
      infected with HIV and those who are not.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
      discussed in Note 2, the Company is a development-stage&#xd;
      enterprise and we are devoting substantially all of our&#xd;
      present efforts to research and development.&amp;#160;&amp;#160;We&#xd;
      have funded our activities to date from government grants and&#xd;
      clinical trial assistance, and from sales of our equity&#xd;
      securities. We will continue to require substantial funds to&#xd;
      continue these activities.&amp;#160;&amp;#160;We anticipate that our&#xd;
      existing cash resources, combined with the proceeds from the&#xd;
      NIH grant discussed in Note 3 and the financing events&#xd;
      discussed in Note 11, should be sufficient to fund our&#xd;
      operations into the first quarter of 2014.&amp;#160;&amp;#160;In&#xd;
      order to meet our operating cash flow requirements, we intend&#xd;
      to conduct additional offerings of our equity securities or&#xd;
      convertible debt instruments. We are also seeking additional&#xd;
      funding for our research programs through government grant&#xd;
      funding mechanisms.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:NatureOfOperations>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;2.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Summary&#xd;
      of Significant Accounting Policies&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Basis&#xd;
      of Presentation and Principles of Consolidation&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      primary business is conducted by our wholly-owned subsidiary,&#xd;
      GeoVax, Inc. The accompanying consolidated financial&#xd;
      statements include the accounts of GeoVax, Inc. from&#xd;
      inception together with those of GeoVax Labs, Inc. from&#xd;
      September 28, 2006 (see Note 5).&amp;#160;&amp;#160;All intercompany&#xd;
      transactions have been eliminated in consolidation.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Development-Stage&#xd;
      Enterprise&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      are devoting all of our present efforts to research and&#xd;
      development and GeoVax is a development stage enterprise as&#xd;
      defined by Financial Accounting Standards Board&#xd;
      (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification&#xd;
      (&amp;#8220;ASC&amp;#8221;) Topic 915, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Development Stage&#xd;
      Entities&lt;/font&gt;.&amp;#160;&amp;#160;All losses accumulated since&#xd;
      inception (June 27, 2001) have been considered as part of our&#xd;
      development stage activities.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Use&#xd;
      of Estimates&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The&#xd;
      preparation of financial statements in conformity with&#xd;
      accounting principles generally accepted in the United States&#xd;
      of America (&amp;#8220;GAAP&amp;#8221;) requires us to make estimates&#xd;
      and assumptions that affect the reported amounts of assets&#xd;
      and liabilities and disclosure of contingent assets and&#xd;
      liabilities at the date of the financial statements and the&#xd;
      reported amounts of revenues and expenses during the&#xd;
      reporting period.&amp;#160;&amp;#160;Actual results may differ from&#xd;
      those estimates.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Cash&#xd;
      and Cash Equivalents&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      consider all highly liquid investments with a maturity of&#xd;
      three months or less when purchased to be cash&#xd;
      equivalents.&amp;#160;&amp;#160;Our cash and cash equivalents consist&#xd;
      primarily of bank deposits and money market&#xd;
      accounts.&amp;#160;&amp;#160;The recorded values approximate fair&#xd;
      market values due to the short maturities.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Fair&#xd;
      Value of Financial Instruments and Concentration of Credit&#xd;
      Risk&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Financial&#xd;
      instruments that subject us to concentration of credit risk&#xd;
      consist primarily of cash and cash equivalents, which are&#xd;
      maintained by a high credit quality financial institution.&#xd;
      The carrying values reported in the balance sheets for cash&#xd;
      and cash equivalents approximate fair values.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
      and Equipment&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
      and equipment are stated at cost, less accumulated&#xd;
      depreciation and amortization.&amp;#160;&amp;#160;The components of&#xd;
      property and equipment as of December 31, 2012 and 2011 are&#xd;
      as follows:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;97%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Laboratory&#xd;
              equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Leasehold&#xd;
              improvements&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
              furniture, fixtures &amp;amp; equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;28,685&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;28,685&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              property and equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;532,290&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;532,290&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accumulated&#xd;
              depreciation and amortization&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(429,804&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(356,084&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
              and equipment, net&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;102,486&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;176,206&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Expenditures&#xd;
      for maintenance and repairs are charged to operations as&#xd;
      incurred, while additions and improvements are&#xd;
      capitalized.&amp;#160;&amp;#160;Depreciation is computed using the&#xd;
      straight-line method over the estimated useful lives of the&#xd;
      assets which range from three to five&#xd;
      years.&amp;#160;&amp;#160;Amortization of leasehold improvements is&#xd;
      computed using the straight-line method over the remaining&#xd;
      term of the related lease.&amp;#160;&amp;#160;Depreciation and&#xd;
      amortization expense was $73,720, $84,131, and $94,887 during&#xd;
      the years ended December 31, 2012, 2011 and 2010,&#xd;
      respectively.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
      Assets&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
      assets consist principally of license agreements for the use&#xd;
      of technology obtained through the issuance of the&#xd;
      Company&amp;#8217;s common stock.&amp;#160;&amp;#160;These license&#xd;
      agreements are amortized on a straight line basis over ten&#xd;
      years.&amp;#160;&amp;#160;Amortization expense related to these&#xd;
      agreements was $19,923, $24,886, and $24,886 during years&#xd;
      ended December 31, 2012, 2011, and 2010, respectively, and is&#xd;
      expected to be $10,000, $10,000, $-0-, $-0-, and $-0- for&#xd;
      each of the next five years, respectively.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Impairment&#xd;
      of Long-Lived Assets&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      review long-lived assets for impairment whenever events or&#xd;
      changes in circumstances indicate that the carrying amount of&#xd;
      an asset may not be recoverable.&amp;#160;&amp;#160;Recoverability of&#xd;
      assets to be held and used is measured by a comparison of the&#xd;
      carrying amount of the assets to the future net cash flows&#xd;
      expected to be generated by such assets.&amp;#160;&amp;#160;If we&#xd;
      consider such assets to be impaired, the impairment to&#xd;
      be&lt;font style=&quot;DISPLAY: inline; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;recognized&#xd;
      is measured by the amount by which the carrying amount of the&#xd;
      assets exceeds the expected future net cash flows from the&#xd;
      assets.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Accrued&#xd;
      Liabilities&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
      part of the process of preparing our financial statements, we&#xd;
      estimate expenses that we believe we have incurred, but have&#xd;
      not yet been billed by our third party vendors. This process&#xd;
      involves identifying services and activities that have been&#xd;
      performed by such vendors on our behalf and estimating the&#xd;
      level to which they have been performed and the associated&#xd;
      cost incurred for such service as of each balance sheet date&#xd;
      in our financial statements. Examples of expenses for which&#xd;
      we accrue include fees for professional services and fees&#xd;
      owed to contract manufacturers in conjunction with the&#xd;
      manufacture of vaccines for our clinical trials. We make&#xd;
      these estimates based upon progress of activities related to&#xd;
      contractual obligations and information received from&#xd;
      vendors.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
      Loss Per Share&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Basic&#xd;
      and diluted loss per common share are computed based on the&#xd;
      weighted average number of common shares outstanding. All&#xd;
      common share equivalents (which consist of options and&#xd;
      warrants) are excluded from the computation of diluted loss&#xd;
      per share since the effect would be anti-dilutive. Common&#xd;
      share equivalents which could potentially dilute basic&#xd;
      earnings per share in the future, and which were excluded&#xd;
      from the computation of diluted loss per share, totaled&#xd;
      approximately 12.3 million, 2.8 million, and 2.0 million at&#xd;
      December 31, 2012, 2011 and 2010, respectively.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
      Recognition&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      recognize revenue in accordance with the SEC&amp;#8217;s Staff&#xd;
      Accounting Bulletin No. 101, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Revenue&#xd;
      Recognition in Financial Statements,&lt;/font&gt; as amended by&#xd;
      Staff Accounting Bulletin No. 104, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Revenue&#xd;
      Recognition,&lt;/font&gt; (&amp;#8220;SAB 104&amp;#8221;). SAB 104 provides&#xd;
      guidance in applying GAAP to revenue recognition issues, and&#xd;
      specifically addresses revenue recognition for upfront,&#xd;
      nonrefundable fees received in connection with research&#xd;
      collaboration agreements.&amp;#160;&amp;#160;During 2012, 2011 and&#xd;
      2010, our revenue consisted of grant funding received&#xd;
      primarily from the NIH (see Note 3).&amp;#160;&amp;#160;Revenue from&#xd;
      this arrangement is approximately equal to the costs incurred&#xd;
      and is recorded as income as the related costs are&#xd;
      incurred.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
      and Development Expense&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
      and development expense primarily consists of costs incurred&#xd;
      in the discovery, development, testing and manufacturing of&#xd;
      our product candidates. These expenses consist primarily of&#xd;
      (i) fees paid to third-party service providers to perform,&#xd;
      monitor and accumulate data related to our preclinical&#xd;
      studies and clinical trials, (ii) costs related to sponsored&#xd;
      research agreements, (iii) the costs to procure and&#xd;
      manufacture materials used in clinical trials, (iv)&#xd;
      laboratory supplies and facility-related expenses to conduct&#xd;
      development, and (v) salaries, benefits, and share-based&#xd;
      compensation for personnel.&amp;#160;&amp;#160;These costs are&#xd;
      charged to expense as incurred.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Patent&#xd;
      Costs&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      expenditures relating to obtaining and protecting patents are&#xd;
      charged to expense when incurred, and are included in general&#xd;
      and administrative expense.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Period&#xd;
      to Period Comparisons&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      operating results are expected to fluctuate for the&#xd;
      foreseeable future. Therefore, period-to-period comparisons&#xd;
      should not be relied upon as predictive of the results for&#xd;
      future periods.&amp;#160;&amp;#160;Certain prior year amounts have&#xd;
      been reclassified to conform to the current year financial&#xd;
      statement presentation.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Income&#xd;
      Taxes&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      account for income taxes using the liability method. Under&#xd;
      this method, deferred tax assets and liabilities are&#xd;
      recognized for the estimated future tax consequences&#xd;
      attributable to differences between the financial statement&#xd;
      carrying amounts of existing assets and liabilities and their&#xd;
      respective tax bases.&amp;#160;&amp;#160;Deferred tax assets and&#xd;
      liabilities are measured using enacted rates in effect for&#xd;
      the year in which temporary differences are expected to be&#xd;
      recovered or settled.&amp;#160;&amp;#160;Deferred tax assets are&#xd;
      reduced by a valuation allowance unless, in the opinion of&#xd;
      management, it is more likely than not that some portion or&#xd;
      all of the deferred tax assets will be realized.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock-Based&#xd;
      Compensation&lt;/font&gt;&lt;br /&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      account for stock-based transactions in which the Company&#xd;
      receives services from employees, directors or others in&#xd;
      exchange for equity instruments based on the fair value of&#xd;
      the award at the grant date.&amp;#160;&amp;#160;Compensation cost for&#xd;
      awards of common stock is estimated based on the price of the&#xd;
      underlying common stock on the date of&#xd;
      issuance.&amp;#160;&amp;#160;Compensation cost for stock options or&#xd;
      warrants is estimated at the grant date based on each&#xd;
      instrument&amp;#8217;s fair value as calculated by the&#xd;
      Black-Scholes option pricing model.&amp;#160;&amp;#160;We recognize&#xd;
      stock-based compensation cost as expense ratably on a&#xd;
      straight-line basis over the requisite service period for the&#xd;
      award.&amp;#160;&amp;#160;See Note 6 for additional stock-based&#xd;
      compensation information.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Recent&#xd;
      Accounting Pronouncements&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;There&#xd;
      have been no recent accounting pronouncements or changes in&#xd;
      accounting pronouncements which we expect to have a material&#xd;
      impact on our financial statements, nor do we believe that&#xd;
      any recently issued, but not yet effective, accounting&#xd;
      standards if currently adopted would have a material effect&#xd;
      on our financial statements.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Basis&#xd;
      of Presentation and Principles of Consolidation&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      primary business is conducted by our wholly-owned subsidiary,&#xd;
      GeoVax, Inc. The accompanying consolidated financial&#xd;
      statements include the accounts of GeoVax, Inc. from&#xd;
      inception together with those of GeoVax Labs, Inc. from&#xd;
      September 28, 2006 (see Note 5).&amp;#160;&amp;#160;All intercompany&#xd;
      transactions have been eliminated in consolidation.&lt;/font&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <govx:DevelopmentStageEnterprisePolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Development-Stage&#xd;
      Enterprise&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      are devoting all of our present efforts to research and&#xd;
      development and GeoVax is a development stage enterprise as&#xd;
      defined by Financial Accounting Standards Board&#xd;
      (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification&#xd;
      (&amp;#8220;ASC&amp;#8221;) Topic 915, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Development Stage&#xd;
      Entities&lt;/font&gt;.&amp;#160;&amp;#160;All losses accumulated since&#xd;
      inception (June 27, 2001) have been considered as part of our&#xd;
      development stage activities.&lt;/font&gt;&lt;/div&gt;</govx:DevelopmentStageEnterprisePolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Use&#xd;
      of Estimates&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The&#xd;
      preparation of financial statements in conformity with&#xd;
      accounting principles generally accepted in the United States&#xd;
      of America (&amp;#8220;GAAP&amp;#8221;) requires us to make estimates&#xd;
      and assumptions that affect the reported amounts of assets&#xd;
      and liabilities and disclosure of contingent assets and&#xd;
      liabilities at the date of the financial statements and the&#xd;
      reported amounts of revenues and expenses during the&#xd;
      reporting period.&amp;#160;&amp;#160;Actual results may differ from&#xd;
      those estimates.&lt;/font&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Cash&#xd;
      and Cash Equivalents&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      consider all highly liquid investments with a maturity of&#xd;
      three months or less when purchased to be cash&#xd;
      equivalents.&amp;#160;&amp;#160;Our cash and cash equivalents consist&#xd;
      primarily of bank deposits and money market&#xd;
      accounts.&amp;#160;&amp;#160;The recorded values approximate fair&#xd;
      market values due to the short maturities.&lt;/font&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Fair&#xd;
      Value of Financial Instruments and Concentration of Credit&#xd;
      Risk&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Financial&#xd;
      instruments that subject us to concentration of credit risk&#xd;
      consist primarily of cash and cash equivalents, which are&#xd;
      maintained by a high credit quality financial institution.&#xd;
      The carrying values reported in the balance sheets for cash&#xd;
      and cash equivalents approximate fair values.&lt;/font&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
      and Equipment&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
      and equipment are stated at cost, less accumulated&#xd;
      depreciation and amortization.&amp;#160;&amp;#160;The components of&#xd;
      property and equipment as of December 31, 2012 and 2011 are&#xd;
      as follows:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;97%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Laboratory&#xd;
              equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Leasehold&#xd;
              improvements&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
              furniture, fixtures &amp;amp; equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;28,685&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;28,685&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              property and equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;532,290&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;532,290&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accumulated&#xd;
              depreciation and amortization&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(429,804&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(356,084&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
              and equipment, net&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;102,486&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;176,206&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Expenditures&#xd;
      for maintenance and repairs are charged to operations as&#xd;
      incurred, while additions and improvements are&#xd;
      capitalized.&amp;#160;&amp;#160;Depreciation is computed using the&#xd;
      straight-line method over the estimated useful lives of the&#xd;
      assets which range from three to five&#xd;
      years.&amp;#160;&amp;#160;Amortization of leasehold improvements is&#xd;
      computed using the straight-line method over the remaining&#xd;
      term of the related lease.&amp;#160;&amp;#160;Depreciation and&#xd;
      amortization expense was $73,720, $84,131, and $94,887 during&#xd;
      the years ended December 31, 2012, 2011 and 2010,&#xd;
      respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c104_From1Jan2012To31Dec2012_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c105_From1Jan2012To31Dec2012_MaximumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:Depreciation unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">73720</us-gaap:Depreciation>
  <us-gaap:Depreciation unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">84131</us-gaap:Depreciation>
  <us-gaap:Depreciation unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">94887</us-gaap:Depreciation>
  <govx:OtherAssetsPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
      Assets&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
      assets consist principally of license agreements for the use&#xd;
      of technology obtained through the issuance of the&#xd;
      Company&amp;#8217;s common stock.&amp;#160;&amp;#160;These license&#xd;
      agreements are amortized on a straight line basis over ten&#xd;
      years.&amp;#160;&amp;#160;Amortization expense related to these&#xd;
      agreements was $19,923, $24,886, and $24,886 during years&#xd;
      ended December 31, 2012, 2011, and 2010, respectively, and is&#xd;
      expected to be $10,000, $10,000, $-0-, $-0-, and $-0- for&#xd;
      each of the next five years, respectively.&lt;/font&gt;&lt;/div&gt;</govx:OtherAssetsPolicyTextBlock>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c106_From1Jan2010To31Dec2010_LicensingAgreementsMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c107_From1Jan2012To31Dec2012_LicensingAgreementsMember" decimals="0">19923</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c108_From1Jan2011To31Dec2011_LicensingAgreementsMember" decimals="0">24886</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets unitRef="usd" contextRef="c106_From1Jan2010To31Dec2010_LicensingAgreementsMember" decimals="0">24886</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths unitRef="usd" contextRef="c109_AsOf31Dec2012_LicensingAgreementsMember" decimals="0">10000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo unitRef="usd" contextRef="c109_AsOf31Dec2012_LicensingAgreementsMember" decimals="0">10000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree unitRef="usd" contextRef="c109_AsOf31Dec2012_LicensingAgreementsMember" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour unitRef="usd" contextRef="c109_AsOf31Dec2012_LicensingAgreementsMember" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive unitRef="usd" contextRef="c109_AsOf31Dec2012_LicensingAgreementsMember" decimals="0">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Impairment&#xd;
      of Long-Lived Assets&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      review long-lived assets for impairment whenever events or&#xd;
      changes in circumstances indicate that the carrying amount of&#xd;
      an asset may not be recoverable.&amp;#160;&amp;#160;Recoverability of&#xd;
      assets to be held and used is measured by a comparison of the&#xd;
      carrying amount of the assets to the future net cash flows&#xd;
      expected to be generated by such assets.&amp;#160;&amp;#160;If we&#xd;
      consider such assets to be impaired, the impairment to&#xd;
      be&lt;font style=&quot;DISPLAY: inline; FONT-WEIGHT: bold&quot;&gt;&amp;#160;&lt;/font&gt;recognized&#xd;
      is measured by the amount by which the carrying amount of the&#xd;
      assets exceeds the expected future net cash flows from the&#xd;
      assets.&lt;/font&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <govx:AccruedLiabilitiesPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Accrued&#xd;
      Liabilities&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
      part of the process of preparing our financial statements, we&#xd;
      estimate expenses that we believe we have incurred, but have&#xd;
      not yet been billed by our third party vendors. This process&#xd;
      involves identifying services and activities that have been&#xd;
      performed by such vendors on our behalf and estimating the&#xd;
      level to which they have been performed and the associated&#xd;
      cost incurred for such service as of each balance sheet date&#xd;
      in our financial statements. Examples of expenses for which&#xd;
      we accrue include fees for professional services and fees&#xd;
      owed to contract manufacturers in conjunction with the&#xd;
      manufacture of vaccines for our clinical trials. We make&#xd;
      these estimates based upon progress of activities related to&#xd;
      contractual obligations and information received from&#xd;
      vendors.&lt;/font&gt;&lt;/div&gt;</govx:AccruedLiabilitiesPolicyTextBlock>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
      Loss Per Share&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Basic&#xd;
      and diluted loss per common share are computed based on the&#xd;
      weighted average number of common shares outstanding. All&#xd;
      common share equivalents (which consist of options and&#xd;
      warrants) are excluded from the computation of diluted loss&#xd;
      per share since the effect would be anti-dilutive. Common&#xd;
      share equivalents which could potentially dilute basic&#xd;
      earnings per share in the future, and which were excluded&#xd;
      from the computation of diluted loss per share, totaled&#xd;
      approximately 12.3 million, 2.8 million, and 2.0 million at&#xd;
      December 31, 2012, 2011 and 2010, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="-5">12300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c5_From1Jan2011To31Dec2011" decimals="-5">2800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount unitRef="shares" contextRef="c6_From1Jan2010To31Dec2010" decimals="-5">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
      Recognition&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      recognize revenue in accordance with the SEC&amp;#8217;s Staff&#xd;
      Accounting Bulletin No. 101, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Revenue&#xd;
      Recognition in Financial Statements,&lt;/font&gt; as amended by&#xd;
      Staff Accounting Bulletin No. 104, &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Revenue&#xd;
      Recognition,&lt;/font&gt; (&amp;#8220;SAB 104&amp;#8221;). SAB 104 provides&#xd;
      guidance in applying GAAP to revenue recognition issues, and&#xd;
      specifically addresses revenue recognition for upfront,&#xd;
      nonrefundable fees received in connection with research&#xd;
      collaboration agreements.&amp;#160;&amp;#160;During 2012, 2011 and&#xd;
      2010, our revenue consisted of grant funding received&#xd;
      primarily from the NIH (see Note 3).&amp;#160;&amp;#160;Revenue from&#xd;
      this arrangement is approximately equal to the costs incurred&#xd;
      and is recorded as income as the related costs are&#xd;
      incurred.&lt;/font&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
      and Development Expense&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
      and development expense primarily consists of costs incurred&#xd;
      in the discovery, development, testing and manufacturing of&#xd;
      our product candidates. These expenses consist primarily of&#xd;
      (i) fees paid to third-party service providers to perform,&#xd;
      monitor and accumulate data related to our preclinical&#xd;
      studies and clinical trials, (ii) costs related to sponsored&#xd;
      research agreements, (iii) the costs to procure and&#xd;
      manufacture materials used in clinical trials, (iv)&#xd;
      laboratory supplies and facility-related expenses to conduct&#xd;
      development, and (v) salaries, benefits, and share-based&#xd;
      compensation for personnel.&amp;#160;&amp;#160;These costs are&#xd;
      charged to expense as incurred.&lt;/font&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Patent&#xd;
      Costs&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      expenditures relating to obtaining and protecting patents are&#xd;
      charged to expense when incurred, and are included in general&#xd;
      and administrative expense.&lt;/font&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <govx:PeriodToPeriodComparisonsPolicyTexBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Period&#xd;
      to Period Comparisons&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      operating results are expected to fluctuate for the&#xd;
      foreseeable future. Therefore, period-to-period comparisons&#xd;
      should not be relied upon as predictive of the results for&#xd;
      future periods.&amp;#160;&amp;#160;Certain prior year amounts have&#xd;
      been reclassified to conform to the current year financial&#xd;
      statement presentation.&lt;/font&gt;&lt;/div&gt;</govx:PeriodToPeriodComparisonsPolicyTexBlock>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Income&#xd;
      Taxes&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      account for income taxes using the liability method. Under&#xd;
      this method, deferred tax assets and liabilities are&#xd;
      recognized for the estimated future tax consequences&#xd;
      attributable to differences between the financial statement&#xd;
      carrying amounts of existing assets and liabilities and their&#xd;
      respective tax bases.&amp;#160;&amp;#160;Deferred tax assets and&#xd;
      liabilities are measured using enacted rates in effect for&#xd;
      the year in which temporary differences are expected to be&#xd;
      recovered or settled.&amp;#160;&amp;#160;Deferred tax assets are&#xd;
      reduced by a valuation allowance unless, in the opinion of&#xd;
      management, it is more likely than not that some portion or&#xd;
      all of the deferred tax assets will be realized.&lt;/font&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock-Based&#xd;
      Compensation&lt;/font&gt;&lt;br /&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      account for stock-based transactions in which the Company&#xd;
      receives services from employees, directors or others in&#xd;
      exchange for equity instruments based on the fair value of&#xd;
      the award at the grant date.&amp;#160;&amp;#160;Compensation cost for&#xd;
      awards of common stock is estimated based on the price of the&#xd;
      underlying common stock on the date of&#xd;
      issuance.&amp;#160;&amp;#160;Compensation cost for stock options or&#xd;
      warrants is estimated at the grant date based on each&#xd;
      instrument&amp;#8217;s fair value as calculated by the&#xd;
      Black-Scholes option pricing model.&amp;#160;&amp;#160;We recognize&#xd;
      stock-based compensation cost as expense ratably on a&#xd;
      straight-line basis over the requisite service period for the&#xd;
      award.&amp;#160;&amp;#160;See Note 6 for additional stock-based&#xd;
      compensation information.&lt;/font&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Recent&#xd;
      Accounting Pronouncements&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;There&#xd;
      have been no recent accounting pronouncements or changes in&#xd;
      accounting pronouncements which we expect to have a material&#xd;
      impact on our financial statements, nor do we believe that&#xd;
      any recently issued, but not yet effective, accounting&#xd;
      standards if currently adopted would have a material effect&#xd;
      on our financial statements.&lt;/font&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;97%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Laboratory&#xd;
              equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;388,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Leasehold&#xd;
              improvements&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;115,605&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
              furniture, fixtures &amp;amp; equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;28,685&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;28,685&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              property and equipment&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;532,290&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;532,290&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accumulated&#xd;
              depreciation and amortization&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(429,804&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(356,084&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Property&#xd;
              and equipment, net&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;102,486&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;176,206&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c110_AsOf31Dec2012_LaboratoryEquipmentMember" decimals="0">388000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c111_AsOf31Dec2011_LaboratoryEquipmentMember" decimals="0">388000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c112_AsOf31Dec2012_LeaseholdImprovementsMember" decimals="0">115605</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c113_AsOf31Dec2011_LeaseholdImprovementsMember" decimals="0">115605</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c114_AsOf31Dec2012_OtherFurnitureFixturesAndEquipmentMember" decimals="0">28685</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c115_AsOf31Dec2011_OtherFurnitureFixturesAndEquipmentMember" decimals="0">28685</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">532290</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">532290</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">429804</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">356084</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <govx:GovernmentGrantsTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;3.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Government&#xd;
      Grants&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;NIH&#xd;
      Grants&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      September 2007, the NIH awarded us an Integrated&#xd;
      Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant&#xd;
      to support our HIV/AIDS vaccine program.&amp;#160;&amp;#160;We are&#xd;
      utilizing this funding to further our HIV/AIDS vaccine&#xd;
      development, optimization and production.&amp;#160;&amp;#160;The&#xd;
      original project period for the grant covered a five year&#xd;
      period ending in August 2012, but was extended for an&#xd;
      additional one year period.&amp;#160;&amp;#160;The aggregate award&#xd;
      totaled $20.4 million, with approximately $1.6 million&#xd;
      remaining and available for use as of December 31,&#xd;
      2012.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      September 2012, the NIH awarded us an additional grant of&#xd;
      $1.9 million to support development of versions of our&#xd;
      HIV/AIDS vaccines to address the clade C subtype of the HIV&#xd;
      virus prevalent in the developing world.&amp;#160;&amp;#160;The&#xd;
      project period of this grant covers a one year period ending&#xd;
      in August 2013.&amp;#160;&amp;#160;There is approximately $1.4&#xd;
      million from this grant remaining and available for use as of&#xd;
      December 31, 2012.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      record revenue associated with these grants as the related&#xd;
      costs and expenses are incurred and such revenue is reported&#xd;
      as a separate line item in our statements of&#xd;
      operations.&amp;#160;&amp;#160;During 2012, 2011, and 2010, we&#xd;
      recorded $2,657,327, $4,899,885, and $4,940,778,&#xd;
      respectively, of revenue associated with these grants.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;QTDP&#xd;
      Grant&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      November 2010, we were awarded a one-time grant of $244,479&#xd;
      pursuant to the Qualifying Therapeutic Discovery Project&#xd;
      (QTDP) program enacted as part of the Patient Protection and&#xd;
      Affordable Care Act of 2010.&amp;#160;&amp;#160;The QTDP program was&#xd;
      intended to provide incentive to smaller companies who are&#xd;
      focusing on innovative therapeutic discoveries.&amp;#160;&amp;#160;We&#xd;
      received the full amount of the grant during 2010, which is&#xd;
      recorded as revenue for 2010 in the accompanying Consolidated&#xd;
      Statement of Operations.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</govx:GovernmentGrantsTextBlock>
  <govx:ProjectPeriodCoveredByGrants contextRef="c116_From1Oct2007To31Aug2012_FirstNIHGrantMember">P5Y</govx:ProjectPeriodCoveredByGrants>
  <govx:ProjectExtensionPeriod contextRef="c117_From1Sep2012To31Aug2013_FirstNIHGrantMember">P1Y</govx:ProjectExtensionPeriod>
  <govx:GrantAward unitRef="usd" contextRef="c116_From1Oct2007To31Aug2012_FirstNIHGrantMember" decimals="-5">20400000</govx:GrantAward>
  <govx:UnusedGrantFunds unitRef="usd" contextRef="c118_AsOf31Dec2012_FirstNIHGrantMember" decimals="-5">1600000</govx:UnusedGrantFunds>
  <govx:GrantAward unitRef="usd" contextRef="c119_From1Sep2012To31Aug2013_SecondNIHGrantMember" decimals="-5">1900000</govx:GrantAward>
  <govx:ProjectPeriodCoveredByGrants contextRef="c119_From1Sep2012To31Aug2013_SecondNIHGrantMember">P1Y</govx:ProjectPeriodCoveredByGrants>
  <govx:UnusedGrantFunds unitRef="usd" contextRef="c120_AsOf31Dec2012_SecondNIHGrantMember" decimals="-5">1400000</govx:UnusedGrantFunds>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c121_From1Jan2012To31Dec2012_NIHGrantsMember" decimals="0">2657327</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c122_From1Jan2011To31Dec2011_NIHGrantsMember" decimals="0">4899885</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c123_From1Jan2010To31Dec2010_NIHGrantsMember" decimals="0">4940778</us-gaap:RevenueFromGrants>
  <govx:GrantAward unitRef="usd" contextRef="c124_From1Jan2010To31Dec2010_QTDPGrantMember" decimals="0">244479</govx:GrantAward>
  <us-gaap:CommitmentsDisclosureTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;4.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Commitments&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Lease&#xd;
      Agreements&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      lease approximately 8,400 square feet of office and&#xd;
      laboratory space located in Smyrna, Georgia (metropolitan&#xd;
      Atlanta). Rent expense for the years ended December 31, 2012,&#xd;
      2011 and 2010 was $118,801, $119,255, and $118,988,&#xd;
      respectively.&amp;#160;&amp;#160;Future minimum lease payments&#xd;
      pursuant to the 62 month lease total $125,180 in 2013 and&#xd;
      $128,920 in 2014.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Other&#xd;
      Commitments&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      the normal course of business, we may enter into various firm&#xd;
      purchase commitments related to production and testing of our&#xd;
      vaccine material, conduct of clinical trials, and other&#xd;
      research-related activities. As of December 31, 2012, we had&#xd;
      approximately $510,000 of unrecorded outstanding purchase&#xd;
      commitments to our vendors and subcontractors, all of which&#xd;
      we expect will be due in 2013.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:CommitmentsDisclosureTextBlock>
  <us-gaap:AreaOfRealEstateProperty unitRef="sqft" contextRef="c0_AsOf31Dec2012" decimals="0">8400</us-gaap:AreaOfRealEstateProperty>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">118801</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">119255</us-gaap:LeaseAndRentalExpense>
  <us-gaap:LeaseAndRentalExpense unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">118988</us-gaap:LeaseAndRentalExpense>
  <govx:OperatingLeaseTermOfLease contextRef="c4_From1Jan2012To31Dec2012">P62M</govx:OperatingLeaseTermOfLease>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">125180</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">128920</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">510000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
  <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;5.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2006&#xd;
      Merger and Recapitalization&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The&#xd;
      Company was originally incorporated in June 1988 under the&#xd;
      laws of Illinois as Dauphin Technology, Inc.&#xd;
      (&amp;#8220;Dauphin&amp;#8221;).&amp;#160;&amp;#160;Dauphin was unsuccessful&#xd;
      and its operations were terminated in December&#xd;
      2003.&amp;#160;&amp;#160;In September 2006, Dauphin completed a&#xd;
      merger (the &amp;#8220;Merger&amp;#8221;) with GeoVax, Inc. which was&#xd;
      incorporated under the laws of Georgia in June&#xd;
      2001.&amp;#160;&amp;#160;As a result of the Merger, the shareholders&#xd;
      of GeoVax, Inc. exchanged their shares of common stock for&#xd;
      Dauphin common stock and GeoVax, Inc. became a wholly-owned&#xd;
      subsidiary of Dauphin.&amp;#160;&amp;#160;Dauphin then changed its&#xd;
      name to GeoVax Labs, Inc. and replaced its officers and&#xd;
      directors with those of GeoVax, Inc.&amp;#160;&amp;#160;Subsequent to&#xd;
      the Merger, the Company has not conducted any business other&#xd;
      than GeoVax, Inc.&amp;#8217;s business of developing human&#xd;
      vaccines.&amp;#160;&amp;#160;The Merger was accounted for under the&#xd;
      purchase method of accounting as a reverse acquisition in&#xd;
      accordance with GAAP. Under this method of accounting,&#xd;
      Dauphin was treated as the acquired company and, accordingly,&#xd;
      all financial information prior to the date of Merger&#xd;
      presented in the accompanying consolidated financial&#xd;
      statements, or in the notes herein, as well as any references&#xd;
      to prior operations, are those of GeoVax, Inc.&amp;#160;&amp;#160;In&#xd;
      June 2008, the Company was reincorporated under the laws of&#xd;
      Delaware.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCgwG4gzQgO1GtJPkRDF8quUM4CUMA/xge9QOZ9RJaXDR38VLtarIvJZPfxcf4bZAv7z120OcgrDNUMQwBRXs2wXDWpxuQWN96ZBSByUAkghHejdWdaGOEUgYXnmREMIK+jg==] CSR-->
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;6.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Stockholders&amp;#8217;&#xd;
      Equity&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Series&#xd;
      A Convertible Preferred Stock&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Our&#xd;
      Certificate of Incorporation authorizes us to issue up to&#xd;
      10,000,000 shares of preferred stock, $.01 par&#xd;
      value.&amp;#160;&amp;#160;In March 2012, we established from the&#xd;
      authorized preferred stock a series of preferred stock,&#xd;
      consisting of 2,200 shares of Series A Convertible Preferred&#xd;
      Stock, $1,000 stated value (&amp;#8220;Series A Preferred&#xd;
      Shares&amp;#8221;) and entered into a Securities Purchase&#xd;
      Agreement (&amp;#8220;SPA&amp;#8221;) whereby we issued to three&#xd;
      institutional investors (&amp;#8220;Purchasers&amp;#8221;) the Series&#xd;
      A Preferred Shares for gross proceeds of $2.2&#xd;
      million.&amp;#160;&amp;#160;Net proceeds to the Company from this&#xd;
      transaction, after deduction of placement agent fees and&#xd;
      other expenses, were approximately $2.0 million.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The&#xd;
      Series A Preferred Shares may be converted at any time at the&#xd;
      option of the Purchasers into shares of our common stock at a&#xd;
      conversion price of $0.75 per share (&amp;#8220;Conversion&#xd;
      Price&amp;#8221;), for an initial aggregate total of 2,933,333&#xd;
      shares of our common stock (&amp;#8220;Conversion&#xd;
      Shares&amp;#8221;).&amp;#160;&amp;#160;The Series A Preferred Shares have&#xd;
      a liquidation preference equal to the initial purchase price,&#xd;
      have no voting rights, and are not entitled to a&#xd;
      dividend.&amp;#160;&amp;#160;Through December 31, 2012, a total of&#xd;
      1,412 Series A Preferred Shares have been converted into&#xd;
      1,882,667 shares of our common stock.&amp;#160;&amp;#160;As of&#xd;
      December 31, 2012, there were 788 shares of Series A&#xd;
      Preferred Shares outstanding, convertible into 1,050,667&#xd;
      shares of our common stock.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Pursuant&#xd;
      to the terms of the SPA, we issued to each Purchaser Series&#xd;
      A, B and C Warrants (collectively, the&#xd;
      &amp;#8220;Warrants&amp;#8221;), each to purchase up to a number of&#xd;
      shares of our common stock equal to 100% of the Conversion&#xd;
      Shares underlying the Series A Preferred Shares (up to&#xd;
      2,933,333 shares in the aggregate for each of the three&#xd;
      series of warrants, or 8,799,999 shares in total)&#xd;
      (&amp;#8220;Warrant Shares&amp;#8221;).&amp;#160;&amp;#160;The Series A&#xd;
      Warrants have an exercise price of $1.00 per share, are&#xd;
      exercisable immediately, and expire on March 21,&#xd;
      2017.&amp;#160;&amp;#160;The Series B Warrants have an exercise price&#xd;
      of $0.75 per share, are exercisable immediately, and expire&#xd;
      on March 21, 2013. The Series C Warrants have an exercise&#xd;
      price of $1.00 per share and expire on March 21, 2017, but&#xd;
      only vest and become exercisable upon, and in proportion to,&#xd;
      the exercise of the one-year Series B&#xd;
      Warrants.&amp;#160;&amp;#160;The Warrants contain anti-dilution&#xd;
      provisions, which may, under certain circumstances, reduce&#xd;
      the exercise price (but have no effect on the number of&#xd;
      shares subject to the Warrants) if we sell or grant options&#xd;
      to purchase, including rights to reprice, our common stock or&#xd;
      common stock equivalents at a price lower than the exercise&#xd;
      price of the Warrants, or if we announce plans to do&#xd;
      so.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      connection with the sale of the Series A Preferred Shares, we&#xd;
      entered into a Registration Rights Agreement&#xd;
      (&amp;#8220;RRA&amp;#8221;) with the Purchasers, pursuant to which we&#xd;
      filed a registration statement with the Securities and&#xd;
      Exchange Commission (&amp;#8220;SEC&amp;#8221;) on April 3, 2012&#xd;
      covering resale of the Conversion Shares and the Warrant&#xd;
      Shares.&amp;#160;&amp;#160;&amp;#160;It was declared effective by the SEC&#xd;
      on April 13, 2012&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Accounting&#xd;
      Treatment and Allocation of Proceeds&lt;/font&gt;.&amp;#160;&amp;#160;We&#xd;
      first assessed the Series A Preferred Shares under ASC Topic&#xd;
      480, &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Distinguishing&#xd;
      Liabilities from Equity&lt;/font&gt;&amp;#8221; (&amp;#8220;ASC 480&amp;#8221;)&#xd;
      and determined such preferred stock not to be a liability&#xd;
      under ASC 480.&amp;#160;&amp;#160;We next assessed the preferred&#xd;
      stock under ASC Topic 815. &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Derivatives and&#xd;
      Hedging&lt;/font&gt;&amp;#8221; (&amp;#8220;ASC 815&amp;#8221;).&amp;#160;&amp;#160;The&#xd;
      preferred stock contains an embedded feature allowing an&#xd;
      optional conversion by the holder into common stock which&#xd;
      meets the definition of a derivative.&amp;#160;&amp;#160;However, we&#xd;
      believe that the preferred stock is an &amp;#8220;equity&#xd;
      host&amp;#8221; (as described by ASC 815) for purposes of&#xd;
      assessing the embedded derivative for potential bifurcation&#xd;
      and determined that the optional conversion feature is&#xd;
      clearly and closely associated to the preferred stock host;&#xd;
      we therefore determined that the embedded derivative does not&#xd;
      require bifurcation and separate recognition under ASC&#xd;
      815.&amp;#160;&amp;#160;We then assessed the preferred stock under&#xd;
      ASC Topic 470, &amp;#8220;&lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline&quot;&gt;Debt&lt;/font&gt;&amp;#8221;&#xd;
      (&amp;#8220;ASC 470&amp;#8221;), and determined there to be a&#xd;
      beneficial conversion feature (&amp;#8220;BCF&amp;#8221;) requiring&#xd;
      recognition at its intrinsic value.&amp;#160;&amp;#160;Since the&#xd;
      conversion option of the preferred stock was immediately&#xd;
      exercisable, the amount allocated to the BCF was immediately&#xd;
      accreted to preferred dividends, resulting in an increase in&#xd;
      the carrying value of the preferred stock.&amp;#160;&amp;#160;We also&#xd;
      assessed the warrants issued in connection with the financing&#xd;
      under ASC 815 and determined that they did not initially meet&#xd;
      the definition of a derivative, but will require evaluation&#xd;
      on an on-going basis.&amp;#160;&amp;#160;As of December 31, 2012, we&#xd;
      determined that the warrants still did not meet the&#xd;
      definition of a derivative.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;The&#xd;
      following is a summary of the allocation of the net proceeds&#xd;
      from the preferred stock financing, and reconciliation to the&#xd;
      carrying value at December 31, 2012:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;95%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                proceeds after transaction costs&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,999,032&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Less:&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#xd;
                &amp;#160;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Fair&#xd;
                value of warrants (recorded to Additional Paid-in&#xd;
                Capital)&lt;/font&gt;&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1,127,418&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Beneficial&#xd;
                conversion feature (recorded to Additional Paid-in&#xd;
                Capital)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;(762,667&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                proceeds allocated to preferred stock&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;108,947&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accretion&#xd;
                of beneficial conversion feature (deemed&#xd;
                dividend)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;762,667&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Initial&#xd;
                carrying value of preferred stock&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;871,614&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Conversions&#xd;
                to common stock&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;(559,418&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Carrying&#xd;
                value of preferred stock at December 31,&#xd;
                2012&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;312,196&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Common&#xd;
      Stock Transactions&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      February 2010, we issued 12,000 shares of our common stock in&#xd;
      settlement of an obligation accrued at December 31, 2009 in&#xd;
      the amount of $90,000.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During&#xd;
      December 2011, we sold an aggregate of 658,520 shares of our&#xd;
      common stock to a group of individual accredited investors&#xd;
      (including members of our board of directors and management&#xd;
      --see Note 9) for an aggregate purchase price of $441,210,&#xd;
      $36,800 of which was received in January 2012 and is&#xd;
      therefore reflected as a receivable (Other Current Asset) in&#xd;
      the accompanying Consolidated Balance Sheet as of December&#xd;
      31, 2011.&amp;#160;&amp;#160;We also issued to the investors warrants&#xd;
      to purchase an aggregate of 987,783 shares of common stock at&#xd;
      a price of $1.00 per share, which expire in December&#xd;
      2016.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;During&#xd;
      January 2012, we sold an aggregate of 407,999 shares of our&#xd;
      common stock to a group of individual accredited investors&#xd;
      (including members of our board of directors and management&#xd;
      --see Note 9) for an aggregate purchase price of&#xd;
      $273,360.&amp;#160;&amp;#160;We also issued to the investors warrants&#xd;
      to purchase an aggregate of 612,001 shares of common stock at&#xd;
      a price of $1.00 per share, which expire in January&#xd;
      2017.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;From&#xd;
      time to time, we issue shares of our common stock to&#xd;
      consultants or others in exchange for&#xd;
      services.&amp;#160;&amp;#160;During 2012, 2011 and 2010 we issued&#xd;
      -0-, 129,245, and 10,500 shares, respectively, for such&#xd;
      services; and we recorded general and administrative expense&#xd;
      of $-0-, $150,000, and $53,813 during each respective period&#xd;
      related to these issuances.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock&#xd;
      Options&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      2006, we adopted the GeoVax Labs, Inc. 2006 Equity Incentive&#xd;
      Plan (the &amp;#8220;Stock Option Plan&amp;#8221;) for the granting&#xd;
      of qualified incentive stock options&#xd;
      (&amp;#8220;ISO&amp;#8217;s&amp;#8221;), nonqualified stock options,&#xd;
      restricted stock awards or restricted stock bonuses to&#xd;
      employees, officers, directors, consultants and advisors of&#xd;
      the Company.&amp;#160;&amp;#160;The exercise price for any option&#xd;
      granted may not be less than fair value (110% of fair value&#xd;
      for ISO&amp;#8217;s granted to certain&#xd;
      employees).&amp;#160;&amp;#160;Options granted under the Stock Option&#xd;
      Plan have a maximum ten-year term and generally vest over&#xd;
      three years.&amp;#160;&amp;#160;The Company has reserved 1,200,000&#xd;
      shares of its common stock for issuance under the Stock&#xd;
      Option Plan.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;A&#xd;
      summary of activity under the Stock Option Plan as of&#xd;
      December 31, 2012, and changes during the year then ended is&#xd;
      presented below:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Number&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;of&#xd;
              Shares&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Price&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Remaining&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Contractual&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Term&#xd;
              (yrs)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Aggregate&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Value&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;928,242&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.43&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Granted&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;238,500&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-435&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;0.70&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercised&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-436&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&#xd;
              or expired&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(97,601&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-437&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;4.02&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,069,141&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4.50&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-438&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;6.2&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;698,995&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.38&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-439&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;4.6&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Additional&#xd;
      information concerning our stock options for the years ended&#xd;
      December 31, 2012, 2011 and 2010 is as follows:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
              average fair value of options granted during the&#xd;
              period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.59&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.79&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.95&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&#xd;
              value of options exercised during the period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              fair value of options vested during the period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;319,920&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;540,339&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;499,557&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      use the Black-Scholes model for determining the grant date&#xd;
      fair value of our stock option grants.&amp;#160;&amp;#160;This model&#xd;
      utilizes certain information, such as the interest rate on a&#xd;
      risk-free security with a term generally equivalent to the&#xd;
      expected life of the option being valued and requires certain&#xd;
      other assumptions, such as the expected amount of time an&#xd;
      option will be outstanding until it is exercised or expired,&#xd;
      to calculate the fair value of stock options&#xd;
      granted.&amp;#160;&amp;#160;The significant assumptions we used in&#xd;
      our fair value calculations were as follows:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
              average risk-free interest rates&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.1&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.4&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.6&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
              dividend yield&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
              life of option (yrs)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.7&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.7&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
              volatility&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;105.2&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;111.2&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;112.9&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock-based&#xd;
      compensation expense related to the Stock Option Plan was&#xd;
      $310,076, $463,752, and $575,662 during the years ended&#xd;
      December 31, 2012, 2011 and 2010,&#xd;
      respectively.&amp;#160;&amp;#160;Stock option expense is allocated to&#xd;
      research and development expense or to general and&#xd;
      administrative expense based on the related employee&#xd;
      classifications and corresponds to the allocation of employee&#xd;
      salaries.&amp;#160;&amp;#160;For the three years ended December 31,&#xd;
      2012, stock option expense was allocated as follows:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: center; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;General&#xd;
              and administrative expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;231,936&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;284,352&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;369,161&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
              and development expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;78,140&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;179,400&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;206,501&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              stock option expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;310,076&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;463,752&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;575,662&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
      of December 31, 2012, there was $271,901 of unrecognized&#xd;
      compensation expense related to stock-based compensation&#xd;
      arrangements.&amp;#160;&amp;#160;The unrecognized compensation&#xd;
      expense is expected to be recognized over a weighted average&#xd;
      remaining period of 2.1 years.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Stock&#xd;
      Purchase Warrants&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      have issued stock purchase warrants in connection with&#xd;
      financing transactions and also in exchange for services from&#xd;
      consultants and others.&amp;#160;&amp;#160;The following table&#xd;
      presents a summary of stock purchase warrant transactions&#xd;
      during the year ended December 31, 2012:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Number&#xd;
              of Shares&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
              Average&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise&#xd;
              Price&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,870,559&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.96&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Series A Warrants (1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,933,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Series B Warrants (1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,933,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.75&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Series C Warrants (1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,933,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Other Warrants (2)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;612,001&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercised&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;--&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;--&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&#xd;
              or expired&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(57,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;11,225,559&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.06&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;8,290,376&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.44&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;(1)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;See&#xd;
      discussion under &amp;#8220;Series A Convertible Preferred&#xd;
      Stock&amp;#8221; above.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;(2)&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;See&#xd;
      discussion under &amp;#8220;Common Stock Transactions&amp;#8221;&#xd;
      above.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;For&#xd;
      stock purchase warrants issued to consultants or others in&#xd;
      exchange for services, we record the related expense over the&#xd;
      service period, or upon the date, that the service was&#xd;
      rendered.&amp;#160;&amp;#160;Expense associated with such&#xd;
      compensatory warrants was $-0-, $7,119, and $121,057 during&#xd;
      the years ended December 31, 2012, 2011 and 2010,&#xd;
      respectively All such expense was allocated to general and&#xd;
      administrative expense.&amp;#160;&amp;#160;As of December 31, 2012,&#xd;
      there was no unrecognized compensation expense related to&#xd;
      compensatory warrants. .&amp;#160;&amp;#160;In addition to&#xd;
      compensatory warrant expense, during 2011 we recorded&#xd;
      $152,126 of general and administrative expense associated&#xd;
      with the extension of certain investor warrants which were&#xd;
      due to expire in 2011 to 2013.&amp;#160;&amp;#160;In January 2013,&#xd;
      certain modifications were made to the terms of the Class B&#xd;
      Warrants in exchange for the exercise of a portion of those&#xd;
      warrants (see Note 11).&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:PreferredStockSharesAuthorized unitRef="shares" contextRef="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="INF">2200</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock unitRef="usd" contextRef="c125_From1Jan2012To31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="-5">2200000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock unitRef="usd" contextRef="c125_From1Jan2012To31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="-5">2000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
  <govx:ConvertiblePreferredStockConversionPricePerShare unitRef="usdPershares" contextRef="c126_AsOf31Mar2012_SeriesAConvertiblePreferredStockMember" decimals="2">0.75</govx:ConvertiblePreferredStockConversionPricePerShare>
  <govx:ConvertiblePreferredStockTotalConversionShares unitRef="shares" contextRef="c126_AsOf31Mar2012_SeriesAConvertiblePreferredStockMember" decimals="INF">2933333</govx:ConvertiblePreferredStockTotalConversionShares>
  <govx:NumberOfPreferredSharesConvertedIntoCommonStock unitRef="shares" contextRef="c127_From1Apr2012To31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="INF">1412</govx:NumberOfPreferredSharesConvertedIntoCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities unitRef="shares" contextRef="c127_From1Apr2012To31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="INF">1882667</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <govx:ConvertiblePreferredStockTotalConversionShares unitRef="shares" contextRef="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="INF">1050667</govx:ConvertiblePreferredStockTotalConversionShares>
  <govx:ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased unitRef="pure" contextRef="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="2">1.00</govx:ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c128_AsOf31Dec2012_SeriesAWarrantsMember" decimals="INF">2933333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c129_AsOf31Dec2012_SeriesBWarrantsMember" decimals="INF">2933333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c130_AsOf31Dec2012_SeriesCWarrantsMember" decimals="INF">2933333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c2_AsOf31Dec2012_SeriesAConvertiblePreferredStockMember" decimals="INF">8799999</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights unitRef="usdPeritem" contextRef="c128_AsOf31Dec2012_SeriesAWarrantsMember" decimals="2">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights unitRef="usdPeritem" contextRef="c129_AsOf31Dec2012_SeriesBWarrantsMember" decimals="2">0.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights unitRef="usdPeritem" contextRef="c130_AsOf31Dec2012_SeriesCWarrantsMember" decimals="2">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c131_From1Feb2010To28Feb2010" decimals="INF">12000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:OtherAccruedLiabilitiesCurrent unitRef="usd" contextRef="c80_AsOf31Dec2009" decimals="0">90000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c132_From1Dec2011To31Dec2011_IndividualAccreditedInvestorsMember" decimals="INF">658520</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c132_From1Dec2011To31Dec2011_IndividualAccreditedInvestorsMember" decimals="0">441210</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c133_From1Jan2012To31Jan2012_IndividualAccreditedInvestorsMember" decimals="0">36800</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <govx:ClassOfWarrantOrRightIssuedDuringPeriod unitRef="usd" contextRef="c132_From1Dec2011To31Dec2011_IndividualAccreditedInvestorsMember" decimals="0">987783</govx:ClassOfWarrantOrRightIssuedDuringPeriod>
  <govx:WarrantsIssuedDuringPeriodExercisePrice unitRef="usdPershares" contextRef="c132_From1Dec2011To31Dec2011_IndividualAccreditedInvestorsMember" decimals="2">1.00</govx:WarrantsIssuedDuringPeriodExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c133_From1Jan2012To31Jan2012_IndividualAccreditedInvestorsMember" decimals="INF">407999</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues unitRef="usd" contextRef="c133_From1Jan2012To31Jan2012_IndividualAccreditedInvestorsMember" decimals="0">273360</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <govx:NumberOfWarrantsIssuedDuringPeriod unitRef="shares" contextRef="c133_From1Jan2012To31Jan2012_IndividualAccreditedInvestorsMember" decimals="INF">612001</govx:NumberOfWarrantsIssuedDuringPeriod>
  <govx:WarrantsIssuedDuringPeriodExercisePrice unitRef="usdPershares" contextRef="c133_From1Jan2012To31Jan2012_IndividualAccreditedInvestorsMember" decimals="2">1.00</govx:WarrantsIssuedDuringPeriodExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c5_From1Jan2011To31Dec2011" decimals="INF">129245</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices unitRef="shares" contextRef="c6_From1Jan2010To31Dec2010" decimals="INF">10500</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c134_From1Jan2012To31Dec2012_CommonStockIssuedForServicesMember_GeneralAndAdministrativeExpenseMember" decimals="0">0</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c135_From1Jan2011To31Dec2011_CommonStockIssuedForServicesMember_GeneralAndAdministrativeExpenseMember" decimals="0">150000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c136_From1Jan2010To31Dec2010_CommonStockIssuedForServicesMember_GeneralAndAdministrativeExpenseMember" decimals="0">53813</us-gaap:AllocatedShareBasedCompensationExpense>
  <govx:MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees unitRef="pure" contextRef="c56_AsOf31Dec2006" decimals="2">1.10</govx:MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c137_From1Jan2006To31Dec2006_MaximumMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c138_From1Jan2006To31Dec2006_StockOptionsMember">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized unitRef="shares" contextRef="c56_AsOf31Dec2006" decimals="INF">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c139_From1Jan2012To31Dec2012_StockOptionsMember" decimals="0">310076</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c140_From1Jan2011To31Dec2011_StockOptionsMember" decimals="0">463752</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation unitRef="usd" contextRef="c141_From1Jan2010To31Dec2010_StockOptionsMember" decimals="0">575662</us-gaap:ShareBasedCompensation>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">271901</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c4_From1Jan2012To31Dec2012">P2Y36D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c142_From1Jan2012To31Dec2012_CompensatoryWarrantsMember_GeneralAndAdministrativeExpenseMember" decimals="0">0</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c143_From1Jan2011To31Dec2011_CompensatoryWarrantsMember_GeneralAndAdministrativeExpenseMember" decimals="0">7119</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c144_From1Jan2010To31Dec2010_CompensatoryWarrantsMember_GeneralAndAdministrativeExpenseMember" decimals="0">121057</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:OtherGeneralAndAdministrativeExpense unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">152126</us-gaap:OtherGeneralAndAdministrativeExpense>
  <govx:AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;95%&quot; style=&quot;FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                proceeds after transaction costs&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,999,032&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Less:&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&#xd;
                &amp;#160;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Fair&#xd;
                value of warrants (recorded to Additional Paid-in&#xd;
                Capital)&lt;/font&gt;&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1,127,418&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Beneficial&#xd;
                conversion feature (recorded to Additional Paid-in&#xd;
                Capital)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;(762,667&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
                proceeds allocated to preferred stock&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;108,947&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accretion&#xd;
                of beneficial conversion feature (deemed&#xd;
                dividend)&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;762,667&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Initial&#xd;
                carrying value of preferred stock&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;871,614&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Conversions&#xd;
                to common stock&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;(559,418&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
          &lt;tr&gt;&#xd;
            &lt;td align=&quot;left&quot; valign=&quot;bottom&quot; width=&quot;85%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &lt;div style=&quot;LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot; align=&quot;left&quot;&gt;&#xd;
                &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Carrying&#xd;
                value of preferred stock at December 31,&#xd;
                2012&lt;/font&gt;&#xd;
              &lt;/div&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font style=&quot;DISPLAY: inline&quot;&gt;312,196&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&#xd;
            &lt;/td&gt;&#xd;
            &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
              &amp;#160;&#xd;
            &lt;/td&gt;&#xd;
          &lt;/tr&gt;&#xd;
        &lt;/table&gt;</govx:AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock unitRef="usd" contextRef="c145_From1Apr2012To31Dec2012" decimals="0">1999032</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued unitRef="usd" contextRef="c145_From1Apr2012To31Dec2012" decimals="0">1127418</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature unitRef="usd" contextRef="c145_From1Apr2012To31Dec2012" decimals="0">762667</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
  <govx:NetProceedsAllocatedToConvertiblePreferredStock unitRef="usd" contextRef="c145_From1Apr2012To31Dec2012" decimals="0">108947</govx:NetProceedsAllocatedToConvertiblePreferredStock>
  <us-gaap:TemporaryEquityAccretionOfDividends unitRef="usd" contextRef="c145_From1Apr2012To31Dec2012" decimals="0">762667</us-gaap:TemporaryEquityAccretionOfDividends>
  <us-gaap:PreferredStockValue unitRef="usd" contextRef="c146_AsOf31Mar2012" decimals="0">871614</us-gaap:PreferredStockValue>
  <us-gaap:ConversionOfStockAmountConverted1 unitRef="usd" contextRef="c145_From1Apr2012To31Dec2012" decimals="0">559418</us-gaap:ConversionOfStockAmountConverted1>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Number&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;of&#xd;
              Shares&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Price&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted-&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Average&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Remaining&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Contractual&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Term&#xd;
              (yrs)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Aggregate&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Value&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;928,242&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;5.43&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Granted&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;238,500&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-435&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;0.70&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercised&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-436&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&#xd;
              or expired&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(97,601&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-437&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;4.02&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,069,141&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4.50&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-438&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;6.2&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;698,995&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.38&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-439&quot; style=&quot;MARGIN-LEFT: 36pt&quot;&gt;&lt;/font&gt;4.6&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-0-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c1_AsOf31Dec2011" decimals="INF">928242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c1_AsOf31Dec2011" decimals="2">5.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="INF">238500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2012To31Dec2012" decimals="2">0.70</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="INF">97601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2012To31Dec2012" decimals="2">4.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">1069141</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf31Dec2012" decimals="2">4.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c4_From1Jan2012To31Dec2012">P6Y73D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">698995</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf31Dec2012" decimals="2">6.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c4_From1Jan2012To31Dec2012">P4Y219D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <govx:AdditionalInformationConcerningStockOptionsTableTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
              average fair value of options granted during the&#xd;
              period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.59&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.79&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.95&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Intrinsic&#xd;
              value of options exercised during the period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              fair value of options vested during the period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;319,920&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;540,339&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;499,557&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</govx:AdditionalInformationConcerningStockOptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c4_From1Jan2012To31Dec2012" decimals="2">0.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c5_From1Jan2011To31Dec2011" decimals="2">0.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue unitRef="usdPershares" contextRef="c6_From1Jan2010To31Dec2010" decimals="2">2.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">319920</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">540339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">499557</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
              average risk-free interest rates&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.1&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.4&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.6&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
              dividend yield&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.0&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
              life of option (yrs)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.7&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;6.7&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expected&#xd;
              volatility&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;105.2&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;111.2&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;112.9&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;%&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c4_From1Jan2012To31Dec2012" decimals="3">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c5_From1Jan2011To31Dec2011" decimals="3">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate unitRef="pure" contextRef="c6_From1Jan2010To31Dec2010" decimals="3">0.026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c4_From1Jan2012To31Dec2012" decimals="3">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c5_From1Jan2011To31Dec2011" decimals="3">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate unitRef="pure" contextRef="c6_From1Jan2010To31Dec2010" decimals="3">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c4_From1Jan2012To31Dec2012">P6Y255D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c5_From1Jan2011To31Dec2011">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c6_From1Jan2010To31Dec2010">P6Y255D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c4_From1Jan2012To31Dec2012" decimals="3">1.052</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c5_From1Jan2011To31Dec2011" decimals="3">1.112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate unitRef="pure" contextRef="c6_From1Jan2010To31Dec2010" decimals="3">1.129</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: center; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;General&#xd;
              and administrative expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;231,936&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;284,352&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;369,161&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
              and development expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;78,140&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;179,400&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;206,501&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;55%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              stock option expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;310,076&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;463,752&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;575,662&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c147_From1Jan2012To31Dec2012_GeneralAndAdministrativeExpenseMember" decimals="0">231936</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c148_From1Jan2011To31Dec2011_GeneralAndAdministrativeExpenseMember" decimals="0">284352</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c149_From1Jan2010To31Dec2010_GeneralAndAdministrativeExpenseMember" decimals="0">369161</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c150_From1Jan2012To31Dec2012_ResearchAndDevelopmentExpenseMember" decimals="0">78140</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c151_From1Jan2011To31Dec2011_ResearchAndDevelopmentExpenseMember" decimals="0">179400</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c152_From1Jan2010To31Dec2010_ResearchAndDevelopmentExpenseMember" decimals="0">206501</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">310076</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">463752</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">575662</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;13%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Number&#xd;
              of Shares&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Weighted&#xd;
              Average&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercise&#xd;
              Price&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,870,559&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.96&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Series A Warrants (1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,933,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Series B Warrants (1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,933,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;0.75&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Series C Warrants (1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,933,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Issued&#xd;
              &amp;#8211; Other Warrants (2)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;612,001&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercised&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;--&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;--&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Forfeited&#xd;
              or expired&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(57,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;7.00&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Outstanding&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;11,225,559&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.06&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Exercisable&#xd;
              at December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;8,290,376&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2.44&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c1_AsOf31Dec2011" decimals="INF">1870559</us-gaap:ClassOfWarrantOrRightOutstanding>
  <govx:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c1_AsOf31Dec2011" decimals="2">7.96</govx:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice>
  <govx:ClassOfWarrantOrRightIssuedDuringPeriod id="_ClassOfWarrantOrRightIssuedDuringPeriod-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usd" unitRef="usd" contextRef="c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember" decimals="0">2933333</govx:ClassOfWarrantOrRightIssuedDuringPeriod>
  <govx:ClassOfWarrantIssuedWeightedAverageExercisePrice id="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember_usdPershares" unitRef="usdPershares" contextRef="c153_From1Jan2012To31Dec2012_SeriesAWarrantsMember" decimals="2">1.00</govx:ClassOfWarrantIssuedWeightedAverageExercisePrice>
  <govx:ClassOfWarrantOrRightIssuedDuringPeriod id="_ClassOfWarrantOrRightIssuedDuringPeriod-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usd" unitRef="usd" contextRef="c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember" decimals="0">2933333</govx:ClassOfWarrantOrRightIssuedDuringPeriod>
  <govx:ClassOfWarrantIssuedWeightedAverageExercisePrice id="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember_usdPershares" unitRef="usdPershares" contextRef="c154_From1Jan2012To31Dec2012_SeriesBWarrantsMember" decimals="2">0.75</govx:ClassOfWarrantIssuedWeightedAverageExercisePrice>
  <govx:ClassOfWarrantOrRightIssuedDuringPeriod id="_ClassOfWarrantOrRightIssuedDuringPeriod-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usd" unitRef="usd" contextRef="c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember" decimals="0">2933333</govx:ClassOfWarrantOrRightIssuedDuringPeriod>
  <govx:ClassOfWarrantIssuedWeightedAverageExercisePrice id="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember_usdPershares" unitRef="usdPershares" contextRef="c155_From1Jan2012To31Dec2012_SeriesCWarrantsMember" decimals="2">1.00</govx:ClassOfWarrantIssuedWeightedAverageExercisePrice>
  <govx:ClassOfWarrantOrRightIssuedDuringPeriod id="_ClassOfWarrantOrRightIssuedDuringPeriod-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usd" unitRef="usd" contextRef="c156_From1Jan2012To31Dec2012_OtherWarrantsMember" decimals="0">612001</govx:ClassOfWarrantOrRightIssuedDuringPeriod>
  <govx:ClassOfWarrantIssuedWeightedAverageExercisePrice id="_ClassOfWarrantIssuedWeightedAverageExercisePrice-c156_From1Jan2012To31Dec2012_OtherWarrantsMember_usdPershares" unitRef="usdPershares" contextRef="c156_From1Jan2012To31Dec2012_OtherWarrantsMember" decimals="2">1.00</govx:ClassOfWarrantIssuedWeightedAverageExercisePrice>
  <govx:ClassOfWarrantOrRightExercises unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">0</govx:ClassOfWarrantOrRightExercises>
  <govx:ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">0</govx:ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice>
  <govx:ClassOfWarrantOrRightForfeituresAndExpirations unitRef="shares" contextRef="c4_From1Jan2012To31Dec2012" decimals="INF">-57000</govx:ClassOfWarrantOrRightForfeituresAndExpirations>
  <govx:ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c4_From1Jan2012To31Dec2012" decimals="2">7.00</govx:ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice>
  <us-gaap:ClassOfWarrantOrRightOutstanding unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">11225559</us-gaap:ClassOfWarrantOrRightOutstanding>
  <govx:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf31Dec2012" decimals="2">2.06</govx:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice>
  <govx:ClassOfWarrantOrRightExercisableNumber unitRef="shares" contextRef="c0_AsOf31Dec2012" decimals="INF">8290376</govx:ClassOfWarrantOrRightExercisableNumber>
  <govx:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice unitRef="usdPershares" contextRef="c0_AsOf31Dec2012" decimals="2">2.44</govx:ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;7.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Retirement&#xd;
      Plan&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      participate in a multi-employer defined contribution&#xd;
      retirement plan (the &amp;#8220;401k Plan&amp;#8221;) administered by&#xd;
      a third party service provider; and the Company contributes&#xd;
      to the 401k Plan on behalf of its employees based upon a&#xd;
      matching formula.&amp;#160;&amp;#160;During the years ended December&#xd;
      31, 2012, 2011 and 2010 our contributions to the 401k Plan&#xd;
      were $50,500, $56,928, and $52,632, respectively.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">50500</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
  <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">56928</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
  <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">52632</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;8.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income&#xd;
      Taxes&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;At&#xd;
      December 31, 2012, we have a consolidated federal net&#xd;
      operating loss (&amp;#8220;NOL&amp;#8221;) carryforward of&#xd;
      approximately $69.8 million, available to offset against&#xd;
      future taxable income which expires in varying amounts in&#xd;
      2013 through 2032.&amp;#160;&amp;#160;Additionally, we have&#xd;
      approximately $764,000 in research and development&#xd;
      (&amp;#8220;R&amp;amp;D&amp;#8221;) tax credits that expire in 2022&#xd;
      through 2031 unless utilized earlier.&amp;#160;&amp;#160;No income&#xd;
      taxes have been paid to date.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;As&#xd;
      a result of the Merger discussed in Note 5, our NOL&#xd;
      carryforward increased substantially due to the addition of&#xd;
      historical NOL carryforwards for Dauphin Technology,&#xd;
      Inc.&amp;#160;&amp;#160;However, Section 382 of the Internal Revenue&#xd;
      Code contains provisions that may limit our utilization of&#xd;
      NOL and R&amp;amp;D tax credit carryforwards in any given year as&#xd;
      a result of significant changes in ownership interests that&#xd;
      have occurred in past periods or may occur in future&#xd;
      periods.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
      income taxes reflect the net effect of temporary differences&#xd;
      between the carrying amounts of assets and liabilities for&#xd;
      financial reporting purposes and the amounts used for income&#xd;
      tax purposes.&amp;#160;&amp;#160;Significant components of our&#xd;
      deferred tax assets and liabilities included the following at&#xd;
      December 31, 2012 and 2011:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
              tax assets:&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              operating loss carryforward&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;24,429,472&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;24,872,082&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
              and development tax credit carryforward&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;763,965&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;763,690&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Stock-based&#xd;
              compensation expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,097,194&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,991,769&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              deferred tax assets&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,290,631&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,627,541&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
              tax liabilities&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Depreciation&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(16,125&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(36,311&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              deferred tax liabilities&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(16,125&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(36,311&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              deferred tax assets&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,274,506&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,591,230&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Valuation&#xd;
              allowance&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(27,274,506&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(27,591,230&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      have established a full valuation allowance equal to the&#xd;
      amount of our net deferred tax assets due to uncertainties&#xd;
      with respect to our ability to generate sufficient taxable&#xd;
      income to realize these assets in the future. A&#xd;
      reconciliation of the income tax benefit on losses at the&#xd;
      U.S. federal statutory rate to the reported income tax&#xd;
      expense is as follows:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;U.S.&#xd;
              federal statutory rate applied to pretax loss&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(725,948&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(797,921&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(934,092&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Permanent&#xd;
              differences&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-440&quot; style=&quot;MARGIN-LEFT: 32.15pt&quot;&gt;&lt;/font&gt;2,674&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4,216&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-441&quot; style=&quot;MARGIN-LEFT: 19.6pt&quot;&gt;&lt;/font&gt;(77,200&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
              and development credits&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-442&quot; style=&quot;MARGIN-LEFT: 57.7pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;32,675&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-443&quot; style=&quot;MARGIN-LEFT: 28.45pt&quot;&gt;&lt;/font&gt;59,959&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Change&#xd;
              in valuation allowance&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-444&quot; style=&quot;MARGIN-LEFT: 18.8pt&quot;&gt;&lt;/font&gt;723,274&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;761,030&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-445&quot; style=&quot;MARGIN-LEFT: 21.8pt&quot;&gt;&lt;/font&gt;951,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Reported&#xd;
              income tax expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="-5">69800000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
              tax assets:&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              operating loss carryforward&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;24,429,472&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;24,872,082&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
              and development tax credit carryforward&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;763,965&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;763,690&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Stock-based&#xd;
              compensation expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2,097,194&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,991,769&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              deferred tax assets&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,290,631&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,627,541&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deferred&#xd;
              tax liabilities&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Depreciation&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(16,125&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(36,311&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Total&#xd;
              deferred tax liabilities&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(16,125&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(36,311&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              deferred tax assets&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,274,506&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,591,230&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Valuation&#xd;
              allowance&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(27,274,506&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(27,591,230&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;70%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;12%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">24429472</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">24872082</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">763965</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">763690</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">2097194</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">1991769</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">27290631</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsGross unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">27627541</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">16125</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
  <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">36311</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
  <us-gaap:DeferredIncomeTaxLiabilities unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">16125</us-gaap:DeferredIncomeTaxLiabilities>
  <us-gaap:DeferredIncomeTaxLiabilities unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">36311</us-gaap:DeferredIncomeTaxLiabilities>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">27274506</us-gaap:DeferredTaxAssetsLiabilitiesNet>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">27591230</us-gaap:DeferredTaxAssetsLiabilitiesNet>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c0_AsOf31Dec2012" decimals="0">27274506</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c1_AsOf31Dec2011" decimals="0">27591230</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;U.S.&#xd;
              federal statutory rate applied to pretax loss&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(725,948&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(797,921&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(934,092&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Permanent&#xd;
              differences&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-440&quot; style=&quot;MARGIN-LEFT: 32.15pt&quot;&gt;&lt;/font&gt;2,674&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;4,216&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-441&quot; style=&quot;MARGIN-LEFT: 19.6pt&quot;&gt;&lt;/font&gt;(77,200&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Research&#xd;
              and development credits&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-442&quot; style=&quot;MARGIN-LEFT: 57.7pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;32,675&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-443&quot; style=&quot;MARGIN-LEFT: 28.45pt&quot;&gt;&lt;/font&gt;59,959&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Change&#xd;
              in valuation allowance&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-444&quot; style=&quot;MARGIN-LEFT: 18.8pt&quot;&gt;&lt;/font&gt;723,274&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;761,030&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-445&quot; style=&quot;MARGIN-LEFT: 21.8pt&quot;&gt;&lt;/font&gt;951,333&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;49%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Reported&#xd;
              income tax expense&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;14%&quot; style=&quot;BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 4px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">-725948</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">-797921</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">-934092</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationNondeductibleExpense unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">2674</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
  <us-gaap:IncomeTaxReconciliationNondeductibleExpense unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">4216</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
  <us-gaap:IncomeTaxReconciliationNondeductibleExpense unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">-77200</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">32675</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <us-gaap:IncomeTaxReconciliationTaxCreditsResearch unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">59959</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c4_From1Jan2012To31Dec2012" decimals="0">723274</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c5_From1Jan2011To31Dec2011" decimals="0">761030</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance unitRef="usd" contextRef="c6_From1Jan2010To31Dec2010" decimals="0">951333</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;9.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Related&#xd;
      Party Transactions&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;We&#xd;
      are obligated to reimburse Emory University (a significant&#xd;
      stockholder of the Company) for ongoing costs in connection&#xd;
      with the filing, prosecution and maintenance of patent&#xd;
      applications subject to a license agreement for technology&#xd;
      associated with the vaccines we are&#xd;
      developing.&amp;#160;&amp;#160;The expense associated with these&#xd;
      ongoing patent cost reimbursements to Emory amounted to&#xd;
      $89,885, $249,907, and $193,674 for the years ended December&#xd;
      31, 2012, 2011, and 2010, respectively.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      connection with our IPCAVD grant from the NIH (see Note 3),&#xd;
      we have entered into two subcontracts with Emory for the&#xd;
      purpose of conducting research and development activities&#xd;
      related to the grant.&amp;#160;&amp;#160;During 2012, 2011, and 2010,&#xd;
      we recorded $552,403, $1,172,758, and $1,391,203,&#xd;
      respectively, of expense associated with these&#xd;
      subcontracts.&amp;#160;&amp;#160;All amounts paid to Emory under&#xd;
      these subcontracts are reimbursable to us pursuant to the NIH&#xd;
      grant.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      March 2008, we entered into a consulting agreement with&#xd;
      Donald Hildebrand, a former member of our Board of Directors&#xd;
      and our former President &amp;amp; Chief Executive Officer,&#xd;
      pursuant to which Mr. Hildebrand has provided business and&#xd;
      technical advisory services to the Company.&amp;#160;&amp;#160;The&#xd;
      term of the consulting agreement, as amended, began on April&#xd;
      1, 2008 and ended on December 31, 2012.&amp;#160;&amp;#160;During&#xd;
      2012, 2011, and 2010, we recorded $24,000, $24,000, and&#xd;
      $57,600, respectively, of expense associated with the&#xd;
      consulting agreement.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;In&#xd;
      December 2011 and January 2012, members of our management and&#xd;
      Board of Directors participated in the private placement&#xd;
      offering of our common stock and warrants (see Note 6),&#xd;
      whereby they purchased an aggregate of 380,954 shares of our&#xd;
      common stock for a total purchase price of $255,239 and&#xd;
      received five-year warrants to purchase an additional 571,432&#xd;
      shares of our common stock exercisable at $1.00 per&#xd;
      share.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c157_From1Jan2012To31Dec2012_OngoingPatentCostReimbursementsMember" decimals="0">89885</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c158_From1Jan2011To31Dec2011_OngoingPatentCostReimbursementsMember" decimals="0">249907</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c159_From1Jan2010To31Dec2010_OngoingPatentCostReimbursementsMember" decimals="0">193674</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c160_From1Jan2012To30Sep2012_ResearchAgreementsMember" decimals="0">552403</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c161_From1Jan2011To31Dec2011_ResearchAgreementsMember" decimals="0">1172758</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c162_From1Jan2010To31Dec2010_ResearchAgreementsMember" decimals="0">1391203</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c163_From1Jan2012To31Dec2012_ConsultingAgreementMember" decimals="0">24000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c164_From1Jan2011To31Dec2011_ConsultingAgreementMember" decimals="0">24000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty unitRef="usd" contextRef="c165_From1Jan2010To31Dec2010_ConsultingAgreementMember" decimals="0">57600</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues unitRef="shares" contextRef="c166_From1Jan2012To31Jan2012_MembersOfBoardOfDirectorsAndManagementMember" decimals="INF">380954</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock unitRef="usd" contextRef="c166_From1Jan2012To31Jan2012_MembersOfBoardOfDirectorsAndManagementMember" decimals="0">255239</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <govx:ClassOfWarrantOrRightPurchasePeriod contextRef="c166_From1Jan2012To31Jan2012_MembersOfBoardOfDirectorsAndManagementMember">P5Y</govx:ClassOfWarrantOrRightPurchasePeriod>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights unitRef="shares" contextRef="c167_AsOf31Jan2012_MembersOfBoardOfDirectorsAndManagementMember" decimals="INF">571432</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights unitRef="usdPeritem" contextRef="c167_AsOf31Jan2012_MembersOfBoardOfDirectorsAndManagementMember" decimals="2">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;10.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Selected&#xd;
      Quarterly Financial Data (unaudited)&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;A&#xd;
      summary of selected quarterly financial data for 2012 and&#xd;
      2011 is as follows:&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;97%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;14&quot; valign=&quot;bottom&quot; width=&quot;46%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&#xd;
              Quarter Ended&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;March&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;June&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;September&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;December&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
              from grants&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;854,063&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;705,698&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;638,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;459,566&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(730,513&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(497,763&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(296,779&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(610,085&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss per share&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.03&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.02&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.03&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;97%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;14&quot; valign=&quot;bottom&quot; width=&quot;46%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&#xd;
              Quarter Ended&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;March&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;June&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;September&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;December&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
              from grants&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;893,002&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,753,033&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,297,006&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;956,844&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(606,282&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(211,344&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(375,852&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1,153,348&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss per share&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.01&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.02&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.08&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;97%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;14&quot; valign=&quot;bottom&quot; width=&quot;46%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2012&#xd;
              Quarter Ended&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;March&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;June&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;September&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;December&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
              from grants&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;854,063&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;705,698&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;638,000&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;459,566&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(730,513&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(497,763&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(296,779&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(610,085&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss per share&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.03&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.02&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.03&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;97%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;14&quot; valign=&quot;bottom&quot; width=&quot;46%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;2011&#xd;
              Quarter Ended&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;March&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;June&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;September&#xd;
              30&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; width=&quot;10%&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;December&#xd;
              31&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Revenue&#xd;
              from grants&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;893,002&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,753,033&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;1,297,006&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;956,844&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(606,282&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(211,344&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(375,852&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1,153,348&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;52%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Net&#xd;
              loss per share&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.04&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.01&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.02&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(0.08&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c168_From1Jan2012To31Mar2012" decimals="0">854063</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c169_From1Apr2012To30Jun2012" decimals="0">705698</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c170_From1Jul2012To30Sep2012" decimals="0">638000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c171_From1Oct2012To31Dec2012" decimals="0">459566</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c172_From1Jan2011To31Mar2011" decimals="0">893002</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c173_From1Apr2011To30Jun2011" decimals="0">1753033</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c174_From1Jul2011To30Sep2011" decimals="0">1297006</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants unitRef="usd" contextRef="c175_From1Oct2011To31Dec2011" decimals="0">956844</us-gaap:RevenueFromGrants>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c168_From1Jan2012To31Mar2012" decimals="0">-730513</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c169_From1Apr2012To30Jun2012" decimals="0">-497763</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c170_From1Jul2012To30Sep2012" decimals="0">-296779</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c171_From1Oct2012To31Dec2012" decimals="0">-610085</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c172_From1Jan2011To31Mar2011" decimals="0">-606282</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c173_From1Apr2011To30Jun2011" decimals="0">-211344</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c174_From1Jul2011To30Sep2011" decimals="0">-375852</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss unitRef="usd" contextRef="c175_From1Oct2011To31Dec2011" decimals="0">-1153348</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c168_From1Jan2012To31Mar2012" decimals="2">-0.04</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c169_From1Apr2012To30Jun2012" decimals="2">-0.03</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c170_From1Jul2012To30Sep2012" decimals="2">-0.02</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c171_From1Oct2012To31Dec2012" decimals="2">-0.03</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c172_From1Jan2011To31Mar2011" decimals="2">-0.04</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c173_From1Apr2011To30Jun2011" decimals="2">-0.01</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c174_From1Jul2011To30Sep2011" decimals="2">-0.02</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic unitRef="usdPershares" contextRef="c175_From1Oct2011To31Dec2011" decimals="2">-0.08</us-gaap:EarningsPerShareBasic>
  <us-gaap:SubsequentEventsTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;11.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Subsequent&#xd;
      Events&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Warrant&#xd;
      Modification and Exercise&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Effective&#xd;
      January 17, 2013, we reduced the exercise price of our&#xd;
      then-outstanding Series B Common Stock Purchase Warrants (see&#xd;
      Note 6).&amp;#160;&amp;#160;The exercise price for all the Series B&#xd;
      Warrants was reduced from $0.75 to $0.60 per&#xd;
      share.&amp;#160;&amp;#160;The exercise price for the Series A&#xd;
      Warrants and Series C Warrants that were issued concurrently&#xd;
      with the Series B Warrants did not change.&amp;#160;&amp;#160;In&#xd;
      consideration for the reduction of the exercise price, the&#xd;
      holders of the Series B Warrants immediately exercised&#xd;
      1,766,667 of the Series B Warrants for cash, resulting in&#xd;
      total proceeds to the Company of $1,060,000.&amp;#160;&amp;#160;The&#xd;
      expiration date of Series B Warrants with respect to the&#xd;
      remaining 1,166,667 shares was extended from March 21, 2013&#xd;
      to May 21, 2013.&amp;#160;&amp;#160;In January 2013, we recorded&#xd;
      general and administrative expense of $218,551 associated&#xd;
      with the warrant modifications.&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights unitRef="usdPeritem" contextRef="c176_AsOf17Jan2013_SeriesBWarrantsMember" decimals="2">0.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <govx:ClassOfWarrantOrRightExercises unitRef="shares" contextRef="c177_From1Jan2013To31Jan2013_SeriesBWarrantsMember" decimals="INF">1766667</govx:ClassOfWarrantOrRightExercises>
  <us-gaap:ProceedsFromWarrantExercises unitRef="usd" contextRef="c177_From1Jan2013To31Jan2013_SeriesBWarrantsMember" decimals="0">1060000</us-gaap:ProceedsFromWarrantExercises>
  <govx:ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended unitRef="shares" contextRef="c176_AsOf17Jan2013_SeriesBWarrantsMember" decimals="INF">1166667</govx:ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended>
  <us-gaap:OtherGeneralAndAdministrativeExpense unitRef="usd" contextRef="c177_From1Jan2013To31Jan2013_SeriesBWarrantsMember" decimals="0">218551</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="c4_From1Jan2012To31Dec2012">&lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;SCHEDULE&#xd;
      II &amp;#8211; VALUATION AND QUALIFYING ACCOUNTS&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
      &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold&quot;&gt;For&#xd;
      the Years Ended December 31, 2012, 2011 and 2010&lt;/font&gt;&#xd;
    &lt;/div&gt;&lt;br/&gt;&lt;table cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr style=&quot;TEXT-ALIGN: left;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;6&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Additions&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Description&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Balance&#xd;
              at&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Beginning&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Of&#xd;
              Period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Charged&#xd;
              to&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Costs&#xd;
              and&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Expenses&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Charged&#xd;
              to&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Other&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Accounts&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Deductions&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Balance&#xd;
              at&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;End&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Of&#xd;
              Period&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left; PADDING-BOTTOM: 2px&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Reserve&#xd;
              Deducted in the Balance Sheet&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;From&#xd;
              the Asset to Which it Applies:&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;Allowance&#xd;
              for Deferred Tax Assets&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td colspan=&quot;2&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;40%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-446&quot; style=&quot;MARGIN-LEFT: 9pt&quot;&gt;&lt;/font&gt;Year ended&#xd;
              December 31, 2012&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,591,230&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;796,237&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;(1,112,961&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;$&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,274,506&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr style=&quot;background-color: #C0FFFF;&quot;&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;40%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-447&quot; style=&quot;MARGIN-LEFT: 9pt&quot;&gt;&lt;/font&gt;Year ended&#xd;
              December 31, 2011&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,576,253&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-448&quot; style=&quot;MARGIN-LEFT: 11.1pt&quot;&gt;&lt;/font&gt;888,561&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-449&quot; style=&quot;MARGIN-LEFT: 46.75pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-450&quot; style=&quot;MARGIN-LEFT: 0.2pt&quot;&gt;&lt;/font&gt;(873,584&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,591,230&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
        &lt;tr&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;40%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-451&quot; style=&quot;MARGIN-LEFT: 9pt&quot;&gt;&lt;/font&gt;Year ended&#xd;
              December 31, 2010&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,091,338&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-452&quot; style=&quot;MARGIN-LEFT: 1.1pt&quot;&gt;&lt;/font&gt;1,160,405&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-453&quot; style=&quot;MARGIN-LEFT: 46.75pt&quot;&gt;&lt;/font&gt;-&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;&lt;font id=&quot;TAB1-454&quot; style=&quot;MARGIN-LEFT: 0.2pt&quot;&gt;&lt;/font&gt;(675,490&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;)&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td valign=&quot;bottom&quot; width=&quot;9%&quot; style=&quot;TEXT-ALIGN: right&quot;&gt;&#xd;
            &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt&quot;&gt;27,576,253&lt;/font&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td nowrap=&quot;nowrap&quot; valign=&quot;bottom&quot; width=&quot;1%&quot; style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &amp;#160;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;&lt;table border=&quot;0&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot; id=&quot;hangingindent-92&quot; width=&quot;100%&quot; style=&quot;TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman&quot;&gt;&#xd;
        &lt;tr valign=&quot;top&quot; style=&quot;TEXT-ALIGN: left; LINE-HEIGHT: 1.25;&quot;&gt;&#xd;
          &lt;td style=&quot;TEXT-ALIGN: left; WIDTH: 18pt&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;&amp;#160;&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td style=&quot;TEXT-ALIGN: left; WIDTH: 18pt&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;(1)&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
          &lt;td style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
            &lt;div style=&quot;TEXT-ALIGN: left&quot;&gt;&#xd;
              &lt;font style=&quot;DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt&quot;&gt;Deductions&#xd;
              represent the effect of expiring NOL carryforwards&#xd;
              from prior years.&lt;/font&gt;&#xd;
            &lt;/div&gt;&#xd;
          &lt;/td&gt;&#xd;
        &lt;/tr&gt;&#xd;
      &lt;/table&gt;&lt;br/&gt;</us-gaap:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
  <us-gaap:ValuationAllowancesAndReservesBalance unitRef="usd" contextRef="c178_AsOf31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">27591230</us-gaap:ValuationAllowancesAndReservesBalance>
  <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense unitRef="usd" contextRef="c179_From1Jan2012To31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">796237</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
  <us-gaap:ValuationAllowancesAndReservesDeductions id="_ValuationAllowancesAndReservesDeductions-c179_From1Jan2012To31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember_usd" unitRef="usd" contextRef="c179_From1Jan2012To31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">1112961</us-gaap:ValuationAllowancesAndReservesDeductions>
  <us-gaap:ValuationAllowancesAndReservesBalance unitRef="usd" contextRef="c180_AsOf31Dec2012_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">27274506</us-gaap:ValuationAllowancesAndReservesBalance>
  <us-gaap:ValuationAllowancesAndReservesBalance unitRef="usd" contextRef="c181_AsOf31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">27576253</us-gaap:ValuationAllowancesAndReservesBalance>
  <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense unitRef="usd" contextRef="c182_From1Jan2011To31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">888561</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
  <us-gaap:ValuationAllowancesAndReservesDeductions id="_ValuationAllowancesAndReservesDeductions-c182_From1Jan2011To31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember_usd" unitRef="usd" contextRef="c182_From1Jan2011To31Dec2011_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">873584</us-gaap:ValuationAllowancesAndReservesDeductions>
  <us-gaap:ValuationAllowancesAndReservesBalance unitRef="usd" contextRef="c183_AsOf31Dec2009_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">27091338</us-gaap:ValuationAllowancesAndReservesBalance>
  <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense unitRef="usd" contextRef="c184_From1Jan2010To31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">1160405</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
  <us-gaap:ValuationAllowancesAndReservesDeductions id="_ValuationAllowancesAndReservesDeductions-c184_From1Jan2010To31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember_usd" unitRef="usd" contextRef="c184_From1Jan2010To31Dec2010_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="0">675490</us-gaap:ValuationAllowancesAndReservesDeductions>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>govx-20121231.xsd
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 14 22:47:45 UTC 2013 -->
<xs:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" targetNamespace="http://geovax.com/20121231" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:govx="http://geovax.com/20121231" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" elementFormDefault="qualified" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20121231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20121231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20121231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="govx-20121231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedBalanceSheet" id="govx_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals" id="govx_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedIncomeStatement" id="govx_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ShareholdersEquityType2or3" id="govx_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - Consolidated Statements of Stockholders' Equity (Deficiency)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ConsolidatedCashFlow" id="govx_ConsolidatedCashFlow">
        <link:definition>005 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note" id="govx_Note">
        <link:definition>006 - Disclosure - Note 1 - Nature of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note0" id="govx_Note0">
        <link:definition>007 - Disclosure - Note 2 - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note00" id="govx_Note00">
        <link:definition>008 - Disclosure - Note 3 - Government Grants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note000" id="govx_Note000">
        <link:definition>009 - Disclosure - Note 4 - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note0000" id="govx_Note0000">
        <link:definition>010 - Disclosure - Note 5 - 2006 Merger and Recapitalization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note00000" id="govx_Note00000">
        <link:definition>011 - Disclosure - Note 6 - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note000000" id="govx_Note000000">
        <link:definition>012 - Disclosure - Note 7 - Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note0000000" id="govx_Note0000000">
        <link:definition>013 - Disclosure - Note 8 - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note00000000" id="govx_Note00000000">
        <link:definition>014 - Disclosure - Note 9 - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note000000000" id="govx_Note000000000">
        <link:definition>015 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Note0000000000" id="govx_Note0000000000">
        <link:definition>016 - Disclosure - Note 11 - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/Schedule" id="govx_Schedule">
        <link:definition>017 - Disclosure - Schedule II - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/AccountingPoliciesByPolicy" id="govx_AccountingPoliciesByPolicy">
        <link:definition>018 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteTables" id="govx_NoteTables">
        <link:definition>019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteTables0" id="govx_NoteTables0">
        <link:definition>020 - Disclosure - Note 6 - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteTables00" id="govx_NoteTables00">
        <link:definition>021 - Disclosure - Note 8 - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteTables000" id="govx_NoteTables000">
        <link:definition>022 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail" id="govx_NoteDetail">
        <link:definition>023 - Disclosure - Note 1 - Nature of Business (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail0" id="govx_NoteDetail0">
        <link:definition>024 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/PropertyandEquipmentTable" id="govx_PropertyandEquipmentTable">
        <link:definition>025 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail00" id="govx_NoteDetail00">
        <link:definition>026 - Disclosure - Note 3 - Government Grants (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail000" id="govx_NoteDetail000">
        <link:definition>027 - Disclosure - Note 4 - Commitments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail0000" id="govx_NoteDetail0000">
        <link:definition>028 - Disclosure - Note 5 - 2006 Merger and Recapitalization (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail00000" id="govx_NoteDetail00000">
        <link:definition>029 - Disclosure - Note 6 - Stockholders' Equity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable" id="govx_AllocationofNetProceedsfromPreferredStockFinancingTable">
        <link:definition>030 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Allocation of Net Proceeds from Preferred Stock Financing</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCgwG4gzQgO1GtJPkRDF8quUM4CUMA/xge9QOZ9RJaXDR38VLtarIvJZPfxcf4bZAv7z120OcgrDNUMQwBRXs2wXDWpxuQWN96ZKu4+pgDA/ftLu0v5mXw57O5DEvAWbz4/Q==] CSR-->
      <link:roleType roleURI="http://geovax.com/role/StockOptionActivityTable" id="govx_StockOptionActivityTable">
        <link:definition>031 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Stock Option Activity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/AdditionalInformationConcerningStockOptionsTable" id="govx_AdditionalInformationConcerningStockOptionsTable">
        <link:definition>032 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Additional Information Concerning Stock Options</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/SignificantAssumptionsUsedinFairValueCalculationsTable" id="govx_SignificantAssumptionsUsedinFairValueCalculationsTable">
        <link:definition>033 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Significant Assumptions Used in Fair Value Calculations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/StockbasedCompensationExpenseTable" id="govx_StockbasedCompensationExpenseTable">
        <link:definition>034 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Stock-based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/StockPurchaseWarrantTransactionsTable" id="govx_StockPurchaseWarrantTransactionsTable">
        <link:definition>035 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Stock Purchase Warrant Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail000000" id="govx_NoteDetail000000">
        <link:definition>036 - Disclosure - Note 7 - Retirement Plan (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail0000000" id="govx_NoteDetail0000000">
        <link:definition>037 - Disclosure - Note 8 - Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable" id="govx_DeferredTaxAssetsandLiabilitiesTable">
        <link:definition>038 - Disclosure - Note 8 - Income Taxes (Detail) - Deferred Tax Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ReconciliationoftheIncomeTaxBenefitTable" id="govx_ReconciliationoftheIncomeTaxBenefitTable">
        <link:definition>039 - Disclosure - Note 8 - Income Taxes (Detail) - Reconciliation of the Income Tax Benefit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail00000000" id="govx_NoteDetail00000000">
        <link:definition>040 - Disclosure - Note 9 - Related Party Transactions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail000000000" id="govx_NoteDetail000000000">
        <link:definition>041 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited) (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/SelectedQuarterlyFinancialDataTable" id="govx_SelectedQuarterlyFinancialDataTable">
        <link:definition>042 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited) (Detail) - Selected Quarterly Financial Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/NoteDetail0000000000" id="govx_NoteDetail0000000000">
        <link:definition>043 - Disclosure - Note 11 - Subsequent Events (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ScheduleDetail" id="govx_ScheduleDetail">
        <link:definition>044 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/ValuationandQualifyingAccountsTable" id="govx_ValuationandQualifyingAccountsTable">
        <link:definition>045 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Detail) - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://geovax.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Disclosure - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-types-2012-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="ConsolidatedBalanceSheetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedBalanceSheetsAbstract"/>
  <xs:element name="CurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CurrentAssetsAbstract"/>
  <xs:element name="CurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CurrentLiabilitiesAbstract"/>
  <xs:element name="PreferredStockStatedValue" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_PreferredStockStatedValue"/>
  <xs:element name="ConsolidatedStatementsOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedStatementsOfOperationsAbstract"/>
  <xs:element name="OtherIncomeExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_OtherIncomeExpenseAbstract"/>
  <xs:element name="BasicAndDilutedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_BasicAndDilutedAbstract"/>
  <xs:element name="ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract"/>
  <xs:element name="AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
  <xs:element name="ConsolidatedStatementsOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsolidatedStatementsOfCashFlowsAbstract"/>
  <xs:element name="CashFlowsFromOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CashFlowsFromOperatingActivitiesAbstract"/>
  <xs:element name="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
  <xs:element name="ChangesInAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ChangesInAssetsAndLiabilitiesAbstract"/>
  <xs:element name="CashFlowsFromInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CashFlowsFromInvestingActivitiesAbstract"/>
  <xs:element name="CashFlowsFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CashFlowsFromFinancingActivitiesAbstract"/>
  <xs:element name="NatureOfOperationsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_NatureOfOperationsTextBlockAbstract"/>
  <xs:element name="SignificantAccountingPoliciesTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SignificantAccountingPoliciesTextBlockAbstract"/>
  <xs:element name="GovernmentGrantsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_GovernmentGrantsTextBlockAbstract"/>
  <xs:element name="GovernmentGrantsTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_GovernmentGrantsTextBlock"/>
  <xs:element name="CommitmentsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CommitmentsDisclosureTextBlockAbstract"/>
  <xs:element name="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract"/>
  <xs:element name="StockholdersEquityNoteDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
  <xs:element name="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract"/>
  <xs:element name="IncomeTaxDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_IncomeTaxDisclosureTextBlockAbstract"/>
  <xs:element name="RelatedPartyTransactionsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
  <xs:element name="QuarterlyFinancialInformationTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_QuarterlyFinancialInformationTextBlockAbstract"/>
  <xs:element name="SubsequentEventsTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SubsequentEventsTextBlockAbstract"/>
  <xs:element name="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract"/>
  <xs:element name="SignificantAccountingPoliciesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SignificantAccountingPoliciesAbstract"/>
  <xs:element name="DevelopmentStageEnterprisePolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_DevelopmentStageEnterprisePolicyTextBlock"/>
  <xs:element name="OtherAssetsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_OtherAssetsPolicyTextBlock"/>
  <xs:element name="AccruedLiabilitiesPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AccruedLiabilitiesPolicyTextBlock"/>
  <xs:element name="PeriodToPeriodComparisonsPolicyTexBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_PeriodToPeriodComparisonsPolicyTexBlock"/>
  <xs:element name="AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock"/>
  <xs:element name="AdditionalInformationConcerningStockOptionsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AdditionalInformationConcerningStockOptionsTableTextBlock"/>
  <xs:element name="PropertyAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_PropertyAndEquipmentAbstract"/>
  <xs:element name="AllocationOfNetProceedsFromPreferredStockFinancingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract"/>
  <xs:element name="NetProceedsAllocatedToConvertiblePreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="govx_NetProceedsAllocatedToConvertiblePreferredStock"/>
  <xs:element name="StockOptionActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockOptionActivityAbstract"/>
  <xs:element name="AdditionalInformationConcerningStockOptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AdditionalInformationConcerningStockOptionsAbstract"/>
  <xs:element name="SignificantAssumptionsUsedInFairValueCalculationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract"/>
  <xs:element name="StockBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockBasedCompensationExpenseAbstract"/>
  <xs:element name="StockPurchaseWarrantTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockPurchaseWarrantTransactionsAbstract"/>
  <xs:element name="ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice"/>
  <xs:element name="ClassOfWarrantOrRightIssuedDuringPeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightIssuedDuringPeriod"/>
  <xs:element name="ClassOfWarrantIssuedWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice"/>
  <xs:element name="ClassOfWarrantOrRightExercises" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightExercises"/>
  <xs:element name="ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice"/>
  <xs:element name="ClassOfWarrantOrRightForfeituresAndExpirations" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightForfeituresAndExpirations"/>
  <xs:element name="ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice"/>
  <xs:element name="ClassOfWarrantOrRightExercisableNumber" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightExercisableNumber"/>
  <xs:element name="ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice"/>
  <xs:element name="DeferredTaxAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_DeferredTaxAssetsAndLiabilitiesAbstract"/>
  <xs:element name="DeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_DeferredTaxAssetsAbstract"/>
  <xs:element name="ReconciliationOfTheIncomeTaxBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ReconciliationOfTheIncomeTaxBenefitAbstract"/>
  <xs:element name="SelectedQuarterlyFinancialDataAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SelectedQuarterlyFinancialDataAbstract"/>
  <xs:element name="ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract"/>
  <xs:element name="AllowanceForDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_AllowanceForDeferredTaxAssetsAbstract"/>
  <xs:element name="RangeDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_RangeDomain"/>
  <xs:element name="ProjectPeriodCoveredByGrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ProjectPeriodCoveredByGrants"/>
  <xs:element name="ProjectExtensionPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ProjectExtensionPeriod"/>
  <xs:element name="GrantAward" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="govx_GrantAward"/>
  <xs:element name="UnusedGrantFunds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="govx_UnusedGrantFunds"/>
  <xs:element name="OperatingLeaseTermOfLease" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_OperatingLeaseTermOfLease"/>
  <xs:element name="SaleOfCommonStockDomain" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SaleOfCommonStockDomain"/>
  <xs:element name="ConvertiblePreferredStockConversionPricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_ConvertiblePreferredStockConversionPricePerShare"/>
  <xs:element name="ConvertiblePreferredStockTotalConversionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_ConvertiblePreferredStockTotalConversionShares"/>
  <xs:element name="NumberOfPreferredSharesConvertedIntoCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_NumberOfPreferredSharesConvertedIntoCommonStock"/>
  <xs:element name="ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased"/>
  <xs:element name="WarrantsIssuedDuringPeriodExercisePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_WarrantsIssuedDuringPeriodExercisePrice"/>
  <xs:element name="NumberOfWarrantsIssuedDuringPeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_NumberOfWarrantsIssuedDuringPeriod"/>
  <xs:element name="MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees"/>
  <xs:element name="ClassOfWarrantOrRightPurchasePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightPurchasePeriod"/>
  <xs:element name="ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended"/>
  <xs:element name="SaleOfCommonStockAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="govx_SaleOfCommonStockAxis"/>
  <xs:element name="MembersOfBoardOfDirectorsAndManagementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_MembersOfBoardOfDirectorsAndManagementMember"/>
  <xs:element name="SecondNIHGrantMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SecondNIHGrantMember"/>
  <xs:element name="StockSubscriptionReceivableMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_StockSubscriptionReceivableMember"/>
  <xs:element name="SeriesAWarrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SeriesAWarrantsMember"/>
  <xs:element name="FirstNIHGrantMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_FirstNIHGrantMember"/>
  <xs:element name="ResearchAgreementsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ResearchAgreementsMember"/>
  <xs:element name="OtherFurnitureFixturesAndEquipmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_OtherFurnitureFixturesAndEquipmentMember"/>
  <xs:element name="SeriesCWarrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SeriesCWarrantsMember"/>
  <xs:element name="SeriesAConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SeriesAConvertiblePreferredStockMember"/>
  <xs:element name="NIHGrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_NIHGrantsMember"/>
  <xs:element name="SeriesBWarrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_SeriesBWarrantsMember"/>
  <xs:element name="QTDPGrantMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_QTDPGrantMember"/>
  <xs:element name="OngoingPatentCostReimbursementsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_OngoingPatentCostReimbursementsMember"/>
  <xs:element name="CompensatoryWarrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CompensatoryWarrantsMember"/>
  <xs:element name="LaboratoryEquipmentMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_LaboratoryEquipmentMember"/>
  <xs:element name="OtherWarrantsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_OtherWarrantsMember"/>
  <xs:element name="ConsultingAgreementMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_ConsultingAgreementMember"/>
  <xs:element name="IndividualAccreditedInvestorsMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_IndividualAccreditedInvestorsMember"/>
  <xs:element name="CommonStockIssuedForServicesMember" type="nonnum:domainItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_CommonStockIssuedForServicesMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="govx_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>govx-20121231_cal.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 14 22:47:45 UTC 2013 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheet" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedIncomeStatement" roleURI="http://geovax.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedCashFlow" roleURI="http://geovax.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_PropertyandEquipmentTable" roleURI="http://geovax.com/role/PropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_AllocationofNetProceedsfromPreferredStockFinancingTable" roleURI="http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsandLiabilitiesTable" roleURI="http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrantsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_GrantsReceivable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromGrants" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCgwG4gzQgO1GtJPkRDF8quUM4CUMA/xge9QOZ9RJaXDR38VLtarIvJZPfxcf4bZAv7z120OcgrDNUMQwBRXs2wXDWpxuQWN96ZKu4+pgDA/ftFF6IEb9q8Rkwi4p+VNKKqQ==] CSR-->
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/PropertyandEquipmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable">
    <loc xlink:type="locator" xlink:label="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:href="govx-20121231.xsd#govx_NetProceedsAllocatedToConvertiblePreferredStock"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="3" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>govx-20121231_def.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 14 22:47:45 UTC 2013 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheet" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedIncomeStatement" roleURI="http://geovax.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ShareholdersEquityType2or3" roleURI="http://geovax.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedCashFlow" roleURI="http://geovax.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note" roleURI="http://geovax.com/role/Note"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0" roleURI="http://geovax.com/role/Note0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note00" roleURI="http://geovax.com/role/Note00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note000" roleURI="http://geovax.com/role/Note000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0000" roleURI="http://geovax.com/role/Note0000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note00000" roleURI="http://geovax.com/role/Note00000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note000000" roleURI="http://geovax.com/role/Note000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0000000" roleURI="http://geovax.com/role/Note0000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note00000000" roleURI="http://geovax.com/role/Note00000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note000000000" roleURI="http://geovax.com/role/Note000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0000000000" roleURI="http://geovax.com/role/Note0000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Schedule" roleURI="http://geovax.com/role/Schedule"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_AccountingPoliciesByPolicy" roleURI="http://geovax.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables" roleURI="http://geovax.com/role/NoteTables"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables0" roleURI="http://geovax.com/role/NoteTables0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables00" roleURI="http://geovax.com/role/NoteTables00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables000" roleURI="http://geovax.com/role/NoteTables000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_PropertyandEquipmentTable" roleURI="http://geovax.com/role/PropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_AllocationofNetProceedsfromPreferredStockFinancingTable" roleURI="http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_StockOptionActivityTable" roleURI="http://geovax.com/role/StockOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_AdditionalInformationConcerningStockOptionsTable" roleURI="http://geovax.com/role/AdditionalInformationConcerningStockOptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_SignificantAssumptionsUsedinFairValueCalculationsTable" roleURI="http://geovax.com/role/SignificantAssumptionsUsedinFairValueCalculationsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_StockbasedCompensationExpenseTable" roleURI="http://geovax.com/role/StockbasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_StockPurchaseWarrantTransactionsTable" roleURI="http://geovax.com/role/StockPurchaseWarrantTransactionsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsandLiabilitiesTable" roleURI="http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ReconciliationoftheIncomeTaxBenefitTable" roleURI="http://geovax.com/role/ReconciliationoftheIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_SelectedQuarterlyFinancialDataTable" roleURI="http://geovax.com/role/SelectedQuarterlyFinancialDataTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ValuationandQualifyingAccountsTable" roleURI="http://geovax.com/role/ValuationandQualifyingAccountsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail" roleURI="http://geovax.com/role/NoteDetail"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0" roleURI="http://geovax.com/role/NoteDetail0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail00" roleURI="http://geovax.com/role/NoteDetail00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail000" roleURI="http://geovax.com/role/NoteDetail000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0000" roleURI="http://geovax.com/role/NoteDetail0000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail00000" roleURI="http://geovax.com/role/NoteDetail00000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail000000" roleURI="http://geovax.com/role/NoteDetail000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0000000" roleURI="http://geovax.com/role/NoteDetail0000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail00000000" roleURI="http://geovax.com/role/NoteDetail00000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail000000000" roleURI="http://geovax.com/role/NoteDetail000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0000000000" roleURI="http://geovax.com/role/NoteDetail0000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ScheduleDetail" roleURI="http://geovax.com/role/ScheduleDetail"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#DocumentAndEntityInformation" roleURI="http://geovax.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesAConvertiblePreferredStockMember" xlink:href="govx-20121231.xsd#govx_SeriesAConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="govx_SeriesAConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentAssetsAbstract" xlink:href="govx-20121231.xsd#govx_CurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="govx_CurrentAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentAssetsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrantsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentAssetsAbstract" xlink:to="us-gaap_GrantsReceivable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_CurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="govx_CurrentLiabilitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesAConvertiblePreferredStockMember" xlink:href="govx-20121231.xsd#govx_SeriesAConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="govx_SeriesAConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_PreferredStockStatedValue" xlink:href="govx-20121231.xsd#govx_PreferredStockStatedValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_PreferredStockStatedValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_OtherIncomeExpenseAbstract" xlink:href="govx-20121231.xsd#govx_OtherIncomeExpenseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_OtherIncomeExpenseAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_BasicAndDilutedAbstract" xlink:href="govx-20121231.xsd#govx_BasicAndDilutedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_BasicAndDilutedAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_StockSubscriptionReceivableMember" xlink:href="govx-20121231.xsd#govx_StockSubscriptionReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="govx_StockSubscriptionReceivableMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:href="govx-20121231.xsd#govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_CashFlowsFromOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_ChangesInAssetsAndLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="govx_ChangesInAssetsAndLiabilitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_CashFlowsFromInvestingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_CashFlowsFromFinancingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestPaid" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NatureOfOperations" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_GovernmentGrantsTextBlock" xlink:href="govx-20121231.xsd#govx_GovernmentGrantsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_GovernmentGrantsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/Schedule">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_DevelopmentStageEnterprisePolicyTextBlock" xlink:href="govx-20121231.xsd#govx_DevelopmentStageEnterprisePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_DevelopmentStageEnterprisePolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UseOfEstimates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_OtherAssetsPolicyTextBlock" xlink:href="govx-20121231.xsd#govx_OtherAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_OtherAssetsPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_AccruedLiabilitiesPolicyTextBlock" xlink:href="govx-20121231.xsd#govx_AccruedLiabilitiesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_AccruedLiabilitiesPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_PeriodToPeriodComparisonsPolicyTexBlock" xlink:href="govx-20121231.xsd#govx_PeriodToPeriodComparisonsPolicyTexBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_PeriodToPeriodComparisonsPolicyTexBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="17" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables0">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" xlink:href="govx-20121231.xsd#govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_AdditionalInformationConcerningStockOptionsTableTextBlock" xlink:href="govx-20121231.xsd#govx_AdditionalInformationConcerningStockOptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_AdditionalInformationConcerningStockOptionsTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables00">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/PropertyandEquipmentTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_LaboratoryEquipmentMember" xlink:href="govx-20121231.xsd#govx_LaboratoryEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="govx_LaboratoryEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_OtherFurnitureFixturesAndEquipmentMember" xlink:href="govx-20121231.xsd#govx_OtherFurnitureFixturesAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="govx_OtherFurnitureFixturesAndEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCgwG4gzQgO1GtJPkRDF8quUM4CUMA/xge9QOZ9RJaXDR38VLtarIvJZPfxcf4bZAv7z120OcgrDNUMQwBRXs2wXDWpxuQWN96ZKu4+pgDA/ftoV3d4Xf7odMphBrtYMNt8g==] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:href="govx-20121231.xsd#govx_NetProceedsAllocatedToConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_NetProceedsAllocatedToConvertiblePreferredStock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAccretionOfDividends" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/StockOptionActivityTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/AdditionalInformationConcerningStockOptionsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/SignificantAssumptionsUsedinFairValueCalculationsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/StockbasedCompensationExpenseTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/StockPurchaseWarrantTransactionsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesAWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesAWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_SeriesAWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesBWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesBWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_SeriesBWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesCWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesCWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_SeriesCWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_OtherWarrantsMember" xlink:href="govx-20121231.xsd#govx_OtherWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_OtherWarrantsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightIssuedDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightIssuedDuringPeriod" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantIssuedWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercises" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightExercises" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightForfeituresAndExpirations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirations" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercisableNumber" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightExercisableNumber" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_DeferredTaxAssetsAbstract" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_DeferredTaxAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ReconciliationoftheIncomeTaxBenefitTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/SelectedQuarterlyFinancialDataTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ValuationandQualifyingAccountsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" xlink:href="govx-20121231.xsd#govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_AllowanceForDeferredTaxAssetsAbstract" xlink:href="govx-20121231.xsd#govx_AllowanceForDeferredTaxAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_AllowanceForDeferredTaxAssetsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_RangeDomain" xlink:href="govx-20121231.xsd#govx_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="govx_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_RangeDomain_0" xlink:href="govx-20121231.xsd#govx_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="govx_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LicensingAgreementsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_RangeDomain" xlink:to="us-gaap_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_RangeDomain" xlink:to="us-gaap_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail00">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_FirstNIHGrantMember" xlink:href="govx-20121231.xsd#govx_FirstNIHGrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="govx_FirstNIHGrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SecondNIHGrantMember" xlink:href="govx-20121231.xsd#govx_SecondNIHGrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="govx_SecondNIHGrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_NIHGrantsMember" xlink:href="govx-20121231.xsd#govx_NIHGrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="govx_NIHGrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_QTDPGrantMember" xlink:href="govx-20121231.xsd#govx_QTDPGrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="govx_QTDPGrantMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ProjectPeriodCoveredByGrants" xlink:href="govx-20121231.xsd#govx_ProjectPeriodCoveredByGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ProjectPeriodCoveredByGrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ProjectExtensionPeriod" xlink:href="govx-20121231.xsd#govx_ProjectExtensionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ProjectExtensionPeriod" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_GrantAward" xlink:href="govx-20121231.xsd#govx_GrantAward"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_GrantAward" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_UnusedGrantFunds" xlink:href="govx-20121231.xsd#govx_UnusedGrantFunds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_UnusedGrantFunds" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_OperatingLeaseTermOfLease" xlink:href="govx-20121231.xsd#govx_OperatingLeaseTermOfLease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_OperatingLeaseTermOfLease" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail00000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockAxis" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="govx_SaleOfCommonStockAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockDomain" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="govx_SaleOfCommonStockAxis" xlink:to="govx_SaleOfCommonStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockDomain_0" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="govx_SaleOfCommonStockAxis" xlink:to="govx_SaleOfCommonStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_RangeDomain" xlink:href="govx-20121231.xsd#govx_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="govx_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_RangeDomain_0" xlink:href="govx-20121231.xsd#govx_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="govx_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NatureOfExpenseAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockOptionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_CommonStockIssuedForServicesMember" xlink:href="govx-20121231.xsd#govx_CommonStockIssuedForServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="govx_CommonStockIssuedForServicesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_CompensatoryWarrantsMember" xlink:href="govx-20121231.xsd#govx_CompensatoryWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="govx_CompensatoryWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesAConvertiblePreferredStockMember" xlink:href="govx-20121231.xsd#govx_SeriesAConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="govx_SeriesAConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_RangeDomain" xlink:to="us-gaap_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_IndividualAccreditedInvestorsMember" xlink:href="govx-20121231.xsd#govx_IndividualAccreditedInvestorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_SaleOfCommonStockDomain" xlink:to="govx_IndividualAccreditedInvestorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesAWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesAWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_SeriesAWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesBWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesBWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_SeriesBWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesCWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesCWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_SeriesCWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_PreferredStockStatedValue" xlink:href="govx-20121231.xsd#govx_PreferredStockStatedValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_PreferredStockStatedValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ConvertiblePreferredStockConversionPricePerShare" xlink:href="govx-20121231.xsd#govx_ConvertiblePreferredStockConversionPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ConvertiblePreferredStockConversionPricePerShare" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ConvertiblePreferredStockTotalConversionShares" xlink:href="govx-20121231.xsd#govx_ConvertiblePreferredStockTotalConversionShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ConvertiblePreferredStockTotalConversionShares" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_NumberOfPreferredSharesConvertedIntoCommonStock" xlink:href="govx-20121231.xsd#govx_NumberOfPreferredSharesConvertedIntoCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_NumberOfPreferredSharesConvertedIntoCommonStock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightIssuedDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightIssuedDuringPeriod" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_WarrantsIssuedDuringPeriodExercisePrice" xlink:href="govx-20121231.xsd#govx_WarrantsIssuedDuringPeriodExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_WarrantsIssuedDuringPeriodExercisePrice" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_NumberOfWarrantsIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_NumberOfWarrantsIssuedDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_NumberOfWarrantsIssuedDuringPeriod" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" xlink:href="govx-20121231.xsd#govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="30" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail00000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockAxis" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="govx_SaleOfCommonStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockDomain" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="govx_SaleOfCommonStockAxis" xlink:to="govx_SaleOfCommonStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockDomain_0" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="govx_SaleOfCommonStockAxis" xlink:to="govx_SaleOfCommonStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NatureOfExpenseAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_OngoingPatentCostReimbursementsMember" xlink:href="govx-20121231.xsd#govx_OngoingPatentCostReimbursementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="govx_OngoingPatentCostReimbursementsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ResearchAgreementsMember" xlink:href="govx-20121231.xsd#govx_ResearchAgreementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="govx_ResearchAgreementsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ConsultingAgreementMember" xlink:href="govx-20121231.xsd#govx_ConsultingAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="govx_ConsultingAgreementMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_MembersOfBoardOfDirectorsAndManagementMember" xlink:href="govx-20121231.xsd#govx_MembersOfBoardOfDirectorsAndManagementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="govx_SaleOfCommonStockDomain" xlink:to="govx_MembersOfBoardOfDirectorsAndManagementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightPurchasePeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightPurchasePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightPurchasePeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0000000000">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesBWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesBWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="govx_SeriesBWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercises" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightExercises" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/ScheduleDetail">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://geovax.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityRegistrantName" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentType" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityPublicFloat" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_AmendmentFlag" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_AmendmentDescription" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>govx-20121231_lab.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 14 22:47:45 UTC 2013 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedBalanceSheetsAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedBalanceSheetsAbstract_lbl" xml:lang="en-US">Consolidated Balance Sheets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedBalanceSheetsAbstract" xlink:to="govx_ConsolidatedBalanceSheetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedBalanceSheetsAbstract_lbl0" xml:lang="en-US">Consolidated Balance Sheets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedBalanceSheetsAbstract" xlink:to="govx_ConsolidatedBalanceSheetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">ASSETS [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentAssetsAbstract" xlink:href="govx-20121231.xsd#govx_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentAssetsAbstract" xlink:to="govx_CurrentAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentAssetsAbstract" xlink:to="govx_CurrentAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrantsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrantsReceivable_lbl" xml:lang="en-US">Grant funds receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsAbstract_lbl" xml:lang="en-US">Other assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsAbstract_lbl0" xml:lang="en-US">Other assets: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Licenses, net of accumulated amortization of $228,856 and $208,933 at December 31, 2012 and 2011 respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits and other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Total other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CurrentLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="govx_CurrentLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current liabilities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CurrentLiabilitiesAbstract" xlink:to="govx_CurrentLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Amounts payable to Emory University (a related party)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&#8217; equity: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $.01 par value, 10,000,000 shares authorized; Series A Convertible Preferred Stock, $1,000 stated value; 788 and -0- shares issued and outstanding at December 31, 2012 and December 31, 2011, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.001 par value, 40,000,000 shares authorized; 18,733,277 and 16,442,611 shares issued and outstanding at December 31, 2012 and 2011, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xml:lang="en-US">Deficit accumulated during the development stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_PreferredStockStatedValue" xlink:href="govx-20121231.xsd#govx_PreferredStockStatedValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_PreferredStockStatedValue_lbl" xml:lang="en-US">Face amount or stated value per share of convertible preferred stock; generally not indicative of the fair market value per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PreferredStockStatedValue" xlink:to="govx_PreferredStockStatedValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Licenses, accumulated amortization (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Pr&#1077;f&#1077;rr&#1077;d stock, par valu&#1077; (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Pr&#1077;f&#1077;rr&#1077;d stock, shar&#1077;s authoriz&#1077;d</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PreferredStockStatedValue_lbl0" xml:lang="en-US">Pr&#1077;f&#1077;rr&#1077;d stock, stat&#1077;d valu&#1077; (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PreferredStockStatedValue" xlink:to="govx_PreferredStockStatedValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Pr&#1077;f&#1077;rr&#1077;d stock, shar&#1077;s issu&#1077;d</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Pr&#1077;f&#1077;rr&#1077;d stock, shar&#1077;s outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedStatementsOfOperationsAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedStatementsOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedStatementsOfOperationsAbstract_lbl" xml:lang="en-US">Consolidated Statements of Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfOperationsAbstract" xlink:to="govx_ConsolidatedStatementsOfOperationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedStatementsOfOperationsAbstract_lbl0" xml:lang="en-US">Consolidated Statements of Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfOperationsAbstract" xlink:to="govx_ConsolidatedStatementsOfOperationsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromGrants_lbl" xml:lang="en-US">Grant revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="us-gaap_RevenueFromGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating expenses: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_OtherIncomeExpenseAbstract" xlink:href="govx-20121231.xsd#govx_OtherIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_OtherIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="govx_OtherIncomeExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_OtherIncomeExpenseAbstract_lbl0" xml:lang="en-US">Other income (expense): [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherIncomeExpenseAbstract" xlink:to="govx_OtherIncomeExpenseAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_BasicAndDilutedAbstract" xlink:href="govx-20121231.xsd#govx_BasicAndDilutedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_BasicAndDilutedAbstract_lbl" xml:lang="en-US">Basic and diluted:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="govx_BasicAndDilutedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_BasicAndDilutedAbstract_lbl0" xml:lang="en-US">Basic and diluted: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_BasicAndDilutedAbstract" xlink:to="govx_BasicAndDilutedAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl" xml:lang="en-US">Consolidated Statements of Stockholders&apos; Equity (Deficiency)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:to="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl0" xml:lang="en-US">Consolidated Statements of Stockholders&apos; Equity (Deficiency) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:to="govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:href="govx-20121231.xsd#govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl" xml:lang="en-US">Represents increases in additional paid in capital attributable to capital contribution at inception.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:to="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl0" xml:lang="en-US">Capital contribution at inception (June 27, 2001)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:to="govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl" xml:lang="en-US">Issuance of common stock for technology license</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Issuance of common stock for technology license (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Cash payments received on stock subscription receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock to common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of preferred stock to common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Common stock issued in connection with merger</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Common stock issued in connection with merger (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon option and warrant exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock upon option and warrant exercise (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of common stock for services (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit_lbl" xml:lang="en-US">Fractional share cash payout upon reverse split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Fractional share cash payout upon reverse split (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Sale of convertible preferred stock and warrants for cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Sale of convertible preferred stock and warrants for cash (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConsolidatedStatementsOfCashFlowsAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedStatementsOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl" xml:lang="en-US">Consolidated Statements of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfCashFlowsAbstract" xlink:to="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl0" xml:lang="en-US">Consolidated Statements of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsolidatedStatementsOfCashFlowsAbstract" xlink:to="govx_ConsolidatedStatementsOfCashFlowsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="govx_CashFlowsFromOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CashFlowsFromOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from operating activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromOperatingActivitiesAbstract" xlink:to="govx_CashFlowsFromOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xml:lang="en-US">Accretion of preferred stock redemption value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation expense, including common stock issued for services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_ChangesInAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl0" xml:lang="en-US">Changes in assets and liabilities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ChangesInAssetsAndLiabilitiesAbstract" xlink:to="govx_ChangesInAssetsAndLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Grant funds receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xml:lang="en-US">Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Total adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="govx_CashFlowsFromInvestingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CashFlowsFromInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from investing activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromInvestingActivitiesAbstract" xlink:to="govx_CashFlowsFromInvestingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided (used) by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="govx_CashFlowsFromFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CashFlowsFromFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from financing activities: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CashFlowsFromFinancingActivitiesAbstract" xlink:to="govx_CashFlowsFromFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from sale of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Proceeds from sale of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_NatureOfOperationsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_NatureOfOperationsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_NatureOfOperationsTextBlockAbstract_lbl" xml:lang="en-US">Note 1 - Nature of Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NatureOfOperationsTextBlockAbstract" xlink:to="govx_NatureOfOperationsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SignificantAccountingPoliciesTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAccountingPoliciesTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SignificantAccountingPoliciesTextBlockAbstract_lbl" xml:lang="en-US">Note 2 - Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SignificantAccountingPoliciesTextBlockAbstract" xlink:to="govx_SignificantAccountingPoliciesTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_GovernmentGrantsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_GovernmentGrantsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_GovernmentGrantsTextBlockAbstract_lbl" xml:lang="en-US">Note 3 - Government Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlockAbstract" xlink:to="govx_GovernmentGrantsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_GovernmentGrantsTextBlock" xlink:href="govx-20121231.xsd#govx_GovernmentGrantsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_GovernmentGrantsTextBlock_lbl" xml:lang="en-US">Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity&apos;s treatment of any unearned or deferred revenue that arises from the transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlock" xlink:to="govx_GovernmentGrantsTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_GovernmentGrantsTextBlock_lbl0" xml:lang="en-US">Government Grants [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlock" xlink:to="govx_GovernmentGrantsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CommitmentsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_CommitmentsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CommitmentsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 4 - Commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CommitmentsDisclosureTextBlockAbstract" xlink:to="govx_CommitmentsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">Commitments Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract_lbl" xml:lang="en-US">Note 5 - 2006 Merger and Recapitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:to="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 6 - Stockholders&apos; Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="govx_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 7 - Retirement Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:to="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_IncomeTaxDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_IncomeTaxDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_IncomeTaxDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 8 - Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_IncomeTaxDisclosureTextBlockAbstract" xlink:to="govx_IncomeTaxDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Note 9 - Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_QuarterlyFinancialInformationTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_QuarterlyFinancialInformationTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_QuarterlyFinancialInformationTextBlockAbstract_lbl" xml:lang="en-US">Note 10 - Selected Quarterly Financial Data (unaudited)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_QuarterlyFinancialInformationTextBlockAbstract" xlink:to="govx_QuarterlyFinancialInformationTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">Quarterly Financial Information [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SubsequentEventsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_SubsequentEventsTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SubsequentEventsTextBlockAbstract_lbl" xml:lang="en-US">Note 11 - Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SubsequentEventsTextBlockAbstract" xlink:to="govx_SubsequentEventsTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract_lbl" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:to="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SignificantAccountingPoliciesAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SignificantAccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies (Abstract)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SignificantAccountingPoliciesAbstract" xlink:to="govx_SignificantAccountingPoliciesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SignificantAccountingPoliciesAbstract_lbl0" xml:lang="en-US">Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SignificantAccountingPoliciesAbstract" xlink:to="govx_SignificantAccountingPoliciesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_DevelopmentStageEnterprisePolicyTextBlock" xlink:href="govx-20121231.xsd#govx_DevelopmentStageEnterprisePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_DevelopmentStageEnterprisePolicyTextBlock_lbl" xml:lang="en-US">Development-Stage Enterprise [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DevelopmentStageEnterprisePolicyTextBlock" xlink:to="govx_DevelopmentStageEnterprisePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_OtherAssetsPolicyTextBlock" xlink:href="govx-20121231.xsd#govx_OtherAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_OtherAssetsPolicyTextBlock_lbl" xml:lang="en-US">Other Assets [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherAssetsPolicyTextBlock" xlink:to="govx_OtherAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_AccruedLiabilitiesPolicyTextBlock" xlink:href="govx-20121231.xsd#govx_AccruedLiabilitiesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AccruedLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US">Accrued Liabilities [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AccruedLiabilitiesPolicyTextBlock" xlink:to="govx_AccruedLiabilitiesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_PeriodToPeriodComparisonsPolicyTexBlock" xlink:href="govx-20121231.xsd#govx_PeriodToPeriodComparisonsPolicyTexBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_PeriodToPeriodComparisonsPolicyTexBlock_lbl" xml:lang="en-US">Period to Period Comparisons [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PeriodToPeriodComparisonsPolicyTexBlock" xlink:to="govx_PeriodToPeriodComparisonsPolicyTexBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_DevelopmentStageEnterprisePolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy regarding development-stage enterprise.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DevelopmentStageEnterprisePolicyTextBlock" xlink:to="govx_DevelopmentStageEnterprisePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_OtherAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy regarding other assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherAssetsPolicyTextBlock" xlink:to="govx_OtherAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_AccruedLiabilitiesPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy regarding accrued liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AccruedLiabilitiesPolicyTextBlock" xlink:to="govx_AccruedLiabilitiesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_PeriodToPeriodComparisonsPolicyTexBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy regarding period to period comparisons.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PeriodToPeriodComparisonsPolicyTexBlock" xlink:to="govx_PeriodToPeriodComparisonsPolicyTexBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" xlink:href="govx-20121231.xsd#govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock_lbl" xml:lang="en-US">Tabular disclosure of allocation of net proceeds from preferred stock financing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" xlink:to="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_AdditionalInformationConcerningStockOptionsTableTextBlock" xlink:href="govx-20121231.xsd#govx_AdditionalInformationConcerningStockOptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_AdditionalInformationConcerningStockOptionsTableTextBlock_lbl" xml:lang="en-US">Tabular disclosure of additional information concerning stock options.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdditionalInformationConcerningStockOptionsTableTextBlock" xlink:to="govx_AdditionalInformationConcerningStockOptionsTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock_lbl0" xml:lang="en-US">Allocation of Net Proceeds from Preferred Stock Financing [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" xlink:to="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AdditionalInformationConcerningStockOptionsTableTextBlock_lbl0" xml:lang="en-US">Additional Information Concerning Stock Options [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdditionalInformationConcerningStockOptionsTableTextBlock" xlink:to="govx_AdditionalInformationConcerningStockOptionsTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Stockholders&apos; Equity Note, Warrants or Rights [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Schedule of Quarterly Financial Information [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_PropertyAndEquipmentAbstract" xlink:href="govx-20121231.xsd#govx_PropertyAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_PropertyAndEquipmentAbstract_lbl" xml:lang="en-US">Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PropertyAndEquipmentAbstract" xlink:to="govx_PropertyAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PropertyAndEquipmentAbstract_lbl0" xml:lang="en-US">Property and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PropertyAndEquipmentAbstract" xlink:to="govx_PropertyAndEquipmentAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract" xlink:href="govx-20121231.xsd#govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract_lbl" xml:lang="en-US">Allocation of Net Proceeds from Preferred Stock Financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract" xlink:to="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract_lbl0" xml:lang="en-US">Allocation of Net Proceeds from Preferred Stock Financing [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract" xlink:to="govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl0" xml:lang="en-US">Net proceeds after transaction costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Less: Fair value of warrants (recorded to Additional Paid-in Capital)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xml:lang="en-US">Beneficial conversion feature (recorded to Additional Paid-in Capital)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:href="govx-20121231.xsd#govx_NetProceedsAllocatedToConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_NetProceedsAllocatedToConvertiblePreferredStock_lbl" xml:lang="en-US">Net proceeds allocated to preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:to="govx_NetProceedsAllocatedToConvertiblePreferredStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="govx_NetProceedsAllocatedToConvertiblePreferredStock_lbl0" xml:lang="en-US">Net proceeds allocated to preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:to="govx_NetProceedsAllocatedToConvertiblePreferredStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends_lbl" xml:lang="en-US">Accretion of beneficial conversion feature (deemed dividend)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionOfDividends" xlink:to="us-gaap_TemporaryEquityAccretionOfDividends_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Carrying value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversions to common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockOptionActivityAbstract" xlink:href="govx-20121231.xsd#govx_StockOptionActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockOptionActivityAbstract_lbl" xml:lang="en-US">Stock Option Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockOptionActivityAbstract" xlink:to="govx_StockOptionActivityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockOptionActivityAbstract_lbl0" xml:lang="en-US">Stock Option Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockOptionActivityAbstract" xlink:to="govx_StockOptionActivityAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding at December 31, 2011</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding at December 31, 2011 (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Forfeited or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited or expired (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Outstanding at December 31, 2012</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Outstanding at December 31, 2012 (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Outstanding at December 31, 2012</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Outstanding at December 31, 2012 (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable at December 31, 2012</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable at December 31, 2012 (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Exercisable at December 31, 2012</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Exercisable at December 31, 2012 (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_AdditionalInformationConcerningStockOptionsAbstract" xlink:href="govx-20121231.xsd#govx_AdditionalInformationConcerningStockOptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AdditionalInformationConcerningStockOptionsAbstract_lbl" xml:lang="en-US">Additional Information Concerning Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdditionalInformationConcerningStockOptionsAbstract" xlink:to="govx_AdditionalInformationConcerningStockOptionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AdditionalInformationConcerningStockOptionsAbstract_lbl0" xml:lang="en-US">Additional Information Concerning Stock Options [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdditionalInformationConcerningStockOptionsAbstract" xlink:to="govx_AdditionalInformationConcerningStockOptionsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average fair value of options granted during the period (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue_lbl" xml:lang="en-US">Total fair value of options vested during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract_lbl" xml:lang="en-US">Significant Assumptions Used in Fair Value Calculations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract" xlink:to="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract_lbl0" xml:lang="en-US">Significant Assumptions Used in Fair Value Calculations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract" xlink:to="govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted average risk-free interest rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life of option (yrs)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockBasedCompensationExpenseAbstract" xlink:href="govx-20121231.xsd#govx_StockBasedCompensationExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockBasedCompensationExpenseAbstract_lbl" xml:lang="en-US">Stock-based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockBasedCompensationExpenseAbstract" xlink:to="govx_StockBasedCompensationExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockBasedCompensationExpenseAbstract_lbl0" xml:lang="en-US">Stock-based Compensation Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockBasedCompensationExpenseAbstract" xlink:to="govx_StockBasedCompensationExpenseAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock option expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_StockPurchaseWarrantTransactionsAbstract" xlink:href="govx-20121231.xsd#govx_StockPurchaseWarrantTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockPurchaseWarrantTransactionsAbstract_lbl" xml:lang="en-US">Stock Purchase Warrant Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockPurchaseWarrantTransactionsAbstract" xlink:to="govx_StockPurchaseWarrantTransactionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockPurchaseWarrantTransactionsAbstract_lbl0" xml:lang="en-US">Stock Purchase Warrant Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockPurchaseWarrantTransactionsAbstract" xlink:to="govx_StockPurchaseWarrantTransactionsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Outstanding at December 31, 2011 (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Class of warrant or right, outstanding, weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Outstanding at December 31, 2011</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightIssuedDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightIssuedDuringPeriod_lbl" xml:lang="en-US">Number of warrants issued during the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:to="govx_ClassOfWarrantOrRightIssuedDuringPeriod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightIssuedDuringPeriod_lbl0" xml:lang="en-US">Number of Shares (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:to="govx_ClassOfWarrantOrRightIssuedDuringPeriod_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantIssuedWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice_lbl" xml:lang="en-US">Class of warrant issued, weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercises" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightExercises_lbl" xml:lang="en-US">Number of warrants exercised during the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercises" xlink:to="govx_ClassOfWarrantOrRightExercises_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightExercises_lbl0" xml:lang="en-US">Exercised (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercises" xlink:to="govx_ClassOfWarrantOrRightExercises_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice_lbl" xml:lang="en-US">Class of warrant or right, exercises, weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightForfeituresAndExpirations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirations_lbl" xml:lang="en-US">Number of warrants forfeited or expired during the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirations_lbl0" xml:lang="en-US">Forfeited or expired (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirations_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice_lbl" xml:lang="en-US">Class of warrant or right, forfeitures and expirations, weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Forfeited or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Outstanding at December 31, 2012 (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Outstanding at December 31, 2012</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl1"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercisableNumber" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightExercisableNumber_lbl" xml:lang="en-US">Number of exercisable warrants outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisableNumber" xlink:to="govx_ClassOfWarrantOrRightExercisableNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightExercisableNumber_lbl0" xml:lang="en-US">Exercisable at December 31, 2012 (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisableNumber" xlink:to="govx_ClassOfWarrantOrRightExercisableNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Class of warrant or right, exercisable, weighted average exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Exercisable at December 31, 2012</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_DeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred Tax Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="govx_DeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_DeferredTaxAssetsAndLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets and Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="govx_DeferredTaxAssetsAndLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_DeferredTaxAssetsAbstract" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_DeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DeferredTaxAssetsAbstract" xlink:to="govx_DeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_DeferredTaxAssetsAbstract_lbl0" xml:lang="en-US">Deferred tax assets: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DeferredTaxAssetsAbstract" xlink:to="govx_DeferredTaxAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Research and development tax credit carryforward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred tax liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ReconciliationOfTheIncomeTaxBenefitAbstract" xlink:href="govx-20121231.xsd#govx_ReconciliationOfTheIncomeTaxBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ReconciliationOfTheIncomeTaxBenefitAbstract_lbl" xml:lang="en-US">Reconciliation of the Income Tax Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ReconciliationOfTheIncomeTaxBenefitAbstract" xlink:to="govx_ReconciliationOfTheIncomeTaxBenefitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ReconciliationOfTheIncomeTaxBenefitAbstract_lbl0" xml:lang="en-US">Reconciliation of the Income Tax Benefit [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ReconciliationOfTheIncomeTaxBenefitAbstract" xlink:to="govx_ReconciliationOfTheIncomeTaxBenefitAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">U.S. federal statutory rate applied to pretax loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Permanent differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xml:lang="en-US">Research and development credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SelectedQuarterlyFinancialDataAbstract" xlink:href="govx-20121231.xsd#govx_SelectedQuarterlyFinancialDataAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SelectedQuarterlyFinancialDataAbstract_lbl" xml:lang="en-US">Selected Quarterly Financial Data</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SelectedQuarterlyFinancialDataAbstract" xlink:to="govx_SelectedQuarterlyFinancialDataAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SelectedQuarterlyFinancialDataAbstract_lbl0" xml:lang="en-US">Selected Quarterly Financial Data [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SelectedQuarterlyFinancialDataAbstract" xlink:to="govx_SelectedQuarterlyFinancialDataAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromGrants_lbl0" xml:lang="en-US">Revenue from grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="us-gaap_RevenueFromGrants_lbl0"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCgwG4gzQgO1GtJPkRDF8quUM4CUMA/xge9QOZ9RJaXDR38VLtarIvJZPfxcf4bZAv7z120OcgrDNUMQwBRXs2wXDWpxuQWN96ZBSByUAkghHey8DLdMPs/BhY6Lnf6J44Cw==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationAndQualifyingAccountsAbstract_lbl" xml:lang="en-US">Valuation and Qualifying Accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:to="us-gaap_ValuationAndQualifyingAccountsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAndQualifyingAccountsAbstract_lbl0" xml:lang="en-US">Valuation and Qualifying Accounts [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:to="us-gaap_ValuationAndQualifyingAccountsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xml:lang="en-US">Valuation Allowances and Reserves [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" xlink:href="govx-20121231.xsd#govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract_lbl" xml:lang="en-US">Reserve Deducted in the Balance Sheet From the Asset to Which it Applies:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" xlink:to="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract_lbl0" xml:lang="en-US">Reserve Deducted in the Balance Sheet From the Asset to Which it Applies: [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" xlink:to="govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_AllowanceForDeferredTaxAssetsAbstract" xlink:href="govx-20121231.xsd#govx_AllowanceForDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_AllowanceForDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Allowance for Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AllowanceForDeferredTaxAssetsAbstract" xlink:to="govx_AllowanceForDeferredTaxAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AllowanceForDeferredTaxAssetsAbstract_lbl0" xml:lang="en-US">Allowance for Deferred Tax Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AllowanceForDeferredTaxAssetsAbstract" xlink:to="govx_AllowanceForDeferredTaxAssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xml:lang="en-US">Balance at Beginning Of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl" xml:lang="en-US">Charged to Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xml:lang="en-US">Deductions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl0" xml:lang="en-US">Balance at End Of Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_RangeDomain" xlink:href="govx-20121231.xsd#govx_RangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_RangeDomain_lbl" xml:lang="en-US">Range [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_RangeDomain" xlink:to="govx_RangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesDomain_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ProjectPeriodCoveredByGrants" xlink:href="govx-20121231.xsd#govx_ProjectPeriodCoveredByGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ProjectPeriodCoveredByGrants_lbl" xml:lang="en-US">Project Period Covered by Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ProjectPeriodCoveredByGrants" xlink:to="govx_ProjectPeriodCoveredByGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ProjectExtensionPeriod" xlink:href="govx-20121231.xsd#govx_ProjectExtensionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ProjectExtensionPeriod_lbl" xml:lang="en-US">Project Extension Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ProjectExtensionPeriod" xlink:to="govx_ProjectExtensionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_GrantAward" xlink:href="govx-20121231.xsd#govx_GrantAward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_GrantAward_lbl" xml:lang="en-US">Grant Award</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GrantAward" xlink:to="govx_GrantAward_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_UnusedGrantFunds" xlink:href="govx-20121231.xsd#govx_UnusedGrantFunds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_UnusedGrantFunds_lbl" xml:lang="en-US">Unused Grant Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_UnusedGrantFunds" xlink:to="govx_UnusedGrantFunds_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromGrants_lbl1" xml:lang="en-US">Revenue from Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="us-gaap_RevenueFromGrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ProjectPeriodCoveredByGrants_lbl0" xml:lang="en-US">The project period covered by grants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ProjectPeriodCoveredByGrants" xlink:to="govx_ProjectPeriodCoveredByGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ProjectExtensionPeriod_lbl0" xml:lang="en-US">Project extension period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ProjectExtensionPeriod" xlink:to="govx_ProjectExtensionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_GrantAward_lbl0" xml:lang="en-US">Grant award.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GrantAward" xlink:to="govx_GrantAward_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_UnusedGrantFunds_lbl0" xml:lang="en-US">Unused grant funds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_UnusedGrantFunds" xlink:to="govx_UnusedGrantFunds_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xml:lang="en-US">Area of Real Estate Property (in Square feet)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_OperatingLeaseTermOfLease" xlink:href="govx-20121231.xsd#govx_OperatingLeaseTermOfLease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_OperatingLeaseTermOfLease_lbl" xml:lang="en-US">Operating Lease, Term of Lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OperatingLeaseTermOfLease" xlink:to="govx_OperatingLeaseTermOfLease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_OperatingLeaseTermOfLease_lbl0" xml:lang="en-US">Term of operating lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OperatingLeaseTermOfLease" xlink:to="govx_OperatingLeaseTermOfLease_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockDomain" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SaleOfCommonStockDomain_lbl" xml:lang="en-US">SaleOfCommonStock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SaleOfCommonStockDomain" xlink:to="govx_SaleOfCommonStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain_lbl" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_PreferredStockStatedValue_lbl1" xml:lang="en-US">(in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PreferredStockStatedValue" xlink:to="govx_PreferredStockStatedValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl1" xml:lang="en-US">Proceeds from Issuance of Preferred Stock and Preference Stock (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConvertiblePreferredStockConversionPricePerShare" xlink:href="govx-20121231.xsd#govx_ConvertiblePreferredStockConversionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConvertiblePreferredStockConversionPricePerShare_lbl" xml:lang="en-US">Convertible Preferred Stock, Conversion Price Per Share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConvertiblePreferredStockConversionPricePerShare" xlink:to="govx_ConvertiblePreferredStockConversionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ConvertiblePreferredStockTotalConversionShares" xlink:href="govx-20121231.xsd#govx_ConvertiblePreferredStockTotalConversionShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConvertiblePreferredStockTotalConversionShares_lbl" xml:lang="en-US">Convertible Preferred Stock, Total Conversion Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConvertiblePreferredStockTotalConversionShares" xlink:to="govx_ConvertiblePreferredStockTotalConversionShares_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_NumberOfPreferredSharesConvertedIntoCommonStock" xlink:href="govx-20121231.xsd#govx_NumberOfPreferredSharesConvertedIntoCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_NumberOfPreferredSharesConvertedIntoCommonStock_lbl" xml:lang="en-US">Number of Preferred Shares Converted into Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NumberOfPreferredSharesConvertedIntoCommonStock" xlink:to="govx_NumberOfPreferredSharesConvertedIntoCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased_lbl" xml:lang="en-US">Class of Warrant or Right, Percentage of Conversion Shares Could Be Purchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" xlink:to="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, New Issues (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other Accrued Liabilities, Current (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US">Proceeds from Issuance of Common Stock (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightIssuedDuringPeriod_lbl1" xml:lang="en-US">(in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightIssuedDuringPeriod" xlink:to="govx_ClassOfWarrantOrRightIssuedDuringPeriod_lbl1"/>
    <loc xlink:type="locator" xlink:label="govx_WarrantsIssuedDuringPeriodExercisePrice" xlink:href="govx-20121231.xsd#govx_WarrantsIssuedDuringPeriodExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_WarrantsIssuedDuringPeriodExercisePrice_lbl" xml:lang="en-US">Warrants Issued During Period, Exercise Price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_WarrantsIssuedDuringPeriodExercisePrice" xlink:to="govx_WarrantsIssuedDuringPeriodExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_NumberOfWarrantsIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_NumberOfWarrantsIssuedDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_NumberOfWarrantsIssuedDuringPeriod_lbl" xml:lang="en-US">Number of Warrants Issued During Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NumberOfWarrantsIssuedDuringPeriod" xlink:to="govx_NumberOfWarrantsIssuedDuringPeriod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Allocated Share-based Compensation Expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" xlink:href="govx-20121231.xsd#govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees_lbl" xml:lang="en-US">Minimum Option Exercise Price as Percentage of Fair Value of ISO&apos;s Granted to Certain Employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" xlink:to="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-based Compensation (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other General and Administrative Expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ConvertiblePreferredStockConversionPricePerShare_lbl0" xml:lang="en-US">Convertible preferred stock, conversion price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConvertiblePreferredStockConversionPricePerShare" xlink:to="govx_ConvertiblePreferredStockConversionPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ConvertiblePreferredStockTotalConversionShares_lbl0" xml:lang="en-US">Convertible preferred stock, total conversion shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConvertiblePreferredStockTotalConversionShares" xlink:to="govx_ConvertiblePreferredStockTotalConversionShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_NumberOfPreferredSharesConvertedIntoCommonStock_lbl0" xml:lang="en-US">Number of preferred shares converted into common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NumberOfPreferredSharesConvertedIntoCommonStock" xlink:to="govx_NumberOfPreferredSharesConvertedIntoCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased_lbl0" xml:lang="en-US">Class of warrant or right, percentage of conversion shares could be purchased.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" xlink:to="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_WarrantsIssuedDuringPeriodExercisePrice_lbl0" xml:lang="en-US">Warrants issued during period, exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_WarrantsIssuedDuringPeriodExercisePrice" xlink:to="govx_WarrantsIssuedDuringPeriodExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_NumberOfWarrantsIssuedDuringPeriod_lbl0" xml:lang="en-US">Number of warrants issued during the reporting period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NumberOfWarrantsIssuedDuringPeriod" xlink:to="govx_NumberOfWarrantsIssuedDuringPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees_lbl0" xml:lang="en-US">Minimum option exercise price as percentage of fair value of ISO&apos;s granted to certain employees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" xlink:to="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightPurchasePeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightPurchasePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightPurchasePeriod_lbl" xml:lang="en-US">Class of Warrant or Right, Purchase Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightPurchasePeriod" xlink:to="govx_ClassOfWarrantOrRightPurchasePeriod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightPurchasePeriod_lbl0" xml:lang="en-US">Class of warrant or right, purchase period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightPurchasePeriod" xlink:to="govx_ClassOfWarrantOrRightPurchasePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="govx_ClassOfWarrantOrRightExercises_lbl1" xml:lang="en-US">Class of Warrant or Right, Exercises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercises" xlink:to="govx_ClassOfWarrantOrRightExercises_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Proceeds from Warrant Exercises (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Remaining Shares Whose Expiration Was Extended</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" xlink:to="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended_lbl0" xml:lang="en-US">Class of warrant or right, number of remaining shares whose expiration was extended.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" xlink:to="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_lbl" xml:lang="en-US">Valuation Allowance of Deferred Tax Assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_lbl" xml:lang="en-US">Accumulated Deficit during Development Stage [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:to="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xml:lang="en-US">Valuation Allowances and Reserves Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario, Unspecified [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionsMember_lbl" xml:lang="en-US">Stock Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionsMember" xlink:to="us-gaap_StockOptionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfExpenseAxis_lbl" xml:lang="en-US">Nature of Expense [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_NatureOfExpenseAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xml:lang="en-US">Licensing Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="us-gaap_LicensingAgreementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="govx_SaleOfCommonStockAxis" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SaleOfCommonStockAxis_lbl" xml:lang="en-US">Sale Of Common Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SaleOfCommonStockAxis" xlink:to="govx_SaleOfCommonStockAxis_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SaleOfCommonStockAxis_lbl0" xml:lang="en-US">Sale of Common Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SaleOfCommonStockAxis" xlink:to="govx_SaleOfCommonStockAxis_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_MembersOfBoardOfDirectorsAndManagementMember" xlink:href="govx-20121231.xsd#govx_MembersOfBoardOfDirectorsAndManagementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_MembersOfBoardOfDirectorsAndManagementMember_lbl" xml:lang="en-US">Members Of Board Of Directors And Management [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MembersOfBoardOfDirectorsAndManagementMember" xlink:to="govx_MembersOfBoardOfDirectorsAndManagementMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_MembersOfBoardOfDirectorsAndManagementMember_lbl0" xml:lang="en-US">Members of Board of Directors and Management [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MembersOfBoardOfDirectorsAndManagementMember" xlink:to="govx_MembersOfBoardOfDirectorsAndManagementMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_SecondNIHGrantMember" xlink:href="govx-20121231.xsd#govx_SecondNIHGrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SecondNIHGrantMember_lbl" xml:lang="en-US">Second NIH Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SecondNIHGrantMember" xlink:to="govx_SecondNIHGrantMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SecondNIHGrantMember_lbl0" xml:lang="en-US">Second NIH Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SecondNIHGrantMember" xlink:to="govx_SecondNIHGrantMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_StockSubscriptionReceivableMember" xlink:href="govx-20121231.xsd#govx_StockSubscriptionReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockSubscriptionReceivableMember_lbl" xml:lang="en-US">Stock Subscription Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockSubscriptionReceivableMember" xlink:to="govx_StockSubscriptionReceivableMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_StockSubscriptionReceivableMember_lbl0" xml:lang="en-US">Stock Subscription Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockSubscriptionReceivableMember" xlink:to="govx_StockSubscriptionReceivableMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesAWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesAWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesAWarrantsMember" xlink:to="govx_SeriesAWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SeriesAWarrantsMember_lbl0" xml:lang="en-US">Series A Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesAWarrantsMember" xlink:to="govx_SeriesAWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_FirstNIHGrantMember" xlink:href="govx-20121231.xsd#govx_FirstNIHGrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_FirstNIHGrantMember_lbl" xml:lang="en-US">First NIH Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_FirstNIHGrantMember" xlink:to="govx_FirstNIHGrantMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_FirstNIHGrantMember_lbl0" xml:lang="en-US">First NIH Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_FirstNIHGrantMember" xlink:to="govx_FirstNIHGrantMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ResearchAgreementsMember" xlink:href="govx-20121231.xsd#govx_ResearchAgreementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ResearchAgreementsMember_lbl" xml:lang="en-US">Research Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ResearchAgreementsMember" xlink:to="govx_ResearchAgreementsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ResearchAgreementsMember_lbl0" xml:lang="en-US">Research Agreements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ResearchAgreementsMember" xlink:to="govx_ResearchAgreementsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_OtherFurnitureFixturesAndEquipmentMember" xlink:href="govx-20121231.xsd#govx_OtherFurnitureFixturesAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_OtherFurnitureFixturesAndEquipmentMember_lbl" xml:lang="en-US">Other Furniture Fixtures And Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherFurnitureFixturesAndEquipmentMember" xlink:to="govx_OtherFurnitureFixturesAndEquipmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_OtherFurnitureFixturesAndEquipmentMember_lbl0" xml:lang="en-US">Other Furniture, Fixtures and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherFurnitureFixturesAndEquipmentMember" xlink:to="govx_OtherFurnitureFixturesAndEquipmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesCWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesCWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SeriesCWarrantsMember_lbl" xml:lang="en-US">Series C Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesCWarrantsMember" xlink:to="govx_SeriesCWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SeriesCWarrantsMember_lbl0" xml:lang="en-US">Series C Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesCWarrantsMember" xlink:to="govx_SeriesCWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesAConvertiblePreferredStockMember" xlink:href="govx-20121231.xsd#govx_SeriesAConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SeriesAConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series A Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesAConvertiblePreferredStockMember" xlink:to="govx_SeriesAConvertiblePreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SeriesAConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Series A Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesAConvertiblePreferredStockMember" xlink:to="govx_SeriesAConvertiblePreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_NIHGrantsMember" xlink:href="govx-20121231.xsd#govx_NIHGrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_NIHGrantsMember_lbl" xml:lang="en-US">NIH Grants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NIHGrantsMember" xlink:to="govx_NIHGrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_NIHGrantsMember_lbl0" xml:lang="en-US">NIH Grants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NIHGrantsMember" xlink:to="govx_NIHGrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_SeriesBWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesBWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SeriesBWarrantsMember_lbl" xml:lang="en-US">Series B Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesBWarrantsMember" xlink:to="govx_SeriesBWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_SeriesBWarrantsMember_lbl0" xml:lang="en-US">Series B Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SeriesBWarrantsMember" xlink:to="govx_SeriesBWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_QTDPGrantMember" xlink:href="govx-20121231.xsd#govx_QTDPGrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_QTDPGrantMember_lbl" xml:lang="en-US">QTDP Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_QTDPGrantMember" xlink:to="govx_QTDPGrantMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_QTDPGrantMember_lbl0" xml:lang="en-US">QTDP Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_QTDPGrantMember" xlink:to="govx_QTDPGrantMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_OngoingPatentCostReimbursementsMember" xlink:href="govx-20121231.xsd#govx_OngoingPatentCostReimbursementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_OngoingPatentCostReimbursementsMember_lbl" xml:lang="en-US">Ongoing Patent Cost Reimbursements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OngoingPatentCostReimbursementsMember" xlink:to="govx_OngoingPatentCostReimbursementsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_OngoingPatentCostReimbursementsMember_lbl0" xml:lang="en-US">Ongoing Patent Cost Reimbursements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OngoingPatentCostReimbursementsMember" xlink:to="govx_OngoingPatentCostReimbursementsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CompensatoryWarrantsMember" xlink:href="govx-20121231.xsd#govx_CompensatoryWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CompensatoryWarrantsMember_lbl" xml:lang="en-US">Compensatory Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CompensatoryWarrantsMember" xlink:to="govx_CompensatoryWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CompensatoryWarrantsMember_lbl0" xml:lang="en-US">Compensatory Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CompensatoryWarrantsMember" xlink:to="govx_CompensatoryWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_LaboratoryEquipmentMember" xlink:href="govx-20121231.xsd#govx_LaboratoryEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_LaboratoryEquipmentMember_lbl" xml:lang="en-US">Laboratory Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_LaboratoryEquipmentMember" xlink:to="govx_LaboratoryEquipmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_LaboratoryEquipmentMember_lbl0" xml:lang="en-US">Laboratory Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_LaboratoryEquipmentMember" xlink:to="govx_LaboratoryEquipmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_OtherWarrantsMember" xlink:href="govx-20121231.xsd#govx_OtherWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_OtherWarrantsMember_lbl" xml:lang="en-US">Other Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherWarrantsMember" xlink:to="govx_OtherWarrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_OtherWarrantsMember_lbl0" xml:lang="en-US">Other Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherWarrantsMember" xlink:to="govx_OtherWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_ConsultingAgreementMember" xlink:href="govx-20121231.xsd#govx_ConsultingAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsultingAgreementMember" xlink:to="govx_ConsultingAgreementMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_ConsultingAgreementMember_lbl0" xml:lang="en-US">Consulting Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConsultingAgreementMember" xlink:to="govx_ConsultingAgreementMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_IndividualAccreditedInvestorsMember" xlink:href="govx-20121231.xsd#govx_IndividualAccreditedInvestorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_IndividualAccreditedInvestorsMember_lbl" xml:lang="en-US">Individual Accredited Investors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_IndividualAccreditedInvestorsMember" xlink:to="govx_IndividualAccreditedInvestorsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_IndividualAccreditedInvestorsMember_lbl0" xml:lang="en-US">Individual Accredited Investors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_IndividualAccreditedInvestorsMember" xlink:to="govx_IndividualAccreditedInvestorsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_CommonStockIssuedForServicesMember" xlink:href="govx-20121231.xsd#govx_CommonStockIssuedForServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CommonStockIssuedForServicesMember_lbl" xml:lang="en-US">Common Stock Issued For Services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CommonStockIssuedForServicesMember" xlink:to="govx_CommonStockIssuedForServicesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="govx_CommonStockIssuedForServicesMember_lbl0" xml:lang="en-US">Common Stock Issued for Services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CommonStockIssuedForServicesMember" xlink:to="govx_CommonStockIssuedForServicesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="govx_DocumentAndEntityInformationAbstract" xlink:href="govx-20121231.xsd#govx_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DocumentAndEntityInformationAbstract" xlink:to="govx_DocumentAndEntityInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice_lbl1" xml:lang="en-US">ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_DevelopmentStageEnterprisePolicyTextBlock_lbl1" xml:lang="en-US">DevelopmentStageEnterprisePolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_DevelopmentStageEnterprisePolicyTextBlock" xlink:to="govx_DevelopmentStageEnterprisePolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SignificantAccountingPoliciesTextBlockAbstract_lbl0" xml:lang="en-US">SignificantAccountingPoliciesTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SignificantAccountingPoliciesTextBlockAbstract" xlink:to="govx_SignificantAccountingPoliciesTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightExercisableNumber_lbl1" xml:lang="en-US">ClassOfWarrantOrRightExercisableNumber</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisableNumber" xlink:to="govx_ClassOfWarrantOrRightExercisableNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock_lbl1" xml:lang="en-US">AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" xlink:to="govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl0" xml:lang="en-US">StockholdersEquityNoteDisclosureTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="govx_StockholdersEquityNoteDisclosureTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConvertiblePreferredStockTotalConversionShares_lbl1" xml:lang="en-US">ConvertiblePreferredStockTotalConversionShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConvertiblePreferredStockTotalConversionShares" xlink:to="govx_ConvertiblePreferredStockTotalConversionShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightForfeituresAndExpirations_lbl1" xml:lang="en-US">ClassOfWarrantOrRightForfeituresAndExpirations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightForfeituresAndExpirations" xlink:to="govx_ClassOfWarrantOrRightForfeituresAndExpirations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ProjectExtensionPeriod_lbl1" xml:lang="en-US">ProjectExtensionPeriod</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ProjectExtensionPeriod" xlink:to="govx_ProjectExtensionPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_UnusedGrantFunds_lbl1" xml:lang="en-US">UnusedGrantFunds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_UnusedGrantFunds" xlink:to="govx_UnusedGrantFunds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_OperatingLeaseTermOfLease_lbl1" xml:lang="en-US">OperatingLeaseTermOfLease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OperatingLeaseTermOfLease" xlink:to="govx_OperatingLeaseTermOfLease_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_QuarterlyFinancialInformationTextBlockAbstract_lbl0" xml:lang="en-US">QuarterlyFinancialInformationTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_QuarterlyFinancialInformationTextBlockAbstract" xlink:to="govx_QuarterlyFinancialInformationTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_IncomeTaxDisclosureTextBlockAbstract_lbl0" xml:lang="en-US">IncomeTaxDisclosureTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_IncomeTaxDisclosureTextBlockAbstract" xlink:to="govx_IncomeTaxDisclosureTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AdditionalInformationConcerningStockOptionsTableTextBlock_lbl1" xml:lang="en-US">AdditionalInformationConcerningStockOptionsTableTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AdditionalInformationConcerningStockOptionsTableTextBlock" xlink:to="govx_AdditionalInformationConcerningStockOptionsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract_lbl0" xml:lang="en-US">MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:to="govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_WarrantsIssuedDuringPeriodExercisePrice_lbl1" xml:lang="en-US">WarrantsIssuedDuringPeriodExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_WarrantsIssuedDuringPeriodExercisePrice" xlink:to="govx_WarrantsIssuedDuringPeriodExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl0" xml:lang="en-US">RelatedPartyTransactionsDisclosureTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="govx_RelatedPartyTransactionsDisclosureTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_AccruedLiabilitiesPolicyTextBlock_lbl1" xml:lang="en-US">AccruedLiabilitiesPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_AccruedLiabilitiesPolicyTextBlock" xlink:to="govx_AccruedLiabilitiesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice_lbl1" xml:lang="en-US">ClassOfWarrantIssuedWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantIssuedWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended_lbl1" xml:lang="en-US">ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" xlink:to="govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_NetProceedsAllocatedToConvertiblePreferredStock_lbl1" xml:lang="en-US">NetProceedsAllocatedToConvertiblePreferredStock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NetProceedsAllocatedToConvertiblePreferredStock" xlink:to="govx_NetProceedsAllocatedToConvertiblePreferredStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_NumberOfWarrantsIssuedDuringPeriod_lbl1" xml:lang="en-US">NumberOfWarrantsIssuedDuringPeriod</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NumberOfWarrantsIssuedDuringPeriod" xlink:to="govx_NumberOfWarrantsIssuedDuringPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US">ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US">ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_CommitmentsDisclosureTextBlockAbstract_lbl0" xml:lang="en-US">CommitmentsDisclosureTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CommitmentsDisclosureTextBlockAbstract" xlink:to="govx_CommitmentsDisclosureTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_GovernmentGrantsTextBlock_lbl1" xml:lang="en-US">GovernmentGrantsTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlock" xlink:to="govx_GovernmentGrantsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ConvertiblePreferredStockConversionPricePerShare_lbl1" xml:lang="en-US">ConvertiblePreferredStockConversionPricePerShare</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ConvertiblePreferredStockConversionPricePerShare" xlink:to="govx_ConvertiblePreferredStockConversionPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightPurchasePeriod_lbl1" xml:lang="en-US">ClassOfWarrantOrRightPurchasePeriod</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightPurchasePeriod" xlink:to="govx_ClassOfWarrantOrRightPurchasePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ProjectPeriodCoveredByGrants_lbl1" xml:lang="en-US">ProjectPeriodCoveredByGrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ProjectPeriodCoveredByGrants" xlink:to="govx_ProjectPeriodCoveredByGrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice_lbl1" xml:lang="en-US">ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" xlink:to="govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_NatureOfOperationsTextBlockAbstract_lbl0" xml:lang="en-US">NatureOfOperationsTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NatureOfOperationsTextBlockAbstract" xlink:to="govx_NatureOfOperationsTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract_lbl0" xml:lang="en-US">ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:to="govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_SubsequentEventsTextBlockAbstract_lbl0" xml:lang="en-US">SubsequentEventsTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_SubsequentEventsTextBlockAbstract" xlink:to="govx_SubsequentEventsTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PeriodToPeriodComparisonsPolicyTexBlock_lbl1" xml:lang="en-US">PeriodToPeriodComparisonsPolicyTexBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PeriodToPeriodComparisonsPolicyTexBlock" xlink:to="govx_PeriodToPeriodComparisonsPolicyTexBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_NumberOfPreferredSharesConvertedIntoCommonStock_lbl1" xml:lang="en-US">NumberOfPreferredSharesConvertedIntoCommonStock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_NumberOfPreferredSharesConvertedIntoCommonStock" xlink:to="govx_NumberOfPreferredSharesConvertedIntoCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightExercises_lbl2" xml:lang="en-US">ClassOfWarrantOrRightExercises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightExercises" xlink:to="govx_ClassOfWarrantOrRightExercises_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract_lbl0" xml:lang="en-US">PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:to="govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees_lbl1" xml:lang="en-US">MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" xlink:to="govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_GrantAward_lbl1" xml:lang="en-US">GrantAward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GrantAward" xlink:to="govx_GrantAward_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased_lbl1" xml:lang="en-US">ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" xlink:to="govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_OtherAssetsPolicyTextBlock_lbl1" xml:lang="en-US">OtherAssetsPolicyTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_OtherAssetsPolicyTextBlock" xlink:to="govx_OtherAssetsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="govx_GovernmentGrantsTextBlockAbstract_lbl0" xml:lang="en-US">GovernmentGrantsTextBlockAbstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_GovernmentGrantsTextBlockAbstract" xlink:to="govx_GovernmentGrantsTextBlockAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl0" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl0" xml:lang="en-US">Schedule of Stockholders&apos; Equity Note, Warrants or Rights [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl0" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl0" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl0" xml:lang="en-US">Operating Leases, Rent Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl0" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl0" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl0" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Quarterly Financial Information [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl0" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Other General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl0" xml:lang="en-US">Other Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl0" xml:lang="en-US">Area of Real Estate Property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl0" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl1" xml:lang="en-US">Valuation Allowances and Reserves, Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Stock Splits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl0" xml:lang="en-US">Quarterly Financial Information [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl0" xml:lang="en-US">Conversion of Stock, Amount Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl0" xml:lang="en-US">Proceeds from Warrant Exercises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl0" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityPublicFloat"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl0" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl0" xml:lang="en-US">Valuation Allowances and Reserves, Deductions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl0" xml:lang="en-US">Development Stage Enterprise, Deficit Accumulated During Development Stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Deposit Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl0" xml:lang="en-US">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>govx-20121231_pre.xml
<TEXT>
<XBRL>
<!-- Generated by iC(tm) - CompSci Interactive Converter - http://www.compsciresources.com -->
<!-- Created: Thu Mar 14 22:47:45 UTC 2013 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheet" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedIncomeStatement" roleURI="http://geovax.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ShareholdersEquityType2or3" roleURI="http://geovax.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ConsolidatedCashFlow" roleURI="http://geovax.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note" roleURI="http://geovax.com/role/Note"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0" roleURI="http://geovax.com/role/Note0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note00" roleURI="http://geovax.com/role/Note00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note000" roleURI="http://geovax.com/role/Note000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0000" roleURI="http://geovax.com/role/Note0000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note00000" roleURI="http://geovax.com/role/Note00000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note000000" roleURI="http://geovax.com/role/Note000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0000000" roleURI="http://geovax.com/role/Note0000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note00000000" roleURI="http://geovax.com/role/Note00000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note000000000" roleURI="http://geovax.com/role/Note000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Note0000000000" roleURI="http://geovax.com/role/Note0000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_Schedule" roleURI="http://geovax.com/role/Schedule"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_AccountingPoliciesByPolicy" roleURI="http://geovax.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables" roleURI="http://geovax.com/role/NoteTables"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables0" roleURI="http://geovax.com/role/NoteTables0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables00" roleURI="http://geovax.com/role/NoteTables00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteTables000" roleURI="http://geovax.com/role/NoteTables000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_PropertyandEquipmentTable" roleURI="http://geovax.com/role/PropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_AllocationofNetProceedsfromPreferredStockFinancingTable" roleURI="http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_StockOptionActivityTable" roleURI="http://geovax.com/role/StockOptionActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_AdditionalInformationConcerningStockOptionsTable" roleURI="http://geovax.com/role/AdditionalInformationConcerningStockOptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_SignificantAssumptionsUsedinFairValueCalculationsTable" roleURI="http://geovax.com/role/SignificantAssumptionsUsedinFairValueCalculationsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_StockbasedCompensationExpenseTable" roleURI="http://geovax.com/role/StockbasedCompensationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_StockPurchaseWarrantTransactionsTable" roleURI="http://geovax.com/role/StockPurchaseWarrantTransactionsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsandLiabilitiesTable" roleURI="http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ReconciliationoftheIncomeTaxBenefitTable" roleURI="http://geovax.com/role/ReconciliationoftheIncomeTaxBenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_SelectedQuarterlyFinancialDataTable" roleURI="http://geovax.com/role/SelectedQuarterlyFinancialDataTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ValuationandQualifyingAccountsTable" roleURI="http://geovax.com/role/ValuationandQualifyingAccountsTable"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail" roleURI="http://geovax.com/role/NoteDetail"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0" roleURI="http://geovax.com/role/NoteDetail0"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail00" roleURI="http://geovax.com/role/NoteDetail00"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail000" roleURI="http://geovax.com/role/NoteDetail000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0000" roleURI="http://geovax.com/role/NoteDetail0000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail00000" roleURI="http://geovax.com/role/NoteDetail00000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail000000" roleURI="http://geovax.com/role/NoteDetail000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0000000" roleURI="http://geovax.com/role/NoteDetail0000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail00000000" roleURI="http://geovax.com/role/NoteDetail00000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail000000000" roleURI="http://geovax.com/role/NoteDetail000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_NoteDetail0000000000" roleURI="http://geovax.com/role/NoteDetail0000000000"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#govx_ScheduleDetail" roleURI="http://geovax.com/role/ScheduleDetail"/>
  <roleRef xlink:type="simple" xlink:href="govx-20121231.xsd#DocumentAndEntityInformation" roleURI="http://geovax.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ConsolidatedBalanceSheetsAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedBalanceSheetsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="SeriesAConvertiblePreferredStockMember" xlink:href="govx-20121231.xsd#govx_SeriesAConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesAConvertiblePreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentAssetsAbstract" xlink:href="govx-20121231.xsd#govx_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="CurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrantsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_GrantsReceivable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsAbstract" xlink:to="us-gaap_DepositsAssetsNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="CurrentLiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentLiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="ConsolidatedBalanceSheetsAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedBalanceSheetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedBalanceSheetsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="SeriesAConvertiblePreferredStockMember" xlink:href="govx-20121231.xsd#govx_SeriesAConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesAConvertiblePreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PreferredStockStatedValue" xlink:href="govx-20121231.xsd#govx_PreferredStockStatedValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="PreferredStockStatedValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfOperationsAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedStatementsOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfOperationsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="OtherIncomeExpenseAbstract" xlink:href="govx-20121231.xsd#govx_OtherIncomeExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OtherIncomeExpenseAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="BasicAndDilutedAbstract" xlink:href="govx-20121231.xsd#govx_BasicAndDilutedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="BasicAndDilutedAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfStockholdersEquityDeficiencyAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0"/>
    <loc xlink:type="locator" xlink:label="StockSubscriptionReceivableMember" xlink:href="govx-20121231.xsd#govx_StockSubscriptionReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="StockSubscriptionReceivableMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" xlink:href="govx-20121231.xsd#govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued_0" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfCashFlowsAbstract" xlink:href="govx-20121231.xsd#govx_ConsolidatedStatementsOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromOperatingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ChangesInAssetsAndLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_ChangesInAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract" xlink:to="ChangesInAssetsAndLiabilitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredCharges" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromInvestingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CashFlowsFromFinancingActivitiesAbstract" xlink:href="govx-20121231.xsd#govx_CashFlowsFromFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="CashFlowsFromFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowsFromFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InterestPaid" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note">
    <loc xlink:type="locator" xlink:label="NatureOfOperationsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_NatureOfOperationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureOfOperationsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NatureOfOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0">
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00">
    <loc xlink:type="locator" xlink:label="GovernmentGrantsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_GovernmentGrantsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GovernmentGrantsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="GovernmentGrantsTextBlock" xlink:href="govx-20121231.xsd#govx_GovernmentGrantsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="GovernmentGrantsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000">
    <loc xlink:type="locator" xlink:label="CommitmentsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_CommitmentsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000">
    <loc xlink:type="locator" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000">
    <loc xlink:type="locator" xlink:label="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000">
    <loc xlink:type="locator" xlink:label="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000">
    <loc xlink:type="locator" xlink:label="IncomeTaxDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_IncomeTaxDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note00000000">
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note000000000">
    <loc xlink:type="locator" xlink:label="QuarterlyFinancialInformationTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_QuarterlyFinancialInformationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="QuarterlyFinancialInformationTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Note0000000000">
    <loc xlink:type="locator" xlink:label="SubsequentEventsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_SubsequentEventsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/Schedule">
    <loc xlink:type="locator" xlink:label="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DevelopmentStageEnterprisePolicyTextBlock" xlink:href="govx-20121231.xsd#govx_DevelopmentStageEnterprisePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="DevelopmentStageEnterprisePolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UseOfEstimates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherAssetsPolicyTextBlock" xlink:href="govx-20121231.xsd#govx_OtherAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OtherAssetsPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedLiabilitiesPolicyTextBlock" xlink:href="govx-20121231.xsd#govx_AccruedLiabilitiesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AccruedLiabilitiesPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PeriodToPeriodComparisonsPolicyTexBlock" xlink:href="govx-20121231.xsd#govx_PeriodToPeriodComparisonsPolicyTexBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="PeriodToPeriodComparisonsPolicyTexBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables">
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables0">
    <loc xlink:type="locator" xlink:label="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" xlink:href="govx-20121231.xsd#govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalInformationConcerningStockOptionsTableTextBlock" xlink:href="govx-20121231.xsd#govx_AdditionalInformationConcerningStockOptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AdditionalInformationConcerningStockOptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables00">
    <loc xlink:type="locator" xlink:label="IncomeTaxDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_IncomeTaxDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteTables000">
    <loc xlink:type="locator" xlink:label="QuarterlyFinancialInformationTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_QuarterlyFinancialInformationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="QuarterlyFinancialInformationTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/PropertyandEquipmentTable">
    <loc xlink:type="locator" xlink:label="PropertyAndEquipmentAbstract" xlink:href="govx-20121231.xsd#govx_PropertyAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyAndEquipmentAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="LaboratoryEquipmentMember" xlink:href="govx-20121231.xsd#govx_LaboratoryEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="LaboratoryEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="OtherFurnitureFixturesAndEquipmentMember" xlink:href="govx-20121231.xsd#govx_OtherFurnitureFixturesAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="OtherFurnitureFixturesAndEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable">
    <loc xlink:type="locator" xlink:label="AllocationOfNetProceedsFromPreferredStockFinancingAbstract" xlink:href="govx-20121231.xsd#govx_AllocationOfNetProceedsFromPreferredStockFinancingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AllocationOfNetProceedsFromPreferredStockFinancingAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
<!-- [WMV4][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt8UCLPdYZl35nXbOCDIyGTq1p9Q9BOYVi2GPRTHo+pgjoNP861n9NVRv7C2G88h/3wwhHkJLayCgwG4gzQgO1GtJPkRDF8quUM4CUMA/xge9QOZ9RJaXDR38VLtarIvJZPfxcf4bZAv7z120OcgrDNUMQwBRXs2wXDWpxuQWN96ZKu4+pgDA/ft+bUwL9x5GgOTH09S0c5Swg==] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetProceedsAllocatedToConvertiblePreferredStock" xlink:href="govx-20121231.xsd#govx_NetProceedsAllocatedToConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NetProceedsAllocatedToConvertiblePreferredStock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAccretionOfDividends" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConversionOfStockAmountConverted1" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/StockOptionActivityTable">
    <loc xlink:type="locator" xlink:label="StockOptionActivityAbstract" xlink:href="govx-20121231.xsd#govx_StockOptionActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockOptionActivityAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/AdditionalInformationConcerningStockOptionsTable">
    <loc xlink:type="locator" xlink:label="AdditionalInformationConcerningStockOptionsAbstract" xlink:href="govx-20121231.xsd#govx_AdditionalInformationConcerningStockOptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdditionalInformationConcerningStockOptionsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/SignificantAssumptionsUsedinFairValueCalculationsTable">
    <loc xlink:type="locator" xlink:label="SignificantAssumptionsUsedInFairValueCalculationsAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAssumptionsUsedInFairValueCalculationsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAssumptionsUsedInFairValueCalculationsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/StockbasedCompensationExpenseTable">
    <loc xlink:type="locator" xlink:label="StockBasedCompensationExpenseAbstract" xlink:href="govx-20121231.xsd#govx_StockBasedCompensationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/StockPurchaseWarrantTransactionsTable">
    <loc xlink:type="locator" xlink:label="StockPurchaseWarrantTransactionsAbstract" xlink:href="govx-20121231.xsd#govx_StockPurchaseWarrantTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockPurchaseWarrantTransactionsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="SeriesAWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesAWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesAWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesBWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesBWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesBWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesCWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesCWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesCWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherWarrantsMember" xlink:href="govx-20121231.xsd#govx_OtherWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="OtherWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightIssuedDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightIssuedDuringPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantIssuedWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantIssuedWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantIssuedWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightExercises" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightExercises" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightForfeituresAndExpirations" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightForfeituresAndExpirations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightForfeituresAndExpirations" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_0" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightExercisableNumber" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightExercisableNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsAbstract" xlink:href="govx-20121231.xsd#govx_DeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="DeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ReconciliationoftheIncomeTaxBenefitTable">
    <loc xlink:type="locator" xlink:label="ReconciliationOfTheIncomeTaxBenefitAbstract" xlink:href="govx-20121231.xsd#govx_ReconciliationOfTheIncomeTaxBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReconciliationOfTheIncomeTaxBenefitAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/SelectedQuarterlyFinancialDataTable">
    <loc xlink:type="locator" xlink:label="SelectedQuarterlyFinancialDataAbstract" xlink:href="govx-20121231.xsd#govx_SelectedQuarterlyFinancialDataAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SelectedQuarterlyFinancialDataAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ValuationandQualifyingAccountsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" xlink:href="govx-20121231.xsd#govx_ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ReserveDeductedInTheBalanceSheetFromTheAssetToWhichItAppliesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowanceForDeferredTaxAssetsAbstract" xlink:href="govx-20121231.xsd#govx_AllowanceForDeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="AllowanceForDeferredTaxAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_0" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail">
    <loc xlink:type="locator" xlink:label="NatureOfOperationsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_NatureOfOperationsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NatureOfOperationsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0">
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_SignificantAccountingPoliciesTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinimumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MinimumMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="1.0"/>
    <loc xlink:type="locator" xlink:label="RangeDomain" xlink:href="govx-20121231.xsd#govx_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="RangeDomain" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_LicensingAgreementsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Depreciation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail00">
    <loc xlink:type="locator" xlink:label="GovernmentGrantsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_GovernmentGrantsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GovernmentGrantsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="FirstNIHGrantMember" xlink:href="govx-20121231.xsd#govx_FirstNIHGrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="FirstNIHGrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecondNIHGrantMember" xlink:href="govx-20121231.xsd#govx_SecondNIHGrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="SecondNIHGrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NIHGrantsMember" xlink:href="govx-20121231.xsd#govx_NIHGrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="NIHGrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="QTDPGrantMember" xlink:href="govx-20121231.xsd#govx_QTDPGrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="QTDPGrantMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="ProjectPeriodCoveredByGrants" xlink:href="govx-20121231.xsd#govx_ProjectPeriodCoveredByGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ProjectPeriodCoveredByGrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProjectExtensionPeriod" xlink:href="govx-20121231.xsd#govx_ProjectExtensionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ProjectExtensionPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrantAward" xlink:href="govx-20121231.xsd#govx_GrantAward"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="GrantAward" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnusedGrantFunds" xlink:href="govx-20121231.xsd#govx_UnusedGrantFunds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="UnusedGrantFunds" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RevenueFromGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromGrants" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail000">
    <loc xlink:type="locator" xlink:label="CommitmentsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_CommitmentsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AreaOfRealEstateProperty" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseTermOfLease" xlink:href="govx-20121231.xsd#govx_OperatingLeaseTermOfLease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="OperatingLeaseTermOfLease" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0000">
    <loc xlink:type="locator" xlink:label="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MergersAcquisitionsAndDispositionsDisclosuresTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail00000">
    <loc xlink:type="locator" xlink:label="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_StockholdersEquityNoteDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityNoteDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_StockOptionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="SeriesAWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesAWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesAWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesBWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesBWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesBWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesCWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesCWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesCWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0"/>
    <loc xlink:type="locator" xlink:label="SeriesAConvertiblePreferredStockMember" xlink:href="govx-20121231.xsd#govx_SeriesAConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesAConvertiblePreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" order="4.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsByReportLineAxis" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsReportLineDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="SaleOfCommonStockAxis" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="SaleOfCommonStockAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IndividualAccreditedInvestorsMember" xlink:href="govx-20121231.xsd#govx_IndividualAccreditedInvestorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfCommonStockAxis" xlink:to="IndividualAccreditedInvestorsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfCommonStockDomain" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfCommonStockAxis" xlink:to="SaleOfCommonStockDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RangeAxis" order="6.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaximumMember" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_MaximumMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RangeDomain" xlink:href="govx-20121231.xsd#govx_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="RangeDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NatureOfExpenseAxis" order="7.0"/>
    <loc xlink:type="locator" xlink:label="CommonStockIssuedForServicesMember" xlink:href="govx-20121231.xsd#govx_CommonStockIssuedForServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="CommonStockIssuedForServicesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CompensatoryWarrantsMember" xlink:href="govx-20121231.xsd#govx_CompensatoryWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="CompensatoryWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain" order="2.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="8.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferredStockStatedValue" xlink:href="govx-20121231.xsd#govx_PreferredStockStatedValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="PreferredStockStatedValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockConversionPricePerShare" xlink:href="govx-20121231.xsd#govx_ConvertiblePreferredStockConversionPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ConvertiblePreferredStockConversionPricePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferredStockTotalConversionShares" xlink:href="govx-20121231.xsd#govx_ConvertiblePreferredStockTotalConversionShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ConvertiblePreferredStockTotalConversionShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfPreferredSharesConvertedIntoCommonStock" xlink:href="govx-20121231.xsd#govx_NumberOfPreferredSharesConvertedIntoCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NumberOfPreferredSharesConvertedIntoCommonStock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightIssuedDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightIssuedDuringPeriod" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsIssuedDuringPeriodExercisePrice" xlink:href="govx-20121231.xsd#govx_WarrantsIssuedDuringPeriodExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="WarrantsIssuedDuringPeriodExercisePrice" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfWarrantsIssuedDuringPeriod" xlink:href="govx-20121231.xsd#govx_NumberOfWarrantsIssuedDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="NumberOfWarrantsIssuedDuringPeriod" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" xlink:href="govx-20121231.xsd#govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail000000">
    <loc xlink:type="locator" xlink:label="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PensionAndOtherPostretirementBenefitsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0000000">
    <loc xlink:type="locator" xlink:label="IncomeTaxDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_IncomeTaxDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail00000000">
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_RelatedPartyTransactionsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="SaleOfCommonStockAxis" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="SaleOfCommonStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MembersOfBoardOfDirectorsAndManagementMember" xlink:href="govx-20121231.xsd#govx_MembersOfBoardOfDirectorsAndManagementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfCommonStockAxis" xlink:to="MembersOfBoardOfDirectorsAndManagementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfCommonStockDomain" xlink:href="govx-20121231.xsd#govx_SaleOfCommonStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfCommonStockAxis" xlink:to="SaleOfCommonStockDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_NatureOfExpenseAxis" order="2.0"/>
    <loc xlink:type="locator" xlink:label="OngoingPatentCostReimbursementsMember" xlink:href="govx-20121231.xsd#govx_OngoingPatentCostReimbursementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="OngoingPatentCostReimbursementsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchAgreementsMember" xlink:href="govx-20121231.xsd#govx_ResearchAgreementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="ResearchAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsultingAgreementMember" xlink:href="govx-20121231.xsd#govx_ConsultingAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="ConsultingAgreementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_InterimPeriodCostsNotAllocableDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightPurchasePeriod" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightPurchasePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightPurchasePeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail000000000">
    <loc xlink:type="locator" xlink:label="QuarterlyFinancialInformationTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_QuarterlyFinancialInformationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="QuarterlyFinancialInformationTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/NoteDetail0000000000">
    <loc xlink:type="locator" xlink:label="SubsequentEventsTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_SubsequentEventsTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="SeriesBWarrantsMember" xlink:href="govx-20121231.xsd#govx_SeriesBWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesBWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightExercises" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightExercises" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" xlink:href="govx-20121231.xsd#govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherGeneralAndAdministrativeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/ScheduleDetail">
    <loc xlink:type="locator" xlink:label="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:href="govx-20121231.xsd#govx_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlockAbstract" xlink:to="us-gaap_StatementTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://geovax.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="govx-20121231.xsd#govx_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityPublicFloat"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" order="5.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="6.0"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentDescription" order="7.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="8.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="9.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="14.0"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="15.0"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>geovax_10k-1231120.jpg
<TEXT>
begin 644 geovax_10k-1231120.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$<`[$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P`^&WPVT?QC
MX=N-1U&YOXYH[MH`()$5=H5#GE2<Y8]Z['_A1?AC_G]U?_O]'_\`&Z/@5_R)
M%Y_V$9/_`$7'7IU84Z<7%-HUG.2DTF>8_P#"B_"__/[J_P#W^C_^-T?\*+\+
M_P#/[J__`'^C_P#C=>G45?LH=B>>7<\Q_P"%%^%_^?W5_P#O]'_\;H_X47X7
M_P"?W5_^_P!'_P#&Z].HH]E#L'/+N>8_\*+\+_\`/[J__?Z/_P"-T?\`"B_"
M_P#S^ZO_`-_H_P#XW7IU&<T>RAV#GEW/,?\`A1?A?_G]U?\`[_1__&Z/^%%^
M%_\`G]U?_O\`1_\`QNO30,9]Z6CV4.P<\NYYC_PHOPO_`,_NK_\`?Z/_`.-T
M?\*+\+_\_NK_`/?Z/_XW7IU%'LH=@YY=SS#_`(47X7`_X_=7_P"_T?\`\;I!
M\#O"Q('V[5^?^FT?_P`;KU`]*3`'I1[*'8.>7<\P_P"%&^%\X^VZO_W^C_\`
MC=`^!OA<Y_TW5\#_`*;1_P#Q%>F!NI(PO8TH("Y`XH]E#L'/+N>9GX&>%\`_
M;=7Y_P"FT?\`\12_\*+\+_\`/[J__?Z/_P"-UZ9G(RO2EW<XQ1[*'8.>7<\R
M'P+\+_\`/[J__?Z/_P"-T?\`"B_"_P#S^ZO_`-_H_P#XW7IA)P3CZ4H.[ZT>
MRAV#GEW/,O\`A1?A?_G]U?\`[_1__&Z3_A1GA?\`Y_=7_P"_T?\`\;KT\T@X
MP*/90[!SR[GF/_"C/"^<?;=7_P"_T?\`\;I?^%%^%_\`G]U?_O\`1_\`QNO3
M12T>RAV#GEW/,?\`A1?A?_G]U?\`[_1__&Z/^%%^%_\`G]U?_O\`1_\`QNO3
MJ*/90[!SR[GF/_"B_"__`#^ZO_W^C_\`C='_``HOPO\`\_NK_P#?Z/\`^-UZ
M=0:/90[!SR[GF'_"B_"^?^/W5_\`O]'_`/&Z7_A1?A?_`)_=7_[_`$?_`,;K
MTT#!)I>]'LH=@YY=SS'_`(47X7_Y_=7_`._T?_QNC_A1?A?_`)_=7_[_`$?_
M`,;KTZBCV4.P<\NYYC_PHOPO_P`_NK_]_H__`(W1_P`*+\+_`//[J_\`W^C_
M`/C=>G44>RAV#GEW/,?^%%^%_P#G]U?_`+_1_P#QN@?`OPO_`,_NK_\`?Z/_
M`.-UZ=11[*'8.>7<\Q_X47X7_P"?W5_^_P!'_P#&Z/\`A1?A?_G]U?\`[_1_
M_&Z].HQ1[*'8.>7<\Q/P+\+C_E]U?_O]'_\`&Z0?`SPN<_Z;J_\`W^C_`/C=
M>GGIQ2=N:/90[!SR[GF0^!?A<_\`+[J__?Z/_P"-T?\`"B_"_P#S^ZO_`-_H
M_P#XW7IU%'LH=@YY=SS'_A1?A?\`Y_=7_P"_T?\`\;H_X47X7_Y_=7_[_1__
M`!NO31[FCG/M1[*'8.>7<\R_X47X7_Y_=7_[_1__`!NC_A1?A?./MNK_`/?Z
M/_XW7IN<Y`H7..>M'LH=@YY=SS+_`(47X7_Y_=7_`._T?_QNC_A1?A?_`)_=
M7_[_`$?_`,;KTZBCV4.P<\NYYC_PHOPO_P`_NK_]_H__`(W1_P`*+\+_`//[
MJ_\`W^C_`/C=>G44>RAV#GEW/,?^%%^%_P#G]U?_`+_1_P#QNC_A1?A?_G]U
M?_O]'_\`&Z].HH]E#L'/+N>8_P#"B_"__/[J_P#W^C_^-T?\*+\+_P#/[J__
M`'^C_P#C=>G44>RAV#GEW/,?^%%^%_\`G]U?_O\`1_\`QNC_`(47X7_Y_=7_
M`._T?_QNO3J*/90[!SR[GF/_``HOPO\`\_NK_P#?Z/\`^-UYW\6O`.E>"]*L
MY=.GO)3=>:CBX=6`VKD8PH]:^DJ\7_:(_P"0'I'^_/\`^@"IG3BHW2*A.3>Y
M\T5W'PV\*0>,=932I9D@,F]O.,(D(VKG&,C^=</7K'P%_P"1XM\G'RS<^G[N
MJJ:I+S(AN=R?V>]/'775Q_V#Q_\`%TO_``SS8`_\AU>1Q_H`_P#BZ]DD)6/(
M.<=<&H9&R@P1MQW/>CV41\\CQ_\`X9]TXY(UY,#K_H`_^+IC?`+2UQG7T&>W
M]GC_`.+KUN641`LV>!@MZ5R6M>(HT=K>TF`1`3(V><]AGTH]E$.>1YGJ'PIT
M6S_U.KFX`)!*6`Q^'SUG/\.=,5=XU",Q`9=S:`;1_P!]5V)FF),NY5;K^Z.%
M7/:JHN(KD?9W9424[9,#!R*/9Q%SR.0;P'I:D@WJH,X!DM`H;W'S<BFCP'8.
MB>7=PF5\E4-L,.!U(.?TKLC8#[%(LQ%Q%&!A@`/IBH1IRQ1-S*%8@$;O3NII
M^SB'/(Y1O`>G@96Z#`KE0+0`^^1FI1\/]+>,-'?`DC(WV84'VSNKLH;>"_6X
M,SO)&@78,X<GV/>J5_9M:.2BER[X"NV"!CJ!1[.(<\CG8?A[H[K)YFIQHZ?>
M"V@88_[ZJ\GPQ\//)Y?]N9;`(VV`/_L_%2PWA%P!+)MD5L-Q@-Q@!J7SKF"X
M6%8PLH&3(G&SG]:/9Q#GD6F^#&C^2)(]=1\C/_'@`![9WU2NOA3H]O#O35Q(
MYX5!8@<^_P`W%7(-8:RN5.2T<A^97<C!^G0U9OM6%Q*8WF,,LZX9E3/3I]#1
M[.(<\C$M?A3:3P2RR7J((V(VK:AR?PW5$OPQL6*DW9$>[:SFR`QZ?Q5VWV^6
MV^R\F-<;2B\%QZFI]6N8EC),J*0@PK'@^YH]G$.>1P8^&6ERQDPZBI89`$EF
M%!/UW5;TOX3Z1?QEI=6$#`?<^PAB3_WU79Z6NFO`DY(FE(X5<[!]:TI;62%?
M.*KY_48X)!Z#`Z4>SB'/(X>3X*:>D?FKJH:+NWV`#C_ONJMG\'[&Y=D?4EC<
M#(7[$"2/7[U>JP/*(U\W<I;L1P?K5>YO[""X@^9#(#ACW(]J/9Q#GD</%\"-
M.EC5O[78$C)']G`X_P#'ZE7X!Z6[*JZ\I+#/_(/'_P`77IUM<R%-QW"*3E&4
MYX[#VIG]I-%J"H$V@C<^>21TP*7LHASR/-_^&?\`32S*-=4LO4#3Q_\`%U7N
M_@3IEK#O_ML.>RKIX_\`BZ]A22,J-DC%2,@CJ:P];-PD\;(V4<8VX^7CU-'L
MHASR/(F^$FGK*R#4=P4@';8CC_QZK_\`PI72%W>9K>TKCIIX/'_?=>G)912K
M&1(7B`X&[EC[^HJSJ,:P6[^5(!)M^[@`=*/9Q#GD>2Q?!G29Y)%CUI2%4D-]
M@&#[??JJ_P`(;".9$;4/E+88K9`X'8_>KO'UV+3T:-UCE3;\\N,*K=MU<?J7
MC5Q>0DB2$L>(8DRKKZY[4_9Q#GD4KWX3:/90EVUI&8'E?L2C'_C]9B?#K39;
MCRH[Y#B,N3]E'!]/O5IK'<:]*LDD>[//E\EL>AK2GW11(D5K)"%!\LL-I-'L
MXASR,NT^$FGSJK2:FD:NN4860(/M][BGI\(],$+2RZGA%_NV()]OX^];UIJ=
MO"@E\UV3;M:/'`/?-6DUZUC"&9)63.5"*2<#V[XI>SB'/(XUOA79>:Z)>AB!
MD9LP/P/S<4W_`(5AIRQ@2:BB3YY3[(,8]0=U=1)>W.H7QN=.:=+1VXG92.1_
M"0:G-IE(O/C,DV23DX`]Z?LXASR.4C^%5B_(U"-UXYCM0?Q'S<UHCX,:8%+-
MJ^0`#A+`$_3[]=7:R_9%CM[:%23R=XX?Z'UKH+.61]XDP&)V@+SCV-'LXASR
M/-O^%*Z?YJK_`&L%!'\6G@'/;^*EA^"FG22B.35Q&^\+@V`/7O\`?KUC[/+(
M%41MD^^!5F&P5KJW8HZL'RQ/>E[.(<\CY^U+X<6%A=7-NE['*T,I3/V4`<'&
M3\W%8L_A:RMT(=E,PR?+%OV'<G-=SK%U#+XGU2!KC84N',BR)PRYSR>V.U9%
M]>-J4,B1!40.-OE-N9UQP3Z?2G[.(<\CF8_#VG/)Y9)W%=X"VP;</8YQ4<^@
M6L#99%"%<J?)&<XR`>>*NI;W4$C06I5TR6=8U`8@^_;%7[E(+H):M,':)5WI
M(>/T]:/9Q#GD<_9Z##=PF0PHF`,_N@0,^]3KX:MG=Q'Y#(HX8Q@;CCL,]*MW
M.I229M(C]EBX4LPRB_7%06EW"+Q4NVB><*55XL_,?5>P-'LXASR(4\.VKS[!
MY13:"7$/1CU7'MZU(OAS3FGDB\Z)?+?:SF`;1^M76OK:6Y`,9C*J5PY^][D^
MM.M;-9\SEDD9R,QCHPS_`#I>SB'/(J'PM8)#YDLL?S<)LMMP8_GQ5RW\"VDH
M9I)X54'JL`/Z9K;:V,]TL<)*H2ID3(SCO@5JQV4LDJ`*%B;EL#YSM[^XI^SB
M'/(R[/X36-VF5U!<CEE%F"0/^^J6\^%.E63QA]28JW5A8#"CU^]7IFG%8[2$
M11E59<[NYK&U)6FFFMWW9&"60D;A1[.(<\CDQ\(='-H]P-9!1>F-/!S[_>K1
ML_@9I=[`LB:YUZ_\2X?_`!==O#8I8Z4L,C!E(!X?.!5S3M1\L[!(0K#@,.WM
M2]G$.>1P%Q\!M,MX'D;75.T$X_L\<_\`C]9%I\(=,GGDBEU41E!N)6Q##'_?
M5>VJ3<QD.3M<;?E/7Z5D-9FPOYW1AYC(,H1P1W-'LXASR/.8O@AI$\1>/758
M`9)_L\=/^^ZJ3?!W289UC.L;E;@,NG@C/_??%>H)<&2X$:HRQ..(_+J_$\=S
M&L0@!!7G';%'LXASR/)Y/@KI$2`MKHR1_P!`\=?3[]8WB+X766AZ)=ZDEWYZ
MP!"`;,*&W.%Z[CCKGH:];NOF:4&421(.=C<J?0^U87CA;BX^'NJ3F3:B+#O3
M&=P\U`.:4Z<5%M%1FVT>!?9+?_GA'_WR**FHKAYGW.FR/H7X%_\`(D7G_81D
M_P#1<=>G5YA\"_\`D2+S_L(R?^BXZ]/KOI?`CEG\3.?EDU6^UZ^M+34([2&U
M2(@&V$A8L&)))(]*F_L[7O\`H/Q_^`*__%4:=_R-6M_]<[;_`-!:MJJ2N2V8
MO]G:]_T'X_\`P!7_`.*H_L[7O^@_'_X`K_\`%5M44[(+F+_9VO?]!^/_`,`5
M_P#BJ/[.U[_H/Q_^`*__`!5;5%%D%S%_L[7O^@_'_P"`*_\`Q5']G:]_T'X_
M_`%?_BJVJ*+(+F+_`&=KW_0?C_\``%?_`(JC^SM>_P"@_'_X`K_\56U119!<
MQ?[.U[_H/Q_^`*__`!5)_9NND_\`(?C_`/`%?_BJVZ*+(+F)_9NN_P#0?CQ_
MUXK_`/%4?V;KN/\`D/Q_^`*__%5MT4607,0:;KH'&OQ_^`*__%4O]G:]_P!!
M^/\`\`5_^*K:HHL@N8G]FZ[_`-!^/_P!7_XJE_L[7?\`H/Q_^`*__%5M4460
M7,7^SM>_Z#\?_@"O_P`51_9VO?\`0?C_`/`%?_BJVJ*+(+F+_9VO?]!^/_P!
M7_XJC^SM>_Z#\?\`X`K_`/%5M44607,7^SM>_P"@_'_X`K_\51_9VO?]!^/_
M`,`5_P#BJVJ*+(+F+_9VO?\`0?C_`/`%?_BJ/[.U[_H/Q_\`@"O_`,56U119
M!<Q?[.U[_H/Q_P#@"O\`\51_9VO?]!^/_P``5_\`BJVJ*+(+F+_9VO?]!^/_
M`,`5_P#BJ/[.U[_H/Q_^`*__`!5;5%%D%S%_L[7O^@_'_P"`*_\`Q5+HUS?'
M4=2L;ZY2Y-L8RDBQ>62&7.",FMFL73/^1GUW_MW_`/0#2M9H#:HHHJA!1110
M`4=:**`&D$-G/'I2@`=.]!&>M)@'C'2@!0:Y3^U[JS\9/;7<I%I(N(P1QFNK
M'-5[G3[6\>-[B%9&C.4)'0T`6.#S0#D4N`,>U%`!1110`4444`%%%%`!1110
M`4444`%>+_M$?\@/2/\`?G_]`%>T5XO^T1_R`](_WY__`$`5%3X2H?$?-%>L
M?`3_`)'JW_W9O_1=>3UZO\!L_P#"<6^%W';-QG'_`"SHGT]0CU/IMS\P(*(`
M<&LC4FO6U33K"SNEMS<"9GD>$2<*%(P"1UW?I6JY"N%;''48X/XUDR*J>*-$
M5#E1'<]3GLE4]A(2Z\.:Q>1NDGB,J'^]LLD!(].O2L>;X:RSHJ2:_*44Y"BU
M0#^==]118+GGH^&#K)O77Y1QC;]E3&/I5>V^$?V6Z>Y3Q)>-(W7?`A`^@KTJ
MBBP7.%M_AW<6I?RM><"3[P-FA!ILGPXGDMY(#K\H23[V+5/TYXKO**+!<X6Q
M^'D^GPI%!KC%5&`7LT8X_.F_\*XE^T/.===I&7;EK1#@>W/%=Y118+GG4GPI
M2683-K+^8%*[OLB9(/KS4$OP@$H&[Q)>`XP2($RP]#ZUZ9118+GFY^$P,(B'
MB"X5!V%LE59O@O!.RL_B&\RO(Q"O7UKU*BBP7.`/PUF,$4)\0SXC^ZWV9-WX
MFD/PR<Q[#KTF/^O5/\:]`HHL%SA]/^']UIBNMOK[X8Y.^T0_UJRG@W4(Y_.7
MQ"P;&,?8TQCZ9KKZ*+!<Y4>%=4W[F\0EC_M6:'^M0-X*O))O-DUI'.,;6L4*
M_EFNQHHL%SEH?"VJ0(4BU\*F<A?L28'TYI'\*ZG),)3KXW@8R+)/\:ZJBBP7
M.6C\+:I%G&OY![-9(?ZTR;PGJ<\3QOXA.UA@XLUR/IS76446"YQ5IX%O;,`1
M^(9"!TWVJG^M/G\$7MRJB77F.W./]$4<>G6NRHHL%SSZ[^&,M[`T,_B*<QL"
M"HM4&152'X/00;-NM2G8NU=ULAP/2O3**+!<\TU3P?<>'[*.[@U7>WG10A/L
MJK]]PI.0>O-21^%I;R4?;(U<*/D+,<_4>E=7XJ!.FVH!`/V^UY/3_6K0S-'&
M=Q;CE2!U'UH6X,YE_"4$D21'&P##L$VD^]-L/"]M87#W)*.N1L+MG;6[/JL7
MW,$R#IGY5_.LJ?6A<.R;0VSY7`7_`#FF(MS?8X5D#-'C.1@<%A7+:U?Q/=PE
M!(V!M_=KG)/7]*W.4\N1E&P#@*.%![FLF]M&:&5[=G`#98`_=/J#T/TH`OV<
M"/&($&`H!8.,DBM'3XX([CRMNTLQ8,W)S]:Y_P`.R74=\UM*%X&/-Z*WY]#7
M121Q(JE!N8.%<*>H]:`-J%6)W;.V6R><>HJQ"`&R"'.0<]\9K,M)UECVQG('
M&P<5IQEFE4$@@$9"C'XT`>%>+M,4^(+RXFC*EKASO3)W#/`//2N=,]Q%=&>&
M6-U"D$E.5&:]#\068GUFZ5I&"M*^-O(SFN<EM[BU\WRC&HF5MPE7K[?I0!AW
M-E)?""\AFC`!`D79RP]L5C3VOFQ#_2&\IB5^==O/8@=1733VZW31!-L<@`W(
M#L(^GI5&71K9RB+;Q.Z`MR<,&],^M`&-;M;7$<=O+"'F3[X;"8]R.]3B.5)H
M7%G;K&K?NG3Y2#Z>]:J:3%=6GF,S)M'S`@`^PSU_&M-+6.\>-66(%<;>#U]:
M`.=:QNKRY#;HR9O0[215G18'BN9K226)Y5X&Y>5]LCO71K:FXD5);:-8T&#*
MIR1CI@>E3Z986\!:-'R\K;G98P/I0!!9:9)&`XEWR,<.>3L'UKL]#LGN]IYC
MCC.%.-V12Z1I+32Y<L"1@\_,??'I76P:4L04AW4`?-@X+>E`&/<1)9[I\,(U
M7'!X'/<5D6J&:]GN58L?NY9\@DUVLUM&;5EV`A@=P/>N5M)'M[A8VC7$O4KT
M7!X&*`+\]IRH,17<HR0>#QWJO)#%8Q[IA@[?E<#[H]*W)K==I!)8X``#8S61
MJDBFU:)`=J-^\YR<?TH`ETMF%P9"YV*V2.GTXK4N83,3*C%">K+SN'I6!#=P
MNIB@BD+N.0#U';GO6W:QD6Z^:Y7@<9Z'UH`IW*&&,R-<';M."W!!^E-2[^QQ
MA'GC=N"2IQP?:IYC%$C>:,P$%=S<D_AVJ&V@T^=F2&,;F7#,PS0!GZDHCV/$
MHFBD.`,@8;WJMX\;R_AAK,;*-Y$'S!<#_6I6ZVFVUO;A7)9HSD%>3BN8\?%S
MX!U?]]F/;#A3_P!=4J9_"RH_$CP*BBBO-.L^A?@5_P`B1>?]A&3_`-%QUZ=7
MF'P+./!%Y_V$9/\`T7'7II;']*]"E\".6?Q,Q]._Y&K6_P#<MO\`T%JVJQ=.
M_P"1IUO_`*YVW_H+5M5:V)84444Q!4<\*7,#PN7".-I*.4;'L001^%244`?/
MOBJ_U6Q^+`T&TUW5X=/DN;:/RUOI"55PF[!)/]XUV/C&P\2>"=)&M:#X@U"[
MM[=@;FUU!Q/E2<;@Q&<=./QKB?&G_)>H?^OVR_E'7LGC_!^'^O;NGV*3\\<5
MS15^8V;^$J>#/%-MX^\,/+(C6]PI\JYBAE92C=058$$`]1^(KR"[\2^+/"GB
M)]574+ZZTA-1N+6.*XN6D1Q&Y!1LG@XZ&MGX!_:?[5UG;_QZ^1'N_P!_)Q^F
M:['P[H-EXE\)^(M+OHPT4NM7NUL<HWF'##W%/6<4^H:1;[&MJ-[8>*/`\VMZ
M?>7486SEEADM[EXF1PI.&"D`D$8P:L^"+/9X6TR^DNKRXN;NSBEF>XN7DRS*
M&.`Q(')["O$M/U74_AKJ.L^&=7W/975O(GRC(W,A"2K['H1_A7NW@X8\$Z"#
MU&GP?^BUJH2YGYDR5D5/'WB+_A&/!]]?HP%RR^5;\\^8W`/X<G\*C^'?B,^)
M_!MG>2OONHQY%P3U,B]_Q&#^-9FN?V3XG\1W^G:E>VL=C86K0!995&;B4<L`
M3_"N/Q8UP'P=UAM"\8W_`(<N9E:.Y9E0JP*F5">0?<9_*AS:FNP*-X^9[Y7D
M?QEFO-`L]/O=*U/4;2:YN767R[R3:1MSPN[`Y],5ZY7D/Q]_Y`FB_P#7V_\`
MZ`:JK\#%3^)$VB:'J]_\.K;Q!:>*M:BU5[5I_P![=&6$D9XV$=\5?^%/Q`NO
M%EG=6FJ[/MMHBR><HVB2,]R.@(-9OA:7QCJ'PTL=+TG2;.""2T,<>H3W8.5)
M()\L#(/)ZUTW@#X?6_@W2;B&>5+N[NP!<-M^3:!@(`>W)SGK4QO=6*E:SN=C
M'/#*<1RHYQG"L#5'6_/N=$NH=/OXK2[EC9(+AB"%>O#O`FDIJ'Q3\1::CO;6
MC+=)*+=C&WEB8?*I'W><=.U=5KW@2T\)?"OQ'!]JDOMY\^(SJ,0_,`-HYP<'
MD]Z:FY*]A.*3M<[KPE;ZEIGA>VAUW5([V\3/F7`;(Z\`L>N/4UN+-$X8I(C!
M>I#`XKR[X4V\%S\)+J&>&.6)IKC*.H8''(X-<E\'?#EOXETO7+.]N+E+3=`7
MBMY3'YAP^-Q')`YXZ&A3V26X..[/H!65E#*P*GD$'BA65U#*P8'N#FO"/A+#
M/XA@UCP[>7]VNEP%9!%#,R,<DKMW#D+QG`ZFK_P8OI[?Q1K^@B61[*'>\2N^
M0A639Q]01GZ4*I>VFX.%K^1[.\B1+ND=47U8X%.!R,CI7CGAOQ2/%/CW79M3
MMKC4-/MT\JSM8H#,D:[B"Q7ID[1R:W/AD/$=E?ZOIVK6-]%I@E:6P>Y'W5W$
M;!SD<$''UIJ=WH)PL>CT445H0%%%%`!6+IG_`",^N_\`;O\`^@&MJL73/^1G
MUW_MW_\`0#2>Z&C:HHHIB"BBB@`HHHH`,T@.:6C-`!29YI:0#%`"T444`%%%
M%`!1110`4444`%%%%`!1110`5XO^T1_R`](_WY__`$`5[17B_P"T1_R`](_W
MY_\`T`5%3X2H?$?-%>L?`7_D>;;_`'9N_P#TSKR>O6/@*`?'-L#T*S#_`,AT
M3Z>H1ZGTJS*9&QRN,-60\A/C'1XR,XAN6W>O"5IR[%#!@=O9UZ?_`%JQ(YE/
MCC28!(7,=O<'GT.RJ>PD=C1113$%5[RSBOK<PS-,J$@YBF:-OS4@U8HH`^9]
M6\1>*/#VOB\36M2DL$U"=(8Y+EW5EBEVE&R>>,5]'6NHVUWI46I)(!;20B8.
M3P%(SDUXYK/A_P#MOX9:W<1+FYT[6[VX3`R2OFG>/RY_"HO`_B-];\#0^#4E
M?[;-<BVRI.5M3\[M]`H9?Q%<\).,K=S:2YE<YWQ1XH\2'Q9%*-8U&UMM0\JX
MBMX[AD$<3MA1@'@E0#^->J^/?#EY;>$KF\T#4]5M[VT'FG;?RMYB#[P(+'G'
M/X5YE\6(DA^)]I%&H5$@M551V`8@"OHME5T*L`588(/<4X1NY)A)V2:/+/@Q
MK1UK3KS[=?WMUJEO)\QGNG<&)L;<*3C@@C.,UT'CVRGO3IMGINH7UGJE[<K$
MCV]RZ!8E^:1BH..%[XZD5Y=ICM\-_C'):.=MA<2>6><#R9#E#_P$_P`C7KNB
M9UGQ/J6N,0UK;9L+'T(4YE<?5L#/HM$'>/*]Q25GS&G<36OA?PW/<2S3/!9P
ML[//*TCMCU8\DDUR/PG\9W'BG2KV'4)-]];3ESD_\LW)*_ER/P%:GB>\L[W7
M]-T&ZN;>*V7_`$V\$TBJ'13A$Y/.7Y_X#7DF@WD'@+XP/;PW4;Z7/+Y.^-PR
M^5)RG(_NG'Y4Y2:DNPHQNGW/HJN!^*R2Z?X/O=8L;V^M;V-HE5X+J1%P7"GY
M0=O0GM7?5PGQA_Y)KJ/_`%TA_P#1BU=3X63#XD<O\.=(U#Q?X4GU"\\4Z_%>
M)<O#&T=ZVP`*I!*GKR33_AUXXUV;QM=^%M8N3J"(\R1W)0!E:,G))'\)QW[X
M]:S/AII7BG4/`EX=!\00V$9NI%$+VH8E]J\B3.5[=N,5+\*=?TG3O$<NB7FD
M"VUN5GBDOO-,AED4G<IS]W)!Z<$UC%_#T-6MSVQY$B4M(ZHH[L<"G`@@$'(/
M0BO)O"NL_P#";?%+6Q?!;C3K&!H[2W<9C'SA2Q4\$G!Y-+X=\1RZ/\7-;\--
M*?[*<M+!$Q)$+B,.=OH"-W'2M?:(SY&>K22QQ`&1U0$X!8XYIU>3_#;4O^$Y
MU_Q'JNK(EU'&\<=K#*-R11DL1M4\9X!SUIWPZ\1WB^+O$?A9YC+!:S3/8K*Q
M8QA9"I7)_AY6A5$[>8.%KGJAD0,5+KN`R1GD#UJGK&L6.A:5/J5_.L5M"N2Q
M/4]@/4FO!?#_`(CMFN==\.>,/-M[O4IW5M1R0\#G@*3P0F0,=N>>M=K\:[*`
M>`K2<J'FAN8HTD![$'.!TYP*7M+Q;0^2S29W/A77/^$A\.6.I,$26YC\PQJ?
MNC)Q^F*VJX3X6:!I-GX0TK5[>PABU"ZM`L]PH^:09SS^(%=W5Q;:5R)6OH%%
M%%4(P_%;*NF6S,,J+^US_P!_5JM//.T1V':X.>GRJ/>K'BS/]E6^T9/VZVQ_
MW]6JT1!C9G4EE^_GC(]Z74?0R;ZS\T#=R'.0".I]1Z&F7,K1R"V2##;!Y8(`
M!7OD^M7SYT\LC#<8UQ\JC./QJC>PO+J*A]D<2KA<C+$^M,18M8EC0IAS$O!5
MEY'X]Q4Y;,+0LD308Z,O'_UZ9;2I&H<MNQQC/45/)O39)`J$_P`4>/NCUH`Y
MF\LVL)XY8YMPSOB)&0/8GTKHK4BYA\\HJ.R#S/+;*CWK.UE#+;N%">>8^&DX
M3\JKZ#<&U4V0?S(Y5#A2>0?:@#9NBUNZ2(5Y8%BPX'TK?LY4D@CD..<;>>:Y
M](`=T[2;@AY7U/I@UJZ89_+C\T9)/\0P10!QFJ:9Y^JSSQ*Q`G;<HZ,?>L&^
MMY8F2-XB`S8*L/F7Z>HKH-5F>VU"\"LZ`RDD$]\]0*@6>VOI8_,02D89=K9)
M/3I0!S%UIH:Y=C$FPCAQS@=ZH7-FMN%D2)OF."R@X)]SZ5Z)-8PW)^?R47@<
M+R/<4^;PI;SHN)688Z$X`]Q0!YQ%8QS(L2[RQ.T\X^H'M6U!ID$`WJ264`%F
M&0N.U=,GA\JXB9<B+A<$9QZY[U>3PW;%0SA648&PDX/U'K0!R45A->,6"@*0
M55DXX^E=-I'AB.,+<MO60+M*NM;5CI$4!"HK!0<*3U_"M=8\*0>?4'B@""UM
M([9$2.,`J,ENY/UJRPW`MRRJ<BG*`<+G!IQ!SN7&">2.E`$$RY0'`+GH*Y?4
MK064_FYZ'<0>,CVKK3MWD#G:?UK*U>'S8D!?"#()[@T`4X;@W`21650.JD]!
MZXKGM>E,#AU#'+$[5/WC[^U:=N8X$E+.DA1>%'K6;=V=P88[AI`['+@],#'2
M@#2T>..]MA.[C('#J*LPW8EE=69MT1()*]1[5!X<A8:6A&0HY.X]:F>='NS!
M`4'!RP`R!_4T`,#37=T48[QD[!T&/7WJG;7%UI\LEO!;B1@3F0'*@>_O2P2-
M'>R*J2*/N>8W/XUIP-;QJ^TQNS]<'&3ZT`)'+(9D:XE+/@@*!63\2K>*+X;Z
MMMQN`A(SU_UJ5M20K]Y594Z_45S7CV93\/-=B$F2OD<,<Y'FITJ9_"RH_$CY
M]HHHKS3K/H7X%\^![S_L(R?^BXZ],VD]>W2O,_@5_P`B1>?]A&3_`-%QUZ:.
M37H4O@1RS^)F-IW_`"-6M_\`7.V_]!:MJL73O^1JUO\`ZYVW_H+5M5:V)844
M44Q!4<\Z6T#S2;]B#<VQ"YQ[``D_A4E%`'SYXKL]3O?BP->M-$U:?3X[FVDW
MI8R`L$";L`@?W37;^+=4U[QIH;:+X?T#4;=+I@MQ<ZA%]G5$!R0`>3GZ5Z91
M62I[Z[E\^VFQQW@_PS:_#SPP8IW>XN)7#W$L$#N68\`!5!.!5;X>WQCBU*TN
M;'4+6:XU.YN8A<6<B!D=BP.XC`X]37=45:C:UA<U]SBOB3X'C\8:$6MU5=4M
M06MW(^]ZH3Z']#5NUU&?PY\/-,D;3KRXO(K")%M(869S((Q\I`'R\CDFNJHH
MY5>Z#FTL<%X2\->']5T6.;5-!2?57_>WDFH6!60R.23RZ\@=!@G``KSSQ[X<
MGT[QM::EX0T:\*P;7:.VL)%CCE1NWR@$'VXKZ`HJ94TU8:FT[F;H6K?VUI<5
MV;2YM)2`)8+F%HV1L<CYAR/<5YI\9H[K7K/3[+2M.U"[FMKEVE\JSD*J-N/O
M;<'GTS7KM%5*/-&PD[.YQWPVG,/@W2]*N+:[M[VVM\2QSVTD>/F_O$8/4=#7
M7RR+#$\C[MJ*6.U2QP/0#D_04ZBFE96$W=W/$OA[9W]A\5-6U"[TO48+.],Z
MP326<@4EI0RY..,@=Z]`^):R3^`]3L[>WN+BYN8_+BC@A:0LV0?X0<<`\FNM
MHJ8PM%H;E=W/+_AH)](^&]]9ZA8W]O<QO*QB>TDW,'X7:-OS<^G3O63\&(+S
MPW!K2ZOINHVIE6*2/?9R'<%#;L87KR.*]FHI*%K>0^??S/$OA!:7V@:UK,FJ
MZ9J-K'/$#$TEG)AMK,Q'"]<'\:7X76.H:9\0]8NK[2]0MK>]658)9;2158F7
M<,G'''K7ME%)4[6UV!SO?S/$TT3Q'\-_'MYJFF://JFCWC,#':KDA6.0N!R"
MI[],5ZMHEWJFHQ&\U"Q;3D9<1VDC!G'JS$<`^@%:U%5&'+L)RN%%%%62%%%%
M`!6+IG_(SZ[_`-N__H!K:K%TS_D9]=_[=_\`T`TGNAHVJ***8@HHHH`****`
M/)_B_;:WH]I#KNC:QJ5M"9/+NHH[IP@)^ZP&>.>#CU%=/\,[^+5?!MI?+<W-
MQ<NOEW37%PTI\U>#]XG;GK@8ZBNAUW28==T.]TR<`QW,3)D]CC@_@<&O%/A)
MK[>%_$>J^'=5D$49WL2QP$ECSN_-0?RK%^[4OT9HO>AZ'H&M:5/J?CNQLK'5
M]4MH4B>ZU)(;QPI4D"-0,_*20W3'`-8'Q@DO/#FEZ?>:3JFIVLL]R8Y-M[(0
M1L)Z%L#IVKMO!UO-)8W.MWB[;O5I?M&".4BZ1)^"X/U)KB/CV<^'=(_Z_#_Z
M+:B:]QL(_$D=1\-(I+KP=IFK7=Y?75Y<PL9'GNG<'YB/NDX'0=JZR\LX[ZW,
M$KS(I(.89FC;C_:4@UR_POS_`,*UT/\`ZXM_Z&U=:TB*RJS*&;[H)Y/TK2/P
MHF7Q,^?=&OM9U3XJS>'9O$>M)IXN[B(".]8.%0.5&3G^Z*Z#QAK?B'X9:WIS
MP:S<ZII=T&)M[\AW&TC<-^,]",&N0T:>\MOC==S:?9"]NEO[O9;F81;_`+^?
MF/`P,G\*[_7O`_B3X@:W97.OK:Z7IELI`MH9?-EY(W#<!C)P!GM7-&[B[;W-
M79-7V/2]/O8M2TZUOH,F&XB65,^C#(_G5FHX(([:WB@A4+%$@1%'8`8`J2NL
MP"BBB@`HHHH`****`"O%_P!HC_D!Z1_OS_\`H`KVBO%_VB/^0'I'^_/_`.@"
MHJ?"5#XCYHKU;X$,$\<6Q/\`=F[_`/3.O*:]7^`PSXXM^`?EFX/_`%SHGT]0
MCU/I&9`'*J7!ZY7[N?I6*(67Q_I<V#M:VG7D8Y`2MY@2KD,1NXP!P/<5E.@3
MQAHRALCR;GOGLE4]A(ZBBBBF(*KWM[#86YGF$I0$#$432-GZ*":L44`<)X!N
M%^PZCIUY8WT$EUJ-U,J7%G(BO&[EA\Q&!D>IK,^'7@1O">NZ_J%Y$?+CD,-F
MVPDF'[Q8`?@./0UZ=14<BTOT*YMSY\^(]AJ>N_$"/4]-T?5+BS2.!3*+*49*
ML2>"H/>O>;&_AU&`S0+,%!VD30/$<_1@#WJU11&%FWW"4KI(\P^+O@FZ\1KI
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M)8[%MK950`6/3D5!X&^'6MW7C0^)]>M18QI<O=);ELNTA)(Z=`">_6O;**A4
MEI=[#Y][=3S71O#<W@SXCZOJIMYI-(U*$LDL$9D,+[@Q5E7+>N"`:?X;\(W=
MQ\2-9\6WT#06TI:.TAE7#N"H4N1_",`X!YYKT>BJY$+G9YKX+T"?P!KVO07-
MO/)IM[(DEI<01-(,`M\C!02"-WICCK2^!O">H:7K'B'Q/?0&&YOY)6M;9QET
M0L6RV.YXX]J])HH4$K>0.;9X]XV\/2^,O#>G7@T"ZM?%<@17C\K:I7C<7;E0
MHZC)R.E=#X]\)ZAJ?PRM](L2UU>60A;!.6EV#!Y/?G->@44>S6OF/G>AQ/PR
M?5T\+6=CJ&DRZ?%90B%3.</,V3E@O55'OUKMJ**I*RL2W=W"BBBF(P?%KB/2
M;=R"0M];$@=_WJU4$\;W)9)%?<V0K^GL?6K7C!@NC0D@$"]MN">O[U:S;=+=
M$8!`,KDQXR/PI=1]!\TC02;HW:,;@6C4\@UG7T\9O'$Y9HU=0K+VS5Y;E8HY
M7+[I,C`*]/09K(C/F7LK2S!3V)/&[TIB-.?R4?R\_+_$Q'(J(7"(QVL78C`8
M<;O0U4N;K.Q6#)A2S.3C:.F#]:S+O6H19-%;*[3G@NOW@!ZB@"?5KG9<[&F2
M1>C!N-F>N0.U0:<\:/M@09QABYX3GMZUE6MA=SW223;Y,+]TCN?[V.M=;X=T
M.)-\LL<K2!/E=S\K?04`;&F6DOD.\X4I(V%(X8GU-;$4(A=8^2,Y&>U";40*
M2<D#C'ZBI5SOY)9L@,1Q0!Q>I1JVH77(SYAW;ATYK$-O]BGRCQK$F<A1G!/<
M5LSR,^HW2/&.96!P>V>":J3PQS>9(A)&,84<#WH`GM/FC:X51Y9&TKG.3WS6
M]82^:0KH4^48&:YBWE,9(4X0<CY>A]/>MO3&9%W,0`W()H`W$@C&!M!W$G=U
MIR*4`##@?D:9%,N%WL`P]!P*DW*^3WS\HQ^M`$@"\Y<YQT/0491/FSGGOUJJ
MMY"7\IFVN3GGJ<50U#6([(L9G`5`#\OS<GIQ0!LM,D8*L-HSUI&F4A0&!'4\
MUQ&H^*K!WCD-T8]O\!]?<=JRY/&169.L2N0H'`_GUH`],,P=20P((Y'2LS4+
MFW6$J9$+,<$$<9]*XBZ\4,'1DNR<,5^4]1[TZ75_MJ;G)$08?.<?B/K0!HPP
M^9.VR9$7!(0#H*BOI0W[HC>5;C!QP>]-M6=?-=1E4;"NY^\IZ<BK3C;=`E0X
MR`I4C;C%`&S:V<?V>-O,(!7C'>J<FG_89'FC`R^./4^M:]N\7V955E,B\'`Z
M5!(OGSNK@KL^\3T.:`*T=U;S(SLH7(QU`)]ZS$:U`*Q.K2G(7<>_U]:N0Z1&
MEYYK[MC`@KNSD54NM/2"Y:94`B!^ZG4_AWH`KPZE>VS-%<^88HSQ)D<CTXKG
M_&]Y(?"NK(5WB:.(F7'&!*I`]C73QVXC9%E9G$OWLG`3T!KF?&MIY'A'69!@
MQMY04%LX/FKT/<5,_A94?B1XK1117FG6?0GP+_Y$B\_[",G_`*+CKT^O,?@5
M_P`B1>?]A&3_`-%QUZ=7H4O@1RS^)G.M/<Z9XCU*<Z7>W,-S'#LDMU1AE0P(
M.6!SR*L?V_+_`-`'5_\`OU'_`/%UM45=B;F+_;\O_0!U?_OU'_\`%T?V_+_T
M`=7_`._4?_Q=;5%%GW"Z,7^WY?\`H`ZO_P!^H_\`XNC^WY?^@#J__?J/_P"+
MK:HHL^X71B_V_+_T`=7_`._4?_Q=']OR_P#0!U?_`+]1_P#Q=;5%%GW"Z,7^
MWY?^@#J__?J/_P"+H_M^7_H`ZO\`]^H__BZVJ3<*+/N%T8W]OR_]`'5_^_4?
M_P`71_;\O_0!U?\`[]1__%ULGIQ2T6?<+HQ?[?E_Z`.K_P#?J/\`^+H_X2"7
M_H`ZO_WZC_\`BZV0<DBE%%GW"Z,7^WY?^@#J_P#WZC_^+H_X2"7_`*`.K_\`
M?J/_`.+K9/2C&0.:+/N%T8W]OR_]`'5_^_4?_P`71_PD$O\`T`=7_P"_4?\`
M\76SU^E`HL^X71C?V_+_`-`'5_\`OU'_`/%T?V_+_P!`'5_^_4?_`,76U1CF
MBS[A=&+_`&_+_P!`'5_^_4?_`,71_P`)!+_T`=7_`._4?_Q=;5)G-%GW"Z,;
M^WY?^@#J_P#WZC_^+H_M^7_H`ZO_`-^H_P#XNMH<446?<+HQ?^$@E_Z`.K_]
M^H__`(NC^WY?^@#J_P#WZC_^+K:HHL^X71B_V_+_`-`'5_\`OU'_`/%T?V_+
M_P!`'5_^_4?_`,76U119]PNC%_M^7_H`ZO\`]^H__BZ/[?E_Z`.K_P#?J/\`
M^+K:-%%GW"Z,7^WY?^@#J_\`WZC_`/BZ;HGVB;5M6OI;*XM8YS$(UG"ACM7!
M.`3Q6V"3G-+18+A1113$%%4]3U6PT:Q>]U&[BMK=!\TDC8'_`-<UY/J?Q*\0
M>,KY]'\`:?*$SB3495QM'J,\*/KS[548MB<DCOO%GCS0O!]N6U&Z#7)&8[6+
MYI'_``[#W-<%I6I?$+X@ZQ::C:G^P="@E$B;@?WP!Z$=7S^"UL^%/A#I^EW`
MU3Q!,=8U9CO9ILM&K?0_>/N?RKTD`*````.`!57C';4FS>XM>1^+OAR^K?%/
M3;V*W8Z;>?O;UE'RJ4Z@G_:&!^=>N45C**DK,TC)K81555"J`%`P`.U>2_&9
M9]<TZQL=+L+^[N+:[9I1%9R$*-I'WMN#R>V:];HHE'F5@B[.YYAX)\5C0/!V
MFZ5?>'_$(N;:,J_EZ9(RYW$\'\:NZ;XIN]7\927EWHVIV&CV-H1"UQ92;Y)7
M8`G`!/3^M>A&BDHO17'S+L?/GAVSU"R^+[ZY<:1JD>FM>7,@F-C+]UPX4XVY
M[BO?[>=+JW2>+=L<97>A0X]P0"/QJ2BB$.4)2Y@HHHJR0HHHH`****`"BBB@
M`KQ?]HC_`)`>D?[\_P#Z`*]HKQ?]HC_D!Z1_OS_^@"HJ?"5#XCYHKU;X$+N\
M;VX_V9O_`$77E->K_`;_`)'BWP<';-C_`+]T3Z>H1ZGTB^%4A-R\9&.5K*OI
M9K35])O19W%R(4F65+<!F7<%P<$CC@UM-&""264GC`.*9(B%`S$8/0$<_G5-
M7)1FW/C:UM)$CN-*U6-I`2H:%>?_`!ZJ;?$O1UD:,V6I[T&6`MP<#_OJM2[T
M^VU"!$N$WJ.F!@_7VK@]2T.XLG9XT#*I8>8@^?!]?446?<=SI3\4=$$@C-GJ
MNX]/]&X_/.*L6OQ#TV]!-MI^J2!3@X@7@_BU>8/&S6_D.K"4#_5L<J^>GT-5
M[:&XT^8S`&-Q_K?WN3R.X[T6?<+GK<GCNSB.'TK5A_V[K_\`%5'+\0]-A!,F
MG:JN/6W7_P"*KSZWU":,3)^\:3:`,')QUSCO56[NU>VB,7FK<KDF1NGXBBS[
MA<]%3XG:-(&*V.JX4X)-M@?J:<WQ+TA(S(;'5-HZ_P"C@X_#=7ED@DD9)9HI
M(_..TKO.W=_>'J/:E^S0I%-`\YW!@Q#MP[>QZT6?<+GJ(^)FCED7[%J8+KN4
M&`#(_P"^J#\2](4*38ZJ`WW<VPY^GS5Y7;0S6B22S-*6<_*&.X@9X&/2KTUO
M<3NDLZ'8!E&Y&WVQ19]PN>AR?%#1(IVA>TU-9%ZK]G''_CU2#XE:24#_`&#5
M=IZ?Z,/_`(JO/52*)3.TCF1@`47H3^/>IK"P>ZU"-0'D!4C._"Y[_C[46?<+
MGHUMXYM+QRMOI6K2,!N($"\#_OJK7_"4<9_L/5^/^F*?_%UFV&GPV$`DC`65
M_OR#J?;%6DNHKC"1[\X_[ZHL^X7%/C.!<YTC5ACKF%?_`(JFCQM;&0QC2=6W
M@9(\A?\`XJJ5SYIN)`(G\CA@[KV':F.8I4!/`7D%3U'H*+/N%S17QM;/G;I.
MK'`W?ZA>G_?5'_":6XC,G]DZMM!QGR%Z_P#?58T@5W58V<LWRG8,$"K/V,N)
M"9PP`PJNN%)']:+/N%R2;XE:3;[?-L=47<<+FW')_P"^J:_Q.T6.<0M9ZF)#
MT'D`Y_\`'JX/6[+9=2W)W*N`5^8XXK,DO(()`\\<C!5\PB/&Y2>C$>GO19]P
MN>N)XVMG3>NDZL5QG/D+T_[ZI3XTMUB\TZ1JVS&<^0O_`,57F^B:BTMJQM9'
MF20Y*LP_3TK?TR\G,;I<PLL8.TJ6^[19]PN;_P#PL;2MY0V6I!P,[3"H/_H5
M2?\`"?Z>%W'3M4`SC)A7_P"*K@=1L+%=0%ZC."N=JD9`]>*L6^JV;VFRY0>8
M#D.D?(SQ@Y_G19]PN=V?&]J%W?V5JNW&<B%2,?\`?5.3QI;R8VZ3JIST_<K_
M`/%5Q$<KB/;'*(EC&T,>1D^QJ[;:U"BM%,0I08+@C^=%GW"YLZYK?]M645E!
MI>H1/]JA<O-$H152168GYO052NW\M661QM7YU`."I]O:JYUR9D0I)&5&1N)&
M0/<5R^N^(UCN`UM;F5&7#2!NXZD"A(#8D_TV58Y=1,!P6#`]!Z'WHNKRVCLP
MD0)R`'.<[>P85QFGW3ZL3;B90J$N)L8V@]LUJ6MBUR\D=@7EN8UP7)(1S_6F
M(MZA=2O&MJDSQA?]:PYRN.]6+&VMK?RK>V0R7<X'S$'&/K3=-\*7EY=Q02>=
M`L8W!';KD\DGO7?:;H,6G$J7#A<@,1R/;/I0!G:1HLJ,)9P%3LN[(!]SZUU4
M42+&F`N1Z]_PI8X(U1""<\=.A^M3,`(SD!2?4=*`!UW*%V@C^Z3P13HD51E<
MC)'!-(,J&!&5'3WH0@.-H(5AU'>@#C);98]1O50%2TK9.[/7GH:A2"?S55`,
MM]Y`>0.U1WUQ/_:MY'$21YC'<3T]OI3[5I&V>>PQMY4$Y!^M`$8A/FK,7VX;
M#<@@GZ5>#A%4A#L`R`/?UK)O(UF#*)?)*9!'UZ$U;MR[6RP#Y\H`01U(]*`-
MVTN1.@^]@X(!'/Y5<FN5@B9FPNP<DG`S63!(UE;AL!BY_C/)'I7)>)/%%XLO
MV6)H[<.VQ1)R1ZG-`%K5O$Z,'\O?%(K$[QT('J:YK4=?FOI9(DC7G`63LX]1
M[UC&266$K/Y;N[?(C\&0@\CBM&TTY;B96;SQM7YH0,KM]J`.?>21W\@R/)*K
M')@.[&>H:KXTF[,*%RK*K<1<D8[8]#79V>@+%"UQ%'",G=O"XS]?4UI0Z-!,
MD<9CVY.2RG'XT`<+;:;J#0EH@!$"492#N]QS6[I-C>FZCBCAVQQ(0ZR-QGZ5
MT]W;^0T:;0%X^?/:KEI;=9!&,`#+CDL/K0`ZSTV7R6$Q3+CH.5_^M4'V2+3Y
M'D+9&,!>HW58U&ZN+2%F1`9"P4$M\O\`G%9O]K7%O>K%+$GD[0V$.XY]J`-:
M)()A'(A8L#N(5N!_A4.J7[Z?;EE*%B<8SG'XTV.X$TKR!L,0"04Z5J"VAFC.
M8PP49RPR<T`0:1=%X?,E^97P4XYY]?2I[H)*P*YR@X`XJK;D>641_P#694';
MWK)N8K[3I&*2,T!;EP,\'M]:`)I+2*6.21U?8S9*`G/Y5@>,[&"'X=:NRLQP
M(BB?W/WJ=:WY4O((46,%ED/#Y_/CZ5SGC1A'X!U8=2YB!*YY_>H><U,_A94?
MB1X=1117FG6?0OP*_P"1(O/^PC)_Z+CKTZO,?@5_R)%Y_P!A&3_T7'7IU>A2
M^!'+4^)A1116A``YHHI.:`%S10:C,F`>02.OM0!)UHJ!KJ*/EY`H'J:<D\4H
M!CE4@^AH`D+<D#K2#CKU-+W]Z1CG@'F@!U(!BFX/&?QI?FSGTH`7/-+2#D9[
MTH-`!1110`4444`%%%%`!128YI:`"BBB@`HHHH`****`"BD![4M`!16'XM\2
MVOA+PY=:M=8/EKB*//,DA^ZH_P`],UR6G?$'3?#'@+3K[Q!>^;JEW$URUO'\
MTDA=BPX_A&"!D]JI1;5Q.21Z02%!)(`'))KS;Q9\7M/TNY.E^'X3K&K,=BK#
MEHU;ZC[Q]A^=<W_Q77Q9?^+0O#;'W#2K^A?]%KTCPGX#T+P=;A=.M@UR1B2Z
ME^:1OQ[#V%591W)NWL<#IGPU\0>,[Z/6/'VH2B/.8]/B;&T>AQPH]AS[UZQI
MFE6&C6*6>G6D5M;H.$C7`^I]3[U<HJ92;*44@HHHJ1A1110`4444`%%%(1GK
M0`M%%%`!1110`4444`%%%%`!1110`5XO^T1_R`](_P!^?_T`5[17B_[1'_(#
MTC_?G_\`0!45/A*A\1\T5ZQ\!?\`D>;;C/RS?^BZ\GKUGX!_\CU;?[LW_HNB
M?3U"/4^G&5_4$'KG^M1EH_,VXR5/?M[TXAV;Y?E8'`]#[TJKA%?(..@[&K)(
M"NU"S'&>@]?8^U4;FR2:,QLFU7&`JMR![&M650,$`,Q_A]JBV*IQUP<A".`*
M`.&NO"TAE'EY9!U=6`D]L5A7>CR02JES!(=K$&3&-P]_6O4#&'D5F48;)SZU
M0OM,L[MA+)`9&'(QGY3ZYH`\R9#;7RCD,<!5"\!?8U&UO-(SQR*AC#;DDC;.
M/]X&N^N/#4,K8,C*-HVJ6^[ZUC)X>D>>:6.:-H@^TKMV\4`<J+.ZF**6>5%?
M/#_+'[YH;28@ZG*/+EMP=N<'T]J[5/#<AZQA(B,*4[^])-X5*3@>:LA5`/F7
M/%`')B/++]F$HP=A![`U8BCN[J61Q+#)`WRH(R258>E='!H+1M\\F^,CD]`3
MZ4RZTQ-/8()T5CR"1A?8'TH`I:9X?DD?[3/(409VJ><^IK<AN[33V(CBC$$*
M_,8ADI[UQ>I^)YHHGA29EV\2$8"OS_#[USU_J<4MR8UFN$1A_P`L`20?1J`/
M3=0\3VJ6\<BRH<_<++C/UK&O/%XM2IBN;?S"`64*<K]*\\FT;4[BY69YV-H.
M0CCKCOGM]*L6%E=3V\\RPR3GGYLY``H`[.Z\9W5S+'#'<B$#C8Z'$IQV/:K'
M_"0%(BD878`/E4_,K'J<^WI61')#*MKYRR*_11OZ^A)[&JDSQ3-)':P)/(K;
M<C*X]<^M`'H6G2PSHLKR(0<`D-R?PJ]-(K`6^5.>NT]*\PM]0GL(BJJ)85;*
MK(V#%Z\]ZUM,\0LMP)!(CJ#B:)FPZKZ^]`&GXET16C2(KYCN"!C/\^U<M<Z=
M;QRI:I;'SUCV[M^>*](M;F&^B::,Y9CMWYZ\=Q6'=Z-#&[7'D'!;&U@2/KQT
MH`Y;1+$J8I(GC!!W;D;:>.WN*O1P7%RY$P99WX>028"G/3\JT%6&PQ'&H:=S
MOX3Y%]C39Y87=-P559]S?2@"A?1FS`%S$TB@E1(^57/;%5TLIQIJSH'\UCYL
MK#D<=!@]\5LW4#75U`LTGVB.-21"/3U'K5:%K-OM".[A"V8HR2,8Z_3\:`,B
M)9[B9`S32QLP(AY&?Q_I3D@N?*V>2RP[VRB*.0#[UNVT^GP,%:X(P>H!X)Z`
M4NHW(N'V%,%0.VT%?8^]`''+'<S7\0(*29;R2F1E?1ATK/N8S]M:2:%6N%0+
M$.=JL3SD?UKT*`6%Q;O<P(_R].>0X'0>HKDY8I;BZCFB01SR;D,3<#_@7IF@
M#0T_3GOY62.14CVA7,:@J']![UZ7I>B06VGJNW+*/E8G&#WS7-^%5BTW,)\H
M1E?O*OW6^G>NW7Y@<'Y2`3\V>?:@`MH+6"/RXXPQ`SD]JM("8P';))R2PX(]
M*A?!.U-WF8R"!TJ=@2$V':I'//0_2@!VU4E9U!!R`?2I756.\DC;P,4U%P20
M/F],\TIW*F&X7&"W>@!PVJJJ.`>@Q2;L$'^+/W30#M`9W&SMGO31)OE.`<Y'
MTQ0!PUQ`C:A=8SDS/N*IQU_G4(N54B-49VSM*D?*H['-:-Y'_I]P=AV*[$M_
MB:S&3S&C"1G8Q(#+UQWH`+T"2Y/E/&TTB@*I!/(]/2M.SLGMT4S2,3W(7DBJ
MMM&I=)]@.#LW==OH:W8,I(6VDX!4#'7W%`%#498K6!FVEOE].GN*\BN93JFJ
M2[_NY.07`*@'@8KT;Q+>R)IMP`09`"#P<`?2O-[%4C2>42LTC@O&VS:K#&,9
MH`UO#^FQ:I=Q7K*Y$6519![]1[5Z%:Z;'"F(\G/I7(>%()DTU'EF8QECSGD`
MUW5G*LVP+MVK\O#8!_QH`;'8I:1/Y:84G).<C-6(U`@08R6.3Z?A4TB!8PJ$
MG>2#G^E5;&TEM[]_WH,##@8YH`DN]/AO$)ZA5SD]<U7T\30G[.ZJ%/W"H//K
MD=JL;9(+@H)%8,3C/5:T8U:,X8]1@F@"GJ&GPW,1,O/E@%0.!FJ]K%#(H,D(
M78V/N_ES6I<B-8P&ZXX!Z&H%N8PJKT/H.E`%'4$&<^:D2,.&8>]2VXG7:L1V
MC.,XZ^]+<VRWD:Y5@H/3H<^M/>)TB,9$ARH&>A4T`5;J+[+#YJ2EBC'>O7FJ
M+-+/ID@CE#R.=R@DXSGI1/I\TCR2M<.8`I#1?WS[FJ40FLO+\RW81#[BJ20/
M<F@"_<3WEO"CLT1.T`J!T]ZYSQI&TW@'6IW#AT6$-G@']ZF,"MV$-=ZJD[;A
M#%QM/?W-4/']PLO@'7Q'M>,B'YP,$'SDXJ9_"RH_$CY\HHHKS3K/H7X%?\B1
M>?\`81D_]%QUZ=7F/P*_Y$B\_P"PC)_Z+CKTXG%>A2^!'+4^)B4#/>@G%*.E
M:$!2'/:E(S56_NS96S3!-^WM0!7UC4H;"PDEDE",!\O/->9ZAXPNGC)M92IS
M\W/6H/$VLMJ-Z;F=R(4.%B%9UAH\NKEFC4Q(YS@]J`(KO7M3>94DN&8L,]>,
M58@\37-N4=96&P].QK470K&P*1HWVB;/S=\59U#PS$ZM.D.U2F0/>@#;\.>-
M!</Y%XW+<AJ[>-TD02)R&'6O`55]*OE,H.TGBO5?!^MM?*]M(<;%!44`=9GC
MG@49Y`]:#G'K0`<<F@!:,"DP*,XP`*`%HI"<#FESQF@`HHII.T<\T`.HI`>O
M:@9'4T`+2$'-+10`44$X&3TK!UO6!%;RPPL`VW[X/2@#6GOK:V($LJJ3VS65
M<^)(+>Y6(XY[UY_>:O*P5LM*XX+5#-,;AEG$FY`/F![&@#T\ZS"C!6=22,\5
M;@O8;EBJ,,CJ,UY`;Z4,H61F]3[5:L[Z<W1,4[(01R3UH`]=`Q2D@`DG`'4U
MBZ-KD=^/(<XE08/O6UP1SR#0!\S?%+Q9<>,?$AM-/CFETRP8QQ>6A(D?^)^/
MR'M]:;\/X+;3M5%SKO@[6-3?(\J9;=Y$B],H1@_G^%?3*QHOW44?04ZM?::6
M2,^36]RKIU[#?V4<\$<L:,.$EB,;+[%3TJU1161H%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!7B_P"T1_R`](_WY_\`T`5[17B_
M[1'_`"`](_WY_P#T`5%3X2H?$?-%>L?`0X\<VY/39-_Z+KR>O6?@'_R/5M_N
MS?\`HNB?3U01ZGT\QVH,#@=,'K28(7F09;@-CI0=QR<\^PI556)7)W]\U9)'
M(4SM.`?NYQ2(&`8$J6QT8<#Z&I6A"MN!!/0D^E)(2<EN(QSGK0!#C"H`!YF.
M-HX`IK("6QG)/\/!/O4^00"H.T#`XQD5&%*R%MI"CH"WZT`0RQ?O5#(&)Y)/
M`Q44T$97,J*4'`7&":M.A1PQR2#\N.F/0TPAF?<665<_E[4`562,-M2/!'&,
M]O:E8(&\OIW!.<-3\IEAL*D'D=>*8[+!#(TAR@ZGV_PH`QM7N7M;9[B<H+=5
M^;YL@_3WK@M<UBXN(3MD<Q'B((OS,/\`:/:NA\57T4D8MTY+8+$'A`>G'>N/
MDN)+2.2%T::YESC/("@=>*`,6ZU"W;3GCDAD$H;AB0V]?IZCUI;&[$D4,MHQ
M26,\QD`!U[@GN:=;Z/#J3^;<;5C7AU9=OXCU-3#[''9W%O'"##"_)"X)]Z`+
M<5PU]$L@E>([B`J_=/L:&U"ZMQ*L`'D@8&T=*SI8PL.V!I%&TX(/`S_>HLGG
MB:'?-YX1P8R&PH/I[B@#6M(HYX#.A/FA<E$.&Z\GZU7F:X:[\R%2RA2>5PQQ
MVQZUI1F>RE$D=O"DT@R2&YV^F*+V,W!6..=49F^\Q`YQT!H`QX9#/#<3?:U!
M=>&V]?7\:HB1`83:R22-;D!V//![^XJS()+5/)=5D)!*PQMP&SUW>M30J88$
M:#S`J$G:1D@D<@GTH`Z?1=<EB"07`,#&0C.!@X[UVD]W!&@7SU/FXWYY!_`5
MY)$CP+#>$>87<%59LKQTXK=T[5FOKZ*79/'"PPIVX`;NN>PH`ZS68Q;:9((P
M=G&UB,_C7(2:I=&[$4MJK6ZK\I8[3QWS_C77Q12RVX61FRP^9&Y`']:YC5=/
MNXY`)=D<3$@(O\?H<T`4+BXC>..9)W\L<J3SM^F.P_6JSZA<6LZK=3#RF()E
MV<MGIR*EMT-YS<1+!;P95>H'Y>E4KVW$MW$D5R6+J"48_)^'O0!K11*EI*51
ML(=RJ3P2>P-=)9")[*&&[M0\TH`59/XJPM+L;F*"YAED9T4@H0W/XU;DU6=%
M"R1.\X4!9-F%^GUH`O?V>L$BVCY23.[:O"@5F@6]G++!^Z9[B3@E2=N.ZG^E
M+<7T[VR(\KB<C!9EPWT-49KN&T=(VW3%FSO7^$F@#2M-4,%^X#,[PD`!AMPO
MH/6NEL/$J&`I*B_(Q/7G/I7EM]J_D7\L3-M5!T&21G^][TVWU&Z&'A8%0W/F
MYY`ZE>^:`/:[2]\^=6+'8RY((Y'OGTK5+H[;CRN/EP./K7D>FZM<6[;_`+0[
MICYG#?=![`5V^@^)(IX$6YF!<YVD=@/:@#K(BN0S]2O4?YXIHF!D:-LX/W<B
MJ\=VDVYHW4Q=G7O[U(DFQ2`P9R,],4`3R'K@J'_VO2JZSMYT8C.8RV#D<&JT
M]P-X94`7J>>3ZYK+OKCRKJU977+2*OR^A/I0!!>*1=W!9QY1E8-CI]#2P:>K
ML9D<`8SA^@'J/K5^X>%;^2%M@#N<XY.?>K,`BVY50P]S_*@"*WLU6-4,:!2-
MQXZFK#J(P26`'<XX%2;E+`XPIY'-1';+&%9F8<@X.:`.(\::JT5OY:1JV#G"
MG&X5YK'(LD,TD1*@2999"2!SZ5ZSK^CVKZ?,R$NRC*%FY^@KR?R[D2S_`&C8
MO[L_NV^8;P>^/;F@#NM,:V2Q@=E7Y@&&W/+>H%:L=V\,[02`1[L;'`P"/IVK
MC/"]\EY=QL;I66W`78BD#<3U&:]!D5KLH(6V*&^9L`G%`&C<.)%089@%&=AQ
MS_A2+$ZW"NCE5Q\P(P/PJ:W"A"PSD`*3BF3B.1V0N!QQDT`3(\!7YI`';@\C
M-,AN%\YE5R>._>LQ=%)=)!(QV?=VMPQ/K6E91+%`XF*O-UY&/RH`OSS),`&Q
MC;G<.<50:-E7*QA]QRF#QBGJ^R60Q1*=V"5!Y/TI]I*V&DN9`N&P`1C\Z`%C
MCD"AY)!*S<`+QMJ1D*;CYAR1W-)/*CW414",?WL_>]A5/4[@+M&\8ZEL\T`4
MKRX,X>-1Y:C(,O)#4V69_P"QYED!&Y=H=1R/3%-M@UY<,]M=!XPP9E<9!QU'
MM5B=D:_0/&(T48((ZT`9?AN!(+$M*TAG=R"LASFH/B#:J/AWK,I."GDX7/K,
ME;4\4@N`8HU5AC#$=ZR/'\:P_#36MV3+)Y)+8/\`SV3\JF?PLJ/Q(^>****\
MTZSZ%^!7_(D7G_81D_\`1<=>ELY4]/EKS3X%\^![S_L(R?\`HN.O3`#FO0I?
M`CEG\3`$,0:=2;1Z4`8%:$"UA^)-3@L--E68\L,*/6ML'/TKBO'3J3`&Q\O:
M@#S:4->:B$D.U"V[%=UX>8"[,3*#&1TZ&N-L"LNKOD#&>":[*VMX(E:[>8K.
MO*!3P:`+<VEQVFLM>P(0@7)!]:ORDWEH)DQL(^8CM6)?>*Y)(/*\K!;AF`[5
M6CU"2R@CE5F,&<LA[T`8>OP>;/A5Y4Y7=WJ[H=W-I968'Y#Z]<UHW2VFIW"7
M(8*0,JIK'N()([A3<9$*-N`6@#U?2]0CO[564C=CD5=)QU->:Z-JRVEZ&23Y
M#_#ZUU&JZJ)+/]V^P#G=F@#4FU.*&Y,3$#'4DU2O?$4,*_NL-[UP5[J[2M)-
M))\J\$YZUBO=WDZ;XR0F>%/4^]`'J,?B-3`6E`4YX-1IXC@C9I&F#KC`7WKS
M(WEVR`NYVJ<-Z5!&UT6<1MNC)R#0!ZO8^)8[B)WD*I@X"DU?L-;M+T[%E&_.
M`#WKQY;34%B,A<D'L.HJ"VOKBUE4QR.)$;(S0![RX#+M[^E.`''M7#:#XT^W
MLEI<XCE.`'/>NW0]?IU]:`'T4@Z<]:6@#&U_4/LEFZ9(9A@$5YO??:&PHG.6
M&<$]J[OQ5<XB\D1AB!D$UY_Y!\]9[AB3G(`/3VH`I)-(Z-$@)V]0!S35A<&,
M1L65C\P':KMLB+=2O&W&<G'\J8DKEV\E?+P>30`Y@%NQ$5.S'*XJI/M21I$E
MV@=1WK76(0J4D?,Q&2Y]*R9[=$\XRH<2#]V:`.D\'7"/=Q3/+\IXY->G`@@$
M=#7C7ANV#O#"K':7R,5['"NR%%SG``H`?1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7B_[1'_`"`](_WY_P#T`5[1
M7B_[1'_(#TC_`'Y__0!45/A*A\1\T5ZQ\!!GQS;C_9F_]%UY/7K/P$_Y'JW_
M`-V;_P!%T3Z>H1ZGU`HQC:>_7UH`W<CIGD8[TPE1C@Y)YP>E2\'!+`9'0&K)
M&@Y8-P1T)--)VAL%EY[CK]*EV<8SWS31DL01]-W-`"?-L/(S[_RJ-U955B2%
M`[=:E"X0#&TTU@01EMS'MCB@"$HJ@$L>G<<FFOMB`P#\S<<=#Z&I'4KA0FY2
M>.>GXTR0C<%.0<8&*`(MK2L8WP%.#[FLS4&5;-E?C<2`Q.,+Z5HN-SC:-K@_
M-CDBL'6Y62*185W7"D$CMCV]:`."UJ[&Z9$=RJ@[<_QFLW3D0O%(S8$8/SDD
M;B>U0ZM<>9K33R0B22,E4BC;'R^I_P`*LV8F>-9P\3HF&"#K_ND=Z`->[T47
MUD$W"+=M^92`<=ZR+S3H])9\LTH?"KCOZY/K74(X"JFTPL?F"=1GTJMK&F3M
M9R2+,JL"#@?R-`')VQ5I`"'58B-P8#('I4YMX7+H(8R-^[:!T/;!JO;K*;JX
M!RTX.7A!^9?QK1L[;%^9'N,JRYB&!@CN,=C0`RZA\F`RW"%%4?*`^3CVK-BN
MEF61)D,K*-WF-S^`KHM0TL782:.0I'G)+#N/:F'3HHYDF"I++@!/,/`]^.U`
M%0&/RQ,\:,\:;E8\G;^'>J#7SRW[KYP,;*"#C`/M]:LZS%*(#%&BAC]\H?O>
MN*R5A>W4QSR@QD?+&H!8D>]`%^_9)HD9`J^4`R!FXSZTOAR6]N9A#(\4>9@8
M]C$K]>>YK*G=Y[A8;>(2*<;P[':O_P!>K'AYXK?5(X5$DA1B[A5/>@#U>)7V
M[`FUXSNW,<__`*ZQ]7%O=2;R)!<`_,K'"JOJ1716A0VL32!2K*,'/7-<)XMU
M2XMK]XEC!5E"&0/@A.]`%&Y,<2-O8^<P*J';*E<]C6=*!Y?EI&"Z*1&0PP/K
MBLV?5X3J/V=4=DA7[K<EQZYZ8J2P,MZ?M-N3D.5$&0`_U-`%^.^DD9(UD>5X
M`IX?:P'_`+-6Y9Q2WB$S2,9`N4W-P?\`Z]9-KH<$B-<[/)8MV/SJ?K6WHUK-
M]KN(YH<6Q7<./FC/KGOF@":Y@VA#Y'[U1AT<YW#U!I!X9B9/M4/S%L\>GTK?
M:(M#@)')$@P%E[MZ9'2I;"`PVF'C?[2O+1KR`IZ$&@#F[?0X%@Q-!%,@.6+_
M`'L^]9[Z0/M$DJ3Q%0/D&,XQUKM4DMFN)8`&#N,9/0'UKF9=(5M4F::>5MB\
M(G&[T]J`.<FC@M4D,#JR@_,&!.\>GM4VF7RP%G@D*[B,1[>=WMZ5MW&DC48?
M)C5;8$';*O/S>A%<G:B]TZYGM;N+R_))5ICRDA[8-`'J'AW6))H_+8+&HX:-
MB,@^M;Z2J^\(QCQ]T=_UZUY!H=^+.VD=9GFF.`R/R0I/\/KBO1M)O5FT_:X,
MFQMQ*-GY?7ZT`:D4V"7#@(00=QR?I5$+OO[:-8W*B16(W=.>IJU&A?>5B=!]
MY3C)'N!443)#>QY=I2)$PS+M(R>]`%/4I[DZO/'$J`M(<$+D_B:DEMY;2U#&
MYP,[F3=@@^Q]*S;J_D@U*Z>0`E;EQ'AL[3GH1[U5N]?8PN\RY=F"GRU#Y'<8
M_K0!L1:QYA4SLAVC'WL8^GK5X3L_(8@GYE`/\/X5YZ]^YE9!#YT>TG+`!ACL
MOI6UI=Z8V3>A;Y,<G!`]#0!K7\H6PFBE:1UEX#+U'O7"ZQH)MHWGM78(O+@G
M._\`VLUV1U!6C(9E0.V,$]1VYIK(E[MA8)&H;DJ<C/I]#0!YK;RSQSM>1(49
MP%=-^6./05Z#HFNP7$<)64*Q^5QNR0?I7'ZIH]Y87#RQ0;E&X$`$%?0Y':LZ
MWN+</#.ZRQ7+'"R*-N6]/3/UH`]>-WYMR0)R$89`[5)%#]HN&9HPN#D.6^\:
M\VMM=U&SN=TYWP(!EP<DGOQ5ZZ\52+$)C!-#$IP5.>">A..U`'HL<OV<A2WR
MXSC/7VQ2K=Q2_O';+'.>.@^E>8Q^++B3+Q1S2,05+*>%^E;^CZG)=Q2-)$XD
M<;"''>@#N[187MQE,Y&,G^?M45U#$ZJAD,9)RI49R/0US4%[/;/Y#$[CR%8G
M!`[`UL1WD3P1-)@'&<$\B@!3*'#"50$088MTS_GTJI=R"2%1\KN#A=G/XU-?
M7K*RI%"=K9P=P('H:6.QR0K2?OF`(Y`R?ZT`,T(&TMFCC2&,$G+;B<U=DGAM
MY@TVV0%L#)`(SZ>M9L@=;CR3.#L[`8QZ]*65$94B8I)"3O8GJGL/6@#5EFC<
M$(P5%(R%&*Y[X@N)/AKK9V$$"$;B<Y_?)5S^W-/ME9X94F9A@J.0M<]XUO/,
M\`ZQ&Z[6<0E5#9^7S4.:F?PLJ/Q(\*HHHKS3K/H7X%?\B1>?]A&3_P!%QUZ<
M:\Q^!7_(D7G_`&$9/_1<=>G5Z%+X$<L_B8=*0\C`/-!.!2`=^]:$#)I/)A=]
MN=HS@5YAXPUA;K+B,[QP`>U>GRN53H,GUKQ;Q3*RZ]<#(8@]!T%`$>@V<=]-
M']K8HK'D#BNEU/[/:RB'=NME&1@Y-8MEI-U<V:36[DEOO%>U=%I]C9PHL%V^
MZ;&`&/+4``AA.CMY$8D$OS`D<K2:=%;N/*8AW1<D'I5BTBDAGEMU`+.=J#LM
M0MI4UI=^3."IDX)7J:`*,.G6PU&62:4F)1N`7H/:MS2+.#5[5S*5"H2`IZXJ
MK=:0;>W:U24(S#.\^E+H$-M!,[M/([(,?+T)H`S=1TY$GD6"+`CYR.U5+R\6
M6SC.YAMX85V!MU>&5I,,LYQN3DCZUAZK:PQH+98POUZF@#EXX8Y;I$0[MW)!
MZ9K1MK5D,N(09L=2>`*M0:0;1?M80M'G[O?%;>G6]GJKL`&1#U!XH`YR/25U
M0I!$,;?F(SU-:-OHMK:3YNI`GRXP.@KH+GP_'9J+BQ<ADX/TK'O;1YKF,1Y,
M9YD:@";3K1#>)$")(G.!6)XFTZWEO)+6WB\HK_RT]ZU]/E:WN9(K<?+'RI/K
M5/599$_?2`.)#\S>E`''6)$.IK%<,5\L_>'?%>TZ%J*:EIRL#DH,5XE<N\NI
MLZ@-&.`:]1\#+Y-JRLX.[D4`=>O/S8P3VIYIH.><<TI`;K0!RWBZ*X:(,B_N
MN[#J*X&>%,%3,57U[FO7=1MFN[*2)3@D5Y7K%A-:7PB\MO,'(..*`,1`K;P"
M^U>H'4BM"*7)C$!_=$?,I&35-;IK>Z90BDCEJBAN661I8G(D8\@T`:LT@EM-
MZ/\`(#@,>OTK/F:2.0*P+#'!-+<2R7`V11*(A_#GOZU;T_39YT4'=-)Z8Z4`
M;?@[2S<'?&<%6SS7IRC:@'H*P_#>DG3K,-(N)'ZCTK8GN8K:%Y9F"(@Y)H`D
M+*"`2`3THR/45Y_JWCN-G(M(B2OW6KF[GQ?JCDO]H`WC'!YH`]B\R-LC>OOS
M3EQC@Y%>$-K^HH3F]*@\GFM#3_&VHV4;1M<%\_=S0![117G%EX_FW(TZ?(>H
MKKM/\16E^J%6QNZGTH`V:*.M%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%>+_M$?\@/2/]^?_P!`%>T5XO\`M$?\@/2/]^?_`-`%14^$J'Q'
MS17K/P#&?'5O_NS?^BZ\FKUGX!_\CU;_`.[-_P"BZ)]/4(]3Z?V9;IC'IQ3]
MNU1TP.@%'5>.%QZTTI\F2#GT!JR1^["YP>.U!R<X/!H)Q@#MUS2%1DDD_GQ0
M`;MR\'/Z4T[4(XQ@8Z4X+@Y[FDW@MM)!8#IWH`B>,-PPY/<?UIC!SM#`')P<
M'D>XJ;:`V[G(]>]1A5#97(9N3D\T`08=W(VKE>C@\G_&L?55DDMX988HW97S
MG//Y5K3HK,&7<&QR5'-9EX3%:S?+M8<J>Q^M`'B/B:*26^EN9K9C.DQ`VOC'
MKQ6EX9ECNMDFQG*G:2%XQ[^]2^+[%)IENMDRH[!G"+N'U&:I>&]1&U[><R0[
MVQ&6`R%[9H`[2:RBG5H0[,@.\$L>#_050,LTM^MM#']HM^K.><'TJY;SJ<!)
M]^!AR1DU:"F.53&`&P-QC-`$5WIMO/@[5C`QR@^8X]#_`$JL]DD*+!]G^TNH
MWC;\OR]16]`$,H+21Y<9VCL!WK*D:V&ILD4C99MS*3V],>E`&5=:K%:2QF6%
MF8'+J@XC4^M3%X]2A6>UDV6R#YQTSGMBENX(KJYEDB"2(S?,2.%`[GZ53OKN
M:RO3"T:O&R@M(A``'O0!#)I<K72(%*^:",3-E?J/>LN_LYH)$6"V26WSLD)Q
MA6]:W!J5A'YJRRK]F7_5!GRQ8]<5BZK?PI&K6*(%8\@DD?4T`1&P@N8WMYKA
MX01E@IPWMBC3$>VNXU24-*I*C/&?\:P9KE[J>$BX24!C&^TD,?0AN];WA[1X
MI[M6N7G\N-@V[?M.<\`^M`'I$DLZ:0'@>,S(.F,`#TQ7F^NW2ZDZB8+&XZD_
MR(KTJ[0VEAYTJ!5;C!Y'X^]>6ZE:@W=P)H]T<@PB^H^M`',WOF01N&+1,,@>
M6V0R]N:Z7PY8&SLXFD971R"RH<$$]/\`]5<W)#/=W*6VQX@?F&6X;'L>]=GH
M<02TC9]A=,;2>`#W&*`.F@MEA>/Y_-..I7K[&M[3X`Y=4141^I)Y7TYK(@U*
M$MN>1<JN6XXQ_2M2TU**1S);!GB.,<8X]_:@#3M[86I)5%,;<,WJ?6G),%F8
M%B%/0]C^(ID>IK<W,<+QF-@""5Z$=C4=S"ERK(KLKJ?E*^U`$E_"#9_:('!*
MG&2O.#V-9]U;PM;YE&\J@`VMTJY.DK6SEY&(&-V?_K5BSRQBW^RHN]RP9&3G
M"^]``+*1X3Y2A9%PR.IZ?6L76+=98VB0."?G*GLP[Y]ZWD\JWA'[S,H.U06^
M]]?:LS4YI5B\Y8EVK_K$89&?K0!P_DHTDD+[\J<IA,%2?0^U==X8N_L=Y%%Y
MQ+0YC!VY#AJY.^F"ZB;J2&8*XPZ..`?7`[5M^'KWRY"N#Y9&79EVE/\`=(ZB
M@#U!$7:&R=P'`/05%]E<7T4KL>67=@\=?\\4Q-0A:)69'WA/E(&21ZXI]I_I
M%PDLB`QM(K+MSC.>Y]:`.!UJ*W-_J;73N8%N6&U6VE#NX)[XK,M+>!;E#-<L
MZ-T4@G:N<G![T[Q#9L^NZDZEY8A<.VPXZ[N<>N/2I%9]D3RNOV8@+^[/?T]A
M0!->*DD<7V648;@AEQQVP35JVDNA)ADCDA.!&ZG#-]:ABF?[/)!'`Q1)#RY!
M`)[^XK4LT7[(4D09)R=G(/N,]!0`XV[W=IF((=F=QQT]Q4YCG@`V2[@`-Y]N
MAJ6*2!)5\IE!`Y&<;1]*JRRQ.W)#`MT^Z3ZT`:2,EW$L$K*57^+."#].XKGM
M3\*R7,I,$;$9RS*!C/KCO6E;K+<2E$RF&XSU'N#726Q(B4.XW(=N[;U/K0!Y
M7-H6JQSL8;;>^T`%QY8)'8]>M17Z:C;>7YT)D=<N\);(';!([5ZC>6K2L`D@
M8L>H'&?2G6.G1/\`//&'<`H"5Y^GO0!Y!;6FL.LJV-L0LQQF4E2/P_K6W8VN
MJV-NDD=UAX21)`^0['Z'@UZA#I:0+A"FWT'512W.E6TXY&#TSMH`XFTUZ4^7
M%J,4.",;]I.#ZUOK-$(2^5:)A\A_AJM/I449;;N)0D`N!S_C7/VVI307,B($
M5"^P1!<@^P],T`=G;);RQ)+*J;3T!Y`IGFR37I9QMA@/4$<_G4*3'$6V-4#<
M;D'\7T[53U.**Q+2LCR%CG`?[WK0!3N=0E%TPLEF,9<[@1T'=LUN6EF-1='=
MBI@/S8.,UB6Q>9_M-MD!3@Q$]!ZD>E=!I#M%"XE+,[GJ/NY]J`)+C1[2*W=8
M$CA/\+`8YKB?&&GF+P7K%RDTDNY8O,\S^']ZO2O1Y600?O"NTY5E;G\JXWQT
M\3_#O6?)DPJK#\F.O[Y.:F?PLJ/Q(\!HHHKS3K/H7X%?\B1>?]A&3_T7'7IU
M>4_!2X\CP-=X&6.I2<?]LXZ]$M]7CF?8P"G.#7H4O@1RS^)FBP)Z4A8*0#WI
MA<,"`X(]<]*K2WT4<9?S%*K[UH01ZQJ,6GV4DSD953Q7EMK8C6)KB^/RQS$A
M2U6_$NLW6IW/DI\L9;#+ZBM"2-3I=M9IA(^,L..:`+&EF+2]*GM%8!U'!KF;
M2\:/5FEDS)+G*ENU;.HVBVMN88Y&DD//T_&L*)3%<AG.^;/W0.@H`UM2U*XM
M42=0<R'=D=<UMZ7J,E[+!<7?$8&-S=<UDVFV\NPHBW*!T/2MNSMK.U#"X;<V
M<H`>!0!:U6P-[,+5@X5^1(*M:'X<CTJU<!_,D;/)JK]ON([=Y(E\T#CUP*CT
MK7+^6%_-3C=@<=!0`MI%<:3J-P/]<'.=GI56_)N]1B$T0C0'YG-7M5OFMY(W
M4YW+]X#-8Y$=UITA;>SLV2<]*`.ADM;>RB:\D??$!A5[5FM/$46XB*PC'2JU
MY!>IIBYDW1*.%[U@-?(+8[BS$'`7WH`Z@:C%+H\S"=@^<#GJ?2L>UD:09EN"
MLF>4'0UG+?XC$4T!R?F!':K<=Q/%9S!47!&?,QD_2@"2YU*%+HJG[O"X<CN*
MS;V^%W92PVN9`/SJG#)+-?;#&5+#!W"KR::(-07RV$<<8W$Y^\:`,_2=+$=U
M&)6SGE@:]%\,^3$'10N">,URD'D17C29W2'H3T%:]D/.*9?RP#EB#B@#N0RE
M@`>:<3@X`K-LKQ#MA4%CZD=*M37UO!C?*!DX'-`$C2[,Y[#)/I7)Z_>0%#*`
MFX'&X]Q5/Q;XF$,GV."926ZE37`2:C<W5P(-S$9QUH`U;F&V$Y)D3YOF^7K6
M9=F"2X+KA`HQ@5)'HMP9F8L1D=<\5<31G.UCR#QNQ0!2M$\T*Z2;-IYW=Z[W
MP[J-A:0GS$&Y?XO6N3M=`EO'E:20Q[>!Q@&I8-'G@DQ+,?+4\*3@F@#HK_QY
M)!<N(0NP'`S7+Z_XFN]2D*/*5A(^Z#1<:)/>W92`8A7DGN:+'2+47;"568*<
M!3WH`SM.TV^U!AY*'RQU]3701^&[6"S\VY7,F[&WTJ]<ZA!8H(K1"LF,84=*
M?I$_VB)S>`E,Y#MQ@T`1W'@^T=HFMT60NHRI[5GW/A>WAD`N%$4IX0&ND$%U
M``^E$W#N?F?/`'I2WNFW,\4<NH,/,S@'/2@#@+[2;BPG*ELJ>F:OZ/>"V(BE
M)#YR`*W?$6GBRM(&EE$Q;ICM7)1RHM\)C]Z/A!0![3I-RUUI\<C=<5=KD_">
MHM(OE/(&SSCTKK*`"BBD8D#@9-`"T$@=>*IW^I6^F6IGNI`H[#/6N#UWQN+J
MW:&W#`?WE-`'=W.I6MDP\Z0*&Z'-10:U:W$_E1RKGZUX[<Z]=WZ>7(6VKTS3
M!J4T3#`;=V(-`'N:S1NVU74GT!J3G->.67B6>.X"),S.O7FN_P##FJS:D2TD
MG"CH>]`'24444`%%%%`!1110`4444`%>+_M$?\@/2/\`?G_]`%>T5XO^T1_R
M`](_WY__`$`5%3X2H?$?-%>L_`/_`)'JW_W9O_0*\FKUGX!_\CU;_P"[-_Z!
M1/IZH(]3ZA`.,J?;GM2@'H<].N:7!7)))`Z4N-P&15DC2/F.3P>QI#MZ$]>M
M##(//`%)@<9."WZT`.R3@J1MI#R2I5L>H%./3ID>E*!^5`$14C`"G:?O,3R*
M8JI_K%C^;MGM4K+SGJ3^E1@X3)7D]<<T`59"60N01@?-C@-_]>JEQ$2P<CY=
MO/TK0\QAPIY/&3T`J!F4-L*@@C!7K0!Q>LZ*9C.X)>$KYBQR'@'_`&:\OU"Q
MFCU.25(YRR`$*H&W;[D_RKWJ[L\P",Y!)P#W4]L5P&M^'[Y9I;L@"9<^9(AP
M''8D>M`&5I-_"\T(,Z&4J,^6-H^A/<UT<30E4DYC5\]1R37GBK=PRN]R%@VY
M<%$P#Z,?>M.WU*=@HGNTG&<@*N"/\*`-N>T:UEDD69@9.A;HJY]:SS=R<^0Z
MHROEN,M)]">E6Y=2EN0L,K/A1@G`./\`ZU5&>WMI_/1LL&`(49XH`O07ODJS
M7`D@Q\Q^7D$_SK/UK48L($&SSN%<#(8>A'K4:ZTLDGF+)&P=_N255O!!>02R
MEF60J<PXZ>A'M0!@A;J`-;QO$W=F."<>V>AIKP"Z#)-(R`IE1G#$_AVI8(8F
M1?F"/`"`[C)D]0/\:C\HW^HP*S,=@)+(V`W^R#V^E`$EC!(L<UY#%Y:`!=HC
MR<^HSUS7I?AS3HA;0I<Q8F=5E$>,_C[5G^'/#KR"WN+MFB!)'V=DR3Z?A7=6
M-LECF5069R0`PQ^5`#;V'-I*9`&*#"I[]J\G\1@Q3R*8E9V!+I@X0^N/2O9)
M;99+5`"5.<@$_>KSOQCIDA\S=&6!'S,IPV/>@#S*ZCDM[Z)B5FMR1\R-D*?;
MO70:?(T22Q866(`E5)&Y?8^M9+6)AE$=FT;JHQ(F.A]__K5IZ?.CL;>)4B?(
M?G[Q/HU`&KHNHF53;QVA:7>!(S#`8>GM]*ZF*%;:5I86$9;D*H+''?CN*PQ!
M#%;1F/S(IF?<Q5OOG^M:EI=0>7$6E;?DKS]X>PH`N_:SYR8N1;JQ_P!;U9Q[
M>@K?B4M:Y24>9C((&:Y9KQ/M$2?96,#9`RF"A]?I6I!?16]LTHE1G!'"?U':
M@#3E#W5N%?Y)"#@J/YUESQ6]H26A:.0KM)0\-5Z!Q=0I<H6*$X7)VX;TK&U"
M=YIVAN)8_,9254<X`]30`]KV"*,74T2JB#!9N-OXU0NKF"^($+NT$AP%5<#(
M]ZX74];\V)[**4-$&.$CR6XZD@U476KR"[6".8.F.77A5XR"!0!T%W`8]ZHL
MI@"L,-S@>],TR6?[*44/*%7"Q`X&/;UJA%XCCGMF;SD9F?\`>X!#`]OE[U:M
M6#7#X;-T5W,\1X!_VA_#Q0!Z3X;A6XTV,$2$2?,/,/W.V!72PPF.>`(RA2P&
MW.`<>WK6%X9@62&.02LQ50=I!V^^*ZA(U:>$)@J&W!2.OKS0!YGXDC)O;I3%
MF-+AF(0@-@G]:Q%LY3?$ND0@)&Q`W4XXW`U9U^]G@U^\!D/E">12P&YE!-4T
MN-SJ9`=P&T$-G=QP?_UT`;^F6,TD;K-$L<`Z*W3K6O-!')%#N)>13QL.`!Z5
MS5MJKEH[>>(N1G]YD$$^E6'U&:*X*Q^9G;TV\?[I]:`-&8>5-&\:A0`26VY(
M^N*;+:W%Q/'<0`,%QG"\,._%42TJ`R>6`2.'#<X]*U-)FFGWN68*N,D#'/I0
M!M65LD,;-(JB0<X`XS[5.FYFQ(K*<_+Z'WINXF(KW)Y(["F,)7)CA8$`<*PQ
MGW^M`%_Y@J[5R5Y(Q][Z58AW`*`@3(P=W.35"(7)E7Y@JXVX[&II9I(LKNS(
MG(`.`#0!I+P=I!`7G!Z'\:4KM)=2.>WM3+>03Q;FSGN`,U+)O"[=NTG\J`,?
M6$3R'+1]!@D<[1ZUP=ZZ2W3XDP\2_*^W&X^E>C:B-MO("5P1T)KR[4XIFUYU
M8$0EMXW/@#'TH`Z>VFVV4&(\[4+.@'\7UIKZK#+;*EX$B<,1L!R2?K26=PPL
MS%+\@9,L5ZD4B:*TD0\M56'J@*_,??/]*`,J9[BTLKN^9HB@;&^,Y95]AWKH
M=/O[:'38FCDW*Z;D#C^E<_%9M'=2RQYN,-CR'&,-]*U$^TRQB,6)MIF`W`\[
M#Z@>E`&X;JTE@C+9_O1_6N;^(MOM\%:E*K%%`B&P#K^]7K6I9WEJ`@4,1D[B
M5YR*P_'\\UQX-U0JK>2/*.0.WF+UJ9_"RH_$CPVBBBO-.L]>^&MX;;P3.@EV
MEM0?`_[9QUW<,R(!(Q(&WGZUR7PDTVUN_!5S-.,R#4751_VSCKH[N#R)A:+N
M+/W/:O1I?`CEG\3%BU<Q78*RN8L_-FJ6M:FIF"V6Z0DY*BB=9HKE+2*%7V\N
M0*H7-LT,Y>)L2#D^GTJR!T5N%8/<2+YTGW1Z5KBU612+B<(L8R"#P:Q88[;4
M1DR'SNF/2F2J1*+-9'D"'!YZT`=+]G>_ME.Y1$O`(ZFJUAI(D:;<AR&V\CDB
MI[?3KRSMTCF/EQM@C/:M"[FAS;P1.R`<O+[T`4=1A%G-'9V8*R.N,@=*S+SS
M].N8[2ZW,&&7;N!701NT'VBY:(SHO*25AZ9J"WUY.91YTS$\-V'I0!J:-K=M
M<E].A0!1]UCU:DUO51I-N0L#"67Y2,=J32=+EAU@7)M/+C['%;^L+8W4:K<,
MA8=3CH*`,+0KV._2)YE"VPSG=ZU?NK*-Y8FTXA(B?G]#4=S'9W-E]FT[;LCY
M<#K5"'65L;9X9%*ITYH`CU;S8-06*WFW[QR>PK!NI([2\2)DSOY+$=Z[>TLX
MM3LQ=J%5U4X!KG-5TZ2[M"J*"ZMUQS0`X_9KF>*($#*Y+]A5C['"5$*SX8M^
M%9NG6LD<;*0,^C=<UI&PECFB:9"D;=#GG-`%.Y7R;Q$&)%7[[*.<5:G@L[T1
MNN]4BY8GC-:7V*(QK.L)R#@\_>K,CO8S(\9@)RQ'ET`5I+821RJHWMG(QT`J
MY97MHLJK)$28UYV]ZDM8IHYQ!'#M27_6.>@%2PZ99V][YS2C9G``/6@"*;Q.
MZ1F6VA([``=:S;VVU+4X$GE9H(1\Y'>NH)L;:X1I(46W/"-CC-)K,UO#&6SY
M@*X"+0!RUMX<M&M'N9B9)9.C,>@JMI&B0OJ+&0%(HSDL>]/FO+BZ6.WB!3G`
M7TKH[F(QZ;`B[?,3'F\=:`(+`6VH:B\,$8,`^4^AJ=+&.PE9)W5@#\D=9SZC
M`EV(;0",,N&*\8-:FG6$%Z9/]+\V4=`3\PH`D^QWB>4TD:R;CG8O\(JCJMOG
M4%E"!D)`..U:]X][#`JX*(.-W>J,$T=XXBC<"-?OR'N:`(8HA!J+QQ+PP'S#
MM5'7M/N+>^@-JFYFY)'>K6JSRZ>_R<(>0W7=21ZQ+=)%<A=I3KD=1ZT`2Z1H
M<LE\9[V(H"OI3=6T*XM[<QHQDCE?/'85))K-Q<7<2V\X,;]?:H=:U^2#;"<F
M-#\S"@!UA;WF@V_EF?;$W/'.*M:?*;N,O,PGB5B3DUF:GKD>K6,,=N,*1M9L
M5!IERNE(^9!AN,$T`+XBM]TJ&!V(/13T%<VEK#&ZX?=*S?-GM6MK%YYXD>)B
MJ'OZ55TVT6::-U&0W1CSS0!V?AFR'VD2K%M55^8^IKKJR-`L)+&V?S'+%SD9
MK7H`3/K6;K>M6VB6#W$[@''RKW)JSJ-]%IME+=3'Y(QG'K7COB'7&\07(E!^
M7=\D9H`9KVOSZ\5=F;9N^5*2UT.[G".<1CC@UH:#X8F>0W=QRBC<%KHWB#$P
M+&S,X^;:?NB@#*A\*A[I#-*HBQ][M2WNBV=C;M"6#2$_(X[U)K.MR"*#2[.!
MLYQG')J]:VA2.*?52L42#@-0!Q%_9+I<JS;=I;O6OHFK2QSH8FX+`X'85)K\
M<<ZM,W,+_P"K^E86A.JZFL0)"!NOK0![G;2^=;1R?WE!J6JEO<1)8+(3LC1,
MDGL*XGQ'XX9A);:9T(P9:`.XN=1M+,'SYT0^A-9J^*M+:3:;A1S@'->-37<]
MTX$\TTTA/3-/6WNGDW>0RHHZ-U-`'N,6IV<C!%N8RQYX-6D=7&58$>QKY_2>
M>%F)>6+!ZDUT.E^);FQD!$[2*,<$T`>PT5DZ7KMOJ5HLB'+C`91V-:PY%`!7
MB_[1'_(#TC_?G_\`0!7M%>+?M$,#HNDKGD//_P"@"HJ?"5#XCYIKUGX!_P#(
M]6W^[-_Z!7DU>L_`/_D>K?\`W9O_`$71/IZH(]3ZB4@MNYY]Z4G!SCKQFD)Z
M<].M)O"KN9N":LD4JK`EEZ=J3:&3##(/2E+;B`3@_P!WVI21N`S^%``K9.,$
M''-!.#MZ4O;DX]::1M0C^''IF@!#SC)!7IQUIKDJP95R1WSP*=E5W!2JD=3Z
M&F$!5P>6/WL#K0!&T7\2D$>XSBA]NX+\@<C-2[2"/F.,9"@4T+DGCC&5SU!^
ME`$,L)`8MT[<52N+*"8-&50$KDYK4ZR*I&?E]>/RIA'SE!C/4D<XH`\[U'PV
M+J:63R)D=OE.!\KK[>E<2?#L\$C)+,0L3<-QG9V&?ZU[E(N?E8E2,XR,?B*R
M[_3[;<_F*-TJ&,-Q@`]<B@#Q:=IQ9.\K.#&Y$1`.<>YID0OI@LT<L2J%PR$Y
MW'L?:O34\/QO''$K(P(.Z1A]_P!O:I%\(631DI:Q-SCCKM]/I0!Y4D#B[0F#
MS9%!RJJ1]3DTQ]%U*^NV\CY($0,VW.X^N:]7O/"EM(JQ1JR-C)5"2%_'TJY:
M:+]C=5=X]P48$:8'XF@#S,>'[F8Q[[5FC."&'?\`"NKT/1+.VNH[5+>W.X%F
MR,MGU]/SKIKC2H;FX8G:$(P=N0,^H]#5NQL+>U"M;@*O<MR<T`/MK>*,!@"N
MT8Y'(/U]*F\M=R2+N+?Q;N14C*60J2#@]`>M/+)L"Q`E@-N,T`02VP9I&WX8
M<H#_`(U@Z[:&XL)G=26`^8KU7_ZU=`K"(N"VYL8)(P!]*K,BLI1P>!AES]X&
M@#Q/5;2["I]F*/(!MEC:/!=?4,.]4=--K;7+M-(8T88`Q@CVSW->@^(](B@A
M81B3R2PRH';OSVKSC5K:`72,I:ZB0DEL?=`Z'`H`ZT3)+!N*M<!3E5B.",>M
M6;.:-G"VLT:S`'Y%7./Q]:XC^UIK<JEM#(89E`9MW0>WJ:O6%]:*JNQ9?-!)
M$;#.,]3CH?:@#JI]0OI[QL2!FC3:$884^O/K5'1M1EEOKB*.U1XY3C;'P0P]
MZAOM5B6&)H@7'11&1S[GWJO927,^^Z@BEB+-M<H-ISZT`=I+((H4M&Q%N^;?
MDE@:S[B)99B3*)#LY\P8R/8^M+%<!_W,I\V385;><'(]*EE^Q2A8$F:,XW'S
M2-WX4`<GJ.G,91*MD+8R28(3!..X)]#UKGGMK9-16-6/E,I1F`R`>U=S>719
MXY1(B)("B)*H!=A[UQE[>2"Y:%'CCE#`J2H'X<=:`$%K$DQDEA6%D`C5H2</
M[^QK;TJ"Y*#!59<8W,H!<?U!K(MH)[B.1I&81R-N4GE1ZY':NGT6Q6<JNQC<
M!?F+'#(O;!Z8H`[_`,+-<RV*8!$2':$'\)KJX%PXRQ;#C)QWJAI%FMK8HD:]
M%!YY.:TTDE,B@;3T+8XX]J`/%=;BBAU74-Q:0_:Y#ACZM3;-QLVM,#)D$)M`
MX]S_`$J#Q38RW'B*]C7HUP[!MQ"XST)'>GQ6TL)2/R55@N7+#<N.Q/O0`_[%
M'#YLR^<(,[AQ\N[/YBG)#+)*D,<HDB>3+8?.?H1Z5K6ML=0LE58&C"=>V:T=
M/\,E!'&&49)W%:`*,*N(]D8=C(2#GC;CVK;L-/>SM@[2,6/S2;1V]JT+73X[
M9]D2@X[DYYJVL9+X:/KP1GH/6@"`QQ"W$BM("PW#:,CZ&H[2*.5U*"19TY;,
MF03V-7DMU5/D!2/./O8R:$C"A28R"2>0>2*`)'#*`S'.#D@#I3HP]PA(1'/<
MCJ:;(@C(_=M(!S@'!-6K:!@P<!U!YVYQ0`ZVA$>XC:,_W:G?L<].GM4@1%*J
M#UX..M,8#8,XR#DDT`9NH1B6VDW88*._)KS*X,;>)PMP/D\K;&^>I)Y!KT37
M[662RD\F79T)*\$\],UY?(?,\6P^<?,AB?!!'F=?Y?C0!W4<\26XMT*;B."P
MXQWYJ\J,UBP'^L(PJGO]*8;>,1*@0J#P`O0#UJ&$2B3#I(H!^4D]*`,V\MKV
MTMC<6VV.24`$-R=WKGTJI9CQ!#JSW-[&LD)0!GCZCV`K:U-V2V,4:M*S,,]B
M,^]5KFYN[6V:V\AC-Y>?,;D?3/K0!DW]LVHZFCPRB$B,@[3M#>Q'>F>,H%M?
MAQJ-M$_""(L"V23YJ=/6M+3Q')IZBX5BI?EF7!'M6'XUN,^#=27;B-B@C'_;
M1:F?PLJ/Q(\7HHHKS3K/;_A"1%X-N)Y#F--0DPOOY<==EJ5PL%O]JG4$2CY"
M!DK7`?"Z1(_!5ZS/@B]<A3T/[M*U4U.68H\TA\@-C%>C2^!'+/XF:=M>P0W?
MF0,<[?G8\U2UPHT>ZW8>6QRQ]:M11VD;LL1Q'-]YN]4=;T]T"P1D^0.<U9!8
MLX!)Y7V*'.`-Y`J74X?L-U;3)&%\LY8#DM4&B:E':0.C2&.-1C'>I4N_,8SQ
MKYRDX#'J*`-.YUI+A$>Y/&,JIXJ%KMKLQSS`)`1AAC'%95QN+H;B,.P;Y14D
MDDK71MI!^X9<X]*`-)=;AB+VJ$_9L84]C45A;HFK(T,8$#\EA352VM--,8AW
MLQRH]!4FE74UH/*DB'D2'ECVH`[J.42J$0`Q@8)!K.O-&$X8QO\`*Q^;Z51@
M$L<<VV7RX#RH!ZU<-U<1V0>/<X(PON:`(4T%8GW6LF">'K/FT3?J8DV!X5/S
M#UJ03:@]PQED^RAQ3K36(;2WN29"\X.`&H`9<M!:L_ERL$#C"+5G4I#-&DL,
M/RJG;C-4898KU9)&V1$=7--LO.O(YD69@D?3'>@"*ULX5*WMQN$:G=L!YS5J
MYFCUF]BEMPQ*GA<X`JG+-,MH\8C!DSCCN*O6,T&GVD9,>-QRY/:@"VMJ%E>Y
MDD(*#!53D5G/IJF-[I3AW/!/'%7)+A=08P:>A$:_.SCN:C+WUVABDMQD?*C=
MA0!67R(]OE7+;VX8MP!4(M-[R6]I&SG()=CQ[UB7=MJWV^.)X=T8;&1TKK&T
MN^%F+9&VR%<EA0!1U&RF4QH[F2!1PPZ`U.EE.!&L*K,Y&6)/2F-*T>G&W:3=
M(C88#FK4J16=C'+:SE;D#)R>HH`9;P6J,SSPYE0YR*R;*_GU'59[*8?(Q.PC
ML*MR79=6D1LSN.5]:S]%TZXB^U7GFKO)..>AH`U[3P[9Y>UE8+*&W;\\XJI<
MWT&C7K-;PD2#Y0_8U!97*+JBM>W"[<\MFK%[K=C-K*(;=9;=?0=:`-N\O'32
M8S<)NDDPWX5D$>9YDUHA$42_.,8!K9MY;75'S/(`H^[#Z"J.IZ@5N/LEM'&E
MKC!;UH`P[#4CJ?FV388#)4GG%:%C$;FT:`E%*_*QQ@XJU9Z-8V=Q%?6YW;AR
M!TS6=-<&QO;G,):23E1_=H`H6JZ?IUY*7G9V#;5%37%I!J&Y[B7;$@SM'>GW
M5E!*MN5A'VB3EB*/LI:1XHP=P&&;L*`&[XK*R$-NBGC<%(YQ6!=6CW!DN`27
M8?+'GH:ZRRT@K=!W*R-MQUZBI8M)VWDR20;<C*MVH`XZRM9KVW*R/TX8>E=A
MX8T;RKD,!F)>F>U.M;.UL@\;PE9)#\K]B:Z#1+![.%V>4/YAR`.@H`UAP***
M0'&<]*`.&^(FJK'8+9H-Q9OFP:X'1[1+R]1@IVJ<<5TGC-DGU"80DL.Y]#6/
MX=D-NIVJ,J<F@#J=0U%!IR6MJVR6$Y89QGVI^DSM-`1M99F'+^E#P6,S12F)
MFD?N/6FZB\VB+"&&$D/..P]Z`+EJ;*TEWW<D;NQZ]Q5"YGBUG5_L[DB`]`QQ
MTI[V=E>6HN[<-)*#D8[FK%Y9I+IYNY(O)F08`'%`&1XEM4-BR0N%CB'!%<=H
MKA]1@<`Y#8^M=#J5W%8Z2T;RF5I>-I[&LS08?-OH8,`2;LXH`[7QIKOV/2(+
M"$[))E&0*X.TM9+Z=+9<J0.<=ZM>*G9]6=)'.8EPOM5KPG;R&<7$DW(')H`[
M#0]'TR"-"T2F5!RS^M&I:=9S7`DBE"D'IBI$@BN%DBFN1%OY5B<5H:78016S
M-,4GD0X4YH`Y:^T^UNI-I`P!Z5R>IV`TVX80'>A/KTKTOQ$BM&L5E$JS/@LP
M]*Y/Q#IO^@B8*$`&&QW-`%;POJ;V.KPHX^1R`1FO80<@'UKY^TF80W]N9B0%
M8<^M>]6<PGLX9%Y#**`+!KPW]H"Z2?3M.C0@^6T^?^^!7M%]=K:Q$GG->`?&
M687%A:R!<`M,/K\HJ*GPLJ'Q'A->L_`3_D>K?_=F_P#1=>35ZS\`^?'5M_NS
M?^BZ)]/5!'J?4+-QR`<#FD9D8@9&3C/O2X7!7@'&,4;=HSQG%62&54[1C`&>
ME.7DDC[O\Z;DDE1D`>W\J7(R`5/M0`[CN!2'GK^%-SY@Z`C/8TJD#@#GT%`"
M%0&)*@@CYB:;@^;NZ@C(QV%/"L`>2<GO2`L<YZ$=10`SIDKDJ3ZTK<J%RR^X
M."*<<D=,D?K3#PY+8.>.>U`"DX0D$#&.V:ADC$T<D>&PPQN7@_GV-5=6UK3M
M`LY+S5;R*WMEX#2'DGT`[GZ5Y7>>/O%'CV[?2_!5B]I:9VR:C*,-CUST7\,F
MJC%L3DD4OB;%;:(':U\;ZH+XGY=-:4R'T^\,%?QKSSP[8ZWXN\0VVDQW]ZS2
MM^]=YG;RT'WF.3V%>W^&/A?H_AP'4]1<ZKJB@R/<S@E$8#.54]3[FE^&_AK_
M`(1_3)]7OD5-1U5S.Y/WHT8EE3V/.3_]:M5-*.AGR-LZ.RM+?2[*UL+2%5@M
M@$4D]0/4]\_SJVQ?=N4*$(P5`Q@5#=%&7"A<=7).!CW]ZYO6/$+6ZI#;W(2+
M[IE89V_XBL#4Z1IH5`1RA!X!#YQ[5FW-\L94&<!1QCJ1Z5YY>>(6CDDBA>02
M,"5=UR,^HQ61<:]?SVS[Y!/*-OSH^`_^%`'JMOKM@#(?M&61L2G'RY-6AK=B
M8F*31G:.<D#\<&O&?[7M[>0I%F!9>"K`EB_?CT]ZM7VJ&2T"2H)W5#$'8;-P
MQU]Z`/4)O%%M$46(K\PZE@#_`/KIH\56*^8XFA((PJ[P"3_2O'+"*Y5&,LA=
M3@A5.[:?;TI)7BFDE=%0@D[@Z<(>W3O0!['#XAB7]V`^[U(R`/KWK4ANXIU2
M6#:V_@$G@5X):SZA;8\J0(NWYY%E)S]%]JVM+U^_BD`*"1.<R+)@M^'2@#V"
MY2.XC9)BNQ<KZC'U]*\TU_06$TIB*1I%P6C_`(AZ`5NZ1XE6[DAMBQ60KGYN
MA'<&MI[:RNH5\\A7+;<#[H/M0!X[=PFWCR(I!&[8<,OS1?A6=#;Q6C&?F&49
M4L%^5QW)]Z]7UKPU-<0236Y,L8;.,_/GZ]Q7#ZIHI@NW;8Y4H`&4DX]0P]*`
M*VG7FG72F.7`C0[HU52.?[P:MPWL$<A@23S<C>I4;3CT-8*![:*&&%!&GF;6
M1QPI[;3Z4VXDEW&U<9?DHPZ$'U-`&_?W,:Q1D;9`W^K<G#)[Y[@=*HO.DJ2H
MQVRP("9(S]_TP*SEA0H;7S')'1B>4;U4].>E6'L6D2%A-M5?G"2\9^F*`(Y]
M8DO3]C6)D4\-D9*^F![TX6:+>N;CR9'=`&B`QC'0^QK0LK*2-58M%YIRR.HP
M0/?/4UHP:,]S-Y+?-(>%8#EF^HH`I:=;F]MDC@GCD@)!&$_>>G->A>'/#BV_
M^D2K,`<9#L"0??':IM!\))9LLDX5'_YYH`2?53721V26SIY181@?=)YS[T`6
MXXUC`X5"!SN/-2@%&3&,D\@'%"1`J&;[Q'UX]*?"I3Y3@Y/''04`>9:C;VMI
MJU_+Y>\R3,=I/\7L/6J,UQ*UV@,<95A@#=M.?]KVJSK=G<W&JW(D0&)+@NI4
MXQSUK+N[6:1-N5*HV[)7.5_Q%`'4Z1<-)&/W7RYP5Z[?I6Y:K"B#YMJGDG&<
M^]<'I^I3".2%8WCP<!N@QZFM*YUU8I%C9G+JO&",$XH`Z<S"-N`&/=MOZ4V6
M],5PD"PEV8Y)7TKF]-\2I<RB!U9=RC[ZX-=)!.H8,<$-GIUH`LK$OF.`<@#.
M">1[XI_D>9'A\<CCL:DB1&5"K8!'7;R/:K2(&VY!<>W6@"O%"S1C<`L8/`ZF
MK,(``R>0#SGBEW#!/.6Z@G-*%W`\$_R-`#B/NLO/&<TR1OW98$,W?:,9IV<J
M-N3CUIK*"QR1CJ30!B7MXZPS/Y#>41M#?Q9KS86<D%U/*;DQ*9LH01N89[^U
M>D:P`0ZE1@<L<XW#M7#W"^;<O*_\$@5,IP%[B@#HK2XDD0*,E%(P\;9X]_:K
M\+)AF#<GZY%<_P"&G8M):\26ZYVL!C!SW]JZ,Q"%B$R5`R%QW/>@!MS/Y4>(
MXP[+@@JN?SJI-*+AERR,[+D1*V"??FIHTC52"-K'GDXP:P[Z%+3S;Q@`\S##
MNW`]AZ4`3?:GAM9EN(OD1OX.<CUKG?&]VEYX-NIH'9HV\O&X8^7>O05=COY#
M.5E56MD.#M;#?K4'C&</X#OU6.-5^3`(`?'F+S4S^%E1^)'B]%%%>:=9Z=X!
M#OX4ECCB9V-\YR#QC8E=%=S)'BT!C#,.GH:YOX?1W,V@21Q$K']L8LX[?(E:
M][I4EI=F3!D!Y#$UZ-+X$<D_B97B6[202O.1&K8Q5[[;<LVUI#*QZ#MBH6CN
M`/,"CR\<AC6OHNCW?FI/-&#`Y^\.PJR37N;&Q.CQ3,@%PPY`[UA37$=I$9K4
MD*I`9/[M=1KJVUI9(1S%CY3[UQUM.]U<26\0383S0!HQW\,4HGE/F,^-H]ZT
MVNK*5#')Q)MRS#M7.WNGB&>/?-A,C;@=*O1)''=B.)Q(CKASUYH`L+&?,CR[
M"-^%)[BNDL[>R>R99I00.`!UK%BLF%ZGGRCR43Y`>U:MNL<$7VM\;4Y/N*`+
M5K<P0Q/OA8QKPI-1VEV;J[\U')QQL'W0*HP:\9II8D16CD^Z,=*EL;28-+\Z
M0`]<'.:`)[Z.]GQ+*$`4\$]Q4\-M80V#_+$]RW4$Y-4]2MQ=O]G29]D:\L#5
M6TT6SMIHI4NI)'/WBQX%`$CZ3%$YE,G!'^K)XK-CO?[+DDD64&#^+GH?04_6
M8FAD=K>=I.P&:YW4HI(O)29&Q(,D=J`+9\68D<P0D\]35Q[IM3A(DE\J)EY6
MN4NXS&HV0E>>2/2M[0[&2],<@#>2O7/>@#J]'U6#3[!(H,.P."<=JN?VDDQ\
MQ1($!^915>#2DGC6%"%16W''4UIO;SB,QVR(RXQMQ@T`#7RV]KEH,;N06[5S
M>H:]<M(P2?:V,`#N*T]0TYOLY62[Z\N/3VK!GM;3R#/(0'3H2:`%L;F1/+=$
MWL3F3/I6OK&RYM1<VN`"O0=C7/QRCR2\*[#("!DT[2YY+=&M+B0H)#U;M0!'
M;WOE1>?,P:5&VD#KBGV%DU[/(\,TOE.VXJ#T^M7)]!CAD22(@F4X#`YYJ6]T
MZ]TFT<6PP",MCJ30`^\6P>)86MU!B^\1U-;-CH.GJ(+N$`QD<YK#\.Z!=3$W
M=W(VZ3HC>E=-<K'IT21N^Z+^&->N:`,Z?31I6J2:B91M8?*OM3)K.VO(5O'F
M$<$IQM[@T^1YKJ_2.5E$8&0I]*;)&RQ.4`D<-B)!TH`=%#-8V[Q0*9%ZQGTI
M+VU6.U@NV8-=2'#Y-6;;4)$=;*9/](<8=!_#4>N6D-K;*B@E@-V,T`9]]IMS
M<WD6R0"5$R`G3%9QCNK24PK(=DAR[GL:BT[4-2:5Y(3N0'!4]:G>X5[SR[DF
M-G'(H`O078@EB02!P#RX[UM0W@NKN5_,!"I@)Z5SJ6]O9W\9AW.IZ8&0#6K)
M:R6L#W"LK3R=0/2@"-+F)[:YY+E&^Z>WTK5T_5%BAQ,"H(^45QKZDXF??#\B
M\DCUJZ^LBXM4EEC4(>.#S0!VZZC;-MS*`6Z9JC?:Q%'%(J<@#&[WKF4U:RF!
M$AQL':JLM_%=!$A##/(!'6@"KJ22N`VT8D..E,T_1Q;.Z22!7;G%:%O(UU*8
M?**X'S,PX_"MF&RL(;?S;F8,%Z9/-`"Z:VG6<1DED!EC&54UD7%G<>(YW\TE
M(@<CMFM8V-H52YC7<CGY5ZU%J-].RI8P0>6Y/RD<8H`HVU@D$,D<TK6XMAE0
MAQFJC>+(1:26\P$@'0GJ:Z6\T]O[$9Y1F4+AV]:XN?0K4*)5D')P4]:`.=OY
M)-3O5F2/Y0>%`KO_``CX:CL[4ZA<IF=Q\F>U+%H=M:V]M'&A$K\L2.E=5;VK
M6E@Z&0,VWY3Z&@#Q[Q5`_P#;%PK*P9NA]ZL^%C-]GD@B3,NW:<U>\4;D=(YF
M5IF;.X=J@L[5M,FCG60G?U`H`Z%=/BNDA,TQ5H_O*3R:TM&NTEAGMH!^\S@`
MGH*KQQQW&GM-+"4D'W#ZU2TN)K&Y2ZC1WE+<K0!LWUM>7>8HT*,HPQ%9/B*U
M6UT,1O+NE`Y%=1)J-S);,Z0A2!\Q/%<U=P++;"1R79C\J]10!PVDVL#7ELMQ
MEDW<^U>X6HCCM8EB&$"C`KRF+2[F*^:=4Y!R$`S76V]_=VH1@"7888'^&@#:
MUIH(8_,E?!QT/>OG_P"+%R)K2%<CY3*0!Z;:],\07E[J%S';,C!6."^.*\R^
M*5F++2+2)F+2YER?;8,5%3X65#XCQ>O6?@&<>.K;_=F_]%UY-7K'P&8)XXMR
M>FR;_P!%T3Z>J"/4^H<)E<CG^'UH7YQV([$&H5?>>05/!7!_2IAM4NPP%/?/
M>K)'')Z'@\8["C:-NW:2,^M,#%A]X<=#Z_6D^8/R`..HZ8_QH`>A;(R,*!2K
MRI[#MQBD7`5?F..W/-+PQ)Y./7H*`!2#G]:21-Z8Y'T.*%`^;:O)[^M<IXL^
M(FA>#HBMW.9[XCY;*$AGS[]E'UII-Z(3:6YU,I2.,^8X$8!+,QP,#U/:O,O$
M_P`6K:*\_LGPG:MK.JN=@:-2T2GVQ][^7O6(NG>.?BLPEU)VT3PZ3N6!0095
M^AY;ZG`]J]+\,>#=%\)VQATJS".0`\[G,DGU;^@XJ[1COJR;M['G^D?"_5O$
M>H)K'CZ_>XDZI8K)A5[[21P![+^=>HV5M:Z?91VEE!%;P1C"Q1+M5:L-AE^Z
M21WQT]Q32X`+`9(XR3FIE)O<I12&-N?<A0L<<CL:JS8:%E0H2O'H*G9P,`D>
M8?NY^Z*S-3DECBD=T!V`GMCZ^]2,Q-9O2L*P@IY(),LCMCCV]:\YO+QI]3?.
M(8\_NUS]Y?4#M5WQ%J9N8O[/9?GQYQ;/++VX[5S<1DO-0CCDCQM3/F+R%]`?
M>@!C72R7+K*TJ+Y@V]NGOZ5HV0C'FF*TV`L55MN,YZ_6K"VJ00.]P8IDC7=\
MZ_=']:MVK?:ML$31LA&00.F10!3N=.N);8-:YG8\%MOS*?\`"J=OI\S3*Q<3
MM*N),'*HP]!7660^RVIB6,($!).>?QJY;:=8PZ3]I)5HVRP3/4Y[>]`',:5H
MEY)$^^=$3)4*B@?Y-:VG>'@EX//B&(AC!&0V>E;T?E(J.IB,;)T'W\^F/ZU#
M$9[<R.\H<$Y5"<,#Z&@#GM1T2`2F4QM#L!0@+G:#_.L>;2=B".)&,04L,=&_
MPKM9[F'4DV<NVW+1GY>>]8KQH\V5=L1J54Y)`^OK0!R<5X8X@G("MRS1D8/U
M%=IX>UNXFF2">#S)$R\;EOE(]!_M8]:YS6;"X:-'$CD*=WR':GUJ#3KEHIH9
M84"!_P#5R;]N3W!']:`/:$:-U#*"HV9PO-9TFDV5Y)(TD+(S?\M>F3Z$=ZIZ
M#.UY,2LC/')QCDB,CKDUUD:K&P8G<N=OS#/_`.J@#A+WP2R)'';,KC?EXB,D
MJ?3Z52;PG=6,C,JB21?E)9?F"]O8UZ2+91(9`^`.JBI%B)^9,'(P7)[?2@#R
MLZ2UM(7F-L<C(^0G>?Y`U?@\-2WC@F*<IC>D;1\`GWKT.73T:)0Z*8P>01V[
M&K"0+$GE*,+VV'@4`<18>!E"B2Y98H%Y2(CYQZDFNHLM(M;7<D*A?X@W]X^M
M:WDQLT9VY*#&X]1FE"1HPVDJ[<#B@!@3:W`Z#D]>?6I0P4J"C!^Q/>G*0N0-
MH)X^M+C<I4#']*`&ID9(ZYY([_AVIX!R,#'/Z4QLJGW<`]3G^5-`W2`=%X.<
M\YH`X34%#:A=HY)3S&._/;/2LV;$4!/EL_(^56P0/:MO7DB\VXV##[SCCC-<
MVD]QY>S`D=.5!'(]1GM0!GM=S*TB.I5<X*R=/SJN4F2<[BVQS^\P<`>F*OFS
M^V[GF=6E."F>@/ICO5>?SQ$\>P.(F"L5)#'_`.M0!<LY(Y1&H)94!##`(]L&
MN@T^;S@4!Y4_*":YRWM_L\<46QD#_-@ME5_*M2QU6W@D+`%Y"3[8/J*`.VBN
MECM@SLH.![5,EU'M7]X.3P,]Z\_>]EG=IA*S`'_EJ-N/:KEK=2-"&,85N6&[
MM["@#MU??N&,X/3-0RWRC<$.YQVST_"N$EFN2RRQ/,54$A4.,^M7[>ZGNU12
M51R1R&W?AF@#JK2[\T$NNUCZ&IYF\M&8#D=/<UB07;P/&%&/+!X*XS]#4MI=
MS:MG=$R1;NG3'U-`$=R[21S/<QN7`S'@<?\`ZZX:[<S:C&725$D/S28[^XKT
MR>'<%C+E0.F>:\VUU;=M;-K'"TJ("X`)!R3[\<4`6-,G>*6XV_O(XB$4AN6/
MH?:M>.]N)@6CB!<':[*WR@?UK$T>![>=?+>-;9U(D!&2#ZYKH8S;PV[VT##S
M"V?4L*`+,$C3*Q95\Q%V\C^=<[-HFH:C?M+/)(54YC&[Y1]*Z9%P`YY4#&%'
M;UJ.[,BC"LFQ$^8.V,GV-`&3/I+)&R3K%(91M)V]<?UK%\;:4+/P9J4L03:5
MB!YY'[Q>U;3--J-NLL3!&1LKN?@_2LOQG<R3>!M8$D;'Y(1YF.,^:E3/X65'
MXD>'T445YIUGN?P?M5N?`MXI7).HR`?]^XZV+NQN$NO*D`+J>`>F*Q_@L3_P
MC<P5SD:A(=G_`&SCYKT1(XH[J663#LQY)_AKT:7P(Y)_$SF)/#4ES&EQ.I"#
MK&/2I-'OOLBS6<X/D1DE1WKJ]6F$>FL4<!BO!!Z5PR[VMEDMG#R[CO8CM5DD
M6KZF;JS=70+!DA!7+V:2V]PC!<8.3CTKH9--N;BZ.[[O7;VJ_8:"C2/)<G;@
M<>]`&->WT%Q"J)ER1\WL:N:%:?9D^VR1N`G\+=#6\-#TY8_M.5CD'\)'!JW;
M0":V(N'0`'Y`.]`%6"YAN@S3Q*LK\(S=%6J-]:F*Y\DRRO`R<;>F:NZS+';1
M*@5-V,9`Z4OA^>*=#:^8)2_&X]J`&:%IH-K/.$"LG"D]ZD$$;7:.7\I!RW/6
MM.]L;BW98[?(CQSCO5"VT^Y661I(RY/W5-`!)K40OC:6UJ09/E+8J?4%CT[3
MVW<9P?FZFJ%Q?_\`"-2?;+JW#O<':`1]VL^_U>+Q#=B!V,<@7*@],4`0-=1Z
MJTCQ9B"?=QWJ*\$]W9PB,[R&PQ/44EAHL\+2-')OBSU%7WL)4D4PL?FY*B@"
M&TTAKO4TB9,[5^<]L5TPM9;15@B@`B8[5*CI546D\-BNUO+F;C=6UH$5S';,
M+EMV#P30!9BM%MI$P,N5P#[UDZ]JK:>P,8"RGAFK2U?4#:1*81ND)P!7/:ON
MOXDEDA^=>".QH`Q=2U5Y8V-M)NR/F)-9#3B\:.%PX4'+D]JZ>3P[9VTT2))S
M(-Q3TS3G\/1P2KY!$JD_,<T`8[6AN(F88^RI]UA5IK.&6P,MW.N_&(\&KVI>
M'KE"&A?$('**W%9[6@L%0R#S8@,@GM0`FC7@LR(+V7<I.5/=:ZV"^MQ(CRR>
M:IX`-<#<S&8F58=I['':I;FZN(K2(1?ZSJ,4`=;J]_-<W"PVS^7LY&.IK)MK
MN>XWN0S21M]]Z2RN6N8X99<+,.":E?5/,N5"0C:#C:HX8T`13WJWD[GYXVQC
M>.];>D6T4\*6YE96AYSW)I(5M(]D4T&9@=W`XJZXL6'F1HRMG+%:`*U^/[.9
MKB,>9.QY)ZBL6]DO;IU8L7+#@]L5T,UZL[AS#\@Z9'44IU"UN$,<$(&T8)`Z
M4`8FF11Z?%,9@/.<?+FLJ^N)9T,?V3]YVDQVKH&N"^VW^R?.3P["K=C8O<3L
M;M578/E4=Z`.?M+R91#:1[%8CEWJY*TLTC+(ZH4^Z`?O57U:Y$$LC0PIG=M(
MQT^E--NL]Q;/.Y56'8XH`MPVL$^YS`QW##;:S[[3(8T#+&Z@GY5;O5V\MX=,
M=6GU!HUD^XH.*I2:BUS>P0(&<I]UCTH`J7$,%O''*T8$C?>3TJ739F:1IYH"
M(P/DP.U+=R%-6$;0&69OO>E2SO=2GR[1-D,8_>Y[4`7;&.?43Y['RK9&QCH2
M*AO&BN[QHH$8K]T$^M6;-A/!$D#$OGE1TQZUTZ6D%I`62)-RKN.1WH`J:7:M
M:VH>Z`15'`-1WES;72R/&JB1/XCUK$BU'5;B]N"B>9&>"C=A3WT2[G59HF88
M.6&<`T`:=W>W,6GG.UD"\@]:Y:QEBGG,KH%13D?6KVL6M[83QR,3+$P^<`]*
MLQF"^T<RK:>2JG!.,9H`C76A=HS22J@4X#"LZ]\0SSA[6W=V!XW#M5V_TV$:
M;&(T0D'D*><4VVLK"*$"V!=W.#ST-`'.KHMW+()KF0N!R.>]:3PR6SQ2&`[N
M@STKH(](CBB8RRMC[H4'/-8=]'?1*T>XNB'([D4`/N9IF@!$Y`7DXZ"M33M9
M6]C^4*DB+CZ^]<U#J#VUL$$?F%F^<$=:N32)IT]OF(*)!EL>_:@#I[B22]TU
MQ&XDD4\HG4BB&R2ZL#''NB=>B/ZU'HUHSV<SQYB=CD'VK:\H(S7$[*`J\>M`
M&&-,GMDD:!]LI^\S]OI56(7\`EN'A+KCDD?>/M5^Z\0+(1&(=V[[M.;40;4%
MW!D*X"`\4`<I'J=],\L4L#",'/(Z"N"^+A+:)8,P.XF8@GTV"O3/L5U`Y%PX
M83G@`]!7F_QCA:VT:PA?.5:;&?38*BI\+*A\1X37J'P1G^S>+X9>?E6;I_US
MKR^O1_A#*8?$L3A0YQ*`OK\E$^GJ@CU/J&.XD,)?<I0`$G%6(6S`KJPPW4YS
M]*X3^U)8R)(V8Q$8V[Q\I%=-I&IQWEN"4VN%^Z1U'K[59)KJRJ'88R>`/4_2
MG@L[@_=QR?>JR2NQ.&.X'T&<?6K&-S)\C!B<$$=O6@"0$HQ+8`[$&CEAC!ZY
MR*:J[BS`Y3L,4I0H/E_BZCI0!YSXWU/QU?>(&\.>&=/^RP-&KR:F3P5/7YL8
M7]34_A+X4Z1X?==1U-CJVK,=QEF&51O4*>I]SDUZ!MQC.>F>.:4A2N[;UZY'
M6JYW:R)Y5>[!VP!UQW!IK'(XX],_TI6`V[OF)ZD#O365<(6X'J.E24,D!.T`
M'?UR:C<,KD!CNVC!QQ4DG*_O-T8YP.]1'+1;6;*G^('I0!"^UI"&;DC&0.GK
M7*Z_<2Q6\J;W2`C:".3732E+<;RRXV'YLURGB#48`F^380$)CW-P3ZF@#S'5
MM2:2]N6`*Q#$:N_(;'H:RK$73W!9"=LC8*1C<JK[&H-3N8UN6$48>61LM$K<
M>_TKH_"U@#:%]^45\G(QP>P':@#1L46426MW*KJ5W#>,$?A6II!LT+%PVYAM
M7Y.`!WS2W45HMM_IT)91]UQU&>XI^BWL2X6YDAX!"[!C<O8GWH`N7&FV[,[Q
MR%=R_*%/WA[U'9642!H5198U!9,/PGKQVJ.ZO9(4E:-8T@`.V0G[WX4VVO8G
MBAS%LE_O$XW>W_UJ`+DL+1B1[:T'G``>:QQ6)=1W,>HG][())#O9E7=@CUKH
M;>=K]KF*Y_=*I`"-T-9=UJ:PSS"S422[@C#IDCWH`BLKCS[4[8S%-N):0<Y]
M_85):G;NB8[YW'``Q]/QJR%,MN&BA$).,`#.3WX]*9=WJP-&^X+(IV@A>']J
M`*-Y$PNG)7HG)4\#V/;!KEKB*8^4+6WC2,N5<R'"_3%=7J1GGMT,$C1,V?,7
M:/S'K7+Q7%S,VSS$<*Q#"5<$MVH`[#PPTL?DP0AV1&\S=&V.>_'<5Z1!M8*S
M1J9`,MCO7DWA@FUO`L\3BX8DJB-G`[Y]J]2L3YT:OC+E.6#<?A0!:B0O)ND!
MR?NX.,_6K"*PB"DHN3A6Z\T@C5F4X^<#'-3%!P-JY')4'J:``*68^8F$;K3C
M%L7<FW;_`'?_`*]/$G\3G''X4[@;!C\*`(A&1N4`;O7-/!S)@J=X'7UIQ<`]
MQZ__`%Z0`$<$GN#0`N01QG=TSCI2;0&/X9SWH7ER`<$=?4TC,,9ZXH`CD&Y2
MO+K_`!#/(K.N'E\Z#[.1]]58DY.W-7Y.(\>;CNQ'7\*H2O&MPLV?F,BJ%49/
M7J:`/,O$6H7?_"0W<338MDD<?+D<YZ&GV<EQ+"\+?,'&&R.<'N*UM2TE;C5K
MHJFTM,Q#GH3GO4J6'F6B_+M<'C8>/QH`BM8(X+9@.>!M!ZCV%"Q0P,2FT`#<
M67G:?>JLCS1R%4DVL.78=.*AAFDBBDD<LZ2G')Y'K@4`8VL7IBMKMX3YLBYV
MR?='TH\*6\KP++=22D@?*'.[D]R>^.U)J>EV<\)'G,#)G@?,"?IVKI/#4%OI
MUBMN"TCXW%G(R3VQZ4`2BSE@B#+G8YY!Y(]^:GB1Y75&A'E,N2P'0^M.2_BN
M+QV**"&PRN/N_A6T'B9`W"8&%Q_%0!CW%ND:.R(Q4'!&,`'_``J&T8QE'"(J
MG[K%L$CTJ],KK=]&//)(X'TJ`!'BD>9?EC;"*H^][F@#2M;=))464LJ9Z`_U
MK3#1VZ]%"XR.>OUK(LY?M!=5CD!`^5L<?4U>MX_M.U9>=JX..AY]*`+4DJLI
MVC*KWQ7!^*#%'=)>+(PF@W"//`YZY%=??,;1-GS[5YV@<_A7#^)+GS@8C$=K
M8W.O4#/>@"IHMVDSO/"XW,=K*Z_R[?C6C?74(1)(T(N5.-C?*7^F/6HK)U$(
MMK!8P(^/+50,^N<U1NIH[RY#RIM"R``;3CCT/K0!N66LW45I*))<1MEN5_U>
M.U7;>]AO;!2Z-L*G+=.?45+;R:5?V2JQ&,=&/.1ZTUH(Y`I<D1JV",8!_"@#
M.NK(K`JQS>7&^<,O!%9WC".2#X?ZG&99)$81,&8<8\U.*Z6VC:YNU+1G;VR.
MH]ZH?$./[/\`#O54X*OY.W_9_>I4S^%E1^)'SY1117FG6>S_``DO(;;PQ,C9
M61K]_G]!Y:5ZG<11)IS/&2589)/>O.?@[!;W/@>[BE0;QJ+D.1T'EQ]Z[:?6
M+**V^S3OA8SC([BO1I?`CEG\3.4O[J](D4,VT'Y48]16GX6_=^8MW&-KC(QV
MJIK;Q7$:WL#_`"H>,]Q6EH6H?:UWQ6PP``1CK5D#-6N4MT<A&5`1C`ZTMG>#
M6M1AC`:*%`,9&-U=%JT4#6T4LB*`!RN*QKF:.X\@6">6RGGB@"76+3[=,;>!
M@ICZD'I63>6TUE=0,TAG(3C:>`:NZNA#I):NZ2G'F@=Q5R&:UAL-@4/.?F0=
MZ`.8M;?4=6U0O-&RP+][(KHH;32]+OT_?8F(W8'2K.FZG&;:8W*>4Q[,,9K`
MN8UN+U9DRRAN0/2@#HG\60)<QQF)BKMM#8K7M9Y+E?-*JJY^7WKE=4ABMD6?
M_EF$!`4=*U="=KV-91+F%1P/>@#0O+33]8CV3JLGEG/TKC=3M-+FNFCLEVW(
M.T$5<FT[47U*Y,3O!;_WNQJG&;;0)56X4.\QSN;M0`^TC.AQO#/-OC(R1Z5-
M!J),7G6B^:!W(YQ5?7(1JT0GM9E5,?,<TSP^&C!M7?RVV_*Q[T`;TTT=UX>E
MN#N61>0.]5=#U"\"BYOPZVNW"#'>MBTA0QC=M;"X('<U81A>`VWD[44=QQF@
M".*2VN[&25`6Z\L.]<_<QSSV3G<ZHC9P!UKKH[6**`1X&U>:Y;4=2:&YEM8G
M4H.OK0!0AN[>[AD_>N9(Q@#'(IZH+=%DCNW95Y(JI<:YI6C1N+<"2XD'/L:R
M+35IIII#E1NYVF@#H;6\$]V<EV`&<,V!6C'9?VE"0P"PR<#VKC8IKQ[C'REF
MZ*.M;EI?W5I$(T!9MW*GM0!!)IEW9W[VZ;"O1<^E=!INBQ+%L9,SD9+$<5S=
M]<7*733*Q:X;HHZ`5IVVIWJF%%F56(^<&@!7T!KF]9HLHL9^;!ZFK)TS4+9D
M:.)-BG//>K*WJVTGG1R%\?>"]S2:GK?FJJQ.$S[T`7I$N4'F@1X8#(/6H;B2
M2U;'E*@<?,1S69/>W\+1GRQ(C8^8&I5O%O[FXBB<M)MQST%`!>S3PV+R/<1O
M&W3;U%7M+MH8K*.5)T".N6!ZYK,@AM+3;:70!#<,^>,U'K4$>F::S1N2#T`-
M`$&H^(Q:7SQ&97P/EP*HR>(I[D))&Y"J?FY[5S=XH"AU^:1^<=Z@>XD38@4J
M#PR]Z`.R>ZM=1F!(91C@@=33)9TN;E5B#-*,*F>!FJFG2S1-'LMSM7!R17;V
MUG91P_;-B-\N[`[&@#-O?#$FL"V:_E"F(9VK4\5M#;64WF1@&/\`U;`<U8L=
M1GO)I@;<K)%T/J*NVXC$#M=%0Q/*GM0!QMKNO+YGFC=20=O'6KHE"V<MK.OD
ME_7J:ZF1;<68EPD:KSNQ6+J;6>IO'(\B1Q#C<QP6/M0!C:1,VF(XW!@3A"3R
M!6Q=7XDL_.23=*@Y4'K6==:`(MUXCO(`,`=B*Y@WLL-[(J!E!7'ET`='H^I7
M']LG[0BGS!PHXQ747UU$EDV95RO)13S7.Z9'!*8&;;OQ\Q[U<CT9)]3DF:Y&
M3T0GK0!(8Y=711$WE$#YMWI5G4[=WT8+"Z)'&/F8=ZCN7:`QH/NKD,R=A[UB
MP//=W4EJKL++.3GO0!1TC3;J_O%:*5S`N?,8FM6:R@LW+G(A4[LKWJ-5NXIO
MLUHQ2W;AB*?#)<B>6TE"RH.%"<G%`%[1[MKB21K2-G5FR0XX%27=G+;V\LR1
M!&=LG/-0VJWEE9L8U*1EL*@'-31W\NHPM'(1&(^"#U)H`PFL&>Z258T:9NO.
M,?A4B6B)=.;E"7'1CR!5*!;DZN65)'1&Y8=,5MK?PSR&"*)I''0$<"@#:M5:
M2!@J#&!@@U%)HK3R"6ZNF.>BYP,55N-1.FZ?M@&7[@>M06EU>7.G,\P8NWW4
M[B@"KJ=@4NGB@($1&-^>GTJ+3X+6!RDBR-($(1FZ$UIWFG+)I,+-<['7WX-$
ME_%]B@M/*W2C"B3'%`%&UL8Y0Q>Z;"G)&>A]*X#X[(B^'M(96#$M.">_W!7H
MES:301R>2J@'[W^]7F'QJ0QZ#I2')/[XENQ.P5%3X65#XCP&O1_A`P7Q-#DD
M`B4$@9_@KSBNZ^&LTL&K*\*EGS(!CJ/DZT3Z>J"/4^@9=&LK^S>)E81R+R87
M*'/L1WKR?19[K2?'#:3J^H7QA5VB&VY=`6ZH>#T/'YUU\&O2K'Y!4Q@,&E<G
M.1ZBN?\`B5IT9^P^(;#(1L1R/_M#E3_.HJK3F70JF];'J=UJ4`T64:@TPMU0
MR2NLC(RX&?O*014/@SPU*OA^%M9O-0GN;L"5O,O908U)RB##<8&,^M<;;ZHO
MB33M*@A)(N,3WZ9R-D9Y''3<V/PS7IFEW:LH\S<7+#RP35JTG<EW2L>.^$KO
M4-0^*;Z-=:KJ3V"W%RHA-[(!A-VT$AL]A7OD%LEO"D,9<(B@*&<L<>A)))^I
MKY^\"-CXVR'D_P"DWG7Z/7T")`0`ASMZCKS44=F55W/-OC"DND>'X=3TZ\OK
M6ZENT1WBNY%#`JW&T-@?='056\%^'KWQ#X$M]77Q)KD.JR>:$E-XSQ!E<@91
MN".!5GXURI)X"M#&R,IU!#E&R/NN#S]<U0^'\WBV3X>V]GHNF6"0R"98M0N+
MKD$NV?W8'4'..>U2[>T^12OR%SX5>/M1\0W-UHVLR>=<PQ^9'<!<%E!P0V.,
MC(Y]Z]/9R!@`#G/)[5Q'P_\`A\O@Q)[BYN!=:C<J!(Z<*BYSM&??O7;RC:%)
M(`'7/3/O6M-24?>,YVOH1.'8@\<_J*22$^65`"^@H5BQ7*"-NO+9'YU&X7?A
M#)N7NK?I5DE6<DQ,HBW)]W/_`-:N#\2,K7$<3+&$9&7A<G\*[BZ=OGB=L`\E
MO3\>U<5K^CD@3&7*JX9W=CD+[4`>7WD4$D\<;!&B8']X<`@CMZYK<T1H3Y49
MO,SHFW./E7ZUSVJP,+FX\N/$439#+U92:-+FF1)$"[8I7`9`<E1VS0!VL5O,
M\[.S*\`R0S'[S>@[8ITUCL#)9R!9V`+H5R0O?I44=V]O9PX+#:P3E<A/P]*D
MM]4BMIW<C[-.H($DJ_+(?K0!+>R?8I;*-H%!"9R[;A[#\:MV"2$JOV81R-ET
MD?G;GMCVKG]6\0*84C8I+)PV0`]54U<PV\<ES-(%?[@4Y8'OQ0!TEY=ZG#.(
M$:&XF;YG<#J/0TVS@A><LVZ)LDL$.<GOC-&EV;7#"8L!YB9?=QO'U[5+/:>7
M?E-L<2?[3Y7\#ZT`7$A>XG>-9!L;E&.1C`Z_6J.I69:!4DN1N3+JR+R&'0XJ
MQ;:A!;S.KQD,!NSNW!@..*K7-\@N$D89B!)&#P<T`9S/)<VV^7S">KA>@QW%
M8U_&)KA)8YS!MQT&"_N?>KU_JUU"H$406"/<RL6P/I66LCSW0,LT2[OGE'4%
M?8=A0!JZ!#*=9@D^UO+@E<1#.`>,&O9M-MXH+>)"6VHG!/&:\[\)Z=)!#'<)
M"`CRYRW&5[;:]'M&CDB/DR*P`Q\W'X4`7T##<2#N8?>([5)&5?:N&P.1D5'$
M"8]K$[!P>:G!W'@GTR!_.@!4#`8;J3DXZ4K@[21Z\X&:%/.`1@=><FE(P0.V
M:`&'Y3M"\']:#G).,+CJ.QI7;A<#K[U7,N5SNV-GKV/M0!(S`J%`Z?Q`=*KS
MET(7())Y4_I1YR36RC*@MG@')%5Y)D*2-^]89&2/7VH`A4RNKQ&4Y`(`P!^1
MIZ?ZV(HS`AE#9_K4+S-(^UXTV$?*6_K31(L5S;DX+%PI"'H<]Z`.:O;IEU2Z
M4Y"F9NA]^U21R.N2!^Y/S=>0:FO(Q)=WBM"4_>/A]N><]:JCRI(MIW`*<<<;
M_7\:`(+J.(G+$E7)*N1\N?0UB7AGW"WMT3S,<2.3L'T]ZZS9`+95<-&!T+"J
M)L(+L$A&('<\8]Z`.+MIGMS%`\`\TL69V/S`>HQ79V)CCBC?!DD8C9L3GW/T
MJ,6EJD$KJGFE#E<+GD=S5;3;QX[@-(C`MPK-V/<$>E`%]K1DN/.;)7>2[-QC
MTK4MK=6C;>=S,V0W(X_I4,=PA^0[6;.=K'MZ_2K\)CGD'`)4YX;MZ4`17$'D
MX^8,HZ@?Q4D&Z1V&&*YQ]W'/]:N!X7WJ`[E3@J%Z?C1+""NY`0['"?-TH`L6
MT2+&2Y4%A@=N:EW"&,;3'&2?F([U65I':..3@@9(`S3)PL:JVU0HSC-`%75U
M\ZW,@PB\J3G!`]17G.K)/YD;-.&1<H?GZ>A->FR(LL3JVU5P.^<BO._$]E+!
M/(8XMV_H-V.?:@"GI,LF;A(-SR':NW&`3ZD_X5NI<^=FW8#S(1S@=*SM'6**
MQ4BW9#C)P.^>HSVK78+I]IQ]]VRV#R*`-#2=-M99I9&C;;@,K#@9K<"12(XC
M"M@##CKFL*V:\6#_`(^46-^#GG)_"IX)KBT3#21N^[GY>HH`U&DEB<,C*54\
M\\BN7^)%RC>"=2BR2W[HC(S_`,M%[UIC=.SN7S&`24]:X[QO=J_A>ZAC7Y-J
M9/.X-YB]?:IG\+*C\2/(:***\TZSW+X0)CP)>N02IU"0,!_USCKH9-`EOT\R
M9=@S^Z]Q7-?"5YCX#O88@0IU"0LV/^F<==5->WJZ6")L(GRAJ]&E\".6?Q,H
M&ULK*`IYXE96P\?H:Z+0M@@18`L:$Y)KF[3P_P#:(7NX&+SR'Y\G]:N32SV7
ME6J1OY?=@.AJR#7U\75I<>?$/,CD&`I[4ZU>,6<`"HLXY)]*;:M=7437%Y&K
MPJN(P#6!;"ZFU24N[+$<X4"@#J;J&*&2-P-[2#YC6?J-I;6TL=Q#(2P[#L*S
M;6ZU*.9FN<QPQ-B/<.HK2_M:R$YG=0^/O>F:`*^M&W,4*K(`\@W`>E2>&)86
MNI8G4$!?O$<52FM+;5I6F,X7<?E`/05M&*+2]+6W@19';J!]Z@"Q?OIT\<EL
M'3('/-<K#JS:"Y+Y6#=\H'1JP_LVHS:XZ"*9(6/WB#BNG\3VL<.FVH2/SFP-
MQ'-`&U;ZJ^HR13#_`(\V'"]R:K:UX>762.-J@_>]*Q_#MQ<7=]%;(A$<?.0.
M!6_>Z[-:77V5(@_^[WH`J2:9:Z78&W0&16^\:Y/4FN(IP(FP!RH]J[/4I-UA
MO,B!G'^KSR*Y)HDF40D,&ZEC0!T'AS6;6V5(9I<RRCHQZ&NI6\P=HCR2>HKR
M]H+="LD1)E0]:Z^R\86:6RQ$;I47!Q0!MZP\ZZ7(R.$(ZGVKR;4KN6:\$=J[
M&1^&;/2NEUC6M0U*TE$8V1CM[5S(98T3S<([\`^]`#8["WLVC>YW2&0XW>AJ
MTP@MWEPNX]4(JJ^L,Q6VAA\T)Z#.33X-+U:\8SSH88ST)&.*`)4OHII@H)6X
MQPP[5KZ5I]U<S*%D8J>68GFJ%L+6VN$M_L[;Q_$PY-=):WJQW*2*"H7@H!0!
MK+I:VUL0"CRL>K#G%5]7O=,T>R\R2-)+K;@*!5Z5VO;F*4AHXT&XG%8UY;17
M-X_EVK20DY#L.]`',W>N265FTT*8,QXSVK'6UU&]E+I,[;ANP.U7/$D\,$GV
M6093/4#[M5K/5Y["!#'_`*D\%N^*`)HY-=A@$(F9B#]T]JET_5)-.N`LB.))
M#R<U8LM9$TSLR_NF'4BJ"WL$EP\"+N#G$;GL:`.Q6YL+NT'F3;9,YY]:I7-V
M+J1X%;?M'+'I5)H%L;,"9U8D<D&JEU<PRP1PQORR_,%ZB@#-:WDGO&-N=SJ>
M/2M;0[(75S()U`G/RC([U+;P0VNG*B$*Y.XECR:N>&YDFU1GDX5#P1W-`&U:
MVTUE;S6ES@2E<CCM4%M<JMJ8'=L@YPO>M/5Y)HOFA`E=Q^0J/0'A)EANXD5\
M9#&@"*UU];*UE`C)D'W6(ZU@W>J2ZG=29D>-^N!6U+?Z?;K<1A#+.3\NT9`K
M'NIHTC54C6.9N6)ZXH`V+#4VN;$6<_*$8R>]8KZ4=1U1()9F1(V^5!T`HM$S
M<0M;S!E)^8$]#7173JKK%"G^E/@94=J`.BMX(8+1+=75@J]S6+J(LK6X5TM$
MDDD^5GVYJ2VT2X#1R2RGKRN>U2:I!<6G^DVR!TCYVGF@#F3:2W&L-'#F`1C<
M,]#6@8U>]4PRDRQCD`]34&G7LNH7S($,;2'YB1TIM[$=%NA)`K2LQPQ%`%V?
M58-(E;SP`#R^[D&H9YI=<E@33X?*A!#,1P2*JW&@7FOVQ8MM4G.#6UI*6^EQ
MQ1;295&TT`&KP21/'Y,J1"1=I4_SK+32[C0F2ZBE\\DY=NO%5?$UGJ>IZK!&
MJ/C<"FWIBN@2VETNV(=O-D=,;.N#0`U;TW6J6YC;(=<LN>%I^H64S78=$"[3
MR1T(J/0?#QM2]W+(WF2G.WTK2U6&=K("%CN'<4`<UJ%S/#,(].`>4GYT4=:D
MDM9-'MQ=2J1*PS@>OI6A+93:9IS7\$?FWFW)!%8VF7=S?SO_`&C.ISSM/4>U
M`%S2]3B>X9+BV(9N4##K6HUY%%,1#$=I4AG["LF:WN+C4VN8PJ)$N%SW%:<$
M$QMC"J@6G5G/4^M`""T233@XE58\Y&\YJ*VMHY^)"=J-D8'6IY=.@\Z!%<M"
M/X,UJS-'%$$78J],T`9"VQ29FBD\R!V^93VKS#X^(B>'])5",>9/Q_P`5[`Q
MMT*^7*F['W0>M>+?':>.XTRP:)2%#3`GWV"HJ?"5#XCYZKO/AG;)=ZNL4OW/
MWA8^F$ZUP==_\+69=<C*LH_UF=PR,;.:)]/5!'J>H/IZR*BI,DL42Y!'49Z@
MUEZC9QW=M-8N6\@J=I1CA6QP<'WK?9K:VBD6*&/#'Y2AY_*HH(C(D1=MTR[L
ML^,J.PQWJFKJQ*T,;P5:_P!@Z2\US%LNKEL@[N54=F';N?QKN;/7;6UA6X\P
MR0B10IC0LPSUPJC-<[=V\4AD?Y+>18P)'0?>'8CWJE8S2:=<"8MYH."!MY'N
M/\*48\JLAMW=V9?ARVU;1?B0^O3:!K$EDT]PRF*U;>5DW;2`?J*](U/QSJ$&
MF3#2?"GB&6]*D1-<6)15)[G!.<5M:7J'VVS@E/!(^9>@K90^441!@-R=QSFI
MC3<59,ISN[M'E7CFVU#4?ASI.CV^FZE<ZG%)#-<JEG)A3L8MEL8)RW;WKI?A
M<\VG>$;'1[VROK2]C>5F6>V=$P7)'S$8Z$=Z[4N\9.%SG[V>@%/!#8&21CD4
M*%I<PG*ZL/`88)(P#S[TQFV@J4R6/3L/>D(`VD2<J<?,.?I3]^`0H!).-I]:
MT)()%#E@3D`'"^],8!<*&QG!PW0U89%9<$!B3T6F,B1N9`,MQD^WTH`KN@8$
MN<9Z`#@UE:I8K>0%-VWCG<N-O^-;,@;D@#:3C'.!566$JCESP?X7/&:`/(?$
M>B0VS2.J8F("L!G8!_>KB&MVMI]R>9(P;<[`8!'JPKW?5;""\A;8HY)##'S#
MVKRS6+.$1W,5[`ZRJVR"93\WN,#J*`&0Z@DBI$'C1'7.W.=Q[8%4=1NUG57>
M<W"NI!A<X"..XJE!:K`#)!&QM^GF1MDGU.#56[1+V=H+6T>'`#N7YW'Z&@"F
MEQDO(YDBEV[0%`*,OH174Z5+-);HDD<1DC;[YQROM6;I]B+N9OM,2&4D*'C7
M&0/6NDLXSI^XL;9X%X)DY+>F/0T`=/I42/;M++D*>,[NOH:CU"*RD7RT+_:@
M,CGC;ZX[U0BU9%AN9)HV50,KSG`'?%9$6KF>Z$C>6XD^ZY&-OXT`;=I8B:!Y
M;BXC)#$)\N,5D76#NWL\4@Y4`C\\5=EU0P1N(\83[X(R![@5S<LTL\KPPS1O
M.5+>6P^^.V#0!$[0SR+%<M-M*G]Z1D%OZ"MS0--BN;Q[01N510TK2)@N?0'T
MJMI6FW=U/%&L(5G7:=SX(]_I7IF@:=<62*2T8>-1DXR6]C0!I:9I$<06682%
MY%^2/HB8],5O01&.,,57+=`R\TD,:(4!W*YYV>E31QML+%R<$A2OI0`]%!P2
M/EQG!/&:?O`BRQP>_%,6)3R%X(ZC_"G84`ALD`_Q_P!*`'(=RYQM/H>M(74?
MQ8S[<@TW[J@A?H0.<53>8QDR12;V)Z=_I0!+/<JL87<"QYRHR*KO*CRD*WR8
M(``X^IJI()EC5E)$F_+*O7-5UFS('60AF;.P?U-`%UW\I2\G[MY!C/ICIFH)
M<.GE,A:+/*A^Y_I3)+AGD9AC!X*XSFH+F/,+/Y8"G[A9MO/I0`]9[?R_*)=$
M5>W/X50MIG2^ME1"4>08).`.>E,FEDN6(B^4`?,'X_`5'%B-[<H"!YR!SG)/
M/!_I0`NK6T\FKSO'OV!B2%..2:(;*0A))'9`K9([Y]*T[LK#>S[Y`F9"0<<?
MC6;=/YUT'D<!4&8]O`/O[T`6+HPR0('S@@CCIGM6(UP(2J_,H`Y.[BM`M"1^
M\D#LWH<#_P"M7,^)+?[>(`]P]O#&^XF,@-[`^M`&R+J)E7R20!G>`.36!=7+
M)$65Y)`Q`S&@WH,_Q8_G5./4$6;R!>8=/]8S9&1Z8J?3I&GG>:%!#'N"R-GY
MF]^:`)3#<PLKE7!4_O"S9)';;726#R0O&YD#JZ%N1@UFLET)2K,JQ!B8QC<0
M.V:UK2-AL:XD+G^#`Z4`;-O<AR#'C('0GFB2ZVDNRG"G@9P,?6JQQ%NV#:=W
M+'H*9,?M`"8W`D@A3CGUH`TX0LDQER3N.1SQ3I9[<9S\K!20I[_A5`YMXPS2
M,/+Z[3G\/>G2WR/9RR2A0I'RL1W]*`,V6\9G9R0H8`J5&%-<_KES<RRK]YD;
MY5*`#''4U+=/=;PJV_R@$H&..?0>M4&@GN95#XC:-?F`YY-`$NBP16A5D\UB
M3A]QW`'N?;Z5H7M[O=0$5,G.6'##MSVI+!&>W0Y*8!R4Y)SWYJ+5+.".%5DG
MD1V8$;6X8>_H*`.BMT"P1JR*6SNW`]_7%2W%HD\4;%@77D$<9K+TL"6P4"4E
MD.2P.<U'>:\;8#-O\J\`@$9'L:`+'D7%M,'ED++)\I$?0>F:YOQI:.W@W59E
MB")$(MQ/5CYJC^M;PN'=]C?ZS.X`G:1]15/QFJI\-=8W$;W$)''_`$V2IG\+
M*C\2/!:***\TZSW'X3W<-G\.+V2=L1G5'#?3RXZ[2Y6VU"SC4*8[5_NMZUP_
MPET;^U?`UX&EP@U!_D(X)\N.O1M.M((($MKAPT:'Y=W&#7H4O@1RS^)E$2MI
MCK8V:^;(RC:?2MN6VDFM`;C8GRC=BFK96?VT7$3J'7KS59-82]EEMMA)!P?I
M6A!6O0TL306#;/+7G'\5<]X?DO3=W,URK`VQX&.M=H;*W:#S8<@J.<51TI?M
M5W-+Y82,9!4C[U`%+5-4L]2A5D8!@.0:Y!;?S[EHXW<0,WS+W^M=E/HL$,S7
M-PRQ*QX0=JJ2V45BIGPK1R<JP[>U`#+S18++1UN+(L\JBLCP\^HSZEODWX)P
MSGH*Z/1=8@2UDANQA2V!GTJ:\O[(VQM-/BW.W\2CI0!/,[F[\N)UDB09DR/Y
M53:_A@F%K+$#%(3@GM3K"\33(-LZ^;(>XYS[54O62X9[G855>2/2@"6QAGCN
M;CR%6&,CMU-9TNG2K*;U;HB8G"BGQ^(Q;+LBC\QY.`31/<.DT;22*"_(C]*`
M(I=-RP5KDM<GGK3'MY5LY;>X=5;.?,'4"K3F[N]1@>TB4,%Y<BI9%,-^C:BN
M58=AQGTH`Y)HYKMUL+%6(+8:4UT=GX7:P@="A,CCB3WJT)XDU6/9;""+V'7W
MKIWO;9+<S/*&11G%`'*/IK>1L<XP,-CJ:Q6T"&:Z`N&*H>F>M=U%+8W`6X$H
M9A\Q4>E8VML+V2&>&!E6,\T`<Z(K;39Y&LX2=G1L=:L3>(KA;4?:(P4S\@QW
MK3AU.TB"*T:%F."I%+=Z9I-P\1\T>;G=MSQ0!4!EO%CO)H%4C&W`Z5K:4UH;
MLS7!3)XY[FKDQMYK;R(@HXVC!KF=0T%;*/)NG$CGCVH`]`E426_E*N5<<$4(
ML=K;I%)@CI6-I%\]M8P02,7QQO/>K6LW*VUNI+?O&/RB@#G_`!3X>LEBDN<?
M?&0OJ:Y;P]IAN;X1RP%H%.2"."*[O4BDMK;[VWS,!\@YQ1JLG]FZ;'%:1+]H
M8?,0.E`'G^M*$U&5;:`I;*<``54%F48W"0L$Z_2O0M%LX+X%KN+;LY.[N:35
M=')@DD@4&)^`H[4`<*NH)<1>68=ZYY(IEY;C,1MH]AZEC0+632;V1-NYBWX5
M>.H&:&6,V_RQG#-[T`:FF^'[;6(T>6X(<+@C-/BT>:V=X+4/Y:'EZ?X<NXW@
M=[;!D7JE=1%=PSPM#'Q>,O*#M0!'I4*FS83A^.A;O5:^TMHKI;K>HML?,`>@
MK1$%Q!9/(6#2*ORK[U@V46HWR/#J+^6DC$!<T`:EM8VMJ'N[15GBF'WNNVL#
M4M*&L2*;=CYY/RBNJM=*&FQ10P.?(_C!-9OB.-K*Q?4+4!-G`"=:`,F+1(-&
MVO<3*#C++GDFNBTN6&[M6N((V65>A8=JYWPK#'K6ZXU!R6CZ*QKM[:VMX^8>
M`.,#I0!D)J,S7P3S0IQR&Z5J&\A.(&.\E?F(Z5%>:;;W$\<C!5P><=ZM"UCC
M0HD8P>OTH`S+AM/LH!+&5PK98CK5%];M9+N$6\(=9#@EATJ[<:=$Y\D1'8Y^
M8FJ=GX6$%T[M+B/L*`-/[6ULT,4:*OFDX]*A6S\RX:YE8%L\JM&H+!9P>;OW
M3(,)D]*R(9;EI!,MPH0#+T`=5YB*06*@@=ZA;[.TJSEM[>G:L&SF;5]X=VC<
M'J>`:T/WEG;.ABX8[5;WH`TDNC+,41/E'\7K4,MVT<ICD=4)^Z*R;!=0@NRL
ML@5,\Y]*T3+8WTKYP2G!;-`&;JVJ?9T\QKC##Y=B]ZXVZTNZBU1;B-G=I?G&
MWH*ZJ_L(IIXWLHC,H;#`UM[+>.)4B$?FX^8$_=H`YZ'5(HXHH[A6+]&-;%OJ
M$10I*P1$'.[H?I3XK"P-PQ)5V(SMQTJI?_8V;;MR,\XZ"@!9;L*4>&-GSD(5
M[T^6"ZGME"+^\)^8'H!5DZE!#;IY,`=1P-H[U7-QLBD$Q=9'.0!Z^E`%2&V:
M.=V6/=(@QCL:\S^.4;)X9TAG0(S27!*C_<%>EF\W.7F5XW`V!5_G7G'QYR?#
MNC,7+<SC_P`<%14^$J'Q'SG7I/P>MA>>)XH"5`82_>./X*\VKT?X0/L\2Q-D
M@@2X_P"^*)]/5!'J>P-ID=E(^^1R$;.V503CV/85F2[(]6Q%,`S`_P`/3UY-
M;URL302E@[[P=N6^Z?:LN+2(O[/$C.SC^,$YQZ9]*LDHFZA%Q%;330A2^5ES
MN+>S57\0W3L(I2JJ86^3RAB,YX_2JLME`91<")7:%B&97^7'8?2MLF/4H8[1
MH&(=-\:@`*![&@#2\&7_`-LL4AE#NRDKOQPN.V*[^"17P0S*`N-QZ&O&]-6_
MT>X6>.%@/,QYD`XD'NO?'K7H5EKQ-N1.GW3AMO##\*`.I6(L<+D*.^?YT_?@
M97EAV[5FV5_#=Q,4<N`>".,>QJ_&P\K<W&?X>V*`)D=G7@9)ZAN#3%8*6D"N
MS=@P^Z*!DDE6[84`XS4N\G@C!'WL_P!*`$!!`;&YAR/:D"@J1N)9N33@I/0_
M04C$`87D@\T`-*G@L<XZ#M5:>+<"LC-N;ICIBK;+V`)`Y_&HG0;B<M@CK[^U
M`&7+;!MX8X4#.[')KEM2T&"ZN4VJ5F0[B^`#]?I7<21`88;>3\_N:J-81R8<
MGGD<GDKWS0!Y%JNBQPR>7Y>%=B-T:[0I)Z^E<QJ'A^]MYVB$JQL5WJ\N=S'^
MHKZ"DLX'1HVB3;MP,CG%8M]X:@GL'41>;(A++YAR0?:@#PFUMI[>"4P`NZ_O
M&0$D''793;K4[^Z\H[/W+])2VT`^A'M[UZDO@=C'NC5HB5SY>,`'ZCI52^\$
M)]G:.>80\[N8?E)_VCZ>]`'G\4%Y-!EIVDG.0)%;Y1ZC\JC2<PS!2DB(%P&7
M`&?4BNW_`.$1BN83GRL,X3?!D*K#Z>M6;?P2[WY14G8+A6P/EQZ>XH`YZWMY
M8HK>">3S+N<E5S]XKCKD>E:6E>';F2\WW4IMT1\J-H+RX]/2NSL/"=S9W"K&
M(S:DEF9C^\5O]GVKIK;2T$:-MPR=`>?QH`H:;HD42J8XUA8#Y-R#.._/>MV.
MV6*-(]JXQ]T\&EBMY!.6<CI\I49`%6DAVMR2S$8)QQ0!#(DWV=Q#Y?G!#Y1D
M&0&QP3[5XX]YXNM_CEX<L=?U.W=9(F=8+#<D.W:W4'J<CO7M:)@<<Y&.!P!7
MGNO>$M8N_C)H'B*"!&TRRM_+FD,@!!PW1>IZB@#/\;ZC?ZY\3]#\$P:C=6%A
M+";B[:U?RY)>"0-PZ#Y?UK-TKQ%J/@GQ3XL\.RW]QJ-C8Z>U[9?:W,CQD`$*
M6[CG]*W_`!KX7UR+QKH_C/P[:Q7US9QF&XLWD"&1"",J3[$UF:3X/UC5M=\1
M:_XFMX["75[4V4%JD@D,*$8RQ'?@4`<H\&M1_"T?$$^)]4&MM)YP7SCY.S?M
MV;.E>KZ+J"ZMHFEZDP,3WMND\I7IDCG]:\QE\-^/'\$Q^`CI-M]G67:-3^T#
M:8=V[[O7->K:?I*Z?HEE81?-#:P+"&4Y#8&,^U`'"W?Q"U-_%FKZ'IN@27]U
M8G&Y)PB%>/F8GIU'UJ'3OB8M[X=UB^?27M[[2Q_I%L9,@D<<&I_#_A?4=&^(
M'B#6;V(#3[["V[I*&9L$=1U'XURUMX1UA+7Q?`UJJG5)3]D!E49Y)^8]NM`%
ME_BWJ]OI5OK(T%QI\K`/.91PWH!Z>YJ:Y^(FH'5;2/6-!FLK/4B!;3N^3DXP
MQ7\:;J?@[6I/A':>'8K.+^TXI$:5`Z]`Q.=W0\5<\6^%-9UL^%UM(T:73RC7
M.^0*$``Z$]>AH`W&F>:U=MRF1."-W+#Z&F:5:7T4MFAE`)G7#YZ#=D@^M6XX
MMEX)7VR$$B)@!P?0>]36MZGV^!BF7>=05'(;GO[B@"EK>H71O+\1/\BW!4*P
M/3/-+;:C%]E\M4)_A)!_B'IFJ'B.:VCU*_6W)^TB=C@#)89YQ6/9WB0L\C2[
M8'8;AG)![T`=%-:M=>8X)8+SE3P16)JBO;VS+`23(^'7/+'USVJU:WDDLNZ)
MO*B'#A3@[3W]ZNM>Z;YRQ1RK)(1ASCM_C0!P]M9I;:C-<WL+!E^16W@#GCD>
MHK8T#3KN"(^668^<'#.>V?Y5K3:5;SWZW!5@C?(/E&#]?6NNM=-CMXUVD*Z+
MCIR10!42TE-WN;S-RCDL.OY=J=)*\,CYCWQ!?E&<8]ZVDC3(5"QSC<1U(K/G
MLT>YE.]F!8$#/&*`,V2>=C&Q7:Q&[;ZCZU-9W4<<D1F)`8DC`]/:M3^SO/CC
M,(&`.1G=D>GM5%=.C0E9-VXO]TC&WV^E`'G/Q-N_%=G:Z?-)J-I%I<U^/(BM
M0R3$=MY],=A5SXD>([RUT:SM[%S;R7MPL/G+R57'./>MOXF:%>^(=!TN&P$/
MF6]XLKB698QL`ZC<1G\*SO&_AY/$>BPG3+RS2\M9EFC,DRJ&8#E3S^M`'.W,
M4W@GQAX?6VU&]N[+4,I/%=R;\L.,CTZU1M+>\\66'B#Q#<ZM>6T]O.Z6D5NY
M5$VC/('7I6W9Z;J_BCQ9H]]KD-EI]EI@+!/M:.9G_`],BL\Z1X@\-Q:SIVF0
M6-]97TKO#<?;$0P[A@AESZ&@#<\"ZS-K?AFUO+V9S*K-')(QQN9>X]\4_P`1
M^-6M/$%OH,&DO>S30[XWC<*6)SQ@]!QR:H>#;2/1M#MK.:[@C:)W:0F1<,Q[
M`YJ";3[G4/B39:NCP?8D@\MG-P@9>".F?>@#8\'>+6O=<N]$U"Q-C?V\9D$?
MF!T=1S@'UJ"#XDWE[H%WJMEX/:YM;.5EN7><!$'MW8]^G%/@\-36_P`1KK6G
MN+4Z:]D8DE%U'N+[0.5SD<U4\-^'[^Q^'.OZ/<36:W=V[O!&+I"#D8R3GB@"
M&^^(,PTR#78_#=PNE2,%^UR3`NK>@7^[GCWK:\2ZB;KX=ZB77_7+"\9/!QYB
M'I63J7AN[?X/VOAY6LSJB.C,/M2;0H8G[V<5I>*+;[/X!N4`R4M[='(;<`P=
M`<'TJ9_"RH_$CR"BBBO-.L]W^#+M#X+N9/,V(-2D'X^7'77Z\\E[8B`*?,8Y
M#(.U?-%GKFJZ?:M;6>I7=O`S;VBBF95+8QG`.,X`Y]JMCQ?XD4`#7M2``P/]
M*?\`QKIA748I6,94FW<^E+'28AIL4=P\B,O)'.35:ZN[/1T\RW5I&YR-O-?.
MW_":>)]V[_A(=4SC&?M;_P"-1GQ7XA8DMK>H$GJ3<O\`XU7UF/87L7W/HZSU
M+4+_`$SS[:!@Q)`!7%6]--P8&,R-'<1?>&W%?-2>,O$T:A4\0:FJCH!=.!_.
ME_X37Q2?^9BU3_P+?_&CZS'L'L7W/?Y+J>>^.Z-I%5N585%JLL'S0C<)9>BC
MD+7@(\7>(PY<:[J08]3]J?/\ZC/B;72^\ZQ?%LYR;A\_SH^LQ[![%]SWZWL9
M)[(&2-@L75BO)%2V3&WMY[JV4L%XR1VKP/\`X3+Q-M*_\)!J>TC!'VI_\:C7
MQ7XA6(Q+K>HB,\E!<O@_AFCZS'L'L7W/HZQ,+Z>'2-S*3N.5S@U2DG&R2T)^
M9N6)%>`)XO\`$D:;$U[4E3T%TX'\ZB;Q-KK.';6+\N.C&X?/\Z/K,>P>Q?<]
MM">1*L-S'M1#F)L=:E`2>_AF"M)(>BXKPV7Q/KLQ4RZQ?N5^[NN'./UHC\3Z
M[#()(]8OT<=&6X<$?K1]9CV#V+[GT59WCRW;""$Q^6/WG'`JHVI37<DI\IFB
MC?"_+G->!KXM\1+OVZYJ(W_?Q<N-WUYYH3Q9XAB7;'K>H*O7"W+C^M'UF/8/
M8ON?0-X\]H/M,\!:%UP!CD&HK&Y:^?:P8!UV*F.GO7@C^+O$<HQ)KNI./1KI
MS_6FQ^*=?A;=%K6H(WJMRX/\Z/K,>P>Q?<]_BT^[\.M)/M\U7X'?FIUN+J,H
M+A2T<O+A5S@5\^-XO\2,,-KVIL.N#=.?ZT@\7>(P,#7=2QZ?:G_QH^LQ[![%
M]SU74BL^K&"$/MR2I`I8K>>Z96??$J=/4FO(E\0ZRDAD75;P.?XA.V?YTX^)
M=<+;CJ]\3Z_:&_QH^LQ[![%]SU!M1N;>[!5V1HSSD\5U47B%M1MTBN;<,[#"
MMCO7S^VM:F^=^H739.3F5CG]:D3Q#K,7W-4O%^D[#^M'UF/8/8ON?1$,\EB%
M69?,;'`49Q6C?+)JNB>8\;*(SV'-?-:^*=?4DKK6H`GK_I+_`.-2CQGXG5=H
M\0ZH%]!=O_C1]9CV#V+[GT;H%I=VMH]Q+&68_<+CG%;<7EW01FMR<]2PZ5\L
M#QKXH`Q_PD6J8_Z^W_QH_P"$V\4_]#%JG_@6_P#C1]9CV#V+[GU#>V9)*PQL
M&<@<#@"LS4;VXCNEL8[=S%&OS.!Q7SE_PF_BG_H8M4_\"G_QI#XU\4,"#XAU
M0@]?]*?_`!H^LQ[![%]SV+Q-:FW@2[CC8Y/S$BJ4$,EW82&-2!MRV!UKR2?Q
M7X@NHO*N-;U"6/\`NO<N1_.HX_$>MPKMCU:^1?1;A@/YT?68]@]B^YZ78O=:
M9,DT3-&C'#`UWGA[4(4D,\@;SG^4$BOG:37M6F_UFI7;_P"],Q_K4B>)=<C"
MA-7OE"],7##'ZT?68]@]B^Y]/:R7M;51'(_G2GY<"N7FFU9K/S$MYIFC;C"G
MK7A[^,?$TA4OK^IL5Y&;I^/UIP\:>*%&!XAU0#VNW_QH^LQ[![%]SZ-T\ZJF
MD[KN)V>8=`.4J?0P;C3Y[:Y1V1"?]8O6OFS_`(3;Q3_T,6J?^!3_`.-(?&OB
MDC!\1:IC_K[?_&CZS'L'L7W/H)-.-I/(8`P+GA0*Z&U@N#`AWE,+AEQWKY:'
MC'Q*'#C7]3W#C/VI\_SIW_":^*?^ABU7_P`"W_QH^LQ[![%]SZ3L5F2_E^T.
MWDI\W-:5QK-K!;&4,6/8`<U\L-XQ\3/G=K^IG/7-T_\`C49\4Z^>NM:@?^WE
M_P#&CZS'L'L7W/IBR\2Q7DLD;(PV]\<"K[ZM;-;KR2&.":^5U\4:\@8)K-^H
M;[P%PXS^M*?%.OE`AUK4-H[?:7Q_.CZS'L'L7W/IR72%U%@^]A'V]ZH:E86^
MAP+(C,>?N]<U\[IXS\3QH$3Q!JBJ.@%V_'ZTR7Q;XBG_`-;KNHR?[UTY_K1]
M9CV#V+[GTW9ZI97L2K'"8U'))7%4]2UV9"PBM_-B!PI`[U\W#Q5X@"E1K>H`
M'J!<OS^M*OBOQ"J!%UO4`H["Y?'\Z/K,>P>Q?<^@)+G5Y3N6!F\SACCI5G2;
M7R;AWGZ*,G!ZFOGE?&7B9`0OB#4P#Z7;_P"-,7Q9XB4DKKFH@GN+E_\`&CZS
M'L'L7W/H6U\1W37\S0VI6UC.&&WDU#/8WUY,][IPE`8YVG-?/Z^*O$"$E-:U
M!2>I%R_/ZU*OC/Q.GW?$&ICZ73_XT?68]@]B^Y]00L+'3@USM^U;,-7/36%^
M]HTMNP=#EL^E?/C^*_$,I)DUS46)Z[KIS_6E3Q;XCCB,2:[J2QGJHNG`_+-'
MUF/8/8ON>\:7-?D*T!WC=\R$=#6Y:WMXVK+:7"J"XR,#.*^:8O%7B"`YBUO4
M(S_LW+C^M/\`^$O\2"7S?[>U+S,8W_:GSCZYH^LQ[![%]SW[5;N^@OYH(D/R
M')<KU%><?&75$U#PUI2*<O&TY8X]4%<1)XP\22@B37M28$8.;ISG]:RM2U"\
MOK&2.ZNIID1'91(Y8`E><9^E*5=25K#5)Q=SCJ]'^$*AO$T*MG!\W[O7[G:O
M.*WM$=DM'9&96\P\JQ!Z#N*VJNT;F<%=V/INULKB!"TK";=EC@`#\:RY]+N[
M"WEEMKC<"&;R@W&:\*^T3X(^T3X/_39O\:3SYL8\Z;'_`%U;_&L_K,>Q?L7W
M/6=*AECW@IM>4!FP.I[_`%KH;6WFM[:-2$25V.Q`0/E_QKP02R#&)91CIB1O
M\:/-D)!\V7([^8W^-+ZS'L'L7W/>;@I%<,I8#@,5SG:?:K"Z;Y^R24F4LI``
M.,>^17S\7<L6,DA)ZGS&R?UIPGF48$\P'M*W^-/ZS'L'L7W/I;1(CIRF,*^%
MS@$@@BNGMG\Q$<.&7'8X'TKY"^T3_P#/>?\`[_-_C3A=W*C"W5P![3O_`(T?
M68]@]B^Y]A,P<`@@$GN>E.C<,6#+@#D$L.:^._MEU_S]W/\`W_?_`!I?MMW_
M`,_=S_W_`'_QH^LQ[![%]S[&W\Y)'3^\*3C:/G4'/J*^.OMMW_S]W7_?]_\`
M&C[9=_\`/W<_]_W_`,:7UF/8/8L^Q<@#"LOKC.*0[0"RD!CVW"OCO[9=G_E[
MN?\`O^_^-)]LN_\`G[N>/^F[_P"-/ZS'L'L7W/L%4))\PQA>H`/2B1`Y"D*5
M[G<,U\?_`&V[_P"?NY_[_O\`XT?;+O\`Y^[G_O\`O_C1]9CV#V+/L#R\$[6`
MW'.21\H]J8\2>:K`*2%P,-7R#]LNO^?NY_[_`+_XT?;+K_G[N?\`O^_^-'UF
M/8/8ON?7)A/DL"`6/49QFB6TCN8Q'+@8'J#^%?(YO;L];NY_[_O_`(T"\NQT
MN[G_`+_O_C1]9CV#V+[GUQ%9Q)&$5(5CSEDVC!-2_9T617CPI'H1Q7R%]MN_
M^?NY_P"_[_XT?;;O_G\NO^_[_P"-'UF/8/8L^OGMD9V=F1R.4Z#'M4D2!`-T
MB%CGG-?'OVV[_P"?NY_[_O\`XTGVNZ_Y^KG_`+_O_C1]9CV#V+[GV&J[67#H
M..<'BL/QGX87Q?H/]EC4IM/'FK)YT!^;CMU'%?+/VR[_`.?NY_[_`+_XT?;;
MO_G\NO\`O^_^-+ZS'L'L6>R_\*&4?\SOJN/\_P"U49^!*YP?&NK''4=__0J\
M>^VW?_/W<_\`?]_\:0WET3DW5SGU\]_\:?UF/8/8L]=D^!R1L`?&>K$D\<=O
M^^JK-\%.7_XJW5B<X!QD'Z_-7E9N[DXS=7''_3=_\:075P.ES<#/I,_^-'UF
M/8/8ON>HGX*LNW/BW4P3GGL#_P!]4V+X-L8EW>+-4C))##(X]Q\W2O+_`+3/
M_P`_$_\`W^;_`!H^T3_\_$__`'^;_&CZS'L'L7W/4#\&8U8AO%NIC'7I_P#%
M50E^$(W.@\3WYP1C=W'_`'U7GOGS9SYTV?7S6_QH,TI.3--G_KJW^-'UF/8/
M8ON>@'X3!8A(/%.H':2''38!Z_-4G_"I"T(D'BC4MC#//''K]ZO.O-D((\V7
M!Z_O&Y_6E,TI&#-,1Z>:W^-'UF/8/8ON=E'\+WDD.[7M0$8..G(/KC/2O1-%
MTQM+^P0?:7ECC>.(2L1EB#U->$>;)_SUE_[^-_C0)9`01++D?]-&_P`:/K,>
MP>Q?<]WU[2(7URXY#N\K.0QX&36!=>'GE`C2=5A#?O#QT'7![5Y0TTK-N:65
MF]3*Q/\`.D\Q^?WDG/7]XW^-'UF/8/8ON>U6>F><JPH=B*,C#!ACW]J/[,=F
M-LD+MO(W2$#`]P>U>*B1U&!)(![2-_C2B>8=)IO^_K?XT?68]@]B^Y]%0:?)
M';+"B!AD9RU:$5D\,:O),[R$=!C(KYF%Q..EQ./I,W^-+]IN/^?F?_O\_P#C
M1]9CV#V+[GU+$"O!?)_O>U.:WWJ!P`WWCGC-?+`NK@#`N;@?]MG_`,:!=7(Z
M7-P/^VS_`.-'UF/8/8ON?545NT$@`<*B]2M-$1DD)7&`<D_UQ7RO]JN?^?FX
M_P"_S_XT?:KG_GYN/^_S_P"-'UF/8/8ON>_^.OAM!XX>R:;4Y;3[*&`$:A@V
M2#W/%<%=?`BTMV"C7KDY.#F)1C]:\^^UW/\`S]7'_?\`?_&D-S.QR;B<GWF;
M_&CZS'L'L7W.T;X*0&X"1:Q<L@'S'RUR/H,U<B^!=FX_>:Y=H>X\I3C]:\^$
M\P.1/,#_`-=6_P`:#<3GK<3_`/?YO\:/K,>P>Q?<Z.[^%^G0WPLX=7NY)CGY
M3$H'USFMFS^!EO<QQN=9NH]YQDPC'X<UP!)+;BS[O7><_P`ZD%S<`8%Q.![3
M-_C2^LQ[![%]ST*Z^!>FV\7'B&Z>4C.!`,8^N:ICX+6/F>4=?G#[03^[7'\Z
MXG[3<?\`/Q/S_P!-F_QIOFRG_EK+G_KHW^-/ZS'L'L7W.YC^#.ERS20#7[H.
MG+9B4C'YUO\`B6R71/A_<:6UR9"D4*1Y'+!9%Y_^M7DPD<'(DD!(QD2-_C09
>';[SNW^\Y/\`,U,L1%IJPU2:=QM%,W&BN4WL?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>geovax_10k-1231121.jpg
<TEXT>
begin 644 geovax_10k-1231121.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`=$#
MA`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[VM-TW3VL+$M86>3;6Y'^C09YMDSCY3Z5?_LO3O^?&T_\``:#_
M`.-TS3?^/#3O^O6#_P!)DK2H`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&
M@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>
MG?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`
M&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\
M!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V
M7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_
M`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/
M_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*'
M]EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'
M_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;
M3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"
MA_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-
M!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?
M&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH
M`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X
M#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`
MGQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z
M*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?
M^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_
M`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5
M^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XV
MG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R].
M_P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-
MU?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^
M-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO
M3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`
MC=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`
M/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[
M+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_
M`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_
M`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC
M^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#
M_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=
M_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;
MH_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&
M@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>
MG?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`
M&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_`!NC^R]._P"?&T_\
M!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/_`:#_P"-U?HH`H?V
M7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`*']EZ=_P`^-I_X#0?_
M`!NC^R]._P"?&T_\!H/_`(W5^B@"A_9>G?\`/C:?^`T'_P`;H_LO3O\`GQM/
M_`:#_P"-U?HH`H?V7IW_`#XVG_@-!_\`&Z/[+T[_`)\;3_P&@_\`C=7Z*`/S
M]_:>T_3X_'^E*-/L,?\`"(V!YM;3OK.O?WK*0_\`CW^)*M_M1_\`)0=*_P"Q
M0T__`-/&O44`?<NF_P#'AIW_`%ZP?^DR5I5FZ;_QX:=_UZP?^DR5HL<<^_/T
MH`6BHR?F7Y^/3UZG![9_+CJ*A,NWJXQG`.X\GVP.W3^="M>,6TI2^&/5V5WZ
MZ*^G^=IE)17,VE%6YY.2BH-M))MV5]5L6J*KJSE@#D<XZY!X],'^?:I=K?WC
M^M*+YHJ2V=_P=GLWKY#;LVI635MI*6Z3Z;;]>FNP^BF;6_O']:3:W][]33#F
M7?\`K^OZW)**BS@@;QG!P,]2<X_H.?\`"G+DCD]_K_C_`)^M'S72^^E^_P#7
MH%[:^=E_>VUCW6OJ/HI,>Y_3_"HR2#C)Z]3T^GIWY_#I1KT5W?;_`(?0$[[^
MZN\M%]Y+141)]^O<]P.@]OY\8'JN<YP_?WX[8]?_`-6>]*ZNH[-[?AV]?\A]
M+]%OM[NS][MH]"2BFKGO[8_+KT'6G4Q)W5PHHHH&%%%%`!1110`4444`%%%%
M`!1110`444A('6DW9:*[[`+129ST/^?Q%!;'8_4#BA/RUTNKK3[OZ8"T444[
MWVU`**;NR<#_`.M_C2@GH>OKV_"C^K`+129`..]+0`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!136)"D^@JJQE7YMY^7<
M=O\`>R,J#^G^>C2TNVDO/3^O^")NS5T[-3=TF]81YN6RN[RV5EN7**J0.[?,
M^X%R!L;M@`$KTSNZ_H*FWCD`DGMG_.?T]*E24I-0]^V\HVLGII^/X7V)YX<L
M97LIQ4HIIQD[I.W*TGS*]FNZ9+149#$`C(]1TZ=_QI?FZ<YZYZ_AG^M,KF5D
M[[].OS'T4S:W]X_K_GK_`)[5"[-NP2RA<?,N#GZ@_KS^!Z4:O97[^G?S]`O?
MX5S/I%-)OTYFM?\`@^99HJ,$C')QD9SC./I[_P`AFI*`3O?R_K\.H4444#"B
MBB@`HHHH`***:=W&#]??^=*_O6L]KWZ;I6]=0'44UMQQC\>U,P_O^?\`]>A-
M-76J_I`2T4#.!GKWH)QUH;:6BOY?\/9`%%%%"=_7JM-'V]0"BD!!Z<TM$6VM
M4UY/_@`%%%%,`HHHH`****`"BBB@`HHYS[<_TQ_6DYYYSZ#'2I<FG%<K=[W:
MVCMO]_3S`6BBBG?;2Z[KUM_7_#@%%%,;?GCI^%,!]%1C?GGIGGI4E`!1110`
M4444`%%%%`!1110`4444`?!'[4?_`"4'2O\`L4-/_P#3QKU%'[4?_)0=*_[%
M#3__`$\:]10!]RZ;_P`>&G?]>L'_`*3)5Z0XV^Y(/Y<?K5'3?^/#3O\`KU@_
M])DJ[*<+R/4]^,<]O\]_>E)-JT;7NK7VNFFKBD[)O;E][[M?QM8X;QU9W&L>
M#?$NG6FLZIX=O+O0M7M+?7M$^SC6-%GFLYDCU73&O(+FS%_89-W:"YMIXC<1
MQ[U(!#?@+_P0K^.W[3?QG^#G[0WQ_P#VK_C[K_Q%\-:7\3_$'P]^'^GZU;Z)
M9:?HN@>#+^]@U#63;Z9HFF7%SKNKW[QV(`N;J*:WM(HH+3S7PW[S?%S6X_#G
MPN^(7B`ED71_!?B753Y88RYM-'NYB(D1<M)^[PBCDD@=,5^,7_!$/]EWXH?#
M?]C#P7;?'+0E\-3:E\0O'GQ,T+P9(Q>YOH_%^L/JNBZ[XGCD7Y+VQ@8FRTN2
M)X89I4O_`#?,5%KR,5&O4SW+/9\\:,:->M7<7>+LE!)=&K-M<UW<_2.'UEJ\
M/.-:V(C@EB\5G7#>%P'MJ5&IC8T*OM\3CJN&56,N6T:*4I)64-):-J7V)!XI
ME_9_\<^)_P!H#X]?M(_$-/`_Q/U"/1?A7^SSK6G:#=1:=<7*6]S;P^'=$T+1
M/^$NUKQ#/Y,]X-/6>[DT^TGD^VJ[(Q3UKX,?MU_LS?'WQC\7O`_PS^(L>M:U
M\!4M1\5)[G3M4TG2/"\]V;J/[)=:UJ5E::5)>V7]G7/]J6D%R[V#H1=0J=KK
M^%/Q'^.)\4?\%OOC-XC^+6FZRGP\_P""??[(OB_XB?#;1M1MI9=,_P"$BU>'
M2_[2\6Z=:*<27-]I]YJ,%G=+BY6.RN?(F1=V?Q&T7XC>)[+_`()N0^+M%_M]
MK']O']NR/Q;^U'XGT:#4+/0_A_\`"K2_%%KIT6A:CJD*6VW1O$PFN[N6Y6Z7
M_42+?RR++\WC2X@K4:DJ484H+ZQ5A'V\*MW%245*+A**LY.UK.R3:/TC+O"C
M"9_E]'$8O'IYUC<%PQ/!1P4L!0RVBLYCCL;.EB(JDJCK8+)<%1JSYJBGB<PQ
M*HQG[J1_=+X%_;2_9V^(GQ+MOA3X4\?QWOC'5M&O-?\`"UM/8ZA8:9XTT?3)
M_)U74?!.KWEO%IGBJVT]F3[7/HSW*Q^:IWMD!8?$/[;W[-/AWQ[H7P_U7XEZ
M>=8U[Q4O@.QU*TM[R]\*0^-[@A;7P5>>+;2.70[#Q7?$A+;1I[]+^9QM6%3A
M3^7G_!1CPA\-OAU^S=\4/VHOV4/`,_BKX\_!7]EJ7X6?"KQ1X)N[S4-!\"?#
MGQ;+I]K?W?@RTT^6715U?3M(B_M0W>D6WV][2RA\^4D\3?L`?`3]D/XG_L(_
M\$_K+6],M?&VI^`-(T#XWVT6A:O>7UII?QBCT@:AXK\0^/DTNX-O/J%CJUU=
M//!XE5KB'4(?W4"2;V'J0Q^85*OL*=+#.;BI0J/VJIS3Y5HG/F6[[[6?5KX6
M?"G#,<IIY_)9O'+JF.J9+]5=7!RS"EF<,'6Q4*TX^Q2^J2A]5BHRA&HI2Q"Y
MWR0B_9OBW^UA9?$O]J+X4Z9^SM^V[\%O#WP_^!:^-?%O[6WP\GTX>)-0U'PA
MI,BZ5MG\0V]R]KH)T;48;FQNK>9[63[1(E[&\VY(C]/-_P`%)/V*(_AM\1/B
M_'\?_!5[\,OA;J$.C>,/&EC=O>:%!K-Q!]IMM)L+B&.4:MJ7V=PPM;%YKA"I
M+(-K`?SF_LC_`+2GP\T%?^"P'_!1K7?#6FW>N>*-?\:_#GX;:%%I&GV4FA^$
M/AW8ZC;1VFOWILHM+M1XFUV/2;FTCO5ENKR?:CR7*R/(GP3\0_AW<_!?_@C7
M^Q_\$-4N+'2O'W_!1?\`:&T7QCXAU<Z5:WL,'@+7+RVOGO3<+9-##?W6FZAH
MNJGRQ%?+';S0P@Q>?7DO/,3"4\3%4:LYX;VCHQA7MS>TITU&%YNU[N5M7N[H
M_3*?A'D.-Q.7Y7B<3B\']4S'(N'(8B%?+_W^*QF6K.\^Q-2I]72E3RC#RCA?
M;64'6M%\SO%_W>W'QJ^%NF?">'XX:SXTT/2/A7=^&+#QB/&6MWHTW1HO#FI6
M<5_8ZC=S7_E?9O.MYHCY,RK,)6\K&\;!\OZ'_P`%'?V4/%'Q3\(?!32?'>LW
M7Q1\<^&]<\8>&?!S>#?%4.KW?AK1([B6;5;JWETD#3[.\@MI+K19KS8-9M3%
M+9&>*:$O^)W_``4[UM-8\6_\$@OV$M"T[Q./V??B+\4O"UOXROYM/GL-)\96
M'PM&F:=IFAW_`)P9I!<WEO)X@-GB.*X@FS.\L12.OFGP?^U#X4?_`(*)?\%2
M/VX;*SUO6[K]EGX*3?`OX3^"_"FAW6IW>K7R*+.]URX\F*'[%;^'-2\/,9Y\
MHFFV6H/(I>)D5M\3Q'B*5:-.C2A3C*K&C*K5IU).+=%U7R<KBM&DE>_-S::I
M,^2R;PGRW,\DJX[%U<55K8K`9AC\OPU+$X6GR\F?X?(LCI8I2IRG[3%XJ&+K
M8NWLU##TXRBH-R;_`%M^"W_!;KX#?&;X_P#Q=\'-;:O\/?@%\(=)CT/4/C]\
M0-%UKP]X8U#XK'4Y5NO!5[J$UFMAX:^RZ/`]S8+KEY;ZEJ=X9?(L6BB8GZ6_
M8H^+/CG5/"7[0W[0GQ>_:N^&'QE_9X\3?$?7/$/P2\6>']$_X1/0OAW\-]):
MYM+S1]:UV[G2VU/['=VQAENH3)"ILY+I+R4Z@T-O_-5\/OB1H'[.G_!`KX@7
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MEU3PI=V"->6/B"P6?3);4K(L[`@G`T?_`(**_L8>)-(^)_B3P_\`M`>!=<\+
M_!S3;75/B%XFTK4/MGA_PU!J$L\=A%/K$`>SDOKHVUPMMIT#->3>1,R+M1L?
MBM^SO\.TC_;W_P""A'_!4?Q%X>U/PS\#/@Q\*=:^"'PBCU2&71K'Q_!\.?#S
MZ;XEUC2X+J5;*\\)^5H']F^'+R6SBLI7O$FM(KB"1W7\;8[G5OA+_P`$9OV@
M?VBM7M;'3/'_`/P4F_::NM+\)O\`8+755M?!^KZ[JJA966TDM(I[32Y=<T6R
M\V-"J31G3WMRNU-I9YF$*=&J\)3<*L,?-653FMA*4)P;]YV]HY6:MUTL]5YF
M`\*>%\SQ4Z6&S7,)QGB>"<IPM*&)P'.\ZSW`5,PSG`U*D\.H7R_"46X32BJ5
M:?LZWM)1Y7_>1\&_B]\/_CM\./!WQ:^%_B&#Q-X#\=Z)::]X:UVWBF@BU/3K
MP$Q3""X"W4)(4CR[CYEQEEQBO4PRM]TYZ_IP?UKX>_X)Z^`_"OPI_9$^`_PJ
M\(7%WJ6C_#KX?>&/"HU^XTZ73HO$>HZ;HMJFJZS8)(!Y]G=WHN)8[E<12AAY
M;-R!]OHH7&#G@_S_`,<_YS7TU"=6>'HU*L5&M-1=2,4^6+:N[7[:=7\]#\)S
M?#8?!9OFF#PDZE3"87&U:.#J5>5U:N'A-QC.JX6ASM+["2_NJ]B2BBBMSSPH
MHHH`****`"BBB@`HHHH`"<`GTKQ/]H?X[?#_`/9K^#OC?XU_$[41IO@SP)H\
M^KZI,&037!12EK86JR$)+>7UPR6UK$2=\[H,=Q[620"1C/OTK\5/^"]OP6^+
MOQM_8$U[2OA):W^L7GA'X@^"_'OB_P`+Z38S:AJOB?P3X?DU,:QI]C:PI(TC
MV4E[9:Y,%CED:WTF6***1Y0!PYC6J4<)7G13=6$%**2[R2OMTW[B;:Z7_K^O
MN/8OV;=9_:9_;5^&%C\=?'7CW7_V=?`OQ`NK7Q+\(_AW\-[/3(O&MGX*BN#+
MHU_X\\1^(M.U2.ZO/$FGD75WHVGZ1;16L,JQI?93GX__`&FOVE?VW/V7OV8/
MVP_C)XN^)>FVOB'X0?&C3/!OPCN=1^%L5UI'CSP'J%I:6WA^#3]/;5K`0ZMJ
M&H^(].35_%D5[<VZ/H-^%TA&9HT_4?X"_M%?`2^^!7PUU+PU\1/"ESI]G\-?
M"$T7AZTU*R7Q18PQZ-9VXMKKPB)SKVGWJ3H;:6UGL4*SJ5(1:_'S_@LGXLO_
M`-I7XL_L`?L1>$[*19OC9\6[7XM>*K#5;ZWT^<>!?`2$3VVK:'-'-)?Q3)>R
M:G:68*I.UM%YLD3+@>1CO;4LLA7C6Q*Q#A&4>1QYY-I-\R:V6J5NBZD3FXQY
ME9NW6^]TM+>I^C'[)W[7'AY?"O[,WP:_:*^*^@R_M@_&/X:V'C_7/`4CV\6I
MV^I:CI::[?:7Y-E&EKIT-C:WAMM*M+K;=7K0,MN\K)BOKGXJ_M%?"'X1:EHG
MAWQKXLM;7Q'XB62XTOPU80W6K^()M,MO,%WKDFD:9!=WUMH-BZ*E[K4\,=C:
MM)'NFWLBG^=SP-?^"OC?_P`%S_%6KW\6FWGA/]B#X6:-\,O!>CVWAZ^N->US
MXB:B-/T/[<FPPVL$_A^>ZU:Y>]G5T>Q^R?9Y(9`Z)X;#^TW=VOBK_@M?^V3\
M1](U*U\=?#>#_AFCX3Z;XBBN))_#7A;43<V5MI=I&$6>*RU;4=/M=6G>V$*N
MEP(Y]Y*D<='-L13H8J'LY1E'$2C1J5(S:^K1I2FZT[6O)2BU[K4==MF'._+\
M?+\^G_`U_:;XZ?M[^#?'O[%OQT_:2_9+^-OAS2+;X+WVK6&I>-?$_@#4O$?A
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M)_O.;6"@E"W5J]^ASOLMOQ=OZ?\`5OVT^)/[0?PQ_9=^$MCXL^/OQ%M=$A\-
M>%=-O?%.L7\)GU2X6"*SL]3UQM+TU))Q;'5+F/[5-!"T,3RK&#D97E)?V]?V
M1HG^&]L/C?X.N-6^+-AX<U+X?Z!:WS7?B#Q-I_C"(R^'KJTT>)1>"+4HE:2)
MI[<&-49I3&$8C^?;3M"\7?M^?MR?\%,OA%^T#XDO/A7\--)E\`?#(^#9M->^
M^)7B#X9^'?%@U#0K;X<Q[X;"'0?&MUIMK?\`B/5/L5_>^7>6</V@1B18_0?&
M'@CP7\6?^"Q'P4^"/@_PY8:7\'_^"<_[.$'C?7(+0Z=)<VMTFFV\GAB`V=M$
M+R+5-._T:T9Y79R;NZ2**&-W$_6LXQD8PA2H*I3I8NO@W*JI>UE&C*T9:.*Y
MFOBTLGL)SF_ABOG=ZZ=K=#^@CP#^U'\"?B=\3/B%\'O`GQ%T;Q)X[^%%G:WW
MCW1["660>'XKR5X46YU`!+)I89$99XXF<6YP)/EVL?*-4_X*$?LC:/XFU+0=
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MCI[*5]>6_326GD*<M+K7JM?ZV]=3^J2'XT_"J^\`:;\3].\>>&=5\`Z[$)-#
M\3Z9J=OJ.DZ[OFDMTCT:XMGD75)I9H98XH;3S9)#&Y52B,P^?/"G[?7[)OC7
MX.>/OC]H?QB\//\`"OX8:UK/AOQWXFOFN=-7P]K>BW!M[G2KNSO(XKU[Q[A&
MCM8(U5KLX%LDI(%?C3^V[J_Q*T'_`(*&_P#!/7]C;PCJ.G?#KX.^$/A_XDU;
M0_'7CFV\WP=KGBVP\%^(-$AG$-H]JDWBSPWI,4\VCVTK+:W.K:Q$TN[:TH[3
MXY?L??L>_#W]@/7?V#[+4]>@O?B3X:^)GQPT7XA:[I,-K_:'Q`\!27GBL>.?
M$UR);?2]+BUZ^N)M.\+65ZQ@U",QI9K<3!&;6.;8VI5JPI8:"C0PTI5?:*:E
M]:5G&FM?@DF^E^TNH2G))M6=O^`N_=_/H?MG\)?VE_@_\;;Z/3/A]XF.K:RW
MA31/&LVD3Z;J.DZG8^&_$2)-X?U#4+"^BBN+"+5[:2.YTX72!KJV=9X@8CFO
MH)#E0?7GH!P3D#`XXZ?ASS7Y+?\`!'#Q3XD^+?[%GPI^+_Q(^%\'@;XGZIX5
MTKP%JGB>XLQ;Z[\1/"OP]1]#\(>(K^:6VMK\6DUC$6M(+A.$57C)C?)_6E05
M4`G)&<GUYZGIR>I]Z];`5ZV(PU"K7A"%2I3E*487Y4TXI6YFWU>[_`N+;BF^
MJO\`?_7](=1117:4%%%%`!1110`4444`%%%%`!1110`4444`%%%%`#6^ZV?0
M]L_XU^:G_!6'XKZO\#OV$_C=\:/#WQ(\:?#/Q!\--$MM=T+5/`4FA+K&I:U<
MZA%H6CZ+,OB#2M6LGTV^U/5K:34(TMXKIH;;]U<Q?.)/THFSY4FT$G:<`9S^
M&.<_2OYA_P#@X%^-?ACQWJ?[(W[!%AXI\-6FI_'/X[>%=9^),.H>,=&T2R\/
M^`_"MS%?WD'B^*ZN8A::=JUM)<SQ?;6BCG^R``,[H#Y><8GZM@9S52-.;DHP
MYE)W<M-.5IW[>FW;[CPXR?\`MKC/(L).*^JT\6\=C9NDL0HX/+:-3'8B#P[T
MJ*O"A[%1^TY\F\DSP;0?VD?^"B7PC^&O_!-[Q-H?QH\;?M!?M-_M.>(M`N?C
M#^SQXGM?"NI^'='^'^MW3S-XDB_X1CPY9ZKX0T^TTV:R,^M:G?RV2I++\F_:
MI_J$^)/QN^'GP9\,Z7KGQ2\06/AF\U5HK32]&5VU'7M>UYK9KA]$\*:-:))J
MOB;5MD4\D=GI%I+<211F;RE4&OYQ-/MO#?PG_P""LG[*7PM_X)FZ-X9D^%TW
M@"^MOVNAX&B?5/A9_P`(Q;O$^EWEUXCT]KW1(O%4-C'=OID%E<*3?31Q72A6
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M5*@N@0Y/F]A^WK^RU?\`QF\._`RS^*>F3^.?&1UFV\(R1VU[_P`(QXJU/PY<
M&TUW0=$\8F$^'=5\1Z)<(]OJ.C6NH/?V\BM$8"ZD'^:OP+\(_P!H[_@G_P#\
M$0?VO_CIH/A'QCI?QW_:G\4>(?B-K'ARS^T_\))\+O`_CS6+S2+7Q%?62*LM
MIJFD>$+]=8U[R8DGM1,AFD3[---%)\)/V7-)_:E^,'_!(/X5?##1+Z+X,_L;
M?!O1?VCOC#\1-.,D?AY/&WC;RO%NGZ''XDMIVLM0\7:EXJM/[4U^V0RW=M%-
M<1ZG/MN&QT_V]C%]0A]1_>8B"E64E42@N:SY?>37NIR;?-8\R/AKPIS9]F+X
M@G5R+"8[,L#@<32E0C7@\JR'^T,77Q=.4)>U@\WG1R;#QI0I>UG-U(RDK)_T
MX?%?]L_]G7X._%'PK\&?'?Q#LM-^)?BG1]5\36/A>SL[[5M0L?"^AV?V[5/$
MFO#38IET'0+2T/GRZIJODVBQGS-VT$U^=7[3_P#P6A^#GPH^(WP6^#GP<\&^
M.?C-\3/CAK/A6\T"'P]X1\27&BP_#*^UJ"V\3^.M,>UL6NO$T.E>'8-:UFTM
MM"@NUN5L8YI6A@.^OS(_;H\9>$9O^"EG[)/[9W[-7A+4_B?XN^(GQ$\<?L8?
M&GX6:GI4EJWCOP7H,2^&_$>NI;WL%S+)X4CT6[FCMM7C@71+\:;$#-N+NGH?
M[-.I>"OB%_P79_:&\8)H-KHOA+]E+X5^!_V;?@_X$T#3I+FXB:]TN(/J>A:9
M:QV\.F:)IMAJFN#4+E1'%'IUO%*9G0>0BJYOCI8E8>-+V*6.P]#GIIN4J52F
MZDG)N;5[QM:RY7:[3.K*O#SAK!Y52XAS'"8K-Y8#@FOQ/B\`\90HQPV<4<=#
M+'E\Z4**K3@WB(8FBU4ES8>$I24XIL_JBTB_35],T[4(UFC6]L[2\1+B"2UG
M5)XD=4GM9E6:VF"L/-@E5987W1N`ZFMNJ<;L.0!M^15"@8.0.01D8/7C(YXJ
MY7UK35D]=%]]E>_X+Y=3^?G*\ZBV]^4U%+2$:C<XPOU<4[-[7V204445(!11
M10`4444`(W0_0_RK\UOVW/VX[[X#>-/A+^SC\&_#MCX]_:B_:"U,:7\//#VH
MS/%H7A+3D+1WWCOQD+>.2Z_L33HH+B6*!/(:[F@$'G1C&[]*6SM..N#C/3..
M]?SK_%OP?X@^#W_!=GX:?M$?&*[,/P0^(7P!O/`GPV\87NFS+X<\%^,;&**V
MNO#6MZ]M-EH]QJ-P-2UR*[U&6VM5@N0HN=X:-?,S2O5HTL/&E&[KXF%*;5^:
M,'JVK==-&]$^_26VK>NOIIJ?=OQW^&_[7_P\^!GCGXL?#SX_>)/&/QW\/>`5
MN8/!3^#-'OOAKK>IV%Q]KU2U\/>#[2T3Q';ZI?6SW%EI5Q/XDOXHKE+6ZDLI
M`"B_%WQ5_:F_:X\*?M\_LC?LF:+\4+&Y\&>,?AIH/Q=^/%Q+X*TS3_$/@?P?
MX<L)IO%#ZIXFN]0FAFFU/5-/N)KL?V187%I8W26R"22'>W[40_&?X<:I?:)I
MWACQ+IWC&36V<Q3^#[RU\16%I8JQ6XU/4=3TJ>YLK;3K=\-/*]VF."H)&*_F
M=^#OQ1B\=?M8?\%7O^"D/B.WM[KP!^SGX*\3?`_X>-=7*>(D&K>$-!GAGMK:
M"T@N&L]'U:>XL-7NA:H<MJ,KSF3;)(WDYC5JT)4?JM2O.,M*B=FH*-D[66[W
M=V]7;?>&V];VO;9Z:6O_`$M=/F?T@_`S]ICX)_M*Z7XNUGX*>/M'\>:5X&\3
M7W@OQ-?:.\YATWQ'81)+<V;/(B[X!$ZM%+'^[E=7\J0@$KXI\3O^"B_[(?PA
ML->U/QG\5+.VT;0/$=CX.N-7TC1-6\0:+=>+[VYEM?\`A%M'U'1[6>TUS7;.
MXB?^T-,TUGN[`E#<HA9<_P`\7[*WC/5?V6?^"(W[3?QU\!6-Q?\`QQ^.%GXN
M^)GBCQ'X1TB]@MO!T/Q!U2;0=!-S<B."!G\):;<7>H3R6@PMI=12_:5(+IP7
MC[3/`%S:_P#!%;]B:WF?P_HFH1>%_P!J+XG:G#IL][?3:Q->+XIN9YX%A<ZA
M=ZUK=E>V%WO,EZZWL"/<2KNVK^WL4J&%_P!F4,16IN4E4C-QBU.,5*R?,U:\
MGJ/G?ELM^[^?_#=3]FOVP?VCOVF/#_[:'[%WP0^!OQ.\/CP5^TEK.DZUXO\`
M`;^!8+;QMX8^&.@(U]XP\:+XLU'4[C[5;ZI;M'8QZ//H%E<630W!6XF8_)-\
M&_C_`/M2>//^"H/Q:_9ZO/B=X;\;?`/X&_#^W\6^)Y_#'A"#PO=Z1XJ\6SR_
M\(MX!\1SRZEJEUJ]W8Z2IU*75+3[+;73,[&UC8F)?D7X!?'7PC\<_P#@J+^U
MS^U-JT&H-X2_91^%T/P6^'>@WVD3G5_#M]I^GWGB#QKKJ6BM+_95C<6D\)O#
M<2"X.UPUO&%7?XA^R5\9_&VA_P#!/?\`X*+_`+=_@#0M8\;_`!X^/?BGXE^-
M]$G\/6+R:MX;\#631>%/""3WRJ\5Q=>$K676=9AM8"[V]M:N22\85N&&/G&K
M4G[>M5G0QF*G6ITX-1]AA72C:-T[N3K*ZN[VNDK.YS^7XZV2VZ?UHC^AGQ)^
MVO\`LQ>#/B]X+^`VO_%;P]IWQ'\?PZS)X5T4R226VI'P]YPUJ&+58(CIL5U8
M>1/Y]N\BOF-PV"'VTM'_`&\_V1_$ME\1-8\.?'+P/KFA_"G1_P#A(/'^NZ=J
M8U#0_#ED8I)5%YJ-ONMX[F1(7,=DN;B5UPJ##&OQ9_8!^!?PW'P2_9W_`&[?
MC)XRTOXB^.?@7^R;XMU/P-H>A6>/"'@JTE?7/&FO:WXQU>\NW-[\1]2UFYGM
MKEKV6"&RF_?VUM'-/)(GY>:/K5[\/_\`@D-^U5^U#J.GV.E>./\`@H)^T%K&
MC>#;9=,L=;C3P7J&J)IT/G1VNGP6L=U%IZZYI5G^[A*PV<<D2/*ZM)V5<[S!
M-5:>&C*GB*#KT%*-3FA"$E!JK:5E)MWT2T\]CG=NG7OV3^_^G8_L<L?VL?V?
MKGX&:9^T@WQ-\.:=\&]?TV'5=*\;:O=G3-/O(+B62WMXHTO#'<R7\TT9@BLU
M7[1(^Q%B!//&>`?V[/V7/B!K^G^$[#XK:1X>\8:O?Z?I^@^#/'EM>^!?&/B'
M^VFF71]1\/>'/$J6&IZOI6KM!*NG:C:6DMI=+'YD<YC9"WX&?M6?!_X`7O[*
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M2Z?:WURDD=O<W"PQN(I'#A49A%X^_;!_9\^&?B_X?>`O$_Q!T^/QC\3]'N?$
MGA+P]I5M>:QJ5UX;M+$ZC=^)+R#3HII=,\.VMB#<S:K?I%:QH)',NU,G^;/]
MBKX67_\`P4?U;]IG6/VKM=N=)TK3OV[-,\3ZM\%(=,6X^)&IZI\/]*TE_!OA
MCQ!)<3M;:7\.M(TB]D_>6ED)=3G?4%N;H6_E@^D?M^>)/!FA_MJ_L@_M=?LP
M>&[WQQ\1M&^,VJ?L4?$'X5OI[647CGP99V$%MJEQIZ7$-V4\*66DZE=:)'KD
M5J-(DV.KLTR;0HYSCZM".+I8."P\ZGLU":G[>-I*+E)<R2C>]G;9Z]&A2OVU
MMIUWM_2_I_TW_#?X@^$/BGX3TSQUX#U6'7?"FO1M<:/K-M')'9ZG;K))']ML
MC)'&9K65E;RKE=RSA=ZG;M+=W7(^!O#FB^$/"FA^&_#7A[3_``MH6CZ;9V>E
M>'M+@M[;3]'LXX$*:=:PVT<4"0V3L]NOEHBML+[1N.>N&>]?149SJ4X3DE%R
MC=QLTTW;OKIK^!84QR`O/'(&1U!/3`P><D?GR0,FG$D`U%+EH^"`<<$G'+*5
M'8]SV!]@:T=[QVLY6??:^GG\OR`_,?\`:_\`VX=?^'WQL^%7['G[/&BZ;XL_
M:7^,B/?V\^MM.?"7PL\&@2B[\<^++:R5[B^CA%O=&PTAGM!J,MO(GVV``;J?
M[2G@#]KWX4?![Q'\2O@]^T#XP\>?%A/^$/M[[PEK/@K2-5\)W-E>ZU8:7XGN
M/!/AK3((=8T.]BM[IM5@N+_5M:@LHK(M,CJSX^&M$\,ZQ^S_`/\`!=;XI?%[
MX\:A%IOPW^-GP&@TSX*>/]:LY+'PGI=UI,FER:GX'NO$TZIING:CIL=C?ZH6
MU&>SMWM[]UM;F>62>-/W'@^,WP]U34+:P\.^([3Q6+FPGU6;4/#%U;ZUHMCI
MMM$]S)J.H:S83R:=:V_EA/WR7LN58CRL*6/A86I4Q,L8\5B8X9^UE"C3BGS1
MC!\L9/FO=R24K)6][2VEWT_KR/QR\7?M8?M,:%_P5$\%_LHI\4M(N/@=X/\`
MA9;_`!L^-FK_`/"):9H6H>%_#5IIL\$.GZUXJDO;^+61J&K:)<7.N7<6E:;]
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M:S=KZ[&7/O\`>OOV]?\`A[']#?CW_@I'^Q]\/+:VNO$OQ30:=J?C>T^'>@:E
MI>@:]KVE>*_%MW(T#:5X7OM-L;BV\1?8I56+5+C3I;BWT^1[=9Y59T#?*'[0
MWQ]_:DTO_@I1^S?^S!\,_BAX<N_AQ\2M)U+XF_$3PK9>"+73_%W@'X?^&+>3
M9=W7B"YU/48=>7Q)KUL+?:VF:9=VMNYA5G8"1ORO^(VF?#3_`(:Y_P""1_['
M&FK_`,(]X$_9P^$^@_M!>(X['39KZZN_$=WHUAXBT_3XD@62.5-=U.">"[V1
MFXN+CSO,,HCBKW[]DK]I'PE\0/VO?^"D7[?7BF/4+S2/A!H&H?"+X:Z<^FRO
MK'A7PU\/=%U/5_%L>HE6==,L=2O]/TZ=!/-'-Y]W+'Y(1-QTJ9O7QMZ5&48N
M.(HI>SA5C5=*5.<I2?,W'22BM(]7;;1.3=E>VJNUIIU6OS_RV/MK]D3X^?M0
M?%C]OW]J?X4^-/B7X;\<_`;]G#3=*TD:OX2\(VOA"VD\?^*I)KK_`(176EFU
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M'5[F^N'>"]DU#9:6Z7\C`PV9XVC"2A2=9NE5JR=6_NRIS4(Q7*U[K6KOK?9K
M02=33EUONY=/+=7[_,_7ZU_X*!?L@ZEX.^)'Q%TOXY^"]5\!_"1+8>.O%VFW
M[WF@://>PRW-O8_VE$)+>]U&6&$RQV%N6NBA0J`)%SZ/K/[4OP&\._"'0/CG
MKWQ*T#1_AMXML+&_\+Z_J$KVYUT:I"DFG66EZ=(4OKS5KP.HM],M8C>L6V["
M0Q'\9&N:5??"7_@C1HE[J@M-/^(?_!2/]HJRU(7,6DVM_$G@CQ#KB(]UE;>2
MU%ZVBW8>-O+BD6U@BM[`!;?,GZ;?MH_#W]GS7)_^"=GP/T;XV>'O"WCK]E-O
M#7Q/T?X9_%6[N/!/@'XZ>%/"$FDV%_;_`-MZHCZ#I/B#4M:TF>'2-6U.SO6M
M+6\U!IXDC6$2Z4^(,5*&(Y\+&$J-#!54VI\C>*Q"HR3=]HP]Y:KWG9O9)J<M
M%))/2_1:V]?U_`_='X:?ML?LR_$[7;'P=HOQ1T;3/'VI7D>GV7P\\9+<^#/B
M'=320"XMV7P;XBCM-?>TNK?%Q978MVMKJ!TD1V5TW:/QT_;*_9Q_9MFT>+XQ
M_$W1_"0UOQ+I?A.W\Y+O4?LVOZV"^F6&J26"3II<M[&IE@%X(QY0,K#RSFOS
M4_9G_9,\72?M0_M"_P#!3SQUX@^'OC#QKXS^'=SH?PW^$'PEURP\<:1X=M?#
M6BSR66EZGXWM`EAXA\37\5KI]C#=Z9IFG&)Y9%2,1/'G\\?^"<'P83_@H'X+
M/Q4_:P\4?:YO#7[;7C3XI'X-VVFK=^,9O'VDVUO:6EE\4+^[DFBLO"/A;3$6
M+2[73]/L;>:S:<W?FR;8Z[%F^):PRCAXRG75392Y4X223>NB[[^5BN9Z;7>U
M]---7_PY_1[\0_VP/V>_AA\1=*^%'B[X@Z=:>.=6\*:MXWDT2UM;S6&T?P7H
M<<4VH>*?$L^GQO;Z!H=O','-_J;6\#)F82&&,N??O!/C#0/'_A71/&?A:\.H
M^'?$5E'J>C:@89H%OM/N,M;WD23I'(8+A,2P2[=DL+))&61E8_RY_M/^(O"=
MC_P4K_91_:?_`&</!M[\4+G]H_4OB1^R=\<_A7J6GQVD>O\`@_PY=V/AC6_$
MEPMQ;WB6?AF[TNX5;?4[FV31]3T[3G@1'>[G-O\`U-^'=&TGP[H6DZ!H-A:Z
M7HFBV%KI6D:;90+;6EAINGPI:65G;0(`L4%M;PQPQ(``J(`.`*ZLNQF,Q-?%
MPQ%*G3AAY0A!P4KR<HW]YN35]'LK#4KO^O+Y=6;5%%%>N4%%%%`'P1^U'_R4
M'2O^Q0T__P!/&O44?M1_\E!TK_L4-/\`_3QKU%`'W+IO_'AIW_7K!_Z3)5]T
MWC!)'4<>]4--_P"/#3O^O6#_`-)DK2H!JZ::NGHUY,S[C3;6[BFM[J-+FVN8
M&MY[:>..6":%QM=)8I%9'5T+(ZL,,K$'(XJ2*RA@CBBB`2.%(XXXT54C18@`
M@1%`50`.@&T<````5<HH22<6EK!<L?)62M]RZCYI=WM%63:7NIQCHM+J,FD[
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MX-\+>'?"FGWEU-?7MCX;T+2]#M+V]N6E:XN[NWTRUM8;BYG,I\V>9'ED`&YS
MDUVU%/DCS1ERKF@K1:5N5;:):;$NO7<90=:JX2FJDHNI-J511<%-INSFHR:Y
MG[VKUN>:?\*;^%?]BZOX;_X5UX'_`.$<U^Y-]KOA_P#X1/0?[#UF^9UD:]U7
M238FPO[LR(LGVBZ@EE#J&#@XQ?N?A?\`#R\LO#VFW?@GPG=:=X2DBF\*Z?<^
M'-&N+'PU+!;K:P/H-G-9/;Z0T$"K%`;".W:*(".,JGRUWE%3[*EI^[A[L>1>
MY'2-T^7;:Z3_`.'9<L7BY/FEB\4WKK]8K7NX.FY?'\;IOD<_B<=&[)'+:OX)
M\)^(+S1]1USP[HFL7_AVY>\\/WFIZ587UUHEW(BQO=:7/=02R6-R8T1?/MFC
MEPJC?A0*R[+X7_#W3O\`A(/L'@KPI9GQ8\DGB<VOAW1[=O$,D@PSZTT5FAU-
MMORDWOGEEX8D5WM%-4Z:;?)"[ES.\4_>2:OJGK9M?,(XK%1BH1Q.(C!<EHQK
MU8I<E5UH))25E&LW425ESMRM<\[F^$OPRN/#%KX)G\`>#)?!EC-!/8^$W\+Z
M(WAVTFMF+PRV^C&Q.GPRQOAXY([=7C8;HRI)SJ>(/`'@OQ;I*Z!XI\+>'?$F
MAI-;7$>C:]HFF:OI<<UGM^R21Z??VL]HCVS*&MW$.Z`C,3+7844>SI\O+R1Y
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MH4CCCBB1(XTCB01QQHB*%6-%`V(H"K@```8JR%QZ],?Y_P`_KS3J*LQ;;=VV
MW:UWJ[>O79;A1110(****`"BBB@`HHHH`****``\\>M1O$DB[77<OH>0."O'
MID$@^H)'0U)12<4[W2=UROS7;\0.`L?A3\,],\1W7C#3OA]X*L?%M\J)>>*+
M/PKH-MXBNTC;<B7.M0:?'J4\:G!5);EE!`(&1FM.[\"^#+_Q!8>+;_PKX=O_
M`!7I,,MOI/B:]T33+GQ!I=O/GSH--UB6U;4+&*7<PD2UN(@X8A]PKK**.5::
M+166FR[":35FKHYC3_!?A/2M8U+Q#IOAO0;#Q!K`0:KKUEH^G6FM:GY8&W^T
M-4M[:.]ON54_Z5/+R!Z5FW/PT^']W#KUM=^#/"ES;>*ITNO$L%QX>T>6+Q#=
MQJBQW6MJ]F1JMQ&(TV2WWG.I4,I!YKN:YOQ?KL_AGPWK'B"WT/5_$LVD6%S?
MIH'A^"&YUS6&MH7D%AI,%S<6EO+?7#*$@2>Y@B+'YI!Q4.G3LVX1LH.+NE;D
MMJO2V_D%EV7?8RY_AI\/KJ;P]<W?@KPG=W'A`[O",]SX<T::7PH?+\IF\-R2
M63/HCO$3&SZ:UL^QF7=M)%78O`_@^'Q'<>,8/#'AZ'Q;>6BZ?>>*8=$TN/Q%
M=Z>FWR[*YUQ;4:G/:(%4);RW3Q#:N$R,U\#?LN_\%&/"O[4O[0/Q9_9]\/\`
MPF^)7@/Q'\$-+L;KXB2?$*/2=,N=(U#5)1!IVC/I^GW6HQ->REG:1HM0F1?+
MQ@'@_I`G,8(.X,N0>.0PR#QQR#7)2J83$1M1C!QC4I0:4>6WL-:=K:?NVK1[
M!9=E]QRR^!/!Z^(W\8KX8\/#Q<]L+)_%`T33/^$ADLEQY=G+K(M1J,EM$%3R
MX'N&C4JI"^K+'P!X+TS7]6\5Z;X5\.:?XGUZVBL]<\1V6AZ7:Z]K-G`VZ*VU
M;5X+5-0U*&,@;([RXF5<<#IC\^/VNO\`@I3X7_9#\;>$O`WC'X(?%_6)O'_C
M3P]\/O`WBNQL]"LO!7BCQ5XD-FMG8Z=K$NJW.I*MH]R4U!YM$B2,*Q#D+D_2
M_P`>_P!H'5O@MX%TK7-$^%/CSXP>/?$"^5X>^%GP^BLKK7-0O(-/%WJ`FU?4
M&M=(L;+3`'-YJ%S+L<%?(ADE:.,S"K@Y5:T(2BY8:<JM6=O@JSM*;VWDM6[/
M5NW8:79?)(Y[]I#]FFX^)WPM'P\^$_B/2O@Y+_PF6B>,]732?"NEMX=\;66E
MZB;[6/!7B[3[5;(76@^,!)/::RR^?.8IBRQ,4CV_E/+_`,$<!X\_:,^&G[0%
MYX2^#_[*6K_#?QT?%VN7/[-NK>*M7U+XKZ=9C;8^'M7L]8TWPEIW@Z-W"W5_
M+HW]KHR_Z(8YE!)_0?\`8+_X*%?#K]N[0_B#)X>\)>*OAO\`$7X1^(1X2^)W
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M=;0V=E!#:VEO''#;VUO%'!!;P0H$B@ABB54CAC4;8XT54C3"(JJ`*NT45481
M@HQC%)15HI=%V_`>VRL%%%%4`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`-8;E*],C&17CGBW]GCX%^/M2N-:\<_"#X9^,=:NTBBN-8\3^!/"^NZI-;P
MIY<=O-?:GI=U<RPI'E%CDD95!^4#"X]EHJ91C./+.,91NG:23U6SU-J&(Q&%
MJ>UPU>MAZK7+[2A4G2G:][<T)1:W>SUV>AQ'@_X;^`OA]IIT?P+X.\+^#=).
M?^)7X7\/Z5H&G`''W;+2K2UMQT&[$?SXRV3S1K'PY\$>(-;TWQ+KGA7PWJ_B
M'14>/1M<U30=+O\`5M($C*TG]F:C=6LEW9!VCC9EMYHU+1JV,Y)[>BI]E3T]
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MI34DFKJPS81T9AR#^78^OOZT^BBKMJWU>_GT,UHK?\/\WN_F%%%%,`HHHH`*
M***`$8;@1DC(QD=1]*QM:\.:'XCT^YTCQ!I.G:WI-\CQ7VEZM8VNH:??0NNQ
MHKNSNX9H+B-E`5DE1E=1M8$$@[5%)I2M=)\K4E=;26S7FN@-7W1R/AGP#X*\
M%Z:='\'>$_#?A322"#I?AO0M*T/3?F#!C]@TNTM;7#;CE?*V]>,DYK:7\-?A
M_H>GZSI&B>"?">C:/XDN+BZ\1:3I7AO1=.TS7KF[3RKJ?6K&SL8;;5)KF/,5
MS)?13O/%^[E+(`!V]%1[&D[WA%W=W==;W_,5EV_I>9R`\"^#8_#K^$%\+>'%
M\)RVYLY/"RZ'I:>'I;(@+]DET5;4:=);!%CC\AK8Q[$12N!3%^'_`((_M#1]
M87PCX9&K^'[,:?H&JC0-)&I:)IX8,+#2+W[']HTZR5LLMM9R0Q*V"JJ:YOXK
M_$2\^%_@O5O&-OX&\9_$.32_LY;PSX"TZRU+Q)=I<3>5+/:6E_J6F6QAL(S]
MJO3+>B06ZLT4;MM!^4?V(/V]O"?[=6C?$SQ5\/\`P+XM\'^&OAAXTN/`&IS^
M,)]-34K[Q+I]M'=ZI9+I5AYYM$TV.XB26=;F[:X8E(ERC&N>=7"_6*>&E*+K
MJ/+3?*FU%VE:[5NBO=!9=ONT/M'3_AWX&TF7Q#/I?A#POIL_BUYI/%4UAX?T
MBSE\2R7$307$FOO;V<;:Q)<6[-;SRZ@;B2:`F.5G7BK>B>"?"7AG1/\`A&O#
MGAK0-`\.^5+`=!T71M-TO1O)N&D:YC_LRQM8+()<F:?[0HA`F$TGF!BQ)_+K
M]H/_`(*M^%?V:OCE\./AU\3_`(%?%G1?A1\3?%%GX#\._M"31Z?%X/O/&M[<
M16ZZ79>'/](\0SV,9F4OJDZ6D*G[D<@RR_K/;RB:&.0-N$BAP2`#M;D<8!&`
M0.0#Z\U.'Q6%Q%2K3IJ+G2<W4]R*NY.//)V6\FE?5WMKT'RKMV>WS_KOZ')6
M/P[\":5H-[X4TOP=X6TWPMJ(G2^\-6'A[1[30+Q+K_CZCN](M[..PN4N>LXG
MMW\TYWY).:K?##X>?\(W8>#QX(\(IX4TN>VNM-\-)X;T=-`L;NUG%S;7-IHZ
M60L+:>&X5)DFB@1PX)+?,V?EK]KK]KW7_P!F?1)[KP;\!/B=^T)XCL=$OO%N
ML^'O``TW3;7P]X4T\RF]UG6=>UH)9PQ0Q6MU)!96\=Q?W#0%1&L;B0=)^Q7^
MV)\,?VYO@7I'QW^$T>L66A7VL:GX=U+2=?MVMM4T/Q)H:6G]IZ3=*$2.8VZ7
M=K,)X289O/#+CH,Z=?!U<1+#)QA6E3:Y+)<].ZYEJK**=[I6%9=EWV^9\Y?M
M1?L5^,?BY\0_%/C$:+\(_CQX"\3^`M&\!6?P*^.D.I:3X1\!RV-W=S:OXG\&
MZWX=T?6=2T_4=<M;J*RO(X+.+<+:WDCEC9&9N0_X)P?\$Q[+]ACQI\:O'UGX
MF@TNQ^,&H65UHWP7\(7>J77P[^&-I!;1)<VVCWNK^7>ZYJ%S<Q%FU6ZL;.;R
MBMN2X3<WOW[1?[>WPZ^`WQZ^`'[,^G:#>_$;XS?'SQA::#IWA;0M2LK$^#/#
MTZ[[_P`:^*+A[:_^PZ;9V_FRV\#P1R:BT,L4<T>":^\+<1LNX#=YG+,5"EB.
M,,!C@`85#G:,*,"N?#8?!2Q=>=%I5\-*,9P3?NODBU>]]XV?S067;\#GM.\"
M^#M*UC4O$6E^%_#VFZ]K95M8UFQT/3+/5M4*@A#J6HV]LEY?.B-Y>ZZGF)C5
M8R2@`I8?`O@^&_L=5C\,Z`FJZ8D\>F:E'HVF1WVFQW3+)<QV%S':K-:I<2KY
MTJPNH>1G8]:ZP<<`8`X`':BO7C"*NU%)R2YE;3[M@LM--M4-5=HZD^_'OZ#W
MIPX]3]:**KE5U*VJ32WV?EMT&%,9`V>2,XZ=L$'^E/HH<4W%M:Q?-'R>UP.>
M\0>$_#7BS3;C1?%&A:/XBT6[4I=Z1KFF6.K:;=*Q8NMS97\%Q;3I)N*NDD3(
MR%E(VNP-70O`W@_POHZ>'O#/ACP_X>T!(&M4T31-%TS2](2V;:&MDTZRM8;1
M+9E!1K=(1"RLRE>:ZNBERQ;YG&+E>]W%-W];`<+I_P`,?AWI.@:AX4TKP-X0
MTWPMJLMS/J?AFP\,:'9^'M0FO,?:IK_1K>PCT^\FN-H,\MQ;R/,0IE+X%79_
M`G@ZZT)/"USX8\/W'AF*."&/PY-HNF2Z#'#;.KP11Z/):MI\:0E1Y02W`3"D
M#*@UU;'"L3V4G@XZ#U/`^IX%?+7[2_[1NK?`3PS!=^$?@_\`$'X[^/-7M]1N
M-`^'GP]BLHM0O8=/B5[F\U#5M4>+3-&T^*5XXA<S-<2/ES#;3%2!A6CAZ5.=
M:I3CRTZ<E+W=/9_:36S7>Z`]Z7P'X,36;;Q$/"OAT:_967]FV6M#1-,75K/3
M=P==/M=16U%W!9JP4K;QS+$`H`0#-5+'X:>`-+L]<T[3/!7A+3M-\3SSW/B7
M3K#PUHEG9>(9[K'VJ77+:WL8X=5>Z^<7+7Z7!N!(XF+@U\<_L$_M^_#C]OGX
M=>+_`!IX`T/Q)X0\0?#SQ.W@SX@^`_%D<(U3PQXECM6G6T_M"VC%I?6MPT<R
MK=0Y"_9I2T4>Y0WQ5^TY_P`%FO$?P/\`VB-1^`OPZ_8=^/?QUM=,U'2M"?XG
M^&99]$\#7>OZG(L$]G:WDOA'6X)['2IY(%O=2348XT9I(6574YXJF/RVFJ>*
MG4A'VDXTH-12;DUHM%T5UTWL*R[?UMM_7XG[5:=X)\):/H"^$])\-Z#IGA5;
M1[!?#5AHVFV>@"PE0QRV7]D6]M'I_P!DD4L'M_LWE,K%"FPXJG#\./`-OX;N
M/!MOX,\+0>#[I&CN?"D/A[2(_#4\3C$D4NA)9KI;Q2#;YD;6NV0J"^XY)Z'2
M[VZO]'TW4+RR.FWM[IUG=76G/+YQL+JXMHYI[)IQ''YQM97:`S+$F\H7$:YV
MCXV_;)_:[UO]E;P/JGB_PY\#/B+\=;O0=,N_$OB/2?!#Z9IEGX9\(Z5$;K5]
M?US6=9D2V2.TL(KRYBM+*.YN;DVI3;'D$[U)X7"T/K$XQ5&:LY6>U3E;OY-Z
M[=%KL,^HKCX;^`IM#T;PS-X-\*3>'O#CVTF@:#+X>TB;2=":RB\JTDT72Y;-
M[/2Y;-3_`*,]C#"\(9A$4#$'\T?VE_V%_&?Q9\=?$KQ)JGAOX-_M->!OB-I_
MA[2-+^&/Q_DUKP[8?""QT>QN;+4?^%>^)O"^C>(=63_A(?M9O-1@FM+58[FW
M@:"4N9)7^POV5/VKOAC^U[^S_P"%?VC?AS<WFG^"/$UE?73#Q#"=/N]%FTEY
M8M7MM2\\11#^SWAD,UV&6V>)3+E5'.#X)_:KT_XV7%W<_L]>$V^+'A30/%\'
MA?7_`!\VMV_AGP=%-;W$*:]=>&-;NK#5'\62:1;NP:#3+*"UNY4\N/4H@WF#
M.=/`XO#^R4E)8F,%%V5W&E-3IQV7P3][UTUV%9=E]Q\U?\$TO^"<EM^P1;?&
M*:V\;3ZC:_%[Q=!XAT[X<Z//J+>`OA;ID22/'X9\+-J+_:M7&^<^9K]U:Z==
M7<,42RVD;$I7Z6:/X"\&>'[W5]1T'PKX<T6^\02>;KUWI.A:5IUUK<IW`R:O
M<6=I#+J4C`[6DO&F=E&"W)SU*QJ0C,OS[5+9R,G`^\NX@XQP&+;3G'.29:[*
M&'I8>$(4H**IQ<8VN[7UEO=ZO4++LON^?]?\$Y6U\$>$K+4K;6;/PWH5KJ]E
M9G3K/4[;1]-M[ZTT\L[FQM[J&V26&T,DCR&W1EC+NYV_,:Z=$V`@$G)+$GU)
M]J?16L81BYRC%*51IS:WDULV,****H`HHHH`^"/VH_\`DH.E?]BAI_\`Z>->
MHH_:C_Y*#I7_`&*&G_\`IXUZB@#[ETW_`(\-._Z]8/\`TF2M*LW3?^/#3O\`
MKU@_])DK2H`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`,UYU\6?'^C?"_X9^-_B-KM_;:?HG@
MSPMKGB;4+^YDV6D%KHVF7.H,\TH^5(6,"H\A(55<G.<`^AL"RD#`)'<`C\00
M1STZ'Z5\??M<_LER?M;>`[_X8ZO\:?B;\-O`?B+1-5\/>-?#_@!_#$"^,=,U
M9HA-!JFHZUX=U?4(!!`LUM"-/FM4:&YD\Q2P4C'$.HJ%5TES5>27(N\K:">V
MU_(_*;_@BX+_`$G]E']I']N36O#VM>-?&7[1GQ@^)OQ57P[X9T][_P`5:KI>
MAZM?V6F^'=$N)C'+J<>IZA;W%SICAH[0QW:;2RCS!]^_LH_MR^._VE_'^M^#
M==_8N_:8_9]L-'T!]=;Q?\9M%T70]`OY5O(K2+1=/:RN[JZN[^199;M59`5B
MC8L>F/>_V3/V8K/]DSX3:-\&M"^(OC'Q]X1\+6]MIOA'_A,X]!6^\/:'90);
M6>CVT^@:1I"W4$,:!GN+^.YNIIF>1I5#;%]X\5^'M3\0^&]<T32_$NI^$]2U
M2PN+.P\3:/'92ZKH<\Z;5U&QBU"UN["2YMV)>)+NUGC)X.`2*\W!83$T,'AD
MYM58*52<7:ZG)WY7NKV;\K];W)C=::VMMYZ7^][:]S\!?VA;N']JO_@MO^S/
M\!3<6=YX/_9'^'.M_'/Q;821/>Q?\)3JL$%GI^D7T!7['!+#!JNC7=C=@B=2
M"(]Q5B/W+^(WCW3/`VDQ&&?2Y?%&L-<6?A?2KS4+*Q;4+XQS/+,QN98]MCIO
MF&:_EC.4BC\LD-*`?AOX!?\`!,O1?@#^T?XW_:@TG]H?XT>+_B-\4VLQ\5$\
M6_\`"$7.E>.;?3(@FEV=\MCX4LK[3[;3V2,P)I-Y9C;'$K#"9/E'[:'_``1A
M^$_[<_Q2?XI?&#X_?M"V]S:P&S\-^%/#/BK2-)\+>$K&2...ZM="M1H<T\!O
M4$JWMT\SW-R)?F=<<\5.EF6&HXRM#"T\1B,3BDW"I9-4^6$>9-.S6DOOV,XQ
MFG)V>L[K56MI:V^VOSZ::_6/[$7P%^#_`,#_``I\2(/AG/#K?B?QI\4/$WC7
MXN>-+=3/;^)/B/XFNAKGB%=,O]\L4^B:=<WITZQ2"61;9;=HFQ(&4?<BC`[]
M2>3G!8DD9]`3@>V*\'_9F_9Y\#?LJ_!+P%\!_APMZWA+X?Z/'I.G76J3)<ZM
MJ4F]YKO5-5N4CB^TZCJ%S))=7<Q!+RR,`=H6O>:]S"4G1P]*FX0@TFW&'PQ<
MFY-+YO[]39;+^M>H4445TC"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@#X8_X*-?'NS_9G_8J_:(^+375E::GHWP[\0Z?X86^N'M4O_%NNV$FB>';
M")T/G-/=:I>011)`//+_`.KPV&'@/_!(?X(3?!3_`()T_!K0XM1M]/\`%GQ%
M\/:G\3=5\07.E1/.WB;XBR2:Y:7VHVKRVTE_=:7;7&F6C6UU<1RS#3A&[QB3
M</4?VU_^">ND?MR6?_",?$?X[?%[PS\-/M'AW4F^&O@J7PI8Z!+KGAJ[DOK/
M6)KO4?#NHZM--)<F!YK::\DLV^SJ/)*DI79>/OV(]'^*?[.OAO\`9_\`'?Q=
M^*]\WA'4=*U;P_\`$[0]=M/"7CZQU#0I`VBSM/X<T_3]'NAIL):VBMKG2Y+.
M>)8OM5O-MQ7C.CB9YNL7[-QA#`SIPF[6]J[-1WNG=O5KYW,>67MIRU<>3E71
M/;YKU?Z'Y!_&;Q)\5O"?_!4;]D3]GS]LO3O#7[57@OQK>WWCW]GSQ-X;\+3>
M!I_A;XHTEY+.[\4^)O!-G=:_8ZW-I<R1I_:+ZG%]D@:2X6/+D']%O'W_``41
M\<>"OCU<_!'1_P!@[]KGQUI%MXKT;PLOQ9\/>$]#'PWN%U2:VAGUR+4KS58Y
MCH6D-.YN[R2,;5MI6V@8KZ@^'W[)_@?PIXP\+?%#QAJ.K?%KXQ>#_"+^!]"^
M*WC[^S[SQ7IWAR9M]W9V`TW3M-TVPEOY&>2_O+*SM[F]*QK<,^-P^FVM7>)X
M_-V%PP\Q069"4*!T#'8&3(9%*F-2,%'Y)G"996I<\WB:E&4ZZKOV:C>5K_NY
MWO[CW>O-=*VB&U+M^3TT6_\`3\V?.OQX\6Z;=^%M=^&&G:WX?TGQ;XZ\+:EI
M>I7&K:II=FOA+POK-M/I6J>)=166X&Z/3+6ZO&L4P\5S?(B`^4Q>OB*X^-W[
M'G_!+[]D3X2>&?#U[KF@_#'4+Y_"W@S5+#P;XA\7:AJNLM)<3ZSXIU"QT.RN
M+ZZ-S+:S7J7[-LN9VM5@?RC$S>(_'G_@@;\`_P!I+XO:W\9_BS^T#^TIXA\4
M:[J<%]<6K>,=%M]&MK&VNX[B#P_9V%OX>A$&A1PH;9+))`8MQG60R5^T?A[X
M=Z%X4\$Z+X#T"WBL-#\.>'K/PWH<211O)IUAIVFQZ;8>0\J2()[>&"WVRF%@
MS1;WC=G.*@LPJ5ZSE@\+3Y(RA1Q$M95$U=N25W>^VJ2^0<K[-=K6ZVW6GS_1
M(_E?_8C^/GP+_:T_X+3>*_BEX7U+Q;JWA[PC\&K;PM\'+[4/`^O176N:U)&]
MQX]U'Q=>W<!/AW4+>=C?Z3!JI@N(HYUC@0B20C^M>W7"#"A0`1@>N<G(P,$G
M)/'7/)KXP_8W_89^%_[%FA?$/3/`6K^)O%FL?%+XA:M\2/&?B_QM<V%]XBU+
M7=7CM[>:&.>QTZQM[33X;>#RX+6W@4+N8EB2"OVL`0,<#KT'`]./:GD^"K82
MA/ZSR?6*TZDZOLTU#2;4+7U^"WXFD=$EZ_UU_,6BBBO8&%%%%`!1110`4444
M`(3@$UX]\4O']GX1TU-(L;G1_P#A,O$EM=6?AG3-1U&RL8@/]3<:Q=M=2([:
M9I0E^V7FQ3YBQ>2I#/N7V!E)&/<GG(]>_/K7XJ_M?_\`!$?X-_ML?%G4/B[\
M8_V@/VC9=8E@:PT'1=#\6:'I?ASPCI3R;WTS0-.7PY-+#!*&=9WDNVEF#G+`
M@&N#&U,53PW-AJ'MJ\K1=-\O*T]'SW>R6^H/9GUW^Q?\`_@G\!_@WXL\%_"/
M41>V>O>-/%^M>/O&UM*()?$?Q!U^66^\3:Y::DLC0R6BWFH&+1KF"=TM0BVX
M=C`!7XI_%7X=?'C_`()@?M\?LC:#^SS\8?BO\7/@Y^U]\2?$6E>,?@U\2/$M
MWXG:UU:WNM*NO$GB"TU6_,OV:"WLM?AU$7$/V9B+`VQBGP';]R]6_88^$.H_
MLFZ5^QW9WOB_P_\`#'0]`T?0])U'P[XANM&\6V3Z#=QZAI^IIK=FJLU_]NB2
MYN&>%H9VW)-#*AQ7;?#G]E_POX.O_`_B3Q?X@U_XO>/?AWX=NO#'A/Q_\0CI
M]]XBTG2KU+9+P6ALK&SLH+Z[%G;K<ZE#;)>3I&J2NYRS>;7RR5=8>G##T<-4
MP<Z<J>(AKS1FN:K"*>MN9*][ZK3SSY6K::]]-[KI>VB^_=GRG<_\%$_'B?'T
M?`ZR_8-_:UO-$_X3J+P7%\9#X6T*R^&'V5YO*/BV35+O5?-C\,0H4G>\>$$(
M&/E@C;7SS_P6)\5_M/\`P;_9W^(OQM\'?$7PCXF_9ZT^UM-+^*_P/OO"S>'=
M?UGP5KTUOH6JV6B?%+3-1U&_$FKSZAY.H;]!BC&G2316]SN.6_;C4=)AU.PO
MM/F9D@O[.YLIC"\D#K!=1/#((GB=)(9`LC,D\<JR))AT*D`C\^/A]_P35^%G
M@_P5XC^$OBGQ_P#%'XO?!+6_%5MXOL_A'\4?$5OXD\-:+J-K??VHEG%?OI\6
MOZGI#:BL5W_9NK:G=VT<D,85&48K;&87'5\/6PKJJ<9TTXS22]Z+5HZJ^J0E
M%VV=WUVMHOOW_P"`G<_+/_@H+\;HOAG_`,$ROV2O@K^RWX`UCX+6_P"UW>^`
M?A=X6\#:+ILG]H^$O".OV]I<^*-`,JI!Y5[+I-[,WVJ=4N;NVCED,4AEVQ]Y
M^SOXQ^*G[)__``4X^'G_``3U^&VK:IXR_9MM?V7?"6NZWH>I+:2)\./$FC)K
M$#ZUI-Y!9:>;>PUF\6`W>E/+=,T]VDH+#(K]H/CM^R_\,OV@/!_ASPGXML9]
M./@C7-(\4^`=:T%TL-5\&>)O#RQKH>KZ-((VC!L!%$ILITDLKF**.&YADB!0
M\7^S_P#L8?#GX#>.?'_Q>75_$OQ(^-GQ2CTZW\=_%CQW=VESXFUFQT==FF:9
M;0:996&D:)IML@0&STG3[>"1D621&<EJY)9;F$L;2JPK\E*%*A':R3A1IPEI
M_BB^WH.SOL]UMV5[]=+WO8^P%^ZN.F![]O6EI%!"@$Y(`!.,9(')QVSUQ2U]
M*KI)/5V5WW9H%%%%,`HHHH`****`/@C]J/\`Y*#I7_8H:?\`^GC7J*/VH_\`
MDH.E?]BAI_\`Z>->HH`^Y=-_X\-._P"O6#_TF2M*LW3?^/#3O^O6#_TF2M*@
M`HHHH`**BF?RXF8[N!_#][\*\J^+7QE^'WP4\+'Q=\1O$EOX>TB2^M]+L?-$
MMQJ&L:O=)++9Z'H.F6D<^H:QK=^()$L]+T^VN+NY966.+`)`W&*YI245?=^5
MO\_P-*-&OB*U.A0HU*U:M)4Z%.E%SG6JO7V<(1O+F4?>NTE;J>M45\EV7[9/
MP,U*[FT2T\5:I)XI@^%U]\8[GP6OAKQ`GCJV\`:=J&GZ7<ZO<^$7TO\`MRVG
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M:O\`&CPWJ7B^;P/HE_>:;=?;/`'C/3/$-_>6,*7,\.B>&=0T*V\1:NT<+LW_
M`!+-+NEF\N5%=1!(:N->C*48QJ0?-2=9/F5E!*_>[>^UTK:NVIQSRK,J:Q'M
M,%7IRPF)6#Q=.4&IX?%2^'#U5;W:LND+W;TL?7%%>-_"SXV_#CXR>&)/&'P[
M\86'B/0X+F:ROIXG6WN-&U"U56O=*UNPNA#=:/JMEO5;S3]2AM;JV?,<D>Y<
MG@?"G[6?P5\;?%;5_@EI'BZ\L?B7HML^H'PSK^A:QX;N=>TQ6V2:CX6FURQL
MHO$]C:'`N[O09+^WM79?M#HC+EPK4I0IU'4C&-57C=ZNV^BO?Y:=;V,WEV9\
M]>BLNQ3Q.&A*I6PRA^]ITH+FG5FOL4X1O.<I6Y8IMGU%17S!\4/VM/@G\'O$
MNF^$O'?B^2RU>]N;:WNQIFD:QK%EX=6]*I:7?C/4M,L;NR\)V-PS8M[S6[BS
MMI3G$@P:^AM+U.VU6V@O["ZBO+*[MH;JVN;>:.>VGMYTCD@N()4+))!.C;X)
M8GDCD3)W=,M5J<GRTYQJ.Z34'>U^][6_I;D5,)BZ.'HXJKAZL,-7BY4J[B_8
MU%%V?LZEE&:B]).+=GH]39HHHK0YT[ZA1110`4444`%%%%`!1110`4444`%%
M%%`!1110`445XE\4OC]\,OA!J.A:-XP\0RQ>(/$[M_87AG1M+U/Q%XEO[:*6
M&WN=0M]#T:TOK\Z99SS0+?:D]NMG9)*'FD^85G.K3IZSFH^H'MM%?*'B/]LK
MX"^&O#'C[Q=/XQO-5T;X7Z]I'AGQ_+X;\.Z]XFN?"^K:UI,'B"V@U/3]$TVZ
MOH/(T:X6[U&?[.T.F1`OJ/D"O`X_^"KW[&,WA#2/B#;_`!`\8S^`M>N+*RT+
MQI%\*?B/)X9UZZU*[6QTZ'2-87PJ;&^FO[PFTLUM9G-U)O6,&5%1L98S#QY;
MU(^]2=5:Z\J:7WZDJ2?]+OZ_UZGZ5T5\^>.OVC_AQ\-_A3H_QH\4W'BB#P)K
M<6B7%G<6?@WQ1JVMP6^OVBWNGRZGX;TO2;G7=,1(2PU![^PB.GR&%+M8WEQ7
MA/CG_@I#^R[\,O\`A7B>._%?C+P_+\5;#1[WX?P:A\,/'L=UXGGUN*:XL-&T
MZV3PV'E\026]O/-<:'M&HVT4?F-#M.14L50@HR=2/+)?%?17VO\`\"XV['WS
M17R7\,/VS?@?\7?B);?"KPGJ_BZS\<WOAW5O%EIHOB_X>^-/!4M_X?T2?3[3
M4[_39O$VAZ5;7@L+O5-.CNHX9&=5N?89](^('Q\^&?PRO;?1_%'B&5]>N#9%
M?#VAZ;J/B+Q$(+^=+2VO9-#T*TU"_M["2XECWWLL"VT$>Z2250%#:QJ1FE*G
M)3CWB]`4D_OMJ>V45POBSX@^$_`FA'Q+XP\06'AW1BUO#'>:K+]G$UQ=KFSM
M;:)E\V>ZG)"16Z1&>1OE,88$'CM+^/'P]U3X>W_Q1.L7FC^#-.NM0L;C4O$N
MB:IX=E^TZ9>-83+#I^KVEG?S"YO/+AT]UM]FHK)&UEYOF(2G5@GRN24E:Z\W
M;3\?S%S+^OE_G^9[717FGP[^*O@SXI:;+JG@W6?MT=G=FRU.RN[.[TW5M,NT
M`_T?4M(U"*TU#3I9/O1+<08D0AE)!%>EU::>SN4%%%%,`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BHI7V#.<=>?3IR0>,`<DDX`!XKY=U7]L7X`Z3<>.!=^/
M81I'PVTW5M5\9^*H=,U2X\(Z,GAY)IM<L+CQ1!9R:&VJ6*6SQ2Z5'=F]$WF0
M[/.`495*]*E_$FH]+/[_`,A-_P!77ZL^IZ*^&_BQ_P`%"?V8_@KK_@?0?B#X
MTUW2;WXE6/AV]\`-;>!?&6K6/C!_%5E)J6AZ9X>O=)T"]L]5UF]LXB_]D6LS
MZI#N3S+50ZL+?P]_;[_9V^)WQ2L/@KX5UWQD?B7J%F-2C\-:S\-/'N@WEIIL
MD$]S!J6I/K7AJQM=.TJYCM9DL]1O;B&WN908D</MS$<50<I0]K!3C45/E<O>
M<I6Y;+SN)23MW_K_`(8^V:*^9O&7[57PJ\#_`!7T?X)ZW<^+AX\URRM=0T^'
M3O`?B_5M'EMKJTN[Z)SXBT_1KG1(VBALIC>6\E[]H@!A21$>X@63PC1_^"GG
M[)^N>(_$O@_0_$GQ"U[Q5X-N;.T\7>&]'^#WQ-U'6O"USJ);[%!KNG6OA66\
MTQKF-5NK=KY(5FM9H9U_=.AI5,9A:32J5Z<&VHI-N[D]DM-QMV1^B%%>)_!S
MX[_#KX]>")/B%\-M?GU/PM!K.O:%=W.IZ5J?AZ]L=5\.77V;6]/U#3=:L;"^
MT^YTR=6CE6X@(\OYRW)VN\(_'OX;>/O&$_@KP;KMSXAU*UTVXU274M,TG4[G
MPPUO:7;V%Q'%XH2T;0YKV*[1XY+.*_:<%3E.U:^UIVB^=>]MU[;_`'BYT^_X
M=?F>U45X=X_^/_PR^'.M6?ASQ%XCFD\1W4NFQCPWH&EZAXCUR--5OHK&RO;S
M3-#MKV]LK&2=]K7=S'%:QIYDLCA(FJ;Q]\>/AM\,M2TG1O&/B0V&JZM$MS'8
M6]E?ZE/:Z>]P;4ZOJPTZPNCHVBQ3`QOJVH_9;$2*R/,H5F"]M32O*7+'^9VL
MU\M=`YEY_AY>?F>UT50L+^TU2SM=0T^[@O;*]ABN;2[MI$GM[BWE42))%+&2
MC*\;!D=6*L"",C%7ZT4DTFFFGLT]/+[R@HHHI@%%%%`!1110`45Y]\1OB9X,
M^%'AF]\7>/=?M/#NA64EO;F[O&YN;V]E$%CIMC`BM<WVIW]PR6]C86<,MU=W
M$D<%O&\LB*?*-%_:L^#>NZCH.B6GBB]A\2>*/"'BGQSHWA*]\/ZU8>++OPOX
M*B@F\0:JGAR[L(M5@2(WUM%:136XEU!FC2R261L5E*O1C-TW4BII7Y;Z^:]4
M!],45^<&D?\`!4K]D;79_%EMH_C#QWJUWX#N%M_'5GI_PC^)EW>>";G[%]M>
MU\3VL'A&271ITLHVOC%J?V>1;?SII`L:*S?27P?_`&H?A-\=_ACJ?QA^&6L:
MOX@\`:6FHROJ\GACQ'IC7\>DV7V^YET:SU+2;2]UFU:W#>5<:;;72SW`-O$"
MZX.5/&X>LH>RJ1G*:D^2+7,E!I2;7DVNNMQ73=EK_2_S/HVBOF#X>?M;?![X
MI^"/%7Q`\(ZCXK;PYX,O1INMOK/@+Q=X?U.341;F[:RTO1]7T>TU35;E85*M
M#IMI=.)F$.TR%5/H'PJ^-7P^^-6CW.O_``[\21:U9V%W_9^K64EO/IVL:'J,
M<0N&T_7-%U"*TU71[]H9HG^SZE:PL8]KID,36GUBCS0@YI2F^5)][7LQGK]%
M?'4W[=7[,\/[2:?LC-\2[9_C_)`+@>!(-*UB>\6&6R-['+)>1::VEI&L&79V
MO?E"9.<G'JOQ#_:'^#GPEU[PIX9^(GQ$\.^&?$'CG7=*\-^%=&O[U([_`%G6
M-;N)+;2K2TM<--OO)E:-<H5RHVDCYC*Q5!Q<E4C:-9T'KM-.VO2W;7Y(ER2=
MG<]PHI!T'?@<_A^'\A2UT%!1110`4444`%%%%`'P1^U'_P`E!TK_`+%#3_\`
MT\:]11^U'_R4'2O^Q0T__P!/&O44`?<NF_\`'AIW_7K!_P"DR5I5FZ;_`,>&
MG?\`7K!_Z3)6E0`4444`1S9\M\8S@8STZCV//I[]?6OS-_;_`/V?='_:&O?V
M?M#\-?&O3/@[^T-\.?'NJ?%G]GO^V--@U[1_$WB'P9H@A\1V6L>&)60ZQH]K
MH^JV\FHRVTL5[IZ7,%U9,;A05_3*;/E/@9.TXY(&[^')`)`SC)P>.QKY?^,_
M[+/PX^-WQ'^"GQ1\8W'B"#Q/\!;_`,::OX!?1=8O-(MX-5\;:3I>C7]]J0LV
M22_>SMM)MY+.UD?[`T\DC7=I<*J`9UX2J490A'FDWOJFE>+;36MTMM[/7N>O
MD&8K*,UHYC+%2P/L85(T\5&$*_).=.<'"5"JG3E"HIJ%31-PE*TDTFOSR^"'
MQR\K]MOPA\.OVR/@SI/PA_;#U+X+>*_"7PM\?^"O$=WXA^%7QT^'.G>(])\0
M>+D\/+/!!J&F:IH5YI>C7LVF^)_M5WID=XT<%TBLF_S[_@CSI6D:YK__``5'
MTS5-/M]0T^^_X*$?&>QO+*ZM0\$NG76GZ-;2VIM6!,\$MNQB>0@K)$JGDL2/
MO_1/V(_#UCXOUGXH>(_BE\2/''QCE\+^+?!7@;XL>);KP_>>*_A;X:\8W5K>
M:EIG@2&+P_!H>G1Q36EN8KB^TG4;N>.&.&\GN47`Y+]D/_@G;X;_`&/_`!E\
M2O&'@[XV?&;Q>GQ;\4Z[X]\?^&O'.M>'M5\/>)/'WB$6AU'QG=06GARQNX-7
M/V5?*CL[JVL$4^6EHD:1HOD4\NKPQE"I*G2GA8J[ES2YWS*S<]>5RNVI-*UM
M97=V?<XSB3AVKE'$>%R['U\+F&-R_AJEAX8:>,A@HXW!X^IBL;+"JI5J3H4I
M0DIQA.?NUIS5)0I\L3YD^!_Q-\7_`+-B?'O]B37=8;4/&GA'Q993?LS3ZYYD
MDVM?"7XM:A/#X8LU=&6YOX/A_?G4-*U2[M]YTZUCTR:3:K$']4X=&\(?##P#
MI!U`A;'P+X=>TMM1OF:\U4J+6*"[83,K7=SJ&J301R2M'F6[NV)"D9SA>,OV
M;?A3XZ^,GPO^/OB3PW%>?%'X16'B72O!?B&.5XIK33?%<5M#J]E<HBA+JUE-
MI'<0PS!A;7`9X2NXL?,_VR?V.M&_;-^'^D?#7Q1\5OB_\+O#^FZS#KUU/\'?
M&,W@C5]9NK4(;*VU/5;:VN+R2RM)%,R00RQAY"LCYV*HZ(X2MAU5E1ITZD:>
M'=*A=VG47,F^9N3LU>UTDK174^?QF:Y3G..P"J5\3EWUJM2S'B3%1C.O%X^$
MHQE5H48\KFYJ,IV<G+GKU-5%'EG[#'[.NE_"JS^/_CSQ#:+9>+?VKOC#XE^,
MOB'PK=RJMSHFA:DEOI/A_2[JS5T*7%MI5O;_`&Z5(D7[7.Z.6E!KX7_;7N_'
M_P`%?^"B7[&?[37QRTKP5XW^`:^.]7_9W^#.D^`HM=@^(?@;XB?&C3;;9XO\
M9/>1G3M;LDC\,S:<FFZ6Z)96DDUY(=Y<5]P?LW?\$U/A[^S9X2^+/A;2_C#^
MT!\1KKXPZ;!I&M>,OBA\3]:\7>-/#^F6\$\,-CX2UZ[,5YHEN9KE[]DMY?+%
M_!#-L;<X'J_PR_8YT3P>_A.X^(WQ*^(G[06J?#W57UCX?ZO\8=2TK7+OPCJ4
ME@^F_P!I:?'I>CZ-#+J,5E-/;P7UXMS?)'<W#?:F9N96#G5PM"BZ%2C*D^;F
M512;;E=W:BNK4E:R=K:-7/8I\19/EO$&>9L\TEG6$QE&K@%AY9?B,!B:F#Q.
M`>%B\#B/;U)86IAZLJ3D^:4I4J<XR52%24'^:<OACXD?LU?$O_@IA%\9_!OB
MKQ[\.OVF[;7_`(A?#'XCV=O;:CX:TS1;'X<?\(]!\-?$<K%#X;OM/OS#;>'A
M*+@ZE)*\J*CHF[[^_P""8/@GXL_#S]@[]F+PA\:M0DU'XBZ/\*O#T.K^>DR7
M=A:7$`N]$T6_-R[32W^AZ+/I^E7,WRK));N=B_*!ZS#^S%I&K>,=9\4?$7QQ
MXS^*6GW/B4^(_#'@CQA?6-QX+\%2>2D,5CHNB6%A817%C;;!+:+K#:E<6\Q\
MQ)R>OT_##Y6U%4!$&%&T#`SG'"J`%&%`[A1WK7!X#ZM5]K*<W)0<%!RCR24I
M*;D]$^9/1;[/2QX_$?$]'-LLIX",,/4Q<IX*>,QN$HSHX>I+!8*C@<,J-&;?
M)4^K4XK&3CRJM73J)>\RRIZ@=L#]!S^>:=4<??\`"I*[TK*UV^MWYN_ZV/C^
MR[)+\/S[^84444P"BBB@`HHHH`****`"BBB@`HHHH`****`&DG(&/K_GVK\O
M?VC_`()>.O$/[4%I^T'^RK\5/!%M^TA\*OA=!X*\;_"#XAVMSJ/@_P`5?#?Q
MAJ[ZOI<-[J&G2KJW@K6KJ^T6X?2-7LDGAO/L\L5_`T*YK]1*^5?%7[)G@SQ!
M\8/&_P`>M+\3^-O"7Q5\:_#K1/AB_B;P]KGV?^PO#>AWMYJ,!T;3+JVO-)%_
M/>WAGN+O4+"^D/D01P&WC\U9>#'T'7II1C>5^F^Z`^%/A+\:OAUX_P#"_P"W
M]X7OOAAJ7P1_:<T[PCK?B/\`:`^&=_JL6OV$UY-\.+O1O#'CKPWJMC!;:=<Z
M+XETS3H[@3);1WDERP^WM/<J\YR_^":?PNTSXT_\$9?V:?AEJ;O:R>(O@?<V
M^GW\.8[S1-<AU_Q%<Z-J]M*`3;7=A?I;7,$N5)`*@_,:^Q)_V&?!G_"!_$'P
MSIWQ+^)NC>-OBZ-)@^*_QET_4M%/Q+\=Z?I.CSZ!%I.JZC=:%<Z1;Z;+H]Q)
M8-;:5H^G1Q1D2VJV\OS5UG[(/[)'AS]C?X8Z=\'/`OQ!^(?C+X>^&[.WTSP7
MH/C[4M+U-/!^DP27,QTS1KBPT?3)Q:3373RRK>R7KF3:T;1!=I\VEEE?VM%U
M%3Y(4G1>N\7;5Z_%Y;;LB*E>[MUV7>WGOZ:?F_FGX!?&WQ!\9OAK\,/@#XRO
M?,^-W@SQ9>^`_P!H"%T>UO5MO@^XAUKQ+&L3>=:?\)IJ$7A[4M%:=%AU.QO=
M3564A17SM_P68@\2)XN_X)G1>"&T"/Q7'^W)X93PY_PE"Z@?#2:DO@/Q:MM_
M;C:9%-JD=D0,8TX)=!N(W;G/ZT^&OV?/AEX1^,7C_P".V@>'X+#XC_$W1-!T
M'QCK,4A']J6GAW*V#O"$$?VHQE4FN`%DD6"!6)VY'S?^U#^P+X8_:J\>?#?Q
MYXS^,GQA\,7'PA\5:7X]^'.@>#-8T'3M#\,>.],LM0TY?%=K%>^'-1N9M1GL
MM4O()DNKB>U9'7RX8F!8W+`U?JM2E*FZDI5;+V<DI*'\UY773UN[KJ6]=_+\
M#S#X9+\=?!,7[5?QK_:3\*>&_$_Q6^'%_P")S\$7\)"^.AW'@N;X7^%]9O?#
M/PWF\01Q:Y'INNZ]HTQUBUU%I96U2WF.=@!KX=^'WQ^^,7P/_9!_9B_;QN-0
ML/&5S^T!XO\``-O\=/A[JGA2SF\6:A/\9?%\VCPW.B>+;:635X[OP8@M-*LM
M%=/[&:QMI/)6)HXL_K5X`_9,N/"_Q`TSQ[XT^/?QC^,CZ+I6K:9I'AGXC:AX
M8N/"]A-K#J;K5ETS1?#&CBXU40AK6&XNI)?*@DD10=U5M`_8?^%OA[Q+#=PZ
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M]-^T-EH)%4?,`#^Q'Q5_96\*?$OQA:_$/3/%/C#X8^.9+"#0/$_B+X?7]GIM
MYXX\(0.S)X3\5?;=/OHK[2E\R8P21Q07]FTK_9KM.M;^I_LS_"V_^$NB?!BT
MT"WT7P;X6&GW7A--)Q;7_A?7M(EEN=*\3:-=&-_(U^TO9Y[XZDZ.TUS-*\L1
M$KBJ6!QOVJG,]W)MW?PO9?/[MM[THI*VK[WZZW5U:WEZ'Q%\/-1\76__``5\
M^.^BZ-!"WPZO?V2?A;J_BV5)G4Q>.8?&>L66@,+55:.2:70/M'FW#,I6)`%S
MBOUASV_SW_PKQ#X2_`KPW\)WU/5;;4=8\5^-?$<>FIXO^(/BFXAO/%GBH:/;
MRVVEQ:K=6]O;0FUL8IYOLEK;Q06]N[;DB8LU>WUZ."IU:<&JM[W?W:6_`H**
M**[@"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`R-:^S?8+O[;)Y-H+*[-U-F1/)
MMO*/GRAXRKJT<>7#(0\>/-!PIK\(E^'?Q._90^!'Q'A\$:9X<_;&_P""?/Q*
ML/B/XYUC2]-O(O#?Q@\#>"_B0VK:MXSO=&U.:.YT/QUHNEPWM_JMO<7"67B-
M(D\N&821HQ_>/5M/75=/OM,E9D@U"RO+&=XW\N5([NWD@9XB8Y%\Q0Y*EE^4
MX;YL%3\/:/\`L"?#_P`+?"KPE\#O!_Q$^*GAGX1Z#8:UI/B'P19>(;*]LO'>
ME^(C(VLZ?XAOM5TN\U.VM+YYI_,@T*[TF-5GD6)8]PQY69T9UJ?+3IIR3^+7
MF>V^NMNW5>:)Y;N]WKZ?Y;>NA^;?[:7CCX<_$&W_`.")?C'X.W]SJ/PNUG]L
M_P""D_@FZN4G%TWANW\+7UGI7VO[8S3-=6PMU23S,2//$5)+?,WWO^VK9ZW\
M(O$_PB_;`\)R7,%K\)]<MO#?QPT_3H!,?$'P4\4W*Z=K-Q=J.)I?!6HW%OXH
MM9'YM8+:[(&'Q5?XV_\`!,_X:?&/5/@K-:_$[XK?#'PW^SK?^&=>^"O@KX<Z
MAX;TCPUX"\6^%+6:RTSQ5IL-UX<O+ZYUC[-,(YSJ-]>64VP&2S9GF,GW%_PK
MNPU+X=R_#CQA>WGC?2=1\*W/A+Q#>>(C;3:AXEL;W39=*O[K6&M;2UM)KO4+
M24K<^5:11*^'B`VJ*Y<-A)SKXN5:C%.HHSISCS<T*D(Q47&^EU:Z_0.7S?3\
M-.WWGE'PGU_3_BKXU\9?%;2;^#4/!^FK;>!_`E[:O*T-]:0!+[Q)J@/,%W:W
M6HSVRZ5=P'R_LT,BEC@A?PBT9?VIIOVX/^"T:?LNS^`H?$7]@?#AY(_$D7B=
M_&DVI#X.W/\`84OPSFT*XCTQ/$,\J>78_P!MB*U.J#3V,GD'>/Z&OAA\%O"7
MP;^%OASX1_#F*?PYX3\)Z(VA>'H8YOM=SI5KM8PRP7-W'(TMU:3R2W5K+<)(
M(YF4NDB+Y9^'O!?_``3+TWX??$?XH_%WP?\`M2_M)Z'\1/C3>:+??$WQ##KW
M@>ZE\33^'K$:9H_G07?@5[6W6RTY4M(Q:6]OF.-2V7+,9QV73Q$<+"%.,I4\
M53JSJ27O.$8S3U4DMY)_TBFK]].SMY?J>,_M6^(]6^&GAW]BK]GSPAH3>&K7
M]JK]H/P/X4^.^NZ4ELLMG<>(-$CU_P`9P>)K6V?*ZQX]OK>XM[V1)8?M-VNY
MVD!9S>TW]IKXJ_L^_%;]JK]FO5M(M/B8GP;_`&7+W]ICX0Z[X3\+V'A.2ZTM
M(O%BVWP[U:PTV:31/[275=`BTW2;ZW"3W]OYCW0$P-?:FF_L:^!V^%VK_#7Q
MCXI\;_$:\U?Q=)X_;XD^,M5M;OXC:?XS@FCN-#U[2M:LM.L;?3[GPU+!;MH"
M6MG%!IZ0M;^3/#/(H[KX2_LW^%?A8^OZQ=ZQKOQ(\?>+]*T_0_&/Q*^($NGZ
MEXN\2Z+H\=U'I&BZC-8Z=860TG3A>79@L;6UMK=GN[B22-Y)"YMY?BE4FXS]
MR7+R)RNHVBHM6]=?O%;UOM\NW;SV/QN\`_'7XN_L[_L\?L:?M8'5;#Q[8_M.
M>+OA1H?QK\$7?A:WF\:7NO\`QNU,6P\3:;XLAFFUJ6?PU*T&GC2+I6TR&RTU
MRFS,N/HOX":CKWB;]LC_`(*J1?$VS@M+?1M,^$?@_P`&RRS/F?X87/PY\3W/
MVJ.*4#R(KC4)=6G=H<H[13,H(`K[%\(_L1?"[PEXFTS48]7\6ZQX)\+>)+7Q
ME\/OA)K&I6]U\.OAUXJM)7N(]7\)Z5]C6]M7CNY9KJUM;G4;JRLI9G^RV\0)
MW=E\3/V8?"7Q'\8#QNFM^)?!FN:GI,?ACQS<>$-2@TYOB-X.AAN([?PKXNDD
MT^=[K3+4WU]]D>V-M>V@N9_)NU2=X@?4<8URRFI1TM%M\JVO^+N_1W%RKSTU
M_K\_^`?,/_!(K5O'NM_L!_`B]^(<:IJQL_$5II/[^2[\SPM8^*=6M/"\WGR*
M&'F:);V[(F-H61<'!S7Z;#.!GTKF_"OA/0O`_A[1?"?A/2[+0_#?AZQM]-T?
M2;&(0VMA86R)'%;01JH545%;&`#N.2>M=+7K8?#JA1IT>:4N1I\TK.3:L[-I
M:K2R\B@HHHKH`****`"BBB@#X-_;D^"7AWX_^$_AKX$;XJK\*/BC8?%;0?'G
MP1UB:TAU6SO?B1\/DNO%%EI^I:#=%+?6]*2UL;J>_M'9)X+9)[BU<2A"?F?P
M'\:-=\._M<?`WX>?ML_"_1/"'[0EYX:\?>%O@+\:_ASK-Q?_``R^+<.KVVF7
M/C#P^NE7<$>MZ'KMO8:'8:J^F:K<W=G!YQ.GR19.?T&^-?[-O@'X]:S\*-;\
M<MK7VKX-^.?^%A^#_P"QM7NM(">)(])O-*M9[Y[0K<7,%LMY).MNMQ$CRH@F
M\V',)X+3/V/O#;>.?^%F>-/'GCSXC^/-&M_%%O\`#;7_`!E>:+?/\)8_%EFE
MGJ+>"+6TT2PLENXECC^SZEJMI>WX6-$DG9<AO"Q>%JSQE*O"%^62YE[W*]OB
M6_W/<#X(_P"":D45S^V-_P`%@8;I5E@E_:E^'L%U!/D*\<_PEA1XS#(#OA>(
M@*H`63)&3A@/2/AS\0]1_9.\>_'_`/9DU[4);JUO[B'XE_LJP7J'[-=Z!\1-
M2&BW'@JW:/$\Z>#_`!O*UQ=6MN";'PQJ$3-A5X]C_9P_X)\>'_V:/BS\0_B]
MX5^./QK\4:W\7]=B\4?%;2_&.L^&KS0_'/B:TTJ/1K#7=5L['PS9O#?66GQB
MUA&FRV,)C(\V.4HN/I[XB?L^_#3XI>._A5\2?&6@Q:EXN^#&L:EK?@+5A+);
MS:7=:U8OIVK12%-WVFSN;?R'^R3;HEGMH9E*ODC/!8!PH14H^QK1Q#M5C\4J
M=3WY1?,MKV>G:_F)*W?_`(?Y&IX7\,:-X"\":!'X@FMII/"NE'4-0U.<Y:'4
M9X)+O6M1A,A,BFXN6N%ASEVC*(NYV-?+7[)/P3LO!_Q'_:3^/>IP2:5XG_:D
M\>Z=XM@\.WK>3>V7@_PIX>L?#&@O)ISE%+ZA`&UG4&AMD>*34+>&YD\S('LW
M[4_[,VD?M6?#"Y^%?B/XB?$KX>:#J%W;W.J:E\+?$0\+:_J$5LXDCLIM5%K<
MSI9^8H>2*(IOY5C@"O#_`-EO_@GCX`_99OO'^JZ+\7_CW\4=7\>Z-::$^L?&
M3XCZCX[U/PO8VJW@9/"5S>PQ?V-]JDNDN;L1(RW%U:6LTBEHAGIKPK+$453P
MOM8TGS.<9*.KM;FOIMKI;7R0SR<_"7X]_LS?M'>'_B3'\5#\;?@Y\:?BO>Z'
MXE\*>)O`&@KXQ^%]_P".)B-#N?"GC/3@VIR>%=+NH?L^IV6I\16DZF`KF7/E
M/_!8:UT];S_@G9J?V:T^U_\`#PSX!@Z@;>(WD=N\NK$H\V/.2)E4J^YU12A4
M8&!7ZA_"SX*R?#O3(;#6OB1X^^*MU87EU<Z3K/Q%U*PU'4M,CNF++;1-INF:
M7!-%:X1;5[J*>XC6-0+C)8M\_?M8?L%^&OVN?%/P[\2^-?B]\7?"MO\`"SQ/
MX<\>>!_#G@?6-!TW1=!^(/A66^FT?QI;K?\`A[4;J;6(?MKPM]IGELS"H_T3
M=S6-7!RA1K1I4Y7KUU7:J23<)JVD7&RLWZO7=6$XW[ZZ?E_E^9]XQR1E5"NA
M^50"I!7T`##C/H,Y]JEKE/"'AN[\,>&]"T"^\1:OXLN]&T^VL9_$GB%K9]<U
MF6W4(VHZG)96]K9O>W"C,Y@M(8RS,45%.T=77N0OR0OORQOZV5QA1115`%%%
M%`!1110!\$?M1_\`)0=*_P"Q0T__`-/&O44?M1_\E!TK_L4-/_\`3QKU%`'W
M+IO_`!X:=_UZP?\`I,E:59NF_P#'AIW_`%ZP?^DR5I4`%%%%`",-P(R1GN.H
MJ,QYZG)]2`:EHIW?]?UMY;$N,6U)J[6U]5]ST_`HS$QD@8X`);@$Y(^7`QC(
MSAL]CQ7FOQ8^+'A7X-?#CQS\5/&M^FE^$/AYX7U?Q;XEO]GG&#2M&LI+^[:%
M!)'YTQAA:.&!27GEEA5#G*GQG]N'6/B!H?[/_B6Z^%^L>%=.\;3ZEX;T_2-+
M\8Z_'X5T?QK_`&CK=I97?P^C\1.ROHVJ^-K*>XT'1M0@W7-MJ-S;R6T<DH`K
M^<+]MC5=*\9?L*?\%"M3N++XZ?!OQAX%_9Y^$O@S4OV7_B=JNIZA9^!+70O'
MVLW.G?$3P9XKM]6N_P#A,M!\8SZK?:;_`&I-N>>+1BEZBX%O;^7C,PG@O;6H
M\T(8;VD6WI[1/=M[Z?9NF]TFDV?=\(<&PXCQ&`G6Q7U;#XC.,!EK4*49R4L1
MCL!1J2M%J:YJ=>2]HX2IQM*,FI.!_6%X.\::?XU\'>%_&6CB5M*\6>'=%\3Z
M4;B-X+E]/U[3H-3LHYK>0+)!<FVN$\VW8,\;AE8`@@=*MRPSO,>%!^<,0F-Q
MVDMM8<]O<')[#^:#]IC1]6_9K\!?\$;O"7P/\??$'X?^#OBS^T-\+/"WQ&\*
MZ9XRUB_L/$6E:_\`#:'Q#J@U6^U>YO\`524N[!;:*S@O8+2-;F3R[=-J`?=?
M[8W@[X9^"X/V7/V?-4^*'Q5D3XC_`!-\6Z;X5^#NB>,-0L=8^-5S)IMQJUS8
M^)?&T-_9:_HGA'P7]K_MB>6RNO.)^S6JF9VAC,PS5)5U/#K_`&:"G.7,UJ^5
M)1VT][3W6W*\4GHCHQ7`]!8G+?J^<5)4,\Q6;RPBJ994I*CALEQN-H8EU*JJ
MM14EAX1<IR5.$&IRJQM*2_3+XH^.-?\``GADZ[X<\":S\1M0&JZ38KX>T&YL
MK2_:UU*\BM9]0\V^=8?(TZ)Y+NX&-[10NJ@.17H"7F5RR!6V[V!)X4!0,'`!
M+LPP`QP#][((K^.#5?VGOVE=<_X(P:)\2W^,WC;1?'OP]_;7M?A';:YHFMSP
M7^I>!;7XUVG@^W\,Z_JKK]NU*&PTJ:.U6]>2&[NS`IN26ED5OTSUS5O'GC'_
M`(+.>+OV?O$WQ'\=:G\%_%/_``3\U+Q?/\.D\17FG:-8:Q?>,M`\/7=QIS:5
M)9WUE<RVPFNX+U;L7B7+2F*95(4<<L\C!>TA'F4^2$8\SM%S2:DU9]O>6N[M
MHST<3X98C#8><*^985?45Q#7JU8PG.5>GDM7*W[+WI\L7*&9TW3Y;747%SFS
M]]8I&9\<;3P&ZD\?>'3Y2"<'GD<U:V>I/^>E?CY_P1!^*GC_`.+7["OA;6/B
M+XFU+Q5J_AKXE?%CP#I6KZS<27NK2^&?!GC?4='T&VU"\GDDN+R[M-.ABMY+
MN5W>0(#(S-\Q_8:O;P]=XBC3JRCR.44[7OND[^3UU_#0^`SK*JN19OF645JU
M*O5R[%U<+4J4H\L92I2:YK+17CRV2Z6WW91116QY@4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`$+KM4D=>V03S@]0.3VZ5&)".F-W''7*Y`=@,@
MCE7"YZX[]YY"0CD$@A3R.H_//\C[#-?A9^TSXQ\46_Q'^.>F_$./QS%\-/$%
M\WPV\-?M2_`WQ-/K$G[/5GJ$&BWNH^#_`(L?#FUU*W-A_9FHA+J3Q0T9O!I&
MJ1-,;8.H;BQ6)6'HQNE.<K65WK]UOO\`Z:;T_K^OZZ;GZY:1\</!&N?%[Q9\
M$--OI;GQYX)\)^&?&/B.U2SE^P6.D^++V_L-(W7V\Q?:YIM-NG:R;;,D/ER'
MY6!/K7G\;G50H`W$@[D)4M\PY&!@]&.XLJ\'D_SY_LQ?!_P7XH_X*]?M]ZI?
MW^N3:KX&^'?[-VJ^"-=M/$'B"T>PU+Q1X"U.#5]7CM1J+:3?RW;746H6UK?V
MMY:VT\BO%#&^XGTW_@DG=^+/BQ\#O'/QD^*WQ5^('B3Q7X#_`&DOVJ/!NGZ[
MXB\03W%HWA71O%6H:%IXU/3=R6%R-+L=-M[ZW$D$(M;FW)AVJ3O\["9G.JVI
MT;OGY8^\UM9K;6W:^NFQ%Y=^K73I;TN?N"9@`"JH3D`C=M()Z#[IP3V!*CU8
M#FN!\)^--=\0ZSXVTW4_!6K>&++PMKYT?1]8U*>VFM_&%D+6&=M<TBWMV,\-
MCY\CV@2Y(D,D+OG:54_SG_#WXR:AX=_;2_80UKX.?%3QY\0/A]^TU\4?VCO!
M'Q(^)?C'Q%=3P_&>T\$6&L7<-]HG@];ZXTCPMH/AG7;8Z3X:O=-BBO-1L=-!
MOE#DR-0U?XL_&ZW^"_\`P79=?C;\27UOX!?%?Q#:_"W7_P"U5;5?#6E:7X#L
M=4MM+L2R"WL]':>Z>"=+2))3:022I()F+')YU#FDG3=/V4\91DDY/FG3PM.M
M"6KZ2>GIL',[_I==KWV73MU^X_I_67</X=V<;0QX';=\ORY'(SP>F:F%?SP^
M&_B-X^\'_M,?\$9K_3/&'B*YF_:8_9QU#2OC,-3UO5-0L_&,>B_!K0O%>F7D
MNDW%PUA::K;:S<S7#:G!;Q3-"^V>24\5_0W'C8,9P"0,CL"<8QP1Z'N.>]>A
M@L4L2G_TYHX>4]=Y5,/2JNZZ:OL6MOZ^[Y;#Z***]-.Z3[C"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@!#]2/PS61J6KP:3I]]J5]-;V]IIUE<WU
MY<3.8XX+>UBEFN)I-W"QP1H&D)D'`<$H0*\N^/VK^(=&^"OQ2U/PKXM\/^"/
M$NG>#=<N="\6^*IH;;PYH>J1V+M8ZAK%Q,5BM],6ZV1W$\C!(E,CLRA<K^)>
MH7?_``F7@7XW>&_B-X:^+_P!^(7@?]C_`/:6O[CX.:QXGU'QE\,_BP=?\*V^
MM:C\5?`'CY-2>345T36(+58=-EC$FF0:OY'V>"$H7\W&9A##/DY>:;C)Q]5&
MZM\[=]O03>C/W(^$?Q=\+?&WX=>%?BGX%DN[GPCXRL&U/0KB^M7L[JZLA<3V
MZ3FV=B8XYV@=X9&<J\6UL`M7I?G-P^T;2KD#.695V]"H*`YSD%LXP1SD#^3.
M[L=8^`7_``0R_9A^*7P1\;^-/AMXU\?>)OV8IO&EYH?BG4+E==D\7^,]#\*:
MG:M'JEU-'I5C<:?,5MK/1A86SW@0O`Y:3?\`LM^UOI?PW^$7P+TW3/$WQC^)
MG@S2_B;\9?!5K_9&BZU<:MXL^)/B7Q9=Z9IL'PA\/:A?74%[HEEXQN!%:SS:
M;,L^FV]S>7-NZ[4V8X7,92I.I5@UR8#!XB5^LJJGSVU5KM:WVMTL9\SM^>VV
MWYWZ::(_0_QOXEU/POX5U_7]&\-7_C#5=)TVYO=/\,:3-##J6N7,"%DL+.6Y
MVP1S3G:J/(=BLWS<`FM'0]7O=6TK3-1O-,ET6YOK*WN;G2+QEEO--GGABE>S
MN)(&:&2:T>0VT^S"-*K%&"C!_EYT3XT_'#1_V"?^"RNA:?X_\6^#K_\`9)^*
M/C+1O@XVF>);O7-=\#Z);>!_#WB9/#)\4ZTUUJFM6-G<ZE<+)<7#?:6`EM[.
M=V57/TEJ/C[XHW/[57_!'?P]+\3/'Q\(_&GX">/M0^)'A5=<DBT+Q-J&@_";
M1]2M]3U)8]MU<7\\^IM]J:29@&,$J(LNYSS_`-L>_"2@IPJ4Y2BFVFK22^6N
MO71;![3EM?6^W3K9_=KJ?T(1OO!/0@X(P>#]2!U&.!D#D;FJ2OQ^_P""2WCW
MQ?KMU^W9\--=U_5=<\*_`K]LGQK\._AI%K6HWNLZAHW@\^'O#^O1Z0^K:G<W
M6IW4%K?ZI="WCNY6^SQG;"S(Q"_L#7JX*M]9PU.NX\KFY::Z<LW%?^DHTC+F
M2:Z_YV"BBBNL84444`%%%%`!1110`4UB0,_ATR/7.,@]..#^!IU?/?[5.J>+
MM&^`GQ#U'P'XH\+^$/%]OI=L=`U?QE=QZ?X<DU%M2LTAT;4-0D9!IX\0ECH4
M%['NGM;C4(I[>.29$0YU:CI4YU$N9PBY6[V!GK7BGQ=H_@WPWK_BS7[J*QT'
MPUI&HZYJ]_(WR6>G:5:27UY<,O1Q#;Q2,567<[IY:`N0*POAC\3-`^+GPZ\%
M_$WPG]J;PUX]\.:3XIT)KVW-O>'2M8LH;^U>[M=[&WF:"95:(N[HS*<-R*_G
ME^/=_:^)?V:_VT[?7]`^-'[/WCWX:_L2_$31[O\`9P\<>)-1\1>%[Q;O66\0
M1_%?P)X]34IQXGLXM=@.CM(T;26\$D%K+%;/+/;-RGQ)T_7/V??^"='_``3+
MU7X(^./&WP]D^)_QS_9-M/B';:9XGUK4+?Q-!X]3P_#KR7LNKW5Y=:=;R1VD
M$T6FV$EEIR!]JVH5N?!><5(2JU9T.:EAZ3JR6U_>IPT=NCG?OY6,G)]][]O\
MMK?YG]0(G/"@+R,J"6S@'#YX`VAF0!ADD-G9Z<7\0O%NK^#?".K>(=!\':GX
M\U;3T@:U\+:%/;6^HZFTUS'`RVUS>;;9/*1VF9GR`B'(Y%?GK^U]X>^&WPT\
M"_"SX::W\4/B7I5E\4/CE::5HWP\T/Q#>CQ%\8];\2S27`^'(\427T&K^&O#
M,4BO?:A?:?<>=9V,+);$-M6OQUUGX^_M`Q?\$EOV[-:M_BIXQ\+>+OV=?VN_
M'OPL\":KH6O2WNKZ+X(T7QCX0TRR\)WGB6]^T:EK%GIB:OJ-K_:ETT&H2R01
MQ3`H"SZXO,Y4)RINB^=86I7;B^]*G4IWMLU=K5].X.HH_%UUO?3HNFW?M?R9
M_5_:7TD]K;SR0?9))X$FD@DQ(UO(8T>:!VC;8TD!9HG8,JF1"4W*>+\<GF*3
MC:<D8SGC/!Y4<XQD8(!XR:_"GQ=XJ^(.H_\`!3O]C3X6W_C_`,;S?"_XH_L-
M?$3Q1XN\"1ZU-!H=SKMDNA:(VH,MDT%ZEU)::DWF:B\\DL5YND@EMFD.[V;_
M`((\?$;QMXZ^!'QLT+QAX@U3Q!;_``E_:P^.GPE\%W&LWMQJFJ6/@?PAKUM#
MX?TV\U.\FGNKYM/AGD@CN;F:69XU7>QQ@;8;,HUL15H<K3A4G%)N[2332U[1
M??[M!J7-JFTGMU=U;;1=?P/UUHI`<@'&,CH>WM^%+7KFBOU"BBB@`HHHH`**
M**`/@C]J/_DH.E?]BAI__IXUZBC]J/\`Y*#I7_8H:?\`^GC7J*`/N73?^/#3
MO^O6#_TF2M*LW3?^/#3O^O6#_P!)DK2H`****`"BBB@#QWXT_!7P#\>?#%EX
M+^)6ACQ!X<L?$_A7QC#8/<W%M%_;O@W7+3Q!H%Q,;9T:XAMM6LK6X>UE)MYA
M#MF5E.*\SO?V0_@UJ_PW^(?PI\3^'M3\:>%OBAINI:%XR'C#7]3\2ZMJ'A_4
M7D8:%;:UJDLFHZ=HNE>=(VAZ9931P:1D#3Q%@&OJME)R<]N,YP#2;#UX]NO7
M_//U]JRE3I2;<J2DW:[:O=_JO[KTW[G72S+,\/2HT,/C\11I8?%+&4H0DU&%
M9<MG&S]V2<8OF5I7BK/W5;\^O'?_``3;_9L^)J_`2/Q3I7C6>']FG4++5?A+
M'8_$#Q;I8T37-,6PM[#Q!?&TU!6UG7;:TL$L%U?4O-N38>9;L3'.XKWSXM?L
MS?"CXUZY\)/$WC[P[+J/B7X(^+SXU^&_B"VU*]TO5]`UJ;3WTN^,5[8R1RS6
M>IV+^7J-@[&VO/*B,XWI&R_197/N?<G_`#_CU-1/&S+A<`YSQGT.#SZ9[$5,
MJ-"=XNA%J5E:<;0=K?%;=:=5Z&\L[SJ<L/.>:8N57#RJ>RJ<[YJ?UAM5N771
M34Y.=FN:[<C\XO'W_!+']CWX@?!VS^`FI>`M8T7X46?Q%U/XK+X2\'^+?$/A
M739O'>K7K:G<:_>II-]!)>SPZJ#J=BEP[+I]](UY;,LV2==/^";O[.X^-1_:
M#+_%,?%T_#?_`(5)'XN3XI^-!>IX"&BKH_\`8NU]3,:Q$+_:?FX\QM=6/6Y6
M?45CE'Z!M%(6R",;&&,_Q'D'\/T[=ZF*L<#/'?\`,_3IQ^58RR["S4>;#8>%
MFI?NHI.Z2LG>*LE_5M3K7%/$BC5IK.L<HU[SJ-UIM2=25/VBDN;7G6&HN=[W
MY87^%6^1OV2OV-_@[^Q;X+U+X>?`RQ\3Z1X0UCQ+?>);G2O$7BO7?%B0:OJ)
M#ZK=6$NN7MW-8KJMUNU"^CMRD5WJ,DE\Z>9*U?7M1A""#QU[>G/'\OZU)77"
M,814804$M+)6_+3[O,\K&8S%YABZ^.QV)JXK$XF495*E:4IS;A"--7E*\FVH
MK5MOH%%%%4<X4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`#)`2C`
M#)QP.1D^G!'\P/7BOF&W_9*^$%MXG\0>+[32-<L-2\9^-KWX@>-[*R\4ZS!H
M_C#Q#>Z5;:.P\4:2DRV&NZ;!96-DMGIE[&UA9S01SVT:-$E?4)SVIBJ0<G]/
M_P!58SHTZR_>1;\K_P!=O6P'SA<?LM?"&;XI>+?C+!X<N=*^(?C3PAIO@?7]
M>T;5M1TMM0T?1UGCT68PV<Z);ZMH<<K1Z7K40%]:(0D#K&`M9'[-O[(GP?\`
MV4/!'B'X>_!_2-;LO"GBK7]5\4ZSIWB'Q/K'BLW6O^(2\WB'59'UV>>1;G6[
MJ2:YU01./M5S/+<R9DD:OJFBLUA,/#54K]-/EZ=OS[@?&/@[]@[]F?P)J'P\
MU3PS\.(+&_\`A'XQ\:^-_AE++J&I7:>"==^($UZ_B9M`2>X_T'3;_P#M&X8:
M9;F.PM';=:QKMR?,1_P2[_98?1_C[H,NE?$B32_VGM6BUGXX6TWQ4\92?\)O
MJ4-_]N:ZOW?4RR-<Q)'I=R("B7.C)!I4RM9Q%3^CE%1+!X:I9NC;IM;^771Z
M/S\NRU#\^8?^";'[-D&M_L_>)7MOB1)KG[+VCVFA_!6]D^*7C:X?PGI]KOB^
MS@2ZL#J"7%G+_9EW)>F1[S3(H[&XW6L<<8_0&!2D2(05P/NG;E1DD+\I*X4?
M*H!(```Z5(1GG'(Z4#=@Y//;_.*JCAJ&'E)4:3BZJO4FMGI;6]];+;R2`6BB
MBNL`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`\Y^)WPS\)?&#P#X
MN^&7CS2I-7\'>.-%O_#_`(DTP7$MH+_1]24I>69GMBL\8F3,9DB994#;HV#8
M(X[PU^SQ\-O"P\0V]OIFHZMIVOZ3+X?_`+-\1:Q?>(=-T?PY<:8FEW?ASPU8
M:D\L'AW1+RTB1+G2],$5I/(3.Z^<6->[T5RNA0D[.B]>K6G3S_K4#X"\7?\`
M!-?]EKQK\%O"O[/VL^%?$\?PK\&>(M,\4Z%X8TKQWXGT^.'5M!NSJ'AH7%Y;
MWL%Q>V7AG4O^)GX=L;LO::/J!%W:1QR*&/O/Q2_9O^%WQH\`>&_AS\1]`NO$
M>A>$=<\,>)?#ES<:G?V^N:5XB\'W5M=^']<M-?AN3JT.HVLUJIFN?M)ENT9H
M[IGCE9:^A**%A,/#54K[*R5]--UIHK?GW`^)/&?[`G[-/C7P'\:?AQJ'@?4-
M/\+_`+1'B>#QA\9K+PWX@U?PW/X]UM+6"TN)-;O]+GBN)+?4;6SMX]6LA(MI
MJ1BCCND:.5S7+I_P3=_9RA\8?`3QVD'Q)?Q/^S5H$'AGX/ZE+\4?&S'POHL,
MD\DMDT)U9H]1CU6.8:;K8O%E.J:1;65A=LT%G`H_0.BLI8'!U6G/!TIN*LG5
M335^5V5KZ:7?G?<#Y#_9Y_8Q^#/[+_B'XH>)_A-:>,K+5OC!XDF\5_$`Z]XW
M\0^);;7?$LL\EX^O?9-:O+BTMM4D$J6<EW"B?Z'!!8C]W;)7UQ$NR-5VA<9^
M55VJ.2<`>G/4<'J/2I**ZZ-*G0IQI4J<:4(K2$/AC=MNWJVWZL`HHHK0`HHH
MH`****`"BBB@`KS3XO?"?P/\;_`&M_#/XCZ-_;_@[Q$^FG5](-S/:+>#2]4L
M]7LTDGMF69(UOK&VDD"G#JA1P58BO2Z*4DG%J2YD]UW`\#M/V<_AI'I7CO0=
M4TO4?%&D?$2PUG0]>M?%VL:AXF$?AK7(WBOO"VCOJKRMH7ACYO,M?#^GE-,M
M9T%S'$)V#+X#XV_X)Q_LS^/OAY\(_A;XA\.^+CX'^!NN:9XF^'6C:5X\\3:<
M=,U[0(8(?#^JWEU;ZA%/J][H"6T47A][XM_9*^:(?DD-??5%<RH4/^?#_P#`
M?\.^O]:@>$_%?]GKX9_&JS\"VGQ$T2?69OAEXOT'QYX)U6#4+W3M;T3Q7X?)
M^P:M:ZQ9S)>^8REX[R$S>5>Q2-'=^8';'@OCO_@G/^RU\0/A/X[^"FK^`[W3
MOAQ\4/B'J/Q1^(7AGPOXF\0>'+/Q;XTU9HGU#4-:DTR]BN+RUN+JWM;QK21C
M#]K@2[93(@%?>%%'U3#U+.5'R]Y:M67F^R7R[`?!D?\`P3V^`"_%OX<?&V9?
MB=/\2?A-X&@^&W@3Q->?%#QA<W&F>#8;)[&?2)8FU00W<6J)LN=4>Z1YK^^A
MANKQY9(K=H^__9A_8Y^#'[(UAXYTSX,6'BW3]/\`B'XHF\9^)K?Q'XQU_P`5
MI?>)[EI'U374_MRZNC;7^L32M=:E/`RR:A<[IIV\PYKZS(!ZC_)HQ@8'X4J>
M!PM*HZM.DH5&U>:W=DN_EH`#.!GK@9X([>Y)_,D^YZTM%%=8!1110`4444`%
M%%%`'P1^U'_R4'2O^Q0T_P#]/&O44?M1_P#)0=*_[%#3_P#T\:]10!]RZ;_Q
MX:=_UZP?^DR5I5FZ;_QX:=_UZP?^DR5I?I2E)13;V7_#`%%1E7[$_7/^-/&<
M#/6G=/9I@+1110`44ASV./PS2`-_>_#`I77<5WV_%?UW_IZ.HHHIC"BBD(/8
MX_`&BZ6[L#]+BT4W#?WOT%&&_O?H*5UW6_\`7](5W_*_O7]=_P"GHZBD&<<\
M_P"?:EIW&%%%-8D#CUHN`ZBH=S>O\O\`"I5.1SU_S_3%*Z>S0[-;IKY"T444
MQ!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!13<-Z_
MH/RIIWGC)_(#^1Z^WX\U*G%J]U82O>UK>=U_7]?=)13`'[G'Y'T^M/III[,?
M6WX]`HHHI@%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`?!'[4?_)0=*_[%#3__`$\:]11^U'_R4'2O^Q0T_P#]/&O44`?<5CG^S;`@
M9(M+<XSC.+>,XSANO3H<],5^2/[2G_!7KX5?LO?M+_#[]E;XA?L__M,WGQ5^
M,.I:AIOP9M_#?A?P3?:)\4Q87-I:3ZGX9U27XAV1M;,WDZVBIX@M]+F>6-V$
M!"AS^MMDXCTRQ=ONI9P,?7BV0X'N>@S@9ZD5_)M_P60(D_X+E_\`!$XJ[J&U
M+Q*%*C[VSQWIKN",?,AC<$E3QN4]?E/5@:,<16<9JZC&I*U[)\L7)7?1:=+=
M#DQM>>'IPE347*<HQM+;6:5].RNS^A;X3?MG?"[XF?$Z[^"&K6/BOX4_&^T\
M/6GBB3X4?$[3;30_%%]H=Q--!_:&B26FI:CHNO16DL,GVXZ-?7KV@*F?RT9"
M?L!+BW"9$J;1GYMWRGC?G<20?D^8D,1CGI7\T/\`P59T_P`>^/O^"L?_``2`
MT']GO4++_A:/@7Q'\3_%'Q*EL[<WL_AKX37LW@7^TQXG2T87.GV6M:?8Z[9Z
M6=2EC3[9DV]K=%YS'\5_M_?#+]H/XH_M6_\`!13P)\0[O6_C"/''P1\&>&_V
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MG";23DD[+I<^`_V^_P!OGP+_`,$^?APOQC^+7PO^,/BSX56<*_\`"5>-_AEH
M?AO7-/\`!4USJEAI6EPZ[;:QXHT'46?5;G4,VRZ7:Z@=EJYE$?RFO./A]_P5
M&^"WB3P)\+_BK\0/AY\9?@+\+?C&WAV+X9?$/XM>%]#T_P`(Z^OBZT6[\-N^
MI>&/%7BI?#L=_;,K0S^(1ID"@;)`AKY8_P"#E=2__!(;]H]`,%K[X;J&/"Y?
MQWHR#+'``!(+,2%48+$9&?E7]KR^T-?^#:3P'X>U$1W'B'Q9^R7\#M$\`Z,L
M:R:UK?BZ]TSPU-I%CX=M"&NIM9FB$[VZ6D,DXB61B`$X]/#X6A4P]"I*-Y5,
M5["37V4XQ?/ZIZ:Z6^1YU?$588BO34VHTZ"K16FLFU[NO33_`(8_J(BU"RFA
MCN8;F.6WFB$\4\9+Q2P-'YJ31R*"K1R1G?&ZDK(O*%JL&6($*9%#-G:N1N;:
M,MM7[S8')P#@<GBOY-_VL?!?[9&A_LN?\$AM'^*'C&X\0>#=#U'P59_M@_!K
MPMK/_"->./BIH-CH]E+)9PZ1<W^FWWBO3O#6C&*'Q%I%M?P3K?R'4&)2591]
M2?\`!$G]C/Q7\(?&W[77QZ\<>'-)T;PQ\4?C!XANOV;=-OO%M[XF\;>"/@QJ
MVJWU]:^'-;M5\1:M8>&;%X1I`MO#DLEU?VDUFY>^DCB!EQK8*%*BZRQ,*BUY
M%",K2?,TO>>FJ7-MV-Z.+J5:GLGAZE.2LY\[C=)VU26_RZ:G]$X8-G!SM)4^
MQ';_`#U[5RGBS5;_`$/0];UFQT'6?$EQI>G7E];Z%H"VS:SK$MI;F>+3M)2\
MNK*R>_O)%%O`+N[MHF<@/*JX(Z>($*<@@$Y7.,A<#"\$_<^[SSQ39;A(0Q<-
M\N!P,Y)!/RC.3@#G`.*X(M)I.*E?1)[/9G7--K24H6U;C;5+H[]#\C/@#_P6
M)_9\^.O[4:?L@77PZ^.'PC^,5Q_PG%O8V/Q9\,:#HNC:IK7PXOX]-\5Z)I^J
MZ+XHU^WN-1L;V18E16,=TRL%<E,5Z#_P4-_X*E?`#_@FOHG@GQ!\<]`^)OB#
M2_'>OIX7L)?AMX>L/$$FD:U>1.VDVNLQ7VLZ.EJ=76.^-E(97WFS=_+\M7EB
M_"/]O+X,^*=)^"6I_P#!0GX568/Q2_8._P""D7[17Q"U9+4+%>>)/A1J7Q'C
MM_&&G7%XA^U2P:9!%_:5MI(BE6XEEF4A$C#-Y+_P<%^,[;XX?\$U/V>_VI(=
M/O[*R^/_`.U3\$?$?A>UU&PFL]8TSP-#X"\5?V!IE[#)*\:3?:3J-[;DE9)H
M;_+!65D'NTL!A:T\,URQI5%*%9.W,JRCSI0OKRN-K777='A5,=B*4<3S\_-"
MTJ$DO=E3<E'W_.Z:T:7EJS^Q7X(_$?4/BS\.="\?:A\/O&_PPDU^)KJW\(_$
M2WT:V\66=D<&TNM1AT#6=?TR-;^!DNK=(-3G989%$H1P5'K5<;\.V_XH3P;'
MG)B\+>'XR<$!MFDVB;E!`;#;=PW`'!&0#D#LJ\.>DYI1Y4IRBDNT9-+[TK_,
M]RDVZ=-MW;A%M]VU?]2*8%HG"Y+8XPVWD$'KD8QU([C(P<XK\@?VN?\`@L-\
M$OV)?B@GPW^//P6_:+T*QG-E<Z;\1=-\'^%]8\!ZAX>U'Q)I?A2+Q<-1MO&D
M>H6.@Q^(=6@TVYDU32+.<N7E$3!%+_K\[!4<DA1NZG`')`YW<<YQSUZ5^)W[
M>'[-/AW]LK]HKXA_L[^(8HTM?B/_`,$W?B9I^B:A+:PW1T;Q)_PO;P)-X>UJ
M"*9XHEN+/4O(=)))HQ`S"4D#:3M@Z<*U6U6ZA%N[7;97_/3HGH98BI4A23I)
M<\MKWWWT/TD^-O[1?@CX%?`S7_V@M>@UKQ'X-T+PPOBJ*R\'VUEJFMZWILEA
M_:H71+674+:WU&?^STENU1+I5:VAEE5G2,M7SG^P)_P46^'7_!1CP1J'Q.^"
MOPG^-/AKX7!KR+3/'_Q'T+PSH.B>(]9TW41IFJ>'M(M]+\6ZWJS:IITA^TSR
M7VG6MD(8VQ<LX$;?BE^P]\;/B%^T+_P38^,/P/\`BOHNJ6'CG_@G?\'OCS\&
MOB2-2AGFL]:\>^&/`>O^#_!5]HNI\&_ET?PQ#K<-Y(4"B74H)K9[F,"1/I'_
M`(-;I%C_`."4'P\(!=7^*GQ68,@RI#:^S`DAG)+`JQ)^8^8KN%W''H8C`4J.
M%Q-1N/M:&*A2BH6UISIRDG+_`,!7;?9,Y*>+KRQ&%A)J=.OAY3DWO&I&<(VC
MY6;T=^]S^CD=!GK_`%Q2TUOX?]X4ZO&B[I,]-.[EY.WX)_J%%%%,84444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%02LT:R2!'D**SJD0!>38@81C.
M/F=MP49`.1DBIZ:7&2.3M(!QZD9`Z]<$'GC!ZT`?CAX@_P""SGP$^'_[4OAC
M]DSXM_"+]H'X2_$'Q7X]\-^`--UWQKX4\,)X&36/&%A/JOA>6Y\1:3XPU-K>
MSUNPMVFM3-9B<0L#+!&YVK]:?MT?MS_";]@7X':O\?OB]I/C37?!F@W>G)JM
ME\/]&L==UZVL[_4[;2CJYL+[5-(A^P6UW>VJ3W1N\(TD6U)"V1^,G_!2W]DK
M5?VN+?\`X*AZ?X*00?%KX.7O[(_QM^$5^D<27R>*O`'PM?Q')HUK?2-&]C#X
MCM+&YL;N6&7<L4_RJTS"*OEO]M3]H>\_;C_X('_M!?M6:KH=[I=SIGP+\`_"
MA;+5;.:UNHO'6D?%?P;IWQ&U6TG9EBET+5=4M=-AL;AXF>(64I=X7DD1O;I8
M/#U5A)\JBYSC"M!-V2FH\KBY7=]5?5_.[/%K8BO3>)?/)PITW*DW;WI+3EEL
MK=%;I??<_IH_8W_:NT7]LGX0:3\;_"'PQ^*/P[\"^*K73-5\%7/Q0TSP[I%[
MXQT#5+$7EKK^CVF@>)/$16P&X6LIOWLYS-'B.%T!<?68SCGK_GTK\VO^"/;9
M_P""8O[$9RS`_L^>`RC,&&Z,Z=^[8;U5BI7!4E1E<-C!!/Z35Y->,8UJL8QY
M5&;BEULG;5[]-3U,/)RI4Y/5R@I/MTV\@HHHK(V"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`/@C]J/_DH.E?]BAI__IXUZBC]J/\`
MY*#I7_8H:?\`^GC7J*`/N.P4/I^G*<@?9K8_*64_+!&PY4@]1R,X(R&!!(/Y
MX_%S_@D[^Q%\<OBNGQP^*7PUUWQ5\4[349-5T3Q?=_$?Q_;ZCX5O)&260^$/
ML?B*WB\+PRS1)-);Z(EG$\RK*R,RJ1^B&F_\>&G?]>L'_I,E7921M/H3^@S_
M`$K2E.I3;]E)P<KWL[7OO<BI3A42YXJ2@^97Z<OO77W'@OPJ_9M^#GP1::^\
M`^#+6SUVZL+;3-0\7:O<7GB/QGJ.F63YM+'4O%NNSW^OWEI;>;*T4$]^T>[+
M;2VXG^<S]M#_`((<_`[]H']IKQ[\;?B]\'OVI/&'BOXK>.Y+M=7_`&<_&W@K
M3?`^B>'K6..#3-9\06?C36+'5M/UF9!G53IB7\4C1QRP+#M"5_01^TQ^U=\+
M_P!EFQ^%>H?%*XUJVMOB_P#%GPA\&/"3:-I$^KR3>-/&\]S;:+%>I#)$;+3\
MP.;G4)2\-NI!>,YKZ>A??#&2.J+NY;&1U`(VY7.1T&X<D<XIX?,:M#$3A3E^
M\C!IMVE:#FO=7->R;2MI?S'B,L=7"8;%5\/_`++CI2K4*DDTISHI0DHM.SY5
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MI62U;^X_';_@K9_P3C\"?M[-\,=2^*'@CXH^-O!'PJT3Q'>6.F?`CQ'H^A?%
M.]\3ZS=6"6]C$OBJZT_PQ=^&I=-6XDD$U_!=+J"1N'V'8V%_P2O_`."6'A+]
MB+QG?_$OX3:[^TUX#\$>+_!]WI/B;X&_'OQKH/BF.76YKVUO-)URSTKPW)>:
M+H>I:):Q7EB_V*_E6Y6[)DW$$U^K_P"S?\>_`'[4/P6\`?'CX92:G-X$^)VB
M0^)/#4VL:=+I.J2:9+/-;1R7MA-)+-9S+)`_[F1VD`ZG!P/>DA4,#Z)MP#TY
M!XP>-V`3C&<<^^E/,:[P$<+SVHR^SRPL[M/25G>^Z:>G?8RQ&6?5,=7>)HN.
M8T\1R5HRE-?5XP]QPY>9*ZDK24HNS3U'Q#"D>Y.<YR6.XCJ<;2=OX5@^*?"V
ME^,/#^M>&M8-Z-,U_3;W2=0.GW]YI=\+/4(3!<BTU+3YK>^L9VC/R7-I<0SQ
M$`QNI&:Z.BN3JGU3NGV9NU=-/9Z,^)_A#_P3W_9;^!VC_$KP_P"`_!>M+H'Q
M=TN^TKXAZ'XD\<^,O%ND>)8M4=Y-5N[VP\2:WJ4']K:H[LVH:K&J7UT2#-,V
M*XOX\?\`!+;]BG]IJS\&:3\:_A/+XT\._#S0O#_AWP7X5N/%_BVR\)>';'PM
M:-8Z%-IOAG3M:MM&@U2PM&:"+5EL_P"T=CN#<?,V?NKQ=XCT_P`'^%O$7BS5
MC(NE>&=$U37]2:&(S3+I^D64^H7C10@@RRK;V\ACC!!9\`'FO&OV7OVD?AW^
MUK\%/!/Q_P#A1+JLWP_\?6-Y?>'I-<TV72-6>WL-3O=(G>[L)7D>#?=6,QB!
M8AX\/D`TGBG3JQBJDE6=ZM-)ZN6D+[I=EL4\!4J82I7^KJ6"C4AAZM1KW8U)
M)SA"^Z;2;6JT3.U^#?P?\$_`GP%I/PT^'D.L6WA/0WNVTVVUWQ'KOBO4(%O+
MA[F6)]:\1W^IZK/"DDC+;Q37<D=O$%AA"QH%'J51QC`)]3G_`#^E253E*3<I
M_$]9>O4B*C%)1=XI))^2_P`MAC(&5TR0'!!()!&[@X(P0?0@Y!Y!S7Q?J7[`
M?[-NJ?'Y?VG+S0O&#?&=+Z.[A\4Q_$KQ[!'!;H;5WT:#2(=?324T">6RM9[G
M1/L?]G3W,$4\D!D12/M.H9FVA3T^;&?3\.IR<#MC).>*(N45)1;7-\5GO;77
M[KBDHZ<VBBU9OHW[J^^]OF?)_P`1/V(_V<OBCX5\?>"?$_@:6V\/?%+QR/B+
M\1+;POXC\0^$+CQAXK_LS^R)[[7;WPUJ>FWE]#>6'[B^L9)S97:C]]`V2:QO
MV5_V`?V7OV+5U:V_9N\#:C\.M&UJT>SNO"]MXQ\6ZOX3MUEOEU"XN-,\-ZWK
M.H:/I=]=7**;J]L+."XN%4)+(PSGH?AI^UE\+/BM\>_CI^SAX4N=<?XD?L\V
MW@FY^(D5[H\UKI$$7Q"TZYU7P^VDZHTCQ:J/LUG*)UB6,P@A#O;YA]51?<!Y
M.<G)SSD]L]O3T&!UI4L9+$0J.-2?+S\DXM_%*":]Y7M=6M;IV1K7R^I@JE&.
M)P_L*OL8U:$;2UHU%"<:BOTFI1::^*]^@_&<>QS2T44;:(COYZO\OR04444`
M%%%%`!1110`4444`%%%?-O[57[4/PT_8[^"_BWX^?&"YUJV^'_@VXT*WUF;0
MM(DUO4HY/$FM:=H&FFWT^.6!YXQJ.H6ZW)64&&.0RGY1@`'TCSZ#\S_A0,]\
M?A_^JOE#]I']L3X0?LK_``L\%?%_XJ7NOVWA#Q[X]^&WPYT";1M"EU:^?Q%\
M5;Q+'PI'=V,<T<EO;--(O]H71?%JHW%6Z5)X[_:[^%/PZ_:,^!7[+GB.[UV/
MXI_M#>'/&WB?X>VUKHDUUHD^G^`;."^\1?VGJZ2K%IDL,%U";-9H9OM1W(N"
MI(S=6"5[_P!?U^3`^K**^6OA]^UM\*?B5^T;\<OV7/#5UKC_`!1_9ZT;P%K_
M`,0(+[2'LM%33OB-I<NL>'3I6K,[1ZA</;0.+R%(XFLP?F#X).5\+?VS?@Y\
M7O'7[3_PZ\(WWB&3Q%^R+XH'@[XNIJ.A2V%I!K7_``CR^)1_85Y)*T>L6[Z9
MEQ/%'$K2!E`P-QS]O3?Q2Y-M;ZOK;;^K`?75%?&?P;_;A^"OQR_91NOVS/`]
M[XBF^#%KX<\;>)Y+K4?#\]CX@&F>`+S5K/7\:&\[323*^BWGV9%G7SP(R-A?
M`XCQ+_P4F_9N\+?L>_"W]N34[_QA_P`*+^+D_P`.8?"-W;^%KB?Q%,WQ3UZ'
MP[X5^WZ")UGL@^H7"+>[YG^Q1#S75N@7MZ/_`#^Z7W6VGEU[]==0/T#HKY2^
M)'[8/PD^%7QR_9U_9Z\67.OI\0?VH3XJ3X716.A3WFDSR>#="7Q%K7]MZHDJ
M1:0J:<=UN98Y?M$O[H%6X-KQ!^UQ\)O#?[4WP\_8\U.XUY/C'\4OAOXO^*WA
M.V@T:6;09?"/@FZL[37)KO6/-6.WO8I;VW$=H8BS"7ELXR>VHO\`Y?-_/T_N
M]M7\_D?U]^WWGU'17RU\)OVN/A-\:OC9^T/\`O!5WX@/C_\`9AUOPMH'Q1AU
M+1);'3+?4?&&B+KVC+H]])*ZZG#)II\^21(U6(G'S`$U)^SM^UG\*/VF?$GQ
M[\+_``TN]>NM3_9P^+>L?!/XC+K.BRZ3##XTT.UM+R\72I9991JNGM%>)Y6H
MQ>3%*00L0QN-JM%M175KKWMY>?\`6@'U#1116P!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!4,T*SQO%(6\N1)(W"L4)61-APRX92,DJP
M((/0U-10!\5_"[]@/]FSX/?%OQ!\;O`WASQ99_$?Q9'J47BG6-2^)'CW7K3Q
M#'J=O+9RQZWH^L^(;[2=22TM)7M])2[LY5TF$B+3A;HJ@8?Q6_X)K_L>_&KX
M9:#\&/B!\*DOOA/X?NO$%[:?#S2?$?B;PYX0NI_%&O-XFU@ZOH6@:OIUAK"3
MZXQU**/48;A;2Y.^V$6,5]PO,8@QYXBD?@'L&P.YZXQQ7S3^R_\`M8_"[]J[
M3_B?J7PNN=;N+;X2?%CQ9\&?%?\`;>BSZ.\?C'P8++^V4LO.DD%_IP-]";;4
M(MD<_P`^$!4DW+&U*%6G_M$U4FU&%GJ]TNG36^]KWZW"&7/%8;%UX8=5,-@J
MD*.)E;W8NM91E)W]UR=TGU:>S:OL_LT_LJ?!?]D;P5<_#KX%Z%J_ACP7/=6M
MU;^']0\5>)?$UCI*V5C%IUI9:''XBU34SHVFP6D$44>GZ>;>U&P.8R_-?1E%
M%3*4I2<I-RDW=M[M]V3&,8)1BK**LDMDNP4444B@HHHH`****`"BBB@`HHHH
M`***^7/VIOVM?A/^R#X8\$^,?B_=Z[::)X^^*G@'X/Z`V@:+-K=RWC#XBZU;
MZ'X=2[@BD0VVF2WTRQW6H,2ELA=BCE>2X'U'1SVZU\K^-/VM_A1\/?VEO@W^
MR?XCO=?3XL?'?PKXX\8>`[:WT66YT5M%^'D5N_B1M4UE9%ALKI#.#:PLC>:-
MN<?Q+=?M:_"FR_:OTO\`8SN+[7?^%S:I\&[OXZ6MJFB2?V#-X&M/$,OAF5WU
MSSO)BU1-3AD5M/,`<PCSA(%X.*KQ;MYZN^WX?U8#ZF^;T'YG_"EKY:^`_P"U
MK\*?VBO&_P"T5\/OAU=Z]-XB_9?^),'PF^*$>L:)-I5K;^++C08/$42Z1<S3
M2+JMDVFW$4GVZ)8H][;`N>:X?X9_MZ_`GXJ_"+]I'XV>%[_Q/)X)_96\7?%O
MP3\5'OO#D]AJ5MKGP1T8Z]XVCTBQEN96U:W6Q/\`H-U%+"E[*HB18SDENK!*
MZ=[VZ]_O_KY7#[=HKX!\6_\`!1[]G3P5^RE\)/VQ]=O_`!<GP>^-.J_"_1_!
M$]KX6N)/$4]W\7M8L]$\(C4=`-QY]B'O;V,WY::465NC7#JR*17J_P"T7^UQ
M\)_V7'^"B_%2[UZV_P"%^?&/P9\#/`!T719M8\WQWX[G>WT2'5O*:+^SM,=D
M59=0D\Q(9),&-B`#/UB/]/T_S_K2X?4]%?*^O?M;_"KP[^U9X$_8YU"ZUT?&
M+XB?"K7/C/X<MH-'EE\/-X)\-:\?#FJ27FN>>(8=1745D5+(0%Y47>K@`T[3
M?VMOA1JO[67B;]C*UO-?;XS>%OA%H7QLU2V;0YH_#L?@CQ)J]YH&F31:Z7,$
MNI-J&GW'F:?Y2/''ARS`\'MX_P!/T_S_`*TN'U-17RK^SI^UW\*/VH)_CA!\
M+[K79Y/V?/B_XD^"/Q$36]%FTD0>.?"]CIM_J<.DM++*-5TN.VU2W>/4(3&L
MTFZ,+&5(JW^RG^UK\)_VQ_`7B+XD_!RXUZX\,^&/B3X[^%.IGQ#HTNB7R^+/
MAWJPT;Q)'%;2S2-)90WQ$=M<@*)ER=J\"E&K2<DE5;;T2ON]++;_`#ZZ@?3]
M%%%=`!1110`4444`%%?+/Q%_:V^$_P`,OVC/@?\`LL^)[W7H?BG^T-I'CG7/
MAU!9Z++=:/+IOP^M+:[\0MJNK"18;"=(YP;-&1O-)P0`!N3X>_M<?"?XF_M%
M?'3]EWPQ=Z^WQ/\`V>=%\#>(?B)'>Z+-::-'IWQ#M[^[\/?V-JS2-'J$AAL9
M/M:JBB`[1ELDUS^VHI_Q6WVOI?33;^M0/J>D.>V/QS_A7R5\(_VQOA#\:/&7
M[3G@+P9>^(IO$'[(_BZR\$_%N/4=!FT^"'7[SPY)XIAAT.XEE==;@;2(3(9H
M!`IFECBY+$IG_!K]MSX*_'G]E"X_;*\`WWB*;X-6GAKQ[XLFNM2\/SZ9KYT?
MX;MK0\1R+HDL[SF>-M`OQ;V_GAKI50KL\P8I5HMVV^?I_G_6@'V+\WH/S/\`
MA1\WH/S/^%?GUXF_X*3_`+-_A3]CWX;?MP:OJ/BY/@A\59OA[;>$[JV\+7#^
M(YI?B;KUKX>\,&\T`W/VBT\R_NT-V6N7%K;*]PX91BO7_B?^UQ\*?A'\<OV=
M_P!GCQ?<Z]#\1_VGYO&L7PNMK'19KO2[B3P%HEKKNO?VUJ2N(]&2*SO(4B6>
M.=Y9FV97&3?M(=_Z_K\O0#ZF^;T'YG_"CYO0?F?\*^7?%'[6GPI\'?M1?#/]
MD'6;KQ`/B]\6/AMXL^*GA."'1)9]`E\*>"]5MM'UJ6^UQ'6"QU`75TCP63Q.
MTL4<CADQ\R?"']K+X6?&WXT?M%?`;P5=:])X]_9>UWP?X<^*::CHDNGZ5;:C
MX\T2[U_01HM[)/*-6B:PL96FFC2);=SL96)^4]I#O_7]?EZ`?4E%?''PG_;=
M^"WQGL?VGM1\%7?B2>W_`&2/'7BSX??%U;_09M/DMO$/@SP_'XEUB/P_YLKK
MK=HNER%X+J$Q":<+`$0FO,=2_P""FW[,^D_L1>&?^"@-YJ?C$?L_>+H?#4^C
MWR>$;I_$SP>*_$<?A?1Y)/#0N?M2&759$28^>1';MY^TC`K-5J3DDJMVWI&_
MIIM^O7L!^BM%9^EWT6I6-K?P,YAO+:"ZB$B[75+B,2H&7G:P5U#(68HRE<\9
M.A6X!1110`4444`?!'[4?_)0=*_[%#3_`/T\:]11^U'_`,E!TK_L4-/_`/3Q
MKU%`'W+IO_'AIW_7K!_Z3)5]^GX_T-4--_X\-._Z]8/_`$F2K[]/Q_H:F?P2
M_P`,OR8'X8?\%Q"?^$*_8+/?_AXI^SCSWYU#6L_G@?D*_<Z+_5IQ_"*_#'_@
MN)_R)/[!G_:13]G#_P!.&M5^YT7^K3_=%>7A7_PJYG_UYR[_`-,U#[S/O^2&
MX!=M7B.,/_5G@B3\****]8^#(9>H_P"`_P#H5?.W[6?_`":]^T5_V1#XI_\`
MJ%ZX/Y5]$R]1_P`!_P#0J^=OVL_^37OVBO\`LB'Q3_\`4,UNHJ_[O6]5_P"V
M';E/_(ZR[_L8Y4O_`"X1\=_\$5>/^"6O[&1[GX26>??_`(F>JFOU,@/#?4?R
MK\L_^"*O_*+3]C+_`+))9_\`ISU6OU,@Z-]1_*N3+/\`D7X+_L%B_P#R9'K\
M:?\`)9\4_P#8\SC_`-654GHHHKN/FSR3X^_\D-^,?_9+O'W_`*BNK5^:O_!!
MS_E%5^R=_P!BEKW_`*F?B.OTJ^/O_)#?C'_V2[Q]_P"HIJU?FK_P0<_Y15?L
MG?\`8I:]_P"IIXCKRY_\C?#_`/8/+_TN)]SA/^3<9\^O^M_#:^_+,_O]Y^P:
M]/R_]!%.IJ]/R_\`013J]0^$A\*^?YL*BF^Y^(J6HION?B*3^S_CI_\`I<2U
MNO5?F?A9^P]_RF&_X*W_`/8'_98_]1#6!_(G\S7[IQ$E.?4U^%G[#_\`RF&_
MX*W_`/8'_98_]1#6*_=.'[GXFO)R;_=\3_V-<U7_`)<H^UX]_P"1SE__`&2/
M!G_K/X4EHHHKUSXD****`"BBB@`HHHH`****`(GZ_A_4U^+W_!P/_P`HL/VB
M/^PI\(/U^+_@C-?M"_7\/ZFOQ>_X.!O^46'[1'_84^#_`/ZM_P`$5RXQM8>=
MO+\T3/X7\OS1X_\`\%P/^4?W[+/_`&>)^PY_ZD]K6S^UM_RFN_X)*_\`9%/V
MK?\`U%M'K&_X+@?\H_OV6?\`L\3]AO\`]2>UK9_:V_Y37?\`!)7_`+(I^U;_
M`.HMH]<%3_>9_P""/Y1(6_RC^<2[^QM_RFY_X*R_]DS_`&2?_4*GKAOV!/\`
MD[7_`(+V?]G`J/\`S"\==S^QM_RFY_X*R_\`9,_V2?\`U"IZX;]@7_D[7_@O
M9_V<"O\`ZI>.L*?PX=]?;8O_`-0\0+[?_;WZG#_\$T_^5>#6?^R-?M5_^I'\
M2J^2/CK_`,JT'[!7_84_8D_]6EH]?6__``33_P"5>#6?^R-?M5_^I'\2J^2/
MCK_RK0?L%?\`84_8D_\`5I:/63?[JG_V*J/Y@]E_7V8GZ&_MM_\`*5[_`((J
M_P"Y^T3_`.JGMZV?C5_RL$?L5?\`9C_[27ZZWH58W[;?_*5[_@BK_N?M$_\`
MJI[>MGXU?\K!'[%?_9C_`.TE_P"GO0JVC\,O^P^A_P"HU`M[_-?^V$7_``3D
M_P"4J'_!:?\`[*?^SS_ZJ"PK2_X(W?\`);/^"OW_`&D?^(W_`*CFA5F_\$Y/
M^4J'_!:?_LI_[//_`*J"PK2_X(W?\EL_X*_?]I'_`(C?^HYH5=.$_AT/^OC_
M`$)C]GUE^2/W5HHHKUC4****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`*S'(.>>#7X8_P#!"W_D3OV^O^TB_P"T5_+PK7[G'H?H?Y5^
M&/\`P0M_Y$[]OK_M(O\`M%?^ZK7C5_\`D9Y3_CS7\*=*WW'WO#__`"0OB'IL
MN#;>5\WKWMZ]>Y^Z]%%%>R?!!1110`4444`%%%%`!1110`4444`%?A#_`,%^
M_P#DW?\`95_[2!?LF?\`JQ;.OW>K\(?^"_?_`";O^RK_`-I`OV3?_5BV=<>-
M?^S5OE^2`@_:M_Y3K?\`!,;_`+-\_:H_](["I]?_`.5B3X??]HR_$'_JZM2J
M#]JW_E.M_P`$QO\`LWS]JC_TCL*GU_\`Y6)/A]_VC+\0?^KJU*N2AO6_[":/
M_IE&;^)?XOTB+_P2-_Y.R_X+2_\`9]>A_P#JH?#=?*?["_\`RC?_`."XO_9R
M/_!2'_U5T=?5G_!(S_D[+_@M)_V?7H?_`*J'PW7RG^PM_P`HW_\`@N+_`-G(
M_P#!2'_U5T=/_EQA/\.(_P#2Z?\`F1T7J_R1XM^T;_RKU?\`!.3_`+*!^P+_
M`.K.\/U^AG_!;7_CZ_X)=?\`:3#]FW_TOO*_//\`:,_Y5ZO^"<G_`&4#]@7_
M`-6=X?K]#/\`@MK_`,??_!+K_M)A^S;_`.E]Y45?@^<?_;!]_P#"O_;2Q\9?
M^5@S]DO_`+1Y_&3_`-6HY_F34'@K_E8F^.'_`&CF^$/_`*M'Q74_QE_Y6#/V
M2_\`M'G\9/\`U:C5!X*_Y6)OCA_VCF^$/_JT?%=%_P#U+PW_`*13*?Q+_%^D
M2I_P14_Y"W_!5S_M)%\:?U\*^%\UM?\`!OK_`,F>_&G_`+/F_:V_]6*U8O\`
MP14_Y"W_``5<_P"TD7QI_P#46\+UM?\`!OK_`,F>_&K_`+/F_:V_]6,U+"_%
ME_G1KW\_WBW%'XEZ+_TD_=:BBBO:-0HHHH`****`/P7_`&S_`/E-W_P2?_[)
M?^UC_P"F/1*?^Q5_RFS_`."LW_9,OV4A_P"4;Q-3/VS_`/E-W_P2?_[)?^UC
M_P"F/1*?^Q5_RFR_X*S?]DR_92_],WB:O$G_`!ZO_8?0_P#22%M\X_E$YC_@
MG;_R<[_P7L_[.,\-?^J%GKA_^"8O_*O1KO\`V0G]KS_TI^)U=Q_P3M_Y.=_X
M+V?]G&>&O_5"SUP__!,7_E7HUW_LA/[7G_I3\3JO#;4O^P>M_P"ETC/HO5_D
MCXR^./\`RK6?L-_]A?\`8M_]6OHE?I9^WG_REH_X(L_]?O[5'_JL="/\Z_-/
MXX_\JUG[#?\`V%_V+?\`U:^BU^EG[>?_`"EH_P""+/\`U^_M4?\`JL-"JJ'\
M-`]_DOR1-^T!_P`I_OV$QV_X88_:,X[?\CUI-2_\$W_^4HG_``6J_P"RL?LW
M_P#JJ[\_S)J+]H#_`)3_`'["?_9C'[1G_J=:34O_``3?_P"4HG_!:K_LK'[-
M_P#ZJJ_JHO5_]AE'_P!(HC3^'_$__;3P_P#X)V?\BY_P7H_[.R_:)_\`5-QU
M\*>-O^553X#_`/8.^`O_`*NW2*^Z_P#@G;_R+G_!>C_L[+]HG_U3<=?"GC;_
M`)55/@/_`-@[X"_^KMTFN%;1_P"P7$_^EA'?[O\`TJ)_8GX1_P"16\-_]B_H
MW_I!!715SOA'_D5O#7_8OZ-_Z005T5>WA_X-'_KTORB;!1116X!1110!\$?M
M1_\`)0=*_P"Q0T__`-/&O44?M1_\E!TK_L4-/_\`3QKU%`'W+IO_`!X:=_UZ
MP?\`I,E7WZ?C_0U0TW_CPT[_`*]8/_29*OOT_'^AJ9_!+_#+\F!^&'_!<3_D
M2?V#/^TBG[.'_IPUJOW.B_U:?[HK\,?^"XG_`")/[!G_`&D4_9P_].&M5^YT
M7^K3_=%>7A?^1KFG_7G+?_3%0^\S_P#Y(;@'_L(XP_\`5G@B2BBBO6/@R&7J
M/^`_^A5\[?M9_P#)KW[17_9$/BG_`.H9K=?1,O4?\!_]"KYV_:S_`.37OVBO
M^R(?%/\`]0S6ZBK_`+O6]5_[8=N4_P#(ZR[_`+&.5?\`J0CX[_X(J_\`*+3]
MC+_LDEG_`.G/5:_4R#HWU'\J_+/_`((J_P#*+3]C+_LDEG_Z<]5K]3(.C?4?
MRKDRO_D7X+_L%C_Z4CU^-/\`DL^*?^QYG'_JRJD]%%%=Q\V>2?'W_DAOQC_[
M)=X^_P#44U:OS5_X(.?\HJOV3O\`L4M>_P#4T\1U^E7Q]_Y(;\8_^R7>/O\`
MU%-6K\U?^"#G_**K]D[_`+%+7O\`U-/$=>7/_D;X?_L'E_Z7$^YPG_)M\^_[
M*_AO_P!5F?G[!KT_+_T$4ZFKT_+_`-!%.KU#X2'PKY_FPJ*;[GXBI:BF^Y^(
MI/[/^.G_`.EQ+6Z]5^9^%G[#_P#RF&_X*W_]@?\`98_]1#6*_=.'[GXFOPL_
M8?\`^4PW_!6__L#_`++'_J(:Q7[IP_<_$UY.3?[OB?\`L:YK_P"I*/M>/O\`
MD=9?_P!DCP9_ZS^$):***]<^)"BBB@`HHHH`****`"BBB@")^OX?U-?B]_P<
M#?\`*+#]HC_L*?!__P!6_P""*_:%^OX?U-?B]_P<#?\`*+#]HC_L*?!__P!6
M_P""*Y<9_N\_E^:)G\+^7YH\?_X+@?\`*/[]EG_L\3]AO_U)[6MG]K;_`)37
M?\$E?^R*?M6_^HMH]8W_``7`_P"4?W[+/_9XG[#?_J3VM;/[6W_*:[_@DK_V
M13]JW_U%M'K@J?[S/_`ORB0M_E'\XEW]C;_E-S_P5E_[)G^R3_ZA4]<-^P+_
M`,G:_P#!>S_LX%?_`%2\==S^QM_RFY_X*R_]DS_9)_\`4*GKAOV!?^3M?^"]
MG_9P*_\`JEXZPI_!A_\`K]B__4/$"^W_`-O?J</_`,$T_P#E7@UG_LC7[5?_
M`*D?Q*KY(^.O_*M!^P5_V%/V)/\`U:6CU];_`/!-/_E7@UG_`+(U^U7_`.I'
M\2J^2/CK_P`JT'[!7_84_8D_]6EH]9/^%3_[%5#\P>R_K[,3]#?VV_\`E*]_
MP15_W/VB?_53V];/QJ_Y6"/V*_\`LQ_]I+_T]Z%6-^VW_P`I7O\`@BK_`+G[
M1/\`ZJ>WK9^-7_*P1^Q7_P!F/_M)?^GO0JVC\$O^P^A_ZC8<M[_/]8$7_!.3
M_E*A_P`%I_\`LI_[//\`ZJ"PK2_X(W?\EL_X*_?]I'_B-_ZCFA5F_P#!.3_E
M*A_P6G_[*?\`L\_^J@L*TO\`@C=_R6S_`(*_?]I'_B-_ZCFA5TX/^'0_Z^/]
M"8[Q]9?DC]U:***]8U"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`****`"BBB@"L>A^A_E7X8_\$+?^1._;Z_[2+_M%?^ZK7[G'H?H?Y5^&/_!"
MW_D3OV^O^TB_[17_`+JM>-7_`.1GE/\`CS;_`--TC[WA_P#Y(3Q#].#/_5O7
M/W7HHHKV3X(****`"BBB@`HHHH`****`"BBB@`K\(?\`@OW_`,F[_LJ_]I`O
MV3?_`%8MG7[O5^$/_!?O_DW?]E7_`+2!?LF_^K%LZX\;_NU;Y?D@(/VK?^4Z
MW_!,;_LWS]JC_P!(["I]?_Y6)/A]_P!HR_$'_JZM2J#]JW_E.M_P3&_[-\_:
MH_\`2.PJ?7_^5B3X??\`:,OQ!_ZNK4JY*&];_L)H_P#IE&;^)?XOTB+_`,$C
M/^3LO^"TG_9]>A_^JA\-U\I_L+?\HW_^"XO_`&<C_P`%(?\`U5T=?5G_``2,
M_P"3LO\`@M)_V?7H?_JH?#=?*?["W_*-_P#X+B_]G(_\%(?_`%5T=/\`Y<83
M_#B/_2Z1'1>K_)'BW[1G_*O5_P`$Y/\`LH'[`O\`ZL[P_7Z&?\%M?^/O_@EU
M_P!I,/V;?_2^\K\\_P!HS_E7J_X)R?\`90/V!?\`U9WA^OT,_P""VO\`Q]_\
M$NO^TF'[-O\`Z7WE15^#YQ_]L'W_`,,?_;2Q\9?^5@S]DO\`[1Y_&3_U:C5!
MX*_Y6)OCA_VCF^$/_JT?%=3_`!E_Y6#/V2_^T>?QD_\`5J-4'@K_`)6)OCA_
MVCF^$/\`ZM'Q71_\UX;_`-(I%/XE_B_2)4_X(J?\A;_@JY_VDB^-/_J+>%ZV
MO^#?7_DSWXU?]GS?M;?^K&:L7_@BI_R%O^"KG_:2+XT_^HMX7K:_X-]?^3/?
MC5_V?-^UM_ZL9J6%^++O^O-?_P!.(2^)>B_])/W6HHHKVC4****`"BBB@#\%
M_P!L_P#Y3=_\$G_^R7_M8_\`ICT2G_L5?\ILO^"LW_9,OV4O_3-XFIG[9_\`
MRF[_`."3_P#V2_\`:Q_],>B4_P#8J_Y39?\`!6;_`+)E^RE_Z9O$U>)/^/5_
M[#Z'_I)"V^<?RB<Q_P`$[?\`DYW_`(+V?]G&>&O_`%0L]</_`,$Q?^5>C7?^
MR$_M>?\`I3\3J[C_`()V_P#)SO\`P7L_[.,\-?\`JA9ZX?\`X)B_\J]&N_\`
M9"?VO/\`TI^)U7AMJ/\`V#U?_2Z1GT7J_P`D?&7QQ_Y5K/V&_P#L+_L6_P#J
MU]%K]+/V\_\`E+1_P19_Z_?VJ/\`U6&A5^:?QQ_Y5K/V&_\`L+_L6_\`JU]%
MK]+/V\_^4M'_``19_P"OW]JC_P!5AH550_AQ![_)?DB;]H#_`)3_`'["?_9C
M'[1G_J=:34O_``3?_P"4HG_!:K_LK'[-_P#ZJJ_J+]H#_E/]^PG_`-F,?M&?
M^IUI-2_\$W_^4HG_``6J_P"RL?LW_P#JJK^JCN_^PRA_Z11&OL_XO_D3P_\`
MX)V_\BY_P7H_[.R_:)_]4W'7PIXV_P"553X#_P#8.^`O_J[=)K[K_P""=O\`
MR+G_``7H_P"SLOVB?_5-QU\*>-O^553X#_\`8.^`O_J[=)KA6T?^P7$_^EA'
M?[O_`$I']B?A'_D5O#7_`&+^C?\`I!!715SOA'_D5O#7_8OZ-_Z005T5>WA_
MX-'_`*]+\HFP4445N`4444`?!'[4?_)0=*_[%#3_`/T\:]11^U'_`,E!TK_L
M4-/_`/3QKU%`'W+IO_'AIW_7K!_Z3)5]^GX_T-4--_X\-._Z]8/_`$F2K[]/
MQ_H:F?P2_P`,OR8'X8?\%Q/^1)_8,_[2*?LX?^G#6J_<Z+_5I_NBOPQ_X+B?
M\B3^P9_VD4_9P_\`3AK5?N=%_JT_W17EX7_D:YI_UYRW_P!,5#[S/_\`DAN`
M?^PCC#_U9X(DHHHKUCX,AEZC_@/_`*%7SM^UG_R:]^T5_P!D0^*?_J&:W7T3
M+U'_``'_`-"KYV_:S_Y->_:*_P"R(?%/_P!0S6ZBK_N];U7_`+8=N4_\CK+O
M^QCE7_J0CX[_`."*O_*+3]C+_LDEG_Z<]5K]3(.C?4?RK\L_^"*O_*+3]C+_
M`+))9_\`ISU6OU,@Z-]1_*N3*_\`D7X+_L%C_P"E(]?C3_DL^*?^QYG'_JRJ
MD]%%%=Q\V>2?'W_DAOQC_P"R7>/O_44U:OS5_P""#G_**K]D[_L4M>_]33Q'
M7Z5?'W_DAOQC_P"R7>/O_44U:OS5_P""#G_**K]D[_L4M>_]33Q'7ES_`.1O
MA_\`L'E_Z7$^YPG_`";?/O\`LK^&_P#U69^?L&O3\O\`T$4ZFKT_+_T$4ZO4
M/A(?"OG^;"HION?B*EJ*;[GXBD_L_P".G_Z7$M;KU7YGX6?L/_\`*8;_`(*W
M_P#8'_98_P#40UBOW3A^Y^)K\+/V'_\`E,-_P5O_`.P/^RQ_ZB&L5^Z</W/Q
M->3DW^[XG_L:YK_ZDH^UX^_Y'67_`/9(\&?^L_A"6BBBO7/B0HHHH`****`"
MBBB@`HHHH`B?K^']37XO?\'`W_*+#]HC_L*?!_\`]6_X(K]H7Z_A_4U^+W_!
MP-_RBP_:(_["GP?_`/5O^"*Y<9_N\_E^:)G\+^7YH\?_`."X'_*/[]EG_L\3
M]AO_`-2>UK9_:V_Y37?\$E?^R*?M6_\`J+:/6-_P7`_Y1_?LL_\`9XG[#?\`
MZD]K6S^UM_RFN_X)*_\`9%/VK?\`U%M'K@J?[S/_``+\HD+?Y1_.)=_8V_Y3
M<_\`!67_`+)G^R3_`.H5/7#?L"_\G:_\%[/^S@5_]4O'7<_L;?\`*;G_`(*R
M_P#9,_V2?_4*GKAOV!?^3M?^"]G_`&<"O_JEXZPI_!A_^OV+_P#4/$"^W_V]
M^IP__!-/_E7@UG_LC7[5?_J1_$JODCXZ_P#*M!^P5_V%/V)/_5I:/7UO_P`$
MT_\`E7@UG_LC7[5?_J1_$JODCXZ_\JT'[!7_`&%/V)/_`%:6CUD_X5/_`+%5
M#\P>R_K[,3]#?VV_^4KW_!%7_<_:)_\`53V];/QJ_P"5@C]BO_LQ_P#:2_\`
M3WH58W[;?_*5[_@BK_N?M$_^JGMZV?C5_P`K!'[%?_9C_P"TE_Z>]"K:/P2_
M[#Z'_J-ARWO\_P!8$7_!.3_E*A_P6G_[*?\`L\_^J@L*TO\`@C=_R6S_`(*_
M?]I'_B-_ZCFA5F_\$Y/^4J'_``6G_P"RG_L\_P#JH+"M+_@C=_R6S_@K]_VD
M?^(W_J.:%73@_P"'0_Z^/]"8[Q]9?DC]U:***]8U"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@"L>A^A_E7X8_P#!"W_D3OV^O^TB
M_P"T5_[JM?N<>A^A_E7X8_\`!"W_`)$[]OK_`+2+_M%?^ZK7C5_^1GE/^/-O
M_3=(^]X?_P"2$\0_3@S_`-6]<_=>BBBO9/@@HHHH`****`"BBB@`HHHH`***
M*`"OPA_X+]_\F[_LJ_\`:0+]DW_U8MG7[O5^$/\`P7[_`.3=_P!E7_M(%^R;
M_P"K%LZX\;_NU;Y?D@(/VK?^4ZW_``3&_P"S?/VJ/_2.PJ?7_P#E8D^'W_:,
MOQ!_ZNK4J@_:M_Y3K?\`!,;_`+-\_:H_](["I]?_`.5B3X??]HR_$'_JZM2K
MDH;UO^PFC_Z91F_B7^+](B_\$C/^3LO^"TG_`&?7H?\`ZJ'PW7RG^PM_RC?_
M`."XO_9R/_!2'_U5T=?5G_!(S_D[+_@M)_V?7H?_`*J'PW7RG^PM_P`HW_\`
M@N+_`-G(_P#!2'_U5T=/_EQA/\.(_P#2Z1'1>K_)'BW[1G_*O5_P3D_[*!^P
M+_ZL[P_7Z&?\%M?^/O\`X)=?]I,/V;?_`$OO*_//]HS_`)5ZO^"<G_90/V!?
M_5G>'Z_0S_@MK_Q]_P#!+K_M)A^S;_Z7WE15^#YQ_P#;!]_\,?\`VTL?&7_E
M8,_9+_[1Y_&3_P!6HU0>"O\`E8F^.'_:.;X0_P#JT?%=3_&7_E8,_9+_`.T>
M?QD_]6HU0>"O^5B;XX?]HYOA#_ZM'Q71_P#->&_](I%/XE_B_2)4_P""*G_(
M6_X*N?\`:2+XT_\`J+>%ZVO^#?7_`),]^-7_`&?-^UM_ZL9JQ?\`@BI_R%O^
M"KG_`&DB^-/_`*BWA>MK_@WU_P"3/?C5_P!GS?M;?^K&:EA?BR[_`*\U_P#T
MXA+XEZ+_`-)/W6HHHKVC4****`"BBB@#\%_VS_\`E-W_`,$G_P#LE_[6/_IC
MT2G_`+%7_*;+_@K-_P!DR_92_P#3-XFIG[9__*;O_@D__P!DO_:Q_P#3'HE/
M_8J_Y39?\%9O^R9?LI?^F;Q-7B3_`(]7_L/H?^DD+;YQ_*)S'_!.W_DYW_@O
M9_V<9X:_]4+/7#_\$Q?^5>C7?^R$_M>?^E/Q.KN/^"=O_)SO_!>S_LXSPU_Z
MH6>N'_X)B_\`*O1KO_9"?VO/_2GXG5>&VH_]@]7_`-+I&?1>K_)'QE\<?^5:
MS]AO_L+_`+%O_JU]%K]+/V\_^4M'_!%G_K]_:H_]5AH5?FG\<?\`E6L_8;_[
M"_[%O_JU]%K]+/V\_P#E+1_P19_Z_?VJ/_58:%54/X<0>_R7Y(F_:`_Y3_?L
M)_\`9C'[1G_J=:34O_!-_P#Y2B?\%JO^RL?LW_\`JJK^HOV@/^4_W["?_9C'
M[1G_`*G6DU+_`,$W_P#E*)_P6J_[*Q^S?_ZJJ_JH[O\`[#*'_I%$:^S_`(O_
M`)$\/_X)V_\`(N?\%Z/^SLOVB?\`U3<=?"GC;_E54^`__8.^`O\`ZNW2:^Z_
M^"=O_(N?\%Z/^SLOVB?_`%3<=?"GC;_E54^`_P#V#O@+_P"KMTFN%;1_[!<3
M_P"EA'?[O_2D?V)^$?\`D5O#7_8OZ-_Z005T5<[X1_Y%;PU_V+^C?^D$%=%7
MMX?^#1_Z]+\HFP4445N`4444`?!'[4?_`"4'2O\`L4-/_P#3QKU%'[4?_)0=
M*_[%#3__`$\:]10!]RZ;_P`>&G?]>L'_`*3)5]^GX_T-4--_X\-._P"O6#_T
MF2K[]/Q_H:F?P2_PR_)@?AA_P7$_Y$G]@S_M(I^SA_Z<-:K]SHO]6G^Z*_#'
M_@N)_P`B3^P9_P!I%/V</_3AK5?N=%_JT_W17EX7_D:YI_UYRW_TQ4/O,_\`
M^2&X!_[".,/_`%9X(DHHHKUCX,AEZC_@/_H5?.W[6?\`R:]^T5_V1#XI_P#J
M&:W7T3+U'_`?_0J^=OVL_P#DU[]HK_LB'Q3_`/4,UNHJ_P"[UO5?^V';E/\`
MR.LN_P"QCE7_`*D(^._^"*O_`"BT_8R_[))9_P#ISU6OU,@Z-]1_*ORS_P""
M*O\`RBT_8R_[))9_^G/5:_4R#HWU'\JY,K_Y%^"_[!8_^E(]?C3_`)+/BG_L
M>9Q_ZLJI/1117<?-GDGQ]_Y(;\8_^R7>/O\`U%-6K\U?^"#G_**K]D[_`+%+
M7O\`U-/$=?I5\??^2&_&/_LEWC[_`-135J_-7_@@Y_RBJ_9._P"Q2U[_`-33
MQ'7ES_Y&^'_[!Y?^EQ/N<)_R;?/O^ROX;_\`59GY^P:]/R_]!%.IJ]/R_P#0
M13J]0^$A\*^?YL*BF^Y^(J6HION?B*3^S_CI_P#I<2UNO5?F?A9^P_\`\IAO
M^"M__8'_`&6/_40UBOW3A^Y^)K\+/V'_`/E,-_P5O_[`_P"RQ_ZB&L5^Z</W
M/Q->3DW^[XG_`+&N:_\`J2C[7C[_`)'67_\`9(\&?^L_A"6BBBO7/B0HHHH`
M****`"BBB@`HHHH`B?K^']37XO?\'`W_`"BP_:(_["GP?_\`5O\`@BOVA?K^
M']37XO?\'`W_`"BP_:(_["GP?_\`5O\`@BN7&?[O/Y?FB9_"_E^:/'_^"X'_
M`"C^_99_[/$_8;_]2>UK9_:V_P"4UW_!)7_LBG[5O_J+:/6-_P`%P/\`E']^
MRS_V>)^PW_ZD]K6S^UM_RFN_X)*_]D4_:M_]1;1ZX*G^\S_P+\HD+?Y1_.)=
M_8V_Y3<_\%9?^R9_LD_^H5/7#?L"_P#)VO\`P7L_[.!7_P!4O'7<_L;?\IN?
M^"LO_9,_V2?_`%"IZX;]@7_D[7_@O9_V<"O_`*I>.L*?P8?_`*_8O_U#Q`OM
M_P#;WZG#_P#!-/\`Y5X-9_[(U^U7_P"I'\2J^2/CK_RK0?L%?]A3]B3_`-6E
MH]?6_P#P33_Y5X-9_P"R-?M5_P#J1_$JODCXZ_\`*M!^P5_V%/V)/_5I:/63
M_A4_^Q50_,'LOZ^S$_0W]MO_`)2O?\$5?]S]HG_U4]O6S\:O^5@C]BO_`+,?
M_:2_]/>A5C?MM_\`*5[_`((J_P"Y^T3_`.JGMZV?C5_RL$?L5_\`9C_[27_I
M[T*MH_!+_L/H?^HV'+>_S_6!%_P3D_Y2H?\`!:?_`+*?^SS_`.J@L*TO^"-W
M_);/^"OW_:1_XC?^HYH59O\`P3D_Y2H?\%I_^RG_`+//_JH+"M+_`((W?\EL
M_P""OW_:1_XC?^HYH5=.#_AT/^OC_0F.\?67Y(_=6BBBO6-0HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`K'H?H?Y5^&/_!"W_D3O
MV^O^TB_[17_NJU^YQZ'Z'^5?AC_P0M_Y$[]OK_M(O^T5_P"ZK7C5_P#D9Y3_
M`(\V_P#3=(^]X?\`^2$\0_3@S_U;US]UZ***]D^""BBB@`HHHH`****`"BBB
M@`HHHH`*_"'_`(+]_P#)N_[*O_:0+]DW_P!6+9U^[U?A#_P7[_Y-W_95_P"T
M@7[)O_JQ;.N/&_[M6^7Y("#]JW_E.M_P3&_[-\_:H_\`2.PJ?7_^5B3X??\`
M:,OQ!_ZNK4J@_:M_Y3K?\$QO^S?/VJ/_`$CL*GU__E8D^'W_`&C+\0?^KJU*
MN2AO6_[":/\`Z91F_B7^+](B_P#!(S_D[+_@M)_V?7H?_JH?#=?*?["W_*-_
M_@N+_P!G(_\`!2'_`-5='7U9_P`$C/\`D[+_`(+2?]GUZ'_ZJ'PW7RG^PM_R
MC?\`^"XO_9R/_!2'_P!5='3_`.7&$_PXC_TND1T7J_R1XM^T9_RKU?\`!.3_
M`+*!^P+_`.K.\/U^AG_!;7_C[_X)=?\`:3#]FW_TOO*_//\`:,_Y5ZO^"<G_
M`&4#]@7_`-6=X?K]#/\`@MK_`,??_!+K_M)A^S;_`.E]Y45?@^<?_;!]_P##
M'_VTL?&7_E8,_9+_`.T>?QD_]6HU0>"O^5B;XX?]HYOA#_ZM'Q74_P`9?^5@
MS]DO_M'G\9/_`%:C5!X*_P"5B;XX?]HYOA#_`.K1\5T?_->&_P#2*13^)?XO
MTB5/^"*G_(6_X*N?]I(OC3_ZBWA>MK_@WU_Y,]^-7_9\W[6W_JQFK%_X(J?\
MA;_@JY_VDB^-/_J+>%ZVO^#?7_DSWXU?]GS?M;?^K&:EA?BR[_KS7_\`3B$O
MB7HO_23]UJ***]HU"BBB@`HHHH`_!?\`;/\`^4W?_!)__LE_[6/_`*8]$I_[
M%7_*;+_@K-_V3+]E+_TS>)J9^V?_`,IN_P#@D_\`]DO_`&L?_3'HE/\`V*O^
M4V7_``5F_P"R9?LI?^F;Q-7B3_CU?^P^A_Z20MOG'\HG,?\`!.W_`).=_P""
M]G_9QGAK_P!4+/7#_P#!,7_E7HUW_LA/[7G_`*4_$ZNX_P""=O\`R<[_`,%[
M/^SC/#7_`*H6>N'_`."8O_*O1KO_`&0G]KS_`-*?B=5X;:C_`-@]7_TND9]%
MZO\`)'QE\<?^5:S]AO\`["_[%O\`ZM?1:_2S]O/_`)2T?\$6?^OW]JC_`-5A
MH5?FG\<?^5:S]AO_`+"_[%O_`*M?1:_2S]O/_E+1_P`$6?\`K]_:H_\`58:%
M54/X<0>_R7Y(F_:`_P"4_P!^PG_V8Q^T9_ZG6DU+_P`$W_\`E*)_P6J_[*Q^
MS?\`^JJOZB_:`_Y3_?L)_P#9C'[1G_J=:34O_!-__E*)_P`%JO\`LK'[-_\`
MZJJ_JH[O_L,H?^D41K[/^+_Y$\/_`."=O_(N?\%Z/^SLOVB?_5-QU\*>-O\`
ME54^`_\`V#O@+_ZNW2:^Z_\`@G;_`,BY_P`%Z/\`L[+]HG_U3<=?"GC;_E54
M^`__`&#O@+_ZNW2:X5M'_L%Q/_I81W^[_P!*1_8GX1_Y%;PU_P!B_HW_`*00
M5T5<[X1_Y%;PU_V+^C?^D$%=%7MX?^#1_P"O2_*)L%%%%;@%%%%`'P1^U'_R
M4'2O^Q0T_P#]/&O44?M1_P#)0=*_[%#3_P#T\:]10!]RZ;_QX:=_UZP?^DR5
M??I^/]#5#3?^/#3O^O6#_P!)DJ^_3\?Z&IG\$O\`#+\F!^&'_!<3_D2?V#/^
MTBG[.'_IPUJOW.B_U:?[HK\,?^"XG_(D_L&?]I%/V</_`$X:U7[G1?ZM/]T5
MY>%_Y&N:?]><M_\`3%0^\S__`)(;@'_L(XP_]6>")****]8^#(9>H_X#_P"A
M5\[?M9_\FO?M%?\`9$/BG_ZAFMU]$R]1_P`!_P#0J^=OVL_^37OVBO\`LB'Q
M3_\`4,UNHJ_[O6]5_P"V';E/_(ZR[_L8Y5_ZD(^._P#@BK_RBT_8R_[))9_^
MG/5:_4R#HWU'\J_+/_@BK_RBT_8R_P"R26?_`*<]5K]3(.C?4?RKDRO_`)%^
M"_[!8_\`I2/7XT_Y+/BG_L>9Q_ZLJI/1117<?-GDGQ]_Y(;\8_\`LEWC[_U%
M-6K\U?\`@@Y_RBJ_9._[%+7O_4T\1U^E7Q]_Y(;\8_\`LEWC[_U%-6K\U?\`
M@@Y_RBJ_9._[%+7O_4T\1UY<_P#D;X?_`+!Y?^EQ/N<)_P`FWS[_`+*_AO\`
M]5F?G[!KT_+_`-!%.IJ]/R_]!%.KU#X2'PKY_FPJ*;[GXBI:BF^Y^(I/[/\`
MCI_^EQ+6Z]5^9^%G[#__`"F&_P""M_\`V!_V6/\`U$-8K]TX?N?B:_"S]A__
M`)3#?\%;_P#L#_LL?^HAK%?NG#]S\37DY-_N^)_[&N:_^I*/M>/O^1UE_P#V
M2/!G_K/X0EHHHKUSXD****`"BBB@`HHHH`****`(GZ_A_4U^+W_!P-_RBP_:
M(_["GP?_`/5O^"*_:%^OX?U-?B]_P<#?\HL/VB/^PI\'_P#U;_@BN7&?[O/Y
M?FB9_"_E^:/'_P#@N!_RC^_99_[/$_8;_P#4GM:V?VMO^4UW_!)7_LBG[5O_
M`*BVCUC?\%P/^4?W[+/_`&>)^PW_`.I/:UL_M;?\IKO^"2O_`&13]JW_`-1;
M1ZX*G^\S_P`"_*)"W^4?SB7?V-O^4W/_``5E_P"R9_LD_P#J%3UPW[`O_)VO
M_!>S_LX%?_5+QUW/[&W_`"FY_P""LO\`V3/]DG_U"IZX;]@7_D[7_@O9_P!G
M`K_ZI>.L*?P8?_K]B_\`U#Q`OM_]O?J</_P33_Y5X-9_[(U^U7_ZD?Q*KY(^
M.O\`RK0?L%?]A3]B3_U:6CU];_\`!-/_`)5X-9_[(U^U7_ZD?Q*KY(^.O_*M
M!^P5_P!A3]B3_P!6EH]9/^%3_P"Q50_,'LOZ^S$_0W]MO_E*]_P15_W/VB?_
M`%4]O6S\:O\`E8(_8K_[,?\`VDO_`$]Z%6-^VW_RE>_X(J_[G[1/_JI[>MGX
MU?\`*P1^Q7_V8_\`M)?^GO0JVC\$O^P^A_ZC8<M[_/\`6!%_P3D_Y2H?\%I_
M^RG_`+//_JH+"M+_`((W?\EL_P""OW_:1_XC?^HYH59O_!.3_E*A_P`%I_\`
MLI_[//\`ZJ"PK2_X(W?\EL_X*_?]I'_B-_ZCFA5TX/\`AT/^OC_0F.\?67Y(
M_=6BBBO6-0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`K'H?H?Y5^&/\`P0M_Y$[]OK_M(O\`M%?^ZK7[G'H?H?Y5^&/_``0M_P"1
M._;Z_P"TB_[17_NJUXU?_D9Y3_CS;_TW2/O>'_\`DA/$/TX,_P#5O7/W7HHH
MKV3X(****`"BBB@`HHHH`****`"BBB@`K\(?^"_?_)N_[*O_`&D"_9-_]6+9
MU^[U?A#_`,%^_P#DW?\`95_[2!?LF_\`JQ;.N/&_[M6^7Y("#]JW_E.M_P`$
MQO\`LWS]JC_TCL*GU_\`Y6)/A]_VC+\0?^KJU*H/VK?^4ZW_``3&_P"S?/VJ
M/_2.PJ?7_P#E8D^'W_:,OQ!_ZNK4JY*&];_L)H_^F49OXE_B_2(O_!(S_D[+
M_@M)_P!GUZ'_`.JA\-U\I_L+?\HW_P#@N+_V<C_P4A_]5='7U9_P2,_Y.R_X
M+2?]GUZ'_P"JA\-U\I_L+?\`*-__`(+B_P#9R/\`P4A_]5='3_Y<83_#B/\`
MTND1T7J_R1XM^T9_RKU?\$Y/^R@?L"_^K.\/U^AG_!;7_C[_`."77_:3#]FW
M_P!+[ROSS_:,_P"5>K_@G)_V4#]@7_U9WA^OT,_X+:_\??\`P2Z_[28?LV_^
ME]Y45?@^<?\`VP??_#'_`-M+'QE_Y6#/V2_^T>?QD_\`5J-4'@K_`)6)OCA_
MVCF^$/\`ZM'Q74_QE_Y6#/V2_P#M'G\9/_5J-4'@K_E8F^.'_:.;X0_^K1\5
MT?\`S7AO_2*13^)?XOTB5/\`@BI_R%O^"KG_`&DB^-/_`*BWA>MK_@WU_P"3
M/?C5_P!GS?M;?^K&:L7_`((J?\A;_@JY_P!I(OC3_P"HMX7K:_X-]?\`DSWX
MU?\`9\W[6W_JQFI87XLN_P"O-?\`].(2^)>B_P#23]UJ***]HU"BBB@`HHHH
M`_!?]L__`)3=_P#!)_\`[)?^UC_Z8]$I_P"Q5_RFR_X*S?\`9,OV4O\`TS>)
MJ9^V?_RF[_X)/_\`9+_VL?\`TQZ)3_V*O^4V7_!6;_LF7[*7_IF\35XD_P"/
M5_[#Z'_I)"V^<?RB<Q_P3M_Y.=_X+V?]G&>&O_5"SUP__!,7_E7HUW_LA/[7
MG_I3\3J[C_@G;_R<[_P7L_[.,\-?^J%GKA_^"8O_`"KT:[_V0G]KS_TI^)U7
MAMJ/_8/5_P#2Z1GT7J_R1\9?''_E6L_8;_["_P"Q;_ZM?1:_2S]O/_E+1_P1
M9_Z_?VJ/_58:%7YI_''_`)5K/V&_^PO^Q;_ZM?1:_2S]O/\`Y2T?\$6?^OW]
MJC_U6&A55#^'$'O\E^2)OV@/^4_W["?_`&8Q^T9_ZG6DU+_P3?\`^4HG_!:K
M_LK'[-__`*JJ_J+]H#_E/]^PG_V8Q^T9_P"IUI-2_P#!-_\`Y2B?\%JO^RL?
MLW_^JJOZJ.[_`.PRA_Z11&OL_P"+_P"1/#_^"=O_`"+G_!>C_L[+]HG_`-4W
M'7PIXV_Y55/@/_V#O@+_`.KMTFONO_@G;_R+G_!>C_L[+]HG_P!4W'7PIXV_
MY55/@/\`]@[X"_\`J[=)KA6T?^P7$_\`I81W^[_TI']B?A'_`)%;PU_V+^C?
M^D$%=%7.^$?^16\-?]B_HW_I!!715[>'_@T?^O2_*)L%%%%;@%%%%`'P1^U'
M_P`E!TK_`+%#3_\`T\:]11^U'_R4'2O^Q0T__P!/&O44`?<NF_\`'AIW_7K!
M_P"DR5??I^/]#5#3?^/#3O\`KU@_])DJ^_3\?Z&IG\$O\,OR8'X8?\%Q/^1)
M_8,_[2*?LX?^G#6J_<Z+_5I_NBOPQ_X+B?\`(D_L&?\`:13]G#_TX:U7[G1?
MZM/]T5Y>%_Y&N:?]><M_],5#[S/_`/DAN`?^PCC#_P!6>")****]8^#(9>H_
MX#_Z%7SM^UG_`,FO?M%?]D0^*?\`ZAFMU]$R]1_P'_T*OG;]K/\`Y->_:*_[
M(A\4_P#U#-;J*O\`N];U7_MAVY3_`,CK+O\`L8Y5_P"I"/CO_@BK_P`HM/V,
MO^R26?\`Z<]5K]3(.C?4?RK\L_\`@BK_`,HM/V,O^R26?_ISU6OU,@Z-]1_*
MN3*_^1?@O^P6/_I2/7XT_P"2SXI_['F<?^K*J3T445W'S9Y)\??^2&_&/_LE
MWC[_`-135J_-7_@@Y_RBJ_9._P"Q2U[_`-33Q'7Z5?'W_DAOQC_[)=X^_P#4
M4U:OS5_X(.?\HJOV3O\`L4M>_P#4T\1UY<_^1OA_^P>7_I<3[G"?\FWS[_LK
M^&__`%69^?L&O3\O_013J:O3\O\`T$4ZO4/A(?"OG^;"HION?B*EJ*;[GXBD
M_L_XZ?\`Z7$M;KU7YGX6?L/_`/*8;_@K?_V!_P!EC_U$-8K]TX?N?B:_"S]A
M_P#Y3#?\%;_^P/\`LL?^HAK%?NG#]S\37DY-_N^)_P"QKFO_`*DH^UX^_P"1
MUE__`&2/!G_K/X0EHHHKUSXD****`"BBB@`HHHH`****`(GZ_A_4U^+W_!P-
M_P`HL/VB/^PI\'__`%;_`((K]H7Z_A_4U^+W_!P-_P`HL/VB/^PI\'__`%;_
M`((KEQG^[S^7YHF?POY?FCQ__@N!_P`H_OV6?^SQ/V&__4GM:V?VMO\`E-=_
MP25_[(I^U;_ZBVCUC?\`!<#_`)1_?LL_]GB?L-_^I/:UL_M;?\IKO^"2O_9%
M/VK?_46T>N"I_O,_\"_*)"W^4?SB7?V-O^4W/_!67_LF?[)/_J%3UPW[`O\`
MR=K_`,%[/^S@5_\`5+QUW/[&W_*;G_@K+_V3/]DG_P!0J>N&_8%_Y.U_X+V?
M]G`K_P"J7CK"G\&'_P"OV+_]0\0+[?\`V]^IP_\`P33_`.5>#6?^R-?M5_\`
MJ1_$JODCXZ_\JT'[!7_84_8D_P#5I:/7UO\`\$T_^5>#6?\`LC7[5?\`ZD?Q
M*KY(^.O_`"K0?L%?]A3]B3_U:6CUD_X5/_L54/S![+^OLQ/T-_;;_P"4KW_!
M%7_<_:)_]5/;UL_&K_E8(_8K_P"S'_VDO_3WH58W[;?_`"E>_P""*O\`N?M$
M_P#JI[>MGXU?\K!'[%?_`&8_^TE_Z>]"K:/P2_[#Z'_J-ARWO\_U@1?\$Y/^
M4J'_``6G_P"RG_L\_P#JH+"M+_@C=_R6S_@K]_VD?^(W_J.:%6;_`,$Y/^4J
M'_!:?_LI_P"SS_ZJ"PK2_P""-W_);/\`@K]_VD?^(W_J.:%73@_X=#_KX_T)
MCO'UE^2/W5HHHKUC4****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`
MHHHH`****`*QZ'Z'^5?AC_P0M_Y$[]OK_M(O^T5_[JM?N<>A^A_E7X8_\$+?
M^1._;Z_[2+_M%?\`NJUXU?\`Y&>4_P"/-O\`TW2/O>'_`/DA/$/TX,_]6]<_
M=>BBBO9/@@HHHH`****`"BBB@`HHHH`****`"OPA_P""_?\`R;O^RK_VD"_9
M-_\`5BV=?N]7X0_\%^_^3=_V5?\`M(%^R;_ZL6SKCQO^[5OE^2`@_:M_Y3K?
M\$QO^S?/VJ/_`$CL*GU__E8D^'W_`&C+\0?^KJU*H/VK?^4ZW_!,;_LWS]JC
M_P!(["I]?_Y6)/A]_P!HR_$'_JZM2KDH;UO^PFC_`.F49OXE_B_2(O\`P2,_
MY.R_X+2?]GUZ'_ZJ'PW7RG^PM_RC?_X+B_\`9R/_``4A_P#571U]6?\`!(S_
M`).R_P""TG_9]>A_^JA\-U\I_L+?\HW_`/@N+_V<C_P4A_\`571T_P#EQA/\
M.(_]+I$=%ZO\D>+?M&?\J]7_``3D_P"R@?L"_P#JSO#]?H9_P6U_X^_^"77_
M`&DP_9M_]+[ROSS_`&C/^5>K_@G)_P!E`_8%_P#5G>'Z_0S_`(+:_P#'W_P2
MZ_[28?LV_P#I?>5%7X/G'_VP??\`PQ_]M+'QE_Y6#/V2_P#M'G\9/_5J-4'@
MK_E8F^.'_:.;X0_^K1\5U/\`&7_E8,_9+_[1Y_&3_P!6HU0>"O\`E8F^.'_:
M.;X0_P#JT?%='_S7AO\`TBD4_B7^+](E3_@BI_R%O^"KG_:2+XT_^HMX7K:_
MX-]?^3/?C5_V?-^UM_ZL9JQ?^"*G_(6_X*N?]I(OC3_ZBWA>MK_@WU_Y,]^-
M7_9\W[6W_JQFI87XLN_Z\U__`$XA+XEZ+_TD_=:BBBO:-0HHHH`****`/P7_
M`&S_`/E-W_P2?_[)?^UC_P"F/1*?^Q5_RFR_X*S?]DR_92_],WB:F?MG_P#*
M;O\`X)/_`/9+_P!K'_TQZ)3_`-BK_E-E_P`%9O\`LF7[*7_IF\35XD_X]7_L
M/H?^DD+;YQ_*)S'_``3M_P"3G?\`@O9_V<9X:_\`5"SUP_\`P3%_Y5Z-=_[(
M3^UY_P"E/Q.KN/\`@G;_`,G._P#!>S_LXSPU_P"J%GKA_P#@F+_RKT:[_P!D
M)_:\_P#2GXG5>&VH_P#8/5_]+I&?1>K_`"1\9?''_E6L_8;_`.PO^Q;_`.K7
MT6OTL_;S_P"4M'_!%G_K]_:H_P#58:%7YI_''_E6L_8;_P"PO^Q;_P"K7T6O
MTL_;S_Y2T?\`!%G_`*_?VJ/_`%6&A55#^'$'O\E^2)OV@/\`E/\`?L)_]F,?
MM&?^IUI-2_\`!-__`)2B?\%JO^RL?LW_`/JJK^HOV@/^4_W["?\`V8Q^T9_Z
MG6DU+_P3?_Y2B?\`!:K_`+*Q^S?_`.JJOZJ.[_[#*'_I%$:^S_B_^1/#_P#@
MG;_R+G_!>C_L[+]HG_U3<=?"GC;_`)55/@/_`-@[X"_^KMTFONO_`()V_P#(
MN?\`!>C_`+.R_:)_]4W'7PIXV_Y55/@/_P!@[X"_^KMTFN%;1_[!<3_Z6$=_
MN_\`2D?V)^$?^16\-?\`8OZ-_P"D$%=%7.^$?^16\-?]B_HW_I!!715[>'_@
MT?\`KTORB;!1116X!1110!\$?M1_\E!TK_L4-/\`_3QKU%'[4?\`R4'2O^Q0
MT_\`]/&O44`?<NF_\>&G?]>L'_I,E7WZ?C_0U0TW_CPT[_KU@_\`29*OOT_'
M^AJ9_!+_``R_)@?AA_P7$_Y$G]@S_M(I^SA_Z<-:K]SHO]6G^Z*_#'_@N)_R
M)/[!G_:13]G#_P!.&M5^YT7^K3_=%>7A?^1KFG_7G+?_`$Q4/O,__P"2&X!_
M[".,/_5G@B2BBBO6/@R&7J/^`_\`H5?.W[6?_)KW[17_`&1#XI_^H9K=?1,O
M4?\``?\`T*OG;]K/_DU[]HK_`+(A\4__`%#-;J*O^[UO5?\`MAVY3_R.LN_[
M&.5?^I"/CO\`X(J_\HM/V,O^R26?_ISU6OU,@Z-]1_*ORS_X(J_\HM/V,O\`
MLDEG_P"G/5:_4R#HWU'\JY,K_P"1?@O^P6/_`*4CU^-/^2SXI_['F<?^K*J3
MT445W'S9Y)\??^2&_&/_`+)=X^_]135J_-7_`((.?\HJOV3O^Q2U[_U-/$=?
MI5\??^2&_&/_`+)=X^_]135J_-7_`((.?\HJOV3O^Q2U[_U-/$=>7/\`Y&^'
M_P"P>7_I<3[G"?\`)M\^_P"ROX;_`/59GY^P:]/R_P#013J:O3\O_013J]0^
M$A\*^?YL*BF^Y^(J6HION?B*3^S_`(Z?_I<2UNO5?F?A9^P__P`IAO\`@K?_
M`-@?]EC_`-1#6*_=.'[GXFOPL_8?_P"4PW_!6_\`[`_[+'_J(:Q7[IP_<_$U
MY.3?[OB?^QKFO_J2C[7C[_D=9?\`]DCP9_ZS^$):***]<^)"BBB@`HHHH`**
M**`"BBB@")^OX?U-?B]_P<#?\HL/VB/^PI\'_P#U;_@BOVA?K^']37XO?\'`
MW_*+#]HC_L*?!_\`]6_X(KEQG^[S^7YHF?POY?FCQ_\`X+@?\H_OV6?^SQ/V
M&_\`U)[6MG]K;_E-=_P25_[(I^U;_P"HMH]8W_!<#_E']^RS_P!GB?L-_P#J
M3VM;/[6W_*:[_@DK_P!D4_:M_P#46T>N"I_O,_\``ORB0M_E'\XEW]C;_E-S
M_P`%9?\`LF?[)/\`ZA4]<-^P+_R=K_P7L_[.!7_U2\==S^QM_P`IN?\`@K+_
M`-DS_9)_]0J>N&_8%_Y.U_X+V?\`9P*_^J7CK"G\&'_Z_8O_`-0\0+[?_;WZ
MG#_\$T_^5>#6?^R-?M5_^I'\2J^2/CK_`,JT'[!7_84_8D_]6EH]?6__``33
M_P"5>#6?^R-?M5_^I'\2J^2/CK_RK0?L%?\`84_8D_\`5I:/63_A4_\`L54/
MS![+^OLQ/T-_;;_Y2O?\$5?]S]HG_P!5/;UL_&K_`)6"/V*_^S'_`-I+_P!/
M>A5C?MM_\I7O^"*O^Y^T3_ZJ>WK9^-7_`"L$?L5_]F/_`+27_I[T*MH_!+_L
M/H?^HV'+>_S_`%@1?\$Y/^4J'_!:?_LI_P"SS_ZJ"PK2_P""-W_);/\`@K]_
MVD?^(W_J.:%6;_P3D_Y2H?\`!:?_`+*?^SS_`.J@L*TO^"-W_);/^"OW_:1_
MXC?^HYH5=.#_`(=#_KX_T)CO'UE^2/W5HHHKUC4****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`*QZ'Z'^5?AC_`,$+?^1._;Z_[2+_
M`+17_NJU^YQZ'Z'^5?AC_P`$+?\`D3OV^O\`M(O^T5_[JM>-7_Y&>4_X\V_]
M-TC[WA__`)(3Q#].#/\`U;US]UZ***]D^""BBB@`HHHH`****`"BBB@`HHHH
M`*_"'_@OW_R;O^RK_P!I`OV3?_5BV=?N]7X0_P#!?O\`Y-W_`&5?^T@7[)O_
M`*L6SKCQO^[5OE^2`@_:M_Y3K?\`!,;_`+-\_:H_](["I]?_`.5B3X??]HR_
M$'_JZM2J#]JW_E.M_P`$QO\`LWS]JC_TCL*GU_\`Y6)/A]_VC+\0?^KJU*N2
MAO6_[":/_IE&;^)?XOTB+_P2,_Y.R_X+2?\`9]>A_P#JH?#=?*?["W_*-_\`
MX+B_]G(_\%(?_571U]6?\$C/^3LO^"TG_9]>A_\`JH?#=?*?["W_`"C?_P""
MXO\`V<C_`,%(?_571T_^7&$_PXC_`-+I$=%ZO\D>+?M&?\J]7_!.3_LH'[`O
M_JSO#]?H9_P6U_X^_P#@EU_VDP_9M_\`2^\K\\_VC/\`E7J_X)R?]E`_8%_]
M6=X?K]#/^"VO_'W_`,$NO^TF'[-O_I?>5%7X/G'_`-L'W_PQ_P#;2Q\9?^5@
MS]DO_M'G\9/_`%:C5!X*_P"5B;XX?]HYOA#_`.K1\5U/\9?^5@S]DO\`[1Y_
M&3_U:C5!X*_Y6)OCA_VCF^$/_JT?%='_`,UX;_TBD4_B7^+](E3_`((J?\A;
M_@JY_P!I(OC3_P"HMX7K:_X-]?\`DSWXU?\`9\W[6W_JQFK%_P""*G_(6_X*
MN?\`:2+XT_\`J+>%ZVO^#?7_`),]^-7_`&?-^UM_ZL9J6%^++O\`KS7_`/3B
M$OB7HO\`TD_=:BBBO:-0HHHH`****`/P7_;/_P"4W?\`P2?_`.R7_M8_^F/1
M*?\`L5?\ILO^"LW_`&3+]E+_`-,WB:F?MG_\IN_^"3__`&2_]K'_`-,>B4_]
MBK_E-E_P5F_[)E^RE_Z9O$U>)/\`CU?^P^A_Z20MOG'\HG,?\$[?^3G?^"]G
M_9QGAK_U0L]</_P3%_Y5Z-=_[(3^UY_Z4_$ZNX_X)V_\G._\%[/^SC/#7_JA
M9ZX?_@F+_P`J]&N_]D)_:\_]*?B=5X;:C_V#U?\`TND9]%ZO\D?&7QQ_Y5K/
MV&_^PO\`L6_^K7T6OTL_;S_Y2T?\$6?^OW]JC_U6&A5^:?QQ_P"5:S]AO_L+
M_L6_^K7T6OTL_;S_`.4M'_!%G_K]_:H_]5AH550_AQ![_)?DB;]H#_E/]^PG
M_P!F,?M&?^IUI-2_\$W_`/E*)_P6J_[*Q^S?_P"JJOZB_:`_Y3_?L)_]F,?M
M&?\`J=:34O\`P3?_`.4HG_!:K_LK'[-__JJK^JCN_P#L,H?^D41K[/\`B_\`
MD3P__@G;_P`BY_P7H_[.R_:)_P#5-QU\*>-O^553X#_]@[X"_P#J[=)K[K_X
M)V_\BY_P7H_[.R_:)_\`5-QU\*>-O^553X#_`/8.^`O_`*NW2:X5M'_L%Q/_
M`*6$=_N_]*1_8GX1_P"16\-?]B_HW_I!!715SOA'_D5O#7_8OZ-_Z005T5>W
MA_X-'_KTORB;!1116X!1110!\$?M1_\`)0=*_P"Q0T__`-/&O44?M1_\E!TK
M_L4-/_\`3QKU%`'W+IO_`!X:=_UZP?\`I,E7WZ?C_0U0TW_CPT[_`*]8/_29
M*OOT_'^AJ9_!+_#+\F!^&'_!<3_D2?V#/^TBG[.'_IPUJOW.B_U:?[HK\,?^
M"XG_`")/[!G_`&D4_9P_].&M5^YT7^K3_=%>7A?^1KFG_7G+?_3%0^\S_P#Y
M(;@'_L(XP_\`5G@B2BBBO6/@R&7J/^`_^A5\[?M9_P#)KW[17_9$/BG_`.H9
MK=?1,O4?\!_]"KYV_:S_`.37OVBO^R(?%/\`]0S6ZBK_`+O6]5_[8=N4_P#(
MZR[_`+&.5?\`J0CX[_X(J_\`*+3]C+_LDEG_`.G/5:_4R#HWU'\J_+/_`((J
M_P#*+3]C+_LDEG_Z<]5K]3(.C?4?RKDRO_D7X+_L%C_Z4CU^-/\`DL^*?^QY
MG'_JRJD]%%%=Q\V>2?'W_DAOQC_[)=X^_P#44U:OS5_X(.?\HJOV3O\`L4M>
M_P#4T\1U^E7Q]_Y(;\8_^R7>/O\`U%-6K\U?^"#G_**K]D[_`+%+7O\`U-/$
M=>7/_D;X?_L'E_Z7$^YPG_)M\^_[*_AO_P!5F?G[!KT_+_T$4ZFKT_+_`-!%
M.KU#X2'PKY_FPJ*;[GXBI:BF^Y^(I/[/^.G_`.EQ+6Z]5^9^%G[#_P#RF&_X
M*W_]@?\`98_]1#6*_=.'[GXFOPL_8?\`^4PW_!6__L#_`++'_J(:Q7[IP_<_
M$UY.3?[OB?\`L:YK_P"I*/M>/O\`D=9?_P!DCP9_ZS^$):***]<^)"BBB@`H
MHHH`****`"BBB@")^OX?U-?B]_P<#?\`*+#]HC_L*?!__P!6_P""*_:%^OX?
MU-?B]_P<#?\`*+#]HC_L*?!__P!6_P""*Y<9_N\_E^:)G\+^7YH\?_X+@?\`
M*/[]EG_L\3]AO_U)[6MG]K;_`)37?\$E?^R*?M6_^HMH]8W_``7`_P"4?W[+
M/_9XG[#?_J3VM;/[6W_*:[_@DK_V13]JW_U%M'K@J?[S/_`ORB0M_E'\XEW]
MC;_E-S_P5E_[)G^R3_ZA4]<-^P+_`,G:_P#!>S_LX%?_`%2\==S^QM_RFY_X
M*R_]DS_9)_\`4*GKAOV!?^3M?^"]G_9P*_\`JEXZPI_!A_\`K]B__4/$"^W_
M`-O?J</_`,$T_P#E7@UG_LC7[5?_`*D?Q*KY(^.O_*M!^P5_V%/V)/\`U:6C
MU];_`/!-/_E7@UG_`+(U^U7_`.I'\2J^2/CK_P`JT'[!7_84_8D_]6EH]9/^
M%3_[%5#\P>R_K[,3]#?VV_\`E*]_P15_W/VB?_53V];/QJ_Y6"/V*_\`LQ_]
MI+_T]Z%6-^VW_P`I7O\`@BK_`+G[1/\`ZJ>WK9^-7_*P1^Q7_P!F/_M)?^GO
M0JVC\$O^P^A_ZC8<M[_/]8$7_!.3_E*A_P`%I_\`LI_[//\`ZJ"PK2_X(W?\
MEL_X*_?]I'_B-_ZCFA5F_P#!.3_E*A_P6G_[*?\`L\_^J@L*TO\`@C=_R6S_
M`(*_?]I'_B-_ZCFA5TX/^'0_Z^/]"8[Q]9?DC]U:***]8U"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"L>A^A_E7X8_\$+?^1._;
MZ_[2+_M%?^ZK7[G'H?H?Y5^&/_!"W_D3OV^O^TB_[17_`+JM>-7_`.1GE/\`
MCS;_`--TC[WA_P#Y(3Q#].#/_5O7/W7HHHKV3X(****`"BBB@`HHHH`****`
M"BBB@`K\(?\`@OW_`,F[_LJ_]I`OV3?_`%8MG7[O5^$/_!?O_DW?]E7_`+2!
M?LF_^K%LZX\;_NU;Y?D@(/VK?^4ZW_!,;_LWS]JC_P!(["I]?_Y6)/A]_P!H
MR_$'_JZM2J#]JW_E.M_P3&_[-\_:H_\`2.PJ?7_^5B3X??\`:,OQ!_ZNK4JY
M*&];_L)H_P#IE&;^)?XOTB+_`,$C/^3LO^"TG_9]>A_^JA\-U\I_L+?\HW_^
M"XO_`&<C_P`%(?\`U5T=?5G_``2,_P"3LO\`@M)_V?7H?_JH?#=?*?["W_*-
M_P#X+B_]G(_\%(?_`%5T=/\`Y<83_#B/_2Z1'1>K_)'BW[1G_*O5_P`$Y/\`
MLH'[`O\`ZL[P_7Z&?\%M?^/O_@EU_P!I,/V;?_2^\K\\_P!HS_E7J_X)R?\`
M90/V!?\`U9WA^OT,_P""VO\`Q]_\$NO^TF'[-O\`Z7WE15^#YQ_]L'W_`,,?
M_;2Q\9?^5@S]DO\`[1Y_&3_U:C5!X*_Y6)OCA_VCF^$/_JT?%=3_`!E_Y6#/
MV2_^T>?QD_\`5J-4'@K_`)6)OCA_VCF^$/\`ZM'Q71_\UX;_`-(I%/XE_B_2
M)4_X(J?\A;_@JY_VDB^-/_J+>%ZVO^#?7_DSWXU?]GS?M;?^K&:L7_@BI_R%
MO^"KG_:2+XT_^HMX7K:_X-]?^3/?C5_V?-^UM_ZL9J6%^++O^O-?_P!.(2^)
M>B_])/W6HHHKVC4****`"BBB@#\%_P!L_P#Y3=_\$G_^R7_M8_\`ICT2G_L5
M?\ILO^"LW_9,OV4O_3-XFIG[9_\`RF[_`."3_P#V2_\`:Q_],>B4_P#8J_Y3
M9?\`!6;_`+)E^RE_Z9O$U>)/^/5_[#Z'_I)"V^<?RB<Q_P`$[?\`DYW_`(+V
M?]G&>&O_`%0L]</_`,$Q?^5>C7?^R$_M>?\`I3\3J[C_`()V_P#)SO\`P7L_
M[.,\-?\`JA9ZX?\`X)B_\J]&N_\`9"?VO/\`TI^)U7AMJ/\`V#U?_2Z1GT7J
M_P`D?&7QQ_Y5K/V&_P#L+_L6_P#JU]%K]+/V\_\`E+1_P19_Z_?VJ/\`U6&A
M5^:?QQ_Y5K/V&_\`L+_L6_\`JU]%K]+/V\_^4M'_``19_P"OW]JC_P!5AH55
M0_AQ![_)?DB;]H#_`)3_`'["?_9C'[1G_J=:34O_``3?_P"4HG_!:K_LK'[-
M_P#ZJJ_J+]H#_E/]^PG_`-F,?M&?^IUI-2_\$W_^4HG_``6J_P"RL?LW_P#J
MJK^JCN_^PRA_Z11&OL_XO_D3P_\`X)V_\BY_P7H_[.R_:)_]4W'7PIXV_P"5
M53X#_P#8.^`O_J[=)K[K_P""=O\`R+G_``7H_P"SLOVB?_5-QU\*>-O^553X
M#_\`8.^`O_J[=)KA6T?^P7$_^EA'?[O_`$I']B?A'_D5O#7_`&+^C?\`I!!7
M15SOA'_D5O#7_8OZ-_Z005T5>WA_X-'_`*]+\HFP4445N`4444`?!'[4?_)0
M=*_[%#3_`/T\:]11^U'_`,E!TK_L4-/_`/3QKU%`'W+IO_'AIW_7K!_Z3)5]
M^GX_T-4--_X\-._Z]8/_`$F2KLK!5R<X'/'M^-*2;BTE=M-)=VU9(.WFTEZM
MV7XGX9?\%Q/^1)_8,_[2*?LX?^G#6J_<Z+_5I_NBOPO_`."X;!O!?[!JC.1_
MP44_9Q_'%]K#''_?0%?NA#_JD_W17E873-<S\Z67I>L*,U+_`,!;2?J?=9Y.
M,^!N`N5WMB>,4]]'_:>"_KL24445ZQ\*0R]1_P`!_P#0J^=OVL_^37OVBO\`
MLB'Q3_\`4,UNOHMU+$?A^AS_`)/2OG/]K0X_9?\`VBA@G/P2^*2\#N?!6N-^
M7'IS65:25&I%OWI:I:ZI<M]O1G=E"?\`;.6OH\PRU_*%=.;_`.W5N?'G_!%7
M_E%I^QE_V22S_P#3GJM?J9!T;ZC^5?EC_P`$4VS_`,$M?V,Q@C;\);(9['.J
M:J,CV_\`U5^I\/`(]_3TQG^?^.*Y<K:>78)K9X6-OOB_R=SUN-/^2RXG?26>
MYPHO>]\PJ37_`)+J3444PN,D<\'!KO/F[ZI=7LNYY/\`'W_DAOQC_P"R7>/O
M_44U:OS5_P""#G_**K]D[_L4M>_]33Q'7Z4?'Q@?@=\8\9./A=X_Y[?\BIJU
M?FK_`,$'&_XU5_LG``D_\(GKH(';/C/Q&<_3GM7ESO\`VOA]'_NTGMT]HOZ_
M$^XPDE_Q#;/Y7O%<7\-W:U_YEN?KIYW1^PJ]/R_]!%.IB'(/'I]>F.WT_P`X
MI]>H?"P^%?/H^X5%-]S\14M13'Y/Q'U_#WI/IY2@WZ*2;?R2;*O;5[+5^BU?
MX'X6?L/_`/*8;_@K?_V!_P!EC_U$-8K]TX?N?B:_"C]A^0#_`(+"?\%<&P2!
MH_[+/09SCPAK/\\<?E]?W7A^Y^)KRLGBXX?$75KYGF4U_AJ5U*$O223:]#[;
MC_3.\OBTT_\`5#@N6W1\/X5)WVZ/J2T445ZQ\2%%%%`!1110`4444`%%%%`$
M3]?P_J:_%[_@X&_Y18?M$?\`84^#_P#ZM_P17[1."3]%S^M?B[_P<#_\HL/V
MA_?5/A!^GQ?\#_XUS8M.5"HHZM6O\FB9_"_E^:/'_P#@N!_RC^_99_[/$_8;
M_P#4GM:V?VMO^4UW_!)7_LBG[5O_`*BVCUC?\%P/^4?W[+/_`&>)^PW_`.I/
M:UL_M;?\IKO^"2O_`&13]JW_`-1;1Z\^K_O-1]%!7^Z)"W^4?SB7?V-O^4W/
M_!67_LF?[)/_`*A4]<-^P+_R=K_P7L_[.!7_`-4O'7<_L;?\IN?^"LO_`&3/
M]DG_`-0J>N%_8#.[]K3_`(+V'&,?M`*?K_Q9B,5C%.,<.I)INMB?_)\)7C'_
M`,">B\Q?;_[>_4XC_@FG_P`J\&L_]D:_:K_]2/XE5\D?'7_E6@_8*_["G[$G
M_JTM'KZW_P"":7_*O#K([_\`"F?VK#^7B/XE5\D?'7_E6@_8*_["G[$G_JTM
M'K*2:I0T>F64HO3:496DO5--?('LOZ^S$_0W]MO_`)2O?\$5?]S]HG_U4]O6
MS\:O^5@C]BO_`+,?_:2_]/>A5C?MM_\`*5[_`((J_P"Y^T3_`.JGMZV?C5_R
ML$?L5_\`9C_[27_I[T*MHI\L]'_O]#I_U#T"WO\`/]8$7_!.3_E*A_P6G_[*
M?^SS_P"J@L*TO^"-W_);/^"OW_:1_P"(W_J.:%6;_P`$X^?^"J/_``6G'K\3
M_P!GG_U4%A6E_P`$;C_Q>S_@K\/^LC_Q'_\`4<T'_&NC".T*">C]H]/N)C]G
MUE^2/W5HHHKUC4****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`*QZ'Z'^5?AC_P0M_Y$[]OK_M(O^T5_P"ZK7[DO*JAAAL@#C`_B!QG
MGCCD^GIZ?AM_P0L_Y$W]ODCD'_@HO^T3CCU7PJ>?3T[_`(5X^)BX9GE/,K>]
MF;[Z5*=+V;TZ2>Q]YP\U_J-XAKK;@QV::_YFM>77^ZT_^"?NO1117L'P8444
M4`%%%%`!1110`4444`%%%%`!7X0_\%^_^3=_V5?^T@7[)O\`ZL6SK]W<@=>*
M_"+_`(+]G_C'?]E4]O\`AX%^R;_ZL6SKCQMWAJUD^G3RB%[;D'[5O_*=;_@F
M-_V;Y^U1_P"D=A4^O_\`*Q)\/O\`M&7X@_\`5U:E4'[5O_*=;_@F-_V;Y^U1
M_P"D=A4^O_\`*Q)\/O\`M&7K_P#ZNO4JXZ+2=;RQ-+\*23^YZ&;^)?XOTB+_
M`,$C/^3LO^"TG_9]>A_^JA\-U\I_L+?\HW_^"XO_`&<C_P`%(?\`U5T=?5G_
M``2-_P"3L_\`@M)_V?7H?_JH?#=?*7[#!Q_P3@_X+B@_]')?\%(1_P"8NCI\
MR]AA-?LU_P`9T[??9D;I+K=_DCQ?]HS_`)5ZO^"<G_90/V!?_5G>'Z_0S_@M
MK_Q]_P#!+K_M)A^S;_Z7WE?GE^T8?^.>O_@G(/\`J?\`]@4_^9.\/U^AO_!;
M7_CZ_P""7)_ZR8?LW?I?W?\`C4S]Z%HZZQ_]L'W_`,,?_;2Q\9?^5@S]DO\`
M[1Y_&3_U:C5!X*_Y6)OCA_VCF^$/_JT?%=3_`!F_Y6#/V2O?_@GG\9/_`%:C
MC^E0>"SC_@XE^.!_ZQS?"'_U:/BNDVDM=%]<PZOYJ%._W%/XE_B_^1*G_!%3
M_D+?\%7/^TD7QI_]1;PO6U_P;Z_\F>_&K_L^;]K;_P!6,U8O_!%3_D+?\%7/
M^TD7QI_]17PO6U_P;Z_\F>_&K_L^;]K;_P!6,U&%WR__`*\U_P#TXA+XEZ+_
M`-)/W6HHHKVC4****`"BBB@#\%_VS_\`E-W_`,$G_P#LE_[6/_ICT2G_`+%7
M_*;+_@K-_P!DR_92_P#3-XFIG[9__*;O_@D__P!DO_:Q_P#3'HE/_8J/_&[/
M_@K,/^J9?LI_^F;Q+_C7B2O[>MI_S'T'_P"2D+;YQ_*)S'_!.W_DYW_@O9_V
M<9X:_P#5"SUP_P#P3%_Y5Z-=_P"R$_M>?^E/Q.KN/^"=O_)SO_!>S_LXSPU_
MZH6>N'_X)B_\J]&O?]D)_:\_]*?B;58=JU'_`+!ZWX3I7^XSZ?-_^VGQE\<?
M^5:S]AO_`+"_[%O_`*M?1:_2S]O/_E+1_P`$6?\`K]_:H_\`58:%7YI_''_E
M6L_8;_["_P"Q;_ZM?1*_2S]O/C_@K3_P19'I>_M4?^JPT*JH-*G&^G]('O\`
M)?DB;]H#_E/]^PG_`-F,?M&?^IUI-2_\$W_^4HG_``6J_P"RL?LW_P#JJK^H
MOV@?^4_W["G_`&8Q^T9_ZG6DU+_P3?./^"HG_!:H_P#56/V;_P#U55_5Q=Y-
M+5_6J4_^W5&DG+T3B_N]!K[/^+_Y$\/_`."=O_(N?\%Z/^SLOVB?_5-QU\*>
M-O\`E54^`_\`V#O@+_ZNW2:^ZO\`@G8<^'/^"]'_`&=E^T3_`.J:B-?"OC;_
M`)55/@/_`-@[X"_^KMTFN**;4+*]\+B;>?O!'?[O_2D?V)^$?^16\-?]B_HW
M_I!!715SGA)@/"WAK/\`T+^C?^F^"NB!SR*]N@G&E135FJ:3\G:)L+1116P!
M1110!\$?M1_\E!TK_L4-/_\`3QKU%'[4?_)0=*_[%#3_`/T\:]10!]RZ;_QX
M:=_UZP?^DR5;N,F)AC.>OX<\\@XXR<$'BJFF_P#'AIW_`%ZP?^DR5:N-WR%>
MS$GIV4XP2..?\FCE<K):.\7U^RU+IZ"DVDG%M2<HJ+BDW&4I**E9M*T6TWKL
MF?S=_P#!=7]ICX%:/>?L;_#35OB?X.TSQQX#_;C^`'CSQ?X8O-8@M]5T'P=8
MSZM<77B+4;>8QO;:5!$\!DO2&@!+H'W*:_?SX4_%WX??&GP7IGC_`.%GBO1/
M&W@O56FCTWQ'H%T+[3+YK:5HIQ:SQXCF2)EQYJ2,C$$+G%?SH?\`!>__`()$
M^(OVX_%'[//Q9^">DVT/Q'M_%NF_"OXI7T42I)+\-O$=Y#)#XKU&;Y1<+X'D
MBOIV1W::>VOS'&"T8-?T+_L]_!?P5^S[\%OAO\&OA]IL&E>$_A[X5TCPWI=K
M;Q+"KKIULL,UU/&`,W5W<>;<73-EWED8.S;0:\#!5,>\WS&5>C&&#G&'L)*_
M.Y1<8ZZ<NJ;VD]H]]?U?B>EPE#PT\/JF5YIB\5GWUC/(9EE]94.3!VK4?K55
MJG)RC&M75%X:ZO.FZCG:48H]HHI,>Y_3_"C'N?T_PKW.?R?]6_S_`"[Z?E(Q
M@2W48V\_GGZU\.?\%!?CS\)/@C^S!\8#\5?'?AOP/'XW^%WQ,\+>%IO$6H0Z
M=#K/B&Z\$ZQ%9Z38RS';+?7,DZ+%;@>9)SM&17V^[?,RGDA,C/U''&*_.+_@
MJ-^Q7HW[=7['_P`4?@O=6<$OBD:=+XH^&VHRQAYM)\;:+;S7.D/:N06@:]9'
MTZ5ERKQ7LFY6*J1RXZ>)A@<35PT83KQ3]G&IS<KT5EHF[]M%]Y[W"4,HJ\4Y
M%1SRM7P^35LSHTLPQ6'Y?:X6-XOVOOOE4([R_NIO1V/G+_@A-\>O@_X[_P""
M??[-?PJ\'_$'PUXA^(7PT^$^FP^//"6EZC#=:UX7DN-:U:.WCUFTA9S932%0
M51V9BN"!M(-?M5'G=]"V?Z5^&O\`P0?_`.">=_\`L)?LDVR_$'0XM,^.'Q<U
M=O%OQ%$L8-[ID-LUQ;Z%X;,K*'\O3K-7GEB0(K37LC2;RB;?W+BSSNX)R1@=
MLCGI^&3_`(5CD\\2\KP3QD(4Z\:,8.G"^ZLEHTK7BM?-)>1ZWB-2R2''?%7^
MKN+GC<H6=XV>&Q=1IK$QKSYE*DXNSC%W@GU233=R>H?XO?<?IUX_7K4N/<_I
M_A2;1U[^O^>/_KUZ*GH]'>VGWK^ON/BFG>+[7O\`-'R!^VA\=OA3\#/@%\1-
M1^+?CKPYX`L/%/@KQKX:T*_\3:C%IEEJ.O7WA35%LM,@GF(C^V7<S"*WMF=9
M)F(5,MQ7YN_\&_GQV^#_`(L_X)]_`#X.>&OB#X<UOXF>`O!FM7/C/P;I^HPW
M&N^';:;QKK"VT^JVD;,UHMR+ZU,!EV^:)5*`\U]U?\%(?V._#/[<7[)'Q4^!
M6NV%I+K&K:+/K'@C4;FWCN&T;QOHPFNO#NH6RN1Y#M=+Y!G1AMCG??N12I^`
M/^"!7_!./6/V%OV:-7UWXJ>'H-)^._QBUA]7\<Q7$:OJ.AZ3HL]QIWAWPS]K
M*_O8K9%NM1G>!EBG>\MW8/Y<1C\&=3-'GV&C"E"6#>#G*I6:=XS=72"Z7LD]
MK6E?6Q^LY:N$*?@[G]*MF6+H\2U.*<HJ4,OM1Y*U#!X/'KZPF_>Y&LP<79-\
M]"UX\T>?]\XA@'U)Y!YP?K4M1HI`.3WSP!Q]<Y-/Q[G]/\*]YU+N]F^GW67]
M?+76Y^3IMI-WO9;[[=;:7%KGO%7B'1O">@:IXF\17\&EZ'H5C=:KJNI73!+:
MQL+*%Y[JZG8](X8D9V]`">@KH,>Y_3_"L7Q!IMCK&DWFD:I:0ZAIFIV\]CJ-
MC<HLEO=V-U"\-U;S1,"DJ30N\9C<%6W8I<TFGRQO+EE9.]F^6ZO;6W_`[V+I
MNFJD'6<E14XRK."3G[*,DZO(I>ZY.FI*-]+M7T/YGOV$/VS?V7+K_@K3_P`%
M']?MOC9X!N=)^,\7[,FC?"N]M]>LYX/'.IZ=X9UNQU"R\.M%(QU*YM[N2WAE
MC@!:%F82XXQ_3M;X\I2,8.3P<@')R,\9(.03@<U_)Q_P3\_X(=_\,[?\%5_C
MM\;O%7AZVN/@/\-);CQ)^SCY\"R64^M^.;N2]DC@MF!2W;P-`9;&U(9V#L#S
MU']8\(_=J`2`.!WX'N<DGU.3GKR>:\#AR>.>%QCQM+V;^O5/9Q2:O%RD[J_3
M6RTVLKO<_4?%F'"L,[RC_57-<5FN'EPOP]/$U<3[)NC/^SZ<*&%O2O:M0I0:
MKQNXJI*T=%8FHI,>Y_3_``HQ[G]/\*]_G\G_`%;_`#_+OI^5BT4F/<_I_A1C
MW/Z?X4<_D_ZM_G^7?0%HI,>Y_3_"C'N?T_PHY_)_U;_/\N^@+128]S^G^%&/
M<_I_A1S^3_JW^?Y=]`6BDQ[G]/\`"C'N?T_PHY_)_P!6_P`_R[Z`QS@_5<?J
M:_`7_@XA^.GP@\-?\$_OC%\&O$7Q"\-Z/\3O&4OPOU3PMX)O;Z*'Q!KNG:7\
M4O"=_J%WIEE)(DES!:VUE-)=2Q!EMD3S)L+BOW\Q\W/(QW`_P]Z_`'_@O]_P
M39UK]O#]F_0?$WPBT&'4?VA?@[XDT^^\(>1%''J&N^&=>FCTOQ'X>-ZRAUMH
MH+G^VO*#'<]@`6"DJW!F$ZOU.M.C%\T-XV=Y6Y=O+7KOZV)DFTU_6Z/DG_@K
M]^W1^R/\5_V*/V=/!7PZ^/OPX\7>)_#W[5/['OB35-&T?Q#:W5Y::!X5\0FY
MU_5F1"?/L=&CMG&I7,`:.W8$/M)`J?\`:6_;^_8W\4?\%9O^":_Q@T#]H7X;
M:I\-OA7\*?VFM&\>^,+77X)-&\,ZCK'AS2X-*M=5N@-EO+J4\4D5FK']XT4A
M&0*\._;]_P"#?Y]1_8=_8R\$?LX^&=/N?CA\%+WPSX1^)VIZ;:06MYXLT#X@
MS-_PGWB._N)%C>X'AG5[F35H+.7.;%'BA5%`0\]\:?\`@W"\/1_MH?L8VOPW
M\-V3?LU2^!])MOVC6BMT2UE\3?#S2X+C4;NXMB/-W_$R5KA'\LR"Q;S%CV;T
M(\>=;,YSE.-!)2C%)-.]_=;OIZ[/_(A1EV6MOT_I^GH?5'[)_P"WI^Q]H'_!
M6S_@I3\8=8_:`^'.G_#OXF_#K]EZU\!^*+C7[9--\47/A_P=<PZ[;:/(2&O)
MM(D4_P!H"(,+9%=Y,!3CB?V,?V[_`-D+P'^T[_P6:U_Q9^T!\-]%T3XV?':.
M_P#A5JMSXAM18^.;%_A,-.%]H-PA:.[L_MT4MMY\;-&9%QN!(!POV0/^"!6@
M?"O_`(*B_M%?$'Q_X*TO5?V4O#6B:CJ?P+T34;6&XTC4[_XF6QM)]+%I*A6/
M_A`-+FU/3+B9U`NGNXIP&/E.GA/[._\`P;<VI^*/_!031_B]H\#^!K?3_$OA
M/]D+5)X8W9/[=,NO:#XPMX518XSX?7R?#)M9I`',#R!&5R[15K9G_L[6'3Y*
MRDTD]G2E#1VTLY=?^'%&79=_ZM^G^1[7_P`$_OVV/V5?`W_!#35/@IXK^.OP
MZT'XH3?";]I;2T\&ZEX@M+?63J>O:W\0;O1;)[7>SP7>L6MW&^EV<H^T7C$"
M(-D"OEKXP?M@_LSZU_P0'_8R_9YTWXS>![SXS>"KO]D"[\5>`+?5DD\0Z)!X
M:^)&EWVOM?:>%\Z%])LXS<:A$PWV<)\V;"J0?<?V6/\`@@5=C_@E5^T!\/OC
M%X1L+3]K'XK:QJ'C'PO<7EI!=ZOX2U3X7W5_:^!-*L[UT,@37X(KF>Z=9!&T
M>NVC2^8T*;?F'QQ_P;H^/1_P3%^"6N>%O!^W]MJ;XA:=XH^*6G*B#4)/"7C2
M^.BZEX7ENBH!?P3;3IK,MR@\W4(HI(9&E78%J;S11C3]BFY8>4+I2T;JN6KY
M;Z1\M]+:!RR\NGZ?T_1^1^B/[67[?'['GC;_`(*6_P#!)OXA^%?V@_AMJ_@C
MX22?'FT^(OBFU\06;Z)X1DU7X:QZ;I[:U>F9$M(KV^_T:SE8&.YF#1QMNQ6U
M\8/V^/V.[S_@MA^R;\<HOV@/AW)\*_"?['7[0/A?Q)XPBUR!]*T3Q+JVLZ%)
MI>AZG-C%IJ=[!'/)#:2@2N$4J"K`GY-^//\`P;>Z79_M*_L%Z?\`"70H(O@J
M-`\-Z'^U+J<,216CZSX%TL:UJ'B.\M@`TJ>-KN.XTM+1-D%C+,)UC1E4CUW]
MI/\`X($>'/B=_P`%:/AA\1M&\%:79_L?>-/#Q\:_&'2=/MH;/3K7Q5X'TJVT
MJ#PNUK!&&6?QN5M+^6\@0",6-V(?*7AG[3-(J<71C=XBE55D_AC2IP:NE>[<
M;^@^65[Z=/S3_"QZE^P;^WG^R!X,_P""C/\`P5D^)'B;]H#X;Z-X*^+'Q%^"
M.H_#WQ#>:_:+8^+-.T3X96VFZG>:.0^ZYM].F@F%].H\N#86?:JFO2O^",G[
M5'[/5_\`M(?\%*_!]A\7?!-[XK^-?[?GQ$\7_"O0;?5X)K[QQX5D\-:7+%XB
M\/I`\QOM*EBL;IUN441H8PDCAW45\Q?L&_\`!`K2/A;^WG^V'XH^,_A+3-?_
M`&?])TKQ/X4_9ZL=3MEN['5-(^*ME<"^OH+9XYH[=_!NBW-UHL,3EIQ?2I*K
MJR!QZU_P1/\`^",>L_L5?M5?M1?&CXMZ+!<2>$/%FM_#;]G6_NK:*4W'@'5+
ME=:E\9Z;E9%LY-1L);/17C1HYK-[*ZC4+YA:M<-/,75PT:M&*A&K><DG\.FV
MGZ_\$49)KR?YVO\`UY??_4NC%AG^A&?]H9)^5NJ_D<FGU&BX!^8DDY)ZY[8R
M<],8_P#KDT_'N?T_PKZ+G\G_`%;_`#_+OIH+128]S^G^%&/<_I_A1S^3_JW^
M?Y=]`6BDQ[G]/\*,>Y_3_"CG\G_5O\_R[Z`M%)CW/Z?X48]S^G^%'/Y/^K?Y
M_EWT!:*3'N?T_P`*,>Y_3_"CG\G_`%;_`#_+OH"T4F/<_I_A1CW/Z?X4<_D_
MZM_G^7?0%HI,>Y_3_"C'N?T_PHY_)_U;_/\`+OH"T4F/<_I_A1CW/Z?X4<_D
M_P"K?Y_EWT!:*3'N?T_PHQ[G]/\`"CG\G_5O\_R[Z`M%)CW/Z?X48]S^G^%'
M/Y/^K?Y_EWT!:*3'N?T_PHP?4_I_A0I[:/I^G^?Y=]`\M^*OQ4\`_!CP5KOQ
M%^)_BC1O!7@S0XHFUGQ+KUTMCI>G+<2?9X);FYDS'#$TTD:&21D1`27<#I_/
M_P#\$(?VGO@/?2_M@_#*P^*/@^\^('Q'_;I^/WCKP3X3@UBVEU;Q'X4O+?PY
M)9:]IL,)D>73+E;2=DN]GE?*HW;F`/[T_';X.>#OC]\'_B+\&_'^EVNK^$?B
M/X3UKPIJ]E>1":'RM7M)X!=*C`JMQ:3.EU;RJ-\4T2LG85_/5_P0>_X)#>(/
MV)/BA^T=\8/C/H]M)XTA\9:_\,/@]=W,,4LO_"M=-OEG/C"P?#_9?^$J9H8E
MCREQ$EC,I*I(%KPLQGF-/-<JC0H*KA%^[Q-2TFX*7+JGM9*S5];Z6L?J_",>
M$9^&GB(\US3'4.(.;(ZN6X*,<.J.,BZ\G@J:3G[1NC5<WBU9J%)*5-\U[?T]
MQOO&>G0\<C!'4-_$,Y&<#ITJ2FA0.G'`'0=!G`Z=LG\S2X]S^G^%>[S^3_JW
M^?Y=]/R@6BDQ[G]/\*,>Y_3_``HY_)_U;_/\N^@+128]S^G^%&/<_I_A1S^3
M_JW^?Y=]`6BDQ[G]/\*,>Y_3_"CG\G_5O\_R[Z`M%)CW/Z?X48]S^G^%'/Y/
M^K?Y_EWT!:*3'N?T_P`*,>Y_3_"CG\G_`%;_`#_+OH$<AP5_')[?_KK^;K_@
MX'_:+^!^E?#G]G+X4:M\2_"UA\0?#'[9_P"RW\0]?\)76JVUOKNF>!=*\=V=
M_JOBF6QF82-I%A8++<3W2C9&L9W$8K^D@J#C=S@]_7\,5_-)_P`%_O\`@E'X
ME_;FA^!WQ5^"?A^VG^+GACQ?H'PQ\7W%K''!>7?PM\7:S';W^L7=Q&NZ7_A#
M3?WNJ)#(IDEMY#'YGE+$B<.95:OU64</!3JR5K6;MJGK9!+6-DM?^"OR/.OV
MB/V]_P!CSQ?_`,%A_P#@GU\9?#O[0GPTU+X:?#KX*?M,>'_&WC&/Q!;KHGAW
M6=8@TZ'1[#4KMLI;SZI(Q%DCG,X&8]V1F;Q-^WS^QY!_P7'\'_'=OV@?AT/A
M1I7_``3SUGP/J'C/^WK0Z/:^,;CXO:AJ4?ABYG#[[76TL?\`2I;"6+SHX"LK
M`*V!\U_%K_@W/\.:=_P4$_8XN/AKX<MQ^RM;^%O"U_\`'=DA1[.7Q9\+A]MN
M8KA9@US+<?$J>-#YSILLFBB&52-]W=?%7_@W_P##WCO_`(*]6_Q$E\%Z4?V,
M?%WA"Y^*OBW0+>T^RZ6GC^W-WH=YX'2WAPWF:G.+?7DEC*?Z(S1AXR0H\6G5
MS2'M+T%[]:G46CNH1BDT[K?[]'OH9\LO+\?)?I_6A[%_P3%_;O\`V0?AQ^TK
M_P`%8O$WC7]H'X;>'-!^*G[9.C^+?`.J:CX@MHK3Q-X:A^&.B:;-X@TR0E1-
MI%O<V[17=X/W5JY43.`ZFOF/]D+]MK]E7P7^PG_P5V^'GB7XZ?#W1O&?QG_:
M!_;ZUCX9Z)?:Y`MUXMTKQM\.5L/"6HZ1&FXWEIKUZK6UC+"2LTFW;][%=O\`
M\$Y_^"`>E_#']H']NJZ_:)\*Z7JWPSU"T\6_!GX"I?V4$]OJ?@OX@V$UQ<^-
M+"W*>5:7-A#>6^@6\2F.[AN-/@EBE\QO,KY6_9]_X-O?$1_9E_;PM_BMI$#_
M`!MT_7/$_AO]E?4KR%)I3HW@*,ZYHGB&U(WA5\?)-'H<4<@`L6`?Y-FZFZF:
M>RH0]BKTU/FT=O>E%V3:]$+DEY>E]MOZ^77KJ_'7]LC]F77?^"(?["OP,TKX
MS^!;[XL?#[Q=^Q#J_C+P+!K$3:]H-AX9^(>D7_B*6^M"`T/]A6-G<WFIL^%A
M@B+DJ#D?>?\`P5R_;M_9!^*MU_P3K7X??M`_#?Q3_P`(!_P4(^`?CGQ<^D^(
M+:Z31?!>B:A.=7\57+1%LZ'9;FC>_3,'GHT>X%'`_-'XA?\`!NCX_3_@G#^S
MWJ/A'PE!'^V3-\0]+UOXO6Q\D7T7A+QUJ5MINH:'-=1[HY8_AO9?\3=Y(RKZ
MG&9[5=[2(*^N/^"D_P#P;]P^,O`/[!_AK]F+P]IEIJ_PY/@WX$_&C5K&SMX)
M+KP'JFIQ7VL_$+45CC9K^YT&YNM:GDC8/,\=_:LJE8."%;,XWO0CK;H_);6?
MK<.67Y+[K?U\O0]S^(W[??[''B7_`(+;_LR_&[2?V@_AO=_"OP]^PY\6/`^L
M^-D\16:Z)IOBZ^^*,US9^';F=R,:I>VJ"2RM4W27!D78K`8:MX>_;Z_8]TG_
M`(+E?&+XZ7W[0'PYM_A/J?["'PK\#6?C:378!HTWC"Q^)'B.\O\`PTL_3^U;
M.SNH)[J#.ZW#E)%#(U>(^)O^#>'PSX>_X*D_L\^)?`7A2TA_8ZT;P;X=^(/C
MS2UMHI[%/B'\,[J$0^&[F*XRUTOC#4+6QU=KB9=J1M>0E65WC:[=_P#!O5X9
M\4_\%9_B/XP\3^#K"7]C'Q#X+U?XFV&GV]O'#IQ^(?C%+K1;OP5:6\:*\4>@
M:A&/%,-Q\L;+<K;A67@S*>:2BDJ$;_6(5;6?PQC%-7L];IM;=%H/ED]=%K?=
M^7K_`,/Y6/9?^"2?[=G[(/PNU'_@I++X_P#V@OAMX5B^(O[??Q:\;>#9-:\0
MV=G%KOA'5?#?AFWT_P`26,ID=9M$N)XS;KJ9\NV%P?)8AP0?7O\`@WH_:-^"
M>I_`7XJ?!_3?B3X5O?B?KG[7/[4GCS3/!5OJ<$^O7/@[6/';7NE>(TL8G:3^
MR;ZW*O;W9Q'("-I.0*^/O^":_P#P0"LO`DW[?.D_M-^'--OK/QM_PFGP(^!D
MNHV-O>&/P!JED;^P^)6EIM$-G<3ZI/:1V=A&(6A_L>9V:/S&#?57_!O]_P`$
MH?%'[#-I\=/BE\<M"MXOC#XE\;ZQ\/\`P?+<HES=Z9\+_"]PJV6J6EV\;!$\
M77DG]H(ENZF.VA6-B5.VM\)/,%4P<*M)*%/FA4:3VG*]UIT_X%P46FGI][\O
MZ[/4_I7C9FW9&!D%2`?NE0<'/\0;=G@#&WWJ2FA0O`)'Y=ACTI<>Y_3_``KZ
M+G\G_5O\_P`N^F@M%)CW/Z?X48]S^G^%'/Y/^K?Y_EWT!:C>0)DMPJAF=NR*
MJYY]SV]J?CW/Z?X4TH#G.3DY(XP>-O(Q@\<8/%'/Y/\`JW^?Y=P/Y?OVW_VS
M?V7=)_X+*?\`!/#QCJ/QL\"VGAWX*>!/VI-#^*VJ2ZU;+!X%UK4]+TBVTS2?
M$"[_`#+#4-0FM[B.UMY!YDK*H13NQ6%^R/\`M[?L@>&_^"M7_!2_XOZU\?\`
MX<:?\.?B3\./V9(/`GBF;785T[Q5-HFB^(_[:M=%;&Z\N=(+C^T(X@QMUR[[
M55B.5_X*#?\`!#%/VCO^"JWP*^-GAWP]:P?L]_%:<:Y^TS:62BVMH-;\"R?:
MWBFBME*2/\0--DM].-PB*;2[@\X+N$ADY[]C_P#X(&:!\+/^"H?[0/Q#\?>"
MM,U+]ESPOX>U#5/@9H]W903:5J]Y\1;?4+'5=#2`K(T'_"%6-Q/:123%)9VN
MEDW;E#K\VYYG*O4Y:,5&>*C4C=2TA'3WM.VV_5-F=I+:V^_R2ZWZ?KY'4?L/
M_MX?L@?#W]HS_@LSK'C#]H'X;Z)I'QI_:!\-ZC\,-2NO$-DUEXTTR+X+S:1+
MJ'A^XADD2_M%U+_1#/'B-9Y(HB2[US'_``3Q_;<_9/\``7_!#G6O@OXT^.WP
M\\/?%"3X*?M1::G@F]\06D>NKJOB63XC2>'=+EMY#&(K[6C=0#387*M>I(KP
M9R!7@_[-O_!MM`_Q)_;^T3XO:5:'P9:Z=J_@O]DK6Y[<2;9O$EM>:]IWC6S2
M,!53P[*=/T22%OD^U1E_*F",:[?]D[_@@+J`_P""4_[1/P\^,7A'3=,_:R^+
M&I:GXS\*3WEM;7%_X2U#X9+J"?#W0[>]:,;$\0W$>H27D]NP1K75X/.4F!0D
M49YFIJFZ$;PH5ES6?*W*=-QMHGHEVZ7UU%RRVT_X>W]??Y'@_P`7_P!K_P#9
MGUC_`(((?LA_L_Z9\9_`]W\8O!-W^R5?>*O`*:K&?$.C6WASXG:5>ZZUY8*&
MDA;1[*"2]OP2PCMHY&SP"?T`_;&_;Z_8Z\<_\%,/^"4'Q)\*_M"_#36/`WPC
MU?\`:7M?B/XGMO$5J-(\(-JWPZT:QTQM:NG*QV:W]Y#+;VAD;][*NP`FOS4\
M;?\`!NO\0Q_P3/\`@QK7ACP;&O[:DWQ!T_Q-\2].86_]HGPCXMODTB]\,2W+
M[H7'@>T<:VTI96OP\ULQ<L@KZ`_:!_X-N-*@_:9_8,TOX2:/9R?!!="T70OV
MJ;^WA\D-J?@-K;6KWQ'<(R@W4OQ$\Z72##N=;>:U64F.-N9I8C,[./U9>[)I
MMJ5G=K:RO9)MOSW#EE?9=/T7_#_@?6/QU_;Y_8\OO^"U'['GQMM?V@/AW+\,
M/!/[&GQ[\,^+/%PUN'^S-`\1:MXRTZZTO0]3<9:UU34+:":XMK68)(\,3,%(
M=2)_V"?V]_V/O!7_``4/_P""M/Q#\3_M`?#?1?!WQ6^)/[/FJ_#C7[WQ!:K8
M^,-,TGX;:I9:S?Z*=P>ZM=*F1%OIE&RU);S2,`UY9^T[_P`$"]`^*7_!63X6
M?$GP_P"#-'MOV0?&F@/XT^+.C65K';:/9>*O!MM!8VWA?[/;(!&OC)C%J'VJ
M(!8UL9()&7[0H,/[!7_!`C0_A7^W7^V!XG^,O@^PUC]GO2]/UOPK^SWI^IV=
MK<66JZ!\7-/ODU:^MXV5_L=QX.L)+G15*IYOVQK6Y38[,]:4:^9RK./L%&S7
MO<K2V3T>]ON_0?+)6VT=U^']?+T*O[#G[<O[)/@'1?\`@LI8^+OCU\.M#N_C
M;^T_\=]<^%RW>NP!/&NBZQ\)TTW2]6T)@/\`2[&]OU:TMY4)$\P01L?,05\;
M>,/VN_V;+C_@W&^#_P"S;!\8/!<OQNT'1?@M<ZK\-DUFW/B:T72?B]8ZIJ`D
MM#MP;73;66_F!`*6JER.]>A?LU_\&V%Z_AC_`(*#Z/\`&'2[<:[;SZSX*_9#
MUEX8FE2#3([O7]&\;0*$V0?VK)/:^&Q:SJPC,/VC;&5ROENK_P#!NU\1Q_P2
MV\*^(-*\%)_PW/)\1(/%/B#1X55=0'A+5=03P_)X&-P?W21Z%;N/$,EXH_?0
M"6W9I%8*.?GS14^9T-*="M3E9.[<WHXM):+1;I^HN679:_\``:^ZWX/R/[5_
MV=OCC\)?CU\-M,\4?![Q_P"&OB+X>TNVTW0K[6?"VH1:GIMOJ]II=E)=6!NH
M6:(W$'FCS45B8R=CX<,*]Y3I^/\`05\;_L"_LG>$OV*?V6/A7^SWX4M[`+X0
M\.V;^(]2LK<6S:]XNU*,7OB36KA`H)>\U.:<Q,[.PMTA52D2QQI]DJ..X]AC
M^N3^M?3X>4XT*$:B;J.G%O1[KENM=;ZZ+Y&BV6EMOR'44F/<_I_A1CW/Z?X5
MMS^3_JW^?Y=]&+12=._TSC_ZU`_7O_G^54G?HUVOUTOH!\$_M1_\E!TK_L4-
M/_\`3QKU%'[4?_)0=*_[%#3_`/T\:]13`^Y=-_X\-._Z]8/_`$F2K5QR$&#R
MX!QGA2#G(#*2#C;QNP2#C`R*NFG%AIW_`%ZV_P#Z3)7R[\?/VBM;\`>*="^%
MGPG^&MS\9_C3K'AZ;Q\?`,7B'3_"5IIGPWTW5TT75_%>J>(]1MK^V@+7TG]F
M:!IL%K-<:SK4EO8R26$$CW<:IIUDEK'5-M>33Z_UN15DX)V[V5^]TD_ZZZGX
MG_M,_%O_`(./M*^/7Q/TW]FC]G_]G;Q%\"[3Q/=P_#?6?$E[H":WJ'AY0#;3
MZ@D_BRTN%F)W<S6L$A&#MP03X:/C7_P=:*,#]F7]EH#L/[0\.8_#_BM?SK^H
M#X+?%WP?\<?A_I?Q$\#S7;Z+JEQJ%E-::E;M::OHVM:/>SZ7KWA_6;4R3);:
MOH.KVMYI6I6\,\\$-W:RI#-)&%8^K5ZJS"%-*F\#A)\B2<I1FY2:2U;4E=_U
MWOYL<OYG.HL5B(N<N914HN--2M*<8)JR4Y6<NNFG4_DJ_P"%V_\`!UK_`-&R
M_LM^O_'_`.'/Q_YG3K_/MFC_`(7;_P`'6O\`T;+^RWZ_\?\`X<_'_F=.O\^V
M:_K5HH_M*G_T+L%_X#4\O[_E_6MZ_LZ?_0;B?_)/+^[Y?B^Y_)0?C9_P=:?>
M_P"&9?V6\^IU#PYP._\`S.A]/0Y//O1_PNW_`(.M#S_PS-^RWSZ:AX=Q]>/&
MOX<_R!K^M>BE_:,+W^H8-K;E<:EK::7Y[_\`#@\ND]/KN)Y>6THIP2E+3]XW
MRW4]+73VZ'\E'_"Z_P#@ZTZ_\,R_LM_7[?X<SZ=/^$T/UYZ?R!\;?^#K3K_P
MS+^RWG')-_X=_3_BL\']#7]:]%5',J<4T\NP,K]7"I=>G[S\[C67..D<7B5#
MEMR.49+GT_>-M-N6EM78_DJ_X7;_`,'6O_1LO[+?K_Q_^'/Q_P"9TZ_S[9H_
MX7;_`,'6O_1LO[+?K_Q_^'/Q_P"9TZ_S[9K^M6BE_:5/_H78+_P&IY?W_+^M
M;K^SI_\`0;B?_)/+^[Y?B^Y_)3_PNW_@ZU/_`#;-^RV/7&H>'!_[NO\`^OCJ
M,TW_`(75_P`'6><_\,R?LM\=_M_AW\,?\5KZ>GX\BOZV**?]IP6V7X)+K[D[
MOY\]_P#AQ/*U)ISQ6)FU\-Y+E6VO*DDWI>[/Y*C\;O\`@ZU/7]F7]EO_`,#_
M``YZ=?\`D=.?3UH_X7;_`,'6O7_AF7]EOW_T_P`.?_-IS^M?UJT4O[2I_P#0
MNP7_`(#4\O[_`)?UK=_V?/KCL2W_`-P_+^[Y?BS^2D_&[_@ZT`R?V9OV6AZY
MU#PY_P#-IS_6HS\<_P#@ZO.0?V9_V6<'&0;_`,.\[@2.#XTR2?IFOZUY"0C$
M*6P,X'4^N/?'(QSGIS7Y^^.OVW+'PEXP\87.D_#O5/$7P*^$.LWOA7X[_&NW
MU>PMX/AYXNB-FG]GZ9X2N(/[5\6:?H+WL#^.]6M;RV;P_%/;+:6.K&25K?6G
MCJ<T[9?@TU\-HSZ6?6>K=M/ZOE/!RA))XS$-/1W<-4U%-:1ZZ_>S\*6^-O\`
MP=7`%3^S-^RSA",C^T/#ORDYQD#QKNYR<$\>].'QQ_X.LL?\FS_LM8R5S]O\
M.\D$\8_X309Z<8'/!&:_IO\`BY\9?`7P4^$OC3XR^/-333/`W@3PM?\`BS5K
M]VA5Y=)L+#[8L=DEY/!'=7M\`EMIMO)+B[N94AMVDD(`\'_9,_:0^)O[1FGW
M_C76_A=\/O"?PDU.PCO_``%XX\&_''0OBM=^())IU,.EZYI.@^&-)M_#&IV>
MF3VMSJ-HVL7TNF:D+O2YB7A61U3Q\9QE*678)*,GHHSU>FNLM_3?S'_9ZIR4
M*>-Q3YDI2<FF[*RA&\D_=A=I+>U^CN?@7_PN[_@ZT_Z-E_9;]_\`B8>&_P"7
M_":Y-+_PNW_@ZUZ_\,R_LM^_^G^'/_FTY_6OZT#]\?5?Z5+6?]I4_P#H78+I
M]FIY?W_+^M;Z?V=+3_;<3]]/R_N>7XL_DJ_X7;_P=:]?^&9?V6_?_3_#G_S:
M<_K1_P`+M_X.M>O_``S+^RW[_P"G^'/_`)M.?UK^M6BC^TJ?_0NP7_@-3R_O
M^7]:W/[.G_T&XG_R3R_N^7XON?R5?\+M_P"#K7_HV7]EOW_T_P`.?7_H=>?U
MYH_X7;_P=:_]&R_LM^_^G^'/K_T.O/Z\U_6K11_:5/\`Z%V"_P#`*GE_?\OZ
MUN?V=/\`Z#<3_P"2>7]WR_%]S^2K_A=O_!UKU_X9E_9;YZ_Z?X</Y_\`%:4?
M\+M_X.M>O_#,O[+?/7_3_#A_/_BM*_K5HH_M*G_T+L%_X!4\O[_E_6MS^SI_
M]!N)_P#)/+^[Y?B^Y_)5_P`+M_X.M>O_``S+^RWSU_T_PX?S_P"*TH_X7;_P
M=:]?^&9?V6^>O^G^'#^?_%:5_6K11_:5/_H78+_P"IY?W_+^M;G]G3_Z#<3_
M`.2>7]WR_%]S^2D_&[_@ZT'7]F;]EK)_ZB'AS]?^*T/?Z\TA^.'_``=9+][]
MF?\`9:&<\F_\.CIU)/\`PFF!CN3T/!YK^KGQ)XBTKPKHVJ^(M=N5L-%T+2[_
M`%G6=0D4F*STK3+2XOK^Z<K\Q2UMK>6:58U=]@RJDG!^*OA?^V;%XU\;>#]-
M\7_#'5_AS\//CE@_LT_$75M6T_48OBJ(=)N->?3]2TBSC%SX-UC6M!T_4O%_
M@_3[NZU1=;\):=<ZI=7.E7;1Z4;CF$79_P!FX)I+^6IK:W]_IY_?WEX%IV>.
MQ-_^W/+^[U_5]S\&A\</^#K$CC]F?]ED@C/%_P"'""/7(\:$$8QR,CWH'QO_
M`.#K(G`_9G_99)QG`O\`PX3@\9'_`!6GYX_&OZ%OVG_VA?%/P<G^&G@[X5?#
M&U^-'QI^+/B.[TCP?\-KCQEIW@&*3P]X?M4O_&?C74_$FI:5K4-MH?@RWNM+
M?4((+&6\E?6+$P0LBW$D/I?P$^->B?&[PUJ>IV.G7OAOQ1X/U_4?!'Q+\#ZH
M87U7P)\0=&6V.N>&]0N+4R6EZ(S<1WVG:C:R+#J6DWMC?QQ1BY,,,O'I0A/^
MS\$N9ZKDF[;?WMO6W7S)6";J3A]?Q/NI./\`#N_A_N6VW_X+/YH/^%V_\'6G
M_1LO[+?_`('>'>__`'.E'_"[?^#K0=/V9?V6^?\`I^\._KCQF?RK^M:BI68P
M7_,OP3_[<G_\G_7WWT_LZ?\`T'8K[Z?E_=7;^GJ?R4_\+M_X.M/^C9?V6Q[_
M`&[P[[?]3I]./;VH_P"%V_\`!UH/^;9OV6S_`-OWAT_R\9XK^M:BA9C!._U#
M!ORY)VZ?W_+\7</[.G_T'8K[X>7]WR]?,_DI_P"%V_\`!UIW_9E_9;_\#O#A
M_#CQI_\`7^M'_"[?^#K3_HV7]EO_`,#O#O\`\VGO7]:U%-YE!N_]GX)>2ISM
MT_OA_9T_^@[%?^4_+O#R_K8_DI_X7=_P=:#_`)ME_9;_`/`[P[]?^ATI?^%V
M_P#!UI_T;+^RW_X'>'?_`)M/\_A7]:M%)9C#_H`P3_[<G_\`)_U\V']G3_Z#
ML5_Y3\O[GE_6M_Y*O^%V_P#!UI_T;+^RWS_T_P#AS_YM/\]>U'_"[?\`@ZU_
MZ-E_9;_\#_#G_P`VGK_CT&:_K5HI_P!I4_\`H78+_P`!J>7]_P`OZUN?V=/_
M`*#<3_Y)Y?W?+\7W/Y*O^%V_\'6O_1LO[+?I_P`?_AS_`.;3U_QZ<T?\+M_X
M.M?^C9?V6_3_`(__``Y_\VGK_CTYK^M6BC^TJ?\`T+L%_P"`U/+^_P"7]:W/
M[.G_`-!N)_\`)/+^[Y?B^Y_)5_PNW_@ZU_Z-E_9;]/\`C_\`#G_S:>O^/3FC
M_A=O_!UK_P!&R_LM^G_'_P"'/_FT]?\`'IS7]:M%']I4_P#H78+_`,!J>7]_
MR_K6Y_9T_P#H-Q/_`))Y?W?+\7W/Y*O^%V_\'6O_`$;+^RWZ?\?_`(<_^;3U
M_P`>G-'_``NW_@ZU_P"C9?V6_3_C_P##G_S:>O\`CTYK^M6BC^TJ?_0NP7_@
M-3R_O^7]:W/[.G_T&XG_`,D\O[OE^+[G\E7_``NW_@ZU_P"C9?V6_3_C_P##
MG_S:>O\`CTYH_P"%V_\`!UK_`-&R_LM^G_'_`.'/_FT]?\>G-?UJT4?VE3_Z
M%V"_\!J>7]_R_K6Y_9T_^@W$_P#DGE_=\OQ?<_DJ_P"%V_\`!UKT_P"&9?V6
M_P#P/\.=.O\`T.OK^M'_``NW_@ZUZ?\`#,O[+?\`X'^'.G7_`*'7U_6OZU:*
M/[2I_P#0NP7_`(#4\O[_`)?UK<_LZ?\`T&XG_P`D\O[OE^+[G\E7_"[?^#K7
MI_PS+^RW_P"!_AS&/_"T]>WKSCO1_P`+M_X.M>G_``S+^RW_`.!_AS&/_"T]
M>WKSCO7]:M%']I4_^A=@O_`:GE_?\OZUN?V=/_H-Q/\`Y)Y?W?+\7W/Y*O\`
MA=O_``=:]/\`AF7]EO\`\#_#F,?^%IZ]O7G'>C_A=O\`P=:]/^&9?V6__`_P
MYC'_`(6GKV]><=Z_K5HH_M*G_P!"[!?^`U/+^_Y?UK<_LZ?_`$&XG_R3R_N^
M7XON?R5?\+M_X.M>G_#,O[+?_@?X<Z=?^AU]?UH_X7;_`,'6O3_AF7]EO_P/
M\.=.O_0Z^OZU_6K11_:5/_H78+_P"IY?W_+^M;G]G3_Z#<3_`.2>7]WR_%]S
M^2K_`(7;_P`'6O3_`(9E_9;_`/`_PYTZ_P#0Z^OZT?\`"[?^#K7_`*-E_9;]
M/^/_`,.?_-IZ_P"/3FOZU:*/[2I_]"[!?^`U/+^_Y?\`#ZW/[.G_`-!N)_\`
M)/+^[Y?B^Y_)5_PNW_@ZU_Z-E_9;]/\`C_\`#G_S:>O^/3FF?\+Q_P"#K'<4
M_P"&:/V6=RX#`:AX<RN>1D?\)IQG((!Y.00"#FOZV*\3^//Q6;X+_#;Q/\0X
MO"OB'QO>:0^AZ=I7A3PW9R7FHZUKGB77-*\-:':@PPW#6&G'5-7MI=>U:2WN
M$T718;S59(98[<0R']I4_P#H78+_`,!J>7]_R_K6Y_9T_P#H-Q/_`))Y?W?+
M\7W/YD6^-_\`P=7L%1OV9_V6<;OE4ZAX='//'_(Z`]B>O7FE;XW?\'6*?,?V
M9OV61CI_I_ASN"Q``\:<G`SWX!/8FOZ&_@5^T5XD\:>*]1^$WQG^&T/P:^.>
ME:(GB^3P1IWBFU\>^&]=\#3WJ6=KXE\,>-[/3-&BU:"PGECTS7;2XT?3Y=,U
M62.S1KI6\]:O[77[6"_LO:-X)U*3X0?$SXCVWC+QYX+\%3Z]X2L]'3PCX(D\
M7>-?#W@^WU;QUK>I:M;76DV4<^O175I_9VDZO/=26XA:.`/O&GUY>TA!9?@[
M2=OAGL[/2\WOIMIYG-]1O3=3ZUB5*$4K<RM)QM[-SC;5T_LK;NF?SWK\</\`
M@ZR<93]F?]EEE_O+J'ALKZ]?^$UZ<Y^OO3_^%V_\'6AZ?LS?LM'_`+B'AS'K
M_P!#K^E?UF6W1L`!<)MZ9QL!S\JJN#G=P.'9QR`"9T^Z/Q_F:S_M*G=K^SL%
MH[?#4[+^_P#U\W?=8"=X_P"VXG6/-]C^Y_=ZW_%]S^2S_A=O_!UK_P!&R_LM
M^G_'_P"'/_FT]?\`'IS1_P`+M_X.M?\`HV7]EO\`\#_#G_S:>O\`CT.:_K5H
MH_M*G_T+L%_X#4\O[_E_6MZ_LZ?_`$&XG_R3R_N^7XON?R5?\+M_X.M?^C9?
MV6^/^G_PY^G_`!6G^>O>C_A=O_!UK_T;+^RWQT_T_P`.?I_Q6GK_`(]Z_K5H
MH_M*G_T+L%_X#4\O[_E_6MS^SI_]!N)_\D\O[OE^+[G\E7_"[?\`@ZU_Z-E_
M9;XZ?Z?X<_3_`(K3U_Q[T?\`"[?^#K7_`*-E_9;XZ?Z?X<_3_BM/7_'O7]:M
M%']I4_\`H78+_P`!J>7]_P`OZUN?V=/_`*#<3_Y)Y?W?+\7W/Y*O^%V_\'6O
M_1LO[+?'3_3_``Y^G_%:>O\`CWH_X7;_`,'6O_1LO[+?'3_3_#GZ?\5IZ_X]
MZ_K5HH_M*G_T+L%_X#4\O[_E_6MS^SI_]!N)_P#)/+^[Y?B^Y_)5_P`+M_X.
MM?\`HV7]EOCI_I_AS]/^*T]?\>]'_"[?^#K7_HV7]EOCI_I_AS]/^*T]?\>]
M?UJT4?VE3_Z%V"_\!J>7]_R_K6Y_9T_^@W$_^2>7]WR_%]S^2@_&[_@ZT'_-
ML_[+8QT_T_PYZ]O^*S/?_'IS0OQO_P"#K)AD?LS?LM$9/(O_``X>1P>GC3J"
M,8/((QBOZ0?VC_C-XQ^%5EX)T;X;_"N^^+?Q%^(^O:AH'A/P_)K"^$_"<$VD
M:+>^(M3N?&/C>;3=9M?"MB^EZ==6^F74^EW8O]7DM-.3RGN%<Z/[/_QYL/C-
MHWB.QU'0KKP7\3/AQKJ^$/BQ\/;VZ@U"X\%^+7TZUUF"RCU6U"6FKZ5JVC7]
MAK>@:K$D#:CH]_:74UI9RR/;QW_:$.5-99@M>O)4>VE[.?\`3_&'@6G9X[$W
M5NL+ZVU^'^KOR/YK/^%X?\'6/7_AFC]E@@9)/]H>'"!@X.3_`,)I@8)P>>.]
M"_''_@ZR;&/V9_V6CUQ_I_AT'Y3@X!\:9X/7%?T"_%/]I+QO:?$N\^#G[/GP
MDM/C1\0/"B^&M5^*8U?QO8_#WPY\/=`\7Q7<F@2W>MW>E:Y-JOB/6K>TGU#3
M=!L-."W.F6LMQ/J=GCC["L3,T<+W$2Q321F26)&,JQR,J>:OG;%#E9=ZJZI$
M)8U$AC5F*+,L>H6Y\OP:<K<ON3\FOM>GRN^MPC@>?6&/Q+2_Z]]+77P?UUW=
M_P"3K_A=O_!UI_T;+^RWZ_\`']X=[<_]#I^7OTYH'QM_X.M.W[,O[+0_[?O#
MO_S:?_KK^M:BI_M&'_0!@_\`P"?_`,G_`%\V7_9T_P#H.Q7_`)3_`/D/+^KL
M_DI_X7;_`,'6G_1LO[+?_@=X=[?]SI^7Z4?\+M_X.M.O_#,O[+?K_P`?WAWM
M_P!SI_GI7]:U%']HP_Z`,'_X!/\`^3_KYL/[.G_T'8K_`,I__(>7]79_)3_P
MNW_@ZT_Z-E_9;_\``[P[VY_Z'3WI?^%W?\'6G_1LO[+?_@=X=[<_]#I7]:M%
M']HP_P"@#!_^`3_^3_KYL/[.G_T'8K_RG_\`(>7]79_)3_PNW_@ZTZ_\,R_L
MM_\`@=X=S_ZFGO1_PN[_`(.M.W[,O[+?_@=X=_\`FT_GCZ\5_6M11_:,/^@#
M!_\`@$_+^_Y?UK<_LZ?_`$'8G_RG_P#(^7]79_)5_P`+M_X.M>O_``S+^RW[
M?Z?X<_\`FTX_2C_A=O\`P=:]?^&9?V6_;_3_``Y_\VG'Z5_6K13_`+2I_P#0
MNP7_`(#4\O[_`)?UK<_LZ?\`T&XG_P`D\O[OE^+[G\E7_"[?^#K7K_PS+^RW
M[?Z?X<_^;3C]*/\`A=O_``=:]?\`AF7]EOV_T_PY_P#-IQ^E?UJT4?VE3_Z%
MV"_\!J>7]_R_K6Y_9T_^@W$_^2>7]WR_%]S^2@_'#_@ZS4C/[,W[+0ST_P")
MAX<SZ\#_`(37/'?CBD/QR_X.L0`W_#-'[+)!Q@C4/#AZ]`/^*UZ\Y`ZFOZRK
MZ4PQM((IIO*BFE\N!-\DGE*',:(2H>1P-L2EU#2E%.021^>VF_M=?&71_BEX
M`\-?%/\`9M?P!X!^+OBN;P?\/->3XD:/XI^))U&=9IM+OO&'PKTK1HIO#.CV
M]M!)<^)M3B\2ZM;^'X[BR\YW\\E*IX^-1SMEN"]RUO=J:JR;TY[WT=[;Z]V1
M4P3I^S_VW$WF[.[A9)-*_P`/EY[ON?A^?C?_`,'60&X_LS_LL@#G)O\`P[Q@
M=3_Q6G&!ZXI%^./_``=8L<)^S1^RR3R>+_P[D8/?_BM.#SD9Y(.1QS7]/?QG
M^*+_``B^'&O>/[;X?^/_`(FR:%:+.O@WX;:9INL>+M21F,9-C9ZKK&C6#16N
M#+>S2ZBGD6ZO*JS,HC;#_9G^,,'[0/P)^%'QKMM`O/"UO\3O!FE>+XO#FHW,
M-WJ.AC5H?._LJ^GMU$,EW8+B"0QNZ!ED0,0BLT_7_P!VI_V=@U>23O"=K.W]
M[R_._42P,_:2A]=Q-HJ^]._V;7]S;\^^]_YHO^%W?\'6G7_AF7]EO_P.\.Y_
M]33_``H_X7;_`,'6F/\`DV7]EO\`\#O#O\O^$TK^M:BE_:,/^@#!;_R3\O[_
M`-YI_9T_^@[$_P#E/R_N^7Y]S^2G_A=O_!UI_P!&R_LM_P#@=X=[?]SI^5'_
M``N[_@ZT_P"C9?V6_P#P.\.__-I7]:U%']HPT_X3\%I_<GKM_?\`+\?O/[.G
M_P!!V)_\I^7]WR_,_DI_X7;_`,'6G_1LO[+?_@=X=_E_PFF?TQ0/C;_P=:?]
M&R_LM?\`@=X=_P#FS%?UK44?VC#3_8,%I_<GKM_?\@_LZ?\`T'8G_P`I_P#R
M/D?R4_\`"[?^#K0<_P##,W[+?)_Y_P#PYVZ=/&F>/>D_X7;_`,'6@Y_X9F_9
M;`_Z_O#@Y_\`"TSG]*_K7IDD@C7<0Q&0,(I8\^W^><`<D"G',J<5KEV"FNJ<
M)W>W]_\`J_07]G3_`.@[$_-P_'W5V[]]C^2P?&[_`(.L^W[,W[+(_P"XAX<'
M3IQ_PFGY4#XW?\'6?_1L_P"RU_X,/#@_]W2OZSOM4>=HW$[MI(V[0=P3[V[:
M3N.-JDL#D$9!J-KN(,%*.20QSA"%VKN^?Y_W>?F"E]H8HV"0`2O[3@]LLPG>
MW)/R_O\`]=>HEE]3_H/K_P#DC[>2_I^9_)K_`,+N_P"#K/\`Z-G_`&6?_!AX
M<_\`FUI/^%W_`/!UF/\`FV;]EK\+_P`.]O\`N=/R/3WK^LH7D.3A7&,`L0JA
M225"MN8%6R/X@`>Q.UMLC74:JS*'<!-_R@`$8+#YG9$7<!D%V50"&8JGS4?V
MG!6OEF%UM;W*FJT_O>G]-A_9]33_`&^O\^3^[TMK_P`%G\NOP@^,?_!SCJ'Q
M;^&%C\7?V<_V;=,^%%UX]\+V_P`2]3T:]\/-JMAX&EU>V3Q/=::$\92R&_@T
M<WDMGLMY@;I(58`'YOZBH5=8BK###`Z#GD\\#&3U/'4GZU+'*LF[:&^7'48R
M#G##D\'&1G&1AA\K*3)7)B<0L4Z;C0I8=0^S2BUS:W]Z\FV^S[,Z\/AG0U=:
MI6;5KS:_2WZ=#X'_`&H?^2@:3_V)^G?^G?7J*7]J/_DH.E?]BAI__IXUZBN<
MZC[CT\XT_3CP/]&MN3G'_'O&*_.#XZ>*=&^`/[9_AS]H;XI3/X<^$&M_LMZI
M\&%\:):W=W8VWQ%3XJ6/B_2?#VI1V5O<2V#:SIKW5MH,\OEPZCK$D>D#?-<V
MZG](-.`-AIP(R#:P?^DR5+>6%E>1M'=VEO=Q.R,T5U$EQ$6C+,C>5,'CW*6)
MW!=W3).!BJ35.2LM.L5U\A2BIZ/K_G?\T?&?_!/[P1XN\"?LZVUCXQT2X\/:
MGXC^)?Q@^(%EI5\KQ:A;^'_B'\2?$GC'PZ=1M7CBDT_49='UBTEO]-FB2;3[
MIY;24!XF-?;50QA5R``,\D]R>@R2<G`&!GH``.!4U*4U*<K*S>MNUQ1BXJU[
MKT].O];A1112*"BBB@`HHHH`****`"BBB@`HHHH`AN"5AE([(3T)X`YX`8MQ
M_``=_P!WOFOP/^*$-WH'PT_;Q_93U+3;U?CQ^T[\7_'_`(O^!_A"/39;A/'?
MA;QK-X973_$6GZQ;"YM9-'T"2QGE\8WLUPB^$HI(5N[>%9HXZ_?4@,"I'!Z]
M1^HY'U%5&T^R>:*Y>U@>Y@22.&Z>-6NH8Y23(D-RP,\0;)R$D7VQ5PFX-/I>
M[6GZKR1G4IJ<6FE?H_FO\CYT\8_$#X&:?\,O&D?Q=UWP7<>!_A];Z3HGQ6C\
M70VFL>'=!NWL--NX+#Q)97]O/;.SQ7ME<VJ2VDS(LMO<NL;F,GY'_9>N?`7B
M[]J/QSXZ_9?AT>/]E.7X(VNAZ_>^!;1-`^'7B3X\0^-X'M]1\*Z'!:6>CWM]
MI'@E;W3=>UC0[6SB@GNK33M1:^O)2]K^H#Z5IDD4T$FG64D%P4,\,EK#)%*8
ME5(S)&Z%'\M414W*=H5=N,"G6NG6-C`+:SM+>UMP2PA@B6*++?>.Q`%)8\L2
M,LWS-DC-4ZCY6HWC=ZK37\%U)A2:ES2=[*R\MGW\K?(M[1P>>WZ4ZBBLC8**
M**`"BBB@`HHHH`****`/*/C?X=U7Q=\)?B=X6T.!;G6?$WPZ\:>'])MGF^S)
M=:GJ_A[4+'3[:2X_Y9)-<7"QLS_NMKMYH9>*_([X<:M#\3?^'<GPI\(V%XWC
M[]C*X\/ZA^TOI&HV-UI2?#"S\(_L^^*/A5J>GZG<2VTT+:AJ?BG5M*U/PUIM
MK)_Q.?#B2Z]%,+>)HY_W%9%?[RYZ>H)`SP2,$KR<J<J<G(JLNG6"/-*EE:I)
M<L&N'2WB1YW52JO,RJ#(ZJ2JN^65>`0*VA5Y59J_]?Y?EW.>=%RDY)VNU^GG
MU]._S_.+]L/QG\%[GP;\)OC!IOQ5N?!OQ1BFUO4/V</'/@7PS=?$;Q/XCN-6
MT1SXA\.>&/`%G\WCO2_$.B1PSZWHPEL3=6]E:S1WL30^6.@_X)Q_!?Q_\)O@
M[XE\0_%34_$5[\2/CG\2?&/QF\8:?XHN+>[U;0KOQ%=V^G:/ITUQ!#;[%D\-
MZ3H]^-/>(/HK7CZ(SS'3?M$_WT=+TUC:L;"T)LO^/0_9XO\`1CMVYA^7$9`)
M"E<%<DK@\U;2%$8LH;<<CEW8`,VXA0S$*,]%4``!5`"JH#E6O#DL[7NKV=OG
M:_IV%"BXSY[Z]?/;U]/EZ,DHHHK`Z0HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*^?\`]I3XY^$?V:O@_P".
MOC=XXMKRY\->!;*PN;^&Q@EN+B>YU?5])T+1X,01S?9K6YUC4;"&]U*=/(TJ
MT6YU"ZC:V@9J^@*K7%G:WD;17=M!=1.,/%<1)-$P'8QR!D/8\KR0I/*K@`_(
M_P#9;_:+_9V\<?%'XA_%7Q9\:?!GCOX\CX>V^N^*+_P>NKWOP]^"GPAEUVQB
MTWX=:7XGDTRUMKMFUJ5-0U6^NPU]K.HM<7EO;QZ=;Q*>T_X*M>.O!OA#]E&S
MO_$^O:=I-MJ7QQ_9M;2;BY5Y'NO[/^.7P_\`$-\;-UM;R58[70M-O=7O&2!E
MCT^QNE\Q9&C9?TMM]`T6U5UM])TVW1U"NEO8VT*R(N=JNL<2!@N2%4@A02!@
M<58NM,TZ]58KRPM;I$*.JW,$<R@IC8P$BMDK]T$_PEE^Z6!Z7B81J4YN-U%Q
M5FTM$DM[+5+3\NM^6%&;ISBY:2OT\UY;7V\M/2+3+ZWO[.WOK.59[2\AANK6
M=2&2XMYXQ+!<QE3@QS1,A1L(6P3L7BM)#E>F.>GZ_P!:188T7:BA1A1\OHHP
MH[\`<#TIX&!BN=M-MQ5HMW7]?\-Z'2K)13UDEOUMI=?>E]PM%%%(84444`%%
M%%`!1110`4444`?&O[:'[5/AG]EOP3X8O]7N](T_Q%\1_$3>!_`^H^*9KS3?
M!&DZ[-8SW]QK?C77K2"9]'\/Z)I=M>:G<B'_`(F.J&V&EZ1%-J-S"H\;_8J^
M*O[-5WI'C?4/`?Q>T[XH>._%GQ;TWPY\5_BQ]@U'3;'XF_&74O!^E:C86/A>
M2XMK2PU#3M'\*?V7H6B0Z7%/;Z7IFDIIUU>3W5K*]?H_?:98:FL::A96M['$
MXD1+N%)U1P0=R+(&4,<;6./G0M&^Z-V4QP:+I-J%6UTZSM529KA4MK>*"-;A
MAM,XBB58_.V_*)=OF*I*JP!(K;V\84U'ELUN[K6[[/R_X.RMSSHN<W+FM?UZ
M)+O_`%ZV9_//XK\!77PR^+G[3^K0ZI\0(OV\_&?[0FO>-OV0=*77/$][H.M>
M`=;TWPE;:+I=G;630^';WX927FG:E'\6-,UR2\B\'12BXMO[/FOX[>?^A#0S
MJ1T[36U5534I-.LWU)(W+1)J!MHOMD<88L=L=P)%1@QRFWL!B\VG6#7$5VUE
M:M=0JR0W+01M/&C;@R),RF14(=AL#!<,PQ@FK815)(&"<9//88'TX],4ZM?V
MR3DN9I:-]-%:UNR6W_#BHT'1T@^5/XEO?5-[MZONO\AU%%%8'2%%%%`!1110
M`4444`%%%%`!1110!G7[QQ#SI7*1QQ2M*^(RJQ#9YK,K_,`B9=G&0L8<$$E:
M_&/5?%WP\^*O[;7PZ^,7[)OQP\1?&7Q^FJ:9\/?C)X&@\37NO_"#X8?`O39[
MRX\87\6@3:?%IG@[QMJ6KQH-.OK=Y=2\1S17&FR2K:V2!/VK9%?&Y0V,@9Y'
MS<'CIG'&>H&<=36=:Z+I%DTKV>EV%JTYS,UO:01&3OM?8BY3.3L^YN);;N)-
M;4ZJIIV3O+?:S_I+^MSGJT74DI-_"URI]-O^#^/D>/\`BWXC>`=0^#GCGX@K
MXGT6Y\#:;X4\8WFH>(Q)]MT6"+0;+4(-5FES`RRIIUQ:W,5PHA#B2!HA'(0#
M7S=_P2V\2Z'XI_8)_9<O_#^HPZG96OPF\/:5/-#N`@U'3!<6FH6,JR0VSK<V
M=PCQW"?98`I*8R.GWR+"R$#VPM+<6\F\20B%!&XD),@=-NU@^3O#`A@2&R#B
MG6UG:6:"*TMH+6)>%BMXDAB0'J(XHPL<88\L$5=QY;)YHE53@X*+M>ZVTV\O
M7\MAQIS4E)R[7\UII^%OZ19HHHK$W"BBB@`HHHH`*HZE!'<V5Q;S)OAGC:*=
M,,=\,H,<R_(0XW1LR[D(9<Y!XJ]5#4XGGL;B".1H6GBDA65%5GB:5&1)$5U=
M2\;LKINCD7<HS&PS1S<EI?RM/[GYZ$R7-%Q[JQ_.7X1_99\.Z?\`M>_#[]C&
M\\-^/3HGPZ^,GQ"_;1M_B):?$/XCZ@M]\.-7-II_@GP;XKF_X2B6QMM/OO%Z
MZMX3TCP]>W-ZL>G_``YAOA;V[ZA=+*FD>$?$&N_M_>,?%_Q&_:>\2^!OBOH_
M[2=I8?#GX0Z=X#U/5O'NO_`:TN--CTVPL+V/6QID'PN\0A=4BU35G\,-<:;I
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M7Q#^)_Q<\8_%'Q/IOC#3-/\`B'K+V'P=^)&KZ)'<ZYX3\`:C$R0ZUXIT'1+?
M6=.M+@N=2FM@L5?TTC0]%)EW:/IC_:7CDN"UA;.;B2$R-%).6B8S/"TTK1O(
M79#+(P(+L3.-&T@6AL!I=A]B)#-:FT@-NS#!#M$4*-)D!O,(+[OGW;N:)XQ3
MMRPY4O\`"^MUNGTV7_#A'!VO>3E?SEIMYKS^7F?''_!/?3]"TS]EWP-:>&?#
M'BSPCHBW7B22PT?Q9XGUWQD?+G\2:M<'4?"OB7Q+/<:WJGP\U9IFU/X>3:FZ
MWZ^#KK1DNHX9!Y,?VU44,$-NBQP1)$BHD:(BA42.,;8XT4?*D<8X2-`$4$[5
M&34M<<Y<\I2[N_\`5M#KIP]G!1U=N^OXGP1^U'_R4'2O^Q0T_P#]/&O44?M1
M_P#)0=*_[%#3_P#T\:]14EGW+IO_`!X:=_UZP?\`I,E:59NF_P#'AIW_`%ZP
M?^DR5I4`&/;]/3I1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`'X4
M444`%%%%`'P1^U'_`,E!TK_L4-/_`/3QKU%'[4?_`"4'2O\`L4-/_P#3QKU%
M`'W+IO\`QX:=_P!>L'_I,E:59NF_\>&G?]>L'_I,E:5`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444U]V
M`5Z@DX]1M/`]\X/X4`.HKX2_:?\`VUH/V;?C/^S)\&[KX8^*_$UQ^TWX]D\`
M>&O&%K=Z+:>%]&U:UTO4-6O;?4S/??VR;N&RM(KL-;:1=6GV>7YIQ,/*K4^#
MO[6-YXO^.WQ-_9C^*7AG3?`'QE^'?AG3/B';V>CZ\-<\.^+/AQKNIW-CIGB+
M1+^]L=*U$RV$EO'9^(8+G3;>VM-0N1#;W,T(2=Y<TG;4E23E*-G>._X?YGVS
M17X^:E_P5P^$]MXXLH-,D\)Z[\/-0^*MS\#X?[,\7QR?%4?$"'6KS0[;5F\#
M?V>]DG@"]O=.GMHM;DUN.Y2ZGM@UL(W)7WC]D']MSQ!^U_#K'B7PI\']5\+>
M!_"OQ=^*OP?\7WGB37-.&OZ)K?PTO#I;77]F:>;NTO([W5K:\L;G[+?2"V?[
M/Y?F!I6C2FGIJ2JU*345--O9(_0NBOA/]J?]MCP?^SMXK\(?"U-8\#V_Q.\<
M:-K7B;1(_B3XI'@[P3:Z!X>O+&'5)=:\0Q6>H75M?W,5\!HUK;:;<BXGMIH[
ME[>-3+7RG9?\%0O%OB/1O@C\7O#?PW\"6_[-7Q/\:S_"_P`6_$_Q+X[UFSU3
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MD>-_A/\``;P1H'Q.\:_"+0O#/C/XKV.O>)9_#5OI?AKQ/;:C<Z;I/AFXLM+U
M<ZIXTNH=*FNK;3=5CTFP-M/$7O0S#'/0?MZ>!?&/PD^"OQ!^&]QX=CU7X]ZI
MJ6@>![7XDZU<>$_"]CXI\.-(?$GA+Q1XGT[2]=72M<C>TU'3='MS8L-5U.T$
M<+>6X9@OGCTU\UL?H#17Y%6W_!13XQ6W[;7PW_98\6_L[67A/PK\6=>^*F@>
M"?'MYXSO)=3U1?A9X-M/$-WXFAT;_A'8K*X\):_J%]#IVCZE;Z@99"-[Q(V5
MKR5/^"PFN^%?!7QF\0?$S]G^^M]7^$7[9&A_L=7MMX(\3VFMZ+)XB\0S:;#I
MGB>\O]2@TV[2RD>^:.2"TM+ADEB\L$LPS'.NS(>(HJ]ZBTWW_P`C]SZ*^(OC
M%^U[;_L[?">7XB?&W0].\&7VJ_$6T^'O@K3Y?$=I+I.NW6OW6SPSJM_J\D,7
M]CZ7/;,;G6'>VGN=.B@D$<%S(51LS]DG]M?PU^T[K7Q1\"02>&5\??"&[T"+
MQ5)X%\2?\)=X#U2P\4::-5TC5O"?B1M-TZXU&U6*5=,OHKFSMKBWUFUO;9DV
MP,::DGHKEJI!R4%).3CSV72-TM?/7^M#[PHI!G`SC.!G'3/?'MZ4M46%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%0W$C16\\J(\CQPRR+&F-\C(C,J)N^7>Y`5=W&2,\5^4
M_@/_`(*,>-/B[X'_`&F_&OPZ^`>L6C?LE_%76/`?Q/\`"_C?Q'IFF^(]0TGP
MEX7C\3^*;[PLNCIJ>EWVN1V!$NG:7=7]K:S&6-)[R)R8P&<ZB@TFF[]C]7J*
M^"O&/_!0/X)^&?V9?AA^TY!K=L_@_P",<_A;2?A^NJWEIIT-QX@\8NUKIEEK
MVH"2:UTVSTV\5X]=O86N3:);7)MX[B1%C/QSK/\`P68\&>%_#UTE_P##Z/QO
MXRT/XU_"CX+:_)\)_%EAXD^'ZZC\8I["#PEXBTKQ/JMKHUYJ6A>;>3V5^R:6
MEQ;:IIUY:;7,19I<TG;47MZ7623[.]_R/V[HKSCP/XC\8ZGH>LZEX^\-6?@V
M]TS6-7@AM+?54U:"Y\/V21RZ?K37?E6\<37<33-<0D$0&!ANK\NV_P""MOPX
MU'QIX7TGPM+X#U;PM\0_'5]\'O!-S)XT/_":V?Q/2_U+1]'NO''A&UTRY.B_
M#?5]=L8=+'B&ROK_`%>W2]BN#I$A\N*2BI5%%I:N]K6\S]BZ*_(WP;^V[^UK
MXWU+QO\`##3_`-G_`.#MC^T1\/?B58^&/$OPKO?B_P")DBMOA[J.B?VIIOQ2
MBUV7X<6T-QH&K3.$L_LD=WB"">.=H;XK;UZ=%^V_X\NOVJ=8_8P@^#$EI\:]
M,^`+_&FRUS5_$EO!\*O$$GV^'1H[32=:L;>^\40Z"^N1ZAI2ZCJGA:RU%KBS
ME<:<;4I<."=1*VCU:73K\S])**^&?@I^V]X(^)?PB^-OQ(\66O\`P@6K?LT^
M(O&OA'XY^%KF_MM0D\+>(/`VDQ:QJ9LKJ)4-WI6JV5S%=^')KF&TN;VT,3S6
M\,CLB\5X;_;DUVT\4_!>;XJ_#[3/!_PK_:?U/2=(^`?C+3/$DNI:I/JVNZ,=
M:T31OB%H]]I>FP>';_7K=T71CIU]JD<\C)&Y5LX"G.*MS22OJK_+_,_1NBOS
MA\=_MK^,UL?C'J7P1^'FA?%Z7X5ZK:^"&\%6GB6]TOXD#X@2>([;0[[_`(2+
MPT=&NI=*\$6>GWD6OQ^(;/[?=7%@C2Q6$D2R,GR'??\`!7+XF67[$OCG]KF3
MX!^%!>_"K]IS6/V>O'O@9?B'J,D'V71/$^B>$;SQ7X;UE?"H_M*5]4UCSH=.
MNK6RA6T@7?=_:':)9<TG;4AUJ2=N=77KY>7FC]VJ*_-7P%^WIXF^*?[0OQL_
M9U\"?!/69?%'P)T_X4:YXIO==U[3-/MM6\/_`!(N)&.K:`T7FF9;33$;4;2V
MO8[.6]AMIU/D,1MY3]I+_@I]\./@5XX^)'A6RNO!NLK\#+32M0^+^F:[XN'A
M[QG-9ZO93ZDNG?"S0$T_4!XO\1Z991`ZC97TNF6_VBYLH8I_G9S0>VCRQE9V
MDTEIW:5_37<_56BN,\">,]&^(7@[PUXZ\-W;7N@>+M"TGQ#HURR;#)I^KV:7
MML7C*@QRB.94D3+!2@PQ):NQ0DCGUH-4[ZCJ***`"BBH97**SC<VP,?+7&^0
MA-P1`>I/UZT`345^8/@7]OGQ]\9?%/[7/@/X4_`/4X/&G[(OC/P_X9\4Z+\0
M_$NFZ*WBFWU'1KSQ%?S^&I_#Z^([>6_FT.WBNO#]AJ$NF"ZGN[2#4Y=/#RO%
MZ!'_`,%$/@6W[(GA?]L5M1NK7X?^+?[%T_3].OY[*/4[/Q+JWB"/PU+H&IR)
M(;2&YT75WFCUN=9?+M[2TGEC#N`A&[*YFJD7%RV2WOT^X^_J*_#WQE_P6<\&
M?#CP7\3=0\0>"--\>^,/ACJGPQBU:/X,^,+3Q7X#FT7XL>(?^$=\.:S%XEU2
MST>^<:;JK6^E^)+&/3);FSU&YBBB#PN)J_7+X=^*/&OB2PUB]\:^%+?P>+?5
M-NA+;ZM#JAU;06L[2\BU.X*1HME,KSS6MU:$R;9(#Y<ISN,J5W:W]:!&K3F[
M0FI/>R/4**_'[QA_P5M^%&@>-WM--O\`P-J7@*S^)Z?!/5+F3Q<T'Q%MO'LN
MMQ>'H]<B\$0Z9>++\.X-6N;.'4M??4HK^T@FEN4TR>.'+:6A?MO?M9:GXO\`
MBG\&I_V?_@];_M`^`O$'@TZ'\.G^+WB:.S\9_#;Q+!>/=?$[2=;E^'05M`LY
M+00I"EO)<QS_`&B/4UL)!!'+0*I%WWT?]?J?K?17YMZE^W!X]\._M.?#/]CG
MQ+\%SI_QG^(OP4\6?%2S\1V_B6WNOA1+?^%8X8;O1]+UAK:#Q+>6$&IS165[
M?7?A^PNU\]9+2QND24Q^F?L_?MAZ'\6].^.FD^-M-M_AO\1_V9-=G\._&SPX
M^IP:IINARQZ!_P`)):^(=(U+;!-J'AC5-'?[7I]Y>6NGS2_9KE7@3R\F7*SM
M9_U8:J0<G'F2DNCOV3\^Z/MBBOS0TG]OR_BB^$/Q/\9>`-.\/?LU_M":]X>\
M+?"GXA0^(WNO%-IKGBB1X=!/C_P]/IMOI>BZ;KLT9CTF?2=:U5@7'VWR@,UU
MGQ,_;)\2Z)>_'6V^$W@30_BGJ7P*T>[MM=^'L/BB\T?XJZKXY,-C>Z-:Z/X2
M/AZ]2Z\%ZC87<MPWB*'4I)Y&TS5(K.SGDB1:=]+^5P=2*WNDNO0_0.BOPJG_
M`."LOQ=L_P!DK]KC]HB__9]\(P^*?V//C'J7PN\?>";?XA:C+IVLV>BV.B2Z
MOK6@ZS-X<MI3=PW>N0);:=>6T'G1Q3^9+!(D:S?2/A'_`(*#^)_B)\>?$G[.
M7@3X(:O>_$'PM\`?A=\?;JZUOQ#I>G>'M9T3XF7-JEM8Z#=Q">Z/V)!?^7/J
M=O9M<-;>7Y:.W$\Z[,CZQ1NE[2-VTEON]OO/U$HK\Q/VF?\`@I)X$^`GCWQ7
M\.-/F\%ZIXI^%_A'3_B!\2-)\7^,8?"E_+X;U"VU"[@T+P##%8ZFWB7Q]<0:
M;.]MHMTFFV+AH(A?//,L:_=?P:^*?AWXV?#'P)\6?"$\D_A?X@>&-)\3:(TN
M/.%GJME#=".X"*%6>WD,D+X.TLK$`9`%)WU1I&<9.2BU+D:3MM=ZGJ%%%%,H
M^"/VH_\`DH.E?]BAI_\`Z>->HH_:C_Y*#I7_`&*&G_\`IXUZB@#[ETW_`(\-
M._Z]8/\`TF2M*LW3?^/#3O\`KU@_])DK2H`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBFL"PP.,YR>XX/
M(]3G'!P,9YH`_$3_`(*Q3:G%^TI_P23N-#L[74-6B_;!\22:=:WD[6MK<3)\
M)O$4C6\MSADA:Y0".&:53'!(1(P;@5]=?"#]FWQ3J_[1_P`4?VNOB[X<T;PK
MX\\>?"S1O@=H/@_2-9M?$ESX;\#:!K6HZG>27?B6PBAL[N[\0ZA<1Z@T<*+_
M`&>8+:*7$R.%]H^-'['_`.SW^T'XR\!>/_B[\.;'QCXO^%]VFH^`-<NM:\1Z
M?<^$]3CG2Z74]&32-4L(;?4/-C$+WFS[3):33V[3>2WE'Z6@C\F&.(=(U"#+
M.YVKPI9Y"TCL0`6>1F=FR7=V)8RXIN^I*BE*4M;RW[?U_6^I^(_[,O[%O[7G
M[)_BSQ-\(_!>B?LX^+/V6X/&_CKXC^"_%_B"+4Y_CC!;^*/$%]XIA^'\_P!J
MTF33%OOMLPM_^$LNM3OK>!W2=K9]F![?_P`$K_V;?CO^S-\)_B_X/^._A/PU
MX9UCQK^T'\6?B]HD?ACQG!XRA.D_$SQ1>>)[:PO+B#2=,2+4='2Z-C?3KYBZ
MA=^;<K\LH-?J=124+.]W_7],A4:49*2@DUJGV/R:_;7_`&._CEXK_:&^%?[8
MO[+ME\)O$WQ=\!>"/$/PL\1?#WXW2:C%X-\5^"?$M_:WL<]IJ-CI^K?V3JFC
M7JO=R3+8BZNK6-K:WN`S8;NM5^#OQ]^)NFVGP(^-_P`(?AKK'P@\2>#=3UKX
MA^+_`(>>+K+POI3_`!"DMY[C2O#.@>"[G17UW^R--O8X/LWB>]O!>7>H.E_>
MP10PK$/TKHJQ^S7,Y7>NZTMT\O(_F]_;>MOVJO#?_!(']J[X>_M.^!/#VB7/
M@3PWX7T3X?\`C'3/B-!X_P!:\8^#[;Q[X=MM#_X3)+70]/\`*\6Z7I=MIMMK
M6HH\L>K3AK^Q97!-?<WA7]GSQY^TAXE_8W\9_%CPMX=\-^`/V6;+P_\`$CP6
MUMKT/B&_^(?C'5_AE:Z#IFL"QBABG\-VGA]-1O)%AU)GNIYI$:$E%8U]T?'S
M]G+X1?M.^!)OAA\<?!UCX]\`76K6FL7WA;4[S5+?3=2NK!IFM%U"/3+NP>[M
MXWE$GV:Y>:#S(XG,;-$C5WWP^^'_`(9^%_A'PYX"\%Z>^D>$O".CVF@^'M*.
MH:EJ(L-+LHTBM;476IW-W>3);QH(HFN+B9TC`1&1!LH)="G*2E)<TDK)OM=.
MWWK]#X(UO]G+XL_!S]I[XS_M!?`[PEHGQ%TW]IS0O`WAOXE>%]6\56OA.^\)
MZUX0M;K2+7QY976IV]Q9:O8_V/=&&_T2U\O4KF2&(0D*`1YS;_L$ZY\//@9\
M$?V;_#_@?X:_&/X3:3?_`!4\9?'GP_X[6#3W\8>,_%$5[XCT#4_"-]=6MU-X
M:UM?&-[<I'K-D\+V-K(CS@P@A?USHH+]FNFB[+I_6O\`6_XB6G_!/[XT>"_B
MC^Q/\;/"4TOB2/\`9R\3?$RW/PA\:>.K?5-5\#?#GXMZ!8Z0WAG2_B-=P21^
M+$^'=S'?R:8US'%<7MA<I;V[AD`'RW\;?^"9/[9>H>'OCWX?\%:9\+?&UK\<
MO^"BG@_]KY'F\77'A:[\*^%/`^M:=>C2KY]2LIH=7O\`6[2Q":?':-YNF.-U
MR_SKC^E^BHY/-_U;^ON[&;P]%IKD6O\`P/\`+^M+?G%^WK^R-XS_`&L/@M\,
M(_!4_A_PO\:_@Q\1?!/QE\`6_BV:XU#P7)XO\-0.+_P[XD:P@G&I:?J-O/<:
M=]NDLIK>*0K=!,@X]@_91\*?M%:5X2NM6_:2\/?!#P?XYU0Q0)X4^!MG>R^'
M]*L;8,4:_P!?U+2]*NM3U"XG+7#106J:=:K-Y=NSW"22/]>T4U'E=[_UH:*G
M",N=*SY>3_MW1_H`HHHJBPHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@!DIQ'(3G`1\X)!QM/0C
MD'T(Y!Z5_-]^PWI7Q>\5ZM_P5D^'?PR\*:'KMK\2?VU?B=X'UCQ'J?B2VT=/
M`-IXB^'6A:-?>);G398IKCQ!;VMO=R3VNBZ,T=R]U"/-90[&OZ/KB%;B">W?
M.R>&2%]K.C;949&VNC*Z'#'#(RLIY5@0#7S=\"?V0?V>_P!FG6_&_B/X*_#V
MT\#ZQ\2KX:MX\N[+6/$.H'Q/K'F22MJ^IQZQJVH0SZH[2,LNH^6M[-$L<,LS
M11HBAG.FIM-MJW8^&?CK_P`$T)M<_8[_`&<_@7\$=6\-:/\`$#]DKQ7X&^(O
MPEN_%]M?#P+K7B?P;))-J-EXJT>PCNGN=,\4K<:A$\%S;W,=G/?"ZD5C"*^?
M/VGOV3_^"@?[0WP.^#?A_P`0_"K]FW3OB%H?[1_PB^+?B70_A;XOF\,^&O#G
MA/X4^(H]?^Q-K>L^&;>Z\1>)/$$S7<*FSM8]/TJ`1`32M<R%?Z`**EQN[W[?
M@DOT_JQ'U>EUCS/JWN]OPTV,6YLFUGP]/IVI6QM6U719;*_LX9DD-LU]8M!=
M6T5PNR-S"99(HYEV(VT.-JGC\6_V6OV./VQ_V3[W4/@IX;\/?LV>-/V;/!^K
M^,_&7PZ\;ZG'?I\;;RVUO6[_`,2:5\-;@ZGH]SIUO?V>HO'!_P`)QJ6H3PPQ
MW*306\ALHUK]OJ*HN5-2:=VK6_"WEY'X]_$'X3_MBWNM?"W]JCP)\$/"FC?M
M66'BNZ\-_$CP9>_&S2X/!.L?`Z*2>=O#-QX@TWPXW]M-]GG>;PVKV4%YI/B8
M-J-RS6DI"^`>)->^)MC_`,%I['Q%X>\`:9JOC<_\$V;.[O\`P#=>+K*U3^T9
M/BGKK2Z5;^+YK6/2E^P7!S<7MW;1V%W&"T*+=%A7[_R*[#"[>C=<\M_#G`S@
M'!.&!XQ@YX^9!^QU^SPOQ\_X:B7X=62_'S[(^F'XD+K'B--8.CO:I:-HAA75
MAIK:(8T$W]D26,EA]L:2\\G[5+).P#IIVU>C3^[Y'S3\//V`=''[/O[6WPW^
M(BZ?'XM_;5\2_$+QI\5I]%RUKI5_XUT:'2-(T:UOE1/M\?A6P@M;-+M$2.Y9
M+ED.QEKC?#7[('Q8^(VG_LO_``T^//ASP]I?@_\`8R\=>#O&?A+QEH?B.WU;
M_A;FI^`O#\^B^$KZ/0(8(=1\%_8)3;:C?Q7TDLDEU"WV5C&YK]9E&U0.3@`9
M)+$X&.68DD^I))/4G-+0-PB[<R3:5E?Y?Y'Y#ZG^QS\6?'7Q4MOB?XK\&>$O
M!_Q>L_B[XDU?PY^T1\+O$T7A+Q!I7PKTKQ!:7?A+PQ\0/"EK:A/B4FM^&1>>
M';^TO91';I,9;ER"NWY>\1?\$POVA]1_9`_:E_8[T2Z\%VEG\3OVKW_:`\`_
M$S5=9>>UNM!\4>/O#WC+7-%U/0+6T74=(UKPX-&^SP3;7L-05F-LV\H:_H9H
MJ7&[;N]?^!_E^7;6/84;WY%V]=M_N/Q]_8\_9E_:<^&7[=/[5GQ[^+/@KP3I
M/@/XT^!/A%X-\.:IX;\>G7+UKKX5:==:=<:G-X?DT6WN=/L?$QO7N[2SN+V6
M?23:K',[-=L1SWB3]C#]JOX3?M;_`!?^*_[,NG_L]^+/A?\`M3^(_"?BCXK0
M?&Z+6[KQ#\./$VA:.FAZEKWAR&SL[I-?T[4=,@A2U\/B:"."\19)G6-B1^T=
M%4'L8J$87=HM-;;II]O+U\S!T#3;G2M%TW3KJ6&>XL[*TMI9;:UALK>22&()
M*\%G;XAMHFDW>5;P@110^6J@-OK<0$#D=Z=10;+1)=@HHHH`*0L!U/0@?B0,
M?H:6HI(A*"K?==61QE@2C`JRC##!(/WA@CM0!_/I^RCJ/Q<M/VU?^"PNG_";
MP;H/B[4->^/GPDT2XEUKQ+:^&X_#CZK\*?L9\1W"WL,R:O8Z?#<I=/HMCB]O
M?)*0MYEPM?17Q$_X)<6>J?\`!/[P%^R-X!\1:5I7C7X3^(?#WQ,\&>*=6MKG
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M:/:?VKIEO?+J`L+][2)+NR345AMUOA;R*\*WGE1BXPLH`#9'545,8\O7^OZO
M]X0I4Z;O"*3VNNW]:GXA_L__`+$W[6O[+/Q(\9_#/X<:7^SIXJ_99\2_$;Q7
M\5]-\9>++34;CXS>'9/%.J'5M1\#V-E<:9-I6HWTUZK26&NZM<G2M-C:#Y)'
MAV'O/BQ\(_VO_&UKX._:2\+?`_P?X4_:Z\`_$(Z1H'AR3XT:8?`]Y\%;@1C6
M]!\0^(+3PYB^TG7H=Y?1/L1O;36;>SU59O(AV5^P%-<%E(&.2,YZ$9&0<@YR
M,\8Y]JH%32;=V[V[?Y'\_/QS\1?%$?\`!7;]B3Q+#\/-,B^)"_L-_'B]U?X;
M2>++2:UBU=/%&GRW&@6OC'[!!9R$7:01PZDT"V<\#/.L2,[[ON_X-_L6Q+H?
M[77B'XMV&D6_CC]MK4;BY^)6EZ%=G4[3PWH`\&KX,T?PK%JH2&/56TBQ:ZDF
MNX$2WEGF;R?E->Z^(OV-_P!GSQ9\>=!_::\1?#ZSU+XX^%;6VL?#7Q`DUGQ'
M%J^B6,,<D4FG6,=MJL%A%IMR)7EO+$6GV:_G$<EY%(8H]OT]`C1QJKDLW\1W
ML^3W(+8(R><`!1G``%2X7=VW_5@5*FI.3BI2?66O1+RZ+\6?CMX:_8=^+'BO
MX0_`C]D?XP>'_#7_``IK]F?QG\._%F@_$C3?$L-_=_$W3OAIJ,U_X8T"X\)&
MWCU+P]>0M]B_M/4KB9HI19+'9J=P-;OQ1_8[^)_Q8^*GB'Q]XH\#^&=)\=P_
M%"YG^#?[0/PY\46WA'XE?#/X=:-INF3:+)XQAM[.-?B+;7FIG4[`>&;R>2Y%
MI-(UU*8&Y_7*BG;2WE8;IQ>CU3W3V?E_7WGX!>,_^":/[0-_\"O^"EO[-_AZ
MZ\(2Z9^V!\2-4^+G@#XE:CK0MX;35O%ZZ)%K_AO6_#4%N]_8OI4VCF]LK]))
M;&YANI8`!*$KU_\`9A_91_:C^&?[?_C'X\?$CP?X&/PSOOV5_A+^SK8>)/#G
MC9;^^U+4?A<UQ._B>+PM=6<6H:=INK[TBBTVXG>X@F'FD\YK]GJ*GD\V9_5J
M-XOD7NM->J74_&?XO?L9?M/^!/VQO'O[3?[*&F?`'Q?IW[1&B^"O#WQB\/?M
M`2>('D\(:CX(CNK72?&?A*32]*UAKE38WLL-SHMD;%IYHDD>1&82+^MG@S1]
M0T'PYHFDZI+83ZA8:?!!?RZ1I\6E:2]YY:-<_P!G6$*HEM9K,72VC5%'DA3(
M/.W5UE%5%<OF:QA&#DXJW,[M+;16T"BBBF4?!'[4?_)0=*_[%#3_`/T\:]11
M^U'_`,E!TK_L4-/_`/3QKU%`'W+IO_'AIW_7K!_Z3)6E6;IO_'AIW_7K!_Z3
M)6E0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`-<D*Q4`D#C.<9[9QS5,W,@/"I@+\Q+8`?'0=<X]LDYZ59G
M8K%(WHN?R_!ORQSTXZC^7]?V^/C]^U/X^_X*@^(/AG\1]=^%6A_\$]$OX/A-
MX>T[3K:*Q\9^(O"]EXNMO$]W\1;*_@GGU[1[_5O#,\6G65LVFK:PRB99[ED4
MC@QN98;`\D:TE&<W>*>EXI.^]ET[WNTEJSZCASA+,>)UBZN$JTL/A,KJ8#Z[
MB*B;_>YEBHX++\,HQ3E;$XF7)*27N0C*3:2U_IZ%P<'<%5EP#N8X)(YVD`Y/
MIP,^V*:MR[=D^]T)(.P'!/0Y(ZX&"?2OYL_B1_P68\6W7_!*W]F7]JCP0/#^
MD?&W]H[XD^`?@E=63QM/8^'/&-SJ@TCXFZIH]F6WW3:(EM<WFF6<KLL<EU$9
M&D$6&^B?A-^UE\0/@A_P4CO/V"O'7C76OB;X2\7_`+-L7QS\$>*/%]U:W7C@
M>.TO[R?7/#/VR&WL+:[T>[TR*^NM'LQ`UQIOV)+9II+>,.TO-<"ZE)*LE&<8
MW73WK6O?6[L[VO:ZZMGKS\,N*,/A,5B<2L/3K4*F>1H85N5\2L@Q.%P^;I25
MTOJ+Q=-QNX.HHR:O;7]Q4NE;:.C')P>".`<,,G#'/W06/'.#P%$Y"@DJQ8G&
MW)X'&>`#P>O''2OXPO%?_!6+]KO4/@[\>?V\-(UKQ=H=S\%?VZ_"G[,GAO\`
M9D-M9'PS?_#K6EO1J&G>)-#$#7E[\2)+JTCM+#6;74ECMYI$3[*Z,RC^G[PI
M\5]0^(NN>`_$,][+\.O".A>#/#?B_P`;66M75A83GQ=XUT&VO=-\!:E<73FT
MSHMMJ%S-JR6UW%=QZI!IT`2:!YMDX#-\+CE:G?F;M&^SLVM.NMK]'9/IHEQ%
MX=Y[PM3PU?,9X6=&I5S'!8GV3E*>&S++(9?.KA=K24UF6'49KFBY-K1+7['!
M.,^V?8_3K5.6Y=257R@01R2S';M!.5"Y#$Y`'(Z<YXJ2WD26+S(W1XY.8V0A
ME964,"""RL6W9W(Q1N-O%?S*_P#!P?\`&#]HO]E;2/V>?BS\`?VFOC%\+KGX
MK_''P]\)_%/ACP[XAT^/PC;^'GT2\OI[_3M-OM(G_L_69KB!#<7S7GD>4&+!
M=Y%:9EC?J&"JXOV56LJ7*W&BDY6<DKNZ:4>]^YXW!_#&(XQX@P7#V%Q^$R[&
M8ZI4AAJN/I8JKA95(4I5?955A*->M%SA"?(^51]HE%R5S^FG[3RJ_)NRH(Y.
M00"2O0]_[N!FE,Y&3E6&X#:"`V._WV09QCN>2./3\$O@SX>^.OC;]H7P+XH_
M9_\`VM_VA_B=\.O@+\;+#X9?M0^$/B=XZ\*>)/!WB[1]<^$UKXO/B+PQ?6NG
M+=W<OAKQ!J^DZ9J.EV\MK</?Q7UN%>*("OF/]KS]O+]HKXT_\%2K?_@FM\$/
M'WCSX!:+;?#G6[JV^(GA_P`(7,FMW?Q;339M2\,ZSJ#R6.IW%Y\*;:58[36[
MVVM(+&Y!ENO.6.UC)Y99S0I1P]6K2K4XXW$T\'1C4LOWKHQJ.4>G*W+EO?>+
M\K_1X3PUS+'YABL!@,RP6*659+F&?9[4=#&X>KE."R^,:M3VU+%8:A4E*I"I
M3G1482YJ<X)R4N:W]1+7!&/D^\<*1\W4<`@$'.>N/EQGYN#31<N<_)CJ!E6`
M^4X8YR>![#J.,U_(3K7[=_[9_P`??VZ/BE^PKX<^.?CSX1:U^SM\#X]3A^(7
M@[X6ZK/)XT^,?@+_`(1+4/%?B7QIX6GT^[U"Z^&WB/3Y/$-GH.F>7:C6)]1\
M.7,$D1OXE7]7?^"0G[3&K?'[X3_'#7_%G[6,/[4%YX3^,&L077B27X8:E\*%
M\!:9=6T5[:>$KS3-;6.XF&GPPS^82)%M(F%L]QN166<)GF'QN*CAZ"U4IPDV
MU=RIS<9^ZY7TY7HEMKV-.(?"[-^'LD_MG%X[`5U]5R3&K"81XZ>(6'X@M++I
M3<<(Z2=2E*$[>TUORK5'[1!SU(.,9R!_GBC?Z`__`%N]?!&A_P#!1_\`94\0
M?$KPM\,-,^(-R^J^/-3U30O`/B6;0-8M_A_XY\0Z+)>1ZKX>\*^.I[*+PSK.
MM6,EA<K+I]CJ<TY9&55)&!)XY_X*1?LG?#N]T9?%/Q%>V\-:SXUNOAS'\1K;
M1=3O_AAI_CJTO+C3Y_"FM^/K6U?P_I.MQ7UM<60L;F\#F>-T))1B/0>.PL/>
ME5]U.SNTE?W4^OXWMKYH^.?#7$4:L:,LEQRK32<*7L9\TE>UDN6]V[KEMS)I
MKENK'WCYG/5?ISN^F.GUY-.5F.00`1^''KWKQ/XK?'_X4_!?P9:?$#XA>+-.
MT3PWJEWI>F:+.&-Y=^(M8UIDCT?1O#MC:":ZUG5=4D=4L;*QBGDN=P\L#!KX
M'\=?\%E?V)?ASX-UOQWXJ\8>.M*T?PGXLG\&^/K*7X7>-W\0_#O7XT'V6P\>
M^'O['75/"<>KM(C:#>:K;QV^M*`;)Y$DB9]*N,PE%J-6M&FY14TY=M';I;1]
M5>U]MQ9=PUQ!FTE#*\HQN-_>2I2E&FY<E2*<G!)+6W*XOSLNNOZR!B3C'?OP
M<?X_YQ3Z^)M._;H^#>I7_P``+2PT_P"*=X?VF-/@UCX82Q?"SQ@UH^FS1K/Y
MOB:\_L];3PFT=HQU0KKDMLPTI6N"IXS]J1L6_BW8R&P,`,,'`'7(#?-SUIT:
M]'$1<J%15(Q?*Y+O9/\`)GGXG`X[`^S6.PM7"SJ^TY:=56;]C5E1FUULJD)1
M?:2:Z,EHHHK8Y0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`*B9V5P/EVG/!/S''H,<^_I[U+7YK_`/!5[]LO
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MW)O$B$S2QWY<K&OZ>_\`!2G]K?7OV1OV1?CA\5_`^B?\)3\1O!G@#5_$&@:8
M62.TL(UGM]*_X2/569@5T_3KV_C:.")O.O)4\N/*I**X89K0EA<;66OU*--U
M&^^(@JE.UGK:+VNO/N>_C>!,YP^8Y#EU*='$QXBJ0AE>*I-J%>7]I5,IKTY.
M2T=#&TI0ORW<;25[V7Z&>?)C=M7;C)&['&?O*S!0PP1PQ0]<^M*L[,FXA1[Y
M&._97?KQMPQR#GCH/Y6_'?\`P5"_:5^#G_!$O]EO]I2VO-0\:_'7X\ZCI?A'
M6OB;J.G6]S8^#W\0^)]7@N?$6J6T(M8(UM-.@;3M(X2.&^^RRRQSLK(_T-^Q
MW^VQ\9?`W[>W[2W[%OQ,USQG\7OA7\+/@OX,^,6A_%;Q0+/4/$OAZ_U_PAX>
M\1ZIX6\3ZO:P:?;WXU'4M<>V\)6HLTODB0:?MF$2,8CG>&]O0P[C>=:G2DGT
MO4A&<;J]E?5NU]%YL]G%>%G$.&R_.,?.KA(_V+BLUPKH3FU4Q,LFS##97C'9
M1:36(Q4'&+<7.*;6R3_HA\UN.%Y)[GI^(Z@9SZ\<CI1+*RJ2J@G&1GIG:6R>
MAQ]`3[&O$?@UK.IW.D.?%_B2UN_&7B6]N/&,OAJ2^MC>^&M&U<P+I6D0Z:#%
M?06EG9Q(97N;<LM[/.KRML`'JGBG2Y=;T#5]'@U34]#EU;3[S3EUK1;E;35]
M*:[MY(%U#3+ETE6&_LR_GVLACD"31H61U!4^RO1.UW:^^E[>7_!U/SJK0GA\
M3[&O+D2G&,Y<DYJ-I*,Y*-.,YSBM7[D9MJ_*FVB^NH+M4,0)')5!A@'8#/RY
M`(&3CE1S4K7+#:!Y88L`5+$,,]MI7D@<D`CH>:_BX^&G[4'QGT?]LK_@H[\-
M/CK^VW^U3<_!O]DBVLE^'&E^&_'GA'2_'.OW=[XLTK1X--CU*\T2T;7=3E&I
MLMO'''Y<:JS2.-N3^Y'PY\1?M(_L-_LE_MC?$K]I'Q]\1/VBY/AOXJ^(7Q`^
M"?B'6(K+Q-XSUOX6P>!/#]_X2L-7T[0+6Q^Q1Z7XH;6[36)KGS)8-+M7U2:8
M0,L<?BX?.88B&*J>R]G'"3FI[ROR2M9:JR=GW:L]MG^C\0^&..X>GA,/_;>`
MS#,L='+%@\)3PF98>EC:N;/"U:"PM7%X3#TY_5Z&.HNNE5YD^7E4K3M^P!N3
MA@NPLHYY'/'/!<;><?>[9X/=INV&TD#:1S@9.[C."#T!('3!'(K^/']FC_@H
M=^V;XC_8D^)/_!4G7_B]XJ\0Z+X+\/\`QD\,^-O@#=_#Z]O_``%=>.+;59!\
M)/$7@&_M--B_L_PSX=L)HH?B%KLE_>6D4]NYDM05<-YCX>_;E_:QO/V:/V?O
MVO\`XA?\%#O&OP$\.?'N\T;1?$6C>+_@!K?CCPU%\1_"'CF>XURP\#:MHFGB
M'P]X1\6>#[RUTZRM;AKZ+4[W2KI;2\LY3-)!S_ZR8-^QC&+YJRYH7LO=4HQ<
MK\UOBT[K73>_MR\$,]C+,8O-\J<<MS)Y-**>-E7Q&?4J'UFME=&-#"U-(4ES
M<\TDW9)ZNW]L23,P8D`8QP.N2,^O/\_I4F]N.."N??.#QZ=1ZU\S>._VD_A?
M\&_`_A7Q;\1?&$5O%XM.DZ;X5M;:PN[GQ%XYUO4M.AN+;3?"WA>PM[G5]8UG
M40#+!I5I;R7&9E0?((W?S?X>_P#!07]EKXE>`K_XB:%\2[.QTO1?'%M\,-9T
MKQ'9W?AWQ9I'Q*O;B&UTWP'J7A75HK36(/%.HSW$*V>D"%KFX\R,Q*P<$>Y]
M:PZ=I3C%J*;5_A]V+VOKH[Z/57]3\GIY'G5:C5KX?+,95HT<9+"NK&G4<95(
M3=*I%.=.,K*K&5-7BKR22W1]P;S@$[5/HV<?@0#[_E09"!D`'CCT+8[?7L.M
M?(?P-_;6^!/[0_C7QU\,O`/B:]MOB7\-IK;_`(3'X>^+]!U3PGXRT:VNP&M-
M2ET#6K:"\N-(OER;74;,3V[YYD5N!RWQL_X*$?LO_`;Q+J?A;Q[X\OEO?#%[
MHUEXZOO#V@:KXDT?X;-K[1G2+OXBZIHUK>6G@^PO4D647>LM;0I`7E=XT7-2
M\9A(THUI58J$YN"=[V:W]++>[=K7:-WP[GWUR>7T\HQM3'QIQK2POLY7C2ER
MR4[)7M--*,KN,KJS;:3^W_/D`!*#[H/?.22/0=!5A&8CD#\,_AUZ_ISFOS7\
M!?\`!4W]E+XC_M%K^RWX3UWQ[J7Q=FTVXUF#1I/AGXP@L)?#UO;374?B:+6Y
M],BTR?P[?1(#IFMPS/8:AY]LML[L6-?2WP#_`&F/`7[1\'C6]^'UCX[TZU\!
M>++OP9K7_"<>!=>\%RR:W8`F\_LQ->M[9M6L875H3>6*RQ"4%`S?+DI8S"8B
M3A0JPG42<G&+;T7+?T:OMO9[!C>'<\RU<V99=BL#'V-/&7KP<(_5\4W]66UV
MI>SJ*+V?*T?2@SSG'MC/ZTM0ABR*^<\@CCU`([`_F`?I4U;GCIW2:ZD;N4YQ
MD8/`^\3V`SQS[D?ER*B7;,Y1HRG<;@,E>Y)#E5VG@_,<XS@=O"?VI[+XMZO\
M"/B7H'P)U5?#WQ>\2^$M6\-_#WQ,[21Q^%?%6N0C3='\37$L5CJ++;Z%=W$>
MHR@VEPK"W`:)U+*?YT?!7[#W_!<KX=_%[X&3_&C_`(*@6/C/P'K7Q'\-P>-/
M"7@Z?4F\1:AX:LYSJ'B!+'^UOAY:6;VRP0"&[=ID*P7#,DD>%(\[%YA5PU:E
M1IY?B,33G_'Q%.W+AUI9J[7,[.[M>W5:'V?#W"N7YYEN9X_&<6Y!D6(P/O83
M*\RGCUF&:V@I-8*.&PU;#Z.\?]IJT4Y*R=G=_P!4J799BNT#'&XD%=V2-O#D
M@G@@>AR<=*<URR-ADSG[@7'S8`+'<6"J,D8R2?:OPR_X*8>#OV_-!^%OQC_:
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MRCO_``YX2EBCM]#B_LS,.HHUQ!&E_J3RPS"/4+J:*.XD@1`.G!YAA\=!.C=-
M7;OUM:]M=KOYWNK:GE9_P?F7#M6BL74H5L/C<NR_-,OK4')RKX;'1K-J4913
MBZ$J$XR35T[*[YHM_09D8`G"Y"D@$[1D`D`MS@9P"<'`YP:JK=R,Y4",A<D\
MG!!SLVL`0<XQCU[G/#=0MC>:9>V:W%Q:M>65S;_:[28V]W;>?"\0N;:X"L8+
MB'>)8)@A\N15D"DC!_C3N?VD_C?\.?\`@IA^VO\`L_?%G]N']J?_`(9T_9F^
M"NL?%/0[73?B#X:TOQGK-_IVE>%-5_L2#6;G1;.+4;O4I]0O+32K0+^[>[03
M.(E0+CF69++OJLI4*U:->NJ3=))J-U]JZ?G973?W&_!W!>)XS>=0P6983!UL
MFRZ695J&)P^/K5,5AH5(4)QP7U/"XA/$QJXBA:%5Q33T35VO[,4NBP?E/EQD
M\X5LG*D]L8]/Z9D\\AMF`2=N#D!<D$G."7]AA`,YYQC/Y%?LR']HG]F'X7?M
M6_%'X]_%?XH?M!_"Z"+0_BW^S]?>*VTSQ3\08_A_?_#NVUV^\(WFE>'+2TF?
M4=(U^5X;IV\U[^V:.\BN!!'M3\;?V,O^"AO[8GQ[^`?Q=_X*3:Y\6?%\/A'X
M%ZA\8=.^('[.T'@2\U/P+XM\.S:);:E\)O\`A"IM-L&%EK'AB]BN4^(6NS:L
M8;'2W%Y=0AY(EK&>=X:A4I4JT*D*E?#8C&QA4LI0HT*C@XM:7^'F6_NR74]7
M`>&F:9G2S;&9?F.7XO*<KQ>19;_:,(XFE"MFG$"I1P>`Y*]&G5A5IU:GL*[J
M4X*->$[-PLS^P0W+#=\A&TCMNZ\#H1R6XQCKC('.'1S2.V-F``<G!'S9Z`9/
M3OS_`/6_B)\)_M]_M?\`Q"_8\\-?MN^,OV__`!C^SCH/Q$\4Z]\-O%MCJWP'
MUWQ_\.]%\7Z)XJ34?#MW\.Y=*TQ3H.C:IX6G?1-3FO)9[?4]<T^YL69)!+(/
MZU[W]HWX9_#3X)?#GXJ_$3XCV3:#XR\.>!5T3Q%<6,EA?>.M8\5:182Z.VA^
M'%274)-7\137B7%MH4$,EXC3+;",O#)EX#.*&82J2IVA2ITU4=Y)OEDDU)IN
MZ].[LGHT9<6>&N<\+5L'AIU\-FF+Q>:YAD\:&6QQ\VL;E<82Q--^TPL(2;<K
M:2U2;NE8^IM^.H(_"DW]>@'8G...N?\`/IFOAOP#_P`%#/V6O'_A'QSXPL_B
M0GAFR^&7B/3_``G\0-)\?Z;J7@?Q+X2\1ZTZIH6CZSX>\065EJ]K=ZW+(L6C
MQ&S+:DRNMKYC*<]+\)OVW_V?_C%\5_%OP-\.>)-5TKXM>#+.+5=8^'_C;P[J
MW@OQ5-H5P0(?$.E:3KUK97&KZ'(2`NH6221?,A)^<9[HXS#<\(^TUJ-**[M]
M%YZ.R5[ZZ=OE)\/YY35=U<JQL%AH2JXA^RE^ZI0Y.:HW:W+'VD+R^"TDVTI)
MGU\')'&TG_9R1^/Z=J=N/?&/U_+/K^E?%/QY_;V_9N_9TU35]!^(7C#4I-6\
M+Z=9:WXVL_!_AK6O&4W@'P_J4WV:S\1>.4\/V5\/"NAR2;V74]7:VMO*BFG=
MHX8Y&7R#P]_P5>_9&\4?M`^%?V9]!\3^,=6^*/CJ&&Z\&6VG_#OQ=<^'?$NA
MW%F+Z/Q=HOBQ=+71-2\*-;!Y!K]K</IZF.6%W$@&2ICL%2G*$\1"$H-)\SWN
MEMW:>EEW]#3#<+\18S"5,;A<FQU;!T:$\2\1&FVG2I6YY2TLHJZ;EHN5W6A^
MFRDG/3'&.>??([4ZOFOX(?M-_#WX^>)/BEX:\#VGCNTU#X2^((?#'BI_%_@+
MQ'X1L&U>47K^5HM[KME9PZY"D5D9II]-:6*&.XLY)'`O+?=])C_/3],=OUK>
MG5IU81J4I*<);26SZ.WS/*Q.%Q&#JNAB:4Z-91IU)4ZBM*,:U.-6%UIO"<6O
M)GP3^U'_`,E!TK_L4-/_`/3QKU%'[4?_`"4'2O\`L4-/_P#3QKU%68'W+IO_
M`!X:=_UZP?\`I,E:59NG?+96"MPRVL&Y3G(_T9/:M#<OK_/_``H`=13=R^O\
M_P#"C<OK_/\`PH`=13=R^O\`/_"C<OK_`#_PH`=13=R^O\_\*-R^O\_\*`'4
M4W<OK_/_``HW+Z_S_P`*`'44W<OK_/\`PHW+Z_S_`,*`'44W<OK_`#_PHW+Z
M_P`_\*`'44W<OK_/_"C<OK_/_"@!U%-W+Z_S_P`*-R^O\_\`"@!U%-W+Z_S_
M`,*-R^O\_P#"@!U%-W+Z_P`_\*-R^O\`/_"@!U%-W+Z_S_PHW+Z_S_PH`=13
M=R^O\_\`"C<OK_/_``H`=13=R^O\_P#"C<OK_/\`PH`ANFVV\IVAOE'RGH<D
M#!R"._H:_FP_;*^"_P`&+/QK^TEJ/[$NK_$/Q+^TY^V-X6\0_"SXC_"_X7-I
MFK_#'Q#J]PZ^'[OQK\2M7U*UN=)\$CP69[F2_ETK4H]3G$]Q;V^ERR3O+%_2
ME(<HP4_,1\N<CGL<[3C!YZ'Z&N/T3P5X9\.-=MH/A[0M$>]NY[ZZDTG3;/3Y
M+R\NI3/=7=TUG;VYEN+B5Y'FF<M)*[%W)8DURXS`T<PH^QK-149J:DTFW;9*
M[5FM?*S>CV/IN%N)*O#&,KXRG4Q=1U_J4%@*<E'`8I83$_7'#-%RR<\/[:GA
MIP4;2YZ;M*.C/Y9O^"@W_!,'4O@Q_P`$P_V'/AW\.-`N_%WBG]C[XS?"KQIX
MZF\,V,TIUH:_J.EQ_%CQF^FVD;37D2W<)N;B2=!.MK'Y\YR&-?0'A;X,Q_M)
M_P#!=#P=^U'X3/\`PD_P?^!G[)%A!%X^T2X^V>%[GXD:S<ZCX?B\+IJ5L9+&
MZU/3]*U359K_`$\3&>SV,EPD;HP']'5Q90W-L]I/%;SVTD;))#,@D256!5H7
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ML2P^'U]?0)J!DLX#8A+F-$;^J::RMKH1B[M[>Y$$L5S`L\23)#=0',-Q"LD;
M>5-$<F.5"KH?N$9-8'B;P;X;\::<=)\7>']!\3Z7Y\5T-.\0:58ZS8FY@??!
M(;+4;2YM-T!YCE,)E!&Y61L&JQF51QE&$*+6%:DNEOM)^\EI*]DG>S6YY?#W
M'F.R>NJV8>VSBG'!XC`N6(G*>(I0JTU&-7"\W,H3A)+WK/F6C^&/+^-G_!!G
M6OVJ]9_8DM9OVG!K,Z0>.O%-M\(K[Q7+J<GC*X^&,-TRZ.==;5(XKMK>"426
M_A]Y`S/H<5BQ(!%?G;_P=)^,OA[<_"W]D+P#+XF\-77B;2_VJ/#WB#Q3X4?4
MK";5;#PI<>$];@N-1UC2?,-W!H]UOCMY+R9(X0K+ASN%?U?VUC%90QVUI!;V
M]M#&+>&"!!%#!;QKMBCAA1%1%0!0%50%``'%<'XG^#_PO\9ZJVM^*_AI\/?$
MVKR00VLNK^(O"&@ZUJ<EI#N\NT>]U'3+FY>U3S)1';M,84W,PCR[4\;EM6MD
MTLMA.E4FXP7/.ZC)1G%N]FWS::+16U[WZ\DX\PV6>)+X]Q632C0CB\1C8Y3D
MV(HX7FG4C6H4[UJU"K%2M556<8P3<N:5[7B?D[^R=XP_8V_9)N/&/AWX-_&3
MX/ZY<_M/_&3PIXG\!?!KX=ZIHAN-#US4_!WA_1/$FEV>GZ+=7.Z!KW0M7\2R
M2S6=G';B4V'F$[2WYAOXZ\&)_P`'3=C?R>)-'@MU_9WU'P<\CZI:K!'XK?P/
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MJ3W\"2-):+I]T\BJMO(4\9_X(P:?XO\`BG^P)_P5J^&/P-\6:=8_&3Q;X_\`
M'EYX)%I>PW&I/!J.C7T6GZE;VAWN^G:L$N;"RO8HVAFNB41]X./[#8/@9\(8
M=2GUE/A;\-X-7N?M_P!IU6W\&>'XM2NSJD4\&IO<WJ:8EQ*^IPW=W!?EY7:\
MBNKE;IYQ.ZUJ>#_A1\.?`-Q=WG@GP!X(\(7E]!#:7MWX9\,:-H5S>VENS&"W
MN[C3-/MIKB*W+N\,$SR01NS&..,MN'%2X?E2K492JJ=*G/,YVC=2OFU.%.HF
MV]?8N,I)V>C5SZ'&^,.$KY77PE#):]/'3R[@7`4,35K1KQHK@2I[7"RD^5.:
MQ<N5-;*,5%;6?X:?\$<O$/[/^M_L#?LQ_!SXKZ+X4UKX[?L[ZIXJTCQ%X(\4
M^&K/5_B#\/\`XD'Q9XN>\OH=(U&RO=;TN[N=-UCS_P"W84MUFM9U_>JFT+^&
M_P"WYXOTWXO?\$U?VUO#_P`!O@AJWP.^#'P0_;@T6"T^'G]G:G-K>M7K:OKE
MQXO^)_B&35VNET'1+W59X%T_3-)FCLK+[8OGQB62,#^Z:Q^'_@O1]:O_`!/H
MOA#PGIGB75FW:GKUCX>TJRUJ_9QME>]U>ULX]1NV=`%8W-S+E0%.0,4ES\/O
M!=[8:SI%[X1\*W.D^(96GU[3I_#^DRV6MS.0[2ZM:26+V^H3-,J2M+>).Q:-
M6(+@,-\3D<\3@L/@774:5+">SYM5+VBE!IO=W=E=;-)KU\W*O%+!95Q/CN)/
M[!Q>+GCLZP^;T<)B<T]IA\+B8YG+,\=*5#V483I8F4Y0HW7/3=FG=N_\N'_!
M1+PY\2C\.?\`@BY^T/;7]W??LT_!?Q!\"?$'QF^QP3:CIWAR>?1_#26?COQ%
M)8I*W]BZ7:)J>G3SR,+2SGN4N)R""1^VWQ3^!W[+/[9?P3_:"\#>$M&^'>M0
M?M"^"(%\9>.O".C:4TGB?4'TU%\':QJOBBPM$&O:AHUQ;Z?<V/VG4+F>PC2+
M_5QA4K[CN?!^@7.@#PM/HFAW/AL62Z;_`&!<:7:2Z(;!4:-;0Z5);M8_9UB(
MC%OY/D;/E$:C`'Q9^U-^SA^T9XJTCX-VG[&?QD\'_LU#X=_$C1O$_B[PPGA)
M(_"/Q!\(VCM%J/A/48O#UI;W5I9RV<LSPVEM`+6XO5MGO',=N`VO]F>P>-E.
M+Q:S&G"$HQ5Y4I4HJ";YFN6+C?9ZN^KN[^6^,GG,N'<+"I0R#$Y!BLTE@<WE
M.<(U:-?-JF=X>69*G"I*=6EBIJE1:3@X)7C%*Z^(?^"(VD_':[^#+^'?VBM+
MU.U\2?LJ>(/&?[,_A"^UC4;J^O/$>E^&=962;Q-?+<QJ)+W[&\&FV&I(2+C2
MB(U(45^\5>>?#_P-:>!=#ATJ"=KFXENKS5-7U!P!<:IJ^HW37E]?7+JBM+++
M*WEAI,N($2,L<9KT'<OK_/\`PKT<!AEA,+3HQT44M&M5HM'Z6M\NUCY+BS/8
M\2<09CG%.@\+1QE15J>'Z4I55[6NE;1.>)J5JK7>=M6.HINY?7^?^%&Y?7^?
M^%=A\Z.HINY?7^?^%&Y?7^?^%`#J*;N7U_G_`(4;E]?Y_P"%`#J*;N7U_G_A
M1N7U_G_A0`ZBF[E]?Y_X4;E]?Y_X4`.HINY?7^?^%&Y?7^?^%`#J*;N7U_G_
M`(4;E]?Y_P"%`#J*;N7U_G_A1N7U_G_A0`ZBF[E]?Y_X4;E]?Y_X4`.HINY?
M7^?^%&Y?7^?^%`#J*;N7U_G_`(4;E]?Y_P"%`#J*;N7U_G_A1N7U_G_A0`ZB
MF[E]?Y_X4;E]?Y_X4`.HINY?7^?^%&Y?7^?^%`#J^5_VP?`'[/OQ6^!'C[X9
M?M.3Z);?"/QYI_\`PC.O_P!N:F-'65]2`%DFFWSLDL>K&YA5M-%D3<-<(%C4
ML>?J;<OK_/\`PKF?$?A3P[XMMXK+Q)HNCZ[80W=MJ$5IK.FV>J6T>H61#V5[
M';WUK/%'=VLF7@ND`GA8*T3J0-LSBITZE.6U2#@]+JSM>ZNK_P!=3JP.(GA,
M9AL52KU\)4PU:%:GBL,^7$T)4Y*2G0E;2H[.*>EE)G\TWP._8FD_:-_;`_90
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MDE3!+`9;CE)RPWU3'0S&M5PU6C"FL-BL=BHSQ-;%QCRJO)+V+C&S_![_`((L
M_!Z#X^_\$=O@9\,_VGO`7P\\:^`=;T[5H?!OA^2TDUFUO/`MIK$EQX7UCQ%;
MZK;F+3/'%EK":K=>?IX9]+FMM/NK*Y6X`*_5$G[+G@;X52>-?A_^S=X56;Q<
MGAN\\>>.O%/C36]5\4>(?'/B_2=.N4^#_A#Q?XSURZU77]8T2VU2"WG32KJ[
M<:1I&F:-%:0+;)#`GZ=:'H&C>&]*M=%T'2M*T32;"/RK#2M%L+;2]+LH]S/Y
M5I864$%M;1%G=RD4:KO=FQDG,R:9;127$T,,$4UXRO=2QQ(LL[1($@,LRJLD
MK0@$1L[,R+A495``[*.5X:GA,/3J*5>=*G3A*<XQ52=E%:M6DN5>[VTU/G\V
MXWS+,L[SW,Z=\-A,[SS%9]6R-5)RRJM6Q-=UW1Q*?+&;3:4ZG)%U)1<W;2W\
M'WPNU?\`:^M/A_\`LPZIX5N=<O/^"F=[_P`%#O'FD?%J#6M2UN7QOJ'PC!M#
M9:%X_N'G.K3?`JU^]I"ZMOT.UM_,;3+8W"F%O[KYM2CT;0Y-8\37=CI=IIFE
MRZIK^HW$Z0:?IL5G:B>^NY;J=D2&UMHX[B66:4JB6\>]R`#5"W\`^$;;Q+<>
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MW5Y:07%S'%IS6\\MCJ`VQR;WCEV;1_3O^TE^U+\$_BE^Q1^W./A]\0/"?BKP
M=\./V<_B9X/U/QOI^KV4GAV?QQJ_PV\0PV_AVVU59FM9KT--I*".*20RW>H1
MQ1^8S9K[P/[./P"9%BD^!WP=>-0%1&^&W@UA$@=V'EYT+"D>8_RA,#<_S-O8
MUT%K\'/A9I_AW4?!UA\-OA]9^$=9F$^L>%K3P=H%OX=U.41PHDU_HD>G+IM[
M<1^1$8IKJWE>(1QK&56-`.+"Y16PCQ5)5$Z>,^L3G.*VE4HU(QB]OM3M=V=K
M+LE]'Q/XD9;Q+C<EQ]3+\]C_`&#/(GEF!K9QA7A,)#*HY32Q3BZ6$IU/:XNC
ME<8QBI>S4JLIN/,V?QT?L:>-O!VG_P#!K9^TQI%UXJT.'5[+1_CQX9N[&?4+
M6.]M->U_Q"EWH.D3VSR+/%J&LV]Q%+IELT8EODF1K8.,X^._VKO'7A2]_P"#
M?/\`X)L^&K+Q+H=UXAT_XT00WVEPZA:3ZA`^F:AXK?4DGLXY'N8CIZ:A927>
M^("WCGMY&VI(A/\`>C;_``3^%-MHUWX:@^&7PXA\.:C=V^H:CH<7@OP\FCW^
MHV:E;&_O=*734L;J\M-["WNI8C<6ZG;')GYJKR?`/X+RZ=;Z3-\)?AA/I=E-
M<W-AI<_@3PS-IUE<WB11WMQ;6;Z2+:WN+Z*&&*\G@ACDN8;>VBG,BP+GF_U?
MG*EA:;G&RR>EEE1O>'O>UG-I/=27+9,^DP?C7@L/FN*S-9#CHSJ^)&*X^HQ>
M;)Q@JV65<MHX&7[G5THUI3E4:YI<O*K(_G"_X*(CQ1I7[8?_``1O_:NO/$*W
MG['GPVN?#%MXXU^P1K_PKX1\3ZW87%I;>-]<OK67[-:Z->V%]I-A#J4F^WMI
M=)EFE,>P;OI__@J)\2_V2/A'^S(?C-X4_9P\,?'K6KG]H#X<>-O#,W@+2)+#
M1Y_C+<W%DWAOXD>)?$WA2&VNM6ETY;2R$M]%/<W5R[0:?+(D3<?N5<>`O"-W
MX>7PC=^%O#%SX32TCT]/"D^@Z7/X;33X]N+)=&DLVTP6BA0%MA9B``X$74E8
M?`7@^WT:#PW!X4\,1>&K9D>#PZF@Z4FB120LCV[1:6MD+"(V[*'A,=LGEL%*
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MZZVZ'I9IXJ0S>&,P<\G6`P&+X6X?X<J_59Q^LT\3PSBWC<!F%"HZ6D9R?LZB
M23DMFM&?S\_\%7/@SXT^%OQ:_8J_X*#?LG>#Y9?&?PW\8>$_@GXM\,:);S>'
M[+7OA5X_U)-$\.V&MV-G:HT.B:+K&M",6TL8ALA/&T:QK'BOWT^#G@M?`/PZ
M\-^''EGN+VUL1<:I<74[7EU<:O?.U]J<MQ=N`]S*;VXF43-RRJO;%?''PE_9
ME_:@TCX]?&GQ-\=?VA],^+_P$\5>--`\=?!WX=/HDVF:Q\-[O2DO(Y/#%P5M
M_P"R[OPS"\MCJ%H(YI+F75M/2^GCB>3"?H?;J(HPAXP3W+9]R2!D^IQUKJP&
M$]CB<PQ$H.#K5:?L[VUBH^\U:^C:C?;6-WN?,\3<05,;DG#F13Q.'S*KD^'J
MJKFM.525:OA<3*.,P.`J2G&$I2RR>(QM"I>-E*45%Z:V?PHINY?7^?\`A1N7
MU_G_`(5ZA\*139R#V`//8'*C)[=\_A7SGHL0\<?&_7?$,L2R:)\,=''A+1GF
MA<2+XGUU8M0US4["?!BEMQI+6>E3-N!2ZMYH]OR,:^C7.[`!&,$'/OCU!'8<
MX..U5H+2UMA*((+>'SW>2;RHDC$LKDEY9`D2B25R2&=OF([FLY<UW9:::='M
MO_7Y:=%"JJ$:EOBJKE;ZQ7NI^ETK?.]G=G\Q?_!63_@KU^QQX(^*>G_L:?$G
MQ?\`$#5?`=O-%JO[1:?"7PSI'BJ]UW3+6Z\^U^#KSZEK^C6%JGB!XC_PF$ID
M+-HN[3B?-E^7]7?V4OB[^S9_P4@_9'CU7PG\(&N_V8_$\=YX(T#P)\2_">BV
M$6L:)X<,5D1=>$[>XUK3K"PLKVU,&FC[3(_[@7"!"$)^P;_X#?!G5;Z]U/5?
MA'\+]5U&_E>YN[_4?`GA>]N[NYDW;Y[JXNM(EEGE.Y@9I3)(V26R2<]WX=\*
MZ!X3TV#1/#&B:)X9T.T+FUTCP]I=EHVFP^80\ABL-,MK2SA:23=+(8X1O=R6
MR>:\JA@<PAB\3B<5BJ6(I5:;A&C%->Y9+DY7H]'*RM\5VW9,^US3B/AFKP[E
M.5Y%E6>93F^`Q-+$U,UGF[J86>-@U+%8RCEL,%3]A5Q$8TZ=.M]8;A&%HN_O
M'YOV7[(GPC^$_B2[^'GP2\'M+XB\2:7#J_Q)\8>+-<U3Q=XF?P/X=67_`(0W
MX<7'B/Q/+K6H?\(7>:H$L+;P;#?V>G:=I`O9=-M8E$HK^5NXUK]L>S^&'B?6
M;B;68_\`@I];_P#!2:UTK0+1;W6+SQA%\'?L&CO_`,(WIDUQY^MG]GF.\FU"
M-5CC/A:*UGN)&"W";5_O:6RMXYYKN.WMDO+E(8KB[2)!/-#;F0P1S2!`TJPF
M641*Y?RQ))L*[VSS3>`_"#>)U\:'PKX:;Q=':FRC\3OHU@_B".S)W-:1ZR]J
M^I1VQ.,P+<^0Q`)C!&:6+RF=>I2J4*RPZBM86TVCI962:>S[W=FF>EPUXEXC
M)(XV688)YM4Q4J-2%:I)RK2J8>-2$:&(<^=_4JT:K]K35OX=-)/='AV?6(?!
M6BWGC8V%GK</AS3[GQ6\-ULTNTU.#389-9EANI=A%A#<K<LD\@7_`$9%D<#)
MQ_#MX@\.?LL?M3?\%K/^"AGA7XF?$'X0P?#?XD_`#4]#^'_Q/\4:KX=O/#FB
M^.9-`\#V.CZ[X>U2ZNEMO[7TJ2-Y98XIVDD%M(I`/%?W9RPK-;R6\L4,T<J-
M%+%*-\<D;H4=)`RL'5P2KAE(92001Q7C"_LX_`=5*CX(_!T*IW1Q#X;>#O+#
M%P[,%&AA4+E4\S:I+E07+')J\TRZKC89?""P\EAL3"M/VKEK913M[S]&][*Z
M./@+C?#\'8KB7$U,'F,Z^>Y96RW"/*\9AL)1RRKB<5A<8\0O;X7$2J0A/"QC
M962YG%J5[KX_'[3_`,"O%/P$^-?@7P'\3_!?C_0?@G^SO+I'CCX@^']7L9?#
M.FZY)X)O-+M8)]3@G:RBEN[2T_M!8TE81K-%&&9F"U_.7_P2#\<^#=%_X-^O
MV[M*UCQ1H^F:E81?M`P:C97VI6L-W8S>(OAY86'A^&\MY)%G@;6KN&2#2U>(
M&]EWQP!R&`_L9TKX1?#'1-$U7PUH_P`-_A[H_AW74\K7?#^E>#O#UAHFM1A5
M14U32K72H=/OD6-50)=V\ZA4``'&*,'P0^$MGINH:+9?"_X;VFBZS+8RZYH]
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MVK7%@)%31=&M+#6[*^NIY!;V5PP\]1SG^FR3X!?!5].32O\`A4WPU;38]1DU
M:/36\$^&_P"STU.6V%E)J2V@TSR%OY+("T>\5!=-;*(#+Y0"UU]MX`\&6OA=
M?!,7A/PM%X-6U:Q7PE%H&EKX;6P?.ZR_L-;--+%J<G,"V@A8,0T;'YCPTN'I
M4X5:4ZRDI8#+\#3E%6Y?[-K1K0F]?^7CLGWM\CZK&^-&&Q&(PN+P^25J=>'$
MW%G$6-YZT82Q,.+\'_9^,PM*JH/V=2AA^;DJV;4I<S3NS\5O^"F7Q)_8S\._
ML:?&3X[67P`\*_M(K?\`B'X8^-;FV^'VGPV@\7^.=/O7?P'XE\1^-?"MJE[>
M_P!A&W:6XN?/O+NTMK@6N(Q>G/Y>^!W\;77_``<'_LF?$'X@2R^;\3?V0=+U
M+3]132SHWAV349_`=]/?>'?#B3K'=7=MH%Y?6NFRBZ9[WST1KI1*V%_KGM_`
M'@^QT$^%+'PEX4M?"[1A6\/V_A_2K?0FPRE8SHD-G'IFP;5(/V7(*J<'`Q)<
M>`O"%YJVB^(+KPQX<EU[PY;R6N@ZN^BZ<^IZ1:S!1-9Z7J+6?VO3;28(@DM[
M*6")\?.K]_0Q&4SQ.,I8B5=06&KX>M2LGK[.E.#6MF_C>KU3^9\GD/B'@LDR
MO,LK648ZK+,LJSO+*>/K9A]9J8+!YKE^&P6'IPI.FH1Q&&^JKGE!).%9IWY8
MN/\`-3^Q7I\/P1_X*B_\%2?`'[:M_P"'Y8/VGQX*UOX5O\0["T_X13XG?#'3
M+SQW%)X8TF/6H6TG7;;0-(UW3-,U31H8[J3=$[W$+E_F]/\`^"OOP(U+PCX'
M_92_;S_9*\&1V?CW]D3Q=H5CIGAKPSIC^&8-;^$'B6^T_1[OPS<Z996UL\7A
MZQN!#/-I\-JD9M+ACM5",?T`:]\/?!_BF_TO4_$WA'PIXBO]$=I-'O=<T'3-
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M[2V@C&%4"O;:I6D1@38Q7"C:H4$`("=@Q@8(7:I]<5;W+Z_S_P`*]RE35&G"
MFG=0BHI_+\^Y^3XO$3Q6+Q6)J?%6Q%:HK.Z495)."7E&-HQ[12/@K]J/_DH.
ME?\`8H:?_P"GC7J*7]J%)&^(&DLD4LBGPAI_S(A89&LZ^""?48Z?2BM#G/E*
MWZ6W_7M#_P"DD=6Z**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
?H`****`"BBB@#X\_:"_Y'+2_^Q8M/_3QKE%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img2.jpg
<TEXT>
begin 644 img2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`9<#
M(`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[^****`"BBB@`HHHH`****`"BBB@`JK>7UEI\/VB_N[:S@!"^=
M=31P1[B<`;Y65<D]!FK5?G+^WOX6^*>J#X8>+/A[(/%.E>`_$)\1>,_A#%=F
MTO?'VA0PRQRP6>QO,N);5Y$G2`+AWB`R.<:4H*K4C!R4.9VYGMMHNROLFVDK
MZNQG5FZ=.4U%R:MHO-I>NE[V2;[)O0_0ZTU"POPYL;VUO!&0)#:W$4X0GH'\
MIFVD]@<9JY7Y(?LC_$WPG;?#[]H'XF?"K6]1UO66UV*YU3X:>-[M]*U'X>:S
M&9(KG1[\7+2&TLX7=VMSMVR11?+]X8\3\3?\%7O&?PZN/B1X8USP/I/BCQ+X
M#UGP#')?:5>M!I-QI7CQV%N\$GE?OI+$85FQB0\YKH6"K3G.%)<W(XIW]V7O
M<G1]%*<5?9WNKHY_KM*,(SJ/E4E)IQO..EWNENU%NUKZ6=F?NW17YC6?[?B^
M#OC'\7?AA\5=&@T^U^'_`,--'^*MIK.GOYD,FAZM9BZ6SN``,7$3.D>X9W9)
MP,8K.N/VX?&>GW/PKOM7T/2[7PG^T9;SVOPJU>*4R3:;K4\;G2K/5H=@W"[V
MEMY8;0O?-3]3KZ>ZDFE*+YE:2E'G]UJ]VH>\TM4DR_K=#^9Z-IJSO&TE#7LN
M9J*>S?D?H-K?Q9^''AO7(_#FN>,-$TS6I86G2PNKR.*9HTQN^\=NX9'R9W\C
M"UWEI=6]];PW=I*D]M<(LL,T9W))&PRK*1P01R*_FE^!_CKQS/\``[]M/]HC
M]H'PEX3^*][\%/C3XTN="M3+);WL+:)+9;K"&YRQ33D21/*@QM+;N/7]A?`_
M[;7[/FG>&O@YI'CGQOX;^'WC7XG^&M"U/PWX'NII_M4@U>%/LEK:>7`R,-Q\
MM"S+DBKKX.=+2"E5<9.$W!<RYE3C4=DKRLHS5VTDN[(HXN-36;C232E%2;B^
M5S<%S-VC=R322U?8^UYKFWM@AN)X8!(ZQH9I$C#R.<(BER-SL>%49)/`%35^
M3'_!1[XN6%EX:72]#\=W/ACQ)\/&TCXEV5O8FZW>('TJY%U#I#FVB<,EP(\2
M1.0&1AD8K:\3_MC_`!'MKS]D[Q!X4@\/3_"SXV6]G8>)?$>HR!;G3-9CLX6F
MMU4C`:ZNB]M%N92)`>,U*P=65.G-?;Y])7BER0YTKOXG*-VDMVK;E2Q5.,YP
M:?N<FL;2OSRY-EJN635V^C3/U-HK\SOBY^VMXC^`GAFYU_XA:5;7K>-_'P\&
M_"2ST*(W5UJ@<QQ&YN(1MWM!*S,R`D,HX..GB>C_`/!23XK2?%?X4_!K6_@M
MJFAZI\2/$VN^&[+Q1KR-I=G>#3-$DU>+4+&S*OYD)*B!QO`#AJ(X*O*/-&*<
M;2=^:-FH*\K:Z\NSMLTT$L91BU&3DFW%6Y7=.;48)V3MS-Z7/V<9E498A1TR
MQ`'/3DUF/K>E)JL>B/?6ZZK+;FZCL2X\][<-L,JIU*!N,^OXU_/Y^T;_`,%"
MOC+XG^"_B'3_``!!9>$OB)X"_:8\'?"7Q%?+(6LKZ#4=:L6@DM7`!$<UO*L=
MRO(Y9?<_<.K?M2ZMX+_:B\-_!KQ=X`T_4O$R?`'4/B1=>,=-E+W5PVF3+'=:
M1:6@7A9IPS)\Q+'`%5+`UHQ3?+S-5'R*2NE34'S=FFIJUM?+4E8VE*5HWLG3
M7,T[-U)2BHKM).+O?0_3:BO@O]EK]J_4/VB/%^J6>CW'AO5?"^EZ5=3:O+87
M31:[X<U_[6JV_A_5]+EB22*>.V+F24,5+)CO7WI7-5ISI3<)JTE9M=K]^S\F
M=-.I&K'F@[QO:_I^#"BBBLRPHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`*@N;JWLX);J[GAMK:%2\T\\BQ0Q(.KR2.51%'=F(`[FIZXOXCZ3I^N>`?&6
ME:I;)=V%YX:UJ.X@DR%=/[/N&&2I!&&`8$$$$`TUJTGLVD[";:3:WL:=OXM\
M+7=K<7UKXCT.YL[3_CZNX-4LIK:VS_SWFCF:.+I_&RU=TO7-&UR)I]&U;3M6
MA1BKS:=>6][$K#JIDMY)$!]LU_,I^PKXSO\`2?V.?CKX='P/\:^.+74/%'Q%
ML[GQ/;M<W4$]O:/="T5;EYS(D=EC,>TC9MXR.GOO[!WQ'\4_!_\`8#^#OB#P
M/INCIK_C)_%VH:_K'BG4Y#=I/IVJ7[06@@F\Z6^NI(XUM$"8$7EC->C5RYTU
M5M4YG3KPHQNHI2YH2ES.TY.-N5^ZU=Z6//I8_G]G>%HSHRJRMS-QM*G%1C>"
M4KNHM5:UM;;G]`5%?BM\%_\`@IWXW^/?C3X0?#KP9\.[&RUGXH^$?%NK0ZMJ
M5^8[:UU;PG<7MK/`\!BX@N9+0NC[N`X&`!7L?@W]I_\`:$E^+'QR^%GCK1_"
M>CZUX%\-6&J>"(89MYU^;4L6]M,244M"U[OA^0.,+GCG&$L%7@Y*:A%QCS-.
M:OR\_L[V5].;\-6;QQE&23BY23ERIJ+MS<G/9]GRZ^;T6I^HU%?E=^T=^V+\
M9/V>_!\?BC7=`\+2KX7\*Z?XI\66D5\)-2U9)9@M[9Z;8K&6@6"+<PG8J&88
M`SQ69\&/^"@/CCX[^/OB1X>\.^"-,\/:#\,M`\)>,=6U34]0+M=>'/$.@V&O
MW)1/*'EW-I;7;+M!;<R=1FDL'6=-U4HN"O>2DK*SBOO;G&W>XWBZ*FJ;<E-V
MM'E=W=2?IM&5[VU7H?J-K/BCP]X>ET^#6]9T_2YM5N1::;%>W45O)>W)&1!;
M+(RF64CG8@+8[4NK>)_#V@M"-;UK3=)^T#,+:C>06:2`=2LEP\:8_P"!5_//
M^U]\==;^/^N?L3_%+0X8+'X?ZC^TU>Z'H%S:7<J:A=QZ-!=6-U)>(FP-!+/"
M[QQOD8*U]W?MD^#M*^-GPO\`C-'K(EDTK0M!L/#.C7<$TT$UCJ.HR0)-J-I+
M"Z%+JV9V590<KT/6M/J?+]752;A[5R531-TW&HJ=EJKN[U5^AG];YG6Y(*7L
M^1PNVN=2ASWV>C7PM7Z/J?I]:WEI?6\=W975O>6DJ[XKFVFCGMY$(R&2:)FC
M=<<Y5B,5BOXO\+I'?2_\)!I#IIF?[1\G4+:9K(AMI%TD4CM`0W!$@4@\&OQG
M_P""<OQ-\9^`?@;X_P#V9O&^IWVJ?$'X27,.E>&+S4[B2;5M:\->)H'N="OD
M>4M-.+.RDCWR\X9>2*^</V._''_"A/V6OVW?C1XCT23XE^)?"GQN\?6VJQ:Y
MJ-P\FHV4'BA[6.R6:4N([>V#@QQH@`"`#I5/`23K)3YG"K2IT^5+]ZJTK1FK
MRT333ZZNW<E8Y-47R652G5G.[_ANE&\HV2;EK=:=O-7_`*(O^$U\)B_TW2SK
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MM^\#<?=YP/"G[<?[0?QSTCX_R_!?X;^'X-8^"7B&YTH66M:F2NN6T-C!J`EB
M;R<I+Y,I!C"MDC`]:Q6"KN"J6@J;LN=S2BFW%6;]9Q^3-7C**DX/GYUKR*#<
MK6;NDK](RZWT/U_HKX&^`'[1?Q+^.6B_!C7-+M?#R1:YH]_=_%*T27=<:%J-
MK*T"V-NNW(<RQ2`JVPXVG&#7WS6%2G*E+EE;F5[I.]K-K7[KKNK,WIU(U8\T
M;\KLTWUND_R>O9Z!1116984444`%%%%`!1110`4444`%%%%`!1110`4444`%
M,DECA1I)I$BC49:21E1%'JS,0!^)I]?G;^UO\3]7;XX?LY_L[V\VK:+H/Q9U
M_47\1>(-/D:W4V>CV$U_'I?VD8"-=26X210<O$Q&.E:4J;JSY5II*3?:,(N4
MGYNRT7<SJU%2AS-7UC%+O*<E&*\E=J[/OJV\0Z#>N([36M+N9#(852"_MI7:
M4`DQJJ2EF<`$E0"0`>.*V*_&S]H[7_A#\!OVE?V;_"-EX,^)&FZ[J_BB\N?#
M/_"(^?)X:\5:BNF7!OHO$`:<!_L]IYUXSD$9B)`J]9_\%,]5\2>+[N_\#_#+
MQ3XG^&^@>+M6\'>)M0T_2FD&F2:%--;ZMJ[W>[_CVLIH)$F0KP`23Q71]3JS
MC&=).49QY[RY86]YQ2OS-7DT[:K5-;HP^MTXRE"HU&49J-HMR?PQ;;5DU;F5
M]'HT]C]A<UBV_B3P]>7\FEVFN:3<ZE#GSM/@U"TFO8MIP?,M8Y6F3!X.Y!S7
MYD7_`/P4#O;7POX>^.J:%97?P!\0^.G^'\E\DQ&L:?=?VB-*359(@A+V\MVR
M1B/@@/GJ*H:SX0\"?L]?MO>%/BV+&>+P_P#M`Z&VC&_EGN&T[2O%`C6YM/+6
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MLF[M\LE'JVMM@^M4XR<)W4M9:)R7)>*YKV6W-&^EE?R9^T[,%4LQ"JH)9B<`
M`<DDG@`#J:Q+#Q/X<U6YDLM,U[1]1O(MWFVMEJ-I=7$6W[WF0PS/(FWON48/
M6O(/@/J'Q:\2>#+C4/C'#X=^V:M--+I47AZ59[1]#N03:&:5,!I9;=U,F.A)
M&>!7Y>?\$Y/"6AZ=^V=^WK+;VTF=`^(PL-%26XN)HM+L[@EIK>RCEE>.&-R2
M655'6IA03AB9.>N'C&5HKFC+FG&%N:ZM9R71[,J5=J6'BH.U>4E>3Y7%1@YW
MY;.]TGU70_;ZL*S\3>']0UB_\/V6L:?=:UI<<<VHZ9!<Q27ME%*2L;W,"L9(
ME<C"EU&:^#?VSOVKO'?[/%IJ^N>'=+\.W>@>$_#4WBS5?MFH*^K:S;V9)O-,
ML+!$=HW2,`^>S`9;IP:_+SX._M#>-(?VHOVM/VB_`.FP7.F2?`#X<_$G5O#V
MKWDL<<>G_;+RXU&WMD8ND=TT:LBNB[FP.V:UHX&I5IRJ744HWALU*3G3BHR=
M_=TG?KMT,ZN,A2JQI6;ES6FK.ZCRRES15O>UBUTU\M_Z4J*_+7QK_P`%%-"L
M_"/PI\2:.=.T!/BAX776="O?$_FV^AZEK4BF*/PW%J0C=(+MKM#$KR*`596]
M:_17X=:YK/B3P5X=UWQ!9VUAJ^J:;;7EY:V<XN;:*2>-9,03@`2QD-E7`&1C
MBN:I0JTHJ4X\JDW%7WO'1Z>5C>G7IU).,)<S24GII:236OFFOT.UHHHK(U"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OSQ_:V\/^(_\`
MA:OPN\?>&(?B1)J7@ZSU)X8/!VA3ZQH]^]QN1+?6XXYHT>)682"%A\P7.17Z
M'45I2J.E-3M?1JSV::LUL^C9G4A[2/+>VL977>+375=4?A5%\+[.Z\&?'73]
M7^''QPB\<_M`2Z9<^+_$^@>#;C2+:VN-&E633_L%C#.1"AV[+KY]TRLP8\U\
MV?%7]C_5?B'/K&K6>C?&71M;\36GPXL=>F_X5S/-9RP?#I0EH;:W6[0Q27JC
M,KEG(8Y/J/Z:**[(9A4@VXQ5W;7FOLH))73LDJ<4ETY8]M>66`A-6E*ZU^S:
M][MNZDM6Y3;>_O/Y_@:_PHU'7/VA_&?QH\:?#[XM:]X>\=?"'3/A1K7@M?A[
M<0JUKIEDME%J*79NG`=L>;Y?E\,`<\5U?A[P5=Z3I?@G0=7^&WQ@\1:1\(?M
M,GPBAOO`<YD\/W<@?['<:@_V@B^>P+8B(\H@=Z_<>BI>.D[+DLHQ48I2:LHK
ME5M-'RWBWNT[._5K!Q6T]VY/W5JVU)WNWIS+F2V3LTM[_P`X/A'X#_%/0/@+
M^TS\#=1L_BKJ-E^T9XCUWQ/=ZO'\+[F"70-0\121-J"QQ_;V\Z()!"L*[EVD
M$\YK[(^'R>%/#'P]^&^@>+?V:_'OC?QU\-?#.GZ%HWCK4?AR3=QSZ9%Y=G>0
M)),\D(C8*_EB7J#@U^NU%$\=*=TX6YI<[Y9.%Y<L8-WBD]8QLUL^J;"&#5.W
M+-Z145S14O=4N9+WF]I-M/=7\C\C_A_XV^(6E:#\0;#XE?"SQYX_UCQ==:E)
MI6IS_"SRETBSO(3#;6,D<]Q.T\-JFWA'C!(.``<CY2\.?!+QNWP/U#X'>.M(
M^,NLZ/:^.X/&O@?5](^'ESIFH^#_`"=6.JG2K*0WDI^S%V,0"[1LZYQBOZ':
M*4<8X7Y:<5>4)Z/:4-(N.GNZ7O:U[ZWZCP:ER\U24K1E'5/6,[<RE[VMVKJ]
M[.UMC\9_VB_#^D_M`?!OPQ\-9?A-\<O#'B3P%-IVK>!_'EEX1FDU'1/$FEK$
MT6J[#)^]^TS1![J/(,JLREN2:^<O^%.?&'4_'W[.WQ'\9W_QL\8>)/@9JNJ:
MK<7%_P##::-/$$FJ:?)IDL44:W8%FBVS[AG?F7YJ_HEHJH8Z5./)&FN5.;5Y
M<S7M(\LTG*+:4DW=)I7U2N@E@HRESN;O[E[*R?(XRBVE*S<7'1M-KN?S=6O[
M+5[<Z7\9+#Q%X7^,NHR_$GXT:+\:-$N+?X?7-O\`\(YK6A75O/96<B_;&^V0
M;;:-7P4W$L>.E>T^(?"/Q%\0_M+:%^T1/H'QA@O='^$FH_"TZ5%\.[@2,NHL
M;A]7BN3=E4DBO,21QLC`(NWIS7[N44WF$Y.[@G[LH[])*$7]G2ZA%?*^]VU'
M`PBDE-JTHRTCK>$G)/XNDI2?_;WD?F+^R)X3M?#GQ+U'6;SX=>-=$\2ZIX?A
MTR_\3W_@]_#6GZPL)C:6\UMEE>*[U661,K/L5MA93G.1^G5%%<E6JZL^=JSL
MEO?96^6G0ZJ5/V4.5.^K=[6WW[]=;[A11161H%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!7G/Q=DUI/AIXT_P"$>6X;69?#^HV]B+6P.IW'G7%N\/[F
MP5XS<R!7.V(.I)[UZ-13B[-.U[-.SZV=["DKIK:Z:OKI^1^"7[.'A'XL_L]_
ML^_$CX'66@_%#7'\:7WB#4-,\02_#*XA.D7'B(S?;3+;_;S]I11+^Y`9,8[Y
MKSOX4?`#QG\/O`?P;\':KI/QEUJ3X+ZEXGFT.>#X>75K8:GIGBQY7U&WU.Q:
M]=)[N!IG:SN'_P!23D+7]&-%=_\`:$[S?LXWJ3YYNZUGRN%_AT]UR5EIJSB6
M!BE!<[M3CR05G91YHSM\7\T4UVT6RL?SD?`W]FS6/@1\</A;\5/#WAWXS:AH
MGPRT[Q786WAR]^'MPUQ?CQ;>7EY>2->B[`C\E[QUB'EG"CBOK_QQ]A\:?M&>
M"/VAG^$OQTTW4O"FBS:+J'A^U\*3I8^([<F22R_M#$@$GV*X?SX@X;#`=*_7
MBBIGC9U)<\HWER.GS<UFX2=Y)V6MVWKOKOIJXX*,(\D9VCSQJ<O+=*<5%)J[
M=K**TV_&_P"%OQ]^&J_'/QM\0O%%QX$^/&D:?\3?ATOP]U[1W\(7%U%96L5P
M]S%?:1NF"6<Q=]DI1&9T!`(%<]^RY\*=7_9Z^(/Q7\4ZMX'^,'C70/B;X0\/
M>#I=!D\`7%H]C8>']%M="A9[DW4GGF>RM%,@V#YV)SVK]\Z*%CI*FZ7)^[<5
M%QYGM'D:5[75G"/6^B3O8/J4>=5.;WTW+FY>KO?2]FGS2T::]X_GMU3]GN#4
M+'X=>%[;P7\<=+\$?"7XHW_Q2\"Z1:>!YUN;+4-2:::[TZZN/M&)[4SSNR#8
MN%PN>]?3OQ5\4^-_&'P9UGX7^#/AQ\6/#.IZ]J/V[4/$>H>`)]2WYNUNRHM_
MM41W;U"J=_"U^NM%#QLI.#G#F=.7-&\KKFNI-N\=;R7,[]6-8-1YK3MSI1E:
M-KQ22LM=%965K=.VOXE>%/"]QX>^(6A_&6?X:?&>;XGZ5\.?^$&O+NT\%7%M
MH&L7<,<<=AKE]I7VAA+/:)$(T5I,A20&&:^<?#'[/_Q.T;X#_M'?!'4;+XJ:
MA;?M`>*=9\73:S%\+[F"30-4UW5?[6O52+[>WGP"7*1J"NT'J:_I#HIK'SCJ
MH*]Z;NY7M[.7-!*ZT47>R7?6]B7@8O>;VFM%;^)%1F]):MI6N[OY[_SYZ?\`
M"+QQ8_$C]FOQ_P#\(]\7)!^SU\+=0^&D6G_\*XN!_P`)!#J,$*3:BTOVS]PZ
MRP(ZQ[6X)3)ZCCO"'[-&LZ%X.MM`U;PY\9-3U?0_VAM0_:%\+ZO#\/+BW33]
M=U*ZFGN--N8/M9^T6X69D0[T`(!&>@_H]HI_VA4M;E71;KI*<OY>\Y;WWUN'
MU&'\U]_L]7&$6_BWM3BKOLOG_/O\7/@,?BWJ'Q4FU;PK\?$L?BS9^%CK,$_@
MZYN)=.U+PM(TUM+I<CS_`.BVEQ*Q,UNBY*@`N:[?]E>UUG]D*[^.WBSQ%X"^
M,OCG2_BAK?\`PDMS96OP[N+>?3`MI%926RC[5(;K?#$@X"\EL#DX_=&FNB2*
MR2(LB,,,CJ&5AZ%2"#^(I/'2=-TI0O3?*G'FM\/):TN6Z^"*OV2735K!1C-5
M(SM4C=J7+>SES7=G*SUG/1_S'Y$?LF^)K7X6ZU\0-;T3X&?&G3],^*GC>XU_
M3;/4/#4Z6>@V.H&(JB1L^+*!7#R21C`7)/')/ZYV\IG@AF,;Q&:*.4QR#;)'
MO0-L<=F7.&'8@U(JJBA4544<!54*H'H```/PIU<U:K[:?/R\KT3]YRO9)+?L
METW;;-Z-+V,.3FNMU[JC9O5[=WMV6@4445B;!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`5\&_MBZ+H/BNZ\'65[X"^(^K>)/"U^OB7PIXS\!Z/)>S:!
MJ,9\MHWN$96"W,:F.>#(#PNPR,FOO*BM*<_9S4[7<>EVO+=>6C6S6CT(J0]I
M%Q;M=IWM?9WZ]=-'T/Q/OM.\7_$#XM_#'XK_`!C\#_%_Q/>?!G4+W4/`FGZ-
MX!N-*0S7VGSZ9-)K#FZG^V.UM<29($?S'.*\T\%_!_Q)\./C!XM\2^"=/^/V
MD?!3QQJNI>(?$/P</@:66VEUK66EDU1K74O-'D6=]+/++/;^4VYVSN[']^Z*
MZECI)-<BY7#DY;^ZHW<M(N+2:DY232YDWHSE>#3:;J/F4N?FY?>YK1B[RO=I
MQBHN+]VUE;0_#'0OAGI6D:2WPXN?A3\9M2^"D7C.7QY8>!Y_!,QGL];FOO[1
M,`O//VM8)=XE2`0C:47GCCW[]HKQ'8_M#?#VS\":C\&OCCX;ETC4M,U30=?T
MOPK,FH:1=Z9)'L>UD$FY#+;H]N^TC*2-G/2OU0HJ7B[RC-TVY0?-%^TEI)VO
M+:S;M[S:U12PJ490Y_=DE&2Y%K%;+5W26MDM%\M?Q?\`C+HC_%+4/A'J=I\.
M?CMHL_PJL;S2DMG\)7-QI^N66H6+V=U+>6@F1'OOF\R*=]Q0EN.:\M^#?PGU
M'X3>$+KX47/P_P#BSXO^$<UIXCGB\+ZQ\/)Y+A?$6NOYT>K/=&ZPPL)L20QK
M$""!AJ_?*BJ6-DH>S4%R7NDY/1W;NG:Z=Y2LUJN;387U./-S\_O/1OEW344T
M];6:BM/3SO\`E5^S;\4OBM\%OAR?`?C'P5\7_'\NGW-X/#NK'P'=6<FG:7(S
M&PT^=7NYC<"R4J@?<-RCIS7Q]\,_!/[1_P`(?B7\=OB9X+_X6!'J?QUU^77=
M9@O?A%=3II,S;EB2R/\`::_ZM",D=6&>*_H6HI1QG*ZC5&'[VWM$[-2LU+9Q
M:7O*^EM;=M1X2ZIIU9_NK^S>MXW2B]>:[O&ZUOO]_P#/AXJ^!VO>//[4O?&.
MC_'O6=:\7?#+4OAUXVNY_!5T]M>"_:1AJVD6KW3KIURGF['QO+JBC(QFK'A3
MX`V/@6^U%_#/@/XXQZ=XR^&>D?"KXBVMYX*N)WUSPYHSS/;O92>>HLKF3SG6
M5]LF1@8&*_H'HJWF%1KEY?=M;E4K+ITMTLK=K1ML3]1A?FYKR_F<;OL];]=;
M]^9WZW_$SQ_X2LO%.E>&O".F_!OXJ6OPX\,^'+/P]:>"]3^'K7]G$8)&:75[
M.3S8WM=4=3N2>-@5D&_DX`_6CX/PV]M\-_"=I::;K.D6MGI-M:0:=X@B:#5K
M6*V00I'=Q.2R,%084DD+BO2Z*YJM=U8QCRV46W\3=[[WON[]=_S.BG1]G)RY
MN9M)?"E9*UDK;)6T2T7YE%%%8&P4444`%%%%`!1110`4444`%%%%`!17.ZOX
MM\,Z#?:9IFLZYIFF:AK5P+72K.\NXH+C4+AN!#:Q.P::0]E0$U!)XW\(0^(4
M\)R^(](C\2R0&Y316O81J#0#.91;EM^T8/.*=F]DWUV>RW8N9+=I:VWZO9>I
MU-%<OI7C7PEKFK:EH6C^(=)U+6-(8)J>G6EY%-=V3'H+B%&+(<\<CK73Y'J*
M&FMTUUU5M]@33U337EJ+11GOVHSGI2&%%%%`!116%XF\0V7A70=3\0ZBEQ)9
M:5:RW<Z6D+W%PZ1*6*PPH"\CMC"JHR3Q2;44VW9)7;[)`>6:U^T)\--!^,WA
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MI](\:ZA8Z1;WNF:;-=P:9JFI,B6MKJ<D:[;7S&8C?(0`17H=Y^T%';>+/AYX
M6B\$>)KT_$#3HM2M]2M+.2>QTFWDCCE+:E,B%8`BR+DN0.?R^6/BKJ>B_MV_
M";X\?!_3?"7B"PT[PYX>L+CPOXFUO2[C3&O/$RP2W<,NDBX17:2SN+:./S8V
M_P"6H'6L?]DSQI\2?`O[,%E\1OV@O#NN:?XW\*Z4_@NTTU+2YU#4;F+2]]G9
M:BL$8,N;]1&\A49(4$],UV_6ZSQ+BJM\+.FJM.LJ2Y8?5Y\F)ISD]'S>ZZ;5
MMY6O8KF?-O[K7,FEIINF_/I^&Q]M^%?VA/AKXP^+?C+X*Z-K,<WCKP-IVGZG
MK>F'`:.VU!I5A:/GYRIB;>`/EXR:J_$O]H?P/\.?$NE^!7>Z\0>/M:MY+S3_
M``CHD1O=6:SB^_=W$$6Y[>WYXE==IP>>*_#SQGK'Q@^"O[8OP%_:;?P%J$GA
MWXE6]SX7^(9\*:1?:C>W&C7TJC3M9UJU@WO`UDDC$K,%,9+=!7TU>^#/&GPJ
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MO)&)#'$C%@'9@"3@5_.=_P`%'_$W@+0/VKO&?PZ\9>/_`!G9Z+XK\*>$M&,L
M>B:[?67@1M-U#S9M0T-]-:.!9+N,B.<D,P7);@"KQV9U,OH>V?LJZ=54XRD_
M80?M$Y0O)W5TDHMK1N7-916A.;@KV36FM^5:^;O]_GY:_P!1=C\8/A=J<WD6
M'CSPQ=3`H#%#JUHSCS6"1Y7S,@.Q`4XP3P*\W_:!_:L^#G[,^F>'-5^*GB$Z
M1;>+-9T_0=",,+7)O=1U2>.VLXEV'&V665`&R1SGZ_R@>-]-M->_:7^./@_X
M&77B#Q-/??LS>"4^'$NA3ZHSW'B6"9((M;:TCG)M;F29!)<.R[E;<'[U]Z?\
M%(O#'Q3O/V+?V/O`WBOPUXD\9_%K0O%'PNUSQ7_8NA7>K7=I:Z3=:7+J<]U-
M"CO');)%)YV6!9E/M7'_`&[B*F'QM2&'A&>%3Y9Q<JM*<XU_9.&BBW*4?>BD
MWIJR/:R<9OE2<=GO%^\EZZK70_8W]H#]N/X1_LY:=X>UKQQ:^*)M"UI=/GN]
M<TC0[J^TK0K/4C&MM=:Q>1+Y5E&S2H"92``<YQ1\2/VZO@;\.1X4:YUF75U\
M5>'+/QE&VEQ&Y&G^$;UXHX=>OMA/D6>^:-6D?"KNSGBO@C]K7]H3X6>+OA]X
M)^`GBKX>?$[4O#7B+0/#5_XRUG0OAQK&L%K/3A:S+I(GMK=C'<2RQ+'*'/R(
M6X!Y'R%^TU^SQXYU/XA:QXW^'_A7Q:?AQ\4_V8;'X7_#C1WTRZ6ZT#5%O;(6
M-E>VA3S=.8VL7VAS,!Y;`@\BJQ.:8N$J_P!5=+$1C[!<L8-SHRDI.HY*]IPT
MA%2TM.3LG9CE4FKVL_AV7PWWOZZ+U/Z9?#'B31_&'A_1_%'A^\BU#1=>T^VU
M/3+V%@T5S9W<2S02HP)!#(P(P:W:^9_V.OAQXC^$O[-'P=^'WBRYFNO$7AKP
M1H>GZJUPQ>6.[AL85E@9CR?)<%!TZ5],5]#1G.=&E.<>2<Z<)3A_+*44Y1^3
M;1LFVDVK-I-KL%%%%:#"BBB@`HHHH`****`"BL/7_$N@>%;!M4\1ZO8:+IR.
ML;7FHW,=K;AW(5%,LK*H+$@`9Y/%9NJ^/O!>AC1SJ_B;1].&OO$FBF[O881J
M33*K1"TWL/.\Q64H5R"",=132;V3?31/U_(3DENTK;W>QUU%<M/XW\(VVO6G
MA>?Q'I$7B&^A-Q9Z0]["+ZXA'62*`MN=?<5U&1ZBBS6Z:OJM.G<:=]M?06BD
MW#U'YT;AZC\Z0"T444`%%%%`!1110`R218HWE<X2-&=CZ*@+$_D*\4^#W[0'
MPY^.%QXWM?`>L)J5QX`\23^%O$,/W9+;4[>-))$V$[B@#@!L8)SCH:ROVC/B
MD?AMX)9+&SO[WQ!XFE_L708K2PN+V%;VYQ&DEZ8!_H]LI<&25R%`R<C%?C7^
MS_JOQ._9A_;X\4:5XB\#:E9?#[]H#PW9:G>S^%](OK_0=$\:`8%U?7$6^&WE
MOPL0=G88).>E>9B\>\-B<-34>:E.JJ6)ERM^S]K%^Q=UHDYI*5^DD]DR)3M*
M*MHW9[Z-[:_U^9^JG[4G[:GPH_90B\&S_$"2]NHO&/BO3/"%NNCQ?;I['4]6
MN(K:R-]#$2\$4DTJ+O<`#/0USOQ=_;^^"GP2\6>#?#?CV+Q1IECXQN=,L;;Q
M5_8=T_AJQO\`6!%_9]G?:J!]G@FG:>)0KL""V.M?SV_M/_`G]J/QGXF^+MOX
MC\!^,O&7B)_VK?!'C'PG<6EK?W=@GP[TZYTB=Y+`_/!''`L4AD2-1AU;/.:_
M0_\`:6^-GPC^)WB7X:?!/XE_"SXKW'ASP)?>$M;UJ72/AQK&H6^M>);&.SDT
M^R.IPVQB2&TNTB:XF9L*$93C!)\EYOC)O%NT,)&,Z$<+'$4Y/FDYU(5(3EI9
M24%.Z3Y%+12;5\_:R][[-FN523^:OI_P/(_8'Q]\=_A_\/K;0&U+4OMVI>*D
M1_#>C::!=:GJRR1B6-[:V0^8T3(03(`5`Z^E9OCSXYV/@/P/;^+[[PYK5W=W
M%E+J"^';2V>75EMH(6GF=H%4O^[C1BPQG(QUQ7X7?MQ_#?X]:K^T#-X^\)Z'
MXL7PUJ/P0TS2O@6VBVUXS^&/&[:C;3PPW\4>Y+.5;8-YKRHN(MT;`5^F/A:X
M\?:1\`T\0?&F#4;_`,7^%/@S!H>M26UE+=7-]XFU#1E^T26]N@+RW'VAVA=D
MSEB>E=U/,,15KXRDZ4J*HK]W4E"\+1^*;OU=G*$=N1W;N4IR<I)JUK=/1OSV
MN[=O,](_9E_;D^$7[4.@>-]8\&G5=*O?A[<-;>)="U^S?3M5M&\EYHI!:S8D
M>*=$)BD`VMD8/-?.MC_P5C^$&N:7\6_$'AKP/X_UW0/@IJ]QHWCO4;+0KJ0:
M=<V\C1LT<:H3-%\C/O4@;`3T&:^0OAS\)O&?@WX^_#CXP?"OP]K,7PG^-?PX
MM]#^.$$^F75C-H6L^&[=,:@;!E5C<31VSPDE=S^;WR:9_P`$M?!L.H^-_P!O
M?X?^,?!GB/1M`^*OQ(UJ[\,_\)!X?N[&PU?PW<1W]H+RWDNHUCD51.CIMR<X
M(Z5PPS',JL\'AN:%*K5J8JE.M['FA4Y*/ML-5IIRLH34H1GK\3E%.Z)52;Y8
MZ)N_O6TEHFFETO?7SOTU/U3TO]L/P_X@^$/P^^,7ASP9XIUW0OB+=V<&C6>G
M6,EQJ*07Q'DW5Q;("\<>W+N6^X`<]\>E:5^T?\.=3^,4?P*.HFU^(K^%XO%;
M:+.NR1--D1&.22/WD9=5=/O`]0*_-;]B?PW\3O@#HOQ?\!?%;0M9C^&?P&\6
MZY<_##5/L\]Y/KNC:C-//ID=I:J"\L6G1JD"(@X5^*^7_P!HK6/C+X3^.'[/
M?[9.B>`;^]M1XNFT;7HO#FE7]SXDU7P%K-PF^/5=/CW31+IRI%E)$`4$G@5T
M/,\12PU#$5(R<I2HK$472?-3A":HXJ<;:VYW>FW>+C%M<W,A\\K1?>UU;6U[
M-K7U^2V/Z1Z*YWPGXCM/%WAO1?$MC%<0VNLZ?;7\,-W"]O<Q+<1J_ES028>*
M1"2K(P!!'-=%7T"::36J:33[IZIFP4444P"BBB@`HHHH`****`"BN>U7Q9X:
MT/4=+TG5]<TW3M3UN8P:38W=U%#<ZA,JEC%:1.P>9PH)VH">*@/C;PDOB$>$
MV\1:2/$A@^U?V*;R$:A]GX_>_9]V_9R.<=_K3L^SVOL]EN_1"YDMVEK;?J]E
MZG445R^D>-?">OZGJ>C:+XATK4]5T:01:I86=Y%-=6,AR`EQ$C%D;@\$5U%#
M36Z:ZZJV^PT[[:^@4444@"BBB@`HHHH`*^1?VN?VOO!?['G@RT\?_$+0]?O_
M``M-?VFG7.HZ+92WHLKJ_N$M;-)TC4E1-<21Q@D]6KZZK\9O^"WD&K>(_P!D
MB?P1X8\/^(O$WB;5_%_A&\LM+\/Z3=:I-);:=KUE=WDD@ME<QK%!$\A+`<+Q
MFN#-*]7#9?BL10:5:E2E.G>/,G..L8\O7F>EEJ^A$VXPDUNE='W%\-_VPOAU
MX[U/PQX?U*UU;P;XB\;:,NO>$=*\1VKV+Z_ITD/GH=/DF"+/.8B',"98#)/3
M-97PW_;E^"?Q3\8?%'X;^%]5DE^(_P`*)[F#7_!MRGV;5[C[.KL)-.@D.^[C
MDVX5XE8;B!]?S;\:?#OQK^T5XK_86U;P%IOB3PSI'P%TO3O$/Q"\476G7&F3
MP0Z=H'V2XT!$F57N9)9AAH02,;N,XSY]J_[(C?&V]\<?M$?LZW'B'X<?M/?#
MKQEXAU"RU&[TZ\T>R\>:8ES<2P:/K$<@1=0MKN'$<4H^X60@\5Y3S',%RJG2
MC7Y9I_#R3Q5'V%*I5]AO'VM*<Y))^[4Y>6Z=[1S5.BOKU5N9<J;MZ-OUM;S/
MVG^$7[0^D?%3P1XI\>/X=UOPMH_A2YU6VO?[<M7M99&T82F_:))`I98C"R@@
M88XZ9KK/@E\;?`GQ^\$Q>/?AYJ:ZIH$NH7^F>>!M9+O3IC!<Q.AY5DD!&#BO
MS;^%?Q`^+6A?LV^#?AQXY\$W.F?&OXE^(?$#:[H4VG74NB1?;+UWOC=7R8BM
M[:Z^<1F1QN1QVS7A'[`?B7XJ?L^?'7]H7]G'6/`^JVFDZ_KLWC'X9W=OI=XW
M@VSU+4_-N=2T6/4SNMHU6Y<8^<9"_2NB&9U(U,#&:G*G7@XUINDXRA7G"-2C
M&26D&XJ491:OS.%VM1JH[P3UYM&[;2=FEY6_&Y^V?Q4^*W@?X,^#=3\=_$'6
M[;0O#^EJOFW-PZJTLLC!(K>W0D&:>5R%CC3+,3P*\`A_;)\'0Z/X=\0:YX3\
M9Z+H_C#7[#0?#%Y=:)=[=1DU/)M+F1=@-M;R*-WF/E<$5\??MY_`K]I/]HWX
M$^'5NM,L[/7/`/Q+\/>,[KPMHMUYL'B?0=)N2]S8RJ&;S79"'6)@0S*!MZ52
M^-'[0G[1FI>*_@?X*_9_^%FB^)?#6H7NB:9XZ@\8>$KY7^'HM($2YU82LT4)
M,)1Q$L2JX)R"1BKKX^O"M47+4I4HT\.Z-Z#J3KSK3:G[O-%I4DDI13YES<[]
MVUQS:;W27+;W6W*[L]/+;\=3[P_:#_:D\-?L_P#ARY\3:KX=\1>)+#3;*+4=
M77P_82WUQIMG/&9(I9HHE)RZ@[5R#P:QO`7[:/PB^(O[.NH_M)^';J^F\&:5
M87UWJ%G+:O'K%K/IZ&2YT^6Q/[U+Q`N/*(#9(&*\&_:!O[G1_@[X@UCQA8:M
MJFK>*->TS29+/1M&NKY;FSM7$;%+.,/+%:L)),!]P5,9KX(\(_"OXC?!*7]J
M/P;!X9U>\_9Q\>^#Y_B3X,-KIMQ+<6OBKQ#IDD<F@V^GHI=62>%-T*H"IDY`
M)K+$8_%T<3:/+.A*E).'L_?H5)1G*C4J-._LVH-33T3E'4'.2EY-/2VJ?1O]
M=/N/KNR_X*\_!K4/AEH/QBM/`GQ"E^'/B3Q##X7TSQ&-!NOLIU:>[-E%%<G;
MBWC:<%?-=MHQDU]P7G[0T%MXD^&_A^#P5XEOU^(MA!J-IJ-G9R366EV\T23[
MM1E52L`$3JV7(':OQI_X)_\`P&D^,?\`P2_\7?L_>,/"^O>'/&,$OBB^L+#7
M](N=+O--U5K^[N]$O+3[4BN'1_+:-XP""1BOMC]D7QA\3?`O[,4'Q`_:"\-Z
MSIWC#P1IDW@K3M/6TGO]0O+32)IK+3=16WC4RE[V..,.0N=@!-9X+&XZI'#R
MQ-1>SQ&$I8GVD:*2I3IR7UJE/5I73C[.[YM9;VU4)R?*V])04KVLD]+K_+U\
MC[>\-?M"?#?Q7\8/%WP0TK6$D\>>"]+M-7UG3&PK1VE[(T<31G/[SE3NQR!R
M1Z>XU_-Y\0=8^,7P:_:[^`?[4B^`;^YT/Q]]K\+_`!`3PII-_?ZA=^'[Z1VT
MS5M;M(3(\#6)N`SB51Y?EX)K^C'1]4M]:TRQU:T$HMM0MH;N`31M%*(YD$BB
M2-OF1P&&Y3R#D'I7H9?C98IXFG5CR5*%9J*Y91YJ%2*G1FE+^[+ED_YHOHT7
M"3ES75K2M\K)I_-,TJ***](L****`"BBB@`HHHH`****`"BBB@#X*_;)T_PA
M!XK_`&=O$.L?9;?7K3XN^'+72;R:[D@E6*XG87$,<2R+'*),(&WJV.HYKYA\
M<K<OJ7CF"V^V-\6I?V@8+G0DC,AUYO`1CB+R6@_UW]C9W[BH\GK7ZW:_X/\`
M#'BF339?$6AZ;K$FD7:7VF/?VL-RUC>1G='<VQE1O*F0\K(F&!Z&G-X1\,-K
M2>(VT+2VUV*#[-'JILX#?)!C'E+<;/-"8[;L5UT\2H0A%QE)Q3ZZ/WN9+;X?
MYE]QRU,.YRE)-+F:Z._PJ-_5;I[Z'Y<?`$?\5K\"4TCSAXOL],^(O_"V?+\P
MWT-VWGG1O^$C`&[S,X-MYXSC[O'7Y)^$.C?MV?M7?%W]II?#W[6^I_#OP]\+
MOBQ?^#-#T2QTFUEA6QAL[6[C;=):R-E1/LY;MGZ?OS:^$_#>CW6K:QI>B:;8
M:GJD<CZA?6MG!#<W;!#S/,B!Y#_O,>]?E-_P3"_Y*?\`MT_]G%:E_P"F?3:Q
MQ6&P^8T*\JJK1="-.4'3KU:,N:=9*5W2E!R5I-)2O96ZJY5*K6PDZ5&$H.%>
MH_:*5.,F_94_<M*2<HMM<TN5KF?Q7T&2?L6?M]M`J)^WIXD$@`R3HEA@G\++
M/3WSWSS7@7PK_:`^-7[(G[:TOP*_:E_:(OOBAX,\4>"-$OO#M[>:7'$]OXEU
MC7O[)M;15MH(FQ,S(-[#:-QS7]`%?SF_M;?`#6_VB/\`@J=X2\.:'JMGI$_A
M/X=>"O&MS->QO(D]IH?C9;V6VC"8(EE6`HA/`8\U\MF&$>!6%K8&6*EB/KE&
M$83Q>(J0J1ES*4)0J57%IJ^_8_1LJQ+XD_M^IF>$P-2IEG"&85\"L-@L-@8P
MQ&$GAUAZTH8.G0C6K1]K/FJ55.=2ZYY.T;?T7QNLJ)(ARCJKJ?56&0?R-/J&
MWB,-O#"3DQ11QDCN44*3^E35](?`A4<L,5Q&T,\231.,/'(BNC#T96!!'U%2
M44`9QT?26@2U;3;%K:-BT<!M83"C'JRQE-@8]R!FH6T#0V`#:/IK`#:`;*W(
M"^@S'P/85KT4K+LON73;[@*=IIUA8*R6-E:VB/\`?6V@CA5O]X1JH/XTZ:QL
M[F'[/<6EO-`3DPRPQR1Y['8RE<CUQ5JBG;R_`#-ET?29EC2;3;&585V0K):P
M.L2_W8PR$(OLN!5J2SM)H1;2VT$EN`%$#Q(T6T#`'EE2F`.@Q5BBE9=E]P%>
M&UMK=$C@MX88X_\`5I%$B(G;Y54`+^`KYR\<_LN?#WQWXL/B[4(HXKZXG6;4
MXGTG2-034P`J^3<2:A:7$R1;5`VPN@&20,\U]*T5%2E3JQ4:D(R2::36S6ST
MM_P5H]!-)[H^$_A]_P`$_O@U\-?VC=5_:5\,S:M:>+]6T:/0)]*3[*FA)ID.
M6BMX;1(@(E24F9=FTASQQQ7V]=:9IUZRO>6%G=,@VJUQ;13,J_W5,B,0/8<5
M>HJ:5"C0C*%&G&$93=248K1SE:\M;ZNR!1459))7O\^YDG0=$;&[2--;``&;
M*W.`.@&8^`.P[5=>RLW6%'M;=DMR#`C0H5A*C"F(;<(0.!MQ@59HK6R[+[AA
M1113`****`"BBB@`HHHH`****`/DG]MW2/#&I_L[>.I?%,<#66G62WT$MQ<R
M6J07D#A[:7S(Y(SN21054D@D8((KXI\5S:=-<V]SXCE\[3KO]F[08_AQ-<N[
MP3>,##%]F&B,3AM4P4(\K]Z5QUK]<]?\/:+XHTNYT7Q#IEGJ^E78"W-A?P1W
M-K.%.0)(95='`/."IK,N/`G@ZZ@T>VN?#>CSV_A_R_[&BEL+9TTWRE"Q"T5H
MR(!&J@((]H4`8Q@5U4L0J<%%J3M*3T=K*2A\/9MQU[I]SFJ4'.;DG%)J*LU?
M57U???1=TC\8="AUV/3[ZUUU=3'Q?E\:?#"3PW'=F?\`X2%M#2TTK^VWL0?W
MOV$#SQ=[?W>[>&&:SOV^]8_:T\0_ME_`'X#_``'_`&@M0^#^D?$;P;J6H:B8
M+&WNXDN]/E9?-*R022%F$97"G`!YYYK]NI?"7AJ?6;?Q#+H>F2:W:0FWMM3>
MS@:\@A)SY<4Y0R(O/16`QQ7Y(_M+?\I4OV//^Q$\4?\`I1/14HT,T4J%>-6,
M%1K5+TJU2C-3A3YH<M2DX344X)VO:5VFFB(RK8#V=6C5M46(P\8RY8RT<[2O
M&<90;:DUJGHEV,YOV#/V]_[&RG_!0[Q[_P`)%Y8^9M'TDZ3YO?\`<_V=YXC]
MM^[WKPWXN?LN_P#!1SX,?"SQU\3];_;]\1:R/!NASZS9Z98:'8VZWMQ:D.MO
M=O-9D?9Y0"KA-K8/!]/Z$J^/?V^KHV7[(?QRN@F\P^"M1?;ZX4<5\QBLIPM/
M#UJD*F-C*G1J2BUC\7O&#:;3K6;32W[(^ZPG$O$&.S3*5AXY;6QE.MA<)@\-
M+*,HAA<34E5C3HT\92^J0HXCVDY*%2IB.:4DVY3ZG>?LF^,?$WQ`_9M^"_C3
MQE>?VCXI\2>`-`U77;[`7[7J5S:*US/M``'F29;``'/'I7T-7R;^PG=&]_8]
M_9VNBNPS_"[PS)L_N[K->/PZ5]95ZN$DY87#2;<G+#T6Y/5MNG%MM]6]V^I\
M[F,,12S#'4L71I8?%4\9B88FA1C&-&CB(UIQK4J,8-PC2IU%*%-0;BH)*+:L
M%%%%=!QA1110!5NK&RO0@O+2VNA$VZ/[1#'-Y;?WD\Q6VMQU&#4$FD:5+*L\
MNFV,DZ[=LSVL+2KL^[AV0L-O\.#QVK1HI63W2?R`A^SP;_-\F+S,`;_+7?@=
M!NQG`[#I5)]$T>20S2:5I[S,P8RM9P-(6'1BYCW%O?.:TZ*&D]TGZH"O+:6L
MPB$UO#*("&A$D2-Y3`8!CW`["!QE<<436EK<1O#/;PS128,D<L2/&^.FY&!5
ML>X-6**=O+\`*D5A8P0?9H;.VBM_F_<1P1I%\WWOW:J%^;^+CGO45MI.EV<G
MFVFG65M+C;YD%K#$^T]MR(IQ[9Q6A11;RVVTV`KRVEK.DD4]M!-'-_K8Y(D=
M),?WU8$-^(-57T;29(XX9-,L'ABR(HGM8&CCSUV(4*IG_9`K2HHMY?@!'%%%
M!&D,,:111C:D<:A$1?154``>P%2444`%%%%`!1110`4444`%%%%`'P3^V#8>
M$[?XB_LQ^(]5EMK77[7XIQ6.FW4UV\#>1/IEZ7B6(.(Y=\F,!T8Y.!VKY`\6
M1ZTVIZ];6HU!OBVWQ>UZ>S2'S3KY\(O9ZC_9TD07][_9(!A"$#R=Q3@G!K]D
M-?\`!WACQ3-IEQXAT/3M7GT:Z6]TN6_M8;E["[4$+<6S2HQAF`)`D3#`<9J0
M^$_#1UM/$9T/3/[=2W^RKJOV.#[<(./W7VC9YNW``QNQ@8KKI8E4XPBXN3BI
M+=6=Y.26U^5W]Y>ECEJ8=SE*2ER\TD]%K\,8O7^;W;I_+S/RP_9_61OBC\%$
MT07!UZU\+:^GQ6$'F?:(]8-S`8QXB':Z8;S#Y_.W=Y?>O5_V=?VG/%'CG]J_
M]JGX0>+M5TI/#/PLG\*-X7:2>&"=!K$5X]U#(6==Y1H4`XR._7G[YTWPKX;T
M;4+_`%72M$TVPU+5&#ZA>VMI##<7CKG#3RQH'D;D\L23WK^<SX5_L._"W]H/
M_@H1^W'_`,)1KOCK26TR^\':C%_PCWBC5=*62?58K^2Y\T6EW$713&HA0DK&
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MTKWZ7Z_1U,-P]'$9=&&;YA/"UJ4)9IB'E%.-3`57_%IX>A_:,OKT8?9FZN&Y
M_P"6)^TW_"4^&O\`H/Z/_P"#&T_^.T?\)3X:_P"@_H__`(,;3_X[7XR_!+_@
ME]^S#\7_`(5^"?B2UQ\6M);Q=HEKK!T[_A:'C!_LAN5W>3N&L$-M]<UZI_PY
MV_9?_P"@S\6O_#G>,?\`Y;T0Q.:3A"<<!A7&<8RB_KTE>,DFG9X2ZNG_`%;7
MW%E?`#2?^MV>ZI/_`)).EUM_U/S]1O\`A*?#7_0?T?\`\&-I_P#':/\`A*?#
M7_0?T?\`\&-I_P#':_+G_ASM^R__`-!GXM?^'.\8_P#RWH_X<[?LO_\`09^+
M7_ASO&/_`,MZKV^:_P#0!A?_``OEY?\`4)Z_UN_[+X`_Z*_/?_$2I?\`S_\`
M7^GI^JMEJNF:CN%AJ%G>E/OBUN89]H_VO+=L?C3[K3K"^*&]LK6[,>=AN((I
MBF>NWS%;;GOBOPQ_9&^$>E_LV?\`!2WXG_!CP'XF\9WO@&7X$Z3XD.C>)O$N
MJZ_#%K$GB%[9[J`ZG=7+1.T("G:1G\Z_=JML%BIXNE4E4I*E4I5ZM"I!3]K'
MFI2LW&?+"Z>ZO%-=3RN)\CP^0X["T,)CIYC@\=EF`S7"XFIA7@JKH8^C[6$*
MN&]MB%3J0UC+EK5(O=/6Q4M["QM8F@M;.VMX7SOBA@CCC;/!W(BA3D=<CFFV
MNG6%B7:RLK6T,IS(;>".$N?5_+5=Q^N:NT5V_+;8^;*<VGV%Q+'//96LT\/^
MJFE@B>6/O\CLI9>?[I%1KI.EI<"Z73K);H-O%P+:$3ACU;S=F_=[[LUH44K+
MLM[[=>_J`=>",BJD.GV-O))-;V=M#+*<RR101H\A/4NZJ&8_4FK=%/Y`4[G3
MK"\18[NRM;F-#N1)X(I55AW"NI`/O2O86,D`M9+.V>V`"B!H(VBVKT'EE2N!
MV&,"K=%*R[+[@*=KI]A9;_L=G:VOF8#_`&>".'?CIN\M5W8]Z=-96=Q";:>U
MMYK<G)AEA1XB0<@E&4KD$YSCK5JBBR6R7W`9LNCZ3,L:3:982I$NV)9+2!UC
M7^Z@9"%'LN!6@B)$BQQHL:(`JHBA550,`*J@``#@`"G44[>7X`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`$-Q_Q[S_]<9?_`$!J_(7_`()A?\E/_;I_
M[.*U+_TSZ;7Z]7'_`![S_P#7&7_T!J_(7_@F%_R4_P#;I_[.*U+_`-,^FUUT
M/]VQO^"A_P"GX')7_P!XP?\`CJ_^FV?L!7\Q7[?_`,3O&OPJ_P""F_@#7/!&
MMSZ!<:GX2^'NB:U>PHA1M#O_`!Y%;WT-R\BE8H)())%>0E=H)(((R/Z=:_#;
MXI_";P1\;O\`@J1XC^'?Q"TE=8\-:Q^SCIAN;<2R6]Q%+!XFGDAGM+N$K/:S
MQN`R30NKJ0"#D5\SGM.I6H86G2ER59X[#JG)MI*5Y-7:U2NK-J]NS/T#@Q-T
M^+U%V;X+SJS[/VF#L?M'H7BOP]KB0PZ9KVE:G=BVBDEBLKZVN91E!ERD,C$`
MG/.,&GWOC#PKIMTUEJ'B+1K*\0J&M;G4;6&=2WW08GD5QN[<<]J^9?@7^Q'\
M#_V>/$MQXK^'5MXLAU6ZL1ITIUKQAKVNVOV8-N`6UU*]N(4<'^-4#8XSBN*^
M.G[$7[-'CGQ'KOQD^*$WBO3[U8H;W5M2M?'?B'1-*MH;!%V2FTL[^"TA1%C!
M?:@#<ENIKN=3&J@I>PP_ME+WX/$35-4TOC]I["]^Z<$ENW8^(O*U[*^EU?2W
M76W;R^9]W12QSQI-#(DL4JAXY(V#HZ,,JR,N0RD<@@X(J2N,^'B>&H_!'AB+
MP=??VEX7BT>RCT*^^U/??:=-2%5M9?M<C/)<;X@I\UW9G^\3DUV==D7>*>FJ
M3T=UJNCZKL^J*"BBBF`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!7XX?M+?\I4OV//^Q$\4?\`I1/7['U^.'[2W_*5+]CS
M_L1/%'_I1/7;@/XM3_L&Q/\`Z:D<F,^"E_V$X?\`].Q/V/KY%_;O$1_9+^-H
MGV>4?!NH;]^`N-O?-?75?'G[?=JU[^R%\<K5'V--X*U%`_/&5'IS[5Y&-_W/
M%?\`8/5_](D>K@H4:F-PE/$8F6"H3Q-"%;&14I2PM*56*J8F*BU)RH0;J)1:
MDW'34V/V'1$/V1OV?!!M\K_A6/AKR]GW=OV-<;<=O3VKZKKY,_82MFL_V//V
M=;5V#M!\+?#,9<9(8K9KR,^M?6=/!_[IA=+?[-0T[?NHZ"QL:-/&8N&'Q,L;
M0AB:\:.,FI*6*I1JR5/$R4FY*5>"51J3;O)WU"BBBNDY@HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`K\>_P!B_P#Y
M2$_MZ_[OP[_])]3K]A*_'O\`8O\`^4A/[>O^[\.__2?4ZZ\/_!QO_7B'_J11
M.3$?Q<'_`-?Y?^FJA^PE>:_&+PAX/\??#+QGX.\?W,-EX-\0:+<Z?XANKBX6
MTA@TZ;;YTDER[(L*K@?.6`%>E5\Y?M<^#?$WQ"_9L^,/@OP;:27WB?Q%X-U'
M3M%M(I1#)<7LWE^7&DI90C-@_,6'UKS\0[4*SY/:6I5'[-IM5+0?N66OO_#L
M]]F=3V>E]-N_D>E_"GPKX4\$?#SPIX5\#W,5WX4T32K>RT.YAN!=Q36,0Q$Z
M7"LZR@C^,,0?6O0J\!_9;\)>(O`OP`^%WA+Q9:R67B+0_"UA8ZK:RR>=)#=Q
M)B1&D!8.0>^37OU%!WHT7R>SO2I_NU?W/<7N:_R_#\@CLM+:+3MIM\@HHHK4
M9^/O@K_E,'\2_P#LVW1O_4IDK]@J_'WP5_RF#^)?_9MNC?\`J4R5^P5>7E7P
M8W_L98S_`-+1]SQU_'X9_P"R,X;_`/4(****]0^&"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***\>N?CW\*;3QNOP\N/%
MEG'XJ:40?8C'-Y"W!Z6SWWE_8TN3_P`\&F$O^STJE&4K\L7*RN[)NR[Z"<HQ
M^)I7=E=VN^VIZW<?\>\__7&7_P!`:OR%_P""87_)3_VZ?^SBM2_],^FU^G6C
M?%+P'XJUC7O"^@^(K+4-<T1)4U"RB8[D8(P;R7("7`3^,P,X7N:_,7_@F%_R
M4_\`;I_[.*U+_P!,^FUU4E*.'QJDFG[.@[-6T=>%F<E:2>(PEFG[]79W_P"7
M;['[`5^/]O\`\I@;[_LW&Q_]2.XK]@*_'^W_`.4P-]_V;C8_^I'<5X&9;Y?_
M`-C'#?G(_0^"OAXM_P"R,SG_`-.8,_8"OG_]J3P'X@^)WP$^)?@7PO#'/KWB
M/PUJ&G:9%*VR-[FX@DCC5FR,`LP!/:OH"O!?VG?B%KOPK^!/Q(\?^&C"NN>&
M?#>H:GIS7"[X1<V\$DD9=3D%=RC(]*[<3R?5Z_M.;V?LJG/R_%R\KYN7SMMY
MGP[V?HR;]F?P1KOPW^`OPK\#>)H8X->\,>#=$T?588FWQQWEE910SJK=P'0X
M.3D<YKW2O$/V;?'>M_$[X%_"_P`?>(S"VN>*_!^C:SJ9@7;";R]LXIIC&H``
M7>QP,5[?1A^7V%#V=^3V-/DYM^3DCRW\[6OYA&W*K;65O2V@4445L,****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBO)?'GQR^&'
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M0+E_NA=G.<]J\C&_[GBNG[BKKV]R1Z^`G"GC<'.KA'CZ4,50E4P*YKXRG&K%
MSPJY5*5\1%.E[J<O?T39-^PC<27?['G[.MS*H62?X6^&9'4`C:S6:DC!]/PK
MZTKY4_8<>*3]D7]GQX2K1-\,?#10K]TK]C7&WV]/:OJNC!_[IA=;_P"S4->_
M[J.OS%C9PGC<7.EA7@:4\57E3P3YKX.$JLW#"OF2E?#Q:I/F2=X:I/0****Z
M3E"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH
M`***\;E^/_PE@\<?\*ZE\7V*>*]_E_82LODB8`DP&^V?8Q<`*=T!F\Q<'*C!
MIJ,I7Y8MV5W9-V7=^0G)*UVE=V5]+OLCV2OQ[_8O_P"4A/[>O^[\._\`TGU.
MOU$\-_%+P'XNUO5_#OA_Q%8ZCK&A2"+4;.)R'C8Y_P!46`6X52,.T!=4.-Q&
M17Y=_L7_`/*0G]O7_=^'?_I/J===!.-'&III^PINS5M'B*+7X')7:=7!M-->
MWDM'?_EU4['["5X7^TQ\2]5^#GP'^)_Q.T2VM[S5?!GA:]UJQMKLLMM-/;;-
MJ3%?F"'=SCFO=*\V^,%CX!U/X9^,K#XHM;I\/[G1;F+Q4UVYBMETD[?M!FD'
M*ITR:\^MS.C54)*$W3FH3>BA+E?+)OHHNS;\CL>S,']GGXAZG\5_@Q\/?B'K
M%O!:ZGXK\/6>JWEO:DFWBFN%RR1%N2HZ#/->SUY]\*[+P1IWP^\+67PX:W?P
M1;Z5;Q^'&M7,EN=-"_N/*<\LF.`37H-%'F5&DI24Y*G!2FM5.7*KR3[2>J]1
M*]E?5V5WW\PHHHK09^/O@K_E,'\2_P#LVW1O_4IDK]@J_'WP5_RF#^)?_9MN
MC?\`J4R5^P5>7E7P8W_L98S_`-+1]SQU_'X9_P"R,X;_`/4(****]0^&"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`1ONGC
M/!X_"OQ-\=3I+\;/$WA^ULYS87?Q56['@I-.G_X26_UTQJ(/%EKJXBW1Z)$^
MTM;B81$J?E]?VSK`?PKX<?65\0OHFFMKB1>2FJ-:0F]6/^Z)RN\#GUZ5O0K*
MBYMQ<N:-EK:SZ7T?WK5=#&M2=512DH\LKNZO=6M_2V?4_+OX#632^./@?I>F
MZ?=Q>)?!>G?$6/XJ'[+/!/;3:AY_]CIJ]S(B)>NX(\DAI2N1R.*PO^"87_)3
M_P!NG_LXK4O_`$SZ;7ZT+HVDV+ZC?6>G6=M>7L<C7=S#!''/<,(VP99%4,Y^
MIK\E_P#@F%_R4_\`;I_[.*U+_P!,^FUTJK[6AC':R5.CN[O7$QD_E=V2Z)):
MG(Z;I5L(FT[U*FJ5MJ*BM.]E=N^K>R/V`K\?[?\`Y3`WW_9N-C_ZD=Q7[`5^
M/]O_`,I@;[_LW&Q_]2.XKYS,M\O_`.QCAOSD?I'!7P\6_P#9&9S_`.G,&?L!
M7G7Q8N?`EG\/?%-S\319GP-%I=R_B/[?'YMI_9HC8W'GQ[6W)Y8;<-IR.,&O
M1:\0_:/^&^K?%WX*?$'X<Z%<6UKJWBKP_?:597%VQ6VBGN87C1I6`8A`6R<`
M_2N^LY*E5<(*<U3GRP:NIOE=HM=5+:W6Y\0]F=C\+;GP3=_#[PE<_#C[)_P@
MTVB6,GAC["GEVG]D-`AL_L\85=D?D[=J[1@8XKOJ\;_9[^'VJ_"GX+?#;X=Z
MW/;W6K>$/"FD:'?W%H2UO+<V%I%;RO"S`$QLR$J2`2,9%>R44>;V5+FBH2]G
M#F@E90ERJ\4NBB]/D)7LKJVBT[>04445H,****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"OR1_;)NK:S^,LH@*Z+-?^!UM=5N=2TV?
M48?%MA]M9F\.:$R0RK9ZM-SY=PAC<%AEL#-?K=6#J_A?P[KTUG<ZSHNG:G/8
M2B>REO+6*>2VE4Y#Q-(I*,"`<COS6U"JJ,^=Q<E9JR=M[>36C7;SW1E6I^UA
MRWL[IWL_GM9K0_&&QT>XC75?#$.@:OI_CG7/&OPSUGP1975O<R:M;^$[&UTL
MZ@(;\KM@@@B26.Y1I4WD.-ISQU'[1X9?^"I?[&P;[P^'_B0-G^\)I@?UK]@7
MT72'OH=3?3;)M0MXO(@O#;Q_:(H<Y\M)=NY4SV!Q7Y!_M+?\I4OV//\`L1/%
M'_I1/7=AZWMJLO=MRX;$WUOJZ-G;R]U=W=O4XZU'V4(:WOB</TMI[:_W^]^"
M/V/KX^_;XM!??LB?'&T+;!-X+U!"V,XRHYK[!KX\_;\FG@_9!^.L]LNZ:'P/
MJDJ*%W$E(BQP.YP#CWQ7@XW_`'/%?]@];_TB1]#E2Q;S3+E@:M.AC7CL(L'7
MJM1I4<5[>G["K4E)2BH4ZO+.;E&45%-M-:&E^PI:_8OV/_V=[0-O%O\`"[PS
M$&/4A;-1G\?P^E?6-?@Y^R+_`,%5_P!G3P9^S/\`!3PKXAMO'8UO0/`&A:9J
M?V;PAK$UO]LM;81S>3+':LCQ[@=K*2".1Q7T;_P]^_9;_P"?;XA?^$9K?_R'
M7!A,URV.%PT7C*$7'#T8N+FDTU3@K-=&KI'UV8<`<?5,?C:F)X?S/%XF>+Q,
M\1BJ.&<Z.)K2K3=6O1E%1C*E6FY5*<HQC%PDFHI:'ZK45^5/_#W[]EO_`)]O
MB%_X1FM__(='_#W[]EO_`)]OB%_X1FM__(==']KY9_T&X?\`\&+R_P`T<?\`
MQ#WC?_HE\X_\))GZK45\._LZ_P#!03]GW]IKQMJ?P[^'VK:M#XPTO3DU6?1-
M<TJ[TJ\>P<L!<11744;/'\K98<<5]Q5UT,11Q,/:X>K"M3NX\\'S1YENKKJN
MJZ'SN9Y3F>2XIX+-L#B<OQ:IPJO#XJE*E5]G57-3J*,DKPFM8R5T^C"BBBMC
MSPHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@!#T/&>.E?A;
MXX6UN?C7KVB:?I]VL5SXYUN6S\%)87/_``DG]NO9WT:^)EU81?+I4\[AX(!/
MY8#J<`BOW3KGSX4\--K/_"0G0],.N;!'_:AM(?MNP=%\_;OQCCKTKHH5O8N;
M<7+FC9).VM[W>C_#7L]68UJ7M>77EY97VO==5NON=T^JT/RS_9_TV\N?BC\&
M++2M/O8M<\&>%]?L?BC(MM/;-#JL]U`T"ZK.ZJEY-*JL4<-)G!^:L?\`8O\`
M^4A/[>O^[\.__2?4Z_7*TT?2K"ZN[VRT^TM;N^96O+B"!(YKEDR%,SJ`SD9.
M,FOR-_8O_P"4A/[>O^[\._\`TGU.NF-7VM+&.UK8>"M>^^)I2>NG5Z:;6.6=
M-TIX17O?$-[66E"45IWM%7?5Z^1^PE?/O[57P]U_XK_L\_%CX=>%T@?Q!XM\
M(W^D:4MR[1P-=W&SRQ*Z@LJ_*<D#BOH*OG[]JGX@^(OA5^SS\6/B'X3>&+Q%
MX3\(W^KZ1)<1":%;NWV>69(CPZC<<J>M>1B>3ZO7]IS>S]C5]IR_%R<DN>U^
MO+>QWRM9WVL[^EM2[^S1X$UOX9_`OX:^!/$:PIK?AKPU8Z9J2V[%X5N8$VN(
MV8`LN>A(KW2O"OV:?'NM_$SX&?#7QSXFF@EU_P`2^&K'4M3>!%BC:ZG3+E(@
M?D'HHZ5[F753AF4'T)`/ZT8=P]A0]G?V?LJ?)S;\O)'EOYVM?S"-N56VLK>E
MM!U%("",@@@]QR*6MAGX^^"O^4P?Q+_[-MT;_P!2F2OV"K\??!7_`"F#^)?_
M`&;;HW_J4R5^P5>7E7P8W_L98S_TM'W/'7\?AG_LC.&__4(****]0^&"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`K#NO$WARQF>
MWO=>T:SN(_\`607.I6<$J?[\<LRNOX@5N5_.%_P5/_9<\._#;68OCY!XY\=:
M[KOC_P`4+I-QX&N/BIJG@[2IGU!A%91Z-'9VEYY"VK$^9MBVMN&YEQSTX6A#
M$552E4=-RTA:'/S2[?%%+2^K=OS.?%5IT*;J1IJ:C\=Y<O+'OI&3>O1+\='_
M`$6Z;JVEZQ`USI.H66I6RR-$UQ8W,5U")%QN3S87=-RY&1NR*T*^%/\`@G;\
M+KWX3?LV>&O#NINXU*ZN)]7OK.7Q!+XGN--GOTCE-C<ZS,L<MY-$A4M(\<;$
M,/E%?==958*G4G",N91DTI6MS6ZVN_S9K2FYTX3<>5RBFXWO9M;7LKV]$0W'
M_'O/_P!<9?\`T!J_(7_@F%_R4_\`;I_[.*U+_P!,^FU^O5Q_Q[S_`/7&7_T!
MJ_(7_@F%_P`E/_;I_P"SBM2_],^FUO0_W;&_X*'_`*?@<]?_`'C!_P".K_Z;
M9^P%?A]^TW:?M-_!;]OFV_:)^%/[/FL_&OPGJGPAM_!DPT6Z$$VGZE#K$UZ3
M*IQE6B88.>M?N#17DXS"_6X4XJK4H3I585J=2FH.49PO;2I&46M=4T?5\.9^
M^'\7BL0\OPN9T,;E^*RS%X+&2Q%.C6PV*Y'->TPM:A6A-2IPE&4*BVLTTS\:
M?^&^_P!N#_I'QX^_\&"__%5Y3\;_`/@HI^W!X?\`A7XSU?\`X8C\;>!S9Z/=
M2#Q5=WJR6^A_NV']H2IO&Y+;_6,N1D+BOWLKXM_X*&Q3S?L<?'>*W)$S^!]5
M"$'!!^S2=^U>?B\)C:>%Q$UFN*;A1J225'"IMQ@W:ZHW5[;K75VZ6^APV?\`
M#6/Q%#`RX)X?R^.,JT\++'RS'B!QP4:\HTGBVI9IRM8=2]JU+1\C3T;/4_V6
M/&.N_$']GGX1>-/$UU]MU[Q+X&T#5]5N@NP3WE[I\,\\FW)QND=N,FO?Z^5_
MV(/^31_V>5/+I\*O!\<I]94T>V#GW^;O7U17J85N6&PTI-MNA1;;U;;IQ;;?
M5M[GPN*HPP^)Q&'IUH8FG0KU:,,13_AUX4JDH1K0U?N58Q4XZOW9+5A1116Y
M@%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M5^.'[2W_`"E2_8\_[$3Q1_Z43U^Q]?CA^TM_RE2_8\_[$3Q1_P"E$]=N`_BU
M/^P;$_\`IJ1R8SX*7_83A_\`T[$_8^OG+]K7P9XA^(7[._Q3\&^%+$ZEX@U_
MPS>V&F6*G!N;F5<+'D\?-R*^C:\._:2^).K?"'X(_$+XC:';P76J^%-`NM4L
MH+K_`%$LT(RJR?[)/6O,Q/(\/751N-/V53G<?B4>5\S7G;8ZWLSB?V6O@[8>
M"?V>/@_X3\8>#=$M?%&@>!M$TW7+>?3+.26'4;>V"W"/(T)+L'SECR3S7OO_
M``@W@S_H5?#_`/X*;'_XS7`?LZ?$/5/BS\#?A?\`$G6X(;;5O&G@_2=?U"WM
MO]1%<WT`ED2+'\`)^7VKVFIP\*7L*/)%.'LJ?(Y17,X\D>5RTW:2;\S6.(K\
ML;5ZUK*W[R>UM/M=CE?^$&\&?]"KX?\`_!38_P#QFC_A!O!G_0J^'_\`P4V/
M_P`9KJJ*VY(?R1_\!7^7DON']8Q'_/\`K?\`@V?_`,D?C=;Z1I6D?\%@(X=*
MTZRTZ)_@':,T=E;16R,V^ZY9(512?<C/O7[(U^/]S_RF%A_[(#:?^AW5?L!7
MGY:K+'I*R698JR2LO^79]EQO*4O]4I2;E)\%9%=R;;>F)W;U"BBBO2/APHHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*_'O\`8O\`
M^4A/[>O^[\.__2?4Z_82OQ[_`&+_`/E(3^WK_N_#O_TGU.NO#_P<;_UXA_ZD
M43DQ'\7!_P#7^7_IJH?L)7"?$[P#I/Q2\`>*_A[KI<:1XLT>ZT:_:/[ZP72;
M69/]I>"/<5W=%<<HQG&4))2C).,DUHTU9I^J.L_/7]GW]A2_^`GBK1M8L/CO
M\2_$?AS0[>XM;'P7K&KW$^@16\IS%$MHSF,+`.(QC@=*Z[]H3]DOQ%\:/%<7
MBO3?CW\2OAK:6VG+;2:/X4UBXL=.?R2SM<O%&ZJ9"I^9B,X4=A7VY5+4HGN-
M.OX(QF2>RNH8QTR\D$B(,]OF85R+`86-%T%2?LKJ7(JE5:I)*TE/F2LEHG;R
M)Y(I<MM%LM>GS/)O@,FA6/PZTGP_H7CZX^)">&S+H]]XGO;TW]_=WUM(PF6]
MN"69KA&RK[CD8Q7LU?"/[`GP:\>?!7X;>,]`^(%FMGJ>K?$;Q+KUDBSM.'TW
M4+V::U?<V""48?+T'2ONZM,)*4\-0E.FZ4G3C>FVVX6TY;RU=DNNHXWY5=6=
MMNQ^/O[07P!_;`\$?M@7_P"U3^S-H_@#QJGB'X<6G@'6/"WC#5YM&>(6NIMJ
M"W=M=16MRW5L$;0",BD_X6M_P5U_Z-Y^!7_AP[__`.4]?L'17(\L2G5G1QF-
MPZJU)5I4Z52GR>TG;GDE.E.2YFKM<UNR/N(<;2EAL%A\PX;X:S:I@,'0P%#%
MX_"X[ZU]4PRY</2J2PV8X:G/V47RQDZ2DU;F;L?CY_PM;_@KK_T;S\"O_#AW
M_P#\IZ/^%K?\%=?^C>?@5_X<._\`_E/7[!T4?V=4_P"AGF/_`(,P_P#\SC_U
MQP7_`$1'!W_A+FWE_P!3CR/Q\_X6M_P5U_Z-Y^!7_AP[_P#^4]'_``M;_@KK
M_P!&\_`K_P`.'?\`_P`IZ_8.BC^SJG_0SS'_`,&8?_YG#_7'!?\`1$<'_P#A
M+FW_`,^/)?<?CY_PM;_@KK_T;S\"O_#AW_\`\IZ/^%K?\%=?^C>?@5_X<.__
M`/E/7[!T4?V=4_Z&>8_^#*'_`,SA_KC@O^B(X._\)<V_^?'DC\?/^%K?\%=?
M^C>?@5_X<.__`/E/1_PM;_@KK_T;S\"O_#AW_P#\IZ_8.BC^SJG_`$,\Q_\`
M!E#_`.9P_P!<<%_T1'!__A+FW_SX\E]Q^/G_``M;_@KK_P!&\_`K_P`.'?\`
M_P`IZ/\`A:W_``5U_P"C>?@5_P"'#O\`_P"4]?L'11_9U3_H9YC_`.#*'_S.
M'^N."_Z(C@__`,)<V_\`GQY+[C\?/^%K?\%=?^C>?@5_X<.__P#E/1_PM;_@
MKK_T;S\"O_#AW_\`\IZ_8.BC^SJG_0SS'_P90_\`F</]<<%_T1'!W_A+FWE_
MU./(_'S_`(6M_P`%=?\`HWGX%?\`AP[_`/\`E/1_PM;_`(*Z_P#1O/P*_P##
MAW__`,IZ_8.BC^SJG_0SS'_P90_^9P_UQP7_`$1'!_\`X2YM_P#/CR7W'X^?
M\+6_X*Z_]&\_`K_PX=__`/*>C_A:W_!77_HWGX%?^'#O_P#Y3U^P=%']G5/^
MAGF/_@RA_P#,X?ZXX+_HB.#_`/PES;_Y\>2^X_$7XC_M,_\`!5+X3^"O$'Q#
M\7?L\_!4^&_"MA+JVL_8?']]+=_8+8;[C[/&=)0/+Y8;8-PRV.17ZH?LZ?%:
M7XX?`_X9?%F?3ETB?QYX2TGQ%-IBN95LI;^W65[=9&`,BQL2`Q`)')%>7_MX
M?\FD?'/_`+$76/\`TF>J'_!/G_DS#]G3_LF'AO\`])!6>&C6H9C+#RQ6(Q%*
M6#=9*NZ<G&:K0A>+A3INSBW=.YV9Q5RW-N#*6<T<ARG)\=1XE_LUSRJ&,I1K
M86>6/$\M:&*QF*4I1JQ3A*/(TKIWOI]DT445ZY^=A1110`5^"G_!7SQ[\'M7
MUGX=_##Q]?\`Q2\%:ND6H:K8>._!7ARZUFVM(8I+>233MD(*F:[(4++E7A*_
M+D&OWKK\O/\`@I'\4]8^"&E?#SXA^'Y_`][J7]L-H,/A/Q@+&*+7[G57CBMY
M4NKJVN#&EHXRX"8.X9(KLP#MBJ;2;E[W(E+D]_E=M7&:MY2C;OH<F-7-AJB;
M2C[KE>+E>/-&ZLI1?S33['NG[!0\+R?L[>%;_P`)R^+[W3=2#7CZMXX@FM]?
MUF<QQQMJ5S!/B2(3K&NU"`%`P*^SZ^<?V6+SQMJ'PET>^\?WWAVZ\27CM=7=
MGX7\@Z5HRW$<<T>E1-;A8G:V5QEE5`0P^45V?BCXU^!?"GB[1?!%_?3W/B'6
M9`BVFGP&Z%A&WW;C4F0XM(&P=LDF`=I]*RK*4Z]3E3D^:3T?-IOO972[V2-:
M3C"C3NU%<L5JN75Z+2[LV^EW;N]SU6X_X]Y_^N,O_H#5^0O_``3"_P"2G_MT
M_P#9Q6I?^F?3:_1[PU\;_AWXV\0Z[X0T#6X[K6-)2X1XR-D-YY2,)6L)2=MT
ML1!$ACR%QSQ7YP_\$PO^2G_MT_\`9Q6I?^F?3:UI1E'#XU233Y*#LTT[.O`Q
MK24J^#<6FN>KJM?^7;/V`HHHKC.P*^,?^"A-U]C_`&._CK<%2PC\$:J=HZG_
M`$>3I[U]G5\;?\%`EB?]C[XZ"<*8AX'U9I-_W0JVLI8M[``D^U<N.O\`4L7;
M_H'K?^FY'7@)X:&.P<\;1GB,'#%4)8JA2DX5*V'56+K4J<TTXSJ4^:,975I-
M.YT7[$7/[)/[/DF`//\`A9X1GP/X?-TBV;'OC.,U]3U^;'["/[5'[/&K?`']
MG_X;Z7\6O!]]XU7X?>&M+C\-V^I*^I?:[;2X%DM!#L'[V':59<\;37UY\3/V
MC/@A\&[ZRTWXG_$KPQX*OM2A>XL;;7+X6LMS"A`>2)2IW*I(!/8UGA,10^I8
M>?MJ/)&A1C*7M(<L9>SA[KE>R?D[/R,L54P\\3B9X6G*AA98BJ\/1J2YIT:$
MJDG1I3DVW*=.FXQDVVVU>[N>UT5R/@CQYX/^)'A^T\5^!O$&G^)O#M\6%IJV
MES>?9S[#AO+DP,X/7BNNKMC*,HJ46I1DDXRB[II[--:-,QN%%%%,`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHKS/XD?%GP=\++*TO/
M$]Y*LNH7,=K8:=91&ZU*\ED8+_H]HAWR+&#ND8<*N332<FE%-M[)*[8I244Y
M2=DMV^AZ97XX?M+?\I4OV//^Q$\4?^E$]?I*?V@/ADGBK2/!LNN)#K>L6D%U
M!%*NV*W:Y57@M+R7.RWO)%92L#G<<U^;7[2IS_P51_8[(Y!\">*"#ZC[1/7=
M@HRC5GS1:OA<2U=6NO92./%2C*G3Y6G;%8=.SO9^TCN?L?7G7Q:L/`>J?#OQ
M38_$Z2SB\"W&F31^(Y-0<1V:Z>1^],[GA4QU)[5Z+7@?[4'P]U_XJ_`?XD_#
M_P`+K`VO>)O#MWIVFBYE\F$W,J_)YDO\"YZGM7EUVU1JM051^SG:FU=3?*[1
M:ZJ3TMU.Q[/T.\^%5EX(TWX<^#K#X:R6<O@.TT*QA\*R6#^99OHR1@6;6S_Q
M1&/&T^E>@5X;^S/X"UWX7_`/X3_#WQ,L*Z_X1\%Z/H>JBWD\Z`7EE;B.;RI.
M-Z;APW>O<J=%MT:3<%3;ITVZ:5E!\JO!+HH[)=+`KV5U;1:=O(****T&?C_<
M_P#*86'_`+(#:?\`H=U7[`5^/]S_`,IA8?\`L@-I_P"AW5?L!7FY;_S'_P#8
MRQ7_`+C/M^-=N$?^R*R+\L2%%%%>D?$!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!117D/B7XW>!/"WC+2/`E]>SW'B#5CS;V$!N8].38
M9!+J<B';9Q,BE@\G&.:<8RD[13;M?17T6[]!.2C\32N[*^FIZ]7X]_L7_P#*
M0G]O7_=^'?\`Z3ZG7Z4^#_C?\.O'7B35_"GA[7(;G6-'<K+"WR+=!3B1[%R<
M7*0MA96CX4D5^:W[%_\`RD)_;U_W?AW_`.D^IUUT(RC1QJDFG["F[--.SQ%$
MY*\E*I@W%J2]O)76NU*H?L)1117&=@53U"=[:POKE,;[>SN9TSTW10O(N?;*
MBKE077D_9KC[1C[/Y$OG[NGD^6WFY]MF[/M0!\9?L/\`Q]\7_M!_#WQ;XG\9
M0V4-_HGC_P`1>&K5;&(Q1FQTN\EAMV=<G,C(H+GN:^U*\`_9Y?X*/X8UL_`Y
M=*7P]_PDNJ#5_P"R<>3_`,)!Y[_VCYNTD>=YV[?GG.<]J]_KGPBFL-152JJ\
MU!<U6+O&H_YD^J)C?E5VF[:M;,****Z"@HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`/D7]O'_DTCXY_]B+K'_I,]4/^"?/_`"9A^SI_V3#PW_Z2
M"K_[>/\`R:1\<_\`L1=8_P#29ZH?\$^?^3,/V=/^R8>&_P#TD%>9_P`SC_NG
M2_\`4BF?<+_DV\O^RTC_`.J29]DT445Z9\.%%%%`!7\Y'_!2WXT_#KQU\0V^
M!OQZT/XU?#W4=`N[G4_`?C?X6^%;GQ$-1T".2.2Z$LRV\MO&]ULCQ\HEAQE6
M`:OZ-Z_$;_@KEXHO%L/A[H7AG3M;U6>_EU5-;N_!_B?PYX4UFQCMECV03:QK
M=C>A$?<W^CH%9\>U=^6M?6HIQNVGRR4N1P:5^9-IQVNFI*SO:Z.',$_JTGS)
M).-XN/,IIR2Y;)Q=[M--.Z/LG_@G;XI^&?BS]GC3K[X5R>,KK0;75;S3KG4?
M'MO-9^)]3U2TBACN+W4K68*UO+*`F8PJJH`P*^89O#'Q+\-_'_XF:E:3^)=7
M\=>,_&TUMIOAZZM3+X83X:20"-;V*\:-O)O;1FF>$)(OS-R#7IG_``22GLYO
MV68Q:Z9K&ER0^,-;AO8=>UJR\0:I+>)Y/FSW6J:?#;VET[Y&7AB13C@5^G)L
M[0W(O#:VYNU3RUN3#&9PAZH)=OF!3Z!L45:GL,5BDH\RE*4??:;^)-7DEM?>
MUKZ:H=*G[?#8:3?*XQC)<J:6JL[*^]MF[ZZ]3\L?@1HFKS^-?@KH,?A_4M/U
MGX46'Q"@^(UQ<63VT*SZUY[:6/MC*/[1W[@%+$^7QBN6_P""87_)3_VZ?^SB
MM2_],^FU^N+V=I`M[<0VL$4]Q%(9YHX4268A&P9750SD=BQ-?D=_P3"_Y*?^
MW3_V<5J7_IGTVFJOM:&,=K6IT>M]7B(R?RNW9=%8B5+V5?"*_->I4Z6VH\J_
M!*_G<_8"BBBO//0"OB7_`(*+_P#)E_Q\'8^!-7![9!M901GKR.#7VU7S'^V3
MX!U3XG_LT?%WP-HR32ZIX@\(ZI9V<5O"UQ/+.]M)LBBA3YG=SA5`YR:YL;&4
M\'BH15Y2P]6*7=N$DD>WPU5I4.(LBK5Y1A0I9OEU2M.?PQI0Q=&4Y2O]E13;
M\CY^_80_9F^!&D_LZ_LZ>/\`3OAGX9L_&'_"L?".H_V]#8JM_P#;KC1[=IKG
MS<D^;(SL6;J237UC\5/@9\&?B7MU_P")G@'0?%D^AV-P;>XU6T6XEM[5$,LL
M<1)!`(3..A(K\GO@=^W!\:?@W\(?AU\*KC]BWXSZO-\/_"6B^%)=5@LIDAU!
M]&LHK-KR*,VA*1SF+S%4DX#8SQ7HNJ_\%'OC%J6F:AIY_8?^-L8O;.YM2_V.
M;Y//B>+=_P`>?;=FO)P^-RRGA*5&4$K4J7M*?U.MRNK"G!-M*CRMIK?_`()]
M9G'`'$F)S;-,1AL'@)X;$9EC:]"4<XR6,94:N)J3I247CTXITY1:32:6C2M8
M^]_V7O'WPG\>?#RY?X-Z/'H7A'PWXDUOPLNFPVIM(8-0T6[:TOA%%TV&5258
M=1S7TC7\]G[+'[5/Q=_9S\#:[X/B_8X^->O#6?&_B?Q:;M+.0"(^(-0>]-K@
M69YM]VPD]<5]-?\`#ROXQ_\`1CGQM_\``.;_`.0ZUPN;X7ZO1]LYPJ\D5.$,
M-B%&+[12I622M:WZ,\Z/AWQ9RKFP6"3MJO[;R33;MF+_`*N?KS17Y*^"/^"H
M5YJ?QA^&GPC^)/[./Q*^%-W\4]7_`+$\-:SXD@=+*:_QD1-NMX]N<'DM7ZU5
MZ.&QF'Q:F\//G]G)0FG"<)1DTI).,XQDKQ::TU1X>=</9OP]4PU/-L*L-+&4
M'B,+*-?#XFE7HQJ2HRG3K86K6I24:L)TY)3O&46FD%%%%=)XH4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!7Y4_M3>&?&</[1NC>.Y-2\3P:9IO
M@T6?P\T[1[4WNF:EXU:_9VM=5C,;I';S6Q6.1S@JK%MP`K]5JK7%G:71B:YM
M8+AH'\R%IH4D,3_WXRZDHW^TN#6M&K[*?-:]XN/R?:_7IZ-F56G[6*C=JTHR
M3UW6U]5?OZI'XWW/AKQS<:KXD\':]X5OX/B-XY\>_#_QCILMO9R/9P:9IJ:=
M)K6S4@N+6&&2*>,0A@K;=N.:E_:/5D_X*F?L;*WWE^'_`(E5L^HFF!_45^Q;
M6=H]PEV]K;M=1J4CN6AC,Z(>2B2E=ZKGL&`K\>?VEO\`E*E^QY_V(GBC_P!*
M)Z[L-6=6K+W5'EPV)V[NC;3RM%67KJSCKTO90A[W-S8G#=+62JW^^\I:^A^Q
M]?/_`.U+X_U_X7?`/XE^/?"\D46O>&O#EWJ.FR3QM+$MS",H7C4@NOJH/-?0
M%>;_`!<U/P)HWPZ\5:G\3([>7P-::9-+XBCNHO.MVT\#]Z)8OXUQVKQZZ;HU
M4IJDW3FE4;LH/E=I-]%%ZW/0>SZ:'(_LQ>.==^)G[/WPD\?>)GBDU_Q9X)T;
M6M6D@0QQ->WMN))C'&Q)12QX4DD"O=J\]^%&I>"=8^''@W5/AO'!%X$OM!L;
MCPK':Q^5;IHTD0-FL,>3LC$>-J]A7H5.C=4:2<U4:ITTZB=U-\JO-/JI;I];
M@MEK?1:]]-_F%%%%:#/Q_N?^4PL/_9`;3_T.ZK]@*_'^Y_Y3"P_]D!M/_0[J
MOV`KS<M_YC_^QEBO_<9]OQKMPC_V161?EB0HHHKTCX@****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`0YP<>E?C!'X4^+WA_XX?$V2VG\1:W
MXZ\>>(=8MSHUY:F3PW:^`6LKV#3;ZTO6C/DWD(D@C!CD79O.03@U^T%5OL=I
M]I^V?9H/M>PQ_:?*3S_+/)3S=N_:2`2N[&>U;T:WLN?W5+GCRZ^M_NOJ[6;L
ME=&-6DJO(W)QY)75O/3NM>SUWV/RI^`7AO7+OXF_!_3;;P_J=C>_"SPQKFD_
M$&\N;22TA&I7EU#);K]I8+_:'FK&YCD;<2%SGUYK]B__`)2$_MZ_[OP[_P#2
M?4Z_7R&SM+>6::"V@AFN"&GEBB1))F'0RNJAG(SP6)K\@_V+_P#E(3^WK_N_
M#O\`])]3KJC5=6GC':UL/!)7OOB:3>OJW;316.6=-4JF$5[WQ#N[6VH3BE]R
MU?5W?DOV$HHHKSCT`JGJ$#W5A?6T>`]Q9W,"$]`\L+QKGVRPS5RJ6I2O!IVH
M3QG$D-E=2QGT>."1T/X,!2>SOM8#XX_8@^`/B_\`9Z^'OBWPQXQGLI[[6_'W
MB'Q+:M9/O066J7DL\"N<G]X$<;AZU]J5\'_L!?&/QY\:?AKXSU_Q_??;]3TK
MXC^)M!LI/*,6S3=/O9H;6/!`)VQJ/FZ&OO"N7`>R^IX?V"E&C[->S4_C4;OX
MO.]R86Y8V5E;0****ZR@HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`/D7]O'_DTCXY_]B+K'_I,]4/\`@GS_`,F8?LZ?]DP\-_\`I(*O_MX_\FD?
M'/\`[$76/_29ZH?\$^?^3,/V=/\`LF'AO_TD%>9_S./^Z=+_`-2*9]PO^3;R
M_P"RTC_ZI)GV31117IGPX4444`%?@W_P6$T;X0>&].\`WNNZ;X'@\2^(;[5Y
M;.]\=S>))M%WJL?VB1K'0=2L;B2?D&-M_EKSE3FOWDK\#/V@?CE\&C\8_B)X
M;^*/[4_@*+4/"^N7L6D^#?%WA;3M2E\)QS'FRM_[2LY]ZOM4&2/[V,`UWY>I
M+$*<5-JFFY*"G=I^ZM81E97>MU;INSBQ[C[!PDX1]H^52FXI*UFW:4HW=EHD
M]]3ZE_X)!VFC6G[)UJ-#U/0-4LI_%VMS^9X8M=1M-#@D?R=T%A%JL]S?>2G\
M+3S2,<\M7ZG5\5_L(>)+?Q3\$DU/3],T.TT<^(-2BT75/#VD+HNF>)M-3R_L
M^OPV$<<4<8O1GF.-4.S@5]J5ABY.6)K2::;J-V;NUZM):_)>>IMA5RX>C%.Z
M5.*32LFK:6U?YD-Q_P`>\_\`UQE_]`:OR$_X)AD#XG_MT9(&?VBM3`R0/^8/
MIOK7Z]W'_'O/_P!<9?\`T!J_"7]@?X5W_COXO?MOWUG\0?%?A$6_[0FIPM9Z
M$]HMM+_Q*--(E<3PNWFG."0<8%71_P!VQO\`@H?^GXF=?_>,'_CJ_P#IMG[O
M[E'\0YZ<CFDW+UW+CZBO#]?^#NJ:WH6A:-%\3/&&E2Z/&R2ZG9268O-3+9^>
M\+PE"RYXV**0_!O5#X/'A;_A9OC(7`N_M/\`;^^S_M0KQ^XW>3Y7E^VS/O7(
M=9[CN7^\OYBC<IX!4_B#7AVA?!S5-&T#6]%E^)GC'4Y=755BU6\>S-[INW'-
MH4A5`6QSO4]:;X.^#6J>%9]0FN?B=XR\0B^L9;-(M5>S9+5I5(%U!Y4*8F3@
MJ6RN1T[$`]R_=D_P$G_=)K&\1.T>@ZT]L0+E-+OF@,>/,$PMI#'LQSNW8Q[U
MXWX7^".K>'=?AUN?XJ^-];ABDE=M*U&2Q-E)Y@8!6$<"OA-V5^;L*R]6^"VI
MV6IW_BV7XK>.6M+26XU>30Q)8_8&AA5IVL@#!O,!53&`6SM//LGL_1@>*_\`
M!/'6OB!K?PD\87/Q)GUBXU>+XK^/;>Q?7HWCNAI$.LRKIZQ"558VRP8$+`;2
MN,5]]?NAU$?_`([7Y^?!6ZTW]J32]>^(G@WQSXZ\#:7I?C#6_"TV@6/]FQ6;
M7OAV]:SN[E$%MG;=R(78G+'.23FOI#Q=\&=4\3OIKV_Q/\9Z"-/LH[1UTN2S
M"WC(J@W-QYL+DS.02VW`R:Y\$HK"T%"HZT53BHU6FG4726O<F.D59WTW[^9^
M>7_!0?:/VKOV`B-H7_A;:Y(P!]QN]?L'N7&=PQZY&*_#C_@H'X#O(_CS^P-X
M0/B_7GNG^*/V8>)&:W_M=6*G]^&V>5YHQQ\F.3[5^J\?P=U-/!LOA0_$OQ@]
MS)>"Z'B%GL_[5C4?\NZGR?*\L]\IGWKGPEOKF::W;KX>ZL]/]DHJW9Z*^G<^
MXXDE-\-\!J5-QC'*<U4)\T7[1//,:VU%:QY7[MI:NUUH>X;E/\0XZ\CB@,IZ
M,#]"*\.\._!W5-"T77=)E^)GC#5I=9A$46HW[V9N],(!'F69CA5`YSSN4C@5
M%X.^#&J>%;V[N[GXG^,_$*W5G-:K;:J]D88&E4J+B(10(?-CSE,Y4'MVKT3X
MD]UWK_>7\Q1O7^\OYBOGS0/@;J^B^(+?6Y?BQXXU2*"X><Z5>R6)LI0[%A$X
M2`/L7.!ALX[TE]\"]8O/$<FOI\6O'-K"]\MX-(ADL?L"(K!C:J&MS)Y)QM.6
MSCO0!]";U_O+^8I=RC^(<].1S7@?B[X)ZMXGUDZK;_%3QMH,9BAC_L_3)+(6
MN8@H+XE@=MSXRW/<XQ5KQ;\'-4\3PZ-#;_$WQCH)TFQ2SDDTQ[-7U!UZW-WY
ML+@S-W*X'M0![EN7&=PQZY&*-RXSN&/7(Q7AVI_!S5-0\*:3X:3XF>,;.XTR
M9Y9-=MWLQJ=^'S^[NBT)C*KGY=BKTYHL_@[JEKX0U#PLWQ-\8W%Q?7"3IK\K
MV?\`:EJJXS#`PA$7EMCG*9YX]P#W'<I_B''7D<4FY3T9?S%>&^&/@WJGAVQU
MNSG^)OC+6GU>U-M%=:A)9F;36./W]H8X5`D&/X@1_2#P?\%=5\*ZG)J-Q\4?
M&GB!)+::W%EJKV1MT:52HF410(PDCSE><<<@T`>\[U_O+^8HW*."R@_45\^:
M-\#-7TKQ'!KTOQ8\<:C##>/='2+N2Q-A*K$D6[A(%?RES@`,#@"EU?X&ZOJG
MB2?7X_BQXXL(9KU;L:1;26(L(E5PQMT#0&3RB!M.7)QWH`^@RRCJP'U(I"RC
MDLH'7DBO"/&7P6U7Q7JZ:I;?%'QIX>C6W@@^P:5)9+:LT(`,Q$L#MYDN,O@X
M],5-XI^#FJ>([+1+2#XF^,=$;2+06LMSITEF)M28`#[1>>9"P,O?Y,#GI0![
MEN7&=PQZY&*-RXSN&/7(Q7AM]\&]4O/"6G^&5^)OC&VN+*X,[Z["]G_:=V#C
M]U.3"8]@P<;5%+IOP=U33_"NJ^&W^)GC&\N-2E62/7+B2S.I6(7^"V*P",*>
M^Y3ZT`>X;E_O+^8HW*>`RD_45X;X2^#>J>&(M9CN/B=XQUXZM8/91OJ;V9;3
MW8,/M5KY4*8F7.5W[E!'2J_@_P""FJ^%M;35[GXI>-?$$2QSH=-U22R:T8S*
M55R(H$?=%G*<]0,T`>];U_O+^8HW*."R@_45\]V7P+UBT\1QZ^WQ:\<W,*:@
MUZ=(EDL?L#H9#(+5@(!)Y`'R8#9V^]/\0?`[5]<\17&NQ?%?QQI4,]S'.NDV
M,EB+&)4VYA0/`9-C[?F^;//!H`^@BRCJP'U(K\</VEF'_#U']CPY&/\`A!/%
M'.>/^/B?OTK]%O&'P6U7Q3?6MY;_`!1\:>'TM[*&T-KI3V2PS-$JJ;B3S8'8
MRR$$M@@9)XK\H_VIO`5[??\`!1?]C?P8OC#7[2ZB\!>)!_PE%N\`UF0QW$X)
M=FC,/SXR<)U[5V8%OVM2RO\`[-B--O\`EU+N<N+^"ET_VG#_`/IV.A^ZNY<9
MW#'KD8KQ#]H[X;:C\8/@I\0?AQH]W;6>H^*M!N=+M+JZ&^WAEF&%>5002H[X
M.<4V;X.:I+X,M_"@^)OC&.Y@O6NSXA5[/^U95;=_H[L8?*\H;N`$SQUZUX5\
M?O#OC3X+_LS_`!BUWPU\2?%VJ>)K+0)]2T?5KX6LU[IUS;+E1:I%!M8.?O!D
M8^E>;B/9^PK>UO[+V4_:*.[AROF2\VKI'2]G?:Q]`?L[_#V_^$OP1^&/PTU:
M[M[W4_!7A'2M`O;FV&V">>P@$4DD2$DJC$9`).!7LNY3P&4GZBOB#]C_`,+>
M,_$OP+\`?$+QC\3/%^N>(?'WP_TR^U2/41:1QV&H:A;AYKBUB2"-HY8V/R!\
M@=QCBO8?"OP0U;PWK<6L3_%;QOK<4?F9TS49+$V;^8"!N$<"O\F<K\W84Z')
M["C[._L_94_9WWY.1<E_/EM?S"-N56VLK>EM#W[>O]Y?S%&Y1P64'ZBOGF+X
M%:Q'XC77C\6_'3PKJ!OO[(:2Q^P%-V[[(1Y&_P`C^'[V<5+XE^!VK^(-?N-;
M@^*_CC1XII(Y%TJPDL191",@[$$D#/M?'S9;//XUJ,_.KQ'XAT+PY_P5\M[S
M7]8TW1[5_@'9HD^HW<-I&[%[K"H\S(K'V!S[5^J@^+GPO)('C_PGD=1_;=CD
M?^1J^"_VJ/\`@E;\`OVN?'FA_$?XE:UXWM?%>A:!;>'8-3\.ZY<Z-//9VX;!
MGDLI8&=G9B6!)7T`KQG6/^"&G[(&J:%HFCV^H_%+2[K25=;C6+/Q_P")/M^K
M;QP;WS-2:/*]O+5<]37D4Z68X:>)5*EA:M.MBZN(C*>(J4YJ-3E]UQ5":NN5
M_:L?HN-Q_!N=X3))9CC^(,#C<LR'`915HX7*<%B\/.I@G43JTZU3-<-/DG&I
M=*5%--6MU/UOTCX@>"-?NQ8:+XLT#5+TJ7%K8ZI:7$Y5>I$<<C,0.^!76[E_
MO+^8K^9GQU^P=\._V1?VN?V2?"/P:\<?$S1)_'FJ^+8?$.N7?BW5=4O;NUM]
M-A>"V:WO[J>T,<;LS`F(MR>>E?OEH'P:U71=#US2)OB=XRU27685CBU&]>S-
MWIA'.^S*0JH8]]X85U8/$U:[Q-.O2A2JX:LJ4E3J2J0?-2IU8M2E"F[VJ6:Y
M=&MV>%Q)DF!RFGDN+RS&XK'8#.\NGCZ$\9A:6#Q-)TL;BL#5I5*5'$XN&E3#
M2E&:J^]&2]U6/=0RGHP/T(I-RG@,I/U%>#^#_@MJOA:ZO;FY^*/C3Q`MW82V
M2P:I)9&.W>56474/E0(?.0G*[LC('%5_#7P/U?P_XAMM=F^*_C?688)I96TG
M4)+$V,PEW8C<1VZOMCS\F&SP,YKM/ESZ`WK_`'E_,4;E'!90?J*^>9_@5J\W
MB1M?'Q:\=1PMJ(OQHZ26/V!4$HD^Q@&`R>00/+.6W;>X-6_%WP3U;Q1KTVM6
M_P`5/&V@PS"`#2],DLA91^2H5B@E@=_WN,OEN_%`'OA91U8#ZD4FY>NY<?45
MX7XN^#.J>*/[)^S_`!/\9Z!_9FGQV,G]F268^W.@`^UW/FPOF=L98KM7D\4:
MO\&=4U3PWHV@1_$_QE83Z2[-+K-J]F-0U$-_#=%H3'@=MB@^_:@#W7<N,[AC
MUR,4;E/\0XZ\CBO"X/@UJD/@^X\+'XG>,I;B>\^UKX@>2S_M2%>?]'C(@\GR
MN>Z9X[=W>&_@YJF@:1X@TR;XF>,=8DUNV%O%?W\EF;K2B!CSK$QPJ@D/4^8K
M#(%`'N093T8'Z$4FY3P&4GZBO"O!?P9U7PEJ5QJ%S\3_`!EXC2>RGM!9ZL]F
M;>)IA@7*"&!&\Z+JA)P.X-4=!^!FKZ+XAMM=E^+/CG5(;>Z:Y;2;V2Q-C,K,
M6\B0)`)/+&<##9QU-`'T'O7^\OYBC>HZLH_$5\]ZG\"]7U#Q'-KR?%GQS9PR
MWPO!I%O)8BPC0,&^S(&@+^2<8.6)Q5GQA\$]6\4ZO_:EM\5/&WA^/R(8?L&E
MR60MLQ``RXE@=O,DQECNQDG`%`'O>Y?[R_F*7<N,[ACUR,5X7XI^#6J>)+;1
MH(/B=XRT1M)LUM9)M.>S$FHLN?\`2+OS(&!E;.3LVC/:G7_P<U2]\):7X83X
MF^,;2XTZ>2:37H)+/^T[X..(KDM"8BB<[=J`^N>10![EN7&=PQZY&*-RG^(<
M=>1Q7AUA\'=4LO"&I^%W^)GC"ZN-0N4N$U^9[,ZI9JF/W-N5A$7EMCG<I/)I
M/"OP<U3PW::W:S_$WQCKC:Q9M:13ZD]FTNFLW_+S9^5"@$P[;]R^HH`]QW*>
MC+^8HWK_`'E_,5X)X0^">K>%M6.IW'Q3\:Z_&;>:#[!JDED;4-*K*)0(H4;?
M'NRG.`0,@U5TSX%:OI_B*'7I/BUXYO88KU[LZ1<26)L)%9B1;,%@#^2N<`;L
MX'6@#Z%WK_>7\Q2EE'5@/J17SWK/P,U?5?$,VN1_%GQSI\,MVER-)M)+$6,:
MHX8P(&@+^4P&U@6)VD\YYJYXR^"^J^*]4CU&V^*'C/P]'':P6QLM*>R%N[0H
M%,S"6!V\R0C<^"%)/`%`'NY91R64#KR17X^?L8,!_P`%"/V]22`"OP[P<C'_
M`![ZGWK]$_%'P=U3Q%I^@V,'Q,\8Z*^BV8M9;O3GLQ/JC``?:+WS874R\9^3
M`Y(K\A?V0_A)J.H?ML?MR>%8_B-XNL[FPG^'MP_B&&2T_M6\#6^I?N9RT)B\
MM<?+M0$5UX?^#C?^O$/_`%(HG)B/XV#_`.O\O_3-2WXG[U[EQG<,>N1BDW*>
MC+^8KP_2?@[JFF>&-7\.R?$SQC?SZHZO'K5T]F=0L`,_+:E81&`<\[E)]".E
M,\)?!K5/#(U87'Q.\9:[_:=D]I&=3>S)L68$"XMO*A3$RYR"V1G''%<AUGN>
MY3P&4GZBH+J:".VN))RIAC@E>8'!S$L;-(,=_D!X[]*\+\)_!35O#.NIK-Q\
M4_&NNQ(LRG3-3DLC9OYP(!(B@1\QY^3YOK5*/X#:H->.L3?%CQS<6KWCW,FB
MRR6/]GR0R$EK-@(!)Y!4E.&W!>AR*`*_P!^*GP)\9^'M:N/A)=:-IVE6GB;4
M]-U.UB2#3G?7;>=X[YC;LR,\C2JQ+[?G)]:^A+O4].L(UEO;ZTM(W^X]Q<10
MJ^1GY6D90>.>*_+:\_X)(_`9?'^H>/O#?C#XE^$+C4?$?_"43:+X?\2WMIHO
M]J-,+B606:SB,K/*"TBE2#N(QC&/?_VA/V)_#'[15AH&D^*/B/\`$71-,\/V
MEM;6MIX;UJ32_.>WA2$7-S-;M'-+,ZI\^YRI))QGFN.B\9&BU4HX=58I*"I5
M)*E+76]Z=Z:2Z)3[$KFMJHW\F[?EI^)]E6>IZ=J"&2QOK2[13M9[>>*90>N"
M49@#BKFY>NY<?45^0?B3X9>#/V.];^"'P9\)^,?BI*OQF\6ZCHHUEM?6_N+6
MYL=--Y]HNVU,W#-&R($"0[<'+$&OT);X.:I)X-A\+?\`"S?&*W*77VH^(!)9
M_P!JNK<B!CY/E>4,]-F:UH5O:\\9*,:U)J-:G"3FH2E%3BE)QCS7A*,M%I>S
MU3&G?M=;I=':_D>Z;EZY&![B@,IZ,#]"*\.T/X.ZIH_AW7-"E^)GC'4IM8V>
M5JUV]F;_`$S;C)LRD(C!;'.]&ZTWP=\&]4\*S:E+<?$[QEX@&H6$MDD>JO9L
MEF\@P+JW\J%")TZJ6W+GJ*W&>Y;E/`92?J*-Z_WE_,5X#X6^".K>'->AUJX^
M*OC;7(HC(3I>HR61LI/,#`!Q%`C_`";LK@]0,U!_PHK5_P#A)/[?_P"%M>.O
M)_M`WW]C^98_8-I?>+7'V?S/('W?O;L=\T`?0NY1P64'ZBE+*.K`?4BO`/$_
MP0U;Q%KTVM0?%;QOHL4KQ,-+T^2R%E'Y1&0HD@9\2`?-S]*M>+_@SJOBF;3Y
M;?XG^,]`%C916CQZ7)9A+MHP`;F?S8'/FOU;;@9Z#G%`'NNY?[P_,4;EQG<,
M>N1BO#M:^#NIZMX;T70(OB9XQTZ;2-WFZQ:/9B_U'=C_`(^RT#1G&.-BKUI8
MO@]JD7@V;PH?B7XPDN9;P70\0L]G_:L:C_EW0^3Y7E=.J9]Z`/<-RG^(<=>1
MQ0&4]&!^A%>'>'?@[JF@Z-KVE3?$SQCJ\FLP"&+4+][,W>ED9_>61CA5`YS_
M`!JP^N:A\'?!?5?"M[=7ES\4/&?B!;FSFM5MM5DLC#"TJE1<1^5`A\V,G<F<
MC/48XH`]VW*>`RD_44;U_O+^8KY^\/\`P.U?1/$,&N2_%?QQJL,5Q+,=*O9+
M(V,BR,2(G$<"OL3.%PP.!3+KX%ZO<^(VUY?BSXY@A:_6]_L>*2Q^P*BN'-J`
M8#)Y+`;2-V=OI0!]";E'!90?J*7<HZL!^(KP3Q=\%-5\3ZVVKV_Q3\:Z#$T<
M*?V;IDED+0&)54L!+`[YDVY?YNI-6?%WP<U3Q.FD);_$WQCH/]EV*6<C:8]F
MK7[H,&ZNO-A<&9N2=N%R>E`'N6Y<9W#'KD8HW+C.X8]<C%>':K\'=4U+PMH_
MAQ/B9XQL9]+D>276[9[,:CJ`;.$NBT)C*KD!=JC@"DM?@YJEMX0O/"[?$WQC
M/<7=RLZZ_*]F=4MU'_+&(B$1;#[IQ^%`'F_[>#`_LD?'/!!QX%U@\$?\^SUD
M_P#!/R[M8_V,OV=%DNK=&_X5AX;^5IXE;_CT'\)<$?E79ZE^S19^(O`?C;X>
M^,/'_B_Q5H7CC29M'U!=3EM?-M;:=-DC6K0Q)M=@3RV:^*=,_P""2OA/0-$T
M_P`-^&_VB/CEH&AZ1#':Z7IVGZ_''!96<7^JM84*86*-?E4>GI7G5J6(AC?K
M=&G"M'ZJZ'LW4]G+F=6,[W<91M:-O+=GV679AE&(X:?#V88ROEU1\00S7ZW'
M!O%T50^H2P<H.%.K"K[13:EI%KEOK?0_6K[=9?\`/Y:_^!$/_P`73TNK:4XC
MN()".H26-R/^^6-?E7+_`,$M].E@,(_:8^/,9*[?.3Q$GF#_`&AE,`_I7R?\
M./A!X[^#_P#P4;\._L]:5\?OBGK7@74OA1J7C"]37-2AO;J?4]->U\I2949%
MBD$C!PH!QCKUISQE6C.BJV&Y(5JM.BIQJJ5JE5J,4X<B=K[N]EMTUSPG#F`S
M+#9E/+,Z^L8O+<!C,SJ86ME]3#J>"P-.-2M4C7=>I!3M+EA2<7*4O)W/Z"\T
M5E:=IKV#RLU]=78E2)0MQMPAC7!9=H!W/U;/'I6K7H'R(5^3G[4'QH_8(_9V
M^+=CH_QL^#VE:EXD\>V^I:[J'BJ3X8?\)49+NT\MDBGOETR[DDEN"YV!9,1D
M?,.:_6.OQ#_X+(?$$>!O#_POLX[/Q5;OXFO[^S;7/!FB^%;_`%JWE7RU@M$N
MO%-O+:P_:&;"Q1LLLA^X"179@8>TQ$:;Y[34E^[FZ;T3:=TI:*U[6.3&R]GA
MY5%R7@XM<\/:+=*R5U9O:]U8_4C]G3XF>`/BQ\+M"\6_##1)?#_@FX5H=#TZ
M31VT%8[2+[C0Z8T,!MHF!RJ>4N/3U]TK\WO^"6ESK=S^R_IAU^V\=6M\FOZD
MGE_$.WL;7Q"8L1-&\MMIJI80PNI!C2U18ASM%?2/Q!_:=\`?#WXJ^"_A#J'V
MR]\3>,8;RY3[''OMM*M[-!(9=0EP5C\T9\M=P9BIP#6=6BU7JTX)RY)3ZW?+
M'5MOK9;O\%L72JIT*52;4>>,.EES2T22Z7>RZ'T5<?\`'O/_`-<9?_0&K\A?
M^"87_)3_`-NG_LXK4O\`TSZ;7W/X'_:6\,>/?$[>%X='U32K?5XM5/@_6[SR
MS8^+(])#IJ,FGJF9(Q:LK!Q,`3C(XKX8_P""87_)3_VZ?^SBM2_],^FUK3A*
M&'QJDFGR4'_Y7AV[;/L[IZHRJSC/$81Q=[5*J>__`#Z;Z^6OH?L!1117$=H4
M444`%4=3M([_`$Z^L97\N*\M+BVD?^XD\31LW/'RAB>:O5C>(EF?0-:2W#FX
M;2[Y80F=YE-M((]F.=V[&,<YI/9^C`\*_9F^!?AKX!>#-;\*^%];DUVRU?QE
MXC\4SW4LD<K17NNWSWES;!HOE`@D<H%.6`'/-?1U?`?_``3PT;XAZ)\)/&%M
M\2(-;M]8E^*_CZYLTUUYWNFTB;697T]XC.2WV9H,&`#Y0F,<8K[\KFP3B\)0
M<*3HP=-.-)W;@OY;DQ^%65M-NQ^/G_!0C_DZ_P#8"_[*V/\`T%J_8.OQ\_X*
M$?\`)U_[`7_96Q_Z"U?L'7/@_P#?,U_[",/_`.H=$^[XF_Y)G@#_`+%&;_\`
MJ^QP4445Z1\,%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445X-
M\>OVA/!7[/VA:1K'BL7=W/KVN:;H.E:7IT9FO;FZU&ZBMA)L`;9#`)?-E=P%
MV*>151C*<E&*<I2=DENR92C"+E)J,5NV>\U^.'[2W_*5+]CS_L1/%'_I1/7W
M->?M7^#+3QA!X=.E:I)HR7&FZ;K/BM?+_LO1-:U=(I-/TN[0_OGFN%GB"O&"
M@+8)R*^&/VE&#?\`!5#]CIEY5O`?B=@?4&XG(/Y5W8.$X59\T6N;#8EJ_7]S
M+_-?>NYR8J<9PI\KORXK#I_^#8_\%>J9^R%>;?%[QEX3^'_PX\5^,?'-K'>^
M%-!TN>^UJUEMENTFLXAF1&MV1UE!'\)4@^E>DUY!\>_AD_QC^$?CCX:QZB-)
M?Q;HMQI:Z@5W"U,PQYA!SG'T->76Y_8U?9Q4JGLY\D7M*7*^5.^EF]'<[7?H
M;GPF\7>%_'OPV\%^,O!-LEGX3\1Z!8ZKH%K';K:)!IMS$'MHUMD1%A"I@>6$
M4+TP*]#KR?X%?#A_A#\'_AW\,I+\:H_@GPOIGA]M15=HO#80B+SPH``WXST%
M>L44N?V5/VB2J>SASI*R4^5<R5NBE=(2O97WLKV[A1116@PHHHH`_'S]MG_D
M^[]A7_L+^,O_`$V05^P0Z#Z#^5?C[^VS_P`GW?L*_P#87\9?^FR"OV"'0?0?
MRKS,#_O>;?\`871_]0\.?<<4_P#)/\`?]D_C_P#UH<U%HHHKTSX<****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHKYG\?\`[4WP[^'WQ9\*?!_4
MC>77B/Q/;W5W)+:1E[/2+6TA>XDFOY0I5"T2,R1[@[`$@$"JA"<VU"+DTG)I
M+HMW\B93C!)R:BFU%-]Y.R7JV?3%?CW^Q?\`\I"?V]?]WX=_^D^IU]V_#W]I
MSPGX_P#%X\*Q:7J>DKJ<5S=>$=6O?+-GXKLK-Q'=7>GA/GCCC=E`$V&<-E>E
M?"7[%_\`RD)_;U_W?AW_`.D^IUUTH3A2QJG%Q?U>#U_["*/;[GV>CU.2M.,Z
MF#<7=?6)*_\`W!F_R:?FFGLS]A****XCM"BBB@`HHHH`^;_C/\$/AY\3_'OP
M;\7^,-;?2]=^&?B.^UKPC:+=00#4M0N[%K2>%HY2'G"0$OLB!(QD\5]'C@`#
MH``/I7YW_MA>!/B-XJ^.G[(>L^#M-U:\T'PM\0M;OO&%Q87#PVUGITNB20P2
M7\:.HFB-P0JJP(#<\5^B"YVKGK@9^N*Y:$DZ^,2H^S<:E+FJ:_O[T8-3U2^!
M/V>C:]WY$K>6EM5KWT7Y;"T445U%!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%?CEK'_*9/P?_`-F^>(__`$.RK]C:_'+6/^4R?@__`+-\\1_^
MAV5>7F?_`#`?]C+!_P#IQ'W/`W\7BK_LB.(__3%(_8VBBBO4/A@K\I_^"F_P
M"N?V@-*^&_AGPY\2_#G@+QS::G/?>'XO%D3S:/=QP2PRW5Z$6.15OK((OV:1
M@`I<C(YK]6*_+K_@I#XR_9>T*T^'6A?M.ZEJ7A[P[KESJ#:=XDT"[UZQU_3Y
MK;RC)%9W/A]'O%@G!Q.A(C8`;JZL$Y+$TW!2<DVUR0525U%_8?Q>:W:.;%J+
MP]13Y5'2_-)PC\2WFM8^MG;L?4G[*'A*?PI\'K31;KXA0_$373-<+KGB:R,;
M60U@01V\\-@D?R1V]N44QQX&.X]?C+QE^R)^T#;?&[P=XRT_XA)XL\/3>*M8
MU/77OM,L$U"PTR\C1(+$7?E"?[+#R(XT<A>3C)Y^M?V*?%OP$\7_``2TJ[_9
MQGO+SX;6%]<Z98W^H+?"^O[FU"">[NGU)$O99I<@O+<+YCGDU]<TW6J4*U6R
MM*3E&2J4XIK1JSBOAM?9/304:5.M1H^\^6*C*+ISDT]G\3^-.V[WWZGYR?"#
MX2_$6R\9?#33=?\`#LNCZ3\$+7QO;MKTTL3VOBEO%!G:&33$B=I(TM_,'F><
MJDXQ7C7_``3"_P"2G_MT_P#9Q6I?^F?3:_7JX_X]Y_\`KC+_`.@-7Y"_\$PO
M^2G_`+=/_9Q6I?\`IGTVM(5)5,/C&TE:%'17MKB(R;UN]9-O?39:&4Z:IU\(
MDV[SJ;^5'E7X)'[`4445P'>%%%%`!6?JU[_9NF:AJ&SS/L5E<W6SIO\`(A>7
M;_P+;C\:T*I:C;07FGWMI<MLM[FUG@G8G;MAEB9)#GMA"3GM0[V=M^@'S;^R
MG^T&/VC?`VO^+QH8T$:-XX\3^$OLH8/YW_"/Z@]E]IR"1F;;OQGOVKZ?KP#]
MG;X4?#CX0^$=9T#X9ZE'JFC:CXM\0:]?3QWB7H36-5O6N=1A,D;R!6BG8J8R
M<I]T@5[_`%AAO:K#TE7E&5;D7M)1LXN75IK2WHEZ(2O97WLKVV/QX_X*<^'_
M`(J:?\2/V4_C'\._AEK_`,3[+X4?$(:WXBT7PZ8?[1%EM;YXEG9$/;J<5;_X
M>6_%[_HR3XV?]\:7_P#)%?KTRJXPZJP]&4,/U!IGD0_\\8O^_:?X5QSP%?ZQ
M7KX?'5,.L1*$JE-4:-2/-"G&FFG.+DKQBKJ^_J?=8?BS+)93E.5YOPM@LW>3
MTL30PN+GF.98.JZ&*Q=3&2IU*>%K1I2<:M6IRRY4^5I/8_&;Q7_P5;\<^!/#
M^I>+?&/['/QFT3PQH<`O-:U>X33?)T^Q5U26ZEQ.24B#!FP#Q7ZO_"SXA:3\
M5_A[X3^(FAQ3P:3XNT:RUJQAN0!/%!>0K*J2@<!UW8..XKYA_P""C,42_L2_
MM&%8HP?^%=:MR$4'K%W`KMOV)?\`DU;X(_\`8B:+_P"DR5.&EBJ6/J86OB7B
M8?5(5XN5*G3<9NJX-+V:5TUWZFV=4<BQW">%SW+,CADF*7$&(RJM3HX_&8RC
M7H1R[#XN$VL9.;A4C4J25X-)QLFKGU/1117JGP`4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%?F%^U[^RQ\<OB/K6I^-/A]\0OM"S7_AL:=X2O\`3;*X
MATJVLM3MY[V73YIXV,4CQH[R2@B0@E,D5^GM%:T:TZ,U.'+=:6E%235T[6?I
MNM3.K2C6AR2YDKWO%M._R:O\^NI^5EQ\`_BNNJ:IX!ET-KRS\:^*?`_C2\\9
MH\2Z=I8\,0V'VRRNH=PF-U<S6LGE^4AC"L,FO/\`]I!#'_P5-_8WC/)3P!XE
M0GU*S3+_`$K]DZ_'#]I;_E*E^QY_V(GBC_THGKMPM656K+F27+AL3M?5NBTV
M]7TBM-M#CQ%*-*$.5M\V)PV_1*K=)?.3^_LD?L?7S5^V!J7B;2/V;_BOJ/@^
M;48/$EIX7O9=)FTI)7U!+M5^1K58093(#TV#/I7TK7E_QG^(FC?"CX8^+_B#
MX@T^75-'\,:3/J5_80I'))<P0C+1HDN$9CV#<>M>1B$G0K*4_9Q=.:=37W%R
MN\M-=%KH=[V?HSAOV2M1\1ZM^S7\%M2\72W\_B6]\`Z%<:U-JB2)J$FH/:@S
MO>+,!*LY;[X<;@>M?1->:_!WQ_I'Q3^%_@;XAZ!82:9HWC#P]I^N:;I\RHDE
MI:7L0DBA=(_W:L@."$^4=N*]*HH65"BHRYTJ5-*;^VE!6E_V\M?F$=E;566O
M?3?YA1116HPHHHH`_,#]O7X-_%[7/B%\!_CI\%?!;_$'QA\)-5UF6/PS)=V]
ME93P:K:QV[2W$TLD3_NPI9`A//6N%'[3/_!3(<?\,:Z%Q_U,L7_R97Z\T5YU
M3+W*M5K4L9BL,Z\HRJ0H^QY)3C",%+]Y1J2NXQ2=I6\C[+"<70IY=@,NS#AW
M),ZCEE*K0P>(S!9DJ]+#UL15Q4J'^R8_#4G!5JU6<6Z;G>;O)I)'X^WG[4?_
M``4ML;2YO)_V-]"6&U@EN)3_`,)+%PD2-(V/]+Z[5-?7?[#?[4.H?M:?!&R^
M)^L>%3X-UM-<UWP]K.@^<)ULM2T'4KC3+M$E#-O7SK9]IW'(Q]3]4^*?^1:U
M_P#[`^H_^DDM?EU_P1X_Y-D\0?\`98?BI_ZFFL5A".(PV88:C+&5\32KX?%2
ME"NJ/NRHRP_+*+ITJ;O^\E>]_*QZF)JY3G7!^=9E2X<RG)\;E>;9'AZ%?+)Y
MC>I1S"GF?UBG6AC,;BH25\+2E!QC"47S7;3/UCHHHKV#\Y"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@"&XC>:":*.0PR212(DJC+1LRD*X!X)4D$#VK\
MD/&?['/Q]3XQ^%O$UI\0HO%GAV^\4Z]?:[<7^F6,>IV&F:G87]O:6C7JQ"X:
MUL_M"1I&CGY1SR*_76BMJ5>=%R<.7WEROFBI:--:7U6_1F56C&LHJ7,N62DN
M5M;-/7H]NI^;OP6^#/Q&L_B'\-X=?\/R:)I'P6T+5M`_MBXEBD@\4-J-Q'+;
MW6F+&S21QJL;"59@I!88]_'?V+_^4A/[>O\`N_#O_P!)]3K]A*_'O]B__E(3
M^WK_`+OP[_\`2?4ZZ:=256EC&TE;#P22_P"PFDW][;?Y:'+4IJE4PB3;OB'J
M_*A.*7R21^PE%%%<!WA1110`4444`?(7[0_[2&I_!CXH_L^>`K+0+35K?XQ^
M+M3\.7M[<2.DNE1V.F-?+/`%.'9RNPAAC%?7BG(!]0#^8KYZ^+_P]^#GB_QS
M\(]<^(UU:P>*O"7B"]U#X=Q3Z@+.2?6)K(P72P0;T^UNMJ23'AMH^;&!7T*.
M``.@``^E<]+VOML5SU(RINI3]C%6O3C[&'-&5ENY\TE>^COY"5[RN]+JR[:*
M_P#F+11170,****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`K\<M8_
MY3)^#_\`LWSQ'_Z'95^QM?CEK'_*9/P?_P!F^>(__0[*O+S/_F`_[&6#_P#3
MB/N>!OXO%7_9$<1_^F*1^QM%%%>H?#!7XH_\%;/`/B+XP6OPT\-_"Z#PMXX^
M(7AO6%U&/X=MK^G:=XJNQ+/"T5U!%)<1W<FFHJ.+RW52LP9<JV,5^UU?S?\`
MQ\_9]_;>O/VF_&7Q4^%_[._@/Q/JFB>/(]:\#_%#Q1XLU/3M?;0+5G8:#;VU
MM;S11:;("%`W_,.J"N_+TO;^T]I"FZ2YH^TE&,9R>BBW*4=-7S<KYK;(XL>W
M['V?)4FJKY9>SC)RBDT[I1C+7MS+E[G[,?L>>!/&7@'X-:1IWCKPUX?\'Z_?
MS'4[CPSX<MXX++1A-!"GV.3RD19;E6C9I9>2[-DFOJBOF7]E#Q1\?_%WPO35
M/VD/!NE^!OB+_:MW;S:%HUV]]I\5A$(Q;2P74B1R3+(=YWNH8XY%?35<M;F]
MK4YG%RYG=P?-'_MV6MUYWU.BCR^RI\O-R\JMSKEE_P!O+2S[HAN/^/>?_KC+
M_P"@-7Y"_P#!,+_DI_[=/_9Q6I?^F?3:_7JX_P"/>?\`ZXR_^@-7Y"_\$PO^
M2G_MT_\`9Q6I?^F?3:VH?[MC?\%#_P!/P,:_^\8/_'5_]-L_8"BBBN0ZPHHH
MH`*R/$$$UUH6LVUNI:XGTR^BA5>&:62VD5`#ZEB`*UZS=9O7T[2-3OXU#/96
M%U=(IZ,T$+R@'V)7%)[.^U@/A_\`X)]_#GQ_\-/A1XOT;XB6%[IVKWWQ4\=:
MQ9PWTQFE?2=1UB6?3YE8LV(Y(2&09&`<8%?>5?(O[&_Q_P!;_:(^'GB3Q;KN
MFVNF76C_`!`\6^$XH;5R\<EKH&I/903,<#$DJ)N<8ZGK7UU7-@526$PZHRE.
MDJ<?9RFK2E'HVN[)C;EC;565OZ_JP4445U%'Q-_P4;_Y,D_:,_[)UJO\XJ[+
M]B7_`)-6^"/_`&(FB_\`I,M<M_P4/L[S4/V+?VAK.PM;B]O+CX>ZK'!:VL4D
M]Q-(?+(2*&)6DD<XX55)]J[#]BZUNK/]ESX*6UY;S6MS%X&T9)K>XC>&:)Q;
M+N22-P'1@>"K`$=Z\Q?\CB?_`&+H?^I$C[>4E_Q#FC&ZYO\`7/$RY;ZV_L7"
M*]M[7TOM<^H****],^("BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`*_'#]I;_E*E^QY_P!B)XH_]*)Z_8^OQP_:6_Y2I?L>?]B)XH_]*)Z[<!_%
MJ?\`8-B?_34CDQGP4O\`L)P__IV)^Q]>6_&KX<Z5\6OA?XP^'>N:D^CZ5XIT
MF?3+W4H]@>TAF&&E4RLJ97_:8"O4J^:OVP;3Q-??LW?%BT\'QZE+XDG\+7J:
M2FD,Z:BUT5^06KQD.LI_A((.:\S$-*A6<H.I%4IMTU>\THMN*MK>2TT.I[/2
M^FQZ3\&OA]IGPI^%G@3X<Z-J+ZOI7@[PYI^A6&IR;-][;6,0BCN&\MF3,@&?
ME8KZ&O3*^=?V2+7Q'9?LT_!6T\7)J$?B:W\`:%%K::JS/J*:@ML!.MXSDN9P
MWWRQSGK7T53H-.A1<8>SBZ5-J&ON)P5H:Z^ZM->P1V5E966G;38****U&%%%
M%`!1110!@^*?^1:U_P#[`^H_^DDM?EU_P1X_Y-D\0?\`98?BI_ZFFL5^HOBG
M_D6M?_[`^H_^DDM?EU_P1X_Y-D\0?]EA^*G_`*FFL5YM;_D:8#_L%Q__`*5@
MS[C*_P#D@>+?^QYPM_Z;SP_6.BBBO2/APHHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"OQ[_`&+_`/E(3^WK_N_#O_TGU.OV$K\>_P!B_P#Y2$_M
MZ_[OP[_])]3KKP_\'&_]>(?^I%$Y,1_%P?\`U_E_Z:J'["4445R'6%%%%`!1
M110!\!?M:?!GX@_$GXU_LH^+/".FF]T/X<^/=9UGQ;<>;Y?V+3[K1VM(9-NX
M;]TQ`Q@XX.*^_%X51Z`#]*^(_P!IW]H3QA\(?B]^S-X'\.P6,NE_%OQMJWA_
MQ"]T/WT5I9:2][&UKP?G\Q0#['TK[<4Y4'U`/YBN/#^Q^L8[V;FZGM:7MU)>
MZI?5Z?*H=UR<M]_>OJ1&W-.U[W5^WPJUOD+111786%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`5^.6L?\`*9/P?_V;YXC_`/0[*OV-K\<M8_Y3
M)^#_`/LWSQ'_`.AV5>7F?_,!_P!C+!_^G$?<\#?Q>*O^R(XC_P#3%(_8VBBB
MO4/A@HHHH`**"<<U\AZ_^TUJ_A#QU=6'BSP#?:+\.DUQ?#%EXPGE/VF]UMQF
M+RM/V\V$Q($=R'Y(;*#%7"$JC:BKM*]KI7]+M7?DM293C"SD[7=O^'[)=6]#
MZVN/^/>?_KC+_P"@-7Y"_P#!,+_DI_[=/_9Q6I?^F?3:^R_A[^T[:^/?%5KH
M-SX;N=(T/Q?!K,GP]UQY/,'B.#15<:D\D1`%N8-C8`9MP[^GQI_P3"_Y*?\`
MMT_]G%:E_P"F?3:ZZ<)4\/C5)6?LZ#[_`/+^/5::.Z?9JQR5)QG7PCB[I5*J
M_P#*5_Q5FNZ9^P%%%%<)VA1110`53U".VEL+R*](%G):SI=%C@"W:-A*2>P"
M%LGM5RLO7+274-&U6Q@P)KS3[RVB+<+YDT$D:9/8;F&32>S]`/'/V?\`PO\`
M!_PIX4U>Q^"\]E<>'+CQ3KM]J3V-P+F)?$-U>-)JZ,X`VR+<E@Z?PG/6O=Z_
M,7]G[6/`_P"P7\.=3\(?M&_$3PUX3U7QC\1/&_BS0O.N;F:.ZTO5M6>ZMPKK
M`^)(XW59%S@-P#Q7W-X(^-GPN^(W@JZ^(O@OQ?IFO>#+(71NM>LVE-G"+($W
M18O&K_N0"6PIZ<9KCPE>DZ5*G+V5&M&FI3PRE%2I+1M.G>\4DT]5;4F+O9:*
M5M8WU7R/5**^7_`_[9W[,OQ(\4VG@KP3\6O#>O\`BB_DDAM-(LY+@W4\D1*N
MB!X$7*L"#EAS7U!733K4JR<J52%6*=FZ<HS2=KV;BVD[-:;C33V:?IK^17NK
M6VOK>6TO((KFVG4I-!/&LD4J'JKHP*L#Z$4ZWMX+6&.WMH8X((E"10Q($CC4
M<!410`H'8`5-16A7,[<MWRWORW=KVM>VU[:7[!1110(****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBOF'XO_'7Q9\-_$L-EI?PZOM>\+:;IQUCQ9XG>
M?[+:Z7IHD,;FR&"+RZB`,KP$I^[Y!)XJH0E4ERQ5WZV_/[DNI,I**O+8^GJ_
M'#]I;_E*E^QY_P!B)XH_]*)Z^O#^V/X?N?$EH-*T"[O/`,=SHNEZUXN9C&=-
MUGQ!'!+I5I]E(^=)DN(@TA8%78C:<9/R#^TFP?\`X*G_`+'3KT?P%XG8?1IY
MR/T-=V#ISIU9\\7'FPN):O\`]>I:>3VT>JNNYQXJI&<*?*[\N*PZ>]OXJV?7
MJM.J:/V1KS[XJ^*M7\$_#[Q3XJT+PY-XMU;0]*N;^R\.V_\`K]6F@0N+2+@_
M/)C"C!R:]!I&`8%6`92,%6&01Z$'@CZUYLDY1DE)P;32DDFXMK1I/1VWL]#N
M/SF^!/[?T?Q8USPEX.U?X$?%7P-X@UR..+4'U70?*T/2+P*?.B>\\S_4HP(2
M38,C'%>M?M"?M=:7\`-=TS0[WX9?$7QJ^I6KW2W?@_1AJ5K;A<?NYY/-39(2
MW`P:^M4L+")Q+'96D<@.1(EM"C@^H=4#`_C3IK.TN2&N+6VG8<`S012D?0NK
M$5R1H8M4'3>,4JMX\M;ZO!6BK73IJ24F[/6ZWVMH3:5K<VM]^7]+GFGP=^*5
MI\7_``1IOC2UT#7/#$>I!BNC>([866K0!<<S6VYBH.>#D@UZI7YL6WB#XD0_
M\%))/"T5WKT7PO7X1M>+IL<<L?AL:QA/WJJJBV^U\]OFYK])ZO"UG6A44E+F
MHUIT)2<5'VDJ:C>HHIM*,KW2"+O=?ROE;[V2U_$****ZB@HHHH`P?%/_`"+6
MO_\`8'U'_P!)):_+K_@CQ_R;)X@_[+#\5/\`U--8K]1?%/\`R+6O_P#8'U'_
M`-)):_+K_@CQ_P`FR>(/^RP_%3_U--8KS:W_`"-,!_V"X_\`]*P9]QE?_)`\
M6_\`8\X6_P#3>>'ZQT445Z1\.%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!117Q]K7[46H>$O'%QI_C+P'J'A_X?/J5SH6E^+;F0_:K_`%:TCEEE(L,?
M+8O'"[17`<EA@E:N$)3NHJ[2O:ZN_)+=OR1$YQA;F=KNRT?WOLO-GV#7X]_L
M7_\`*0G]O7_=^'?_`*3ZG7VE\-/VHK'QUXUM/#-_X=N=$T_Q1;7.H>`-7DD,
MB>(M.LG$=U<.F`+<[G0Q*"V\$Y(KXM_8O_Y2$_MZ_P"[\.__`$GU.NNE"=.E
MC5-6?U>F^_\`S$4>JTT>C[,Y:TXSJX1P:DEB)+3O[&I^A^PE%%%<)VA1110`
M4444`?%W[6/Q-_9L^$FK?";QI^T%#]FDT_Q)>#P5X@?3KF^@T/5Y+)EGGE:U
MAG>W$MN3$'*@$G&:]N^'7Q[^%'Q5\"WWQ(\!^*K;7?!FFQW4MYK$-O=Q0PQV
M4;27#&.X@BF/EHC$XC)."!FN]\3^#/"GC2TCL/%GA_2O$-G#)YL5MJUG#>11
MR8QO1)E8*V.,C!INB>"O"?AK2)M`T#P_I6D:-<"19],L+.*WLY!*"L@>"-0A
M#@D,".<G-<RIXB.(JS4J'L*B3Y?925;VBA&*<ZBGRRC[NW*FHV2>ER?>N]K/
MRUO9+5_+MY'S7X'_`&[/V7/B-XQLO`/@_P"*.G:QXKU"YEM+32HK#58Y9;B#
M=YL8DFLHX@4*,"6<#C@FOKP'/(Z&OA?]J/4/A[^RO\+-1^-'A'X6>$;CQ%H^
MM:#9VQCT^UL90=;UBUTV:874<)='1;IGX^\1CO7V+X0UJ3Q'X6\/Z]+$L$FL
M:18ZB\*G<L;75NDI16P,A2V`<"IP]6JYU*&(G2G7@HU+4:=2$%2J<T87YY3O
M+FA.]GM;17"+=VFTY+71-:/;>_YG1T445UE!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`5^.6L?\ID_!_P#V;YXC_P#0[*OV-K\<M8_Y3)^#_P#LWSQ'
M_P"AV5>7F?\`S`?]C+!_^G$?<\#?Q>*O^R(XC_\`3%(_8VBBBO4/A@HHHH`*
M_-WQMIGQX\9?'*[L_$7PKM]8\!V>K?V=X6U(ZR8]*T[3YT,<GB:[L?LY6XU.
MWW;H(2P*,OW^<5^D5%:TJGLW)J,9-QLF^:\==U9K6VC[IV,ZE/VBBN:44I)N
MUO>MT=T_PV/SV^$?P0^(VB>+_`%GXDTZTT_PY\$[/QA::/K,5SYTOBI?$_FM
MYIMMBBS%J''`9@Q!YS7A'_!,+_DI_P"W3_V<5J7_`*9]-K]>KC_CWG_ZXR_^
M@-7Y"_\`!,+_`)*?^W3_`-G%:E_Z9]-KJA4E4P^,<K:4Z*T7?$1;?JY-OYZ:
M').FJ=?"*-]:E3?RH\J7R22^7>[/V`HHHK@.\****`"BBB@#S7Q]\'?AA\4F
ML7^(7@G0/%K:8'6P.M6,=V;42'+B'?\`=#'DXZ]ZT?#7PS\!>#_#<_A#PQX6
MTC1?#-R)Q/HMA:I!82"Z!$X:%?E/F@D-GK7<T5'LZ?,Y^SASM6<^2/,UV<K7
M:T6C8>=M3XH\1Z-^R?\`L^_$SX8Z<WPX\.^'_''Q$UUM(\'ZCI.B1+/_`&DY
M+,9+A2#""226]3TK[7KY&^/W[-]S\8OBI\!OB##X@ATF+X0^+!XBGL9(!*^J
MJ`1Y$;EE\H\_>PWTKZYK##QG"IB8NE3I4E4A[#V<8QYXNG%SE)1Z^T<E=V=E
ML3&Z<E9))KEMVLK_`(A111744%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`5\$_M3?\+UU?Q=H/A_PC\.AXQ^&_V2.]U9+;6#IL^I:FL^V/3M0V
MP2G^SE0++(#D2#*D<U][45I3J>SFI\L96O92O9/H]&G==/\`/514A[2/+S..
MJ=U;6SV=TU9GY@?\,Z?$^YU:^\+)H6FZ9X4\=^)/!_CS4]3ANLCPK/X>CLW;
MP[#:B,"Z'F6WE1S!DPA#`<"O+/VD4\O_`(*F_L<1]=G@'Q,F?]V:9?Z5^R5?
MCA^TM_RE2_8\_P"Q$\4?^E$]=V%JRJU9\UO=PV)VOJW1:;=V];12[:;7;;X\
M12C3IT^6^N)P]_\`P:G;[VW\]-#]CZ***\T[PHHHH`^8%_:*\)M^U`_[.@T*
M<>+%\&GQ6==^SQ^0;$;3]F^T8\S?@CY<XZ\<5]/U\.^,?`GP:^''[4L7[2'C
M?XEZ;X9\17O@MO"5MH>L7T5G:S6H"AKF/S2NYQ@9QGK[U]8:!\0O!/BGP_-X
MJ\/>)M(U?P[;B4SZQ97<<]C$(!NFWSJ2@\L<OS\O>N3#5)\U>%>=+G5>HZ<(
MRCS*@E'D<HIW3WNWKLV2F[M-J]W9=;:;_?\`BCLJ*P?#?BCP]XOTR+6O#&L6
M&N:5,SI%?Z=<1W-M(T;%7598RRDJP((SD$<UO5U)II---/5-:I^C*"BBBF!@
M^*?^1:U__L#ZC_Z22U^77_!'C_DV3Q!_V6'XJ?\`J::Q7ZC>*`3X;UX`$DZ1
MJ(``R23:RX`'K7X"?\$T_P!N;]EKX%_!/Q9X"^*WQ:\/^"_%UA\7OB?)>:)K
M/VJWO((Y_&&K2PNR?9V^62-U=2."K`CW\C&5J-#,LOG7JTZ,'A\?'GJ3C"/,
MY81I7DTKM)V6^A^B\.9;F&:<#\78;+,#B\PQ"SGA>HZ&"P]7%5E3C3SM2J.E
M1A.?)%M)RY>5-I-ZH_H8HK\^_P#AZ5^PC_T<-X)_\"+K_P"1:^I?@W\>?A1\
M?_#T_BKX1^,=+\::#;7/V2;4=*>1X([@`GRB9$C.[`/:NZEC,)6ER4<30JSL
MWR4ZL)RLMWRQDWIU/D\=P[Q!EE#ZSF61YM@,,I1@Z^,R[%X:BIRTC'VM:E"'
M-+[*O=]#U^BBBND\8****`"BBB@`HHHH`****`"BBB@`HHHH`*_-+QGI'QY\
M>_&?4M-\4_":UU+P3'=7ND>%=9_MO9IFBV%[9W$#^))K#[,5N-35G7RD+*45
MV&[U_2VBM:53V3DU&,FXN*;YO=OU5FM;:?,SJ4_:**YG%)W:234O*2:>GW'Y
MY?!KX"_$;2?B#X%?Q19V>F^'_@YHNIZ%HVIPW!N)?%$>ISI-'<F+:OV3R1%M
M=-S]1S7A'[%__*0G]O7_`'?AW_Z3ZG7["5^/?[%__*0G]O7_`'?AW_Z3ZG75
M3J2JTL8Y6TP\%HO^HFDV_5MM_D<E2FJ=3")7=\0VV_*C-)>B227IK=G["444
M5P'>%%%%`!1110`4444`>(_M!^"_A=X^^&VH>'?C#=067@F?4-(N+R>YNELX
MEO+34+>XTX&=@0I:\CA"C^)B!WKU;P]9Z;I^A:38Z,ROI-II]K!ISJV]6LXH
ME6!@XX8&,+SWKY)_;U^%GC7XQ?L[:]X)\`V0O_$=YKWA2\M[<W#6P:#3M?L+
MR[;S5Y&RWAD;'?&.]?4'@'3;S1O!/A72M039?:=H.F6=VFXMMN+>UCCE7<>N
M'4C/>N6+?UNLO8I)4*+]O9WFW*K>G?:T+*25[^^]"?M/W>B][OY>=CKJ***Z
MB@HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*_'+6/^4R?@__`+-\\1_^
MAV5?L;7XY:Q_RF3\'_\`9OGB/_T.RKR\S_Y@/^QE@_\`TXC[G@;^+Q5_V1'$
M?_IBD?L;1117J'PP4444`%%%%`$-Q_Q[S_\`7&7_`-`:OR%_X)A?\E/_`&Z?
M^SBM2_\`3/IM?KU<?\>\_P#UQE_]`:OR%_X)A?\`)3_VZ?\`LXK4O_3/IM==
M#_=L;_@H?^GX')7_`-XP?^.K_P"FV?L!1117(=84444`%%%%`!1110!^:?[;
MGQ-\:_#?XP_LOWNCZQKFE>"YO&LC^/?[,CDDL9M%AC9Y!J8C1\0#;_%M^M>U
M?#3]NG]G7XM^,[;P#X)\7OJ7B2[,ZP69LIX@YMVV2?O'4*,-ZFOK#4-&TG5U
M5-5TRPU)4#!%OK2"Z5`PPVP3QN%W#@XQFN8TGX9_#W0M075=&\%^&M+U)"Q2
M^L-&L+6Z4O\`>*S0P)(NX\G##-</L,5#$5:M*O3]E6J0G.G4ISDXJ$(0<:<E
M4BH\W*Y-\KU>Q-I)MIZ-IM-;625EKULWL>'?&G]L[X!_`#Q);^%OBAXN7P_J
MMS;PW:)+;3/"MO,VQ)9)44JB[NI)X[U]&^&?$FC>+]!TOQ+X?O8M1T;6;.&_
MTZ]A.Z*XMIU#QR(?1E->8?&O0O@U;>#?$WC7XM^%O#^K>']"TB:ZUN^U32+6
M_GBTV#!<*\L;384D85'&#TQ77?"[5_!VN^`?"^K?#^.*+P;?:7!-X?C@B\B%
M-/8?N5CB_P"6:A>B]A6M.598BI"I4H2@X*=*G",HUHQYN5N=YR4HMZ<R2L]!
MJ]W=JW16U^>IWU%%%=(PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"OQP_:6_Y2I?L>?]B)XH_]*)Z_8^OQP_:6_P"4J7['G_8B>*/_`$HGKMP'
M\6I_V#8G_P!-2.3&?!2_["</_P"G8G['T445Q'6%%%%`'AWQ=_9N^"GQW_L_
M_A;'@+2?&)TLL;`ZB;A6M]^-VPV\T)(.!PV?:K/ASX#_``T^'_PRUSX7_#[P
MGI_AWPKJFGZK!_8MH]P+5I]0M7A9BTDKR@NQ7)#CI7M%9&OW4UEH6M7EN=L]
MII6H7,!QG$L%I++&?P=163HT>>57V5/VDHN,JBA'GE%I)IRM=II+1NPK*][*
M[T;MJSX\_8,_9\\6_LU?!>Y^'7BZ:WEND\6:[JNGI:W<EY#;Z7?W3S6L"R2N
M[@HK<J6X/2OMJOA+_@GS\9?'OQO^#.K^+/B'>+>ZU:^.O$FC0RI"T`%A87CQ
M6R;6Y.U`.>AK[MK'`.B\%AOJ_/['V4?9\_QJ/12\T*%N6/*K*V@4445UE#71
M9%9'4,C@JRL,AE(P00>H(KPV]_9E^`&HW=S?WWPC\!W5Y>327%U<S>'-->6>
M>5B\DLKFWR[NQ+,QR23DU[I143IPJ6YX0G;;GBI6]+IV.G#XS%X1R>%Q6(PS
MFDIO#UJE%S2=TI.G*/,D]KWMKW/`?^&6/V=?^B-_#_\`\)K3/_D>O3_!W@'P
M9\/M/DTKP3X:TCPQILLGG266C64%C;O+S\[10(B%N3SC-=?12C1I0?-"E3A+
M:\81B_O23+KYCF&*A[+$X[&8BG=2]G7Q-:K"ZV?+.<HW71VN@HHHK0XPHHHH
M`****`"BBB@`HHHH`****`"BBB@`HHHH`*_'O]B__E(3^WK_`+OP[_\`2?4Z
M_82OQ[_8O_Y2$_MZ_P"[\.__`$GU.NO#_P`'&_\`7B'_`*D43DQ'\7!_]?Y?
M^FJA^PE%%%<AUA1110`4444`%%%%`'R=^VG\;?$_[/WP*UKXD>$8+&XUK3]:
M\-Z?#'J$9EMC#JVMV6GW!9`5)98;ARASPP!]C]$^"=8N?$/A#PUKEXJ+=:MH
MNGZA<+&,1K-=6T<L@09.%#,<#)KSSX_I\(I/AQJ"_&\:6?`)U#23?#5VV67V
MT:A;G3-[;DP_V[R/+Y^_BO4_#XTH:'I(T/R_['&GVO\`9GD\Q?8O*7[/Y9_N
M>7MV^U<T54^MU6ZJE3=&DHT4_>IRYJG--QW2FK)/6_(]K:SKS/72VW;S-BBB
MBNDH****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OQRUC_`)3)^#_^S?/$
M?_H=E7[&U^.6L?\`*9/P?_V;YXC_`/0[*O+S/_F`_P"QE@__`$XC[G@;^+Q5
M_P!D1Q'_`.F*1^QM%%%>H?#!1110`445G:OJ"Z5I>H:FZ&1+"SN+MD7JX@B:
M3:/<[<4`6[C_`(]Y_P#KC+_Z`U?D+_P3"_Y*?^W3_P!G%:E_Z9]-KZ4^%?[0
M_CGQ3XL\()XDL]+/A3XOVOBFX\%V]E'(NHZ-'X9\U+A-4E=S'.UQL'EF)5P3
M@CBOS=_8P_:Q^!'[.OQJ_;:\.?&#QO9^"]:U/X^ZAJ5C8ZLCV\EU8/I.G(EU
M"7"B2)G5E#+D9!YKT:-"JJ.,IJ+G*5.BTH>\]*\>;1:WBTT_-:76IY]:O3=;
M"3<E&*J5$W.T5K2NM6^J::]5UNC^@ZBO@/\`X>=?L5_]%I\._P#?T?\`Q5'_
M``\Z_8K_`.BT^'?^_H_^*KF^JXG_`)\5O_!<O\O-?>=/UK#?\_Z7_@R/^?FO
MO/ORBO@/_AYU^Q7_`-%I\._]_1_\51_P\Z_8K_Z+3X=_[^C_`.*H^JXG_GQ6
M_P#!<O\`+S7WA]:PW_/^E_X,C_GYK[S[\HKX#_X>=?L5_P#1:?#O_?T?_%4?
M\/.OV*_^BT^'?^_H_P#BJ/JN)_Y\5O\`P7+_`"\U]X?6L-_S_I?^#(_Y^:^\
M^_**^`_^'G7[%?\`T6GP[_W]'_Q5'_#SK]BO_HM/AW_OZ/\`XJCZKB?^?%;_
M`,%R_P`O-?>'UK#?\_Z7_@R/^?FOO/ORBO@/_AYU^Q7_`-%I\._]_1_\51_P
M\Z_8K_Z+3X=_[^C_`.*H^JXG_GQ6_P#!<O\`+S7WA]:PW_/^E_X,C_GYK[SZ
M5_:'^&][\7_@K\1OAIIUY#87WC'PU>Z+;7EPI:&WEN0NV21002HV\@'-6O@-
M\/KSX5?"+P)\/M0NXKZ\\+:%::7<7<"E8IY(%VEXU))"GL"<U\5?$?\`X*-?
MLC^*_`_B7P[X:_:(T+POKVK:9/9Z9K\#J\VE74F`EW&IW`M'R0"#]*F\`?\`
M!1W]D3PQX.T#0?$/[0NA>)-:TRPAMM0UR9U274KA!A[EU&T!G[C%<_U&O]9]
MK]4K\WL/9^TY'R\OM%+DY=^:[YKVLTTK]"?K.&YK^WI7M:_M(]6M+7_'TWT/
MTLHKX#_X>=?L5_\`1:?#O_?T?_%4?\/.OV*_^BT^'?\`OZ/_`(JNCZKB?^?%
M;_P7+_+S7WE?6L-_S_I?^#(_Y^:^\^_**^`_^'G7[%?_`$6GP[_W]'_Q5'_#
MSK]BO_HM/AW_`+^C_P"*H^JXG_GQ6_\`!<O\O-?>'UK#?\_Z7_@R/^?FOO/O
MRBO@/_AYU^Q7_P!%I\._]_1_\51_P\Z_8K_Z+3X=_P"_H_\`BJ/JN)_Y\5O_
M``7+_+S7WA]:PW_/^E_X,C_GYK[S[\HKX#_X>=?L5_\`1:?#O_?T?_%4?\/.
MOV*_^BT^'?\`OZ/_`(JCZKB?^?%;_P`%R_R\U]X?6L-_S_I?^#(_Y^:^\^_*
M*^`_^'G7[%?_`$6GP[_W]'_Q5'_#SK]BO_HM/AW_`+^C_P"*H^JXG_GQ6_\`
M!<O\O-?>'UK#?\_Z7_@R/^?FOO/ORBO@/_AYU^Q7_P!%I\._]_1_\51_P\Z_
M8K_Z+3X=_P"_H_\`BJ/JN)_Y\5O_``7+_+S7WA]:PW_/^E_X,C_GYK[S[\HK
MX#_X>=?L5_\`1:?#O_?T?_%4?\/.OV*_^BT^'?\`OZ/_`(JCZKB?^?%;_P`%
MR_R\U]X?6L-_S_I?^#(_Y^:^\^_**^`_^'G7[%?_`$6GP[_W]'_Q5/C_`."F
M_P"Q9)(D:?&GPZ7D=8T'FCEW(50.>I)`I?5<3_SXJ_\`@N7^7F@^M8;_`)_T
MO_!D?\_-?>??-%8_A_7M+\4:-IOB#1+I+W2=6M(;ZPNX^8[BVN$62*5#W5T8
M$>QK7)P"?0$_E6!O<6OQP_:6_P"4J7['G_8B>*/_`$HGKZ2\3?M/^,]-\=^)
M+^QT_3?^%=^"/&.A^!-<L)E<ZU?:CKTD"0:A9SJXAC@A>X59(W0NP7([5\5?
MMQ_%+P7\'?\`@HY^R%\1/B)JJ^'/!]MX)\16]QKEU%)]A@N)YIFC@EG`\M'9
M2"`S9/85Z."I3C6=U=SPV(Y5'5W]BW:RZVDM%?<X,75@Z<7>RIXG#N3>B2]J
MO>O_`"W3U=MC]TJ*^`_^'G7[%?\`T6GP[_W]'_Q5'_#SK]BO_HM/AW_OZ/\`
MXJN;ZKB?^?%;_P`%R_R\U]YT?6L-_P`_Z7_@R/\`GYK[S[\HKX#_`.'G7[%?
M_1:?#O\`W]'_`,51_P`/.OV*_P#HM/AW_OZ/_BJ/JN)_Y\5O_!<O\O-?>'UK
M#?\`/^E_X,C_`)^:^\^_*IZC+;0:??3WH!LX;2YENPPRIMHX7><$=P8PP([U
M\'_\/.OV*_\`HM/AW_OZ/_BJ@NO^"F7[$MY;7%I<?&?PZ\%U!+;S(91\T4R-
M'(OWOXD8C\:7U7$_]`]7_P`%R_R\U]X?6L-_S_I?^#(_Y^:^\^A/V<_&WP=\
M=^"+S5_@G!:V_A6+7]4LKI+2T^QQ?VQ;SLM^QBP`7,F=SC[QYKW^ORX^%G[;
M_P#P3Q^#7AZ?POX`^*/A?1-&N=2O-6FM()3L:^OI#+<S'<Y.9'))YKTO_AYU
M^Q7_`-%I\._]_1_\565#!XR-&G&KAY*HHI35.E)0YNO(K;:JWKYB6*P]E>O1
MO9;5(VZ;:^:/ORBO@/\`X>=?L5_]%I\._P#?T?\`Q5'_``\Z_8K_`.BT^'?^
M_H_^*K;ZKB?^?%;_`,%R_P`O-?>/ZUAO^?\`2_\`!D?\_-?>??E%?`?_``\Z
M_8K_`.BT^'?^_H_^*H_X>=?L5_\`1:?#O_?T?_%4?5<3_P`^*W_@N7^7FOO#
MZUAO^?\`2_\`!D?\_-?>??E%?`?_``\Z_8K_`.BT^'?^_H_^*H_X>=?L5_\`
M1:?#O_?T?_%4?5<3_P`^*W_@N7^7FOO#ZUAO^?\`2_\`!D?\_-?>??E%?`?_
M``\Z_8K_`.BT^'?^_H_^*H_X>=?L5_\`1:?#O_?T?_%4?5<3_P`^*W_@N7^7
MFOO#ZUAO^?\`2_\`!D?\_-?>??E%?`?_``\Z_8K_`.BT^'?^_H_^*H_X>=?L
M5_\`1:?#O_?T?_%4?5<3_P`^*W_@N7^7FOO#ZUAO^?\`2_\`!D?\_-?>??E%
M?`?_``\Z_8K_`.BT^'?^_H_^*H_X>=?L5_\`1:?#O_?T?_%4?5<3_P`^*W_@
MN7^7FOO#ZUAO^?\`2_\`!D?\_-?>??E%?`?_``\Z_8K_`.BT^'?^_H_^*H_X
M>=?L5_\`1:?#O_?T?_%4?5<3_P`^*W_@N7^7FOO#ZUAO^?\`2_\`!D?\_-?>
M??E%?`?_``\Z_8K_`.BT^'?^_H_^*H_X>=?L5_\`1:?#O_?T?_%4?5<3_P`^
M*W_@N7^7FOO#ZUAO^?\`2_\`!D?\_-?>??E%?`?_``\Z_8K_`.BT^'?^_H_^
M*H_X>=?L5_\`1:?#O_?T?_%4?5<3_P`^*W_@N7^7FOO#ZUAO^?\`2_\`!D?\
M_-?>??E%?`?_``\Z_8K_`.BT^'?^_H_^*H_X>=?L5_\`1:?#O_?T?_%4OJN)
M_P"?%7_P7+_+S0?6L-_S_I?^#(_Y^:^\^_**\<^#/Q\^%?Q_T&Z\2_"GQ58^
M*]&LKDV=S>6+;HX[@9S&3ZC::]-U[5$T/1-7UF1#+'I.FWNHO&O#2)96\EPR
M*>Q81E1[FLG&49<DHM23LXM6:;Z6-5*,HJ46I1:NI+5-=TUN:U?CW^Q?_P`I
M"?V]?]WX=_\`I/J=?2WPC_:1\:^)O'GA.Q\46.FGPW\5M+U'6O!D>GI(E[HU
MGIDZ0>3JKR.R3S7'F!MT04+M.>"*_/'X0?M+?!O]G'_@H3^VU_PN/Q=;>"CX
MDB\`RZ&=5C>&/4HK>WU$3R6LC`+((RZAMI.,\XKNH4*JIXRFHN4Y8>#48>\W
M;$4KV2[6:?H<->M3<\)/F48JN[N?NI7HS:>O=--==4?OY17P'_P\Z_8K_P"B
MT^'?^_H_^*H_X>=?L5_]%I\._P#?T?\`Q5<_U7$_\^*W_@N7^7FOO.GZUAO^
M?]+_`,&1_P`_-?>??E%?`?\`P\Z_8K_Z+3X=_P"_H_\`BJ/^'G7[%?\`T6GP
M[_W]'_Q5'U7$_P#/BM_X+E_EYK[P^M8;_G_2_P#!D?\`/S7WGWY17P'_`,/.
MOV*_^BT^'?\`OZ/_`(JC_AYU^Q7_`-%I\._]_1_\51]5Q/\`SXK?^"Y?Y>:^
M\/K6&_Y_TO\`P9'_`#\U]Y]^45\!_P##SK]BO_HM/AW_`+^C_P"*H_X>=?L5
M_P#1:?#O_?T?_%4?5<3_`,^*W_@N7^7FOO#ZUAO^?]+_`,&1_P`_-?>>B?MM
M_!?Q5\?/@+K?PZ\&M:)KE_K?AF_A-ZX2#R=)URRU"YW$D#<8;=]H[M@5]'^!
M](NO#_@_PSH=[M-WI.B:=87)0Y3SK:VCBDVGN-RG%?DE^UQ_P58^`7AOX+:S
MJOP7^,N@3>/(=7\/1V,48\]GLI]8M(M3(0$_=L6G8GL.:]X\(_\`!4#]CZX\
M+^'Y]:^-/AT:O-I%C)J0,@4_;'MT-QE<_*?,W9!Z5Q0PTOK^(4</B/K"P^'=
M2\)<GLG.M[*RM>_,IW>SNK$_6,-?F]M3U25_:1L_37?7\NZ/T>HKX#_X>=?L
M5_\`1:?#O_?T?_%4?\/.OV*_^BT^'?\`OZ/_`(JNWZKB?^?%;_P7+_+S7WE?
M6L-_S_I?^#(_Y^:^\^_**^`_^'G7[%?_`$6GP[_W]'_Q5'_#SK]BO_HM/AW_
M`+^C_P"*H^JXG_GQ6_\`!<O\O-?>'UK#?\_Z7_@R/^?FOO/ORBO@/_AYU^Q7
M_P!%I\._]_1_\51_P\Z_8K_Z+3X=_P"_H_\`BJ/JN)_Y\5O_``7+_+S7WA]:
MPW_/^E_X,C_GYK[S[\HKX#_X>=?L5_\`1:?#O_?T?_%4?\/.OV*_^BT^'?\`
MOZ/_`(JCZKB?^?%;_P`%R_R\U]X?6L-_S_I?^#(_Y^:^\^_**^`_^'G7[%?_
M`$6GP[_W]'_Q5'_#SK]BO_HM/AW_`+^C_P"*H^JXG_GQ6_\`!<O\O-?>'UK#
M?\_Z7_@R/^?FOO/ORBO@/_AYU^Q7_P!%I\._]_1_\51_P\Z_8K_Z+3X=_P"_
MH_\`BJ/JN)_Y\5O_``7+_+S7WA]:PW_/^E_X,C_GYK[S[\HKX#_X>=?L5_\`
M1:?#O_?T?_%4?\/.OV*_^BT^'?\`OZ/_`(JCZKB?^?%;_P`%R_R\U]X?6L-_
MS_I?^#(_Y^:^\^_**^`_^'G7[%?_`$6GP[_W]'_Q5'_#SK]BO_HM/AW_`+^C
M_P"*H^JXG_GQ6_\`!<O\O-?>'UK#?\_Z7_@R/^?FOO/OROQRUC_E,GX/_P"S
M?/$?_H=E7TC_`,/.OV*_^BT^'?\`OZ/_`(JOS!U3]MC]FN7_`(*A^%_C&GQ+
MT9OAY:?!;7/#]QXA$G^BQZM<O:>3:,W3S'V-@9[5YF98/%R^H\N&KRMF.$D^
M6E.5HJHFY.T79);MZ;=S[3@K,,!1J<3NMC<+257@WB"C3=2O3@JE:I0I>SI0
MYI+FJ5+6A"-Y2>R9_1U17)^!_&_AKXB^%])\9>$-3AUCP[KEJEYIFHVYS#<V
M\G*2(?[I[5UE=C33::::T::LUZH^1332:U35TUU3V84444AA5+4K&+5-/O=.
MGR(;ZUGM92OWA'/&T;$>X#<5=HH`^.?A=^S+J_@KQEX=U/6O$EKJGACX=+KD
M/P[TVWADCO;6'Q"SMJ(U:1QY<S8<B+RL`8Y]\KXEZ3^Q])\3(M&\>?#[P3J_
MC#7)HUU36;KPM8WL5K=2X2VCUK5#:O';W-P^$B2ZE$C'&!7VW7Y,_%SX>^-/
M^%A_$SPE!X<U._O_`(H>-_#GB'POJEO;2RZ=#INES6SW@N[X*8[-X$C:18Y)
M$WY^12:ZZ,I5JDG.I*%H?8:AO)7VLM+N<N[6Z.2K!4Z:4(*2<[^]'GMI96OW
MLH+R9]JQ_LC_`+,DJ))'\%OAR\<BJZ.OAC22K*PRK*1:X((.0:?_`,,B?LS_
M`/1$_AW_`.$OI7_R+7N_A^SGT_0]'L;GFXL]-LK:;!S^]AMXXWYYS\RGFM>L
M'5J_\_:G_@<O\S=4J7_/JG_X!'_(^<?^&1/V9_\`HB?P[_\`"7TK_P"1:XGX
M@_`/]D?X:>&+_P`6>)O@SX"BTRP"AEM?!^G75S-+(PCA@@MX;1I)999&5$1%
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M`*(G\.__``E]*_\`D6C_`(9$_9G_`.B)_#O_`,)?2O\`Y%KZ.HK/VU7_`)^U
M/_`Y?YFGLJ7_`#ZI_P#@$?\`(^'?BA\+/V)/@[;:'<^//AC\-=)_X236;70=
M&@/A;2Y;F]U&\8K#%%"EJ7*Y^_)C:G&3R*]/@_9*_9DN(89XO@I\.S'/%'+&
M?^$7TKE)%#J?^/7N"*^%/VS/@U^TGXE\8VWC#3=,\&^-?#=EXJ\/'PK8S0ZK
M)J_ANS2YS?W*10G[,TSJ%8RE24*_*0#@_K5H:SIHNDI<J$N%TVR6=`"`LPMH
MQ(HSS@/D#-;U'.%*E..(G*4W/F2J2?+90:5KW5N9IWW:TT,*<8RJ58RH0C&/
M+RMTXZWO=WM;6U[=%OV7@O\`PR)^S/\`]$3^'?\`X2^E?_(M'_#(G[,__1$_
MAW_X2^E?_(M?1U%8>VJ_\_:G_@<O\S?V5+_GU3_\`C_D?-TG[)'[,D,;RR_!
M;X<QQQJSN[>&=)5511EF8FVP``,DFO(O`_PN_8\^(7B?7/#?AOX'>$;M="7]
M]K;>!K*/0[MQ(T3QV&IM9?9;MHW5E?R9&VD'(KZF^+^D>(=?^%_CK1?"D[VO
MB/4_#6J6>CW$3!)(KZ:W=(71CP&!/RD]#BOA;]B+PSX^\#ZC-X0ME\2-X$TK
M2ROB*3Q9!+#<KXWDN)9-0_LII%3S;*0,KJ\6Z`[C@[LUO"4Y4:M1UI\T6E&/
MM)+3K)Z]=HKJ[]C"I&,:M*"HPY97YI>SAOT6J7FV]=+*VMU]1_\`#(G[,_\`
MT1/X=_\`A+Z5_P#(M'_#(G[,_P#T1/X=_P#A+Z5_\BU]'45A[:K_`,_:G_@<
MO\S?V5+_`)]4_P#P"/\`D?./_#(G[,__`$1/X=_^$OI7_P`BUX9\8/`W[%GP
M6.FP>*/@MX-NM0U4-)::9HW@>RU.^-M'GSKM[>ULI)%MH@#OE("C!YK]`:_-
MW]N>QU676/!=Y:Z;K^G645GJ44WC+POI4^L:K%/-#*D6A26MM#.ZV=\S!9IG
MCVQK(6#*1FMJ$IU*L8SJU>5WO:I)/17LM_P39E6A"%-RC2IW3C_R[CUDD^B[
M]=#VCP1^SQ^R3\0?#6F^*_#7P>^'5YI&J0B6WE_X1;2T<'H\<B-:[DDC;*NC
M<JP(-=9_PR)^S/\`]$3^'?\`X2^E?_(M:?[,UI?6/P9\'6^H^'?^$8NDL?GT
MTJR2$$Y6[F1_G2:Z'[Z1'`968@@=*][J)U*D9RBJM2RDTOWDGHGW3LRX4Z<H
M0;I4[N,6_P!W%:M)O1J^Y\X_\,B?LS_]$3^'?_A+Z5_\BURGC?\`9X_9)^'O
MA?5_&'B;X-^`+70]$M9+S4+B'PAIUS)%!&,NRPQ6C2.0.R@U]<UY]\5_LO\`
MPK?QM]LL3J4/_"-:P#9+:&^DN':QF$<<=JJ2--(SE0B*C$MC`S2C5JN44ZE5
MIR2:4Y)VOK9WT8Y4J:C)JE3NDVOW<7K;M8^,]3\,_L+Z?X'\*>/D^$W@>_T;
MQK:Q7_AZ&Q\$65SJ5[8R'YKL:?%9M<)!!P;B1DVPCER!S7LGAW]F7]E#Q7HU
MAK^A?"#X;7^EZE`EQ:W,/AK2&1T<9QD6QPRG*LIY5@0<$5\;>&K?6-(^'O[.
MGQ`E\(^(9=#\/_#'Q;X+U32DT:[75+#6M?81:;YNE-#Y\<*E3NE\H"-><@<U
M]X_LO^$==\$?!;P=H'B.W-IJMO9R27%LQW-"+B>2>-&Y.&"2+E?X3QVKHK<T
M(<T:U7XY12=1NZ4I*VEOA48MOKS[+0YZ*C.5I4:5N1/^$KI\L'J]=W*2L]?<
MW92_X9$_9G_Z(G\._P#PE]*_^1:/^&1/V9_^B)_#O_PE]*_^1:^CJ*Y?;5?^
M?M3_`,#E_F=/L:7_`#ZI_P#@$?\`(^%O$7PQ_8G\+_$?PU\*M8^$_@&W\9>+
M+*\O]%L?^$,L&@N;:PC,MRQNQ9F%&C0%MC,&/:N>\)>%OV(O%?C:[\%Z=\'_
M``7::E:W,MO87M_X(LK'3=6N[5L30Z3?3V:P7LL#*2ZP,Q7;R*Z3]H=H;?\`
M:+_9LOH_#NI:@]O=^+([_5;#1I[R&QAN-.B2WCO;Z&)TMHYG#*HE=5)S7DGA
M[XC:#\4?VB-!TO6?!/BWP]8^"M=U:U\':5;^$]2T_36OU0B]UW4=5%I'8^1<
M#(A59OG89())KKBIR@I\]?\`A<\FJK=I*4EI'JI66CLDKN^QRRY8S<>2@OWJ
MBDZ:]Z+C!ZNVC3E+;5M));V_333=-L=(L;73-,M8;*PLH4M[2TMXUB@MX(E"
MQQ11H`J(B@*JJ````!5T\@CUXHHK@.X^)O$7[*%]JWCW5[RU\206_P`/?%?B
M72O&/BC1GBD.JS:]HKQ/8BRN!^Z2TW01M(K?.3N`.*[C]H:Y_9\M(-!@^,WA
M/0_%]P'5=)L;[P_!X@O[2W'[N6]$+0336UE$,F>XPL2`'<>M?4-?G_\`M0:+
MKNE?$[3O'2Z#J6MZ!J/PUU_P#"NF6LM]-;Z_K,LGV*6:"))&C@_>*KW!4",$
MEF`!QU4IRJU(*<VN6+Y>5\LFTDDDUU:27=I6.>I"-.$G&*?-)<W,N9)7[=E=
MM+NV>NZ)^R_^RIXBTJRUK1O@_P##6^TW4(([FTNH/#6D/'+%*H96#+;$=#R.
MQXK5_P"&1/V9_P#HB?P[_P#"7TK_`.1:WOV<O">M^"?@YX*\.>(8?L^K6&E0
MK=0%MYA=P&\HG)Y0':1GC&*]PK.=6I&4E&M4DE)I/GEJD]]RH4J;A%NE33<8
MMKDCHVE=;'SC_P`,B?LS_P#1$_AW_P"$OI7_`,BUGZK^RO\`LMZ+IU[JNH?!
MCX=PV5A;RW5S+_PBVE-LAA4N[!1:Y)"@X`Y-?3U87B>]@T[P_K%_<V#ZI!9Z
M?=7$NG1Q>?)>)#$TAMTA*L)7E"[53:=Q.,'I256JVE[2KJUM.5_EKN-TJ6K]
ME3Z_8C;\O(^'/A;X'_8F^+=]?:;X;^#G@N"_LVE:&UU?P/9:9-J-I$Y0WVG)
M=62-=VN1_KH=R#C)YKW+_AD3]F?_`*(G\.__``E]*_\`D6OFC]F[Q[HWQ5^,
M\OBK4/"OBCPYKNGZ+JFG>'=(N?"^HZ%HWAW0A*B-;SW,]K!;7-]>;5;;&[(F
MW]V%SS^DM:UY5:<^55*R]V+M*I)V;WLU:Z\[>EU9F=&-*I#F]G2?O-)JG%76
MFMK.V_W'SC_PR)^S/_T1/X=_^$OI7_R+1_PR)^S/_P!$3^'?_A+Z5_\`(M?1
MU5;U;F2SNDLW2*[:"5;:20$HDY0B)G`Y*J^"1Z5C[:K_`,_:G_@<O\S7V5+?
MV5/_`,`C_D?$NH_"W]B33/B=H?P@N/AC\-3X]\06-WJ5AHL7A;2Y9!9V49EG
MEN&2U*P#:#L$F-Q&!7JW_#(G[,__`$1/X=_^$OI7_P`BU\,>%?@S^T?X7_:Y
M^&'C?QII?@S7[?4;OQL^O^,]*AU(W\.FS6073;&8S$P6\:IM6)$5$,VX@$5^
MNM;UI2I^S4,1.?-34I-5&US7::5GHE;9Z]>IC1C&?M.>A"'+4Y8ITHJ\>6+3
MUO=ZN]M.G0^<?^&1/V9_^B)_#O\`\)?2O_D6C_AD3]F?_HB?P[_\)?2O_D6O
MHZBL/;5?^?M3_P`#E_F;>RI?\^J?_@$?\CY6\1?LS?LG^%-&OM>U[X0_#73]
M+T^%IKFYG\-:0JJH'"+FV&Z1SA8T7+.Y"J"2!7(_#+X(_LG_`!2T:XUW0_@+
MX3L["*[DM8FU?P-9:;)=*C$+<6\=S9(TD$@&Y)%!5E((/-7/VXO`'BGXB_!Q
MM$\.S:I%:0Z[I6H>(DT8G^TIM#L;N&XO8[5!\TDABC;]V@+OT0;L5L?LCKXT
MB\%:G;:]#J,?A2VOHH/`3:W$\&N/HB1;6&HPR!9$99`!")%#^7C=SFMTY_5W
M5]O4Y^?EY?:25DN7SUD[O3LKF/+#V_L_804>7F4O9QU>NFVRMOW:6YTO_#(G
M[,__`$1/X=_^$OI7_P`BT?\`#(G[,_\`T1/X=_\`A+Z5_P#(M?1U%8>VJ_\`
M/VI_X'+_`#-O8TO^?5/_`,`C_D?./_#(G[,__1$_AW_X2^E?_(M>>?$WX(_L
M@?"CPU+XG\5?!OP#%9B9+6V@M?"&FW5Y?7DH)BM+.VBM#+//(%.R.-2QP<`U
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M=VM?W<5U[6_)V/G'_AD3]F?_`*(G\.__``E]*_\`D6J]W^R;^S%96T]W/\%?
MAXL-M$\TK#PMI3$1QJ68@"UR<`'@<U]+5%<!6@F#J'0Q2!E*[@R[#D%3UR.,
M=ZR]M5_Y^5/_``.7^9I[&E_SZI_^`1_R/SUT'P_^P;XE\'^)_&^D?"_P#/HG
MA36[CPYJ1D\&6$-TVM6^`=/M;62T6:YN)6(6%(U+2L0%!)KT+X=?`[]D'XGZ
M(=<\,_!OP"\44QM[RSO/"&FVFH6%P!N\B]LYK19K:4H5<)*JL58'&#7R=IOA
MW6M;\,?&.;0_".L6L'AO]I+2/&<]A)HMSIQU'0-&:QN+ZYTNW:&(7R,(I-@M
MUD\U\@9S7V/^R]I>JS7_`,7/'ESI-YHNB_$+QLFN^'+/4('M+P:?'IEK9LT]
MG(J/;L9X9"$9`2,-WKLJIPA*4:U6Z:LG5;W4/=:77WI._9?,Y:?+*48RHTM4
M[VI);<WO:K2UDK/>_<ZG_AD3]F?_`*(G\.__``E]*_\`D6C_`(9$_9G_`.B)
M_#O_`,)?2O\`Y%KZ.HKC]M5_Y^U/_`Y?YG5[*E_SZI_^`1_R/FF[_9-_9BLK
M6XO)_@K\/%AM89)Y6'A;2F(CB0NY"BUR2%4X`Y-?-]I;_L#:EX,\0^.=*^%7
M@O4-'\-ZU-X>OHX/`=JU_)J\$K0O9VUD+$SS/YB%5V*0W49&,_I%,JO#*CJ'
M1HW5D8;@RE2"I4\$$<8[U^3WP_\`'(^%W@W]HCQ$WPQUS56L?B?.FCZ6?"EW
M(LEQ<3RQQZM960M"]U:PNXFDGM4;<JY#;C711=2HIMSK2<73LE4:OS2Y;:[>
MIA5C3@XVITDFIMMTHNW*K]$?=G[/S_!N?P@US\&_#^D>&-(GGW:CHNG:3%HE
MS9WN#F/4=.2*&2"<<\3(&/.*]HUC3(-:TK4M(NMPMM4L;O3[@KPWDW<#P2;3
MV;9(<>]?(O['=UH6L:!XN\1V%CXA@US7M:6]\2WFNZ-?:'%=:@ZN?*TVROH8
M'%I:`F%7$?S@`DDY-?9=855RU9).3::UD[RO9/5];/2_6VRV-Z3YJ479)-;1
MT5MM$K6OV1\9?"W]EW4_!GC?1-=U[Q);ZIH7@"ROM)^'FGVL4D5S::;J,JRS
M+JTCC9--&T:",Q8&TMNR:;\3X_V2M;^*%MH7Q%\$>#O$'C"^2*UN]<U#PS9:
MA%8R-\MI9ZKJ[VSI;239(@CN)1G#8'6OL^OR2^*/PZ\;#X@?$WP9#X=U*\U'
MXG>*O#VM>&-6M[:673H;#3+AI;M[J_53'9M`C!0CR(S[OD!`-;4I.M.3G4E!
MQ@K.$E#1R7,[VZ7<Y=WU,*L52A&,(1DG*[4ES]%9:][**;T2VV2/MU/V1OV9
M7573X*_#ID=0R,OAC22&5@"K`_9>0000>XIW_#(G[,__`$1/X=_^$OI7_P`B
MU[]I-O)::7IMK-_K;:PM()>_[R*".-^>_P`RFM"L/;5?^?M3_P`#E_F;JE2_
MY]4__`(_Y'SC_P`,B?LS_P#1$_AW_P"$OI7_`,BTC?LB_LS*"Q^"GP[`4$D_
M\(OI7``R?^77TKZ/IKG",2-P"L2/4`'C\>E'MJO_`#]J?^!R_P`P]E2_Y]4_
M_`(_Y'YXZ1X:_8;UCX@WGPZA^$/@FWU6UN#8I?W?@BSMM&N]17[]A:ZG+9+:
MS70R,1)(78D``DBOH+_AD3]F?_HB?P[_`/"8TK_Y%KY*UWXD>'O'_P"T!IW@
MS6_`GBO0M%\'^,H#I$&G^$=2@MM>U]7B?^W+S68;,6BZ?#\C!O.#2,C*^5%?
MJ$.@^@K>M*I3]G:=:+E!2:=1R^:::WW:Z;79C1C3GSWITI<LN6ZIQ7K=-::[
M=^R/G+_AD3]F?_HB?P[_`/"7TK_Y%H_X9$_9G_Z(G\.__"7TK_Y%KZ.H.>U8
M>VJ_\_:G_@<O\S;V5+_GU3_\`C_D?"7Q8^$O[#GPL@T&W^(7PO\`AMII\4:Q
M9Z-HUI_PBVF2W-]J-S,B01Q0QVID*^85W/C:`.:]<B_9%_9E:*,I\$_AWY9C
M0I_Q2^E?<*@K_P`NOH:^$_VP/@M^TEXA\<V_C:QT[P;XU\/6/C+PC_PB=M+!
MJ;ZSX9TR/5K*34IXHHC]F:<[9':8H2L1(W<5^N.G^>+"R%R%6X%K`)U3.U9?
M*7>%SS@-D#/-;5$X0I58UI2J5%)5&INZ4.5QC_-9<[W;5[V,*:C.I5C*A",8
M6Y+TTKWNF]K-OE6W2W?3Y]_X9$_9G_Z(G\.__"7TK_Y%H_X9$_9G_P"B)_#O
M_P`)?2O_`)%KZ.HK'VU7_G[4_P#`Y?YF_L:7_/JG_P"`1_R/FV;]DK]F*WBE
MGG^"_P`.8H88WEED?PSI*I'&BEG=F-L`%5022>@%>1^!/A=^QW\1?$>N>'_#
M/P.\(72:$0LNLOX&LXM%O),E76PU%[(6UWL(()AD;FOI[XTZ+XB\1?"WQMH?
MA2=[;Q!J>@WMIIT\;!9$EFB*'RV/`<H6"YXW$5\0_L-^&O'_`()N&\()'XA;
MP1HVCBVU^;Q7!+#>#QBKM]K_`++:55\ZS=RQ9T)A(V^6?7>#G*C4J.O/F@TE
M'VDEH_M;N]WI%:7UU,9QA&K3@J$'&2=Y*G%ZI[;;6U;MIH?4'_#(G[,__1$_
MAW_X2^E?_(M'_#(G[,__`$1/X=_^$OI7_P`BU]'45A[:K_S]J?\`@<O\S;V5
M+_GU3_\``(_Y'SC_`,,B?LS_`/1$_AW_`.$OI7_R+7A?Q=\#?L6?!J;2[+Q+
M\%?!]YJFL%VLM+T7P-9ZI?/;PC=/=-!:V4CK!"N6DD8!5`.>E?H%7YL?MPV.
MJ2>)/!-W;6'B'2+-+'5H)/&OA;2KG6-4@N)H`D.BR6MM#.R6>HM^YGF:/]VK
M$JRD9K?#RG4JJ,ZM7ELWI4DMEZM_):O9&5>$(4W*-*G>\5\$>K2?1?CIWT/<
MO!O[.?[)?COPWI?BOPY\'OAU>Z/J\'GVEP/"VE*2`Q1T=3:Y22.16CD0X*NI
M!&173_\`#(G[,_\`T1/X=_\`A+Z5_P#(M=!^SI:WME\&_!5MJ'AX>%[N/3F\
MW1P&5H=TTC+/(K?,DMXI%U*C8*O*P(!%>W5E.I4C.<55J64I)?O)/1-VU3ML
M7"G3<8MTJ=W%-_NXK5I/9JZ^9\X_\,B?LS_]$3^'?_A+Z5_\BT?\,B?LS_\`
M1$_AW_X2^E?_`"+7T=14^VJ_\_:G_@<O\RO94O\`GU3_`/`(_P"1\#:;X%_8
M9U3QQXO^'D'PO^'L?B3P-IIU?Q'!=>#]/MK>SL0`3.+J6T6*10""=K<5;^&_
MPT_8L^*5[J6G>&?A!X$-]IK.QM[[P986,EY9J^Q=1L%GLU-W82'&RZAW1'<O
MS<BO-/B'X<U/Q'^TE\9/#_A_PWJ$5WK/P5N["WU9=)FMM+O]2FGC,5L=5$26
M\]P5XVF9F4=>*Z/]F;0/$&H_$SPQK[^'M3T33/`'PDC^'.O2:E9RV(NO$MO=
MVCR-:K(D?VN!4MY`MR@=&&-K8-=;4E3<_;54_9PDDZKT;BG\U*6D5HUYG*K>
MTC'V-)Q<Y1NJ:U2:6FFG*M7?>ZV/HC_AD3]F?_HB?P[_`/"7TK_Y%H_X9$_9
MG_Z(G\.__"7TK_Y%KZ.HKD]M5_Y^U/\`P.7^9U>RI?\`/JG_`.`1_P`CY"\=
M_L^?LC_#CPMJWC'Q3\'/`%IH>B6SW=_<0^$=-N9(X4^\RPQ6A=\>BBO(-<TO
M]AG1_#'@CQ3'\'/"FJZ5X_M%U/0%TKP!;7L[:6"/-U&Y@@L6DMK>WRIEDE"B
M,'+$"OM+XQ?9_P#A5_CDW5@VIQ#PUJW^@QV9OY+AS9RJD<=HJ2--(6(V*J,=
MV"!Q7YS)\6IO`7[-WP.\.P^!O$=KJWB3PI=:/>ZZ/!VHW][X3TQ7=-1MGLX;
M.2ZM;FZC=%@C=%0_>*G`-=-%U*B5YUI2]HHV55QO'DE+S=TUTW3LM3GJJG"3
M]RDH^SYK^R3?-SQC;I>]_+STN?IC\/QX.'A#0_\`A`8--MO";643:-!I,44-
MC%:$?)'!%"!'&$.5*`#:P(Q795XQ^SY9:%8?"#P1;^&K+5;#1AI$3V=MK5O-
M:ZFJN[N[7=M<*DT,CR%W\MU4HK`8%>SUR3TG)7;M)J\MWKN]]>YU0^"&B5XQ
M=H[:I;>78****DH****`"FE5)#%5+#HQ4$CZ'&1^%.HH`****`"D95<%64,I
MZJP#`_4'(-+10`Q(XXQB.-(P>H1%4?DH`I]%%`!112$9!'3((R.V:`/RD_X*
M8_\`!3#PA^PYX!F_X1ZU@\<_%B?R;BR\'6@DN_L6G^:BSW^LM:AS86X5ML;S
M&/>[#;D9KWO]AW]N'X<_MH?"_2O%GAYFT'QC#8VK>*O!&I9MM8T:\DC!<_9)
MMLSV<C;C!<*ICD495C7YV?\`!4W]D[X<?"[]DO\`:F^+FC6&H^(OB/\`$:6T
MN]1U[5FFU?4K"T.HV[1Z5HWFF9["QA!($-L$4CJ,"OK']C+]DOX9+X2_9W_:
M.TJTU#PS\0H?A)HFDZZNE336%AXDADLH1&VN:=&8X;NYMMK>5+/&TB%VP1FO
MG:=?-GG-2E*5%X94*4WA4G[E.=:</:1K6UK*,5.46E!I\FZ4GBG4]JUIR\J;
MCV5VKI]_P>JZ'ZAT445]$;!30JKG:JKDY.`!D^IQU/UIU%`!1110`4QT208=
M$<=<.H8?J#3Z*``#`P!@#H`,"BBB@`I"`000"#U!&0?J#2T4`,\N/:%\M-HZ
M+L7:/H,8I]%%`!1110`THC$,44L.A*@D?0D9'X4T0PJV]8HP_P#?$:AO^^@,
M_K4E%`!1110`4C*K<,H89SA@#SZ\]Z6B@`HHHH`*.O!&1110!&L,2$LD4:,>
MK*BJ3]2`#4E%%`!36945G=@J*"S,Q`55`R22>``.23P!3JY[Q;X?C\5^&M<\
M-37EWI\6MZ;=:;)>V$K07EM'=1F)Y;>5"K1RJK$HZL"IY!I-M)M*[L[+:[Z*
M_2_<#\0_VY_^"T?@K]E[XV_#SX8^`/#,_P`4;-_$?]D_%#4]&AGNX-#BD,:&
MTTRYMU:&ZU:V#-)-:H[NJ[05R<5^PGP5^-7P_P#C[X`T3XC?#G6[;6=!UFVC
MF_=2*;FPN2H\^PO[?/FVMW;2;HI8I55@RGC'-?SZ?\%!/V7/AI^SOXM_X)_^
M"OA]X<EN;35/VC4OO%.JWD$FIZGK]Q?7-I)<W.NWLBRS7(?>4/VF1E"`*.!@
M?N'\"?V5/AQ^S]XI\>>*/AR-0TBR^(MW'JVI^%DNI?\`A'K#4G"M-<Z7IQ?[
M/8M.03*L$:!F9B>2<_/Y?6S6>98^&)G0J4*<Z"=&%XO"^TH*I'V4_P#EZK^[
M4YDFY>_&R]TQ@ZCG.]N5-:=KQ3T?7^MCZAHHHKZ$V$(!!!`(/!!&0?J*``HP
MH"@=`!@#\!Q2T4`%%%%`!2,H8%64,#U#`$'Z@\4M%`#554&U%5%'0*H4?D`!
M3J**`"BBB@!H1!G"*-WWL*!N^N!S^-*`%&%``]`,#\A2T4`%%%%`!49BB((,
M<9#<L"BD-]1C!_&I**`&(B1C$:(@ZX10H_)0*?110`4TJI8,54L.C%06'T.,
MBG44`%%%%`!1110!'Y,6[?Y4>_\`O^6N[_OK&?UJ2BB@`HHHH`0@'@@$>A&?
MYTM%%`!1110`4U55<[55<G)VJ!D^IQU/N:=10`4444`%,=$D&'1''7#J&'Z@
MT^B@``P,`8`Z`#`HHHH`****`&[%W;]J[NF[:-V/3=C/ZTH55SM4+DY.`!D^
MIQU-+10!Y)\;/C7X`^`7P^USXC?$77+71=#T6TEF'G2#[3?W(4^18V%N#YMU
M=W$FV.*&)6=F;@5^/_[!W_!:/P7^T_\`%?QQ\+/B1X9N/AE<P^*[W3/AUK.J
MPW%GI^O6(GD6RL;V>Z5([767B56^RNR,_P`VU3BOTY^/'[*WPX^/WBCP)XK^
M(JZAK%I\.+B;5=*\+R7,O_"/7^I+N:"ZU73=_P!FOFMR<Q+/&ZJ<$#(K\.O^
M"??[+OPU_:+\7?M_>"_B%X=FM;72_P!HR:^\+ZM90R:7J>@7-C>7<EK=:#?1
MK%+;!-@4?9G5-A*GC@_/9A6S6&98&&&E1A0J2KI49)R^L^SH*K+VL[)TE>\*
M?*I6E[TFU[IC-U.>*BTD[Z?S62;OV\K?/0_IE!21`RE9(W4$$8964C((/(((
MY!Z&F-!"P"M#$P7[H,:D#OP"..?2L/PGX?C\*>&M$\-Q7EUJ$6BZ=;:='>WT
MC37EREK&(DEN)79GDE95&YV8DGDFNAKZ!-M)M6=E=7O9]5?K;OU-A``H"J`H
M'``&`!Z`#@4M%%,`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`P?$GA?P
M[XPTFYT'Q5HNF^(-&O`!=:7JUI%>V5P%(91+;S*T;@,`1N!Y%:&FZ9I^C6%K
MI>E6=OI^G6,*6]G96D2PVUM!&-J10Q(`D<:`855``'2KU%*ROS67-:U[:V[7
MWMY`%%%%,`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`.6\0^"/"'BVYTB\\3>&]'UVZT"[%_HEQJEC!
M>2Z7>J01=6+S(S6\X*C$D95A@<UU(&``!@#@#V%%%)))MI).5N9I:NRLKOK9
M:*_0`HHHI@%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`"$`@@C((P0>X/45R_A[P1X0\)7.KWGACPWHV@W6O7;7^M7&EV$%G+
MJEZQ):ZOGA13<3DLQ,DF6))YKJ:*32;3:3<;V;6JOH[/=7ZVW`****8!1110
M`4444`%%%%`!1110`4444`%%%%`!7R3^V9\=?'?[/GPDD\>?#SPC9^.-?AU:
MQM5\/7=U):&]MYI`+A;:2-'9KE8M[11X`=P`2,U];5\X?M+?"'Q3\8_"OA_0
MO"VOVGA^YTSQ3I>M7EQ>6:WJ7%E8S++-:I&[`*\H4J'YQG\]:+@JM-U$G!23
MDI7Y6ENG;6SVT,ZW/[*?L^93M[KC;F3[KFTOZGQKX"_X*3^'=2O/%GBOQ_'H
MWA7X7^$M%\.+KUZMQ<W&M^'O%FL"&&ZT76+$0_Z,+6^E^S+(2=S%>:]D/_!2
M;]E%;Y-.D\?1QW3^)H/"!1[2Y&S7KJ"6YMK)_P!UP\UO#++'V9$8@\5Q'CC_
M`()L?#3Q18?'^#2M2GT"7]H"W\,3^(X;6%39VFM>&Y[:Z34+:'(1&O+BW#W(
M0+NW9R37QA=_\$BOBG)XU?78?C'HIT>?XCZ%\1IK*7PQ:M.;[0M(U'1X;-93
M)D0R0:@\C'^^BG'IZ"AEM2\G4G2LE:.JO[L-/AG=\SJ)NZVCM<X)3S&G9*$:
MJN[RT;MS2_O15N50LMTW+>VGV[\9?^"B7PJT/X6_$OQ-\'O$&@^-_&O@7PO<
M^*;/P[=7,UG!K5G82Q1Z@+2X$1,AL_-5;@1JQC=E5@,UU7P;_P""@'P3\>_`
MRP^+/B[Q1H_A&_L]#T?4/&&@W-PRSZ)>:NDAM;<+*JR2)=-%*MJ^W][L./6O
M@70?^"/'BBSETNRU3XNP3Z+;:'\2_#-Y';Z+%!<7&D_$&]L+YF\U9<^?I\EB
MJQDYRK$`K7?:;_P2!T"\^'?Q$\,>,?'UUJ^N>++'P9I6E7]I:BQM-/LO`#W9
MT!Y;:*0I-,ZWDJW;G!EXSDXPW3RQ04?;3;]I%NHDW+E;491M91M92G>UTVEJ
M)5,R<K^Q@ER-<K:Y>:W,G=-M.[Y.VC>A]I>%?^"AG[+?C7QAIO@3PS\0;36/
M%&JZ?)J5KI=C%/<3F"#!NE<11L%DM@R-,A.4#KD#->P?%[]IOX-_`U-"_P"%
MC>+K/0I_$2F;3+27>UU+9QJCW-\T**SI:6B2*US,P"Q`C<:_/GX+?\$QG^#'
M[2WPZ^.?AG7]!T_2/"WA+5M#U_PO!HT.=;U76X8+>_U=KQF++*R6T;!=N-Q)
M&#7MG[9W[!T'[4?BCPKXSTWQA)X6US0O#?B/P3<I):+>V=SX<\6P0VFK^7"S
MJL5['!"!:S@;HV.5(-82IX'V].,:U3V+IMU)O5J>MHZ1T6BN[2W-HSQOL:DI
MTH>U4TH0CLX6C>6LM7K+1VU1C^%/V^C\6?VMK_\`9U^$GAJUUK0?"'A?2_%O
MB_QC?3SPVTVDZR[I:3:(8XWBNE7RV9B[H#T'(P?1M-_:?\=?$_Q5\5=/^"'A
M'2?%.A_!_4;[P[K=W>W\EO<:QXIMK..Z&DZ=&L;#`$L8:1RI!)QQBO,?V5_V
M#=>_9L^/?BGXDV_CBVUSPAK?PU\-_#FST&;38TO[:S\.2SW$-W+J&\R2RSS7
M,F]2.$`7->OZ#^S#XG^%?Q$\9>)O@SXLM/#GAOXG^)3XF\;^'[NP2X4:K)##
M!/?Z=*6!BEFBB564*,8SFG4^IJ;C2Y6HT:7)*7/RRJ73JN>SYK744E9/Y,(?
M6N6+J<R;JSYXQ<;QA_R[Y>G+>W->\FNVI\[_``J_X*-W#?M!?$CX)?'WP_HO
MPV;PA8^&Y;#5(K^>ZCEU/Q%/#;0:3>EXE2&X^T2B*+#-YC%1FOH[QM^VC\-;
M?0_BE8>!-;T[5/B+X`\'ZWXKL_#.JF?3_P"V+?1[2>X:6V9X@\MJTD)B,T2L
M,@X-?"_QR_X):?$+XN_%;XO_`!#B^+EEI*?$?5OA]JUC"NAPRW.F3>!=7M=7
MBWS^:K2B\FM@L@.,*Q'-=GJ?_!,OQAJ7B^W\?7_QCEU/Q+!\*_%'PU:>YTF)
M8Y8/$D5[_I4JK+A_L4EX5B1LYCC49K64,ODX3]JH-PASTXJ;BJBA3;7O1^&4
MN>+L]+73UTRC/'Q4H^S<TINTY./,X.<DMGO&*C)>[K?5&-^S/_P5)U'XF>-+
M/3OBQX9\.>`O!MS\&7^*ESXCCU::9=/>#7CH,NGSK-#&N))E+PN"6<D+C-?5
M4'_!2S]D6YU;1]#M_B;ITVJ:W#>SVEI$LLD@2PAENK@S;$81%;2&2Z&\C,(W
M]*_/KP!_P1X\:V<6H:'\0_BS8:]X8O/A--\+EM=.T6/3[L0+K[>)+34C<1RE
MA+%?[%9.C1@@GI6GJ/\`P1SF@UGX=ZQX0\9:+X9N/#&@^(M'\2RPZ)#/<>);
MC6/#U[X:MM0GF=U9)K6QNPX"YS(G7G-:5*>5SFVJK@K.RAS<FB;5^=2E=NR=
MEIH^K:B%3,XPBO9*3NG)U.7FUE%-+EDHV2O).]VKK='Z0?$3]O/]FGX9Z5X=
MUG7_`!]92V?BC3['5M,;3EDO&;3=1FBMK.]E6%&,4$]Q/#`C/MS)(J]Q5E/V
M[/V9?^$EA\)W/Q*T:SUN73DOVM+F7RY(&DM&ODL95QE;YK5))A!]_8C''%?B
M?\5/V)_VG/A)XI^!/A#P5X*\._%WP]X5T"Q\*^(==U2`646M:;8:I;:A96^I
M1*DZLMLUM'*K'I+&OK7W9X>_X)@>%+WXG:_\9=:M=*CUGQM;Z=XDGT+4;9=2
MM?"OC.'3&T^1M.$A19+3R;BXB,>%7:V-M9RP^`A"+=><N93<90E!MM22BG"U
MX:7D^;?H5#$8Z<W%48KE<%)2C)))QO-J5TIZVCIYO78_0KX(_M(?"W]H.'7K
MKX9ZR^M6GAZZCM;RZ%O-%;R-*&,;V\LB*LR,$)RA)'\0!XKWJOC;]D;]EB?]
MF2R\;67_``E3ZY8^+-7CU6STB.T2TT[P^1YGGP:;$A/EP3,X81#Y8P`!FOLF
MO/K*FJDE1;E35N5O=Z*]]%UNMCOHNI*G%U8J-1WYDMEKTU?3SN%%%%9&H444
M4`%%%%`!1110`4444`%%%%`!1110`5\D?MF_'7Q]^SY\)T\=?#GP?9>.O$!\
M0:7I<?AV[NI;1KR&[=_.%M)$CLUPL2,T<>`'88S7UO7SG^TA\)?%?Q>\.>%M
M'\*Z]9:#<:'XST3Q+=37MDE['=6NF2.TMF(W8!3.CE0_.WK@UK0<%5INHDX*
M2YE*_*UV=M=?(RK*;I34+J=O=<;73NM5?33?4^,?A[_P4K\*:L_B?QGX^ET3
MPI\,/#>A>%9-4O/M%S-KFB>*->GN+6YT/6+$0$6QLYX0-Y;E74G`KV3_`(>3
M_LH"_337\?QQW3^)D\(;&M+KY=?EM[>ZAL6(A.))H+F&1.Q#C!KSKQ]_P3(^
M%WBS3/CQ;Z5J=SH%Q\=K3P_/KD-K&IL;/7M#E:?^TK:WX1?M4K?O8U`&`.37
MQ_<_\$B?BDWC8Z[!\8]%_L63XGZ/\2Y;&3PS;&?[9I.G66FK8K+YF?)>&QC8
MMC[S$XKT%#+:EY.I.EHK0U2^&GI?DG=\SJ)MO6RVNSA<\P@HI4XU.\M_M2U^
M*/V>5VU=V]['V]\9?^"A_P`+=$^%7Q1\4_!WQ!H/C7QG\/O">I^+[7P_>7,U
MG;ZYI^C+(^H+9W`B+2M#Y,D;^6K;'4AL8KK_`(2_M^_`_P`;_!2S^*GBOQ7I
M'A2]L=$T*^\6Z'=7#)<:-J.MVT$EM8JDJI)+]HFF$-JVS]Z<`<U^?VA?\$=O
M$]HFD:9JOQ>AGT>V\*_$;P;J"V^BQPW%UI/CU[V9I/-$H/GV,M[)Y9.XE549
M!KOK'_@D'H=_X`^(/A_QAX_NM6\0>*HO!=OIE]:6OV&SL8/A_<07&@"2UCE*
M2R2-;1B[=N9`6#9INEEB@H^WFWSQ;FHMRY6U&4;62M92G>R:;2U!5,QYN9T8
M6<&N5M*/,DVG=-M-R:C;5-*^A]K>%/\`@H5^RWXW\8:9X#\+?$.RUGQ/JNGK
MJ-IIMC%/<2M`9VMG#>7$P62*1&$B$Y4`D@#FO6OB[^T]\&O@>VA0_$3Q;9Z)
M=>(E$VF6<F]KJ6T"[Y;UH45G2T@0%YIG"I&JL2>#7Y^?!3_@F)_PI?\`:5^'
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M\?\`Q/\`$^'QS;ZWX3U;X<>&/A]IVA2:;''?VUOX;L;2RBNY]0#F6>2=;4,X
M8<%CR>M>O>&_V7?$OPC^(?C'Q)\%/%%CX;\,?$SQ$/$?C70+W3X[HC47C9+J
MYTZ=F!ADN6=I'``^=B<D\TZGU-2:I<K2HTN24N>TJETZOM-FI6NH\NBZ7=A4
M_K;BG4NFZT^=1Y;QAM3Y-;.-]97]Y]K'@'PJ_P""BUT?C]\2?@G^T#X>T;X9
M3>#;3P>]EJ2W\]S%)J7BG3([_P#LJ\9H@D,]O(_D+AFWL!SDU](^+?VQOAW)
MI'Q2TKX>ZUIVJ_$GX?\`A'7/%5MX8U8SV']JVFB6LES<30,\0DDM08Q$TT:L
M%=U]:^#OCG_P2T^(WQB^)OQ@\?GXOV>DM\2M8\"ZQ:(NA12W&EW'@E;:*W)F
M\Y6E%S'`6<<`,W0]_1I/^";_`(U_X3I_B5-\7FU7Q4_PE\;?#!Y;W2(A#)!X
MR>,O=NBRX?\`L]4V6Z,#\IQE16DH9?+DFJJA)PAS4XJ;@JBA3;O>-^64N>,K
M2TW1$9XY<T73<ESR49MPY^1RDD][7C'E:T:;;78X[]F;_@J?J'Q+\:V6G?%S
MPSX;\`>#+KX*6GQ9NO$L>K33)IOFM!'+87"S11J%,LZI$^2S,0,"OK*#_@I5
M^R-<ZMI.AV_Q-TZ?5=7M[ZYM[.%99)(X].91=^?LC81-$'5B&(^7GIS7YZ^`
MO^".7C&WM]2T'XC_`!:L=>\,7WP=3X3+::;HD6G70M[.ZMKVQU(W,<I82K-:
M1ATZ$$\^NWJ'_!'BXM]?\`Z[X0\9:'X8N/#WA_Q'HWBAX=#AGG\2W&N6ZVZZ
ME-,S*R3VX4$`9R2:UJ4\JE-M5G!6T5-2Y-(W3]Z+DVWH[+MYLSISS.,$G24W
M?5S<>;>*=E&2C9)MKOKVU_1CXC?M[?LT?#+2_#^L:]X^LIK+Q+86>J:;)IRR
M7A.G7[B*TO)1"CF*&=SMC=P`Q!QTJW%^W;^S*WB:/PE/\2='M-::S%V]M<S>
M6T3&$3BSD!&5O/*96\C&_!Z=J_%#XG?L3?M.?"#Q3\!O!W@SP/X:^,'AWPGX
M:TCPIXBUS5(!9P:]8:?>-/;PZG"$G5A:K(Y0DY4CWK[I\/\`_!+_`,*W/Q,\
M4?&+4[728-8\;I!XG_L/4;8:G:^%/&AM4ADET\2E1)9J%$8APJX'3'-9RP^`
MIQBY5IR4XS<91E%W:DE%2A;F@K7D[K6UEKH7#$8V<I15*"<)04E*,E9.-Y-2
MO:=G966U^I^AOP1_:1^%O[0<.M77PSUE]:M-#N3;75T+>:*WD(D:+?;RR(J3
M)YB.OR,2"IR!7O5?&_[(_P"RS/\`LRV/C6Q'BI];T_Q3KTVL6&CQVJ6FG^'H
MYB&>STZ)2?+MS)O<1CY5+''6OLBO/K*FJDE1;E35N5O=Z*]]%UNMCNHNHZ<7
M5BHU/M)>OJPHHHK(U"BBB@`HHHH`****`"BBB@`HHHH`****`"D.<''IWI:1
MLX..N#CZXX_6@#\@/BC_`,%$OB%\+_BQ\7?AKXA\":!IFF^'KNWTOX:^,[S5
M+B/1_$>N/:Q7LVBZI)Y.VQO/L\F80N[S'*KG)Q7O5K_P4;_9[T&UCTGXA>+K
M31/&NDP^%;?Q;I-O%<S0:5J_BJWM'T^W2;R?GBN;B\BAMY/XV=0<&LOQO^PG
M:_&6S^,VA_%S6+'5=&^('CK2/&WA>?3[".UU/PO>:/#;1VXBND;>Y<VJ^:<K
MO4E6&":^=?CU_P`$H[GX@:WX@\0>`_B0OA[4/$L/PZ?4O[1TJ*_1[SX=7VEW
MFGNN]QA+K^RXDF'H[<XKU(K+ZG)&HW2:45.5/FY6TJ5WJI/6]2Z2MSQTT>GF
MR>/ASR@E53?N1E9-)N;M:\;M>XD[_"^LEK]>Z?\`\%&/V5-1L=3OH/B':@:5
MJ][H=S;O!<+<_P!I:<[K?V\<1B!D>T2.2:;;G;#&SYVC->*#_@I7X-TO]J4?
M"CQ!+H4'P@USX:6?CSPM\2[6\FFCFFNM1L],CLKZ,1>5;QR7%VJI(7^]M4XS
M7RIH_P#P2#^),-Q9:AJOQATB>^@\>>-/&=P;?PW;Q13_`/"9^']3T2[LRHD(
MVVQU-YXF.?FC7@<$;-G_`,$<=3DT/POI>J?%UI7L_"R?#_Q#)%I,:F]\*6WB
M2R\26K6C><6M;\7%A!"\J'.POS@XJU2RN%[UY34HN.TGR-O24?<CJN7JFGS6
MTW(=7,I6_<*+4D].5)I6O%^]+25WMJN6^I^CGCS]O?\`9<^'&N:AX?\`$_Q0
MT.UU'2].74;R))_-\I9+8WD-O\@.;F:T5[B.(99HD9NU>L?"3]H?X6_&WP>W
MCSP#KZ:GX5738]7_`+7:&:"U.GO`]P;D22QH#&D2,SD$[<<XK\T?'W_!(KP)
MK_BWQ[XDTG5+6=_&7ABPLK-M=M!J+Z%XDTO0Y-`L]9M!*YRWV2>9W7(&\CKU
MK[;_`&8/V9+SX)?LMZ-^SQXEUZWU^?3_``KJ/A*Y\0V%E'I[W-C>V<UDDWE1
M$E9HXI2<[B<@8/<\M6&"5*+I5:DJC<%)225DXWFU&WV6K:RUOH=%*>,=62JT
MZ<:?+/E<7=MII13=UNKNZ1Y'\8?^"FO[//P]^%OQ/\?>&M?3QIJ/P[TY[UM"
MTU9&N-3074=D+FS)0>?91W$R++<1;D4'KFM.V_;.U?PU^S3X#^-'Q$\-:?IW
MB3XIZII6E>`_#>GW4TL>HW?B(;]$@GEECCDBEDC#-.NT[-IVY[?$.J?\$;=0
M;PCXP\.Z1\51#<7?@R\^'OA"ZN-*CE73?#=_JUGJMP^HQM(1J%]YEE"B3RDN
MJEL'FOT=\4?LDZ9\0?V>OAO\(/&>K+-X@^&L7A[4-!\465LL/V3Q-X=A\NRU
M2&V#;5&<AHPP&&(S6TXY?!4U"4JEZW[R3YE)4U%625DK.7Q?:M==$WG!X^;F
MYQ4&J5H13CRN?-JWN[\OPZI7WZI>"_M,_M;?M)?LW_"W6_B5K/PI\,ZIH_A[
M0(?$%_J4.LW*V9,\UNB:4A$&\W6R<X.W!9",\C/NGA[]NOX%ZA\.;;QSJ?B:
M&VDM(=-C\3:;;0W%Q<:!J%W9P7-Q%>HL3-%#;F;F60*"O/K7GGQ__98^-?[0
MG[.OC#X+^*/B9I-MJ/B+[#86NKV^BQ&"VTNRFAEW26Q<"2YE$"`N2,$GUKYH
M\'?\$MOB!H.K?%"XNOC6$T;XFV5K#JVCVNAP+"TT>FQZ?-DF7`BVQ*Z*H&&)
MHC'!3I+VDX4ZL9RNZ?.E.'[M):QDKZS<=K..NC"4L9"I>G"=2G*"TJ<EX37-
MKI*.]H)W;^)VU1TG[4__``4I\0_"+QIH.G_"[PUX9\?>#?%/P;\7?%/0O$3Z
MM-"+D^$K1;NXL]L4+J8[E7$:2`E@ZG(KWWP;_P`%&O@-_P`(%\/-<^*/B[1/
M!7BWQAX1T_Q/J'AUKHRG21?QG[/#(Y4-_I4J/%:[@&E88`S7P]XZ_P""1WQ*
MU7PY\+O#'A;XRV%A9?#GX3^,?A8)KW0HKF:_LO&;2B^O69YLI);QNHB3)Y'!
M%=M;?\$AO#\UUX4UWQ+K^G^)M>T_X=:3X,UW^T-.5M.N-1\,O<3Z!K=I:;RD
M,T$\P>1%^]LY-:RAE;I4U[1J2YN:4%+GE9OE<E)<JO%IZ==--3*,\R]I-^SO
M%\MHSY>6-U'FMR^\^67,E>VFMF?>_P`./V[/V9OBC8-J7A?XCZ5+9KHVHZ^L
MUTSVRRZ5I,L\6HW<?G(F^*U>VF$C+G`3/0US&C?\%%?V6M:_X3!H?'L%M!X(
M2U?6KF\AEMX%-_*(=/C@DD15F>^=D%L$+>9O7'!S7YN:'_P2>^)OPJ\.Z/J>
ME>/M)\97?@KP'\1_"T'A=]$CM+3Q#:>+O[2N+>VG:.4[&MY;XQAMK$HHQC-<
M+^SE^PU\8OC9\)?B1\)_C]\.]&\!)=ZQH6KZ%XTTV8OK%Q?>%+Z&XT?3[Y/)
MB,NGP"VA159V7RQCM2^K9?:<UB)2A&4%\45))SLY*+BG.T-;*UK_`"']8Q]X
M0=&*J.,F_=;@VHKE7,FU"\M-7KV5U;];Y/\`@H%^R^;7PI<6/Q"LM5D\8WRZ
M=I%GIJ2W=T;HS>0\<T44;F-H905E4\K@D\5]F6=W#?VEM>V[%H+N".XA8@J3
M'*@="00"#@C@@$=Z_)5/^"8&C6%A\/+7PGKVF>"+KP?J^G>([K5-#TF)-3N=
M:AODN-4D%V7W_9M4@#P30X"_O&>OUILK<VEG:VID,IM[>*$R$8,AC14+D#@%
ML9KAQ$</'D^KRG.[GS<VZ5UR[)+5>;\SLP\L3+F]O",;*/+R[-V][JWH_)%J
MBBBN8Z0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@!I56P656(Y&5!Q],CBG444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`-9%8@LJL1T+*"1],CC\*=110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4U55<[
M55<G)VJ!D^IQU-.HH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M0$'D$$>W-+0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!7S5^T+^UU\`OV6;71+SXX>/M*\$0>(I9H=(?4I`GVR2W"M,L8)&=@=2?K
M7TK7B/QC_9Q^"GQ_M]+M?C!\/?#_`([@T:2273(]<LTNELY)@!(T.\'87"@$
MC&<5C7]O[*7U9TE6TY'64G3W5^;D:EM>UNIZ.4O*ECZ#SN..GEEY_68Y;*C#
M&->SE[/V,L1&5)6J<CES+6"DE9V/C+_A\1_P3W_Z."\*?^!"_P#Q5'_#XC_@
MGO\`]'!>%/\`P(7_`.*KU'_AVC^PW_T;I\/?_!1%_A1_P[1_8;_Z-T^'O_@H
MB_PKS;9]_/E?_@&)\O[W]:^1]O[7PF_Z!>.__"G)/+_IUZ_=YG<_L]_MN?LU
M_M2:IK&C?!'XE:-XVU'0;:*\U2UTV4/):V\S^7'*Z@DA6?Y<GO7UC7S[\'?V
M5_@!\`;[4M2^$'PQ\,^!;[5X4M]1N=#L8[66[AC;>D<KH,LJL=P!/6OH*O1P
M_P!85*/UITG6N^9T%-4[=+<]Y7MOY[:'Q></)GCZCR&&8PRWDI^RCFDL//&*
M?(O:\\L,HTN7GOR65^7=W/%_B=\?OAI\(M4T;1_'&LMIE_K]O?7.F1>0\@GB
MTZWEN[LAAP#%!#)(1UPN>G-<S%^U9\%I=-\(:N/%")I_C9]FAW,D+)&X,GDK
M)<,QQ!$\N(T=CAF(`SFL?]J3]G,?M">&='TVQUF/PWKNBZFEU9ZV+6.>=+.<
M>1J-HK,C.B75HTD3;>#N.X8KY?\`VC_V%_&?Q'TCX>:)\/?%.@Z/IG@VQT.S
M-AJ5A*L(N-(O;:\DU"W-BUNXEN3`4D1V9#O)*GK7I4H8:4:?M)RA)N2J7VBE
M\+7N];K2_1WW1X-2>(BZG)!3BDN2UDVVUIJU\.M_)KJC[3M_VCOA)<ZYX@T&
M+Q3:FY\-6;WVI7)XL!%$N9$@NS^ZFFC/R-$IW!_EZUR]O^U!\*=:.@7NF>/=
M%TRSO[J_62RU>-K>_O;;3H9I;B6U1W4I&L<33"8AD:-217@?AW]DKXBV?A7Q
M1\/=4\0>$V\,:Q!=7]OJEKI4B^(VUN^N!>SQ7%^Y9FTQ;G*)`N&\C"DGDURW
MB7]D;XU>);/X>BYU?X:6]WX-_M*TE^S^'YXTN=/GTF\TJV4,D@8S2"X2:Y+E
M@[*<#I5*GA;O][IT;>C]S>SAUEI;[*[DNIB='[+K=JW]Y)K272-W?[6NBV/L
M/P3^TW\%_B'9:UJ/A+QIIVK6.A6C7UW<P2`Q2VB`[Y[5L_Z1&K#8S1Y`<JO<
M5Y5K7[=OP/TCQ!X"T%-0U&^?Q[J-YIEI<6UE+(FF7%DQ64ZH%W?9(R`65Y"`
M5!/:O!/AW^Q9\6_"GV6SF\4>"M*T^V^&FH^#,^'=%EM)I-2NKF"=+YUD9H7C
M*PM'('1I,/E6!KS3P!_P3R^,'AK6YKZ[\9^"ELKGQ!-?2*FDWEQ=16%Y;W,%
MXMM+<S2B"YD\Y75T"HI!X'`JXTL%>;=9M)>ZKZO1J]U#=.SM;7;1.ZEU<9:'
M[K5OWFDNZZ.6UKK?S/OJQ_:]^!&N:/XVU+P_X]TC46\$&6#5(H9E=Q=[7\A(
M45LSB1T(4IG(5B.`:C_9.^.&L?'OP!K7C#6+?3H&L_&&M:'8'3&+03Z?82(+
M:=B2Q\UT;+CC!XQQS\G^$/V!-7\)>#=8\/Z3)X(TO4[/5[/4M!U6RTV\,VNO
M8-.86\6>?-(+P.+AC(D0C4D`8QQ7U5^R?\#O&'P)\&>(]!\9>)=*\1ZAK_B[
M5O$Z-HNGMINGZ?'J1B(L8+<]%AV$`]\_6LZD<-&G4]G-SES0Y'+>UKR:226M
M];O2UK:,NG+$RJ0]I'EBH2YN5>[S:6NV[Z6TLM6V]K'U11117&=85Y!\:OCO
M\+OV>_!\WCSXM>*;#PCX6@GBMI=5U!Q'`LTS;8T+$CEF(`]37K]>=?$WX3?#
MOXR>')/"7Q,\*Z5XO\.RRI-)I6KVZ7-H\L3!HW,;@@LK`$'UK.K[7V<_8N"J
M\K]FZBDX*73F4?>MZ"=[.UK]+WM\SXNT#_@JW^PGXGUK2O#VB?'CPI>ZOK5]
M;Z=IMG%=(9+F\NI%B@A0;OO22,%'O^-?<_BGQWX7\&>$-0\=^(]4@TWPOI6F
MMJ]]JDS!8(+!(?/:X9CT01`N3Z5\RZ1_P3[_`&.="U.PUG2?@)X"L=3TNZAO
M;"\@T>W2:VNK=Q)#-$P3*O&ZAE(Z$"OJ?7?"GA[Q-X=O/">NZ5:ZEX=U"R;3
MKS2KF,26L]DT9B:WDC;(,9C.W;TQQTKEPZS'DJ_6I81U+?N?8QJJ*=O^7G.[
MM7M\/GKL*//9\W+?IRII;=;ZGR?\&?\`@H-^R;\?_&L/P\^%'Q;\/^+/%L\4
MLT>D:?<+)<-'#N\Q@H)R%VG/TK[2KYG^&W['?[-7P@\3Q^,OAO\`"+PCX2\3
M1))%'J^DZ9#;7B))G>HE10V&R<\\YYKZ8K;#?6E3_P!K=!U;O6@IJ'+96TGK
M>]_+8(\UO?Y;W^S>UOGU/-?&_P`6?!'P[U'1=+\5ZJ--N_$`O/[*1XR5NFL+
M:6\N8T8<>8EO!))MZE5)`KS*\_:[^`=B_AR"X\>:8MYXIM/M^DV/F`W<ED)T
MMWNI(0=T4"32)&\C8`9@#R:9^TK\%?$'Q=TGPS<>$=6TO1_$_A+4[S4-+N=6
MLS=V;-?Z9=:7*)43$I"17;2*%<`LHSFOA4_L"?&>VTW2[0^,OA_K.I:;X'UC
MPPNMWWA^<7:W6J:W9ZLDL)1E,4%NELT**N&&X<\5ZE*GA903J57&5]5?UU7N
MM6^'K=W>VZYZM3$1E)0I\T4KQ:2U^'35K7XONU/N/5/VPO@5I&NW?AV]\5;-
M3LM6TK19XTMI'07^M1O+IT2N#AA<QHSHPX*@FNK3]I'X1'7]>\-R^*K2UU+P
M[9/?Z@MTRP1?9XE#2FW=V`F>(E4=5&5=E!ZU\UVG[$\]U\2_AS\0M:\0Z>T?
MAS0M*B\4Z#;:=']BUWQ%H]K]ELM3_>HS?N%:3RS*S2#/!ZUXCXS_`."?WQ0\
M3?&O7/'?_"=Z"?#NKV&M6)22RNDU06^IW=O>6]N?*D2T*6CVR1;C#N>-W!8\
M&JC2P<K)UI1]R[;U7/=*R]WLI._9K9W)=3%*[]DI7G:,596CH^9OF\[6\GY'
MW9)^U3\&8O"<7C&3Q(4TN?43ID,+6TBZA+<AMI*61_>M'_%Y@!7;S7/+^UU\
M$-*TF37]8^*'AF[TS4O$5UH>ABP?]_+?6XC,FE",NS3W]OYB^<J`$9^Z,&O(
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MP@**K`FOF7XD_L&_&CQS\&?"OP]/C?PG'JFA:=JVES`Z=>KI3)?SRS07D029
M;I98!)M*&7RSCA.QY_PM_P`$X?B+:>#OACI/C36?AOXNU#X>W5W!:6%SH=[#
MH:V&H>6EQ=_9XIXY9=114W1RRR.-P!QG-7&C@N2\JSYN=K1Z\BYK:.%O>]U7
MOIJR74QGM$HTER<D6VUIS/DNK\U]%S:)/Y=/K7XL_M?:9X<^*?PD^'G@&^T3
M7V\9ZY%9^(G:3S&M+"YCADMVLG5@KW.V3S)(^2D;*Q`S7W.#D`^U?F1K?[$7
MC^X^)_A;Q-H'C/PQH_AK1/'&G^.;ZW.C22ZO/-!:V5G<Z-8W9)%MIQALQY2=
M07.YCV_3=00J@\D``GU(')KFKJBHTO8OF?*^=ZWNW=<VB2=G:RO:VYT475;J
MNJFO>7(NEDK/EUO9O76SOY"U^='[?_[1GQD^%7A*'P#^SYX&U/Q%\4_&VE:M
M)I_B66TE_P"$8\&6-E9S3W.L:K?8\E)88XV:WA9E+RA>H.#^B]<CXX\,1^+?
M"OB/04\B"[UK0M2TB"^DB5WMC?VLMN'W8W[5,FXJ&&<5Y^*IU:U"I3I5949R
M5E4@ESI=5%O2,I+12U<;W6ILTVFD[7ZK^O\`AMS^<G_@DY^VW^V/J=OIME^T
MC9ZM\7/`/Q`\=>(_"^A_$/1;5KR\\):_H]_=6US9:Y';H?(TF1[>0VUPX4*K
M1J6)'/\`1[XN\8^'/`OA^]\4>*]4MM&T+3T22\U"\<100K(RHF]FX!9F50.Y
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M[`FO$Q^Q3?N=4N'\>26][/'IL.E2V=C!"FEQV>COH]QY48BVAKB&5W.!M,A!
M(K@]'_X)V)I+R[_B!-J>+G3[BUNM0TVR>^C^P:=/IZ*\J6PR`)RZD8(*CFO5
M-#Z=\4?M.^&/"'Q1\.^"-;@2V\/^)O#DNN:3XK6ZCDM;MEF@B2%(5&X1DS8,
MQ?8#@=ZZ[5?VD_@KHEYK=CJ?C[0K2X\/VD%[JBRWD8$$-Q@)SNY;+*K+V8@&
MO'/$G[(X\0:1\/[.3Q7(-1\(:(GAF\U"6W25[_13/#<3)%OC8PW#R0)B52,`
M8KD?$G[!OAC4)?&$^B:S]@N?%,-I$UU=P+>31^7-#/=!_-5D*2/"HC`'R#(]
M*`/J#6?CU\,M!A\/SZEX@AAC\31I-IA"D[K:10R74HX,5NP9?WKX7YAZUY;\
M)_VD+SXL?$3QQI6BZ$L7P_\`!-S>:7?^);J7R)!J-DH=V2%P#);2JV4D4[5`
MR21BHOB/^RW#X[F\-7$?B#^S'T[1K;P_K*0VT?E7VF0QQ*PM4V$6LY:)2'3;
MCD=Q77?"'X$-\-O#_CKP[?:Y_:]KXQU;4;]9DMH[>XL[>^MTM_LY=$7S/*1`
M59LG=S36ZOM?7T!WL[;]/4\5^(O[?'PT\(:YX;L]%C?Q!H-[XH;PUXDU^*3R
MK?1+@ND=NT,;*QOQ<R&1(S"P`:-@3Z>]7G[2WPBAO/#^D6OB[2KG7/%NDW6J
M^&-.^U1H^JI;Q,XAC8MA97=3$J$9\P%>U?*NI_L%7T^F^%M)L/'XBT_PIXFN
MM:LK>XTJTE$UH\CS6EM=,+??<36\LDA$LK,>1@BN'F_X)M:A)=?#+6?^%H7<
MGB'X>W[3QZC+;#,EHM_<7T5K;JB+Y:EKAHI0WRF-0`*[N3`M1_>RBTI)OWO>
MWY6URZ.]KI='W1P\^,3;]FI)\ME[JY=(\R3OJM]];WTV1Z=\+/V]]%\3WOBF
M7XD^&5^&7ASPSH2ZO)K>J:G!-#=22:W?:1':Q*JQXD<V@E09RV_:.:]]L_VN
MOV?]0\0:;X9L/B)HE[JVIV]K=106UPDH@AO=HM6NG4[8//=A''O(W2?+UKXE
MLO\`@F?J>H1^)K#QU\5+KQ1HFKPVJZ?I<EKY4-K-8:Q<ZS:&X**C31K<W!61
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M%60BY/EK=1!W^\^X5^A_AG]A[3?#_P`9/!'Q/3Q5,EGX(T.'3;+1;:VB03W"
M6XMV\V1HS_HNW+(@(8-CG%*K1P5.R5:<I<DI.UG%NRY+/ETN]UY#I5<74U=*
M$8\R6MTTN9<RM?5J/5:7O?8]8\2?MC?`?PIK]UX8UOQ='9ZU:7\^ES6<D+!T
MO[>V>[:W.2"':%"Z#^(8QUKSSX&_MS_#CXM:CXMTO5C'X/O?#^H7T=G#J5PN
M+[2K599H;\RD(L3W-I']K6W;,BQ$D\#FO\1?V#OAS\1?BXOQ7U.\NH;T:M8:
MP^EPI$+*:\L8DB661"GS-(B%9,Y#*Q!R,Y\QN_\`@GQ?WNNWUY)\0Q;Z3J/C
M/5?$EU96>FPVT\FFZCI=WI2Z,9XHE;[/!;W6$7.`47&,4HQP+A9SFIN$6V[^
M[/JHI1L^J;>FUGN-RQBG?DBX*4E96]Z-E9R?-H^NE^JML?3MA^V1^SIJG]DK
M8?$O0+F;7+R]L=,MXKI&GNIM/9Q=&.,$DQQB-W,GW=BEN`*]*\!?&CX>?%+1
MM=UOX>>(;+Q5;^'[B\L[]-,E6:5+NT$F8=J%CF8QD0GI)_#7PSX4_P"";_AC
MPGJG@:33M>MXM%\*QZ]:WNG#3XGDU"VU>"XM49;B2-Y8KB*"X)DE5U+2#</2
MOHC]G_\`9>TS]G?P-XJ\*^"-22WO-=N+B:TU#RCBV($BV,LP(W2SQB3=,Y)W
ML,BLZL<(HMTJDY2O&RDM+.3O=I75HI/9N[^1=.6*<DJE.$8ZW:>OPP>FK3]Y
MR7RU\O!G_;3^(8T;Q$\WPXBTWQ1)X^G\(^$_#.HWL=OJ)L8DNKB#5M7A<![6
M&]M;262V#JN_J,U4N_\`@H3!I5SX/GUCP;+8Z/J]C$NL74ERH9-3N(WVIIPV
MXNK>WFC,5R\9(B,D8;&:]`UW]C/4?$FAW.JZMX_NI_BO=:S9:Q)XQ6!4AWV%
MO<6=K;"T"`>3%:74T8.-V2I).,UU!_8V\)7?A#P+X-U?49-2TSPH+F:_\ZW@
M:;5[VZ4[I7G,9FBC20F18T=1G&<UIS8+2\;ZN_+SZ>[:Z[J_PWM=ZM+4SY<7
M;279IRY7?WHZ22VTYN:UU;1'L7PH^,^B?$/X>MX]N[K3=+@@2XN-3M5OH9VT
M:*'+>5J#(1Y4X0`NK`8+`=:^:_C-^WQ\//!OA+3;_P``!_%WB7Q!XIM/"&BZ
M6(GB7^T;R;R8+BY.#Y=E*P;RK@X23:2IX(KNOA7^R)H7PZ\'?$/PC/XBU/5;
M;QW`^G,[/L%CID7F?8UC4``W2>8?.G.6E"J&)Q7C&G_L"7UGJOA76I/B")K[
MP[XJT/5)5;3+=K:]T3PY/+-IFG/$8<+/^_D6><`-)\I)XJ8+!\\W*4G%2]R/
MO14E9:-VE+XKK76R7?2W+%<D$H+F<??=TVG=*_17Y=;6WOM9'O\`XI_:V^&O
MPET+PB?C3K%EX0\6>(-.M+N[T&"47TE@UU@(\S1XV02$_)(0%/([5POQ6_;H
M^'?P\U_PGIEC&=<TS5M7MM.\1:I%,L7]@PW\4$FFSBW93)=_;O.VQ"/`!4\\
M50_:!_8<T/\`:"^*&E>-_$GB2>RT>QT&'2;C2+2VA,EQ-:DO;R+)+&ZK%YAS
M(O#8`"D5YA+_`,$ZKRXU#5_$M]\5=5U/Q'/_`&2-%@O;*RDT32DT:4FTVV@M
M@\LBP[$WR,Q#+E354XX&T93G+F:;G"SY4Y-)*+2;7)=N]WLM'L3.6,O*,81L
MG'DE>-VHV<G)7LW+9)6WEM9'UU;?M-_"B1_$NI2>.?#?_"/>&O#UIK^HSI?P
MFYL8+F5XQ]KBW;HV)0HJ-ABX*CD5G:[^U_\``K1-#T'7E\86VJ6?B:RFO]&_
MLL&\>YMX@_SNL63&KR(8D9N&D!4<BOCOPE^Q%;^))_BKX-UK2KO2/"5_X7TG
MPQ;ZQ<R)]JU_7-/U.XU>?5&2(1O_`&=)+=%$B;)VKMSC%>U>&_V'-#\*OX,&
MC>(6M+30/#+>%]7LOL5K<6]_8+--=P?94N(9!;2+=3,SRKARF`&S4RIX.+UJ
M5&U;16LUR)[I2M)RW[;-:W3C4Q4E=4XJ]^^CYDM$W&Z4=?/7L=[X/_;6^"7B
MKPQX(\22ZW)I#>/]8N]%\/Z5?0/%J4]S:ZC+IID>V?;(D$EQ$524C:<C%;7B
M+]K/X-^"O$VM>'?%GCSP]97MCJL6DVFF0W23:G)>-8K?26[VR'?YJ0DRE<<1
M?,>!7S-;?\$[8AK7PZO[[XBW]Q9>`]>O=9BMEL[:-V276)M8MK2V*0!8XDED
M6.7<"64'!R:K^./^"?>N>+OC=K7Q83XB6EO9ZGJEUJ\.AS:+:S_9KVY\/-H`
ME$KP,2R0MYH.XD2#/O5<F!<G^]DH\LWL]^9<D4^5V?+=-V\]+Z)3QB2O3BY7
MC'1K9Q7-)JZ6DME>]M#M+S]NS1;_`..$_P`/?"NGV]YX,\+:/%KGCOQA?W"V
M5GIFFW5C]LM[JSEE'EW)^9(GB0[E<D'D''NEY^U[\![;PQH7BV'QK9:CI'B.
M::'2GTW_`$R69H&,<C-%$2R1K*/*,A^7S"%SDU\R_#;_`()_7WA[0_B;X?\`
M'?Q#;Q=I_P`0-'32T*V$5K<6`A*FW_TA(DE>(!%1TWD%<@5V/A#]A+0O!&G^
M`+/P_P"(C8?\(E;WFEZC$MC;W%IJ.D7MS]MFAA@NHI5BN#<JA-Q@/M!PP-$X
MX*Z2G+W>57BI6G[C<I-N-T^;16CHM-;W2A+&6O*,?>;;3M[CYHI124K-<MWO
MO?:QZ'X-_;>^!7BGPUIOB:^\21^&;76?&.K>"M*@UT&RN+W5-*O'LI&CCEVM
MY$DR%4DP5R5&3G-0:E^V#X1;]H#P;\#/#-LGB"?Q#:WT^I:Y;748MM,FLW5/
MLRQX)N'^;]ZT;?N6PK#)KQ&\_P""<7AK5+[1;[6O%=SJW]@^.-6\4Z7:7%M$
MEG86FJZDVIR6EM#"B+YZ3[,32!N`?6NRT#]A6PT#XW>'?BO:>/=8AT[PKJ^J
M:QIOAV"&U6.ZN-:D\[48M0N3"9Y+<S8:&-)%"*,8XY3C@DY-3F_=J<L6GRJ3
M7[O5+F=KZW25[OH/FQC44X17OT^9JUW'W74T;LKZVZKSZ?H'1117"=H4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%
M`!1110`4444`%%%%`!1110`>^.:***`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
(H`****`/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E3CBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 9 - Related Party Transactions (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="5">12 Months Ended</th>
        <th class="th" colspan="1">138 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="5">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2005</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012

</div>
          <div>Members of Board of Directors and Management [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Ongoing Patent Cost Reimbursements [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Ongoing Patent Cost Reimbursements [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Ongoing Patent Cost Reimbursements [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012

</div>
          <div>Research Agreements [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Research Agreements [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Research Agreements [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Consulting Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Consulting Agreement [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Consulting Agreement [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related Party Transaction, Expenses from Transactions with Related Party</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 89,885<span></span></td>
        <td class="nump">$ 249,907<span></span></td>
        <td class="nump">$ 193,674<span></span></td>
        <td class="nump">$ 552,403<span></span></td>
        <td class="nump">$ 1,172,758<span></span></td>
        <td class="nump">$ 1,391,203<span></span></td>
        <td class="nump">$ 24,000<span></span></td>
        <td class="nump">$ 24,000<span></span></td>
        <td class="nump">$ 57,600<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in Shares)</a></td>
        <td class="nump">12,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">380,954<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 310,160<span></span></td>
        <td class="nump">$ 404,410<span></span></td>
        <td class="nump">$ 500,000<span></span></td>
        <td class="nump">$ 1,500,000<span></span></td>
        <td class="nump">$ 750,000<span></span></td>
        <td class="nump">$ 15,836,468<span></span></td>
        <td class="nump">$ 255,239<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightPurchasePeriod', window );">Class of Warrant or Right, Purchase Period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">571,432<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightPurchasePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right, purchase period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightPurchasePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercise price of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 57<br><br> -Paragraph 2<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E4AAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Detail) - Stock-based Compensation Expense (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock option expense</a></td>
        <td class="nump">$ 310,076<span></span></td>
        <td class="nump">$ 463,752<span></span></td>
        <td class="nump">$ 575,662<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and Administrative Expense [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock option expense</a></td>
        <td class="nump">231,936<span></span></td>
        <td class="nump">284,352<span></span></td>
        <td class="nump">369,161<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and Development Expense [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock option expense</a></td>
        <td class="nump">$ 78,140<span></span></td>
        <td class="nump">$ 179,400<span></span></td>
        <td class="nump">$ 206,501<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph g(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ELGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 2 - Summary of Significant Accounting Policies (Detail) - Property and Equipment (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
        <td class="nump">$ 532,290<span></span></td>
        <td class="nump">$ 532,290<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
        <td class="num">(429,804)<span></span></td>
        <td class="num">(356,084)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">102,486<span></span></td>
        <td class="nump">176,206<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Laboratory Equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
        <td class="nump">388,000<span></span></td>
        <td class="nump">388,000<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leasehold Improvements [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
        <td class="nump">115,605<span></span></td>
        <td class="nump">115,605<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Other Furniture, Fixtures and Equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
        <td class="nump">$ 28,685<span></span></td>
        <td class="nump">$ 28,685<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross amount of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 7<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -Subparagraph b, c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EJOAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts (Detail) - Valuation and Qualifying Accounts (Valuation Allowance of Deferred Tax Assets [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="6">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th" colspan="2">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Valuation Allowance of Deferred Tax Assets [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning Of Period</a></td>
        <td class="nump">$ 27,591,230<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 27,576,253<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 27,091,338<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to Costs and Expenses</a></td>
        <td class="nump">796,237<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">888,561<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,160,405<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
        <td class="num">(1,112,961)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="num">(873,584)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="num">(675,490)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End Of Period</a></td>
        <td class="nump">$ 27,274,506<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 27,591,230<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 27,576,253<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr>
        <td colspan="7"></td>
      </tr>
      <tr>
        <td colspan="7">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">Deductions represent the effect of expiring NOL carryforwards from prior years.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 09<br><br> -Article 12<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e24092-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ValuationAllowancesAndReservesBalance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, charged to costs and expenses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 09<br><br> -Article 12<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e24092-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of the deductions in a given period to allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, representing receivables written off as uncollectible and portions of the reserves utilized, respectively.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 09<br><br> -Article 12<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e24092-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ValuationAllowancesAndReservesDeductions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E5OAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 8 - Income Taxes (Detail) - Deferred Tax Assets and Liabilities (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
        <td class="nump">$ 24,429,472<span></span></td>
        <td class="nump">$ 24,872,082<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforward</a></td>
        <td class="nump">763,965<span></span></td>
        <td class="nump">763,690<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation expense</a></td>
        <td class="nump">2,097,194<span></span></td>
        <td class="nump">1,991,769<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
        <td class="nump">27,290,631<span></span></td>
        <td class="nump">27,627,541<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation</a></td>
        <td class="num">(16,125)<span></span></td>
        <td class="num">(36,311)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
        <td class="num">(16,125)<span></span></td>
        <td class="num">(36,311)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
        <td class="nump">27,274,506<span></span></td>
        <td class="nump">27,591,230<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
        <td class="num">$ (27,274,506)<span></span></td>
        <td class="num">$ (27,591,230)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_DeferredTaxAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_DeferredTaxAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax liability to taxable temporary differences.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43, 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Liability<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510232<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 15<br><br> -Subparagraph b(2)<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredIncomeTaxLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43, 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards, net of deferred tax liability attributable to taxable temporary differences.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsLiabilitiesNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6969291&amp;loc=d3e28680-109314<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43, 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 11<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6969291&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43-49<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 17<br><br> -Subparagraph e<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 11<br><br> -Subparagraph d, e, f<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6969291&amp;loc=d3e28680-109314<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Government Grants<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_GovernmentGrantsTextBlock', window );">Government Grants [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Government

      Grants</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NIH

      Grants</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      September 2007, the NIH awarded us an Integrated

      Preclinical/Clinical AIDS Vaccine Development (IPCAVD) grant

      to support our HIV/AIDS vaccine program.&#160;&#160;We are

      utilizing this funding to further our HIV/AIDS vaccine

      development, optimization and production.&#160;&#160;The

      original project period for the grant covered a five year

      period ending in August 2012, but was extended for an

      additional one year period.&#160;&#160;The aggregate award

      totaled $20.4 million, with approximately $1.6 million

      remaining and available for use as of December 31,

      2012.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      September 2012, the NIH awarded us an additional grant of

      $1.9 million to support development of versions of our

      HIV/AIDS vaccines to address the clade C subtype of the HIV

      virus prevalent in the developing world.&#160;&#160;The

      project period of this grant covers a one year period ending

      in August 2013.&#160;&#160;There is approximately $1.4

      million from this grant remaining and available for use as of

      December 31, 2012.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      record revenue associated with these grants as the related

      costs and expenses are incurred and such revenue is reported

      as a separate line item in our statements of

      operations.&#160;&#160;During 2012, 2011, and 2010, we

      recorded $2,657,327, $4,899,885, and $4,940,778,

      respectively, of revenue associated with these grants.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">QTDP

      Grant</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      November 2010, we were awarded a one-time grant of $244,479

      pursuant to the Qualifying Therapeutic Discovery Project

      (QTDP) program enacted as part of the Patient Protection and

      Affordable Care Act of 2010.&#160;&#160;The QTDP program was

      intended to provide incentive to smaller companies who are

      focusing on innovative therapeutic discoveries.&#160;&#160;We

      received the full amount of the grant during 2010, which is

      recorded as revenue for 2010 in the accompanying Consolidated

      Statement of Operations.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_GovernmentGrantsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_GovernmentGrantsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>22
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?06YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7T)A;&%N8V5?4VAE971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0V]N<V]L:61A=&5D7T)A;&%N8V5?4VAE971S7U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7U-T871E;65N='-?;V9?3W!E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N<V]L:61A=&5D7U-T871E;65N='-?;V9?4W1O/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A
M=&5D7U-T871E;65N='-?;V9?0V%S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\Q7TYA='5R95]O9E]"=7-I;F5S<SPO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?,E]3=6UM
M87)Y7V]F7U-I9VYI9FEC86YT7SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DYO=&5?,U]';W9E<FYM96YT7T=R86YT<SPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970P.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-%]#;VUM:71M
M96YT<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970Q,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO
M=&5?-5\R,#`V7TUE<F=E<E]A;F1?4F5C87!I=#PO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,2YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-E]3=&]C:VAO;&1E<G-?17%U
M:71Y/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#$R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T
M95\W7U)E=&ER96UE;G1?4&QA;CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DYO=&5?.%]);F-O;65?5&%X97,\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7SE?4F5L871E9%]087)T
M>5]4<F%N<V%C=&D\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y.;W1E7S$P7U-E;&5C=&5D7U%U87)T97)L>5]&:6X\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,38N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S$Q7U-U8G-E<75E
M;G1?179E;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#$W+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^4V-H961U;&5?24E?5F%L=6%T:6]N7V%N9%]1=6%L/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#$X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^06-C;W5N=&EN9U]0;VQI8VEE
M<U]B>5]0;VQI8WE?/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#$Y+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^3F]T95\R7U-U;6UA<GE?;V9?4VEG;FEF:6-A;G1?,3PO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970R,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-E]3=&]C:VAO
M;&1E<G-?17%U:71Y7U1A8CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,2YH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/DYO=&5?.%]);F-O;65?5&%X97-?5&%B;&5S/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#(R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\Q,%]396QE8W1E
M9%]1=6%R=&5R;'E?1FEN,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,RYH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/DYO=&5?,E]3=6UM87)Y7V]F7U-I9VYI9FEC86YT7S(\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,C0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7S)?4W5M
M;6%R>5]O9E]3:6=N:69I8V%N=%\S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(U+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^3F]T95\S7T=O=F5R;FUE;G1?1W)A;G1S7T1E=&%I
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#(V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\T
M7T-O;6UI=&UE;G1S7T1E=&%I;#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DYO=&5?-E]3=&]C:VAO;&1E<G-?17%U:71Y7T1E=#PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970R."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-E]3
M=&]C:VAO;&1E<G-?17%U:71Y7T1E=#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,CDN:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y.;W1E7S9?4W1O8VMH;VQD97)S7T5Q=6ET>5]$
M970R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#,P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T
M95\V7U-T;V-K:&]L9&5R<U]%<75I='E?1&5T,SPO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,2YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/DYO=&5?-E]3=&]C:VAO;&1E<G-?17%U
M:71Y7T1E=#0\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,S(N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y.;W1E7S9?4W1O8VMH;VQD97)S7T5Q=6ET>5]$970U/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#,S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\V7U-T;V-K:&]L9&5R
M<U]%<75I='E?1&5T-CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S-"YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/DYO=&5?-U]2971I<F5M96YT7U!L86Y?1&5T86EL/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#,U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\X7TEN8V]M95]4
M87AE<U]$971A:6P\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,S8N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y.;W1E7SA?26YC;VUE7U1A>&5S7T1E=&%I;%]$968\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,S<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.;W1E7SA?26YC;VUE7U1A
M>&5S7T1E=&%I;%]296,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S@N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y.;W1E7SE?4F5L871E9%]087)T>5]4<F%N<V%C=&DQ/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#,Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3F]T95\Q,%]396QE
M8W1E9%]1=6%R=&5R;'E?1FEN,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970T,"YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DYO=&5?,3%?4W5B<V5Q=65N=%]%=F5N='-?1&5T83PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970T,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-C:&5D=6QE
M7TE)7U9A;'5A=&EO;E]A;F1?475A;#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-#(N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`\+W@Z17AC96Q7;W)K<VAE
M971S/@T*("`\>#I3='EL97-H965T($A2968],T0B5V]R:W-H965T<R]R97!O
M<G0N8W-S(B\^#0H@(#QX.D%C=&EV95-H965T/C`\+W@Z06-T:79E4VAE970^
M#0H@(#QX.E!R;W1E8W13=')U8W1U<F4^1F%L<V4\+W@Z4')O=&5C=%-T<G5C
M='5R93X-"B`@/'@Z4')O=&5C=%=I;F1O=W,^1F%L<V4\+W@Z4')O=&5C=%=I
M;F1O=W,^#0H@/"]X.D5X8V5L5V]R:V)O;VL^#0H\+WAM;#X\(5ME;F1I9ETM
M+3X-"CPO:&5A9#X-"B`@/&)O9'D^#0H@("`\<#Y4:&ES('!A9V4@<VAO=6QD
M(&)E(&]P96YE9"!W:71H($UI8W)O<V]F="!%>&-E;"!84"!O<B!N97=E<BX\
M+W`^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M1592044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1&]C=6UE;G0@06YD($5N
M=&ET>2!);F9O<FUA=&EO;B`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,34L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!A;F0@16YT:71Y
M($EN9F]R;6%T:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%)E9VES=')A;G0@3F%M93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^1V5O5F%X($QA8G,L($EN
M8RX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1O8W5M96YT(%1Y<&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/C$P+4L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-U<G)E;G0@1FES8V%L(%EE87(@16YD($1A=&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/BTM,3(M,S$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#;VUM
M;VX@4W1O8VLL(%-H87)E<R!/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C`L-#DY+#DT-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%!U8FQI8R!&;&]A
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,"PQ-S8L.30T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y!;65N9&UE;G0@1FQA9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^9F%L<V4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D5N=&ET>2!#96YT<F%L($EN9&5X($ME>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^,#`P,#@S,C0X.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($-U<G)E
M;G0@4F5P;W)T:6YG(%-T871U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%;G1I='D@5F]L=6YT87)Y($9I;&5R<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^3F\\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!&:6QE<B!#871E9V]R
M>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^4VUA;&QE<B!297!O
M<G1I;F<@0V]M<&%N>3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^16YT:71Y(%=E;&PM:VYO=VX@4V5A<V]N960@27-S
M=65R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y.;SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE
M;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#Y$96,@,S$L#0H)"3(P,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!996%R($9O
M8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XR,#$R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U
M;65N="!&:7-C86P@4&5R:6]D($9O8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#Y&63QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?
M-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S+U-H965T,#(N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5.,T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D-O;G-O
M;&ED871E9"!"86QA;F-E(%-H965T<R`H55-$("0I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#
M=7)R96YT(&%S<V5T<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#`S-2PY,C4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,38W+#DX
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1W)A;G0@9G5N9',@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C8V+#(T.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$X,RPU,34\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R97!A:60@97AP96YS97,@
M86YD(&]T:&5R(&-U<G)E;G0@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT,BPS,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV-BPU,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C=7)R96YT(&%S<V5T
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS-#0L-#<T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT
M,3@L,#`S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y0<F]P97)T>2!A;F0@97%U:7!M96YT+"!N970@;V8@86-C=6UU
M;&%T960@9&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,BPT.#8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-S8L,C`V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D]T:&5R(&%S<V5T<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3&EC96YS97,L(&YE="!O9B!A8V-U;75L871E9"!A;6]R
M=&EZ871I;VX@;V8@)#(R."PX-38@86YD("0R,#@L.3,S(&%T($1E8V5M8F5R
M(#,Q+"`R,#$R(&%N9"`R,#$Q(')E<W!E8W1I=F5L>3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SDL.3(S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97!O<VET<R!A;F0@
M;W1H97(@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,2PP,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,2PP,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;"!O=&AE<B!A<W-E=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,Q+#`Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P+#DS,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&%S<V5T
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT-S<L.3<P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PV
M-#4L,30R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@;&EA8FEL:71I97,Z/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S('!A
M>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V,RPW.#@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,S@L,S,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!8V-R=65D(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,RPX-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,C4L.#8Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]U;G1S('!A>6%B;&4@=&\@
M16UO<GD@56YI=F5R<VET>2`H82!R96QA=&5D('!A<G1Y*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3(Y+#,W,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8W-RPS,C<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C
M=7)R96YT(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS,C<L,#,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.30Q+#4S-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6ET;65N=',@*$YO=&4@-"D\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G/B@)D@97%U:71Y.CPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R
M960@<W1O8VLL("0N,#$@<&%R('9A;'5E+"`Q,"PP,#`L,#`P('-H87)E<R!A
M=71H;W)I>F5D.R!397)I97,@02!#;VYV97)T:6)L92!0<F5F97)R960@4W1O
M8VLL("0Q+#`P,"!S=&%T960@=F%L=64[(#<X."!A;F0@+3`M('-H87)E<R!I
M<W-U960@86YD(&]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$R(&%N
M9"!$96-E;6)E<B`S,2P@,C`Q,2P@<F5S<&5C=&EV96QY/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS,3(L,3DV/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL("0N
M,#`Q('!A<B!V86QU92P@-#`L,#`P+#`P,"!S:&%R97,@875T:&]R:7IE9#L@
M,3@L-S,S+#(W-R!A;F0@,38L-#0R+#8Q,2!S:&%R97,@:7-S=65D(&%N9"!O
M=71S=&%N9&EN9R!A="!$96-E;6)E<B`S,2P@,C`Q,B!A;F0@,C`Q,2P@<F5S
M<&5C=&EV96QY/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ."PW
M,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-BPT-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%D9&ET:6]N86P@<&%I9"UI;B!C87!I=&%L/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PU.#<L,30X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,L,S$Y+#$V-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1&5F:6-I="!A8V-U;75L871E9"!D=7)I;F<@=&AE(&1E=F5L;W!M96YT('-T
M86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-"PW-C<L,30R
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(R+#8S,BPP,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&]T86P@<W1O8VMH;VQD97)SXH"9(&5Q=6ET>3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PQ-3`L.3,U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`S+#8P
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1O=&%L(&QI86)I;&ET:65S(&%N9"!S=&]C:VAO;&1E<G/B@)D@97%U
M:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-#<W+#DW
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,2PV-#4L,30R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P15=-044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0V]N<V]L
M:61A=&5D($)A;&%N8V4@4VAE971S("A087)E;G1H971I8V%L<RD@*%531"`D
M*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DQI8V5N<V5S+"!A8V-U;75L871E9"!A;6]R=&EZ871I;VX@*&EN
M($1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(R
M."PX-38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(P."PY,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!RT+5FT+5R<M"U9"!S=&]C:RP@<&%R('9A;'70
MM2`H:6X@1&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#`N,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!RT+5FT+5R<M"U9"!S=&]C:RP@
M<VAA<M"U<R!A=71H;W)I>M"U9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<&%R
M('9A;'5E("AI;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL
M('-H87)E<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R
M97,@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ."PW
M,S,L,C<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,38L-#0R+#8Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@;W5T<W1A
M;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+#<S,RPR
M-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-BPT-#(L-C$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y397)I97,@02!#;VYV97)T:6)L92!0<F5F97)R960@
M4W1O8VL@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4'+0M6;0M7)RT+5D('-T;V-K+"!S:&%RT+5S(&%U=&AO<FEZT+5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#(P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4'+0M6;0M7)R
MT+5D('-T;V-K+"!S=&%TT+5D('9A;'70M2`H:6X@1&]L;&%R<R!P97(@<VAA
M<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<M"U9M"U<G+0M60@<W1O8VLL('-H87+0M7,@:7-S=="U9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S@X/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4'+0M6;0M7)RT+5D('-T
M;V-K+"!S:&%RT+5S(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P13%%04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V]N
M<V]L:61A=&5D(%-T871E;65N=',@;V8@3W!E<F%T:6]N<R`H55-$("0I/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C$S."!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1W)A;G0@<F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`R+#8U-RPS,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L.#DY+#@X-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2PQ.#4L,C4W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`R,BPY-CDL,#$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]P97)A=&EN9R!E>'!E;G-E<SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S96%R
M8V@@86YD(&1E=F5L;W!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS+#`T,RPU,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT+#(W-BPS-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#<Y,RPY-38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR."PV-S0L,3DX/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'
M96YE<F%L(&%N9"!A9&UI;FES=')A=&EV93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PW-3(L-S8U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY-S(L-34U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPQ-C(L,3,T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL-#`P
M+#0R-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/@T*("`@("`@("`\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0L-SDV+#(X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<L,C0X+#DS,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<L.34V+#`Y,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X+#`W-"PV,C(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,
M;W-S(&9R;VT@;W!E<F%T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,BPQ,S@L.38P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#(L,S0Y+#`T-2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#<W,"PX,S,I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C4L,3`U+#8P
M,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3W1H97(@:6YC;VUE("AE>'!E;G-E*3H\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)E<W0@:6YC
M;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#@R,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C$Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C,L-3`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S0T+#$S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^26YT97)E<W0@97AP96YS93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH-2PV-CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^#0H@("`@("`@(#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPX,C`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#(Q.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#4P-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,S."PT
M-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@R+#$S-2PQ-#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XD("@R+#,T-BPX,C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+#<T-RPS,C@I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R-"PW-C<L
M,30R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY"87-I8R!A;F0@9&EL=71E9#H\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R!P97(@8V]M;6]N
M('-H87)E("AI;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,"XQ,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,34I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C$X*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BXP.2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E=E:6=H=&5D(&%V97)A9V4@<VAA<F5S(&]U='-T86YD:6YG("AI;B!3:&%R
M97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ."PS,34L-C8Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,34L-S,U+#4T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$U+#8U,2PS,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PX-S$L.34U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
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M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14PV0DT^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0Q/CQS=')O;F<^0V]N<V]L:61A=&5D(%-T871E;65N=',@;V8@4W1O8VMH
M;VQD97)S)R!%<75I='D@*$1E9FEC:65N8WDI("A54T0@)"D\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5R:65S($$@4')E
M9F5R<F5D(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D-O;6UO;B!3=&]C:R!;365M8F5R73QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y!9&1I=&EO;F%L(%!A:60M:6X@0V%P:71A
M;"!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y3
M=&]C:R!3=6)S8W)I<'1I;VX@4F5C96EV86)L92!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!8V-U;75L871E9"!$969I8VET
M(&1U<FEN9R!$979E;&]P;65N="!3=&%G92!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y4;W1A;#QB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!*=6XN(#(V+"`R,#`Q
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<&ET86P@8V]N
M=')I8G5T:6]N(&%T(&EN8V5P=&EO;B`H2G5N92`R-RP@,C`P,2D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3<P+#4Y,BD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-S`L-3DR
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0F%L86YC92!A="!$96,N(#,Q+"`R,#`Q/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$W,"PU.3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3<P+#4X,BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,3@L,3,W*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8Q."PQ,S<I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-SDP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,BPS,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#<P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM
M;VX@<W1O8VL@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L-S@Y+#DU-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K(&9O
M<B!T96-H;F]L;V=Y(&QI8V5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C<P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$T."PQ-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-#@L.#4V/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@
M<W1O8VL@9F]R('1E8VAN;VQO9WD@;&EC96YS92`H:6X@4VAA<F5S*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`T+#4S-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A
M="!$96,N(#,Q+"`R,#`R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS+#0Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$T-2PX-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@W.#@L-S(Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#8S.2PS.3,I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E("AI;B!3
M:&%R97,I(&%T($1E8RX@,S$L(#(P,#(\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,L-#DT+#0X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#DT-RPX,#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.30W+#@P-"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F
M(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PR,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR+#0U."PS.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR+#0U.2PV,#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S
M=&]C:R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PR,CDL,C<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E8RX@,S$L(#(P,#,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L-S(T/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV,#0L,C(Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PW,S8L
M-3,S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@W,BPT,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN(%-H87)E<RD@870@1&5C+B`S,2P@
M,C`P,SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PW,C,L-S8V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPS
M-3$L.#(X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(L,S4Q+#@R."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT.#,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DX."PT,S8\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M+#<U,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C,Y+#DQ.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K("AI
M;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0X
M,BPV,#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-A<V@@<&%Y;65N=',@<F5C96EV960@;VX@<W1O8VL@<W5B<V-R
M:7!T:6]N(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@
M9F]R('1E8VAN;VQO9WD@;&EC96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XY.2PY-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@
M<W1O8VL@9F]R('1E8VAN;VQO9WD@;&EC96YS92`H:6X@4VAA<F5S*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#DL-#(P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T
M($1E8RX@,S$L(#(P,#0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8L,C4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-2PV.3(L-C`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,BPP,#`L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L,#@X+#,V,2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S.#DL-#DW*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F%L86YC92`H:6X@4VAA<F5S*2!A="!$96,N(#,Q+"`R,#`T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#(U-2PW.3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#8Q,2PP.#8I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PV,3$L
M,#@V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V%S:"!P87EM96YT<R!R96-E:79E9"!O;B!S=&]C:R!S=6)S8W)I
M<'1I;VX@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E8RX@,S$L(#(P
M,#4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L,C4V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PV.3(L
M-C`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-3`P+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@U+#8Y.2PT-#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-3`P+#4X,RD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN(%-H
M87)E<RD@870@1&5C+B`S,2P@,C`P-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-BPR-34L-SDQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-3@T+#$V-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@U.#0L,38V*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!P87EM96YT
M<R!R96-E:79E9"!O;B!S=&]C:R!S=6)S8W)I<'1I;VX@<F5C96EV86)L93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;G9E<G-I;VX@;V8@<')E9F5R<F5D('-T;V-K('1O(&-O;6UO;B!S=&]C
M:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPU-3$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`W,2PU
M-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#`W-2PQ,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;G9E<G-I;VX@;V8@<')E9F5R<F5D('-T;V-K('1O
M(&-O;6UO;B!S=&]C:R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,RPU-3`L.#4Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@:7-S=65D(&EN
M(&-O;FYE8W1I;VX@=VET:"!M97)G97(\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0L,S8P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PW,#@L-#@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW,3(L.#0Y/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O
M8VL@:7-S=65D(&EN(&-O;FYE8W1I;VX@=VET:"!M97)G97(@*&EN(%-H87)E
M<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,S4Y+#@Y,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K('5P;VX@;W!T:6]N(&%N9"!W87)R
M86YT(&5X97)C:7-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#4W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K('5P;VX@;W!T:6]N(&%N
M9"!W87)R86YT(&5X97)C:7-E("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU-BPX,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@1&5C+B`S,2P@
M,C`P-CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L,C(T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PT
M-S(L-C`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-BPR.#,L-C$S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(L,C`S+#(Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92`H:6X@4VAA<F5S
M*2!A="!$96,N(#,Q+"`R,#`V/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-"PR,C,L,S4X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH-"PR-#$L-SDV*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#0L,C0Q+#<Y-BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F
M(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#`W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPQ-C(L-30S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,RPQ-C(L.34P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O
M8VL@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0P-BPW,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&]P=&EO
M;B!A;F0@=V%R<F%N="!E>&5R8VES93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0L.3DX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C
M:R!U<&]N(&]P=&EO;B!A;F0@=V%R<F%N="!E>&5R8VES92`H:6X@4VAA<F5S
M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPT-S$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K
M+6)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#4Q."PT.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4Q."PT.38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@
M1&5C+B`S,2P@,C`P-SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,30L-C,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3,L,34X+#8T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$P+#4R-2PT,#DI/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV-#<L.#8V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E
M("AI;B!3:&%R97,I(&%T($1E8RX@,S$L(#(P,#<\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$T+#8S,BPU-3@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#<R."PQ.#<I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPW,C@L,3@W*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#<W,"PW.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#<W,2PP.3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F
M(&-O;6UO;B!S=&]C:R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S`V+#0Q.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K
M(&9O<B!S97)V:6-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW,RPY.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW-"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!F;W(@
M<V5R=FEC97,@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N
M<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.30U+#`T.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M.30U+#`T.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F%L86YC92!A="!$96,N(#,Q+"`R,#`X/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PY-#D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-BPY-#@L-#8V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,30L,C4S+#4Y
M-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR+#<P.2PX,3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN(%-H87)E<RD@870@1&5C+B`S,2P@
M,C`P.#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L.30X+#DW
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L
M,C@T+#(U,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@S+#(X-"PR-3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-3$Y+#<X-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M-3(P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K("AI;B!3:&%R97,I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,38L,C8Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U
M86YC92!O9B!C;VUM;VX@<W1O8VL@9F]R('-E<G9I8V5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S$L-#DU/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$L-3`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O
M9B!C;VUM;VX@<W1O8VL@9F]R('-E<G9I8V5S("AI;B!3:&%R97,I/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#4P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@
M8V]M;6]N('-T;V-K('5P;VX@;W!T:6]N(&%N9"!W87)R86YT(&5X97)C:7-E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-C,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0Y.2PU,S<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&]P=&EO
M;B!A;F0@=V%R<F%N="!E>&5R8VES92`H:6X@4VAA<F5S*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#8R+#@R-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VLM8F%S960@8V]M
M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,C8W+#$V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,C8W+#$V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!$96,N(#,Q+"`R
M,#`Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PV,S,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,2PR
M-C8L-#0W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,3<L-3,W+#@T."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS+#<T-"PR,S(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN(%-H87)E
M<RD@870@1&5C+B`S,2P@,C`P.3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,34L-C,R+#4V-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#(L-S0W+#,R."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#<T-RPS,C@I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O
M9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.#DL.3@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@*&EN
M(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K(&9O<B!S97)V:6-E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,RPX,#,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,RPX,3,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES
M<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!F;W(@<V5R=FEC97,@*&EN(%-H87)E
M<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#4P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#4P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8Y-BPW,3D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV.38L-S$Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&<F%C=&EO
M;F%L('-H87)E(&-A<V@@<&%Y;W5T('5P;VX@<F5V97)S92!S<&QI=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PR,3`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PR,3`I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&<F%C
M=&EO;F%L('-H87)E(&-A<V@@<&%Y;W5T('5P;VX@<F5V97)S92!S<&QI="`H
M:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C$X
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0F%L86YC92!A="!$96,N(#,Q+"`R,#$P/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-2PV-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR,BPQ,#4L-S0W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C`L,C@U+#$W-BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@S
M-BPR,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D)A;&%N8V4@*&EN(%-H87)E<RD@870@1&5C+B`S,2P@,C`Q,#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L-C4T+#@T-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,S0V+#@R
M-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@R+#,T-BPX,C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8U.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0T,"PU-3$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-#$L,C$P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@*&EN(%-H87)E<RD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8U."PU,C`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O
M;6UO;B!S=&]C:R!F;W(@<V5R=FEC97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$T.2PX-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM
M;VX@<W1O8VL@9F]R('-E<G9I8V5S("AI;B!3:&%R97,I/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,CDL,C0U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(Y+#(T-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!P87EM
M96YT<R!R96-E:79E9"!O;B!S=&]C:R!S=6)S8W)I<'1I;VX@<F5C96EV86)L
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#`T+#0Q,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O
M8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8R,BPY.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,C(L.3DW/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E(&%T($1E
M8RX@,S$L(#(P,3$\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V
M+#0T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(S+#,Q.2PQ-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R,BPV,S(L,#`R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<P,RPV,#<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@*&EN
M(%-H87)E<RD@870@1&5C+B`S,2P@,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,38L-#0R+#8Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#(L,3,U+#$T,"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#$S-2PQ-#`I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U
M86YC92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(W,BPY-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR-S,L,S8P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@
M<W1O8VL@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0P-RPY.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-A;&4@;V8@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T
M;V-K(&%N9"!W87)R86YT<R!F;W(@8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.#<Q+#8Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L,3(W+#0Q.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.3DY+#`S,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V%L92!O
M9B!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VL@86YD('=A<G)A;G1S(&9O
M<B!C87-H("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR+#(P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K(&9O<B!S97)V
M:6-E<R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0V%S:"!P87EM96YT<R!R96-E:79E9"!O;B!S=&]C:R!S=6)S8W)I
M<'1I;VX@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S$P+#$V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]N=F5R<VEO;B!O9B!P<F5F97)R960@<W1O8VL@=&\@
M8V]M;6]N('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U
M-3DL-#$X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L.#@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-34W+#4S-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R<VEO;B!O9B!P<F5F97)R960@
M<W1O8VL@=&\@8V]M;6]N('-T;V-K("AI;B!3:&%R97,I/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Q+#0Q,BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@X,BPV-C<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E
M(&]F(&-O;6UO;B!S=&]C:R!U<&]N(&]P=&EO;B!A;F0@=V%R<F%N="!E>&5R
M8VES92`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q,"PP-S8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,3`L,#<V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA
M;F-E(&%T($1E8RX@,S$L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,S$R+#$Y-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,3@L-S,S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-2PU.#<L,30X/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R-"PW-C<L
M,30R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,2PQ-3`L.3,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E("AI;B!3:&%R97,I(&%T($1E8RX@
M,S$L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X
M+#<S,RPR-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-0T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R-&%D-#9A-E\X.3(R7S0U8SA?
M8C@X,U]A8C9D,&9C.6,W-S4O5V]R:W-H965T<R]3:&5E=#`V+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%5C1!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VYS;VQI9&%T
M960@4W1A=&5M96YT<R!O9B!#87-H($9L;W=S("A54T0@)"D\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#8^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#(^,3,X($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CY$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0R/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^1&5C+B`S,2P@,C`Q
M,#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,CY$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D-A<V@@9FQO=W,@9G)O;2!O<&5R871I;F<@86-T
M:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPQ,S4L,30P*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPS-#8L.#(V*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPW-#<L,S(X*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C0L-S8W+#$T,BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^061J=7-T;65N=',@=&\@
M<F5C;VYC:6QE(&YE="!L;W-S('1O(&YE="!C87-H('5S960@:6X@;W!E<F%T
M:6YG(&%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E
M<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XY,RPV-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,#DL,#$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$Y
M+#<W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8U.2PR.#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)E=&EO;B!O9B!P<F5F
M97)R960@<W1O8VL@<F5D96UP=&EO;B!V86QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,S0V+#8W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4L(&EN
M8VQU9&EN9R!C;VUM;VX@<W1O8VL@:7-S=65D(&9O<B!S97)V:6-E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S$P+#`W-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C<W,BPY.3<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW-3`L-3,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-BPV-CDL.#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D-H86YG97,@:6X@87-S971S(&%N9"!L:6%B:6QI=&EE<SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G0@9G5N9',@<F5C96EV86)L
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#(L-S,S*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Y,"PW-C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q-3,L.34T*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#(V-BPR-#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F5P86ED(&5X<&5N<V5S(&%N9"!O=&AE<B!C=7)R96YT(&%S<V5T
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3(L-3DS*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y+#$R,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#0L,C$U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#0R+#,P,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1E9F5R<F5D(&]F9F5R:6YG(&-O<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,S`L
M-#`R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#,P+#0P,BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D1E<&]S:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,2PP,3`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,3$L,#$P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L92!A;F0@86-C<G5E9"!E>'!E
M;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C$T+#4P,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,3DL.3(W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,SDL,#,S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-#$U+#@R-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L(&%D:G5S=&UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@S,#8L,3`W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L,#0S+#(P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P
M.2PW-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#<W,BPP,S0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S:"!U<V5D
M(&EN(&]P97)A=&EN9R!A8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R+#0T,2PR-#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,S`S+#8R,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M+#0S-RPU-S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,38L.3DU
M+#$P."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M0V%S:"!F;&]W<R!F<F]M(&EN=F5S=&EN9R!A8W1I=FET:65S.CPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!P<F]P97)T>2!A;F0@
M97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,2PX.38I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH-"PW,#8I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-3,X+#0Y,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!R;V-E961S(&9R;VT@<V%L92!O9B!P<F]P97)T>2!A;F0@97%U:7!M
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU+#4X,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L-3@P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@<')O
M=FED960@*'5S960I(&)Y(&EN=F5S=&EN9R!A8W1I=FET:65S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q,2PX.38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.#<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3,R+#DQ,"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!F;&]W
M<R!F<F]M(&9I;F%N8VEN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M('-A;&4@;V8@8V]M;6]N('-T;V-K
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,3`L,38P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#`T+#0Q,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$U+#@S-BPT-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R
M;V-E961S(&9R;VT@<V%L92!O9B!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.3DY+#`S,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S(W+#0W-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H('!R;W9I9&5D
M(&)Y(&9I;F%N8VEN9R!A8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#,P.2PQ.3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/'-U<#Y;,5T\+W-U<#X\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0P-"PT,3`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/'-U<#Y;,5T\+W-U<#X\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELQ73PO
M<W5P/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@L-38S+#DT
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M<W5P/ELQ73PO<W5P/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&EN8W)E87-E("AD96-R96%S92D@:6X@8V%S:"!A;F0@8V%S:"!E
M<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,R
M+#`U-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX."PX.3,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#0S-BPV.3<I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP,S4L.3(U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S(&%T
M(&)E9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,38W+#DX,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L,#<Y+#`X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-3$U
M+#<X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<R!A="!E;F0@;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#`S-2PY,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#$V-RPY.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`W.2PP
M.#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`S-2PY,C4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U<'!L96UE;G1A;"!D:7-C
M;&]S=7)E(&]F(&-A<V@@9FQO=R!I;F9O<FUA=&EO;B!);G1E<F5S="!P86ED
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4L-C8Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L<W!A;CTS
M1#D^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1I;FYE
M<D9O;W1N;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P/ELQ73PO=&0^
M#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$."!V86QI9VX],T1T;W`^4W5P<&QE
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M=&5M8F5R(#(X+"`R,#`V+B`@07,@9&ES8W5S<V5D(&EN($YO=&4@-BP@9'5R
M:6YG(#(P,3(L(&%N(&%G9W)E9V%T92!O9B`Q+#0Q,B!S:&%R97,@;V8@=&AE
M($-O;7!A;GDG<R!O=71S=&%N9&EN9R!397)I97,@02!#;VYV97)T:6)L92!0
M<F5F97)R960@4W1O8VL@=V5R92!C;VYV97)T960@:6YT;R`Q+#@X,BPV-C<@
M<VAA<F5S(&]F(&-O;6UO;B!S=&]C:RX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C
M.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S+U-H965T,#<N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$@+2!.
M871U<F4@;V8@0G5S:6YE<W,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYA='5R92!O9B!/<&5R871I;VYS(%M497AT($)L;V-K
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)SX-"B`@#0H@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G/C$N)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[)B,Q-C`[3F%T=7)E#0H@(`T*("`@("`@;V8@0G5S:6YE
M<W,\+V9O;G0^#0H@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/D=E;U9A>`T*(`T*("`@("`@3&%B<RP@26YC
M+B`H)B,X,C(P.T=E;U9A>"8C.#(R,3L@;W(@=&AE#0H@("`@#0H@("`@("`F
M(S@R,C`[0V]M<&%N>28C.#(R,3LI+"!I<R!A(&)I;W1E8VAN;VQO9WD@8V]M
M<&%N>2!D979E;&]P:6YG#0H@#0H@("`@("!V86-C:6YE<R!T:&%T('!R979E
M;G0@86YD(&9I9VAT($AU;6%N($EM;75N;V1E9FEC:65N8WD@5FER=7,-"B`@
M#0H@("`@("`H)B,X,C(P.TA)5B8C.#(R,3LI(&EN9F5C=&EO;G,N)B,Q-C`[
M)B,Q-C`[2$E6(&EN9F5C=&EO;G,-"B`@("`@#0H@("`@("!R97-U;'0@:6X@
M06-Q=6ER960@26UM=6YO9&5F:6-I96YC>2!3>6YD<F]M90T*(`T*("`@("`@
M*"8C.#(R,#M!2413)B,X,C(Q.RDN)B,Q-C`[)B,Q-C`[5V4@:&%V92!E>&-L
M=7-I=F5L>2!L:6-E;G-E9`T*("`@(`T*("`@("`@9G)O;2!%;6]R>2!5;FEV
M97)S:71Y("@F(S@R,C`[16UO<GDF(S@R,C$[*2!V86-C:6YE#0H@#0H@("`@
M("!T96-H;F]L;V=Y('=H:6-H('=A<R!D979E;&]P960@:6X@8V]L;&%B;W)A
M=&EO;B!W:71H('1H90T*("`@#0H@("`@("!.871I;VYA;"!);G-T:71U=&5S
M(&]F($AE86QT:"`H)B,X,C(P.TY)2"8C.#(R,3LI(&%N9"!T:&4-"B`@#0H@
M("`@("!#96YT97)S(&9O<B!$:7-E87-E($-O;G1R;VP@86YD(%!R979E;G1I
M;VX-"B`@("`-"B`@("`@("@F(S@R,C`[0T1#)B,X,C(Q.RDN)B,Q-C`[)B,Q
M-C`[1V5O5F%X(&ES(&EN8V]R<&]R871E9"!U;F1E<@T*("`@#0H@("`@("!T
M:&4@;&%W<R!O9B!T:&4@4W1A=&4@;V8@1&5L87=A<F4@86YD(&]U<B!P<FEN
M8VEP86P@;V9F:6-E<PT*(`T*("`@("`@87)E(&QO8V%T960@:6X@4VUY<FYA
M+"!'96]R9VEA("AM971R;W!O;&ET86X@071L86YT80T*("`@(`T*("`@("`@
M87)E82DN/"]F;VYT/@T*(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=7(-"B`@(`T*("`@("`@;6]S="!A
M9'9A;F-E9"!V86-C:6YE<R!U;F1E<B!D979E;&]P;65N="!A9&1R97-S('1H
M92!C;&%D92!"#0H@(`T*("`@("`@<W5B='EP92!O9B!T:&4@2$E6('9I<G5S
M('1H870@:7,@;6]S="!P<F5V86QE;G0@:6X@=&AE(%5N:71E9`T*("`@#0H@
M("`@("!3=&%T97,@86YD('1H92!D979E;&]P960@=V]R;&0N)B,Q-C`[)B,Q
M-C`[3W5R('9A8V-I;F5S(&%R90T*("`@(`T*("`@("`@8F5I;F<@979A;'5A
M=&5D('1O(&1E=&5R;6EN92!T:&5I<B!P;W1E;G1I86P@=&\@*&$I('!R979E
M;G0-"B`-"B`@("`@($A)5B!I;F9E8W1I;VX@86YD("AB*2!T;R!S97)V92!A
M<R!A('1H97)A<'D@9F]R(&EN9&EV:61U86QS#0H@#0H@("`@("!W:&\@87)E
M(&%L<F5A9'D@:6YF96-T960@=VET:"!(258N)B,Q-C`[)B,Q-C`[5&AE<V4@
M=F%C8VEN97,-"B`@("`@#0H@("`@("!A<F4@8W5R<F5N=&QY(&)E:6YG(&5V
M86QU871E9"!I;B!H=6UA;G,@+2T@8F]T:"!I;B!T:&]S90T*("`@#0H@("`@
M("!I;F9E8W1E9"!W:71H($A)5B!A;F0@=&AO<V4@=VAO(&%R92!N;W0N/"]F
M;VYT/@T*("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($9/3E0M4TE:13H@,3!P="<^07,-"B`@#0H@("`@("!D:7-C=7-S960@:6X@
M3F]T92`R+"!T:&4@0V]M<&%N>2!I<R!A(&1E=F5L;W!M96YT+7-T86=E#0H@
M(`T*("`@("`@96YT97)P<FES92!A;F0@=V4@87)E(&1E=F]T:6YG('-U8G-T
M86YT:6%L;'D@86QL(&]F(&]U<@T*("`-"B`@("`@('!R97-E;G0@969F;W)T
M<R!T;R!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0N)B,Q-C`[)B,Q-C`[5V4-
M"B`@(`T*("`@("`@:&%V92!F=6YD960@;W5R(&%C=&EV:71I97,@=&\@9&%T
M92!F<F]M(&=O=F5R;FUE;G0@9W)A;G1S(&%N9`T*("`@#0H@("`@("!C;&EN
M:6-A;"!T<FEA;"!A<W-I<W1A;F-E+"!A;F0@9G)O;2!S86QE<R!O9B!O=7(@
M97%U:71Y#0H@(`T*("`@("`@<V5C=7)I=&EE<RX@5V4@=VEL;"!C;VYT:6YU
M92!T;R!R97%U:7)E('-U8G-T86YT:6%L(&9U;F1S('1O#0H@(`T*("`@("`@
M8V]N=&EN=64@=&AE<V4@86-T:79I=&EE<RXF(S$V,#LF(S$V,#M792!A;G1I
M8VEP871E('1H870@;W5R#0H@("`@(`T*("`@("`@97AI<W1I;F<@8V%S:"!R
M97-O=7)C97,L(&-O;6)I;F5D('=I=&@@=&AE('!R;V-E961S(&9R;VT@=&AE
M#0H@(`T*("`@("`@3DE((&=R86YT(&1I<V-U<W-E9"!I;B!.;W1E(#,@86YD
M('1H92!F:6YA;F-I;F<@979E;G1S#0H@#0H@("`@("!D:7-C=7-S960@:6X@
M3F]T92`Q,2P@<VAO=6QD(&)E('-U9F9I8VEE;G0@=&\@9G5N9"!O=7(-"B`-
M"B`@("`@(&]P97)A=&EO;G,@:6YT;R!T:&4@9FER<W0@<75A<G1E<B!O9B`R
M,#$T+B8C,38P.R8C,38P.TEN#0H@#0H@("`@("!O<F1E<B!T;R!M965T(&]U
M<B!O<&5R871I;F<@8V%S:"!F;&]W(')E<75I<F5M96YT<RP@=V4@:6YT96YD
M#0H@("`-"B`@("`@('1O(&-O;F1U8W0@861D:71I;VYA;"!O9F9E<FEN9W,@
M;V8@;W5R(&5Q=6ET>2!S96-U<FET:65S(&]R#0H@#0H@("`@("!C;VYV97)T
M:6)L92!D96)T(&EN<W1R=6UE;G1S+B!792!A<F4@86QS;R!S965K:6YG(&%D
M9&ET:6]N86P-"B`@#0H@("`@("!F=6YD:6YG(&9O<B!O=7(@<F5S96%R8V@@
M<')O9W)A;7,@=&AR;W5G:"!G;W9E<FYM96YT(&=R86YT#0H@("`@(`T*("`@
M("`@9G5N9&EN9R!M96-H86YI<VUS+CPO9F]N=#X-"B`@("`-"B`@("`\+V1I
M=CX\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C.%]B
M.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S+U-H965T,#@N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#(@+2!3=6UM
M87)Y(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-I9VYI9FEC86YT
M($%C8V]U;G1I;F<@4&]L:6-I97,@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^,BXF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#M3=6UM87)Y#0H@("`-"B`@("`@(&]F(%-I9VYI9FEC86YT($%C8V]U
M;G1I;F<@4&]L:6-I97,\+V9O;G0^#0H@("`@#0H@("`@/"]D:78^/&)R+SX\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P="<^0F%S:7,-"B`@("`@#0H@("`@("!O9B!0<F5S96YT871I;VX@
M86YD(%!R:6YC:7!L97,@;V8@0V]N<V]L:61A=&EO;CPO9F]N=#X-"B`@#0H@
M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/D]U<@T*("`@#0H@("`@("!P<FEM87)Y(&)U<VEN97-S(&ES(&-O;F1U
M8W1E9"!B>2!O=7(@=VAO;&QY+6]W;F5D('-U8G-I9&EA<GDL#0H@("`-"B`@
M("`@($=E;U9A>"P@26YC+B!4:&4@86-C;VUP86YY:6YG(&-O;G-O;&ED871E
M9"!F:6YA;F-I86P-"B`@("`-"B`@("`@('-T871E;65N=',@:6YC;'5D92!T
M:&4@86-C;W5N=',@;V8@1V5O5F%X+"!);F,N(&9R;VT-"B`@("`-"B`@("`@
M(&EN8V5P=&EO;B!T;V=E=&AE<B!W:71H('1H;W-E(&]F($=E;U9A>"!,86)S
M+"!);F,N(&9R;VT-"B`@#0H@("`@("!397!T96UB97(@,C@L(#(P,#8@*'-E
M92!.;W1E(#4I+B8C,38P.R8C,38P.T%L;"!I;G1E<F-O;7!A;GD-"B`@("`@
M#0H@("`@("!T<F%N<V%C=&EO;G,@:&%V92!B965N(&5L:6UI;F%T960@:6X@
M8V]N<V]L:61A=&EO;BX\+V9O;G0^#0H@#0H@("`@/"]D:78^/&)R+SX\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O
M;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P="<^1&5V96QO<&UE;G0M4W1A9V4-"B`@#0H@("`@("!%;G1E<G!R:7-E
M/"]F;VYT/@T*("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P="<^5V4-"B`@#0H@("`@("!A<F4@9&5V;W1I
M;F<@86QL(&]F(&]U<B!P<F5S96YT(&5F9F]R=',@=&\@<F5S96%R8V@@86YD
M#0H@(`T*("`@("`@9&5V96QO<&UE;G0@86YD($=E;U9A>"!I<R!A(&1E=F5L
M;W!M96YT('-T86=E(&5N=&5R<')I<V4@87,-"B`-"B`@("`@(&1E9FEN960@
M8GD@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A<F1S($)O87)D#0H@("`@
M#0H@("`@("`H)B,X,C(P.T9!4T(F(S@R,C$[*2!!8V-O=6YT:6YG(%-T86YD
M87)D<R!#;V1I9FEC871I;VX-"B`@("`-"B`@("`@("@F(S@R,C`[05-#)B,X
M,C(Q.RD@5&]P:6,@.3$U+"`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I
M=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^1&5V96QO<&UE;G0@4W1A9V4-"B`@
M("`-"B`@("`@($5N=&ET:65S/"]F;VYT/BXF(S$V,#LF(S$V,#M!;&P@;&]S
M<V5S(&%C8W5M=6QA=&5D('-I;F-E#0H@(`T*("`@("`@:6YC97!T:6]N("A*
M=6YE(#(W+"`R,#`Q*2!H879E(&)E96X@8V]N<VED97)E9"!A<R!P87)T(&]F
M(&]U<@T*("`@#0H@("`@("!D979E;&]P;65N="!S=&%G92!A8W1I=FET:65S
M+CPO9F]N=#X-"B`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS
M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY5<V4-
M"B`@(`T*("`@("`@;V8@17-T:6UA=&5S/"]F;VYT/@T*("`-"B`@("`\+V1I
M=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@
M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^5&AE
M#0H@("`-"B`@("`@('!R97!A<F%T:6]N(&]F(&9I;F%N8VEA;"!S=&%T96UE
M;G1S(&EN(&-O;F9O<FUI='D@=VET:`T*(`T*("`@("`@86-C;W5N=&EN9R!P
M<FEN8VEP;&5S(&=E;F5R86QL>2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T
M871E<PT*("`@#0H@("`@("!O9B!!;65R:6-A("@F(S@R,C`[1T%!4"8C.#(R
M,3LI(')E<75I<F5S('5S('1O(&UA:V4@97-T:6UA=&5S#0H@#0H@("`@("!A
M;F0@87-S=6UP=&EO;G,@=&AA="!A9F9E8W0@=&AE(')E<&]R=&5D(&%M;W5N
M=',@;V8@87-S971S#0H@("`@(`T*("`@("`@86YD(&QI86)I;&ET:65S(&%N
M9"!D:7-C;&]S=7)E(&]F(&-O;G1I;F=E;G0@87-S971S(&%N9`T*("`-"B`@
M("`@(&QI86)I;&ET:65S(&%T('1H92!D871E(&]F('1H92!F:6YA;F-I86P@
M<W1A=&5M96YT<R!A;F0@=&AE#0H@#0H@("`@("!R97!O<G1E9"!A;6]U;G1S
M(&]F(')E=F5N=65S(&%N9"!E>'!E;G-E<R!D=7)I;F<@=&AE#0H@("`@#0H@
M("`@("!R97!O<G1I;F<@<&5R:6]D+B8C,38P.R8C,38P.T%C='5A;"!R97-U
M;'1S(&UA>2!D:69F97(@9G)O;0T*("`@(`T*("`@("`@=&AO<V4@97-T:6UA
M=&5S+CPO9F]N=#X-"B`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS
M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87-H
M#0H@("`@#0H@("`@("!A;F0@0V%S:"!%<75I=F%L96YT<SPO9F]N=#X-"B`@
M("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/E=E#0H@(`T*("`@("`@8V]N<VED97(@86QL(&AI9VAL>2!L
M:7%U:60@:6YV97-T;65N=',@=VET:"!A(&UA='5R:71Y(&]F#0H@("`@#0H@
M("`@("!T:')E92!M;VYT:',@;W(@;&5S<R!W:&5N('!U<F-H87-E9"!T;R!B
M92!C87-H#0H@("`-"B`@("`@(&5Q=6EV86QE;G1S+B8C,38P.R8C,38P.T]U
M<B!C87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S(&-O;G-I<W0-"B`-"B`@("`@
M('!R:6UA<FEL>2!O9B!B86YK(&1E<&]S:71S(&%N9"!M;VYE>2!M87)K970-
M"B`@("`@#0H@("`@("!A8V-O=6YT<RXF(S$V,#LF(S$V,#M4:&4@<F5C;W)D
M960@=F%L=65S(&%P<')O>&EM871E(&9A:7(-"B`@#0H@("`@("!M87)K970@
M=F%L=65S(&1U92!T;R!T:&4@<VAO<G0@;6%T=7)I=&EE<RX\+V9O;G0^#0H@
M(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z
M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D9A:7(-"B`@("`-"B`@("`@
M(%9A;'5E(&]F($9I;F%N8VEA;"!);G-T<G5M96YT<R!A;F0@0V]N8V5N=')A
M=&EO;B!O9B!#<F5D:70-"B`@("`@#0H@("`@("!2:7-K/"]F;VYT/@T*("`@
M(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY&:6YA;F-I86P-"B`@("`-"B`@("`@(&EN<W1R=6UE;G1S('1H
M870@<W5B:F5C="!U<R!T;R!C;VYC96YT<F%T:6]N(&]F(&-R961I="!R:7-K
M#0H@#0H@("`@("!C;VYS:7-T('!R:6UA<FEL>2!O9B!C87-H(&%N9"!C87-H
M(&5Q=6EV86QE;G1S+"!W:&EC:"!A<F4-"B`@("`-"B`@("`@(&UA:6YT86EN
M960@8GD@82!H:6=H(&-R961I="!Q=6%L:71Y(&9I;F%N8VEA;"!I;G-T:71U
M=&EO;BX-"B`@("`@#0H@("`@("!4:&4@8V%R<GEI;F<@=F%L=65S(')E<&]R
M=&5D(&EN('1H92!B86QA;F-E('-H965T<R!F;W(@8V%S:`T*(`T*("`@("`@
M86YD(&-A<V@@97%U:79A;&5N=',@87!P<F]X:6UA=&4@9F%I<B!V86QU97,N
M/"]F;VYT/@T*("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS
M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0<F]P
M97)T>0T*("`@#0H@("`@("!A;F0@17%U:7!M96YT/"]F;VYT/@T*("`@#0H@
M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/E!R;W!E<G1Y#0H@("`-"B`@("`@(&%N9"!E<75I<&UE;G0@87)E('-T
M871E9"!A="!C;W-T+"!L97-S(&%C8W5M=6QA=&5D#0H@(`T*("`@("`@9&5P
M<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VXN)B,Q-C`[)B,Q-C`[5&AE(&-O
M;7!O;F5N=',@;V8-"B`@("`-"B`@("`@('!R;W!E<G1Y(&%N9"!E<75I<&UE
M;G0@87,@;V8@1&5C96UB97(@,S$L(#(P,3(@86YD(#(P,3$@87)E#0H@#0H@
M("`@("!A<R!F;VQL;W=S.CPO9F]N=#X-"B`-"B`@("`\+V1I=CX\8G(O/CQT
M86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$
M.3<E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SX-"B`@("`-"B`@
M("`@("`@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[)SX-"B`@("`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G
M/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXR,#$R/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS
M1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,C`Q,3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DQA8F]R871O<GD-"B`@(`T*("`@
M("`@("`@("`@("!E<75I<&UE;G0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@
M/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,S@X+#`P,#PO9F]N
M=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C,X."PP,#`\+V9O;G0^#0H@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@
M("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#<P)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY,96%S96AO;&0-"B`@#0H@("`@("`@("`@("`@(&EM
M<')O=F5M96YT<SPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,3$U+#8P-3PO9F]N=#X-
M"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,34L-C`U/"]F;VYT/@T*(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@
M("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[
M)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE<@T*("`@#0H@("`@
M("`@("`@("`@(&9U<FYI='5R92P@9FEX='5R97,@)F%M<#L@97%U:7!M96YT
M/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^,C@L-C@U/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXR."PV.#4\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@
M("`@("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E1O=&%L#0H@("`-"B`@("`@("`@("`@("`@<')O
M<&5R='D@86YD(&5Q=6EP;65N=#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-3,R+#(Y
M,#PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU,S(L,CDP/"]F
M;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*
M("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z
M("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!8V-U;75L
M871E9`T*("`@(`T*("`@("`@("`@("`@("!D97!R96-I871I;VX@86YD(&%M
M;W)T:7IA=&EO;CPO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@T,CDL.#`T/"]F;VYT/@T*("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^
M#0H@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B@S-38L,#@T/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@
M("`@("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`T<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0<F]P97)T
M>0T*(`T*("`@("`@("`@("`@("!A;F0@97%U:7!M96YT+"!N970\+V9O;G0^
M#0H@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`T<'@G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ
M,#(L-#@V/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L
M969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$W-BPR,#8\+V9O;G0^#0H@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`\+W1R/@T*("`@("`-"B`@("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@#0H@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^17AP96YD:71U<F5S#0H@(`T*
M("`@("`@9F]R(&UA:6YT96YA;F-E(&%N9"!R97!A:7)S(&%R92!C:&%R9V5D
M('1O(&]P97)A=&EO;G,@87,-"B`@(`T*("`@("`@:6YC=7)R960L('=H:6QE
M(&%D9&ET:6]N<R!A;F0@:6UP<F]V96UE;G1S(&%R90T*("`@#0H@("`@("!C
M87!I=&%L:7IE9"XF(S$V,#LF(S$V,#M$97!R96-I871I;VX@:7,@8V]M<'5T
M960@=7-I;F<@=&AE#0H@("`-"B`@("`@('-T<F%I9VAT+6QI;F4@;65T:&]D
M(&]V97(@=&AE(&5S=&EM871E9"!U<V5F=6P@;&EV97,@;V8@=&AE#0H@#0H@
M("`@("!A<W-E=',@=VAI8V@@<F%N9V4@9G)O;2!T:')E92!T;R!F:79E#0H@
M("`@#0H@("`@("!Y96%R<RXF(S$V,#LF(S$V,#M!;6]R=&EZ871I;VX@;V8@
M;&5A<V5H;VQD(&EM<')O=F5M96YT<R!I<PT*("`@(`T*("`@("`@8V]M<'5T
M960@=7-I;F<@=&AE('-T<F%I9VAT+6QI;F4@;65T:&]D(&]V97(@=&AE(')E
M;6%I;FEN9PT*("`@("`-"B`@("`@('1E<FT@;V8@=&AE(')E;&%T960@;&5A
M<V4N)B,Q-C`[)B,Q-C`[1&5P<F5C:6%T:6]N(&%N9`T*("`@(`T*("`@("`@
M86UO<G1I>F%T:6]N(&5X<&5N<V4@=V%S("0W,RPW,C`L("0X-"PQ,S$L(&%N
M9"`D.30L.#@W(&1U<FEN9PT*("`@#0H@("`@("!T:&4@>65A<G,@96YD960@
M1&5C96UB97(@,S$L(#(P,3(L(#(P,3$@86YD(#(P,3`L#0H@#0H@("`@("!R
M97-P96-T:79E;'DN/"]F;VYT/@T*("`@#0H@("`@/"]D:78^/&)R+SX\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O
M;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P="<^3W1H97(-"B`@("`@#0H@("`@("!!<W-E=',\+V9O;G0^#0H@#0H@
M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/D]T:&5R#0H@("`@(`T*("`@("`@87-S971S(&-O;G-I<W0@<')I;F-I
M<&%L;'D@;V8@;&EC96YS92!A9W)E96UE;G1S(&9O<B!T:&4@=7-E#0H@(`T*
M("`@("`@;V8@=&5C:&YO;&]G>2!O8G1A:6YE9"!T:')O=6=H('1H92!I<W-U
M86YC92!O9B!T:&4-"B`@#0H@("`@("!#;VUP86YY)B,X,C$W.W,@8V]M;6]N
M('-T;V-K+B8C,38P.R8C,38P.U1H97-E(&QI8V5N<V4-"B`@(`T*("`@("`@
M86=R965M96YT<R!A<F4@86UO<G1I>F5D(&]N(&$@<W1R86EG:'0@;&EN92!B
M87-I<R!O=F5R('1E;@T*("`@("`-"B`@("`@('EE87)S+B8C,38P.R8C,38P
M.T%M;W)T:7IA=&EO;B!E>'!E;G-E(')E;&%T960@=&\@=&AE<V4-"B`@("`@
M#0H@("`@("!A9W)E96UE;G1S('=A<R`D,3DL.3(S+"`D,C0L.#@V+"!A;F0@
M)#(T+#@X-B!D=7)I;F<@>65A<G,-"B`@("`-"B`@("`@(&5N9&5D($1E8V5M
M8F5R(#,Q+"`R,#$R+"`R,#$Q+"!A;F0@,C`Q,"P@<F5S<&5C=&EV96QY+"!A
M;F0@:7,-"B`@(`T*("`@("`@97AP96-T960@=&\@8F4@)#$P+#`P,"P@)#$P
M+#`P,"P@)"TP+2P@)"TP+2P@86YD("0M,"T@9F]R#0H@("`@#0H@("`@("!E
M86-H(&]F('1H92!N97AT(&9I=F4@>65A<G,L(')E<W!E8W1I=F5L>2X\+V9O
M;G0^#0H@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M
M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEM<&%I<FUE;G0-
M"B`@("`@#0H@("`@("!O9B!,;VYG+4QI=F5D($%S<V5T<SPO9F]N=#X-"B`@
M("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/E=E#0H@(`T*("`@("`@<F5V:65W(&QO;F<M;&EV960@87-S
M971S(&9O<B!I;7!A:7)M96YT('=H96YE=F5R(&5V96YT<R!O<@T*("`@("`-
M"B`@("`@(&-H86YG97,@:6X@8VER8W5M<W1A;F-E<R!I;F1I8V%T92!T:&%T
M('1H92!C87)R>6EN9R!A;6]U;G0@;V8-"B`@(`T*("`@("`@86X@87-S970@
M;6%Y(&YO="!B92!R96-O=F5R86)L92XF(S$V,#LF(S$V,#M296-O=F5R86)I
M;&ET>2!O9@T*(`T*("`@("`@87-S971S('1O(&)E(&AE;&0@86YD('5S960@
M:7,@;65A<W5R960@8GD@82!C;VUP87)I<V]N(&]F('1H90T*("`@#0H@("`@
M("!C87)R>6EN9R!A;6]U;G0@;V8@=&AE(&%S<V5T<R!T;R!T:&4@9G5T=7)E
M(&YE="!C87-H(&9L;W=S#0H@("`@(`T*("`@("`@97AP96-T960@=&\@8F4@
M9V5N97)A=&5D(&)Y('-U8V@@87-S971S+B8C,38P.R8C,38P.TEF('=E#0H@
M(`T*("`@("`@8V]N<VED97(@<W5C:"!A<W-E=',@=&\@8F4@:6UP86ER960L
M('1H92!I;7!A:7)M96YT('1O#0H@#0H@("`@("!B93QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/B8C,38P.SPO
M9F]N=#YR96-O9VYI>F5D#0H@(`T*("`@("`@:7,@;65A<W5R960@8GD@=&AE
M(&%M;W5N="!B>2!W:&EC:"!T:&4@8V%R<GEI;F<@86UO=6YT(&]F('1H90T*
M("`@#0H@("`@("!A<W-E=',@97AC965D<R!T:&4@97AP96-T960@9G5T=7)E
M(&YE="!C87-H(&9L;W=S(&9R;VT@=&AE#0H@("`@(`T*("`@("`@87-S971S
M+CPO9F]N=#X-"B`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G
M1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^06-C<G5E
M9`T*("`-"B`@("`@($QI86)I;&ET:65S/"]F;VYT/@T*(`T*("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!<PT*
M("`-"B`@("`@('!A<G0@;V8@=&AE('!R;V-E<W,@;V8@<')E<&%R:6YG(&]U
M<B!F:6YA;F-I86P@<W1A=&5M96YT<RP@=V4-"B`@(`T*("`@("`@97-T:6UA
M=&4@97AP96YS97,@=&AA="!W92!B96QI979E('=E(&AA=F4@:6YC=7)R960L
M(&)U="!H879E#0H@(`T*("`@("`@;F]T('EE="!B965N(&)I;&QE9"!B>2!O
M=7(@=&AI<F0@<&%R='D@=F5N9&]R<RX@5&AI<R!P<F]C97-S#0H@(`T*("`@
M("`@:6YV;VQV97,@:61E;G1I9GEI;F<@<V5R=FEC97,@86YD(&%C=&EV:71I
M97,@=&AA="!H879E(&)E96X-"B`-"B`@("`@('!E<F9O<FUE9"!B>2!S=6-H
M('9E;F1O<G,@;VX@;W5R(&)E:&%L9B!A;F0@97-T:6UA=&EN9R!T:&4-"B`@
M("`@#0H@("`@("!L979E;"!T;R!W:&EC:"!T:&5Y(&AA=F4@8F5E;B!P97)F
M;W)M960@86YD('1H92!A<W-O8VEA=&5D#0H@("`@(`T*("`@("`@8V]S="!I
M;F-U<G)E9"!F;W(@<W5C:"!S97)V:6-E(&%S(&]F(&5A8V@@8F%L86YC92!S
M:&5E="!D871E#0H@(`T*("`@("`@:6X@;W5R(&9I;F%N8VEA;"!S=&%T96UE
M;G1S+B!%>&%M<&QE<R!O9B!E>'!E;G-E<R!F;W(@=VAI8V@-"B`-"B`@("`@
M('=E(&%C8W)U92!I;F-L=61E(&9E97,@9F]R('!R;V9E<W-I;VYA;"!S97)V
M:6-E<R!A;F0@9F5E<PT*("`@(`T*("`@("`@;W=E9"!T;R!C;VYT<F%C="!M
M86YU9F%C='5R97)S(&EN(&-O;FIU;F-T:6]N('=I=&@@=&AE#0H@#0H@("`@
M("!M86YU9F%C='5R92!O9B!V86-C:6YE<R!F;W(@;W5R(&-L:6YI8V%L('1R
M:6%L<RX@5V4@;6%K90T*("`@#0H@("`@("!T:&5S92!E<W1I;6%T97,@8F%S
M960@=7!O;B!P<F]G<F5S<R!O9B!A8W1I=FET:65S(')E;&%T960@=&\-"B`@
M#0H@("`@("!C;VYT<F%C='5A;"!O8FQI9V%T:6]N<R!A;F0@:6YF;W)M871I
M;VX@<F5C96EV960@9G)O;0T*("`@("`-"B`@("`@('9E;F1O<G,N/"]F;VYT
M/@T*("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U3
M5%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^3F5T#0H@("`-"B`@
M("`@($QO<W,@4&5R(%-H87)E/"]F;VYT/@T*("`@(`T*("`@(#PO9&EV/CQB
M<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"87-I8PT*
M("`@("`-"B`@("`@(&%N9"!D:6QU=&5D(&QO<W,@<&5R(&-O;6UO;B!S:&%R
M92!A<F4@8V]M<'5T960@8F%S960@;VX@=&AE#0H@#0H@("`@("!W96EG:'1E
M9"!A=F5R86=E(&YU;6)E<B!O9B!C;VUM;VX@<VAA<F5S(&]U='-T86YD:6YG
M+B!!;&P-"B`@("`-"B`@("`@(&-O;6UO;B!S:&%R92!E<75I=F%L96YT<R`H
M=VAI8V@@8V]N<VES="!O9B!O<'1I;VYS(&%N9`T*(`T*("`@("`@=V%R<F%N
M=',I(&%R92!E>&-L=61E9"!F<F]M('1H92!C;VUP=71A=&EO;B!O9B!D:6QU
M=&5D(&QO<W,-"B`-"B`@("`@('!E<B!S:&%R92!S:6YC92!T:&4@969F96-T
M('=O=6QD(&)E(&%N=&DM9&EL=71I=F4N($-O;6UO;@T*("`@(`T*("`@("`@
M<VAA<F4@97%U:79A;&5N=',@=VAI8V@@8V]U;&0@<&]T96YT:6%L;'D@9&EL
M=71E(&)A<VEC#0H@#0H@("`@("!E87)N:6YG<R!P97(@<VAA<F4@:6X@=&AE
M(&9U='5R92P@86YD('=H:6-H('=E<F4@97AC;'5D960-"B`@("`-"B`@("`@
M(&9R;VT@=&AE(&-O;7!U=&%T:6]N(&]F(&1I;'5T960@;&]S<R!P97(@<VAA
M<F4L('1O=&%L960-"B`@#0H@("`@("!A<'!R;WAI;6%T96QY(#$R+C,@;6EL
M;&EO;BP@,BXX(&UI;&QI;VXL(&%N9"`R+C`@;6EL;&EO;B!A=`T*(`T*("`@
M("`@1&5C96UB97(@,S$L(#(P,3(L(#(P,3$@86YD(#(P,3`L(')E<W!E8W1I
M=F5L>2X\+V9O;G0^#0H@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE
M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E
M=F5N=64-"B`@#0H@("`@("!296-O9VYI=&EO;CPO9F]N=#X-"B`-"B`@("`\
M+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@
M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^
M5V4-"B`@#0H@("`@("!R96-O9VYI>F4@<F5V96YU92!I;B!A8V-O<F1A;F-E
M('=I=&@@=&AE(%-%0R8C.#(Q-SMS(%-T869F#0H@("`@#0H@("`@("!!8V-O
M=6YT:6YG($)U;&QE=&EN($YO+B`Q,#$L(#QF;VYT('-T>6QE/3-$)T9/3E0M
M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2979E;G5E#0H@("`@
M#0H@("`@("!296-O9VYI=&EO;B!I;B!&:6YA;F-I86P@4W1A=&5M96YT<RP\
M+V9O;G0^(&%S(&%M96YD960@8GD-"B`@("`@#0H@("`@("!3=&%F9B!!8V-O
M=6YT:6YG($)U;&QE=&EN($YO+B`Q,#0L(#QF;VYT('-T>6QE/3-$)T9/3E0M
M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY2979E;G5E#0H@("`@
M(`T*("`@("`@4F5C;V=N:71I;VXL/"]F;VYT/B`H)B,X,C(P.U-!0B`Q,#0F
M(S@R,C$[*2X@4T%"(#$P-"!P<F]V:61E<PT*("`-"B`@("`@(&=U:61A;F-E
M(&EN(&%P<&QY:6YG($=!05`@=&\@<F5V96YU92!R96-O9VYI=&EO;B!I<W-U
M97,L(&%N9`T*("`-"B`@("`@('-P96-I9FEC86QL>2!A9&1R97-S97,@<F5V
M96YU92!R96-O9VYI=&EO;B!F;W(@=7!F<F]N="P-"B`@#0H@("`@("!N;VYR
M969U;F1A8FQE(&9E97,@<F5C96EV960@:6X@8V]N;F5C=&EO;B!W:71H(')E
M<V5A<F-H#0H@(`T*("`@("`@8V]L;&%B;W)A=&EO;B!A9W)E96UE;G1S+B8C
M,38P.R8C,38P.T1U<FEN9R`R,#$R+"`R,#$Q(&%N9`T*("`@#0H@("`@("`R
M,#$P+"!O=7(@<F5V96YU92!C;VYS:7-T960@;V8@9W)A;G0@9G5N9&EN9R!R
M96-E:79E9`T*("`@("`-"B`@("`@('!R:6UA<FEL>2!F<F]M('1H92!.24@@
M*'-E92!.;W1E(#,I+B8C,38P.R8C,38P.U)E=F5N=64@9G)O;0T*("`@("`-
M"B`@("`@('1H:7,@87)R86YG96UE;G0@:7,@87!P<F]X:6UA=&5L>2!E<75A
M;"!T;R!T:&4@8V]S=',@:6YC=7)R960-"B`@(`T*("`@("`@86YD(&ES(')E
M8V]R9&5D(&%S(&EN8V]M92!A<R!T:&4@<F5L871E9"!C;W-T<R!A<F4-"B`@
M#0H@("`@("!I;F-U<G)E9"X\+V9O;G0^#0H@("`@#0H@("`@/"]D:78^/&)R
M+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@
M("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^4F5S96%R8V@-"B`@(`T*("`@("`@86YD($1E=F5L;W!M
M96YT($5X<&5N<V4\+V9O;G0^#0H@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^4F5S96%R8V@-"B`@(`T*
M("`@("`@86YD(&1E=F5L;W!M96YT(&5X<&5N<V4@<')I;6%R:6QY(&-O;G-I
M<W1S(&]F(&-O<W1S(&EN8W5R<F5D#0H@(`T*("`@("`@:6X@=&AE(&1I<V-O
M=F5R>2P@9&5V96QO<&UE;G0L('1E<W1I;F<@86YD(&UA;G5F86-T=7)I;F<@
M;V8-"B`-"B`@("`@(&]U<B!P<F]D=6-T(&-A;F1I9&%T97,N(%1H97-E(&5X
M<&5N<V5S(&-O;G-I<W0@<')I;6%R:6QY(&]F#0H@#0H@("`@("`H:2D@9F5E
M<R!P86ED('1O('1H:7)D+7!A<G1Y('-E<G9I8V4@<')O=FED97)S('1O('!E
M<F9O<FTL#0H@("`@(`T*("`@("`@;6]N:71O<B!A;F0@86-C=6UU;&%T92!D
M871A(')E;&%T960@=&\@;W5R('!R96-L:6YI8V%L#0H@#0H@("`@("!S='5D
M:65S(&%N9"!C;&EN:6-A;"!T<FEA;',L("AI:2D@8V]S=',@<F5L871E9"!T
M;R!S<&]N<V]R960-"B`@#0H@("`@("!R97-E87)C:"!A9W)E96UE;G1S+"`H
M:6EI*2!T:&4@8V]S=',@=&\@<')O8W5R92!A;F0-"B`@(`T*("`@("`@;6%N
M=69A8W1U<F4@;6%T97)I86QS('5S960@:6X@8VQI;FEC86P@=')I86QS+"`H
M:78I#0H@("`-"B`@("`@(&QA8F]R871O<GD@<W5P<&QI97,@86YD(&9A8VEL
M:71Y+7)E;&%T960@97AP96YS97,@=&\@8V]N9'5C=`T*("`-"B`@("`@(&1E
M=F5L;W!M96YT+"!A;F0@*'8I('-A;&%R:65S+"!B96YE9FET<RP@86YD('-H
M87)E+6)A<V5D#0H@("`-"B`@("`@(&-O;7!E;G-A=&EO;B!F;W(@<&5R<V]N
M;F5L+B8C,38P.R8C,38P.U1H97-E(&-O<W1S(&%R90T*("`@(`T*("`@("`@
M8VAA<F=E9"!T;R!E>'!E;G-E(&%S(&EN8W5R<F5D+CPO9F]N=#X-"B`-"B`@
M("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L
M:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0871E;G0-"B`-"B`@("`@($-O<W1S
M/"]F;VYT/@T*("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P="<^3W5R#0H@("`-"B`@("`@(&5X<&5N9&ET
M=7)E<R!R96QA=&EN9R!T;R!O8G1A:6YI;F<@86YD('!R;W1E8W1I;F<@<&%T
M96YT<R!A<F4-"B`@(`T*("`@("`@8VAA<F=E9"!T;R!E>'!E;G-E('=H96X@
M:6YC=7)R960L(&%N9"!A<F4@:6YC;'5D960@:6X@9V5N97)A;`T*("`@#0H@
M("`@("!A;F0@861M:6YI<W1R871I=F4@97AP96YS92X\+V9O;G0^#0H@(`T*
M("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET
M86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E!E<FEO9`T*(`T*("`@("`@=&\@
M4&5R:6]D($-O;7!A<FES;VYS/"]F;VYT/@T*(`T*("`@(#PO9&EV/CQB<B\^
M/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=7(-"B`@(`T*
M("`@("`@;W!E<F%T:6YG(')E<W5L=',@87)E(&5X<&5C=&5D('1O(&9L=6-T
M=6%T92!F;W(@=&AE#0H@("`-"B`@("`@(&9O<F5S965A8FQE(&9U='5R92X@
M5&AE<F5F;W)E+"!P97)I;V0M=&\M<&5R:6]D(&-O;7!A<FES;VYS#0H@#0H@
M("`@("!S:&]U;&0@;F]T(&)E(')E;&EE9"!U<&]N(&%S('!R961I8W1I=F4@
M;V8@=&AE(')E<W5L=',@9F]R#0H@("`@(`T*("`@("`@9G5T=7)E('!E<FEO
M9',N)B,Q-C`[)B,Q-C`[0V5R=&%I;B!P<FEO<B!Y96%R(&%M;W5N=',@:&%V
M90T*("`@#0H@("`@("!B965N(')E8VQA<W-I9FEE9"!T;R!C;VYF;W)M('1O
M('1H92!C=7)R96YT('EE87(@9FEN86YC:6%L#0H@("`@(`T*("`@("`@<W1A
M=&5M96YT('!R97-E;G1A=&EO;BX\+V9O;G0^#0H@("`-"B`@("`\+V1I=CX\
M8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@
M("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY);F-O;64-"B`-"B`@("`@(%1A>&5S/"]F;VYT/@T*
M("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^5V4-"B`@#0H@("`@("!A8V-O=6YT(&9O<B!I;F-O;64@
M=&%X97,@=7-I;F<@=&AE(&QI86)I;&ET>2!M971H;V0N(%5N9&5R#0H@("`@
M(`T*("`@("`@=&AI<R!M971H;V0L(&1E9F5R<F5D('1A>"!A<W-E=',@86YD
M(&QI86)I;&ET:65S(&%R90T*("`@(`T*("`@("`@<F5C;V=N:7IE9"!F;W(@
M=&AE(&5S=&EM871E9"!F=71U<F4@=&%X(&-O;G-E<75E;F-E<PT*("`@(`T*
M("`@("`@871T<FEB=71A8FQE('1O(&1I9F9E<F5N8V5S(&)E='=E96X@=&AE
M(&9I;F%N8VEA;"!S=&%T96UE;G0-"B`-"B`@("`@(&-A<G)Y:6YG(&%M;W5N
M=',@;V8@97AI<W1I;F<@87-S971S(&%N9"!L:6%B:6QI=&EE<R!A;F0@=&AE
M:7(-"B`@(`T*("`@("`@<F5S<&5C=&EV92!T87@@8F%S97,N)B,Q-C`[)B,Q
M-C`[1&5F97)R960@=&%X(&%S<V5T<R!A;F0-"B`-"B`@("`@(&QI86)I;&ET
M:65S(&%R92!M96%S=7)E9"!U<VEN9R!E;F%C=&5D(')A=&5S(&EN(&5F9F5C
M="!F;W(-"B`@("`@#0H@("`@("!T:&4@>65A<B!I;B!W:&EC:"!T96UP;W)A
M<GD@9&EF9F5R96YC97,@87)E(&5X<&5C=&5D('1O(&)E#0H@("`@(`T*("`@
M("`@<F5C;W9E<F5D(&]R('-E='1L960N)B,Q-C`[)B,Q-C`[1&5F97)R960@
M=&%X(&%S<V5T<R!A<F4-"B`-"B`@("`@(')E9'5C960@8GD@82!V86QU871I
M;VX@86QL;W=A;F-E('5N;&5S<RP@:6X@=&AE(&]P:6YI;VX@;V8-"B`@("`@
M#0H@("`@("!M86YA9V5M96YT+"!I="!I<R!M;W)E(&QI:V5L>2!T:&%N(&YO
M="!T:&%T('-O;64@<&]R=&EO;B!O<@T*(`T*("`@("`@86QL(&]F('1H92!D
M969E<G)E9"!T87@@87-S971S('=I;&P@8F4@<F5A;&EZ960N/"]F;VYT/@T*
M("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,
M13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^4W1O8VLM0F%S960-"B`-
M"B`@("`@($-O;7!E;G-A=&EO;CPO9F]N=#X\8G(@+SX-"B`@("`-"B`@("`\
M+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@
M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^
M5V4-"B`@#0H@("`@("!A8V-O=6YT(&9O<B!S=&]C:RUB87-E9"!T<F%N<V%C
M=&EO;G,@:6X@=VAI8V@@=&AE($-O;7!A;GD-"B`@("`-"B`@("`@(')E8V5I
M=F5S('-E<G9I8V5S(&9R;VT@96UP;&]Y965S+"!D:7)E8W1O<G,@;W(@;W1H
M97)S(&EN#0H@("`-"B`@("`@(&5X8VAA;F=E(&9O<B!E<75I='D@:6YS=')U
M;65N=',@8F%S960@;VX@=&AE(&9A:7(@=F%L=64@;V8-"B`@("`@#0H@("`@
M("!T:&4@87=A<F0@870@=&AE(&=R86YT(&1A=&4N)B,Q-C`[)B,Q-C`[0V]M
M<&5N<V%T:6]N(&-O<W0@9F]R#0H@#0H@("`@("!A=V%R9',@;V8@8V]M;6]N
M('-T;V-K(&ES(&5S=&EM871E9"!B87-E9"!O;B!T:&4@<')I8V4@;V8@=&AE
M#0H@("`-"B`@("`@('5N9&5R;'EI;F<@8V]M;6]N('-T;V-K(&]N('1H92!D
M871E(&]F#0H@("`@(`T*("`@("`@:7-S=6%N8V4N)B,Q-C`[)B,Q-C`[0V]M
M<&5N<V%T:6]N(&-O<W0@9F]R('-T;V-K(&]P=&EO;G,@;W(-"B`@("`-"B`@
M("`@('=A<G)A;G1S(&ES(&5S=&EM871E9"!A="!T:&4@9W)A;G0@9&%T92!B
M87-E9"!O;B!E86-H#0H@("`@(`T*("`@("`@:6YS=')U;65N="8C.#(Q-SMS
M(&9A:7(@=F%L=64@87,@8V%L8W5L871E9"!B>2!T:&4-"B`-"B`@("`@($)L
M86-K+5-C:&]L97,@;W!T:6]N('!R:6-I;F<@;6]D96PN)B,Q-C`[)B,Q-C`[
M5V4@<F5C;V=N:7IE#0H@("`@#0H@("`@("!S=&]C:RUB87-E9"!C;VUP96YS
M871I;VX@8V]S="!A<R!E>'!E;G-E(')A=&%B;'D@;VX@80T*("`@("`-"B`@
M("`@('-T<F%I9VAT+6QI;F4@8F%S:7,@;W9E<B!T:&4@<F5Q=6ES:71E('-E
M<G9I8V4@<&5R:6]D(&9O<B!T:&4-"B`@(`T*("`@("`@87=A<F0N)B,Q-C`[
M)B,Q-C`[4V5E($YO=&4@-B!F;W(@861D:71I;VYA;"!S=&]C:RUB87-E9`T*
M("`@("`-"B`@("`@(&-O;7!E;G-A=&EO;B!I;F9O<FUA=&EO;BX\+V9O;G0^
M#0H@("`@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T9/3E0M
M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E8V5N=`T*(`T*
M("`@("`@06-C;W5N=&EN9R!0<F]N;W5N8V5M96YT<SPO9F]N=#X-"B`@("`@
M#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/E1H97)E#0H@("`@(`T*("`@("`@:&%V92!B965N(&YO(')E8V5N
M="!A8V-O=6YT:6YG('!R;VYO=6YC96UE;G1S(&]R(&-H86YG97,@:6X-"B`-
M"B`@("`@(&%C8V]U;G1I;F<@<')O;F]U;F-E;65N=',@=VAI8V@@=V4@97AP
M96-T('1O(&AA=F4@82!M871E<FEA;`T*("`-"B`@("`@(&EM<&%C="!O;B!O
M=7(@9FEN86YC:6%L('-T871E;65N=',L(&YO<B!D;R!W92!B96QI979E('1H
M870-"B`@("`@#0H@("`@("!A;GD@<F5C96YT;'D@:7-S=65D+"!B=70@;F]T
M('EE="!E9F9E8W1I=F4L(&%C8V]U;G1I;F<-"B`-"B`@("`@('-T86YD87)D
M<R!I9B!C=7)R96YT;'D@861O<'1E9"!W;W5L9"!H879E(&$@;6%T97)I86P@
M969F96-T#0H@#0H@("`@("!O;B!O=7(@9FEN86YC:6%L('-T871E;65N=',N
M/"]F;VYT/@T*("`@#0H@("`@/"]D:78^/&)R+SX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S(T860T-F$V7S@Y,C)?-#5C.%]B
M.#@S7V%B-F0P9F,Y8S<W-0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\R-&%D-#9A-E\X.3(R7S0U8SA?8C@X,U]A8C9D,&9C.6,W-S4O5V]R:W-H
M965T<R]3:&5E=#`Y+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^3F]T92`S("T@1V]V97)N;65N="!'<F%N=',\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=O=F5R;FUE;G0@1W)A
M;G1S(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(
M5#H@8F]L9"<^,RXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M';W9E<FYM96YT#0H@
M#0H@("`@("!'<F%N=',\+V9O;G0^#0H@#0H@("`@/"]D:78^/&)R+SX\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O
M;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P="<^3DE(#0H@("`-"B`@("`@($=R86YT<SPO9F]N=#X-"B`-"B`@("`\
M+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@
M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^
M26X-"B`@#0H@("`@("!397!T96UB97(@,C`P-RP@=&AE($Y)2"!A=V%R9&5D
M('5S(&%N($EN=&5G<F%T960-"B`@("`@#0H@("`@("!0<F5C;&EN:6-A;"]#
M;&EN:6-A;"!!2413(%9A8V-I;F4@1&5V96QO<&UE;G0@*$E00T%61"D@9W)A
M;G0-"B`@#0H@("`@("!T;R!S=7!P;W)T(&]U<B!(258O04E$4R!V86-C:6YE
M('!R;V=R86TN)B,Q-C`[)B,Q-C`[5V4@87)E#0H@("`-"B`@("`@('5T:6QI
M>FEN9R!T:&ES(&9U;F1I;F<@=&\@9G5R=&AE<B!O=7(@2$E6+T%)1%,@=F%C
M8VEN90T*(`T*("`@("`@9&5V96QO<&UE;G0L(&]P=&EM:7IA=&EO;B!A;F0@
M<')O9'5C=&EO;BXF(S$V,#LF(S$V,#M4:&4-"B`-"B`@("`@(&]R:6=I;F%L
M('!R;VIE8W0@<&5R:6]D(&9O<B!T:&4@9W)A;G0@8V]V97)E9"!A(&9I=F4@
M>65A<@T*("`@(`T*("`@("`@<&5R:6]D(&5N9&EN9R!I;B!!=6=U<W0@,C`Q
M,BP@8G5T('=A<R!E>'1E;F1E9"!F;W(@86X-"B`@("`@#0H@("`@("!A9&1I
M=&EO;F%L(&]N92!Y96%R('!E<FEO9"XF(S$V,#LF(S$V,#M4:&4@86=G<F5G
M871E(&%W87)D#0H@("`-"B`@("`@('1O=&%L960@)#(P+C0@;6EL;&EO;BP@
M=VET:"!A<'!R;WAI;6%T96QY("0Q+C8@;6EL;&EO;@T*(`T*("`@("`@<F5M
M86EN:6YG(&%N9"!A=F%I;&%B;&4@9F]R('5S92!A<R!O9B!$96-E;6)E<B`S
M,2P-"B`@#0H@("`@("`R,#$R+CPO9F]N=#X-"B`@("`@#0H@("`@/"]D:78^
M/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEN#0H@
M(`T*("`@("`@4V5P=&5M8F5R(#(P,3(L('1H92!.24@@87=A<F1E9"!U<R!A
M;B!A9&1I=&EO;F%L(&=R86YT(&]F#0H@("`@#0H@("`@("`D,2XY(&UI;&QI
M;VX@=&\@<W5P<&]R="!D979E;&]P;65N="!O9B!V97)S:6]N<R!O9B!O=7(-
M"B`-"B`@("`@($A)5B]!2413('9A8V-I;F5S('1O(&%D9')E<W,@=&AE(&-L
M861E($,@<W5B='EP92!O9B!T:&4@2$E6#0H@#0H@("`@("!V:7)U<R!P<F5V
M86QE;G0@:6X@=&AE(&1E=F5L;W!I;F<@=V]R;&0N)B,Q-C`[)B,Q-C`[5&AE
M#0H@("`@(`T*("`@("`@<')O:F5C="!P97)I;V0@;V8@=&AI<R!G<F%N="!C
M;W9E<G,@82!O;F4@>65A<B!P97)I;V0@96YD:6YG#0H@(`T*("`@("`@:6X@
M075G=7-T(#(P,3,N)B,Q-C`[)B,Q-C`[5&AE<F4@:7,@87!P<F]X:6UA=&5L
M>2`D,2XT#0H@("`@#0H@("`@("!M:6QL:6]N(&9R;VT@=&AI<R!G<F%N="!R
M96UA:6YI;F<@86YD(&%V86EL86)L92!F;W(@=7-E(&%S(&]F#0H@("`-"B`@
M("`@($1E8V5M8F5R(#,Q+"`R,#$R+CPO9F]N=#X-"B`@(`T*("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY790T*
M("`-"B`@("`@(')E8V]R9"!R979E;G5E(&%S<V]C:6%T960@=VET:"!T:&5S
M92!G<F%N=',@87,@=&AE(')E;&%T960-"B`@("`@#0H@("`@("!C;W-T<R!A
M;F0@97AP96YS97,@87)E(&EN8W5R<F5D(&%N9"!S=6-H(')E=F5N=64@:7,@
M<F5P;W)T960-"B`@#0H@("`@("!A<R!A('-E<&%R871E(&QI;F4@:71E;2!I
M;B!O=7(@<W1A=&5M96YT<R!O9@T*(`T*("`@("`@;W!E<F%T:6]N<RXF(S$V
M,#LF(S$V,#M$=7)I;F<@,C`Q,BP@,C`Q,2P@86YD(#(P,3`L('=E#0H@("`@
M#0H@("`@("!R96-O<F1E9"`D,BPV-3<L,S(W+"`D-"PX.3DL.#@U+"!A;F0@
M)#0L.30P+#<W."P-"B`@("`@#0H@("`@("!R97-P96-T:79E;'DL(&]F(')E
M=F5N=64@87-S;V-I871E9"!W:71H('1H97-E(&=R86YT<RX\+V9O;G0^#0H@
M("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,
M13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^451$4`T*("`@(`T*("`@
M("`@1W)A;G0\+V9O;G0^#0H@("`@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);@T*("`-"B`@("`@($YO
M=F5M8F5R(#(P,3`L('=E('=E<F4@87=A<F1E9"!A(&]N92UT:6UE(&=R86YT
M(&]F("0R-#0L-#<Y#0H@#0H@("`@("!P=7)S=6%N="!T;R!T:&4@475A;&EF
M>6EN9R!4:&5R87!E=71I8R!$:7-C;W9E<GD@4')O:F5C=`T*("`@#0H@("`@
M("`H451$4"D@<')O9W)A;2!E;F%C=&5D(&%S('!A<G0@;V8@=&AE(%!A=&EE
M;G0@4')O=&5C=&EO;B!A;F0-"B`@#0H@("`@("!!9F9O<F1A8FQE($-A<F4@
M06-T(&]F(#(P,3`N)B,Q-C`[)B,Q-C`[5&AE(%%41%`@<')O9W)A;2!W87,-
M"B`@("`@#0H@("`@("!I;G1E;F1E9"!T;R!P<F]V:61E(&EN8V5N=&EV92!T
M;R!S;6%L;&5R(&-O;7!A;FEE<R!W:&\@87)E#0H@("`@(`T*("`@("`@9F]C
M=7-I;F<@;VX@:6YN;W9A=&EV92!T:&5R87!E=71I8R!D:7-C;W9E<FEE<RXF
M(S$V,#LF(S$V,#M790T*(`T*("`@("`@<F5C96EV960@=&AE(&9U;&P@86UO
M=6YT(&]F('1H92!G<F%N="!D=7)I;F<@,C`Q,"P@=VAI8V@@:7,-"B`-"B`@
M("`@(')E8V]R9&5D(&%S(')E=F5N=64@9F]R(#(P,3`@:6X@=&AE(&%C8V]M
M<&%N>6EN9R!#;VYS;VQI9&%T960-"B`@(`T*("`@("`@4W1A=&5M96YT(&]F
M($]P97)A=&EO;G,N/"]F;VYT/@T*("`@(`T*("`@(#PO9&EV/CQB<B\^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-"`M($-O;6UI=&UE;G1S/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM:71M
M96YT<R!$:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^-"XF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#M#;VUM:71M96YT<SPO9F]N=#X-"B`@("`@#0H@("`@/"]D:78^/&)R+SX\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P="<^3&5A<V4-"B`@("`@#0H@("`@("!!9W)E96UE;G1S/"]F;VYT
M/@T*("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/
M3E0M4TE:13H@,3!P="<^5V4-"B`@#0H@("`@("!L96%S92!A<'!R;WAI;6%T
M96QY(#@L-#`P('-Q=6%R92!F965T(&]F(&]F9FEC92!A;F0-"B`@(`T*("`@
M("`@;&%B;W)A=&]R>2!S<&%C92!L;V-A=&5D(&EN(%-M>7)N82P@1V5O<F=I
M82`H;65T<F]P;VQI=&%N#0H@("`@#0H@("`@("!!=&QA;G1A*2X@4F5N="!E
M>'!E;G-E(&9O<B!T:&4@>65A<G,@96YD960@1&5C96UB97(@,S$L(#(P,3(L
M#0H@("`-"B`@("`@(#(P,3$@86YD(#(P,3`@=V%S("0Q,3@L.#`Q+"`D,3$Y
M+#(U-2P@86YD("0Q,3@L.3@X+`T*("`@#0H@("`@("!R97-P96-T:79E;'DN
M)B,Q-C`[)B,Q-C`[1G5T=7)E(&UI;FEM=6T@;&5A<V4@<&%Y;65N=',-"B`@
M("`-"B`@("`@('!U<G-U86YT('1O('1H92`V,B!M;VYT:"!L96%S92!T;W1A
M;"`D,3(U+#$X,"!I;B`R,#$S(&%N9`T*("`@(`T*("`@("`@)#$R."PY,C`@
M:6X@,C`Q-"X\+V9O;G0^#0H@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/D]T:&5R#0H@("`@(`T*("`@("`@0V]M;6ET;65N=',\+V9O;G0^#0H@#0H@
M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/DEN#0H@(`T*("`@("`@=&AE(&YO<FUA;"!C;W5R<V4@;V8@8G5S:6YE
M<W,L('=E(&UA>2!E;G1E<B!I;G1O('9A<FEO=7,@9FER;0T*("`@#0H@("`@
M("!P=7)C:&%S92!C;VUM:71M96YT<R!R96QA=&5D('1O('!R;V1U8W1I;VX@
M86YD('1E<W1I;F<@;V8@;W5R#0H@("`-"B`@("`@('9A8V-I;F4@;6%T97)I
M86PL(&-O;F1U8W0@;V8@8VQI;FEC86P@=')I86QS+"!A;F0@;W1H97(-"B`@
M#0H@("`@("!R97-E87)C:"UR96QA=&5D(&%C=&EV:71I97,N($%S(&]F($1E
M8V5M8F5R(#,Q+"`R,#$R+"!W92!H860-"B`@#0H@("`@("!A<'!R;WAI;6%T
M96QY("0U,3`L,#`P(&]F('5N<F5C;W)D960@;W5T<W1A;F1I;F<@<'5R8VAA
M<V4-"B`@("`-"B`@("`@(&-O;6UI=&UE;G1S('1O(&]U<B!V96YD;W)S(&%N
M9"!S=6)C;VYT<F%C=&]R<RP@86QL(&]F('=H:6-H#0H@#0H@("`@("!W92!E
M>'!E8W0@=VEL;"!B92!D=64@:6X@,C`Q,RX\+V9O;G0^#0H@("`@(`T*("`@
M(#PO9&EV/CQB<B\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-2`M
M(#(P,#8@365R9V5R(&%N9"!296-A<&ET86QI>F%T:6]N/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-97)G97)S+"!!8W%U:7-I
M=&EO;G,@86YD($1I<W!O<VET:6]N<R!$:7-C;&]S=7)E<R!;5&5X="!";&]C
M:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`-"B`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^-2XF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LR,#`V#0H@("`@(`T*("`@("`@365R9V5R
M(&%N9"!296-A<&ET86QI>F%T:6]N/"]F;VYT/@T*("`-"B`@("`\+V1I=CX\
M8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^5&AE#0H@
M("`-"B`@("`@($-O;7!A;GD@=V%S(&]R:6=I;F%L;'D@:6YC;W)P;W)A=&5D
M(&EN($IU;F4@,3DX."!U;F1E<B!T:&4-"B`@("`@#0H@("`@("!L87=S(&]F
M($EL;&EN;VES(&%S($1A=7!H:6X@5&5C:&YO;&]G>2P@26YC+@T*(`T*("`@
M("`@*"8C.#(R,#M$875P:&EN)B,X,C(Q.RDN)B,Q-C`[)B,Q-C`[1&%U<&AI
M;B!W87,@=6YS=6-C97-S9G5L#0H@("`-"B`@("`@(&%N9"!I=',@;W!E<F%T
M:6]N<R!W97)E('1E<FUI;F%T960@:6X@1&5C96UB97(-"B`@(`T*("`@("`@
M,C`P,RXF(S$V,#LF(S$V,#M);B!397!T96UB97(@,C`P-BP@1&%U<&AI;B!C
M;VUP;&5T960@80T*("`@("`-"B`@("`@(&UE<F=E<B`H=&AE("8C.#(R,#M-
M97)G97(F(S@R,C$[*2!W:71H($=E;U9A>"P@26YC+B!W:&EC:"!W87,-"B`-
M"B`@("`@(&EN8V]R<&]R871E9"!U;F1E<B!T:&4@;&%W<R!O9B!'96]R9VEA
M(&EN($IU;F4-"B`@(`T*("`@("`@,C`P,2XF(S$V,#LF(S$V,#M!<R!A(')E
M<W5L="!O9B!T:&4@365R9V5R+"!T:&4@<VAA<F5H;VQD97)S#0H@("`@(`T*
M("`@("`@;V8@1V5O5F%X+"!);F,N(&5X8VAA;F=E9"!T:&5I<B!S:&%R97,@
M;V8@8V]M;6]N('-T;V-K(&9O<@T*("`@("`-"B`@("`@($1A=7!H:6X@8V]M
M;6]N('-T;V-K(&%N9"!'96]687@L($EN8RX@8F5C86UE(&$@=VAO;&QY+6]W
M;F5D#0H@#0H@("`@("!S=6)S:61I87)Y(&]F($1A=7!H:6XN)B,Q-C`[)B,Q
M-C`[1&%U<&AI;B!T:&5N(&-H86YG960@:71S#0H@("`-"B`@("`@(&YA;64@
M=&\@1V5O5F%X($QA8G,L($EN8RX@86YD(')E<&QA8V5D(&ET<R!O9F9I8V5R
M<R!A;F0-"B`@#0H@("`@("!D:7)E8W1O<G,@=VET:"!T:&]S92!O9B!'96]6
M87@L($EN8RXF(S$V,#LF(S$V,#M3=6)S97%U96YT('1O#0H@#0H@("`@("!T
M:&4@365R9V5R+"!T:&4@0V]M<&%N>2!H87,@;F]T(&-O;F1U8W1E9"!A;GD@
M8G5S:6YE<W,@;W1H97(-"B`@#0H@("`@("!T:&%N($=E;U9A>"P@26YC+B8C
M.#(Q-SMS(&)U<VEN97-S(&]F(&1E=F5L;W!I;F<@:'5M86X-"B`@("`@#0H@
M("`@("!V86-C:6YE<RXF(S$V,#LF(S$V,#M4:&4@365R9V5R('=A<R!A8V-O
M=6YT960@9F]R('5N9&5R('1H90T*("`@(`T*("`@("`@<'5R8VAA<V4@;65T
M:&]D(&]F(&%C8V]U;G1I;F<@87,@82!R979E<G-E(&%C<75I<VET:6]N(&EN
M#0H@("`@#0H@("`@("!A8V-O<F1A;F-E('=I=&@@1T%!4"X@56YD97(@=&AI
M<R!M971H;V0@;V8@86-C;W5N=&EN9RP-"B`-"B`@("`@($1A=7!H:6X@=V%S
M('1R96%T960@87,@=&AE(&%C<75I<F5D(&-O;7!A;GD@86YD+"!A8V-O<F1I
M;F=L>2P-"B`@(`T*("`@("`@86QL(&9I;F%N8VEA;"!I;F9O<FUA=&EO;B!P
M<FEO<B!T;R!T:&4@9&%T92!O9B!-97)G97(-"B`@("`@#0H@("`@("!P<F5S
M96YT960@:6X@=&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960@9FEN86YC
M:6%L#0H@("`@#0H@("`@("!S=&%T96UE;G1S+"!O<B!I;B!T:&4@;F]T97,@
M:&5R96EN+"!A<R!W96QL(&%S(&%N>2!R969E<F5N8V5S#0H@("`-"B`@("`@
M('1O('!R:6]R(&]P97)A=&EO;G,L(&%R92!T:&]S92!O9B!'96]687@L($EN
M8RXF(S$V,#LF(S$V,#M);@T*("`@("`-"B`@("`@($IU;F4@,C`P."P@=&AE
M($-O;7!A;GD@=V%S(')E:6YC;W)P;W)A=&5D('5N9&5R('1H92!L87=S(&]F
M#0H@#0H@("`@("!$96QA=V%R92X\+V9O;G0^#0H@("`@#0H@("`@/"]D:78^
M/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
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M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`V("T@4W1O8VMH
M;VQD97)S)R!%<75I='D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-T;V-K:&]L9&5R<R<@17%U:71Y($YO=&4@1&ES8VQO<W5R
M92!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@(`T*("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD)SXV+B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.U-T;V-K:&]L9&5R
M<R8C.#(Q-SL-"B`@("`-"B`@("`@($5Q=6ET>3PO9F]N=#X-"B`-"B`@("`\
M+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@
M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY397)I97,-"B`-"B`@("`@($$@0V]N=F5R
M=&EB;&4@4')E9F5R<F5D(%-T;V-K/"]F;VYT/@T*("`@(`T*("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=7(-
M"B`@(`T*("`@("`@0V5R=&EF:6-A=&4@;V8@26YC;W)P;W)A=&EO;B!A=71H
M;W)I>F5S('5S('1O(&ES<W5E('5P('1O#0H@("`@#0H@("`@("`Q,"PP,#`L
M,#`P('-H87)E<R!O9B!P<F5F97)R960@<W1O8VLL("0N,#$@<&%R#0H@("`-
M"B`@("`@('9A;'5E+B8C,38P.R8C,38P.TEN($UA<F-H(#(P,3(L('=E(&5S
M=&%B;&ES:&5D(&9R;VT@=&AE#0H@#0H@("`@("!A=71H;W)I>F5D('!R969E
M<G)E9"!S=&]C:R!A('-E<FEE<R!O9B!P<F5F97)R960@<W1O8VLL#0H@(`T*
M("`@("`@8V]N<VES=&EN9R!O9B`R+#(P,"!S:&%R97,@;V8@4V5R:65S($$@
M0V]N=F5R=&EB;&4@4')E9F5R<F5D#0H@(`T*("`@("`@4W1O8VLL("0Q+#`P
M,"!S=&%T960@=F%L=64@*"8C.#(R,#M397)I97,@02!0<F5F97)R960-"B`@
M("`-"B`@("`@(%-H87)E<R8C.#(R,3LI(&%N9"!E;G1E<F5D(&EN=&\@82!3
M96-U<FET:65S(%!U<F-H87-E#0H@("`@#0H@("`@("!!9W)E96UE;G0@*"8C
M.#(R,#M34$$F(S@R,C$[*2!W:&5R96)Y('=E(&ES<W5E9"!T;R!T:')E90T*
M(`T*("`@("`@:6YS=&ET=71I;VYA;"!I;G9E<W1O<G,@*"8C.#(R,#M0=7)C
M:&%S97)S)B,X,C(Q.RD@=&AE(%-E<FEE<PT*(`T*("`@("`@02!0<F5F97)R
M960@4VAA<F5S(&9O<B!G<F]S<R!P<F]C965D<R!O9B`D,BXR#0H@(`T*("`@
M("`@;6EL;&EO;BXF(S$V,#LF(S$V,#M.970@<')O8V5E9',@=&\@=&AE($-O
M;7!A;GD@9G)O;2!T:&ES#0H@(`T*("`@("`@=')A;G-A8W1I;VXL(&%F=&5R
M(&1E9'5C=&EO;B!O9B!P;&%C96UE;G0@86=E;G0@9F5E<R!A;F0-"B`@(`T*
M("`@("`@;W1H97(@97AP96YS97,L('=E<F4@87!P<F]X:6UA=&5L>2`D,BXP
M(&UI;&QI;VXN/"]F;VYT/@T*("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E1H90T*("`@#0H@("`@("!3
M97)I97,@02!0<F5F97)R960@4VAA<F5S(&UA>2!B92!C;VYV97)T960@870@
M86YY('1I;64@870@=&AE#0H@("`-"B`@("`@(&]P=&EO;B!O9B!T:&4@4'5R
M8VAA<V5R<R!I;G1O('-H87)E<R!O9B!O=7(@8V]M;6]N('-T;V-K(&%T(&$-
M"B`@(`T*("`@("`@8V]N=F5R<VEO;B!P<FEC92!O9B`D,"XW-2!P97(@<VAA
M<F4@*"8C.#(R,#M#;VYV97)S:6]N#0H@("`@(`T*("`@("`@4')I8V4F(S@R
M,C$[*2P@9F]R(&%N(&EN:71I86P@86=G<F5G871E('1O=&%L(&]F(#(L.3,S
M+#,S,PT*("`@(`T*("`@("`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@
M*"8C.#(R,#M#;VYV97)S:6]N#0H@#0H@("`@("!3:&%R97,F(S@R,C$[*2XF
M(S$V,#LF(S$V,#M4:&4@4V5R:65S($$@4')E9F5R<F5D(%-H87)E<R!H879E
M#0H@("`@(`T*("`@("`@82!L:7%U:61A=&EO;B!P<F5F97)E;F-E(&5Q=6%L
M('1O('1H92!I;FET:6%L('!U<F-H87-E('!R:6-E+`T*("`@#0H@("`@("!H
M879E(&YO('9O=&EN9R!R:6=H=',L(&%N9"!A<F4@;F]T(&5N=&ET;&5D('1O
M(&$-"B`@("`@#0H@("`@("!D:79I9&5N9"XF(S$V,#LF(S$V,#M4:')O=6=H
M($1E8V5M8F5R(#,Q+"`R,#$R+"!A('1O=&%L(&]F#0H@("`-"B`@("`@(#$L
M-#$R(%-E<FEE<R!!(%!R969E<G)E9"!3:&%R97,@:&%V92!B965N(&-O;G9E
M<G1E9"!I;G1O#0H@("`-"B`@("`@(#$L.#@R+#8V-R!S:&%R97,@;V8@;W5R
M(&-O;6UO;B!S=&]C:RXF(S$V,#LF(S$V,#M!<R!O9@T*("`@(`T*("`@("`@
M1&5C96UB97(@,S$L(#(P,3(L('1H97)E('=E<F4@-S@X('-H87)E<R!O9B!3
M97)I97,@00T*("`@(`T*("`@("`@4')E9F5R<F5D(%-H87)E<R!O=71S=&%N
M9&EN9RP@8V]N=F5R=&EB;&4@:6YT;R`Q+#`U,"PV-C<-"B`@(`T*("`@("`@
M<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VLN/"]F;VYT/@T*("`-"B`@("`\
M+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@
M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^
M4'5R<W5A;G0-"B`@(`T*("`@("`@=&\@=&AE('1E<FUS(&]F('1H92!34$$L
M('=E(&ES<W5E9"!T;R!E86-H(%!U<F-H87-E<B!397)I97,-"B`-"B`@("`@
M($$L($(@86YD($,@5V%R<F%N=',@*&-O;&QE8W1I=F5L>2P@=&AE#0H@("`@
M(`T*("`@("`@)B,X,C(P.U=A<G)A;G1S)B,X,C(Q.RDL(&5A8V@@=&\@<'5R
M8VAA<V4@=7`@=&\@82!N=6UB97(@;V8-"B`@("`-"B`@("`@('-H87)E<R!O
M9B!O=7(@8V]M;6]N('-T;V-K(&5Q=6%L('1O(#$P,"4@;V8@=&AE($-O;G9E
M<G-I;VX-"B`@("`@#0H@("`@("!3:&%R97,@=6YD97)L>6EN9R!T:&4@4V5R
M:65S($$@4')E9F5R<F5D(%-H87)E<R`H=7`@=&\-"B`-"B`@("`@(#(L.3,S
M+#,S,R!S:&%R97,@:6X@=&AE(&%G9W)E9V%T92!F;W(@96%C:"!O9B!T:&4@
M=&AR964-"B`@#0H@("`@("!S97)I97,@;V8@=V%R<F%N=',L(&]R(#@L-SDY
M+#DY.2!S:&%R97,@:6X@=&]T86PI#0H@#0H@("`@("`H)B,X,C(P.U=A<G)A
M;G0@4VAA<F5S)B,X,C(Q.RDN)B,Q-C`[)B,Q-C`[5&AE(%-E<FEE<R!!#0H@
M("`-"B`@("`@(%=A<G)A;G1S(&AA=F4@86X@97AE<F-I<V4@<')I8V4@;V8@
M)#$N,#`@<&5R('-H87)E+"!A<F4-"B`@#0H@("`@("!E>&5R8VES86)L92!I
M;6UE9&EA=&5L>2P@86YD(&5X<&ER92!O;B!-87)C:"`R,2P-"B`@("`@#0H@
M("`@("`R,#$W+B8C,38P.R8C,38P.U1H92!397)I97,@0B!787)R86YT<R!H
M879E(&%N(&5X97)C:7-E('!R:6-E#0H@#0H@("`@("!O9B`D,"XW-2!P97(@
M<VAA<F4L(&%R92!E>&5R8VES86)L92!I;6UE9&EA=&5L>2P@86YD(&5X<&ER
M90T*(`T*("`@("`@;VX@36%R8V@@,C$L(#(P,3,N(%1H92!397)I97,@0R!7
M87)R86YT<R!H879E(&%N(&5X97)C:7-E#0H@("`@#0H@("`@("!P<FEC92!O
M9B`D,2XP,"!P97(@<VAA<F4@86YD(&5X<&ER92!O;B!-87)C:"`R,2P@,C`Q
M-RP@8G5T#0H@("`@(`T*("`@("`@;VYL>2!V97-T(&%N9"!B96-O;64@97AE
M<F-I<V%B;&4@=7!O;BP@86YD(&EN('!R;W!O<G1I;VX@=&\L#0H@(`T*("`@
M("`@=&AE(&5X97)C:7-E(&]F('1H92!O;F4M>65A<B!397)I97,@0@T*("`@
M(`T*("`@("`@5V%R<F%N=',N)B,Q-C`[)B,Q-C`[5&AE(%=A<G)A;G1S(&-O
M;G1A:6X@86YT:2UD:6QU=&EO;@T*("`@("`-"B`@("`@('!R;W9I<VEO;G,L
M('=H:6-H(&UA>2P@=6YD97(@8V5R=&%I;B!C:7)C=6US=&%N8V5S+"!R961U
M8V4-"B`@("`@#0H@("`@("!T:&4@97AE<F-I<V4@<')I8V4@*&)U="!H879E
M(&YO(&5F9F5C="!O;B!T:&4@;G5M8F5R(&]F#0H@(`T*("`@("`@<VAA<F5S
M('-U8FIE8W0@=&\@=&AE(%=A<G)A;G1S*2!I9B!W92!S96QL(&]R(&=R86YT
M(&]P=&EO;G,-"B`-"B`@("`@('1O('!U<F-H87-E+"!I;F-L=61I;F<@<FEG
M:'1S('1O(')E<')I8V4L(&]U<B!C;VUM;VX@<W1O8VL@;W(-"B`@(`T*("`@
M("`@8V]M;6]N('-T;V-K(&5Q=6EV86QE;G1S(&%T(&$@<')I8V4@;&]W97(@
M=&AA;B!T:&4@97AE<F-I<V4-"B`-"B`@("`@('!R:6-E(&]F('1H92!787)R
M86YT<RP@;W(@:68@=V4@86YN;W5N8V4@<&QA;G,@=&\@9&\-"B`@("`-"B`@
M("`@('-O+CPO9F]N=#X-"B`@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);@T*("`-"B`@("`@(&-O;FYE
M8W1I;VX@=VET:"!T:&4@<V%L92!O9B!T:&4@4V5R:65S($$@4')E9F5R<F5D
M(%-H87)E<RP@=V4-"B`@(`T*("`@("`@96YT97)E9"!I;G1O(&$@4F5G:7-T
M<F%T:6]N(%)I9VAT<R!!9W)E96UE;G0-"B`-"B`@("`@("@F(S@R,C`[4E)!
M)B,X,C(Q.RD@=VET:"!T:&4@4'5R8VAA<V5R<RP@<'5R<W5A;G0@=&\@=VAI
M8V@@=V4-"B`-"B`@("`@(&9I;&5D(&$@<F5G:7-T<F%T:6]N('-T871E;65N
M="!W:71H('1H92!396-U<FET:65S(&%N9`T*(`T*("`@("`@17AC:&%N9V4@
M0V]M;6ES<VEO;B`H)B,X,C(P.U-%0R8C.#(R,3LI(&]N($%P<FEL(#,L(#(P
M,3(-"B`-"B`@("`@(&-O=F5R:6YG(')E<V%L92!O9B!T:&4@0V]N=F5R<VEO
M;B!3:&%R97,@86YD('1H92!787)R86YT#0H@("`-"B`@("`@(%-H87)E<RXF
M(S$V,#LF(S$V,#LF(S$V,#M)="!W87,@9&5C;&%R960@969F96-T:79E(&)Y
M('1H92!314,-"B`@("`@#0H@("`@("!O;B!!<')I;"`Q,RP@,C`Q,CPO9F]N
M=#X-"B`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI
M8SL@1$E34$Q!63H@:6YL:6YE)SY!8V-O=6YT:6YG#0H@#0H@("`@("!4<F5A
M=&UE;G0@86YD($%L;&]C871I;VX@;V8@4')O8V5E9',\+V9O;G0^+B8C,38P
M.R8C,38P.U=E#0H@("`@#0H@("`@("!F:7)S="!A<W-E<W-E9"!T:&4@4V5R
M:65S($$@4')E9F5R<F5D(%-H87)E<R!U;F1E<B!!4T,@5&]P:6,-"B`@#0H@
M("`@("`T.#`L("8C.#(R,#L\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I
M=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^1&ES=&EN9W5I<VAI;F<-"B`@(`T*
M("`@("`@3&EA8FEL:71I97,@9G)O;2!%<75I='D\+V9O;G0^)B,X,C(Q.R`H
M)B,X,C(P.T%30R`T.#`F(S@R,C$[*0T*(`T*("`@("`@86YD(&1E=&5R;6EN
M960@<W5C:"!P<F5F97)R960@<W1O8VL@;F]T('1O(&)E(&$@;&EA8FEL:71Y
M#0H@("`@#0H@("`@("!U;F1E<B!!4T,@-#@P+B8C,38P.R8C,38P.U=E(&YE
M>'0@87-S97-S960@=&AE('!R969E<G)E9`T*(`T*("`@("`@<W1O8VL@=6YD
M97(@05-#(%1O<&EC(#@Q-2X@)B,X,C(P.SQF;VYT('-T>6QE/3-$)T9/3E0M
M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY$97)I=F%T:79E<R!A
M;F0-"B`-"B`@("`@($AE9&=I;F<\+V9O;G0^)B,X,C(Q.R`H)B,X,C(P.T%3
M0R`X,34F(S@R,C$[*2XF(S$V,#LF(S$V,#M4:&4-"B`@("`-"B`@("`@('!R
M969E<G)E9"!S=&]C:R!C;VYT86EN<R!A;B!E;6)E9&1E9"!F96%T=7)E(&%L
M;&]W:6YG(&%N#0H@("`-"B`@("`@(&]P=&EO;F%L(&-O;G9E<G-I;VX@8GD@
M=&AE(&AO;&1E<B!I;G1O(&-O;6UO;B!S=&]C:R!W:&EC:`T*("`@(`T*("`@
M("`@;65E=',@=&AE(&1E9FEN:71I;VX@;V8@82!D97)I=F%T:79E+B8C,38P
M.R8C,38P.TAO=V5V97(L('=E#0H@("`@(`T*("`@("`@8F5L:65V92!T:&%T
M('1H92!P<F5F97)R960@<W1O8VL@:7,@86X@)B,X,C(P.V5Q=6ET>0T*("`@
M#0H@("`@("!H;W-T)B,X,C(Q.R`H87,@9&5S8W)I8F5D(&)Y($%30R`X,34I
M(&9O<B!P=7)P;W-E<R!O9@T*("`@(`T*("`@("`@87-S97-S:6YG('1H92!E
M;6)E9&1E9"!D97)I=F%T:79E(&9O<B!P;W1E;G1I86P@8FEF=7)C871I;VX-
M"B`-"B`@("`@(&%N9"!D971E<FUI;F5D('1H870@=&AE(&]P=&EO;F%L(&-O
M;G9E<G-I;VX@9F5A='5R92!I<PT*(`T*("`@("`@8VQE87)L>2!A;F0@8VQO
M<V5L>2!A<W-O8VEA=&5D('1O('1H92!P<F5F97)R960@<W1O8VL@:&]S=#L-
M"B`-"B`@("`@('=E('1H97)E9F]R92!D971E<FUI;F5D('1H870@=&AE(&5M
M8F5D9&5D(&1E<FEV871I=F4@9&]E<R!N;W0-"B`@(`T*("`@("`@<F5Q=6ER
M92!B:69U<F-A=&EO;B!A;F0@<V5P87)A=&4@<F5C;V=N:71I;VX@=6YD97(@
M05-##0H@#0H@("`@("`X,34N)B,Q-C`[)B,Q-C`[5V4@=&AE;B!A<W-E<W-E
M9"!T:&4@<')E9F5R<F5D('-T;V-K('5N9&5R#0H@("`-"B`@("`@($%30R!4
M;W!I8R`T-S`L("8C.#(R,#L\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I
M=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^1&5B=#PO9F]N=#XF(S@R,C$[#0H@
M(`T*("`@("`@*"8C.#(R,#M!4T,@-#<P)B,X,C(Q.RDL(&%N9"!D971E<FUI
M;F5D('1H97)E('1O(&)E(&$-"B`@(`T*("`@("`@8F5N969I8VEA;"!C;VYV
M97)S:6]N(&9E871U<F4@*"8C.#(R,#M"0T8F(S@R,C$[*2!R97%U:7)I;F<-
M"B`@("`-"B`@("`@(')E8V]G;FET:6]N(&%T(&ET<R!I;G1R:6YS:6,@=F%L
M=64N)B,Q-C`[)B,Q-C`[4VEN8V4@=&AE#0H@#0H@("`@("!C;VYV97)S:6]N
M(&]P=&EO;B!O9B!T:&4@<')E9F5R<F5D('-T;V-K('=A<R!I;6UE9&EA=&5L
M>0T*("`@#0H@("`@("!E>&5R8VES86)L92P@=&AE(&%M;W5N="!A;&QO8V%T
M960@=&\@=&AE($)#1B!W87,@:6UM961I871E;'D-"B`@#0H@("`@("!A8V-R
M971E9"!T;R!P<F5F97)R960@9&EV:61E;F1S+"!R97-U;'1I;F<@:6X@86X@
M:6YC<F5A<V4@:6X-"B`@#0H@("`@("!T:&4@8V%R<GEI;F<@=F%L=64@;V8@
M=&AE('!R969E<G)E9"!S=&]C:RXF(S$V,#LF(S$V,#M792!A;'-O#0H@#0H@
M("`@("!A<W-E<W-E9"!T:&4@=V%R<F%N=',@:7-S=65D(&EN(&-O;FYE8W1I
M;VX@=VET:"!T:&4@9FEN86YC:6YG#0H@("`-"B`@("`@('5N9&5R($%30R`X
M,34@86YD(&1E=&5R;6EN960@=&AA="!T:&5Y(&1I9"!N;W0@:6YI=&EA;&QY
M(&UE970-"B`@(`T*("`@("`@=&AE(&1E9FEN:71I;VX@;V8@82!D97)I=F%T
M:79E+"!B=70@=VEL;"!R97%U:7)E(&5V86QU871I;VX-"B`-"B`@("`@(&]N
M(&%N(&]N+6=O:6YG(&)A<VES+B8C,38P.R8C,38P.T%S(&]F($1E8V5M8F5R
M(#,Q+"`R,#$R+"!W90T*("`@("`-"B`@("`@(&1E=&5R;6EN960@=&AA="!T
M:&4@=V%R<F%N=',@<W1I;&P@9&ED(&YO="!M965T('1H90T*("`@#0H@("`@
M("!D969I;FET:6]N(&]F(&$@9&5R:79A=&EV92X\+V9O;G0^#0H@(`T*("`@
M(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-
M"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY4:&4-"B`@(`T*("`@("`@9F]L;&]W:6YG(&ES(&$@<W5M;6%R>2!O9B!T
M:&4@86QL;V-A=&EO;B!O9B!T:&4@;F5T('!R;V-E961S#0H@(`T*("`@("`@
M9G)O;2!T:&4@<')E9F5R<F5D('-T;V-K(&9I;F%N8VEN9RP@86YD(')E8V]N
M8VEL:6%T:6]N('1O('1H90T*("`@#0H@("`@("!C87)R>6EN9R!V86QU92!A
M="!$96-E;6)E<B`S,2P@,C`Q,CH\+V9O;G0^#0H@#0H@("`@/"]D:78^/&)R
M+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T
M:#TS1#DU)2!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;B<^#0H@#0H@("`@("`@("`@/'1R('-T>6QE
M/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@
M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.#4E/@T*("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)TQ)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N
M/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^3F5T#0H@("`-"B`@("`@("`@("`@("`@("!P
M<F]C965D<R!A9G1E<B!T<F%N<V%C=&EO;B!C;W-T<SPO9F]N=#X-"B`@#0H@
M("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^#0H@("`@(`T*("`@("`@("`@("`@("`F(S$V,#L-"B`@("`@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#DY.2PP,S(\+V9O
M;G0^/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`@("8C,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*(`T*
M("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0X-24^#0H@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,97-S.B8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.PT*("`@("`-"B`@("`@("`@("`@("`@("`F(S$V
M,#L\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1F%I<@T*("`@
M(`T*("`@("`@("`@("`@("`@('9A;'5E(&]F('=A<G)A;G1S("AR96-O<F1E
M9"!T;R!!9&1I=&EO;F%L(%!A:60M:6X-"B`-"B`@("`@("`@("`@("`@("!#
M87!I=&%L*3PO9F]N=#X\+V9O;G0^#0H@#0H@("`@("`@("`@("`@(#PO9&EV
M/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\
M=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*
M("`@#0H@("`@("`@("`@("`@("8C,38P.PT*("`@("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("`@("`F(S$V,#L-"B`@("`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^*#$L,3(W+#0Q.#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^*3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS
M1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@U
M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!0041$24Y'+4Q%1E0Z
M(#!P=#L@34%21TE.+4Q%1E0Z(#EP="<^#0H@("`@#0H@("`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@34%2
M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@#0H@("`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D)E;F5F
M:6-I86P-"B`@("`@#0H@("`@("`@("`@("`@("`@8V]N=F5R<VEO;B!F96%T
M=7)E("AR96-O<F1E9"!T;R!!9&1I=&EO;F%L(%!A:60M:6X-"B`@#0H@("`@
M("`@("`@("`@("`@0V%P:71A;"D\+V9O;G0^#0H@("`-"B`@("`@("`@("`@
M("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@(`T*("`@("`@("`@("`@("`F
M(S$V,#L-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<^#0H@(`T*("`@("`@("`@("`@("`F(S$V,#L-"B`@("`@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4G/B@W-C(L-C8W/"]F;VYT/CPO9F]N=#X\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@
M/'1R/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0X-24^#0H@("`@#0H@("`@("`@("`@("`@(#QD
M:78@<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970-"B`@(`T*
M("`@("`@("`@("`@("`@('!R;V-E961S(&%L;&]C871E9"!T;R!P<F5F97)R
M960@<W1O8VL\+V9O;G0^#0H@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@
M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@
M("`@)B,Q-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@
M("8C,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^,3`X+#DT-SPO9F]N=#X\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@
M)B,Q-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@
M("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@/'1D(&%L
M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X-24@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^06-C<F5T:6]N
M#0H@("`@#0H@("`@("`@("`@("`@("`@;V8@8F5N969I8VEA;"!C;VYV97)S
M:6]N(&9E871U<F4@*&1E96UE9`T*("`-"B`@("`@("`@("`@("`@("!D:79I
M9&5N9"D\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@("`-"B`@("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@
M("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-
M"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE)SXW-C(L-C8W/"]F;VYT/CPO9F]N=#X\+V9O;G0^#0H@("`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-
M"B`@("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^
M#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#@U)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEN:71I86P-"B`@#0H@
M("`@("`@("`@("`@("`@8V%R<GEI;F<@=F%L=64@;V8@<')E9F5R<F5D('-T
M;V-K/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`@(`T*("`@("`@("`@("`@("`F
M(S$V,#L-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@)B,Q
M-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXX-S$L-C$T/"]F;VYT/CPO9F]N=#X-"B`@("`-
M"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`F(S$V
M,#L-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M(#PO='(^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD
M+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@U)2!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;VYV97)S:6]N<PT*
M(`T*("`@("`@("`@("`@("`@('1O(&-O;6UO;B!S=&]C:SPO9F]N=#X-"B`@
M("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO
M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`-
M"B`@("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@)B,Q
M-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R
M:6=H="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE)SXH-34Y+#0Q
M.#PO9F]N=#X\+V9O;G0^/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-
M"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^
M#0H@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#4E('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`-"B`@("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D-A<G)Y:6YG#0H@
M("`-"B`@("`@("`@("`@("`@("!V86QU92!O9B!P<F5F97)R960@<W1O8VL@
M870@1&5C96UB97(@,S$L#0H@(`T*("`@("`@("`@("`@("`@(#(P,3(\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@
M("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<^
M#0H@("`-"B`@("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*("`@("`@("`@
M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N
M=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H
M="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,S$R+#$Y-CPO
M9F]N=#X\+V9O;G0^/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+W1D/@T*
M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@("8C
M,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@/"]T<CX-"B`@#0H@("`@("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/D-O;6UO;@T*(`T*("`@("`@4W1O8VL@5')A;G-A8W1I;VYS/"]F;VYT/@T*
M("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/DEN#0H@(`T*("`@("`@1F5B<G5A<GD@,C`Q,"P@=V4@:7-S
M=65D(#$R+#`P,"!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!I;@T*("`@
M#0H@("`@("!S971T;&5M96YT(&]F(&%N(&]B;&EG871I;VX@86-C<G5E9"!A
M="!$96-E;6)E<B`S,2P@,C`P.2!I;@T*(`T*("`@("`@=&AE(&%M;W5N="!O
M9B`D.3`L,#`P+CPO9F]N=#X-"B`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D1U<FEN9PT*(`T*("`@("`@
M1&5C96UB97(@,C`Q,2P@=V4@<V]L9"!A;B!A9V=R96=A=&4@;V8@-C4X+#4R
M,"!S:&%R97,@;V8@;W5R#0H@(`T*("`@("`@8V]M;6]N('-T;V-K('1O(&$@
M9W)O=7`@;V8@:6YD:79I9'5A;"!A8V-R961I=&5D(&EN=F5S=&]R<PT*("`@
M("`-"B`@("`@("AI;F-L=61I;F<@;65M8F5R<R!O9B!O=7(@8F]A<F0@;V8@
M9&ER96-T;W)S(&%N9"!M86YA9V5M96YT#0H@#0H@("`@("`M+7-E92!.;W1E
M(#DI(&9O<B!A;B!A9V=R96=A=&4@<'5R8VAA<V4@<')I8V4@;V8@)#0T,2PR
M,3`L#0H@("`@(`T*("`@("`@)#,V+#@P,"!O9B!W:&EC:"!W87,@<F5C96EV
M960@:6X@2F%N=6%R>2`R,#$R(&%N9"!I<PT*("`@(`T*("`@("`@=&AE<F5F
M;W)E(')E9FQE8W1E9"!A<R!A(')E8V5I=F%B;&4@*$]T:&5R($-U<G)E;G0@
M07-S970I(&EN#0H@(`T*("`@("`@=&AE(&%C8V]M<&%N>6EN9R!#;VYS;VQI
M9&%T960@0F%L86YC92!3:&5E="!A<R!O9B!$96-E;6)E<@T*("`@("`-"B`@
M("`@(#,Q+"`R,#$Q+B8C,38P.R8C,38P.U=E(&%L<V\@:7-S=65D('1O('1H
M92!I;G9E<W1O<G,@=V%R<F%N=',-"B`-"B`@("`@('1O('!U<F-H87-E(&%N
M(&%G9W)E9V%T92!O9B`Y.#<L-S@S('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@
M870-"B`@(`T*("`@("`@82!P<FEC92!O9B`D,2XP,"!P97(@<VAA<F4L('=H
M:6-H(&5X<&ER92!I;B!$96-E;6)E<@T*("`@(`T*("`@("`@,C`Q-BX\+V9O
M;G0^#0H@("`@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY$=7)I;F<-"B`-"B`@("`@($IA;G5A<GD@,C`Q
M,BP@=V4@<V]L9"!A;B!A9V=R96=A=&4@;V8@-#`W+#DY.2!S:&%R97,@;V8@
M;W5R#0H@#0H@("`@("!C;VUM;VX@<W1O8VL@=&\@82!G<F]U<"!O9B!I;F1I
M=FED=6%L(&%C8W)E9&ET960@:6YV97-T;W)S#0H@("`@(`T*("`@("`@*&EN
M8VQU9&EN9R!M96UB97)S(&]F(&]U<B!B;V%R9"!O9B!D:7)E8W1O<G,@86YD
M(&UA;F%G96UE;G0-"B`-"B`@("`@("TM<V5E($YO=&4@.2D@9F]R(&%N(&%G
M9W)E9V%T92!P=7)C:&%S92!P<FEC92!O9@T*("`@("`-"B`@("`@("0R-S,L
M,S8P+B8C,38P.R8C,38P.U=E(&%L<V\@:7-S=65D('1O('1H92!I;G9E<W1O
M<G,@=V%R<F%N=',-"B`-"B`@("`@('1O('!U<F-H87-E(&%N(&%G9W)E9V%T
M92!O9B`V,3(L,#`Q('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@870-"B`@(`T*
M("`@("`@82!P<FEC92!O9B`D,2XP,"!P97(@<VAA<F4L('=H:6-H(&5X<&ER
M92!I;B!*86YU87)Y#0H@("`-"B`@("`@(#(P,3<N/"]F;VYT/@T*("`@("`-
M"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P="<^1G)O;0T*("`@(`T*("`@("`@=&EM92!T;R!T:6UE+"!W92!I<W-U
M92!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!T;PT*("`@(`T*("`@("`@
M8V]N<W5L=&%N=',@;W(@;W1H97)S(&EN(&5X8VAA;F=E(&9O<@T*("`@(`T*
M("`@("`@<V5R=FEC97,N)B,Q-C`[)B,Q-C`[1'5R:6YG(#(P,3(L(#(P,3$@
M86YD(#(P,3`@=V4@:7-S=65D#0H@(`T*("`@("`@+3`M+"`Q,CDL,C0U+"!A
M;F0@,3`L-3`P('-H87)E<RP@<F5S<&5C=&EV96QY+"!F;W(@<W5C:`T*("`-
M"B`@("`@('-E<G9I8V5S.R!A;F0@=V4@<F5C;W)D960@9V5N97)A;"!A;F0@
M861M:6YI<W1R871I=F4@97AP96YS90T*("`-"B`@("`@(&]F("0M,"TL("0Q
M-3`L,#`P+"!A;F0@)#4S+#@Q,R!D=7)I;F<@96%C:"!R97-P96-T:79E('!E
M<FEO9`T*("`-"B`@("`@(')E;&%T960@=&\@=&AE<V4@:7-S=6%N8V5S+CPO
M9F]N=#X-"B`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].
M5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^4W1O8VL-"B`@
M("`@#0H@("`@("!/<'1I;VYS/"]F;VYT/@T*("`-"B`@("`\+V1I=CX\8G(O
M/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^26X-"B`@#0H@
M("`@("`R,#`V+"!W92!A9&]P=&5D('1H92!'96]687@@3&%B<RP@26YC+B`R
M,#`V($5Q=6ET>2!);F-E;G1I=F4-"B`@#0H@("`@("!0;&%N("AT:&4@)B,X
M,C(P.U-T;V-K($]P=&EO;B!0;&%N)B,X,C(Q.RD@9F]R('1H92!G<F%N=&EN
M9PT*("`@(`T*("`@("`@;V8@<75A;&EF:65D(&EN8V5N=&EV92!S=&]C:R!O
M<'1I;VYS#0H@("`-"B`@("`@("@F(S@R,C`[25-/)B,X,C$W.W,F(S@R,C$[
M*2P@;F]N<75A;&EF:65D('-T;V-K(&]P=&EO;G,L#0H@("`@(`T*("`@("`@
M<F5S=')I8W1E9"!S=&]C:R!A=V%R9',@;W(@<F5S=')I8W1E9"!S=&]C:R!B
M;VYU<V5S('1O#0H@#0H@("`@("!E;7!L;WEE97,L(&]F9FEC97)S+"!D:7)E
M8W1O<G,L(&-O;G-U;'1A;G1S(&%N9"!A9'9I<V]R<R!O9@T*(`T*("`@("`@
M=&AE($-O;7!A;GDN)B,Q-C`[)B,Q-C`[5&AE(&5X97)C:7-E('!R:6-E(&9O
M<B!A;GD@;W!T:6]N#0H@(`T*("`@("`@9W)A;G1E9"!M87D@;F]T(&)E(&QE
M<W,@=&AA;B!F86ER('9A;'5E("@Q,3`E(&]F(&9A:7(@=F%L=64-"B`-"B`@
M("`@(&9O<B!)4T\F(S@R,3<[<R!G<F%N=&5D('1O(&-E<G1A:6X-"B`@("`@
M#0H@("`@("!E;7!L;WEE97,I+B8C,38P.R8C,38P.T]P=&EO;G,@9W)A;G1E
M9"!U;F1E<B!T:&4@4W1O8VL@3W!T:6]N#0H@#0H@("`@("!0;&%N(&AA=F4@
M82!M87AI;75M('1E;BUY96%R('1E<FT@86YD(&=E;F5R86QL>2!V97-T(&]V
M97(-"B`@("`-"B`@("`@('1H<F5E('EE87)S+B8C,38P.R8C,38P.U1H92!#
M;VUP86YY(&AA<R!R97-E<G9E9"`Q+#(P,"PP,#`-"B`@(`T*("`@("`@<VAA
M<F5S(&]F(&ET<R!C;VUM;VX@<W1O8VL@9F]R(&ES<W5A;F-E('5N9&5R('1H
M92!3=&]C:PT*("`-"B`@("`@($]P=&EO;B!0;&%N+CPO9F]N=#X-"B`@#0H@
M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/D$-"B`-"B`@("`@('-U;6UA<GD@;V8@86-T:79I='D@=6YD97(@=&AE
M(%-T;V-K($]P=&EO;B!0;&%N(&%S(&]F#0H@("`@(`T*("`@("`@1&5C96UB
M97(@,S$L(#(P,3(L(&%N9"!C:&%N9V5S(&1U<FEN9R!T:&4@>65A<B!T:&5N
M(&5N9&5D(&ES#0H@(`T*("`@("`@<')E<V5N=&5D(&)E;&]W.CPO9F]N=#X-
M"B`-"B`@("`\+V1I=CX\8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L
M;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;B<^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#LG/@T*("`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/DYU;6)E<CPO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@
M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SYO9@T*("`@("`-"B`@("`@("`@("`@("`@4VAA<F5S/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^5V5I9VAT960M/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/D%V97)A9V4\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@
M("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N
M=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/D5X97)C:7-E/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^4')I8V4\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G
M/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY796EG:'1E9"T\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^079E<F%G93PO9F]N
M=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M4F5M86EN:6YG/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*
M("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/D-O;G1R86-T=6%L/"]F;VYT/@T*("`-"B`@("`@
M("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E1E<FT-"B`@#0H@("`@
M("`@("`@("`@("AY<G,I/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+V1I
M=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT
M97(G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY!9V=R96=A=&4\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^26YT<FEN<VEC/"]F;VYT/@T*("`@("`-"B`@
M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E9A;'5E/"]F;VYT
M/@T*(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@
M("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&
M.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^3W5T<W1A
M;F1I;F<-"B`@("`-"B`@("`@("`@("`@("`@870@1&5C96UB97(@,S$L(#(P
M,3$\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^.3(X+#(T,CPO9F]N
M=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU+C0S/"]F;VYT/@T*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L
M<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY'<F%N=&5D/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(S."PU,#`\+V9O;G0^#0H@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TT,S4@
M<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#,V<'0G/CPO9F]N=#XP+C<P/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@
M(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@
M("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^17AE<F-I<V5D/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^+3PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TT
M,S8@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#,V<'0G/CPO9F]N=#XM/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@
M("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P
M>"<^#0H@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY&;W)F96ET960-"B`@#0H@("`@("`@("`@
M("`@(&]R(&5X<&ER960\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M*#DW+#8P,3PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@
M:60],T1404(Q+30S-R!S='EL93TS1"=-05)'24XM3$5&5#H@,S9P="<^/"]F
M;VYT/C0N,#(\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T
M)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@
M("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[
M)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`T<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=71S=&%N9&EN9PT*("`@
M(`T*("`@("`@("`@("`@("!A="!$96-E;6)E<B`S,2P@,C`Q,CPO9F]N=#X-
M"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ+#`V.2PQ-#$\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ
M(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-"XU
M,#PO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T14
M04(Q+30S."!S='EL93TS1"=-05)'24XM3$5&5#H@,S9P="<^/"]F;VYT/C8N
M,CPO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ
M(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BTP+3PO9F]N=#X-"B`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@
M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/D5X97)C:7-A8FQE#0H@("`@#0H@("`@("`@("`@("`@
M(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/@T*("`@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!
M3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C8Y."PY.34\
M+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4
M+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE
M9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4
M+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C8N,S@\+V9O;G0^#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R
M:6=H="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TT,SD@<W1Y;&4],T0G34%2
M1TE.+4Q%1E0Z(#,V<'0G/CPO9F]N=#XT+C8\+V9O;G0^#0H@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$58
M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXM,"T\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@
M("`@("`\+W1A8FQE/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/D%D9&ET:6]N86P-"B`@("`@#0H@("`@("!I;F9O<FUA=&EO;B!C
M;VYC97)N:6YG(&]U<B!S=&]C:R!O<'1I;VYS(&9O<B!T:&4@>65A<G,@96YD
M960-"B`@#0H@("`@("!$96-E;6)E<B`S,2P@,C`Q,BP@,C`Q,2!A;F0@,C`Q
M,"!I<R!A<R!F;VQL;W=S.CPO9F]N=#X-"B`@#0H@("`@/"]D:78^/&)R+SX\
M=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS
M1#$P,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG/@T*("`@("`-
M"B`@("`@("`@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[)SX-"B`@
M("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$R/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E
M<B<^#0H@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,3$\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!C96YT97(G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L
M<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@
M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^,C`Q,#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$
M)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-34E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E:6=H=&5D#0H@
M#0H@("`@("`@("`@("`@(&%V97)A9V4@9F%I<B!V86QU92!O9B!O<'1I;VYS
M(&=R86YT960@9'5R:6YG('1H90T*("`@#0H@("`@("`@("`@("`@('!E<FEO
M9#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/C`N-3D\+V9O;G0^#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C`N-SD\+V9O;G0^#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/C(N.34\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-
M"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-34E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/DEN=')I;G-I8PT*("`-"B`@("`@("`@("`@("`@=F%L=64@;V8@;W!T
M:6]N<R!E>&5R8VES960@9'5R:6YG('1H92!P97)I;V0\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/BT\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/BT\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R
M('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-34E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E1O
M=&%L#0H@("`-"B`@("`@("`@("`@("`@9F%I<B!V86QU92!O9B!O<'1I;VYS
M('9E<W1E9"!D=7)I;F<@=&AE('!E<FEO9#PO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXS,3DL.3(P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C4T,"PS,SD\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^-#DY+#4U-SPO9F]N=#X-"B`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`\+W1A
M8FQE/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E
M#0H@(`T*("`@("`@=7-E('1H92!";&%C:RU38VAO;&5S(&UO9&5L(&9O<B!D
M971E<FUI;FEN9R!T:&4@9W)A;G0@9&%T90T*("`@("`-"B`@("`@(&9A:7(@
M=F%L=64@;V8@;W5R('-T;V-K(&]P=&EO;B!G<F%N=',N)B,Q-C`[)B,Q-C`[
M5&AI<R!M;V1E;`T*("`@("`-"B`@("`@('5T:6QI>F5S(&-E<G1A:6X@:6YF
M;W)M871I;VXL('-U8V@@87,@=&AE(&EN=&5R97-T(')A=&4@;VX@80T*("`-
M"B`@("`@(')I<VLM9G)E92!S96-U<FET>2!W:71H(&$@=&5R;2!G96YE<F%L
M;'D@97%U:79A;&5N="!T;R!T:&4-"B`@("`@#0H@("`@("!E>'!E8W1E9"!L
M:69E(&]F('1H92!O<'1I;VX@8F5I;F<@=F%L=65D(&%N9"!R97%U:7)E<R!C
M97)T86EN#0H@("`-"B`@("`@(&]T:&5R(&%S<W5M<'1I;VYS+"!S=6-H(&%S
M('1H92!E>'!E8W1E9"!A;6]U;G0@;V8@=&EM92!A;@T*("`@(`T*("`@("`@
M;W!T:6]N('=I;&P@8F4@;W5T<W1A;F1I;F<@=6YT:6P@:70@:7,@97AE<F-I
M<V5D(&]R(&5X<&ER960L#0H@(`T*("`@("`@=&\@8V%L8W5L871E('1H92!F
M86ER('9A;'5E(&]F('-T;V-K(&]P=&EO;G,-"B`-"B`@("`@(&=R86YT960N
M)B,Q-C`[)B,Q-C`[5&AE('-I9VYI9FEC86YT(&%S<W5M<'1I;VYS('=E('5S
M960@:6X-"B`@(`T*("`@("`@;W5R(&9A:7(@=F%L=64@8V%L8W5L871I;VYS
M('=E<F4@87,@9F]L;&]W<SH\+V9O;G0^#0H@("`@#0H@("`@/"]D:78^/&)R
M+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T
M:#TS1#$P,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG/@T*("`@
M("`-"B`@("`@("`@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[)SX-
M"B`@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#4U)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P
M86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,CPO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N
M=&5R)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q
M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R
M)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*
M("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z
M("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-34E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E=E:6=H=&5D#0H@#0H@("`@("`@("`@("`@(&%V
M97)A9V4@<FES:RUF<F5E(&EN=&5R97-T(')A=&5S/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXQ+C$\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,2XT/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B4\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/C(N-CPO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T
M<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-34E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D5X<&5C=&5D#0H@#0H@("`@
M("`@("`@("`@(&1I=FED96YD('EI96QD/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXP+C`\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)3PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,"XP
M/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B4\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C`N,#PO9F]N
M=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@
M#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&
M1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#4U)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY%>'!E8W1E9`T*(`T*("`@("`@("`@("`@("!L:69E(&]F
M(&]P=&EO;B`H>7)S*3PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+C<\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C<\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3,E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@
M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXV+C<\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#4U)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E8W1E9`T*(`T*("`@("`@
M("`@("`@("!V;VQA=&EL:71Y/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,3`U
M+C(\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3$N
M,CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B4\+V9O
M;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R
M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$Q,BXY
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)3PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@/"]T86)L93X\8G(O/CQD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY3=&]C:RUB87-E9`T*(`T*("`@("`@8V]M<&5N
M<V%T:6]N(&5X<&5N<V4@<F5L871E9"!T;R!T:&4@4W1O8VL@3W!T:6]N(%!L
M86X@=V%S#0H@("`@#0H@("`@("`D,S$P+#`W-BP@)#0V,RPW-3(L(&%N9"`D
M-3<U+#8V,B!D=7)I;F<@=&AE('EE87)S(&5N9&5D#0H@(`T*("`@("`@1&5C
M96UB97(@,S$L(#(P,3(L(#(P,3$@86YD(#(P,3`L#0H@("`@(`T*("`@("`@
M<F5S<&5C=&EV96QY+B8C,38P.R8C,38P.U-T;V-K(&]P=&EO;B!E>'!E;G-E
M(&ES(&%L;&]C871E9"!T;PT*(`T*("`@("`@<F5S96%R8V@@86YD(&1E=F5L
M;W!M96YT(&5X<&5N<V4@;W(@=&\@9V5N97)A;"!A;F0-"B`@#0H@("`@("!A
M9&UI;FES=')A=&EV92!E>'!E;G-E(&)A<V5D(&]N('1H92!R96QA=&5D(&5M
M<&QO>65E#0H@("`@#0H@("`@("!C;&%S<VEF:6-A=&EO;G,@86YD(&-O<G)E
M<W!O;F1S('1O('1H92!A;&QO8V%T:6]N(&]F(&5M<&QO>65E#0H@("`-"B`@
M("`@('-A;&%R:65S+B8C,38P.R8C,38P.T9O<B!T:&4@=&AR964@>65A<G,@
M96YD960@1&5C96UB97(@,S$L#0H@("`@#0H@("`@("`R,#$R+"!S=&]C:R!O
M<'1I;VX@97AP96YS92!W87,@86QL;V-A=&5D(&%S(&9O;&QO=W,Z/"]F;VYT
M/@T*("`-"B`@("`\+V1I=CX\8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@
M8V5L;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;B<^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#LG/@T*("`@("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXR,#$R/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E
M<B<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C
M96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT/@T*("`@("`-"B`@
M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,G!X)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@
M<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U-24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1V5N
M97)A;`T*("`@("`-"B`@("`@("`@("`@("`@86YD(&%D;6EN:7-T<F%T:79E
M(&5X<&5N<V4\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O
M;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,S$L.3,V/"]F;VYT/@T*(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^,C@T+#,U,CPO9F]N=#X-"B`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C,V.2PQ-C$\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4U)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^4F5S96%R8V@-"B`-"B`@("`@("`@("`@("`@
M86YD(&1E=F5L;W!M96YT(&5X<&5N<V4\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C<X+#$T,#PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,3<Y+#0P,#PO9F]N=#X-"B`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXR,#8L-3`Q/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@
M("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C
M0S!&1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#4U)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^5&]T86P-"B`@
M(`T*("`@("`@("`@("`@("!S=&]C:R!O<'1I;VX@97AP96YS93PO9F]N=#X-
M"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@-'!X)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M,S$P+#`W-CPO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@
M;&5F="<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT-C,L-S4R/"]F;VYT/@T*(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F
M="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-
M"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C4W-2PV-C(\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-
M"B`@("`@(#PO=&%B;&4^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P="<^07,-"B`@#0H@("`@("!O9B!$96-E;6)E<B`S,2P@,C`Q,BP@
M=&AE<F4@=V%S("0R-S$L.3`Q(&]F('5N<F5C;V=N:7IE9`T*("`@#0H@("`@
M("!C;VUP96YS871I;VX@97AP96YS92!R96QA=&5D('1O('-T;V-K+6)A<V5D
M(&-O;7!E;G-A=&EO;@T*("`@#0H@("`@("!A<G)A;F=E;65N=',N)B,Q-C`[
M)B,Q-C`[5&AE('5N<F5C;V=N:7IE9"!C;VUP96YS871I;VX-"B`@("`-"B`@
M("`@(&5X<&5N<V4@:7,@97AP96-T960@=&\@8F4@<F5C;V=N:7IE9"!O=F5R
M(&$@=V5I9VAT960@879E<F%G90T*("`-"B`@("`@(')E;6%I;FEN9R!P97)I
M;V0@;V8@,BXQ('EE87)S+CPO9F]N=#X-"B`@("`@#0H@("`@/"]D:78^/&)R
M+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@
M("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^4W1O8VL-"B`@("`@#0H@("`@("!0=7)C:&%S92!787)R
M86YT<SPO9F]N=#X-"B`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E#0H@(`T*("`@("`@:&%V92!I<W-U
M960@<W1O8VL@<'5R8VAA<V4@=V%R<F%N=',@:6X@8V]N;F5C=&EO;B!W:71H
M#0H@#0H@("`@("!F:6YA;F-I;F<@=')A;G-A8W1I;VYS(&%N9"!A;'-O(&EN
M(&5X8VAA;F=E(&9O<B!S97)V:6-E<R!F<F]M#0H@("`-"B`@("`@(&-O;G-U
M;'1A;G1S(&%N9"!O=&AE<G,N)B,Q-C`[)B,Q-C`[5&AE(&9O;&QO=VEN9R!T
M86)L90T*("`@(`T*("`@("`@<')E<V5N=',@82!S=6UM87)Y(&]F('-T;V-K
M('!U<F-H87-E('=A<G)A;G0@=')A;G-A8W1I;VYS#0H@("`@#0H@("`@("!D
M=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@,S$L(#(P,3(Z/"]F;VYT
M/@T*("`@("`-"B`@("`\+V1I=CX\8G(O/CQT86)L92!C96QL<&%D9&EN9STS
M1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;B<^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#LG/@T*("`@("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3,E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY.=6UB97(-"B`@("`-"B`@("`@("`@("`@("`@;V8@4VAA<F5S/"]F;VYT
M/@T*("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/E=E:6=H=&5D#0H@#0H@("`@("`@("`@("`@($%V97)A9V4\+V9O;G0^#0H@
M("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^17AE
M<F-I<V4-"B`-"B`@("`@("`@("`@("`@4')I8V4\+V9O;G0^#0H@("`-"B`@
M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@
M(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P
M1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^3W5T<W1A;F1I;F<-"B`@("`-"B`@("`@("`@("`@("`@
M870@1&5C96UB97(@,S$L(#(P,3$\+V9O;G0^#0H@("`-"B`@("`@("`@("`@
M(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ
M+#@W,"PU-3D\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/C<N.38\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DES<W5E9`T*
M("`@(`T*("`@("`@("`@("`@("`F(S@R,3$[(%-E<FEE<R!!(%=A<G)A;G1S
M("@Q*3PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#DS,RPS,S,\+V9O;G0^#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C`P/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO
M<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^27-S=65D#0H@("`@#0H@("`@("`@("`@("`@
M("8C.#(Q,3L@4V5R:65S($(@5V%R<F%N=',@*#$I/"]F;VYT/@T*(`T*("`@
M("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C(L.3,S+#,S,SPO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C`N-S4\+V9O;G0^#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT
M<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/DES<W5E9`T*("`@(`T*("`@("`@("`@("`@("`F(S@R,3$[(%-E
M<FEE<R!#(%=A<G)A;G1S("@Q*3PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#DS
M,RPS,S,\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXQ+C`P/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G
M8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^27-S=65D#0H@("`@
M#0H@("`@("`@("`@("`@("8C.#(Q,3L@3W1H97(@5V%R<F%N=',@*#(I/"]F
M;VYT/@T*("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^-C$R+#`P,3PO9F]N=#X-"B`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+C`P/"]F;VYT/@T*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*
M("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<P)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY%>&5R8VES960\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/BTM/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/BTM/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A
M8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.
M12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY&;W)F96ET960-"B`@#0H@("`@("`@("`@("`@(&]R(&5X<&ER
M960\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^*#4W+#`P,#PO9F]N=#X-"B`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H
M="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C<N,#`\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@
M("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@
M("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M3W5T<W1A;F1I;F<-"B`@("`-"B`@("`@("`@("`@("`@870@1&5C96UB97(@
M,S$L(#(P,3(\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-
M"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,2PR,C4L-34Y/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'
M3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-
M"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/C(N,#8\+V9O;G0^#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N
M9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/D5X97)C:7-A8FQE#0H@("`@#0H@("`@("`@("`@("`@(&%T($1E8V5M8F5R
M(#,Q+"`R,#$R/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^
M#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^."PR.3`L,S<V/"]F;VYT/@T*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^,BXT-#PO9F]N=#X-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M/"]T<CX-"B`@("`@#0H@("`@("`\+W1A8FQE/CQB<B\^/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL
M93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH
M,2DF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M3964-"B`-
M"B`@("`@(&1I<V-U<W-I;VX@=6YD97(@)B,X,C(P.U-E<FEE<R!!($-O;G9E
M<G1I8FQE(%!R969E<G)E9`T*("`@("`-"B`@("`@(%-T;V-K)B,X,C(Q.R!A
M8F]V92X\+V9O;G0^#0H@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B@R*28C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.U-E90T*
M(`T*("`@("`@9&ES8W5S<VEO;B!U;F1E<B`F(S@R,C`[0V]M;6]N(%-T;V-K
M(%1R86YS86-T:6]N<R8C.#(R,3L-"B`-"B`@("`@(&%B;W9E+CPO9F]N=#X-
M"B`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P="<^1F]R#0H@("`-"B`@("`@('-T;V-K('!U<F-H87-E('=A<G)A
M;G1S(&ES<W5E9"!T;R!C;VYS=6QT86YT<R!O<B!O=&AE<G,@:6X-"B`@("`@
M#0H@("`@("!E>&-H86YG92!F;W(@<V5R=FEC97,L('=E(')E8V]R9"!T:&4@
M<F5L871E9"!E>'!E;G-E(&]V97(@=&AE#0H@("`-"B`@("`@('-E<G9I8V4@
M<&5R:6]D+"!O<B!U<&]N('1H92!D871E+"!T:&%T('1H92!S97)V:6-E('=A
M<PT*(`T*("`@("`@<F5N9&5R960N)B,Q-C`[)B,Q-C`[17AP96YS92!A<W-O
M8VEA=&5D('=I=&@@<W5C:`T*("`@(`T*("`@("`@8V]M<&5N<V%T;W)Y('=A
M<G)A;G1S('=A<R`D+3`M+"`D-RPQ,3DL(&%N9"`D,3(Q+#`U-R!D=7)I;F<-
M"B`-"B`@("`@('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,BP@
M,C`Q,2!A;F0@,C`Q,"P-"B`-"B`@("`@(')E<W!E8W1I=F5L>2!!;&P@<W5C
M:"!E>'!E;G-E('=A<R!A;&QO8V%T960@=&\@9V5N97)A;"!A;F0-"B`@("`@
M#0H@("`@("!A9&UI;FES=')A=&EV92!E>'!E;G-E+B8C,38P.R8C,38P.T%S
M(&]F($1E8V5M8F5R(#,Q+"`R,#$R+`T*("`@(`T*("`@("`@=&AE<F4@=V%S
M(&YO('5N<F5C;V=N:7IE9"!C;VUP96YS871I;VX@97AP96YS92!R96QA=&5D
M('1O#0H@("`@#0H@("`@("!C;VUP96YS871O<GD@=V%R<F%N=',N("XF(S$V
M,#LF(S$V,#M);B!A9&1I=&EO;B!T;PT*("`@("`-"B`@("`@(&-O;7!E;G-A
M=&]R>2!W87)R86YT(&5X<&5N<V4L(&1U<FEN9R`R,#$Q('=E(')E8V]R9&5D
M#0H@("`@(`T*("`@("`@)#$U,BPQ,C8@;V8@9V5N97)A;"!A;F0@861M:6YI
M<W1R871I=F4@97AP96YS92!A<W-O8VEA=&5D#0H@("`@#0H@("`@("!W:71H
M('1H92!E>'1E;G-I;VX@;V8@8V5R=&%I;B!I;G9E<W1O<B!W87)R86YT<R!W
M:&EC:"!W97)E#0H@("`@(`T*("`@("`@9'5E('1O(&5X<&ER92!I;B`R,#$Q
M('1O(#(P,3,N)B,Q-C`[)B,Q-C`[26X@2F%N=6%R>2`R,#$S+`T*("`@#0H@
M("`@("!C97)T86EN(&UO9&EF:6-A=&EO;G,@=V5R92!M861E('1O('1H92!T
M97)M<R!O9B!T:&4@0VQA<W,@0@T*(`T*("`@("`@5V%R<F%N=',@:6X@97AC
M:&%N9V4@9F]R('1H92!E>&5R8VES92!O9B!A('!O<G1I;VX@;V8@=&AO<V4-
M"B`-"B`@("`@('=A<G)A;G1S("AS964@3F]T92`Q,2DN/"]F;VYT/@T*("`@
M#0H@("`@/"]D:78^/&)R+SX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
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M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T
M92`W("T@4F5T:7)E;65N="!0;&%N/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y096YS:6]N(&%N9"!/=&AE<B!0;W-T<F5T:7)E
M;65N="!"96YE9FET<R!$:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX-"B`@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G/C<N)B,Q-C`[)B,Q
M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[
M)B,Q-C`[)B,Q-C`[4F5T:7)E;65N=`T*(`T*("`@("`@4&QA;CPO9F]N=#X-
M"B`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^5V4-"B`@#0H@("`@("!P87)T:6-I<&%T92!I;B!A(&UU
M;'1I+65M<&QO>65R(&1E9FEN960@8V]N=')I8G5T:6]N#0H@("`@#0H@("`@
M("!R971I<F5M96YT('!L86X@*'1H92`F(S@R,C`[-#`Q:R!0;&%N)B,X,C(Q
M.RD@861M:6YI<W1E<F5D(&)Y#0H@#0H@("`@("!A('1H:7)D('!A<G1Y('-E
M<G9I8V4@<')O=FED97([(&%N9"!T:&4@0V]M<&%N>2!C;VYT<FEB=71E<PT*
M(`T*("`@("`@=&\@=&AE(#0P,6L@4&QA;B!O;B!B96AA;&8@;V8@:71S(&5M
M<&QO>65E<R!B87-E9"!U<&]N(&$-"B`@(`T*("`@("`@;6%T8VAI;F<@9F]R
M;75L82XF(S$V,#LF(S$V,#M$=7)I;F<@=&AE('EE87)S(&5N9&5D($1E8V5M
M8F5R#0H@("`@(`T*("`@("`@,S$L(#(P,3(L(#(P,3$@86YD(#(P,3`@;W5R
M(&-O;G1R:6)U=&EO;G,@=&\@=&AE(#0P,6L@4&QA;@T*("`@("`-"B`@("`@
M('=E<F4@)#4P+#4P,"P@)#4V+#DR."P@86YD("0U,BPV,S(L(')E<W!E8W1I
M=F5L>2X\+V9O;G0^#0H@("`@#0H@("`@/"]D:78^/&)R+SX\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
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M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3F]T92`X("T@26YC;VUE(%1A>&5S/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-O;64@5&%X($1I
M<V-L;W-U<F4@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4
M+5=%24=(5#H@8F]L9"<^."XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M);F-O;64-
M"B`@#0H@("`@("!487AE<SPO9F]N=#X-"B`@("`@#0H@("`@/"]D:78^/&)R
M+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D%T#0H@(`T*
M("`@("`@1&5C96UB97(@,S$L(#(P,3(L('=E(&AA=F4@82!C;VYS;VQI9&%T
M960@9F5D97)A;"!N970-"B`@("`@#0H@("`@("!O<&5R871I;F<@;&]S<R`H
M)B,X,C(P.TY/3"8C.#(R,3LI(&-A<G)Y9F]R=V%R9"!O9@T*("`@("`-"B`@
M("`@(&%P<')O>&EM871E;'D@)#8Y+C@@;6EL;&EO;BP@879A:6QA8FQE('1O
M(&]F9G-E="!A9V%I;G-T#0H@("`-"B`@("`@(&9U='5R92!T87AA8FQE(&EN
M8V]M92!W:&EC:"!E>'!I<F5S(&EN('9A<GEI;F<@86UO=6YT<R!I;@T*("`@
M(`T*("`@("`@,C`Q,R!T:')O=6=H(#(P,S(N)B,Q-C`[)B,Q-C`[061D:71I
M;VYA;&QY+"!W92!H879E#0H@#0H@("`@("!A<'!R;WAI;6%T96QY("0W-C0L
M,#`P(&EN(')E<V5A<F-H(&%N9"!D979E;&]P;65N=`T*("`-"B`@("`@("@F
M(S@R,C`[4B9A;7`[1"8C.#(R,3LI('1A>"!C<F5D:71S('1H870@97AP:7)E
M(&EN(#(P,C(-"B`@("`-"B`@("`@('1H<F]U9V@@,C`S,2!U;FQE<W,@=71I
M;&EZ960@96%R;&EE<BXF(S$V,#LF(S$V,#M.;R!I;F-O;64-"B`@(`T*("`@
M("`@=&%X97,@:&%V92!B965N('!A:60@=&\@9&%T92X\+V9O;G0^#0H@("`@
M#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/D%S#0H@(`T*("`@("`@82!R97-U;'0@;V8@=&AE($UE<F=E<B!D
M:7-C=7-S960@:6X@3F]T92`U+"!O=7(@3D],#0H@("`-"B`@("`@(&-A<G)Y
M9F]R=V%R9"!I;F-R96%S960@<W5B<W1A;G1I86QL>2!D=64@=&\@=&AE(&%D
M9&ET:6]N(&]F#0H@#0H@("`@("!H:7-T;W)I8V%L($Y/3"!C87)R>69O<G=A
M<F1S(&9O<B!$875P:&EN(%1E8VAN;VQO9WDL#0H@("`@#0H@("`@("!);F,N
M)B,Q-C`[)B,Q-C`[2&]W979E<BP@4V5C=&EO;B`S.#(@;V8@=&AE($EN=&5R
M;F%L(%)E=F5N=64-"B`@("`@#0H@("`@("!#;V1E(&-O;G1A:6YS('!R;W9I
M<VEO;G,@=&AA="!M87D@;&EM:70@;W5R('5T:6QI>F%T:6]N(&]F#0H@("`@
M(`T*("`@("`@3D],(&%N9"!2)F%M<#M$('1A>"!C<F5D:70@8V%R<GEF;W)W
M87)D<R!I;B!A;GD@9VEV96X@>65A<B!A<PT*("`-"B`@("`@(&$@<F5S=6QT
M(&]F('-I9VYI9FEC86YT(&-H86YG97,@:6X@;W=N97)S:&EP(&EN=&5R97-T
M<R!T:&%T#0H@#0H@("`@("!H879E(&]C8W5R<F5D(&EN('!A<W0@<&5R:6]D
M<R!O<B!M87D@;V-C=7(@:6X@9G5T=7)E#0H@("`@#0H@("`@("!P97)I;V1S
M+CPO9F]N=#X-"B`@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY$969E<G)E9`T*("`@#0H@("`@("!I;F-O
M;64@=&%X97,@<F5F;&5C="!T:&4@;F5T(&5F9F5C="!O9B!T96UP;W)A<GD@
M9&EF9F5R96YC97,-"B`@#0H@("`@("!B971W965N('1H92!C87)R>6EN9R!A
M;6]U;G1S(&]F(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@9F]R#0H@("`@(`T*
M("`@("`@9FEN86YC:6%L(')E<&]R=&EN9R!P=7)P;W-E<R!A;F0@=&AE(&%M
M;W5N=',@=7-E9"!F;W(@:6YC;VUE#0H@(`T*("`@("`@=&%X('!U<G!O<V5S
M+B8C,38P.R8C,38P.U-I9VYI9FEC86YT(&-O;7!O;F5N=',@;V8@;W5R#0H@
M("`@#0H@("`@("!D969E<G)E9"!T87@@87-S971S(&%N9"!L:6%B:6QI=&EE
M<R!I;F-L=61E9"!T:&4@9F]L;&]W:6YG(&%T#0H@("`-"B`@("`@($1E8V5M
M8F5R(#,Q+"`R,#$R(&%N9"`R,#$Q.CPO9F]N=#X-"B`@#0H@("`@/"]D:78^
M/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W
M:61T:#TS1#$P,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG/@T*
M("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M)SX-"B`@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$R/"]F;VYT/@T*
M("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,3PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@
M("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-
M"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$969E<G)E9`T*
M(`T*("`@("`@("`@("`@("!T87@@87-S971S.CPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU,1494.B`T)2<^#0H@(`T*("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/DYE=`T*(`T*("`@("`@("`@("`@("!O<&5R871I;F<@;&]S<R!C
M87)R>69O<G=A<F0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C0L-#(Y+#0W,CPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(T+#@W,BPP.#(\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N
M9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU,1494.B`T)2<^#0H@(`T*("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR
M-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E<V5A
M<F-H#0H@#0H@("`@("`@("`@("`@(&%N9"!D979E;&]P;65N="!T87@@8W)E
M9&ET(&-A<G)Y9F]R=V%R9#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I
M=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-S8S+#DV
M-3PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW
M-C,L-CDP/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>#L@4$%$1$E.
M1RU,1494.B`T)2<^#0H@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=&]C:RUB87-E9`T*("`@
M(`T*("`@("`@("`@("`@("!C;VUP96YS871I;VX@97AP96YS93PO9F]N=#X-
M"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXR+#`Y-RPQ.30\+V9O;G0^#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXQ+#DY,2PW-CD\+V9O;G0^#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO
M='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC
M;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@4$%$1$E.1RU,1494.B`T)2<^#0H@(`T*("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E1O=&%L#0H@
M("`-"B`@("`@("`@("`@("`@9&5F97)R960@=&%X(&%S<V5T<SPO9F]N=#X-
M"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^,C<L,CDP+#8S,3PO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-RPV,C<L-30Q/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*
M("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO
M='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC
M;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^1&5F97)R960-"B`-"B`@("`@("`@("`@
M("`@=&%X(&QI86)I;&ET:65S/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-
M"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@[(%!!1$1)3D<M3$5&5#H@-"4G/@T*("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1&5P
M<F5C:6%T:6]N/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@Q-BPQ,C4\+V9O;G0^#0H@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXH,S8L,S$Q/"]F;VYT/@T*(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*
M("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z
M("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@[(%!!1$1)3D<M3$5&5#H@-"4G/@T*("`@#0H@
M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*
M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^5&]T86P-"B`@(`T*("`@("`@("`@("`@("!D969E<G)E9"!T
M87@@;&EA8FEL:71I97,\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,38L,3(U/"]F;VYT
M/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^*#,V+#,Q,3PO9F]N=#X-"B`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T
M<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DYE=`T*(`T*("`@("`@("`@("`@
M("!D969E<G)E9"!T87@@87-S971S/"]F;VYT/@T*("`-"B`@("`@("`@("`@
M(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR
M-RPR-S0L-3`V/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C(W+#4Y,2PR,S`\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\
M='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#<P)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^5F%L=6%T:6]N#0H@(`T*
M("`@("`@("`@("`@("!A;&QO=V%N8V4\+V9O;G0^#0H@(`T*("`@("`@("`@
M("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C<L
M,C<T+#4P-CPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C<L-3DQ
M+#(S,#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\
M='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P
M>"<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#1P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-
M"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/BT\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^
M#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^
M#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`\+W1A8FQE
M/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@(`T*
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E#0H@
M(`T*("`@("`@:&%V92!E<W1A8FQI<VAE9"!A(&9U;&P@=F%L=6%T:6]N(&%L
M;&]W86YC92!E<75A;"!T;R!T:&4-"B`@(`T*("`@("`@86UO=6YT(&]F(&]U
M<B!N970@9&5F97)R960@=&%X(&%S<V5T<R!D=64@=&\@=6YC97)T86EN=&EE
M<PT*("`@("`-"B`@("`@('=I=&@@<F5S<&5C="!T;R!O=7(@86)I;&ET>2!T
M;R!G96YE<F%T92!S=69F:6-I96YT('1A>&%B;&4-"B`@("`@#0H@("`@("!I
M;F-O;64@=&\@<F5A;&EZ92!T:&5S92!A<W-E=',@:6X@=&AE(&9U='5R92X@
M00T*("`@(`T*("`@("`@<F5C;VYC:6QI871I;VX@;V8@=&AE(&EN8V]M92!T
M87@@8F5N969I="!O;B!L;W-S97,@870@=&AE#0H@("`@#0H@("`@("!5+E,N
M(&9E9&5R86P@<W1A='5T;W)Y(')A=&4@=&\@=&AE(')E<&]R=&5D(&EN8V]M
M92!T87@-"B`-"B`@("`@(&5X<&5N<V4@:7,@87,@9F]L;&]W<SH\+V9O;G0^
M#0H@(`T*("`@(#PO9&EV/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C
M96QL<W!A8VEN9STS1#`@=VED=&@],T0Q,#`E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N)SX-"B`@("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R<^#0H@("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^,C`Q,CPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P
M,3$\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$P/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@
M("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@
M(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0T.24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^52Y3+@T*("`-"B`@("`@("`@("`@("`@9F5D97)A
M;"!S=&%T=71O<GD@<F%T92!A<'!L:65D('1O('!R971A>"!L;W-S/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q-"4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXH-S(U+#DT.#PO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$T)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B@W.3<L.3(Q/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,30E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#DS
M-"PP.3(\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO
M='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0Y)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097)M86YE;G0-"B`@#0H@
M("`@("`@("`@("`@(&1I9F9E<F5N8V5S/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$T)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/CQF;VYT(&ED/3-$5$%",2TT-#`@<W1Y;&4],T0G34%21TE.+4Q%1E0Z
M(#,R+C$U<'0G/CPO9F]N=#XR+#8W-#PO9F]N=#X-"B`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,30E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^-"PR,38\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,30E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T1404(Q+30T
M,2!S='EL93TS1"=-05)'24XM3$5&5#H@,3DN-G!T)SX\+V9O;G0^*#<W+#(P
M,#PO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO
M<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0T.24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^4F5S96%R8V@-"B`-"B`@("`@("`@("`@("`@
M86YD(&1E=F5L;W!M96YT(&-R961I=',\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,30E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M/&9O;G0@:60],T1404(Q+30T,B!S='EL93TS1"=-05)'24XM3$5&5#H@-3<N
M-W!T)SX\+V9O;G0^+3PO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,30E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^,S(L-C<U/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M-#0S('-T>6QE
M/3-$)TU!4D=)3BU,1494.B`R."XT-7!T)SX\+V9O;G0^-3DL.34Y/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#0Y)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*
M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^0VAA;F=E#0H@("`@#0H@("`@("`@("`@("`@(&EN('9A;'5A=&EO;B!A
M;&QO=V%N8V4\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,30E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M
M-#0T('-T>6QE/3-$)TU!4D=)3BU,1494.B`Q."XX<'0G/CPO9F]N=#XW,C,L
M,C<T/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-S8Q+#`S
M,#PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,30E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS
M1%1!0C$M-#0U('-T>6QE/3-$)TU!4D=)3BU,1494.B`R,2XX<'0G/CPO9F]N
M=#XY-3$L,S,S/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-
M"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&
M1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`T<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY297!O<G1E9`T*(`T*
M("`@("`@("`@("`@("!I;F-O;64@=&%X(&5X<&5N<V4\+V9O;G0^#0H@#0H@
M("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G
M/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@
M;&5F="<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H
M="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`T<'@G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@
M("`@(`T*("`@("`@/"]T86)L93X\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?
M86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T
M860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S
M+U-H965T,34N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY.;W1E(#D@+2!296QA=&5D(%!A<G1Y(%1R86YS86-T:6]N<SQB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5L871E9"!0
M87)T>2!4<F%N<V%C=&EO;G,@1&ES8VQO<W5R92!;5&5X="!";&]C:UT\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SXY+B8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P
M.R8C,38P.R8C,38P.U)E;&%T960-"B`@(`T*("`@("`@4&%R='D@5')A;G-A
M8W1I;VYS/"]F;VYT/@T*("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E#0H@(`T*("`@("`@87)E(&]B
M;&EG871E9"!T;R!R96EM8G5R<V4@16UO<GD@56YI=F5R<VET>2`H82!S:6=N
M:69I8V%N=`T*("`@("`-"B`@("`@('-T;V-K:&]L9&5R(&]F('1H92!#;VUP
M86YY*2!F;W(@;VYG;VEN9R!C;W-T<R!I;B!C;VYN96-T:6]N#0H@#0H@("`@
M("!W:71H('1H92!F:6QI;F<L('!R;W-E8W5T:6]N(&%N9"!M86EN=&5N86YC
M92!O9B!P871E;G0-"B`-"B`@("`@(&%P<&QI8V%T:6]N<R!S=6)J96-T('1O
M(&$@;&EC96YS92!A9W)E96UE;G0@9F]R('1E8VAN;VQO9WD-"B`@("`@#0H@
M("`@("!A<W-O8VEA=&5D('=I=&@@=&AE('9A8V-I;F5S('=E(&%R90T*("`-
M"B`@("`@(&1E=F5L;W!I;F<N)B,Q-C`[)B,Q-C`[5&AE(&5X<&5N<V4@87-S
M;V-I871E9"!W:71H('1H97-E#0H@#0H@("`@("!O;F=O:6YG('!A=&5N="!C
M;W-T(')E:6UB=7)S96UE;G1S('1O($5M;W)Y(&%M;W5N=&5D('1O#0H@(`T*
M("`@("`@)#@Y+#@X-2P@)#(T.2PY,#<L(&%N9"`D,3DS+#8W-"!F;W(@=&AE
M('EE87)S(&5N9&5D($1E8V5M8F5R#0H@(`T*("`@("`@,S$L(#(P,3(L(#(P
M,3$L(&%N9"`R,#$P+"!R97-P96-T:79E;'DN/"]F;VYT/@T*("`@(`T*("`@
M(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-
M"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY);@T*("`-"B`@("`@(&-O;FYE8W1I;VX@=VET:"!O=7(@25!#059$(&=R
M86YT(&9R;VT@=&AE($Y)2"`H<V5E($YO=&4@,RDL#0H@#0H@("`@("!W92!H
M879E(&5N=&5R960@:6YT;R!T=V\@<W5B8V]N=')A8W1S('=I=&@@16UO<GD@
M9F]R('1H90T*("`@#0H@("`@("!P=7)P;W-E(&]F(&-O;F1U8W1I;F<@<F5S
M96%R8V@@86YD(&1E=F5L;W!M96YT(&%C=&EV:71I97,-"B`@("`-"B`@("`@
M(')E;&%T960@=&\@=&AE(&=R86YT+B8C,38P.R8C,38P.T1U<FEN9R`R,#$R
M+"`R,#$Q+"!A;F0@,C`Q,"P-"B`-"B`@("`@('=E(')E8V]R9&5D("0U-3(L
M-#`S+"`D,2PQ-S(L-S4X+"!A;F0@)#$L,SDQ+#(P,RP-"B`-"B`@("`@(')E
M<W!E8W1I=F5L>2P@;V8@97AP96YS92!A<W-O8VEA=&5D('=I=&@@=&AE<V4-
M"B`@(`T*("`@("`@<W5B8V]N=')A8W1S+B8C,38P.R8C,38P.T%L;"!A;6]U
M;G1S('!A:60@=&\@16UO<GD@=6YD97(-"B`-"B`@("`@('1H97-E('-U8F-O
M;G1R86-T<R!A<F4@<F5I;6)U<G-A8FQE('1O('5S('!U<G-U86YT('1O('1H
M92!.24@-"B`@(`T*("`@("`@9W)A;G0N/"]F;VYT/@T*(`T*("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);@T*
M("`-"B`@("`@($UA<F-H(#(P,#@L('=E(&5N=&5R960@:6YT;R!A(&-O;G-U
M;'1I;F<@86=R965M96YT('=I=&@-"B`@#0H@("`@("!$;VYA;&0@2&EL9&5B
M<F%N9"P@82!F;W)M97(@;65M8F5R(&]F(&]U<B!";V%R9"!O9B!$:7)E8W1O
M<G,-"B`@#0H@("`@("!A;F0@;W5R(&9O<FUE<B!0<F5S:61E;G0@)F%M<#L@
M0VAI968@17AE8W5T:79E($]F9FEC97(L#0H@#0H@("`@("!P=7)S=6%N="!T
M;R!W:&EC:"!-<BX@2&EL9&5B<F%N9"!H87,@<')O=FED960@8G5S:6YE<W,@
M86YD#0H@("`@(`T*("`@("`@=&5C:&YI8V%L(&%D=FES;W)Y('-E<G9I8V5S
M('1O('1H92!#;VUP86YY+B8C,38P.R8C,38P.U1H90T*("`@#0H@("`@("!T
M97)M(&]F('1H92!C;VYS=6QT:6YG(&%G<F5E;65N="P@87,@86UE;F1E9"P@
M8F5G86X@;VX@07!R:6P-"B`@#0H@("`@("`Q+"`R,#`X(&%N9"!E;F1E9"!O
M;B!$96-E;6)E<B`S,2P@,C`Q,BXF(S$V,#LF(S$V,#M$=7)I;F<-"B`@#0H@
M("`@("`R,#$R+"`R,#$Q+"!A;F0@,C`Q,"P@=V4@<F5C;W)D960@)#(T+#`P
M,"P@)#(T+#`P,"P@86YD#0H@(`T*("`@("`@)#4W+#8P,"P@<F5S<&5C=&EV
M96QY+"!O9B!E>'!E;G-E(&%S<V]C:6%T960@=VET:"!T:&4-"B`@("`@#0H@
M("`@("!C;VYS=6QT:6YG(&%G<F5E;65N="X\+V9O;G0^#0H@#0H@("`@/"]D
M:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@
M(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEN
M#0H@(`T*("`@("`@1&5C96UB97(@,C`Q,2!A;F0@2F%N=6%R>2`R,#$R+"!M
M96UB97)S(&]F(&]U<B!M86YA9V5M96YT(&%N9`T*("`@#0H@("`@("!";V%R
M9"!O9B!$:7)E8W1O<G,@<&%R=&EC:7!A=&5D(&EN('1H92!P<FEV871E('!L
M86-E;65N=`T*("`@#0H@("`@("!O9F9E<FEN9R!O9B!O=7(@8V]M;6]N('-T
M;V-K(&%N9"!W87)R86YT<R`H<V5E($YO=&4@-BDL#0H@(`T*("`@("`@=VAE
M<F5B>2!T:&5Y('!U<F-H87-E9"!A;B!A9V=R96=A=&4@;V8@,S@P+#DU-"!S
M:&%R97,@;V8@;W5R#0H@(`T*("`@("`@8V]M;6]N('-T;V-K(&9O<B!A('1O
M=&%L('!U<F-H87-E('!R:6-E(&]F("0R-34L,C,Y(&%N9`T*("`-"B`@("`@
M(')E8V5I=F5D(&9I=F4M>65A<B!W87)R86YT<R!T;R!P=7)C:&%S92!A;B!A
M9&1I=&EO;F%L(#4W,2PT,S(-"B`@(`T*("`@("`@<VAA<F5S(&]F(&]U<B!C
M;VUM;VX@<W1O8VL@97AE<F-I<V%B;&4@870@)#$N,#`@<&5R#0H@("`-"B`@
M("`@('-H87)E+CPO9F]N=#X-"B`-"B`@("`\+V1I=CX\8G(O/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR
M,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W
M-2]7;W)K<VAE971S+U-H965T,38N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#$P("T@4V5L96-T960@475A<G1E<FQY
M($9I;F%N8VEA;"!$871A("AU;F%U9&ET960I/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y1=6%R=&5R;'D@1FEN86YC:6%L($EN
M9F]R;6%T:6]N(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U714E'2%0Z(&)O;&0G/C$P+B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.U-E;&5C
M=&5D#0H@("`@(`T*("`@("`@475A<G1E<FQY($9I;F%N8VEA;"!$871A("AU
M;F%U9&ET960I/"]F;VYT/@T*(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!#0H@#0H@("`@("!S=6UM87)Y
M(&]F('-E;&5C=&5D('%U87)T97)L>2!F:6YA;F-I86P@9&%T82!F;W(@,C`Q
M,B!A;F0-"B`@("`-"B`@("`@(#(P,3$@:7,@87,@9F]L;&]W<SH\+V9O;G0^
M#0H@("`@#0H@("`@/"]D:78^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P
M(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#DW)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;B<^#0H@("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R<^#0H@("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0U,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!C;VQS<&%N/3-$,30@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-#8E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,3(-"B`@#0H@
M("`@("`@("`@("`@(%%U87)T97(@16YD960\+V9O;G0^#0H@#0H@("`@("`@
M("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@
M("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0U,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C
M96YT97(G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DUA<F-H#0H@("`-"B`@("`@("`@
M("`@("`@,S$\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY*=6YE#0H@(`T*("`@("`@
M("`@("`@("`S,#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97(G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E-E<'1E;6)E<@T*("`-
M"B`@("`@("`@("`@("`@,S`\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@
M/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E
M<@T*(`T*("`@("`@("`@("`@("`S,3PO9F]N=#X-"B`@("`@#0H@("`@("`@
M("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/
M5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@
M("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-
M"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/E)E=F5N=64-"B`@("`@#0H@("`@("`@("`@("`@(&9R;VT@9W)A;G1S
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/C@U-"PP-C,\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^-S`U+#8Y.#PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV,S@L,#`P
M/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C0U.2PU-C8\+V9O;G0^#0H@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*
M("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#4R)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY.970-"B`-"B`@("`@("`@("`@("`@;&]S<SPO
M9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B@W,S`L-3$S/"]F;VYT/@T*("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXH-#DW+#<V,SPO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#(Y
M-BPW-SD\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@V,3`L,#@U/"]F
M;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@
M("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#
M,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/DYE=`T*(`T*("`@("`@("`@("`@("!L;W-S('!E<B!S
M:&%R93PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B@P+C`T/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B@P+C`S/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B@P+C`R/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@P+C`S/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@
M("`@(`T*("`@("`@/"]T86)L93X\8G(O/CQT86)L92!C96QL<&%D9&EN9STS
M1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$.3<E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)SX-"B`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#LG/@T*("`@("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@8V]L<W!A;CTS1#$T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#0V)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q#0H@(`T*
M("`@("`@("`@("`@("!1=6%R=&5R($5N9&5D/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@
M("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L
M<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-87)C:`T*("`@#0H@("`@("`@
M("`@("`@(#,Q/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*
M("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^2G5N90T*("`-"B`@("`@
M("`@("`@("`@,S`\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY397!T96UB97(-"B`@
M#0H@("`@("`@("`@("`@(#,P/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@
M(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$P)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1&5C96UB
M97(-"B`-"B`@("`@("`@("`@("`@,S$\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@
M("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^
M#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#4R)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY2979E;G5E#0H@("`@(`T*("`@("`@("`@("`@("!F<F]M(&=R86YT
M<SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXX.3,L,#`R/"]F;VYT/@T*(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/C$L-S4S+#`S,SPO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$L
M,CDW+#`P-CPO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CDU-BPX-#0\
M+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970-"B`-"B`@("`@("`@("`@
M("`@;&]S<SPO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@V,#8L,C@R/"]F;VYT/@T*("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXH,C$Q+#,T-#PO9F]N=#X-"B`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*#,W-2PX-3(\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@Q
M+#$U,RPS-#@\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O
M=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970-"B`-"B`@("`@("`@("`@
M("`@;&]S<R!P97(@<VAA<F4\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D
M:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP-#PO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP,3PO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXH,"XP,CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXH,"XP.#PO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`\+W1R/@T*("`@("`-"B`@("`@(#PO=&%B;&4^/&)R+SX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
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M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^3F]T92`Q,2`M(%-U8G-E<75E;G0@179E;G1S
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6)S
M97%U96YT($5V96YT<R!;5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0G/C$Q+B8C,38P.R8C,38P.R8C,38P.R8C
M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P
M.U-U8G-E<75E;G0-"B`@#0H@("`@("!%=F5N=',\+V9O;G0^#0H@#0H@("`@
M/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*
M("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P="<^5V%R<F%N=`T*("`-"B`@("`@($UO9&EF
M:6-A=&EO;B!A;F0@17AE<F-I<V4\+V9O;G0^#0H@("`@(`T*("`@(#PO9&EV
M/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%9F9E
M8W1I=F4-"B`@("`-"B`@("`@($IA;G5A<GD@,3<L(#(P,3,L('=E(')E9'5C
M960@=&AE(&5X97)C:7-E('!R:6-E(&]F(&]U<@T*(`T*("`@("`@=&AE;BUO
M=71S=&%N9&EN9R!397)I97,@0B!#;VUM;VX@4W1O8VL@4'5R8VAA<V4@5V%R
M<F%N=',@*'-E90T*("`@#0H@("`@("!.;W1E(#8I+B8C,38P.R8C,38P.U1H
M92!E>&5R8VES92!P<FEC92!F;W(@86QL('1H92!397)I97,@0@T*("`@(`T*
M("`@("`@5V%R<F%N=',@=V%S(')E9'5C960@9G)O;2`D,"XW-2!T;R`D,"XV
M,"!P97(-"B`-"B`@("`@('-H87)E+B8C,38P.R8C,38P.U1H92!E>&5R8VES
M92!P<FEC92!F;W(@=&AE(%-E<FEE<R!!#0H@("`-"B`@("`@(%=A<G)A;G1S
M(&%N9"!397)I97,@0R!787)R86YT<R!T:&%T('=E<F4@:7-S=65D(&-O;F-U
M<G)E;G1L>0T*("`-"B`@("`@('=I=&@@=&AE(%-E<FEE<R!"(%=A<G)A;G1S
M(&1I9"!N;W0@8VAA;F=E+B8C,38P.R8C,38P.TEN#0H@#0H@("`@("!C;VYS
M:61E<F%T:6]N(&9O<B!T:&4@<F5D=6-T:6]N(&]F('1H92!E>&5R8VES92!P
M<FEC92P@=&AE#0H@("`@(`T*("`@("`@:&]L9&5R<R!O9B!T:&4@4V5R:65S
M($(@5V%R<F%N=',@:6UM961I871E;'D@97AE<F-I<V5D#0H@#0H@("`@("`Q
M+#<V-BPV-C<@;V8@=&AE(%-E<FEE<R!"(%=A<G)A;G1S(&9O<B!C87-H+"!R
M97-U;'1I;F<@:6X-"B`@("`-"B`@("`@('1O=&%L('!R;V-E961S('1O('1H
M92!#;VUP86YY(&]F("0Q+#`V,"PP,#`N)B,Q-C`[)B,Q-C`[5&AE#0H@("`@
M#0H@("`@("!E>'!I<F%T:6]N(&1A=&4@;V8@4V5R:65S($(@5V%R<F%N=',@
M=VET:"!R97-P96-T('1O('1H90T*("`@#0H@("`@("!R96UA:6YI;F<@,2PQ
M-C8L-C8W('-H87)E<R!W87,@97AT96YD960@9G)O;2!-87)C:"`R,2P@,C`Q
M,PT*(`T*("`@("`@=&\@36%Y(#(Q+"`R,#$S+B8C,38P.R8C,38P.TEN($IA
M;G5A<GD@,C`Q,RP@=V4@<F5C;W)D960-"B`-"B`@("`@(&=E;F5R86P@86YD
M(&%D;6EN:7-T<F%T:79E(&5X<&5N<V4@;V8@)#(Q."PU-3$@87-S;V-I871E
M9`T*("`@(`T*("`@("`@=VET:"!T:&4@=V%R<F%N="!M;V1I9FEC871I;VYS
M+CPO9F]N=#X-"B`-"B`@("`\+V1I=CX\8G(O/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X
M.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE
M971S+U-H965T,3@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY38VAE9'5L92!)22`M(%9A;'5A=&EO;B!A;F0@475A;&EF>6EN
M9R!!8V-O=6YT<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4V-H961U;&4@;V8@5F%L=6%T:6]N(&%N9"!1=6%L:69Y:6YG($%C
M8V]U;G1S($1I<V-L;W-U<F4@6U1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD)SY30TA%1%5,10T*("`-"B`@
M("`@($E)("8C.#(Q,3L@5D%,54%424].($%.1"!154%,249924Y'($%#0T]5
M3E13/"]F;VYT/@T*("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0G/D9O<@T*
M("`-"B`@("`@('1H92!996%R<R!%;F1E9"!$96-E;6)E<B`S,2P@,C`Q,BP@
M,C`Q,2!A;F0@,C`Q,#PO9F]N=#X-"B`@(`T*("`@(#PO9&EV/CQB<B\^/'1A
M8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@=VED=&@],T0Q
M,#`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SX-"B`@("`@#0H@
M("`@("`@(#QT<B!S='EL93TS1"=415A4+4%,24=..B!L969T.R<^#0H@("`@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#8@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^061D:71I;VYS/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M<'@G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT
M<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1&5S8W)I<'1I;VX\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97(G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M0F%L86YC90T*("`@("`-"B`@("`@("`@("`@("`@870\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^0F5G:6YN
M:6YG/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-
M"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D]F#0H@("`@(`T*("`@("`@("`@("`@("!097)I;V0\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#:&%R9V5D#0H@("`@(`T*
M("`@("`@("`@("`@("!T;SPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#;W-T<PT*("`@#0H@("`@("`@("`@
M("`@(&%N9#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-
M"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D5X<&5N<V5S/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@
M/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M8V5N=&5R)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!C96YT97(G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS
M1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^0VAA<F=E9`T*("`@("`-"B`@("`@("`@("`@("`@=&\\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M3W1H97(\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@
M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY!8V-O=6YT<SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO
M9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<B<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B@Q*3PO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@
M("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N
M=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/D1E9'5C=&EO;G,\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97(G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@
M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY"86QA;F-E#0H@("`@(`T*("`@("`@("`@("`@("!A=#PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY%;F0\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@
M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY/9@T*("`@("`-"B`@("`@("`@("`@("`@4&5R:6]D/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@
M("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C
M0S!&1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@
M("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M4F5S97)V90T*("`@("`-"B`@("`@("`@("`@("`@1&5D=6-T960@:6X@=&AE
M($)A;&%N8V4@4VAE970\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/D9R;VT-"B`@#0H@("`@("`@("`@("`@('1H
M92!!<W-E="!T;R!7:&EC:"!I="!!<'!L:65S.CPO9F]N=#X-"B`@(`T*("`@
M("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO
M='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A
M;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/D%L;&]W86YC90T*("`-"B`@("`@("`@("`@("`@9F]R
M($1E9F5R<F5D(%1A>"!!<W-E=',\+V9O;G0^#0H@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@
M#0H@("`@("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-#`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TT-#8@<W1Y;&4]
M,T0G34%21TE.+4Q%1E0Z(#EP="<^/"]F;VYT/EEE87(@96YD960-"B`@#0H@
M("`@("`@("`@("`@($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXR-RPU.3$L,C,P/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/C<Y-BPR,S<\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M+3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#$L,3$R
M+#DV,3PO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\
M+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(W+#(W-"PU,#8\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N
M9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0T,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T1404(Q+30T-R!S
M='EL93TS1"=-05)'24XM3$5&5#H@.7!T)SX\+V9O;G0^665A<B!E;F1E9`T*
M("`-"B`@("`@("`@("`@("`@1&5C96UB97(@,S$L(#(P,3$\+V9O;G0^#0H@
M("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXR-RPU-S8L,C4S/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M-#0X('-T
M>6QE/3-$)TU!4D=)3BU,1494.B`Q,2XQ<'0G/CPO9F]N=#XX.#@L-38Q/"]F
M;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT
M(&ED/3-$5$%",2TT-#D@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0V+C<U<'0G
M/CPO9F]N=#XM/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/CQF;VYT(&ED/3-$5$%",2TT-3`@<W1Y;&4],T0G34%21TE.+4Q%
M1E0Z(#`N,G!T)SX\+V9O;G0^*#@W,RPU.#0\+V9O;G0^#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXR-RPU.3$L,C,P/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@
M("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0T,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T1404(Q+30U,2!S='EL93TS1"=-
M05)'24XM3$5&5#H@.7!T)SX\+V9O;G0^665A<B!E;F1E9`T*("`-"B`@("`@
M("`@("`@("`@1&5C96UB97(@,S$L(#(P,3`\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXR-RPP.3$L,S,X/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M-#4R('-T>6QE/3-$)TU!
M4D=)3BU,1494.B`Q+C%P="<^/"]F;VYT/C$L,38P+#0P-3PO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL
M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T14
M04(Q+30U,R!S='EL93TS1"=-05)'24XM3$5&5#H@-#8N-S5P="<^/"]F;VYT
M/BT\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M/&9O;G0@:60],T1404(Q+30U-"!S='EL93TS1"=-05)'24XM3$5&5#H@,"XR
M<'0G/CPO9F]N=#XH-C<U+#0Y,#PO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C(W+#4W-BPR-3,\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@/"]T
M86)L93X\8G(O/CQT86)L92!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!C
M96QL<W!A8VEN9STS1#`@:60],T1H86YG:6YG:6YD96YT+3DR('=I9'1H/3-$
M,3`P)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^#0H@(`T*("`@
M("`@("`\='(@=F%L:6=N/3-$=&]P('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R<^#0H@(`T*("`@("`@("`@(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,3AP="<^#0H@("`@
M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]D
M:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,3AP="<^#0H@
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@Q*3PO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^1&5D=6-T:6]N<PT*("`@#0H@("`@("`@("`@("`@(')E
M<')E<V5N="!T:&4@969F96-T(&]F(&5X<&ER:6YG($Y/3"!C87)R>69O<G=A
M<F1S#0H@("`@(`T*("`@("`@("`@("`@("!F<F]M('!R:6]R('EE87)S+CPO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@
M/"]T86)L93X\8G(O/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?
M-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S+U-H965T,3DN:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$530T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D%C8V]U
M;G1I;F<@4&]L:6-I97,L(&)Y(%!O;&EC>2`H4&]L:6-I97,I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I<R!O9B!!8V-O
M=6YT:6YG+"!0;VQI8WD@6U!O;&EC>2!497AT($)L;V-K73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY"87-I<PT*("`@("`-"B`@("`@(&]F(%!R97-E
M;G1A=&EO;B!A;F0@4')I;F-I<&QE<R!O9B!#;VYS;VQI9&%T:6]N/"]F;VYT
M/@T*("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^3W5R#0H@("`-"B`@("`@('!R:6UA<GD@8G5S:6YE<W,@
M:7,@8V]N9'5C=&5D(&)Y(&]U<B!W:&]L;'DM;W=N960@<W5B<VED:6%R>2P-
M"B`@(`T*("`@("`@1V5O5F%X+"!);F,N(%1H92!A8V-O;7!A;GEI;F<@8V]N
M<V]L:61A=&5D(&9I;F%N8VEA;`T*("`@(`T*("`@("`@<W1A=&5M96YT<R!I
M;F-L=61E('1H92!A8V-O=6YT<R!O9B!'96]687@L($EN8RX@9G)O;0T*("`@
M(`T*("`@("`@:6YC97!T:6]N('1O9V5T:&5R('=I=&@@=&AO<V4@;V8@1V5O
M5F%X($QA8G,L($EN8RX@9G)O;0T*("`-"B`@("`@(%-E<'1E;6)E<B`R."P@
M,C`P-B`H<V5E($YO=&4@-2DN)B,Q-C`[)B,Q-C`[06QL(&EN=&5R8V]M<&%N
M>0T*("`@("`-"B`@("`@('1R86YS86-T:6]N<R!H879E(&)E96X@96QI;6EN
M871E9"!I;B!C;VYS;VQI9&%T:6]N+CPO9F]N=#X\+V1I=CX\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E=F5L;W!M
M96YT+5-T86=E($5N=&5R<')I<V4@6U!O;&EC>2!497AT($)L;V-K73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L
M:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$979E;&]P;65N="U3=&%G90T*("`-
M"B`@("`@($5N=&5R<')I<V4\+V9O;G0^#0H@("`@(`T*("`@(#PO9&EV/CQB
M<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY790T*("`-
M"B`@("`@(&%R92!D979O=&EN9R!A;&P@;V8@;W5R('!R97-E;G0@969F;W)T
M<R!T;R!R97-E87)C:"!A;F0-"B`@#0H@("`@("!D979E;&]P;65N="!A;F0@
M1V5O5F%X(&ES(&$@9&5V96QO<&UE;G0@<W1A9V4@96YT97)P<FES92!A<PT*
M(`T*("`@("`@9&5F:6YE9"!B>2!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N
M9&%R9',@0F]A<F0-"B`@("`-"B`@("`@("@F(S@R,C`[1D%30B8C.#(R,3LI
M($%C8V]U;G1I;F<@4W1A;F1A<F1S($-O9&EF:6-A=&EO;@T*("`@(`T*("`@
M("`@*"8C.#(R,#M!4T,F(S@R,C$[*2!4;W!I8R`Y,34L(#QF;VYT('-T>6QE
M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY$979E
M;&]P;65N="!3=&%G90T*("`@(`T*("`@("`@16YT:71I97,\+V9O;G0^+B8C
M,38P.R8C,38P.T%L;"!L;W-S97,@86-C=6UU;&%T960@<VEN8V4-"B`@#0H@
M("`@("!I;F-E<'1I;VX@*$IU;F4@,C<L(#(P,#$I(&AA=F4@8F5E;B!C;VYS
M:61E<F5D(&%S('!A<G0@;V8@;W5R#0H@("`-"B`@("`@(&1E=F5L;W!M96YT
M('-T86=E(&%C=&EV:71I97,N/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^57-E(&]F($5S=&EM
M871E<RP@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,13H@:71A;&EC.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/
M3E0M4TE:13H@,3!P="<^57-E#0H@("`@#0H@("`@("!O9B!%<W1I;6%T97,\
M+V9O;G0^#0H@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY4:&4-"B`@(`T*("`@("`@<')E<&%R871I;VX@
M;V8@9FEN86YC:6%L('-T871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H#0H@
M#0H@("`@("!A8V-O=6YT:6YG('!R:6YC:7!L97,@9V5N97)A;&QY(&%C8V5P
M=&5D(&EN('1H92!5;FET960@4W1A=&5S#0H@("`-"B`@("`@(&]F($%M97)I
M8V$@*"8C.#(R,#M'04%0)B,X,C(Q.RD@<F5Q=6ER97,@=7,@=&\@;6%K92!E
M<W1I;6%T97,-"B`-"B`@("`@(&%N9"!A<W-U;7!T:6]N<R!T:&%T(&%F9F5C
M="!T:&4@<F5P;W)T960@86UO=6YT<R!O9B!A<W-E=',-"B`@("`@#0H@("`@
M("!A;F0@;&EA8FEL:71I97,@86YD(&1I<V-L;W-U<F4@;V8@8V]N=&EN9V5N
M="!A<W-E=',@86YD#0H@(`T*("`@("`@;&EA8FEL:71I97,@870@=&AE(&1A
M=&4@;V8@=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%N9"!T:&4-"B`-"B`@
M("`@(')E<&]R=&5D(&%M;W5N=',@;V8@<F5V96YU97,@86YD(&5X<&5N<V5S
M(&1U<FEN9R!T:&4-"B`@("`-"B`@("`@(')E<&]R=&EN9R!P97)I;V0N)B,Q
M-C`[)B,Q-C`[06-T=6%L(')E<W5L=',@;6%Y(&1I9F9E<B!F<F]M#0H@("`@
M#0H@("`@("!T:&]S92!E<W1I;6%T97,N/"]F;VYT/CPO9&EV/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A
M;F0@0V%S:"!%<75I=F%L96YT<RP@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C
M:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,
M13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^0V%S:`T*("`@#0H@("`@
M("!A;F0@0V%S:"!%<75I=F%L96YT<SPO9F]N=#X-"B`@("`@#0H@("`@/"]D
M:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@
M(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E=E
M#0H@(`T*("`@("`@8V]N<VED97(@86QL(&AI9VAL>2!L:7%U:60@:6YV97-T
M;65N=',@=VET:"!A(&UA='5R:71Y(&]F#0H@("`@#0H@("`@("!T:')E92!M
M;VYT:',@;W(@;&5S<R!W:&5N('!U<F-H87-E9"!T;R!B92!C87-H#0H@("`-
M"B`@("`@(&5Q=6EV86QE;G1S+B8C,38P.R8C,38P.T]U<B!C87-H(&%N9"!C
M87-H(&5Q=6EV86QE;G1S(&-O;G-I<W0-"B`-"B`@("`@('!R:6UA<FEL>2!O
M9B!B86YK(&1E<&]S:71S(&%N9"!M;VYE>2!M87)K970-"B`@("`@#0H@("`@
M("!A8V-O=6YT<RXF(S$V,#LF(S$V,#M4:&4@<F5C;W)D960@=F%L=65S(&%P
M<')O>&EM871E(&9A:7(-"B`@#0H@("`@("!M87)K970@=F%L=65S(&1U92!T
M;R!T:&4@<VAO<G0@;6%T=7)I=&EE<RX\+V9O;G0^/"]D:78^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A
M;'5E(&]F($9I;F%N8VEA;"!);G-T<G5M96YT<RP@4&]L:6-Y(%M0;VQI8WD@
M5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD
M:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^/&9O;G0@<W1Y;&4],T0G
M1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^1F%I<@T*
M("`@#0H@("`@("!686QU92!O9B!&:6YA;F-I86P@26YS=')U;65N=',@86YD
M($-O;F-E;G1R871I;VX@;V8@0W)E9&ET#0H@("`@(`T*("`@("`@4FES:SPO
M9F]N=#X-"B`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($9/3E0M4TE:13H@,3!P="<^1FEN86YC:6%L#0H@("`@#0H@("`@("!I;G-T
M<G5M96YT<R!T:&%T('-U8FIE8W0@=7,@=&\@8V]N8V5N=')A=&EO;B!O9B!C
M<F5D:70@<FES:PT*(`T*("`@("`@8V]N<VES="!P<FEM87)I;'D@;V8@8V%S
M:"!A;F0@8V%S:"!E<75I=F%L96YT<RP@=VAI8V@@87)E#0H@("`@#0H@("`@
M("!M86EN=&%I;F5D(&)Y(&$@:&EG:"!C<F5D:70@<75A;&ET>2!F:6YA;F-I
M86P@:6YS=&ET=71I;VXN#0H@("`@(`T*("`@("`@5&AE(&-A<G)Y:6YG('9A
M;'5E<R!R97!O<G1E9"!I;B!T:&4@8F%L86YC92!S:&5E=',@9F]R(&-A<V@-
M"B`-"B`@("`@(&%N9"!C87-H(&5Q=6EV86QE;G1S(&%P<')O>&EM871E(&9A
M:7(@=F%L=65S+CPO9F]N=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y+"!0;&%N="!A;F0@
M17%U:7!M96YT+"!0;VQI8WD@6U!O;&EC>2!497AT($)L;V-K73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY0<F]P97)T>0T*("`@("`-"B`@("`@(&%N
M9"!%<75I<&UE;G0\+V9O;G0^#0H@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^4')O<&5R='D-"B`@(`T*
M("`@("`@86YD(&5Q=6EP;65N="!A<F4@<W1A=&5D(&%T(&-O<W0L(&QE<W,@
M86-C=6UU;&%T960-"B`@#0H@("`@("!D97!R96-I871I;VX@86YD(&%M;W)T
M:7IA=&EO;BXF(S$V,#LF(S$V,#M4:&4@8V]M<&]N96YT<R!O9@T*("`@(`T*
M("`@("`@<')O<&5R='D@86YD(&5Q=6EP;65N="!A<R!O9B!$96-E;6)E<B`S
M,2P@,C`Q,B!A;F0@,C`Q,2!A<F4-"B`-"B`@("`@(&%S(&9O;&QO=W,Z/"]F
M;VYT/@T*(`T*("`@(#PO9&EV/CQB<B\^/'1A8FQE(&-E;&QP861D:6YG/3-$
M,"!C96QL<W!A8VEN9STS1#`@=VED=&@],T0Y-R4@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86XG/@T*("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#LG/@T*("`@("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R<'@G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P
M,3(\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*
M("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@
M("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG
M/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^3&%B;W)A=&]R>0T*("`@#0H@("`@("`@("`@("`@(&5Q=6EP;65N
M=#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXS.#@L,#`P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,S@X+#`P,#PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR
M-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DQE87-E
M:&]L9`T*("`-"B`@("`@("`@("`@("`@:6UP<F]V96UE;G1S/"]F;VYT/@T*
M("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXQ,34L-C`U/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C$Q-2PV,#4\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G
M8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*
M("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-
M"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/D]T:&5R#0H@("`-"B`@("`@("`@("`@("`@9G5R;FET=7)E
M+"!F:7AT=7)E<R`F86UP.R!E<75I<&UE;G0\+V9O;G0^#0H@(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR."PV.#4\
M+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T
M)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(X+#8X-3PO9F]N=#X-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^5&]T
M86P-"B`@(`T*("`@("`@("`@("`@("!P<F]P97)T>2!A;F0@97%U:7!M96YT
M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXU,S(L,CDP/"]F;VYT/@T*(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C4S,BPR.3`\+V9O;G0^#0H@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@
M<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^
M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/D%C8W5M=6QA=&5D#0H@("`@#0H@("`@("`@
M("`@("`@(&1E<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N/"]F;VYT/@T*
M("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ
M(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^*#0R.2PX,#0\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#,U-BPP.#0\+V9O
M;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^
M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^
M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/E!R;W!E<G1Y#0H@#0H@("`@("`@("`@("`@
M(&%N9"!E<75I<&UE;G0L(&YE=#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L
M969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$P,BPT.#8\+V9O;G0^#0H@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T
M)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,3<V+#(P-CPO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`T<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*
M("`@("`@/"]T86)L93X\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY%>'!E;F1I='5R97,-"B`@#0H@("`@("!F;W(@;6%I;G1E;F%N
M8V4@86YD(')E<&%I<G,@87)E(&-H87)G960@=&\@;W!E<F%T:6]N<R!A<PT*
M("`@#0H@("`@("!I;F-U<G)E9"P@=VAI;&4@861D:71I;VYS(&%N9"!I;7!R
M;W9E;65N=',@87)E#0H@("`-"B`@("`@(&-A<&ET86QI>F5D+B8C,38P.R8C
M,38P.T1E<')E8VEA=&EO;B!I<R!C;VUP=71E9"!U<VEN9R!T:&4-"B`@(`T*
M("`@("`@<W1R86EG:'0M;&EN92!M971H;V0@;W9E<B!T:&4@97-T:6UA=&5D
M('5S969U;"!L:79E<R!O9B!T:&4-"B`-"B`@("`@(&%S<V5T<R!W:&EC:"!R
M86YG92!F<F]M('1H<F5E('1O(&9I=F4-"B`@("`-"B`@("`@('EE87)S+B8C
M,38P.R8C,38P.T%M;W)T:7IA=&EO;B!O9B!L96%S96AO;&0@:6UP<F]V96UE
M;G1S(&ES#0H@("`@#0H@("`@("!C;VUP=71E9"!U<VEN9R!T:&4@<W1R86EG
M:'0M;&EN92!M971H;V0@;W9E<B!T:&4@<F5M86EN:6YG#0H@("`@(`T*("`@
M("`@=&5R;2!O9B!T:&4@<F5L871E9"!L96%S92XF(S$V,#LF(S$V,#M$97!R
M96-I871I;VX@86YD#0H@("`@#0H@("`@("!A;6]R=&EZ871I;VX@97AP96YS
M92!W87,@)#<S+#<R,"P@)#@T+#$S,2P@86YD("0Y-"PX.#<@9'5R:6YG#0H@
M("`-"B`@("`@('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B`S,2P@,C`Q,BP@
M,C`Q,2!A;F0@,C`Q,"P-"B`-"B`@("`@(')E<W!E8W1I=F5L>2X\+V9O;G0^
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/=&AE<B!!<W-E=',@6U!O;&EC>2!497AT($)L;V-K73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L
M:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE<@T*("`@("`-"B`@("`@($%S
M<V5T<SPO9F]N=#X-"B`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P="<^3W1H97(-"B`@("`@#0H@("`@("!A<W-E
M=',@8V]N<VES="!P<FEN8VEP86QL>2!O9B!L:6-E;G-E(&%G<F5E;65N=',@
M9F]R('1H92!U<V4-"B`@#0H@("`@("!O9B!T96-H;F]L;V=Y(&]B=&%I;F5D
M('1H<F]U9V@@=&AE(&ES<W5A;F-E(&]F('1H90T*("`-"B`@("`@($-O;7!A
M;GDF(S@R,3<[<R!C;VUM;VX@<W1O8VLN)B,Q-C`[)B,Q-C`[5&AE<V4@;&EC
M96YS90T*("`@#0H@("`@("!A9W)E96UE;G1S(&%R92!A;6]R=&EZ960@;VX@
M82!S=')A:6=H="!L:6YE(&)A<VES(&]V97(@=&5N#0H@("`@(`T*("`@("`@
M>65A<G,N)B,Q-C`[)B,Q-C`[06UO<G1I>F%T:6]N(&5X<&5N<V4@<F5L871E
M9"!T;R!T:&5S90T*("`@("`-"B`@("`@(&%G<F5E;65N=',@=V%S("0Q.2PY
M,C,L("0R-"PX.#8L(&%N9"`D,C0L.#@V(&1U<FEN9R!Y96%R<PT*("`@(`T*
M("`@("`@96YD960@1&5C96UB97(@,S$L(#(P,3(L(#(P,3$L(&%N9"`R,#$P
M+"!R97-P96-T:79E;'DL(&%N9"!I<PT*("`@#0H@("`@("!E>'!E8W1E9"!T
M;R!B92`D,3`L,#`P+"`D,3`L,#`P+"`D+3`M+"`D+3`M+"!A;F0@)"TP+2!F
M;W(-"B`@("`-"B`@("`@(&5A8V@@;V8@=&AE(&YE>'0@9FEV92!Y96%R<RP@
M<F5S<&5C=&EV96QY+CPO9F]N=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEM<&%I<FUE;G0@;W(@1&ES
M<&]S86P@;V8@3&]N9RU,:79E9"!!<W-E=',L(%!O;&EC>2!;4&]L:6-Y(%1E
M>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DEM<&%I<FUE
M;G0-"B`@("`-"B`@("`@(&]F($QO;F<M3&EV960@07-S971S/"]F;VYT/@T*
M("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P="<^5V4-"B`@#0H@("`@("!R979I97<@;&]N9RUL:79E9"!A
M<W-E=',@9F]R(&EM<&%I<FUE;G0@=VAE;F5V97(@979E;G1S(&]R#0H@("`@
M(`T*("`@("`@8VAA;F=E<R!I;B!C:7)C=6US=&%N8V5S(&EN9&EC871E('1H
M870@=&AE(&-A<G)Y:6YG(&%M;W5N="!O9@T*("`@#0H@("`@("!A;B!A<W-E
M="!M87D@;F]T(&)E(')E8V]V97)A8FQE+B8C,38P.R8C,38P.U)E8V]V97)A
M8FEL:71Y(&]F#0H@#0H@("`@("!A<W-E=',@=&\@8F4@:&5L9"!A;F0@=7-E
M9"!I<R!M96%S=7)E9"!B>2!A(&-O;7!A<FES;VX@;V8@=&AE#0H@("`-"B`@
M("`@(&-A<G)Y:6YG(&%M;W5N="!O9B!T:&4@87-S971S('1O('1H92!F=71U
M<F4@;F5T(&-A<V@@9FQO=W,-"B`@("`@#0H@("`@("!E>'!E8W1E9"!T;R!B
M92!G96YE<F%T960@8GD@<W5C:"!A<W-E=',N)B,Q-C`[)B,Q-C`[268@=V4-
M"B`@#0H@("`@("!C;VYS:61E<B!S=6-H(&%S<V5T<R!T;R!B92!I;7!A:7)E
M9"P@=&AE(&EM<&%I<FUE;G0@=&\-"B`-"B`@("`@(&)E/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+5=%24=(5#H@8F]L9"<^)B,Q-C`[
M/"]F;VYT/G)E8V]G;FEZ960-"B`@#0H@("`@("!I<R!M96%S=7)E9"!B>2!T
M:&4@86UO=6YT(&)Y('=H:6-H('1H92!C87)R>6EN9R!A;6]U;G0@;V8@=&AE
M#0H@("`-"B`@("`@(&%S<V5T<R!E>&-E961S('1H92!E>'!E8W1E9"!F=71U
M<F4@;F5T(&-A<V@@9FQO=W,@9G)O;2!T:&4-"B`@("`@#0H@("`@("!A<W-E
M=',N/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!,:6%B:6QI=&EE<R!;4&]L:6-Y
M(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D%C8W)U
M960-"B`@("`-"B`@("`@($QI86)I;&ET:65S/"]F;VYT/@T*(`T*("`@(#PO
M9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!
M<PT*("`-"B`@("`@('!A<G0@;V8@=&AE('!R;V-E<W,@;V8@<')E<&%R:6YG
M(&]U<B!F:6YA;F-I86P@<W1A=&5M96YT<RP@=V4-"B`@(`T*("`@("`@97-T
M:6UA=&4@97AP96YS97,@=&AA="!W92!B96QI979E('=E(&AA=F4@:6YC=7)R
M960L(&)U="!H879E#0H@(`T*("`@("`@;F]T('EE="!B965N(&)I;&QE9"!B
M>2!O=7(@=&AI<F0@<&%R='D@=F5N9&]R<RX@5&AI<R!P<F]C97-S#0H@(`T*
M("`@("`@:6YV;VQV97,@:61E;G1I9GEI;F<@<V5R=FEC97,@86YD(&%C=&EV
M:71I97,@=&AA="!H879E(&)E96X-"B`-"B`@("`@('!E<F9O<FUE9"!B>2!S
M=6-H('9E;F1O<G,@;VX@;W5R(&)E:&%L9B!A;F0@97-T:6UA=&EN9R!T:&4-
M"B`@("`@#0H@("`@("!L979E;"!T;R!W:&EC:"!T:&5Y(&AA=F4@8F5E;B!P
M97)F;W)M960@86YD('1H92!A<W-O8VEA=&5D#0H@("`@(`T*("`@("`@8V]S
M="!I;F-U<G)E9"!F;W(@<W5C:"!S97)V:6-E(&%S(&]F(&5A8V@@8F%L86YC
M92!S:&5E="!D871E#0H@(`T*("`@("`@:6X@;W5R(&9I;F%N8VEA;"!S=&%T
M96UE;G1S+B!%>&%M<&QE<R!O9B!E>'!E;G-E<R!F;W(@=VAI8V@-"B`-"B`@
M("`@('=E(&%C8W)U92!I;F-L=61E(&9E97,@9F]R('!R;V9E<W-I;VYA;"!S
M97)V:6-E<R!A;F0@9F5E<PT*("`@(`T*("`@("`@;W=E9"!T;R!C;VYT<F%C
M="!M86YU9F%C='5R97)S(&EN(&-O;FIU;F-T:6]N('=I=&@@=&AE#0H@#0H@
M("`@("!M86YU9F%C='5R92!O9B!V86-C:6YE<R!F;W(@;W5R(&-L:6YI8V%L
M('1R:6%L<RX@5V4@;6%K90T*("`@#0H@("`@("!T:&5S92!E<W1I;6%T97,@
M8F%S960@=7!O;B!P<F]G<F5S<R!O9B!A8W1I=FET:65S(')E;&%T960@=&\-
M"B`@#0H@("`@("!C;VYT<F%C='5A;"!O8FQI9V%T:6]N<R!A;F0@:6YF;W)M
M871I;VX@<F5C96EV960@9G)O;0T*("`@("`-"B`@("`@('9E;F1O<G,N/"]F
M;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^16%R;FEN9W,@4&5R(%-H87)E+"!0;VQI8WD@6U!O;&EC
M>2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX\9F]N="!S='EL93TS
M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970-
M"B`-"B`@("`@($QO<W,@4&5R(%-H87)E/"]F;VYT/@T*("`@(`T*("`@(#PO
M9&EV/CQB<B\^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"
M87-I8PT*("`@("`-"B`@("`@(&%N9"!D:6QU=&5D(&QO<W,@<&5R(&-O;6UO
M;B!S:&%R92!A<F4@8V]M<'5T960@8F%S960@;VX@=&AE#0H@#0H@("`@("!W
M96EG:'1E9"!A=F5R86=E(&YU;6)E<B!O9B!C;VUM;VX@<VAA<F5S(&]U='-T
M86YD:6YG+B!!;&P-"B`@("`-"B`@("`@(&-O;6UO;B!S:&%R92!E<75I=F%L
M96YT<R`H=VAI8V@@8V]N<VES="!O9B!O<'1I;VYS(&%N9`T*(`T*("`@("`@
M=V%R<F%N=',I(&%R92!E>&-L=61E9"!F<F]M('1H92!C;VUP=71A=&EO;B!O
M9B!D:6QU=&5D(&QO<W,-"B`-"B`@("`@('!E<B!S:&%R92!S:6YC92!T:&4@
M969F96-T('=O=6QD(&)E(&%N=&DM9&EL=71I=F4N($-O;6UO;@T*("`@(`T*
M("`@("`@<VAA<F4@97%U:79A;&5N=',@=VAI8V@@8V]U;&0@<&]T96YT:6%L
M;'D@9&EL=71E(&)A<VEC#0H@#0H@("`@("!E87)N:6YG<R!P97(@<VAA<F4@
M:6X@=&AE(&9U='5R92P@86YD('=H:6-H('=E<F4@97AC;'5D960-"B`@("`-
M"B`@("`@(&9R;VT@=&AE(&-O;7!U=&%T:6]N(&]F(&1I;'5T960@;&]S<R!P
M97(@<VAA<F4L('1O=&%L960-"B`@#0H@("`@("!A<'!R;WAI;6%T96QY(#$R
M+C,@;6EL;&EO;BP@,BXX(&UI;&QI;VXL(&%N9"`R+C`@;6EL;&EO;B!A=`T*
M(`T*("`@("`@1&5C96UB97(@,S$L(#(P,3(L(#(P,3$@86YD(#(P,3`L(')E
M<W!E8W1I=F5L>2X\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2979E;G5E(%)E8V]G;FET:6]N
M+"!0;VQI8WD@6U!O;&EC>2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY2979E;G5E#0H@(`T*("`@("`@4F5C;V=N:71I;VX\+V9O
M;G0^#0H@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/E=E#0H@(`T*("`@("`@<F5C;V=N:7IE(')E=F5N=64@
M:6X@86-C;W)D86YC92!W:71H('1H92!314,F(S@R,3<[<R!3=&%F9@T*("`@
M(`T*("`@("`@06-C;W5N=&EN9R!"=6QL971I;B!.;RX@,3`Q+"`\9F]N="!S
M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^
M4F5V96YU90T*("`@(`T*("`@("`@4F5C;V=N:71I;VX@:6X@1FEN86YC:6%L
M(%-T871E;65N=',L/"]F;VYT/B!A<R!A;65N9&5D(&)Y#0H@("`@(`T*("`@
M("`@4W1A9F8@06-C;W5N=&EN9R!"=6QL971I;B!.;RX@,3`T+"`\9F]N="!S
M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN92<^
M4F5V96YU90T*("`@("`-"B`@("`@(%)E8V]G;FET:6]N+#PO9F]N=#X@*"8C
M.#(R,#M304(@,3`T)B,X,C(Q.RDN(%-!0B`Q,#0@<')O=FED97,-"B`@#0H@
M("`@("!G=6ED86YC92!I;B!A<'!L>6EN9R!'04%0('1O(')E=F5N=64@<F5C
M;V=N:71I;VX@:7-S=65S+"!A;F0-"B`@#0H@("`@("!S<&5C:69I8V%L;'D@
M861D<F5S<V5S(')E=F5N=64@<F5C;V=N:71I;VX@9F]R('5P9G)O;G0L#0H@
M(`T*("`@("`@;F]N<F5F=6YD86)L92!F965S(')E8V5I=F5D(&EN(&-O;FYE
M8W1I;VX@=VET:"!R97-E87)C:`T*("`-"B`@("`@(&-O;&QA8F]R871I;VX@
M86=R965M96YT<RXF(S$V,#LF(S$V,#M$=7)I;F<@,C`Q,BP@,C`Q,2!A;F0-
M"B`@(`T*("`@("`@,C`Q,"P@;W5R(')E=F5N=64@8V]N<VES=&5D(&]F(&=R
M86YT(&9U;F1I;F<@<F5C96EV960-"B`@("`@#0H@("`@("!P<FEM87)I;'D@
M9G)O;2!T:&4@3DE(("AS964@3F]T92`S*2XF(S$V,#LF(S$V,#M2979E;G5E
M(&9R;VT-"B`@("`@#0H@("`@("!T:&ES(&%R<F%N9V5M96YT(&ES(&%P<')O
M>&EM871E;'D@97%U86P@=&\@=&AE(&-O<W1S(&EN8W5R<F5D#0H@("`-"B`@
M("`@(&%N9"!I<R!R96-O<F1E9"!A<R!I;F-O;64@87,@=&AE(')E;&%T960@
M8V]S=',@87)E#0H@(`T*("`@("`@:6YC=7)R960N/"]F;VYT/CPO9&EV/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4F5S96%R8V@@86YD($1E=F5L;W!M96YT($5X<&5N<V4L(%!O;&EC>2!;4&]L
M:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E
M<V5A<F-H#0H@("`@(`T*("`@("`@86YD($1E=F5L;W!M96YT($5X<&5N<V4\
M+V9O;G0^#0H@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($9/3E0M4TE:13H@,3!P="<^4F5S96%R8V@-"B`@(`T*("`@("`@86YD(&1E
M=F5L;W!M96YT(&5X<&5N<V4@<')I;6%R:6QY(&-O;G-I<W1S(&]F(&-O<W1S
M(&EN8W5R<F5D#0H@(`T*("`@("`@:6X@=&AE(&1I<V-O=F5R>2P@9&5V96QO
M<&UE;G0L('1E<W1I;F<@86YD(&UA;G5F86-T=7)I;F<@;V8-"B`-"B`@("`@
M(&]U<B!P<F]D=6-T(&-A;F1I9&%T97,N(%1H97-E(&5X<&5N<V5S(&-O;G-I
M<W0@<')I;6%R:6QY(&]F#0H@#0H@("`@("`H:2D@9F5E<R!P86ED('1O('1H
M:7)D+7!A<G1Y('-E<G9I8V4@<')O=FED97)S('1O('!E<F9O<FTL#0H@("`@
M(`T*("`@("`@;6]N:71O<B!A;F0@86-C=6UU;&%T92!D871A(')E;&%T960@
M=&\@;W5R('!R96-L:6YI8V%L#0H@#0H@("`@("!S='5D:65S(&%N9"!C;&EN
M:6-A;"!T<FEA;',L("AI:2D@8V]S=',@<F5L871E9"!T;R!S<&]N<V]R960-
M"B`@#0H@("`@("!R97-E87)C:"!A9W)E96UE;G1S+"`H:6EI*2!T:&4@8V]S
M=',@=&\@<')O8W5R92!A;F0-"B`@(`T*("`@("`@;6%N=69A8W1U<F4@;6%T
M97)I86QS('5S960@:6X@8VQI;FEC86P@=')I86QS+"`H:78I#0H@("`-"B`@
M("`@(&QA8F]R871O<GD@<W5P<&QI97,@86YD(&9A8VEL:71Y+7)E;&%T960@
M97AP96YS97,@=&\@8V]N9'5C=`T*("`-"B`@("`@(&1E=F5L;W!M96YT+"!A
M;F0@*'8I('-A;&%R:65S+"!B96YE9FET<RP@86YD('-H87)E+6)A<V5D#0H@
M("`-"B`@("`@(&-O;7!E;G-A=&EO;B!F;W(@<&5R<V]N;F5L+B8C,38P.R8C
M,38P.U1H97-E(&-O<W1S(&%R90T*("`@(`T*("`@("`@8VAA<F=E9"!T;R!E
M>'!E;G-E(&%S(&EN8W5R<F5D+CPO9F]N=#X\+V1I=CX\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&%N9VEB;&4@
M07-S971S+"!&:6YI=&4M3&EV960L(%!O;&EC>2!;4&]L:6-Y(%1E>'0@0FQO
M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4U19
M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E!A=&5N=`T*(`T*("`@
M("`@0V]S=',\+V9O;G0^#0H@("`@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=7(-"B`@(`T*("`@("`@
M97AP96YD:71U<F5S(')E;&%T:6YG('1O(&]B=&%I;FEN9R!A;F0@<')O=&5C
M=&EN9R!P871E;G1S(&%R90T*("`@#0H@("`@("!C:&%R9V5D('1O(&5X<&5N
M<V4@=VAE;B!I;F-U<G)E9"P@86YD(&%R92!I;F-L=61E9"!I;B!G96YE<F%L
M#0H@("`-"B`@("`@(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E+CPO9F]N
M=#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!E<FEO9"!T;R!097)I;V0@0V]M<&%R:7-O;G,@6U!O;&EC
M>2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX\9F]N="!S='EL93TS
M1"=&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097)I
M;V0-"B`@("`-"B`@("`@('1O(%!E<FEO9"!#;VUP87)I<V]N<SPO9F]N=#X-
M"B`-"B`@("`\+V1I=CX\8G(O/CQD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P="<^3W5R#0H@("`-"B`@("`@(&]P97)A=&EN9R!R97-U;'1S(&%R
M92!E>'!E8W1E9"!T;R!F;'5C='5A=&4@9F]R('1H90T*("`@#0H@("`@("!F
M;W)E<V5E86)L92!F=71U<F4N(%1H97)E9F]R92P@<&5R:6]D+71O+7!E<FEO
M9"!C;VUP87)I<V]N<PT*(`T*("`@("`@<VAO=6QD(&YO="!B92!R96QI960@
M=7!O;B!A<R!P<F5D:6-T:79E(&]F('1H92!R97-U;'1S(&9O<@T*("`@("`-
M"B`@("`@(&9U='5R92!P97)I;V1S+B8C,38P.R8C,38P.T-E<G1A:6X@<')I
M;W(@>65A<B!A;6]U;G1S(&AA=F4-"B`@(`T*("`@("`@8F5E;B!R96-L87-S
M:69I960@=&\@8V]N9F]R;2!T;R!T:&4@8W5R<F5N="!Y96%R(&9I;F%N8VEA
M;`T*("`@("`-"B`@("`@('-T871E;65N="!P<F5S96YT871I;VXN/"]F;VYT
M/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^26YC;VUE(%1A>"P@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C
M:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^/&9O;G0@<W1Y;&4],T0G1D].5"U35%E,
M13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P="<^26YC;VUE#0H@(`T*("`@
M("`@5&%X97,\+V9O;G0^#0H@("`@(`T*("`@(#PO9&EV/CQB<B\^/&1I=B!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@
M5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY790T*("`-"B`@("`@(&%C
M8V]U;G0@9F]R(&EN8V]M92!T87AE<R!U<VEN9R!T:&4@;&EA8FEL:71Y(&UE
M=&AO9"X@56YD97(-"B`@("`@#0H@("`@("!T:&ES(&UE=&AO9"P@9&5F97)R
M960@=&%X(&%S<V5T<R!A;F0@;&EA8FEL:71I97,@87)E#0H@("`@#0H@("`@
M("!R96-O9VYI>F5D(&9O<B!T:&4@97-T:6UA=&5D(&9U='5R92!T87@@8V]N
M<V5Q=65N8V5S#0H@("`@#0H@("`@("!A='1R:6)U=&%B;&4@=&\@9&EF9F5R
M96YC97,@8F5T=V5E;B!T:&4@9FEN86YC:6%L('-T871E;65N=`T*(`T*("`@
M("`@8V%R<GEI;F<@86UO=6YT<R!O9B!E>&ES=&EN9R!A<W-E=',@86YD(&QI
M86)I;&ET:65S(&%N9"!T:&5I<@T*("`@#0H@("`@("!R97-P96-T:79E('1A
M>"!B87-E<RXF(S$V,#LF(S$V,#M$969E<G)E9"!T87@@87-S971S(&%N9`T*
M(`T*("`@("`@;&EA8FEL:71I97,@87)E(&UE87-U<F5D('5S:6YG(&5N86-T
M960@<F%T97,@:6X@969F96-T(&9O<@T*("`@("`-"B`@("`@('1H92!Y96%R
M(&EN('=H:6-H('1E;7!O<F%R>2!D:69F97)E;F-E<R!A<F4@97AP96-T960@
M=&\@8F4-"B`@("`@#0H@("`@("!R96-O=F5R960@;W(@<V5T=&QE9"XF(S$V
M,#LF(S$V,#M$969E<G)E9"!T87@@87-S971S(&%R90T*(`T*("`@("`@<F5D
M=6-E9"!B>2!A('9A;'5A=&EO;B!A;&QO=V%N8V4@=6YL97-S+"!I;B!T:&4@
M;W!I;FEO;B!O9@T*("`@("`-"B`@("`@(&UA;F%G96UE;G0L(&ET(&ES(&UO
M<F4@;&EK96QY('1H86X@;F]T('1H870@<V]M92!P;W)T:6]N(&]R#0H@#0H@
M("`@("!A;&P@;V8@=&AE(&1E9F5R<F5D('1A>"!A<W-E=',@=VEL;"!B92!R
M96%L:7IE9"X\+V9O;G0^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92UB87-E9"!#;VUP96YS871I
M;VXL($]P=&EO;B!A;F0@26YC96YT:79E(%!L86YS(%!O;&EC>2!;4&]L:6-Y
M(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E-T;V-K
M+4)A<V5D#0H@("`@#0H@("`@("!#;VUP96YS871I;VX\+V9O;G0^/&)R("\^
M#0H@("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*("`@(`T*("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/E=E#0H@(`T*("`@("`@86-C;W5N="!F;W(@<W1O8VLM
M8F%S960@=')A;G-A8W1I;VYS(&EN('=H:6-H('1H92!#;VUP86YY#0H@("`@
M#0H@("`@("!R96-E:79E<R!S97)V:6-E<R!F<F]M(&5M<&QO>65E<RP@9&ER
M96-T;W)S(&]R(&]T:&5R<R!I;@T*("`@#0H@("`@("!E>&-H86YG92!F;W(@
M97%U:71Y(&EN<W1R=6UE;G1S(&)A<V5D(&]N('1H92!F86ER('9A;'5E(&]F
M#0H@("`@(`T*("`@("`@=&AE(&%W87)D(&%T('1H92!G<F%N="!D871E+B8C
M,38P.R8C,38P.T-O;7!E;G-A=&EO;B!C;W-T(&9O<@T*(`T*("`@("`@87=A
M<F1S(&]F(&-O;6UO;B!S=&]C:R!I<R!E<W1I;6%T960@8F%S960@;VX@=&AE
M('!R:6-E(&]F('1H90T*("`@#0H@("`@("!U;F1E<FQY:6YG(&-O;6UO;B!S
M=&]C:R!O;B!T:&4@9&%T92!O9@T*("`@("`-"B`@("`@(&ES<W5A;F-E+B8C
M,38P.R8C,38P.T-O;7!E;G-A=&EO;B!C;W-T(&9O<B!S=&]C:R!O<'1I;VYS
M(&]R#0H@("`@#0H@("`@("!W87)R86YT<R!I<R!E<W1I;6%T960@870@=&AE
M(&=R86YT(&1A=&4@8F%S960@;VX@96%C:`T*("`@("`-"B`@("`@(&EN<W1R
M=6UE;G0F(S@R,3<[<R!F86ER('9A;'5E(&%S(&-A;&-U;&%T960@8GD@=&AE
M#0H@#0H@("`@("!";&%C:RU38VAO;&5S(&]P=&EO;B!P<FEC:6YG(&UO9&5L
M+B8C,38P.R8C,38P.U=E(')E8V]G;FEZ90T*("`@(`T*("`@("`@<W1O8VLM
M8F%S960@8V]M<&5N<V%T:6]N(&-O<W0@87,@97AP96YS92!R871A8FQY(&]N
M(&$-"B`@("`@#0H@("`@("!S=')A:6=H="UL:6YE(&)A<VES(&]V97(@=&AE
M(')E<75I<VET92!S97)V:6-E('!E<FEO9"!F;W(@=&AE#0H@("`-"B`@("`@
M(&%W87)D+B8C,38P.R8C,38P.U-E92!.;W1E(#8@9F]R(&%D9&ET:6]N86P@
M<W1O8VLM8F%S960-"B`@("`@#0H@("`@("!C;VUP96YS871I;VX@:6YF;W)M
M871I;VXN/"]F;VYT/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5W($%C8V]U;G1I;F<@4')O;F]U;F-E
M;65N=',L(%!O;&EC>2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E)E8V5N=`T*(`T*("`@("`@06-C;W5N=&EN9R!0
M<F]N;W5N8V5M96YT<SPO9F]N=#X-"B`@("`@#0H@("`@/"]D:78^/&)R+SX\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E1H97)E#0H@("`@
M(`T*("`@("`@:&%V92!B965N(&YO(')E8V5N="!A8V-O=6YT:6YG('!R;VYO
M=6YC96UE;G1S(&]R(&-H86YG97,@:6X-"B`-"B`@("`@(&%C8V]U;G1I;F<@
M<')O;F]U;F-E;65N=',@=VAI8V@@=V4@97AP96-T('1O(&AA=F4@82!M871E
M<FEA;`T*("`-"B`@("`@(&EM<&%C="!O;B!O=7(@9FEN86YC:6%L('-T871E
M;65N=',L(&YO<B!D;R!W92!B96QI979E('1H870-"B`@("`@#0H@("`@("!A
M;GD@<F5C96YT;'D@:7-S=65D+"!B=70@;F]T('EE="!E9F9E8W1I=F4L(&%C
M8V]U;G1I;F<-"B`-"B`@("`@('-T86YD87)D<R!I9B!C=7)R96YT;'D@861O
M<'1E9"!W;W5L9"!H879E(&$@;6%T97)I86P@969F96-T#0H@#0H@("`@("!O
M;B!O=7(@9FEN86YC:6%L('-T871E;65N=',N/"]F;VYT/CPO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?
M.#DR,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y
M8S<W-2]7;W)K<VAE971S+U-H965T,C`N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY.;W1E(#(@+2!3=6UM87)Y(&]F(%-I9VYI
M9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,@*%1A8FQE<RD\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y+"!0;&%N
M="!A;F0@17%U:7!M96YT(%M486)L92!497AT($)L;V-K73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C
M96QL<W!A8VEN9STS1#`@=VED=&@],T0Y-R4@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86XG/@T*("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R<^#0H@("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M,G!X)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,CPO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)
M3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,3$\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]4
M5$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@
M(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@
M("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY,86)O<F%T;W)Y#0H@("`-"B`@("`@("`@("`@("`@97%U:7!M96YT/"]F
M;VYT/@T*("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^
M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C,X."PP,#`\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXS.#@L,#`P/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^3&5A<V5H;VQD
M#0H@(`T*("`@("`@("`@("`@("!I;7!R;W9E;65N=',\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C$Q-2PV,#4\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^,3$U+#8P-3PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K
M9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@
M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^3W1H97(-"B`@(`T*("`@("`@("`@("`@("!F=7)N:71U<F4L(&9I
M>'1U<F5S("9A;7`[(&5Q=6EP;65N=#PO9F]N=#X-"B`@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(X+#8X-3PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C@L-C@U/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A;`T*
M("`@#0H@("`@("`@("`@("`@('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+V9O
M;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C4S,BPR.3`\+V9O;G0^#0H@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^-3,R+#(Y,#PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<B!S='EL
M93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@("`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^06-C=6UU;&%T960-"B`@("`-"B`@("`@("`@("`@
M("`@9&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X
M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH
M-#(Y+#@P-#PO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,S4V+#`X-#PO9F]N=#X-
M"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^4')O<&5R='D-"B`-"B`@("`@("`@("`@("`@86YD
M(&5Q=6EP;65N="P@;F5T/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^,3`R+#0X-CPO9F]N=#X-"B`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXQ-S8L,C`V/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@
M("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C
M.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S+U-H965T,C$N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5-0T%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-B`M
M(%-T;V-K:&]L9&5R<R<@17%U:71Y("A486)L97,I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;&QO8V%T:6]N(&]F($YE="!0
M<F]C965D<R!F<F]M(%!R969E<G)E9"!3=&]C:R!&:6YA;F-I;F<@6U1A8FQE
M(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS
M1#DU)2!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;B<^#0H@(`T*("`@("`@("`@(#QT<B!S='EL93TS
M1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@#0H@("`@("`@("`@
M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@U
M)3X-"B`@("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/DYE=`T*("`@#0H@("`@("`@("`@("`@("`@<')O
M8V5E9',@869T97(@=')A;G-A8W1I;VX@8V]S=',\+V9O;G0^#0H@(`T*("`@
M("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/@T*("`@("`-"B`@("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,2PY.3DL,#,R/"]F;VYT
M/CPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@
M("`@("`@("`F(S$V,#L-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT<CX-"B`-"B`@
M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.#4E/@T*("`@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^3&5S<SHF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#L-"B`@("`@#0H@("`@("`@("`@("`@("`@)B,Q-C`[
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D9A:7(-"B`@("`-
M"B`@("`@("`@("`@("`@("!V86QU92!O9B!W87)R86YT<R`H<F5C;W)D960@
M=&\@061D:71I;VYA;"!086ED+6EN#0H@#0H@("`@("`@("`@("`@("`@0V%P
M:71A;"D\+V9O;G0^/"]F;VYT/@T*(`T*("`@("`@("`@("`@("`\+V1I=CX-
M"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D
M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@
M(`T*("`@("`@("`@("`@("`F(S$V,#L-"B`@("`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-
M"B`@("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T
M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B@Q+#$R-RPT,3@\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@
M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/BD\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-
M"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G
M8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@
M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X-24@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@4$%$1$E.1RU,1494.B`P
M<'0[($U!4D=)3BU,1494.B`Y<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#,V<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@(`T*("`@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"96YE9FEC
M:6%L#0H@("`@(`T*("`@("`@("`@("`@("`@(&-O;G9E<G-I;VX@9F5A='5R
M92`H<F5C;W)D960@=&\@061D:71I;VYA;"!086ED+6EN#0H@(`T*("`@("`@
M("`@("`@("`@($-A<&ET86PI/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`@
M(#PO9&EV/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`-"B`@("`@("`@("`@("`@)B,Q
M-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`-"B`@("`@("`@("`@("`@)B,Q-C`[#0H@("`@(`T*("`@("`@
M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE)SXH-S8R+#8V-SPO9F]N=#X\+V9O;G0^/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\
M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT
M<CX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.#4E/@T*("`@(`T*("`@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^3F5T#0H@("`-"B`@
M("`@("`@("`@("`@("!P<F]C965D<R!A;&QO8V%T960@=&\@<')E9F5R<F5D
M('-T;V-K/"]F;VYT/@T*("`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*
M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@("`@("`@
M("8C,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`F
M(S$V,#L-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/C$P."PY-#<\+V9O;G0^/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@("8C
M,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@
M("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`-"B`@("`@("`@("`@(#QT9"!A;&EG
M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#4E('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@/&1I
M=B!S='EL93TS1"=,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)R!A;&EG;CTS1&QE9G0^#0H@#0H@("`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D%C8W)E=&EO;@T*
M("`@(`T*("`@("`@("`@("`@("`@(&]F(&)E;F5F:6-I86P@8V]N=F5R<VEO
M;B!F96%T=7)E("AD965M960-"B`@#0H@("`@("`@("`@("`@("`@9&EV:61E
M;F0I/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G/@T*("`@#0H@("`@("`@("`@("`@("8C,38P.PT*("`@("`-"B`@
M("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@
M("`@("`@("`@("8C,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@
M("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN92<^-S8R+#8V-SPO9F]N=#X\+V9O;G0^/"]F;VYT/@T*("`@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@#0H@
M("`@("`@("`@("`@("8C,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@/"]T<CX-"B`@#0H@("`@("`@("`@/'1R/@T*
M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0X-24^#0H@("`@#0H@("`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);FET:6%L#0H@(`T*("`@
M("`@("`@("`@("`@(&-A<G)Y:6YG('9A;'5E(&]F('!R969E<G)E9"!S=&]C
M:SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@
M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@)B,Q
M-C`[#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`@("8C,38P
M.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^.#<Q+#8Q-#PO9F]N=#X\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@)B,Q-C`[
M#0H@("`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\
M+W1R/@T*("`-"B`@("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC
M;VQO<CH@(T,P1D9&1CLG/@T*(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$
M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X-24@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)TQ)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`-"B`@("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^0V]N=F5R<VEO;G,-"B`-
M"B`@("`@("`@("`@("`@("!T;R!C;VUM;VX@<W1O8VL\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D
M/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@#0H@
M("`@("`@("`@("`@("8C,38P.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`@("8C,38P
M.PT*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#4U.2PT,3@\
M+V9O;G0^/"]F;VYT/CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO=&0^
M#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@
M(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*
M("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@86QI9VX]
M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@U)2!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/@T*(`T*("`@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87)R>6EN9PT*("`@
M#0H@("`@("`@("`@("`@("`@=F%L=64@;V8@<')E9F5R<F5D('-T;V-K(&%T
M($1E8V5M8F5R(#,Q+`T*("`-"B`@("`@("`@("`@("`@("`R,#$R/"]F;VYT
M/@T*("`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@
M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G/@T*
M("`@#0H@("`@("`@("`@("`@("8C,38P.PT*("`@("`-"B`@("`@("`@("`@
M(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C,Q,BPQ.38\+V9O
M;G0^/"]F;VYT/CPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@
M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@(`T*("`@("`@("`@("`@("`F(S$V
M,#L-"B`@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@
M(#PO='(^#0H@(`T*("`@("`@("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@4VAA
M<F4M8F%S960@0V]M<&5N<V%T:6]N+"!3=&]C:R!/<'1I;VYS+"!!8W1I=FET
M>2!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P
M('=I9'1H/3-$,3`P)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^
M#0H@#0H@("`@("`@(#QT<B!S='EL93TS1"=415A4+4%,24=..B!L969T.R<^
M#0H@("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^3G5M8F5R/"]F;VYT/@T*
M("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@(#QD
M:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@
M,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/F]F#0H@
M("`@(`T*("`@("`@("`@("`@("!3:&%R97,\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY796EG:'1E9"T\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS
M1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^079E<F%G93PO9F]N=#X-
M"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^17AE
M<F-I<V4\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@
M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E
M<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY0<FEC93PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO9&EV
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E
M<B<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/E=E:6=H=&5D+3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-
M"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY!=F5R86=E/"]F;VYT/@T*("`@#0H@("`@("`@
M("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY296UA:6YI;F<\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M0V]N=')A8W1U86P\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@
M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C
M96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^5&5R;0T*("`-"B`@("`@("`@("`@("`@*'ER<RD\
M+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D%G9W)E9V%T93PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY);G1R:6YS:6,\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^5F%L=64\+V9O;G0^#0H@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE
M/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=71S=&%N9&EN9PT*("`@(`T*("`@
M("`@("`@("`@("!A="!$96-E;6)E<B`S,2P@,C`Q,3PO9F]N=#X-"B`@(`T*
M("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXY,C@L,C0R/"]F;VYT/@T*(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C4N-#,\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\
M+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/D=R86YT960\+V9O;G0^#0H@("`-"B`@("`@("`@
M("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^,C,X+#4P,#PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^/&9O;G0@:60],T1404(Q+30S-2!S='EL93TS1"=-05)'24XM
M3$5&5#H@,S9P="<^/"]F;VYT/C`N-S`\+V9O;G0^#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A
M8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY%>&5R8VES960\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^/&9O;G0@:60],T1404(Q+30S-B!S='EL93TS1"=-05)'
M24XM3$5&5#H@,S9P="<^/"]F;VYT/BT\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A
M;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@(`T*("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/D9O<F9E:71E9`T*("`-"B`@("`@("`@("`@("`@;W(@97AP:7)E9#PO
M9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P
M>"<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.3<L-C`Q/"]F;VYT/@T*
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M-#,W('-T
M>6QE/3-$)TU!4D=)3BU,1494.B`S-G!T)SX\+V9O;G0^-"XP,CPO9F]N=#X-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T
M)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,
M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4]
M,T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@
M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!
M63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/D]U='-T86YD:6YG#0H@("`@#0H@("`@("`@("`@("`@
M(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/@T*("`@#0H@("`@("`@("`@
M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!
M3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$L,#8Y+#$T
M,3PO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+C4P/"]F;VYT/@T*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T
M)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M-#,X('-T>6QE/3-$
M)TU!4D=)3BU,1494.B`S-G!T)SX\+V9O;G0^-BXR/"]F;VYT/@T*("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^+3`M/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`T<'@G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@
M(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#4R)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^17AE
M<F-I<V%B;&4-"B`@("`-"B`@("`@("`@("`@("`@870@1&5C96UB97(@,S$L
M(#(P,3(\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^-CDX+#DY-3PO9F]N=#X-"B`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-
M"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^-BXS.#PO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^
M#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O
M;G0@:60],T1404(Q+30S.2!S='EL93TS1"=-05)'24XM3$5&5#H@,S9P="<^
M/"]F;VYT/C0N-CPO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-
M"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BTP+3PO9F]N=#X-
M"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@(#PO=&%B;&4^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M9&1I=&EO;F%L($EN9F]R;6%T:6]N($-O;F-E<FYI;F<@4W1O8VL@3W!T:6]N
M<R!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P
M('=I9'1H/3-$,3`P)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^
M#0H@("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R<^#0H@("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^
M#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,CPO9F]N=#X-
M"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@("`@
M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E
M<B<^#0H@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/C(P,3`\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G
M/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<B!S
M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@("`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4U)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD
M:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N
M,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY796EG
M:'1E9`T*(`T*("`@("`@("`@("`@("!A=F5R86=E(&9A:7(@=F%L=64@;V8@
M;W!T:6]N<R!G<F%N=&5D(&1U<FEN9R!T:&4-"B`@(`T*("`@("`@("`@("`@
M("!P97)I;V0\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\
M+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C4Y/"]F;VYT/@T*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O
M;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXP+C<Y/"]F;VYT/@T*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR+CDU/"]F;VYT/@T*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@
M("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#4U)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY);G1R:6YS:6,-"B`@#0H@("`@("`@("`@("`@('9A;'5E
M(&]F(&]P=&EO;G,@97AE<F-I<V5D(&1U<FEN9R!T:&4@<&5R:6]D/"]F;VYT
M/@T*("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@
M("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^
M#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#4U)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY4;W1A;`T*("`@#0H@("`@("`@("`@("`@(&9A:7(@=F%L=64@;V8@
M;W!T:6]N<R!V97-T960@9'5R:6YG('1H92!P97)I;V0\+V9O;G0^#0H@("`@
M#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^,S$Y+#DR,#PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXU-#`L,S,Y/"]F;VYT/@T*(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C0Y.2PU-3<\+V9O;G0^#0H@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@
M("`@/"]T86)L93X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(%-H87)E+6)A<V5D(%!A>6UE;G0@
M07=A<F0L(%-T;V-K($]P=&EO;G,L(%9A;'5A=&EO;B!!<W-U;7!T:6]N<R!;
M5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('=I
M9'1H/3-$,3`P)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^#0H@
M("`-"B`@("`@("`@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[)SX-
M"B`@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#4U)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P
M86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,CPO9F]N=#X-"B`@("`@#0H@
M("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N
M=&5R)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$Q
M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R
M)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*
M("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z
M("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-34E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/E=E:6=H=&5D#0H@#0H@("`@("`@("`@("`@(&%V
M97)A9V4@<FES:RUF<F5E(&EN=&5R97-T(')A=&5S/"]F;VYT/@T*("`@("`-
M"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXQ+C$\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^,2XT/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B4\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/C(N-CPO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T
M<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-34E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D5X<&5C=&5D#0H@#0H@("`@
M("`@("`@("`@(&1I=FED96YD('EI96QD/"]F;VYT/@T*("`-"B`@("`@("`@
M("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXP+C`\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)3PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,"XP
M/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B4\+V9O;G0^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C`N,#PO9F]N
M=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@
M#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&
M1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#4U)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY%>'!E8W1E9`T*(`T*("`@("`@("`@("`@("!L:69E(&]F
M(&]P=&EO;B`H>7)S*3PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+C<\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@("`-"B`@("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C<\+V9O;G0^
M#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3,E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@
M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXV+C<\+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#4U)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%>'!E8W1E9`T*(`T*("`@("`@
M("`@("`@("!V;VQA=&EL:71Y/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,3`U
M+C(\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3$N
M,CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B4\+V9O
M;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R
M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$Q,BXY
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)3PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@/"]T86)L93X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($5M<&QO>65E
M(%-E<G9I8V4@4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N+"!!;&QO8V%T:6]N
M(&]F(%)E8V]G;FEZ960@4&5R:6]D($-O<W1S(%M486)L92!497AT($)L;V-K
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'1A8FQE(&-E;&QP
M861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@=VED=&@],T0Q,#`E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SX-"B`@("`-"B`@("`@("`@/'1R
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[)SX-"B`@("`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@
M4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L
M<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@
M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT
M97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^,C`Q,CPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L
M969T)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97(G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)
M1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M,C`Q,3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G
M/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,#PO9F]N=#X-
M"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@
M("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[
M)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-34E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/D=E;F5R86P-"B`@("`@#0H@("`@("`@("`@("`@(&%N9"!A9&UI
M;FES=')A=&EV92!E>'!E;G-E/"]F;VYT/@T*("`@(`T*("`@("`@("`@("`@
M/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C,Q+#DS-CPO9F]N
M=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(X-"PS-3(\+V9O;G0^#0H@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXS-CDL,38Q/"]F;VYT/@T*(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R
M/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0U-24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%
M3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E<V5A<F-H#0H@#0H@("`@
M("`@("`@("`@(&%N9"!D979E;&]P;65N="!E>'!E;G-E/"]F;VYT/@T*(`T*
M("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X
M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW
M."PQ-#`\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$W.2PT,#`\+V9O
M;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT
M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^,C`V+#4P,3PO9F]N=#X-"B`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N
M9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0U-24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/E1O=&%L#0H@("`-"B`@("`@("`@("`@("`@<W1O8VL@;W!T:6]N(&5X<&5N
M<V4\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/C,Q,"PP-S8\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T
M)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-#8S+#<U,CPO
M9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=.
M.B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXU-S4L-C8R/"]F;VYT/@T*(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T
M<CX-"B`@("`@#0H@("`@("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@4W1O8VMH
M;VQD97)S)R!%<75I='D@3F]T92P@5V%R<F%N=',@;W(@4FEG:'1S(%M486)L
M92!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@=VED=&@]
M,T0Q,#`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SX-"B`@#0H@
M("`@("`@(#QT<B!S='EL93TS1"=415A4+4%,24=..B!L969T.R<^#0H@("`@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P
M>"<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,R4@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G
M/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'
M3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/DYU;6)E<@T*("`@(`T*("`@("`@("`@("`@
M("!O9B!3:&%R97,\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!L969T)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R
M)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^5V5I9VAT960-"B`-"B`@("`@("`@("`@("`@
M079E<F%G93PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E
M;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY%>&5R8VES90T*(`T*("`@("`@("`@("`@("!0<FEC
M93PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K
M9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=71S=&%N9&EN9PT*("`@
M(`T*("`@("`@("`@("`@("!A="!$96-E;6)E<B`S,2P@,C`Q,3PO9F]N=#X-
M"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C$L.#<P+#4U.3PO9F]N=#X-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*
M("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^-RXY-CPO9F]N=#X-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@
M/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)
M3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*
M("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^27-S=65D#0H@("`@#0H@("`@("`@("`@("`@("8C.#(Q,3L@
M4V5R:65S($$@5V%R<F%N=',@*#$I/"]F;VYT/@T*(`T*("`@("`@("`@("`@
M/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(L
M.3,S+#,S,SPO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C$N,#`\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<B!S='EL93TS
M1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@("`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY)<W-U960-"B`@
M("`-"B`@("`@("`@("`@("`@)B,X,C$Q.R!397)I97,@0B!787)R86YT<R`H
M,2D\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,BPY,S,L,S,S/"]F;VYT/@T*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,"XW-3PO9F]N=#X-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*
M("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^27-S=65D#0H@("`@#0H@("`@("`@
M("`@("`@("8C.#(Q,3L@4V5R:65S($,@5V%R<F%N=',@*#$I/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H
M="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/C(L.3,S+#,S,SPO9F]N=#X-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$N,#`\+V9O;G0^#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@
M("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^
M#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#<P)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@
M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY)<W-U960-"B`@("`-"B`@("`@("`@("`@("`@)B,X,C$Q.R!/=&AE
M<B!787)R86YT<R`H,BD\+V9O;G0^#0H@("`-"B`@("`@("`@("`@(#PO9&EV
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@
M<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV,3(L,#`Q
M/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$N
M,#`\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D5X97)C:7-E9#PO
M9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^+2T\+V9O;G0^#0H@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^+2T\+V9O;G0^#0H@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@
M("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*
M("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W
M,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ
M(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D9O<F9E:71E9`T*("`-"B`@("`@
M("`@("`@("`@;W(@97AP:7)E9#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@
M/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-3<L,#`P
M/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-RXP,#PO9F]N=#X-"B`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`T<'@G/@T*
M("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY/=71S=&%N9&EN9PT*("`@(`T*("`@("`@("`@
M("`@("!A="!$96-E;6)E<B`S,2P@,C`Q,CPO9F]N=#X-"B`@(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C$Q
M+#(R-2PU-3D\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-
M"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,BXP-CPO9F]N
M=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^
M#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<B!S
M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@("`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<P)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-
M"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^17AE<F-I<V%B;&4-"B`@("`-"B`@("`@("`@
M("`@("`@870@1&5C96UB97(@,S$L(#(P,3(\+V9O;G0^#0H@("`-"B`@("`@
M("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX
M+#(Y,"PS-S8\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$58
M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<^#0H@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+C0T/"]F;VYT
M/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)SX-
M"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@(#PO=&%B;&4^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
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M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15!%
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@."`M($EN8V]M92!487AE
M<R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4V-H961U;&4@;V8@1&5F97)R960@5&%X($%S<V5T<R!A;F0@3&EA
M8FEL:71I97,@6U1A8FQE(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C
M:6YG/3-$,"!W:61T:#TS1#$P,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86XG/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[)SX-"B`@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,G!X)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M<'@G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$R
M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,3PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@
M("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z("-#
M,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@
M(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z
M(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$
M969E<G)E9`T*(`T*("`@("`@("`@("`@("!T87@@87-S971S.CPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS
M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU,1494.B`T)2<^
M#0H@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/DYE=`T*(`T*("`@("`@("`@("`@("!O<&5R871I
M;F<@;&]S<R!C87)R>69O<G=A<F0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C0L-#(Y
M+#0W,CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C(T
M+#@W,BPP.#(\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G
M8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU,1494.B`T)2<^#0H@(`T*("`@("`@
M("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%
M24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-
M"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/E)E<V5A<F-H#0H@#0H@("`@("`@("`@("`@(&%N9"!D979E;&]P;65N
M="!T87@@8W)E9&ET(&-A<G)Y9F]R=V%R9#PO9F]N=#X-"B`@#0H@("`@("`@
M("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^-S8S+#DV-3PO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXW-C,L-CDP/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P
M>#L@4$%$1$E.1RU,1494.B`T)2<^#0H@("`-"B`@("`@("`@("`@(#QD:78@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'2%0Z(#$N,C4[
M(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@("`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=&]C:RUB
M87-E9`T*("`@(`T*("`@("`@("`@("`@("!C;VUP96YS871I;VX@97AP96YS
M93PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR+#`Y-RPQ.30\+V9O;G0^#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXQ+#DY,2PW-CD\+V9O;G0^#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C
M:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU,1494.B`T)2<^#0H@(`T*("`@("`@("`@
M("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(
M5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/E1O=&%L#0H@("`-"B`@("`@("`@("`@("`@9&5F97)R960@=&%X(&%S<V5T
M<SPO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C<L,CDP+#8S,3PO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-RPV,C<L-30Q
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C
M:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W,"4@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1&5F97)R960-"B`-"B`@
M("`@("`@("`@("`@=&%X(&QI86)I;&ET:65S/"]F;VYT/@T*("`@#0H@("`@
M("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@
M("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@
M("`@(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)
M3D<M0D]45$]-.B`R<'@[(%!!1$1)3D<M3$5&5#H@-"4G/@T*("`@#0H@("`@
M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M
M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@
M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^1&5P<F5C:6%T:6]N/"]F;VYT/@T*("`@#0H@("`@("`@("`@("`\
M+V1I=CX-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@Q-BPQ,C4\
M+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,S8L,S$Q/"]F;VYT/@T*(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@[(%!!1$1)3D<M3$5&5#H@-"4G
M/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^5&]T86P-"B`@(`T*("`@("`@("`@("`@("!D
M969E<G)E9"!T87@@;&EA8FEL:71I97,\+V9O;G0^#0H@(`T*("`@("`@("`@
M("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-
M"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,38L
M,3(U/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$R)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#,V+#,Q,3PO9F]N=#X-
M"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@(#QT<CX-"B`@("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$
M)V)A8VMG<F]U;F0M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S`E('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL
M93TS1"=415A4+4%,24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DYE=`T*(`T*("`@
M("`@("`@("`@("!D969E<G)E9"!T87@@87-S971S/"]F;VYT/@T*("`-"B`@
M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXR-RPR-S0L-3`V/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$R)2!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/C(W+#4Y,2PR,S`\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*
M("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<P)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^5F%L=6%T
M:6]N#0H@(`T*("`@("`@("`@("`@("!A;&QO=V%N8V4\+V9O;G0^#0H@(`T*
M("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X
M)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q
M-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXH,C<L,C<T+#4P-CPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O
M;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXH,C<L-3DQ+#(S,#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*
M("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&
M1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0W,"4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"
M3U143TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M4$%$1$E.1RU"3U143TTZ(#1P>"<^#0H@("`@#0H@("`@("`@("`@("`F(S$V
M,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/BT\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<^#0H@(`T*("`@
M("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'
M3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3(E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/BT\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#1P>"<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@
M("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4V-H961U;&4@;V8@169F96-T:79E($EN8V]M92!487@@
M4F%T92!296-O;F-I;&EA=&EO;B!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQT86)L92!C96QL<&%D9&EN9STS
M1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;B<^#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#LG/@T*("`@("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.
M1RU"3U143TTZ(#)P>"<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`-"B`@
M("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@8V5N=&5R.R!,
M24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-
M"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/C(P,3(\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^
M#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`@#0H@("`@("`@
M("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(
M14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXR,#$Q/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A;CTS1#(@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@
M/&1I=B!S='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4
M.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q
M,#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R
M/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L
M;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/E4N4RX-"B`@#0H@("`@("`@("`@("`@(&9E
M9&5R86P@<W1A='5T;W)Y(')A=&4@87!P;&EE9"!T;R!P<F5T87@@;&]S<SPO
M9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,30E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^*#<R-2PY-#@\+V9O;G0^#0H@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q-"4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXH-SDW+#DR,3PO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T9#X-
M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-
M"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$T)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B@Y,S0L,#DR/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T.24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4
M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^4&5R;6%N96YT#0H@
M(`T*("`@("`@("`@("`@("!D:69F97)E;F-E<SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C
M,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q-"4@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*
M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SX\9F]N="!I9#TS1%1!0C$M-#0P('-T>6QE/3-$)TU!4D=)3BU,
M1494.B`S,BXQ-7!T)SX\+V9O;G0^,BPV-S0\+V9O;G0^#0H@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C0L,C$V/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@
M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT(&ED/3-$5$%"
M,2TT-#$@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#$Y+C9P="<^/"]F;VYT/B@W
M-RPR,#`\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\
M+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\
M+W1R/@T*("`@("`-"B`@("`@("`@/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M
M8V]L;W(Z("-#,$9&1D8[)SX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P
M=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T)SX-"B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/E)E<V5A<F-H#0H@#0H@("`@("`@("`@
M("`@(&%N9"!D979E;&]P;65N="!C<F5D:71S/"]F;VYT/@T*(`T*("`@("`@
M("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS
M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$T)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/CQF;VYT(&ED/3-$5$%",2TT-#(@<W1Y;&4],T0G34%21TE.+4Q%1E0Z
M(#4W+C=P="<^/"]F;VYT/BT\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@("8C,38P.PT*
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/C,R+#8W-3PO9F]N=#X-"B`@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S
M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@
M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,30E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T1404(Q+30T,R!S
M='EL93TS1"=-05)'24XM3$5&5#H@,C@N-#5P="<^/"]F;VYT/C4Y+#DU.3PO
M9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@
M("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\
M+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T.24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@
M("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T.R!,24Y%
M+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`@
M("`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/D-H86YG90T*("`@(`T*("`@("`@("`@("`@("!I;B!V86QU871I
M;VX@86QL;W=A;F-E/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV
M/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@4$%$1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@#0H@("`@("`@
M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$T)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@:60],T14
M04(Q+30T-"!S='EL93TS1"=-05)'24XM3$5&5#H@,3@N.'!T)SX\+V9O;G0^
M-S(S+#(W-#PO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@
M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q-"4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^#0H@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/C<V
M,2PP,S`\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@)B,Q-C`[#0H@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@
M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$T)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^/&9O;G0@
M:60],T1404(Q+30T-2!S='EL93TS1"=-05)'24XM3$5&5#H@,C$N.'!T)SX\
M+V9O;G0^.34Q+#,S,SPO9F]N=#X-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$
M1$E.1RU"3U143TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[
M#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@
M("`@#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C
M0S!&1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#0Y)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$
M24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^4F5P;W)T960-
M"B`-"B`@("`@("`@("`@("`@:6YC;VUE('1A>"!E>'!E;G-E/"]F;VYT/@T*
M(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@
M-'!X)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q-"4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M+3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!415A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-
M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@
M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q-"4@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@5$585"U!3$E'3CH@<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^+3PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L
M969T)SX-"B`@#0H@("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
M8FQE.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("8C,38P
M.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@
M<FEG:'0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^+3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`@#0H@("`@("`@("`@("`F
M(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R
M/@T*("`@("`-"B`@("`@(#PO=&%B;&4^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
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M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/DYO=&4@,3`@+2!396QE8W1E9"!1=6%R=&5R;'D@1FEN86YC:6%L($1A
M=&$@*'5N875D:71E9"D@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(%%U87)T97)L>2!&:6YA
M;F-I86P@26YF;W)M871I;VX@6U1A8FQE(%1E>'0@0FQO8VM=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P
M(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#DW)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;B<^#0H@(`T*("`@("`@("`\='(@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#LG/@T*("`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@8V]L<W!A;CTS1#$T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0V
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&-E;G1E<B<^#0H@#0H@("`@("`@("`@("`\9&EV('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$R#0H@(`T*("`@
M("`@("`@("`@("!1=6%R=&5R($5N9&5D/"]F;VYT/@T*(`T*("`@("`@("`@
M("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@
M(#QT<CX-"B`@("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-3(E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@8V]L<W!A
M;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N
M=&5R)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-87)C:`T*("`@#0H@("`@("`@("`@
M("`@(#,Q/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^2G5N90T*("`-"B`@("`@("`@
M("`@("`@,S`\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!C96YT97(G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^#0H@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@8V5N=&5R)SX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&-E;G1E<CL@3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY397!T96UB97(-"B`@#0H@
M("`@("`@("`@("`@(#,P/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO
M9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@8V5N=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P
M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&-E;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S
M='EL93TS1"=415A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^1&5C96UB97(-
M"B`-"B`@("`@("`@("`@("`@,S$\+V9O;G0^#0H@("`@(`T*("`@("`@("`@
M("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@4$%$1$E.1RU"3U14
M3TTZ(#)P>"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@#0H@("`@("`@
M(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&1D9&.R<^#0H@
M("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@
M("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@3$E.12U(14E'
M2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^#0H@("`@#0H@
M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY2979E;G5E#0H@("`@(`T*("`@("`@("`@("`@("!F<F]M(&=R86YT<SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXX-30L,#8S/"]F;VYT/@T*(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^
M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/@T*("`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/C<P-2PV.3@\+V9O;G0^#0H@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^-C,X+#`P,#PO
M9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@
M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@
M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^
M)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT-3DL-38V/"]F;VYT/@T*(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N
M;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*
M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@
M("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0U,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^3F5T#0H@#0H@("`@("`@("`@("`@(&QO<W,\+V9O
M;G0^#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@
M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXH-S,P+#4Q,SPO9F]N=#X-"B`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^*#0Y-RPW-C,\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T
M)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@R.38L
M-S<Y/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O
M;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,
M24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-C$P+#`X-3PO9F]N
M=#X-"B`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T<CX-"B`@("`@
M#0H@("`@("`@(#QT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0S!&
M1D9&.R<^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#4R)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-
M"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M3$E.12U(14E'2%0Z(#$N,C4[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^
M#0H@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY.970-"B`-"B`@("`@("`@("`@("`@;&]S<R!P97(@<VAA
M<F4\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXH,"XP-#PO9F]N=#X-"B`@("`-"B`@("`@("`@
M("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@
M("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P
M.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@
M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-
M"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXH,"XP,SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*
M("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*
M("`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0G/BD\+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-
M"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@
M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH
M,"XP,CPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\
M+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XP,SPO9F]N
M=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@
M/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\+V9O;G0^#0H@
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@
M("`-"B`@("`@(#PO=&%B;&4^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL
M<W!A8VEN9STS1#`@=VED=&@],T0Y-R4@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86XG/@T*("`-"B`@("`@("`@/'1R('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[)SX-"B`@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#4R)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0
M041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T.R!0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D
M(&-O;'-P86X],T0Q-"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T-B4@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97(G/@T*(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=4
M15A4+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^,C`Q,0T*("`-"B`@("`@("`@
M("`@("`@475A<G1E<B!%;F1E9#PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO
M9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^
M#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#4R)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/
M33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'
M+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<B<^
M#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4%,24=.
M.B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^36%R8V@-"B`@(`T*("`@("`@("`@("`@("`S
M,3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E
M<B<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT
M97(G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4],T0G5$585"U!
M3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$585"U)3D1%3E0Z
M(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/DIU;F4-"B`@#0H@("`@("`@("`@("`@
M(#,P/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@("`-
M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N
M=&5R)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!415A4+4%,24=..B!C96YT97(G/@T*("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P
M86X],T0R('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E
M;G1E<B<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!C96YT97([($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^4V5P=&5M8F5R#0H@(`T*("`@("`@
M("`@("`@("`S,#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`\+V1I=CX-
M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&-E;G1E<B<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)SX-"B`@#0H@("`@("`@("`@
M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F
M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,
M24=..B!C96YT97(G/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@8V5N=&5R.R!,24Y%+4A%24=(5#H@,2XR-3L@5$58
M5"U)3D1%3E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T)SX-"B`-"B`@("`@("`@("`@("`@/&9O
M;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/D1E8V5M8F5R#0H@#0H@
M("`@("`@("`@("`@(#,Q/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO
M9&EV/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D<M0D]45$]-.B`R
M<'@G/@T*("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@
M<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@(T,P1D9&1CLG/@T*("`@(`T*
M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($Q)3D4M2$5)1TA4.B`Q
M+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/@T*("`@(`T*("`@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^4F5V
M96YU90T*("`@("`-"B`@("`@("`@("`@("`@9G)O;2!G<F%N=',\+V9O;G0^
M#0H@("`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q
M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@
M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B0\+V9O;G0^#0H@("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^.#DS+#`P,CPO9F]N=#X-"B`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-
M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#<U
M,RPP,S,\+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C
M,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@
M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#(Y-RPP,#8\
M+V9O;G0^#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@
M("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO
M9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@
M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@
M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M="<^)#PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@
M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY-38L.#0T/"]F;VYT/@T*
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@
M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`\+W1R/@T*("`@("`-
M"B`@("`@("`@/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0U,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^3F5T#0H@#0H@("`@("`@("`@("`@(&QO<W,\
M+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@
M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*
M("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G
M/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXH-C`V+#(X,CPO9F]N=#X-"B`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*#(Q,2PS-#0\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@
M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*3PO9F]N=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@("`@("`@("`\
M+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B@S
M-S4L.#4R/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@
M("`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@
M("`@("`@("`@/&9O;G0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/BD\
M+V9O;G0^#0H@("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X-"B`@("`-"B`@
M("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@
M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2PQ-3,L,S0X
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*3PO9F]N
M=#X-"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^
M#0H@("`@(`T*("`@("`@("`\='(@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO
M<CH@(T,P1D9&1CLG/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0U,B4@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^
M#0H@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($Q)3D4M2$5)1TA4.B`Q+C(U.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/@T*("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P="<^3F5T#0H@#0H@("`@("`@("`@("`@(&QO<W,@
M<&5R('-H87)E/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO9&EV/@T*("`@
M("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T
M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@
M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[
M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4
M+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#`N,#0\+V9O;G0^#0H@("`@#0H@
M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@
M("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-
M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@
M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*
M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P="<^*#`N,#$\+V9O;G0^#0H@("`@#0H@("`@("`@("`@
M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L
M969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D
M/@T*("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@
M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@
M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@
M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P="<^*#`N,#(\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@
M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@
M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@
M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^#0H@
M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO
M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@
M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P="<^*#`N
M,#@\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@
M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@
M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F
M;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@/"]T
M<CX-"B`@("`@#0H@("`@("`\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?
M86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T
M860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S
M+U-H965T,C0N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5,,D%%/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/DYO=&4@,B`M(%-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@06-C;W5N
M=&EN9R!0;VQI8VEE<R`H1&5T86EL*2`H55-$("0I/&)R/E-H87)E(&1A=&$@
M:6X@36EL;&EO;G,L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$P/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97!R96-I871I
M;VX@*&EN($1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#<S+#<R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@.#0L,3,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Y-"PX.#<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%N=&ED:6QU=&EV92!396-U
M<FET:65S($5X8VQU9&5D(&9R;VT@0V]M<'5T871I;VX@;V8@16%R;FEN9W,@
M4&5R(%-H87)E+"!!;6]U;G0@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$R+C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-:6YI;75M(%M-96UB97)=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y+"!0;&%N
M="!A;F0@17%U:7!M96YT+"!5<V5F=6P@3&EF93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^,R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%X:6UU;2!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2P@4&QA;G0@
M86YD($5Q=6EP;65N="P@57-E9G5L($QI9F4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/C4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQI8V5N<VEN9R!!9W)E96UE;G1S(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9I;FET
M92U,:79E9"!);G1A;F=I8FQE($%S<V5T+"!5<V5F=6P@3&EF93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,3`@>65A<G,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO
M;B!O9B!);G1A;F=I8FQE($%S<V5T<R`H:6X@1&]L;&%R<RD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y+#DR,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T+#@X-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T+#@X-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1FEN
M:71E+4QI=F5D($EN=&%N9VEB;&4@07-S971S+"!!;6]R=&EZ871I;VX@17AP
M96YS92P@3F5X="!4=V5L=F4@36]N=&AS("AI;B!$;VQL87)S*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&:6YI=&4M3&EV960@
M26YT86YG:6)L92!!<W-E=',L($%M;W)T:7IA=&EO;B!%>'!E;G-E+"!996%R
M(%1W;R`H:6X@1&]L;&%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1FEN:71E+4QI=F5D($EN=&%N9VEB;&4@07-S971S+"!!
M;6]R=&EZ871I;VX@17AP96YS92P@665A<B!4:')E92`H:6X@1&]L;&%R<RD\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9I;FET92U,:79E
M9"!);G1A;F=I8FQE($%S<V5T<RP@06UO<G1I>F%T:6]N($5X<&5N<V4L(%EE
M87(@1F]U<B`H:6X@1&]L;&%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D9I;FET92U,:79E9"!);G1A;F=I8FQE($%S<V5T<RP@06UO
M<G1I>F%T:6]N($5X<&5N<V4L(%EE87(@1FEV92`H:6X@1&]L;&%R<RD\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X
M7V(X.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K
M<VAE971S+U-H965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,1T%%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,3X\<W1R;VYG/DYO=&4@,B`M(%-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@
M06-C;W5N=&EN9R!0;VQI8VEE<R`H1&5T86EL*2`M(%!R;W!E<G1Y(&%N9"!%
M<75I<&UE;G0@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y(&%N9"!E<75I<&UE;G0L
M(&=R;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4S,BPR
M.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#4S,BPR.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;B!A;F0@86UO
M<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T,CDL
M.#`T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,U-BPP.#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD(&5Q=6EP;65N="P@;F5T/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#(L-#@V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<V+#(P-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3&%B;W)A=&]R>2!%<75I<&UE;G0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD(&5Q=6EP;65N="P@9W)O
M<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X."PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#@L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y,96%S96AO;&0@26UP<F]V96UE;G1S(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y(&%N9"!E<75I<&UE
M;G0L(&=R;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,34L
M-C`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3$U+#8P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W1H97(@1G5R;FET=7)E+"!&:7AT=7)E<R!A;F0@17%U
M:7!M96YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!R;W!E<G1Y(&%N9"!E<75I<&UE;G0L(&=R;W-S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#(X+#8X-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C@L-C@U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U(0D<^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^3F]T92`S("T@1V]V97)N;65N="!'<F%N=',@
M*$1E=&%I;"D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$.#XS($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C$S."!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XU.2!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M-#XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q
M,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L
M(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S
M,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N
M(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^075G+B`S,2P@,C`Q,SQB<CY&:7)S="!.24@@1W)A;G0@6TUE;6)E
M<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^075G+B`S,2P@
M,C`Q,CQB<CY&:7)S="!.24@@1W)A;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY&:7)S="!.
M24@@1W)A;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^075G+B`S,2P@,C`Q,SQB<CY396-O;F0@3DE(($=R86YT(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^4V5C;VYD($Y)2"!'<F%N="!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/DY)2"!'
M<F%N=',@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,3QB<CY.24@@1W)A;G1S(%M-96UB97)=/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^
M3DE(($=R86YT<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$P/&)R/E%41%`@1W)A;G0@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;VIE8W0@
M4&5R:6]D($-O=F5R960@8GD@1W)A;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XU('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]J96-T($5X=&5N<VEO;B!0
M97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C$@>65A<CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1W)A;G0@07=A<F0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,C`L-#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,2PY,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-#0L-#<Y/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G5S960@1W)A;G0@
M1G5N9',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-C`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L-#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4F5V96YU92!F<F]M($=R86YT<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`T-3DL-38V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V,S@L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`W,#4L-CDX
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`X-30L,#8S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Y-38L.#0T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#(Y-RPP,#8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-S4S+#`S,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.#DS
M+#`P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,BPV-3<L,S(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`T+#@Y.2PX.#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4L,3@U+#(U-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C(L.38Y
M+#`Q.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,BPV-3<L,S(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`T+#@Y.2PX.#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L.30P+#<W.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR
M,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W
M-2]7;W)K<VAE971S+U-H965T,C<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-34%#/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-"`M($-O;6UI=&UE;G1S("A$971A
M:6PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3(\8G(^<W%F=#QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%R96$@;V8@4F5A;"!%<W1A=&4@4')O<&5R
M='D@*&EN(%-Q=6%R92!F965T*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^."PT,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]P97)A=&EN9R!,96%S97,L(%)E;G0@17AP96YS93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,3@L.#`Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,3DL
M,C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`Q,3@L.3@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y/<&5R871I;F<@3&5A<V4L(%1E<FT@;V8@3&5A<V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C8R(&UO;G1H<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!E
M<F%T:6YG($QE87-E<RP@1G5T=7)E($UI;FEM=6T@4&%Y;65N=',@1'5E+"!.
M97AT(%1W96QV92!-;VYT:',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$R-2PQ.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]P97)A=&EN9R!,96%S97,L($9U='5R92!-:6YI;75M
M(%!A>6UE;G1S+"!$=64@:6X@5'=O(%EE87)S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,C@L.3(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E8V]R9&5D(%5N8V]N9&ET:6]N
M86P@4'5R8VAA<V4@3V)L:6=A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`U,3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P15A'2$T^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M3F]T92`V("T@4W1O8VMH;VQD97)S)R!%<75I='D@*$1E=&%I;"D@*%531"`D
M*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$Q/C$R($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$S."!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$-CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#D^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,2!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q
M,#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,#D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`P.#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#`W/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,#8\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`P-3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#`T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,#,\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P,CQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^4W1O8VL@3W!T:6]N
M<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$Q/&)R/E-T;V-K($]P=&EO;G,@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB<CY3
M=&]C:R!/<'1I;VYS(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,#8\8G(^4W1O8VL@3W!T:6]N<R!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CY$96,N(#,Q+"`R,#$R/&)R/E-E<FEE<R!!(%=A<G)A;G1S(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@,S$L
M(#(P,3,\8G(^4V5R:65S($(@5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^1&5C+B`S,2P@
M,C`Q,CQB<CY397)I97,@0B!787)R86YT<R!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#$W+"`R,#$S/&)R/E-E<FEE
M<R!"(%=A<G)A;G1S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0R/D1E8RX@,S$L(#(P,3(\8G(^4V5R:65S
M($,@5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY397)I97,@02!#;VYV97)T:6)L
M92!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY397)I97,@02!#;VYV
M97)T:6)L92!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,CQB<CY397)I97,@
M02!#;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CY3
M97)I97,@02!#;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,CQB<CY'96YE<F%L(&%N9"!!9&UI;FES=')A=&EV92!%>'!E;G-E(%M-96UB
M97)=/&)R/D-O;6UO;B!3=&]C:R!)<W-U960@9F]R(%-E<G9I8V5S(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^1V5N97)A;"!A;F0@061M:6YI<W1R871I=F4@17AP96YS92!;
M365M8F5R73QB<CY#;VUM;VX@4W1O8VL@27-S=65D(&9O<B!397)V:6-E<R!;
M365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$P/&)R/D=E;F5R86P@86YD($%D;6EN:7-T<F%T:79E($5X<&5N
M<V4@6TUE;6)E<ET\8G(^0V]M;6]N(%-T;V-K($ES<W5E9"!F;W(@4V5R=FEC
M97,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CY'96YE<F%L(&%N9"!!9&UI;FES=')A=&EV92!%
M>'!E;G-E(%M-96UB97)=/&)R/D-O;7!E;G-A=&]R>2!787)R86YT<R!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$Q/&)R/D=E;F5R86P@86YD($%D;6EN:7-T<F%T:79E($5X<&5N<V4@
M6TUE;6)E<ET\8G(^0V]M<&5N<V%T;W)Y(%=A<G)A;G1S(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\
M8G(^1V5N97)A;"!A;F0@061M:6YI<W1R871I=F4@17AP96YS92!;365M8F5R
M73QB<CY#;VUP96YS871O<GD@5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY'96YE
M<F%L(&%N9"!!9&UI;FES=')A=&EV92!%>'!E;G-E(%M-96UB97)=/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^
M1V5N97)A;"!A;F0@061M:6YI<W1R871I=F4@17AP96YS92!;365M8F5R73QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$P
M/&)R/D=E;F5R86P@86YD($%D;6EN:7-T<F%T:79E($5X<&5N<V4@6TUE;6)E
M<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`S,2P@
M,C`Q,CQB<CY);F1I=FED=6%L($%C8W)E9&ET960@26YV97-T;W)S(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^26YD:79I9'5A;"!!8V-R961I=&5D($EN=F5S=&]R<R!;365M
M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#`V/&)R/DUA>&EM=6T@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!3=&]C:RP@4VAA<F5S($%U
M=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#(P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<F5F97)R960@4W1O8VLL(%!A<B!O<B!3=&%T960@5F%L=64@4&5R(%-H
M87)E("AI;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^*&EN($1O
M;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`Q+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@27-S=6%N8V4@
M;V8@4')E9F5R<F5D(%-T;V-K(&%N9"!0<F5F97)E;F-E(%-T;V-K("AI;B!$
M;VQL87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#DY
M.2PP,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$L.3DY+#`S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,BPW,C<L-#<U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#(P,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E
M961S(&9R;VT@27-S=6%N8V4@;V8@0V]N=F5R=&EB;&4@4')E9F5R<F5D(%-T
M;V-K("AI;B!$;VQL87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VYV97)T:6)L92!0<F5F97)R960@4W1O8VLL($-O
M;G9E<G-I;VX@4')I8V4@4&5R(%-H87)E("AI;B!$;VQL87)S('!E<B!S:&%R
M92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XW-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N
M=F5R=&EB;&4@4')E9F5R<F5D(%-T;V-K+"!4;W1A;"!#;VYV97)S:6]N(%-H
M87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP-3`L-C8W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PP-3`L-C8W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPY,S,L,S,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@4')E9F5R<F5D(%-H87)E
M<R!#;VYV97)T960@:6YT;R!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L-#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!)<W-U960@1'5R:6YG(%!E
M<FEO9"P@4VAA<F5S+"!#;VYV97)S:6]N(&]F($-O;G9E<G1I8FQE(%-E8W5R
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#@R+#8V
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')E9F5R<F5D(%-T;V-K+"!3:&%R97,@3W5T<W1A;F1I;F<\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-L87-S(&]F(%=A
M<G)A;G0@;W(@4FEG:'0L(%!E<F-E;G1A9V4@;V8@0V]N=F5R<VEO;B!3:&%R
M97,@0V]U;&0@0F4@4'5R8VAA<V5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3`P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VQA<W,@;V8@5V%R<F%N="!O<B!2
M:6=H="P@3G5M8F5R(&]F(%-E8W5R:71I97,@0V%L;&5D(&)Y(%=A<G)A;G1S
M(&]R(%)I9VAT<R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPY,S,L,S,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPY,S,L,S,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY
M,S,L,S,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PW.3DL.3DY
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M."PW.3DL.3DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#;&%S<R!O9B!787)R86YT(&]R(%)I9VAT+"!%>&5R8VES
M92!0<FEC92!O9B!787)R86YT<R!O<B!2:6=H=',@*&EN($1O;&QA<G,@<&5R
M($ET96TI/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XW-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C`N-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E-T;V-K($ES<W5E9"!$=7)I;F<@4&5R:6]D+"!3:&%R97,L($YE=R!)
M<W-U97,@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$R+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0P-RPY.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV-3@L-3(P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!!8V-R=65D($QI86)I
M;&ET:65S+"!#=7)R96YT("AI;B!$;VQL87)S*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!)<W-U960@1'5R:6YG(%!E
M<FEO9"P@5F%L=64L($YE=R!)<W-U97,@*&EN($1O;&QA<G,I/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S,L,S8P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#0Q+#(Q,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDP+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M-3(P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-S<Q+#`Y,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L,38R+#DU,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S.2PY,3D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0U.2PV,#D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M-S,L,S8P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#0Q+#(Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!)<W-U86YC92!O9B!#;VUM
M;VX@4W1O8VL@*&EN($1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS,3`L,38P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#`T+#0Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-3`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,34L.#,V+#0V.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,V+#@P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^*&EN($1O;&QA<G,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#DS,RPS,S,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/'-U<#Y;,5T\+W-U<#X\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.3,S+#,S,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELQ73PO<W5P
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY,S,L,S,S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CQS=7`^
M6S%=/"]S=7`^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.#<L
M-S@S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y787)R86YT<R!)<W-U960@1'5R:6YG(%!E<FEO9"P@17AE<F-I<V4@
M4')I8V4@*&EN($1O;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@5V%R<F%N=',@27-S
M=65D($1U<FEN9R!097)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C8Q,BPP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-T;V-K($ES<W5E9"!$=7)I;F<@4&5R:6]D+"!3:&%R
M97,L($ES<W5E9"!F;W(@4V5R=FEC97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,CDL,C0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3`L-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;&QO8V%T960@4VAA<F4M8F%S
M960@0V]M<&5N<V%T:6]N($5X<&5N<V4@*&EN($1O;&QA<G,I/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,3`L,#<V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8S+#<U,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4W-2PV-C(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,34P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4S+#@Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XW+#$Q.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$R,2PP-3<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S$L.3,V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C@T+#,U,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V.2PQ
M-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DUI;FEM=6T@3W!T:6]N($5X97)C:7-E(%!R:6-E(&%S(%!E<F-E;G1A
M9V4@;V8@1F%I<B!686QU92!O9B!)4T\G<R!'<F%N=&5D('1O($-E<G1A:6X@
M16UP;&]Y965S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3`N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@
M4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"P@1F%I<B!686QU92!!<W-U;7!T
M:6]N<RP@17AP96-T960@5&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^-B!Y96%R<R`R-34@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/C<@>65A<G,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XV('EE87)S(#(U-2!D87ES
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M,3`@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N
M="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!!=V%R9"!697-T:6YG
M(%!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,R!Y96%R
M<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H
M87)E+6)A<V5D(%!A>6UE;G0@07=A<F0L($YU;6)E<B!O9B!3:&%R97,@075T
M:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3:&%R92UB87-E9"!#;VUP96YS871I;VX@*&EN($1O;&QA<G,I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,3`L,#<V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S<R+#DY-SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<U
M,"PU,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV+#8V.2PX,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XS,3`L,#<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#8S+#<U,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4W-2PV-C(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5M<&QO>65E
M(%-E<G9I8V4@4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N+"!.;VYV97-T960@
M07=A<F1S+"!4;W1A;"!#;VUP96YS871I;VX@0V]S="!.;W0@>65T(%)E8V]G
M;FEZ960@*&EN($1O;&QA<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-S$L.3`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C<Q+#DP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(W,2PY,#$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5M<&QO>65E(%-E<G9I8V4@
M4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N+"!.;VYV97-T960@07=A<F1S+"!4
M;W1A;"!#;VUP96YS871I;VX@0V]S="!.;W0@>65T(%)E8V]G;FEZ960L(%!E
M<FEO9"!F;W(@4F5C;V=N:71I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/C(@>65A<G,@,S8@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@1V5N97)A;"!A;F0@061M
M:6YI<W1R871I=F4@17AP96YS92`H:6X@1&]L;&%R<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,34R+#$R-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,C$X+#4U,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1D(&-O;'-P86X],T0T,SX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1&EN;F5R1F]O=&YO=&4^#0H@("`@("`@(#QT9"!V86QI9VX]
M,T1T;W`^6S%=/"]T9#X-"B`@("`@("`@/'1D(&-O;'-P86X],T0T,B!V86QI
M9VX],T1T;W`^4V5E(&1I<V-U<W-I;VX@=6YD97(@(E-E<FEE<R!!($-O;G9E
M<G1I8FQE(%!R969E<G)E9"!3=&]C:R(@86)O=F4N/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
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M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%4D1!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.
M;W1E(#8@+2!3=&]C:VAO;&1E<G,G($5Q=6ET>2`H1&5T86EL*2`M($%L;&]C
M871I;VX@;V8@3F5T(%!R;V-E961S(&9R;VT@4')E9F5R<F5D(%-T;V-K($9I
M;F%N8VEN9R`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,3,X($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@<')O
M8V5E9',@869T97(@=')A;G-A8W1I;VX@8V]S=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,2PY.3DL,#,R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#DY.2PP,S(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L-S(W
M+#0W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3&5S<SH@1F%I<B!V86QU92!O9B!W87)R86YT<R`H<F5C;W)D960@
M=&\@061D:71I;VYA;"!086ED+6EN($-A<&ET86PI/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q+#$R-RPT,3@I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"96YE9FEC:6%L(&-O;G9E
M<G-I;VX@9F5A='5R92`H<F5C;W)D960@=&\@061D:71I;VYA;"!086ED+6EN
M($-A<&ET86PI/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-C(L
M-C8W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYE="!P<F]C965D<R!A;&QO8V%T960@=&\@<')E9F5R<F5D('-T
M;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#@L.30W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M8V-R971I;VX@;V8@8F5N969I8VEA;"!C;VYV97)S:6]N(&9E871U<F4@*&1E
M96UE9"!D:79I9&5N9"D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<V,BPV-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<G)Y:6YG('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,3(L,3DV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,S$R+#$Y-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q,BPQ.38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX-S$L-C$T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV
M97)S:6]N<R!T;R!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H-34Y+#0Q."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
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M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%2$-!13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY.;W1E(#8@+2!3=&]C:VAO;&1E<G,G($5Q=6ET>2`H1&5T86EL*2`M(%-T
M;V-K($]P=&EO;B!!8W1I=FET>2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!A="!$96-E;6)E
M<B`S,2P@,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3(X
M+#(T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W5T<W1A;F1I;F<@870@1&5C96UB97(@,S$L(#(P,3$@*&EN($1O
M;&QA<G,@<&5R('-H87)E*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`U+C0S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,S@L-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y'<F%N=&5D("AI;B!$;VQL87)S('!E<B!S:&%R92D\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XW/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES
M960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E
M9"`H:6X@1&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D9O<F9E:71E9"!O<B!E>'!I<F5D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y-RPV,#$I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)F96ET960@;W(@
M97AP:7)E9"`H:6X@1&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#0N,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&%T($1E8V5M
M8F5R(#,Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#`V.2PQ-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$R("AI
M;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-"XU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!A="!$96-E;6)E<B`S,2P@,C`Q
M,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-B!Y96%R<R`W,R!D
M87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y/=71S=&%N9&EN9R!A="!$96-E;6)E<B`S,2P@,C`Q,B`H:6X@1&]L
M;&%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE
M<F-I<V%B;&4@870@1&5C96UB97(@,S$L(#(P,3(\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8Y."PY.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-A8FQE(&%T($1E8V5M
M8F5R(#,Q+"`R,#$R("AI;B!$;VQL87)S('!E<B!S:&%R92D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-BXS.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V%B;&4@870@
M1&5C96UB97(@,S$L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/C0@>65A<G,@,C$Y(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-A8FQE(&%T($1E8V5M8F5R
M(#,Q+"`R,#$R("AI;B!$;VQL87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14M$04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F]T92`V
M("T@4W1O8VMH;VQD97)S)R!%<75I='D@*$1E=&%I;"D@+2!!9&1I=&EO;F%L
M($EN9F]R;6%T:6]N($-O;F-E<FYI;F<@4W1O8VL@3W!T:6]N<R`H55-$("0I
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5V5I9VAT960@879E<F%G92!F86ER('9A;'5E(&]F(&]P=&EO;G,@9W)A;G1E
M9"!D=7)I;F<@=&AE('!E<FEO9"`H:6X@1&]L;&%R<R!P97(@<VAA<F4I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N-3D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N-SD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(N
M.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1O=&%L(&9A:7(@=F%L=64@;V8@;W!T:6]N<R!V97-T960@9'5R:6YG
M('1H92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,S$Y+#DR,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-30P+#,S.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@-#DY+#4U-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?
M86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T
M860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S
M+U-H965T,S(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$4S1T%#/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/DYO=&4@-B`M(%-T;V-K:&]L9&5R<R<@17%U:71Y("A$971A:6PI
M("T@4VEG;FEF:6-A;G0@07-S=6UP=&EO;G,@57-E9"!I;B!&86ER(%9A;'5E
M($-A;&-U;&%T:6]N<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E=E:6=H=&5D(&%V97)A9V4@<FES:RUF<F5E(&EN=&5R
M97-T(')A=&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C$P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$N-#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BXV,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5X<&5C=&5D(&1I=FED96YD('EI96QD/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C
M=&5D(&QI9F4@;V8@;W!T:6]N("AY<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XV('EE87)S(#(U-2!D87ES/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-R!Y96%R<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C8@>65A<G,@,C4U
M(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5X<&5C=&5D('9O;&%T:6QI='D\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$P-2XR,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,3$N,C`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$R+CDP)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T
M-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7
M;W)K<VAE971S+U-H965T,S,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4T04%%/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/DYO=&4@-B`M(%-T;V-K:&]L9&5R<R<@17%U:71Y
M("A$971A:6PI("T@4W1O8VLM8F%S960@0V]M<&5N<V%T:6]N($5X<&5N<V4@
M*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3`\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T;V-K(&]P=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#,Q,"PP-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0V,RPW-3(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4W-2PV-C(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=E
M;F5R86P@86YD($%D;6EN:7-T<F%T:79E($5X<&5N<V4@6TUE;6)E<ET\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@;W!T:6]N(&5X
M<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S,2PY,S8\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M.#0L,S4R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S8Y+#$V,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD($1E=F5L;W!M96YT($5X<&5N
M<V4@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4W1O8VL@;W!T:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-S@L,30P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q-SDL-#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R,#8L-3`Q/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15E*04<^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3F]T92`V("T@4W1O8VMH;VQD97)S)R!%<75I='D@
M*$1E=&%I;"D@+2!3=&]C:R!0=7)C:&%S92!787)R86YT(%1R86YS86-T:6]N
M<R`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DIA;BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I;F<@870@
M1&5C96UB97(@,S$L(#(P,3$@*&EN(%-H87)E<RD\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L.#<P+#4U.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W5T<W1A;F1I;F<@870@1&5C96UB97(@,S$L(#(P,3$\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-RXY-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V5D("AI;B!3:&%R97,I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1F]R9F5I=&5D(&]R(&5X<&ER960@*&EN(%-H87)E<RD\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4W+#`P,"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D9O<F9E:71E9"!O<B!E>'!I<F5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R
M,#$R("AI;B!3:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ,2PR,C4L-34Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M=71S=&%N9&EN9R!A="!$96-E;6)E<B`S,2P@,C`Q,CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`R+C`V/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%>&5R8VES86)L92!A="!$96-E;6)E<B`S,2P@,C`Q,B`H
M:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PR
M.3`L,S<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES
M86)L92!A="!$96-E;6)E<B`S,2P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`R+C0T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y397)I97,@02!787)R86YT<R!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.=6UB97(@;V8@4VAA<F5S("AI;B!$;VQL87)S*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#DS,RPS,S,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/'-U<#Y;,5T\+W-U<#X\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E
M<F%G92!%>&5R8VES92!0<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&9N/CQS=7`^6S%=/"]S=7`^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-E<FEE<R!"(%=A<G)A;G1S(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DYU;6)E<B!O9B!3:&%R97,@*&EN($1O;&QA<G,I/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DS,RPS,S,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/'-U<#Y;,5T\+W-U
M<#X\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@
M079E<F%G92!%>&5R8VES92!0<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P+C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CQS=7`^6S%=/"]S=7`^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E9"`H:6X@4VAA<F5S*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW-C8L-C8W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y397)I97,@0R!787)R86YT<R!;365M8F5R
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@4VAA<F5S("AI;B!$;VQL
M87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY,S,L,S,S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CQS
M=7`^6S%=/"]S=7`^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E=E:6=H=&5D($%V97)A9V4@17AE<F-I<V4@4')I8V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELQ73PO<W5P/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!787)R86YT<R!;365M8F5R
M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@4VAA<F5S("AI;B!$;VQL
M87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V,3(L,#`Q
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CQS
M=7`^6S)=/"]S=7`^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E=E:6=H=&5D($%V97)A9V4@17AE<F-I<V4@4')I8V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELR73PO<W5P/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L<W!A;CTS1#0^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1I;FYE<D9O
M;W1N;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P/ELQ73PO=&0^#0H@
M("`@("`@(#QT9"!C;VQS<&%N/3-$,R!V86QI9VX],T1T;W`^4V5E(&1I<V-U
M<W-I;VX@=6YD97(@(E-E<FEE<R!!($-O;G9E<G1I8FQE(%!R969E<G)E9"!3
M=&]C:R(@86)O=F4N/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1I;FYE<D9O;W1N;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P
M/ELR73PO=&0^#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,R!V86QI9VX],T1T
M;W`^4V5E(&1I<V-U<W-I;VX@=6YD97(@(D-O;6UO;B!3=&]C:R!4<F%N<V%C
M=&EO;G,B(&%B;W9E+CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R-&%D
M-#9A-E\X.3(R7S0U8SA?8C@X,U]A8C9D,&9C.6,W-S4-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?86(V
M9#!F8SEC-S<U+U=O<FMS:&5E=',O4VAE970S-2YH=&UL#0I#;VYT96YT+51R
M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y
M<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*
M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14E(
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@-R`M(%)E=&ER96UE;G0@
M4&QA;B`H1&5T86EL*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5F:6YE9"!#;VYT<FEB=71I;VX@4&QA
M;BP@16UP;&]Y97(@1&ES8W)E=&EO;F%R>2!#;VYT<FEB=71I;VX@06UO=6YT
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4P+#4P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-38L
M.3(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`U,BPV,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
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M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%0D@^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^3F]T92`X("T@
M26YC;VUE(%1A>&5S("A$971A:6PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!4
M87@@07-S971S+"!/<&5R871I;F<@3&]S<R!#87)R>69O<G=A<F1S+"!$;VUE
M<W1I8SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V.2PX,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y$969E<G)E9"!487@@07-S971S+"!487@@0W)E9&ET($-A<G)Y9F]R
M=V%R9',L(%)E<V5A<F-H/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#<V,RPY-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#<V,RPV.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
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M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%-4]!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N
M9SY.;W1E(#@@+2!);F-O;64@5&%X97,@*$1E=&%I;"D@+2!$969E<G)E9"!4
M87@@07-S971S(&%N9"!,:6%B:6QI=&EE<R`H55-$("0I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY$969E<G)E9"!T87@@87-S971S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF
M;W)W87)D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(T+#0R
M.2PT-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(T+#@W,BPP.#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!D979E;&]P;65N="!T
M87@@8W)E9&ET(&-A<G)Y9F]R=V%R9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-S8S+#DV-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<V,RPV.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D(&-O;7!E;G-A
M=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#`Y-RPQ.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#DY,2PW-CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!D969E<G)E9"!T87@@87-S971S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-RPR.3`L-C,Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C<L
M-C(W+#4T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY$969E<G)E9"!T87@@;&EA8FEL:71I97,\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5P<F5C
M:6%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-BPQ,C4I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,S8L,S$Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E1O=&%L(&1E9F5R<F5D('1A>"!L:6%B:6QI=&EE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,38L,3(U*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,V+#,Q,2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.
M970@9&5F97)R960@=&%X(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C<L,C<T+#4P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(W+#4Y,2PR,S`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E9A;'5A=&EO;B!A;&QO
M=V%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C<L,C<T
M+#4P-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#(W+#4Y,2PR,S`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P13-'04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M3F]T92`X("T@26YC;VUE(%1A>&5S("A$971A:6PI("T@4F5C;VYC:6QI871I
M;VX@;V8@=&AE($EN8V]M92!487@@0F5N969I="`H55-$("0I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^52Y3+B!F961E
M<F%L('-T871U=&]R>2!R871E(&%P<&QI960@=&\@<')E=&%X(&QO<W,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-S(U+#DT."D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#<Y-RPY
M,C$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XD("@Y,S0L,#DR*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4&5R;6%N96YT(&1I9F9E<F5N8V5S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#8W-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L,C$V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S<L,C`P*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S
M96%R8V@@86YD(&1E=F5L;W!M96YT(&-R961I=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,R+#8W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4Y+#DU.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAA;F=E(&EN('9A;'5A
M=&EO;B!A;&QO=V%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-S(S+#(W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@-S8Q+#`S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@.34Q+#,S,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X
M.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE
M971S+U-H965T,SDN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4S0T)'/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/DYO=&4@.2`M(%)E;&%T960@4&%R='D@5')A;G-A8W1I;VYS
M("A$971A:6PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$-3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XQ,S@@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0U/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$P
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#`V/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,#4\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`P-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIA;BX@,S$L(#(P,3(\8G(^365M8F5R<R!O9B!";V%R9"!O9B!$:7)E8W1O
M<G,@86YD($UA;F%G96UE;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY/;F=O:6YG(%!A=&5N
M="!#;W-T(%)E:6UB=7)S96UE;G1S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^3VYG;VEN9R!0
M871E;G0@0V]S="!296EM8G5R<V5M96YT<R!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$P/&)R/D]N9V]I
M;F<@4&%T96YT($-O<W0@4F5I;6)U<G-E;65N=',@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CY2
M97-E87)C:"!!9W)E96UE;G1S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^4F5S96%R8V@@06=R
M965M96YT<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$P/&)R/E)E<V5A<F-H($%G<F5E;65N=',@6TUE
M;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,CQB<CY#;VYS=6QT:6YG($%G<F5E;65N="!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R
M/D-O;G-U;'1I;F<@06=R965M96YT(%M-96UB97)=/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^0V]N<W5L=&EN
M9R!!9W)E96UE;G0@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)E;&%T960@4&%R='D@5')A;G-A8W1I;VXL($5X<&5N
M<V5S(&9R;VT@5')A;G-A8W1I;VYS('=I=&@@4F5L871E9"!087)T>3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X.2PX.#4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(T.2PY,#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$Y,RPV-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#4U,BPT,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$L,3<R+#<U.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PS.3$L,C`S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#(T+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@-3<L-C`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!)<W-U960@1'5R:6YG(%!E<FEO
M9"P@4VAA<F5S+"!.97<@27-S=65S("AI;B!3:&%R97,I/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#`L.34T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F
M<F]M($ES<W5A;F-E(&]F($-O;6UO;B!3=&]C:SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`S,3`L,38P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T,#0L-#$P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#<U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$U+#@S-BPT-C@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(U-2PR,SD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-L87-S
M(&]F(%=A<G)A;G0@;W(@4FEG:'0L(%!U<F-H87-E(%!E<FEO9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^-2!Y96%R<SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VQA<W,@;V8@5V%R
M<F%N="!O<B!2:6=H="P@3G5M8F5R(&]F(%-E8W5R:71I97,@0V%L;&5D(&)Y
M(%=A<G)A;G1S(&]R(%)I9VAT<R`H:6X@4VAA<F5S*3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-3<Q+#0S,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VQA<W,@;V8@5V%R<F%N="!O
M<B!2:6=H="P@17AE<F-I<V4@4')I8V4@;V8@5V%R<F%N=',@;W(@4FEG:'1S
M("AI;B!$;VQL87)S('!E<B!)=&5M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X.#-?86(V9#!F8SEC-S<U#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(T860T-F$V7S@Y,C)?-#5C
M.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE971S+U-H965T-#`N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$4V3T%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DYO=&4@,3`@
M+2!396QE8W1E9"!1=6%R=&5R;'D@1FEN86YC:6%L($1A=&$@*'5N875D:71E
M9"D@*$1E=&%I;"D@+2!396QE8W1E9"!1=6%R=&5R;'D@1FEN86YC:6%L($1A
M=&$@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$.#XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$S."!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/E-E<"X@,S`L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5N+B`S,"P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y-87(N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,#$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P.3QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`X/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#<\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-CQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`U/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#0\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P,SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E=F5N=64@
M9G)O;2!G<F%N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-#4Y+#4V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-C,X+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@-S`U+#8Y.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.#4T+#`V,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.34V+#@T-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,2PR.3<L,#`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Q+#<U,RPP,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#@Y,RPP,#(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L-C4W+#,R-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"PX
M.3DL.#@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`U+#$X-2PR-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#(R+#DV.2PP,3D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#8Q,"PP.#4I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R.38L-S<Y
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)"`H-#DW+#<V,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B0@*#<S,"PU,3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q+#$U,RPS-#@I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@S-S4L.#4R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,C$Q+#,T-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#8P-BPR.#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XD("@Q-S`L-3DR*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPQ,S4L,30P*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,BPS
M-#8L.#(V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H,BPW-#<L,S(X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^)"`H,RPR.#0L,C4R*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,RPW,C@L,3@W*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M-"PR-#$L-SDV*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H-3@T+#$V-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L-C$Q+#`X-BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(L,S4Q+#@R."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#DT-RPX,#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XD("@V,3@L,3,W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^)"`H,C0L-S8W+#$T,BD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S('!E
M<B!S:&%R92`H:6X@1&]L;&%R<R!P97(@<VAA<F4I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#`N,#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C`R*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XP,RD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,#0I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@P+C`X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H,"XP,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#`N,#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C`T*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C1A9#0V839?.#DR,E\T-6,X7V(X
M.#-?86(V9#!F8SEC-S<U#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S(T860T-F$V7S@Y,C)?-#5C.%]B.#@S7V%B-F0P9F,Y8S<W-2]7;W)K<VAE
M971S+U-H965T-#$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5014%%/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/DYO=&4@,3$@+2!3=6)S97%U96YT($5V96YT<R`H1&5T86EL
M*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*86XN(#,Q+"`R,#$S/&)R/E-E<FEE<R!"(%=A<G)A;G1S(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@
M,3<L(#(P,3,\8G(^4V5R:65S($(@5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY3
M97)I97,@0B!787)R86YT<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0VQA<W,@;V8@5V%R<F%N="!O<B!2:6=H="P@
M17AE<F-I<V4@4')I8V4@;V8@5V%R<F%N=',@;W(@4FEG:'1S("AI;B!$;VQL
M87)S('!E<B!)=&5M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,"XV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,"XW-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0VQA<W,@;V8@5V%R<F%N="!O<B!2:6=H="P@17AE<F-I<V5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW-C8L-C8W/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M<F]C965D<R!F<F]M(%=A<G)A;G0@17AE<F-I<V5S("AI;B!$;VQL87)S*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#`V,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-L
M87-S(&]F(%=A<G)A;G0@;W(@4FEG:'0L($YU;6)E<B!O9B!296UA:6YI;F<@
M4VAA<F5S(%=H;W-E($5X<&ER871I;VX@5V%S($5X=&5N9&5D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$V-BPV-C<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R($=E;F5R
M86P@86YD($%D;6EN:7-T<F%T:79E($5X<&5N<V4@*&EN($1O;&QA<G,I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$U,BPQ,C8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(Q."PU
M-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S(T
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M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M2D]!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY38VAE9'5L92!)22`M(%9A
M;'5A=&EO;B!A;F0@475A;&EF>6EN9R!!8V-O=6YT<R`H1&5T86EL*2`M(%9A
M;'5A=&EO;B!A;F0@475A;&EF>6EN9R!!8V-O=6YT<R`H5F%L=6%T:6]N($%L
M;&]W86YC92!O9B!$969E<G)E9"!487@@07-S971S(%M-96UB97)=+"!54T0@
M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#8^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#(^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CY$96,N(#,Q+"`R,#$P
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y686QU871I
M;VX@06QL;W=A;F-E(&]F($1E9F5R<F5D(%1A>"!!<W-E=',@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L86YC92!A="!"
M96=I;FYI;F<@3V8@4&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(W+#4Y,2PR,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#(W+#4W-BPR-3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#(W+#`Y,2PS,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-H
M87)G960@=&\@0V]S=',@86YD($5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XW.38L,C,W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^.#@X+#4V,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,38P+#0P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5D=6-T
M:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ,3(L.38Q
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M<W5P/ELQ73PO<W5P/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M.#<S+#4X-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/'-U<#Y;,5T\+W-U<#X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#8W-2PT.3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CQS=7`^6S%=/"]S=7`^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@16YD($]F(%!E<FEO9#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-RPR-S0L-3`V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-RPU.3$L,C,P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-RPU-S8L,C4S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L<W!A;CTS1#<^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1I;FYE<D9O;W1N
M;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P/ELQ73PO=&0^#0H@("`@
M("`@(#QT9"!C;VQS<&%N/3-$-B!V86QI9VX],T1T;W`^1&5D=6-T:6]N<R!R
M97!R97-E;G0@=&AE(&5F9F5C="!O9B!E>'!I<FEN9R!.3TP@8V%R<GEF;W)W
M87)D<R!F<F]M('!R:6]R('EE87)S+CPO=&0^#0H@("`@("`\+W1R/@T*("`@
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M;VLN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`Q+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970P,BYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,#,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#`T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#8N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#`W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970P."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#DN:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$P+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970Q,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,3(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$S+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-"YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,34N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#$V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-RYH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3@N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#$Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970R,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C$N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(R+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970R,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,C0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(U+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-BYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,C<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#(X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R.2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S`N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#,Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970S,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S,N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,T+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970S-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,S8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,W
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S."YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,SDN:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#0P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T
M,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#(N:'1M;"(O/@T*
M/"]X;6P^#0HM+2TM+2T]7TYE>'1087)T7S(T860T-F$V7S@Y,C)?-#5C.%]B
4.#@S7V%B-F0P9F,Y8S<W-2TM#0H`
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ERDAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Detail) - Allocation of Net Proceeds from Preferred Stock Financing (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">138 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Net proceeds after transaction costs</a></td>
        <td class="nump">$ 1,999,032<span></span></td>
        <td class="nump">$ 1,999,032<span></span></td>
        <td class="nump">$ 2,727,475<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Less: Fair value of warrants (recorded to Additional Paid-in Capital)</a></td>
        <td class="num">(1,127,418)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Beneficial conversion feature (recorded to Additional Paid-in Capital)</a></td>
        <td class="num">(762,667)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_NetProceedsAllocatedToConvertiblePreferredStock', window );">Net proceeds allocated to preferred stock</a></td>
        <td class="nump">108,947<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Accretion of beneficial conversion feature (deemed dividend)</a></td>
        <td class="nump">762,667<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Carrying value</a></td>
        <td class="nump">312,196<span></span></td>
        <td class="nump">312,196<span></span></td>
        <td class="nump">312,196<span></span></td>
        <td class="nump">871,614<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversions to common stock</a></td>
        <td class="num">$ (559,418)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_NetProceedsAllocatedToConvertiblePreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net proceeds allocated to preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_NetProceedsAllocatedToConvertiblePreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Adjustment to Additional Paid in Capital resulting from the recognition of deferred taxes for the temporary difference of the convertible debt with a beneficial conversion feature. A beneficial conversion feature is a nondetachable conversion feature that is in-the-money.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Beneficial Conversion Feature<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505963<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 05-8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 51<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917533&amp;loc=d3e34017-109320<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Increase in additional paid in capital due to warrants issued during the period. Includes also the proceeds of debt securities issued with detachable stock purchase warrants that are allocable to the warrants. These warrants qualify for equity classification and provide the holder with a right to purchase stock from the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Warrant<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 14<br><br> -Paragraph 16<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7656322&amp;loc=d3e4724-112606<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 32<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConversionOfStockAmountConverted1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionOfDividends">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of accretion of temporary equity during the period due to unpaid dividends.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquityAccretionOfDividends</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EXGHM">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="11">12 Months Ended</th>
        <th class="th" colspan="1">138 Months Ended</th>
        <th class="th" colspan="6">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="9">12 Months Ended</th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2005</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2003</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2002</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006

</div>
          <div>Stock Options [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2012

</div>
          <div>Series A Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2013

</div>
          <div>Series B Warrants [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2012

</div>
          <div>Series B Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 17, 2013

</div>
          <div>Series B Warrants [Member]</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2012

</div>
          <div>Series C Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Series A Convertible Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Series A Convertible Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012

</div>
          <div>Series A Convertible Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Series A Convertible Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>General and Administrative Expense [Member]

</div>
          <div>Common Stock Issued for Services [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>General and Administrative Expense [Member]

</div>
          <div>Common Stock Issued for Services [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>General and Administrative Expense [Member]

</div>
          <div>Common Stock Issued for Services [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>General and Administrative Expense [Member]

</div>
          <div>Compensatory Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>General and Administrative Expense [Member]

</div>
          <div>Compensatory Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>General and Administrative Expense [Member]

</div>
          <div>Compensatory Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>General and Administrative Expense [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>General and Administrative Expense [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>General and Administrative Expense [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2012

</div>
          <div>Individual Accredited Investors [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Individual Accredited Investors [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006

</div>
          <div>Maximum [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">2,200<span></span></td>
        <td class="nump">2,200<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share (in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_PreferredStockStatedValue', window );">(in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 1,000<span></span></td>
        <td class="nump">$ 1,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from Issuance of Preferred Stock and Preference Stock (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,999,032<span></span></td>
        <td class="nump">$ 1,999,032<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,727,475<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from Issuance of Convertible Preferred Stock (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ConvertiblePreferredStockConversionPricePerShare', window );">Convertible Preferred Stock, Conversion Price Per Share (in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.75<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ConvertiblePreferredStockTotalConversionShares', window );">Convertible Preferred Stock, Total Conversion Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,050,667<span></span></td>
        <td class="nump">1,050,667<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_NumberOfPreferredSharesConvertedIntoCommonStock', window );">Number of Preferred Shares Converted into Common Stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,412<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock Issued During Period, Shares, Conversion of Convertible Securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,882,667<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">788<span></span></td>
        <td class="nump">788<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased', window );">Class of Warrant or Right, Percentage of Conversion Shares Could Be Purchased</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">8,799,999<span></span></td>
        <td class="nump">8,799,999<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.00<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.75<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">0.60<span></span></td>
        <td class="nump">1.00<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues (in Shares)</a></td>
        <td class="nump">12,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">407,999<span></span></td>
        <td class="nump">658,520<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other Accrued Liabilities, Current (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">90,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">273,360<span></span></td>
        <td class="nump">441,210<span></span></td>
        <td class="nump">90,000<span></span></td>
        <td class="nump">1,520,000<span></span></td>
        <td class="nump">1,771,091<span></span></td>
        <td class="nump">3,162,950<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">239,919<span></span></td>
        <td class="nump">2,459,609<span></span></td>
        <td class="nump">470<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">273,360<span></span></td>
        <td class="nump">441,210<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">310,160<span></span></td>
        <td class="nump">404,410<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500,000<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="nump">750,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,836,468<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">36,800<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightIssuedDuringPeriod', window );">(in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">987,783<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_WarrantsIssuedDuringPeriodExercisePrice', window );">Warrants Issued During Period, Exercise Price (in Dollars per share)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_NumberOfWarrantsIssuedDuringPeriod', window );">Number of Warrants Issued During Period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">612,001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock Issued During Period, Shares, Issued for Services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">129,245<span></span></td>
        <td class="nump">10,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Allocated Share-based Compensation Expense (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">310,076<span></span></td>
        <td class="nump">463,752<span></span></td>
        <td class="nump">575,662<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">150,000<span></span></td>
        <td class="nump">53,813<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">7,119<span></span></td>
        <td class="nump">121,057<span></span></td>
        <td class="nump">231,936<span></span></td>
        <td class="nump">284,352<span></span></td>
        <td class="nump">369,161<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees', window );">Minimum Option Exercise Price as Percentage of Fair Value of ISO's Granted to Certain Employees</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">110.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">6 years 255 days<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">6 years 255 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Compensation (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">310,076<span></span></td>
        <td class="nump">772,997<span></span></td>
        <td class="nump">750,532<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,669,815<span></span></td>
        <td class="nump">310,076<span></span></td>
        <td class="nump">463,752<span></span></td>
        <td class="nump">575,662<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">271,901<span></span></td>
        <td class="nump">271,901<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">271,901<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2 years 36 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other General and Administrative Expense (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 152,126<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 218,551<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr>
        <td colspan="43"></td>
      </tr>
      <tr>
        <td colspan="43">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">See discussion under "Series A Convertible Preferred Stock" above.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightIssuedDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants issued during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightIssuedDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right, percentage of conversion shares could be purchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightPercentageOfConversionSharesCouldBePurchased</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ConvertiblePreferredStockConversionPricePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Convertible preferred stock, conversion price per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ConvertiblePreferredStockConversionPricePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ConvertiblePreferredStockTotalConversionShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Convertible preferred stock, total conversion shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ConvertiblePreferredStockTotalConversionShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Minimum option exercise price as percentage of fair value of ISO's granted to certain employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_MinimumOptionExercisePriceAsPercentageOfFairValueOfISOsGrantedToCertainEmployees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_NumberOfPreferredSharesConvertedIntoCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of preferred shares converted into common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_NumberOfPreferredSharesConvertedIntoCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_NumberOfWarrantsIssuedDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants issued during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_NumberOfWarrantsIssuedDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_PreferredStockStatedValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of convertible preferred stock; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_PreferredStockStatedValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_WarrantsIssuedDuringPeriodExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants issued during period, exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_WarrantsIssuedDuringPeriodExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph g(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercise price of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the aggregate unrecognized cost of equity-based awards made to employees under equity-based compensation awards that have yet to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph h<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Section A<br><br> -Paragraph 7<br><br> -Chapter 3<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6911-107765<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6935-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e7018-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of expenses not otherwise specified in the taxonomy for managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherGeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-30)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4, 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EHCAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Detail) - Stock Option Activity (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December 31, 2011</a></td>
        <td class="nump">928,242<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at December 31, 2011 (in Dollars per share)</a></td>
        <td class="nump">$ 5.43<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
        <td class="nump">238,500<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in Dollars per share)</a></td>
        <td class="nump">$ 0.70<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in Dollars per share)</a></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or expired</a></td>
        <td class="num">(97,601)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired (in Dollars per share)</a></td>
        <td class="nump">$ 4.02<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December 31, 2012</a></td>
        <td class="nump">1,069,141<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at December 31, 2012 (in Dollars per share)</a></td>
        <td class="nump">$ 4.50<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding at December 31, 2012</a></td>
        <td class="text">6 years 73 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at December 31, 2012 (in Dollars)</a></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at December 31, 2012</a></td>
        <td class="nump">698,995<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at December 31, 2012 (in Dollars per share)</a></td>
        <td class="nump">$ 6.38<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at December 31, 2012</a></td>
        <td class="text">4 years 219 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at December 31, 2012 (in Dollars)</a></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(c), d(2)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(c)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price of options that were either forfeited or expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph d(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(b)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(a)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph b(1)(a)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance on stock options awarded.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EKDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Detail) - Additional Information Concerning Stock Options (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted during the period (in Dollars per share)</a></td>
        <td class="nump">$ 0.59<span></span></td>
        <td class="nump">$ 0.79<span></span></td>
        <td class="nump">$ 2.95<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue', window );">Total fair value of options vested during the period</a></td>
        <td class="nump">$ 319,920<span></span></td>
        <td class="nump">$ 540,339<span></span></td>
        <td class="nump">$ 499,557<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph c(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 2 - Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Summary

      of Significant Accounting Policies</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basis

      of Presentation and Principles of Consolidation</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      primary business is conducted by our wholly-owned subsidiary,

      GeoVax, Inc. The accompanying consolidated financial

      statements include the accounts of GeoVax, Inc. from

      inception together with those of GeoVax Labs, Inc. from

      September 28, 2006 (see Note 5).&#160;&#160;All intercompany

      transactions have been eliminated in consolidation.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Development-Stage

      Enterprise</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      are devoting all of our present efforts to research and

      development and GeoVax is a development stage enterprise as

      defined by Financial Accounting Standards Board

      (&#8220;FASB&#8221;) Accounting Standards Codification

      (&#8220;ASC&#8221;) Topic 915, <font style="FONT-STYLE: italic; DISPLAY: inline">Development Stage

      Entities</font>.&#160;&#160;All losses accumulated since

      inception (June 27, 2001) have been considered as part of our

      development stage activities.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Use

      of Estimates</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The

      preparation of financial statements in conformity with

      accounting principles generally accepted in the United States

      of America (&#8220;GAAP&#8221;) requires us to make estimates

      and assumptions that affect the reported amounts of assets

      and liabilities and disclosure of contingent assets and

      liabilities at the date of the financial statements and the

      reported amounts of revenues and expenses during the

      reporting period.&#160;&#160;Actual results may differ from

      those estimates.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash

      and Cash Equivalents</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      consider all highly liquid investments with a maturity of

      three months or less when purchased to be cash

      equivalents.&#160;&#160;Our cash and cash equivalents consist

      primarily of bank deposits and money market

      accounts.&#160;&#160;The recorded values approximate fair

      market values due to the short maturities.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair

      Value of Financial Instruments and Concentration of Credit

      Risk</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial

      instruments that subject us to concentration of credit risk

      consist primarily of cash and cash equivalents, which are

      maintained by a high credit quality financial institution.

      The carrying values reported in the balance sheets for cash

      and cash equivalents approximate fair values.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property

      and Equipment</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property

      and equipment are stated at cost, less accumulated

      depreciation and amortization.&#160;&#160;The components of

      property and equipment as of December 31, 2012 and 2011 are

      as follows:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory

              equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold

              improvements</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other

              furniture, fixtures &amp; equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              property and equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated

              depreciation and amortization</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(429,804</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(356,084</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property

              and equipment, net</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,486</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expenditures

      for maintenance and repairs are charged to operations as

      incurred, while additions and improvements are

      capitalized.&#160;&#160;Depreciation is computed using the

      straight-line method over the estimated useful lives of the

      assets which range from three to five

      years.&#160;&#160;Amortization of leasehold improvements is

      computed using the straight-line method over the remaining

      term of the related lease.&#160;&#160;Depreciation and

      amortization expense was $73,720, $84,131, and $94,887 during

      the years ended December 31, 2012, 2011 and 2010,

      respectively.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

      Assets</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

      assets consist principally of license agreements for the use

      of technology obtained through the issuance of the

      Company&#8217;s common stock.&#160;&#160;These license

      agreements are amortized on a straight line basis over ten

      years.&#160;&#160;Amortization expense related to these

      agreements was $19,923, $24,886, and $24,886 during years

      ended December 31, 2012, 2011, and 2010, respectively, and is

      expected to be $10,000, $10,000, $-0-, $-0-, and $-0- for

      each of the next five years, respectively.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impairment

      of Long-Lived Assets</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      review long-lived assets for impairment whenever events or

      changes in circumstances indicate that the carrying amount of

      an asset may not be recoverable.&#160;&#160;Recoverability of

      assets to be held and used is measured by a comparison of the

      carrying amount of the assets to the future net cash flows

      expected to be generated by such assets.&#160;&#160;If we

      consider such assets to be impaired, the impairment to

      be<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>recognized

      is measured by the amount by which the carrying amount of the

      assets exceeds the expected future net cash flows from the

      assets.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accrued

      Liabilities</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

      part of the process of preparing our financial statements, we

      estimate expenses that we believe we have incurred, but have

      not yet been billed by our third party vendors. This process

      involves identifying services and activities that have been

      performed by such vendors on our behalf and estimating the

      level to which they have been performed and the associated

      cost incurred for such service as of each balance sheet date

      in our financial statements. Examples of expenses for which

      we accrue include fees for professional services and fees

      owed to contract manufacturers in conjunction with the

      manufacture of vaccines for our clinical trials. We make

      these estimates based upon progress of activities related to

      contractual obligations and information received from

      vendors.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net

      Loss Per Share</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic

      and diluted loss per common share are computed based on the

      weighted average number of common shares outstanding. All

      common share equivalents (which consist of options and

      warrants) are excluded from the computation of diluted loss

      per share since the effect would be anti-dilutive. Common

      share equivalents which could potentially dilute basic

      earnings per share in the future, and which were excluded

      from the computation of diluted loss per share, totaled

      approximately 12.3 million, 2.8 million, and 2.0 million at

      December 31, 2012, 2011 and 2010, respectively.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue

      Recognition</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      recognize revenue in accordance with the SEC&#8217;s Staff

      Accounting Bulletin No. 101, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue

      Recognition in Financial Statements,</font> as amended by

      Staff Accounting Bulletin No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue

      Recognition,</font> (&#8220;SAB 104&#8221;). SAB 104 provides

      guidance in applying GAAP to revenue recognition issues, and

      specifically addresses revenue recognition for upfront,

      nonrefundable fees received in connection with research

      collaboration agreements.&#160;&#160;During 2012, 2011 and

      2010, our revenue consisted of grant funding received

      primarily from the NIH (see Note 3).&#160;&#160;Revenue from

      this arrangement is approximately equal to the costs incurred

      and is recorded as income as the related costs are

      incurred.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research

      and Development Expense</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research

      and development expense primarily consists of costs incurred

      in the discovery, development, testing and manufacturing of

      our product candidates. These expenses consist primarily of

      (i) fees paid to third-party service providers to perform,

      monitor and accumulate data related to our preclinical

      studies and clinical trials, (ii) costs related to sponsored

      research agreements, (iii) the costs to procure and

      manufacture materials used in clinical trials, (iv)

      laboratory supplies and facility-related expenses to conduct

      development, and (v) salaries, benefits, and share-based

      compensation for personnel.&#160;&#160;These costs are

      charged to expense as incurred.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patent

      Costs</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      expenditures relating to obtaining and protecting patents are

      charged to expense when incurred, and are included in general

      and administrative expense.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Period

      to Period Comparisons</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      operating results are expected to fluctuate for the

      foreseeable future. Therefore, period-to-period comparisons

      should not be relied upon as predictive of the results for

      future periods.&#160;&#160;Certain prior year amounts have

      been reclassified to conform to the current year financial

      statement presentation.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income

      Taxes</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      account for income taxes using the liability method. Under

      this method, deferred tax assets and liabilities are

      recognized for the estimated future tax consequences

      attributable to differences between the financial statement

      carrying amounts of existing assets and liabilities and their

      respective tax bases.&#160;&#160;Deferred tax assets and

      liabilities are measured using enacted rates in effect for

      the year in which temporary differences are expected to be

      recovered or settled.&#160;&#160;Deferred tax assets are

      reduced by a valuation allowance unless, in the opinion of

      management, it is more likely than not that some portion or

      all of the deferred tax assets will be realized.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based

      Compensation</font><br />

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      account for stock-based transactions in which the Company

      receives services from employees, directors or others in

      exchange for equity instruments based on the fair value of

      the award at the grant date.&#160;&#160;Compensation cost for

      awards of common stock is estimated based on the price of the

      underlying common stock on the date of

      issuance.&#160;&#160;Compensation cost for stock options or

      warrants is estimated at the grant date based on each

      instrument&#8217;s fair value as calculated by the

      Black-Scholes option pricing model.&#160;&#160;We recognize

      stock-based compensation cost as expense ratably on a

      straight-line basis over the requisite service period for the

      award.&#160;&#160;See Note 6 for additional stock-based

      compensation information.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recent

      Accounting Pronouncements</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There

      have been no recent accounting pronouncements or changes in

      accounting pronouncements which we expect to have a material

      impact on our financial statements, nor do we believe that

      any recently issued, but not yet effective, accounting

      standards if currently adopted would have a material effect

      on our financial statements.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>28
<FILENAME>0001437749-13-003092-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-13-003092-xbrl.zip
M4$L#!!0````(`$-1<D)\04^]Y,<``$G3#``1`!P`9V]V>"TR,#$R,3(S,2YX
M;6Q55`D``ST@1U$]($=1=7@+``$$)0X```0Y`0``[%UK<]LXEOV^5?L?N-ZJ
MJ=VJ*"+XIB=QE6(G/>YU8J^=WIEO*9J$9$Y3I!HD';M__0*D9#XD2*0("I0&
MJ9GJ1**(>^\YN`_P$OCP'Z.1]`L,(7(2Z$F/KY)_^5_)_+^ED709S1</KB]=
MAPG^UDW\9X@_"Y\APO_&WS\ER>)\//[Y\^=[%U\:NSZ"<90B%\;D`VDTNI#(
MGW__MP]DD$L$R1#GTO>G5/KJ(`EHDJ*<:^:YIDN_?;^4%!FH^8_P+UX>42"]
MS(,P_GA6&HA\_#Y"L[$BR^K8#^/$"5UXEE]Y3K[U6USOP>+J[,H8NN]GT?,8
M?X%_`921#$8J*-_>J_UB>6]CG'^YNC2-1S/'6;Q=.W7BQ^S:Y1<;[A[XX>];
M9"=?/SIQH6NPY>)_W."K5U=BA5[>KIW!Z-EY(?AD(@"E$`"+EKPN8+Q1Z.R;
M#5*G":+*88_QMZL+_3C2%&!N0R>_8O6#):?>?K")8X4QZL;[J68W!K9MC[-O
MWRZ--UV'!0#C?WR]>7"?X-P9O1%EQ6!)^D!N<AYGW]_#J93=])R8Y>-9[,\7
M`4$F^^P)P>G',V+UT<K$[U]B[VQ\D=_(C?"$>DDDW_MXYLH_)O'M5`57T"47
MYP.2R_"%,$S\Y/7B[0/\D>^1#Z<^GH"9*+"BS(J^E]?_<W8AXS^6JFB6_6%<
M_*Q\_W$QP.JC!41^Y%6'S&R17&38X_^IX,-X]=G;G8K?Y3J.ETJN[E15&E24
M!L-6&C!26JDB_>,!_QK&DZ5']1\#>(>)`Q&"WD,2N;]_A?-'B,XN#F8:?+L8
MSN:P4#'[+'=LY_!E$?BNG^1B29Z/+XS]*/QXMG1IYP\)]N_DYY>!$V-5,RTF
M+WY\=D$FPWDSA3^,-PY83,3<]F^2<B>S6B6SP)4SKJSFJ_;C"XKFX%<G)&3Y
M'@W91V-%47*%8;I816@9&Z#XM&ID&'K%M4MCK3[;TUAZV5B@,-80?7O%6*"%
ML0`C8QEE8\F%L>2A&TMN82R9D;',S%B*^6L:DB1M;1X.UUS$5L9(,0\Z$2V*
MN62<<WF>GV#/[@1WCN]=AY?.PD^<H!2/CBXB??XCQ7*20C4*\3_C/"JM+MNJ
M\)9XU#D:[<L"F96'L:DL.*5)P\Q<0-XR:UPWG:<!6;JX@E-"E*L4^>'L"C[#
M(%H0>F`ZSN#QIG4[)E$K_?O-\O@3I5*Y"I]Z0)]:9/@RJPP?*'4T6\_UT\)V
M0%.]#[C5*MQ##(5]J%TN9.6BD)65'Y@(\R@\\E6)[9Q>4Y%*6[;1J441+K/*
M_8%.15K$*2ZY/Q<6&#06#-'A\3>729\T(AT82CK`GR96)7D0L9-M["SE/<P>
M,MHUQ$0,Y%"KL4)3D>MH"N<\%.?<!]S5A99!IBY]J*V4DQ&U2$94$6_ZJ]74
M%OF$RBB?4%0JTB).<:G5N+!`H[%@B`Z/O[ET^J01Z<!0T@'^-#$JR8.(G;W5
M:BJKO,>L(29B((=:C1F:5AU-X9R'XIS[@+NZT#+(U*4'M56YG(QH13*BB7C3
M7ZVFM<@G-$;YA`JH2(LXQ:56X\("A<J";!H\I(^QB_P%L<X]=*'_[#P&Y;:P
MTR!"WO*_2^%M0>P$J*#2J##$V,??7!K=?XK,<"B9(7^:Z)4\4J11O97M&JL4
MV*@A)M(A#F4[,S3-&IHBK3EH6M,'I%9]@HIX.Y1XVP?<U96806:C/:BM559B
M]"*_U(4+XUB9Z2UR2)U1#JD!&A6&.!?XFTNASAP1*083*?C3I/KFC"XJL[XJ
M,YU52-1JB(G*C$-EQ@Q-O8:F2&MX56;,(#7J$U3$VZ'$VS[@KJZM##(;[4-M
MJYQ?&D5^:0@7QK$R,UKDD`:K'-*F46&(<X&[N729.G-$\MU;=PD7I`$5:9&T
M<^DNX<("A<X"D1D.)3/D3Y/J2HP(!KVMQ!B,4F!=JR$FG#J'E1AF:.IU-(5S
M'HIS[@/NZBK-($N5/M2N[(EB%LF(*>)-?\6'V2*?,%GE$Q85:1&GN!0?7%A@
MTU@P1(?'W5R&3)\T(AT82CK`GR;5/4Q$[.RM5C,9Y3V&4D-,Q$`.M1HS--4Z
MFL(Y#\4Y]P%W=:%ED*E+'VI7]D2QBF3$$O&FOUK-:I%/6*SR"8.*M(A37&HU
M+BPP:2P8HL/C;RZ+/FE$.C"4=(`_3:IOSHC8V5NM9C'*>TRYAIB(@1QJ-69H
M@CJ:PCD/Q3GW`7=UH660J4L?:E?V#;&+9,06\::_6LUND4_8K$ZMU*A(BSC%
MI5;CP@*=QH(A.CS^YC+HDT:D`T-)!_C3I/HNC8B=O=5J-JN\QZHA)F(@AUJ-
M&9IV'4WAG(?BG'N`VZHNM`PR=>E#[?)K.4`NSIV71;SIK58#<O-\`E_+)I^P
M%"K2(D[QJ-7XL$"ELT#$MZ'$-_XTJ729B&#06_%1(-8UD.LUQ(13/WSQP0Y-
MHXZF<,Y#<<Y]P&U6X1YV\<%.[7+7"@!%,@)$O.FO^``M\@G`*I^PJ4B+.,6E
M^.#!`ENFLT#$MZ'$-_XTJ73)B&#07_$!&`5R6ZDA)IPZA^*#&9IJ'4WAG(?B
MG/N`N]S$`Y0B*BO"\?:7A2LM`JO"*K#J5*2%P^:2A7-A@4%EP0.^$8PG=PA.
M(4+0.^F9OT794_8!)MT'B#`_E##/GR:57B;A&@Y;ERFL4CN[AJ)(Z`:.&)#E
M&F2[,K.3`F\(930[*$$=RM8!]L30'5"$[07P?!D,Z%\=A.^K'FQVMM=9'<GJ
M".@,=%XN%LF_IEE".6"=<1YEC%29@<[T%9.O?NC/T_D1ULWW3CB#U?E:488^
M'8\_VP4R?67DJ_-R0HB6E3EM1`UJH^.-[Q)3A;/)#,$L;,7'5M)^P3,S@3?^
M,\1)$O9E,_\Q@),XADG\Z?6K\\\(709.7`N_5+U/NN,5R/05#\$$7DS@XQ/H
M_4:"";R8P*/#`,CUA1&!_P'Q[Z/V`O5UDQOG,4).$J%74I1FQ>6Q(7J'(FR%
MY/4NP):9A-Z;(I]>O[\N8.G4-:JR/>9XO:!8;_T1*!X.158-!0`H];D(G1@^
M18%W/5^@Z+GN7T\*R3?/2M?YV"9EO1](P,D!3G:S4ZO-SMOD":(O*<+I0XK@
M%_^%_"<N&^1T76Y3W8]MRNJU*2LP'@K&[.;Q<H7KUDU6YW-,TEDVH[_X*$Z^
M7?_M%^24@#T.7/\&G2!YNG00O$4S)_3_=/)3A)]AF,*'*$4N+)\WO$'5@QUD
ME*UG-5S"D"TFA2M8+F8]P,5J,2L'716@'ZAERVX*NLH,]'HSCH#Z>!HZ@$V=
ML0\07^JMX7B:0&Y2]H!/H`X_:Y7ZBI2`^[B2:`50'QRM]#JZ1>*6*-;T/.DG
MQHI"?3HDX.X5;BZ/@!3Z3D@"[E[AYM(%H&A4N/_W^]7=OT)(KNEYVG#3&[J6
MS?V74?@,44(>DE)?:C@6(KSUWV9/>&^GF1Z59*R)RB?^2@M05ILJY>VY@@F<
MF%!MR579Y.K+=;')`HGY/@B4Z_-=._Q\I[S#]G<'U;*[(X%]B?92_EMT[\^>
MDG78J_H=6R./4F_-RK7Z=.*H?3INU-3UQ2ZBU>6)HW9YY*@M5[B^P,>\*%*L
MY5^']AI/O:)0FE<4^%K%ZAY-U.7RT')-J+P\=!UZ_K/OI4XP<5T<8_V$M&`^
MPSB)T-&L(>2L=@)X.RV]0EMB?`,M#[HQ&6C,`69K1JJZ5E4N_RHXP($#[:I(
M?"T3#C3:+NDZCE/H?8D0CA//O@N7QOGQ"PPAPM8+O8DW]T,_3I"3^,_P\\L"
M@U!^\W?@5%G%R6\.Z::YG2X5*'%EMS4:4:55782MX:6$OI_GBR!ZA7`YX,.3
M@^`G)X8>>3<9_RQ;*9L$0>1F?[N=WD,WFH7^G]"[R_AP&<6D;_X>+B*4W/AA
MK1VP$8ZG_3:-JC?9O5=,!#$13OQE(I7^JJF8"&(B<)D(7!ZZJ.4W;66C.-G2
M$&_1=VXW-5J<06DP0]2B(II-X]L%F2OQ$<(Z^>D@;_TUCW6M#M1-S`=>F_Z4
M5,#+$%X^&;I&WV]?P'O\>:=&/[M1P'O\V92F;%MHRE/6"+U6GT`T+B>.@PA;
M:PF*"78G9**`&&K`4K<M*0G*"\J?W.*11N]+%907E#_%92)-I_7J#;KK@$L/
MFU;K61V:A?KHY=3H&_:=W&+YOZKCX9->TO?_$\0Z$6+Q2>)L:A(GB'4BQ.*2
M*NDR-13>PQ@ZR'W"YBGMG[]&*T&J*JD:F.V4'PGH@!H"!:&.G%!<0I^N4$.?
M(-21$XI/R%OOL1;O;YUL2:;3NZG%>U^GA_:NM_+%^V*GA#;]H-EL2\XUK$\#
MZ0VZG71%05^MO0UGD1_.[O#MPX1D/??0GS^F*#[6':/I#ZH:J7KBTYV^NBJ(
MP(D(?$I"^FJH(`(G(G`IY8RUU4MYN0MJL3:P?MS.L0-/4VVX+\;:V:F8G=%N
ML+0HT.X!;2Y.WFBP[B?0[@%M/IZ<OBAW&85Q&B3E(\2.;6UW6_\91;E3KN@,
M;4L7K@#[M)[?&/J6_E,!]FD]6S'65^16^]?D6L:WTT^1@[S;Z96/H$MV=9F$
MWE<G=&95_(<-_\Y];-IHNRVV<TW;V>QG8YC+#E/!!*Y,J';2`B:=M(:U-M\'
MVD?<91ZH;.:!7>]*EW]-PV.P58NN=-E@4NJ;JX6=-*@M[`S=5N;!ET5,4#JF
M[9C>=FASNAFC_,1</X(C]U=@T+9JE[@S\E>F6O97H/!7@[=58W\%F/DKK>RO
M0.&O!F^KQOX*,/-7>ME?E:O_@=NJN;]B5CR;^=M9P,P=EBIZEGK<]5@E7A:8
MW;-BL]*QH!95L,"OWX>0:HLXJ;*J;TVK=A3R_SE!^M:C^],)75P;7BU/1_CN
MO$SB&";'N&G*NEZDAB5/+-`SC-=W4VEAAX.<N,GL8&23OJN5P'Y`V/-_TF'5
M3RT0_!@0/_HX\<`"%<1E@?A`$9>9(4X_UE-@/R#L^3\*M=2R;Y!MP8\A\:/P
M#;+-S#?0-U\2V`\(>QY/SM/0SVF2QEYY!6`.G3A%\,*/(TT!YOEO#U<?QJL/
MI>)^Y/>E?Y=O=P=13-X:C4N-%-FY*K"B-?G)MW0.$=G^ZD(JP[U3B,+D];M4
M[W\%PVCNAZOO-HU!0/7/<X$W:%J,4K_7FZT+W7;8YLTJ-5M31-AQLS^F2:65
M?/6[-$'GY,NR,MMOM<`7;;Q5+ACY>MW\NRC@)W!>=1W#Y8`;S1>QZY\3F?OA
M0."'OY]/HR@)HP3>X'](+]E'"?9('\_PQ,0S&'IGRT]1%%2=*`'B?81F8QP>
MU#'Y>DPN+$VP['=!Y%;NF[VD':'5;0/G$08?SWY\@\FE$S_=H8@([7UZ_2TF
MYQQ]P8J%+FD9<A.L3N+#>.327V`ECF-YXR<$IQ_/_I/AC<<5\U:L5]$0SYCL
M(.@VEEO=J&:6:1(F/V3\X3S`'X4S#$LX^NWA[.(A72R"K$_""7#,B=T@(OR0
MHJD41N'(Q1I+?G9*%%91<D)/FJX4EIPWC<^EZU#"7CB$+HDWTD\_>9*2)RA]
MA6B6!;/837&X\?"]I&]$3_V=Y`0!&89<AO\?2E&:D)3`([?._<7J:_)VOA.^
M_L591/%?8VF.+\JV%91P((-P[CP&D(R^.C!56JQ.3)5BTC(B_83H[8),AB0J
MC>!FS27+2YWLHP>X2/(PK%CO)+)M^WM)FL0;]##>25Z*B,@$7JQ4*#FS&8(S
M'+'(G<`[#2C;U2GKG2_R2A.I=/ZK]'8`K/1`50>\LRSEG6&8%,7>?QA7B':Q
MF7\35)UD#G)73,)_W4'`Y17C*2;&J$[$*9X0?4S/)"K8'2$/HH]G8-,,Z\%]
MT`]1ZN@^MM]XB_L8%'R-S,,1/OK1/QWAVW[C8X&OD7DXPI<_"53,K'-"!@RC
M]XX[CX_!=S:S#@V^/:#;^/@R/RKJ*@N0^08ZH_:[Q&R"L^?1:!#WFIZ!3>D9
MA*ND@^15*4ZDD?27/](H^6N35"&_4G(>HV>X(0/@Q./#4.6-VX`QMW-)_PZ)
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MLX2A$/P22ZY&Y\<?)EUW7?G#3HCCX`]SH^_@3\U%W^!_%+UUJ]?5G)@<<T#^
M\_F/U']V`AP6XDER2;P_#@5$,BB13J%[`G`V^+)/+_O`K;V_<29YT/7G3A!_
M/)//+H"LZK:B?QBW&N^"M9#55PY`74A@F+8E=Q3RERRCNH<NQ#\@#W'V-IIB
M&(IF%>+4[UP`O,_8.VQAJ3K0VXQ]A[,)Q_=6^SN%7I9AYI2]3#&#<9JQMRDT
M125]IBW&NF`JW79C&88N6UVD8V0EH&J:9FJ%)+4QZY`Q4A]HP,)^LO&P=RA:
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M1J+4W%`*OT?W,'`2Z-TYB(E9@&*KY6E`'V.#6]Q+GATIEVFJBKF?/$SIHIBX
MM"GDV(A.E^&WF\'6@-YR>/(XQ$^R';-);8/'PI4,#%W2?=;&#"_Q>>@''\\2
M3,IRL=EQG#5]=XWSUB.7/>#I6*>J0`%V)6-;N_D&AUS:S[)KG6R9Y1A7O_%&
M,)N.O#/\:&U&GGB>3U8JG.`.USK7X:6S\!,G*/VN0XJJZY8)RJ7O[M'J3K";
M?-MMI:@JL(%A=)&O=*#D0T(>W>#1T0+Y,;R"4_+*)G;WZ3S-'%K^X*_^BP[V
MU4S#K.0:W:59R\K[5&\'/(JAXBJG3_4R2)^BP(,H)E5<\MJEW""9;<F)K]]\
MW>NU$V"[O7`$,V1SU_BT&(:=.U-KU!/N74/5)U87T5IFZ&U%VU+7E@@XF4<X
M?_DS6P?N,,<5R]*-1C4U9>Q^I=\QA66K4NQUE[X:R7&*>(OPQ,8_RL+;'439
MZ<$5B4O/PIL:7CF[D-_75BH;#+LAIV`H[Q93]R5O=E4\29.G")'CE@LYVUKT
M^ML7LK:7_Z')61]N5Y;84KPM!NPH7K858.WBPMR-T%5J&V<MF^1+KY%4[[_<
M*:.^>$JDWR[-!3N9U:I!]Y.YB<`-6)`WTNQ@0'<C9T2I++/0A6DXO1I)WMW4
MF>0[N%W(O5/JV]+[T<,P>DFBAI9OKL-AS%_3@%8B]A7UU"R*E,-(@T&WU]%]
M!;P>1&4<Z[2U8+)EK&UH,PYRC.5JY+QVY@5DN40IK]=2QFF"8".)=J8"AJ8I
M!MC,K[82-7<S#`RUW0MVD(V!R;;+=H]K]3"%I*DF;U/85G=0WQI::[[0JRO,
M:Z/4*XQ68E!W4Z@W/EBVC0NYOL2@[@I0?_8&+%W1>[,&_?7VM:K6-FP9V-L%
M61-E>51DZ)66=9;M&2RXHLJ:JBM*6:@M(UXPDJXQA1334$W]P-(U999FVJI=
M7J@XB'3-"6<9I@9LJ[%\]8XL&$+D!/CBB3?W0S].D)/XSY`A^X"I8X3+O5K;
MQ]S@03M(V92%BFTJNLY+RJ9L5(&A`%7C)&5C5@(;9V.:TDK.:FO&@NQ`A\/I
M\GLF(1-/94.Q2D%B;91.8C1EFDGV[%3EOL1H2B43>S79[DV,QES1+-G4C')T
MVB0(393KT(WF\":*F3!DA">791N;C%(,1#5+,UF:TF2DJ)HM:WJ?LC3ER@BG
MYK)5Z6YB+DMCPHP4'<B8NSNEJ<ESG>TK2()A?M4U><B&/V&285E*B32TD=:B
M[SXB-0YH2CD-[56DIC125%W6F\G47:C&?%(U#:B-T*O)E'_,,F[JAE'!K#)"
M;?QO41A5:<^R8JCPF3K4AO1B+['VXW3O8NW)ZRUR=9>I.:U52S-`0VM5Y8()
M^["J`ZW,J/(0F^!J*D*;:&I8BM&#""V"J&:JBM6#""UBYUIK35V(B@2?'11B
MOL2KE>9/3NR[I++T@S0I+T9N6>UNQ!(%RR:_!R6Y=@S=AZ2-R+245.<J:2/.
M+26UN$K:C)I$5.6];+<1M2IK;:>!;REY3G4[S7Y;6IZEJK`_=9<+V"JH1N_]
M!*I#T(M:C7B>JZ6;JJYKX"C4:C0IEFH9.L[YK*-0J]D,RO4"E@GL\BK6WGJ5
M>BDFWC_3/"&.OT>T3M)50VF8(/\QS=X1)G$%+G8U6ED4]63P@S(6I4-DV6[1
M7=I2)#Z`_C95_X-HV#K7`/(6P$IMJGGCZN9NU8T(CH`IZ_:6S&1/@1L;>+<`
MW9I<*P\:]Z#W]O[7;K(I==F8(KF[];2EN-7SMS8":>T:?Z/%UG>RRI_P_C][
MU]X<I['EOPJ56YMRJC0)W;SMC:MD2[)UX\@J2TDV^T^*`49BS<`$&,O:3[_G
M-,P`#0S-:^1X?5,W=F:8[M]Y/_K!E??`ODHZG#4IIPQRD3+(]*_2JG'++AIJ
MF):EJ1SN3D@UTVCY&=LSTD!(`W\'4H&UL&'QJMJ%9`;\6BO^/D8'12/M3\S$
MI.AMI-16-X;PO8<)7&]CY]Y.O/<K_BCI])9@R*JFB!H"#ZR'"-IIFM0H#)D_
M/B&(9RY2IK$/HII$(U\69:+F`M@KYP]&8!=/G8QVMH^*MSHQB6((]G3$X8KR
MLG/^FI_IL:&M\E)V(>>AJ):JEC?55O>UC<D[>H%A:PM6]\&I48@L#E$_^]5,
ME;??20]V49F'-TK/#=,TJ#5?7DFK*7I=SQ4+_GF*O)*6+W63E<(6%0&#()1:
MD%L^?5XYE`HYH^')\TJJM.+O8W<4[$XQGSY-IFH;.77`EBZ/YK]PY*%:.Y]'
M.1!+-4Q9G3I0"O.Q<_X1@9+J%=\EXA=4@RI&^9CX9(&R'QA6O5`^W9\V4%*#
M0]3+8'59I;0[4HX":/(`1[9@%%U3.F/5&,#5U(/7=8C4*NGNP4P?*A6Y;(UJ
M88VJ2*A431!V=[4V>Z@<2D56VO!R/WYL44@K_EZ69YFFJ@C6:7.20UO)R<Z!
M;)>)$_NLNU[<0MG253*TZD&EIZ))::.IMK_%LLB`Z,^=4XP<SW,3G!*?R&Z/
M%;SO9$+V\\SOQ-5T&>,(2D29/@CG?.V\45X5"G*!1FI;-T^4KM[-HA$^5A4T
MAV-2,XW'M2QK>$]O/N)$S8;(XKYUJKZ>HK9S?E021Q6-F`=WC`T$+,K-3@1#
MJQ5%JR2/(DY$IYIF6&2&:J4?&)E!X5.2:8L!1><0];%@3;<@A^7;/1,#-#B`
M_;,@_KCV'"A-GHVCS%&535/1.\O`,8"K-57-'!734JW.J["FS%?42HS4"E>A
M]18YT6JWT/1.:<;10MIHF0;IT&W4M)7%(WL`.B&R>6C/\T#`HGSL1#`T?*C5
M#2#:DX:/?F".$3Y4E4/TI84/5>,`]@X?O(5.OW:EZCP31QDCL-52U7[7&/8$
M7(W)-6,$EFFUSM"\P<,L.PJ]<!1Z;X$/\L@34F*U43(%SAYE>W8S$[Y$$D?9
MW])TXSGP:.IW=D<UN54D`BOKFB:;`M6A(-0>>T!ZD-UP2&@@S3*C6+`8_G*H
M):W4]MMQ:N`V^7\8\<)V"N1IA`@VEB<B+[^%R@%?F_C9*PYG-%95T2S3$C76
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MT]2GWW>C66WD-`"VM+EVH8Q(XL98!%4-T8*G/=>9,=49;BG\3KK>&=R,5$UC
M0:IE=6]1?SHB1>U*$]Y^T(<,=G=LTQBHRTL;?@@*A-?YL)>+O(F[DM9I1$8T
M`K4@'S@'8&W*EZ8F652`<Q$E?J&0W"Z<<>O75"6&-?UZH#!K.Q$,+2CTZL$=
MD5!!5%W!%[G-45#T@R-G8#H2X#%P*`>GEXTK1#-UM6,G]QAT"H]NW**WK$$B
M5CNL,NG2H%ZMT'@UI[IJF/J3U!-ZY>2,69BB*;*\(^NJP#[?N>N)H32PF\X'
M;!6?&+W>BKY??]B0#5-P^67&>D(WVLBI`R:RP'+#F'HB^_PBBF^\^)/OS&L-
M1&@C:0NP/FIU@*I)C:-VAXPHGOF(F<96#,42O73DB+2)&HZA"E<,8N@G3IRG
M<FB6JLFUA:,OLU80=WHS$25>*YCMPAF51BD&-8EYZ$Z'@8!%6=N)8'"M4-UC
M*Q0*5$LUK?+KB2:L%7K!D3,P'=GM"#B&S,'I9>,Z\$GMRGS'H",\NG&U@DHU
M1:O5^I/6"D:U^.+5G!JR9=:2[J/4"D;E%(A5F*(ETFDE.JUMA3]^K3"4!IE1
M\-2U@J&VHN_9AK,,L_NZK+EK!4-K(Z<&F,YX`G;XVL,HBU!U6KE@?,CJPWS]
MZQ&&HNJ"RUK')VHB^U$M2U-&;A^9D4IQL^IQ^'$,'<.J\7'6I8TIQN<I\4;8
ME&!CYWBD3&-)"JE?>/;DE;BP_2A$1,F>KA*?RMU1W2"UG=U?9B4N[OMF(DK\
M'1QZNW#&5>+4A#)E^GNQA5G;B6!H)6Y4#RR)A`&BX:J=KLY1B?>#(V=@YENU
M,TP.3J][<\`>],[C9F/063RZD==500)FJMVG#D=`-JNMC9KW-U25*D]R:[A9
MW@)=>76%T.V.XNL4LUU3/90"YKE[UX$38Z>MV'OMO,4W83\Q*:+OHK(&EM]S
ME@?CC$`>51_,E'F.L8HO;D%K(C/1%%,6["<<<;%.T&X`?&VC^IC2;>)L>2(1
MZ1;DTI,L:AUE,Z.H\"8E2]P/?O#P[&C6;[G9!'[G56NC'.&"$M&+GNO`:L6$
MR*N&BM\?0347A)8]8S]\=<%-1Y_P6R#'$C"LV#.5=O:/NZ*L\Z660ZM#L[+)
M3BP+T'0-%R#GJ`[[P<FJ0ZWC'-88.!H'IU=U"#JH&3-6AZ;.HQNG9#(U-6+,
MNDYK&E7(O#1-1:>UY9WC5(?E/1Z5]S6*7'NDF9KPW9OSK70.I0'#MC;VZMGQ
MZ*U6]+U.N*BR\'4B,QYX$WQELJI60]6$!>W``G&,'1!J457T?']3X3%7537<
M,(CH&S&.2<XTED)4RQ0XR7=LZD1-A_2XX/M)5I(F$A-$1*MV'>676RB*BF]2
MLH;EZY;<+J"15PJK>F6;RF3YNE79FR?FE'55I3IIO91Q3#[7#XZ<@9EO-<>B
M')Q>^;JB$(O,N*_24GATXY2,Z@J5Y:=X^X?5^LYVH0L5#,MZ^@-00VE@%RKT
M7X*8&KW6BKZ7SAO4TOHO#4U,3*LD:F@5X3O*!B7+[]-[+^[2?;V5\Y!<^%YR
M>AU[*R^./?>0%5`JO)3"4/5A.D=&@_:,IH&]>XCH1'`_[`PD3&,`A%!#%6CF
M5JCHD_IV$B*J_`2<IEQ;.>]$>KQ+3R<RC`6IO]%J,.1^]U6,NA1S$IM::)HE
MK([343^1`HS)"H@)";/>O3WX"[OU=D06@13_PRY^G<CI:IJAB;YN3$S)YR]K
M)R)=(;)<:[%_N<6\:'":E*R!Q;S1+J!Q=191-*+*<Q3SE<V'/>.DT?[R[5%%
MZD!,3`DHZ3SF-YA7%H=+)*1`O4#G.5#:#XZ<@YFMM0#FQ^'I505J&B3SG?M"
M1^$C/+YQ-JD:.B#NNX_TS-O$,`[S-_#WP,._G(;NZ3J"L/*_[/,IW*&EZ.4N
ME\BT-3\R%JMP&UVV9&+T!SLM6M&='818AC&`M=.BS4(--?Z]Q5W]I%T1=,VB
MY7>0"\.MXJTZ7S"=F/WP_>J#YWIK=KSLS$^<:!L>W#XC#%M1(14O<;G'_`TU
M!SK=5WRXGR7K:)RIZ>A$+SBBEF08W(K&/'!$3<709*W2+Y@'CK@MZ+IE$JT;
M$*<_D&O%'CP%H[(_+TMOL9DD>35I)30?G*^NWH/AB:K5@EJ@Y;(PP&G0"3MD
M3;$TM0_W)@(HK'=4UVDYMQG'/G"%&TBHSG*'>/X9%=<#%\Y:;MWO6!5N]U'-
M.JB4(D!$M'4L0<)J3"Q"Z204S4V2J.ZKM.S.AA,T,SG"EJ)2129'D=!NA-<0
M`NXF<I.J(JOR007C9A6QCAY`A;5F",Y.F)LH\=.I3=8R#X:=^JQ\E3@6J7A9
M()/^4*?%*FQF`\%VH86T'!/PY-I^Q%"&504DZEO/?>?;2S_H?JN78&1:Z*1Z
M3\0P*)V1=BP]PELPB6518SPY1Q"1J#DHEGPXHQ6F:&:"Q$,3T2IOCII$YRKG
M0B`)C$+'#[Q*>_<V>FTG]]=Q],EW/??5XV]0K5R&[S=>#,5*>'?JI/ZGZ2Q+
MD752?EG'E``;%/18](M:(I55A99?J_.5T"]LMK)E:'.*_TFH%[9QPS"HK*AS
MT<\O*QW3L"GN\U>KUVSV$-P,T(5S0$56=$H&(I\!N/`90*HJ8$U#D<\!7=@2
M%D2W+(W(YE#P?/_8?MR=?L271<8>#`,_3!^O`SM,(53BB@E;<YED18&8Y65`
M\<EG0RY<FAGR<.`SX!96&$TQU?+MW+V@<TL-Q:NT;^S`>[^:E>.:9K:\Q[MC
M\I>SP!9G^'#<0I[E,OSD)3-X<\XVQ6<7BY\]88MJB6FHPS#/PFQQ-ZXIU"+R
M)-`[7W$_T8(:T5OTNG'2:6$*5^PRI%-/!U.\T:.9BJ[J9B^D`CBYY=C0S3[P
MX,O)5*&VW7@8E-GI$5\&,O`6!6T\04(NY<(/8;RJ2_'=G[_[2_SY1;NL_F)\
MF.)$!92<Q**='JH!WC$9T>H8.ADQU*7TX</1V-`:+CO9<"#0?DZ>AW[P\W=I
MO/6^^ZEQ`^9L!+4;;R=%XD[8U'3%*F_'ZJ7C/#OPE^`5\`_,Z3Y!MH=-1[:[
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M`N_8Q$[D[(`ZT7ZU8\"@U(^%RBHDWJI:YNVA"6OHKK?+P'<N@L@^V.@`]Y"I
MNLRTJ\%]$$/G<)2&?ED2PRE(QT4)703VG3#O5S"3EXU>&>!E35U?PS>Q'5R&
MKO?Y%^]1>`:\'<14J&I:%6961WM9-X]<$3YX&]R3&][=I':Z382G_=-+*O,U
MCM9HE[]'P39,[?CQP@^\6'S&JZ@\(3=*XTSLJ]>@W'=1+,[0&]`.^)VTIT7"
M?9MV^%B>OC+TRX:Y__""X)<P>@AO(-)$(61>>!PC'DAMRV@OZ^ZG,.P+^$2<
MN_COJB?B1FJ=*XNM_6:[^+-IKM)(C:XU^[ZO^\-_ESU@XVCU'AKH;PR%<K[R
M$(7BQ'T?I"]<_Y.4I(^!]_/W?V^C],7M^7_=+D[?7;ZY>BX%WBI](;V[O#I?
MO#V_?//V]KE$?J3:"XD]='EU=GX%'\D;>.CL\N;ZW>F?SZ5E`&[QA?3KZ8<W
MEU>+=^<7NR?R3SYDX\!'V7S?W\'___79?9&1A?]#6"L@H8)K/X$?!G[HO9`N
MWE_=+BY.?[U\!Q_>^FNH=ZZ\!^E#M+;#_-N;R_\^!\AL>O;!'SD5RRAPB^G)
MC]_;Z\V+?Q%=?G&,OV42XXB.5M*K;0*4)0G2_Q,RH.!-]A3[`@3&/H>_+^.?
M=G_]@L0XJR"+V;+TI\P>J90+2<\R?IN4RKM'=Q^0%U(42^F]5P=<_"9WI:4?
M_7`B^8ED2TL_2CWG/HR"Z`Z=-7L.HC4[)P5>N`KID^TX*%68#S*`30R/`4,@
M69!6_MU]*KW=`IG2Y7J]#2.7';SR0N=1^MV/MPFG(F62WE[^7H8&S%QY#K/^
M1F6&QTN/[.G>#PU)S#9(X1$I7Y]RZY!N'D,7/(E7I:\,ZO3R[*:,JA'*'YYT
M;W_R).^S$X#"`]<>)4AC<..J6Q/("B:4SM<8%7\+?7;P.'VLS,F^K+`BYW@5
M9DEB#_>^<R\]V,E.9D`L$.Y$06`OH\R'2@]^>E]6D=TX5W9VB`^4+(%XMTU!
MLF"Z;ST[@!^4@5U=OJW`0I$7`^[&P_0'<XL5:.29G[!R\S683!P%[!?7F<+`
MG#7>E"=[??:ZD_%YO0`Z[(=.%&^05';,T_5BGDP`*@7V`Z,-_XY9DH?_<>;!
MQY#S,G#1-@:-AM'\#7`D6JWP)K<JW_%1<"5L)F#RS?HQ#NT3";#$=[XM/5M[
M0.HF"GS(GZ73%%?G[!JE,(@--'USBP)N\?VV)LQUE(#'<3]A0]TM'!(3_,X&
MV$*L[;K@"!(F<2>P74]ZQ:EKLEVF6#;F:H%NY1-ZJLR[@6JQN=#+L=(;18[/
M@>VFA77O!F-*E>P,HV2-#U$<N(TZ#-05!-AQW8,O/<R#<?HMT[DT@G'!PM;P
M"YS%!XT%]PT6!1H+7SZS?]@YY:KB5CPFP_AL^0/^(O%B\%XV1@+<#VQO'IGQ
M^E#^??+=+911U8$>[B-F!78`6NP^YH,BE>AB8)I&0F_O/?`$.U+K#AM'=+)2
M!OPG3S6P_1[C2B(M%I#LP#Q,$%%2\V<U-+DXX-$]\C!*FXRO@//-`$NSG?)A
MVX6289LDF5BN0/DD>L(4/D\QLJRB9(>+!`]:<Z.P.`'.-LE<[X/'1`._BECE
M!X:)+0A4:]`'^!>::+3W!;M10-43M$MO!3J;)JC/^(D=0T3$84LH6H(WKT`L
MEJ_0EV3QP"Z6']#V,&RP('X70?0.F9NYP[84LWM^,`<X[SMHF3':IYTD/E+E
M>"=9QH0#)7:0Q5R<S6,GRWDGM;^+Y$<)LHT''[B!)9$?;KV,8I;BE'G&*$#$
MW%#%SY@]%L2UI38X'(;#U,M<8B&"$IG>9Y]M+Y`<.[E'`<!3$#E/,)E<@NZY
M^_0#!)8MBF:TU_,'R#(R?C:HF;)WK:O=4HK$/!WGH>J_).1$2NZC;>"":P$^
MK;(D,$7N(:<*LO;E2U%]^B$\E<T:0S#X>VO'H+HH,:@ZU4;&78;<:#&&)AAF
M[7F,A[OQ=SQ;!='#3HYL8]4)6@3,[-65"H8!,;I;AP6X_!(&S%8\O-^`4Z62
M\@"**BJGN.X&#&6)T2U)8U:B9YJ6N?D$8X3W$;$6\W%B0R;B`Q@Y</*]$8*\
M09QK#*AQM+V[K]E-79MV8ZTAQ;5#/UDG+=[ZH+,N+<?5&@JUNR;\N]`'E<"M
M5-DN?[Q0!I(X4)+DUON<OD(O_:T-T:\-08_<AKC9KM=V_,B;"YA#2;Y2(6!I
M)^$!VO6%B;A#R)G4;O]\!V+#2UI\IS3MR/3@E0TQK6[$P/7K+#;;^X3S.BNM
M\G`'56$"`G#9]TTB^(H$,&,Q!"D4:KVTS)MMF'WEX0$"X/*1N6/(?"&-6D0/
M&(LQ3?!='WYTP@^6E=1YQPE2=D@0\GX0BU1[B7GN+@3O(T$I7<$RB`41+,R#
MK<NR#384GI]"V5?FP4R@-@C\TF/W?D"XN_/8'9=Y#H&9_'Z(<H>L-,Z^(H,Q
MV/T^$C5/(%S+NO0,8EF6%&C-;853R*XP\,8YY77=QF7(Q,Y:3UF^N/2\4/("
M'ZJR7;WBE-7[*Z_UY_0OI?N:%C<-=<3YOH[X5M*)\O0/GHF5TJLHMKK**[XP
M++=>P-\7#;I*.2BQ<K!2`/()O+=B50-XKXN=FRD'[AM<G+9CJ")>1?#'P4[B
MQ>G-JTK?LG&<UY'+$H3.QN3I3:4Q*=U&&]^1+**=##:-1EV7RKI>T7:6RU=T
MO=6-!1%400EZWMU5:%*"CI636^%KG_U[&T(Y;S!?27XH.3=T9SX4,3"$G4@;
M*(&J!7FC$F2"+A>9WS*MX5;[6[W;!2(XA\I[C7W';RF4$!=OZVL@&[QU)%\G
M`8[N,YMJ)H,F`%YPC44UIB+<ND#A539%FGOGA5!SL@Z6@S:6I09%!SEO&3>(
M]70-U;QC5Y?]3D^O*\XG;Q@DTI:YYK7]$=SJ7A^J^$(TW&2;7::6][?M%39+
M&9Z8[;E`ZU[OLS2;70W1T*N%L8+2^7O6:/,3!]P-%-KXRZS-=,<"07:O13U:
M5$;(0+CYHDRIQ5.50F7-J5CKJT-G'?!MCLW+KI%)))?=`-FX4AKO]YQLV.Z$
M9I_JI%L`E"TN)L#O1Z`;^R[-.6R6J^X%\BT)'&RTN`&ROHH&HL4OI-+6R&\Y
MX.`<<!?A6?YW[]_=LW5L8"WZ+#P_EID@J\)LT/T4VXI07JX:]#Z&&FL-R.^Q
MZ0@,A++TX1ZRB,T6,D>\D`_=U=)CO4_>^7F%-%N7S%C/%.7/_E+Z149%PJU]
M936R'R!::6F''R%+83?@9/X!D'J/0%'\T6MH1^[JUK9E+7`'#O9W<24R8"YG
MLXFCS\SFI97M\TL6V3R[A]VLA8\>+[D'#[1C;%NV]!5I\IP.XZ+@>X$BVYX-
M*E`4%9=%QSOS)Q'DPKB!<Y<,O(:,UV_0B@]^\O&KSV8GDT9KKZBTXI"E),EV
M^3^8DV09C<.+PV'BD&+D/K^6@79?-?56-W&2;YII6G%?VWZ8VKOZTV:N<#?O
MWQ#^T>D5R8F?;YMA39Z:EJ![</*]^CN+WZ<K>2:XM`-<$03S]S!1PA64PBV6
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MVYN<B.P_9A,_6E.7#_NGF<[1N/1/9M(W__)_[?T+<]O(T3`*_Q5\/GZK[#J0
M%@#OF\15LFQOG+-K*Y9V]]GGU*DM"!A*2$"`P46R\NN_[AG<,2!!BJ0`LEW)
M6A:)07=/WZ>GNTOZ1>^3?MG2&O=17,1G01/!)1[B+<C"7>#'GGT&(N8'/RK_
MUZ7V"?[(7,6-E%?1=YYH;7SG5GO0R9CO($SRL[A]Y-=+\M(_;%4XO1?9;+?]
M^G:[WT,!/#K"O&ZAZ7=)$&,=10*\%?G"+N!@.E4U36O,16Q`EFV,VPXXB&2K
M`[)%A"&E0TJGV[+5RJ,F)[D[3C+>D,>QLE*O5U&<Q3+P'T3YTR&#V&-1S62S
M.D:87M@N71^I8VU$MJO3K$0R1H0AY4/*AU+1K<\(R/<NWJ;%:Z5-N>EY''@.
M-@Y0E;GS'7\(13LU_'^_,]='?*"T"W+1^?[VMG03VLEM[0$I9TS5\51F9[<B
MVUYL[7-Y\03XD$282$?:[RBUWPZ]W,XS("7N^Q4\W/A1?I^I^F;Y30+*W_='
MOQ-A^IQ"&PT,U9C1V7.W68EDC`A#RH>4#^7O*7^_#>M<U&X'UP%8>4^8DO>=
M$F%*7U'ZJC7EW@R-F3K5ANMDF'+W+8CY=E=I0))<4GJ=)=T1*+W!:*QJTPXK
MO3ZD[)^K[3J7JJ\3>4C1PSHN*+<FJKZZE+A784%9]KY_L8*<+TY`][=6_4`A
MQ?;C6Y=URD/KQ!6SC0C6D(H[9"&M9JC#Z;BSB;AG\Q\);O<%E^A&"N]@"F\R
M5@VMNPIOAWYKY^5U99`@/L0VC_QSM[-=0HL`[ZU)Z$?LSV_S8OOJK%'LALL;
M\C*/-\E%MQRG-3A!*$;&WIO!G6@G7IC8:-8F*C@>'RYK\\:_+LL&&8JNS\5+
MML6>P.G3EKGD76;_R^1S`3X4#QGX_*W%,N:SJ,/*O(%TQ3`*3%079T@X9<&B
M>]]6<#(B;PF<C@S`!=@\=A77>6#I[.JR0"?C%40[X\#T[E@Z61-[L.-X2WBT
MQKQ/S`SD#<TO"L<C^$(WO9]<)E)AY%M&I!K2:[`,&.YL-F"^N!8..$X'001,
M3*[AD*PG?V$*:TZD(E+)-`@^,/WU9*!.#$U57D^'JHZ=79$=7L^&ZG0Z2<9%
M5+<.8>+T4Q@?$EMK#*LF76%%>UA-+6\8\/@2AS#CG'AYIV;QS5(TV5T%L5I#
M")'?3Y_FTNV='(X+,;2DR00>!5GW3,)$IQ1:JN,\&S[&!C6"8W'Y,>]`PPAM
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M83*"/2H.E1`SKPK=[#--X@E(^)0JSX]0;G%2#<"`<8=4:7U+/W?<XFB?BET0
M.N">@4^(HA[S0>LAN'<FCO]*IF;PX:F!$PHO4N(!US$04V*S=_`A8#$&!9A]
MS\>D2P:25=23F+J6C+\-8YSSP5>5CVJ?*X^-HY`*#R=KBRW%0(+;KGR#([],
MK%NV`2/*!V@WA**XBW<>FJP*V)5-X.04Q(5_B0A!SCNR_4FP9M\MQNQ0A"4I
MF:7;DL8=,JN6D)\T^K9ZY\*R@KBVX3_G(_3(X6U%QFI^(1UDBNP-X:V%0T?@
MGV(B),H(3L&5C2)4<ZV1JZ$D;,\'#G)]_8@C5%T'%#_^R$>JYNF(VSCBOZK`
MA0K[B45B]BKLL9O/\H[NG<#F@#\I8$ML'SQ0Y>8>A#]!H*H5O`??Q?0!:#0O
M<N9<]$,6/#A6,A\Q']`J`,ZFOI8UVI(%./^RH%:3UZ/GC)#=LGO3G8NC4T&*
MZK3%;"T7I\2B2LW4TE-AV&S^IF3@(VH0'R/\0J5G05M#D))2E-M=#ER"8C*^
MA?N=I5%+?-IDC5:-&WZN?/P.^C@97I_M,+Z.XU"FU2.?=PXBFXU`G[/DV[!+
M<]@EB`MP_>(^X%=J\N`_"KN&(S4#V"FPYUX\AQ]``P?I7-)_Q1X?1Y[.2*\D
MB0J/(/`/`!K.BN?@(+X6"!4X&+`A`2`-J/[.^#!12>JC.-`2PR/,]RSAQ8`5
MA"Y">@K\E$<\=1/+T<%YFOZMZ]R9A70<G[,J0B<P=HR[5:4)F]DRJ0!0(F5[
MI?@EGWJ8&18?=O(*'*#K>TR'KDB$'P5U=T7)]V;H6!+WA\_'=7ER%$=RHW[+
MDACW/`D1L#Q_*J3*]^IR_,@P-8%J$;WT._#`8A[<\XF[^7(@A'&$L0/.CCI7
M+MSZW+W2VXLSY=X(A9SF?G#&]S*3S`HTX$>:\,Q;#CXXBJCG[,P-3!#*,LE%
M"M0,2P()GTXN?$TQFOC1CR',N,7$?^2<\25`&YQC6F@AF=1>QR=%!Y=9^A%:
M0)[($M#P!(]5AH:9`2:EPP)8R:0^X?:*!(=8]Y$5,*]!TX82^5L@HL`KQ34G
MKS#E#^#6C?.!L@"'`-92%>-\FO^#IW3.M?07BEF9@KHV44WYEQWI@6]B^G1E
M([^)N*WAXLD1D7:/R98D\DWG>Z-DXGS>P.9^7>K]*-<?+TL9X^O(G-?G_5WD
M,]O?Q^!BPT_*%_\<H``!V99IFKA`R@<(?SZ,]CJ/+DH,@BZLN1`)W=NGNGWA
MV*W`9K@/;&3H5,`NSJZ_OGB/D!3'UY\KR2_1>7R`Z*0:N=S%CMA7W.7ETN61
MRT\7%U?H#Z<<$!2I&88Q"U7)L'G4:\X<?5S0H:9MHZO*W=/Z(N@4QTO0W5ZD
MUJ(R+V#SV+/Y@$;NT6?^J7#$/5;PP^$E8$S2T*!@>UU7C$;A6CK+^,O/-D6.
MOZRNJ^Z:T-[HR:<()?8;_8BY<H=F6D&X<:D4XOI.YK-S,\OUY?/?E3<A@Q_`
M=BJ#MPUI0_%2N8L>86C*784[CB>FJ<HVC>%8W33EA]%<F(5S]:PFSS5F([=-
M_E5_P<.\XFFQ6"8_RZ\6`C0,R3TB+;Q?`U?B[-+V?,#0WA>C4S^*,/G8H[-#
MD-4ND#4]3\P%-I'W4(0"$@DJ9#A03&PGY*G^)[6X,+B@&-QC:AC>F&<->"*L
M<AB`V@:$V(XM3`*#:L%T"L]$\1Q!FA^1S>4N+_3&>2M4Z=)TDJ-1)[#/1((K
M3>(D%B+@:?@D/:36=0W$!$X$^EMDM=+;P9CI,8N'KP)VEJ8]RO"$46P[24:F
MDAA1`5B`5A"XL%ZX!"S].K%3`U!0\GP)6"-7=8A0X%N8FY&H]F+J!M4EAR,Y
M<_%D\#V\K2[A9G.XE#`&,YHB!\OR<YZS%),\;<G33;BU%81*O()KO'EXJX2F
M"SN+=O>6>6SN1,("BZCFC$>SM<,?"(C@569F<&%+0[2>[HKS_*I*+QV<I55@
MJ6B8X4I5?T3*9Y]Z_LJ,LD/DO"(CI!/C#6ILXEJ+85:H=Q1JA.?)_:0^)M6_
MH!4B="?AGTN^#_+:Q#KOXUESX8B!*\,@RT1SQ2&.2&O]R_A7[07`@'4PF`A(
M%Z5TP#.D"+2V7TF>P7:)7XL*)WY23H=XVTI44OO+HYLP=I/2KF)9P-R-\;`!
MG(&D6*VZ!/P:C`P3D1U/]'%?!N(]'W-S2[Y99Y%_)GXJ%#A4LIGA/4\V9B47
M8&^3,Q(3C^B8[?`,6U[>*@">RRI"DH-V\4IY@'C)`E0:Z&`!8EA(E9SKA\5S
MQ4)9`N.'*JX9AA`09V=+Z%!E(1@J#B\2BV5G877HLL,Q1"N$O[D]I[.8YU1N
M\6"VS%`WYG?I^3X9W'990U,DQD1%ED@61$C20J&ZZZ0U3Z)(_5SYU;-EI;$\
MF2&^@Y'3G/$S9U@NK9=!"^KF91E2=S4OX,DJ9_.*_T3D<4F,G=A_8H8U8+5%
MS`A\_MN87R)!P;6=.4##OPM"'CVBG/-#B_I9=IF]*N5`R?&VD\2!#5B)8WFG
MIHCS$P2.`3K_#7DM.>W*H%4(F5<WB9UCGLG5>\`/HT$')H=&4E6:ENWC]Y*B
M`[980F`4/)5H5S4<MY*49U)'A]FU`$+4*'(;+X9(L`PJ\@V?QU9:-_=@NG&2
M&'1=_Y&G/V//92$$54GL[B_!/^,G29(`V/1,D6:#K_-4VP+,%Q#RWYAHB^Y-
MCQLF7N81HB0LL4P9%PLJM7ZNFUHH&9L_.O`Y-V_IM1A2^EMKK&LL9#][GP?*
M>:B5A\EE`G,R*C\<:^[R(+:`WQ\0^0D%HAV@LR5.NG,-`=R?7D"0*''&;V5E
M)3P\:0XZQ?6?&&9#;`>^$_'ZJ$#Q\:H%+ET/!D79+P<)3Z[!"#D>A%^QN`90
MK`90YJ83<!7!I-+/*Z4>S0"".%$F+#+_F)F3^X[%-`POHYK7]``N%Q8K#)!J
MJ%ARDU4"$?S0ZEV.;+$8C:HXQBFMECR*<$KQ2J^(M$<B73BI79!<1$BK%\JH
MU.B6(X<59!+0LJTJ'3@6-@J\?LMT+=&G,*G++=/X/5XK/KNV[GU>7<9AYG1$
M0BU\NR$K]CO+/8EZ)42!N:T:A<PPOY-BH@OQQ&^_R%S\X@V^XG48'KH`NX8.
M$"E+TXK8J"'$XKPD1>4Z/6$:\V?3VYG<:<GPD%7^%1`K5(TU'.X<DX;<[^F.
M5?,2"Z?+5X'OP<]6BZ&T1T'J79&59Q/J3)R7O7H^MRKP>C.G]K)$;30E^361
MBJIN?"@M5DH<6W1K^5O-[$BA>DH$-@^^YS>7PZH`;:#8?K&Z&;U*6?7;4X(6
M:!E^0I^4/:<USL)K!UNJ%E"HGLE`;,`-D3-/TQ/\(!^4)2@X425602E9MW)J
MM:+`=W,7]J\_Q.'9G6DN?[QV0`UC?8$7Y9)RY8-80NQRP[Y'[Y$]WXGU_IH^
MA?6"X==YY8DG\=_L*5XK"__XQN9_>V4-__P$?H;^#]/#FH`;?Z!_8!;^^.I=
M9\3JT`J+T['.>>"$7!424SQJO1*769,R[DL\MW/QZ')E-V!28ZO3K^)P]PFD
M.L2Z\E#T0.`'B/F]A4=P;]RG,_\1+P"'\6WHV`X\I%87^XGYOYG?5>6S9_$,
M+%<*W`<7?F.Z8Y@KJ>4F:ZG),"O`CY*ETAQ'Z3VETI5"K0@3SECDWS%TX-,*
M,S]D^1+*S^9M6%\GJ\Z"-43=I3'%$AYM7*BH&<DK:BX@NL:F%X%5B3YR5[\8
ML.0F!#3Q`H@2905).7N?UR+(E*5S-=9.(:5J[,Y_^/YCH=SC.C+OV$<$&Q@B
M9*3&-I2L`BG/."TKG)23EIRN[3,``6:T'GR1WA19KJ0>).2U-7,((T191EZ^
M4:LG+%;CH%E)-`&6MI4^"W$;%99M7-::)E]HSCLB@)+,"T$+SO9UYOF\]^&O
M&O&*-9:?+J[?%PLLY>M<^C;W5+C)6[7<Q?5E:;4;?^E8RDP?[:*<M%@E5N3U
M$K?7;S8V:DNLI<?L;3X20%PFJ)?_)2K]S3]BB&B-"5?)^MN"#DUO_XKRPO2&
MH%\W>_6-SF\^K=*VF^G-=YEH9W[CKR'[.O^87<,BQ;I&"?P:UMD+MC2C('E^
M;0/8NN>'%V6SFRVRN"IQ1#`Y@[E-]*!6Q*V9=YY4J&"49Z',"H\&G;A?/0?_
MQ:OE:YU*`(B+!<1_EEG295@U7E)F/'<5\$-`5/5XVS&_V%B!S^--'>)%DDSD
MAR>F.&H2:3`\1&%V\0!-')/(@N'Z01K68H+Z2BYGHC`#*;AAJ1R+R<_%HF+N
MM.G(+SNRJQX]U4%/2LC%$UE)8-)KIGB9M[P(WSZ>_I/K:''5,ZUVP*84XM1-
M[GH+%SO;D#:^:UDIOJOJS$LSO+_P;/SK8WX_C'S4#74`TD]6-8:_5PJ$)0]U
M:P\UZSZ"WNF]<W</.M!U@+2H`1]`)I*D'H:B/-T%HEGHUE*2(FP"N`#([WGF
M$(^1177@,@:_5IQ\\;8FEF1;"]<HI2+]%6^.X[;S2FG\H7CQ,BG\+NN;8A6X
M<FMZ_\;Y3'[H)/H)(&5/@%'P;R9+)";!>U.)<'XKA!^\E&Z9\`.9"IW%>](O
MVS%+ZY_">]!G*6'7^'(;J9=J_N\3`/4;OO[K/'/^/^=G?^)ITDGK).B362]$
M^2TY)"U$507*"I7E>YB5SKV72RS.DS#>-R?\]]%?%]K99C3FY(JGVJ(`);[]
M%SI1<7KCH+P=%M\.)4#JERN6)'=*FC61FAQ_R"JQ>&M9,PW`3:YMT_?BI334
MJ[DWA0@X42R2:34NN2FV5DJ42N9?):YKJ0&)Z+^1:]ZB.:VITZHN2][01C6U
MTC*2*#,=D''EXJF&9W],QV&0T[1I`7AIU$@U'OBX<CXXJ9BUY"P2,YO9PA-]
M//[A51U8]J`*!\BLC8W,$SHKAD4VNAV8HP?'181/-4K(1\$G78EJ+1G29@QZ
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M78M1<P<ERF`ZQ=D?C;F(#<ARD&%SQV'<CDZVB#"D=$CI=%NV6GG4Y"1WQTE.
MAS9*O5ZE-,KQD$'LL:AFLED=(TPO;)>NC]2Q-B+;U6E6(ADCPI#R(>5#J>C6
M9P3D>S?-5*Z^>1X'GB.&R,R=[Z(!+.<U_'^_,]='?*"T"W+1^?[VMG03VLEM
M[0$I9TS5\51F9[<BVUYL[7-Y\03XD$282$?:[RBUWPZ]W,XS("7N^Q4\W.`$
MR*;@07Z3@/+W_='O1)@^I]!&`T,U9G3VW&U6(ADCPI#R(>5#^7O*WV_#.A>U
MV\%U`%;>$Z;D?:=$F-)7E+YJ3;DW0V.F3K7A.AFFW'T+8K[=51J0))>47F=)
M=P1*;S`:J]JTPTJO#RG[YVJ[SJ7JZT0>4O2PC@O*K8FJKRXE[E584):][U^L
M(.>+$]#]K54_4$BQ_?C699WRT#IQQ6PC@C6DX@Y92*L9ZG`Z[FPB[MG\1X+;
M?<$ENI'".YC"FXQ50^NNPMNAW]IY>5T9)(@/L<TC_]SM;)?0(L![:Q+Z$2<7
MV+S8/JS0$=ON\LZ_S./=>-$MQSD63B#&?UOW9G`G6J.C-V^*L0]F;=:$X_%1
MA#;O,.RR;&RI:"]=O&1;;#Z</FV92]YG]K^-L\,+APQ\H-IB&4?9\'/)?-7R
ML%8QI3Z?UIH/N8U#-H]=Q>7CBXN3>M.%TB'?O&]R(*83XW!CT4\>R#*'1VO,
MB]/5Y<W9+PK'(_A"-[V?7":24Y]R7T=Z#98!PYW-!D@6UXI8L$A'9`1,S`CB
MD*PG?SZ"(U^N>.:33=-]-$/E]62@3@Q-55Y/AZJ.G5V1'5[/ANIT.DD&:52W
M+IU.'RK`M`!7K3&LFG2%%>UA-;6\8<#C2S%#TWUJTQ*Z;6OG=_P-ZSM"_\HY
MZF=GSLK-H'6ML1WTG[_`-BWBQ2\<SU?OK@9_M(`O?U%MP,<6P(V:@3._EX`;
M/1.X$C?%GB-`B$/[5=ONV8H-SR],-_S;*^W5N\D`."P'J;B\I)-WV[>7Z*'G
M;]<K;Y\.@:UW_O9Q\>U:_G:M\O;9$.1H[=OYD"U^&>N":S-J6K[IG,_B1;9<
M4PEJ-GJ#I7Q5=UV0P_@@#21,S&MAC`$.O>*SKM`X.A8W)>8=&%MA&)-YZFBX
M*ZX,FC-FW7N^Z]_!T[?),`,PU'Y\=\\?PI'+W,TI6OIL@<MDP&AQ>#T8W06(
M*A^]WM3U'`!,`*V:L@+<Z$PE9A*`0CN:66^E-E">>75*M70ILEGVB547<UQ"
MR;#M`G#<5.LS=68,P%0;:)W'B:D6_TAG7G$@:HRSTDZKN:$NV6;Q>Z?F28JY
MW-DTGM?PG*:A!Y']<*:=I?_E(,)/R!9UL$QPV1(GQP/]QETU@8+:VDU8HSMK
MUNV3@R/9?H9U[<]>!/ZB`T$(?[39]C9J^S]_YGP%E+_(-BNSP[I6,,1M7EN#
MM<@X7^>5Y\)5]DG7)HW^0C/,9=NESX#=<@Q6`_.N9DJ?`_RTR;BW!MX`PSM^
M&>"WX9:=`M_,:V%QJ8]"$WT!T&\>F?O`?O'Y\*V5R,W^O`B_SK=@)E`-6AMQ
M:`/B!D(M6^X/T#`WCWX'$4T@DSBF6ZS#`^"]X/@\_!"NG6#X"6<A=P]!!&L'
M'/H)C6$'L8/OUK#[O,",%+[Q:_#!"9=^:+I?YS_[WAU?FJ*:K5SRG*HUUPF\
M)J3N&2=O<YR3/T*Q3N%MM3&6`7MPX#D72>IRDB9Q#T8S3K8-?!XEPP@`Y\[B
M#"5)Q&3=8Q)2C!)V`BM>A!&&-/@+&T>9,S%0+BJ.8!,C;0LCF;(8P!.0\"&T
MGA^AQXVC(P$&3)Y+PXUOZ>>.6YRU68GHA/=^SUR;.^DQSM>$^&;!3)SNF\R8
MPY2F&3BA2(5*TKAU##AB^3OXC-\8,]M80B)FQ<UQ,%2=<)7`0@Q5C@0H88Q3
M\?BJ4IP_SY7'QMFDA8>3M<668C:<1YWY!D=^F5BW;`-&_#V1D%OL9KGN/`5W
M\<[#8+,"=F43.#D%<>%?(LTMYQW9_B18L^\68W8H<NLIF:7;DB;/9?%H0O[U
M*=MMS$$Z;Y3'<Q>6%<3,_CF?'4W&8T,=EY"PIE@+-*7$6"M"5H_D0"-FBFX9
M^!;.Z8-_BO'R*)'HELKFFJNYCLJ57G+2E4\OY];AD8'J<1TP,_CCO0E_YR=X
MMW'$?U6!"\W#$T,3P3P%]M@5"@2AB>Z=P.:`/RE@N6P_",^5FWM0-0D"51WD
M/?@NGKB!_O0B9\X53<B"!\=*AJV;F)H14]TYP!Q$?'-9?RY9`"9T45#BR>LQ
MPX:0W;)[TYV+:D-!BNKH]FPM%ZCAH@+/E.!3_MK"FY+I\:BO?,RU%X2@8!O"
M**,HM_(<N`3%9.(AST^5QJ#RT?4U6C5N^+GR\3MH?U<<768[C*_C.)1I!1MM
M<J%%P-S8!L/)DF_#+LUAE\`3Q_6+^X!?J7N'C\**HI(,8*?`>_#B.?P`^CX0
MGHGO_2OV+)Z1Y,.Y:^>JA4<0^`<`#:1(@(/X6B!4X,[`A@2`-*#Z.X-G_EUC
M<)[<S-@\Q#0J'I$NX<6`%00J0GH*_)1G1NL&G:,3PUO]6]>Y,PLGV![NODBQ
M@FEEW(E#6U;?^U0`UB45UQJARHGC1S/`P]SPB@77]V;`R&1MJ&F_L,H(]I]]
M8`X@I\+IN:H<A2Q6X6WOS="Q)/X;B(GMN+Q$P47*@LK,SD_N^?E'P/(J!B&H
MOE=7#8\,3T50TV*8<0<N9,S/%7"R=6$YD.LXPN`')[B>*Q=N?<QVZ>W%$=)O
MA(Y/CYU@97^9"7L%&G"$37CF+0<?/%U4G7;FQR8(9?4<10K4;%4"2>B@QN?.
M\GR.4[\?_1CBI%LLOXF<,[X$*)AS/)$"^&MHU?%)T<%EEGZ$1I6?H0EH^-F2
M58:&)=JD`%8RF%OX[>)L1:S[R`J8UZ!I0XG\+1`286.?6EA2&.H-<.O&^4!9
M@(\!:ZF*<3[-_\%/D\ZU]!>*61'JM>4B&U>(K%&\%35]`;1/=_":@0?`5?O'
MA'JHE2]S.GV=5Q>_$.%6EI@3K+Y-:<39Z-4[W1AHY83Q3L![`91;U6,@RL9T
M/QBG+']0K%O5@7"LM0-A_0U34S'[)M(+^##Y(1O:SX2$%058H"@%SEMF69.4
M%^9;D<)HT2"N\`.;AUAI(*)<?[PL%7E<1^:\/JT>_'.4`8P7W\<0[<)/RA?_
M'*``P[(MTS1Q@90/$/Y/6=QWG0?Z)0;!:-)<B!J,VZ>Z7\:Q6X'-<!_8R-"I
M@/TFW0-#^\OUQ7N$)/N-_I>WYTKR2XSC'AR[5KI\%SMB7W&7ETN7)Q%^NKBX
MPM`TY8"@2,TPC%FH%BI8,X<*_`%GCN$F^!ZF;6/4R"/%^B(8G\9+\'F\2*TE
M2+R`S6//QM2Y"*ZS4%'$Q!XKA,3P$G#"TBB]X+.ZKACLR;V;[*A-7IDKRG+*
M;DXU1!9>#P;5*4*)WXO^]URY0_=60;AQJ13B^DXN`[`W@0,4RCR^+Y__KKP)
M&?P`/J<R>-MP7B!>*H^6(\P2<1?[CN.)^>FR+PA^KNFFN7Y,K(199J5^G,$/
M&7"_`IN?LN!7_07/N!1KG<4R>25ZM8R]C5NXUA)*K:?8\PO/_H#I)I\7RR;'
MG^)QLI_K[6=)<"K[7Z"KDA!6&MF315U+V%)D7R!K6F.8:X1$H80B1I>(:"&;
MB7)H.R$_1'Q2BPM#;(B)/#QT@C?F&4*>]*X<,Z(Z`RUAQQ8>+X'NPM0ISSKS
M?&":"RT4EB:@5A=ZX[P5NGII.DFYI!/89R*9G29L$Q,4\`.^)!6LUOD/@G4G
M`@,A,MAI\RS,ZIK%@DP!.TM3G&5XPBBVG23[6DF"J@`L0"L(7%@O7`*6?IW8
MJ84I6!&^!*R1ZU)$*/`MS,-*;$<Q38OZF,.1G.9Z,O@>WE:7<+,QU4H8@YU.
MD8-E^0GR68I)?D3!4\NXM16$2KR":[QY>*N$I@L[BX;]EGEL[D3"Q(MTPQE/
M,]6.E2'T@5>9F46'+0W1/+LK:GRK-J-T))]>DDI%PPPWM"5K[4*]#J]:45,H
MMB%3TD[C79E15OZ2EX&'5.RR06%_7!OQPPKW#86>XH=N?E*4GRIX4#L1.L3P
MSR7?!_G=P+IP89E,X;R2:]L@.];BFDE4=]3ZA_.OV@N``8OO,3>2+MJJ[F"=
MP&6%:_R`YPJTI6_?^.+ORZS6)3_GH81).RGE!*RQ-7"$^$0IT)9R)UL*;7*]
MEX>`8>PF5U:*15-S-\;#47!HDDLXU27@UV#'F`A_^2D"]\<@*/8Q\;_DFW46
M^6?BIT+Y5^6H)+SG)QE901KX#,F9KHDE!<QV>/H^O\$J`)[+ZN62,B3Q2GD4
M?<D"U$OH)`)B>$$DJ7H*BW40A:(MQ@^!73,,G;F3G86C4YC%J:B;O$@LEIW=
MUZ'+#O,1K1#^YC[)VK/CEJKE7<UCP&#XQOQ..=M-:V4YY2KN*!!26N5$GD*[
MA*TI<I*B"E;D:2(D:>&&N^ND=:;B=ONY\JMGRRX2\CR2^`[&E'/&*V]@N;1&
M$4V_F]=:2!WYO&@RNV>8MPI(%`DNB5$E^T_,L.ZV?AD^@FCH-N;=)U`=V,X<
MH.'?!=41/:+VX.>L]8J>LA:LE&`F13Y.$B$W8"6*DYR:>L\//3D&&!8UI!3E
MM"N#5B%D7E$J=HYY)C<:`2_)`<V:G'-+%71ZWQ^_EY1>L<420L;@J42[JCFZ
ME62;D]IE3&P&$+Q'D=O844*"95`I1(#/8RNM57XPW3C)R;JN_\@SS['GLA#"
MS22KX2_!(>2'WY+4@.F9(L,)7^=9S@4812#DOS''&=V;'C=WO-@M1$E8XO4(
M7"RHU%>[;FKW9&S^Z,#GW&BF_33:^+5RLR!)8/+#P?<84U\68NBOO'@"@E=8
M"6L/'A@V!`@I"FVG&*_Q=O'9^V*FHA"-YF2N;>5MH/Q`U4K/L#K\7K?($2D0
M$`*=+5$&E.LBD+/T8KC$7##>."8KF>0G(Z"]7/^)84;*=N`[$:]'#10?;Q'C
MTO5X65SJX"!A60^8.\>#"#46U[.+I5+*W'0"KHR85,_PRM1',X`X5UP"$<<[
MF!V5^[[%5!@O6YW7-`XN%Q;+KY!JJ,)RXU@"$?SHZAW[;+$8S;<XJRNMECR*
M<$KQ2J_NMT<B73@I[))<$$]+N\JHU.B6(X<5NQ+0LJTJG2H7-@JB%LMT+3%*
M(;EU4:;Q>^Q\=G9MW?N\FI?#S.F(A%KX=D-F\G>6^RSU,K$"<ULU"IEAWBO`
M1&?EB7<ED(4HQ29#Q38%//0"=@T=(%*6*A>Q74.(R'E)BLIU>HPXYL^F#:2X
M>Y3A(:NT+B!6J-)M8_>V,&;U+"SHH/QL_2KP/?C1$LEV\0C%6AL?0UDU7[A0
MOE"F,85?;<G*,S%U`<JO.'@^MVCP>C.G]K)$;31C^07$BIEH?"BM(DW<=W3>
M^5O-[$BI>DH(]A:^YS=??5`!VD"Q_>)-%O2=96?"3PE:H.%X"4ARQ26]SR)B
M$Q!SM8!"]4P.(B!N!)UYFMKAE2*@J$&YBO+="DK)NI53RQ67.5HHK$UU35U;
M-3;LVDX_B2#78JZ[1(7MW24\JR7-*?&3$/:R_DFQE^5LTJZ9Y48=)YM^T?#\
MJKZB'--@-7#KNFJN;9:Z@R;_Q??UI(LG$68=82P?)2BEC)$0I1VY-IF]@1J2
M!6UHM\ITBE4.9SS+T.UY;U'OK?0W2AO[_$D%V_0(IK$UF^J4'5"IST0B_=(E
M_:+W2;^<T.A$\5E?IY^VVH-.1L0'89*?LPI%N5)2\DE%,B[:BVS2).LC)TPG
MYF]T;;3W8#K%)J^-15P;D(5&>Y^N;!%A2.F0TNFV;+7RJ,E)[HZ3G`ZJD7J]
M2FE\S2&#V&-1S62S.D:87M@N71^I8VU$MJO3K$0R1H0AY4/*AU+1K<\(R/=N
M&IY5??,\#CQ'M.R;.]_%I5O.:_C_?F>NC_A`:1?DHO/]'4^>;J"=W-8>D'+&
M5!U/979V*[+MQ=8^EQ=/@`])A(ETI/V.4OOMT,OM/`-2XKY?P<,-]MMN"AZ6
MR7T`,2%C5:P@I6JWPH63S!018?J<0AL-#-68T=ESMUF)9(P(0\J'E`_E[RE_
MOPWK7&2]@.L-7M(_-L.6P$[28@C[5!8&)%/ROE,B3.DK2E^UIMR;H3%3I]IP
MG0Q3[KX%,=_N*@U(DDM*K[.D.P*E-QB-56W:8:77AY3]<[5=YU+U=2(/*7I8
MQP5ISQZ9L57*B7L5%I1E[_L7*\CYX@1T?VO5#Q12;#^^=5FG/+1.7#';B&`-
MJ;A#%M)JACJ<CCN;B'LV_Y'@=E]PB6ZD\`ZF\"9CU="ZJ_!VZ+=V7EY7!@GB
M0^SRB)_GG2C7]Y&LS`AO?."G`.?#9V.PX]"NS,#6=>W/B_#K/&L]^6?>KR5;
MY1<^\[TX%5M[]6XPG99F8J^&0=+M_CE`ZR6@]7X`;50IG5[Z_5RXW2L%6]='
M8VVT`=@[@WE0)70/8!Y6Z,PO>'Q*+W)\2JYQ%!>5(F!,Q]--X-\A!J,*U?N&
M046G5,`:#0QCMHD0[HJN9:KN%*K"(>2'PEDC_(S3P'G'\XO"D6/CXMM3=6C,
MIMHPAW]7$+T[/**K-VH`>F6Z/T3Y"+"?L`>_)W8;AQCTN,%\R?';PF=:UP,]
M^<7O"1*WV,0B>_M`.HU@?S_E^U;&6^QBHT=<RMFY/6UE+_9E/U,#OGS^>S60
M.062[F[`724PN&;+B%MLQ="TB<JG?0"-Q00//NE+,3WE,ZB:NZ!4V)*M<)6/
MN/[A,IT4??'YP[7RFVE9.$RD.*O]S>>KRXO?/KP5@U<JP."0ZWB)([%X__R_
M?_[M![[00[(0.'KPV*)I1HIDK&P<.:[S7S%FS@F5>>S9R9#:>1R@+R-]45ED
M2^.H<6;+(E'@Z7A;'&'-9Y'(ATJ75_,A+'=PW@D\^"\<DU">I)(,I$GGFYG*
M'&>YX>"T&J,D#S*!DN,I%_%='$8*JGTQ^^"13W^)X!O)J#O3J^]?802+[R4S
MVL3230@IYMU=P.YP9@YGDRK1([R*`&]\;6CG0V7AN"XLKT(X'MTKYA+P_LYG
M\+A/RFO]?)Q^H4RF@"T*,X3-!]-QQ<!1P"(6D[?].7"6)9AWH*L57D(JG*_,
MV9!B:*L8D)_DBJ'`/()Q"T.=TI5@DV?I)A=%O"!7N)?`\*$8X31'H2RS0U5"
M^?1X>#D$'Z&8Q.J:-E,N8?';Z&F9S8R%Y\H+/3A!S(?+/@"+PHN3F7X)+,AO
MCW[@-K)^77PJ8LS?"YJF(,9`J*ID)4);(7E)A.4."Y_N@H.L:G(TK-$])3F?
M5E8`JI5H566Z*&DK9(LD:_UD.ASE%=CPUP/S^-2PT,=(`2?,H(8$=@P3,Q#B
M7HCY6Z[<^.*,+S$.-)GR%:8STOG4=/Y)&%OWV=L<'-6.XL>J'=Y,Y-.0+4VT
M\PJ?`N:`!D"N1!N9C[#)N",S:6*F-,BN?`AG'""S"36"8928Y0X_:6`4Y.-9
MN8IY;:CCT40=&."7O!ZJT]E,G4Y'XFGX]VRHJ9/)5*U3)9^"ZCZI*))M:-U@
M+(Z(H_?IE__SYL-5#0KNF9,-WMH&?\&\9F*"N:S`_P*6F6!N5L[P*"$SOB`S
MPZ$ZG,S*$KJ,`YRK&*5SR_\9P^[/^7A&M"CFDH&C;"D?G)!;K"><OO:O;*Q5
M#M`;W.:WJ1^>#0#&<>UF$*5&]PJ4`=I66"1B5NHI5W"[F(.]L;GAN425=6'Q
MYQ'31K\3WYZ]')S;NN0[7N+M`J*8%G9LK@S%@#_N?"Q,UP6*\J'T'@XV?KSW
M2U.BL[7FOB7F'/.1@Y[_8(I%"@2S$X(Y#5.6?Z^-&N:C1&TQXC-VW63H<TJY
M9!IEIC!QT_E4-2>L+21TI!EFR@WM-SZ3^C0XYHQ/-,7%+D$[8P%AT8QDKEXV
MG1[`^%I0YILKQ&1P?6/6JIC:2G@L'6[/`Y[W3^*!:AYZ+/);7ZT(PU3,;X&G
MQ'/JGYP@C,`QY<\ER>=W5Z,_$DA6O21/-!>_^A$#)O1$Q3-52"8"$G"/TTR;
M@&30`(E>@:2R_+LB!/S)"S[6=656?C-J%)*69Z-7[PQMJ&G\[*GRSN+>_.J!
M)VCSSSY!S+SFE&!:.>=H`05(1P&(ZNNVHLJL<6>N05H\>PU`L_54V81C-X2F
MSBC-++OM/AG5$]96=!FNV:AR5OZ;4$:(>T*7E1#I37GK/U.HY&=Z!CB&X!?F
MN??:>R5'IAO"9A1ATW/8]#6P#<%1G1:/N_8`VZ`(FY;#IJV##9QF\)G;P;:)
M]!G#1HC0:C<P&.[D<`CNBD3LJA2Z]!<+)^(1"/HIKA_&`>O[<<A^7<N5)R+#
M`Y^(%/;O^$."?89:O/*A[JY>W`6,AB4_,S?C(FTKR;6I"B90"?\38Y@R9XR[
MR?Y\CF/0\[@F7R*K`%)P)BY3@`H\XP!N^?7B*?!,5?F)^<&=8RIO%BP*_"4X
MYE$A-9_M:(0GP^;;<^4;.N?I'/?TI`#SB:$BPIU:>DZM@H6&*\N[\).!U^"X
MJ5,-'H"?9JHQ2E,K^'NP8+4EBFD5J?+X%&,YB+)P/&<1+Q)B+LTGP96U\XM*
M4#HVE`5L]'WR'#]%`&",D:I/>5"#WE.1XH4,LP$0&^F7AM+(Y8C8?Y_:I=2$
M-H=CM?8^(MKN+9F#+.[Y`3@^X*L`Z_,SBEO,,+`PY,F=A?FD\,&7F,;PE0<3
M`H`X5.9.L*B*(LB.=8]28N7[DF:)D]Q'<BK)13IB(9_87CQ:R1=+CU?3F>8J
M.E/X.'X_/=M5(OPH%"K"+S!)03N`0K+NSU(P3%053H2Y$>6B=ER7Y(,![7NS
MEHHN'VZ,=`TG]^`*L9=E/OPXX@/;^23ZA!RU+2Z2!\B"B6SP=VT_")/4^"WZ
MC0&`"K\"W%P7W\)S+N6$2S[6_M&!+]TRQ<9LNI<<U6QA<7,??+5G6_>$+P)F
M?IU_8Z;[D6?ETT*BW$$/_S./-JK9F@Z+Q:A-+ZB#PGV1"\]&`P7?3BS4BD"A
MV3.O%FU.P33E($E?M`-X1DU!7@V>&1C(_<,S;@JCZO0!$]T:'AY=):D][XY_
M^88%BZ]S_F/KX.EJ;/R2A&J-BU4+$LM?#(6/\(MP$:X2W^!#S"[QP.HY98?@
M*("?D%-DL_?6MZ[E\Y^]FT?_#^Z*/0/T*7@O&X.>OUJ24/@UTY2_>JC.DV/Z
MJT13?KUUG3N>YWUO@I=IL>M[\&PO1#9Z^X):72M5M3\#"`E*O[#@C@7AA?6?
MV`GY4EAY#"ISZ2?_S-5G[PLE7RXQ,#IP8L#0M''=X12;S:WT-V:92^[GKFN3
M1!YHL2/L?:T<[E(<"/'P+RU$`P_+`>$,EGZ0AJG_B,$;U,&^@":P&8\VZQOD
MFH_<J?OL`I2^PVL5/ICQ\AX6N&'6O>>[_MV3JGSVK/.R+_5&[/W4,+2_)$]D
MO]'_\E9>1)"LC)#'7AA;%GC-\[C6\1;YQ<$:A>P82YR9@F<+86F*8.J(UH-D
M35YW\]DK5TJ.U0Q7/&1S&7=XZT1:""Y^@\Y_`6O!W$6D13W"3\S_S?PN:):<
M_&7'G/D19V&SLOW)MB--+23;*,%0EV)X@>4?H#=C-SN-%%"*TJ_PW@SX=1M0
MP'4TQ7MST-EWT._>G3CH=`+Q-`</'7((2L((-?/<ET2:!;KFW\1M+;WA%G3"
M@@'(CP"4^W3F/WKIP6:Z$#CWH6,[9O#$8P^Q[$KF`F#AO0GD3IZR2%?T\)40
M1@A(E)_-VS`!!^$+V-(U+9;P'\\/B3"C$MW8#AA%C#?2&A1?Q()%_&107@,^
M[#\QXQF3,JK5W4KE'(PLQ)Q1&L_Q@J"G+.B4AG$1H"\!96KHD[^$A4?GQ9JY
M^W@A*RU-B_4:#_03)8]"C:?58/:30M6ZWJE%O@L&E.,%=\FCO*)-<#%6W>$!
M>.8H@#C45L+'`AO=CD3X+BZNSI5?DS>#0I.]02T3OJB6(HB:DFH(<?P.;\<:
MK.04'CE!35X*"[E/M?P:1I]S4%*>!9$V0#S';`&'?ADXF/03>3(\PT>@$B4B
MJ4B$2-Q+-%VM$,`J%`+D;ZL1)R_W4L%2I"L!+X$88PVBXZF(Z"/#&H:0LU7`
MYO`!D+,F-SPA@1CD6EGE=6JM>?^SA+NXE0)]-BWS_",OB5BM)2N;R%PLJ6';
M%3P\SSL5!ZA__?^=G2G_[^^__#;\__[?_[&6\?<_O-',_N_DX>Z/)^_7#_'C
M3Y-@-OE_C'_]>O,4NI,'Z[^:^X]H^NOESU?V'__K#D;>_]Q^O?SP^>FGF__H
MR]D_9^^__O&;8_QT]>WF[_[_O;S[E__E:CK6O=F7W[X]3"Z-GZ;3^Q\&CX_W
M?__W/WXVGR[O'G\:WOWWGW=?]9^B?US]^]N'3]/_Q+_^,KS\]9>+'[[?L=D_
MO_[O[-L_S/_Y\&TP_>WGR`P^/_SC?Z_FWZWY\/9_+QXF_]4-[:MU%WSX\NLO
M_WQ\_^U_0N/Q?S[\OOP>__/W+[/Q_[Z_?O_TZ\6_[^[_SOYE_VZ;/WW]^.O=
M'__C+;Y]_.7S__-__^ON;W_[_Y3+ZV]G9_5`[!HM0&)Z\(Y4]/0%V/"HS@!?
MS-<?']C7+^YEP;#4U(_8Y^/.-.\SBW_-:]+*:NX"B\#`,D8.%MU=<76-]HGO
MR=$7O^[L?*2>/[]$FH*[E]CESYGIX>GW&(Q<X/P7EH]Y#MH)PY@I\3)SX@HK
MB40W3W;G+O,RVRGN"ZO*ZW--QX++>A[?C5E3^/(+YN;SI#L+L=V#$]ZC%R`N
M"%1J%3/`[2H$O$X<^4L&7<6=1'?#R0X?#-4HH2;8M(DSJS=2$NQU09^(FW:.
M<RFBS-:LKE-8B0-0"K]X"3V>O7"W"2^7`'!6'/#S"^6JZ7PA.W0O@W!U48[M
MT&.Z?4*Z\]VWA2L'CU9#.Z!4%"<7:AP@2<CCA.+:*2A!&7YT;N1"7Q!T07?T
MK^_X%?5EX%N,V:$H'#XW*@1/+I!(.>H+B_+'$\<T]<"R"R?5T"(PO=#DIU+@
M_LWQH,MFZ3$5LA*&3YR8YAW^=\Y8*#MAYV%+=N%!38JBRV=&QKF6PT\W5;9-
M&-6%*>4B/*R\Y2<'*+@8]D0\"N#EZ/!S5%\,[TZ*G>95XADC"X'+M0*>TI6C
M_RC/K1042W)C#&,+BVO>U]KY9(17K,1B);FYS+XON\(*"Q3%24UN2P)DH`!`
M%O,;CZ(L@>NRV6"@#@:#>NS4C,DJB)JU4V/\W+P]]^:#)&=G*JX#GI6=1I5I
MQ(:M)?&(5\AQBG06:G,"U\)5?`5$A,J#S]4[;S>5G`\C\3'O@'7WD2OTG20[
M!B+FV,QKNFT7^/'=O>S0V,QVH0J3K@YU8PU9@&TQS9,Q+G)??9WIU%#'X\F*
MS6Q*HTFN0$IPB/A-/JZZ)M.IQ";6%JDA4S@!5U-\N`7E\@1F<J0A"E7<5F%$
MF?4VBO(JJ5R2Y#E0?C#7'*9J#GP!M6SXF0F.6*;]Y%9;5=YS0;I4?C<#40_\
MQO)=-[_5)LW)%[1+^EQ9K?%W8SHF%6WNAX)`>3'G3PGOKM!FF=;0->W_I`BO
M4K0)X_)\C/LDKN6OTF)O"FYREL%.]6X*69KERE0TZFZ.:`)1P=/*L<H<V,>$
M4#S/-54GLYDZF\V*BZ.N>=M\A)%0>AN]766@;+.YG@+[P[ZSP')2%<QMG'X.
MWF]FX]3"W:5TE>0A?K?*62R8[7"G2$WOB3J@<_PL(M`E%RA!14W6`?]^';25
M2Z(U\RQ2@"V`K2Q4@%Q4WR@%J"Z;H:JGDAMHVD0G3A;>64%R`N*!UXG^.G_X
MEH&<E'&+E]SK]7A6%N<Q8B,@?B&^&C(ARV:43%@8+_KQ^^,I\6O(I&@W;EM&
M%\R2F0X6AD7.F>VX/-Z0I9']!R<4N5IQ%`4NGYKD4BTP-;B&Y016O$`K9*$G
M'J`[+]%+)90$V=]@@XK4A6#S.996^4F6N:*+*IHHC&_YC?M$VZ9XO56<.2K:
M$%/2/,3A5R*YSUE1KP4%J.)YFAO;N0>#GP9,N#QUE>?7HNZJ1G1$9X&0>ZT)
MLJ[_R!/0IE<B1>629LJ.1:Q$]ITC9GJ>'Z.S!G&2Q\&TZQF$T*=P9]L*31`,
M+[FOFMX.5T+8S,R4-]FIXC7V3`F7DPG?V)T31DE.Z)M@M"QYT&Q;OGVK9!)2
MN/+H22T54B>'QA76FCLNOR\<%*'(CGCR50LICRSNSE*RR9FN*`4.>>152GI\
MO"R!"A]?`$N[RD"XO.75Q+59%#I6)''N/*0N`"]?S06B%J#R;ZW)8G\6K7!L
M9KDF[HE0-WB9]_9)X`VP2U1Z@H">8D#><1NYVC;9G:]PD1VWEIGF!D]818((
MN.+"Y3<KDI3"59*,*FW2RDO9!7K,\<(J=H=@\#][C5,J+.#%]:5RXR\=JZ)$
MAE--+?KASZ?&!Y$_C9WP/N\9D[WO9\>\=5PALSSQ)CLZR>6R)+*(`\!;%-M*
M#AC(;#-1.\.23B+59##&^:!X;AG/+@A@GFH4SHD&+VQJX.6Q[Y5=6)9SN/GI
M-+ZYLA'*5!^=[YCTP`3BVK]$(?Z=V7>X(6TI#>"U"0XD;FJ9X(G_QOLO85;!
MYMV]0#+P[HT)0O$H>OO(TV_\^D&F9!/])T[DA*TJ^3.%2OC"2@O&HC#IFS3G
MV2(A@R;\.R68%+V_@Q_T@$4JCQ(G\9:Y#N,-%D3ZL(:XPU$N4)4)5J_FI?PP
M*NT#5_VA%3A`*\0XV8RW/%`$X[GT0R9-VPA63,/4C-8YDF(%/\(\%Q#VUIF#
M63:C6DJO(D<9AK(M27>RVO+!<L'_=\4(=SSYQC1WH9]-X@U7:8;$J+3>?!0]
M+!C`SJ10R1"U?<9+B:K$#ABO<BFB+FY6I(V$L`#X+F&13&#+`*'<-F@$7I$E
MUPA%)5"%*M<)P\G.U3&[C9IDOF(+:KIV4M*U:ITO>*FB4*95G&Z9!\+&2X,D
MW%)\U?O+3R5/3.Q1P784=B_?'-A\+%P#'0!?#8%TS<>)U]A2I7YB6`"KG.JO
M[ADZ8X58O^8ZYV&S*.U)FJ28;GJ5,F%V0+1AK4*-5\"R.U$I%&G>F4>L6/&8
M-%#D"7]X`!-CCNS^E@5.*$];B6-'.7J-[2G=L)+**C%VFH=*,X6\!+(>D"0E
M6W5'(+>&($]-&N<)<+>YR4Z2_*!$4)O7,IDK=7O271(O0J7RC_WT8HGFX^H`
M_GMVYR/=;LW0D7OK*VZ(20X.)%HKHQ]X2P!8BB=B)SN,6F6YR,_?\KAP[J?N
MA\.[R<6+15)^R\6XY+#S3$_A%+DB;FE10DUY9`*@)E6W("46.)UFDDZ3;79%
M;H%C:HSVXS;%1GQDAF(QUUUB)TSO+B&QE@P;P4_P$GC]D^)LDME(-IQDHWDA
M3;]H>'[5'!V.U[:3R8L+9;-;B@-:\BD^+0>W3%/B-$X]2=]4E<#]REL#5DVD
MV%(:V\^)^5)7XOF?K%)#5%T4"C%$!\EFC5>&OC).L+[;Y>DSLF]L/#%*7BB9
M+9F;DH;O[`FLE<J^%>3[Y`;IM*K]TD4ZL&K3:;7['J:TS\5U/#=4M4$E3]AD
M5C;>AX.,P%JGQ9XO;^+SH($%A/4A@_+R!N5G"$U^W*+6NU'AE9AGGY!_,IUZ
MM_S\3Q:[91'#FZRI!+B/%WE+\RO3L<\<KXG\E^)6ZMO-Y'V7EO19@B`SL$=D
M7@\.>1\,X!M=U8V).M2GQV:7]DDUZ8#VW5N][L5<)8BJLS&-Y?=\8&;=OHG?
MS%H/5M^]M1V,GV-N#VUOWV?YW54F5);Z;6.]6INO)D/P0M'?.@[LBPF33NX%
M^!5^&7?CT=J=L6^;X-4PD/B(0L`VBQ>,\63,:\Q7^(\K;N5MO,TO-$)9)J3'
M:+TI9GWYF+5E$K1XCE@Y7J!,*(5JW0C5]INKU*;J;+C*\O3!V*P-"@^2K.Q?
MV-:*L4_;DESPPI'BQ8@Z`-B_=W51CHWUW=5[[/F?M`Y%'H)UQNY0#$8Q6'],
MVV8QV'8A6)>-XI81&)WKG8AE^RP*_QJ-4KW&L46(U!E;U;5(@V*DE];U6R\^
MG>CJ6!]2C$0Q$L5(,@')+VN&3>^OW">2BT]GC`<%.A3H],<^;7C8-!K-ZG4?
M_;9M=-CT<B9R2":RC8E,@JGF4ZFF**MZ2:4Q7FOJ3-`3LRKCHP[8G];F!^!7
M;#^^=5D+NWI87=252P`;T:W);I^LX1[HAJK/QD>=H6QE3/8:J(K/\#I?2M*N
MWNW,@):RT3Z;BE_R2*YL1WE39N4FOU`FGSXLOEXR0!TF\4H*[ZW]U"=V&\1X
M71;'_15[1H("*'<$KW4E<VK-/D(61:[H[H37FSW%SV:M\4OQL>C86[D&J\V4
MZG6'POU[[)0WX]W)Z8ITNSW^$`>U)D89R7'*)-]FB%YQ,$^A@R50>CR:JB.C
MLNL5CBGQ`&\SAFFU)7[9\?CA,O;GY#T0;$>TNDU:BM>UR9N\#]Z"PY=QVJUO
M!GP*3CZX""]>`^;FG:1]V=E9R)B"(SJ4V=NTCW*.6KFI,.>IX5!7#6#Y.E"O
M!V-U*B:_9M.P\,8W<QZ2266FEXJ,(9HKUN=,Y\U.X"_LH"IF])C)0OP*]QL^
M]EA)AU!>A"`_;^4]($K3="Z+TW22(88*GV*(KR@T-*CCEEP\ET_C2MI%E-K%
MLT)'^/3J4D56"XU=J_PTFT[4R730-(K+K!7.F2MZCHK-2%ID2N:I98L`@N.M
MIN.2ODA?6&3Q9G4QU";%MK5%=7%4VD*B(XS)0!V,&YN*[5B.QMP:Z_N1HV2O
MJTN(=KPD12VE".<^U:V`(V;WX=^Y<[7*J9+,9\%I)K$;\4NC.,X,C0;O$9T.
M/"R--,Q]L>`!.$#>]T:(?"+=:`^XN*`+F'N`%2MTIIVIX!3.5&,X$DU0P'B.
M,@^1-S5:YIW"4:BP<U]EE12JO_`5'D6G+GZ-Z(YY+$!5@)W\[87C)3U#'U@Z
M=*.R%+(V!^JU/A(3;/BSKT<#=:H/%%N@R%MRYZ"A'#A^%;?"#'L@;B@HP+L+
M'[O/N==Q4/SPK:8ZORX;([8C(NS>`C8Q!Q8[,]O^,DK:>-5G@^+7DJZ<^`OL
M%?A0E:`K\!QK4V)%;"TVB7^CU-4-Q1H?X'VN9<W=0"JQ/[\S=[@M3UZ<]K$N
M]L4NV/7"ZS]??RW._BQWKO-\+U^\M*3$C0>AC\`&1GEN&^RNS55H[:-;WXNQ
M'6.U[3];+%W_B:%Z2V>KJKF/H994LU!<#T[H!_5ICX5)18V]TBN]RH5;\I1@
M6-DZ3G]F\X$XV'#LE@'_AZ'H]CTWG2"=4:7K8DA"_KLR8/B6"LVSQ?$<7;1<
MKU,WHXR\I6@BY-E2^3#,(G^50>'L*/KG`U[?<>Z\$C%/M*#'UFN<Q(F=2!O?
M8T=G2?`5@'^'SS5WIB].J\79I0$&=SJ."D-;4LML9!;;X<WLR_.$,WM1Q;.R
M:P6I.G;#LBO]=U'FD4)S-\S\/:!ZD_.68"<SE+KOLO$^V.&4NU-AZCO@DH+Y
ML"$H\]!-J<T7RP??WC+7?WS!CFXX#Z55(OR03=Z*5)?69=7`6W<,L_9LZ/F'
M]]44?^T0H)[@MVMBW&-H+1_9+0776'L8LVVYC,7G%:Q%:(WB$ZL<3O4=]$SP
M"Q]+TO),M7S,3H0LOE)F!M(_R1"EMJ5(*\G<2L"V.?'<L9"]D(I[/N2D[8Y7
M2']G6(C![+-6-;ND\]8YSQ`<F7>L;:T&D;*9E!_3Z5D[,1(G3DPQ^K8I4&I/
M1K*U9&O)UI*M[0(YR=;NC)3?V,)TO-J4*^+,K6_,18%I1;'I4A[AV=2\8<%"
M2CE%>?,4A&T:6Y)C0XX-.3;[L\1IY129C]VT[DAFLQ$Y=T'.W_@9?$]BWRT/
MI':F7NN79Y3JQUNW>9"`L?5!W3K#V-6C^X-P_-<X"B/3LV7E0ND?R7`T_7">
MU'XV_:5.C;L(5\,%R_IN[HT+9\94-8:R2\LOKE77TH4X:6-U>]C[S:<B1*/S
MX6"M6B89.JP,/2?T;-$5;N?PTM;3UG=^ZUM%'A1,U+EDSQ;H)U%03K'!\<#U
M\FZ-,9CB53:*#7K.25V%Z^4Y/%O<L5/X+M[K9\/!2`)Z;9Y=>9U,1+3SB4QF
MCMHOZ#QWDDM(6T];_Q+1`)U#=#MT2$MXY<$#A0\]A>OEG:LV%91'IA"/D(^Z
M"M?+\W=C\#!^1O!`0M,]YB0'DK:>MOYX3A*VZQ]PTD'")S^8,VQ$*!4T!;L'
MB<YYG3^"Z':KBV=/B^D%Y"W[RN^5H]_,)NI8DU73'5SI[F#3#TFYA@FY76"L
M_HI$?R'O@C`WAF*39X1BPW--/LSE&!1$%SGI4#)PJ$M)ZV<>=<#C)]XBWCI4
M-'G*]V2*+0E':^?YMA_-4R?720>J6]ZJ66_H#Q"V[FEXTT'U\_X'M[T0,K,]
M35,[H)>LJ]IXINK#]5?(]F8=#C#7CYB])\CLD]4/<!WIR)3#\'ST@E6+I!=(
M+QP:F2,0VL:\UU2"6MN\U_A<Z@V3'B#1(?_@9%7-F28M3>J&5MA5ZJ2KU0R4
M/#H(CR>ET'SR-"6/*'E$^C]_XW@V56>ST4O52Y!CV`M&)\?P]!3#.42;E#CJ
MIR@1,J<IM(V)HYD$M?8%4^/NAHBD![H@.N0?G)RJH<31UHDC\2%/1R2ZMJ-#
M;XL`[V_FK6T[.,+6=.N4<KRY'RQ,/N'6\CV+!3@H0_%C+.\J#,3.)G7S*<AB
M>&UE3R1#<+'M+I^$"S]HBA/B_-RY[[K^8R@;;)LL54KYE/>.)ML6P%LG7AO5
MA/;KND]7H*4Q#9UIA-^83]Y31IG&I="X%))#J1S*ZR1)#DD.20X/*8?RNL2.
MRB'=>6DH6QBUB576$Z9CD>]AA2$=3BJ70U/,VE3FIA/@KL1,\>=9Y'LG6D0K
M=AQ@:`Q!L%S;*,J2!8[?T`ZNZU4-+QK:[1[:(TIEZFOKEKIPDUP['\TZ?)K9
MK98!))TDG0>6S@E))TDG26<GI=,XE]8'GJ!TM@K"**[J3%R5#_.59<*4>C#%
MTJ;9A7!J1=Q$4=-Q0ML+M?RB+86[I)6/FQ?[!2U)#DE.5WBQ7]"2Y/1)<N@X
MYHC#AAL_RHL1JV^6G\(\L#!J&S50W'"LT/9"AP_TF3HS7FS\9Y>T^'%S8[^@
M[87LC(::.AC(SBI(=HZ*&_L%;2]D9SB;J:/1A&1G3?0@/J3;05%2&E6A7APR
M[E^_QP+,LVOKWG=AJ85O,Y??`K)9Q(*%XZ5^.*^/4FPS8G525WSYRJTB\6AX
M7MCG[*>;>R=Y:7W5.')<Y[\`E,6"R'2\XBTF50ECZQXO&B%L#A9X0N2@!`">
M`F\T*\@&3OCOLWG`F!(R"V*+Z`GX.(+G%412N6,>"TS7?5+8?V('$&&`:N07
MB\#RM=CW);,P2'&=.<<7(4@PO65(+DX)F]^("G#!(,>ANN<^/!P`&F&\$!%0
M&;'L7>8"(MZ(OPVV'):NR5("P:/CN@`&;$+6Z%F!)QU7<2*\FI6?S.0SB=0*
MM0!SRW2MV$5J(ACE_2W=&"MKGJ2(KF&K@?J@5)RY8R$K%9!6'AGRHZU("`3,
M5'A]"E?R5,#6W35+5RH%AV5=0+?-=GG;;/,L2ML2X$X[,8>N8\YPV+06OX39
MH/7]Z0TK]#=-A!U[C7[G[ZQMUX7@>?<VNM=5X84O!-&]FB[);.?OMY',]E!F
MR?Z^A"QW_H[<WAQ..JJEH]I=W9S+TRBEC$MX2.$ZRL1SOZ#M19I</Y?Z;]U4
MYJVTT]Y(]7]V58UTE-S>+VA[(IM#DDV2S5.#MA>R:72Y2^UQR6:KB(J"I,X$
M21^3TUAYD`1T<6SFV<J3PURZYG9"T/9"KVOGTAP8Z77RN8X96I)-DLW3X?9^
M04NR2;)))TP4/,&?M)8VJ6)]\Q2$;Z7<1#'4'BH.MAF(LHJ3^1H'9>7#\O+X
M7';]8E_<V1'+<6I.S'.*\;9T8DY9IJ021?)TNO)$9HO,UDN*&9W.'%.`\>#C
MK3'7B9XHK#@A:'N18M*UT7G#!:&^:MTNIYF.F^/[!6T_Y%/723Y)/D\1VI[(
MIW$NGWM`\GGH8QKQ(75=$2^[QE899[=F6`U++'^Q9%XH)C)CEP\O9$K`L..&
MG70>4?C#RE=Q(G+EFI[R:(8UAGD]T#55FXQ5Y?5P/%`G(T/EG4=>CR8C=3PV
MBKT4MY_JK-9W.F`A!ES.`W.?I`T_KHL]8%(<<3JT"]N6(%JF"BP)$&+[$WBM
MS6!E?[G`7BSITSB=VD_;M>"W*FB8-G:L":/`1+BRQ_@&8%\8)$)*9;98NOX3
M8S6*6JX9AKQ+B6@S@L!8?H#X^IX=IMN3H('(^?/::NEBH>F:@</DW6\^)=.V
MHWN\4U78G=)^U``4^Q/*R`L<4J`OS>'N4F>4'=SF/*"5*/#K;BSKYH1)+R5O
M=]&U5\2AS@]=NBW>^6XMVVY_@_/9:]%YH2G*O:(1J9<NJ9?.-Y8A]4+JA=1+
M7]5+YWO=[*&/8A_$I55!`94W][/ZX">1DVJN[,$LDCP]=<":G&.9+WM`*]\O
MPM#@79E-'.CJ;"!K:T#'0R1;1!A2.OM0.M.A.AC),HFD=$BVB#"D=/9`E,%X
MINIC67Z1E,X+!_:'C-6?<61ZNA'\MZ3X1)ZT:ZA(62-I70S<CSC#M@MRT7G'
M]N9P$]JUO;"WOPNG4U4?MLF5OYRY?"XOG@`?D@@3Z4C[;5$S/YFI0ZV[TZM)
M]9'\$NDZ2+K^JSY#&ZLCK3])DF,N@.YW341]9X:49UG'.C=^E-=)5-\LN]0B
MY;#^95GDK-%#F=V;L04**;8?W[JL4_Y=)TX:-B)8PU'$(0\BQ*7$SMK89_,?
M"6[W!9?H1@KO4#1+[EZ3PB/!)877-[J1PMN<9DE[B<XJO!W&ZIV7UY59%/$A
M=601+[L(*]3SY[+F)]$]"T0WC=?&1%=GFHY?C+V`6?Z=Y_PW:Z"2K;.NHTN8
MMX(I?;>ZCAD$IG?'L,A$WC3DYIZ5`)&NEBU7Z+O"D@:9",TMPI:MX#\`\J;R
MF`R!3N<]5R@5L(7I>-A+9LD"Q[>1(L:Y+OJ6G*]4H:7\3'<Y<#4+"IZZ^>-G
M8"HG`LUD%5Z[BT9!==F]B@/K'EA&^9VS122=M'U$)-X5.7^O\NX]L#3(0!@#
M=XL<XS(E[6-"6G@GB)+G84\C$.%')ZJ4@LT=S_0LWDL)'@A-*V\/9+JAC\^S
M[[`F2*\R]P,E9,&#8P'$<[`#=77AA;$;\1?C"CYJG&:!%VU\^+NY)J]2<XFM
MD_A:2A@O%F;PA-(IQ[0$?FVE2KLH23\BKB*E#87:R#OU%-IE3Z$B328M2;+=
M:5*G&B1N6</8Q2;VN[C_OND!TU'?@/\2HZ)J/-L"M7A];X*Z;#:E)8[H:"/\
M'=?'O*AT[Z'RXF7'OU!/BYU*].])7")_]442K*Q/X;21Z!,G]<?O++"<D,E?
M?16`/WNXX_A.5]?L=Z[("Y2\M',?USM970TX#R(_7^,HA*`.XYI&`,RH%D[)
M.X)UO<9EK='J5,S0'6A[<9545Z<331V-Y(W5NZG+#Q$!'B5'TFWO/HKHY'PF
MJ[`Z0>ELY5.1F]09-^DSS\0WOYLSPM30];\HUPS;YRL7V1&(\D:7C88F9^DX
MH>V%)C;4V6"@#@8#4L?'SY']@K87\J.?2Z^BGJ#H4':(W)Z"V_.>W)[3A+87
M:IO<GA/BR'Y!VPOYT<XG(Q*=_#-*X!RO)W-)GLQI0ML+34R>S`EQ9+^@[87\
M4`*G_!DE<$[=[?F*%SH*/H\A\WFHQN=8H>V%UA[KAJKUJ!,:>3PG`6TO9(<\
MGO)GE+OIBQ.3UOC;+6KJR"4Y'FA[H5;/SL@;.79&[!>T)#:]$9M^YUYH:M,6
MC/_)#^;,R2Z'UE[N!]CWQ@D:O)VN^SHOUNC@V*YSGTQW^S>CB:K18(]=D%*>
ML25A.E5\^J\<)OU*6G7S;O[+^H0T86)?E_!EO4S[Z"&V&C31/2/PC-[`';0`
MW6W<J^NJ88P:;_9WQ!3LO%\Y,7Q7D=DGLW>B;T#/%(1QKO6IK<"V+A)E&<FC
MW/#(5-IZ-_U#'N41V23R*#>0CJEJS#1U(!WWU16K0?YD)]B=_,G34P_&^7#8
M8<W0;7]2?/B"TUOT:>>'9^!]0LG<A+8_7;-*NUO;":TX#'$*!+CLX,ZE=?T&
M?CEI1W7I>P\LB!R<9G`5L#D+@L+-@&PM,=@C?5[_BV+>^@],/BU%/%-R"+N\
MWR^XX<;A-OS27RS@]WP?E9OBY(Q\4\NK->YP)_:W6X-:/OE!55TVCF<1TULB
MOS0[Q0^2T2D`29TSI?-85.513#\*;#[F)!W2E(Y*XM.0X(,:8.+Y9/J1BJ^.
ME\`:N(8-*^#4*`@"\9_I5Q_-L,P;`8Y3`44A'?3R,0'`#$/?<CA,.(5&"6/K
MOK8MV=0G/WC*B<0G5IUI9ZKR>J+J^DSEPV5>ZX:N:J-),MRE#%(ZZ25L&O4B
M.A3SA>`'3:UB%.)8*>>!N4_*A>MR:#-:(CRF"VR8CL&Z8QX+3!=7JV^7:2\<
MSPFCP,3UTD6DM+H(Y9.[:G3*)WEY?O/<+,G$KG84/U>DX'WV%)QNPY<N++5R
MK10&-9W!P\F>\:K,NKS61X:J&V.D18&R#80L,%8-.<YHR`KL>P3?1;AA30LL
MG.EX(%L/#.0R*##:O0/;_`BTK4-EQPRW6M1=X5@DC@C\!OX>-)'K'Z87X]@B
M_(Y:%;T4CH5O.W/',L7D)7R[LC!M_C:$/6+!@O,%_N/2!725]V5N_;TP[*FD
M'`3JHC`>5S"5I1]$"1FB>[_:$C\CQ)N0,>6+'S%%U]]N8=?_^D,<GMV9YO)'
M;F+N?1<41/CQ/[$3/>&R'\`VN7X8!^P&MN8]:O1W&;7_FCZ;>2!\$3'@Y"(&
MN`/.ZK'G1-_8_&^O0O[)*U2A$2S'?V<9?UZ$7^<#':0)9>A/X>-<%#R<\O*_
M<)E[I=C,<A:F&_[MU><OGUZ]`VNIY=BLANB=!`/?8LP./T$X@=<L3<]B7^?E
M52X\6_R"P8?"(F>8Q:%=04LW1G_B:CJP%N)UXS\'Q;.1P%`K([D-T._:X=X(
MW(&1UEHAW;AJOM5W_L/W'QN_)SY`S</'3%RQ@#--"5GXI92#004F//R+&6R)
MJ_'J'?;C^>L/6X%9D,G5S]_XX`SGBPC!6".@NT!/B.AL@'_6X2B%L8JAF+-4
MY';^M6119G_V(E\XSQ6F;4!Q(OCV8AD\GV\YLOI0-Q),-X2UKIWXK\7M[P_<
M.%]Q)["X#%*J)`;7S(*O1DZ+[=T][M.I,1Y/*L9E:P3>[8^W=V1\=&VD<82W
MY.P"=N@W?)TGGL+7X!LFT(!:./?'O,LT7?[XI1^[]GN6SNHL6%L(8MC.T04]
MA7=/4TR?"VV=UZ5+IA*4\\0E^/7,?O^4NE3)%]<S^U1.@G2==:IK1V#6C/"^
MT9Y)T7Y_Y&@/-"G:E\>-]HZ4VG0RPS\'ID)Z/YC[-]F'$M2%0^9$;/%\&<^T
MVG-`DP1&>\-P8W'._,N>8+BYY.YK#U?Z+E_8(_]HO2;2A9/UB=UB&NO&-Z;)
MCW5GPB@%/.W>7S>DO`70A64%\.#/CGGKN$(Z8Y![+UH5Q4U+M-=F10BU5^]F
MY8!L]7O>[8>:AJ"F8`X]=UGU/S][MO/@V+'I(DS,=KB#+1)(3?I^/)J.C"U(
MW@:SWTPW9A+$),'S[K""71I"_*&OQZD,7MO$B#2RDF$TJ*4#DA^WP&@PGK9)
M!)3CJ'6N=9TBA]NBV70RF0Y6N=)UZ-X5,4JU5_UK)377+HFQ.]3*,4)+(#>,
M>MNKBIVQ(%<50VU2\HE>2E7L4K",R6`PWEY5E'(<S;M]X(T:HQG5*QF89NCV
M*%<[P^L0<B5^_\D/KI/SRC7;-FS*]]8VI*U]K4&P9PQ*&>NBVI,X9C-C..HH
M&N,B&EJ.AL2_U$:M_4LI%B4D+M+S5?[`>TSJ7!:.-M-3Y97*K)&)_BR8\QHH
M0D#^_$F</%YX]D7IW#%YLU3C%=!O!_]>T&[DO'VAK8_*KOL+XM[(KOO"?328
MZH,M4,^MPB_PID6\^+H47RCHV(NPF//\9#H!MY5?YY^OOX8_H99F]HU_*8Z1
M/RZ6KO_$B@(MR=2.QJ48;%RS`WIJ!W8-5M570?K<5NES@;;GCBU@\?=/^5>N
MS"?\U<6C&=C9^RY@%Q<<NA#):N%;6;#0JRPQ*;"$-LY80AO_^8OY'5%,]O7=
ME:[]4=!?>P-0HK&ES%)_U_OJN_A_?@/#GNG7&OK31O2Y+(C]#3,:#*HDV!%8
ML@S(MLMGN<'-*@)6\7Z>(2G9L%U#*!."VOJK-=RL^22\OI^52%?7M,EX'7JU
MU,KF0`ZU1A.T%LCA>#`9&8<`4F^T%6N!'$U&X_'&0*:Z,#$[\H>^^-Q39T*(
MPN1L+__\T@^C+W[T!P,\LJJO%7A6$IZU&$V?83BS=Q`E\K^W=PF5`_8]^15^
M3V\;7[R[,OX8C#\<@"12,"5TVH%?-#16N<)9T5XY"WXX%W@/"`]6.<&[1'BB
MZ[,NN+[#X2K7=Y<88P)X--G!/O,4_QH(5N'<*L3F\8FA&^/*T<*:]U;R4`F.
MO)CD"XN*2>+RH><GQS,]"_R>&[S>DE4WMM8^_%(0/JI8S'676&_KW27UZ5IR
MT0<_"9>F5?^D>"]H-I)=#-KHNE/3+QJ>7WF[\%DWR.L7NR);*=Z.RF_0M;PU
M-4VIL_;^=?7^PGYO*S1@U42*%,B]W7,#9I??KL,_RT0,%',>X?6"_"()\'L8
MA;+"81F)*U?%)7?)2[?,9-_8^+;FJFMOLHMO!P)KTRZSAVT9(+TINE^Z;-FI
M^*!DV6]K(W4VFZG:H-)W874KS`WVX47Z(^]>WNH73NO6APS*RQN4GUD8_KC%
M1<=&A5=BGGU"CHF]QHU5D$UB?LLFOT63WG'"JSP7R<TITU6N3,<^2V_VU1>Z
M-)=XM_3M9O*^2TOZ+$&0&=@C,J\'A[P/!O"-KNK&1!WJTV.S2_NDFK05\^ZM
M7O=BKA)$DFZX>;>*NGT3OYFU;I^U>VL[&#_'W![:WKYG'IL[EF.ZJTRHE5VH
M4.;,C.*`M;->K<U7DR%XH>AO'0?VQ80]N_/XRZ.UIP;DQQ0"MEF\8(PG8T,=
MCR<K_,>U/7*[9J?;-4T_1NM-,>O+QZPMDZ#%EB#+]%1`M'ZA3"B%:MT(U?:;
MJ]2FZFRXRO+TP=BL#0H/DJSL7]C6BK%/VY+P@GP,I%8D$OVY<IL%;=+(S&9L
MT3@<#CN_/3@V\^R&44]=L3L4@U$,UA_3MED,MET(UF6CN&4$1N=Z)V+9/F,!
M8Y9DE&08S2!XP@:`V3E9BQ"I,[:J:Y$&Q4@OK>NW'RPPT=6Q/EQO#3IM#BA&
MHAAI3P*2-_<*F][/^R7S%M;-IJ,[QH,"'0IT^F.?-CQL&HUF];J/?MLV.FQZ
M.1,I&TM")K)F(I-@JOE4JBG*JDYT:XS7&B>]]<.L2L?;O+S]V<\4K\/JHJY<
M`MC%Q*C3-=P#W5#UV7A#N]TOL]W*F.PU4!6?I9.NDM8:S[U,*!V5L/-!`\-1
M4__NZO7*V6RF#8QU+?0V'B!P8?\K#B/LJ1#>^'D!(M8??O:2*L/D.JOHZ+(C
M='1C`@YMX7[KIG!LA4FAC>X'=AO][D3W>2#\*3GYVPF"DW&YB_JNH"MW'"\P
M=G9!^,;?;OQ#^[W3IK-AVB]]0PBJW1INV&+I!V;P),:69">W7^<?DO/5U;WT
MMMZ/%B^6-=0LXL+[SZR&KC)\H0+3=**/]6'3X!.^?)5>Q7[[0L07?NQ%V3@"
M?3?4@GBS))UK7ROK/&/=,SMV6=*@I79EO=C_XP+'0,$VO/A];EUK.0K[D%>\
MRY:NDI"M@;;._UKK%#X_:J_:]GT.B>TBM):/K):":ZSUPK;-DV%_,!:L14@2
MR==7.=R$P(,&`Z))5,M@:N4P]1,GI#]O#N=$!Z[6.<CGSZS?)M39L9"]D(I[
M/N2D[8Y72']GF(%A]EFKPSK2>>L*2<&[->]8VR0-D;*9E&EST]T8B1,G)N\0
M*Z$DV5JRM61K#R2$9&O)UG:3E-_8PG0\/+DFSMQ-J5P4F%84FR[E$9Y-3>S.
MWG!*^.8I"-MTM"#'AAP;<FSV9XGO[@)V9T8-L1HIO$WO[$2!XX6.1>3<!3GY
ML6A?8M\M#Z1VIE[K53-*]>.M[W=(P-CZH&Z=85S#\(*TAV+WVO[LF>._QE$8
MF9Y=*$6M`5`I.,7"4OUPGM1^-OVE3HV["%=#965]-_?&A3-CJAI#6;7RBVO5
MM70A3MI8W1ZVL/E4A&AT/ARL5<LD0X>5H>>$GBVN@^\<7MIZVOK.;WVKR(."
MB3J7[-D"):-#*38X'KA>WJTQ!E-UI&D4&_2<D[H*U\MS>+:X8Z?P7;S7SX:#
MD03T6B/[\CJ9B&CG$YG,'+5?T'GN))>0MIZV_B6B`3J'Z';HD);PRH,'"A]Z
M"M?+.U=M*BB/3"$>(1]U%:Z7Y^_&X&'\C."!A*9[S$D.)&T];?WQG"1LUS_@
MI(.$3WXP9T[4.#C##Q3V?>D$W3^"Z':KBV>WB>T%Y"T;RNV5H]_,)NI8DU73
M'5SI[F#3#TFYAM$X76"L_HI$?R'O@C`WAF*39X1BPW--WL7U&!1$%SGI4#)P
MJ$M)ZYL==\#C)]XBWCI4-'G*]V2*[0A':P?YM._)6R?720>J6]ZJ66_H#Q"V
M[JEK\T'U\_X[MK\0,K,]M5$_H)>LJ]IXINK#]5?(]F8=#M#0GYB])\CLD]4/
M<!WIR)3#\'ST@E6+I!=(+QP:F2,0VL:\UU2"6MN\U_A<Z@V3'B#1(?_@9%7-
MF28M3>J&5MA5ZJ2KU0R4/#H(CR>ET'SD%"6/*'E$^C]_XW@V56>ST4O52Y!C
MV`M&)\?P]!3#^6"ZU@"27NBF*!$RIRFTC8FCF02U]@538YDB(#U`HD/^P<FJ
M&DH<;9TX$A_F$[!W-X.U-F99OM`%3F:^8SC?^/U3_I4K\PE_=?%H!G;RFD+=
MC9C-F$^L#?D8P>K0VF2$KACVJA<'U7[^\NG5NYDQ-8:%N=@[AZ\^!GB'KTB'
MR"333](K]GS`4VF4[Q4+-B6/\>H=]IO<"VE6P2V;!?S,-_.N9>%G#ZC@^/9/
M@1^&:]BF>5IPE8&,P72D:;NCD@36S84HW.@ES^:B5M0"?L*.11M0:G=8U"F(
MFDM,@O\0!\"18@TQB;2HUK*N%;M@&`U(4,!_8QBV$8UU1$P7/S`W5$AQ4"S>
M[5:[)'<68Z#$A6=_Q.N)?(4,EIWIFMEDK.F[4S5K`=^#*E[[SH,I([QV<T!:
MKC5Y+^HF:24_H,YYNC:>Z<,=\I[<3^JNH[2"0)R71CMT`9[I*-VN?_/MQF_.
MAL(5QIGA+"ZCK?"]NQK_,1E\J%#IL+#NE\>R23U\QDR)J]HSTX9V<5OH]D")
MPJ'V3E3.>#:=S4:[HT4-OMUKW<(K]JQP\#!D+Z0YL,)I?G.3$.OM%<[P#T.?
M[5#C;`&LS-7<#01E>=9WIV[V`MZ[A&_N_(?O/U[8MH/?-]W/WMP/%OPM0#F+
M!4C#8NA3SB:UWGJ>RL-'%8NY[M*T40,FJ3@M2<_A)^'2M.J?E+)YFM8NG[=1
MUK+I%PW/KZR6D=PNK$&W+K.XT778?G4ZZ0JT-*&R,S,`&TOI]E1,1Y-B:5(L
MR:%4#N571$D.20Y)#@\IA_(KF1V50VKWT7!C8]0F5%E/F).^FY%&]G(Y-$6\
MK\Q-)\!=B9GBSQ5?!*O*G9B.I=C\.$^)[IE<VRC*DI\)R(6NZQ<Z7C2TVSVT
M1U3%I:^]LM6%)GK:^6C6X4+N;G5+).DDZ3RP=$Y(.DDZ23H[*9W&N?1JY`E*
M9ZL@C.*JSL15V8&@-!.FU(,IEE5>YN'4BKB)HJ;CA+87:OE%IREU22L?-R_V
M"UJ2')*<KO!BOZ`ER>F3Y-!QS!&'#3=^9+I-IRCR4Y@'%D9MHP:*&XX5VE[H
M\($^4V>&[/#]Y+3X<7-COZ#MA>R,AIHZ&,C.*DAVCHH;^P5M+V1G.)NIH]&$
M9&=-]"`^S!NC/._ZRH[OG:]L?\`__&!&[!/XR/4+B<_OY#":[:OGQ5I,>D#'
M49&.>D[':H<5/&TG.C;3<5RDHY;34:O0$<]%CX6.O_'X-7V[G%Y;MMR`>`/"
MC=T1J@'4ER=(*_D#@H`3"3[D"1"DE2`!0<`S`,?@X`21-!HK+E:TJ?B\`"(,
MXP5=$UUU371E%G3WMT0WSWZV+=WO=/!QZ/L'&0Z;WJ$I839HW?)QPYLUFR:P
MC_UN3>?OFF[7./5Y]ZVZUPCVA2_RT7VX+LELY^^EDLSV4&;)_KZ$+'?^;NO>
M'$XJL:`2BUW=>`V<\-]G\X`Q>!VH"PCKE<",6'A(X3K*`Z-^0=N+XRW]7.J_
M=5.9M]).>R/5_]E5%>%1<GN_H.V);`Y)-DDV3PW:7LBFT>7!6L<EFZTB*@J2
M.A,D??R^9%9CD`1T<6SFV<J3PURZGGI"T/9"KVOGTAP8Z77RN8X96I)-DLW3
MX?9^04NR2;)))TP4/,$?UYD7[N\J;YZ"\*V4FRB&VD/%P38SG%=Q,E_CH*Q\
M6%X>G\NN3>V+.SMB.4[-B7E.,=Z63LPIRY14HDB>3E>>R&R1V7I),:/3F6,*
M,!Y\UXP<UXF>**PX(6A[D6+2M=%YPP6AOFK=+J>9CIOC^P5M/^13UTD^23Y/
M$=J>R*=Q+I]70O)YZ&,:\6'>+6D_W1V:IM!OTZ0BZT=1>-LW)_SWIX#A!'-^
MS>6;&14Z:RSC@&W3?&6`O7XT7=]!9XVV0.^JZ<A.B-2J(4M"I.&I$JE5DQ9!
M)&-\)$1*0_</20GE+L5-VT6KH[9`=XI(&XC;Z1)I`W%[<2+=KG_?[2;ONV'!
M0F_=*.EJ_(<Q&GVHT&`O,+T0\LT"\^YJ\L=A$'\9S)NEX*6W?=<R]EN6!]Z9
MD='/M9&Q9]50!GO?[N\6Q&IK;/1SB-9.G5AMC0X0R]A%8\+G$2N+W#XNEJ[_
MQ-@U"QX<BS6`XT*`QG_Z.O_&+/_.<_[+;-'Z[](/HY!:]*V*_B5%CKOOT;>#
MOB('S%<4LEV[R?%L3IBT/<YV+5=Z11SJ0=:EOD6=[QNX[?8WI$%[+3J'$I(^
MTXC42Y?42^=;'))Z(?5"ZJ6OZJ7S71?WT-&[#^+2JK25+MKULP[V)^:Q()^7
M67^[Z=F*:2\<SPFCP(R<!Z:P[YB_80>L#C]DM4P?1/+H"//ZP%5@O:A4,@:Z
M.AO(&FQ1H1+)%A&&E,X^E,YTJ`Y&LDPB*1V2+2(,*9T]$&4PGJGZ6)9?)*7S
MPH'](6/U9QR9GFX$_XV%S`RL>WG2#L-WFSTPUU]B@<>*V+WK@?L19]AV02XZ
M[]C>'&Y"N[:M(_;7^F2JZL,VN?*7,Y?/Y<43X$,282(=:;\M;F].9NI0DZD_
M4GT]84*27R(=J;YM2B3&ZDCK3Y+DF`N@^UT34=^9(>59UK'.C1_E=1+5-X?8
MD"#M1[RJ/J)_618Y:_109O=F;(%"BNW'MR[KE'_7B9.&C0C6<!1QR(,(75.U
M27=++I[-?R2XW1=<HALIO$/1;#@>J),.EWN0PCL!P26ZD<([%,U&DY$Z'G=7
MX>TP5N^\O*[,HH@/5_4&W'&'B4I#F>1!9LO7_2B"_+QS1QS:E<8=^G#2U*;B
MS^3>Q85G7Y0N5R3+_L(6MRPH-OC07KTS!OIL4.CBU@["=PE-=XK8M*F!RW:(
M38>#8E.<%T1LUM1L92O$!N.9/M:[@-A(:V3%M(`(,/N05PJM0FLRU8?:-ECM
M`2^]D1,WQTN?S(;:%HCM'"FCD0LW1\K0QB-M"Q[<,5*M^F.AR.B:-NF"DFO5
MHPH`A@AJT@GEU:I/%``,'A`X0,\&N-"C%Y/?][YKLR#\^)_8B9Z^^!'[W<16
M4U'X-?B&3A]U<EH1F4K.BW;?QZE(D$E+>FQW@M>I]NA;UHUV<835+GH.;'JH
M=]1=![[$:#`;SQ/]N<)U8B@+<_9RDM>'FJ07E>X]5+N\[/!'ZB.R4XG^G:&S
MT337Z^(!0KB[ALX%&TOTB9/ZXW<66$[(Y*^^"ASK@"40G:YHVN]4P1<H,VKG
M/JYWLDZZH.AK'(61Z6%0TPB`&2D0#O&P7AGHJM+8A:WK=45KC5:G8H;N0-N+
MZ[NZ.IUHZF@D'ZO435U^B`CP*#F2;MCW440GYS-95=L)2F<KGXK<I,ZX29_#
M,$[C.=F[.2-,#5W_BW+-`@=6O5#2W+/R1G^[YJ2?G*7C@;87FMA09X.!.A@,
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M9CGHZ][W+H'OSG_XOO;+:6_@I`MP6MO&.]66!BM<`7DV!-]X]0Y;K/WUAV=#
MD@U::%Y)7"WX$`>PE)ADI#CVWU[]V?++9Y8^&C2.@Q%W,"]2IA`S1?[DXR96
MSBS9<,7JE)+9`/^LHE\=D<)(&<ECXOLK-UU"M?5/;4F^`E.UXK7G$!2X$6N.
MI=1<C^!ZH=H!`S;._4BP>[\Q`VZX8K\9<`OR;<R`SR`H,"`V+.@R`X[68'>Y
M,0-NN&*_&7`+\FW,@,\@:`\TX+@1.WX?<&/VVVB]"O.-=4/#(6']X+V-*;<Q
MYVU-RV?SW3K&2[\?KG&UV\Y;DX-:?=F[55M=_?*S_>S=PKZ:X&N02FI&8P#R
MPK,_8GDHGXJV$_+SF.=L--$:&&8=#"W8I?'9PVP2#XNVQ*[%ONTH+-5*<5U]
MBW3=,$:;QJ6'#$Q7(``[@(=TAPE,"V<?8K36,PD_-6;:8+(2^-HK-P-S[Z0?
M#EM"WXKT*?]=,2_$X<:>S>W1E1]&`8N<@.$TT/?,8W,G"C\XH>7Z(4C6=K,7
M.W6&5\IR;9A_O.'YQR_L4?FV:I#C[PDBM[YKYQ!,S@OIN@/\]"W;QW+&^LHU
MO555.*7#0?CY-O@A_;%3&[G'?<S?]CNKI$Z79A`YEK,T(_`[/<54%K$;.6=,
MC!`/0&KG\#Z;RT?@W,9H@6H@YR*F+&$WE#<@>UDC#T/[RU#3_RWV*?V=_I>W
MBIF,BV8!K'_[5-Y54XGNG<#F\#TIH9ADKBP#_\&Q<7(8J&4%WX(364WO*8>/
MA>6%(I]_+P-!\3WEEMV;[AS'&((V4!)<@8*W..-5B9?P%;.:@5Z8D76/)G/N
M!T`C4\K](@S@+WQB9@!K>S:LF)YIUX4V/>06$XPX5CB95O'CH$3RL(9'?:U'
M(*3R>J2I(TU3X8>Q.C.F*E_S]<A0QP-X"^CI);-P/+?[=+Z%U.26?EM-*QEW
M_4'PV&4!7\0P&6,?X"*XM.^9P5/Q2Q<+/P:6V\%PY9$V*LZW?AY`!\6P[33F
MT1B8H9<8MA[?;`"'[Q'#SY[E+]B-^?V(W(>7\AVF!_8=Q-Y5D(:ME$^P)==!
MYCI<1!7ZU2JU5#!!RKWYP,!Z@T#PRSLX/UV9,[#9IJMX+*J;+7_),+`%LPE"
M%2IO"G[#EZ\_ESP&"V*$)["_CR9X!OZ\OI:Y!`_A.^B$".R;\GH\.Y\J"\=U
M0:[!$#Z8CLO'IH,M]>?SD$6*>6<Z7AA5C?T\QKA;B<SO_/L.9Q_E\=ZQ[I.K
ML"%Z2P^@.Q!PD^L,_%5M2X`N`S#<@1_?W<,_!H:4\R]LV^&ZR'6?,BI6'*(R
M:I/Q$*\H(A0`#/@:`!E:>IN!:?>7N9N<+5`D[#?^,_[_0XG`@+`":M%&MRBZ
M-Z,$67R+H1E&#;L"8CKH<)?!!H(6=9W_PJX#4*[#`BG"7_R$J%7*1RB4@HEN
M&?/`_W-LW"]DI&T<EA.5U;"R^29R"7CVZ/.B&_D+"^[0NP=3%H?H],(.8\F#
M,E*Y[XF25]F9DO#!Y@6,>\MA?(M)DLA!WE7LF*6>JIGP=":HZ4+WX//[$+V#
M0H#7E-8-T;M6/ICQ$EQMY899]Y[O^G=/:HU\H-&EC/5W_Q$D(%"5:W1SX>V#
MJ9$B_1F'#H.,*=_@*U[,ZOKCTK<9M^6H%42T$0KO&X5A83XIKK-P(DXBP>=F
M"<7B6H@;2F1!U@KR54$;0R^(8N[`,?=XZ*"8J[8P=.X\9PXD!/ZQ[DWO3N@C
M_]'#;(RSA']@6!4F8ERA/PJ7;UEQ$(B-7YHA!&[\["+$R_Z()_\</Q2JL$;_
MY.MRD22)K$DDN*,,Z5V5JL2T"+47L+D+;,N9%6REPN9S_">R+P2I?@#F!D06
M?ADPSV)5!KEET2.J3'R:<U?1-,$:)@@Z_(0\Z3KF+7!OA$W%@0?KS`N^L^E9
M(-,`$[R8F^=E'"Q]/&!)8^]T[1CU``JN(W.SD.?31Z4B>UUD9@CG?8\E$(.8
MU7;)3@C)UVU`">!P8PR\$<JY[[K^(Z=%S<[77)@T`M=_E#'V6K[F16:*Q5QW
MB>K/NTNX2$MJYO"3<&E:]4]*)79:RUL(&Q43-OVBX?G5U7J2"QHU\-;5^ZVM
MXMS!M>8#UNAV$5K+1W9+P376%GIN>RG?8FAOVE3(KM+\8I7#Z?Z#7G]IO,JR
MI\LLV]3Y]KC)Q(Y!)TD\:DF4M6ONK"2^=#^K+MW5W*@I'MV^;(H_JJ_.?6FI
MWWOP^Y;/V>:7U=4O85MVK6`ZZT;3UO=WZUM9D9>YQ"_T]O#_D`%984"^L$AN
M.RKG-\6\YB&]K*/LF[P3:(_^+F_7&DD;0W5HS-3AI"'@/XB6[U)/:1)2$M(.
M"NET8JC:E(2T^%DWPGSRYO;,_=^2FA&Y2U<I)&DZMFX^(BOQ%/EV1P!M+W3Z
M9#Q09V/9./B3T^;'S8W]@K8WLC.>=7?F0=<\H9=Q;@HG/BT\'G)Y"F_E/9[.
M^!6?1@"P_(AYH2CJ8]_Q9[:BPJW$,)UR<VCFS6'QZ?]8"PB%9Q-5GW6YS=R.
MY]X0MQ,^1R*]NCJ;Z>ID+)]'T`WI[<=D&LIP'8>[=^-'IBMWUZ1%Y)3,.AUH
M>Q&0&Q/>$GP\:"A6[*92[WB,T5V>[!>T?9&@,?Q_-"0)*G[6H<06:8N3@'9G
MVN)E"B:[),+'S2C]@I;8FD+SEH0YZ5!\_=V3PN7M7AZW=$<G]0M:TJ#$*$<(
M+;'U\8:L5(NQ$X]@&3#+X746O33X5%]Q6'SZ?T+[1A^KNM'=VM0=UU;LDY1O
MY>E<$J83Q><(E,-@K`ZD74FZH1QV5;K19:W0[Q04N:4'K1E9D[`B]Y4LU)%9
M*')?NV*H3EV8C@V?(U`.Y+Z^N%;H7**TX^Y$=T\/^@4MG740HQPAM,365-M#
MM3W/:`M(5VQ.&MJ^7!`P)D-UI(WESO?)J>KCYLE^0=L7"1K-=-48R!K'G*($
M=2X,?T:NXW2]FM],-S8+HZZK+S=QI)3I6=+F,%UW:>CPY[#X'$%^=YVCU!$]
M3X=`)R-4QX;/<2B)E;Y@1Y0$'09U/>56WY'A?AL#'<;+DB/1)1RD^@;`5FP_
MOG59IPQH)YK:;T2PAGC]@#0[Z[1B?C;W';4L'14RI!A(,>S?M!XFJ2<^Q,'?
M_'/X5T<'W1<!WMN<^]^KX]_OS0>FL!`)Y(3WS%9,91Z[+O*#2+'ER32%_2<V
M727R<6Y[%6HQ;#Z9"@],'4DGP=LQP^=C6"V(3,?C!=JU+7MTHGLE8.&261%^
M'5<4]=Q/^,\[YN%(,Z:$\7SN6$XR`H-O<6TM,?,>'PL8L/A_&0(?LA0@QQ-#
MZ.,H#MBY<E'S^P)F^9X%[Q;$`/SP^^FJ@-DM0#-W`'./#UB#?3"C(H&RE7X]
MOSY7YLP&V%W86S.*(S]X4C@F@J;PLJ4?1$"R?/VR?DYZ7BL.O"54YCYNC7PF
MJ'BBE-TLLSX7"3[Q?FG:=GWB/7X2+DVK_DE)(6@M0X:--%_3+QJ>7ZU;)-%4
M#;QUVFFMR=E!!'M`AZ*+T-($[BY-X&Z8NK6?PY/G3DGM66)QQZ"3)!ZU)#8T
MQR1))$DD23RH)+8Y-^F,)+YT54%7CSB&,ZHJ?K8P8"C;4'K3$.":RZ7K8"[`
M5Y8!XU>T(5B6"E37ZW->-'*CR<:K"#+L0TWFFXDQ4F?#Z;K:M.XD=%MIP\X>
MMI,.(!W0/1TPFZ@S0QK;D0X@'4`ZX`1TP&PP5+69---*.J#7'1@HR-S!?E^Q
M`+[`O*@ATK2=^9P%S+,:FM)3('FDT/9"NV>+.W8*X<5[_6PXU"3`EZ1Q8)SK
MH^I2&7<;ZG@BG0'<5Y-!3'X$T/9")(>JH=--\E-@QWY!VPOA:;1G^CI[IL_.
MQXWF[,UDHAJ:_&2MKT+9^R"(CN7Z&3%]8R$S`^M>?CQN>K9BLP?F^LL%ELQ:
M`;,=:=<?"IR.$]I^&QI#`GQ)*$>3\TFCH9%>H>BKA2'^/@)H>R&-`\PWR-J*
M5^$@\>D]0_8+VEZ(3Z,Q&ZPS9L;T?-B<!1S-U-EH=E114Q]:>K6+4JBEUQ:2
M<GEO>G?U2W/I'\>3W4AL89>Z&+]0AZ_#XB,U%;UJWM-H1X;K[(@^/9\VFI&)
M,<#&81VV(SMN&48B1/@<B4J8C'55D_;R(LDE3C]>?/HON8W&?+0V*-17&//9
M2%<'@T&'C?FN`J43O92V;5^=DXXKOR4M5>1G8H4^+DEKE1X>AU$KPQ.H7J>.
M9?OV3:F5X3$B0XJ!%`,I!E(,I!A(,9Q>C].__A"'9W>FN?SQ,X]T;LSO'YS0
M<OTP#M@-^QZ]QT#N'5_HK^E7/R2-.^'+%[Q+YM<E]MMTO+N?_3"\-(/@:>X'
MCV9@AQ]@S3!R+"7VG.@;F__M51S:KQ0+=A$6Y[^PM#\OPJ_S@?Z!6=A8[I5B
M,\M9F&[XMU=GHU?OQK.IAG]R4+=X_SNEC,*U=<_LV&5?Y[7%+CS[9T=T$W58
M>(-$RPA1!GSXYR=@6OT?IH=PW_@Y"N\XJU$#36J@V2%HJ5E8EYJ%40--:MM'
MDM@%2>Q5`\V7+A7JT@G)1O6$=.:1OS7U>>7REK?CES:./WCYW'.V^65U]4O8
MEETKF,ZZT;3U_=WZ5E9D-T?GFXZL$WH[39B1`9$:D"\LDML./\W$\/:MBE7(
MQ1S2RSK*"RW4Q:W-Y*ZNW?`QANK0F*G#24/`W\WT]2',%0DI"6EWA'0Z,51M
M2D):_*P;83YY<WLO@=RD+0BF!T1KD+7N'?EVQPEM+W3Z9#Q09V-9:X*3T^;'
MS8W]@K8WLC.>=??N6-<\H9=Q;@HG/BT\'G)Y"F^]C@#2LULS3`]!)`!8_@)O
M?(B6`LVW/[KOYE`[@</BTWZB?%=O($(H/)NH^HQN_A.WGQH^_9=>79W-='4R
M[E/_)[KJ2QFN_4G$C1^9KMQ=4Q0[J88I%+Y0,NMTH.U%0&Y,5&.FJ>-!0[%B
M-Y5ZQV.,[O)DOZ#MBP2-X?^C(4E0\;,.);9(6YP$M#O3%B]3,-DE$3YN1ND7
MM,36%)K3#)I=W#UQ\]O7O3QNZ8Y.ZA>TI$&)48X06F+KXPU9J19C)Q[!,F"6
MP^LL>FGPJ;[BL/CT_X3VC3Y6=:.[M:D[KJW8)RF?._#TU(7IV/`Y`N4P&*L#
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MXP:1><\\-G>B\/K>#-A[[.-=_,*E'T;/$`!M-M%GP]7(/1>\%Z;`ZMW59S-]
M,IZ]+`5^"G"$X/:[.#%FVGB@KT""O^'=6M%?"\@:U309&Y/1\%F`%"S$58!#
M%J.G*]?T(B#TQ__$CIC,LS6I]+%NR%50F_>NUI[/A7PU;0>PP7+"/A/RSY[E
M+UAYG9T36/:2)I._*4!;T6T3@#+F+7SW"WN.VIT8D^%(&Z^0D_*KUBF0]H"M
M$^#13#<&JZS=9H!E)XH7Z='A7JE6?]V[]?[.9C`^FX!M8,R=Z(_S.;,BYX%E
M#/O-C-@W!C!9L`U\H;(G709W^.<GB(+T?Y@>4O3&SXG[CL<N^*AB,===FK8-
M'F,2>VA)/(*?A$O3JG]2"E^TE@G.C>*TIE\T/+\Z$I+D?FO@K8NEU@;(.\BW
M'S#]T45HGS.(?)-C(PML(@O:)!]658.(50Y7#W+08A!4$BWR(SLK]7CN3/>>
M'8/N&'22Q*.6Q(96WB2))(DDB0>5Q#95'IV1Q)>N@>QJ0<9P1G>@GBT,OYY?
MGS<4"L^9S0+3A=>:41SYP9,20-2JF,NEZ^#=*%]9!HPWE/%#:GW<`6B/Z61Z
MV(<;)&\FQDB=#:?K*NF[<_S<2AMVMC20=`#I@.[I@-E$G1G2V(YT`.D`T@$G
MH`-F@Z&JS:295M(!O>X714'F#O;[B@7P!>9%#9&F[<SG+&">U3!"AP+)(X6V
M%]H]6]RQ4P@OWNMGPZ$F`;XDC0/C7!]5E\JXVU#'D^$QF0QB\B.`MA<B.50-
MG?K>G`([]@O:7@A/HSW3U]DS?78^;C1G;R83U=#D)VM]%<K>!T%T+-?/B"F]
M>"(_'C<]6['9`W-]48]N\9LKLMB)`J?CA+;?AL:0`%\2RM'D?-)H:*07/OMJ
M88B_CP#:7DCC`/,-LB$H53A(?'K/D/V"MA?BTVC,!NN,F3$]'S9G`4<S=3::
M'574U(<&I.VB%&I`NH6D7-Z;WAUK?+?CX1:)VW.KFY%*Z=JM^(7ZD1X6'ZFI
MZ%6KP48[,EQG1_3I^;31C$R,`;8Y[;`=V7&#4Q(APN=(5,)DK*N:M/,H22YQ
M^O'BTW_);33FH[5!H;["F,]&NCH8##ILS'<5*)WHI;1MNP">=%SYC2W](&*V
M_$S,X:U5^,0N)CI\]?`XC!HOGT#U.O57W;=O2HV7CQ$94@RD&$@QD&(@Q4"*
MX80[LF_>3++:$C5_L/10]NND0W+2$ODB^B0:@5RG?4!*+U[59K.Y;V6YX>;9
MQ!C-AM,<VYU"^&+HCXKHZSGZU7ZC9Y/99&;HQX;^N(B^EJ.O5=&?#8;:S'A9
M]+_XG@T"!H(%DI.\8!>L;8PGP[68R5[^;B]@MV7)H:&/.P1V:U::3`Q-VQ+P
M=HR2#0IH-96@+;T'P">CM7#7W[T?J-N2>S2;C69[A%I4DGSVGMGMN:VL3HR!
MT4):-X"JWA1ZOYBV9;?)6-<&Z^6DPYBV9='92!\,!OO%]!MSP=#85V80/=T$
MIA>:%CX1?G!"R_7#.-BRKW>'4OU%]W3#N.&&QPU?(&[XMJI#^.\)%K>^:^>O
MGYT7_.P#_)1L9=6EYUNK%/=VQ=E<Z5@!?KX-?DA_[-".[G5/\[?]SBH<9`9,
M\6\A>D,Z8Q/!@#F+VS@`!^#C`IL,_NI!;!.$#A#\C:F$$.8Y<\<RL^81!<C#
M"-"_!X9A@>+/E>B>*3BUQ?2>WBIS'W[GW?F.=P="%T8A%AZ"]'G,RH>CIPL]
M.M$]?WP."L&[4Y5EX(?,BD6-HF<K"],!N?6X5H(W+0'X%*`,,>R+:'%=$2IA
M?/LO>!'B9RKP:^[@F'<!8_S"%@(7,>O>\UW_[JF.F!F&ON5P"F6@/9B6!3L1
M*H\,B5@A:W(=#("72LP-+)`<B\D6#UD9EY1P`D].OWR?$(,0,1/[92[\V!-[
M68'I]72F3J<C57EM#&?J3)NHG):O]=D`6Q\(*@!@3^`4A`I#GTP!!<@6MRRH
M+#705045(_^O+M9!;:\"6.%2Q,/NT[D\\4!B61/+SUZ%P+ED"*;PXT#Y?'5Y
M\=L'Y0[4'K`L6"J^6U\^_UUY$S+XP8?X;_!6K8@24^[-!^`V["`,&PIRXRO1
MHX\B@<8O``4:BG<(_DFXH*IREW&P!!E$:8/'N+,.#!FDWFOU"B2JY0<^T*1&
MR$#H=.18A)^C(Q62#W&`[Y#R60W)`/R'`#GV]6ADJ$-M`&RNJ_K$4">C:<KH
MZ@"'2L-GY<>+/*LBABU$LZ#U"H24X@&N2B*5(4BP8^>R&H.,!658^"O*FX,J
M.I5V/EH$GH]#W)$P1E9("`F,4`4MH6W3P3N)X"H1_(4S-L2OP#Z/%0$R40C"
MV.5"D-L19)+**A]\SW1MY>\.6,5;V`X;>!%E;`$V<L%5*S(<BO=[WPQL_,<'
M!Y@Y\H.P:JJ!A_&+R=-7P+:.C:_EK(;_5R[O'397/G[GMA*D_NL<;#4+*OQ>
MY)S'>P>P_"4X+X`(&B-$D_O@H$#=QB':N1#?7S>-W&R"G046MQ^<$+DZ9,$#
MO#5,&3/Q`9H,895I@<R+U'V041D("+`LN'U2E5MV9WI@()6+9>"X%8IQ*Z5-
M.>6$/8,OIB8M,V(KE$]E/;G)*VD?8ZAJFJ;F/^14R^SP:**.M8JM7*=WZI27
MT89D?3M9SW@"]Y9O+02!L0G,++9<2&J8BBJL;MX)D2\(1;I879!![0>18SE+
MOJ7@^")O`[\^8,IVZ9H67ZNZCH]=V'![D[="I+P`_N5>-H?QT0Q0P8<%^S].
M[7]N&^]!;=T^X2N?4/*M>YRF",\#UP#;H-^/+QA,-74V&BHA#EQ,$:TY)04`
MT$\P0<0C$/UT6<1)>.2OC=%(-08S"?L#31BPO`W._0,[0V<S1P2;F*=K(82V
M[:`/!*\8371U.#!JQK<(;AE`]IT%EB,LIAF!]3_7-&69N;+E)386G#R%L4&Z
MH9K\;G@T28&&F(THKO@[Z(+B(RM'JHTF3=F,/[^*<.**1Q,X2_-;*9;XA3-[
M)7$SG4'HL!;IMI`?E!#3IBS<5H2`V`E"IUU2XH"DF#6EZ;8B!02.I>.4/I%B
MK%7%0[MF2RX>:5K\(K6J<NPASH`P8Z?8'Q)_O5$J6N*O0W`%L=4."7`XY(U&
M.6B+/$22QDYW_W#(#QH-PV7F4F;H-^A`K7BLUS/.'S9R_FG@/VID_K;XCR;C
M_>)_C1[<YS",F2T"L2OPA'V;3P,/P</G'Q4&&`LWL(;IN,;IR8]_"K3"KW/N
MK'^=9Z[ZA6?_DGGW=>0_?_GTZAWXRN`J%XJ!6D$K0?,J\"W&;$XA_!+FL[_.
M+[D7RQ==O9&[1P]Y&^S:H'"*O!;&`EYW_L/W'R]="%^_SG\7/OW7X!L6P%TE
M7KV@S)X0>7<U^N.O/[0%HN9N2)_Y$N/27^?7S(*MQ83FI>FZS'[_E'PO3+ZX
MGALGR93CG?`@Q$,0#N7;]$S@)<PI7?&C"*K8%09ZV8<2&@"_(IDCMM@;'0PP
MP^=%/;0-Q#4N^">$_1$+W*=/#IXO.:;[V<.,FZB=H(/C[0Z.=>W`)\?7S`4F
M8I*,9;;!2K;#R@<S,I4WL6?&-K"L+>L%2FFT6AKMHIQ6#N/%`E-F_EP)$^HK
M_\F(/<^(;2.Q,7V$$E+**A?RK+KBA)CHG?M8Z!'^N.51XFYFL<\FG1S%OO)^
M[>XGL1<I,C+VW*]I?W?$<V6Q@J5R0'K0OJA7Y"I/WM73-CLMKW./G]NC0#Z0
MMT[04Q[':TAV#_\DEE/YB$=IA[K.W>E^"7V0O%:M&7;3;8&L`EF%75B%]?/8
M2T34]F,4Y#0]6</P2]X`OVX:!M*!FU("=M4F[()A^BR"+TNZ/E..E%?GE=<_
M8J]:HIVI+OF,'%)=_1%`4EVDNHY6=5VS922[@T'ZB_07Z2_27UW77^4K9$<8
M.)Y2?JM5,O$%^KRVRSRV2IIU\ASW($SRC3TP+Y9<-4G_\$N'_%+9L0Z&[X,,
M'AUA#MS4;6U+Z*;Y5@<DR70T5+6QK.5X-VW>RU*+)(L(0RKGN6-/M)$ZGDU)
MY9!D$6%(Y1R")./!%"_)D\HAR2+"D,HY!$F&HYDZ&H])Y70O;4B9P,YD`K^P
MJ"X4^,?U0VGJCQ)_9)]Z0Y@^V*DWDX&FCG3IT$&R5'5ZR:[LD6R1TND,87JA
M=(:SB3J1'CN0TB&ETUG9(L+T6>D8L[$ZF<Q(Z9#2Z9-L$6'ZK'3&NJ9JTQ$I
MG<,HG58)0*H;/,)L(;;<%3UV*6_8#_U-A.FS8=/.M>&.J$)VC42+=`[IG#8Z
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M8:?;D(84SUI:M4H"4@WA$68,J0%PWW0X$:;/QHT:`)-#W3_1(L+T7.<T7.DA
MG4,ZIZNB183IN<ZA!L"D<WHF6D28GNL<RAEV(V<H/I0T`/[K#W%X=F>:RQ^3
MUI7NTR?',SW+,=W/WMP/%F;D^-X-^QZ]QPS;.[[D7].'KJU[9L<N^SI?_3B^
M.5M#L0!)^,<W-O_;*VOXYR<@C?X/TS,TW;CQ!_H'9N&/K][QS3_>[L0K$[K4
MG+A3"I?:4";DHN;$W>XE@II3>EI`S8G[*7FMS@(/>;QWS,0FJ[`+JT!-ICIH
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M9*1.1^3ID-+IE6P18?JL='15'PW`UY$-.-V&-*1XUM*J51*0:@B/,&-(37_[
MIL.),'TV;M3TEQSJ_HD6$:;G.J?A2@_I'-(Y714M(DS/=0XU_26=TS/1(L+T
M7.=0SK`;.4/Q8=KT]Z\_Q.'9G6DN?[RV[ID=N^SK/.E<Z3Y]<CS3LQS3_>S-
M_6!A1H[OW>"3-^Q[]!ZS;.^RI?^:KI/<B_T$2/[$+[\JL>=$W]C\;Z_BT'ZE
M6(`6/,Y_8>GCZ9_X3?T?IF=HNG'C#_1?S`!_?*78S'(6IAO^[97VZMUT--3&
M@QS<VFO>/1.0F0#D8ADD@&C_B#T)(!-M-)Y-]P?(1$LH$KLI(-=L*0%D/)AJ
MFK9'0'0!R%<K2K?F`[,D@`Q'L]%XO$=`C"*/Z#F/Z%4>F0TTS=@C((,BC^@Y
MCU0!T2>C@398QZW/`F58Y!(]YY(:*,9LHFGK=N=9H(R*?*+G?%(%!;AD.AQN
MLCU?6/39L_P%^QGSX3O1(V>3@3;2"UM3>L>[K=_?5GV<#6>3R7CG[V^M-<Z,
MV7@RF>W\_6V5Q=E8U[3I:.?O;ZLCSL;:V)@:.W]_6]5P9NCZH"@%.WI_6WUP
M-IB,IJ/=X]]6"9SI^F@P&$X;`2A#\-$,/,>["Z]8<(U'8>_-T+%*D,`G_)`L
MW$XE&``29OYS>*2OK"O)YT#62EDDD`T."5D[-9)`9AP4LE8*YD5HUDKUO`2?
MM5-*"63Z02%KI:Y>A,]:*;($LNG&D%W'MR'[3\R\Z",X/U&815)E,(8UU94R
M^[O.5DQL$1+?\)#X"X3$WU;-?/D]P>/6=^T<`%T_+Z1<#O!3OG>5B%MLI21H
M%U\H%6?`S[?!#^F/_=E(L3,W?_P,6^-$INM8A==NM;DY!+^;`?K_%:K^XMO.
MW+%XUD$Q/5OY^)T%EA-*RV$R\(^"V+LB[,?YG%F1\\!JKP7-$IO!DZ)/5`7T
MRD!5'ID2,#NVF*U$]TQA";&59>!83/'GBA]7NA+"U[PS/X[""'8'=)]RS0('
M('NO7/J+!6S:=82*[2H.K'L35DJV.53>A(Q5$[1?_(@IX[=2D;ZIPS/W`\5T
M70YJ^MH:DMD+'\TP0XZW97NMG4]&2N3C#V,-*ZW*J'';L`DL!3@NJJAE8"`3
M)U^ZS'\;W9L14#]@BA.&,<,VG9X5!P'H%/>I(A./3G1?PCE?QG8P-QHI0&OO
M3@[[9Z^,);PH=&P6"!%+T>"$XK^!3:^S@HJ_JZ<5[T$W@TU-GZG#YRP6S';,
MB+E/V8IV&1Y=G8S'ZG@\:5X%@;3,\%X%,,/8C9#M'*^V\Y$/*@K@]2W&[!`W
M&I<#MER:WA.N_EI7M;&F:IK6M,NU-=GWI9.0R@8T<)4Z?'R#`+0ER%WRVBH[
M!&QA.N@K`+YZ@J_P13B?@@_`<&208%0^1T(Q="&E%?GSX>.G[,.&+<]$O2#F
MEA_85>+?,0\XP>5,:MH+@#",$-T'9(`E\T*.\6M#GZJCD:Z88>A;N)UVC5`9
MDSX*JBB+@B8/SS>UDX44=9/S5/>S+ET`\.L\V9>OP3<\!$D-R!7R<?9AF'P:
M5AU$)V*+FGLX_O,"UM4GPC4;_"E8X'VZUB^\>VO%540=DV.Q#6B%//N=__!]
M]1H%1!I\W$G1O1R@>]D:G<]?/F%^<PQ_)G_]H04PE93"52*3"$#RA`1N68;A
M&4!C'A3$O90N7P7(N_7$_A+C2[[.OZ72S+W^\/=[/V0?,TWQNQE^3.5YW:9L
MS%EB*_2U6[$QJ)4M^PJR'/PDU,.%9U^4E,/'1#?L<>M`Y8#&R7>N#3RU5')^
MO/6;Z<8<8WCVGS%XLO,GH,F%9?DQ0/#!"2W7#^.`[3XT.W3GZI>,SJXO__[Q
MPZ\_?ZPX,)\_*\(X30U=_XORV\7/OU[<?/[Z1;GX\D'YYZ]`J$]_?/[RDW)Q
M>?GUUR\WUU)?_UF>_DNU#S_T!GSRJS,0T"3_P4QPTOA,0B7M-:X,A`=A\/_J
MW`.`'^23$M;2?C<C9'5-VF_^A6?(%N1)>O5F]V-D=]`ZO5*XD#N)DL^?69?2
M16@W'7JPCV;US\=BFZJ79U5*'8I--ID@T:XR9]<L,]Z(T/N9SM)%@U:$;V^E
M4!=@0GC8V*(D:F?7X)XK;#O@Z:YH[1IHI)]/2S\30W2#(;:<:[PU(BMK2%/G
M=V4E[PNZ`%T]["D"N,<14J$5.$NTFC*CN1>+>2C?J%/*AER]G?+M>],U/6O%
M0"4SVI$3>.J$9G>.AWE@(N<NR/EUWLRR>(KDV^MOOO0R=&DW(;.+B00R+J<F
MI)?W9G!7.*NNO3WR21ONA-!^&(5R!E3P9*'Q])\HW)+"R0GG(8=*DE4AJT)6
MA:S*R_G86/)!IN/9IRE)D0N9#C(=9#I>5!3?Z`U='DBE;9CM3JK5F^_?M*<E
M:332:*31*'_?;4)_E&91B(XGG;CO1;W`@?K4/Z=^Y:1+![ZQD`4/*U2X\+:8
M#2_BY>2)SE>N[QF3:O?=JZ3CW@&\6R(EG2C?OPA#QN\5_G[O6/>*$RD7RZ7K
ML/!'J:IZP5J/?M>-[5%14LD@;3UM/6T];3UM/6T];7W'MKY5'/<RH1FQ,[$S
M;3UM/6T];3UM/6T];3UM/1U!'%D"_,)U_<?".7+UY=@`\`.;LR!@MG)C?A<I
M\8,5?Y!6V0V\_=$JM/6T];3UM/6T];3UM/7'O?5[3GX7&QP.6_4W7+\])QTL
M9(L[=HK[Q7O];#@<2VA;PF=6728+'K!#IL+;X#9$(+6VF?(JP4/''[L?EKI/
M#=JOT:ZO6VSQ#@G2AY&NQD0=S735&,C;Q![&2NQAKFN_F+Y?T)*('I0DD]D8
MY'.R)C5&PDG"2<)Y<.$\VQ5)2#1)-$DT=TF2-[JJZX8Z&^O'Y=KNDV8-E]F[
M+5>D!4@+K`IPC<E0'6GCX]("1U%>09G40V52)Q+:[BN3VF!O*9-ZG-#VQ`J,
M)F/5&`W("AP_1_8+VC[(3Z-=F:ZS*[I^KC>:ENETJHX:XC,2R6-B\GY!VVN1
MG*T3R>'X?#)JE$EY1I.D\9CXNU_0]ED:1]HZ:=3.C499?#.=#-31='A4(DGY
M2Y+Z(Y%ZJI[9)KE(^<+.YPM'^CJSM<-\88/P4+[P.*'MB6+70+$/!E-2[,?/
MD?V"M@_RTVA7#`GLY7SABG2AK@)YU:$V(J$\?C;O%[2]%LK!.J&DC.&I\W>_
MH.VU-`[72>/*C.%X,E*',WE(U5>1I(PA2?V12#T5HFR2,10?FK<N2Q7=;?!#
M^B/_O7+K!S8+$KC3PQ:+N>[2M&W'NY-\$BY-J_Y)IH;O3>_.P?_9S(O.9H:,
M:%JKY..&7-+TBX;G:YM2S;.6.2#REZU`KJ<Z5[PH8\/5:_[^^</-WV&U:8N,
M9YN$[-I%MI+B&T[?+T#?;^ML=\[N=2G>2]KRL/259;=?+)O=?EMV-HSOV5M2
MI43_6+PPD$]JU14E8,N`A:`C^4@3-I\S*U+\N<*^+YT`%*CRY>O/BF4&P=/<
M#Q[-P`[EQ,8_<]!HRC)P_$!Y8F80GA_@2&`[R_/7'^+P[,XTES]>6_=`(Y=]
MG?]FNK&)M+KP['_&H'3G3X!_.J7U@Q-:KA_&`;MAWZ/W>#;T3KSHK^E2^0)I
MV[P0EDK&^(3I=)[8<Z)O;/ZW5W%HOU(L(`ZLQW]AZ9/IGQ?AU_E`_\`L+,'^
ML[[DUWG:<._&_"[:[?W"SV%>*3:SG(7IAG][I;UZ9TQ&,]T8:#FFK<![EY*O
M)5;)T.4;'T?-P^^3>>BKL9S]B9-U]'^8'G;LN/%3?(UGX#N9C8W!I"VV#6!O
MBGTN7NAXO)*`+__VV:Z(\"<G[\&)K>NZ,1OK;:F=(_YN,_JVD9FI5I*9YZ!E
M3(S)<*2-]RPSK;#22UAIS],$DS&$*AW4!%.CR)QZSIS/T7S3Z734GC=?7A/L
MA@CK-<%^B#T9C*;#K13!KB5F4)08;?8LB=%F^F`P[:+$#(N;J.6;^!P-H4,,
M--1&NQ"90\G,3LC00F;V0>[Q9#2<M7;,*C+SUQ^^WP:NL*/_?U!+`P04````
M"`!#47)"F-GI+LL)```E:P``%0`<`&=O=G@M,C`Q,C$R,S%?8V%L+GAM;%54
M"0`#/2!'43T@1U%U>`L``00E#@``!#D!``#M75MSXK@2?C]5YS_X9%_.UA9#
M(,PDI"9316#")I,$0LAELK6U)6P!FAC+D60N^?5',H88WS$6)C-G7@+&UM?J
MK[NE;DF>S_\I%)0F-"`!#&I*;Z:@^G_9Z'>EH-3QR+Q5D7)N,/ZKRM`8\FO&
M&!+^G?\^9,P\+A8GD\D'E=]*540@Q191(147E$+ABR+^_?M?GP5(G4`!<:QT
MAY9R!8A2JBCE\G'E\+CR4;GKUI7R?NE@_A!_0D?&<P]0J$Q'ND%/]EQ@TQ[1
M/V`R*);W]P^*BQOWYG<>3\6%E?LG!_;=I6JU6K1_7=Y*4="-O-E2\?'J\E8=
MPA$H((,R8*@"@*)C:E^\Q"I@"!L)Y%)"[Q#?"HO;"N)2H50N')0^3*FV]V6N
M.47Y3+`..["OV*(?LYD)3_8H&IFZD,B^-B2P?[(WP.,I;Z54+I7G;?PFKOS#
M&:-81YK0_2G014]NAQ"R/44T?-<Y7_9A`/$83`5U1?%3,?3)XI?L13LW."Z\
M9?SS"!IK2N=]6`B8N81U0(=G.IZL)]KRJ6)FC+8)-KD/SH"A?7VQD"FZW`4]
M\72<9.&/9B=>3=<=[\#]:\@XI`JA1OL$C]K\.4@(U&X95I_/D,%M"AF#A,*G
M;3B[KC4<E"Z8UBB%C'(]7B+00SIB"-*$_4C4"A?:EE@%NFKI=J\ON7PKDL,I
M@X8&M87LHO7UO7GA*QR,ZW<%P-8W)HOV=="#^LF>10L#`,Q_YL+7+=X7X;!N
M_3DRV/&N#VC/#GK.<T6AUR+4&5U<L35=V"\YL>^W8(#B8C1)(:KPPIIA.Z.P
M^S'0>8NTQNJ`D!DWE'N@6U!&%Y(!%UT<N`BOD=4^`J(N9.0?5]CVCR[.'45J
MC49V:P7$H^/B>>$T,4PRO+;^,-$@.=DK[2D3B`9#)CXZAKPV94T".$0'JI##
M];P.F@T[/HPW87>2!K].'(V7/1I/[2@\D)H`:5^G)C0HY)2WV!`2Z9Z>!/8M
MC.\J/8F4YS!VX&<L%6$NB&MLJ/(H"@9*Z]U\B.:*ON0I!9^\\>GU`'%S=EJ'
M4N2/0<S=NB*)=%M9G.I"@G`ZGAK0Q!3Q4+\%"PO%<DF_T\R$*RLD3&\P[9(W
MW]J)03!(O<&!U&?GZ8>^>6[4YG-C5G,E2)("4B3>:D=VBX=H1<7/2':K-R'>
M'3I,I[(M5WHG<185@+*)0]14%5M\OMD&,S'9E)GH!2/EG1:%L[82ED+4E&4R
MQ#&(!;7MF%$X6.Z3I,2,A&DK/#JEFQY9L(L[4!=%E38@DHF)0,MWS$Y&2Y2R
MPK.B=,38=<`AUGFK5(Q/;":#D`"4#9-O5Q536DTJ"";G*78X79[\VJ^?T&E@
MND(A'HVP(5?_/HQ\G3>9[OV*R;KT5-,T)$0%>AL@GMK6@8D8T%W`4@:[>-1W
MX1M)M)?MG+8!QU#']L3_EH$!_"J6B4V"*&S`/E(1X\.P-;+L<-^P"#(&WB?D
M%!$VENH]N&,6RG?,H?)F#H7T,U37%("GA-L9?F,Q=RB!B%2*F]F(66M(*O%>
M>A9T5T1A['/1L_8I<T74NX,@I1>T3+&/AGN;LP8@I4SG!TD?Q#N00LZ[6-QS
M!0BG81G"1P/F7>D-H\]MQC$JR[3\/M^8I7.HFC9"!J),R#>&$@F*@\PW[B1B
M*%9K&5<!ED+-H\@EIG+]W@63VK(ZW'0-"YYQ[<Y7E>4XNQ<D[Q$Y@JI5'_=I
M)\:O=[@S`3[C=X#")JG`-3;PJBP2`U0XV`8N?&Z,(64BD,^;M/>\\BLR.A"*
ME;,YQ;+H-JIPA66]+K=H6:))>2%RKW.O285'0:'>G<ZY(9,[KJT"Y+]6&-CA
MP(#JOBVN#KF3/8FPL^@Y4F!R9F_S_^OAZK[R]U^/JFE-OQL?J]KKX7CP?6;<
M-:Q)\Y!4#[^5?]QU9U0_'*NO^_H%.[JK7[:U[T_ZP4?CL=>J-\YGS>Y+R:S>
M5$];W^]1N=GN=/_$?YB#'_BZ??2I9%2O[SOCPWJY>70T+!Y,)L,_GR\NP:P^
MF#0K@]>;0:O49!?MYT[C[.C%NKNJU.^N:L7I`%9O6D_5S@5X;'0.CNXO&2#G
MXXNG=G^J]BN]I]KX\+54WF^I`]*XOKNZF9QV'FEY\MAX,*?6S<-U]=/3-ZO"
MQ6C4BGUV=O;I_&NO^G+4>9Z@BOG'_?6W;R\W)R=_*_7;CG/R05ZZNMQ5GG[$
MJVD_K'D`IV)51L6&BG2X8C%=+'#:!(\1%_)T=D=%HKRT_IHX$F*7`.049C.4
M+VU5JP%-`E5DL\<_Z]!V7YY7C#!AZ-6^+FDK5#QNSOMT)-B/9S-5`M5GN_JS
MNL`DEI%MU%:_`S4X,FU1$+67^^4OS$7#YS],RC:`M<C(>C'J=@@(/`5<7G$*
MCH^(TEP]!"GOJ8-L=L,4G/'V:"XM@4"LBLS_GAN>[3HBHOBVB\C),5))DG-.
M*-L,TO+C7[M*OW3EE^'MA,663,$-^,LQOJ)MA]B/V>2N?C#GC,;B#%[@68WM
M<)Y(DE_.&)+QXUC))UE6LH"O\U%JL*T@X`7]^:=X"13O,'V8R2:%(#S[R,;6
MG3\`]^=.YY*IWF'[R+\ND;IVF6,)8PWT#=9>?L'R[`9VZ%'7[NVLV:Q[V;IQ
MQNOD(5V;+R7EY8U!Z)M4D.8OI1`KQ[=`AZU^Z&DI.16DY/`[Z\D1]N`YAI9<
MU5D>QN&9J>-@-94C$+A=BI.CYUU#VI#?-=0<MN*999A:OE4FES`5A)Y-F#JG
MU!)O@VGU)6^UCP?=V9`4P7U82`I1:Z:!*!#.4S<WM/D%*%[XLUUJ8R7)>\.+
M!++CM1\VJ<KPQ49M2!#6O"F7#.+7PL^9[C2Z\J0.Z\Z<=VFWH*3N!X[F,3;^
M$W4_,%B$+6)MY5A#^#O^TF=N._QNC+4/TB^/12788+#5F7UFLN4][T]B+9[S
M^AF1X@^[A2UZ7MH75*[OE_;;*%T0#C+4NMAY0Z]X*=0JZ*K)AKSA<MTVLTY!
M_C]YC7.R3:C/</H:L+U[\VV((8>8'P`1AS"$E&^>*&VO82(AWCGY*;0>?F1$
M(O.N3C5@CST@-IQ?HOS>,PB81:2D-9G)EM=0O$U#24:2?T[L/G(D?6Q.]-+E
M#:S9UWZ32%J/"T':Y$4.G@:7&:U8+K)?\=O'9`*(MIW^1,#G7R",YGEU`_,:
M:LVR+.@#YA_J_#MB*Z"+<\Q;X31&A+PSE@U8C5-NUCN3@P3P[)9R[ZCE4[A3
M:,`^8C1XRVT=RSGE*$7.G&M(FYG)YBQ%U952&])\9P"73_(&Z$B\C#S"U>16
M2S?KBK`K\2Z*^Q!S3J9BJ>.92P1)]<<XR'RW""542&0\<B)7;#;_SOH7;-!1
MVP."3[(N__LF.[K^#U!+`P04````"`!#47)"?59.!CHQ``"%V0,`%0`<`&=O
M=G@M,C`Q,C$R,S%?9&5F+GAM;%54"0`#/2!'43T@1U%U>`L``00E#@``!#D!
M``#M?5MSV[BR[ONI.O_!._OE[#KEY=QF)9F:.56R;&=YEF,IMI+,S*Y=4S`)
M29BA2`U`RE9^_0%`4J(D7@`*S4N"];#BD41T\^L&T#<T?OJ/T].3]]C'%(78
M/7E8GY#A_PD7_W5R>C(,%LM[AYQ<^R'_U@G)"O//_!6F_+_Y]_,P7/YX=O;X
M^/@/A_^4.81B%D34P4Q\<')Z^O].Q/_^]__Z21`94BQ(_'@RF4<G'Q`]>?'Z
MY.7+'U^_^?'U#R>?)L.3E\]?O(H?XD]XQ/_K`3%\\K3P?/;SLPRQIP?J_2.@
ML[.7SY^_.DM_^"S^Y8]/XH.=WS^^DK]^\>[=NS/Y[>:GC.3]D`_[XNS7#S?W
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MG70*ME'J&N2?F]4P7>KF=4V;`]-:I\\`@/[58`)&$^LP8DXGA0'F1I["8KOY
MI4$0!HX31'Y(_-F8;R8.P>Q\+?]:5_-3\JQ!=9V@!P\K6#V9WYJ=K_&@B@J2
M_M@X`*H:NOFUT?F:CJK)A-'Y.J;!DGME:^2[P@Y;"A-1$JKFJ?A1<ZHR\+S$
M7PJFMSCD)!V,73:EP6+,G\.48O<^#)R_KHC/37(^:Q29KSNPN5>3HX^6@H6!
M\)"%#:S&>^&3IE;/@>L2,3KRKOUI0!<2)VX:.YCZ'(D,?:8*M^Z(!E7\GLQ\
M,N7>F1\.&(L6,9E/#+O$OT*$?D9>A(?(<R(/Z;Q3S7&-;7$",^'_NR+:@GTF
MB5P^B3^QCB:5CV&4W7%$G3DG]P51RF&;\/]C(CRD`;K2,,:6Z8MD*9B@)RYC
M'#*^V-T0]$`\KLY8E6FE40QM;G?8X=.*CYPL;N$<QQ$`3OP<^WA*5-=WY9$,
MKHG8PPYWO3]&2$0*O76R^B+O`H5(5444!C''LICE$B`N4T[1(],U7]`2*TY5
M050&,6M_7>`0$4_-\$A^"\&`HNF3_MB@`9@,J<>`80,P'563">,.VV9@74;,
M!A&VPVKS83J<D!E9GQ<0/:W)"I3&UF4'4'=KLP2FQ?4Y,JG/:81#=<G?^[T!
M;"X")Q+>X8![BG[(W96,$Z!@/94]G=4F1!U5'@LR:VEB3*34?I"LNX239IS2
MJ8NG*/+"9R<)F2S+FS&('Y[Q1\Z2WYP=/IXN#<#,!@M$_-J\QD]G5!""VSD?
M@CK1`S[=4-9C.&\`<'V0T)PN\.(!4TU\=Q[=+LL0;"+/TV-./+!EB2LK\:7#
M?L.)[["%GT+LN]A-&1-/ZZ=WDS6%D_("9V=\&98):#J\AQZP]_.SB)W.$%K^
ML4EC<K[P-?^3Y0(D7W.*V(-\U^3A,[$FG6$O9.DG<I4Z??XBR9S_9PF5C%[5
M9SKQ!@`9WO79=R0YH+L\<\FGK"1*H*8ER3,B4J8BES`H!B*@+J8_/^-;9*R_
M/W*',^0*=NG)7_$Y@&=QPCO]W@L8=G]^%M)HYRUKRF/H(<9&4QE3&#P16%TZ
M(+9=7HW+*7=I+97;CFKFRNP0K$/Q[8NGGGRRE"Z2C<R\8'*H[$YRLR(YW)M+
MY5&DFEG1Y.&D(!-30OGC>8-B@99):MP!"$7@E(CEA:&5+`F648+9(*FK(WS^
M[F8N/B0VBE+<36DHT/FQ:UCER:%X71`"T,*D<IK4FB-Q<'?PP$)1]`@Q._8H
MP,V,:FFH;?G[D%1/!-T%*J[VBJBHPBL30%&=6.Z36PUH'-?\=]AH>,&;JJS[
M-1=^Q.;<]1;_B#3O"GF</!N$0T2IB%++-!?(3J!$.&MF-":K:IW;V1+4$(0R
MI]Z+'!F[PP[FI($<D`,:+4P@/:$<HF)XCTX)\0UHB8B;)%6Y'HS".:8Q@PFW
M$!)1(0OH@1B3DQ)\B>A>0FSG@#+*DT9K^XZ&GAYN\/N2,&Q8I:5&8P_%<>"T
MWN@6`TV>$GHMRTEERI2A9=X"2^EF%`;2!LXCTZ8A7"V07&!@UJPK\>[XAJS$
MP8\0^3/A`\6D@>9*!<5V]A@%E<P*J`JU:M.LEK`N\#)@A+,64PI\!VZO*:35
MYM11%$\Q3I6+V;$+&:Q0\@EUTOFLP"81Q"O3SDM,"<[XZC;8Z=LGZ+XVC6ZF
M")';"3)"MG,H#W(;5Z;=[@ZB%N92!]+LMI_UI;(\U(B`Y3W>XN305<W]`%DN
M&D!AWZ1.<XS6(I(`Z3#F4VH]!E:B>CO+60%04)$O3H\/D"VUAI5-`;'VPRSJ
M\BG""\;0NHCP)+C#GJ@/&2,*+*$2:BV'*Q7E4P97Y;YRM(4`*)G"2=.K[:<,
M,YCY,PP6"Q(N9#K!=X>!/#>*?7%J%"0C4T*NE3W(A+1*,:R>577WIF:-[7+S
MNH]B4["QRYS1VKF<3#$!6.8SCTR[J7X=R>2"!%8KQF=OX,.*XX!&BU-&?VW;
M10<N^K\]XCM&Q+WVAVA)0N1E6`"QNJNI]F?FJ$"HL"/5C$6OL!?(--%]B&;X
M4K1N6U+"\`4'S2$A=PZB121MSXN(\CUR_PF8J/717/5FLIJ0@,K.9\I>:<9.
M:=L1.-8J40G>@L1NVXC9MNL%U/;2"O!+!/=#J<_VT]GN89G,^2/H4S3[K0?M
MH1I[J,8>J@';+.RA&GNHQAZJL8=J[*&:1@_5E-1F91RBP2+@K'U-6@J8GT$U
MN.A#W4(=<&%2&;LJQ2W;$96OX,K`U1A3V3(:/MI:2+EU/U1%GJHHJN0U#(A1
M4F.#*)P'E'S=NCMPXCN@V(=96`5:951'?Y_;([G5$:6MK?CI+L-=]>)0579Y
MXKUF+&IN/B346@V%UIT(*5*5T1ASPAE%H;BXPR7^K"D)94GV4DP[F"6R^J=A
M6642(4T:""IDN[SN:<&7B.Z-^4*5A'03-D$9N99#U)J"*C0&W@)FTJ&WJ")2
MO3"Q"W%*!//.?)1HGR+P_E1*KY\RRMN=7E0W2V@XN;-_59.)](C-Z=B<SM$Y
MG7L'^XB2`#R?LT,(R@Z&2.3L(@26,$C)?/+9$CMD2K`+E\PI)@9I[>JE=/(T
M<T=`Q8`!'>HMI`B3VBD54B<2/+5%I);CJ3N5[O`*^Q&^XDS'O6`@I'-(I`?N
M1PXR"F*H=])Z*6Z/Y599TG8$MG%$(;$^>.\E4,&TDKC##/.W$*VK,H6&"768
MR5)&L-4^!55JNCM]2G$#VG;BBY@]3G3@+C@Z@C]Q[S*@O*I(MAC'U!)8)70J
MFY"9Y:^19:_=/4A+-#D`P1W)VA"+_?";@,'*(T.F^XT\<\$Q7VXN<W2RQTA,
M)VU'IM/0H.3QSJ96*M];(3E93^NO_15F\OQC3/E:'#O@GT"H?B&M-O1?4=6R
MDZ`8*[C^JRD-P(U\GT2+#0MTY;&'#4QMTFW@![O+'Z`PBHGU1BPE>,&X*K<X
MA-VS=PGT(@>RATEU^42=G?H<,>((1X=XD2@4U-FFBY[M-+KE;UU9]U!+NR^1
MO"27I4GZ/?(0^EY%LJU^*17ZEM7_2M3`@O1?,)G-!7<KO@;.\&TD7F8TE5QD
M$I$-B+$F)ZU98QKBK0NRVJ&!!A*_DM.=$X<3/LC+@+YZ=D1^R*9];=K76-HW
M5DMQ-7C@R_XXT.G?7()@TH+(`^=#!A3SW2,&EPG.)]1`@E$E!5RFI3L&03Y:
M,*>6<HG!9(`+A=.1`WY'R4<U!UQOH8L/ME6?\#.TS)60:S4D7[J.["QS98#!
M3*1,*1^<9`Z)]$,>.>#`1,`*.A/!2:2<8)OI$F7A5&!FNI%3?%17EKQ&#\RA
M9"F(;R\XTCFY7#E*RS&:2AFH@@'6*3#;JRGNWI3?L@EP!NEQT&)F3'U&:8*J
MDC.K,<D&[I]1G`5BDZ"H9UO:NLT/*7F())HB'HN7AR?4"V:A`3+=3G>:P!',
M-K0I!=64@OE#Y-]OKSFU*%%AJS+S^QCT4;##\U\=!S_OR)?Q$^-2Q#&1>(<;
M<\<KB(]JWN)'^0U0)$Z%<!_DI(:@0E;4I`!C[6E#@ON4^[/2*:!8?=P<8![*
MDHBFYV!,M,_"RV)7>=8<9/HU+;@LU>[7>:I`IW`$'6#"Q1]?!?0>TQ5QFM\`
M#QGHP[D134@K3[&;GY!M"K:(@\YZSG4153GT7K.!3N!@[#)Q7$S0%>V)1U/@
MMO_51'NQ1RI@E\H-X`1DV<H0-WL463[!SZ;QXSUV^"]#H/N%CF.HKU-6%>]4
M$XQ?_5"ZE'1)$50YZJ]_JHQYJ@P`$9\2+1TX?T>$230;7P!V:/?=\-H%,A6F
MZ2LB2I6L)5GF$._KPIV'8RK*IB)*4IOD=R.9$6&73Y@ZA`%%:[69Z*W#6P9L
M*F3#=?ZE:M:VC,NXZ/%J7`IN*N>2`%5]0<O6&GDZ)SAZ0)R,R(ACG\FVV^\I
M4!JR-B_]6+5KH9S*W7B/196,=URULO0(S"W5>AQT7LBZB*:B+>O2:'[Q%AUU
M*,-;1IJWN')8Z+N;E(=J6I,`T'JMQ$X81]29\\5D-(WO3FC:]CJ@WV^SZQ#.
M5*R&RUI+U:M%H18PT'L[JUBP)4&M%AJQ#A&;7WG!X[,CM@-[$,\>Q+/]5VW_
M5=M_U?9?M?U7_=T2^G2#E9G/36NQ@1.257PCKTXC$>7!NFP_:<("U9#U^RA[
MKZ6#U97PQFHK#H]'W&%N<CC$PYRRH#D)^!_B#3XQ<6_`L5/(%*VV^L+4D:59
MD*$FY`5>4KXJR_`D_]O#$E(?_,)+);IMB=OPU,C.;#6\@6R7W8/5`\>ADOQH
M>H==O)#YB0O"G"#R08+#.N3;7+D!Q:\E`;C&!$G#JMWL!(CYFD^IE=`PM&R+
M4`4YB3V<(W^&V;6?W*;KNS<$/1"OAGFK--(W)3$=!,WW($[UA5MX%'-UN<#Q
MO]>9`^0@MG$YP=:ZLFFI\FY[UE(`81J&'!+E:_H2$7%D7*[L:0-3WY7'&>""
M^S4Y^1;DK`8Y3*^20VY2-O@+TEE34W>?:*NNKCG)'F`)UX\_C_@R8"1L?-[F
MT&W-TS4IRD,T%7930[+DMK6PHMD8K<5^(%PL;FU'./L^S4A7B9-O8556@[SR
M4/OQI4]9*W$;1YL$PE`<TV!%7.R>KPM-1O#"J&/YZ]WB8%8Z4*?J$U>B)0W1
MH-Z>,W9D4%M7Q!5E&T<DA>*K-@PEA<H&ZU=2J!06TX&,35`,K=,*2W'8@6*N
M(EPIPO780W[(5QG1AF:9%$"8CTJJ4^_(O%/0W9V8HP:\8('G[4'4>^3AT;19
M$6N0[TS*4%?*.A`#IG?SEOB<5VEP!\VCWL^9K`,O^`YZ17S$S3@S.VC98/W:
M04MA@7)_;9.$\GFFH*OU^B8TU.YB+VWHN_$'F'_9L'@K.6DOD&%<X-6H0[8'
MS5OI<UZKP8TTCWI'-E)->>O`:W@C35D0]+E*B7^$8;;B)IL(G<G3#/NA-0@9
M:]'O_GD?/3C-=VXNYV/`U8W2-=<L>0"I.7GN$^[!F3Q%!*&"@.F=G^*()TQ^
M(#-^#\2QBX="*\R&SE/=!B%^=O3)EX-7M\>G[/$I77G8XU/V^)0]/F6/3WT+
MQZ<V'A(*(\I]X"0[!]3$*X=*+QIKYJ&C&@MHR#9Z;@^76^O(6D?6.K+6D;6.
MK'5DN+4UF?F<F",2ZW'1H^A$$WC$(9A-^.)Z[@%E910I]\**4D6Q:Y95;%I9
MV\K:5M:VLK:5M:VL;65M*T.->]X'*TQ]P9WLK%MD2Q64E!4_W?D:LI(75RS6
M;,SZ2<P?:_]8^\?:/];^L?:/M7^L_6.P@BQ8+$A\5E*T`N+#1A2#QI0J*';9
M=E(%3:D51',6E#"AK/EDS2=K/EGSR9I/UGRRYI,Q\^D#IC-,=Z[-&_@N-PID
M,QKQGUL#`3955Y.3[I^UJ`NQLM`;-,2>VQIR:XI94\R:8M84LZ:8-<7,5DF)
M0]+SP./C,W&4+UR+7;>AH)8Z\1:ZJ>GN5<HX5@NS:?O*UJ%;"\M:6-;"LA:6
MM;"LA678PAK'+Y$V/A\'+!07BE#)\SGV.6:-91%K\])Y^ZL^RATTQVSQNC7(
MK$%F#3)KD%F#S!IDI@VRN)_]!#TU9'25TNO%(<!RQ#IW]"]K0UDCRAI1UHBR
M1I0UHJP198TH<T;4'?8X@^X8T7`]H<AGR-FK*@*UJ73(]\+$TL*SHQ:7K9BW
MYI8UMZRY9<TM:VY9<\NHN?4QXH8!IMXZN?X`>=?^-*`+V=@2U-)2I-P+(TL5
MQ:[:5[80WEI8UL*R%I:UL*R%92TLPX7PT0/#?T><P<L5+NYJ94A*A<3ZT,BA
M!*JN]'"X=^;8C3QL(U+67K+VDK67K+UD[25K+QFUEY(==C05E_W)",K`=S]&
MR"/3M;R>4W8+;RHA>`P[W>_F<!3876KI<-A#_GPM_UK;DG=KK%ECS1IKUEBS
MQIHUU@P;:^>($3::[NV^R<X+:I<I4NY%^E`51=7TH;(89??Y"[S"7K"46A:B
M&;X4ESXO*6&X5(P%;?C51^OLT4]=5!*QO#2^47UBW#"_9"%9<'9!;(8]"MUW
M6/8A2;!_97YIR[^*OH&538WPYNJ'[LI*$<%$A*]+1%A+@%>(4.'5<H7)E&4P
M/NIBRP>$`-4(]T"`B@@F`OS!M`#'-.`^1K@>>^*2.-\52B07Y`8FH3+M/N35
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MEXK-8`!$[JE\>2:!.PGB?X<!MWLH88&_W5K5;0S5L;H;?=*#))6)\8C&IEU*
M$Q9\$:WN2JD:IE0RQ:&*>MDJ8<B<(SZ0T`J^JLI"BM$R*:?@_'"6^:P5_C=@
MW*D.&YVW%VMAF\JY.(Y1<P;>XL=,EH8&/O_3P9EH6`,S4YN'7NQU^LBF0BZ-
MHC1YG$X6.##;\AR*85MN9,N-;+F1+3>RY4;'2*C/Y4:%B:QV<H%]<HI4H.M2
M0??6H+)-RZU)94TJ:U)9D\J:5-:D,AKE'WCR2Q%0F][BD-L(#L8NN^)O,.;"
MP91B5UY`EY1_^3.Y!&B6&!Q+I+O&E2$0U6Z*.>(D97X053(51U+9P`G)BH3K
M,OF:/E!9FZON!ZT-(%]=55YCOKNN!&NG/]DP\!TLBS*R;-69Z+5'[W#EU[&X
MP16HYRG9&*W%FPP>$76S7&U/]S(6+:HE##?5C^"P%WD,TU)1J(X_5GTN%TLO
M6&-\C^F*.#A_R<KN<DD9T%?^9DDNG$'W-0)CMKO&10."4JC</WYQRKW`^`NB
M%/DA&]$[,ILWICVZS'1X8S*`=&6U?QO1/GN_CHWWV7B?C??9>)^-]]EX'Z!A
M=I'$IB;H*2XO'OC9,S1-NH=ZK/2AYKXVS$J-3H]Q]J93+").>%,E>\??1S@*
MOL-9BCO6-RCZ&OST2_YU`*^,_;5@EMM+F*Q-;FUR:Y-;F]S:Y-8F![+)RR\2
M:M`LTV&D9WD9+8P[=&-36L&)LL6;<C>P)TZL:=:>:59867R^GO#'H0PU%;*`
MQH%!RTT)0`4[SG!)/7\8SJ!3(=NZ::>AV6JE]AE(*^4))4T8VT]1GFU:@7#2
M5+4.]0NV;M!#0,67ZPW9#SNF4&E!5O'3[8;0--:<30E6"1(J+FZ]Z72#$<,B
MHWZ]6-)@%1]'SA.`F4E41J[52@1-@2G!!U32+-ON7464XQ-1?$6>Q#\LR[/&
M!%(>K'_S21TGE?;&AG>K]S1@S1J-,<4^9!:J0(-)(`T<)UI$'F?0O<!+BITX
M<<'_]G#2BF.P"&A(OLK/"YF$$*HQWGI0[65.#@K3VNRDOL4@TB^EUXO05#EB
M*@7D#46@MJ6E0?:DR[3BI(N-3]GXE$T==C@`95.'-G5H4X>]3!UF3YM>,Q;Q
M;1>/IKN[,3<IX@\P_U)^`F2'U>&D^^=OZD(,)_2!^V?$0AE-F03;LXEC1-QK
M?XB6)$1><NQ#,+RU[HQZ7=I,Q*+^Z3].3T_^^\N'SZ__Y[]_=9;1TV_^#^_<
MKV]6L]_6_J>+Z/']&_KNS;]?_OEILF;>FY7S];GW2_CVT_!F[/[VN_?J!__7
MA]'PXGK]?O+WB^6[C^_.1[]])B_?C^\F_PK^[W+V9W`[?OO/%_Z[V\]WJS?#
ME^_?OIV?O7I\G/_KKU]NT'HX>WS_>O;UXVSTXGWXR_BONXNKMW]'GSZ\'G[Z
M,#A[FN%W'T>_O[O[!?UZ<??J[>>;$-'KU2^_CZ=/SO3UP^^#U9NO+UX^'SDS
M>G'[Z</'Q_.[7]G+QU\OOBR?HH]?;M_]\_=_1Z\Y&Q>#LVD8?'[EOOYU^B9P
M/RSGYS3\[<-M^';V\\__<S*\OSL][4&TH8:JP<6+5)@9!OZ*.U.B:?(%?@B_
MD'`>?R36^BN,1)BKK>F@Q%L?@A#&Y*#@W.J'@#.N:>*Q8G<29!C:7;N5(L&Z
M8W98BO4P4CF'7&]63_!B&5`4)W;"M;C-`\?'5R_(BKC8=T&\-16R?8@'*\%7
M>="WIO&9U1%Y4QB,97E(I@]F8PXX"B=NZUY7N%E<DX/`@X5HIIS,:.R^@)!,
M-=%>!&`5L%.]L:N!*&RF@\1.[YAG1P?(;)351EEME-5&66V4U499;92U\H*7
M@0A[S'!<0IC?[2EI]#2*0A8BWR7^[#:"JAXSSV3W^^R9EPM4+T9SG'[!HH\/
M=@?<.!47TS_Q#4I<2T^)`V,'-<1Z+UR%QN2H$D5M11/?RVY2UW[<40RL4@^"
MS>]"PW+EHUI$9%Z;F!:[G5O;#++?X9!P*])4B"C7]$0#YZ\X&74147&;F&1&
M\LVR[3=3?D#2HS6XZ$.TN0ZX,,'GHW4UY;"_BX_>&_1"O1H6:F4\OA43ZRJ@
M4TPV!S*>EH3*$38OU46#JYKI;V$#/%YR"IF$;BI=YY9'T!?Z)E9+6)$GFOP6
M8/%\J'ZI!VT/^PX+W/GGP\`/*7+""'D33!<OP;2WX=?HC<XV+=Y$4]]U:YO/
MO,HUYYCXC#A@111PS':_%`-04&FXV'`?AV,Y3E9JD8KL;L+AD,EO/N&0(Y=4
M@\K25FWK4-],/U76OXN`L+(<4TT$J-P^=M<O?H>B71^DWJV-U_@>C+I:XDW5
MM22IT;:N[EH+75?)?6Z_,\T[$%:J8"49BJ8.WFO>/V=;==M*4%L):BM!;26H
MK02UE:!=J@0M+9"07UYP`*X0H9V-!.J^PC<?U-&6:4=K3#]CQOE.WZ/3.EC$
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M!PO?0//<AT@0N-S`@DIF&-ZR"Q>1`N*T@4A)62RKH1F?U58HD4/=R`G#+TQ$
M#DY)X4.NI0&];T9/E0*+M?3T/?8Q19ZX<<I=<!&Q4)P>7.'$OH2[)E&-<*MQ
M%MAM)JLUBE*`N6[V#C/,49ESZA=XA;U`7EL%K@`J9-N-?S0G?R41&+^<-J6^
MZ1V>_X8)&Q`ZH$BY%R=\5%%4%6-3H85QQ!6/<YM<`#'A_\>0LUO1<;2O;@,,
M-L!0-\`P]!!CHVFBGR-Z)TKSH"(#Q<0`]R*#7GT)6%"N3BY).)>ZC%PC+D>)
M9URIJI6B@O9+2XC".)>5XFK71S0E,?,>FKSAA9N>!+-!0C'WUOJ"NV[RGVRQ
MC%MAF=A<;%/PVJ8G18;6>6V(]Y_L%<0'KVVZCB1#:U@;XOTG>P7QP6N;KIJ0
MM$;A'-,:`.<]UV826`??W'>&*1G(92O34::QG3-+LP=%2-6X@2PX56356Z$4
M3)NC"'2YJL<`?"#K6RY+ARULZPLO9ZSN%L/H05+=-_Q8><14#<\JA4$['1BL
MB5-E[9&AR;-ILEM_SFR'Z.>2EH&@LKVUL45K0Q1F$U(;OF\31P\[LPVAB]DI
M;+U:7WS%0W;V!'8M?%2O8H24$LP$K$>NC[9&36`K.PX;7FF+^F?66%5WNUSV
M>`7-Z5UIJ*^N$FG0K4^Q862/):?6`;*R[K*!#/-%<GWR!#T-&,,AXP[D#4$/
MHM:>X&R"V>:7;7[9-@WH9E+9-@VP30-LTP`@$<$T#9!VQ,'N.WA@LO^NDHU5
M_'3G#:B2%X<Z*']`<L277^X.^;.;@+$A-^76TX"*@X@@>XL.^99<%S65S,X9
M+4RA*F8.F.!_#/E_DW"'@;2$MQ'A5K#02F+0@'BKD`5JN9?'1_I94K:[4_'M
MN^?8Y["&++_45Y1]-Z4&1_/91N#)C*H<+R*PZYD/V`6[8;F`4E]7`.6;CH\5
M2R8(D6\4&1=/'L4N&U*JH%5.(H.B&M.`6P#A>NR)KI2^>_EW1)9)2*`AV16S
MT&HYCIIJ5\NU!&$5=_\X85_[3K#`NPQ!2C:77LN!_?J"S$</YMCHP<*=H7F+
MF[%^]DAV-C^JC!G\KA?3%5UP-F<7'Y$/<_V7"MF>[7_%\"D5[320;Q$G4'V'
M*Y5D,)B&<[Q9%A*+>)MSL2D7FW*Q*1>;<K$I%YMRL2D78][,9L/=W8PW'R?Q
MJF0['H17V!7-/\1K17S4]?9YH$:29AGLP2D4PQ*!2B$5L'D;"/,O<D+"]PK`
M9APZY#M=_58+3[!8<`$7FUP':.9(G7CGW6<-'($<Z0(.AG/1>O;:;\G/-L!5
M7V6OA7QU3]^FNNY@3S8=_A@A&F+JK:^(SUDDR+M`(;+NN77/K7MNW7/KGEOW
MW+KG`.[Y'5YA/\)7G.GXSD\(Z1P2Z8&;G(,,E*M[B\/8IKL!JHO9)=`+=W4/
M$S"']!)1G_@S-L8T+8XB#H0,\@EUWMDHP$?-J6S`?]@X-\@7/H1'IFO.[L!Q
M@L@/F?4?K/_0MO]PZ'Z+`\(B/D-7F$WX"%`.A2)ER/W`H)>ABB-,7_!RZG#N
MAQ+==F_`T%-P=9%J=/\$F9J0#HNJ6-OM!PHK647/QI!D1].#P"A<.W\=\BV;
MXSH+6[F$2Q`V'&60M?4)BQ<R>R4*/B=S;IUZ@I/[.<:A\-SX1Y*12?!E3ISY
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M41SVB..%Y^L/Z,^`RB:[4/-?AWQ/DM%:B#8NU"T#MVB1N]B`"S:7A4;F8<D*
M5F,>*`H]'W&84@1--F#<A%JB;W<1;E;ZJLY&+16X(8YX8W\VF%$L5RK`9'8Q
ML7;#M347P*Q,2W"$JSKYP/E>1`LX@>T2:+/!:8ZQFX5_#PFP*-<']`2,^`Z!
M+B.^BP38`E78.>T3P]/(NR%3$*=?A6P?<DQ*\$$U,UM2[,1'2B%$M#-^#U+U
MNWB8OLZQ>B^#G3!*=#M_2$$-/:"#\(-%0$/R52K(:+IOB4`(K8)B'Q:X*M#,
MWONH8#%F&4J*,6[Q4SAYQ-X*?PC\<-YT:$2%HQZLG\=B;OHNRGI\_881G3P&
M[:M`RD@O:J!J8EQY8V6#,N>2;GCC+6>E#XM[;9@K[\%L2.I7003B)M;DI(U;
M":`E'D-<??ME<U/]BO^V(T(7G'R30I<05UZQ65OH`S\D+O&BD-.YQTY$93OI
MRR?'BUSLB@,,XMJ+*$S,SOVSS9SK"*9[OAG&NJ\2A@10?6EG\Q4Z28F.K=&Q
M-3HMU>C\"R,OG`_Y/!G1&?*3Y37I4W+/]U-1B0Z4PE>F#6B?&DS?JT,)=9&:
M"@=PB7L-ZFWG['6U7E?,4&5+^CS`).IU1=UNCKX9:9NOM)*YMRM"67A[_2_9
M+RHOV5A0JI;W7)NVGO[:M"EGRX7`;!F,I',O6I^Z-;#.?;#=H,H1<.?#8/AF
M2$DII9%;9U*`]?XSO87YX.6KTX#Z"'^<7(QUM7G_F=XB?/#RAI-UDLB8!G]B
M)^3>)@G<8;#"%+OGZ[R^AP5PEP[0Z8B\POL#;(@)P4OA<HN]/Z:L`_7^HQU.
M>)6^L?EF#)*<E-U`7`RL!&KFYUW.(QR\FND^")+`)S_B8T@R5Y&_?Q%Y`8('
M#W6V-J+@'<'Z"]A.LOJ=9*N2V@U'.$6(TX8W;7C3-@?H9M32-@>PS0%L<P`@
M$<'VV1]0C$;3.^X@7S+!:EK@#9)L+J+5@_QQ(4QPHKG!B&'9P<D/.5VX9F?Y
MA#KK0%3@`Q$"&W%AHY#X,TES@NEB-)5_*OEFQ4]WWMDM>7&H'H"[)-E5%$84
M)P>RQF@MS\)=1'@848IABF(T.>C\1-%%5.T.-BC!7ON3QT`498'8V/I,=']S
MJ@&L@I]?4\J??(H=,;S[R1<Y(`D7\L81=>:<N]&#1V8R_)YMX0M7X'8,.]V7
M_%%@JU2SMQ+MD15M-MYCXSTVWF/C/3;>8^,]-M[3F:WYN>W4;#?G%C=GF7B?
MK.'N)MLET).N;WNHP+3W2J]9Q*XX*\,9CIO-4RHZNT@G\WR]_4WB>$K.MNSY
MKN@<`MO\#81/.%]0:>?/5?N=Z0DB'*C:<PAN@0P-*&5JMYR]%7V"ZR,J.ZJ-
MIE^0X"\<T3LRFX=0.T0QL7Z<,2H!"^K6NUR2<#M`&;FVCPU5JFJEJ*`7YQ*B
M,&MLI;C:72M-20QN^=O,^83Z?1@X?X%'K0Z(]6/Y*P$+JHE:EA+XJI>ETM#L
M40E9%:EFSN39P0DLJ'A(#'1UVQ=+)X)4]82B%J&J&4:<8S?R\&AZN5AZP1KC
M>TQ71&2N<NU13PXG>S;<82>8^>0KMT:3<R1,&*EW>!E0&=H`6Q"A>>Y#1@!<
M;@KE)O54S@S#6W;A%G@@3MN]O*.I&9_55BB10UGD,/S";'=P2MKRGOG-Z"E0
MDX%[),#AG"T"O\`!*3KZGOMDAW>]LO<UVR`VGY+&+4U%S[;G&50K2S'$8$Y!
M&3G%>YW*D&YCX3H>9T`[WU[KE@=%=56FOE+;:]WLM6[YT,'%(V^1J$#FEE)\
M)@-JGN>1Z<.,SX6GNAJWEBBN_9!;@HN,.7@;A+')R+F#\U65Z+:[OI1H:59:
M:@C"E%RHT(9QXU3EU^XZ9U"$H->B2:-JM!3H`-Z'ED.E[=X_@"5#NSF=0WS-
MWY,F-]",E7S-6(3=JX`F_KE."S*%8=H\?J*S;6QL"Q5HX*02JU=`UTGN55,:
M18^W>+JOKA`*D8#HO\<%3#`;#`-_A6DH.JV/.=*84NQ*3=!J@:@T5,MK6G$R
M-]/]4`T3&*/!7BI8@`18*OD]]C%%'M^J!NZ"OSX+Q7G,%4[,$CA)J!%NM145
M;'HM*VU%*0`T?;WV7;(B;L2).PZ?Y"04-T^L,.._U]F&5,9IIV6`2AQZL_PI
MP0%D""1+;PT;(/_)%K=_A:+)_1VG8,,W&QN+:9W7AGC_R5Y!?/#:IDMF,[2&
MM2'>?[)7$!^\-E19WJY1)G<F-HC">4#%[@.Q7U=0['([&%708"+*NU3'B(ZH
M9-?]C+P(I]?TP(NLD'+;@98:LBM&4:4I<)VFRSN:LR6LM+`5/]WE65/UXE!-
ME,8T<#!VF>CM*F(QHOG':+K+B(BLR0^PZ`PB/H&9/[4XZ7[OE;H0JS0Z-BGT
MPBA$<](N9J$'79*U435],7`2UBN@%W\A6[I3[E_G;X6%84_-03N]R]7$J3+Q
M:E!8DR!$WI:3V'HZ3E3Y0W:V)UTM?"JOWZTUI6XC\1+9)5N22YB3=X<&F6"'
MDIATQ^SP^E</([B+<S-YI8N($G\6AP>S##$90,QHU_:J3[!\:WV..BQ[4Y@K
MW*AKS',?12$+D>]R+IMRW;,D.[OB*F-6?;EM+<,E+_[#U<@177MG&TMJN]P/
M@\ASSW':PU#M`IGCJ73>BS0`9"IA\P4NN<REF\=V11@BSQ-7.Z41ON2'S;5I
MT&"IT[:N,=Q3E3!X`50I;Y=/7&,)P]((WWS9O")4\=&#S;D>OJG`S1^D+#46
M;O&C_*IY0VQ+N1<S6A7%5(X`<:11.,=4I&XY#S<$/1`O7D0`.ZZ74^SRWJP*
M6BHO4X<[*O1%QI?;F'1[A'NPCBHBF`JPM%^VT;AM0>@!-E*[%YOHNO`4L$L%
M5QH^,N79'.I1??\E9ZSNID7T($EE4A8GTI=(:NT<4MPQBY0DHCI6QR6B#$DJ
M$6.QFIWX83$;6F'5DF$Z+@<5(-*TN_EVFV4VY4&I?N,6^B$'G0^FZ2*:BM9X
M9\6D<C8)S!\4U@+>&J9(N1=6A"J*J1@-1DODZI!<UA.?8-I9F`<L&^*[0H1*
MNW0TO;X?,7EK+W8GP1#3D".1UEJKI12-$^VRFP8$<ZH0`-$4H8D/)4?GDI-S
M#_LGYS;,#_@RM(C/Q`D%=L0K8+IX`;*^PW';9:UJ0EBIBIF^CJWR;&;IT<S/
MF(6;;0].I4SQUWV#PJ@T4ITQ5H-T-)N;G$0#5=;FF?QVU:=8+JD.E<6[#.I0
M<XK0BYAD`4:I4,R50FF=T[L-Y#$N'*\Z+"G7VGXOSNK=!N%O.-R>XH,0+!RS
MW0TC-""H5+N*HW+=4JUXO^..=O*1^!V(+=+P&_3!Y&U:J*ENEL0GZR<[*XX.
M@Z4\J^AVWNY00R\]Y5(5V&S^-KOX.CM[GYV]S\Y>-MO1;GGVLEE[V:R];!9(
M1%J7S6K+Z4*`(BQ"/Z3D(1+HB%YNB>E(+PAS*!:?(KK._BB]H=Z\*(_DJ`>1
M@V,Q5^QGT8*IEMAJUEBSQIHUUJRQ9HTU:ZQ98\VHL2:/!T[0TX`Q'+(17Q60
M2"O>!(P-$:7K:4!E'(^S(Q*.#H3\ZK#1^3!9+6R!KMXXX(7_,91=^G;XN,,,
M<QSFC<BX@H5^F-UZJ"HV-6O#SA:&MC6RK9'=K)%M+Q$[N$3,9(]:>XF8O43L
M&[M$S%XS5/N:(=.BL-<,V6N&[#5#;5TS)-??D3\+1`TP7Q;\4%"_PV3Q$%$6
M7[2CT4-:;:16G;):5Z,H(@1SH6#B^`UF%&L+I/#AWET15`R#^<!6VFJ0\7G-
MQ;XAJ74O4-'3[9;HU;P9J!"*RF!$C2-M<F@VFIX'B+JCZ06AV!$70`Q\]P/R
MT4Q7%EH#MC$QM.[(T(,'+']RASUQ['&,:+B>4.0SY&0./,JN"IF/V1<2SK./
M0)@$Q[+4BP.G1^,.>U6A[>+4;!<G<YWV4P9L3YGZPE/O*6/NV&])B\>D?^.Q
MW63VQNGR&0-U,!2:Z=M^EM]A/\NR@Z^VFV5O)*_:S;+JC&HK6519KVCSJ#:/
M:HL5NYD@L<6*MEC1%BL"B4BK6+&=_3D^4&!W:+M#M[-#YYJ\4+MT,3'`_<#@
M9ET"ENF$72E)N!V[C%PC*?"2+;M252M%I5%U95I8,'MWI;C:K5DP)3&E?;Q&
MF9R]1!RPY,`&K7H0M#)[97PI*XIW3)8/T<^,008"N'ODM_FBA'@!\.;3;`?T
M>A'F+T>LP>1:FEJXP^+-B#^+,[1?YIS@Y=.24-FFZ@MBEWN^IOY$TB?5SPE7
M`U*H+)[M[77,)-7J[55QK5$#`9Y[9X[=R$N"/#;W8B,[-O?2W7".S;W8W(O-
MO7PGN9>+P(EDQW'?O?1#$JZO_6E`%W%/Z^_AK+F+R1_QF]_AF;2A_/`6+4IV
M:H:=?W`;F\N&Q-SR/_:9+!RUNTVLBX$PO*@(0JG:3?COCD=Z9[3.&N^'[VV\
M4ER02*XUO2+,0=YO&-%+W[W@?!T/<^'(G0YLE&-B]GC-=@YE2I)C)WL4A2Q$
MOLN];E-+2RF-SLM$!:?*<%--Z8RC!X\X5UZ`2EI9Z@DC.V2GEZ`<!!2"//I(
M#S@7KN#DRD,&5'YWN`XG('+>7:7R^0B`+S!S*%F67]6BC7-VU&Y;+?E`5-<?
MUUW:.26*O&MN8S_]&Y<<M--<S?>&[7*(N02,!/:R6W#JXAYOXG=X&5!Q5%:P
M&)6X%IKPYX_>\86F')E$%F4W.=>6QN?`B_P0T?45\3`U)H;]8?LQ"P[`2)`W
M=F/SEI2D,.1LS0)J;.W9';0GIN,>$JDS9=)-C0E]P9[W;S]X].\Q8H&/77E$
ME)H"OVCXGHBA$)U4(*8:&F7]Y^2>=%.>;?ZP75]["L!(<3=W<CE+;.M#7_%/
M#*S[10-W?.<MQ".%WZ#3NDLKO84+`/WLT-VV^4L@20505;-0%%W_Z4Q0$O<!
M2P3^/U!+`P04````"`!#47)"5WALS<)E``#K7`4`%0`<`&=O=G@M,C`Q,C$R
M,S%?;&%B+GAM;%54"0`#/2!'43T@1U%U>`L``00E#@``!#D!``#MO?ESY#:2
M,/K[BWC_`[Z9C0D[GM3=:GM\S1%1K:-'LVI)EM3V>!P3&Q2)*M%FD662):G\
MUW\X>(!%W"0!JM]NQ$[+$I%(9"82F8E$YE__S^$A>`]3F`<EC,#]#L3'GY7K
MS\$A.,[6F]LP!N=IB?X:EO$C1+]+'V&._AO]_:$L-]^]?OWT]/0J1)\689S#
M(MOF(2SP+\#AX=\!_K__]__Y*Y[D.(=XBN_`W<,6?`AR</0E>/OVNR^__N[+
M/X./=\?@[9NC+^@@-"*)TU_O@P*"YW62%G_[`S/9\WV>O,KRU>NW;]Y\\;K^
M\`_TR^^>\2\ZWS]]0;X^^O;;;U^3OS:?%C'O0P3VZ/6_/ES<A@]P'1S&:5$&
M:8@G*.+O"O++BRP,RCA+-?`"PB_P?QW6GQWB7QT>O3W\XNC5<Q']X>^4<@#\
M-<\2>`.7@*#^7;G;P+_]H8C7FP1C1'[WD,,E'Y,DSU_C\:]3N,+$Q[-\BV<Y
M^@K/\L?JUW<P+^!%<`^3/P#\^<>;<^'*ONT`9$:^=HMR5@:)'<KM2+<H6V';
M0S3!O[A`"'50A<\E3",8U<AB$!+A)#.0K=``QJ"SL`,TP5*>Y35,,O/?_K#*
M'I__!^F!(DOB"*/X+DCP_KA]@+`L%O=%B95%EVIX#*+*T=NCMU2^_Z@)Y76M
M0BB"&(,.BK7&,5EWR4B[Q<K^)[E/B`9!P](5(GUZ^/'V#W]GQX%J(*`C__J:
M3/#W[CH6>9?:01[6^*`?%0NIOG@=9FB:37F8L,M9YMG:E$]E9K3^UW\?F2G)
M('Z\,6,(^+D>_)^6-Y\.=][0;6.TJ[?%X2H(-O]SG`1%<;6\+;/PUY-L'<0I
M5_^1]2Z#XIXLNAK\&N_PUS`IB_HW9,\?OCFJ3K4_2F:98J?SA$J,@FACXP]!
MM@3D4_`S_;@5')=2H^82EA3%$NV%8U$40A4_CF#LS3"ZFA'J?CX"`I%8W-Z>
MWMVRJL.+%/#9P4H`9S6N]UD?!9ZRIA3EZN670EFB=2TLJ6V>P[24;2V1]<0=
M^?KO3JTE'@XB14J_!0'Y^#MF^[@_>&5$;P];X>)>[V,]H?TC0H)K\W1)++!S
M7AR]WS`.D+E%$Q0/BS3"_YS^MHT?@P3-42S*XR#/=W&Z^B%(MGPG;ZB1HS6Q
M&U$RPDFT?]$@$*01"/$/L!WN5U<;\;=C'FG3PE2QUS.\SP,$\0:&$$&_%X02
M!DI9;XZQ#P"9..U/+I`<\AE8;M.H`'GSL:<#0,4<5D2XZQN@BZYSN`GBZ/1Y
M`],"(N&[*A]@3A5>I?VFD!&=:5_W7.!))4<#)8$P52,!I$,+HI(R/!J$G>//
MJX=FP&E6X'3)PCI&%B[<A++&DZJ1+5(F]*M>HT"*2!18)#`^G0Z)</#%P%83
M91N8E[MK1)42R1D^`3=K!/<23J2")/.Y]DEER`BU#AU"M`VLOS\`*2QQ;"@(
MP^UZFY!88P0WZ)"+R041^3Q89WD9_TY^X3UHH,/XKD92T,I>!AG=-F5,B3>-
M^\`2!PN!J)$O^UZR#V&1<(B5$=':7.]K`1X\3[E#Y!G<!XQ#<?,85`WP+$[C
M$E[$CS`Z3TM$J1B9NW2"B4X$Q8R.[5$Y-H*=>A&'Q`3E'@.LUL=_^Z^W;[\Y
M^.;/7Y$CX;_>OOGFX-LOO@!!"4Z0>[&^1]+XQ=$!3H)X2[Y`/QPA9ZG80))Y
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M-]S+C3\'$<6U?]*.F,/=OX01^Q?2HK6ZSP(08")+!6#)/K=\@.$\&)09L`C#
M;)N6Q76PPY=[4UZ*\&=R>_?/1T*4XE9]##;T:]^6H)15'<M0O$K;V!@"F6]A
MQ(C@M*(BF,QQ1$R(B%AB\/?-O:S7ZU<ER_9$1K)2^Q#5%MYE-Y!$`Z^#?&*Y
MD<SF,B-$C(9(;-8=/0/*#)RNLWP'/J;Q([)$D/T%/@M`3D&BS_)R][EO:U/-
MVDX42TZ3<1S8"45+J(L<ARVT55'W<I^Q@#R?8GKJ2**'+#,@L_4Z+M<DNRV-
MCK.TC-,53$,TP13B(IO.<;:C&!/A*ZYF!/CL,BLA^/)SS^F-:N9UDAH52[:U
M@=P&Q^3A,+>Q,./H%SN@CI=`,M"7WZO/1%:4-&):#O>R>1Q+PH<Y.,)3,.7-
MH$NQ:[2#(3IP:`ALLKQXWC1.`Z0<!,2YIO1+4.!/#\!_O7ISA&U0\(A''8"C
M-P=OWI#_!\5#D.-LU&WYD.7Q[S#Z"[B%.=*[8%&73<#WWZ"%>5O!/*+C2V+@
M$L!_`5]_\PVYN3U\<UA#CHL"^U?D/G=;XJ($$=+MX@R"_=^B_YU3/H%$VO8R
M8KG,&B+H^)#,TFFEO#>'2R]L?W*)M9.EC&QWA?M+J7`??7/P]1=?'+S]^FLB
M;4=?'7SYY=N#KXZ.;.55(J*^#"^>D.Q;6STZ#XE(1E&,\X6"Y#J(H_/T.-C$
MR)5AIIDDY*2>U:E^5N,CBB4T`P'.HC^,4Q#2L=Y/>7W.=B)3>I08H@M/(-II
M&<GHO2V#%3S%U7XV>5S`$[B,P[A<M#EM)]L<[>#]$9-$LX9C-9J^Y15DF8J6
MPF0N,KR;9DX`@/(!@JB%@LV(%?2J.,>3J&XJV"BT':"<^Z:W&]?73["MCX<T
MV%8(G2WOJE?,-[EC-3#JILHJ\)%4-$'\S21JR\5)*E9,[);8B#,6,UU^FV2>
M6(7LR+5YUVVZ);XEQ]<19)N(1T\0]8DRI+B1DB:9\D9K$8C.61!"G'Z_1<=A
MEG<<:[!!7@?Q3W!*?LBXY9NNJ_\7L")%$9-D!]*L!#%R7G#-OT<R$!^ZRR#.
MP3K(?X7E/NQ7?K,KE+QODBODE)W@+0ES2"^8]Q%3Z$(++.;SYD2`H?(=BO`!
MRF?(%SK)DB3("\\7&O;2H?FV1$8[Z\O\[DZY#O*KG-DNUS"_Q1M_^G"I<&;W
M;VAUT!+&5?_TQZ,W7W_]EV7U;U[_HHFTUG&HZO>L`+>*]G/?;_P-9$(<U)02
M;\@3[XYR)T&Y11/`FUY4>S.Z+S$AP<9>,K'D5;]K(Z+U1_.*JHN8+I9%+IG<
M5?N4&B2\2SX=?B$HS>\,5,I+MMW>C'7247DX)Z%\5RJCFLWEA8D8C9'T!+X,
MZ>F(N2B(+GM5RH&AR[!22#W(5^TUD2M98Z?T+7`,+B-)'7/OYCT^HLEPE?3M
M$VE(9<#V&L6E0:\SK6-320,EK2ODYO)XCN:Z`;L%=[Q*0WVH&+HPTF73N4_/
M%&"B)6V]I`3/Z74:C!0(ELCJ'D>>IK/>1%,Y+^;.Q\-$BFBVBO=34L$\J?SL
M&V;C2,_$1IET/N]RI#;)N,(T)[M+AZ%2L>):7!8/H)G6%>0,)4GJ5\NK#>X]
M%:._6O>.48";X-)3NX6,'#6=7C(M!'SSU,+P8DM9<I+;OT2#-*[VOP5NRI8S
M(K[Q<\\_72;:UZ2[@8\PW<(SA#0MQ#S%^=.?Q*T1W)M?6D,[IU][/U2$K&%/
M$O[2;*6ADJYT515'GK9FJ'`R'^5XA-B(*HC6WS>/L;_S?2^AY%ZGC)=TO4YS
MD:6H<`N+]FG/T_@OFP=#.HS=P`(BI''K!29#LYIE&@TOF]"I-$E1$6SF>@S)
M?V,R?3T'.[38V#T-5&L?DL9.6]@F"/@B6L=IC&459VM-*%>J*9TVXI#C(K(I
MZ"A:I+PSSF^*D"8S.YTZ-`@PX*J@IPV=&!T^TG5[2`ADQW-A<A$_I$?8./;G
M>1IF:WB1%=,*`3/-^-7JM:6@Q4*4>XC^!#!S0-8/3?@V-ONLXLK'WB)MSB'B
M&)/RLQ18W<'%)*0E&>ZVQI\8$6G+@IB,`)]5AN_GW_D+4:DYT40S%(MU6.1/
MCHFXBT&/[C,),8W&A$%5_L[31UB0BB@4_CE^.(9^,X7R%L[EU,L082'8O/6?
M*SGRK;Q5_&(UN'2E0]R)&M"$[L/^%&,&EO2?K.YAH1*12L5X]CT%W.E*1G]=
MUAD:EUF:=6V%">5"/-D4H4>5(2C$1ND6>)(-):]8*9&OSEY>8#FMD]"=P,O[
MX`X*`F%`WX`$_=EKU)/+C(X0]%9B></]+BCB$(>WXF2+'Q^9V/ZBL9/P5FK\
M"S`1L)A\34.3]'NOM;T5'&C,3=D:W3UVD&#!,_;[I)Y#&;.QZ#[D2N$TR%.D
MP8LZ'W-OFBDTL&I*E\%?!2ZRP`U.S0VK#";R*GIF;V(,.<RJ=1VJ#'`K?X3Q
MZ@'+\".R'U;P<HL+6ETMR51,QI0#4;3$Q*E+:H>C0')K8""@T#A9=T2.:?J:
MWZ3S86+"RO,`$EH'-$69/OU*%;0(#TQ#05U8PRP^K0E<IF(,QM8\U:]3OS38
M9,5?``4./FO!>WK,/YIT*)/*M&GKXL0=!5/#S$$],9A!*Z;YR<2`5[`4['&V
MWF0IFO0D6P?Q)&5*^!,Y-1]Y&`C4525YS<?@9_JYW\0F*;,Z-J%PJ1:6(!'1
M1?3+ED:@B[M,5*ZQKMJ8EGE\O\5?+'#(`:VJ5_M&<$Z.,,W8(J4LVS0<9V%&
MU`8A3/1CG(8Y#`K\?B<%0;?\)VC+?X*@I/#K%B/U[T-F8ER9-JZG?N7Q7!U/
MIAI-.A(O'%Z&CH,Q]ZQ5\1Y\]L]M"L';KW%QXC='G_N,:,U6%O;O9"<_IGIA
M6AYO>Q'G%Q)RGH2:&YC'&3:<\E(6R>>7'>1'(-%_AIZ3`X>4\YR0S*>I])Z5
MC\^1#I$]A=R&T/EH4)W=B1\M]U\J>]EUZG?*E21P8UE^1$+Q(IGW#-G#5MO#
M0J+)9A,F-*7L`,^6[%@*B=;)OB9$)04M+N$3^<LDE]9Z$[M]?:>%DR@I!OV1
M"!&I)-N^`O<K2";<[2ER+4H,:B'6GX&*M@_)VY_9Z5V[&6Z&(L@_,CS:$=IL
MUQ!)'FGL[XYE<G^-N/T0%/!J22O+NM:*O?F=WMF98&8JG\LL!R4,'](LR58[
MD-`"QK/5G")!T%6@7'(-R4^5;@V/8BM`P,>C:2,,QY'?%Z-V!\BSA'X#2HYF
M(811@2L%U"2_6D[<]4H]J?N2V@J,1'?(0?&`^V?3*\,<AA"710>-L!;;^R+,
M8QK;I'_&<7#/2=S:3.]6A-0AT336`&WB6"`BXAF;SA&W,$1?EA,U4QZ&D,MK
MQ$&8BK,CJG%8`^^UZ"#W."_![](6'%US0H^<0UM=B73_G/:!+D8.2X"-@_$8
M&^+%F"-C;A`3^HX<R2![<Q'^MHT+<J?F_$#HS.VC/[<&7AIE%.O.L?C^/DM3
MW`T6_>DI+A_`&N8KF,_C;L1``'05>X]08T=YJT*S?F24,[FS=^W&J(TAIP(%
M/".)%<N#MJKERNP$YC?YVQ5Q8HK39YB'<3'1_:`Q$K,)RW'1,XUM;#?8NJ#>
M(GYM]!3DI/8@K`#.ULZ62HBN"A:3<+)XG6_)EF$QN\B=$Q%_,9;S4)%7T728
M_4&J?O+V&)[U/D"3X%1<F!8DA_1]/M%K:6M<G(=/+)`4B#X!=TB&8-%OQLRD
M@L-0\>B)MBWE)C)6Z*_/LOP6YH]QZ#XVV$=@1OY@#SF;ZY>B&CN#;$13(="U
M1?ATFL8G]"FQ(@SFY1V.*K4B"V-.0JP0#&WS0BS&EH*LD\%.&UALDGB20E^&
M&+@T),Q0$[50QT_HZ%,:6A<@K.X8LVU)K6=<B1[M)E!@*)ZM"3MY8.77@FA3
M7:_<4,*VL[G7Q!P4YG:!TD=Q'$F>3T:PG8QH*V4!`:>X$B'%'5T;P'12URD<
M2HQ$[EJ05/9"<U?5N]UC`A4%L26P),_5=N@S7M?H;<DT>AI'U<_*L3BRLXY?
MR7F0%IU$)%_*K8>I=.Z3;/2J*CB/ZRS)GL9IA-:'YK:(M#9>YI512,(;@>&W
M[)DQ(Y65+?C$<?CLV@@QPTHF+=NXU4H^5?995:^FT]3@<+IC4ZU^@>S91Y+$
M8J8G=(&Y+ZNDB9DL_75)Q(KM0Y"N0-"`\-;_RHJ/K9R94,9=`20#K/@%&#08
MYKMIECO&6;SE[-=QN(%X+7$"+V&)BPK<9>@'C,7'`D;GZ5#E,=9<;DV0D;`6
MZ!T&.LZ\S&OX(*V*4.#?XI^)4;PM:*:02COYK3`R7(SX948&$M]7W9EA:/-T
MWXA",YOJOR]`@@9U$#G!]:;"F-P<HY\32,KAI-%BG2&_^/=.`:PQXPE:\[J\
M6M!!2*`LV:&TWQPSQGL0RX3#;*1`FR`#I.^ZCKF0L,0B#',RR]7R!D9P39)V
M3N(BS+;I)#==)M.[?S"GC9OH#*_'\)Y3Y`T4\(@CD]X?S!D+0O?IG!FQ!D1?
MJW+;W9R;22*N_)D<UQ#A(F&9EW6`R]`E6U+#.N3DFO,S7_S5K!&RN5>]AD\A
MT_LFZET]()+"XCRECX^1PKV(@_LXL0B*:$%R>/FICY4H&D+'DGJ89#0Y;9-V
MO%=GPXASK3>M30]7)Y`96MP@B))/L['O)V;:&^M+Y_.J^NL)I/^>IS?-Z_9)
MLB;D$XYWN6?2OTV"D:CM,\EU7V[3J)A/.0`M7G8[O*E6/JP!X#YT9#_AJL(G
ME155MZE,(W(C.%VE%4M,YB&,.J@*I+0:6AM&5#]FI.%IN$7`D`A3Q>DW`7B8
MH,@%6IMZXTIZ/1_2X/G*E2+=GW34D[PKPG>JG`DE=L(@1^4_9DOT`S7AB]*W
MG:[-8+DP\DA@[R/RX&^R(BZ=:U/.O*/%U(:HSCY>XM`:_M!OET43?JKDC+ON
M01V@]^=8A"3.45P'.VPNX(A=&.;(OV9,5#?2IX7)Z%ECCS"_STQUH`ZJXC`;
M&8KS;DD+!A(!IJ.;`WYV:M)$2N0RK4VZ(0>Y\+JD+35_E^$;D^L\>XPC&+W;
M">].IA#^4?$;_2)9U>]V3.P%N^0N(ZU*VHGF]*QB)($2/KH8@Z0#SHCJ,M'3
MUC"8?8)8I$:KYV&"?:ESG^W[G;VY!.QU]#"4U('I@.?I(RS&2@>4`?.;#BC!
M3#,=,*XAS#,=4(./_*PR%67\I`,JL-))!^0R;'[I@%,Q;D!KA^NJ!NQ=1HHR
MY1"I(Z2`RMTU(GB)K$[<H66#/YDD4T!_]A$/,7T76Q\_442R*GI,<P7H6.+)
MP'J@[PP!8_YW$@3,Z&-[:<.6\,5OC*Z6;J748'J?!:`5N`F#YA0"U:1%]81+
M):R^RS]KBH&H$+0.J>PCE0++CJ/%'7H&O-GGXQEPL%-Y!IL*!/@,^PB?@_L=
MUP[PGBEH+@T:7H*(7L.]A+,X#9!7/8Z7(`/FUTN08*;I)2QK"//T$C3XR#<V
M593QXR4HL-+Q$K@,FY^7,!7CWHQ_*:!\2J[5?(''.[Y5PJW=[]\8&;<7Q:"'
M!_P9]A)YTXC^`J(_.FZ6HL3$:6%<.QP-#>E.AKC7&]=APJ$69"W"#;FO$AA#
M',7GT+#FS3X?PYJ#G;9AC2QJWIGI6?.:"X&&/2TBDVW(`L^!-@#^!WN5CT@;
MX,M<4A5D_[)W"EDUFG]\NT`EK";H2<0UKCX%GT75QY^3TOI8BG'@@OP`VPF\
M:E\;D6`EUYAF4\2B-GJMJOFX+M#6R_,=VF6D;)/4;N>Q#P0EN(>K.$VQ0L*'
M*\'&;U1*:ZGZ_.32:/0-NM'IBJV-(*\GO92)$.?E]MGWJ3+PR/Y^YCQ%/A8L
M2EQ6<IKT,@:^VT=P[-2BIV_;S28AE7*"!$1Q$299L<VI*U@[]TCA+[-\39_$
MU3`!3H+V+5@\WG63OO8(8!6\NPQ*1)*K994WD*7%'7PNWR78`C>)V^G`<1ZR
MTT!*9!YD)01'X!!0$%ADWFV+.(6%M[014W8U41Y=*M@:JWWXD[A/_5F\M$_O
MXR$2H49RVD_!SYCT@-#>3\!0S;2.N\-?K/G=%A'$VWB5QLLXQ-=E-#\5ESK,
MDCA$_I*=VC$$Z;8:D!ER,DWT%FFBV^UZ'>0[+%`,8-!"!C5HKQK*CLF-LK*@
MV8"Z`5J33:'--&?VHN'T<!/97'+1Y"M`/]4$C)C?J2Z@3R!+3?D^>X1YBBU7
M\G364CFJH3B5+SV<9&KP"Z0&6P"`0O!W[Z;-I4:[Z:W>KCJ?$/8P69G":H^R
M<$O<,K9^A]9:1"_2.LY=T.J=#=Z5.U+$!%?=3[>05$!#^Q=/_0J<+T'Y``&:
M*"YWX"$HD)^X))<.)1V+=18>W?X:+YM4EZT!(L:E14!J_A<'!!PS*PS"!X#<
M2YC'R`G%8_%09@B("[""*;*ODF17>ZDP(J@%Y!ZHZ'R.<5QODS)&KBV`U+T%
MI"+VJBI\^QF9]SE8HR\.0`23&!&3V`W-N$V>1=NP1.@V[6'0&(QZ'J\>:*6X
M;0&K]\Z?D[\P#O0ZP,DR$=*`:%/BO_$I3M:^1:3>8PI:P1-,$OSO`_+`\1?%
M_B=HE@@BJJV1SQ612!"IB(3H<M?'!>+G&QN$+(C7FRPO\>'SRS9:4=J0U00;
MG).&F%!"[,31N[4X#3$Y<%&"A)0/K@KD5>+!,+DW;9`469\.5([^%&RRXB^8
M;3`@KTW(XM(=6BD,<KP>+%#UQ5XC1@\!9F2,7YZ3.T`,D.'\JQDJ.GT%-TGN
MA^51(XH<]XX6@;7R8AE@6_@5IQC$]-U4JVGM;!)-4.X-$SW$9-;)E\@Z8:#X
MKA1OPC*FSK@V%:R#TO(Y)KG.E,_HH^6L'"5)+_!J$&!,'H&6\G0?HL7=SD6(
MFA1V:NL#Z8G>Z1>^2",T!WGOC_^SG<_2Q1HXA>LZ;\/0E2F_/R/EA[#X"M`I
MB,5V`T/:R,QWU=41I:'1E".0<D@ND]WT4RA72TS<9Y/:(2H0^@K8`6#!$:EG
M`3):>DZAKV'"P^KN`32U[F9$D@$?LB1"$^.;\W*'-=!0P]0<JCL)MD-0IJZ_
MPA<*#$#JL@(*UZ^>MF9O>X=@1:FA[35U)ISD*D%[<C_=C750D]4NYDDH($(\
M5Q/86!QZO>"T:6;;Z.D:I@6M'$_*7EUG:"/`,LY)"/$=3.$R'N[K#Y[$L88=
MBJ],X7Z-%.Y-`PS@-Z-^U>Q8$M!HW5&H-^3MBN7\4^AD:UR<JVA;3$6O6"@X
M8@@3@*`+$=0@E<K;RPN7@2+4>>,RA+"V:IW6L;H+GH>J;BU`;L/Y.BC)-/`W
M2`-3&``!\9PE8\*H1L-J4V!0E53A%%,H2NE\7K)?9!@)Q*N5*K5)ZJG0I)*I
M>^4DY22PS&JYH;>LUT%>[NZ82_.ARLH&KEO=98&A3)5]2XQ)>F5-8`(6J,^+
MR@$L;M2<+;'LM9[!C%,H09/IO>A$`P0%8BN65@TOWH?.M!`)5H6:4LQ2HWZ_
M11/`/-E5#U"#Y+Q]SF*G3`U!NM6C9LA)WW:\P1%0F,`0BV4#%S2`P4E0!N"S
M;1ILHQA]\[E/M6K'YT:C6I#-7IGJ33:%'M6<V8L*U<--(+$\\62&S\C4-&,^
MJS$-"&3[_&1[7\#?MLC]/GV$UDG5:BCN<Y>4.$DUX1%Y7%)#`!2$'S$RXU-[
MX:.U?NN$)2'X2:YSA)/Y2%,28B-\<KLG1S.[F5%QLG,3(UV[74K2;?@`HRVN
M'HF?=P=5]UZD^Y)XN2/U0VC?AL&WV2/,XSHY:02<15)900;GYTC7-=!)E+J%
M7[]7\OBB9$3Q:)7C2&0=DJTT`(=)=.P`=-SG+0W`5K4?LJ5Z-\S401]!I#K*
M?B"1[;.99(\)QWL+/:%63X0*70<ARW>DG]7C/_>HK4U8I_?">?+>P@->K*L*
MINJ^2O_4^&3?3OA=4,3%U7(/_([^[Z0GH.;,7D(E>K@)]`89C,^U=O@!%<$=
M^+GZ=TX>B9D(L">6`9DL`R8G\!$F&2EI?UL&*WB**PYM\`M%J80*CB=]:&YC
MRMIX";MA-N,/"0#00I"*G',]:,S/1A>:T<@^=ORQ0`;8:5'&^,7T)&6$]F9P
M;\UW$1#(U$?:\Z7Y3%.%^5!@?):QBHJSXB&^I*"0Y?1GIM[$#J,F1HC)VA)@
MSX_\P`R?]:EI)`,:55#Y2LQ*/,^".">E&Z^6S$T&LA9)Q8MJJBG$4V]B#^*I
MA9A`//%8$J(@^I"]_6K&SUI0C:2!%51]H@UHB\5O7^1`E6K/[>/.0Q<Y<2%_
M,OR`)/F71+DV(/2$U5-U?R-QV*OGKT\QNXL3ICN[C?,A&>[6VQ`C(A`GFD5/
M1\Q*Q6FRI?$A%"L?D+.\WB!EB<7M*J<O3X/D:GF1I:N+^!%&&D(S4BZS#1X>
MSF,;/$69SPTH7-*H!H:/:@SND,"K9'?&+LP0`>KD3=L2UJIR\R(,\RV,+N+@
M/DY(RPD;Q:B&XCX*K<1)((W5.,`,5&E,YPI3FVN-WM2CAG5RRVF0XWX(N!/$
M[4.0RT-[XRA*U93.'\$I$!*(6ST*H&&`C)NO=:?)95:;Z1!EP'/-&UKV[J8M
MM^=`\M23>LJO5Z`ES*JGI0.9@;/VAK5YWDVEUR'.D,<?!41KP&$A)LQ]^KR!
M:1W>GD84U=/Z\'XU\!)*(QU)J^"T8T$U>.:BJ2T%7>'4H]:0#BZ(QO%]`JGY
M>!:C/0")/3F=;*HG]?0T4X&6\'UF/:[Q1>A0ZJ#,]]369OY>7Q@-*EE>"=-^
M87<9_?<85]W-XR)+6YM4W_70A>6\"H@66L(""'@4+B1<_<0`F)TS8LA-IM2'
M/HD&F(C-.V07P1O17.YOB$6H*%^?SUF1R3G)?7TN=C@LDY"Q%_,N*""16'1`
MDRS/JTV5ZXGFQ>6['R&.8D]X3V>#AOO*7>9(BA(Y,:3#>PP*L+`.`(5&K,4&
M'KDS*>9L*`Z0HDZ^L26!!ZC32_C$)(OE68I^#"%SG>A`S1KCX*?'ER&6PAZS
M3YU$V`Z@67M#MJ+2;95L0<3QKT.4O4:,<MMX><^JYB,Y7`5YA'\1,:F"!4D5
MA,UDKWR^+W>4&?C&2S,9^<7C,(YFY':6MDEYY?'-[&CWL'Y8I'7',8Q3074Y
ME+1S>.RH,M$UT!L?"M3`&QS&PDWC6U<_A>U<'GGIP(M^,\CQ$:;G^,GQ\NE;
MJY&RR>H"/]\%.+HX&W];G^-::5PC/75<).2/V,]97L(231="&!5G"/7KO&J'
M1<H?5QF/Z8J0U3"A8>@DHPNE^O0;B+)`9-%'VR3(]SJ?!\UD^+]26.)F<&0^
MVG5L4\\("CPE6-9SOO*;-S&2[+3GZ1A$MZW3NH@B<I/9*7)SC$E`[MS)O#06
M4-AL`6OH'JP':V3-I+Z9!<1,X:2PF:>2]HS.Y-.4'RP;K8@/(JV'O*\1MB3/
MPEQT5!Z"#*X[*J\!3EMB@`:\]%S_7QTX@FG:EEW@!T19&5V$9?P8ESN91AR[
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MSJ$I[1QX`&K8^-DBA3X?7W\TR1*<B1;$'FZ2GE3AA+O@F=X]+U+V+M.E[6F&
MBI>JRW:X:NR+&AYI5E0]*L=769TGD_-PRD:2(?XF,*>K??7P]NA:+B'V_F&3
MXGH3E.1A4QJBB6FE>X<;P0(?O[O!'&$=6ZT&RG2'`Q@NZ`*>[[ZPERN!B65'
MYA%VB+P)A,.M88*(YS"$`:H:NT'=:F3&CHB%^/!W@"E-;5]350D7;*Z%68=E
M&0#W%W@R=!1Y-=V$&H_7KSH\:5.X5`L>/>R1V-*>%Z[G$Q_\7(_S_#IM3$Z\
M&1#"$^=%H<$GV3J(TRE.(YUI)[#'>!)F@))=530\'OQ,(7B3.@M^ZZ7/=8EC
M;2<))WB?9\4DU7(5,\Y%^@@V.@<,;"5NA<?,5M(Z'-42LI8&UO*U",/M>DL:
M5Y[`30Y#:NJCGQ-8O4M;K+.\C'\GOQ>B,H4DCH;;B('.;ZG(IG"%T9)9ZV-A
M+RY\58,'$0.?R'S``/9NJX\M8NS6&)7(H^?O9&606&6F7T(]^XW1;2DLO88F
M9&LQ4FK-VJT3;8TSW(S\KP'@7T)ZI<)WL\ZK])E=.U@@!F1/>G(-AR$Z<D;M
M/'S+V8C!%"_V=%Y!-3B>%\46H06OEEULD1JFOX#HC^0W(F&X9-^0!$LT.RC;
MEN<@Q/?MOH\CB^4*#BIKPMG>H2ZB7[9%2=[-WV5M:N%U$$?GZ7&PB9%A4=W>
M8I1@-(GY;8S$>.K-P,PVQ5)PL%W`HO@.D-X#CW7O@:<Z8^`S9%EF>03)0U0F
MX17/<ABGH)KG<_^VMJW@=(QJ*Y(.2:C1F?$X2Q^1P8B+G)W`^_+'N'R@ORK0
MMV<P*+<Y]+4-M'#SXX6.A+VH]1I,X3(F-T9A,P0LZ1BK;3/776,B?J:;29L!
M5D7#&0.ELEM@=)<Q<W;/,BTGR!2FAT>&AB@*Z_FPADX-A]0CZ#Z:]?M4UI+'
MC4%K0ZQ)O%E1R,062[7Q*N&IOX<I'OAI;ZW>P?4FRX-\1U,+<=422'VCD_@Q
MCF`:37)1H3.MX]L*#90D?0Q@[5S?RT_5",(UCOI6(/U;G08"P!Z-NM3R43*$
MW1VD)Y=(F1PC0YCT3B=>@V]+AH,XWZ<5K,]6!;3F2I5LO%CCDCZ5PH'1T10*
M0#WIJ$>4OM&M1$S4F+$95^#3*,S6:[3ONT>1G]Z+NNSM]%W4HH)E&A7SGJM^
M76L4Q9>-=QB=4^$BRMYC'@$V[Z[]=@738$C;9EVQX"DL2V&D7($,M^L]C_S<
M,/=+9L.`5\G\!UHX8K0BU4#?[?BO-*L'FE?;LBB#%!>`N]RN[V$^Q>DQ/I)C
MWQ_3BG>W99"7TK3@L1<BZDK8?@>"$IS`$.*OP1='!P#1^,BW[3.9U*EK.`\E
M]H`*SR,B]"/$S\!@M$#G,R[K^@SS$!=US>-PDLBJ*]2G.$[<[TW9$BUW+/@L
M3L%)EB1!7N#ZFJ#`N'@/QSH6Z8FVMY)?`^H+#,3R/;G5.D_IX^C),DFG0-.5
M:3CA&@2;E7P)(^_!G`F%:\R=)B+LA+NJ,$)I=J?IB.C[J!S@;GGR#:H\-&>Y
M:<>77:/-/#)SQO:TI"<`]I)IGL/)-L=]+:CIAY=3L&6%:C0C4=B@^<"_CC=>
M$Y?KEI3QJ*)K3%ZNEC9;@9>W^TZ7*&K47(O<IZFNK>1X5(UMSB3[6@$#3<6S
M+%_"&-^=XI(?I\^;."<0&M3GZ/RHD?:23S;YL@3[N1J']G.6`XB'=8_16>[B
ML>1R3+])CP&^(O]*[&9W7D^ZH%D>WU.NV&#WJX.7GZ1.<!W1',[.T=-W:.S]
M-)WTH.)>U/"\.D60_>T+%TA_MV*]+@,O4GA4V\-&I#Y-U?<RKFVLWB5W\+Q7
MXWEOC.<-Q+5&T.^/LY1D<&R#Y`[FZ[>3&46.E^$XD]?#$NTN<=_.()+A1Z)[
M"L`#N[S%-!B$SQ%><5K$82?==TY.D!A9#R7BIUJ+Y?9ES_)/*?."+Y43'=H<
M3@RJ[SX0L\IHP#4CYYN_V$?2Z:W:V-C+[P%(`=-/T#L32MJ8&XU/:X\YBPQ"
M+RT>J(NZGP+#;A9GN54_3:_74)8GVM=3)RL.,,W%6(I,\TD>F_E8AK?PO]MU
M#CZZ7Z+C.T"LQW1\;=DUS/$=!^&NU3_W7;^/[02;&S'N/G.VO?<6-,*I/H>L
MG$E%<Z*=R^.$\08U;6-J5C33`JZS=LJV&(I*.9@UQ/7[;'<`PVUZW_:?^3HJ
MAVF'XBC]CN?P+-@CFX=?F(WV2F3/PB%_/`E*B*O^S39X;KJ$EQ3%,UR;0.'6
MXT!`!X)EIXIC5FW$5?5^(R*YZJ!\@(`F`WR:@05+T9_NC98>>STJBQ]@@="K
MT9VU4A"AZN9(G7@5@FU^AVO#"?;V(X'4W]HO_4)-(9)C;E89,ZSJ3M[&JS1>
MQB&N[]\V6O]8X$D:\,=!$N+^#<8>A3UTY^5];#$5%?]IX0$&(,`0`3K)2`UC
M`A2P4+W6IQPL"VW1FD'4=%M9:`BJW+I#=ISGN2#_?Y4`#T6-&IP8;&_BXM>S
M'.+(#40R5^)FJ[.R,[21?B$6A^YZ=%V,'(T]7*+!:-_1T2!'PXN7ZC28"NDH
MEH<14V:Q;T^?-S#$S::J`J4O8M]RD7[!^Y:W'N'M`_VT*98+=C%,9O``WY50
M3K9/A4P8M$]M[D-DV,TO'4"-[4O)=%>N1+4GDWC)./'@L]U<,F`GE<)1[@#U
M:.\^.UV&UP\9ML>3N-R]J%-S#VTG+=P<+DBU21^;KS\ETU8NDY,?FAP6V.2K
MMU5\>PCBF=("FM?$5D+R4AU;A96L3O8AT9Z`'0VJX1[#(29<ZU9LUJ*%^Q+:
M.F@)BVE+>,1O'_FI,<P^+G6ZWB39#L);F#_&(13H*Z9AY0T,LU4:_X[4%0GU
M'^-FC3=PD^7E19SN-;L?\WB>"%.7%][3+$%T!E>3@6HV0*;C;)4#T&W.VDX*
MZ*R`3'L`Z,0`SPQ^IG/[VE1NQ)<]R2?DW8!+ZZ8]$Q^?2E5,L1TU9W9=<5</
M+6ECC,JAA'N'O*?F@D8,[K0.U*?$D"XJUXA[#PAXU=+S+F_Z^!K>R.H"<_FL
MP0@SJ5#5XT$%`+`0?'?\,.!AUS;1I8J+0]88*W%O%BFSYM*0W`GGWMA'@8Z3
MH"BNEM4$5_D-O@.;SCR43>?VMD*"B:AS%QZ!3:]:WK(<D%%],\M+_RXU)SN=
MNQ3KM^X2QX/+/.-W)E7LG..+EF9O$!5F0YIZ$(O!]WL:778K16^?*%;I:"K(
M^B_)!?;/H`DFL(F4'9*'(*S2@T^M'LPQE`.0M8`/P--^/@6L@(,-AO[*HSTU
MAIPT)_5@$CON*38*TA8E[8[\16)GQ6\+:TT\;[\TO[T>X\`:_2;,3F'U,1.U
M<B>U2QCE5("8C&73QG,2WL'_17?**Y\Q9T.NRJ500"='V0:F>''[MC<,I.8-
M_^GPI\BE7BE46\U`P8]LZF@`G2*(:*@NU%CJVC14:Y@8,?Z5AS[C!?*I23YW
M!?VL<>2IEB:_MQH$ZE&`#)N-.>J(C38]>L0ZK6D58F]^M"!FXR@U*.F;&[5^
MT+4XYG&4]=@G/\&Z='%;Q$&-D+0O%S]T\BGP852_HH$\3<A$#_P,+`H3?,WC
M);6R*(P,C9F)ZG#G69^Z7DT/4VSGV1]P7AP=UPH1-C*QUU1BD&,?>W::28B?
MOLFRY'7>T8R7S$1TE8R7BZN<B*ZS8<U1Y&D:83^E?>/GT^>@57DBB[FFL97L
MIIM)Y-8*>7-#:ME.`X(THO).)WIY%U&#Y,MRF^@5!YZO%K2QQ>3])O]7%E3M
MD3PT[=))';#NMN7S8)PZG^+-^`>"E&&CW)0>67!R?K:IKWOFHPGB0:)V)Q:Q
MGVY3DGG%>90M1UHO"C*UCQN/BLF#>34S.UO:3<24,#,*QW0QDX1>Y%6J.9'A
M3Y!QD]S]F+5JL=08+R/!;EB3%'7`&`-^>7Z-11N4<4@\GPLJ'71M=->\]953
M;MM>@YW`)<R1!W@7/"^*`I;8*;J(@WO\A#^&9L^D=&$Y/C\UT1*HI7HT0,,!
M'4]B+0P$?[:.(?<::3,AB<LT.@.\>/I"@U<S>7/O@'$#,NOZLPQ3`]Z>1PI1
M46WV$@E00$9\Y]&>4/)!(A=>GCA*T9#N6(;@<WG$.!+U!SQ3[,&]VD`<K4Q7
M%UE1'"-;8;?,<ER29^^J=YP'9B;3NWY+;X";*)@!D8M1#P()&@5"9ICO<FT6
MO&>CHZ;TL>^"V)L)_7",_CLN.[/<P`*BY3\X$50%"F[?W!IB)Q#7^L_$H(G@
M(TRR#7;1B>8,"3BA_,Y#@/7D0BK$&I2S?<'+FZO^756/HE--)8W>P10NX[+@
MU[#`)55<R?I@/-TWJY]B&1JETD*V#-=^%96Y[)*QQ$ZUE4:A]Y!N]#VDWN?H
M<'*R:^A,$^0XX58N1H)/,)$VAHGZ1K+?Y^]RODG%KEWM"(I:&:@:77A$X2R/
MZM,BE(7E*.'$K_Q;"HH8B,'RG5:S5>.C='X3>8SJ4^&+S1V<'/IUCKVX<G>=
MX+8I:73ZVS8FEK$[52!&8<0#YELJABE<X<)IYLI!B*106VQR&,;DM)^A&"K9
MKI9+.46&GD_G*3(V87?&*462.]^H89FN!-[I6CH\Q/3M'<$YY5429:SEB9V0
M`B-&71C0E]"-Y[DWY>CWS<:F=!<A2=Q/:E%[-X)D#)4:UYSU#ZC?V@./:[XW
MI62?@G0_N64B,>-,.Z;);76NBC`3R%SS(0CJ+^=RI*I8*Q4X`0'L4A%P4>(T
M1/);%2F^>X"-XJR"$4;WD";PIKB^D%]-&F`GC`BS$'#F%'ZV1H&0&_`*C-\L
M&0NN-O=JIC1RXO/98,;S_G39Q[T._939.,1%;.!VYVQ^784ZZUG+,QC!/$AN
MRZ#<(JB[=OQ$C7S&1=#M1=:HN`N4VL=7MZ_`D@X$13V2=*`$P6:3Q-AHRP!R
M38ESD!6>0Z&3"!Q[YHY/=%O'5H#)999&,-J&97R?P`F+^IM,[SH;P0`W@=Q?
MPWP=I/@^-XJ7R,J"2/*\^R06'-<072%51E?[S77QI-D'^I.[[.>BC95IO@'-
M-?#=#MB8XQJ"*:#-`!=:,-'Q`VZQ=IYZ\K!'P&H&DFR`KNC%"8&`V\L_2OSS
MF2E?"]G1$'U38MI6EKB%"6D3^/TVR)%_G.S.XA0!C8/D)"@#LZ8L>J#<>_9Z
MB(F25:K!H!D-FN$`C_?:*<Z(>VU3#WV"N//@]9'B]F)1L4F0Q/P)\NS-%%DT
MJOR'&V20I%MXAM;YGCP^%D=9R(<`4P2LR*=^'<8>YCPM+5@>W1U__3^'A^#G
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MM[_]!QS?WAP>VEMFIT&>QNFJ0'Y7G>`6AU,86_R)G'9VY&$@N1PCJ?`;F(,"
M?\V6(F]_Z[G_BI1[G<Z(PK4/L.I;FRC%^C&)ESLTQR(,LVTJ>BLUCC!ISNS4
MYC'#37U!EI)#M1H.ZO%>K\O,&,[*GP%1W,9R]1'CG:I*=OE_9NF2=U:5]OK3
MU!X6?M2)(Q#Y(RRF:TJG-:_+<TH'(:7Z:,<2T:Q'SZ4GL`FS^;*HH(VM8UZ!
M.B&!69RQ=/>`#LL$SW3[`&&)35'T*Q(4N,M^?(C#A_-R02YDS%X'CS*1C^OZ
MX6A+(JT(-*AAXX`4O@JNP`,"'^`)R*_)%/@.C$P"XA)4TWSG,S0PIOPP%\<C
M$=UE8L`X*/-]V9$$93;!B5E+C76YJ$9'GV7YL%(*>I!<5VK6PDJ@[)JQN'@M
MX!3L\)CC8L2W1MSTJ>'J5MH,+9ZF47)I+C4:)F;9&^MD";G!5JDC]V9]/;&W
MUL!:Z`ET1WW.!25X!U=QBB,[X&H):#>Y65OV>PS7-^U9BDPCB\</0;["SSGP
MDUY:$GFJ%!X[1%PG\UAA*;YBQE]C*PQ_3YW2:HCGBXA!4J$OP#)ZV2?\*/QA
MFE[4ZX#B)'#2SNWGE8(N>L)G?_4'<Q;//H<-HB5=$KBM$&ZL]7GF&7,0HFDX
M1^#\&#;&`6A;X_(&Y[;P`JFB$!7SO;/2:<RDHC@1R5;J!S+=>^U]>K;.]]XR
M[%7\69S&);R('[$+7R*P.%V4FN@?@E^RG%1,O0S67,Z.H^E-47![A6.(G4"J
M*)1#`@:T<"H_[P`04(`69\;`>)%T+_K&4CY8S6-#05LC7/C8_&,!E]OD(EY.
M8G+K3.NC@(D&7J),^6KD`2!CJ45=CSX`=#S``/P:,`8,9V52ES`#BDJV=1VF
MD+@.?`^I8>S\&J4MV/P6SUDM/,YTG]_NK<Q6%XGUWK3*2&M>9V7K3;"R.3P%
MNFAFAZ5<&VG39D`"Q&*-^VS^7CT.W3^(IY!#Q8P^SD,Y2J++%&80?D#<,]_X
MRLV'`.HQF14]#8I8GX$2PX^=MHI57<+G\NX))H_P0Y:6#Y.(Y$",/)RSPS"V
M]$8Z$E^!/@`8.*#0`04_HU-]'%G3=%MT*3^^Y<";^B<8Y'=/F?_]4B/B)3'6
M"M51]P>&B?9')M@5+V!;[$F2_6Y@R3M);$HT)Q)^QS:U'!4?1HXEKA/L!0SV
MQ9X1/7D:N!T:&CNRI_"D9TBZYK$="";N"Z#;(3K^5L!01>?"2]D,K#`-VPL-
MC8>4-;>8%GT[D]V`,7D1NP%].\%N0&->_&Y@A&G@;JAI/&0W+-(RCN)D6R)@
MMS#<YJ0^Y>ESF&PC&.%D7-Q78%M6CO[^BSV$VG::6L[C(.9^KXR"MRBBQ,`&
M+7!00Z?OJ!GX..Q4SX"S$&@K8;+'T"RS:"X\B2!V(E6C,63(/OL'#)+RX1@!
MO,I705KMYNHE^2T1PPE?DQG,[O:67!\QP9:@``"&`%@0!Z"N+5!!\9R:82\'
MK"P;DLLTCD1R1*[S[!<8EC1GZ3A[A#F,WNVZU1"D"3I2`.[?ALG0$5]BXR%5
MWA:H!H'['7COL4:%-G>:=!_ETNTRMBJPI\\E,D60_%'X)K*Q/]3U&QD^&@II
M:+[VF]*NP8)]`>"MT[K]+!&?!6[MIL5QYG/G#6;;N06L)1^`Q5Y'/N?<[).T
MX>#>$JPT^L=T6\"(0#K;IOO=2`5\ZPURV[!^?WI105KR&57+@'SHK]VWB,P-
M+[EK&E_U(35_GUD4:#KBT+=3H&G_\'MI)9J.QG<'HRS<XO2O3E:0B?7!2R"_
M>X!@4QTZ-%T=A*T)0LMDO?(GYZ.:(%/4)]-E"N=8Y+&C/O]A<_Y3IKQZT0;`
MF]$5NI+LW;.,1VJJQP/\B5?J:A_(;SRH%-XQPB-F=382?0&6^$N/2L/J<!Q4
MN6>1P^!J>8,\YE-<J1[6J;N3!"M%<WF(/PI0$844T><X2H@'`#H"U$-H?/"W
M+8ZM+"$L/_=]]*M8V@G[R>@P)))W`8,"DB=0:(\F$[['Y4_D/`&7BX9`FIHV
M]H",*G`4+BWK6QRO*8Y2MK&"(UZO;?6FABH$]!W,UU=+\J.6(R8>[=R?%J*B
M)PX'``_!VH;\I\<HFI(CS;$D7[)MHEX7:G&V+;<Y_!"G\7J[O@YV^/@O3K;P
M>)OG$[5*-<3`N=8QPT];'5$XH`($:D@`@>(EJGK56'9"PJHR"R(.,+@T9SM/
M[YXR?'\]2::V.1+N331C'(>*]P&6;UR/#&>9$HB>TTNM1<5"NO?(.,3T^YCF
M,,SR"$8?4[3**,8N6I!<(PEY0"A<W2?QBKAM;$&SZ5(DAJ#C7NH'8"L,_M80
M00<DJ&&"%JAG@1]!<EC1'TK+*6YAE7$+J2G%C8-6UF+6Z+D$?_[*6Z[*F+:C
M1;F,FOMUK708X<P5Y)[0^AQYCJL[$+7W;M=^4ZE"$K(B_W.'ID#^#7["/&V!
MADGP=%(L=,H5B`(Q>`#`(^92#7E*,6.5V61$MK[BO@T2>+5$V*RS]+;,PE\-
MRM.(QCHM+RE`0M35:/_KO@2Z;XPC9T';"4>R4FL%>YXB:R9>UY=615E<9B6N
M?Q0&]\F$"E-K7K?-W=0("82J&EKERAQ4!?;0<-",YQ:K\:+J3!C>[=>F21\_
M15RJXJED7]`\W\6V?,CR^'<HN>VLZ\F280=5@C!H1WKGEGQA/#[ID,+#(^TN
M6M=!?I7CSL`PPD778)V!K,TI!`!D.:`@`('1)GTK.P7-@)4B"JA9*J>=\T#Y
MGKRU>(GR;)3,\9)B(%@$)\M`NMS137:-#*?K/`LAC`J<`71>%%OL!5\MNXAB
MJY'\`K=S)K\1L:>&1O.@:GC8-]W;A*3>50NT^N5\GK+:D86__^P)/*!*&V?.
MXRQ%`D'Z57>GG\)$,T7!RZEBA*(XZUD@\@RDGOC/J(2!I;"H95Q.2:L,72%(
M^@>2N97'8>]`E'JBQD#=O\TP15%4QULLD0>@!04(K+F:1(,$H3F*K2AJ]PQ$
M.-5=5@9).Q\UMX>)+!^DVY1T,^1L1)4`8@66@O)K!MJQ62V08JI9-O:YW*[O
M8<[:(`1DA0!Y5ITQ@2(M@32%Z?HADR%^HKZR!,J>.4O=_@82B%/2)@'#HO+J
M4T]:\KJ12ANZ37$\:G@R!`%L?<#H9)O'Z8I&FUB$"_)RF=EI[3MG88MT8JY1
ML(#";4)U%'3GY-PS^UKX?MV98;3A7D:,0&WW=^N\^-;5MBQ*Y(ZB-9C&^IBA
MOMU5Z;IT0WT]4EC?#)&:XU?+'P-\.U5>Y3?QZ@$_;@GQQ?>J<0[:`^TXVR;1
M.UC?S.N]F1P^B_.(UV"41?82*6V/U$\%&0<X">P#T$)OU1-C-0$R`W@'FW20
MR%?^^KBBTYI6H]#<-AC#G;T^5UN5>!PD"7[R57U75!].DOPW%"4O!2@'(FV^
M;UIKCRDA0\'C]X7U!,V(@ELGQL=Q,)+(L<?%&-2WKU3)G?WT&6WAN(#$3V_^
MZ'[CJ/#P$-JTP=-\@]0`JWA1^\W^GF!C1^<E7'L.[@^1)N6>T*'RV/&8H=[1
M)7PB?QKD!2$@]`N^'O04W=9;M[&'LT>Q(:\!R@>8+\(P1_-<Q,%]G%!%.N&3
M%OF,/E(PY"B)TOKQ(%"-`LPPY)'3@3.Z4-1C<R=M7TT3]PZT8%.02^Q!6H1`
MZ"F1631]T%JS@0;A$6L^5_][T3RS6WXV[#FCS:=<J<FEYAYYYA%!Z$N91@:-
MM\/99!UZWKQH_=8!K-INZP/N&'A:82I=6.[4N0E:@M.W,?7Y^GS/-U#G;3F7
M/T,.-_)G0C;;E_"U8RV>R^A63@+&L<RI,5)>O4D%S^\5L#[;>A=L"H),<,H,
M=1KI[\^R_!;FCTC@!SF/U5^7."VW`C=KS[&W>&,/4D`^+Z%5FHE?5K>[O2=&
M3&T/'G^;T92;A_=X/&`!U(5-A#7IO13)T5HTCZ\FY+(]`:KWV5<;"I$Y6!8%
M>W5Q%L0Y<2BNEN>W5P6I"P6CN^P8YF40IZ?K39+MH&9:T>B3.C>.QUZ!X#2J
M"P?0>?:-G:#8NW/#LU7O#'!_P]NK/P6;K/A+`:IY`<X8H3.#9FJ/95^F$K[F
MU)N$3<YKKY#M?R]YD%F]Q[S??X_9+&N!#H$U(4*!M4:(%P?S]9'P*!4I6&92
M?#?%?E=-3*OW'K"RR,Q^`.KY2>TA[T^7IB,M]Z">F)'V%U_*-[_2)[\_P*)L
MS(ZC[A'@Z.FZ"7Y^-O!(V(O>#`_?L?3%>S6;WYKJ4XJET5-W4\8,N*"QQJ6Y
M'1<\O)S%/A0B^7(VHV@)T^U()C-D=H]^)Q/74?:GE%<^;A[Y*S&VOV;5;(V_
M)GT^#BR[4UOE56"#/\<E3KDKD)E$Q**H'CFT?\=%`BZS\B=8WL`P6Z53*<[I
MD'5_.3O96@2:M)ZO#MD)XS](8]:S4A5:M&]XF$V$IR:5+W:P!.WL\]I<DTLW
MNS^GY>B0$G^384:MMK,LKWZ%OYO$=7&\`A^'F]LE^M42!W47,GR'P*#E-_/`
MSS9QHD+$,F!M.9"4I_<PA7F0+-)H$:WC-"Y*7!SP$4Y805YK7O>EG36PDJ;&
M56-)K8WNZ%E>R)APOY<HIT.G"52PLIBGS3MSGN?!OBK<-,_1"OH<+6S?]&S(
M#4238N&Y!JB79_I>6B69/]\VYG))SD*&UX3#Q5Q9/-6S]TG*5"GY:_$0FL?@
M-G+$L)?&D,+N"_*0IE(2WGOM\>3A";F'GENCO!'D;NGZ_<Q3^WXFI^]G-IU+
MXM[&1K_!#S/OD2JH)WDUOXQ-_R\S??06,T@"Y`E%D\,6T[RGB&9%;:JL*%CG
M$Y#3W&,W,@<YDM.D/&GK<WG>G5R%/_&YB,Q1D,--EI<M3_UNW,GR$CTQ;XKT
M$1ZKZS2?C*;Y=+<E3O/I:O`E3JUXY*3YK-HTG[!*\X'UW*_^-\_'E%'6\843
MN(Q3'/E(RSR^WV*D<#GT"GQ^$A=A#DF+B'S'?C1=:Y*!&'EX6CP,8T&\H@(*
MV`$`@SVH\^%RT('<_9+"]OI(;!S18L,:(Q#:MF3%266IWP7/BZ*`9=%VZ,B*
MXA@=";MEEI-0X4FVQMD6X42;PQ@-YU$Z"R3%FX`ZA`@4H+`.`-.["H$#'7@'
MH(;H_59L@,3LR;P5,7U<KO1P13\<H_^.RPZ>-["`B)`/(AN#RW7\,X6US_$:
MG.<$,,/%:_%:AW[61_\-3'#&_G60E[L[9%X40<CDZI-'GLROBQ_C\H$=,H5Z
M&XJ2EZ<B`Y$6J+[J$T"^`0R`@_JFHGILS,(&3P@XZ`SUK@='$C-VGXQ!\?'M
M1.K6GJ:13%BTGE"_Y<B#W@MSKP;?=&_*WUH_&N*'TZI8F<&[41TX\WCWWD7*
MHC9>W0&Q_WQT)N%5+O<4`=0^46823^\A9AHQK]DUAZC:A/QR6Q!$C%D=LBE$
MU20TJH/Y:0ZML28]YNR1P-H`955_-4,/DZD:</3F\V(ZRC#2:JY1RU@S:J8E
M9D3L%5D"7&)8%G>7UFF\@;C1&O*FZ67:CP]((2`[,LZ)&O\Q*$Z?2YA&0ZKO
MFD\U#T/"&.\A]42;2>KW(V0:T,Z#1A>@GLES?L>H`B77M79,F(=M8X6[H?F3
M-A*4-Q)4Y0H\$0F"K00](0F"U52^4X3F+D)#>DSC)FY86FY#F`;(?EL\QY.<
MY_R)7#8YY6(@>F17?0)^QA_YZ8^KQ:)NO1;1`@<\'\77FO1U7))D3]3A[X4^
M/T`LM5.(C<GTKEHO6^`F$+,&`FA`8.W(B:F#GRF@__C.<K:0!U9&36DVH/1`
MO1M.?]O&Y0X_!\A2W&5\<@W'G=!M/WL9*J)W+N13T'Z[K_M\E;'28"-7"PK7
M/N3=&!/KG$[I]2<9/P`N$Y_>_,(F9TRY5(Z"\E(<7<2@3N5S[@)MTPT6(3*X
MM^3*`B<]A'%)\\Q.X"-,L@TYD7&>T'0"8XB!2ZO+##6!H#%`0`6ESE9DX``"
M:#8GI9U8=`JUF=-N5$NO6*01OK_.'V%QAR!,=7)JSNS?ON.AI6_:%>0E6ST>
M8`#S.&/-."\WYX0DLK?DSI`C7,*+^)$\MD!$QJ]MJ*7X;O<A^"7+B2L]E72:
M3.]:1`UP$\@IA7!(0(`61NUVW.\``0-H6*<GKGX$UD(B6*DUI9J]Z"ZBB#PL
M#I+K($:3'0>;N`R2"2T!Z81.G1`I*J*#OAD#\*##.`75L/D<ZSHL[9SB2CH,
M<4CJ_#*D=AFSH,JNF4[.=*:=X&9$)F\:*`G3M^A(<CZS!F7]S+PG>WYRL[0Y
MW<V_TB.+?0@9YC$Z]KO/7Z>3/-ET;MUD"2:BL#(9`1;[+<&YRLU/N$7-S$ZP
M14$"6Y?Z'S!(RH?C((=7^2I(X]^)D7F#Y#?=PEO"Q<GL/>VY'>LW7;P$LD>'
MXWQL"%@`.">;@``5C'GX)*82P$JE$:6L]1[W_FXJH11/YE@*A8B8)A3TQ&PV
MK11%8B5?^I#,J@W,RQU^'56B4QK'K3>T".6401>=:1W+E@9*XD0K,O*`O+HK
MB2'7C#[@AUH\I5GI\GHOVTJ+,/8V7/@`HVT"KY9:];:J#A+H)YRIT*VHA6MM
M(3?ZAKP@OXC3R01X<IR=)B=,O!AAG@.=%BMH@T)W[?0T':PI=5G5L",H'.#@
M$<4"8#1FD4OA2,X[-K(+U@XI$%YEBWQ,BPT,XV4,HY,,9Q]-LVE%DSD^:X2(
M*#*"#@`S`OQ,Q\S`;U,QL2N1LK7;OU'$U;.GTO8M<*=!S&9:4>@(_WT.FJU'
M_$X,J+.*(>%&XN#3>A@39GUQ9G%]L])'0:082`"G^G)&@1PAHWHMWOJK''#A
M@1\]3^FV="=P+16=V45W&*3?"?]VU].5!8\IG2N*WK+L)>`"(HOF(4NB\_4F
MSQY)*M:$JD(VG=MPL`03@:0T(P`[9"Z95!J,9&5(M7S;4/"'X!G78)I.@KH3
MN-8HG=E%[?KH-[.Y`N6RA)6%_J)&R..MPF_DR)H\A[<WF6OW1(2(*LQ:W2?Y
M-TB5?.,F[7*7:^V15/7;)M0=G0F<ZPYV=D6KS]GH#AY+.KJCMRA[W7$9E-L<
M!U[H;?=46H,WC5,OE8.`J`\Y^9*$^^K<ACG<]DD8Q<J&:)U#/-J+.$2PXG2U
M6.5P<FM5.)GC\T6(B,A4K;\'[8#9Z!0E"SMVJG3EUD>-HH'#="*E-[%;5T@+
M)X&D:73]F$V0Q8CIK!#J$\C4;2)/BV^#I%N7J7_R"8HB\$>ZN`D33R\*O*%O
MP56WI);OB(N:^LWS;_%2'5;%E6/";2$9)+U"9C[=C3$HOM^20W^CT8V*')9W
M69!'5\N3.(<A^A:_@O@0I`'M)LI3_H+]9P30B8UIC);($:$@\(XE0/`/#1B`
MX(`6D'?+PIJY;>EP4XHYKR-CBB&WPGS%U*QF:L8R-5`S]1/G:J_!@,$9#M%*
MHLOS?Y!J\@8JA#O0D7LA1$"8$(T_!>A;0#[FR(C[PT1"^/8L$:W160%O*1K<
MDUM-ZQ=&;(NZ-Q0>/OQOM_=%F,<;FAH<PO@QN$^X?IIHGRFAN(H'ZJ$CO;]F
M!X)VY#QD1)==K<!HT<)=AVM]I+@;UY1#GPR+WEC$?BN-0=ZEU-U_C$Y/WDAW
M#C!O>M5KHJ8=USQD049[1J>+%NK<_15APC]$=6C^XHAN[P&?Q7E16EBIO''N
M_%G.[,+W\3GNURTSFCRP6T+UAMFB-3IW-`6(\+:7DMHOB=(#G+_FT:[T3DJP
MM82#W>TO$0JJ!]@SNES2XD,C`M(%.]]Q,FQXVTZ7_B^4`0,V(FG.?K;-TQC?
M/)_%S_B?@GV"9;`QM8&YC-;H(B78NF0X:,:#&@")Z#8@YK&;39G9")<1C=Q&
M@$Q0XVW]/?X=M`P,Y`S\-+EG'5(BEO6QM<.Y/]*QPWELXG`>S]+A%-!^S_?A
M+=2/P\G!1.)P*FC^XHAN[W!6/BSMK%[BREWJRC/R6(\*E-LPKA9.JH@0,WQ^
MM68LV+@?P=`AC^OPKC9FTKB2$><^/:Y91WQK]]ODZ-T?X]+LWIM;E*Y;1T(X
M:M\Y\P4D;KC,6Y);8YB#`6^SR:CZ(L@ZS$I]9VVE[H]T;*6^,[%2W\W22A70
M?D]3\A;JQTKE8"(YOA0T?W%$M[=2O[\[N3:]$MD?X_(XVIM;L+7P5[.)S`M(
MW'"5MR2WQQ$'`][FD5'U19#5]CBZ2E=9G*ZN@Q*__,N*\@;&Z_LM(JGIE8<>
M)#>/(/01$H54Z5A`!Y-B2J`[?`YR8L2\-A:G31>G/3[-<./&46V8]LEQ[8W=
M>Y6F_E66[RR,4\EP9Q:J&`=Q\YQF@-1L<BXC:FZT/0SEJW9ML\K1X7:KU.7"
M"V:#O16+")WE!*K-=:=XM$O+5HB%Z*5K\_VL;K^4K&B$0;Y@MQ:P%!?>?M2C
M_HLEO[6EC*\P+4Y&WCAW64"<V:59!//2OQ*:=Z^610>?\S0`O2-/@]8OBM@#
MLGN.L[38)B5;#,#([!2-=GF^";$0VIWU]VVVUPS.-R4K&&-'MF"WYYL4%[Z]
MJ4/]%TM^V_/M/(WBQSC:!LDB#',8Q25NS?4("_RVTF!+ZL!QN3DU\!%LTW8D
M:(>"9NP<9,:`:8WTZ!+$[3;6Q(JWH<WY]$DQRG;#,U48SHMB"Z.S+*_*HAM&
M?E1@W)F[:F1T^BC3H0"-K0OQSV*SZS.,C4KHT,.YK:R'ER!:U&/44LZH3XA3
M`PSMDRS<8DL!)]VF95SNSE-$MS5M>'"/JQ^%I=:&UP+D+.BK@XU@S]=#:9HU
M&0R8T>#G>KQGQ\R$<XT\:=/%X8T<MWL3DO,EC)M\\.=-G!,DBQ\A_C.,%H\P
M#U;P]!GF85S`ZQQM"8SY$4\[C#:#1S=LM#7TE<S(#'":EKO?<AV)-<PW.<8H
M2^)P=P>?RW=(`?XJ$@YM`)ZWNRZ:_3UO1B&G!6GB51HOXQ`WSPK#;)MB[Y5@
M%<.BP8M53-P<)R,HGO.>C'#M\=*&8$YC7CQ54JD(7$'B<EO;+-IZNC?:[]V?
M%HIZ*E9`%X='+]O2ZA*6UWD60A@59VB]W3SPLS@-TA#)VAW&5JE3A\+U=\P.
MQ;S'^7%([+Y@$6X8@9PU?%56[BZS$I[$19AD!3((]!6S*2"/[R=,4>VK9CNJ
M.>6L\)W'758&"?UK@425-,`KA&K:"(K?\]8,5UY,W9A@WL];H>D^CG_DF:%&
MN`[T==PS%)T/O\`0F08EKH6>I;2]I(AQ_*\]!B/Y"/6X(%NELQC1QW1;P(AD
M3)]MTTBX._:_\RO_^]CT:,M?EM/"%1N(]T^Z(IVG[F"^OEJ2'T44%@[PFI`K
M0JJ?_B!?K[M[CN^W08Y\^V17V9)!PH3WM*TV,RA^=X,9KCW.V1#,[2UUF*WA
M7?!L87SKC/7+/!T,.=>?NB1QR:A%%,589CH"=(S7GZ=(,;#=/#4]:%N`'@]_
M:YS[3O,P<CHS(3[`?(4<@$6(_+V"8(P-2"29FZSZSU9*]>.9PZ!Z%(!AB/>D
M8`SJ.A.%.OV17M.>;',<F"5FK=85E>9P?P$2301[3#2BB]-@R`U,@A)&U\@$
MV-TA'`LD-%VATMZQ%J!\5^\S1KC'66OZ.3V8PS!'<G<1!_=Q@I0&+#2O!94#
MO5Y#*+'K'ZEZA/!V[T_UP_#;?36<&=T?J9%5!+!TJ>8[G8/>;UTM;^`ZB(D)
M1P*F/SYD!6SC;3\&!0D)15`8\1H'NM<LL%%6H!?8M"2[NX@%<R-6793!Z"X3
M1MU%4F$(QF=-(3-,>VRV(I@S([B6-['1)^2@<J3'\EI*W/ILTB2$V]L_11+"
M:*EUFC!GIX4U\3;.[M`[GST*P=6V+,H@C9!TJG!]JRL$FC!G)P2:>.L)@1%A
MW3Z(B$M2(L3"V]4;[;M$@P:*G.M^?;HX-*G?9TAF4HP6K3>H=%Z%`WSN-B%2
M/38HUNMRGPCLJC;S@^Q?=*03R]HX8T8`Q_/>,4-6/VE&2C7?+NHU`O\0%%!N
MIVH,G=V)UD5/[^#B4</=OJOR0^CDQU@;P.C=CBH#12X,=XS7_21#3)09(UFY
M[WU2&R[CO<31@CBCJ)T)VD:^@@Y-';+_,L`I<5?+*K\%7[;JFH@:0WVJ20WT
M^BZ]+C7<J<G;\`%&VP0A]4.0;.DCOC3Z?ALD\7*'ZT#0)R(V-OX(H'UVBAZ.
M?8__HQ';76WN[7T!?]LB,_KT$;)FM)+YJH%^ZW6KL.NS3H\0#E4K/=_OLOJ<
M7V^"/"Z03FDNY:3^G>9P?R%3303[YH\)79P&3^N(;NO1D*N4RM?!)3C*C'FM
MKXIS:X+Q>5-AAJDP!&Y$,'=58:5FF%&@LQDU.\>OP<S0"G4=CKRFKP#0<4HJ
MR5UG2"O#,LY)#:MW,(7+V,J(&0K7I_X<ACE'L8Y!8J<:]T.<QNOMFN9Y=CRA
M18'.AQ`ACERDJ^59$.?8)$,_GM]>%<17)I>B2,T$<7JZWB39#HJ?LXT]CT\U
M,/9:>G(T#5/<J1J"R.(IR(41OO8+K\'R!HM^='QO"9[O#EFN[S^(/,ZV2?0.
MUL%$PZBJ`>#9';TFR&M&9(WI[+B>\*(H8*F;7BD>,8-RMUR\>EQ2+=IEFJOP
MQDQE(BD'>G7UE=CI7QWZ</6WQ>$J"#;_0S;I.[PQFWX`V!;#NWM%#;!=^\EU
ML",5NK""K]ZX&&01\/8:@7UXCX$#%@'`8`#N=X#]KL("$#0.0(4(^J%%Y0#4
MR(`*&U"C`[R&[!V3G95!+QQWI&@F6)N\'-!D<KM?1^B%"V>_YM#$K'+E!C;+
MT*IZI5$>#+3#03T>_(PA``+"5WE0LX5R.6U`(L?Z8K'.\C+^O:J!=(Y,V'2%
M<T.HZ23B&CL*9$O0C@-TH._31;XL'H]T".'8,&D+R[*YR=2IJ+V)JZ6<4YVB
MNQ0,H'`.J&I&ZK>&A3G99Y^?O6:R=NZ6,R>>6^Y^3',89GD$HX\I(DC]I+I!
M[3Z)5T08WP6(H2&\?8"P1$**E(>(URU(T('9,KB%ZGN##E@^C]V#J>GB;J-&
M]A*6QT'Q<)UGCW&$,X@^%OC&A=:))Y?59?Q(7@$*,SA@"3`(4,/`EM9G&`R(
MT\]!`PFTH'PS7'_1//Z:DLRXO'X$XZ;^<O4".HU.@K)A.JVO75&"4*&`X2OD
MUKY&0U_CDMOX!U)[^_#-T6%5?5L,UM$Y+T1`56";?@S0UP!_[N6V1<D4+"+R
M%;K<U](SIXT*UA%"DH-["T/T:2VX7$=+XP1O@>,SG`$/6OCS/M.5Y#$^Y#4)
M[B0..]CE(__S`]5U=)%'0HMON&-._@'5=*"7./VR7'(.Z4;UQH6L<>V(L]5K
M\:;`=DY']/NO3[GW\A48@.D/:D#[>J6!!;JI,#Y$PW#A/.Y;T<ZIZKB!CS#=
MPAMDYJY28MYR[C7XY4_(0,",/*#QE1WXN?J7%V3QP4GE(GF\TZ3,RPW$GJ<E
M.MR*."1W]A/J?7Y`MID>D/E?[$&@(NS$,5H>%TW;OF-;=X'FB/`\9TFP&NZ=
M=,&YB8'TYA4X(\TW`'_D*?PKI'GM?/17XCP$+TJA5N>0`SJ"'V?WLKU%:^%N
M3_G"'<=KFS<(_&KS=;F)*F5$@TL50&Q[L2#_%&RRXB^`0@88]$';F#C+`06/
M6(K+&W#/=E^JVY9"7-X/([=CXZV`B$X/N$)BV_#G]!F?*%6C'['Y1H>2CF?,
M8%"-GK$MIUPSWYK3))7;S8T<A`UR!7;724`;M-5=ZC\6<+E-+N*ET#"KAR).
MX<&T=5T]_`!0``!#\'S!J;%&@>^D1QJW'%M$OVP+6B[B+L/.01K&";R$)2U2
M?)$5Z/>\H')3,5P=AV?F`&4&FED`#M#3><!G>*;/\9\E$?MF3D'$WL\EZH@4
MY%ZYCLXAYX:7_;-#G4._`4IT1@NVSI0H0`M8E"GA^:`WIHO\J+<DL]-;@`;9
MT^428@&%35GTFZ"$M:#'M(Y]KT*V2B@:J+6"07`!!@RZD*7VGU^A,">,7"IL
M"=TYD+0=<-J;]1BIK1R70(_@\W_#QI2Q=\3Y8!U>$W(1$'CF5>O=ZF-`O@;H
M<V_7A%*FU)ZZ>(5^%,1)%5-&`DL349!68VH`F^N&&B#1"10D.3H8H#-6"T;D
MD&L$"\JZM4YK!!N-Q6`GXG2'N\SW!^!]CFPE[_:B;$T\=JEIX#AFCQ#)<6N@
M$TC_/4^O<[@)XJC&M')#ZX>:\M2[&AKXK(;W.;+U006R]M_)_B30YI)[9T<%
M'H.'T',&"5E-T\_!"5D-I/DG9'$6;9"0)229TW!;3_NW;D.29$_X<E=+Q]+!
M!XP?UHSW&EK36)],WRK)\K(>8!G4\IWZWI1!Y9-_@&51C]D+Q[W;$,@/A?$C
M1M;45&!&^I86Z;+TSOX>'5P>\7UT:FUXC"1M9<R:YIRHAGL.W2N7I\<B+DT<
M;R"$0YQBS8#S)>ZW))\'<:0J2I'C&!\NCI*E0;YC/Y*_C:B@`G8$N8]!2KN"
M##J@NU]2X'X=Y6&$$1@$@TGMU+!;A.%VO26=K4[@)H<AC>VAGQ-81879=US"
MFRGA?4X+'[`3'(!F"N*OL9,<@+T+OH/N#9]?H1F+8MS[FU&YX==#8$(/R+4Q
M\@[0]_/R!KIKT?($>,MW?9E&NC(CN;C!A522*C0@XD1[84J&(3;<,$D1?O<<
M=R$\-DA6[)KX[`862W_[C?<H%8L,7\3W%^14P?0+$LNK,>/H??NMX#+72YBH
MMQ!N.$BP7,>VXUF<QB6\B!])!<O."V[V)*IVVD\PR,_0_"+.4&B'!%S_B?M!
MQPIHT[$P5(#!>G8)[&C!8^X0JCJ]6!L85CC+\B6,L2#CZZ*V!5]QGK:=%J8.
M(3%(4#NR18/<'OAKM^:,S%.$C#1Y.^C=\!GREX*$RG^X;?3D\)?#^X#=9>D+
M,%`]'J:?UZH0#?!F+FCP9_\1,6^MKLTQ"Y6+OIWB($-C7MY!AKX=Z2!KJ#J;
MA^3DIG1(N1<"P.\)HEP?]PC0I(K3L/)Z$\0YUAI7.%RVR8H@N5I>9.F*2)FP
M`"4WTMS`PH\X:FC8,<#PJMU;;UF-I']?H6@+DG"CT]:D=>KH28NUDVNHMM%L
M_11%V+L1P\(,KP8TCWD.]NX.F6^8%S]>][0-'7ALMZ>G^TH.5>=@:8E$M%?I
M5S.H:%CA*[2O.^MQ_$"*A)&O@[S<W2'>%D%(K'.#Q/D*!"`P``MDKEGR!HOF
ML<R89HZ#,0+\*NN*E%I@T?XQ+A_8(<9\/JA-UZIT14<$GA!TT!GJ^7'<(-H8
MB(,9N5T72>"^W#1Y+2-]%JO<^-Z,7YTU"VU@?8(Y?P\E,]$7(4*XB*7!<!W_
MA87C_1I">\7&'DV?7,ZYB?&X5\?<[HW3M&[@.D"^>+HB605((VV#Y`[FZRF+
M6FDFZ36H`08W@)'S77[8/3>$AJ(/H?!5S.'[+3H>89[LJMQF_')HF>5KR^=[
M#3C0P`,,0-GS'+^O<PSHP)4;>X(Z-DJ87(A%&O5/7!&7V4=6=0808V;Z.J%4
MR^$F)FB1P.JRI'J#M\USI!ANX`:'7=/5;1F48]R82*&[NS:1H:%X44G'@&80
MH*.\7J#H\&SOC:5XZ:ZMF$OXQ!3=S[,4_1B2DZJ*'FJ&9Q&<3H>"#J395F$Q
M73TWN<.*@HZU]@>8KY!^8JUF7$*&!([CO;B(NO12!:WK;-`2/`Q$QK^<5:<*
M.UKP6#^$JB[O8<QN]BX1HG=/,'F$'Y"I^2#T1NWN33%T0,$#"M^[#3",/,.O
M4OD$=YLZSA:;641-AX`@1@LX#C9Q&21,O=<3>%_B$%E;1?H,DAPWS5)`[0P`
M3X%3=ZI)#CIU=/$\-#C)U/"NIO)Z<(Q%+Y[PC,L+MWF=Z/2K4X_INW5%HC([
MH"D)58WYW+MB$"Z':P?(U^[601<K('5%-JE>%U5DFYGBEM=DTZ>.:W.<)&J\
MARF2HP0_$(G6"%7<_1'7[U$E_9,R"=5@^A"G,WP>Z?\Z*^3Q3)\R[A\'[#T7
M03_LE7#H!`/3J&Y:SD_;/,X*LR<V^.?F#XVAU0D$8VFH9ST`PG@QGMKWIIZ"
MG#R!FHYM+DU[7&8"H8;_P<&GQR!I'4^E'T=J<F#1(#\PXV?KL&LMEYLXHT\G
MMYDRW.CA6Z/+W$5)WYZ2T#BRKJ^#W/O+2KU(JFCUW>B(>?'W$UB$>;QA7S^-
M4`.>A>I$2$2S*PO",]_Z$0,5-WK5X?=7YS@^AK1Y7%PM]_J/Z@8_R6C2'[(9
M/UL-JK=2WF8UH9'E!JX?&=RA[X9OW`XT%X?R_J2JAR#X&^^MXUA:[S_V:!;A
MUGOE9KDRS4)$*:62#&%F]/P2@1GDN+:+%CE>1JLVW0=GOFM5:3TT-*AB]4D^
M171=V6H$J7%<91^=DU&<;'&,HFVM>/H<)ML(1CCI%!,"6>YX%5?+TR#'&3X%
M6@RA@[QH#PN<Z60):O`TSY>9@-3'KJ;`$DPWPD&O?(^G6BQCT(H;3Q^/"4XO
M[8(X)\VPKI9,*E!1YEOF;ED8PT6#:4,RS'0VEZH!,%L+56OAW+"N/L6<'I9-
M!5_=IVY-Y7K-EVR>:JIQ%\5CC)P`+C<54TCW$JV1YN'(`^I-(:/F>Z^[@[L"
M8<"<OU0OMQK(;\RWD*TS?JQ%?CJL6]'[>(\1OLXL^<+$7)&3PK&-DL/@:GD#
M@^04.10EK`N1"<T.]#T^5/`(0(<T-=X\ZR314KA6@7393G52?6M,:W6=;;&!
M^R%.X_5V71G!Q<D6JG9+K^07!00J2+6G4P`$2YZ&XV4G&1&!N[,LR.B\"37R
M>>A=$M$#UQDR3F`9Y]3YJ:Z7#!YX5?"8*OE=D,V=G_J1IY>6:I;DX+%_&&F=
M5_/3/@55YY[GI'G)AI0>;S/H3:AIC2L:%,[60-==-W<S&=',K;W2Z/GZ[:[Z
M1*R_]&NX[^,M/<2ZBYM=+F@5BVXK(@Q,^JP#]G,H!F&\?JYY:4?$^6:%XWI/
M=T_9!$6T$%2_\28;.G#C3_8$G7TET+N''$Y108W`]>['6])C)"%H23NSUC*%
MXC[F/:DS-/657:%[9T?1L;J>F^D%W7@,L+J.&YO_3LV8?ONF@A03+V#^"(MW
M05)W=.)E$G!Z6M%[X'K\`:@@>-==6NODL=^`0&YS"]K.M;35!KQ%&"$A$LAK
M0O*)R-T=;FJ[2N/?D;02D<0YN>KGC)W^P=64H)I3F"M]`-J):3BTGKK2/B29
M6MI0U&_%@I&)RU4PTW)R!DT0A;W6C9L@JGK<SZ@)HF8#>U.2.54R"!<DE449
MKX-2S#/T%5$*]7=SKBS:71&/(;PUS^"M`MG?^]VV;)XL4+7+:4GF.1)GLFYN
M_I\QW5QRE?HVBBAV[0G.)(#=P9D;ONDORD?Q/U'ULQN(G_I"\LWM)HG%17-U
M2L95T`#]EL+SS2'#Y7.M#QL*NL^B':=:V#GN/Y<6<4@2H-Q7BFOFIUEGWKVB
MZ4@K]*0G9*3;N-!^!J3F11DOM72VMV.*-?*8K$46YQD%56;#74:JT.30N*MC
MDQ>"KV@H#.V>C7XN-K67S+W:-"28TP-!RTV^Q(4^"AQHPQH$+834`^D^1+[,
MRI]@V3K1PCVK'^YHIJ4'`7YWCF?N/R#'Q87!#I9,2,3W9I^*K%PU,2T/G79:
M:>(W_%40ZZDZPBIO?F=>\U,L<M0@;0R.>@I93,US4,V63O+HV3#JNSZ2$([K
MF%Y]&Z2R,:-F69A<OBJNVZY!![>&7:_D19LSF17%<9#GNV66$XUTDJV1?HI#
MHT(D3`XJ@@<Z``]`#7)>[8#5).#QUIJ27JJ4]U0'U1K(V#E'!$OQPRAL_2C>
M%(GU-`5'C,0&(+$<B[F^,;(@B_X-J@9U78M!\P+'0".WSY`T6L1X?8*DJ9#5
M1+`L6U!5]47ZOCJ5JZYK_6?=@VLWR^9P)51ZZ"@J.9.1U,*K(Y'<1_J.9<N,
MG7MEG574<.I+R@O)JS:_NA#_;-2`WD)Y"L&$1*[#_QSCGPT<LL9_F\A1%-LU
M_=TP-VPOY+OGAS'),>V$4J=L-EZ9/0EU/;2A3'(L9_OWA^=I5=^G0`O!Z.%:
MB[WGBA*38?_N%:?CU2!!!9,6I^P_[/1O3UC00F!I6%/5Z8U\4S,8B3`65EKL
MH*HN#"/A/1)3CAFK#GJ*T\&@&>W97U<LC>^R:]'#_0NF$,*(-*FKW@S4R97"
MG5B/H45`ZN<5S3#O]W.R-7'#]DH:.&:*YG/3\_3N*<-9WAK/E!0/=P_PRUVL
M3A%$DCSO_9+>F`8\SEH2DE&3AG[:69S`_#@HX2K+&Z]^J&/6!>K>$^O,+W>]
MR*>@_M9;_3D),[IN57]I`UHK76_ODS@\2[*@'(OU+$A7509[,\M93C\$Y$M_
M!4&%'.CR>W]5,WL4(WH3<;E=W\.\<@6*Q;9\R'+9U>L(J3ATRL9Y*T`[ZPRC
MJP-HJ!]['<PHY[=EO.*.#8I-N;+C($EP#C6_N;M1*4Q&:MJB<10^EK=ZAF:$
M?V-Q((VXEOX89'?NJW??$S)/#>4W-YPGF>R3S1FG:2F7S/>^M>@T*-C_0Y8@
MQS#(J74R6F_&?;".)$R(@-RL:#ZF-N4<VC`*^-*U,'B+]%+QB=Y(X2MCM7=8
M=T?"7_M^T<!9@-2UVU^GTR0F61KX)7PB?RI$#T%U\N=Q[TL*Q?M)J;=8KCEE
M0";'YQ[5XO*G);XKSQ$D>'1ED=^S+0V/G!NX(@V/TO(R6(]0'I\+U5E?"][L
M\M.F_1;@CSUQ7,6/[DG#69_CS<-D*C%7#<99XIU\KTY-,FE]+,_;TG#QO/UK
M1;]/(VF<G@!G65[]"G\GO!%RE$G>//-<8O>TQ>M3S3#G\H`GISZD8&:1.56Y
MDN;":#85:QJ,+(O6S#.Z-RH?K$)_$TB"8UF76>/T]VA'5GM]D/-2_16KTQK<
M##K':2_=V)41$,][T]#WN20*P,VV)R-\7P'SUZ$PI'HK'G"A]R-,DO].LZ?T
M%@9%EL*(,+CY?JA[)`+O_H97@(G<9\*##G_%HT`]C.[XW+O[I&!<UX^2+=ZI
ML2TT_(?5$9Y?]J1ZH8(T'2WRN`P`RNN<G<!H&Q*C0,0XC5IP+1"O]ZZZ*^5Q
MSHQ*KM^M/<(D(W)T6V+S+"UAOLECG&"YC,.X7(3A=KU-@K(^\?='B`_6YCM`
M/@0M;,Q6`ATPX&LSJC?0\ZNVH03BG]CCD-W#8Z>][-L3N,F*N&1:XAAF,%<`
M0"_8/)-$Y?X"^1>CNH2QC517%9/.XB(,$IRM=YI&)T@^AIMC0L@N+3$1$@(C
MK/H<T.]IP6,T`N`A'NTO%9-JTTNZ6BN3O>XK2T'6D:5P.\+]N1BTLRL-(0JJ
M/L"5?%2133+$Y_LW)9?VVP3S%^P^.P8BF&5565N2"T,^J^N0^PUV["$MR&;I
MKZMC?VEMOS8X@G8PL<BQPR'>=\N@N"=+J@;2S0>3LJA_L[\+!3.XK:C6F5NP
M[YJ/*J_+\U-T+D.Z\:S>HFS.YQZXBSB%Y^A'B?8=00K:69S7/NBAH!8(_"D@
MW_['?Z!=R"BN='17V6B(:AGHK[_62T&_0O^%KR;(WOR_4$L#!!0````(`$-1
M<D*'![!L`#4``$KI`P`5`!P`9V]V>"TR,#$R,3(S,5]P<F4N>&UL550)``,]
M($=1/2!'475X"P`!!"4.```$.0$``.U]ZW/;MK;O]SMS_P>?G"_WS)G4SJ--
MTFGWC"S9J;L=2[&5I.V9,QV:A"2T%*F"I&SEK[\`'Q(E\8$G`3K8'W8=6\):
M^*V%A?4`%G[ZC^?/3]Z#`"`G!M[)_>8$#O]?O/ROD^<GPW"YNG/AR540X[^Z
M,5P#_+M@#1#^-_[[(HY7/YZ>/CP\?.?BCT8N1"`*$^2"B/SBY/GS?YV0__W?
M__,3(3)$@)#X\62Z2$X^..CDQ>N3ER]_?/WFQ]??GWR:#D]>GKUXE7T)?\.'
MP=_W3@1.'I=^$/W\K$3L\1[YWX5H?OKR[.S5:?'!9]DG?WPDO]C[_,.K]-,O
MWKU[=YK^=?O1"%9]$`_[XO2W#]=W[@(LG><PB&(G<`F!"/X8I;^\#ETGAF%`
MP==)[2?(OYX7'WM.?O7\Q<OGKUY\]QAYS_Z5(7=R\A,*?7`+9B<IZS_&FQ7X
M^5D$ERN?<)3^;H'`[.=G\W#]B$=Y\?+%RVR,_R2_^1-++`I]Z!'LSQV?S.1N
M`4#\[(0,_.GV:CN'.0C7SB,1W2GYTVGM-T__I9:U/R<.`D&\`#%T'3_BY_1P
M(!6,7P68#7`7XY^7F!8;LX=?)@Q*X?!N@6>^"'T/H.CBGP3&FRD>XF6(7K4S
MV/!=S)]L_(9.M+CTPP<VX+;?.I6V4&["&+0SD7Y*EAZ1P<[H:)Y)GND9+=TS
M64+/1J,F>R9O,>0#TI,NP)9*G8'\F5P-8Z4N7]>8.9"M=>P,*-`_#B;4:"(/
M(_)TDOA57N)3&-OM)R6",'#=,`EB&,PG>#-Q(8C.-^E/FW9^&KXK45VGSKT/
M*+R>TF?EKM=L4$H%*3XL'0!:#=U^6NIZ+49E9$+J>IV@<(6#K8T3>,0/6Q$7
M,274SE/]5^6IRL#W\S`HG-V`&)-T`?"B&0J7$_P]@!#P[N+0_?L2!M@EQZN&
MDGG>@>5-+1U]O"(L#$C@2WQ@.MYKORG+>@X\#Y+1'?\JF(5HF>*$76,7H``C
M4:(?T<+-.J)$%;^#\P#.<'06Q(,H2I89F4\1\&!PZ4#TV?$3,'1\-_$=ECEQ
MCBMMBR.8D;#>(TD4$$0ID8M'\B-@T:3F,:2R.TF0N\#DOC@(8=BF^/\BDO5A
M`)UJ&&EF>I2;@JGSB&4,X@@;NVOHW$,?JS.@99IJ%$F;VRUP\;+"(^?&+5Z`
M+`.`B9^#`,P@K7VG'DFB300^<''H_3%Q2`+0W^36U_%'3NS0J@C%(/)8)JL\
M!0C+%%/TX6R##5KNQ=$J",T@<OVO$8@=Z-,Y'OEG53!`Z?H4'Y;H`.9#LC$@
MV0$L1F5D0GK`MAV8E1&Y283=L,Q\R$XGE$9FYT6)GG*RHDIC>=E1J+O<+"G3
M8GZ.9.ISD>&@-?D'GY>`S2AT$Q(=#G"D&,0X7"D%`13>4].WR]JT0B#"GTO_
M<(WYV>,4/,8@\(!7\$J&9B]+;86"R>$`<H]"&E"&J"#@._?`__E9W5#1X#Z*
M2<E3J(RU&Z4$!#5O2?1\[CBK/[?%H=Q=*3.4(Y26%6=.=)_6%O,OGA)&3X$?
M1\5O4M:?G[W(2XS_64.AT"E^3K%\P17^,5+*[8[*/KQE31N@_0DXR"UXPC_N
MJ=EQ?3;_Q.DJ+2(^=Q?0WVHHR44PZ$\<U@LT1!Y`/S][\=V9'#T9^DX4C6=I
M,#9XA&J%<$3L]%]Z1-&\7"KQ/P9*4!1W`.&(<9"?D8"8_GZZZ@-8W@-$&6Q1
M#:5-\ZFUCB!/BTL._QF&_V15?.(ZP[:6UY11'$I&(/WDO@*R+:'R'$;ATH&!
MBK530:4?8FR"Z6CE&#"7=@M0VJCR";S\KN24,RM0ED"J=A[D*,\!A=)>K1/I
MHPV_C/8A*+)6.9NGER`RFR8!U7EWE=_<T=>`>_4L".8UT]0"^=9<.-$"AP?D
M/Z04M79\S&$TB(<.0B23EJ;BE1A:*L+EU=ZEZ]BDD'O6E@X^?A'[HMOF>Y+G
MCVZ!"S!WBF*4(QI:%B"UT(XA*6V0_/+A$@_VM58.]/+"$5:E<;P`*)M#/B$5
M$J,AJ\M5H)8C%78EUX%;M`+NAD(95DE+X[['H,G'#LBAN'@VPS!V_&LQF14'
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M!B6-64O,$DI`^:BO6MG5$-.<`J.77QU8VMS(40*FX2WPR>&+B8,42["!FLY4
M-*7\FK"2D;X4]F442JYVT?5L#VQ"3<!!D9#3'(;+)8R7:5TJ\(9A>D,2!.1^
MI)*Z7@,Y3;NA#+DVHBAAD7*>*NLRP&@.*?HI5HJX@B>H/SSPQ%T;+)W#4E:)
MKR*C^^@*BPPK8=+HNQ)3$09J979$0^L*9#>E^_CH*A3M[M9.'.A=!4-G!?&&
M6V)02;C13K5/RX\&1"E>+&\Q8@W\,"U*WL7.'%R0?FDK!",P`C/HPAA'3\DR
M29WO48+PKG[X#35E"V&N>K3B9<B`8S=^EZE0`.9DX&O!>.AXRMTX6?KC(5&7
M2F9>7DE:7D<Z7G<PQ!W6UB"8B_A[*4'N3Z>'-]**/ZB_J7;8EM!>7+,7U^S%
M-7MQS5Y<,^S&D[VX9B^N&6D!KB5?7&LXZ5<*G`;+$*^"KWEK`/D*QL&%,3([
M<ATH#U+6PBLCO2@A)XQ=U3%*9^FEJ;0)0&E_:/5IXEK*YAB=1J'3XBCE9I`4
M6:<,18,D7H0(?MT%.>ID?$2Q'^NY#;;.;P0=,+13,RJ?K?[;9HNC8=;\E37A
M='"5<EQ%4=+=>LJI:4[?\BZD`BO^C)Z$&Y-'7(V3F#P#XL%@WI48RR1[*LL]
MU/CS=Z("+56*NO1G:,B:;6&9`,SE^T/G'FN)NRY<F"9RVE/NC-*L]5W>Z#W6
MH'K;K"/5D]BB%JE<>F]U!!-'3"G>,QOI]56053OF.PG2[+K>=?BR%?/EE])8
MVU&B\6R\(B_5D6[BW*6NEN%$ZO>VXM6'BA>=/C&5OL2D<.>"P$$P5%[UVB-D
M1DS1GNS>1V<?>C[<\P$_!=$*N'`&@:>N:E)/S!C7OTK]]B11CU<I2ZW[1*&V
MXLDM6(,@`9>8GZSODPHU.B;2BU"C`AN-YZ9S8Q_,\Q9":INWU!(S9N$WBJX!
M+#WWH7<Z%0$\6=(5KW2(,^=2S=IK(JBY#4B;2N^OQD;D]/5SR1Z@]C%?`V\)
M`TBF0-Z;5BC4-I):O2,FJ;:"I[/">#233DRM[LV127X5$`GTR]H[ZBHFLBR&
MOPXCM4(KD3'$AZ3;%\OP:!%8VBHHXZ+HB<B2$VGXNAFA8:48FB:M_3[E5;`&
M47J'-^/PBEQ#P;]1L7YJ:>E91.W*6%Y$]4!)<$(X19=QH-#E."2A*PY@%=4!
M,!SN1.T]*3Y9W81!N&^%%4JMGE@_Y-<`EJQ=BU.*(%;K8>P3Z$E%Z``5B?WF
MV*1T[D30)8$B]!-R.)7%LZC[KN$BJ)VRP,TS"?F."R=]ASDJ3EH<L*EBY;21
MU.(?MFAD>1&U0B8G"<DGSR\`SA=D`FMLE>?@)B&72,:SE-%2^;<#,7-RHL?!
M9!`_+\+2'FGHHMJ>SF;OBNP4#_(R1*^>L3Z.4U,;/;Z$FUVF!X%;TP:(L?I.
M14!&@=46Y'M3D&=1.H82O9A4,D:&X7(5!H1-Y87Z2H*&9,?:*ZS5<$DZ-)'=
MR6R_H"I)(@WD3*G`-FGGGGR:H*NNY'.?`%0GD6,B?9-#!4PRK%5-FR1UDF@F
M:(BUHA5*"WJ')T48+]BG!SR3^\A%<$6H[)X&8[E;WSJ*.0%V&^P4B,C+YO,V
MB-YVC,IZ2%4WCE*XOM@X,*-H0[W>&.$M)<)X4_P'K*D[\U=-J%_RJ0&KE`HS
M8S[=G?<;>'\E6<TJFH9U/0F+UH1!C.!]D@)"\KE@==PTH<;*2R!CAF0J<ZPR
M0-29O+-%"_JBA98#1]]R$T4:435TUN.H`ZYP2!F2_`V*Q0X=J;[P=WS+SWA!
M55WLXW"&JT0DMKHRGC)W;9*.GMX$O@$/Z5\49<9H"/=#L'082NE_(%7*F4;J
M$/,AY3[96@H<I=6752SK]+1)UTLZ(]IO,9?1D]$;0<EJ[EJZ9:J&9`CYE_"^
M<#E:)NPO7^E+-_OU98CN`%I#M_N=^9B!?MQ]8@151M<%^4M;I_3K.#`X,\&+
M*7^3!BEIZ@D*70"\B%RQ)-R17L[CF>('1MJ)]F3KID"O2&9T?B*]R0AE+8DC
M#"?A=MN>^`ZX^).QHH?7Q!CJ[]*G1;S0%,&\E_R=P"1MH>6HSZ$\->J%QO"<
MP%<?^0W<?Q(8I1GZSNW)'NW^.XW[4!9B%VM/*M].:!)X!?'^;A952!;RYKG%
M(>6!@";53/\V3DMKT<4C0"Z,%*7@F9GH<8*@"=I"'80ZH<I?_;H5H8F+7N\`
MC?`6RL"1&I02/Z9LI;UYJA28<'[O8$;)01`01"GF[Y&BVC<W+WW9+KAP+C1$
M1TM6FN,:V5&^E0^57'-GY*`'FL"*:2%_P::N\C<,TMP+6Z`=K]T[C14L]#]P
MK,*U4`():48%/N0D0>X"FZ_Q+'O5IFOW\8A^WSW'8T"+,SK=/PC4J*L:)5_#
MP!-P%>NE+]YR3]:INC_/.CQ7UPMI'L%3"(W[7-U%4.J5(GRL3I'$>M@^_Q"5
M0E#<I^O*@M+1;7WH1(M+/WQXQK&_UUW$+<:4TVC]>#3^LIB]U-VW2]VUNL32
M9-WV6+<]UFV/=1,FT]V=JZWA(`<TMITW!VX,UVD)E6UOHAW,&*VI]&+H,=']
M+O6W<EF*54O;KTYUV1U_+Q]Y"]PP<*$/,%^$HVF(?R#S^Q211WU$EZ`L6EKV
M51XQ2P-76L]]SK4\`IBJ"U.<\<\^2`$/E#\*3D57BSI(7C=EHT`'MKY^_?LM
M9`:NBU(.Q[-;X(%E6N,<P<@-DT!)38B%O+9-0:%Z,,&O]3)NWGQQOZZI+`UU
M3$E3,4BA[.L@E?'F.*MSOG"".8BN@BQ+C>W3-73NH<_AF5.-]'2$28F<K`XX
MG`W1L5G!>C8"V7^O2BUZE#CSS03UA+Y,*K[?-;T1/8ZM6W(/]6,&\:ZR<B#I
MQI-R4[06#[STFINZ\AXG)[U7"#J\]7?;/^:\8!F#@>9=&8-#HOJB?7DJ<`0D
MQRZ^+^VIC&IO%:.K,()QYY:@@JZ>T%^FS(^AY-CH:Q:Y)'GCF()$#]'$V9`=
MBX2>.,I(0'G:W6@`%2>]WPOH\.9O";(&Z#Z4D`6J]85W.<QI2-SA"0K7T`/>
M^:;6,59^6E24OWY9&KFB$6A)<OCN"&_I0*,:,5#7%)0*EAQ8]4#\B2"!NE_V
M6)BDNE_38#VJ^S5BHKM6@'>QXG@[N0>'`%8UK%SQ9N([08Q-&CDCE[9X59(=
MIJ=NPN*ET.Z]W"\#ME*S#.+M*>X<'XQGW>H"`WDSRL>LZL""KYQ2@,S]O&*V
M'>[G5=1[:!)8L#5A/[^$@8.=4SG[>=-@/=K/&S$1$)J<_=SV&*I?K!3:S-=Q
M2-NQK6H6#XK.@9?]`N`_=JP#K9QH2@=)UXIVR'46]VNVG8J9=[BE5U$W84MG
MU`<6;#5MZ06KA$^LFN0_Q-5<8R>4)#+3>S&'B4X5BL!$WY`#U)7^`!^@`F<$
M]J0O4?8#K+L(;;":IG=9NQ/Z(>%>7`6GQ)`_]R^U`3P5MVIN&C+(_(E(O70W
MD2,17W&'E+\@C#U+'$R2'A5JRGZE\7NQ:O<1D=/>NZN;HS=A#)ZQAP<W3IP@
M[)7F=8(PB*:8[+E/7%.6\)UF'/OH[Y.\'\J@0IV][6LOAC8A;B^&VHNA)EX,
MW0;*1Q9%2;+AF$I/_,PJ?"3F%SOU6<YXVEO<P7F`5XU+BF'9(2O2;"?TR9/R
MG`X,XY"VT<73<V3XM,IVNS!C$[).C75J3'9JZ*R+$MVBH]P3YX<6Q]XZ1,0C
M8M*P]^$:H(``E[8BYG2`VD<1:S1J_1Y3_1YJ_6%Q=:RS8YT=Z^Q\:\Y.K2D1
MVX+,T8M*UZ1AUI*/?77GA*1Y&<:>H\LES.XJD48E?A@E"/#Y(I1#68?D:3HD
M;)IDO1)3=A'KE5BOQ$2O9'L^I]&N*#G>U$S1&,5JS+BTP2;-Q^G8P\E*3TR:
M]`&@.>:Y_!+@(/`P*FG[!_+/'4*<>1A!$A+J#-8C,LXCDJ-W3)Z2=92LHV0=
M)1,FT[VCQ&=N5.@:)R>&2*[1K>(%69:[U;6W=<9Q//GX#28RFFAZB7U4<5?%
M.E7&.57<RD7O1UDGRCI1UHDR83(:#OS0FA<U2YN6N!G+O=%38D!27KVM<_>(
MZR3T!`11]HQ$VGMT$N*="L00I:">@P#,H'@Y3IB(=9^>H/LD2_6L-V7"[F>]
M*>M-F>Q-\5H;%=K&S8L9QJ#1U^+'N<^N%_.9ZZS_\M1Y%/6MJ`:RM\V>GOO$
MHD'VCID9FYIUDJR39+*3U&135&A4([V>W"=KQJR_M\AV.24F5;H%/FD2/G%0
MO)DB)XCP-K1?B^3S<WC&M6[/TW-[!/3+>D%F[%K6"[)>D,E>$(.)4:%@+.1[
MXB,Q(=IWEXGC6/C'!",#D+_)>SD[_E4P"]$RY8S/7V(<TKI*3\]5XM,JZR69
ML:M9+\EZ229[2736185N45+NB6]$BV/OW2*N\]O)?03^23`W%VO`W9JH?13;
M">!IND#4^F.;`)BR3UF_Q_H])OL]M29%B3K5$C-&G1J=FP:P>G?K_\Y=`"_Q
M`7MZI_CF>$9><,FD%'C8\?/A;),^W)7VH12ND<F@8^__/TD_2)X&VB8`AFQL
MUE&RCI+1CA*_S5&C</SL&"+#9E=+!.Z^]00X[MQ]ODE_VK`>Q&YL!R[O!1#K
M7SUM_XI%BZP'9<B.9STHZT&9[$&=.Q&,QK,#BY)O=$J=)4K*/2FQT>(HN\1&
M+?`16`,_7*5+)G;FX((\)+M",`*-LJYQ1.A',\-05\J.`9*2X>Y6;,5,/D78
MZ[Z(8KC$,U*RSQY0,,0B-BZZ0U!*%E$XQ&#OW%OYLG8'AI2.<'F+,%:@E!CF
M<GXEZ<4"9E%?.A"E#Z6/9Z43%=@#3Y8[?E6(FHYP+T1-B6$NZM>Z1#U!X0J@
M>#/Q2=P5>$0MTQVC@X5-3=L89[Q1XO10YD+_7DK=CEKD:3.!012!%JM=XQ(U
M?-U@'ZAITKD8?M#F]%PM5]A*$-['*&LZZOCCV748S*_A&G@4LI)TAY2'CUY8
M83Z$<\5XT[51QM$52C`EZ-Q#'\80<"W4]E$,CSDI8,@E]+9;"UJP?^&@`(?`
MT02@NP6>;`=+M(VDP2:8&K5<J._D=*_AN+.V!D$";H$;SH.T^W,'<FTG:OAB
M94"O2#)(*9%QB#<">-(D_BHE1BX>5R`H$B)J!-Q.MA_^+16`A8PE9)(XVV_$
M3C"']S[(]G8<>\$8I)N].AFW$^W)(J9`KQ!PMTDHO&?`T)N&V7^'(7;K$(S"
M8.<9T/M'M&.9G"&DQJ,0E[9<TK:W2Q=Q3!TMDT79#E0A0_$D$5]%ECAKYTX$
M4CW#QC[%;KS*C\=@OO'4L(D@>0^%N4$>-GK@%7.A6VB$>`:)4R=NP$.I%(C"
M`/_H@E)FLX/5SLQ#3S9A=FP+=1#.9'5YJ3$]"Q#Q-%QO/"G$>>R?;4C;ZN$;
M.W]F6ST8?F[(GD.SY]!,/H=66QS44V'M5VA$`U[?CM_O7"#FQN?V13[K!JES
M@^R+?-8/LGZ0]8/D^D$#/_T]26W-;D",=W07`"^ZQ'Q-BMTZ-3WY8;E@GO+&
M>/)!E(@A8JETAL01E/LZC,!EUNJ<9\I\EOB,!FX,UWCO:5("V7=:N;DR8V]H
MSC)+P%[>'0$VR^%YZ7&"O:9NPS!P07J<I,PYC\G@'MWH\V\"H&F]9%"EIQ-G
M0^8Y>'"05V9\=T<[BI)ENP:HLQ<"'/:D)B%;+A)O.(@JVL5RY8<;`.X`6D,7
M5-O'\N:;'W'ZBA'(J^^1ZA96RI@UV>'I0%2R;E^(VKK*F/N+@Y`3Q-$8W<+Y
MHC,58V7&Z'U0`M;2+FMTVS,VSRVROSYDGU6T*42QI6F?5;1Y0YLWM'E#-9W0
M1OD6C.U+=DAY$)2O"G49`;*Q8HPJ4GI*C$!+;48K$L_-9H!DL,!V&[K%\R:1
M0.!BUK,W`3I4$@Y^^J8I/)!+RR;J<*KM^U36U3;"U;;O4UFGVSK=UNE6[70W
MVYD.O2D61GI76V%"N8^/614'.9WR&<Y4K3E*.<5@Y0.A3/Y3XP#V.:NGZ3'1
M:$T'+UG5'FD^WTSQUU7Y2S1DC=F]:S<\*O`$!87M8XC([S?;T3^`Y3U`5*:E
M_MNZT650/`)Y`PPR3]PSKY]KX$2`E/&NEBL4KK/KD54"DK-NFLAI+H`R"I0*
M0*$@,&VY=IF@`,8)`I?PD?PG*G/&L)"H!^O9NJ('2>MYK/J;-_C+ZD)+&K(]
M$S@3HJ7C47W)9<B./6MQ>H_"J%O?**.H6]\$K\KEL/%OVKY8@6;@NLDR\?$<
MO!'`E-VL+(!_]D'>ZV*P#%$,OZ:_KYV'"LE+XZT79Z'D28*CAO,N4Z8`S`E]
M19O3#5"B)HWT>I)L:L9,P-<(8\?7DE/:G?<,R_=B9BWW8G@R3NQ7<)CR40+#
MVVS5T\Q6B6N<?97=%`_95OMLM:^SB.NG_WC^_.1_OGSX_/I__^<W=Y4\_AY\
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M!<!_3'^CR/7DX<0076[S2+E`UII^'GA_)5&<YDRGX>ZRY<2!WE4P=%80>\/Y
MG1(RIYTK*S5L96:B#_K``:V\.)0WN4'!\S`,UCCR(LV51^`^_@+C1?:K"'_V
M$C@D`:Q+2ZAXZT=R0YHD.&)A&<F-DI>?.__`FX8EEO<M(U5@R3JFT9)F!DC@
MKO%>4H/+,DS!<A4B)RN?QAORM`G(PKD17$,/!)Z22(F&K#%^>^."I@*0_QZO
M8%9[7]?2]][4N'_'9/JPEU?"(^M"+9?`=H8^OPH\6))6K[GY`-X+%>)K)]J3
M[#$%>AR/JM7Y8EUED$O-*_9ZWSQCCQPKAF)OPECS?0G'\6V&U[@,+X7&,*5P
M;0;79G!M!M>$R6BXKU'=$(?D2N8@.YI4W;XI[]PT3N(H=@(/!O.;1-512OE,
MFF$^&ATG!9+ASW^NTEY(F'$4"S\$(W%B7P!IO0.\`?8EG3FX>`3(A1$.YZ&K
MQF?IB/6>^/:=29+_YG>5XFK1VO=ILZBK(.LJINQ$H@HVOQ%MK)00__$FOV0G
M%:E<Q#0CXXRE1/:-3C]KD:?$=IF<\2$.4K-JVRA!Y%VDS!*3^47EWI\%WTKJ
MG1Q<&!/9-.L2![S:4M["BE],HK^VC&T&/='!CL4JK:VF%@?P,D0S`+=WMAY7
M$*4C;"=OHCO8SO33V'G%92>OB&&F=AIG<95.Z(D88+5"SU7^33_M\5%^[,\S
M$_6X,G?Y]%6S4CJYPKWE30-=!%Y?LI?&*V.K^?R&-+1-D+G>OI.AM_Q*>]\^
MUWOFN=X"4DO#OQ^&05J!3AQ_"M#RI3+U[7@:/?($NA9PD947NAFNW0I?X6G!
M((*NLJ-XZIC]QNSLH:@*!933$;AS)<SW"5+S-[=V?LSD-U`[KY!,H6N"E2#=
MBM:W,)Z6]6^D1DDMR4)=A>L_6OS-^FG6N2-*#F'KF,:WX6]R";C0:>&WUT3,
ML)Q)[WLRIBOO(;??G(X>B:M018Y:%%;S^U!3,V76-U[9WZQ@H,#6Z(9C7/MZ
MQ=.[^R"@7_8)"S..L-LK$?9*Q%.^$M%X2B_]XPAS?NE`9&S&D74*9I@>I9$W
MLU1EM$W5H\"?082G5DS5:$6M8_6;J)'7RHG_NL1AJK*3N]1P'N!-R"7=1:,H
M66:3^X3G#(/MI(:.[Y(&M/NA">--ZUI"5]6$V.YA<X]N;VD_Q4A%6-OL'6Y#
M'$P;L-B`Y4D&+%LS5#)0MS#Z^Q(!DO($&,68/,MKE.='S?33]@'I92<E$#%`
M,R\>\>(G+Q#D3;QZH9F53'][FEDM.WEQ2G>UO*;9F5>(;N?6&"=`32V/0EPR
MKGB;8QT_AR2<\&&\Z95]/&#;$%^N>P-Y*#[^:]Q;Y>RT)][1&B43"R(@U!WO
M".1\4/8^>:TCV5S,D\S%L&A1!WF7[?/=%\N5'VX`N`-H#5U08U)*+[K<`C><
M!_`KMBAIUG<81N2:]2U8A2A%6ED*1S7/IF>#E,M,0F+I/0@`<GSR')NWA`$D
MBAW#-<@U7=UCMW2$=<<]'2V[LMI02N0@C<5I5VXQI!B.!:8V`FO@A^DS;<J%
M3T-6>YBA0?94XCC84;CD+F=*NPFI2T8KXE3OWJ%!M51)O"8?;>:.K"J?OGTC
MHAK6?`&K6!Z4E'MRV8461SD)ZF[CW$F"#3N>4?ZLT!3_7X1CB+WC">R!;L.H
M[+$NS6`RBL<VWC4SWF50)H:0E^\)#=^)HO$LYV2,;LGI.561:CTQ[4YHZY[6
M`)3@RZO84X`@&N0C1U710)TQJ?RF5I>K59\(IC4SEO4((`_\Y]SP'WZS+_`?
MS9B_YB<._Y`;_L-O]@7^HQD+/-<N`/\X7@#$`7[5]_26AJBPKYRNQ(:\$C=A
M=:%^$SG-L265$*E@*[74_7;CY4J$2FU;.M.N,DU3Q-$8(;<C)_W)#C81MS%(
MWTZDQL(+$3#&GZ\4LAAV<I^\D"/XXW[C_#*N&,OD0Q_4>$AY,$)`5!E/DM<E
MQ:"&YR3909+FKXFONVV?=/[EMANBAT:S-'_^-PS$GK5HYDO--D@W?*\6'AMP
M>AK^5W)<VRJ;7[SU0YIQ%(9>G`W@<+3%EQ/ULC&J9@'SD>N=&\2)JK3V\6JB
M5C4=N.GB5G,5@`4]R>W:NXM<#T6O*'8U5<:BT,EL=R[54:OKM,OAE.WWPS5Y
MQ=("(M#-6\@>M_&GU+>F["O;5]G2I9C$:W$GW9V^&>5L3IW'012!.,(VZ1HZ
M]^3.#`3;PS=,*G@TYF!O3*:C-[1CB9]FL>=NC#MWPZA(],=N;'L/V][#MO<P
M83+=E5>/C8G8/E1YYM,XEZ9AUM).;G'N9T>LC7&\@I$+YM=A%`VQ$[:9A8C<
M\%5B95G(&[0#-NQY3(!J;&-RQ"?^88C_#>,]'HO[/IT(OX4%3<<?Q,3?!JN4
M?B'2-*#X77Z/8>_F3>"=@P#,8!Q5WWT@UV^Z4A-A/O7LO,*J)"X?:8<EI:G=
M>X0-8R>*DU'JI1G)01(HX(>QXXO6%TILM>82I,NP+N-@KM]'"YN>\^/-W$U0
MB!V7>#/Q2;//P+OX)X'I7=_NI%S/@N:#D'3+H%T#&C#F\`QKGEX7U(JKP`V7
M8)]OE2I024][.8)?XM7X<:SX??%.#\RYI+VXQ.0-Z,:;.R!I1H:-UIQ7HR;@
M8TG>I3/^2&.N[>WY!R=0\RPB#=G>[=?U`'*X8K46NK-*$VF9$+A85].QPEF\
M`%L#E4</I:YF;.JW/_9X-CT>FRG;QS*>2$!BBT_F%I\X=(JIU9DM0MDBE"U"
M&3&9[N_X;2W)OI79_CI/LA5V)KX$'NE[1OA)\*B;W?<5=:65RV`O;@]*EHG&
M`DO-3&Y"XJPE;@RQNBMLN\1"7GMX+:0;U8C*Z<,N5?3;4I#2JAH]<3/\"!Z1
M5R'9_27%%B:'"](T^RK0%(Y+X*J_"L*$O81^Y!UV:@-^VE3]8^*@&"!_<PD#
M/`WH^",G=KB#]^9AV1JUT0UE0_:G&;*S:9*-UDV)KFRT;J-UDZ/U6[`&00(N
M,3_9N\4JU.B82"^BY@IL=!\LO0%QYIM=*SK=LT^@)R'L`2HZ@]0+!P4PF$<3
M@(KS8M!5(:AJ0F9LBXW"JD%(6J#91;BPC7><@'AD/IQM\)0&KALF01QQAPL%
M1+MPJFIXE0?#*"G;*.-I1AE\"L@2;0BNAR*]0*[+D2056H-HBD=0%7Q04M8N
ML'8/DA9#10(;SXZ21NJ>F6$AKUUT;,K=+-(&E*N#'9GK4%T82D57J^LC4XA5
MF-8F;8RT-=*CU1R.45J0(J<_IPOL-_H$K;L%`#$)T?"O4HV?AE\6T%U<Q8/5
MRF>]DR^%D#D2JG3$Y8"IISG^=I%<ADCLUBO=2$;G*2C!D'4/0L&6D:M=]WM&
M0=AH^3)BR!]!2^D#3,?M$(?\<W+0GMR;RWK`J3JKP<>(X<9;$&4I15DUWF-V
MV.2H3V8G'N2.MC%U#0'IEZ'DZ(+;?)Y>S0Z@IH4BPQ[0=YF7<.3OA5O?5*^+
MI.I-&&.G-':@SY,[O7%(6]'Q+&\,05[7P]3/\8?_9O(+:<:Q;^$]R>PG@PJI
M?@;/GJZPIRM,$($]75'.5W6["YZQ-J>\@_,`B\`EU]ZS4@UY;23TH4O:77+M
MAHQ#"O<?M+NB<;LBGU8IKPG>DJ/(JG;%W>"FFZX2#$<U`BY</\``+I.ENN+<
M/@'MP=>1'I71/0#C8$OC!-AY5`SP'@'#`=X'0\@RI(2JO+6Z6D_I\UH=WDJ$
M]F8CY:CG)5;F&%S#-:GYQ'AX<K,K*Q:<;SXX?X4H;1*NRJ:RD->NM.V&EPE-
M*?*[AMC9CL@YG#D"*7,*CU#4$],=FW"H<5EN#2@>FG?IRVS'W8VSK#15RI=:
M)0N:JV""$F4&O#)/8*21:0A,7PG9DMH>:9\B,$O\:SA3$H71D-5M7^BR\50`
MZCDC4;`X`IBFF]W<5"',O?%[44C?1T1:?TCI&X7:14A%UPS#V"A-.OSD=>;E
M$O)@&:(8?LT;+1WN3RK$VT*Q'^:U#38]3^Y2>!QEQO-3%S?@,9X^`'\-/H1!
MO.@ZN*+AJ!?66Q1U70\"\_'_.W#0]"'4KRP%(^;$Y!*U9(NRM`>$.]0.K!,=
M.PC-K/1C:^$&6MH#Q1WIQV68*$D-<7)B2"5%LFYD(,MZH+@KS<"?-40S""=/
M5#-2D/E?-I:@&8,@AA[TDQBS<@?<!*7-M"\>73_Q@$?N>9"73)(X=[,/;V;C
MB25J7B:0PU@?]$:2"/@?2CY6HXY/L9!C+&SJ^SY<`Q00:+.V&WQ'5]I'L;?8
MG^:)%6K]Z:!-UB_`\>/%$/,Z1G,GR+>)O+/,'78>R#%N1157:MK&..ZUA1!Z
M&`7E=@E1%-]<_9)J3E5YM<;:5'U/[_[$JGD$[LK92^QYQ-H]T0T#CT,8E5_4
MK>0\\JA&0,N%SH*)RC,'=7<I#K[31Q$<S5M608$)_8_3T81U%1Q^IX_H'\U;
M5N)?V6:N[E0'`W7-^7P>2?-@7,KHFU+!Z*XGQ@2%?P$WGJ1W]H;$Y07>^::J
MB6.-?6@<P/!L?_/D]9R[R'FZ('%RA('*F&,1Q>%735'J)A$<35>+=Y)*?D`>
M@:;+#>P^KGM7;`:Y/"^);PPS8?LI2"+@I9Q<)L'AB_4U"!]]R>`#)<<3E':\
M@#=M8-OR\K3EY2CMXYWC/M2<($TSI&QZ,@R72QBGIY=','+],$H0X,N34@YE
MDZ5/,UG*IDGV80%3P@A[]=U>?3<Q+-T6/A%PQK-;',U?1(1&<6!>23FYCI8A
MZ#>Z,_5`R0IC^6Z;`2<":8,A#)JOL$U;-2$SS'"CX&H0DG>M@$EN>=.:8)ZR
M-05H.9ZE/U(Y@?7?-L8>5\JB8=:ZPN6"\7W6HLN$-!?*+Y1/G$WF<25@F"`"
M@8J5Q<A!#Y8<*Z;RXGB5*G`53!]"<F1,B9O+SD0?=DT.:&6=_^=2A4\!`B[A
MP/L4D)HN)(@Z_B1![@)/8'SOPWF*<KD3L[H#>"+L]$$]A."6=1=`2RXI2R:Q
M*>D'@.:8\X'[3P*C%"K26G($HU68_W.7&N`\C2=(@M\&V]R3N;DG.7K'E).R
M*2F;DK(I*1,FT[=NC+N]E?$48XQMUB+T\00BTB4BWJ2#"E9MV$<5WY?L#FK<
M#LJM7/2;)E_VEQQ9F&[4/<RV3\"<TTJU5NT`$2D],%/ICU>IIZ2N%5@%%>UX
M5^K7ODX?0R/C";3BR5+@D7M;((CR62/2KB_-.IQO=I_),Q$IMSN6`X]T#5+;
M`DP)GWH]AW:9*Y&-E)6:]B`;S[XXA)EXC&[A?!&KLHWUQ(SQ9&O-9`-0ASX@
M\VT21!XPRT=FN<90_4VM45FK/F6W1RIGK.=T;,;,.3?\A]_L"_Q',Y96'^2`
M?\@-_^$W^P+_T8REE07E[0/JO(`F<IK/>E+)D`HV*0TQMSM33BKU'Y6G^8Z(
MF;]!-P!U*`B^#7H8!FN`8M)?8U*LSY0(^X[=-I3V,*95ZTK;>"LN$N_IBMBV
ME"?E)JU,I1]B;())4IG"70`O\<%X=K%<^>$&`*PZ:TBJFY6!D9\.E_8=N05N
M.`_@5QP6Y5>J(A(MW8)5B-(\ES)3J)IGTXLGRF6V?TF22['>@P`@Q\?!\<!;
MP@"25")I:).?>5.7>J(CK/O62D?+KJPVE!*1T]%>SK1VDU*W.2CB5*\-T:!>
MJB0NE$N[<P@(Y+Y*&-2XYW7N8.4W#=T9:J8I\U`2->17@0?7T$NPI7%=3`_&
MI/W=&D3XHRPY!)IQ=(4^C6I%!$(%@B[G^XA[A@>0ZKZKKYK9)HK:V<IQH.V;
M<H<PE'K>"N!JGSQK??*,[TVYI__DF5C9K7C1.7>+52WM*C*F+_)*:$I]C#F6
M>\DN7T51`KS+$.4>)(NS0#&,7G`;M(H@3`.#+G=AZ[^':,-1"VKXNE9STBZ1
MVEEK:5=3\'T5X$'@LA0SW81Q%E?A9:LN3J:B:[)$V0#</SE@LE5N./OZ5O#!
MMW+)(`WHHT$2+T)$@G85.M9"T9A*UW73/:(VV/2^\+;/W<1!8Y1.R_OL^`DH
M>HBK%VXM9>V>.(^4ZW&4^&(<:VNY/37<\4:U:]=_V^Q%V#!KW9>[)RAT`?`B
MTH2*.'GD#N%XML\P.4N8_@*0"X;D-VI6(A<GAH0G+<N2#V3^6]^'W<"D:D=M
M`;\[M:AG07<-34`A&G#5]>1;+4O9'])VF0C'@]5;=&WPQ3BHX;LO.TC2'FF3
M(\QI&#O^CMG,.Q039?609@0M;$*L`4?:(VJL2_(F(?%^>?M(.<KY3U]U"DN9
M&RHQLHYIM)%E!DCKHV>E]-HH03"89RF`,L]16IDN*>CN_24UASJ%.#):-V2A
MSO\:6E6?5BE)D'$21[$3>'@R765!RB0--NW4J,EZG(QU7ZXZ%(X5TB4HSK>.
MX6[W&8:)[YV#H@D,7:MP<2IF!]D24"S2(MV_$-1X/Z#8T'8&:.CX/GDGH*@!
MY!_L[A(>`TN&.^_2D"^41T\!II+]BT>L_C`":?2Q_6/WVM+&1R]<!CZ$"ZV0
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MS&`19;YO:(>7=\.[/^R&MYWD`)N\9=9#D:P!ETP5H.4+);N).F[-5KTNQ%4H
MHZZ'4%H[,S8V9OP,HGB[&:M3/EG\]<'1D2J/0KLZ/V8G/)UMH:J#^Q#RF7S*
MBE8OF4+;9"09)6I;=RK3DY1Q#4J%^+H_`5AP1M7<Y"9,.SR`S.)%^6G&W=_)
M7;.;,/X=Q+O6)RI40!VS)F=@.A!5H8?B65&SE##;E2]#E/^*?$Z)S]3Q#/KA
MQ'<MUD*+)62*^6OF+<W(E%7.V^CVP#^BPZ^0LJQDLX:7<\C3.6Q7'O'4B;0"
M+\5H@M<$`C%$F=>($9M!JA?KFV]&BA*QC^K(YG9'15OR6);J*7YCQ[Y*=[A\
M[*MT]E4Z#9TY]EZE8U:G$38G`7$0@QC!^X1,FCQ!DWN2B-@98GU"C.&F_"%U
MCP,+<M2+](0HZI(;..GPR-+7#!G;@>+!P-1Y%/6[J`82WA>M:V6<:\6B02SO
M^EH'RCI0UH$R83):'*AT]\5691!%(([&*T`2*,'\.HRBH8/09A:B--6&82.U
M2U>1U\3,AADFH,U18D=7GG<D1R/P#\.T<_<>O[<8<@S7HA-M:&&A+TXS&ZX2
M&Z9I\Y*S1[_9VC(#GYPFG#@HWDR1$T38JR&G<D3=9IYQK1?]]+QH`?U2YE3;
MUSDZ[R*<M3".QK/S$)O=\6P$$7#)HQ2#P/O@!$YVPH:AO3/3@'K\S=8G(MA`
MT>2HV%<[)+[:89O\<S7Y?\F'^CB8A^3P)R8=Q.2DPBV`R_L$+X;TA74&:T,W
MDF;'N*4/.24:>MI$%W[X8(X`LW1JOVSTVPOU4Y8<BK!TCXP2G\3+6YZ8'ERH
M^[;N[%7KDPNUTY;8N]F^NF#^JPNO>OWJ@MBKXC6!6@YOVF>A'+]]@?&B_!45
M2BC*4D^N=`HC+['`:QM0&7NINZ)YC83&)K9UC<&M:SC\CE76I"/P^+W`RBZ;
M>0M-T<8U!^/H]@QY^HT>(,'_@H.<*UZVGZBN=2RKGZB,NZBVI6B/=(2VI:BL
M:Z-Z:I%9,9)-,3\FV*,%R-]<P@!OB]#QKX)9B)8I@WR%2,8A;0WRZ=4@^;3*
MGNDS(]%AS_39,WT=GNG3M%GFNR5C;3:YC\`_"6;J8DT*"'P[9/LH8KDANS&:
MNC%2ZP_+7B@S%E&U(]83,\8JUQJR!J`$17$'$(Y7SSD>6Z_^IE8/HU6?TN,>
MU3/6^U1R)>?J/)0F<IIC;"H94L%6X[`;N<"5W3ZPZ1ZCTSVR+FB*9?H+;BE?
M!VT>PIC=E#Z_7YJ_O#*;<)4MY[%&./(+;$?T>I*3;\9,VW&>QE+!+2![%`SF
M69WWRP)KSL7C"J(4WB].='$06[*O2'92/5RY''CJ+M[9GE0=]J22]*I3%PFB
M.W<!O,3/DT0<A91B@/&,M%O.!!=X'Q/'A[,-.>GHNJ0YA/`U+QET)&30;6[)
MO-R2/`UDRC[94HPMQ=A2C`F3Z44I9A2Z2=K)._`N@AC&FU)IF/TV==-H3/LJ
MU4"LJ\X#\,]LM%LP3]VD(+YQE@T;9P3<[S`_I_B;V3K#/QPNK]I1]:@ABPB(
M4M:#(IA-)P,7S$SQY\11WAM-RY[!`^X^!@?KG!G1_*W62^PU./[OP$$7@3?"
MYD0<W=J1M;E0/&C7XW-X2X37=I0.*F<!]CB)H]@)/.S4R;(DC31Z)0\:S$KQ
MJ9!D)LF]#]U+/W0:>BVR":(\9&\L3@4:I1.57&9G@'GP"!^7OB-!R_>'TU3:
MX('V`(<<UA^XRE)[XXU`Y"*X:GZ>A!G>\JC]<4>J0<FQ?B/@CN3&"(^,R!E(
M#SS^&S3<W&.TV0?#Z@JJ!*ST(3`YY&\Y(MS2J-F.?`M6(2*7C$GTDS0D%QA1
MKQZ]1R:E&:5<!.^X+4PV_.?03S`$:',)?8"DH7\X;/]T_@B8(NHYX]TJLW'3
MX8;8\9R'2)J)V1^TAW[@`2H%UB(A9C;P%^#[_P["A^`..%$8`"^]*HID`5\W
M?`]%4(M4(8R7$N+]27$+4TYH6CULGXQ-#3`%YJ]XC4TQ[B[>O<2_D6#?ZP;N
MT<9:BTV!ND#`N3]V\>*3`N3+0_?'@V^`IP#_^YU369/G_NF4C$G>T$W_^?\!
M4$L#!!0````(`$-1<D)DB'GTSQ```/>P```1`!P`9V]V>"TR,#$R,3(S,2YX
M<V155`D``ST@1U$]($=1=7@+``$$)0X```0Y`0``[5UM4]NX%OY^9^Y_\.7+
M[<Z]-.2%4IC"3$B`31=("*&TW;FSH]A*HM:Q4\D.27_]E60[<1Q)EB'M:F?=
M+P5;+\\YCW1TSI$LWOUK?]^Z@A[$((".-5Q:J/4JF/YB[5LM?SJ[MY'5\0+Z
MU@[0'-)GWAQB^CM]/PF"V4FE\O3T]-JF18F-,"1^B&U(V`-K?__,8O_^^8]W
MK),6AJR+$VLP":T;@*UJPZK53AI')XU#ZV'0LFH'U7I4B=98D!-B3^`46(NI
MZY&3Q1"[Z'0OU2=[\MK'XTKMX*!>01X)@&?#O;B\%T[%I9T`5X+E#%9H"8B1
MO6<%`(]A<`NFD,R`#5?5QM"?@P43A791K55K]6K2^H)L-/Y43X!4*Q]OKN\Y
M\!42W],`XWO[*T!1O;$_7^A@"<D^:V*-:`3(D+>>O.%5]@^J^RD!7.1]%<E0
M/3X^KO"W2=&MDIN*9Z^'@%#%0Q=.H1=<^GC:AB,0NL'IWK<0N&B$H+.7XM$)
M5NVEVSJL1"_WSN@`L"PV!(#G^0$(D.^=\8'$AA-_/ILA;^2?)<_H4X;C)`'3
MAR.+"W'"%'"Z1]!TYK*QP9]-,!R=[C'][B?*_,,%P]<485($8!O[+E1KJ#+#
M_HS.!D15O%9#U,!6[4VML=<5VB=TK]>0]RIG.Y-GAN%/EX?V2>@`X'QEQ-H=
M40X<_73!:)_(0P*Q=B64#=R?+A3MTPY=(5F;8K'2`RJ(Q7YXZ'=$1HFW2!<'
MXKO(86;^'+C,'-]/(`SV+.1$$O\A+9(L%9:5[GJM^#-J6^F:<T]'%[<R?'U:
MMV7%C5F\-?*NDJTN:CTDT.EZ9_SG[-B-6XB+J.MN#H]LS9R.,S1D:J^8J&Q0
ML3VA7DS2'SV`J0(F,$`4$M'@+%M#@\*:/H76J\WF?Q%P6A*:(;3CT<=PI6$)
MB=E2VXK<(*VN(FWU@EC^R.K.F!])JY4S4$[8_80.[(GO.A"3BV\A"I:L6LW'
M]11?BD)"36XPUM!G[#[P[:]Q/_^VHIZL5]1_0S:"GKT43;N2QNR\:P$RN73]
M)\F$6[T6R+]!W*$^<:Q-BS5:3C4Y1[=^`%.<\%\UEJDW5/5M1&S7)R&&]!=6
MT6+^QRT(V!.J__.0(`\2B?9+]2?J/\CH_R!W$AP)M<]=AW`Z!7C)[18:>S2P
MM`&=)TW;]D,O0-[8ZM'90@U7.2=R2-EBY4!C67DK)(:Y!U?^'&*/&ZTK3"DI
M]9^G_VT"#O+\L&.A^AM1IFZ*`KXT"!5?ZGVM=X'BH[&OTGWU0*A[MES7V')Q
M`_$88@MXCM6'-IBA`+CH.Y>MG`FYC(@H.=!8IZM5(2MON!.U[=:6GFP>#T(B
M<A?L:DU(`UO&^S1XQY$SVZ/!?<E`+@-B"C169[9W(F"!K=E1O&\-P*)TC/1(
MD+"0MT17&T(.COE,<'D0UP.8!M@#ZB01MJ4FRY24A&0(D3&BL78?BJ,YMJ3?
M0Q?:C):[$+!=37=I72(/>#8"KM4&`;!>A1X('43+"#,A)5%;1$F9TEK2):$W
MS_V'0P*_A6PQN9A+?=V2DBC):$^@$[KI[,?J4>Z,V8K`DZI6IT-_^P#<D$O"
M'=X[OL6[9-%W'(B7Q"B(62<KDES%^9+_M$Q1I2B4[PALA>F"_,A_V4F/J$7K
M5?)0;.%*VA(3-P!#%Y*,>8L?YOG(XN"]6%++>A5U5JY$&C1EEZ'D:>[\J8EC
M?5E4J2*EI&23$@DG>6YU31SG9T.;<GH4XD)&1KY'71,'_,4]:B5C)6$Q86T8
M`.1FV(H?YBP[-7%20+R3Q;9]6:.E&Z##1W;Z)$_SUQ=QDJ"H*Z#BJJ2*4M6+
MCL<M:8S"5NH9RT)R<Y,B3EXF;V*)DPK/))'62I#PD&J%I6178R)*9F*N5R%.
M-0BW,\OI5H@0&2,:KH5X\S^SR:FDHV0CRX:4#IV,7$V\ZZ^S]5G.FH(\R8G*
MW82KB1,,\JA53DU)#$O3N:YO\^[\T2T,Z/)L0^B0$?:G/0Q'$&/H<,7&T8TW
MSOH6SVTAA^AZT?3$VL=8(V+."<5D):`LALI:P8I:LE;`_@:#A'^B]OOCS8?&
M_W[_:,_"Q2?O\-CY?C0??UIZ#^WPZ>H('Q_]5OOR,%@2]VAN?S]PWP=O'UK7
M/>?39[=^Z'T<=EOMSO)J\*TZ.[X[/N]^^H!J5[W^X%?_/[/Q%_^V]_9-U3N^
M_="?'[5J5V_?3BKUIZ?)KU_?7X-E:_QTU1A_OQMWJU?!^][7?OOR[;?PX:;1
M>KAI5A9C>'S7_7S<?P\^MOOUMQ^N`X`[\_>?>Z.%/6H,/S?G1]^KM8.N/<;M
MVX>;NZ?S_D=2>_K8?IPMPKO'V^,WGW\+&Q1&NUD9!=?AP?QP^O'I\*A[V+Z8
M-Q^'WQN5N]/3_UFM^W[\U=YSMQW8P.G.&`--]L4@.[><F1?2(OEK4;W8@8_T
MV(]&=-2ME?1;[E,H#*#C<*C`[7@C'T]YSRW?LZEG3$U"BD6R9?F*5LWS"NOB
MA).6S5MAL5)@K#6:C9$AVKDJ1P.;U^M(MDE(.(VT]4#[0]XE0)AM"<+6&M36
MF'AF`QHV09SBTK()Z?!\#<IBJ"SD60P7W^R$5AI9F1Y3FW_V):'#/AZ''N%=
M7RS8CU"X$*@+:]`OSJ9I+PG['("51F#%$$I;H""Y%V)[0E7W"##+D*0/-`EY
MSBVO3M;4Q?DV_94_Z=^*`>0?P2K)%@2HB@A5(_5=%Z?<!"=%R_BT("\J8O(R
MH75QTFU[?[5,Y^2PTHX#:*HOZE#`@`#/N49@B%S$OM//6D:MXOFS2IRAD]+'
M2B>!/GUC15WS#%ZJ\W+BB2GN0YO&#E1)<6HGF,!(RU25Y]"CHFSM,FE7R4O]
MB'-\*J(WNV9I']IYJK05]U^RK6EFE78V?W^C(<[>J4^(E]L=Q6E2\Z2S\=$0
M)YN><\JEI"\GHHC5N=+F2IE,EUOQA$;I'$O:V-T)IE2@D5>Q])L*S-^<"9R[
M(=:0''T2?DE0'GW2_Z)@ZSA:YH6&9=W*V13\OJ"D*Y^NE1*I#M<J3#28M:DZ
MI?,FW%:*YKFLEI^8O#`*]>V095*:GG/A!2A8IG8^(LZ5)?)\V(,M'S9ISFJR
MPVN\P?1NR]]GEKZK;%Q.R9]&SS8NLHR>T\=H.O-Q8'E;=X^J+CB-[D6]CK?R
M%578;_M)O7WV:+]:VZ]77R^(L[KGKR`,)GATTV`Q&$F]9\%0WV@J`<)!I&N.
M`9CQBA7H!F35UOZZK16B@IK9OE-61SG96DPUQTPUU3<O!Y*^3[88&-^[5>#1
M0"2\TU5WN"056.>'VVJ([YCEO9[NR6XF),TA"=B5Q7M6=`,GOSWXA#ZC2T@G
M@%,V:_<L$)<ZW0MPR.[.Y*5F5';?&?!Z3HACJ^DAUV6K8%*64!>2VKF0O;W"
M?CA+.J%AP53C\L0UQ(Q:,Q*&F%V"&*7H#))*"*MRII8BE5TT3A01-JD\F^>W
M^+UL#M\G3L2A4X_!Y)?XB<09`9<(Y8FL=?!\<>30*F>*898:I>MKYKJC]7V.
M!A&FCU5A.KK!!.(H#QIO]YHCH0*;=$B>`X)LZGZUD1M2Q9@CC`R8VNQ).$[O
M]48[O6V8W%1ICL@O0J^:IDWG2TBB(_`#?WVRJ0>0T_%:T=GKY#_?HY(/.=9F
M0`<3G$5"I94S]3T:<>%E(1.UUD_T;ABM:J=[-K4ZZ`6F:P?2I;U)O1&57,WY
M%S!PVU#E"VY2]!+[T]@PLG">'WLT:_G51:H]+Y(M+W@+@VN?T"?T!]8-.];5
M\8S6QJX$D0^,"?#&D'2\V'7;V&\V1P]Z,%6107I8=;PY)*92KHU4Z;^E&UD=
MVS=>7!52E;C1M\MIEV\`%\&Y2Y=7<R35`:D2,GUB=NLZ&`/E+8A7:J+6'U]&
MWUX:*&H^1*5W*ZV^"A_YGPPZ"9+GS_3/=BY>3@RY^CYSG1PVD#Q-G$H&HX\>
M2=.F7CQ!4=#)0APR\^-?UTV;.(!?B%^Q\&['.'SSUN0!41RR/,SHT6B=Q22>
MPX/XGD]KK$ZVQF>MS)X>+Y9`KIS5H3>C%:"%4KIZQ:>X^"&N]!DNHT5^#FBI
M!K:/Y:2V`@T4OB!>J=SK0R71F1(#1<V'J%SUDOW\[FBU/=\4'1<P>JSO0@C5
M^J?R@@W2@A9,A9QM.(>NSR^IN0_`&%ZP/Q(ZPXC`Z%9)TWQ:?;S2"<[7PR@A
M8::,"H!2H2C[M(]T>L5,V?)Q*DU7+P+C1_^SK_T`Y9XN<:M63!)6%ZW<U5I?
M]=!-7SYQF7/YA'&LOU0,A88*?J1NG&J>C5]AU9-;R)JI^]#,6;24Z)33O_@X
M,D?J%V!7ZB355MP%I"8G_@/?B`+=;/U'[APZ</B2C<.BDN2E+S8O)S%G)*C`
M*60J8"G,D?4YH.6AF?3RB8[X\@ES]/!\Z'FC_%QR\X)!LFO!S)-3<?.`8:+J
M(%5FX%U`2'<45^_B/AI/@FX8L"-E#A7I$;('T&E2N\A"H`7$-@N`,+(-.+GV
M(O2%U=*ADPDZ[9!1';G9.UW@=JH$`5;UZ:F-1J+:/Y3[7<NM`5E^PD&DP:0N
MR<QT)BDQ@>(UP`+,9NO^I3@N!+X8VY<^'D'$=M_9KA9=+U"\`6\J^W+`B@-M
MA1KZ*PZ-YPFC.A2D&(`,]6TX'4+\XD'R8U;";9S/MA2LC;^@+Z"+7N4+;-VX
M8NH).%V@<@.QW8+!PNFXMYMWF71'@^UK5,P1L0A8]::;\K8#<P36Q*F4M0\)
MQ'/8AD[(FNIX5&OICZ98SHL^XF-FX#].D#WI!,W9S#5JZNY$BMQTYA-KCRZ1
M!D]S/9B*!;O/3@&W_2E`7B;K[O"'/]E+2<-1)]&_T*F0;-[0)0HZY\OH*-TF
M*0FDG[V]I`*8+]C%(HC."(GBYC]7I"PT^2%3)FSS">#=AOV9O/9+OXA)H53:
M@P>/?:'.2U^&GD-V(-/*A=MMJGX+J5*NU2<.UQ`0.(!XVAWQ'XT8<W)T<J?L
M'K"3)^P(JN_QG)\YUDT&3?E-E7B')7K!YR'SR'MQ#&%`7%$4<=Y7BN+6!G[T
MC5K<)&_JY<F''R>]&*_4>$;Q9W>T;H17B)MG'D_@I\:1`5F7HH@+IY/I@+'9
MA25C/H4V%=GR0]<YATEVW\E,`U;/@.BZD`0*)R%NE6PGK4U+.NDB50B;C"MY
M4P8-?@5(A8@WR$/3<!KMM6XHIDG28V:U&=D==>Z[A"_Q?!N>3C"ZC%Q,9ZZ_
MA&LS^*>-_IT+5#3CF$PC@]QG'9P%4]')J.M#YD6P+7L^]A\G/H'K7.XC(-QG
M=^#+9\J/L8O%Y5!^U)=ULIH+E/4,?GRD[@0G#II&D5(GQPOD`*6NP`UDVJ%*
M._=IE-(=M1&F89B/6;KR!GAT(K'"42D3G-Q">)5$LOR><]OYE=L%<P04XI(?
MC.&7Q-"F;8RX/>Q#&Z(YZ]@@D7)!*N(MB@229K+T&224$)AB*;E$F`3FC3<1
M+'42GT!`UY7F&,/H8@MS9)%B4PG$#]U?AMCC.Y67:+':L$R.J)HCH#96N<'@
MP[9EZGS*`E.=#8LFH#0F-DVT7*1R(YA,3X/HRD+*&7#GI@ZX+##%@+L;M'N&
M&>\L)/FG3][89]$BH"YNT/))T(=H.@PQ,<V$ZP'-R>K%9TU]O#1OV"G0*<;>
M-1CZF-<Q<%62@U-_BF<>.2)8>=<NABZ_[R=Q.<P11@Y.2DO'<]`<.2%PV>=Z
MD/^)A.A*(QIAF2.9#DSYB<-U:!PETBY]3->".;*A02)JH%0>DU+<#V[.^0(M
ME)Q(?@=W=`-Q9"3_#U!+`0(>`Q0````(`$-1<D)\04^]Y,<``$G3#``1`!@`
M``````$```"D@0````!G;W9X+3(P,3(Q,C,Q+GAM;%54!0`#/2!'475X"P`!
M!"4.```$.0$``%!+`0(>`Q0````(`$-1<D*8V>DNRPD``"5K```5`!@`````
M``$```"D@2_(``!G;W9X+3(P,3(Q,C,Q7V-A;"YX;6Q55`4``ST@1U%U>`L`
M`00E#@``!#D!``!02P$"'@,4````"`!#47)"?59.!CHQ``"%V0,`%0`8````
M```!````I(%)T@``9V]V>"TR,#$R,3(S,5]D968N>&UL550%``,]($=1=7@+
M``$$)0X```0Y`0``4$L!`AX#%`````@`0U%R0E=X;,W"90``ZUP%`!4`&```
M`````0```*2!T@,!`&=O=G@M,C`Q,C$R,S%?;&%B+GAM;%54!0`#/2!'475X
M"P`!!"4.```$.0$``%!+`0(>`Q0````(`$-1<D*'![!L`#4``$KI`P`5`!@`
M``````$```"D@>-I`0!G;W9X+3(P,3(Q,C,Q7W!R92YX;6Q55`4``ST@1U%U
M>`L``00E#@``!#D!``!02P$"'@,4````"`!#47)"9(AY],\0``#WL```$0`8
M```````!````I($RGP$`9V]V>"TR,#$R,3(S,2YX<V155`4``ST@1U%U>`L`
A`00E#@``!#D!``!02P4&``````8`!@`:`@``3+`!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E3GAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Detail) - Significant Assumptions Used in Fair Value Calculations<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free interest rates</a></td>
        <td class="nump">1.10%<span></span></td>
        <td class="nump">1.40%<span></span></td>
        <td class="nump">2.60%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of option (yrs)</a></td>
        <td class="text">6 years 255 days<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">6 years 255 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
        <td class="nump">105.20%<span></span></td>
        <td class="nump">111.20%<span></span></td>
        <td class="nump">112.90%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph e(2)(c)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph e(2)(b)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph e(2)(d)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E6OAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 10 - Selected Quarterly Financial Data (unaudited) (Detail) - Selected Quarterly Financial Data (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="11">12 Months Ended</th>
        <th class="th" colspan="1">138 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2001</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2005</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2003</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2002</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Revenue from grants</a></td>
        <td class="nump">$ 459,566<span></span></td>
        <td class="nump">$ 638,000<span></span></td>
        <td class="nump">$ 705,698<span></span></td>
        <td class="nump">$ 854,063<span></span></td>
        <td class="nump">$ 956,844<span></span></td>
        <td class="nump">$ 1,297,006<span></span></td>
        <td class="nump">$ 1,753,033<span></span></td>
        <td class="nump">$ 893,002<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,657,327<span></span></td>
        <td class="nump">$ 4,899,885<span></span></td>
        <td class="nump">$ 5,185,257<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 22,969,019<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (610,085)<span></span></td>
        <td class="num">$ (296,779)<span></span></td>
        <td class="num">$ (497,763)<span></span></td>
        <td class="num">$ (730,513)<span></span></td>
        <td class="num">$ (1,153,348)<span></span></td>
        <td class="num">$ (375,852)<span></span></td>
        <td class="num">$ (211,344)<span></span></td>
        <td class="num">$ (606,282)<span></span></td>
        <td class="num">$ (170,592)<span></span></td>
        <td class="num">$ (2,135,140)<span></span></td>
        <td class="num">$ (2,346,826)<span></span></td>
        <td class="num">$ (2,747,328)<span></span></td>
        <td class="num">$ (3,284,252)<span></span></td>
        <td class="num">$ (3,728,187)<span></span></td>
        <td class="num">$ (4,241,796)<span></span></td>
        <td class="num">$ (584,166)<span></span></td>
        <td class="num">$ (1,611,086)<span></span></td>
        <td class="num">$ (2,351,828)<span></span></td>
        <td class="num">$ (947,804)<span></span></td>
        <td class="num">$ (618,137)<span></span></td>
        <td class="num">$ (24,767,142)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share (in Dollars per share)</a></td>
        <td class="num">$ (0.03)<span></span></td>
        <td class="num">$ (0.02)<span></span></td>
        <td class="num">$ (0.03)<span></span></td>
        <td class="num">$ (0.04)<span></span></td>
        <td class="num">$ (0.08)<span></span></td>
        <td class="num">$ (0.02)<span></span></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="num">$ (0.04)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 21<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 36, 37, 38<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.23)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=16381557&amp;loc=d3e4984-109258<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 18<br><br> -Article 7<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueFromGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EN3AE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CurrentAssetsAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 1,035,925<span></span></td>
        <td class="nump">$ 1,167,980<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grant funds receivable</a></td>
        <td class="nump">266,248<span></span></td>
        <td class="nump">183,515<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">42,301<span></span></td>
        <td class="nump">66,508<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">1,344,474<span></span></td>
        <td class="nump">1,418,003<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation and amortization</a></td>
        <td class="nump">102,486<span></span></td>
        <td class="nump">176,206<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Licenses, net of accumulated amortization of $228,856 and $208,933 at December 31, 2012 and 2011 respectively</a></td>
        <td class="nump">20,000<span></span></td>
        <td class="nump">39,923<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits and other assets</a></td>
        <td class="nump">11,010<span></span></td>
        <td class="nump">11,010<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
        <td class="nump">31,010<span></span></td>
        <td class="nump">50,933<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">1,477,970<span></span></td>
        <td class="nump">1,645,142<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">163,788<span></span></td>
        <td class="nump">138,339<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
        <td class="nump">33,877<span></span></td>
        <td class="nump">125,869<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Amounts payable to Emory University (a related party)</a></td>
        <td class="nump">129,370<span></span></td>
        <td class="nump">677,327<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">327,035<span></span></td>
        <td class="nump">941,535<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments (Note 4)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#x2019; equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value, 10,000,000 shares authorized; Series A Convertible Preferred Stock, $1,000 stated value; 788 and -0- shares issued and outstanding at December 31, 2012 and December 31, 2011, respectively</a></td>
        <td class="nump">312,196<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value, 40,000,000 shares authorized; 18,733,277 and 16,442,611 shares issued and outstanding at December 31, 2012 and 2011, respectively</a></td>
        <td class="nump">18,733<span></span></td>
        <td class="nump">16,443<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
        <td class="nump">25,587,148<span></span></td>
        <td class="nump">23,319,166<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage', window );">Deficit accumulated during the development stage</a></td>
        <td class="num">(24,767,142)<span></span></td>
        <td class="num">(22,632,002)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#x2019; equity</a></td>
        <td class="nump">1,150,935<span></span></td>
        <td class="nump">703,607<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#x2019; equity</a></td>
        <td class="nump">$ 1,477,970<span></span></td>
        <td class="nump">$ 1,645,142<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CurrentAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CurrentAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CurrentLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CurrentLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapitalCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Concepts (CON)<br><br><br><br> -Number 6<br><br><br><br> -Paragraph 25<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7, 26<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 7<br><br><br><br> -Footnote 1<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6952336&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 5<br><br><br><br> -Paragraph 8, 9<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepositsAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cumulative net losses reported during the development stage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 210<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472335&amp;loc=d3e37729-110921<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 7<br><br><br><br> -Paragraph 11<br><br><br><br> -Subparagraph a<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 57<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph d<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> -Subparagraph 1<br><br><br><br> -Article 4<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DueToRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 142<br><br><br><br> -Paragraph 45<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GrantsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Principles Board Opinion (APB)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 10<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 129<br><br><br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 43<br><br><br><br> -Section A<br><br><br><br> -Paragraph 4<br><br><br><br> -Chapter 3<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 12<br><br><br><br> -Paragraph 5<br><br><br><br> -Subparagraph b, c<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph A3<br><br><br><br> -Appendix A<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EV4AG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="6">12 Months Ended</th>
        <th class="th" colspan="2">138 Months Ended</th>
      </tr>
      <tr>
        <th class="th" colspan="2">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CashFlowsFromOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,135,140)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">$ (2,346,826)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">$ (2,747,328)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">$ (24,767,142)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">93,643<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">109,017<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">119,773<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">659,280<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Accretion of preferred stock redemption value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">346,673<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense, including common stock issued for services</a></td>
        <td class="nump">310,076<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">772,997<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">750,532<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">6,669,815<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ChangesInAssetsAndLiabilitiesAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Grant funds receivable</a></td>
        <td class="num">(82,733)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">290,760<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(153,954)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(266,248)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
        <td class="num">(12,593)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">19,122<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(4,215)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(42,301)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCharges', window );">Deferred offering costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">430,402<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(430,402)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposits</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">980<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(11,010)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(11,010)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
        <td class="num">(614,500)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">419,927<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">39,033<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">415,825<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Total adjustments</a></td>
        <td class="num">(306,107)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">2,043,205<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">309,757<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">7,772,034<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
        <td class="num">(2,441,247)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(303,621)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(2,437,571)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(16,995,108)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CashFlowsFromInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(11,896)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(4,706)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(538,490)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">5,580<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">5,580<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided (used) by investing activities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(11,896)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">874<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(532,910)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_CashFlowsFromFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
        <td class="nump">310,160<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">404,410<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">15,836,468<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from sale of preferred stock</a></td>
        <td class="nump">1,999,032<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">2,727,475<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">2,309,192<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump">404,410<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump">18,563,943<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash and cash equivalents</a></td>
        <td class="num">(132,055)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">88,893<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num">(2,436,697)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,035,925<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of period</a></td>
        <td class="nump">1,167,980<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,079,087<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">3,515,784<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
        <td class="nump">1,035,925<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,167,980<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,079,087<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">1,035,925<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Supplemental disclosure of cash flow information Interest paid</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump">$ 5,669<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr>
        <td colspan="9"></td>
      </tr>
      <tr>
        <td colspan="9">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">Supplemental disclosure of non-cash investing and financing activities: In connection with the Merger discussed in Note 5, all of the then outstanding shares of the Company's mandatory redeemable convertible preferred stock were converted into shares of common stock as of September 28, 2006.  As discussed in Note 6, during 2012, an aggregate of 1,412 shares of the Company's outstanding Series A Convertible Preferred Stock were converted into 1,882,667 shares of common stock.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_AdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CashFlowsFromFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CashFlowsFromFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CashFlowsFromInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CashFlowsFromInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_CashFlowsFromOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_CashFlowsFromOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ChangesInAssetsAndLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ChangesInAssetsAndLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6361293&amp;loc=d3e6676-107765<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3044-108585<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7<br><br> -Footnote 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDeferredCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDepositOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 29<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from financing activity for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow from investing activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3574-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3536-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3521-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3213-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 17<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of accretion of the preferred stock redemption discount during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockAccretionOfRedemptionDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 16<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EIH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 7 - Retirement Plan (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined Contribution Plan, Employer Discretionary Contribution Amount</a></td>
        <td class="nump">$ 50,500<span></span></td>
        <td class="nump">$ 56,928<span></span></td>
        <td class="nump">$ 52,632<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EPE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 - Income Taxes (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred

              tax assets:</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              operating loss carryforward</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,429,472</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,872,082</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

              and development tax credit carryforward</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,965</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,690</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based

              compensation expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,097,194</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,991,769</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              deferred tax assets</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,290,631</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,627,541</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred

              tax liabilities</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,125</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36,311</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              deferred tax liabilities</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,125</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36,311</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              deferred tax assets</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,274,506</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,230</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation

              allowance</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,274,506</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,591,230</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S.

              federal statutory rate applied to pretax loss</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(725,948</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(797,921</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(934,092</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Permanent

              differences</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-440" style="MARGIN-LEFT: 32.15pt"></font>2,674</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,216</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-441" style="MARGIN-LEFT: 19.6pt"></font>(77,200</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

              and development credits</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-442" style="MARGIN-LEFT: 57.7pt"></font>-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,675</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-443" style="MARGIN-LEFT: 28.45pt"></font>59,959</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change

              in valuation allowance</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-444" style="MARGIN-LEFT: 18.8pt"></font>723,274</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">761,030</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-445" style="MARGIN-LEFT: 21.8pt"></font>951,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reported

              income tax expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EBH">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Note 8 - Income Taxes (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</a></td>
        <td class="nump">$ 69,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Deferred Tax Assets, Tax Credit Carryforwards, Research</a></td>
        <td class="nump">$ 763,965<span></span></td>
        <td class="nump">$ 763,690<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6969291&amp;loc=d3e28680-109314<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43, 289<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EL2AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 2 - Summary of Significant Accounting Policies (Detail) (USD $)<br>Share data in Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation (in Dollars)</a></td>
        <td class="nump">$ 73,720<span></span></td>
        <td class="nump">$ 84,131<span></span></td>
        <td class="nump">$ 94,887<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)</a></td>
        <td class="nump">12.3<span></span></td>
        <td class="nump">2.8<span></span></td>
        <td class="nump">2.0<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Licensing Agreements [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets (in Dollars)</a></td>
        <td class="nump">19,923<span></span></td>
        <td class="nump">24,886<span></span></td>
        <td class="nump">24,886<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months (in Dollars)</a></td>
        <td class="nump">10,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two (in Dollars)</a></td>
        <td class="nump">10,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Three (in Dollars)</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four (in Dollars)</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five (in Dollars)</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 45<br><br> -Subparagraph a(2)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 07-4<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 171<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph c<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 13, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Depreciation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the next fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the fifth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the fourth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the third fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of amortization expense expected to be recognized during the second fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.1.0.1
 *
 */

var moreDialog = null;
var Show = {
    Default:'raw',

    more:function( obj ){
        var bClosed = false;
        if( moreDialog != null )
        {
			try
			{
				bClosed = moreDialog.closed;
			}
			catch(e)
			{
				//Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control
				// that somtimes causes it to throw when checking the closed property on a child window that has been
				//closed.  So if the exception occurs we assume the window is closed and move on from there.
				bClosed = true;
			}

			if( !bClosed ){
				moreDialog.close();
			}
        }

        obj = obj.parentNode.getElementsByTagName( 'pre' )[0];
		var hasHtmlTag = false;
		var objHtml = '';
		var raw = '';

		//Check for raw HTML
		var nodes = obj.getElementsByTagName( '*' );
		if( nodes.length ){
			objHtml = obj.innerHTML;
		}else{
			if( obj.innerText ){
				raw = obj.innerText;
			}else{
				raw = obj.textContent;
			}

			var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g );
			if( matches && matches.length ){
				objHtml = raw;

				//If there is an html node it will be 1st or 2nd,
				//   but we can check a little further.
				var n = Math.min( 5, matches.length );
				for( var i = 0; i < n; i++ ){
					var el = matches[ i ].toString().toLowerCase();
					if( el.indexOf( '<html' ) >= 0 ){
						hasHtmlTag = true;
						break;
					}
				}
			}
		}

        if( objHtml.length ){
			var html = '';

			if( hasHtmlTag ){
				html = objHtml;
			}else{
				html = '<html>'+
					"\n"+'<head>'+
					"\n"+'    <title>Report Preview Details</title>'+
					"\n"+'    <style type="text/css">'+
					"\n"+'    body {'+
					"\n"+'    }'+
					"\n"+'    table {'+
					"\n"+'    }'+
					"\n"+'    </style>'+
					"\n"+'</head>'+
					"\n"+'<body>'+
						objHtml +
					"\n"+'</body>'+
					"\n"+'</html>';
			}

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write( html );
			moreDialog.document.close();

			if( !hasHtmlTag ){
				moreDialog.document.body.style.margin = '0.5em';
			}
        }
        else
        {
			//default view logic
			var lines = raw.split( "\n" );
			var longest = 0;

			if( lines.length > 0 ){
				for( var p = 0; p < lines.length; p++ ){
					longest = Math.max( longest, lines[p].length );
				}
			}

			//Decide on the default view
			this.Default = longest < 120 ? 'raw' : 'formatted';

			//Build formatted view
			var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ;
			var formatted = '';

			if( text.length > 0 ){
				if( text.length == 1 ){
					text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ;
					formatted = "<p>"+ text.join( "<br /><br />\n" ) +"</p>";
				}else{
					for( var p = 0; p < text.length; p++ ){
						formatted += "<p>" + text[p] + "</p>\n";
					}
				}
			}else{
				formatted = '<p>' + raw + '</p>';
			}

			html = '<html>'+
				"\n"+'<head>'+
				"\n"+'    <title>Report Preview Details</title>'+
				"\n"+'    <style type="text/css">'+
				"\n"+'    body {'+
				"\n"+'       background-color: #f0f9ee;'+
				"\n"+'       font-family: Arial, san-serif; font-size: 0.8em;'+
				"\n"+'    }'+
				"\n"+'    table {'+
				"\n"+'       font-size: 1em;'+
				"\n"+'    }'+
				"\n"+'    </style>'+
				"\n"+'</head>'+
				"\n"+'<body>'+
				"\n"+'    <table border="0" width="100%">'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            formatted: <a href="javascript:void(0);" onclick="opener.Show.toggle( window, this );">'+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +'</a>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <div id="formatted" style="display: none;">'+formatted+'</div>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    <tr>'+
				"\n"+'        <td>'+
				"\n"+'            <pre id="raw" style="display: none; font-size: 1.2em;">'+raw+'</pre>'+
				"\n"+'        </td>'+
				"\n"+'    </tr>'+
				"\n"+'    </table>'+
				"\n"+'</body>'+
				"\n"+'</html>';

			moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes");
			moreDialog.document.write(html);
			moreDialog.document.close();

			this.toggle( moreDialog );
        }

		moreDialog.document.title = 'Report Preview Details';
    },

    toggle:function( win, domLink ){
        var domId = this.Default;

        var doc = win.document;
        var domEl = doc.getElementById( domId );
        domEl.style.display = 'block';

        this.Default = domId == 'raw' ? 'formatted' : 'raw';

        if( domLink ){
            domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed';
        }

        var domElOpposite = doc.getElementById( this.Default );
        domElOpposite.style.display = 'none';
    },

	LastAR : null,
	showAR : function ( link, id, win ){
		if( Show.LastAR ){
			Show.hideAR();
		}

		var ref = link;
		do {
			ref = ref.nextSibling;
		} while (ref && ref.nodeName != 'TABLE');

		if (!ref || ref.nodeName != 'TABLE') {
			var tmp = win ?
				win.document.getElementById(id) :
				document.getElementById(id);

			if( tmp ){
				ref = tmp.cloneNode(true);
				ref.id = '';
				link.parentNode.appendChild(ref);
			}
		}

		if( ref ){
			ref.style.display = 'block';
			Show.LastAR = ref;
		}
	},

	toggleNext : function( link ){
		var ref = link;

		do{
			ref = ref.nextSibling;
		}while( ref.nodeName != 'DIV' );

		if( ref.style &&
			ref.style.display &&
			ref.style.display == 'none' ){
			ref.style.display = 'block';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '+', '-' );
			}else{
				link.innerText = link.innerText.replace( '+', '-' );
			}
		}else{
			ref.style.display = 'none';

			if( link.textContent ){
				link.textContent = link.textContent.replace( '-', '+' );
			}else{
				link.innerText = link.innerText.replace( '-', '+' );
			}
		}
	},

	hideAR : function(){
		Show.LastAR.style.display = 'none';
	}
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 1 - Nature of Business<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Nature

      of Business</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax

      Labs, Inc. (&#8220;GeoVax&#8221; or the

      &#8220;Company&#8221;), is a biotechnology company developing

      vaccines that prevent and fight Human Immunodeficiency Virus

      (&#8220;HIV&#8221;) infections.&#160;&#160;HIV infections

      result in Acquired Immunodeficiency Syndrome

      (&#8220;AIDS&#8221;).&#160;&#160;We have exclusively licensed

      from Emory University (&#8220;Emory&#8221;) vaccine

      technology which was developed in collaboration with the

      National Institutes of Health (&#8220;NIH&#8221;) and the

      Centers for Disease Control and Prevention

      (&#8220;CDC&#8221;).&#160;&#160;GeoVax is incorporated under

      the laws of the State of Delaware and our principal offices

      are located in Smyrna, Georgia (metropolitan Atlanta

      area).</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      most advanced vaccines under development address the clade B

      subtype of the HIV virus that is most prevalent in the United

      States and the developed world.&#160;&#160;Our vaccines are

      being evaluated to determine their potential to (a) prevent

      HIV infection and (b) to serve as a therapy for individuals

      who are already infected with HIV.&#160;&#160;These vaccines

      are currently being evaluated in humans -- both in those

      infected with HIV and those who are not.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

      discussed in Note 2, the Company is a development-stage

      enterprise and we are devoting substantially all of our

      present efforts to research and development.&#160;&#160;We

      have funded our activities to date from government grants and

      clinical trial assistance, and from sales of our equity

      securities. We will continue to require substantial funds to

      continue these activities.&#160;&#160;We anticipate that our

      existing cash resources, combined with the proceeds from the

      NIH grant discussed in Note 3 and the financing events

      discussed in Note 11, should be sufficient to fund our

      operations into the first quarter of 2014.&#160;&#160;In

      order to meet our operating cash flow requirements, we intend

      to conduct additional offerings of our equity securities or

      convertible debt instruments. We are also seeking additional

      funding for our research programs through government grant

      funding mechanisms.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NatureOfOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EWMAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Licenses, accumulated amortization (in Dollars)</a></td>
        <td class="nump">$ 228,856<span></span></td>
        <td class="nump">$ 208,933<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Pr&#x435;f&#x435;rr&#x435;d stock, par valu&#x435; (in Dollars per share)</a></td>
        <td class="nump">$ 0.01<span></span></td>
        <td class="nump">$ 0.01<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Pr&#x435;f&#x435;rr&#x435;d stock, shar&#x435;s authoriz&#x435;d</a></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">10,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">40,000,000<span></span></td>
        <td class="nump">40,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">18,733,277<span></span></td>
        <td class="nump">16,442,611<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">18,733,277<span></span></td>
        <td class="nump">16,442,611<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series A Convertible Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Pr&#x435;f&#x435;rr&#x435;d stock, shar&#x435;s authoriz&#x435;d</a></td>
        <td class="nump">2,200<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_PreferredStockStatedValue', window );">Pr&#x435;f&#x435;rr&#x435;d stock, stat&#x435;d valu&#x435; (in Dollars per share)</a></td>
        <td class="nump">$ 1,000<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Pr&#x435;f&#x435;rr&#x435;d stock, shar&#x435;s issu&#x435;d</a></td>
        <td class="nump">788<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Pr&#x435;f&#x435;rr&#x435;d stock, shar&#x435;s outstanding</a></td>
        <td class="nump">788<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_PreferredStockStatedValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of convertible preferred stock; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_PreferredStockStatedValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7658586&amp;loc=d3e16323-109275<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 45<br><br> -Subparagraph a(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 11 - Subsequent Events<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent

      Events</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Warrant

      Modification and Exercise</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Effective

      January 17, 2013, we reduced the exercise price of our

      then-outstanding Series B Common Stock Purchase Warrants (see

      Note 6).&#160;&#160;The exercise price for all the Series B

      Warrants was reduced from $0.75 to $0.60 per

      share.&#160;&#160;The exercise price for the Series A

      Warrants and Series C Warrants that were issued concurrently

      with the Series B Warrants did not change.&#160;&#160;In

      consideration for the reduction of the exercise price, the

      holders of the Series B Warrants immediately exercised

      1,766,667 of the Series B Warrants for cash, resulting in

      total proceeds to the Company of $1,060,000.&#160;&#160;The

      expiration date of Series B Warrants with respect to the

      remaining 1,166,667 shares was extended from March 21, 2013

      to May 21, 2013.&#160;&#160;In January 2013, we recorded

      general and administrative expense of $218,551 associated

      with the warrant modifications.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EVRAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document And Entity Information (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 15, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">GeoVax Labs, Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-K<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,499,944<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10,176,944<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000832489<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Dec. 31,
         2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">FY<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityPublicFloat</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Schedule II - Valuation and Qualifying Accounts<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE

      II &#8211; VALUATION AND QUALIFYING ACCOUNTS</font>

    </div><br/><div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For

      the Years Ended December 31, 2012, 2011 and 2010</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additions</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Description</font>

            </div>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance

              at</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beginning</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of

              Period</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged

              to</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Costs

              and</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expenses</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Charged

              to</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deductions</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance

              at</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">End</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Of

              Period</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve

              Deducted in the Balance Sheet</font>

            </div>

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From

              the Asset to Which it Applies:</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowance

              for Deferred Tax Assets</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="40%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-446" style="MARGIN-LEFT: 9pt"></font>Year ended

              December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,230</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">796,237</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,112,961</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,274,506</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="40%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-447" style="MARGIN-LEFT: 9pt"></font>Year ended

              December 31, 2011</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-448" style="MARGIN-LEFT: 11.1pt"></font>888,561</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-449" style="MARGIN-LEFT: 46.75pt"></font>-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-450" style="MARGIN-LEFT: 0.2pt"></font>(873,584</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,230</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="40%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-451" style="MARGIN-LEFT: 9pt"></font>Year ended

              December 31, 2010</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,091,338</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-452" style="MARGIN-LEFT: 1.1pt"></font>1,160,405</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-453" style="MARGIN-LEFT: 46.75pt"></font>-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-454" style="MARGIN-LEFT: 0.2pt"></font>(675,490</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,576,253</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

      </table><br/><table border="0" cellpadding="0" cellspacing="0" id="hangingindent-92" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr valign="top" style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25;">

          <td style="TEXT-ALIGN: left; WIDTH: 18pt">

            <div style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>

            </div>

          </td>

          <td style="TEXT-ALIGN: left; WIDTH: 18pt">

            <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font>

            </div>

          </td>

          <td style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deductions

              represent the effect of expiring NOL carryforwards

              from prior years.</font>

            </div>

          </td>

        </tr>

      </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for any allowance and reserve accounts (their beginning and ending balances, as well as a reconciliation by type of activity during the period). Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 09<br><br> -Article 12<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e24092-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E1EAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Operations (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1">138 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Grant revenue</a></td>
        <td class="nump">$ 2,657,327<span></span></td>
        <td class="nump">$ 4,899,885<span></span></td>
        <td class="nump">$ 5,185,257<span></span></td>
        <td class="nump">$ 22,969,019<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">3,043,522<span></span></td>
        <td class="nump">4,276,375<span></span></td>
        <td class="nump">4,793,956<span></span></td>
        <td class="nump">28,674,198<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">1,752,765<span></span></td>
        <td class="nump">2,972,555<span></span></td>
        <td class="nump">3,162,134<span></span></td>
        <td class="nump">19,400,424<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );"></a></td>
        <td class="nump">4,796,287<span></span></td>
        <td class="nump">7,248,930<span></span></td>
        <td class="nump">7,956,090<span></span></td>
        <td class="nump">48,074,622<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(2,138,960)<span></span></td>
        <td class="num">(2,349,045)<span></span></td>
        <td class="num">(2,770,833)<span></span></td>
        <td class="num">(25,105,603)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_OtherIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
        <td class="nump">3,820<span></span></td>
        <td class="nump">2,219<span></span></td>
        <td class="nump">23,505<span></span></td>
        <td class="nump">344,130<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,669)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );"></a></td>
        <td class="nump">3,820<span></span></td>
        <td class="nump">2,219<span></span></td>
        <td class="nump">23,505<span></span></td>
        <td class="nump">338,461<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (2,135,140)<span></span></td>
        <td class="num">$ (2,346,826)<span></span></td>
        <td class="num">$ (2,747,328)<span></span></td>
        <td class="num">$ (24,767,142)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_BasicAndDilutedAbstract', window );"><strong>Basic and diluted:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per common share (in Dollars per share)</a></td>
        <td class="num">$ (0.12)<span></span></td>
        <td class="num">$ (0.15)<span></span></td>
        <td class="num">$ (0.18)<span></span></td>
        <td class="num">$ (2.09)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding (in Shares)</a></td>
        <td class="nump">18,315,669<span></span></td>
        <td class="nump">15,735,541<span></span></td>
        <td class="nump">15,651,308<span></span></td>
        <td class="nump">11,871,955<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_BasicAndDilutedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_BasicAndDilutedAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_OtherIncomeExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_OtherIncomeExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher OTS<br><br><br><br> -Name Federal Regulation (FR)<br><br><br><br> -Number Title 12<br><br><br><br> -Section 563c.102<br><br><br><br> -Paragraph 9<br><br><br><br> -Chapter V<br><br><br><br> -Subsection II<br><br><br><br> -LegacyDoc This is a non-GAAP reference that was included in the 2009 taxonomy.  It will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 34<br><br><br><br> -Paragraph 21<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 115<br><br><br><br> -Paragraph 14<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 130<br><br><br><br> -Paragraph 10, 15<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Emerging Issues Task Force (EITF)<br><br><br><br> -Number 87-21<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 95<br><br><br><br> -Paragraph 28, 29, 30<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br><br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph A7<br><br><br><br> -Appendix A<br><br><br><br><br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph 38<br><br><br><br> -Subparagraph a<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher AICPA<br><br><br><br> -Name Accounting Research Bulletin (ARB)<br><br><br><br> -Number 51<br><br><br><br> -Paragraph 38<br><br><br><br> -Subparagraph d<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 141<br><br><br><br> -Paragraph 51<br><br><br><br> -Subparagraph g<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 86<br><br><br><br> -Paragraph 11, 12<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br><br><br> -Number 2<br><br><br><br> -Paragraph 12, 13<br><br><br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueFromGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stockholders&#8217;

      Equity</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Series

      A Convertible Preferred Stock</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      Certificate of Incorporation authorizes us to issue up to

      10,000,000 shares of preferred stock, $.01 par

      value.&#160;&#160;In March 2012, we established from the

      authorized preferred stock a series of preferred stock,

      consisting of 2,200 shares of Series A Convertible Preferred

      Stock, $1,000 stated value (&#8220;Series A Preferred

      Shares&#8221;) and entered into a Securities Purchase

      Agreement (&#8220;SPA&#8221;) whereby we issued to three

      institutional investors (&#8220;Purchasers&#8221;) the Series

      A Preferred Shares for gross proceeds of $2.2

      million.&#160;&#160;Net proceeds to the Company from this

      transaction, after deduction of placement agent fees and

      other expenses, were approximately $2.0 million.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The

      Series A Preferred Shares may be converted at any time at the

      option of the Purchasers into shares of our common stock at a

      conversion price of $0.75 per share (&#8220;Conversion

      Price&#8221;), for an initial aggregate total of 2,933,333

      shares of our common stock (&#8220;Conversion

      Shares&#8221;).&#160;&#160;The Series A Preferred Shares have

      a liquidation preference equal to the initial purchase price,

      have no voting rights, and are not entitled to a

      dividend.&#160;&#160;Through December 31, 2012, a total of

      1,412 Series A Preferred Shares have been converted into

      1,882,667 shares of our common stock.&#160;&#160;As of

      December 31, 2012, there were 788 shares of Series A

      Preferred Shares outstanding, convertible into 1,050,667

      shares of our common stock.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant

      to the terms of the SPA, we issued to each Purchaser Series

      A, B and C Warrants (collectively, the

      &#8220;Warrants&#8221;), each to purchase up to a number of

      shares of our common stock equal to 100% of the Conversion

      Shares underlying the Series A Preferred Shares (up to

      2,933,333 shares in the aggregate for each of the three

      series of warrants, or 8,799,999 shares in total)

      (&#8220;Warrant Shares&#8221;).&#160;&#160;The Series A

      Warrants have an exercise price of $1.00 per share, are

      exercisable immediately, and expire on March 21,

      2017.&#160;&#160;The Series B Warrants have an exercise price

      of $0.75 per share, are exercisable immediately, and expire

      on March 21, 2013. The Series C Warrants have an exercise

      price of $1.00 per share and expire on March 21, 2017, but

      only vest and become exercisable upon, and in proportion to,

      the exercise of the one-year Series B

      Warrants.&#160;&#160;The Warrants contain anti-dilution

      provisions, which may, under certain circumstances, reduce

      the exercise price (but have no effect on the number of

      shares subject to the Warrants) if we sell or grant options

      to purchase, including rights to reprice, our common stock or

      common stock equivalents at a price lower than the exercise

      price of the Warrants, or if we announce plans to do

      so.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      connection with the sale of the Series A Preferred Shares, we

      entered into a Registration Rights Agreement

      (&#8220;RRA&#8221;) with the Purchasers, pursuant to which we

      filed a registration statement with the Securities and

      Exchange Commission (&#8220;SEC&#8221;) on April 3, 2012

      covering resale of the Conversion Shares and the Warrant

      Shares.&#160;&#160;&#160;It was declared effective by the SEC

      on April 13, 2012</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Accounting

      Treatment and Allocation of Proceeds</font>.&#160;&#160;We

      first assessed the Series A Preferred Shares under ASC Topic

      480, &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Distinguishing

      Liabilities from Equity</font>&#8221; (&#8220;ASC 480&#8221;)

      and determined such preferred stock not to be a liability

      under ASC 480.&#160;&#160;We next assessed the preferred

      stock under ASC Topic 815. &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Derivatives and

      Hedging</font>&#8221; (&#8220;ASC 815&#8221;).&#160;&#160;The

      preferred stock contains an embedded feature allowing an

      optional conversion by the holder into common stock which

      meets the definition of a derivative.&#160;&#160;However, we

      believe that the preferred stock is an &#8220;equity

      host&#8221; (as described by ASC 815) for purposes of

      assessing the embedded derivative for potential bifurcation

      and determined that the optional conversion feature is

      clearly and closely associated to the preferred stock host;

      we therefore determined that the embedded derivative does not

      require bifurcation and separate recognition under ASC

      815.&#160;&#160;We then assessed the preferred stock under

      ASC Topic 470, &#8220;<font style="FONT-STYLE: italic; DISPLAY: inline">Debt</font>&#8221;

      (&#8220;ASC 470&#8221;), and determined there to be a

      beneficial conversion feature (&#8220;BCF&#8221;) requiring

      recognition at its intrinsic value.&#160;&#160;Since the

      conversion option of the preferred stock was immediately

      exercisable, the amount allocated to the BCF was immediately

      accreted to preferred dividends, resulting in an increase in

      the carrying value of the preferred stock.&#160;&#160;We also

      assessed the warrants issued in connection with the financing

      under ASC 815 and determined that they did not initially meet

      the definition of a derivative, but will require evaluation

      on an on-going basis.&#160;&#160;As of December 31, 2012, we

      determined that the warrants still did not meet the

      definition of a derivative.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The

      following is a summary of the allocation of the net proceeds

      from the preferred stock financing, and reconciliation to the

      carrying value at December 31, 2012:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                proceeds after transaction costs</font>

              </div>

            </td>

            <td valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,999,032</font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less:&#160;&#160;&#160;&#160;&#160;

                &#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair

                value of warrants (recorded to Additional Paid-in

                Capital)</font></font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,127,418</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beneficial

                conversion feature (recorded to Additional Paid-in

                Capital)</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(762,667</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                proceeds allocated to preferred stock</font>

              </div>

            </td>

            <td valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108,947</font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accretion

                of beneficial conversion feature (deemed

                dividend)</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">762,667</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              &#160;

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial

                carrying value of preferred stock</font>

              </div>

            </td>

            <td valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">871,614</font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversions

                to common stock</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(559,418</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying

                value of preferred stock at December 31,

                2012</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">312,196</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              &#160;

            </td>

          </tr>

        </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Common

      Stock Transactions</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      February 2010, we issued 12,000 shares of our common stock in

      settlement of an obligation accrued at December 31, 2009 in

      the amount of $90,000.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During

      December 2011, we sold an aggregate of 658,520 shares of our

      common stock to a group of individual accredited investors

      (including members of our board of directors and management

      --see Note 9) for an aggregate purchase price of $441,210,

      $36,800 of which was received in January 2012 and is

      therefore reflected as a receivable (Other Current Asset) in

      the accompanying Consolidated Balance Sheet as of December

      31, 2011.&#160;&#160;We also issued to the investors warrants

      to purchase an aggregate of 987,783 shares of common stock at

      a price of $1.00 per share, which expire in December

      2016.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During

      January 2012, we sold an aggregate of 407,999 shares of our

      common stock to a group of individual accredited investors

      (including members of our board of directors and management

      --see Note 9) for an aggregate purchase price of

      $273,360.&#160;&#160;We also issued to the investors warrants

      to purchase an aggregate of 612,001 shares of common stock at

      a price of $1.00 per share, which expire in January

      2017.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From

      time to time, we issue shares of our common stock to

      consultants or others in exchange for

      services.&#160;&#160;During 2012, 2011 and 2010 we issued

      -0-, 129,245, and 10,500 shares, respectively, for such

      services; and we recorded general and administrative expense

      of $-0-, $150,000, and $53,813 during each respective period

      related to these issuances.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock

      Options</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      2006, we adopted the GeoVax Labs, Inc. 2006 Equity Incentive

      Plan (the &#8220;Stock Option Plan&#8221;) for the granting

      of qualified incentive stock options

      (&#8220;ISO&#8217;s&#8221;), nonqualified stock options,

      restricted stock awards or restricted stock bonuses to

      employees, officers, directors, consultants and advisors of

      the Company.&#160;&#160;The exercise price for any option

      granted may not be less than fair value (110% of fair value

      for ISO&#8217;s granted to certain

      employees).&#160;&#160;Options granted under the Stock Option

      Plan have a maximum ten-year term and generally vest over

      three years.&#160;&#160;The Company has reserved 1,200,000

      shares of its common stock for issuance under the Stock

      Option Plan.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A

      summary of activity under the Stock Option Plan as of

      December 31, 2012, and changes during the year then ended is

      presented below:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of

              Shares</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term

              (yrs)</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2011</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">928,242</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.43</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">238,500</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-435" style="MARGIN-LEFT: 36pt"></font>0.70</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-436" style="MARGIN-LEFT: 36pt"></font>-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited

              or expired</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(97,601</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-437" style="MARGIN-LEFT: 36pt"></font>4.02</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,069,141</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.50</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-438" style="MARGIN-LEFT: 36pt"></font>6.2</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">698,995</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.38</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-439" style="MARGIN-LEFT: 36pt"></font>4.6</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional

      information concerning our stock options for the years ended

      December 31, 2012, 2011 and 2010 is as follows:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

              average fair value of options granted during the

              period</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.59</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.79</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.95</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic

              value of options exercised during the period</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              fair value of options vested during the period</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">319,920</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">540,339</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">499,557</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      use the Black-Scholes model for determining the grant date

      fair value of our stock option grants.&#160;&#160;This model

      utilizes certain information, such as the interest rate on a

      risk-free security with a term generally equivalent to the

      expected life of the option being valued and requires certain

      other assumptions, such as the expected amount of time an

      option will be outstanding until it is exercised or expired,

      to calculate the fair value of stock options

      granted.&#160;&#160;The significant assumptions we used in

      our fair value calculations were as follows:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

              average risk-free interest rates</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.1</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.6</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

              dividend yield</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

              life of option (yrs)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: right">

            <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: right">

            <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: right">

            <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

              volatility</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105.2</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111.2</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.9</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-based

      compensation expense related to the Stock Option Plan was

      $310,076, $463,752, and $575,662 during the years ended

      December 31, 2012, 2011 and 2010,

      respectively.&#160;&#160;Stock option expense is allocated to

      research and development expense or to general and

      administrative expense based on the related employee

      classifications and corresponds to the allocation of employee

      salaries.&#160;&#160;For the three years ended December 31,

      2012, stock option expense was allocated as follows:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General

              and administrative expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">231,936</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">284,352</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">369,161</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

              and development expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78,140</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179,400</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206,501</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              stock option expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">310,076</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463,752</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575,662</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

      of December 31, 2012, there was $271,901 of unrecognized

      compensation expense related to stock-based compensation

      arrangements.&#160;&#160;The unrecognized compensation

      expense is expected to be recognized over a weighted average

      remaining period of 2.1 years.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock

      Purchase Warrants</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      have issued stock purchase warrants in connection with

      financing transactions and also in exchange for services from

      consultants and others.&#160;&#160;The following table

      presents a summary of stock purchase warrant transactions

      during the year ended December 31, 2012:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number

              of Shares</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

              Average</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise

              Price</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2011</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,870,559</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.96</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Series A Warrants (1)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Series B Warrants (1)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.75</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Series C Warrants (1)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Other Warrants (2)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">612,001</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited

              or expired</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(57,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,225,559</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.06</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,290,376</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.44</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)&#160;&#160;&#160;&#160;&#160;&#160;See

      discussion under &#8220;Series A Convertible Preferred

      Stock&#8221; above.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)&#160;&#160;&#160;&#160;&#160;&#160;See

      discussion under &#8220;Common Stock Transactions&#8221;

      above.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For

      stock purchase warrants issued to consultants or others in

      exchange for services, we record the related expense over the

      service period, or upon the date, that the service was

      rendered.&#160;&#160;Expense associated with such

      compensatory warrants was $-0-, $7,119, and $121,057 during

      the years ended December 31, 2012, 2011 and 2010,

      respectively All such expense was allocated to general and

      administrative expense.&#160;&#160;As of December 31, 2012,

      there was no unrecognized compensation expense related to

      compensatory warrants. .&#160;&#160;In addition to

      compensatory warrant expense, during 2011 we recorded

      $152,126 of general and administrative expense associated

      with the extension of certain investor warrants which were

      due to expire in 2011 to 2013.&#160;&#160;In January 2013,

      certain modifications were made to the terms of the Class B

      Warrants in exchange for the exercise of a portion of those

      warrants (see Note 11).</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable).  Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187143-122770<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Section B<br><br> -Paragraph 7, 11A<br><br> -Chapter 1<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 5<br><br> -Paragraph 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 20: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 2, 3, 4, 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 21: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 22: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 23: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 5 - 2006 Merger and Recapitalization<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2006

      Merger and Recapitalization</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The

      Company was originally incorporated in June 1988 under the

      laws of Illinois as Dauphin Technology, Inc.

      (&#8220;Dauphin&#8221;).&#160;&#160;Dauphin was unsuccessful

      and its operations were terminated in December

      2003.&#160;&#160;In September 2006, Dauphin completed a

      merger (the &#8220;Merger&#8221;) with GeoVax, Inc. which was

      incorporated under the laws of Georgia in June

      2001.&#160;&#160;As a result of the Merger, the shareholders

      of GeoVax, Inc. exchanged their shares of common stock for

      Dauphin common stock and GeoVax, Inc. became a wholly-owned

      subsidiary of Dauphin.&#160;&#160;Dauphin then changed its

      name to GeoVax Labs, Inc. and replaced its officers and

      directors with those of GeoVax, Inc.&#160;&#160;Subsequent to

      the Merger, the Company has not conducted any business other

      than GeoVax, Inc.&#8217;s business of developing human

      vaccines.&#160;&#160;The Merger was accounted for under the

      purchase method of accounting as a reverse acquisition in

      accordance with GAAP. Under this method of accounting,

      Dauphin was treated as the acquired company and, accordingly,

      all financial information prior to the date of Merger

      presented in the accompanying consolidated financial

      statements, or in the notes herein, as well as any references

      to prior operations, are those of GeoVax, Inc.&#160;&#160;In

      June 2008, the Company was reincorporated under the laws of

      Delaware.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 10 - Selected Quarterly Financial Data (unaudited) (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of Quarterly Financial Information [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012

              Quarter Ended</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue

              from grants</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">854,063</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">705,698</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">638,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">459,566</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(730,513</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(497,763</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(296,779</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(610,085</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss per share</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

      </table><table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011

              Quarter Ended</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue

              from grants</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">893,002</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,753,033</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,297,006</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">956,844</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(606,282</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(211,344</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(375,852</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,153,348</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss per share</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.08</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

      </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)-(j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20225539&amp;loc=d3e1280-108306<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0ESCAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Accounting, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basis

      of Presentation and Principles of Consolidation</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      primary business is conducted by our wholly-owned subsidiary,

      GeoVax, Inc. The accompanying consolidated financial

      statements include the accounts of GeoVax, Inc. from

      inception together with those of GeoVax Labs, Inc. from

      September 28, 2006 (see Note 5).&#160;&#160;All intercompany

      transactions have been eliminated in consolidation.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_DevelopmentStageEnterprisePolicyTextBlock', window );">Development-Stage Enterprise [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Development-Stage

      Enterprise</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      are devoting all of our present efforts to research and

      development and GeoVax is a development stage enterprise as

      defined by Financial Accounting Standards Board

      (&#8220;FASB&#8221;) Accounting Standards Codification

      (&#8220;ASC&#8221;) Topic 915, <font style="FONT-STYLE: italic; DISPLAY: inline">Development Stage

      Entities</font>.&#160;&#160;All losses accumulated since

      inception (June 27, 2001) have been considered as part of our

      development stage activities.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Use

      of Estimates</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The

      preparation of financial statements in conformity with

      accounting principles generally accepted in the United States

      of America (&#8220;GAAP&#8221;) requires us to make estimates

      and assumptions that affect the reported amounts of assets

      and liabilities and disclosure of contingent assets and

      liabilities at the date of the financial statements and the

      reported amounts of revenues and expenses during the

      reporting period.&#160;&#160;Actual results may differ from

      those estimates.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash

      and Cash Equivalents</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      consider all highly liquid investments with a maturity of

      three months or less when purchased to be cash

      equivalents.&#160;&#160;Our cash and cash equivalents consist

      primarily of bank deposits and money market

      accounts.&#160;&#160;The recorded values approximate fair

      market values due to the short maturities.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair

      Value of Financial Instruments and Concentration of Credit

      Risk</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial

      instruments that subject us to concentration of credit risk

      consist primarily of cash and cash equivalents, which are

      maintained by a high credit quality financial institution.

      The carrying values reported in the balance sheets for cash

      and cash equivalents approximate fair values.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property

      and Equipment</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property

      and equipment are stated at cost, less accumulated

      depreciation and amortization.&#160;&#160;The components of

      property and equipment as of December 31, 2012 and 2011 are

      as follows:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory

              equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold

              improvements</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other

              furniture, fixtures &amp; equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              property and equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated

              depreciation and amortization</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(429,804</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(356,084</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property

              and equipment, net</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,486</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Expenditures

      for maintenance and repairs are charged to operations as

      incurred, while additions and improvements are

      capitalized.&#160;&#160;Depreciation is computed using the

      straight-line method over the estimated useful lives of the

      assets which range from three to five

      years.&#160;&#160;Amortization of leasehold improvements is

      computed using the straight-line method over the remaining

      term of the related lease.&#160;&#160;Depreciation and

      amortization expense was $73,720, $84,131, and $94,887 during

      the years ended December 31, 2012, 2011 and 2010,

      respectively.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_OtherAssetsPolicyTextBlock', window );">Other Assets [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

      Assets</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

      assets consist principally of license agreements for the use

      of technology obtained through the issuance of the

      Company&#8217;s common stock.&#160;&#160;These license

      agreements are amortized on a straight line basis over ten

      years.&#160;&#160;Amortization expense related to these

      agreements was $19,923, $24,886, and $24,886 during years

      ended December 31, 2012, 2011, and 2010, respectively, and is

      expected to be $10,000, $10,000, $-0-, $-0-, and $-0- for

      each of the next five years, respectively.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Impairment

      of Long-Lived Assets</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      review long-lived assets for impairment whenever events or

      changes in circumstances indicate that the carrying amount of

      an asset may not be recoverable.&#160;&#160;Recoverability of

      assets to be held and used is measured by a comparison of the

      carrying amount of the assets to the future net cash flows

      expected to be generated by such assets.&#160;&#160;If we

      consider such assets to be impaired, the impairment to

      be<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>recognized

      is measured by the amount by which the carrying amount of the

      assets exceeds the expected future net cash flows from the

      assets.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_AccruedLiabilitiesPolicyTextBlock', window );">Accrued Liabilities [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accrued

      Liabilities</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

      part of the process of preparing our financial statements, we

      estimate expenses that we believe we have incurred, but have

      not yet been billed by our third party vendors. This process

      involves identifying services and activities that have been

      performed by such vendors on our behalf and estimating the

      level to which they have been performed and the associated

      cost incurred for such service as of each balance sheet date

      in our financial statements. Examples of expenses for which

      we accrue include fees for professional services and fees

      owed to contract manufacturers in conjunction with the

      manufacture of vaccines for our clinical trials. We make

      these estimates based upon progress of activities related to

      contractual obligations and information received from

      vendors.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net

      Loss Per Share</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic

      and diluted loss per common share are computed based on the

      weighted average number of common shares outstanding. All

      common share equivalents (which consist of options and

      warrants) are excluded from the computation of diluted loss

      per share since the effect would be anti-dilutive. Common

      share equivalents which could potentially dilute basic

      earnings per share in the future, and which were excluded

      from the computation of diluted loss per share, totaled

      approximately 12.3 million, 2.8 million, and 2.0 million at

      December 31, 2012, 2011 and 2010, respectively.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenue

      Recognition</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      recognize revenue in accordance with the SEC&#8217;s Staff

      Accounting Bulletin No. 101, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue

      Recognition in Financial Statements,</font> as amended by

      Staff Accounting Bulletin No. 104, <font style="FONT-STYLE: italic; DISPLAY: inline">Revenue

      Recognition,</font> (&#8220;SAB 104&#8221;). SAB 104 provides

      guidance in applying GAAP to revenue recognition issues, and

      specifically addresses revenue recognition for upfront,

      nonrefundable fees received in connection with research

      collaboration agreements.&#160;&#160;During 2012, 2011 and

      2010, our revenue consisted of grant funding received

      primarily from the NIH (see Note 3).&#160;&#160;Revenue from

      this arrangement is approximately equal to the costs incurred

      and is recorded as income as the related costs are

      incurred.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research

      and Development Expense</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research

      and development expense primarily consists of costs incurred

      in the discovery, development, testing and manufacturing of

      our product candidates. These expenses consist primarily of

      (i) fees paid to third-party service providers to perform,

      monitor and accumulate data related to our preclinical

      studies and clinical trials, (ii) costs related to sponsored

      research agreements, (iii) the costs to procure and

      manufacture materials used in clinical trials, (iv)

      laboratory supplies and facility-related expenses to conduct

      development, and (v) salaries, benefits, and share-based

      compensation for personnel.&#160;&#160;These costs are

      charged to expense as incurred.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patent

      Costs</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      expenditures relating to obtaining and protecting patents are

      charged to expense when incurred, and are included in general

      and administrative expense.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_PeriodToPeriodComparisonsPolicyTexBlock', window );">Period to Period Comparisons [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Period

      to Period Comparisons</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our

      operating results are expected to fluctuate for the

      foreseeable future. Therefore, period-to-period comparisons

      should not be relied upon as predictive of the results for

      future periods.&#160;&#160;Certain prior year amounts have

      been reclassified to conform to the current year financial

      statement presentation.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Tax, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income

      Taxes</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      account for income taxes using the liability method. Under

      this method, deferred tax assets and liabilities are

      recognized for the estimated future tax consequences

      attributable to differences between the financial statement

      carrying amounts of existing assets and liabilities and their

      respective tax bases.&#160;&#160;Deferred tax assets and

      liabilities are measured using enacted rates in effect for

      the year in which temporary differences are expected to be

      recovered or settled.&#160;&#160;Deferred tax assets are

      reduced by a valuation allowance unless, in the opinion of

      management, it is more likely than not that some portion or

      all of the deferred tax assets will be realized.</font></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-Based

      Compensation</font><br />

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      account for stock-based transactions in which the Company

      receives services from employees, directors or others in

      exchange for equity instruments based on the fair value of

      the award at the grant date.&#160;&#160;Compensation cost for

      awards of common stock is estimated based on the price of the

      underlying common stock on the date of

      issuance.&#160;&#160;Compensation cost for stock options or

      warrants is estimated at the grant date based on each

      instrument&#8217;s fair value as calculated by the

      Black-Scholes option pricing model.&#160;&#160;We recognize

      stock-based compensation cost as expense ratably on a

      straight-line basis over the requisite service period for the

      award.&#160;&#160;See Note 6 for additional stock-based

      compensation information.</font></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recent

      Accounting Pronouncements</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There

      have been no recent accounting pronouncements or changes in

      accounting pronouncements which we expect to have a material

      impact on our financial statements, nor do we believe that

      any recently issued, but not yet effective, accounting

      standards if currently adopted would have a material effect

      on our financial statements.</font></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_AccruedLiabilitiesPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding accrued liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_AccruedLiabilitiesPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_DevelopmentStageEnterprisePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding development-stage enterprise.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_DevelopmentStageEnterprisePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_OtherAssetsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding other assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_OtherAssetsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_PeriodToPeriodComparisonsPolicyTexBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding period to period comparisons.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_PeriodToPeriodComparisonsPolicyTexBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 7, 8, 9, 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Technical Practice Aid (TPA)<br><br> -Number 2110<br><br> -Paragraph 6<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122427<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 40<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 128<br><br> -Paragraph 6, 8-16, 60<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for determining the fair value of financial instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155942<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 107<br><br> -Paragraph 8, 10, 12, 13, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueOfFinancialInstrumentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 144<br><br> -Paragraph 7-15, 26, 30-37<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section CC<br><br> -Subsection 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 48<br><br> -Paragraph 20<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-109318<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 4<br><br> -Paragraph 11<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 6-34, 43, 47, 49<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-109318<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 142<br><br> -Paragraph 11-15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144471<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 144<br><br> -Paragraph 7-18, 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsFiniteLivedPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for property, plant and equipment which may include the basis of such assets, depreciation methods used and estimated useful lives, the entity's capitalization policy, including its accounting treatment for costs incurred for repairs and maintenance activities, whether such asset balances include capitalized interest and the method by which such is calculated, how disposals of such assets are accounted for and how impairment of such assets is assessed and recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 12, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 34<br><br> -Paragraph 8, 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 43<br><br> -Section C<br><br> -Paragraph 5<br><br> -Chapter 9<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 144<br><br> -Paragraph 7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 2<br><br> -Paragraph 8, 12, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Interpretation (FIN)<br><br> -Number 6<br><br> -Paragraph 5, 6, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 141<br><br> -Paragraph 42<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2127266<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Research and Development<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpensePolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6600647&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 22<br><br> -Paragraph 8, 12, 13<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2228939<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 06-11<br><br> -Paragraph 7<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Statement of Position (SOP)<br><br> -Number 94-6<br><br> -Paragraph 11, 14<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 9 - Related Party Transactions<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions Disclosure [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related

      Party Transactions</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      are obligated to reimburse Emory University (a significant

      stockholder of the Company) for ongoing costs in connection

      with the filing, prosecution and maintenance of patent

      applications subject to a license agreement for technology

      associated with the vaccines we are

      developing.&#160;&#160;The expense associated with these

      ongoing patent cost reimbursements to Emory amounted to

      $89,885, $249,907, and $193,674 for the years ended December

      31, 2012, 2011, and 2010, respectively.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      connection with our IPCAVD grant from the NIH (see Note 3),

      we have entered into two subcontracts with Emory for the

      purpose of conducting research and development activities

      related to the grant.&#160;&#160;During 2012, 2011, and 2010,

      we recorded $552,403, $1,172,758, and $1,391,203,

      respectively, of expense associated with these

      subcontracts.&#160;&#160;All amounts paid to Emory under

      these subcontracts are reimbursable to us pursuant to the NIH

      grant.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      March 2008, we entered into a consulting agreement with

      Donald Hildebrand, a former member of our Board of Directors

      and our former President &amp; Chief Executive Officer,

      pursuant to which Mr. Hildebrand has provided business and

      technical advisory services to the Company.&#160;&#160;The

      term of the consulting agreement, as amended, began on April

      1, 2008 and ended on December 31, 2012.&#160;&#160;During

      2012, 2011, and 2010, we recorded $24,000, $24,000, and

      $57,600, respectively, of expense associated with the

      consulting agreement.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      December 2011 and January 2012, members of our management and

      Board of Directors participated in the private placement

      offering of our common stock and warrants (see Note 6),

      whereby they purchased an aggregate of 380,954 shares of our

      common stock for a total purchase price of $255,239 and

      received five-year warrants to purchase an additional 571,432

      shares of our common stock exercisable at $1.00 per

      share.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 57<br><br> -Paragraph 1-4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph b<br><br> -Article 3A<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph k<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RelatedPartyTransactionsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 7 - Retirement Plan<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension and Other Postretirement Benefits Disclosure [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Retirement

      Plan</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      participate in a multi-employer defined contribution

      retirement plan (the &#8220;401k Plan&#8221;) administered by

      a third party service provider; and the Company contributes

      to the 401k Plan on behalf of its employees based upon a

      matching formula.&#160;&#160;During the years ended December

      31, 2012, 2011 and 2010 our contributions to the 401k Plan

      were $50,500, $56,928, and $52,632, respectively.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for pension and other postretirement benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 158<br><br> -Paragraph 7, 21, 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name FASB Staff Position (FSP)<br><br> -Number FAS106-2<br><br> -Paragraph 20, 21, 22<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Implementation Guide (Q and A)<br><br> -Number FAS88<br><br> -Paragraph 63<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 106<br><br> -Paragraph 518<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 715<br><br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5, 6, 7, 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 8<br><br> -Subparagraph m<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 87<br><br> -Paragraph 264<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 30<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 03-2<br><br> -Paragraph 8<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph h<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 132R<br><br> -Paragraph 5<br><br> -Subparagraph q<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 - Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income

      Taxes</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At

      December 31, 2012, we have a consolidated federal net

      operating loss (&#8220;NOL&#8221;) carryforward of

      approximately $69.8 million, available to offset against

      future taxable income which expires in varying amounts in

      2013 through 2032.&#160;&#160;Additionally, we have

      approximately $764,000 in research and development

      (&#8220;R&amp;D&#8221;) tax credits that expire in 2022

      through 2031 unless utilized earlier.&#160;&#160;No income

      taxes have been paid to date.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As

      a result of the Merger discussed in Note 5, our NOL

      carryforward increased substantially due to the addition of

      historical NOL carryforwards for Dauphin Technology,

      Inc.&#160;&#160;However, Section 382 of the Internal Revenue

      Code contains provisions that may limit our utilization of

      NOL and R&amp;D tax credit carryforwards in any given year as

      a result of significant changes in ownership interests that

      have occurred in past periods or may occur in future

      periods.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deferred

      income taxes reflect the net effect of temporary differences

      between the carrying amounts of assets and liabilities for

      financial reporting purposes and the amounts used for income

      tax purposes.&#160;&#160;Significant components of our

      deferred tax assets and liabilities included the following at

      December 31, 2012 and 2011:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred

              tax assets:</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              operating loss carryforward</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,429,472</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,872,082</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

              and development tax credit carryforward</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,965</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">763,690</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based

              compensation expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,097,194</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,991,769</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              deferred tax assets</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,290,631</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,627,541</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred

              tax liabilities</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,125</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36,311</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; PADDING-LEFT: 4%">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              deferred tax liabilities</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,125</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36,311</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              deferred tax assets</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,274,506</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,591,230</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation

              allowance</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,274,506</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,591,230</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      have established a full valuation allowance equal to the

      amount of our net deferred tax assets due to uncertainties

      with respect to our ability to generate sufficient taxable

      income to realize these assets in the future. A

      reconciliation of the income tax benefit on losses at the

      U.S. federal statutory rate to the reported income tax

      expense is as follows:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S.

              federal statutory rate applied to pretax loss</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(725,948</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(797,921</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(934,092</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Permanent

              differences</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-440" style="MARGIN-LEFT: 32.15pt"></font>2,674</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,216</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-441" style="MARGIN-LEFT: 19.6pt"></font>(77,200</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

              and development credits</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-442" style="MARGIN-LEFT: 57.7pt"></font>-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32,675</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-443" style="MARGIN-LEFT: 28.45pt"></font>59,959</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Change

              in valuation allowance</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-444" style="MARGIN-LEFT: 18.8pt"></font>723,274</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">761,030</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-445" style="MARGIN-LEFT: 21.8pt"></font>951,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reported

              income tax expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="14%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 136, 172<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 43, 44, 45, 46, 47, 48, 49<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 10 - Selected Quarterly Financial Data (unaudited)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Financial Information [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">10.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selected

      Quarterly Financial Data (unaudited)</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A

      summary of selected quarterly financial data for 2012 and

      2011 is as follows:</font>

    </div><br/><table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012

              Quarter Ended</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue

              from grants</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">854,063</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">705,698</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">638,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">459,566</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(730,513</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(497,763</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(296,779</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(610,085</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss per share</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.03</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

      </table><br/><table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011

              Quarter Ended</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September

              30</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December

              31</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenue

              from grants</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">893,002</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,753,033</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,297,006</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">956,844</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(606,282</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(211,344</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(375,852</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,153,348</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

              loss per share</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.04</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.01</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.02</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="9%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.08</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

      </table><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the quarterly financial data in the annual financial statements.  The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)-(j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20225539&amp;loc=d3e1280-108306<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section G<br><br> -Subsection 1<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e765-108305<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 28<br><br> -Paragraph 30<br><br> -Subparagraph a-j<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e725-108305<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 28<br><br> -Paragraph 23, 24<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-K (SK)<br><br> -Number 229<br><br> -Section 302<br><br> -Paragraph a<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_QuarterlyFinancialInformationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EYJAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Detail) - Stock Purchase Warrant Transactions (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jan. 31, 2013</div>
        </th>
        <th class="th" colspan="2">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding at December 31, 2011 (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,870,559<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice', window );">Outstanding at December 31, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 7.96<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightExercises', window );">Exercised (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice', window );">Exercised</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightForfeituresAndExpirations', window );">Forfeited or expired (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(57,000)<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice', window );">Forfeited or expired</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 7.00<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding at December 31, 2012 (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">11,225,559<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice', window );">Outstanding at December 31, 2012</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2.06<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightExercisableNumber', window );">Exercisable at December 31, 2012 (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,290,376<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice', window );">Exercisable at December 31, 2012</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2.44<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series A Warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightIssuedDuringPeriod', window );">Number of Shares (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantIssuedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series B Warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightIssuedDuringPeriod', window );">Number of Shares (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantIssuedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.75<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightExercises', window );">Exercised (in Shares)</a></td>
        <td class="nump">1,766,667<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series C Warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightIssuedDuringPeriod', window );">Number of Shares (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,933,333<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantIssuedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Other Warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightIssuedDuringPeriod', window );">Number of Shares (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 612,001<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantIssuedWeightedAverageExercisePrice', window );">Weighted Average Exercise Price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.00<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
      </tr>
      <tr>
        <td colspan="4"></td>
      </tr>
      <tr>
        <td colspan="4">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">See discussion under "Series A Convertible Preferred Stock" above.</td>
            </tr>
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[2]</td>
              <td style="vertical-align: top;" valign="top">See discussion under "Common Stock Transactions" above.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantIssuedWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant issued, weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantIssuedWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of exercisable warrants outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right, exercisable, weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants exercised during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightExercises</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right, exercises, weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightExercisesWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightForfeituresAndExpirations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants forfeited or expired during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightForfeituresAndExpirations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right, forfeitures and expirations, weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightForfeituresAndExpirationsWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightIssuedDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants issued during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightIssuedDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right, outstanding, weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate amount of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EMCAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 6 - Stockholders' Equity (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock', window );">Allocation of Net Proceeds from Preferred Stock Financing [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                proceeds after transaction costs</font>

              </div>

            </td>

            <td valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,999,032</font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less:&#160;&#160;&#160;&#160;&#160;

                &#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fair

                value of warrants (recorded to Additional Paid-in

                Capital)</font></font>

              </div>

            </td>

            <td align="left" valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,127,418</font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beneficial

                conversion feature (recorded to Additional Paid-in

                Capital)</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(762,667</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net

                proceeds allocated to preferred stock</font>

              </div>

            </td>

            <td valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">108,947</font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accretion

                of beneficial conversion feature (deemed

                dividend)</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">762,667</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              &#160;

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Initial

                carrying value of preferred stock</font>

              </div>

            </td>

            <td valign="bottom" width="1%">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">871,614</font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

              &#160;

            </td>

          </tr>

          <tr style="background-color: #C0FFFF;">

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 2px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Conversions

                to common stock</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

              &#160;

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(559,418</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

            </td>

          </tr>

          <tr>

            <td align="left" valign="bottom" width="85%" style="PADDING-BOTTOM: 4px">

              <div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">

                <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying

                value of preferred stock at December 31,

                2012</font>

              </div>

            </td>

            <td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px">

              &#160;

            </td>

            <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

            </td>

            <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">312,196</font></font></font>

            </td>

            <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

              &#160;

            </td>

          </tr>

        </table><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of

              Shares</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Price</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Remaining</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contractual</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term

              (yrs)</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Aggregate</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2011</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">928,242</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.43</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">238,500</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-435" style="MARGIN-LEFT: 36pt"></font>0.70</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-436" style="MARGIN-LEFT: 36pt"></font>-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited

              or expired</font>

            </div>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(97,601</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-437" style="MARGIN-LEFT: 36pt"></font>4.02</font>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,069,141</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.50</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-438" style="MARGIN-LEFT: 36pt"></font>6.2</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">698,995</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.38</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1-439" style="MARGIN-LEFT: 36pt"></font>4.6</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-0-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_AdditionalInformationConcerningStockOptionsTableTextBlock', window );">Additional Information Concerning Stock Options [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

              average fair value of options granted during the

              period</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.59</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.79</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.95</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intrinsic

              value of options exercised during the period</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              fair value of options vested during the period</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">319,920</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">540,339</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">499,557</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

      </table><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

              average risk-free interest rates</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.1</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.4</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.6</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

              dividend yield</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.0</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

              life of option (yrs)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: right">

            <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="TEXT-ALIGN: right">

            <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="TEXT-ALIGN: right">

            <div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.7</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected

              volatility</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105.2</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">111.2</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112.9</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font>

          </td>

        </tr>

      </table><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General

              and administrative expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">231,936</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">284,352</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">369,161</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research

              and development expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78,140</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179,400</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">206,501</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="55%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              stock option expense</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">310,076</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463,752</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575,662</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

      </table><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="100%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number

              of Shares</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted

              Average</font>

            </div>

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise

              Price</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2011</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,870,559</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.96</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Series A Warrants (1)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Series B Warrants (1)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.75</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Series C Warrants (1)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,933,333</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issued

              &#8211; Other Warrants (2)</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">612,001</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercised</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">--</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited

              or expired</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(57,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.00</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            &#160;

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Outstanding

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,225,559</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.06</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercisable

              at December 31, 2012</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,290,376</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            &#160;

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.44</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            &#160;

          </td>

        </tr>

      </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_AdditionalInformationConcerningStockOptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of additional information concerning stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_AdditionalInformationConcerningStockOptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of allocation of net proceeds from preferred stock financing.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_AllocationOfNetProceedsFromPreferredStockFinancingTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph A240<br><br> -Subparagraph g(1)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 123R<br><br> -Paragraph 64<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6793087&amp;loc=d3e301413-122809<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number D-98<br><br> -Paragraph 2<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EMHBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 3 - Government Grants (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1">138 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">59 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="4">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2011</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2013

</div>
          <div>First NIH Grant [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2012

</div>
          <div>First NIH Grant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>First NIH Grant [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2013

</div>
          <div>Second NIH Grant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Second NIH Grant [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>NIH Grants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>NIH Grants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>NIH Grants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>QTDP Grant [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ProjectPeriodCoveredByGrants', window );">Project Period Covered by Grants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">1 year<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ProjectExtensionPeriod', window );">Project Extension Period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">1 year<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_GrantAward', window );">Grant Award</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 20,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 244,479<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_UnusedGrantFunds', window );">Unused Grant Funds</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Revenue from Grants</a></td>
        <td class="nump">$ 459,566<span></span></td>
        <td class="nump">$ 638,000<span></span></td>
        <td class="nump">$ 705,698<span></span></td>
        <td class="nump">$ 854,063<span></span></td>
        <td class="nump">$ 956,844<span></span></td>
        <td class="nump">$ 1,297,006<span></span></td>
        <td class="nump">$ 1,753,033<span></span></td>
        <td class="nump">$ 893,002<span></span></td>
        <td class="nump">$ 2,657,327<span></span></td>
        <td class="nump">$ 4,899,885<span></span></td>
        <td class="nump">$ 5,185,257<span></span></td>
        <td class="nump">$ 22,969,019<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 2,657,327<span></span></td>
        <td class="nump">$ 4,899,885<span></span></td>
        <td class="nump">$ 4,940,778<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_GrantAward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Grant award.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_GrantAward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ProjectExtensionPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Project extension period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ProjectExtensionPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ProjectPeriodCoveredByGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The project period covered by grants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ProjectPeriodCoveredByGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_UnusedGrantFunds">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unused grant funds.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_UnusedGrantFunds</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueFromGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EPEAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 11 - Subsequent Events (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2013

</div>
          <div>Series B Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 17, 2013

</div>
          <div>Series B Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Series B Warrants [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.60<span></span></td>
        <td class="nump">0.75<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightExercises', window );">Class of Warrant or Right, Exercises</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,766,667<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from Warrant Exercises (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,060,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended', window );">Class of Warrant or Right, Number of Remaining Shares Whose Expiration Was Extended</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,166,667<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other General and Administrative Expense (in Dollars)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 152,126<span></span></td>
        <td class="nump">$ 218,551<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants exercised during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightExercises</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class of warrant or right, number of remaining shares whose expiration was extended.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_ClassOfWarrantOrRightNumberOfRemainingSharesWhoseExpirationWasExtended</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exercise price of each class of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6881521&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of expenses not otherwise specified in the taxonomy for managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherGeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromWarrantExercises</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EL6BM">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficiency) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Series A Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Additional Paid-in Capital [Member]</div>
        </th>
        <th class="th">
          <div>Stock Subscription Receivable [Member]</div>
        </th>
        <th class="th">
          <div>Accumulated Deficit during Development Stage [Member]</div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 26, 2001</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception', window );">Capital contribution at inception (June 27, 2001)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(170,592)<span></span></td>
        <td class="num">(170,592)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2001</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(170,592)<span></span></td>
        <td class="num">(170,582)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(618,137)<span></span></td>
        <td class="num">(618,137)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,790<span></span></td>
        <td class="num">(2,320)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">470<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,789,954<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock for technology license</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">705<span></span></td>
        <td class="nump">148,151<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">148,856<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock for technology license (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">704,534<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2002</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,495<span></span></td>
        <td class="nump">145,841<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(788,729)<span></span></td>
        <td class="num">(639,393)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2002</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,494,488<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(947,804)<span></span></td>
        <td class="num">(947,804)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,229<span></span></td>
        <td class="nump">2,458,380<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,459,609<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,229,278<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2003</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,724<span></span></td>
        <td class="nump">2,604,221<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,736,533)<span></span></td>
        <td class="nump">872,412<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2003</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,723,766<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,351,828)<span></span></td>
        <td class="num">(2,351,828)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,483<span></span></td>
        <td class="nump">2,988,436<span></span></td>
        <td class="num">(2,750,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">239,919<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,482,605<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">750,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">750,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock for technology license</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">49<span></span></td>
        <td class="nump">99,951<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock for technology license (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">49,420<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2004</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,256<span></span></td>
        <td class="nump">5,692,608<span></span></td>
        <td class="num">(2,000,000)<span></span></td>
        <td class="num">(4,088,361)<span></span></td>
        <td class="num">(389,497)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2004</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,255,791<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,611,086)<span></span></td>
        <td class="num">(1,611,086)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2005</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,256<span></span></td>
        <td class="nump">5,692,608<span></span></td>
        <td class="num">(500,000)<span></span></td>
        <td class="num">(5,699,447)<span></span></td>
        <td class="num">(500,583)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2005</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,255,791<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(584,166)<span></span></td>
        <td class="num">(584,166)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,551<span></span></td>
        <td class="nump">1,071,565<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,075,116<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,550,851<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Common stock issued in connection with merger</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,360<span></span></td>
        <td class="nump">1,708,489<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,712,849<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issued in connection with merger (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,359,891<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon option and warrant exercise</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">57<span></span></td>
        <td class="num">(57)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon option and warrant exercise (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">56,825<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2006</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,224<span></span></td>
        <td class="nump">8,472,605<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(6,283,613)<span></span></td>
        <td class="nump">2,203,216<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2006</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,223,358<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(4,241,796)<span></span></td>
        <td class="num">(4,241,796)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">407<span></span></td>
        <td class="nump">3,162,543<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,162,950<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">406,729<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon option and warrant exercise</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="nump">4,998<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon option and warrant exercise (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,471<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,518,496<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,518,496<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2007</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,633<span></span></td>
        <td class="nump">13,158,642<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(10,525,409)<span></span></td>
        <td class="nump">2,647,866<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2007</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,632,558<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,728,187)<span></span></td>
        <td class="num">(3,728,187)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">306<span></span></td>
        <td class="nump">1,770,785<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,771,091<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">306,419<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10<span></span></td>
        <td class="nump">73,990<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">74,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,945,049<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,945,049<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2008</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,949<span></span></td>
        <td class="nump">16,948,466<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(14,253,596)<span></span></td>
        <td class="nump">2,709,819<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2008</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">14,948,977<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(3,284,252)<span></span></td>
        <td class="num">(3,284,252)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">216<span></span></td>
        <td class="nump">1,519,784<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,520,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">216,261<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5<span></span></td>
        <td class="nump">31,495<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">31,500<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon option and warrant exercise</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">463<span></span></td>
        <td class="nump">1,499,537<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon option and warrant exercise (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">462,826<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,267,165<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,267,165<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2009</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,633<span></span></td>
        <td class="nump">21,266,447<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(17,537,848)<span></span></td>
        <td class="nump">3,744,232<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2009</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,632,564<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,747,328)<span></span></td>
        <td class="num">(2,747,328)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12<span></span></td>
        <td class="nump">89,988<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">90,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10<span></span></td>
        <td class="nump">53,803<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">53,813<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,500<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">696,719<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">696,719<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit', window );">Fractional share cash payout upon reverse split</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,210)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,210)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Fractional share cash payout upon reverse split (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(218)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2010</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,655<span></span></td>
        <td class="nump">22,105,747<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(20,285,176)<span></span></td>
        <td class="nump">1,836,226<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2010</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,654,846<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,346,826)<span></span></td>
        <td class="num">(2,346,826)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">659<span></span></td>
        <td class="nump">440,551<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">441,210<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">658,520<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">129<span></span></td>
        <td class="nump">149,871<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">150,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">129,245<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">129,245<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">404,410<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">622,997<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">622,997<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16,443<span></span></td>
        <td class="nump">23,319,166<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(22,632,002)<span></span></td>
        <td class="nump">703,607<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16,442,611<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,135,140)<span></span></td>
        <td class="num">(2,135,140)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">408<span></span></td>
        <td class="nump">272,952<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">273,360<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">407,999<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Sale of convertible preferred stock and warrants for cash</a></td>
        <td class="nump">871,614<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,127,418<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,999,032<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Sale of convertible preferred stock and warrants for cash (in Shares)</a></td>
        <td class="nump">2,200<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock for services (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash payments received on stock subscription receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">310,160<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock</a></td>
        <td class="num">(559,418)<span></span></td>
        <td class="nump">1,882<span></span></td>
        <td class="nump">557,536<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of preferred stock to common stock (in Shares)</a></td>
        <td class="num">(1,412)<span></span></td>
        <td class="nump">1,882,667<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon option and warrant exercise (in Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">310,076<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">310,076<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2012</a></td>
        <td class="nump">$ 312,196<span></span></td>
        <td class="nump">$ 18,733<span></span></td>
        <td class="nump">$ 25,587,148<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (24,767,142)<span></span></td>
        <td class="nump">$ 1,150,935<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in Shares) at Dec. 31, 2012</a></td>
        <td class="nump">788<span></span></td>
        <td class="nump">18,733,277<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents increases in additional paid in capital attributable to capital contribution at inception.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionAtInception</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate adjustment to additional paid in capital for stock to account for a stock split in the case where the per-share par value or stated value is not reduced or increased proportionately such that the total par value or stated value remains the same for all shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Stock Split<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6525746<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalStockSplit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6880815&amp;loc=d3e20235-122688<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 130<br><br> -Paragraph 10, 15<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Emerging Issues Task Force (EITF)<br><br> -Number 87-21<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 28, 29, 30<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3602-108585<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=20435746&amp;loc=d3e565-108580<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A7<br><br> -Appendix A<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph 38<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 95<br><br> -Paragraph 18<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6943989&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross value of stock (or other type of equity) granted during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). This element is not the recognition of equity-based compensation expense in pursuant to FAS 123R. That element is AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue (Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Value).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Research Bulletin (ARB)<br><br> -Number 51<br><br> -Paragraph A3<br><br> -Appendix A<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6228006&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period pursuant to acquisitions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 141<br><br> -Paragraph 53<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 141<br><br> -Paragraph 51<br><br> -Subparagraph d<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesAcquisitions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-30)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4, 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reduction in the number of shares during the period as a result of a reverse stock split.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued pursuant to acquisitions during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueAcquisitions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gross value of stock issued during the period upon the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 129<br><br> -Paragraph 4, 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued as a result of the exercise of stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6959260&amp;loc=d3e187085-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 10<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 4 - Commitments<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments Disclosure [Text Block]</a></td>
        <td class="text"><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Commitments</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Lease

      Agreements</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We

      lease approximately 8,400 square feet of office and

      laboratory space located in Smyrna, Georgia (metropolitan

      Atlanta). Rent expense for the years ended December 31, 2012,

      2011 and 2010 was $118,801, $119,255, and $118,988,

      respectively.&#160;&#160;Future minimum lease payments

      pursuant to the 62 month lease total $125,180 in 2013 and

      $128,920 in 2014.</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other

      Commitments</font>

    </div><br/><div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

      <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In

      the normal course of business, we may enter into various firm

      purchase commitments related to production and testing of our

      vaccine material, conduct of clinical trials, and other

      research-related activities. As of December 31, 2012, we had

      approximately $510,000 of unrecorded outstanding purchase

      commitments to our vendors and subcontractors, all of which

      we expect will be due in 2013.</font>

    </div><br/><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 17<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.17)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-03.(a)(19))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 25<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EMMAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 4 - Commitments (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>sqft</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of Real Estate Property (in Square feet)</a></td>
        <td class="nump">8,400<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating Leases, Rent Expense</a></td>
        <td class="nump">$ 118,801<span></span></td>
        <td class="nump">$ 119,255<span></span></td>
        <td class="nump">$ 118,988<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_govx_OperatingLeaseTermOfLease', window );">Operating Lease, Term of Lease</a></td>
        <td class="text">62 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Operating Leases, Future Minimum Payments Due, Next Twelve Months</a></td>
        <td class="nump">125,180<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Operating Leases, Future Minimum Payments, Due in Two Years</a></td>
        <td class="nump">128,920<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Unrecorded Unconditional Purchase Obligation</a></td>
        <td class="nump">$ 510,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_govx_OperatingLeaseTermOfLease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Term of operating lease.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>govx_OperatingLeaseTermOfLease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>govx_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Area of a real estate property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AreaOfRealEstateProperty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:areaItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Rental expense incurred for leased assets including furniture and equipment which has not been recognized in costs and expenses applicable to sales and revenues; for example, cost of goods sold or other operating costs and expenses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LeaseAndRentalExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the next fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 16<br><br> -Subparagraph b(i)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 122<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 16<br><br> -Subparagraph b(i)<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 13<br><br> -Paragraph 122<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25336-109308<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 47<br><br> -Paragraph 7<br><br> -Subparagraph b<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.4.0.6</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>185</ContextCount>
  <ElementCount>226</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>31</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Disclosure - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Stockholders' Equity (Deficiency)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficiency)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - Note 1 - Nature of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note</Role>
      <ShortName>Note 1 - Nature of Business</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Note 2 - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0</Role>
      <ShortName>Note 2 - Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Note 3 - Government Grants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note00</Role>
      <ShortName>Note 3 - Government Grants</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Note 4 - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note000</Role>
      <ShortName>Note 4 - Commitments</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Note 5 - 2006 Merger and Recapitalization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0000</Role>
      <ShortName>Note 5 - 2006 Merger and Recapitalization</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Note 6 - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note00000</Role>
      <ShortName>Note 6 - Stockholders' Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Note 7 - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note000000</Role>
      <ShortName>Note 7 - Retirement Plan</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Note 8 - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0000000</Role>
      <ShortName>Note 8 - Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Note 9 - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note00000000</Role>
      <ShortName>Note 9 - Related Party Transactions</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note000000000</Role>
      <ShortName>Note 10 - Selected Quarterly Financial Data (unaudited)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Note 11 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Note0000000000</Role>
      <ShortName>Note 11 - Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Schedule II - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/Schedule</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteTables</Role>
      <ShortName>Note 2 - Summary of Significant Accounting Policies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Note 6 - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteTables0</Role>
      <ShortName>Note 6 - Stockholders' Equity (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Note 8 - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteTables00</Role>
      <ShortName>Note 8 - Income Taxes (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteTables000</Role>
      <ShortName>Note 10 - Selected Quarterly Financial Data (unaudited) (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>024 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail0</Role>
      <ShortName>Note 2 - Summary of Significant Accounting Policies (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>025 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Detail) - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/PropertyandEquipmentTable</Role>
      <ShortName>Note 2 - Summary of Significant Accounting Policies (Detail) - Property and Equipment</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>026 - Disclosure - Note 3 - Government Grants (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail00</Role>
      <ShortName>Note 3 - Government Grants (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>027 - Disclosure - Note 4 - Commitments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail000</Role>
      <ShortName>Note 4 - Commitments (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>029 - Disclosure - Note 6 - Stockholders' Equity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail00000</Role>
      <ShortName>Note 6 - Stockholders' Equity (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>030 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Allocation of Net Proceeds from Preferred Stock Financing</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/AllocationofNetProceedsfromPreferredStockFinancingTable</Role>
      <ShortName>Note 6 - Stockholders' Equity (Detail) - Allocation of Net Proceeds from Preferred Stock Financing</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>031 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Stock Option Activity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/StockOptionActivityTable</Role>
      <ShortName>Note 6 - Stockholders' Equity (Detail) - Stock Option Activity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>032 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Additional Information Concerning Stock Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/AdditionalInformationConcerningStockOptionsTable</Role>
      <ShortName>Note 6 - Stockholders' Equity (Detail) - Additional Information Concerning Stock Options</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>033 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Significant Assumptions Used in Fair Value Calculations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/SignificantAssumptionsUsedinFairValueCalculationsTable</Role>
      <ShortName>Note 6 - Stockholders' Equity (Detail) - Significant Assumptions Used in Fair Value Calculations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>034 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Stock-based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/StockbasedCompensationExpenseTable</Role>
      <ShortName>Note 6 - Stockholders' Equity (Detail) - Stock-based Compensation Expense</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>035 - Disclosure - Note 6 - Stockholders' Equity (Detail) - Stock Purchase Warrant Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/StockPurchaseWarrantTransactionsTable</Role>
      <ShortName>Note 6 - Stockholders' Equity (Detail) - Stock Purchase Warrant Transactions</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>036 - Disclosure - Note 7 - Retirement Plan (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail000000</Role>
      <ShortName>Note 7 - Retirement Plan (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>037 - Disclosure - Note 8 - Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail0000000</Role>
      <ShortName>Note 8 - Income Taxes (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>038 - Disclosure - Note 8 - Income Taxes (Detail) - Deferred Tax Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/DeferredTaxAssetsandLiabilitiesTable</Role>
      <ShortName>Note 8 - Income Taxes (Detail) - Deferred Tax Assets and Liabilities</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>039 - Disclosure - Note 8 - Income Taxes (Detail) - Reconciliation of the Income Tax Benefit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ReconciliationoftheIncomeTaxBenefitTable</Role>
      <ShortName>Note 8 - Income Taxes (Detail) - Reconciliation of the Income Tax Benefit</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>040 - Disclosure - Note 9 - Related Party Transactions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail00000000</Role>
      <ShortName>Note 9 - Related Party Transactions (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>042 - Disclosure - Note 10 - Selected Quarterly Financial Data (unaudited) (Detail) - Selected Quarterly Financial Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/SelectedQuarterlyFinancialDataTable</Role>
      <ShortName>Note 10 - Selected Quarterly Financial Data (unaudited) (Detail) - Selected Quarterly Financial Data</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>043 - Disclosure - Note 11 - Subsequent Events (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/NoteDetail0000000000</Role>
      <ShortName>Note 11 - Subsequent Events (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>045 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Detail) - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://geovax.com/role/ValuationandQualifyingAccountsTable</Role>
      <ShortName>Schedule II - Valuation and Qualifying Accounts (Detail) - Valuation and Qualifying Accounts</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element govx_GrantAward had a mix of decimals attribute values: -5 0.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock had a mix of decimals attribute values: -5 0.</Log>
    <Log type="Info">'Monetary' elements on report '037 - Disclosure - Note 8 - Income Taxes (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 001 - Statement - Consolidated Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2002'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2001'</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Parentheticals)</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - Consolidated Statements of Operations</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '6 Months Ended
Dec. 31, 2001'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2004'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2003'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2002'</Log>
    <Log type="Info">Process Flow-Through: 005 - Statement - Consolidated Statements of Cash Flows</Log>
  </Logs>
  <InputFiles>
    <File>govx-20121231.xml</File>
    <File>govx-20121231.xsd</File>
    <File>govx-20121231_cal.xml</File>
    <File>govx-20121231_def.xml</File>
    <File>govx-20121231_lab.xml</File>
    <File>govx-20121231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0E3GAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 8 - Income Taxes (Detail) - Reconciliation of the Income Tax Benefit (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory rate applied to pretax loss</a></td>
        <td class="num">$ (725,948)<span></span></td>
        <td class="num">$ (797,921)<span></span></td>
        <td class="num">$ (934,092)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Permanent differences</a></td>
        <td class="nump">2,674<span></span></td>
        <td class="nump">4,216<span></span></td>
        <td class="num">(77,200)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">32,675<span></span></td>
        <td class="nump">59,959<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
        <td class="nump">$ 723,274<span></span></td>
        <td class="nump">$ 761,030<span></span></td>
        <td class="nump">$ 951,333<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of the difference between total income tax expense or benefit as reported in the Income Statement and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to changes in the valuation allowance for deferred tax assets in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 26<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32123-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Statement of Financial Accounting Standard (FAS)<br><br> -Number 109<br><br> -Paragraph 47<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the differences between total income tax expense or benefit as reported in the Income Statement for the period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to nondeductible expenses under enacted tax laws, or differences in the methodologies used to determine expense amounts for financial statements prepared in accordance with generally accepted accounting principles and enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationNondeductibleExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of the difference between total income tax expense or benefit as reported in the Income Statement and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations attributable to research tax credits generated or utilized under enacted tax laws during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationTaxCreditsResearch</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.6</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Note 2 - Summary of Significant Accounting Policies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
        <td class="text"><table cellpadding="0" cellspacing="0" width="97%" style="TEXT-ALIGN: left; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

        <tr style="TEXT-ALIGN: left;">

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">

            <div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font>

            </div>

          </td>

          <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory

              equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">388,000</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold

              improvements</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115,605</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other

              furniture, fixtures &amp; equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,685</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total

              property and equipment</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">532,290</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

        <tr style="background-color: #C0FFFF;">

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated

              depreciation and amortization</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(429,804</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(356,084</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font>

          </td>

        </tr>

        <tr>

          <td valign="bottom" width="70%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">

              <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property

              and equipment, net</font>

            </div>

          </td>

          <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">102,486</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

          <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>

          </td>

          <td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,206</font>

          </td>

          <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px">

            <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>

          </td>

        </tr>

      </table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher AICPA<br><br> -Name Accounting Principles Board Opinion (APB)<br><br> -Number 12<br><br> -Paragraph 5<br><br> -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009.  This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
